Citrus Sinensis ID: 003935
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 785 | 2.2.26 [Sep-21-2011] | |||||||
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.328 | 0.314 | 0.477 | 1e-70 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.324 | 0.273 | 0.471 | 1e-70 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.361 | 0.310 | 0.383 | 8e-56 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.337 | 0.353 | 0.414 | 2e-55 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.319 | 0.390 | 0.409 | 2e-54 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.319 | 0.363 | 0.406 | 2e-52 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.321 | 0.155 | 0.391 | 7e-51 | |
| Q5UQG7 | 1651 | Putative serine/threonine | N/A | no | 0.319 | 0.152 | 0.390 | 1e-49 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.317 | 0.193 | 0.373 | 3e-49 | |
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.388 | 0.782 | 0.344 | 8e-48 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 268 bits (686), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 126/264 (47%), Positives = 181/264 (68%), Gaps = 6/264 (2%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILS 579
++ +I + +L + ++G G FG V R W+G+DVA+K+ +EQD AE + +F E++I+
Sbjct: 542 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMK 601
Query: 580 RLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 639
RLRHPN++LF+GA T+PP LS++TEY+ GSLY L+H SG +++L RR+L M D+ +G
Sbjct: 602 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 661
Query: 640 LMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 697
+ +H IVHRDLKS N LV+K +TVK+CDFGLSR+ + + S+AGTPEWMAPE
Sbjct: 662 MNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE 721
Query: 698 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLG 754
++R+EP EK D++S GVI+WEL TL +PW + P +VV AV + RLEIP +
Sbjct: 722 VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 781
Query: 755 RLIADCWA-EPQERPSCEEILSRL 777
+I CW EP +RPS I+ L
Sbjct: 782 AIIEGCWTNEPWKRPSFATIMDLL 805
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 268 bits (685), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 124/263 (47%), Positives = 180/263 (68%), Gaps = 8/263 (3%)
Query: 521 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR 580
E I +++L + R+G+G +GEV+ W+GT+VA+K FL+QD + + +F +E+ I+ R
Sbjct: 661 ECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEVRIMRR 720
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
LRHPNV+ FLGA T+PP LS++TE++ GSLY ++H K + RR++KM D+ G+
Sbjct: 721 LRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRP--KSHIDERRRIKMALDVAMGM 778
Query: 641 MCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 698
C+H IVHRDLK+ N LV+ +W VK+ DFGLSR+ ++ + S+AGTPEWMAPE+
Sbjct: 779 NCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 838
Query: 699 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 755
+RNEP EKCD++S GVI+WEL TL PW G+ P +VV AV + RLEIP + +GR
Sbjct: 839 LRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPVVGR 898
Query: 756 LIADCW-AEPQERPSCEEILSRL 777
+I +CW +P RPS ++ L
Sbjct: 899 IILECWQTDPNLRPSFAQLTEVL 921
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 219 bits (558), Expect = 8e-56, Method: Compositional matrix adjust.
Identities = 118/308 (38%), Positives = 183/308 (59%), Gaps = 24/308 (7%)
Query: 475 SPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELTVGTR 534
SP++Y + G+ S V+E P Q + + + I FSEL + ++
Sbjct: 624 SPNQYNNQGNILKNSG-------------SVVEPPSQQQQ---YFSDIEISFSELKISSK 667
Query: 535 VGIGFFGEVFRGIWNGTDVAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 593
+G G FG V++G+W G+ VAIK + + +D+ + +E+F E++ILSRLRHPN++L + AC
Sbjct: 668 LGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSRLRHPNIVLLMAAC 727
Query: 594 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL 653
T PP L ITEY+ GSLY +H +K K++ + K+ I +G+ +H ++HRD+
Sbjct: 728 TAPPNLCFITEYLPGGSLYDALH--SKKIKMNMQLYKKLAIQIAQGMNYLHLSGVIHRDI 785
Query: 654 KSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSL 713
KS N L+++H VKICDFGLS++ + S + S G+P WM+PEL+ E +TEK D+++
Sbjct: 786 KSLNLLLDEHMNVKICDFGLSKLKSKS-TEMTKSIGSPIWMSPELLMGEDYTEKVDVYAF 844
Query: 714 GVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPS 769
G+I+WEL T P+ G+ ++ AV + R IP L LI CW +P +RPS
Sbjct: 845 GIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQACWHQDPLKRPS 904
Query: 770 CEEILSRL 777
EIL+ L
Sbjct: 905 FTEILNLL 912
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 217 bits (553), Expect = 2e-55, Method: Compositional matrix adjust.
Identities = 117/282 (41%), Positives = 166/282 (58%), Gaps = 17/282 (6%)
Query: 508 SPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAEN 567
SP+ + +E ID SE+ V R+G G EVF G W G VAIK + L E+
Sbjct: 470 SPLLKTDYKTLFEIKPIDISEIVVQNRIGRGSCAEVFTGTWRGIIVAIK---KAKLLNED 526
Query: 568 MEDFCNEI----SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK 623
EDF NE+ +I+S+LRHPN+ FLG C PP + ++ EYM LGSLY ++H
Sbjct: 527 DEDFLNELAQEATIMSQLRHPNICQFLGTCNNPPEILIVMEYMPLGSLYRILH--DPSIS 584
Query: 624 LSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681
L W R M DI +G+ +H ++HRDLKS N LV++H+ VKI DFGLS
Sbjct: 585 LDWPRMKSMALDIAKGMNYLHCCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKHL 644
Query: 682 MRDS--SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV 739
+ + + GTP W APE++RN+P+TEK D+FS +++WE+ T P++G+ ++V +V
Sbjct: 645 DKKTAMTPVGTPCWTAPEVLRNDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISV 704
Query: 740 ANEGSRLEIP---EGPLGRLIADCWAE-PQERPSCEEILSRL 777
R +P P RLI +CW+E PQ+RPS +EI+ RL
Sbjct: 705 GQHKLRPIVPPQVSAPFTRLITECWSEDPQQRPSFQEIVKRL 746
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 214 bits (545), Expect = 2e-54, Method: Compositional matrix adjust.
Identities = 107/261 (40%), Positives = 165/261 (63%), Gaps = 10/261 (3%)
Query: 523 NIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR 582
+ID ++ +G R+G G +GEV+ G W G+ VA+K ++ +++F EI+++ LR
Sbjct: 368 DIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLR 427
Query: 583 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
HPNVI FLG+C PP + + TEYM GSLY ++H Q +L W +KM+ D +G++
Sbjct: 428 HPNVIQFLGSCLIPPDICICTEYMPRGSLYSILH--DQALQLQWSLLIKMMIDAAKGVIY 485
Query: 643 IHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 700
+H I+HRDLKS N LV+++W VK+ DFGLS I + ++ GTP W +PE++R
Sbjct: 486 LHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTI--EQQGATMTACGTPCWTSPEVLR 543
Query: 701 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE-GP--LGRLI 757
++ +TEK D++S G+I+WE T P+ G+ P +V++AV EG R +P+ GP +L+
Sbjct: 544 SQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKYIQLL 603
Query: 758 ADCWAE-PQERPSCEEILSRL 777
DC E P RP+ E+ L RL
Sbjct: 604 IDCLNENPSHRPTMEQCLERL 624
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 208 bits (529), Expect = 2e-52, Method: Compositional matrix adjust.
Identities = 106/261 (40%), Positives = 164/261 (62%), Gaps = 10/261 (3%)
Query: 523 NIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR 582
+ID ++ +G R+G G FGEV+ G W G+ VA+K ++ +++F EI+++ LR
Sbjct: 385 DIDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLR 444
Query: 583 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
HPNVI FLG+C P + + TEYM GSLY ++H +K K+SW +M+ D +G++
Sbjct: 445 HPNVIQFLGSCLISPDICICTEYMPRGSLYSILH--NEKIKISWSLVKRMMIDAAKGIIY 502
Query: 643 IHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 700
+H I+HRDLKS N LV+++W VK+ DFGLS I + ++ GTP W +PE++R
Sbjct: 503 LHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTI--EQQGATMTACGTPCWTSPEVLR 560
Query: 701 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE-GP--LGRLI 757
++ +TEK D++S G+I+WE T P+ G+ P +V++AV EG R P+ GP +L+
Sbjct: 561 SQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYIQLL 620
Query: 758 ADCWAE-PQERPSCEEILSRL 777
DC E P +RP+ E+ L L
Sbjct: 621 KDCLNENPSQRPTMEQCLEIL 641
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 202 bits (515), Expect = 7e-51, Method: Compositional matrix adjust.
Identities = 103/263 (39%), Positives = 159/263 (60%), Gaps = 11/263 (4%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 581
W I++ E+++G ++G+G +G VF G W G DVA+K F++Q L+ + +F E++ LS L
Sbjct: 1357 WIINYDEISIGKQIGLGSYGIVFNGKWKGVDVAVKKFVKQKLSETQLLEFRAEMAFLSEL 1416
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
+H N++ F+GAC K P + ++TEYM +G+L + L K+++ KLK+L G+
Sbjct: 1417 KHSNIVTFIGACIKKPNICIVTEYMRMGNLRDV--LKNPDIKITFANKLKLLYGAAMGID 1474
Query: 642 CIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 699
+H IVHRD+K AN LV++H+ VKI DFG +RI D+ + GTP W APE+I
Sbjct: 1475 YLHSSNPMIVHRDIKPANILVDEHFNVKIADFGFARIKEDNTTM--TRCGTPCWTAPEVI 1532
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRL 756
R E + EK D+FS GV+MWE+ T P+ +V + EG R IP +L
Sbjct: 1533 RGEKYCEKADVFSFGVVMWEVLTGKEPFAECNFMKVSLDIL-EGGRPIIPSDCPHEFAKL 1591
Query: 757 IADCW-AEPQERPSCEEILSRLL 778
I CW A+ +RP+ E++ +L+
Sbjct: 1592 IKKCWHAKAHKRPTMTEVVQQLM 1614
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5UQG7|YR818_MIMIV Putative serine/threonine-protein kinase/receptor R818 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R818 PE=4 SV=1 | Back alignment and function description |
|---|
Score = 198 bits (504), Expect = 1e-49, Method: Compositional matrix adjust.
Identities = 103/264 (39%), Positives = 164/264 (62%), Gaps = 13/264 (4%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 581
W I++ ++ +G ++G+G +G V G W +VA+K F++Q + + M +F EI+ LS+L
Sbjct: 1387 WIINYDDIQIGKQIGVGSYGIVNMGKWKNINVAVKKFVKQKIDEKQMLEFRAEIAFLSQL 1446
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
RHP++IL +GAC K P + ++TE+M GSL ++I + K W+ K+KML G+
Sbjct: 1447 RHPHIILMIGACLKRPNICIVTEFMGNGSLRNVI----KTTKPEWKLKIKMLYQTALGIG 1502
Query: 642 CIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 699
+H I+HRD+K +N LV+ VKI DFG +RI ++ + + GTP W APE+I
Sbjct: 1503 YLHNSDPIIIHRDIKPSNILVDDSMNVKIADFGFARIKEENSVM--TRCGTPCWTAPEII 1560
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLG--RL 756
R E +TEK D+FS G++MWE+ T P+ G +V + EG+R +IP + P+ +L
Sbjct: 1561 RGEKYTEKVDVFSFGIVMWEVLTCKEPFSGCNFMKVSMDIL-EGARPQIPSDCPIDFTKL 1619
Query: 757 IADCW-AEPQERPSCEEILSRLLD 779
+ CW A+P +RPS E+++ L D
Sbjct: 1620 MKQCWHAKPDKRPSMEDVIMGLND 1643
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (501), Expect = 3e-49, Method: Compositional matrix adjust.
Identities = 97/260 (37%), Positives = 157/260 (60%), Gaps = 11/260 (4%)
Query: 521 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR 580
EW + SE+ +G R+G G +G+VFRG W GT+VA+K+ ++ + + D E+ +L +
Sbjct: 843 EWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLKLISDLRKEVDLLCK 902
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
LRHPN++LF+GACT+P ++TEY+ GSL ++ L + ++ W +L++ D RG+
Sbjct: 903 LRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANI--LLDESIEMDWGLRLQLGFDCARGM 960
Query: 641 MCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 698
+H I+HRDLK+ N LV+ W VK+ DFGL+ + + + + + GT W+APE+
Sbjct: 961 TYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTFAK--TMCGTTGWVAPEV 1018
Query: 699 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGR 755
+ E +TEK D++S +++WEL T P+ G +VV ++ + G RL +P
Sbjct: 1019 LAEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSI-DRGERLPMPAWCPPKYAA 1077
Query: 756 LIADCW-AEPQERPSCEEIL 774
L+ CW +P RPS EIL
Sbjct: 1078 LMNRCWETDPTHRPSFPEIL 1097
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 192 bits (488), Expect = 8e-48, Method: Compositional matrix adjust.
Identities = 110/319 (34%), Positives = 174/319 (54%), Gaps = 14/319 (4%)
Query: 471 SLPSSPHEYGSHGSERGGSSGYMANSEF--VSTWNKVLESPMFQNKPLLA--YEEWNIDF 526
SLP+ P S + R + M F + +W+ +LES + EEW D
Sbjct: 24 SLPNLPCNPSSSKTNRYAEAETMEKKRFDSMESWSMILESENVETWEASKGEREEWTADL 83
Query: 527 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFL----EQDLTAENMEDFCNEISILSRLR 582
S+L +G + G ++RGI+ VA+K+ +++ A+ + F +E+++LSRL
Sbjct: 84 SQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEVALLSRLF 143
Query: 583 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
HPN++ F+ AC KPP +ITEYM G+L ++ + LS L++ DI RG+
Sbjct: 144 HPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLN-KKEPYSLSIETVLRLALDISRGMEY 202
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE 702
+H ++HRDLKS N L+N VK+ DFG S + T + GT WMAPE+I+ +
Sbjct: 203 LHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQC-REAKGNMGTYRWMAPEMIKEK 261
Query: 703 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIAD 759
P+T K D++S G+++WEL T P++G+ P + +AVA + R +P + L LI
Sbjct: 262 PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQPALAHLIKR 321
Query: 760 CWAE-PQERPSCEEILSRL 777
CW+E P +RP I++ L
Sbjct: 322 CWSENPSKRPDFSNIVAVL 340
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 785 | ||||||
| 255575293 | 810 | protein kinase, putative [Ricinus commun | 0.987 | 0.956 | 0.813 | 0.0 | |
| 224131388 | 822 | predicted protein [Populus trichocarpa] | 0.998 | 0.953 | 0.798 | 0.0 | |
| 225446619 | 817 | PREDICTED: uncharacterized protein LOC10 | 0.992 | 0.953 | 0.786 | 0.0 | |
| 356543914 | 813 | PREDICTED: uncharacterized protein LOC10 | 0.988 | 0.954 | 0.774 | 0.0 | |
| 356549852 | 813 | PREDICTED: uncharacterized protein LOC10 | 0.988 | 0.954 | 0.772 | 0.0 | |
| 356543086 | 816 | PREDICTED: uncharacterized protein LOC10 | 0.994 | 0.957 | 0.769 | 0.0 | |
| 356517339 | 812 | PREDICTED: uncharacterized protein LOC10 | 0.984 | 0.951 | 0.75 | 0.0 | |
| 356543916 | 791 | PREDICTED: uncharacterized protein LOC10 | 0.963 | 0.955 | 0.756 | 0.0 | |
| 357474617 | 803 | Tyrosine-protein kinase ABL2 [Medicago t | 0.971 | 0.950 | 0.750 | 0.0 | |
| 356517341 | 768 | PREDICTED: uncharacterized protein LOC10 | 0.935 | 0.955 | 0.742 | 0.0 |
| >gi|255575293|ref|XP_002528550.1| protein kinase, putative [Ricinus communis] gi|223532052|gb|EEF33862.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1342 bits (3472), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 667/820 (81%), Positives = 717/820 (87%), Gaps = 45/820 (5%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETRDD G AEQG NA WW+ DFIE F SVSL SQE++LSNKESPRN+E+D LSSQTA
Sbjct: 1 MEETRDDVGPAEQGPSNALWWSSDFIEKFESVSLLSQEDSLSNKESPRNYEEDNLSSQTA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQILWSTGMLSE IPNGFYSV+P+KRLKELFDSIPT D+LHALG EG +ADII VD+KKD
Sbjct: 61 SQILWSTGMLSERIPNGFYSVVPEKRLKELFDSIPTFDDLHALGAEGFKADIIFVDAKKD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETS--HMFET 178
KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLV+D YKRP+VESPAKAALEETS HMFE
Sbjct: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVSDVYKRPNVESPAKAALEETSHVHMFEN 180
Query: 179 RGVQLLGQIRHGSCRPRAILFKVLADTVGLESRLM-GLPNDGTMECVDSYKHMSVIVVLN 237
RG+QLLGQI+HGSCRPRAILFKVLADTVGLESRLM GLPNDGT+EC DS+KHMSVIVVLN
Sbjct: 181 RGIQLLGQIKHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTVECADSFKHMSVIVVLN 240
Query: 238 SVELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVD 297
SVELLVDLMRFPGQLIPR+T+AIFM+HISAAGESDSAENDSCDSPLEPNSPLYG SERVD
Sbjct: 241 SVELLVDLMRFPGQLIPRTTRAIFMTHISAAGESDSAENDSCDSPLEPNSPLYGFSERVD 300
Query: 298 PDSSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLSFSHSEPNIATTFWRRSR 357
PDS+EKDES Q RKLE N+SGP+LRNMMLR A S+DRKLS SHSEPNIATTFWRRSR
Sbjct: 301 PDSAEKDESLQFHRKLE--GNVSGPALRNMMLRSATSIDRKLSLSHSEPNIATTFWRRSR 358
Query: 358 RKVIAEQRTASS--------------------------------RSEGASTSEARRIRRR 385
+KVIAEQRTASS RS GAS SE RRIRRR
Sbjct: 359 KKVIAEQRTASSSPEHPSFRARGRSMLSGDRHSIRDYADDEAAPRSVGASASETRRIRRR 418
Query: 386 SISITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGT 445
SIS+TPEIGDDIVRAVRAMNE+LKQNRLL+ER + DN +D +N SN L
Sbjct: 419 SISMTPEIGDDIVRAVRAMNESLKQNRLLRERDD--------KDNGTDFQRNVSNLDLDG 470
Query: 446 HDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKV 505
HD+ISGGRSALY L RD +NSQKAISLPSSPH+Y SH S+R G SG+ N E VSTWNKV
Sbjct: 471 HDDISGGRSALYTLQRDHINSQKAISLPSSPHQYRSHISDRRGPSGHAVNDELVSTWNKV 530
Query: 506 LESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA 565
LESPMF NKPLL ++EWNIDF+ELTVGTRVGIGFFGEVFRG+WNGTDVAIKVFLEQDLTA
Sbjct: 531 LESPMFNNKPLLPFQEWNIDFTELTVGTRVGIGFFGEVFRGVWNGTDVAIKVFLEQDLTA 590
Query: 566 ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLS 625
ENMEDFCNEISILSRLRHPNVILFLGAC KPP LSM+TEYME+GSLY+LIHLSGQKK+LS
Sbjct: 591 ENMEDFCNEISILSRLRHPNVILFLGACMKPPHLSMVTEYMEMGSLYYLIHLSGQKKRLS 650
Query: 626 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685
WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI+T++P+RDS
Sbjct: 651 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIMTETPIRDS 710
Query: 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 745
SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV PERVVYAVANE SR
Sbjct: 711 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVPPERVVYAVANERSR 770
Query: 746 LEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 785
L+IPEGPLGRLI+DCW EP ERPSCEEIL+RLLDCEYSLC
Sbjct: 771 LDIPEGPLGRLISDCWGEPHERPSCEEILARLLDCEYSLC 810
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224131388|ref|XP_002321072.1| predicted protein [Populus trichocarpa] gi|222861845|gb|EEE99387.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1318 bits (3410), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 657/823 (79%), Positives = 716/823 (86%), Gaps = 39/823 (4%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETRDD+G AEQG N+ WW DFIE F SVSL SQE+TL NKES +N+E+DGLSSQTA
Sbjct: 1 MEETRDDSGPAEQGPSNSVWWGSDFIEKFESVSLLSQEDTLRNKESHKNYEEDGLSSQTA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQ+LWSTGMLSE IPNGFYSVIPDKRLKELF +IPT+DELH+LG EG +ADIILVD+KKD
Sbjct: 61 SQVLWSTGMLSEQIPNGFYSVIPDKRLKELFVNIPTLDELHSLGAEGCKADIILVDAKKD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRG 180
KKLSMLKQLIV LVKGLNSNPAAMIKKIAGLVADFYKRP+VESPAKAALEE SHM E RG
Sbjct: 121 KKLSMLKQLIVPLVKGLNSNPAAMIKKIAGLVADFYKRPNVESPAKAALEEASHMLENRG 180
Query: 181 VQLLGQIRHGSCRPRAILFKVLADTVGLESRLM-GLPNDGTMECVDSYKHMSVIVVLNSV 239
VQLLGQIRHGSCRPRAI FKVLAD+VGLESRL+ GLPNDG +ECVDSYKHMSVIV+LNSV
Sbjct: 181 VQLLGQIRHGSCRPRAIFFKVLADSVGLESRLVVGLPNDGIVECVDSYKHMSVIVMLNSV 240
Query: 240 ELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPD 299
ELLVDLMR PGQL+PRST+AIFM+HISAAGESDSAENDSCDSPLEPNSP+YG +ERVDPD
Sbjct: 241 ELLVDLMRSPGQLMPRSTRAIFMTHISAAGESDSAENDSCDSPLEPNSPMYGFAERVDPD 300
Query: 300 SSEKDE-SFQVQRKLETPANISGPSLRNMMLRPAASLDRKLSFSHSEPNIATTFWRRSRR 358
S+EKDE S QV RKLE +N+ GPSLRNMMLR A S+DRKLS SHSEPNIATTFWRRSR+
Sbjct: 301 SAEKDEGSLQVHRKLEASSNVLGPSLRNMMLRSATSIDRKLSLSHSEPNIATTFWRRSRK 360
Query: 359 KVIAEQRTASS----------------------------------RSEGASTSEARRIRR 384
KVIAEQRTASS RSEGAS SEARR+RR
Sbjct: 361 KVIAEQRTASSSPEHPSFRGRGRSMLSGDRHSIRHYADDVAISSHRSEGASMSEARRMRR 420
Query: 385 RSISITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRS--SNDNTSDLPKNASNFH 442
RSIS+TPEIGDDIVRAVRAMNETLKQNRLL E+G+DR FT + DN +DL KN SNF
Sbjct: 421 RSISMTPEIGDDIVRAVRAMNETLKQNRLLMEQGDDRLFTNNLGDKDNGTDLQKNVSNFS 480
Query: 443 LGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTW 502
L DEISGGRSALY L R+++NSQKAISLPSSPHEY S SER G SG++A+ + VSTW
Sbjct: 481 LDGRDEISGGRSALYTLERNRINSQKAISLPSSPHEYRSQTSERSGPSGFVADDQLVSTW 540
Query: 503 NKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQD 562
NKVLESP+F N P L ++EW+IDFSELTVGTRVGIGFFGEVFRGIWNGT+VA+KVFLEQD
Sbjct: 541 NKVLESPLFHNNPPLPFQEWHIDFSELTVGTRVGIGFFGEVFRGIWNGTEVAVKVFLEQD 600
Query: 563 LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKK 622
LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM+TEYME+GSLY+LIH SGQ K
Sbjct: 601 LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMVTEYMEMGSLYYLIHSSGQ-K 659
Query: 623 KLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682
KLSWRR+LKMLRDICRGLMCIHRMKIVHRDLKSANCLVN H T+KICDFGLSR++TD P+
Sbjct: 660 KLSWRRRLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNNHKTIKICDFGLSRVMTDIPI 719
Query: 683 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE 742
RDSSSAGTPEWMAPELIRNEP TEKCDIFSLGVIMWELCTL+RPWEGV P+RVV AVANE
Sbjct: 720 RDSSSAGTPEWMAPELIRNEPVTEKCDIFSLGVIMWELCTLSRPWEGVPPKRVVDAVANE 779
Query: 743 GSRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 785
GSRLEIPEGPLGRLI+DCWAEP RPSC EIL+RLLDCEY+ C
Sbjct: 780 GSRLEIPEGPLGRLISDCWAEPDLRPSCGEILTRLLDCEYTSC 822
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225446619|ref|XP_002280724.1| PREDICTED: uncharacterized protein LOC100255804 [Vitis vinifera] gi|302143427|emb|CBI21988.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1295 bits (3351), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 647/823 (78%), Positives = 707/823 (85%), Gaps = 44/823 (5%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETRDDAG AEQG P TWW DFIE FGSVSL SQEE LSNK S N EQD LSSQTA
Sbjct: 1 MEETRDDAGPAEQGSPVTTWWPSDFIERFGSVSLVSQEEILSNKNSNSNTEQDELSSQTA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQILWSTGMLSEPIPNGFYSVIPDK+LKE+FD IPT+DEL+ALG EG RADIILVD+ +D
Sbjct: 61 SQILWSTGMLSEPIPNGFYSVIPDKKLKEIFDDIPTLDELYALGSEGVRADIILVDAVRD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVE-SPAKAALEETSHMFETR 179
KKLSMLKQLIVALVKGLNSNPAA+IKKIAGLV+DFYKRP++E SPAKAALEETSH+ E R
Sbjct: 121 KKLSMLKQLIVALVKGLNSNPAAVIKKIAGLVSDFYKRPNLELSPAKAALEETSHVSENR 180
Query: 180 GVQLLGQIRHGSCRPRAILFKVLADTVGLESRLM-GLPNDGTMECVDSYKHMSVIVVLNS 238
QLLGQI+HGSCRPRAILFKVLADTVGLESRLM GLPNDG + CVDSYKHMSVIV+LNS
Sbjct: 181 VAQLLGQIKHGSCRPRAILFKVLADTVGLESRLMVGLPNDGAIGCVDSYKHMSVIVMLNS 240
Query: 239 VELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDP 298
ELLVDLMRFPGQLIPRST+AIFM+HISAAGESDSAENDSCDSPLEPNSPLYG S+RVDP
Sbjct: 241 GELLVDLMRFPGQLIPRSTRAIFMTHISAAGESDSAENDSCDSPLEPNSPLYGFSDRVDP 300
Query: 299 DSSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLSFSHSEPNIATTFWRRSRR 358
DS+EKDE Q QR+LE +N+SGPSLRN+MLR S+DRKLS SHSEPNIATTFWRRSRR
Sbjct: 301 DSTEKDEGLQFQRRLEASSNVSGPSLRNVMLRSTPSIDRKLSLSHSEPNIATTFWRRSRR 360
Query: 359 KVIAEQRTASS----------------------------------RSEGASTSEARRIRR 384
KVIAEQRTASS RS+GASTS + R
Sbjct: 361 KVIAEQRTASSSPEHPSFRARGRSMLSGDRKSFRDYADDIAASSYRSDGASTSTSETRRI 420
Query: 385 RSISIT--PEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFH 442
R SI+ PEIGDDIVRAVRAMNETLK NRL++++G+DR F SSN D+ KN S+FH
Sbjct: 421 RRRSISITPEIGDDIVRAVRAMNETLKANRLMRDQGDDRAF--SSN---PDIQKNVSDFH 475
Query: 443 LGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTW 502
L H EIS G S++Y L R+Q++SQKAISLPSSPHE+ S S R G+S + N E VS W
Sbjct: 476 LDGHGEISHGSSSMYTLPREQISSQKAISLPSSPHEFRSQTSGRSGTSD-IVNDEMVSIW 534
Query: 503 NKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQD 562
N+VLE PMF +KPLL ++EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQD
Sbjct: 535 NRVLEKPMFHSKPLLPFQEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQD 594
Query: 563 LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKK 622
LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME+GSLY+LIHLSGQKK
Sbjct: 595 LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMEIGSLYYLIHLSGQKK 654
Query: 623 KLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682
KLSWRR++KMLRDICRGLMCIHRMKIVHRD+KSANCLVNKHWTVKICDFGLSR++TD+P+
Sbjct: 655 KLSWRRRIKMLRDICRGLMCIHRMKIVHRDIKSANCLVNKHWTVKICDFGLSRVMTDTPL 714
Query: 683 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE 742
RDSSSAGTPEWMAPELIRNEPFTEKCDIFS G+IMWELCTLNRPWEGV PERVVYAVA+E
Sbjct: 715 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSFGMIMWELCTLNRPWEGVPPERVVYAVAHE 774
Query: 743 GSRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 785
GSRL+IPEGPLG LIADCWAEP +RPSCE+ILSRL DCEY+LC
Sbjct: 775 GSRLDIPEGPLGMLIADCWAEPHQRPSCEDILSRLQDCEYTLC 817
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356543914|ref|XP_003540403.1| PREDICTED: uncharacterized protein LOC100803469 isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1271 bits (3290), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 637/822 (77%), Positives = 701/822 (85%), Gaps = 46/822 (5%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETR+DAG AEQG N +WW DF+E FGSVSLGSQ+E LSNKESPR+F++D LSSQ A
Sbjct: 1 MEETREDAGPAEQGPSNVSWWPSDFVEKFGSVSLGSQDEILSNKESPRHFDKDVLSSQKA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQ LW G+LSEPIPNGFYSVIP+ RLKELFDSIPT+DELHALGGEG +ADIILVDS+KD
Sbjct: 61 SQTLWRIGVLSEPIPNGFYSVIPETRLKELFDSIPTLDELHALGGEGFKADIILVDSEKD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRG 180
KKLSMLK+LI+ALV+GLNSNPAA+IKKIAGLV+DFYK P+VESPAKAAL+E+SHMFE RG
Sbjct: 121 KKLSMLKKLIMALVRGLNSNPAAIIKKIAGLVSDFYKCPNVESPAKAALDESSHMFENRG 180
Query: 181 VQLLGQIRHGSCRPRAILFKVLADTVGLESRLM-GLPNDGTMECVDSYKHMSVIVVLNSV 239
VQ+LGQI+HGSCRPRAILFKVLADTVGLESRLM GLPNDG +EC DSYKHMSVIVVLNSV
Sbjct: 181 VQMLGQIKHGSCRPRAILFKVLADTVGLESRLMVGLPNDGAIECQDSYKHMSVIVVLNSV 240
Query: 240 ELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPD 299
E+LVDLMRFPGQL+PRSTKA+FM+HIS AGESDSAENDSCDSPLEPNSPL+GVSER+DP+
Sbjct: 241 EMLVDLMRFPGQLLPRSTKAVFMTHIS-AGESDSAENDSCDSPLEPNSPLFGVSERLDPN 299
Query: 300 SSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLSFSHSEPNIATTFWRRSRRK 359
S+EK+E+ Q R+ E +N+SG SLRN+M + LS SHSEPNIAT F RRSRRK
Sbjct: 300 SAEKEENLQFHRRFEASSNVSGLSLRNVM----LRSNSSLSLSHSEPNIATAFGRRSRRK 355
Query: 360 VIAEQRTASS-------RSEGASTSEARRIRRRSIS------------------------ 388
VIAEQRTASS R+ G S R R +
Sbjct: 356 VIAEQRTASSSPEHPSFRARGRSMLSGDRTTFRDFADDQATSSYRSDNTSSSEARRIRRR 415
Query: 389 ---ITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTSD--LPKNASNFHL 443
ITPEIGDDIVRAVRAMNETLKQNRLL+ERG+D F S N+++SD L KN SNFHL
Sbjct: 416 SISITPEIGDDIVRAVRAMNETLKQNRLLRERGDDNSFPNSPNNSSSDANLQKNVSNFHL 475
Query: 444 GTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWN 503
HDE RSALY+ RDQ SQKA+SLPSSPH+YG S+R GSS Y N E STWN
Sbjct: 476 DGHDE----RSALYSFQRDQGASQKAMSLPSSPHDYGGQASKRSGSSRYGVNDEMESTWN 531
Query: 504 KVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDL 563
KVLESPMF NKPLL YE+WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDL
Sbjct: 532 KVLESPMFNNKPLLPYEKWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDL 591
Query: 564 TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK 623
TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM+TEYMELGSLY+LIHL+GQKKK
Sbjct: 592 TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMVTEYMELGSLYYLIHLNGQKKK 651
Query: 624 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683
L+WRR+L+MLRDIC+GLMCIHRMK+VHRDLKSANCLVNKHWTVKICDFGLSRI+T+SPMR
Sbjct: 652 LNWRRRLRMLRDICKGLMCIHRMKVVHRDLKSANCLVNKHWTVKICDFGLSRIMTESPMR 711
Query: 684 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG 743
DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV PERVVY+VANEG
Sbjct: 712 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVPPERVVYSVANEG 771
Query: 744 SRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 785
SRLEIPEGPLGRLI++CWAE ERPSCEEILSRL+D EYSLC
Sbjct: 772 SRLEIPEGPLGRLISECWAECHERPSCEEILSRLVDIEYSLC 813
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549852|ref|XP_003543304.1| PREDICTED: uncharacterized protein LOC100810612 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1265 bits (3274), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 635/822 (77%), Positives = 699/822 (85%), Gaps = 46/822 (5%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETR+DAG AEQG N WW DF+E FGSVSLGSQ+ETLSNKESPR+ +D LSS A
Sbjct: 1 MEETREDAGPAEQGPSNVLWWPSDFVEKFGSVSLGSQDETLSNKESPRHVVEDVLSSLKA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQ LW TGMLSEPIPNGFYSVIP+ RLKELF SIPT+DELHALGGEG +ADIILVDS+KD
Sbjct: 61 SQTLWQTGMLSEPIPNGFYSVIPETRLKELFYSIPTLDELHALGGEGFKADIILVDSEKD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRG 180
KKLSMLKQLI+ALV+GLN+NPAA+IKKIAGLV+DFYKRP+VESPAKAAL+ETSHMFE RG
Sbjct: 121 KKLSMLKQLIMALVRGLNANPAAIIKKIAGLVSDFYKRPNVESPAKAALDETSHMFENRG 180
Query: 181 VQLLGQIRHGSCRPRAILFKVLADTVGLESRLM-GLPNDGTMECVDSYKHMSVIVVLNSV 239
VQ+LGQI+HGSCRPRAILFKVLADTVGLESRLM GLPNDG +EC DSYKHMSVIVVLNS+
Sbjct: 181 VQMLGQIKHGSCRPRAILFKVLADTVGLESRLMVGLPNDGAIECQDSYKHMSVIVVLNSL 240
Query: 240 ELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPD 299
E+LVDLMRFPGQL+PRSTK++FM+HIS AGESDSAENDSCDSPLEPNSPL+GVSER+D +
Sbjct: 241 EMLVDLMRFPGQLLPRSTKSVFMTHIS-AGESDSAENDSCDSPLEPNSPLFGVSERLDSN 299
Query: 300 SSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLSFSHSEPNIATTFWRRSRRK 359
S+EK+E+ Q R+ E +N+SG SLRN+MLR ++ LS SHSEPNIAT F RRSRRK
Sbjct: 300 SAEKEENLQFHRRFEASSNVSGLSLRNVMLRSNSN----LSLSHSEPNIATAFGRRSRRK 355
Query: 360 VIAEQRTASS-------RSEGASTSEARRIRRRSIS------------------------ 388
VIAEQRTASS R+ G S R R +
Sbjct: 356 VIAEQRTASSSPEHPSFRARGRSMLSGDRTTFRDFTDDQATSSYRSDGTSSSEARRIRRR 415
Query: 389 ---ITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTSD--LPKNASNFHL 443
ITPEIGDDIVRAVRAMNETLKQNRLL+ERG+D F S N+++SD L KN SNFHL
Sbjct: 416 SISITPEIGDDIVRAVRAMNETLKQNRLLRERGDDNSFPNSPNNSSSDANLQKNVSNFHL 475
Query: 444 GTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWN 503
HDE RSALY+ RDQ SQKA+SLPSSPH+Y SER G S Y N E STWN
Sbjct: 476 DGHDE----RSALYSFQRDQGTSQKAMSLPSSPHDYRGQASERSGPSRYGVNDEMESTWN 531
Query: 504 KVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDL 563
KVLESPMF NKPLL YE+WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDL
Sbjct: 532 KVLESPMFNNKPLLPYEKWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDL 591
Query: 564 TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK 623
TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM+TEYMELGSLY+L+HLSGQKKK
Sbjct: 592 TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMVTEYMELGSLYYLMHLSGQKKK 651
Query: 624 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683
L+WRR+L+MLRDIC+GLMCIHRMK+VHRDLKSANCLVNKHWTVKICDFGLSRI+T+SPMR
Sbjct: 652 LNWRRRLRMLRDICKGLMCIHRMKVVHRDLKSANCLVNKHWTVKICDFGLSRIMTESPMR 711
Query: 684 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG 743
DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV PERVVY+VA+EG
Sbjct: 712 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVPPERVVYSVAHEG 771
Query: 744 SRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 785
SRLEIPEGPLGRLI++CWAE +RPSCEEILSRL+D EYSLC
Sbjct: 772 SRLEIPEGPLGRLISECWAECHQRPSCEEILSRLVDIEYSLC 813
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356543086|ref|XP_003539994.1| PREDICTED: uncharacterized protein LOC100807193 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1250 bits (3234), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 631/820 (76%), Positives = 695/820 (84%), Gaps = 39/820 (4%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETR+DAG AE+ N +WW DF+E F SVSL SQ+ETL+NKESPR+ +D +S Q A
Sbjct: 1 MEETREDAGPAERRPSNMSWWPSDFVEKFESVSLSSQDETLNNKESPRHSNRDVMSPQKA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQILW TGMLSEPIPNGFYSVI +KRLK+LFDSIPT++EL ALGGEG RAD+I+VD++KD
Sbjct: 61 SQILWRTGMLSEPIPNGFYSVILEKRLKKLFDSIPTLEELQALGGEGFRADVIVVDAEKD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRG 180
++LSMLKQLIVALV+GLNSNP AMIKKIAGLV+DFYKR +VESPAKAALEE+SHMFE RG
Sbjct: 121 RRLSMLKQLIVALVRGLNSNPPAMIKKIAGLVSDFYKRSNVESPAKAALEESSHMFENRG 180
Query: 181 VQLLGQIRHGSCRPRAILFKVLADTVGLESRLM-GLPNDGTMECVDSYKHMSVIVVLNSV 239
VQ+LGQIRHGSCRPRAILFKVLADTVGLESRLM G PNDG ECVDSYKHMSVIVVLNSV
Sbjct: 181 VQMLGQIRHGSCRPRAILFKVLADTVGLESRLMMGFPNDGAAECVDSYKHMSVIVVLNSV 240
Query: 240 ELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPD 299
ELLVDLMRFPGQL+PRSTK+I M+HISAAGESDSAENDSCDSPLEPNSPLYGVSER+DP
Sbjct: 241 ELLVDLMRFPGQLLPRSTKSILMTHISAAGESDSAENDSCDSPLEPNSPLYGVSERLDPK 300
Query: 300 SSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLSFSHSEPNIATTFWRRSRRK 359
EK+E+ Q R+ E +N+SG LRNMMLR SLDR SFSHSEPNIAT F RRSRRK
Sbjct: 301 CVEKEENLQFHRRFEVSSNVSGLPLRNMMLRSNTSLDRNWSFSHSEPNIATAFGRRSRRK 360
Query: 360 VIAEQRTASS--------------------------------RSEGASTSEARRIRRRSI 387
VIAEQRTASS +S+GAS+SEARRIRRRSI
Sbjct: 361 VIAEQRTASSSPEHPSLRAHGRSKLSGDRTSFRDFADDQSSYKSDGASSSEARRIRRRSI 420
Query: 388 SITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTS--DLPKNASNFHLGT 445
SITPEIGDDI RAVRAMN+TLKQ RL +E+G D + S D TS DL KN SNFHL
Sbjct: 421 SITPEIGDDIARAVRAMNKTLKQKRLPREQGGDSSLSHSPIDRTSSLDLQKNVSNFHLDG 480
Query: 446 HDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKV 505
H E RS LY L RD + SQKA+SLPSSPH+Y SER +S Y N E STWNK+
Sbjct: 481 HHE----RSPLYLLHRDPVTSQKAMSLPSSPHDYRVQASERSEASEYTTNDELESTWNKI 536
Query: 506 LESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA 565
LESPMF N+PLL YEEWNIDF+EL VGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA
Sbjct: 537 LESPMFSNRPLLPYEEWNIDFTELNVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA 596
Query: 566 ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLS 625
ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM+TEYME+GSL++LIH+SGQKKKLS
Sbjct: 597 ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMVTEYMEMGSLFYLIHVSGQKKKLS 656
Query: 626 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685
WRR+LKMLRDICRGLM IHRMKI+HRD+KSANCLV+KHW VKICDFGLSRIIT+SPMRDS
Sbjct: 657 WRRRLKMLRDICRGLMHIHRMKIIHRDVKSANCLVDKHWIVKICDFGLSRIITESPMRDS 716
Query: 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 745
SSAGTPEWMAPELIRNEPF+EKCDIFSLGVIMWELCTLNRPWEGV PERVVY VANEG+R
Sbjct: 717 SSAGTPEWMAPELIRNEPFSEKCDIFSLGVIMWELCTLNRPWEGVPPERVVYTVANEGAR 776
Query: 746 LEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 785
L+IPEGPLGRLI++CWAEP ERPSCEEILSRL+D EYS+C
Sbjct: 777 LDIPEGPLGRLISECWAEPHERPSCEEILSRLVDIEYSMC 816
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356517339|ref|XP_003527345.1| PREDICTED: uncharacterized protein LOC100806527 isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1249 bits (3231), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 618/824 (75%), Positives = 689/824 (83%), Gaps = 51/824 (6%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETR+DAG E+ N +WW DF++ F SVSL +Q+ETL+NKESPR+ QD +S Q A
Sbjct: 1 MEETREDAGQPERRPSNMSWWPSDFVDKFESVSLSAQDETLNNKESPRHSNQDVMSPQKA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQILW TGMLSEPIPNGFYSVIP+KRLK+LFDSIPT+DEL A+GGEG RAD+I+VD++KD
Sbjct: 61 SQILWRTGMLSEPIPNGFYSVIPEKRLKKLFDSIPTLDELQAMGGEGFRADVIVVDAEKD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRG 180
++LSMLKQLIVALV+GLNSNP AMIKKIAGLV+DFYK P+VESPAKAALEE+ +MFE RG
Sbjct: 121 RRLSMLKQLIVALVRGLNSNPPAMIKKIAGLVSDFYKPPNVESPAKAALEESCNMFENRG 180
Query: 181 VQLLGQIRHGSCRPRAILFKVLADTVGLESRLM-GLPNDGTMECVDSYKHMSVIVVLNSV 239
VQ+LGQIRHGSC PRAILFKVLAD+VGLESRLM G PNDG ECVDSYKHMSVIVVLN+V
Sbjct: 181 VQMLGQIRHGSCCPRAILFKVLADSVGLESRLMMGFPNDGAAECVDSYKHMSVIVVLNTV 240
Query: 240 ELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPD 299
ELLVDLMRFPGQL+PRSTK+I M+HISAAGESDSAENDSCDSPLEPNSPLYGVSE V
Sbjct: 241 ELLVDLMRFPGQLLPRSTKSILMTHISAAGESDSAENDSCDSPLEPNSPLYGVSESV--- 297
Query: 300 SSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLSFSHSEPNIATTFWRRSRRK 359
EK+E+ Q R+ E +N+SG LRNMMLR SLDR LSFSHSEPNIAT F RRSRRK
Sbjct: 298 --EKEENLQFHRRFEVSSNVSGLPLRNMMLRSNTSLDRNLSFSHSEPNIATAFGRRSRRK 355
Query: 360 VIAEQRTASS------------------------------------RSEGASTSEARRIR 383
VIAEQRTASS +S+GAS+SEARRIR
Sbjct: 356 VIAEQRTASSSPEHPSLRAHGRSKLSGDRTAFRDFADDQSTLRSSYKSDGASSSEARRIR 415
Query: 384 RRSISITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTS--DLPKNASNF 441
R SISITPEIGDDI RAVRAMNETLKQNRLL+E+G D + S D TS DL KN SNF
Sbjct: 416 R-SISITPEIGDDIARAVRAMNETLKQNRLLREQGGDSSLSHSPIDRTSSADLQKNVSNF 474
Query: 442 HLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVST 501
HL H E RS LY RD + SQKA+SLPSSPH+Y SER +S Y+ N E T
Sbjct: 475 HLDNHHE----RSPLY--LRDPVTSQKAMSLPSSPHDYRGQASERSKASEYILNDELEFT 528
Query: 502 WNKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ 561
WNK+LESPMF N+PLL YEEWNIDF+ELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ
Sbjct: 529 WNKILESPMFSNRPLLPYEEWNIDFTELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ 588
Query: 562 DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK 621
DLT ENMEDFCNEISILSRLRHPNVILFLGACT+PPRLSM+TEYME+GSL++LIH+SGQK
Sbjct: 589 DLTTENMEDFCNEISILSRLRHPNVILFLGACTRPPRLSMVTEYMEMGSLFYLIHVSGQK 648
Query: 622 KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681
KKLSWRR+LKML+DICRGLM IHRMKI+HRD+KSANCLV+KHW VKICDFGLSRI+T+SP
Sbjct: 649 KKLSWRRRLKMLQDICRGLMHIHRMKIIHRDVKSANCLVDKHWIVKICDFGLSRIVTESP 708
Query: 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN 741
RDSSSAGTPEWMAPELIRNEPFTEKCDIFS GVI+WELCTLNRPWEGV PERVVY VAN
Sbjct: 709 TRDSSSAGTPEWMAPELIRNEPFTEKCDIFSFGVIIWELCTLNRPWEGVPPERVVYTVAN 768
Query: 742 EGSRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 785
EG+RL+IP+GPLGRLI++CWAEP ERPSCEEILSRL+D EYS+C
Sbjct: 769 EGARLDIPDGPLGRLISECWAEPHERPSCEEILSRLVDIEYSMC 812
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356543916|ref|XP_003540404.1| PREDICTED: uncharacterized protein LOC100803469 isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1232 bits (3188), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 620/820 (75%), Positives = 687/820 (83%), Gaps = 64/820 (7%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETR+DAG AEQG N +WW DF+E FGSVSLGSQ+E LSNKESPR+F++D LSSQ A
Sbjct: 1 MEETREDAGPAEQGPSNVSWWPSDFVEKFGSVSLGSQDEILSNKESPRHFDKDVLSSQKA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQ LW G+LSEPIPNGFYSVIP+ RLKELFDSIPT+DELHALGGEG +ADIILVDS+KD
Sbjct: 61 SQTLWRIGVLSEPIPNGFYSVIPETRLKELFDSIPTLDELHALGGEGFKADIILVDSEKD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRG 180
KKLSMLK+LI+ALV+GLNSNPAA+IKKIAGLV+DFYK P+VESPAKAAL+E+SHMFE RG
Sbjct: 121 KKLSMLKKLIMALVRGLNSNPAAIIKKIAGLVSDFYKCPNVESPAKAALDESSHMFENRG 180
Query: 181 VQLLGQIRHGSCRPRAILFKVLADTVGLESRLM-GLPNDGTMECVDSYKHMSVIVVLNSV 239
VQ+LGQI+HGSCRPRAILFKVLADTVGLESRLM GLPNDG +EC DSYKHMSVIVVLNSV
Sbjct: 181 VQMLGQIKHGSCRPRAILFKVLADTVGLESRLMVGLPNDGAIECQDSYKHMSVIVVLNSV 240
Query: 240 ELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPD 299
E+LVDLMRFPGQL+PRSTKA+FM+HIS AGESDSAENDSCDSPLEPNSPL+GVSER+DP+
Sbjct: 241 EMLVDLMRFPGQLLPRSTKAVFMTHIS-AGESDSAENDSCDSPLEPNSPLFGVSERLDPN 299
Query: 300 SSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLSFSHSEPNIATTFWRRSRRK 359
S+EK+E+ Q R+ E +N+SG SLRN+M + LS SHSEPNIAT F RRSRRK
Sbjct: 300 SAEKEENLQFHRRFEASSNVSGLSLRNVM----LRSNSSLSLSHSEPNIATAFGRRSRRK 355
Query: 360 VIAEQRTASS-------RSEGASTSEARRIRRRSIS------------------------ 388
VIAEQRTASS R+ G S R R +
Sbjct: 356 VIAEQRTASSSPEHPSFRARGRSMLSGDRTTFRDFADDQATSSYRSDNTSSSEARRIRRR 415
Query: 389 ---ITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGT 445
ITPEIGDDIVRAVRAMNETLKQNRLL+ERG+D F S N+++SD
Sbjct: 416 SISITPEIGDDIVRAVRAMNETLKQNRLLRERGDDNSFPNSPNNSSSD------------ 463
Query: 446 HDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKV 505
NL ++ ++SQKA+SLPSSPH+YG S+R GSS Y N E STWNKV
Sbjct: 464 -----------ANLQKN-VSSQKAMSLPSSPHDYGGQASKRSGSSRYGVNDEMESTWNKV 511
Query: 506 LESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA 565
LESPMF NKPLL YE+WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA
Sbjct: 512 LESPMFNNKPLLPYEKWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA 571
Query: 566 ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLS 625
ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM+TEYMELGSLY+LIHL+GQKKKL+
Sbjct: 572 ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMVTEYMELGSLYYLIHLNGQKKKLN 631
Query: 626 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685
WRR+L+MLRDIC+GLMCIHRMK+VHRDLKSANCLVNKHWTVKICDFGLSRI+T+SPMRDS
Sbjct: 632 WRRRLRMLRDICKGLMCIHRMKVVHRDLKSANCLVNKHWTVKICDFGLSRIMTESPMRDS 691
Query: 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 745
SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV PERVVY+VANEGSR
Sbjct: 692 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVPPERVVYSVANEGSR 751
Query: 746 LEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 785
LEIPEGPLGRLI++CWAE ERPSCEEILSRL+D EYSLC
Sbjct: 752 LEIPEGPLGRLISECWAECHERPSCEEILSRLVDIEYSLC 791
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357474617|ref|XP_003607593.1| Tyrosine-protein kinase ABL2 [Medicago truncatula] gi|355508648|gb|AES89790.1| Tyrosine-protein kinase ABL2 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1212 bits (3135), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 618/823 (75%), Positives = 679/823 (82%), Gaps = 60/823 (7%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
ME TR+DA DFI FGSVSLG+Q+ETL+NKESPR+ QD +S Q A
Sbjct: 1 MERTREDAR-----------MPSDFIGKFGSVSLGTQDETLNNKESPRHSNQDFMSPQRA 49
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQILW TGMLSEPIPNGFYSV+P+KRLK+LFDSIPT+DEL ALGGEG RAD+I+VD+KKD
Sbjct: 50 SQILWHTGMLSEPIPNGFYSVVPEKRLKKLFDSIPTLDELQALGGEGFRADVIVVDAKKD 109
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRG 180
+KLSMLKQLIV LVKGLN+NP A+IKKIAGLV+DFYKRP+VESPAKAALEE+SHMFE+ G
Sbjct: 110 RKLSMLKQLIVTLVKGLNTNPGAIIKKIAGLVSDFYKRPNVESPAKAALEESSHMFESHG 169
Query: 181 VQLLGQIRHGSCRPRAILFKVLADTVGLESRLM-GLPNDGTMECVDSYKHMSVIVVLNSV 239
VQ+LGQI+HGSCRPRAILFKVLADTVGLESRLM G P DG +CVDSYKHMSVIV LNSV
Sbjct: 170 VQMLGQIKHGSCRPRAILFKVLADTVGLESRLMMGFPTDGAADCVDSYKHMSVIVALNSV 229
Query: 240 ELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPD 299
ELLVDLMRFPGQL+PRS K+I M+HISAAGESDSAENDSCDSPLEPNSPLYGVSE
Sbjct: 230 ELLVDLMRFPGQLLPRSIKSILMTHISAAGESDSAENDSCDSPLEPNSPLYGVSE----- 284
Query: 300 SSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLSFSHSEPNIATTFWRRSRRK 359
S+EKD++ Q R+ E +N+S P LRNMMLR LDRKLSFSHSEPNIAT+F RRSRRK
Sbjct: 285 SAEKDDNLQFHRRFEASSNVSSPPLRNMMLRSNTCLDRKLSFSHSEPNIATSFGRRSRRK 344
Query: 360 VIAEQRTASS------------------------------------RSEGASTSEARRIR 383
VIAEQRTASS +S+GAS+S RRIR
Sbjct: 345 VIAEQRTASSSPEHPSFQARGQSKLGGEKTAFRDFADDQATSRSSYKSDGASSSGPRRIR 404
Query: 384 RRSISITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTS--DLPKNASNF 441
RRSISITPEIGDDI RAVRAMNE LKQNRLL+E+G+D S ND TS +L KN SNF
Sbjct: 405 RRSISITPEIGDDIARAVRAMNEKLKQNRLLREQGDDSSLPHSPNDRTSSAELQKNLSNF 464
Query: 442 HLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVST 501
L H+ S LY L RD + SQKA+SLPSSPH+Y SE GY N E ST
Sbjct: 465 RLDGHET-----SPLYPLYRDNVPSQKAVSLPSSPHDYRRQTSETSRPLGYELNDELEST 519
Query: 502 WNKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ 561
WNK+LES M NKPLL YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ
Sbjct: 520 WNKILESSMADNKPLLPYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ 579
Query: 562 DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK 621
DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM+TEYME+GSL++LIH+SGQK
Sbjct: 580 DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMVTEYMEMGSLFYLIHVSGQK 639
Query: 622 KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681
KKLSWRR+LKMLRDICRGLM IHRMKI+HRD+KSANCLV+KHWTVK+CDFGLSRIIT+SP
Sbjct: 640 KKLSWRRRLKMLRDICRGLMHIHRMKIIHRDVKSANCLVDKHWTVKVCDFGLSRIITESP 699
Query: 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN 741
MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELC L+RPWEGV PERVVY VAN
Sbjct: 700 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCNLSRPWEGVPPERVVYTVAN 759
Query: 742 EGSRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSL 784
EGSRLEIPEGPLGRLI++CWAEP ERPSCEEILSRL+D EYS+
Sbjct: 760 EGSRLEIPEGPLGRLISECWAEPNERPSCEEILSRLVDIEYSM 802
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356517341|ref|XP_003527346.1| PREDICTED: uncharacterized protein LOC100806527 isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1207 bits (3122), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 594/800 (74%), Positives = 663/800 (82%), Gaps = 66/800 (8%)
Query: 19 TWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTASQILWSTGMLSEPIPNGF 78
+WW DF++ F SVSL +Q+ETL+NKESPR+ QD +S Q ASQILW TGMLSEPIPNGF
Sbjct: 2 SWWPSDFVDKFESVSLSAQDETLNNKESPRHSNQDVMSPQKASQILWRTGMLSEPIPNGF 61
Query: 79 YSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKDKKLSMLKQLIVALVKGLN 138
YSVIP+KRLK+LFDSIPT+DEL A+GGEG RAD+I+VD++KD++LSMLKQLIVALV+GLN
Sbjct: 62 YSVIPEKRLKKLFDSIPTLDELQAMGGEGFRADVIVVDAEKDRRLSMLKQLIVALVRGLN 121
Query: 139 SNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRGVQLLGQIRHGSCRPRAIL 198
SNP AMIKKIAGLV+DFYK P+VESPAKAALEE+ +MFE RGVQ+LGQIRHGSC PRAIL
Sbjct: 122 SNPPAMIKKIAGLVSDFYKPPNVESPAKAALEESCNMFENRGVQMLGQIRHGSCCPRAIL 181
Query: 199 FKVLADTVGLESRLM-GLPNDGTMECVDSYKHMSVIVVLNSVELLVDLMRFPGQLIPRST 257
FKVLAD+VGLESRLM G PNDG ECVDSYKHMSVIVVLN+VELLVDLMRFPGQL+PRST
Sbjct: 182 FKVLADSVGLESRLMMGFPNDGAAECVDSYKHMSVIVVLNTVELLVDLMRFPGQLLPRST 241
Query: 258 KAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPDSSEKDESFQVQRKLETPA 317
K+I M+HISAAGESDSAENDSCDSPLEPNSPLYGVSER+DP EK+E+ Q R+ E +
Sbjct: 242 KSILMTHISAAGESDSAENDSCDSPLEPNSPLYGVSERLDPKRVEKEENLQFHRRFEVSS 301
Query: 318 NISGPSLRNMMLRPAASLDRKLSFSHSEPNIATTFWRRSRRKVIAEQRTASS-------- 369
N+SG LRNMMLR SLDR LSFSHSEPNIAT F RRSRRKVIAEQRTASS
Sbjct: 302 NVSGLPLRNMMLRSNTSLDRNLSFSHSEPNIATAFGRRSRRKVIAEQRTASSSPEHPSLR 361
Query: 370 ------------------------RSEGASTSEARRIRRRSISITPEIGDDIVRAVRAMN 405
+S+GAS+SEARRIRR SISITPEIGDDI RAVRAMN
Sbjct: 362 AHGRSKLSGDRTAFRDFADDQSSYKSDGASSSEARRIRR-SISITPEIGDDIARAVRAMN 420
Query: 406 ETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMN 465
ETLKQNRLL+E+G D S LY RD +
Sbjct: 421 ETLKQNRLLREQGGDSSL------------------------------SPLY--LRDPVT 448
Query: 466 SQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWNID 525
SQKA+SLPSSPH+Y SER +S Y+ N E TWNK+LESPMF N+PLL YEEWNID
Sbjct: 449 SQKAMSLPSSPHDYRGQASERSKASEYILNDELEFTWNKILESPMFSNRPLLPYEEWNID 508
Query: 526 FSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN 585
F+ELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLT ENMEDFCNEISILSRLRHPN
Sbjct: 509 FTELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTTENMEDFCNEISILSRLRHPN 568
Query: 586 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 645
VILFLGACT+PPRLSM+TEYME+GSL++LIH+SGQKKKLSWRR+LKML+DICRGLM IHR
Sbjct: 569 VILFLGACTRPPRLSMVTEYMEMGSLFYLIHVSGQKKKLSWRRRLKMLQDICRGLMHIHR 628
Query: 646 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT 705
MKI+HRD+KSANCLV+KHW VKICDFGLSRI+T+SP RDSSSAGTPEWMAPELIRNEPFT
Sbjct: 629 MKIIHRDVKSANCLVDKHWIVKICDFGLSRIVTESPTRDSSSAGTPEWMAPELIRNEPFT 688
Query: 706 EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAEPQ 765
EKCDIFS GVI+WELCTLNRPWEGV PERVVY VANEG+RL+IP+GPLGRLI++CWAEP
Sbjct: 689 EKCDIFSFGVIIWELCTLNRPWEGVPPERVVYTVANEGARLDIPDGPLGRLISECWAEPH 748
Query: 766 ERPSCEEILSRLLDCEYSLC 785
ERPSCEEILSRL+D EYS+C
Sbjct: 749 ERPSCEEILSRLVDIEYSMC 768
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 785 | ||||||
| TAIR|locus:2076416 | 809 | AT3G58640 [Arabidopsis thalian | 0.569 | 0.552 | 0.694 | 1.6e-299 | |
| TAIR|locus:2052786 | 775 | AT2G31010 [Arabidopsis thalian | 0.969 | 0.981 | 0.653 | 7.5e-263 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.318 | 0.242 | 0.511 | 7e-80 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.332 | 0.296 | 0.477 | 1.5e-79 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.324 | 0.257 | 0.498 | 2e-79 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.338 | 0.285 | 0.460 | 4.1e-79 | |
| TAIR|locus:2144613 | 821 | CTR1 "CONSTITUTIVE TRIPLE RESP | 0.342 | 0.327 | 0.474 | 5.9e-76 | |
| TAIR|locus:2127228 | 736 | AT4G23050 [Arabidopsis thalian | 0.342 | 0.365 | 0.45 | 5.6e-65 | |
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.329 | 0.335 | 0.456 | 1.2e-60 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.328 | 0.337 | 0.441 | 1.5e-58 |
| TAIR|locus:2076416 AT3G58640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1620 (575.3 bits), Expect = 1.6e-299, Sum P(2) = 1.6e-299
Identities = 318/458 (69%), Positives = 355/458 (77%)
Query: 330 RPAASLDRKLSFSHSEPNIATTFWRRSRRKVIAEQRTASSRSEGXXXXXXXXXXXXXXXX 389
R A+S LSF ++ + + R + T+S +S G
Sbjct: 361 RTASSSPEHLSFRARTKSMLSGD-KNLARDFTGDVATSSCKSVGGAKMETKRIRRRSISI 419
Query: 390 XXXXGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNT--SDLPKNASNFHLGTHD 447
GDDIVRAVRAMNE LKQNRL +E+G+D S ND T S L KN S FHL HD
Sbjct: 420 TPEIGDDIVRAVRAMNEALKQNRLSKEQGDDDSSPNSPNDRTESSHLQKNVSGFHLDAHD 479
Query: 448 EISGGRSALYNLSRDQMNSQKAISLPSSPXXXXXXXXXXXXXXXXMANSEFVSTWNKVLE 507
++SGGRS L SR+ ++ QKAISLPSSP +++ W+KVL
Sbjct: 480 QVSGGRSTL---SREPLDPQKAISLPSSPQNYRSQYEQSGSSHRNISH-----IWDKVLG 531
Query: 508 SPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAEN 567
SPMFQNKPLL YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAEN
Sbjct: 532 SPMFQNKPLLPYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAEN 591
Query: 568 MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWR 627
MEDFCNEISILSRLRHPNVILFLGACTKPPRLS+ITEYME+GSLY+L+HLSGQKK+LSWR
Sbjct: 592 MEDFCNEISILSRLRHPNVILFLGACTKPPRLSLITEYMEMGSLYYLLHLSGQKKRLSWR 651
Query: 628 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 687
RKLKMLRDICRGLMCIHRM IVHRD+KSANCL++ WTVKICDFGLSRI+T + MRD+ S
Sbjct: 652 RKLKMLRDICRGLMCIHRMGIVHRDIKSANCLLSNKWTVKICDFGLSRIMTGTTMRDTVS 711
Query: 688 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE 747
AGTPEWMAPELIRNEPF+EKCDIFSLGVIMWELCTL RPWEGV PERVVYA+A EG+RLE
Sbjct: 712 AGTPEWMAPELIRNEPFSEKCDIFSLGVIMWELCTLTRPWEGVPPERVVYAIAYEGARLE 771
Query: 748 IPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 785
IPEGPLG+LIADCW EP++RPSC EILSRLLDCEYSLC
Sbjct: 772 IPEGPLGKLIADCWTEPEQRPSCNEILSRLLDCEYSLC 809
|
|
| TAIR|locus:2052786 AT2G31010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2529 (895.3 bits), Expect = 7.5e-263, P = 7.5e-263
Identities = 522/799 (65%), Positives = 598/799 (74%)
Query: 1 MEETRDDAGS-AEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQT 59
MEE RDD S QG + E +S SQ E LS K+SPR+ EQD Q
Sbjct: 1 MEERRDDESSPTHQG--------SELAERVKLLSFESQGEALS-KDSPRSVEQDCSPGQR 51
Query: 60 ASQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVXXXX 119
ASQ LW TG+LSEPIPNGFYSV+PDKR+KEL++ +PT ELHALG EG R ++ILV
Sbjct: 52 ASQHLWDTGILSEPIPNGFYSVVPDKRVKELYNRLPTPSELHALGEEGVRIEVILVDFQK 111
Query: 120 XXXXXXXXQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETR 179
QLI LV G +NPA +IKKIAG V+DFYKRP++ESP+K ALEE + +FE
Sbjct: 112 DKKLAMLKQLITTLVSGSGTNPALVIKKIAGTVSDFYKRPTLESPSKLALEENAFLFENH 171
Query: 180 GVQLLGQIRHGSCRPRAILFKVLADTVGLESRLM-GLPNDGTMECVDSYKHMSVIVVLNS 238
G QLLGQI+ G CR RAILFKVLADTVGLESRL+ GLP+DGT+ C+DS KHMSVIVVLNS
Sbjct: 172 GAQLLGQIKRGCCRARAILFKVLADTVGLESRLVVGLPSDGTVNCMDSNKHMSVIVVLNS 231
Query: 239 VELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDP 298
VELLVDL+RFPGQL+PRS KAIFMSHIS AGESDSAENDSCDSPLEPNSPLY ER DP
Sbjct: 232 VELLVDLIRFPGQLVPRSAKAIFMSHISPAGESDSAENDSCDSPLEPNSPLY---ERRDP 288
Query: 299 DSSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLS-FSHSEPNIATTFWRRSR 357
+S+EKDE+ Q RKLE N SG SLR++MLRP+ +++RKLS SHSEPN+AT FWRRSR
Sbjct: 289 ESTEKDENLQFYRKLEGYPNASGSSLRSLMLRPSTAIERKLSNTSHSEPNVATVFWRRSR 348
Query: 358 RKVIAEQRTASSRSEG-XXXXXXXXXXXXXXXXXXXXGDDIVRAVRAMNETLKQNR---- 412
RKVIAEQRTASS E G+ + + +E K R
Sbjct: 349 RKVIAEQRTASSSPEHPSMRRGRSMLSTGRNSFRDYTGEASSPSSSSTSEIRKTRRRSFR 408
Query: 413 LLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDE----ISGGRSALYNLSRDQMNSQK 468
+ E G+D S+ + K + G DE I S L+ L D++NS+K
Sbjct: 409 ITPEIGDD---IASAVREMYEKSKQ-NRLLQGREDENSSVIDNNVSGLH-LD-DELNSKK 462
Query: 469 AISLPSSPXXXXXXXXXXXXXXXXMANSEFV--STWNKVLESPMFQNKPLLAYEEWNIDF 526
+SLPSSP SEF TWNKV+ES QN+PLL Y+EW+IDF
Sbjct: 463 TMSLPSSPHAYRCQTFGRR------GPSEFAVKDTWNKVVESSTLQNQPLLPYQEWDIDF 516
Query: 527 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV 586
SELTVGTRVGIGFFGEVFRG+WNGTDVAIK+FLEQDLTAENMEDFCNEISILSR+RHPNV
Sbjct: 517 SELTVGTRVGIGFFGEVFRGVWNGTDVAIKLFLEQDLTAENMEDFCNEISILSRVRHPNV 576
Query: 587 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 646
+LFLGACTKPPRLSMITEYMELGSLY+LIH+SGQKKKLSW R+L+MLRDICRGLMCIHRM
Sbjct: 577 VLFLGACTKPPRLSMITEYMELGSLYYLIHMSGQKKKLSWHRRLRMLRDICRGLMCIHRM 636
Query: 647 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTE 706
KIVHRDLKSANCLV+KHWTVKICDFGLSRI+TD M+D+SSAGTPEWMAPELIRN PFTE
Sbjct: 637 KIVHRDLKSANCLVDKHWTVKICDFGLSRIMTDENMKDTSSAGTPEWMAPELIRNRPFTE 696
Query: 707 KCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAEPQE 766
KCDIFSLGVIMWEL TL +PWEGV PE+VV+AVA+EGSRLEIP+GPL +LIADCWAEP+E
Sbjct: 697 KCDIFSLGVIMWELSTLRKPWEGVPPEKVVFAVAHEGSRLEIPDGPLSKLIADCWAEPEE 756
Query: 767 RPSCEEILSRLLDCEYSLC 785
RP+CEEIL LLDCEY+LC
Sbjct: 757 RPNCEEILRGLLDCEYTLC 775
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 688 (247.2 bits), Expect = 7.0e-80, Sum P(2) = 7.0e-80
Identities = 132/258 (51%), Positives = 185/258 (71%)
Query: 526 FSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN 585
+ E+TVG R+G+G +GEV+RG W+GT+VA+K FL+QDLT E +E+F +E+ I+ +LRHPN
Sbjct: 745 WEEITVGERIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALEEFRSEVRIMKKLRHPN 804
Query: 586 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 645
++LF+GA T+PP LS++TE++ GSLY LIH + L RR+L+M D RG+ +H
Sbjct: 805 IVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQ--LDERRRLRMALDAARGMNYLHS 862
Query: 646 MK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP 703
IVHRDLKS N LV+K+W VK+CDFGLSR+ + + S+AGT EWMAPE++RNEP
Sbjct: 863 CNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKSTAGTAEWMAPEVLRNEP 922
Query: 704 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE--GP-LGRLIADC 760
EKCD++S GVI+WEL TL +PW + P +VV AV + RL+IP+ P + LI+ C
Sbjct: 923 ADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPDFVDPAIADLISKC 982
Query: 761 W-AEPQERPSCEEILSRL 777
W + + RPS EI++ L
Sbjct: 983 WQTDSKLRPSFAEIMASL 1000
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 690 (248.0 bits), Expect = 1.5e-79, Sum P(2) = 1.5e-79
Identities = 129/270 (47%), Positives = 186/270 (68%)
Query: 515 PLLAYE-EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCN 573
PLL +W I + +L +G R+GIG +GEV+R WNGT+VA+K FL+QD + + + F +
Sbjct: 594 PLLGEAAKWEIMWEDLQIGERIGIGSYGEVYRAEWNGTEVAVKKFLDQDFSGDALTQFKS 653
Query: 574 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 633
EI I+ RLRHPNV+LF+GA T+PP S++TE++ GSLY L+H + L +R+++M
Sbjct: 654 EIEIMLRLRHPNVVLFMGAVTRPPNFSILTEFLPRGSLYRLLHRPNHQ--LDEKRRMRMA 711
Query: 634 RDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 691
D+ +G+ +H +VHRDLKS N LV+K+W VK+CDFGLSR+ + + S+AGTP
Sbjct: 712 LDVAKGMNYLHTSHPTVVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHHTYLSSKSTAGTP 771
Query: 692 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG 751
EWMAPE++RNEP EKCD++S GVI+WEL T PW+G+ P +VV AV + RLEIP+
Sbjct: 772 EWMAPEVLRNEPANEKCDVYSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDD 831
Query: 752 ---PLGRLIADCW-AEPQERPSCEEILSRL 777
+ ++I +CW EP RPS +++ L
Sbjct: 832 IDLTVAQIIRECWQTEPHLRPSFTQLMQSL 861
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 680 (244.4 bits), Expect = 2.0e-79, Sum P(2) = 2.0e-79
Identities = 131/263 (49%), Positives = 184/263 (69%)
Query: 521 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR 580
E I + E+TV R+G+G +GEV+RG W+GT VA+K F++QD+T E +E+F +E+ ++ R
Sbjct: 707 ECEILWEEITVAERIGLGSYGEVYRGDWHGTAVAVKKFIDQDITGEALEEFRSEVRMMRR 766
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
LRHPN++LF+GA T+PP LS++TE++ GSLY LIH + L R++L+M D RG+
Sbjct: 767 LRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQ--LDERKRLRMALDAARGM 824
Query: 641 MCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 698
+H IVHRDLKS N LV+K+W VK+CDFGLSR+ + + S+AGT EWMAPE+
Sbjct: 825 NYLHSCNPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTYLSSKSTAGTAEWMAPEV 884
Query: 699 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE--GP-LGR 755
+RNEP EKCD++S GVI+WEL TL +PW + P +VV AV + RL+IPE P +
Sbjct: 885 LRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPEFVDPGIAD 944
Query: 756 LIADCW-AEPQERPSCEEILSRL 777
+I CW +P+ RPS EI+ L
Sbjct: 945 IIRKCWQTDPRLRPSFGEIMDSL 967
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 675 (242.7 bits), Expect = 4.1e-79, Sum P(2) = 4.1e-79
Identities = 128/278 (46%), Positives = 189/278 (67%)
Query: 506 LESPMFQNKPLLAYE----EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ 561
L+S ++N P + + E I +++L + R+G+G +GEV+ W+GT+VA+K FL+Q
Sbjct: 642 LDSTSYRNDPQVLDDADVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQ 701
Query: 562 DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK 621
D + + +F +E+ I+ RLRHPNV+ FLGA T+PP LS++TE++ GSLY ++H K
Sbjct: 702 DFSGAALAEFRSEVRIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRP--K 759
Query: 622 KKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679
+ RR++KM D+ G+ C+H IVHRDLK+ N LV+ +W VK+ DFGLSR+ +
Sbjct: 760 SHIDERRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHN 819
Query: 680 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV 739
+ + S+AGTPEWMAPE++RNEP EKCD++S GVI+WEL TL PW G+ P +VV AV
Sbjct: 820 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAV 879
Query: 740 ANEGSRLEIPE--GPL-GRLIADCW-AEPQERPSCEEI 773
+ RLEIP+ P+ GR+I +CW +P RPS ++
Sbjct: 880 GFQNRRLEIPKELDPVVGRIILECWQTDPNLRPSFAQL 917
|
|
| TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 681 (244.8 bits), Expect = 5.9e-76, Sum P(2) = 5.9e-76
Identities = 131/276 (47%), Positives = 187/276 (67%)
Query: 509 PMFQNKPL-LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAEN 567
P N+ L L ++ +I + +L + ++G G FG V R W+G+DVA+K+ +EQD AE
Sbjct: 530 PNRANRELGLDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAER 589
Query: 568 MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWR 627
+ +F E++I+ RLRHPN++LF+GA T+PP LS++TEY+ GSLY L+H SG +++L R
Sbjct: 590 VNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDER 649
Query: 628 RKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685
R+L M D+ +G+ +H IVHRDLKS N LV+K +TVK+CDFGLSR+ + +
Sbjct: 650 RRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK 709
Query: 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 745
S+AGTPEWMAPE++R+EP EK D++S GVI+WEL TL +PW + P +VV AV + R
Sbjct: 710 SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR 769
Query: 746 LEIPEG--P-LGRLIADCWA-EPQERPSCEEILSRL 777
LEIP P + +I CW EP +RPS I+ L
Sbjct: 770 LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 805
|
|
| TAIR|locus:2127228 AT4G23050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 611 (220.1 bits), Expect = 5.6e-65, Sum P(3) = 5.6e-65
Identities = 126/280 (45%), Positives = 184/280 (65%)
Query: 507 ESPMFQ-NKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA 565
+SP+ Q N L+ I + +L +G VG G F V RG+WNG+DVAIKV+ + D A
Sbjct: 445 QSPVNQRNNRLVTDSSCEIRWEDLQLGEEVGRGSFAAVHRGVWNGSDVAIKVYFDGDYNA 504
Query: 566 ENMEDFCNEISILSRLRHPNVILFLGA-CTKPPRLSMITEYMELGSLYHLIHLSGQKKKL 624
+ + EI+I+ +LRHPNV+LF+GA CT+ + ++I EYM GSL+ ++H + Q L
Sbjct: 505 MTLTECKKEINIMKKLRHPNVLLFMGAVCTEE-KSAIIMEYMPRGSLFKILHNTNQP--L 561
Query: 625 SWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682
+R+L+M D+ RG+ +HR IVHRDLKS+N LV+K+W VK+ DFGLS+ + +
Sbjct: 562 DKKRRLRMALDVARGMNYLHRRNPPIVHRDLKSSNLLVDKNWNVKVGDFGLSKWKNATFL 621
Query: 683 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE 742
S GTP+WMAPE++R+EP EKCD+FS GVI+WEL T PW+ + +VV V
Sbjct: 622 STKSGKGTPQWMAPEVLRSEPSNEKCDVFSFGVILWELMTTLVPWDRLNSIQVVGVVGFM 681
Query: 743 GSRLEIPEG--P-LGRLIADCW-AEPQERPSCEEILSRLL 778
RL++PEG P + +I DCW +P +RPS EE++S+++
Sbjct: 682 DRRLDLPEGLNPRIASIIQDCWQTDPAKRPSFEELISQMM 721
|
|
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 621 (223.7 bits), Expect = 1.2e-60, P = 1.2e-60
Identities = 122/267 (45%), Positives = 179/267 (67%)
Query: 521 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR 580
E+ I + +LT+G +VG G G V+ G+W G+DVA+KVF +Q+ +AE +E F E+ ++ R
Sbjct: 486 EYEILWDDLTIGEQVGQGSCGTVYHGLWFGSDVAVKVFSKQEYSAEVIESFKQEVLLMKR 545
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
LRHPNV+LF+GA T P RL +++E++ GSL+ L+ S KL WRR++ M DI RG+
Sbjct: 546 LRHPNVLLFMGAVTSPQRLCIVSEFLPRGSLFRLLQKS--TSKLDWRRRIHMALDIARGM 603
Query: 641 MCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 698
+H I+HRDLKS+N LV+K+WTVK+ DFGLSRI ++ + S GTP+WMAPE+
Sbjct: 604 NYLHHCSPPIIHRDLKSSNLLVDKNWTVKVADFGLSRIKHETYLTSKSGKGTPQWMAPEV 663
Query: 699 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR--- 755
+RNE EK DI+S GV++WEL T PWE + +V+ AV RLEIP+ R
Sbjct: 664 LRNESADEKSDIYSFGVVLWELATEKIPWETLNSMQVIGAVGFMDQRLEIPKDIDPRWIS 723
Query: 756 LIADCW-AEPQERPSCEEILSRLLDCE 781
L+ CW ++ + RP+ +E++ +L D +
Sbjct: 724 LMESCWHSDTKLRPTFQELMDKLRDLQ 750
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 601 (216.6 bits), Expect = 1.5e-58, P = 1.5e-58
Identities = 118/267 (44%), Positives = 178/267 (66%)
Query: 521 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR 580
++ I + +LT+G ++G G G V+ G+W G+DVA+KVF +Q+ + E + F E+S++ R
Sbjct: 479 DYEILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEIITSFKQEVSLMKR 538
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
LRHPNV+LF+GA P RL ++TE++ GSL+ L L K KL RR++ M DI RG+
Sbjct: 539 LRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRL--LQRNKSKLDLRRRIHMASDIARGM 596
Query: 641 MCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 698
+H I+HRDLKS+N LV+++WTVK+ DFGLSRI ++ + ++ GTP+WMAPE+
Sbjct: 597 NYLHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETYLT-TNGRGTPQWMAPEV 655
Query: 699 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIA 758
+RNE EK D++S GV++WEL T PWE + +V+ AV RLE+P+ + IA
Sbjct: 656 LRNEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQRLEVPKDVDPQWIA 715
Query: 759 ---DCW-AEPQERPSCEEILSRLLDCE 781
CW +EPQ RPS +E++ +L + +
Sbjct: 716 LMESCWHSEPQCRPSFQELMDKLRELQ 742
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 785 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-77 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-75 | |
| pfam14381 | 203 | pfam14381, EDR1, Ethylene-responsive protein kinas | 9e-74 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-73 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-73 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-69 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-66 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-62 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-54 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-50 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-50 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-48 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-47 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-46 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-46 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-46 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-45 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-44 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-42 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-42 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-42 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-42 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-40 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-40 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-40 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-39 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-39 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-39 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-39 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-39 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-38 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-38 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-37 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-37 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-37 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-37 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-37 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-37 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-37 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-37 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-36 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-36 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-36 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-36 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-36 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-35 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-35 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-35 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-35 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-35 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-35 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-34 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-34 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-34 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-34 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-33 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-33 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-33 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-32 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-32 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-32 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-32 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-32 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-32 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-32 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-31 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-31 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-31 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-31 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-31 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-31 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-30 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-30 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-30 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-30 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-30 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-30 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-29 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-29 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-29 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-29 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-29 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-28 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-28 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-28 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-28 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-28 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-27 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-27 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-27 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-27 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-26 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-26 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-26 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-26 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-26 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-26 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-26 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-25 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-25 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-25 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-25 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-25 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-25 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-24 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-24 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-24 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-24 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-24 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-23 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-23 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-23 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-23 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-23 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-22 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-22 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-22 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-22 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-22 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-22 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-22 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-22 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-21 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-21 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-21 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-21 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-21 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-21 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-20 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-20 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-20 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-19 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-19 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-18 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-18 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-18 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-17 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-17 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-17 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-17 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-16 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-16 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-16 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-14 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-13 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.001 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 248 bits (636), Expect = 7e-77
Identities = 100/262 (38%), Positives = 148/262 (56%), Gaps = 17/262 (6%)
Query: 529 LTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCNEISILSRLR 582
L +G ++G G FGEV++G G T VA+K L++ + E E+F E SI+ +L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKT-LKEGASEEEREEFLEEASIMKKLS 59
Query: 583 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
HPN++ LG CT+ L ++TEYM G L L +KL+ + L+M I +G+
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLD--FLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT-DSPMRDSSSAGTP-EWMAPELIR 700
+ VHRDL + NCLV ++ VKI DFGLSR I D R P +WMAPE ++
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 701 NEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRL 756
+ FT K D++S GV++WE+ TL +P+ G+ E V+ + +G RL PE L L
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENCPDELYEL 236
Query: 757 IADCWAE-PQERPSCEEILSRL 777
+ CWA P++RP+ E++ L
Sbjct: 237 MLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 245 bits (627), Expect = 2e-75
Identities = 100/261 (38%), Positives = 146/261 (55%), Gaps = 16/261 (6%)
Query: 529 LTVGTRVGIGFFGEVFRGIWNGT------DVAIKVFLEQDLTAENMEDFCNEISILSRLR 582
LT+G ++G G FGEV++G G +VA+K L++D + + +E+F E I+ +L
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 583 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
HPNV+ LG CT+ L ++ EYME G L L +L + KLS L I RG+
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDL--LSYLRKNRPKLSLSDLLSFALQIARGMEY 117
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRN 701
+ +HRDL + NCLV ++ VKI DFGLSR + D P WMAPE ++
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 702 EPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 757
FT K D++S GV++WE+ TL +P+ G+ E V+ + N G RL P L L+
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKN-GYRLPQPPNCPPELYDLM 236
Query: 758 ADCWAE-PQERPSCEEILSRL 777
CWAE P++RP+ E++ L
Sbjct: 237 LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|222722 pfam14381, EDR1, Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Score = 238 bits (609), Expect = 9e-74
Identities = 74/208 (35%), Positives = 112/208 (53%), Gaps = 12/208 (5%)
Query: 54 GLSSQTASQILWSTGMLS--EPIPNGFYSVIPDKRLKEL--FDSIPTVDELHALGGEGHR 109
S++ S W G LS + IP+GFY + +L F IP++++L A+
Sbjct: 1 RSSAEALSHRYWVYGCLSYDDKIPDGFYDIYGMDPCSDLKEFGRIPSLEDLQAVPPGDSS 60
Query: 110 ADIILVDSKKDKKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAAL 169
+++LVD + D KL L+QL LV G +N AA+++K+AGLV+D P ++ + A
Sbjct: 61 FEVVLVDRRTDPKLKELEQLARCLVSGCGTNTAALVQKLAGLVSDHMGGPVKDAESMLAR 120
Query: 170 EE--TSHMFETRGVQLLGQIRHGSCRPRAILFKVLADTVGLESRL-MGLPNDGTMECVDS 226
+ ++ + E GV LG ++ G CR RA+LFKVLAD++GL RL G C
Sbjct: 121 WKECSNELKENSGVVPLGSLKIGLCRHRALLFKVLADSIGLPCRLVKGCKY-----CGSD 175
Query: 227 YKHMSVIVVLNSVELLVDLMRFPGQLIP 254
+++ + E LVDLM PG LIP
Sbjct: 176 DDASNLVKFDDGREYLVDLMGAPGTLIP 203
|
EDR1 regulates disease resistance and ethylene-induced senescence, and is also involved in stress response signalling and cell death regulation. Length = 203 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 238 bits (610), Expect = 4e-73
Identities = 94/261 (36%), Positives = 142/261 (54%), Gaps = 15/261 (5%)
Query: 529 LTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCNEISILSRLR 582
LT+G ++G G FGEV++G G +VA+K L++D + + +E+F E I+ +L
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 583 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
HPN++ LG CT+ L ++ EYM G L + + K+LS L I RG+
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSFALQIARGMEY 118
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRN 701
+ +HRDL + NCLV ++ VKI DFGLSR + D P WMAPE ++
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 702 EPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 757
FT K D++S GV++WE+ TL P+ G+ V+ + G RL P L +L+
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKK-GYRLPKPPNCPPELYKLM 237
Query: 758 ADCWAE-PQERPSCEEILSRL 777
CWAE P++RP+ E++ L
Sbjct: 238 LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 238 bits (610), Expect = 4e-73
Identities = 98/261 (37%), Positives = 144/261 (55%), Gaps = 20/261 (7%)
Query: 535 VGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 589
+G G FGEV++G G T+VA+K L++D + E +DF E ++ +L HPNV+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKT-LKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 590 LGACTKPPRLSMITEYMELGSLYHLI------HLSGQKKKLSWRRKLKMLRDICRGLMCI 643
LG CT+ L ++ EYME G L + S +K LS + L I +G+ +
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 644 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-RDSSSAGTP-EWMAPELIRN 701
K VHRDL + NCLV + VKI DFGLSR + D R + P WMAPE +++
Sbjct: 122 ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD 181
Query: 702 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 757
FT K D++S GV++WE+ TL P+ G+ E V+ + +G RL PE L L+
Sbjct: 182 GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL-RKGYRLPKPEYCPDELYELM 240
Query: 758 ADCWA-EPQERPSCEEILSRL 777
CW +P++RP+ E++ RL
Sbjct: 241 LSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 227 bits (580), Expect = 9e-69
Identities = 79/253 (31%), Positives = 127/253 (50%), Gaps = 13/253 (5%)
Query: 530 TVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
+ ++G G FG+V+ T VAIKV +++ ++ E EI IL +L+HPN++
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKV-IKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
+L ++ EY E G L+ L+ ++ +LS LR I L +H
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLK---KRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 648 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 707
IVHRDLK N L+++ VK+ DFGL+R + + GTPE+MAPE++ + + +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT-TFVGTPEYMAPEVLLGKGYGKA 176
Query: 708 CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEGPLGR----LIADCWA 762
DI+SLGVI++EL T P+ G ++ + PE + LI
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLV 236
Query: 763 -EPQERPSCEEIL 774
+P++R + EE L
Sbjct: 237 KDPEKRLTAEEAL 249
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 218 bits (557), Expect = 4e-66
Identities = 83/248 (33%), Positives = 123/248 (49%), Gaps = 38/248 (15%)
Query: 535 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 592
+G G FG V+ T VAIK+ ++D + +E+ EI IL +L HPN++ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-SLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 593 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 652
L ++ EY E GSL L+ + KLS L++L I GL +H I+HRD
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 653 LKSANCLVNK-HWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP-FTEKCDI 710
LK N L++ + VK+ DFGLS+++T + GTP +MAPE++ + ++EK DI
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 711 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPS 769
+SLGVI++EL L LI +P++RPS
Sbjct: 178 WSLGVILYELPELKD------------------------------LIRKMLQKDPEKRPS 207
Query: 770 CEEILSRL 777
+EIL L
Sbjct: 208 AKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 1e-62
Identities = 81/258 (31%), Positives = 129/258 (50%), Gaps = 15/258 (5%)
Query: 529 LTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV 586
+ ++G G FG V++ GT VA+K+ ++ ++ + EI IL RL HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 587 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 646
+ + A L ++ EY E G L+ + + LS K+ I RGL +H
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLS---RGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 647 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR-NEPFT 705
I+HRDLK N L++++ VKI DFGL++ + S ++ GTP +MAPE++ +
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 706 EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR---LEIPEGPLGR-----LI 757
K D++SLGVI++EL T P+ G + + + P+ G LI
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 758 ADCWA-EPQERPSCEEIL 774
C +P +RP+ EEIL
Sbjct: 238 KKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 186 bits (476), Expect = 6e-54
Identities = 88/260 (33%), Positives = 132/260 (50%), Gaps = 18/260 (6%)
Query: 528 ELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN 585
E T G +G G FG V+ + G +A+K + E +E EI ILS L+HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 586 VILFLGACTKPPR--LSMITEYMELGSLYHLIHLSGQKKKLSWR--RKLKMLRDICRGLM 641
++ + G+ + L++ EY+ GSL L+ + KL RK R I GL
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK---KFGKLPEPVIRKY--TRQILEGLA 115
Query: 642 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS--AGTPEWMAPELI 699
+H IVHRD+K AN LV+ VK+ DFG ++ + D + + GTP WMAPE+I
Sbjct: 116 YLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIPEG--PLGRL 756
R E + DI+SLG + E+ T PW + P +Y + + G EIPE +
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKD 235
Query: 757 -IADCWA-EPQERPSCEEIL 774
+ C +P++RP+ +E+L
Sbjct: 236 FLRKCLRRDPKKRPTADELL 255
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 7e-50
Identities = 79/254 (31%), Positives = 128/254 (50%), Gaps = 10/254 (3%)
Query: 528 ELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN 585
+G +G G FG V++G+ G VAIK + + E ++ EI +L L+HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 586 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 645
++ ++G+ L +I EY E GSL +I G + + +GL +H
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHE 117
Query: 646 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT 705
++HRD+K+AN L K VK+ DFG++ + D D+S GTP WMAPE+I +
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 706 EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA 762
DI+SLG + EL T N P+ + P ++ + + +PEG L + C+
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD-DHPPLPEGISPELKDFLMQCFQ 236
Query: 763 -EPQERPSCEEILS 775
+P RP+ +++L
Sbjct: 237 KDPNLRPTAKQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 7e-50
Identities = 90/265 (33%), Positives = 134/265 (50%), Gaps = 12/265 (4%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSR 580
W I L + ++G G FGEV+ G WNG T VA+K ++ E F E I+ +
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE---AFLQEAQIMKK 57
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
LRH ++ C++ + ++TEYM GSL + SG+ KKL + + M I G+
Sbjct: 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLK-SGEGKKLRLPQLVDMAAQIAEGM 116
Query: 641 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 699
+ +HRDL + N LV ++ KI DFGL+R+I D A P +W APE
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAA 176
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGR 755
FT K D++S G+++ E+ T R P+ G+ V+ V G R+ P L
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPEELYD 235
Query: 756 LIADCW-AEPQERPSCEEILSRLLD 779
L+ CW +P+ERP+ E + S L D
Sbjct: 236 LMLQCWDKDPEERPTFEYLQSFLED 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 1e-48
Identities = 77/249 (30%), Positives = 131/249 (52%), Gaps = 8/249 (3%)
Query: 535 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 592
+G G FG+V+ R +G +K +++ + ED NE+ IL +L HPN+I + +
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 593 CTKPPRLSMITEYMELGSLYHLIHLSGQKKK-LSWRRKLKMLRDICRGLMCIHRMKIVHR 651
+ +L ++ EY + G L I ++ K + L +C L +H KI+HR
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHR 127
Query: 652 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 711
D+K N + + VK+ DFG+S++++ + + GTP +++PEL +N+P+ K DI+
Sbjct: 128 DIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIW 187
Query: 712 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP---LGRLIADC-WAEPQER 767
SLG +++ELCTL P+EG + + G IP L L++ +P+ER
Sbjct: 188 SLGCVLYELCTLKHPFEGENLLELALKILK-GQYPPIPSQYSSELRNLVSSLLQKDPEER 246
Query: 768 PSCEEILSR 776
PS +IL
Sbjct: 247 PSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 8e-47
Identities = 94/262 (35%), Positives = 141/262 (53%), Gaps = 13/262 (4%)
Query: 524 IDFSELTVGTRVGIGFFGEVFRGIWNGT-DVAIKVFLEQDLTAENMEDFCNEISILSRLR 582
ID SELT +G G FG V G W G DVAIK+ E + + +DF E ++ +L
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLS 57
Query: 583 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
HPN++ G CTK + ++TEYM G L L +L +K KL L M D+C +
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCL--LNYLRERKGKLGTEWLLDMCSDVCEAMEY 115
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRN 701
+ +HRDL + NCLV + VK+ DFGL+R + D S P +W PE+
Sbjct: 116 LESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY 175
Query: 702 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE---GPLGRLI 757
F+ K D++S GV+MWE+ + + P+E VV +V+ G RL P+ + ++
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIM 234
Query: 758 ADCWAE-PQERPSCEEILSRLL 778
CW E P++RP+ +++LS+L
Sbjct: 235 YSCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 99/266 (37%), Positives = 137/266 (51%), Gaps = 16/266 (6%)
Query: 524 IDFSELTVGTRVGIGFFGEVFRGIWNGT-----DVAIKVFLEQDLTAENMEDFCNEISIL 578
ID S +T+ +G G FGEV RG DVAIK L+ + + DF E SI+
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKT-LKAGSSDKQRLDFLTEASIM 59
Query: 579 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 638
+ HPN+I G TK + +ITEYME GSL L K + + + MLR I
Sbjct: 60 GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKF--LRENDGKFTVGQLVGMLRGIAS 117
Query: 639 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS-PMRDSSSAGTP-EWMAP 696
G+ + M VHRDL + N LVN + K+ DFGLSR + DS + P W AP
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAP 177
Query: 697 ELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPE---GP 752
E I FT D++S G++MWE+ + RP+ + + V+ AV +G RL P
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV-EDGYRLPPPMDCPSA 236
Query: 753 LGRLIADCW-AEPQERPSCEEILSRL 777
L +L+ DCW + ERP+ +I+S L
Sbjct: 237 LYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 3e-46
Identities = 86/264 (32%), Positives = 134/264 (50%), Gaps = 31/264 (11%)
Query: 527 SELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENMEDFCNEISILSRLRH 583
T+ +G G FGEV++ I T+ VAIKV LE+ + +ED EI LS+ R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE--DEIEDIQQEIQFLSQCRS 58
Query: 584 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 643
P + + G+ K +L +I EY GS L+ KL +LR++ GL +
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYL 114
Query: 644 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP 703
H +HRD+K+AN L+++ VK+ DFG+S +T + + ++ GTP WMAPE+I+
Sbjct: 115 HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 704 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAE 763
+ EK DI+SLG+ EL P + P RV++ IP+ L + +++
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF---------LIPKNNPPSLEGNKFSK 225
Query: 764 -------------PQERPSCEEIL 774
P+ERPS +E+L
Sbjct: 226 PFKDFVSLCLNKDPKERPSAKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 7e-46
Identities = 78/254 (30%), Positives = 134/254 (52%), Gaps = 12/254 (4%)
Query: 529 LTVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV 586
++G G GEV++ T +VAIK L +N E NEI I+ +HPN+
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKM---RLRKQNKELIINEILIMKDCKHPNI 77
Query: 587 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 646
+ + + L ++ EYM+ GSL +I + +++ + + R++ +GL +H
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLTDIITQN--FVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 647 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTE 706
++HRD+KS N L++K +VK+ DFG + +T + +S GTP WMAPE+I+ + +
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGP 195
Query: 707 KCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIADCWA 762
K DI+SLG++ E+ P+ P R ++ + +G L+ PE + C
Sbjct: 196 KVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLV 255
Query: 763 -EPQERPSCEEILS 775
+P++RPS EE+L
Sbjct: 256 KDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 3e-45
Identities = 86/261 (32%), Positives = 145/261 (55%), Gaps = 13/261 (4%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 581
W I+ EL +G +G G FG+V G + G VA+K L+ D TA + F E S+++ L
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKC-LKDDSTA--AQAFLAEASVMTTL 57
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
RHPN++ LG + L ++TEYM GSL + G + ++ ++L D+C G+
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGME 116
Query: 642 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 701
+ VHRDL + N LV++ K+ DFGL++ ++ S +W APE +R
Sbjct: 117 YLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKLPVKWTAPEALRE 173
Query: 702 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 757
+ F+ K D++S G+++WE+ + R P+ + + VV V G R+E PEG + +++
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-GYRMEAPEGCPPEVYKVM 232
Query: 758 ADCW-AEPQERPSCEEILSRL 777
DCW +P +RP+ +++ +L
Sbjct: 233 KDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 4e-45
Identities = 83/249 (33%), Positives = 134/249 (53%), Gaps = 12/249 (4%)
Query: 534 RVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 591
++G G FGEV++ G +VAIKV + + E E NEI IL + +HPN++ + G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPNIVKYYG 64
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651
+ K L ++ E+ GSL L+ + Q S + +++ +GL +H I+HR
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYV--CKELLKGLEYLHSNGIIHR 122
Query: 652 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 711
D+K+AN L+ VK+ DFGLS ++D+ R+ + GTP WMAPE+I +P+ K DI+
Sbjct: 123 DIKAANILLTSDGEVKLIDFGLSAQLSDTKARN-TMVGTPYWMAPEVINGKPYDYKADIW 181
Query: 712 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIADCWA-EPQE 766
SLG+ EL P+ + P + ++ +A G L PE + C P++
Sbjct: 182 SLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEK 241
Query: 767 RPSCEEILS 775
RP+ E++L
Sbjct: 242 RPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 4e-44
Identities = 85/267 (31%), Positives = 136/267 (50%), Gaps = 16/267 (5%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENM--EDFCNEISIL 578
W ID + + + ++G G FGEV+ G+WN T VA+K L M +DF E I+
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKT-----LKPGTMDPKDFLAEAQIM 55
Query: 579 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 638
+LRHP +I CT + ++TE M+ GSL + G + L + + M +
Sbjct: 56 KKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQ-GGAGRALKLPQLIDMAAQVAS 114
Query: 639 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPE 697
G+ + +HRDL + N LV ++ K+ DFGL+R+I + A P +W APE
Sbjct: 115 GMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPE 174
Query: 698 LIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PL 753
F+ K D++S G+++ E+ T R P+ G+ V+ V +G R+ P G L
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKEL 233
Query: 754 GRLIADCW-AEPQERPSCEEILSRLLD 779
++ DCW +P +RP+ E + +L D
Sbjct: 234 YDIMLDCWKEDPDDRPTFETLQWKLED 260
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 3e-42
Identities = 88/262 (33%), Positives = 139/262 (53%), Gaps = 13/262 (4%)
Query: 524 IDFSELTVGTRVGIGFFGEVFRGIWNGT-DVAIKVFLEQDLTAENMEDFCNEISILSRLR 582
ID +LT +G G FG V G W G DVAIK+ E ++ + +F E ++ +L
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLS 57
Query: 583 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
H ++ G CTK + ++TEYM G L L +L K+ + L+M +D+C G+
Sbjct: 58 HEKLVQLYGVCTKQRPIYIVTEYMSNGCL--LNYLREHGKRFQPSQLLEMCKDVCEGMAY 115
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRN 701
+ + +HRDL + NCLV+ VK+ DFGLSR + D S + P W PE++
Sbjct: 116 LESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLY 175
Query: 702 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEGPLGRLIA-- 758
F+ K D+++ GV+MWE+ +L + P+E V V+ +G RL P ++ A
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIM 234
Query: 759 -DCWAE-PQERPSCEEILSRLL 778
CW E +ERP+ +++LS +
Sbjct: 235 YSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 4e-42
Identities = 83/260 (31%), Positives = 144/260 (55%), Gaps = 13/260 (5%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILS 579
W ++ +++T+ ++G G +GEV+ G+W VA+K E + +E+F E +++
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMK 57
Query: 580 RLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 639
++HPN++ LG CT+ P +ITE+M G+L + +++++ L M I
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSA 116
Query: 640 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPEL 698
+ + + +HRDL + NCLV ++ VK+ DFGLSR++T + A P +W APE
Sbjct: 117 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 176
Query: 699 IRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPEG---PLG 754
+ F+ K D+++ GV++WE+ T P+ G+ + VY + +G R+E PEG +
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKGYRMERPEGCPPKVY 235
Query: 755 RLIADCWA-EPQERPSCEEI 773
L+ CW P +RPS EI
Sbjct: 236 ELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 5e-42
Identities = 92/261 (35%), Positives = 139/261 (53%), Gaps = 13/261 (4%)
Query: 524 IDFSELTVGTRVGIGFFGEVFRGIWNGT-DVAIKVFLEQDLTAENMEDFCNEISILSRLR 582
I+ SELT +G G FG V G W VAIK E A + EDF E ++ +L
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINE---GAMSEEDFIEEAKVMMKLS 57
Query: 583 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
HP ++ G CT+ L ++TE+ME G L + +L ++ KLS L M +D+C G+
Sbjct: 58 HPKLVQLYGVCTQQKPLYIVTEFMENGCLLN--YLRQRQGKLSKDMLLSMCQDVCEGMEY 115
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRN 701
+ R +HRDL + NCLV+ VK+ DFG++R + D SS A P +W PE+
Sbjct: 116 LERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF 175
Query: 702 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE---GPLGRLI 757
++ K D++S GV+MWE+ T + P+E VV ++ G RL P+ + ++
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFRLYRPKLASMTVYEVM 234
Query: 758 ADCWAE-PQERPSCEEILSRL 777
CW E P+ RP+ E+L +
Sbjct: 235 YSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 5e-42
Identities = 89/281 (31%), Positives = 142/281 (50%), Gaps = 27/281 (9%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNE 574
W + ++T+ +G G FG V+ G+ G T VAIK E E +E F NE
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNE 59
Query: 575 ISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK---------LS 625
S++ +V+ LG + ++ E M G L +L ++ + +
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKS--YLRSRRPEAENNPGLGPPT 117
Query: 626 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMR 683
++ ++M +I G+ + K VHRDL + NC+V + TVKI DFG++R I TD +
Sbjct: 118 LQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 684 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANE 742
WMAPE +++ FT K D++S GV++WE+ TL +P++G+ E V+ V +
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-D 236
Query: 743 GSRLEIPEGP---LGRLIADCWA-EPQERPSCEEILSRLLD 779
G L++PE L L+ CW P+ RP+ EI+S L D
Sbjct: 237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 85/250 (34%), Positives = 141/250 (56%), Gaps = 15/250 (6%)
Query: 535 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRH---PNVILF 589
+G G +G V+RG T VA+K+ + D +++ D E+++LS+LR PN+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKI-INLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 590 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 649
G+ K PRL +I EY E GS+ L+ ++ + ++R++ L IH++ ++
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVGVI 123
Query: 650 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKC 708
HRD+K+AN LV VK+CDFG++ ++ + + S+ GTP WMAPE+I + + K
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKA 183
Query: 709 DIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIPEGP--LGRLIADCW-AEP 764
DI+SLG+ ++E+ T N P+ V R + + ++ RLE L +A C EP
Sbjct: 184 DIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEP 243
Query: 765 QERPSCEEIL 774
+ER S EE+L
Sbjct: 244 KERLSAEELL 253
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 5e-40
Identities = 83/263 (31%), Positives = 138/263 (52%), Gaps = 12/263 (4%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNGT-DVAIKVFLEQDLTAENMEDFCNEISILSR 580
W E T+ ++G G+FGEV+ G+W VAIK+ L+ D +DF E+ L R
Sbjct: 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKI-LKSD-DLLKQQDFQKEVQALKR 58
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
LRH ++I C+ + +ITE ME GSL + S + + L + M + G+
Sbjct: 59 LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLR-SPEGQVLPVASLIDMACQVAEGM 117
Query: 641 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 699
+ +HRDL + N LV + K+ DFGL+R+I + + SS P +W APE
Sbjct: 118 AYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKWTAPEAA 176
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIP-EGP--LGR 755
+ F+ K D++S G++++E+ T + P+ G+ V + G R+ P + P + +
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYK 235
Query: 756 LIADCW-AEPQERPSCEEILSRL 777
++ +CW AEP++RPS + + L
Sbjct: 236 IMLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 5e-40
Identities = 82/267 (30%), Positives = 131/267 (49%), Gaps = 16/267 (5%)
Query: 524 IDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDFCNEISIL 578
I ++T+G +G G FG+V++G++ VA+K + + E F E I+
Sbjct: 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVREKFLQEAYIM 61
Query: 579 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 638
+ HP+++ +G T+ P + ++ E LG L +L K L + +
Sbjct: 62 RQFDHPHIVKLIGVITENP-VWIVMELAPLGELRS--YLQVNKYSLDLASLILYSYQLST 118
Query: 639 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPE 697
L + + VHRD+ + N LV+ VK+ DFGLSR + D +S P +WMAPE
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 698 LIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPEG---PL 753
I FT D++ GV MWE+ L +P++GV V+ + N G RL +P L
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN-GERLPMPPNCPPTL 237
Query: 754 GRLIADCWA-EPQERPSCEEILSRLLD 779
L+ CWA +P +RP E+ ++L D
Sbjct: 238 YSLMTKCWAYDPSKRPRFTELKAQLSD 264
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 77/251 (30%), Positives = 126/251 (50%), Gaps = 10/251 (3%)
Query: 535 VGIGFFGE--VFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 592
+G G FGE ++R + + V K L+ + D NEI ILS L+HPN+I +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 593 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKL-SWRRKLKMLRDICRGLMCIHRMKIVHR 651
L + EY G+LY I QK +L L L I + IH+ I+HR
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKI--VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHR 125
Query: 652 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 711
D+K+ N + K +K+ DFG+S+I+ + GTP +M+PEL + + K DI+
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIW 185
Query: 712 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQER 767
+LG +++EL TL R ++ P +V + +G+ + L L+ +P++R
Sbjct: 186 ALGCVLYELLTLKRTFDATNPLNLVVKIV-QGNYTPVVSVYSSELISLVHSLLQQDPEKR 244
Query: 768 PSCEEILSRLL 778
P+ +E+L + L
Sbjct: 245 PTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 89/261 (34%), Positives = 137/261 (52%), Gaps = 13/261 (4%)
Query: 524 IDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR 582
I SELT+ +G G FG V+ G W VAIK E A + EDF E ++ +L
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE---GAMSEEDFIEEAQVMMKLS 57
Query: 583 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
HP ++ G CT+ + ++ E+ME G L +L Q+ K S L M D+C G+
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSD--YLRAQRGKFSQETLLGMCLDVCEGMAY 115
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRN 701
+ ++HRDL + NCLV ++ VK+ DFG++R + D S+ P +W +PE+
Sbjct: 116 LESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF 175
Query: 702 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE---GPLGRLI 757
++ K D++S GV+MWE+ + + P+E VV + N G RL P + L+
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI-NAGFRLYKPRLASQSVYELM 234
Query: 758 ADCWAE-PQERPSCEEILSRL 777
CW E P++RPS +L +L
Sbjct: 235 QHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 77/254 (30%), Positives = 134/254 (52%), Gaps = 16/254 (6%)
Query: 534 RVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 592
++G G FG+V++G+ T+VA+K L + F E IL + HPN++ +G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKT-CRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 593 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 652
C + + ++ E + GSL L L +K +L+ ++ L+M D G+ + +HRD
Sbjct: 61 CVQKQPIYIVMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRD 118
Query: 653 LKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WMAPELIRNEPFTEKC 708
L + NCLV ++ +KI DFG+SR + + S G + W APE + +T +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 709 DIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-E 763
D++S G+++WE +L + P+ G+ ++ + G R+ P+ + RL+ CWA +
Sbjct: 177 DVWSYGILLWETFSLGDTPYPGMSNQQTRERI-ESGYRMPAPQLCPEEIYRLMLQCWAYD 235
Query: 764 PQERPSCEEILSRL 777
P+ RPS EI + L
Sbjct: 236 PENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 77/249 (30%), Positives = 129/249 (51%), Gaps = 15/249 (6%)
Query: 535 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 592
+G G +G V++ I G VAIKV E++++ EISIL + P ++ + G+
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 593 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 652
K L ++ EY GS+ ++ ++ K L+ +L +GL +H K +HRD
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNKKIHRD 124
Query: 653 LKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-AGTPEWMAPELIRNEPFTEKCDIF 711
+K+ N L+N+ K+ DFG+S +TD+ M ++ GTP WMAPE+I+ + K DI+
Sbjct: 125 IKAGNILLNEEGQAKLADFGVSGQLTDT-MAKRNTVIGTPFWMAPEVIQEIGYNNKADIW 183
Query: 712 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIADCWA-EPQE 766
SLG+ E+ P+ + P R ++ + N+ L PE + C +P+E
Sbjct: 184 SLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEE 243
Query: 767 RPSCEEILS 775
RPS ++L
Sbjct: 244 RPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 9e-39
Identities = 92/265 (34%), Positives = 135/265 (50%), Gaps = 13/265 (4%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSR 580
W I L + ++G G FGEV+ G WNG T VA+K ++ E+ F E I+ +
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES---FLEEAQIMKK 57
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
LRH ++ ++ P + ++TEYM GSL + G+ + L + M + G+
Sbjct: 58 LRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLK-DGEGRALKLPNLVDMAAQVAAGM 115
Query: 641 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 699
I RM +HRDL+SAN LV KI DFGL+R+I D+ A P +W APE
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGR 755
FT K D++S G+++ EL T R P+ G + R V G R+ P+ L
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPG-MNNREVLEQVERGYRMPCPQDCPISLHE 234
Query: 756 LIADCW-AEPQERPSCEEILSRLLD 779
L+ CW +P+ERP+ E + S L D
Sbjct: 235 LMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 95/265 (35%), Positives = 136/265 (51%), Gaps = 13/265 (4%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNGT-DVAIKVFLEQDLTAENMEDFCNEISILSR 580
W I L + ++G G FGEV+ G WNGT VAIK + E F E I+ +
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKK 57
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
LRH ++ ++ P + ++TE+M GSL + G K L + + M I G+
Sbjct: 58 LRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLK-EGDGKYLKLPQLVDMAAQIADGM 115
Query: 641 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 699
I RM +HRDL++AN LV + KI DFGL+R+I D+ A P +W APE
Sbjct: 116 AYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGR 755
FT K D++S G+++ EL T R P+ G++ V+ V G R+ P+G L
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV-ERGYRMPCPQGCPESLHE 234
Query: 756 LIADCW-AEPQERPSCEEILSRLLD 779
L+ CW +P ERP+ E I S L D
Sbjct: 235 LMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 7e-38
Identities = 83/281 (29%), Positives = 128/281 (45%), Gaps = 50/281 (17%)
Query: 535 VGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 588
+G G FG+V ++ G VA+K L ++ DF EI IL L H N++
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKS-LNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 589 FLGACTKPPR--LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 646
+ G C KP L +I EY+ GSL +L + +++ +R L IC+G+ +
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRD--YLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 647 KIVHRDLKSANCLVNKHWTVKICDFGLSRIIT------------DSPMRDSSSAGTPEWM 694
+ +HRDL + N LV VKI DFGL++++ +SP+ W
Sbjct: 129 RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF---------WY 179
Query: 695 APELIRNEPFTEKCDIFSLGVIMWELCTLNRP--------WEGVLPERVVYAVAN----- 741
APE +R F+ D++S GV ++EL T P + + V
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239
Query: 742 -EGSRLEIPEG-P--LGRLIADCW-AEPQERPSCEEILSRL 777
EG RL P P + L+ CW AEPQ+RPS +++ +
Sbjct: 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 1e-37
Identities = 82/261 (31%), Positives = 145/261 (55%), Gaps = 15/261 (5%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 581
W ++ +LT+G +G G FG V +G + G VA+K ++ D+TA+ F E +++++L
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKN-IKCDVTAQA---FLEETAVMTKL 56
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
H N++ LG L ++ E M G+L + + G + +S + L+ D+ G+
Sbjct: 57 HHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGME 114
Query: 642 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 701
+ K+VHRDL + N LV++ K+ DFGL+R+ M +S +W APE +++
Sbjct: 115 YLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLPVKWTAPEALKH 171
Query: 702 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 757
+ F+ K D++S GV++WE+ + R P+ + + V V +G R+E PEG + L+
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV-EKGYRMEPPEGCPADVYVLM 230
Query: 758 ADCW-AEPQERPSCEEILSRL 777
CW EP++RPS ++ +L
Sbjct: 231 TSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 94/266 (35%), Positives = 143/266 (53%), Gaps = 15/266 (5%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSR 580
W + L + ++G G FGEV+ G +NG T VAIK + ++ E F E +++ +
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA---FLAEANLMKQ 57
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
L+HP ++ T+ P + +ITEYME GSL + + + KL+ + + M I G+
Sbjct: 58 LQHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLK-TPEGIKLTINKLIDMAAQIAEGM 115
Query: 641 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 699
I R +HRDL++AN LV++ KI DFGL+R+I D+ A P +W APE I
Sbjct: 116 AFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVL-PERVVYAVANEGSRLEIPEG---PLG 754
FT K D++S G+++ E+ T R P+ G+ PE V G R+ P+ L
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNLERGYRMPRPDNCPEELY 233
Query: 755 RLIADCWAE-PQERPSCEEILSRLLD 779
L+ CW E P+ERP+ E + S L D
Sbjct: 234 ELMRLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 1e-37
Identities = 82/256 (32%), Positives = 134/256 (52%), Gaps = 18/256 (7%)
Query: 530 TVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
V ++G G +G V++ + + A+K ++ + ED NEI IL+ + HPN+I
Sbjct: 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII 62
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKL-----SWRRKLKMLRDICRGLMC 642
+ A +L ++ EY G L I +K+KL WR +++ RGL
Sbjct: 63 SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL----LRGLQA 118
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE 702
+H KI+HRDLKSAN L+ + VKI D G+S+++ + + + GTP +MAPE+ +
Sbjct: 119 LHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK--TQIGTPHYMAPEVWKGR 176
Query: 703 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIAD 759
P++ K DI+SLG +++E+ T P+E + + Y V G IP L I
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-GKYPPIPPIYSQDLQNFIRS 235
Query: 760 CW-AEPQERPSCEEIL 774
+P+ RP+C++IL
Sbjct: 236 MLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 96/267 (35%), Positives = 137/267 (51%), Gaps = 17/267 (6%)
Query: 524 IDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISIL 578
ID S + + +G G FGEV G VAIK L+ T + DF +E SI+
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKT-LKAGYTEKQRRDFLSEASIM 59
Query: 579 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 638
+ HPN+I G TK + ++TEYME GSL L + + + + MLR I
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAF--LRKHDGQFTVIQLVGMLRGIAS 117
Query: 639 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP---EWMA 695
G+ + M VHRDL + N LVN + K+ DFGLSR++ D P ++ G W A
Sbjct: 118 GMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA 177
Query: 696 PELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG--- 751
PE I FT D++S G++MWE+ + RP+ + + V+ A+ EG RL P
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI-EEGYRLPAPMDCPA 236
Query: 752 PLGRLIADCW-AEPQERPSCEEILSRL 777
L +L+ DCW + ERP E+I+S L
Sbjct: 237 ALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 2e-37
Identities = 85/267 (31%), Positives = 135/267 (50%), Gaps = 22/267 (8%)
Query: 533 TRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENME-DFCNEISILSRLRHP 584
T +G G FGEVF G + V +K + EN++ +F E+ + +L H
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHK 68
Query: 585 NVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK------KKLSWRRKLKMLRDICR 638
NV+ LG C + MI EY +LG L + + K LS ++K+ + I
Sbjct: 69 NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128
Query: 639 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPE 697
G+ + + VHRDL + NCLV+ VK+ LS+ + +S +A P W+APE
Sbjct: 129 GMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 698 LIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PL 753
++ + F+ K D++S GV+MWE+ T P+ G+ E V+ + L +PEG L
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRL 248
Query: 754 GRLIADCWA-EPQERPSCEEILSRLLD 779
+L+ CWA P++RPS E++S L +
Sbjct: 249 YKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 2e-37
Identities = 79/264 (29%), Positives = 136/264 (51%), Gaps = 18/264 (6%)
Query: 527 SELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSR 580
+EL +G G FG V++G+W VAIKV L ++ + + ++ +E +++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKV-LREETSPKANKEILDEAYVMAS 65
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
+ HP+V+ LG C ++ +IT+ M LG L L ++ K + + L I +G+
Sbjct: 66 VDHPHVVRLLGICLSS-QVQLITQLMPLGCL--LDYVRNHKDNIGSQYLLNWCVQIAKGM 122
Query: 641 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII-TDSPMRDSSSAGTP-EWMAPEL 698
+ ++VHRDL + N LV VKI DFGL++++ D + P +WMA E
Sbjct: 123 SYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 699 IRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPE---GPLG 754
I + +T K D++S GV +WEL T +P+EG+ P + + +G RL P +
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGERLPQPPICTIDVY 241
Query: 755 RLIADCWAEPQE-RPSCEEILSRL 777
++ CW E RP+ +E+++
Sbjct: 242 MVLVKCWMIDAESRPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 3e-37
Identities = 96/266 (36%), Positives = 141/266 (53%), Gaps = 15/266 (5%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNGT-DVAIKVFLEQDLTAENMEDFCNEISILSR 580
W I L + ++G G FGEV+ G WNGT VAIK ++ E F E ++ +
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKK 57
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK-LSWRRKLKMLRDICRG 639
LRH ++ ++ P + ++TEYM GSL L L G+ K L + + M I G
Sbjct: 58 LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASG 114
Query: 640 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPEL 698
+ + RM VHRDL++AN LV ++ K+ DFGL+R+I D+ A P +W APE
Sbjct: 115 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 699 IRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIP-EGP--LG 754
FT K D++S G+++ EL T R P+ G++ V+ V G R+ P E P L
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESLH 233
Query: 755 RLIADCW-AEPQERPSCEEILSRLLD 779
L+ CW EP+ERP+ E + + L D
Sbjct: 234 DLMCQCWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 9e-37
Identities = 97/296 (32%), Positives = 139/296 (46%), Gaps = 59/296 (19%)
Query: 527 SELTVGTRVGIGFFGEV----------------FRGIWNG--TDVAIKVFLEQDLTAENM 568
L ++G G FGEV VA+KV L D +
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKV-LRPDASDNAR 63
Query: 569 EDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-----YHLIHLSG---Q 620
EDF E+ ILSRL PN+ LG CT P L MI EYME G L H+ SG
Sbjct: 64 EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123
Query: 621 KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680
K LS+ L M I G+ + + VHRDL + NCLV K++T+KI DFG+SR + S
Sbjct: 124 SKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS 183
Query: 681 -----------PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR--PW 727
P+R WMA E + FT K D+++ GV +WE+ TL R P+
Sbjct: 184 DYYRVQGRAPLPIR---------WMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY 234
Query: 728 EGVLPERVV----YAVANEGSRLEIPEGP-----LGRLIADCWA-EPQERPSCEEI 773
E + ++V+ + ++G ++ +P P + L+ +CW + ++RP+ EI
Sbjct: 235 EHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 93/258 (36%), Positives = 135/258 (52%), Gaps = 18/258 (6%)
Query: 535 VGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 589
+G G FGEVFRGI VAIK L+ T + +DF +E SI+ + H N+I
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKT-LKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 590 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 649
G TK +ITEYME G+L +L + S + + MLR I G+ + M V
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDK--YLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 650 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP---EWMAPELIRNEPFTE 706
HRDL + N LVN + K+ DFGLSR++ D P +++G W APE I FT
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS 189
Query: 707 KCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW- 761
D++S G++MWE+ + RP+ + V+ A+ N+G RL P + +L+ CW
Sbjct: 190 ASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-NDGFRLPAPMDCPSAVYQLMLQCWQ 248
Query: 762 AEPQERPSCEEILSRLLD 779
+ RP +I++ LLD
Sbjct: 249 QDRARRPRFVDIVN-LLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 79/259 (30%), Positives = 116/259 (44%), Gaps = 16/259 (6%)
Query: 534 RVGIGFFGEVFRGIW---NGT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 588
++G G FG V RG W G VA+K L+ D ++ M+DF E +I+ L H N+I
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKC-LKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 589 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 648
G P L M+TE LGSL + I G+ + +
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRLRKD-ALGHFLISTLCDYAVQIANGMRYLESKRF 118
Query: 649 VHRDLKSANCLVNKHWTVKICDFGLSR--IITDSPMRDSSSAGTP-EWMAPELIRNEPFT 705
+HRDL + N L+ VKI DFGL R + P W APE +R F+
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178
Query: 706 EKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW 761
D++ GV +WE+ T PW G+ +++ + EG RLE PE + ++ CW
Sbjct: 179 HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCW 238
Query: 762 A-EPQERPSCEEILSRLLD 779
A P +RP+ + L +
Sbjct: 239 AHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 85/286 (29%), Positives = 147/286 (51%), Gaps = 30/286 (10%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFC 572
EW + LT+G +G G FG+V + G D VA+K+ L+ D T +++ D
Sbjct: 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKM-LKDDATEKDLSDLV 63
Query: 573 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-------------YHLIHLS 618
+E+ ++ + +H N+I LG CT+ L ++ EY G+L
Sbjct: 64 SEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123
Query: 619 GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678
++ L+ + + + RG+ + K +HRDL + N LV + +KI DFGL+R I
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIH 183
Query: 679 DSPM-RDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERV 735
R +++ P +WMAPE + + +T + D++S GV++WE+ TL P+ G+ P
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEE 242
Query: 736 VYAVANEGSRLEIPEG---PLGRLIADCWAE-PQERPSCEEILSRL 777
++ + EG R+E P+ L L+ DCW E P +RP+ ++++ L
Sbjct: 243 LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 89/284 (31%), Positives = 143/284 (50%), Gaps = 37/284 (13%)
Query: 529 LTVGTRVGIGFFGEVFR-------GIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 581
L +G +G G FG+V + G T VA+K+ E ++E D +E ++L ++
Sbjct: 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELR-DLLSEFNLLKQV 60
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ--------------------- 620
HP+VI GAC++ L +I EY + GSL + S +
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 621 KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--T 678
++ L+ + I RG+ + MK+VHRDL + N LV + +KI DFGLSR +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 679 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVY 737
DS ++ S +WMA E + + +T + D++S GV++WE+ TL P+ G+ PER ++
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-LF 239
Query: 738 AVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 777
+ G R+E PE + L+ CW EP +RP+ +I L
Sbjct: 240 NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 83/271 (30%), Positives = 135/271 (49%), Gaps = 25/271 (9%)
Query: 529 LTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFCNEISILSRL 581
+T+ +G G FGEV+ G++ G D VA+K L + + ++ DF E I+S+
Sbjct: 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKT-LPESCSEQDESDFLMEALIMSKF 66
Query: 582 RHPNVILFLGAC-TKPPRLSMITEYMELGSLYHLIHLS----GQKKKLSWRRKLKMLRDI 636
H N++ +G + PR ++ E M G L + + + L+ + L RD+
Sbjct: 67 NHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 637 CRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLSR-IITDSPMRDSSSAGTP- 691
+G + +HRD+ + NCL+ KI DFG++R I S R A P
Sbjct: 126 AKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 692 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE 750
+WM PE + FT K D++S GV++WE+ +L P+ G + V G RL+ P+
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG-RTNQEVMEFVTGGGRLDPPK 244
Query: 751 G---PLGRLIADCW-AEPQERPSCEEILSRL 777
G P+ R++ DCW P++RP+ IL R+
Sbjct: 245 GCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 87/246 (35%), Positives = 140/246 (56%), Gaps = 10/246 (4%)
Query: 534 RVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 591
++G G FGEVF+GI N T VAIK+ ++ + + +ED EI++LS+ P V + G
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651
+ K +L +I EY+ GS L+ + L + +LR+I +GL +H K +HR
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKKIHR 125
Query: 652 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 711
D+K+AN L+++H VK+ DFG++ +TD+ ++ ++ GTP WMAPE+I+ + K DI+
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIW 185
Query: 712 SLGVIMWELCTLNRPWEGVLPERVVYAV-ANEGSRLEIP-EGPLGRLIADCW-AEPQERP 768
SLG+ EL P + P +V++ + N LE PL + C EP RP
Sbjct: 186 SLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 245
Query: 769 SCEEIL 774
+ +E+L
Sbjct: 246 TAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 76/260 (29%), Positives = 129/260 (49%), Gaps = 18/260 (6%)
Query: 530 TVGTRVGIGFFGEVFRGI--WNGTDVA---IKVFLEQDLTAENMEDFCNEISILSRLRHP 584
+ ++G G F V++ I +G VA +++F D A+ +D EI +L +L HP
Sbjct: 5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD--AKARQDCLKEIDLLKQLDHP 62
Query: 585 NVILFLGACTKPPRLSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLMCI 643
NVI +L + + L+++ E + G L +I H QK+ + R K +C L +
Sbjct: 63 NVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM 122
Query: 644 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP 703
H +I+HRD+K AN + VK+ D GL R + S GTP +M+PE I
Sbjct: 123 HSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182
Query: 704 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-------LGRL 756
+ K DI+SLG +++E+ L P+ G + +Y++ + + + P P L L
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEKCDYPPLPADHYSEELRDL 240
Query: 757 IADCW-AEPQERPSCEEILS 775
++ C +P++RP +L
Sbjct: 241 VSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 86/272 (31%), Positives = 133/272 (48%), Gaps = 35/272 (12%)
Query: 535 VGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
+G G FG VF+ G T VA+K+ L+++ +A+ DF E ++++ HPN++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 588 LFLGACTKPPRLSMITEYMELGSLYH-LIHLS------------------GQKKKLSWRR 628
LG C + ++ EYM G L L H S LS
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 629 KLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDSS 686
+L + + + G+ + K VHRDL + NCLV ++ VKI DFGLSR I D +
Sbjct: 132 QLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEN 191
Query: 687 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSR 745
A WM PE I +T + D+++ GV++WE+ + +P+ G+ E V+Y V +G+
Sbjct: 192 DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYV-RDGNV 250
Query: 746 LEIPEG-PLG--RLIADCWA-EPQERPSCEEI 773
L P+ PL L+ CW+ P +RPS I
Sbjct: 251 LSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 78/255 (30%), Positives = 124/255 (48%), Gaps = 18/255 (7%)
Query: 532 GTRVGIGFFGEVFRGI--WNGTDVAIKVFL---EQDLTAENMEDFCNEISILSRLRHPNV 586
G +G G FG V+ G+ +G A+K + E ++ EI++LS+L+HPN+
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 587 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML--RDICRGLMCIH 644
+ +LG + L + E + GSL L+ KK S+ + L R I GL +H
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLL-----KKYGSFPEPVIRLYTRQILLGLEYLH 119
Query: 645 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-P 703
VHRD+K AN LV+ + VK+ DFG+++ + + S G+P WMAPE+I +
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA-KSFKGSPYWMAPEVIAQQGG 178
Query: 704 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE--GPLGRL-IADC 760
+ DI+SLG + E+ T PW + V+ + IP+ + I C
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKC 238
Query: 761 W-AEPQERPSCEEIL 774
+P RP+ E+L
Sbjct: 239 LQRDPSLRPTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 82/261 (31%), Positives = 132/261 (50%), Gaps = 30/261 (11%)
Query: 534 RVGIGFFGEVF--RGIWNGTDVAIKVF-LEQDLTAENMEDFCNEISILSRLRHPNVILFL 590
R+G G +G+V+ R I G VAIKV LE ++ E EIS+L RHPN++ +
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYF 66
Query: 591 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK------MLRDICRGLMCIH 644
G+ + +L ++ EY GSL + ++ R L + R+ +GL +H
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQDIYQVT--------RGPLSELQIAYVCRETLKGLAYLH 118
Query: 645 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI---RN 701
+HRD+K AN L+ + VK+ DFG+S +T + + S GTP WMAPE+ R
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERK 178
Query: 702 EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS---RLEIPE--GPLGRL 756
+ KCDI++LG+ EL L P + P R ++ ++ +L+ E P+
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHD 238
Query: 757 -IADCWA-EPQERPSCEEILS 775
I C +P++RP+ ++L
Sbjct: 239 FIKKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 88/269 (32%), Positives = 137/269 (50%), Gaps = 33/269 (12%)
Query: 535 VGIGFFGEVFRG-----IWNGTD---VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV 586
+G G FGEV+ G + G+ VA+K L + T + ++F E ++S HPN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKT-LRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 587 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK------LSWRRKLKMLRDICRGL 640
+ LG C +I E ME G L +L + + L+ + L + D+ +G
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLS--YLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 641 MCIHRMKIVHRDLKSANCLV-----NKHWTVKICDFGLSRIITDSPMRDSSSAG--TPEW 693
+ + +M +HRDL + NCLV + VKI DFGL+R I S G W
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 694 MAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPE-- 750
MAPE + + FT + D++S GV+MWE+ TL +P+ + + V+ V G RL+ PE
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-RLQKPENC 238
Query: 751 -GPLGRLIADCWA-EPQERPS---CEEIL 774
+ +L+ +CWA +P ERP+ +EIL
Sbjct: 239 PDKIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 73/262 (27%), Positives = 123/262 (46%), Gaps = 29/262 (11%)
Query: 534 RVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENM-----EDFCNEISILSRLRHPNVIL 588
+G G FG V + K+ + +++ NM + +E++IL L+HPN++
Sbjct: 7 TIGKGSFGTVRKVRRKSDG---KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 589 FLGACTKPP--RLSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLMCIHR 645
+ L ++ EY E G L LI ++K + ++L + L H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 646 -----MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 700
++HRDLK AN ++ + VK+ DFGL++I+ + GTP +M+PE +
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLN 183
Query: 701 NEPFTEKCDIFSLGVIMWELCTLNRPWEG----VLPERVVYAVANEGSRLEIPEG---PL 753
+ + EK DI+SLG +++ELC L+ P+ L ++ EG IP L
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI-----KEGKFRRIPYRYSSEL 238
Query: 754 GRLIADCWA-EPQERPSCEEIL 774
+I +P +RPS EE+L
Sbjct: 239 NEVIKSMLNVDPDKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 85/268 (31%), Positives = 132/268 (49%), Gaps = 27/268 (10%)
Query: 535 VGIGFFGEVFRG----IWNGTD---VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
+G G FG+VF G + D VA+K L++ + + +DF E +L+ +H N++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKT-LKETASNDARKDFEREAELLTNFQHENIV 71
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSG-----------QKKKLSWRRKLKMLRDI 636
F G CT+ M+ EYME G L + G +L+ + L++ I
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 637 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTP-EWM 694
G++ + VHRDL + NCLV VKI DFG+SR + T R P WM
Sbjct: 132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWM 191
Query: 695 APELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG-P 752
PE I FT + D++S GV++WE+ T + PW G+ E V+ + +G L+ P P
Sbjct: 192 PPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI-TQGRLLQRPRTCP 250
Query: 753 LG--RLIADCW-AEPQERPSCEEILSRL 777
++ CW +PQ+R + ++I RL
Sbjct: 251 SEVYDIMLGCWKRDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 75/269 (27%), Positives = 124/269 (46%), Gaps = 34/269 (12%)
Query: 527 SELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHP 584
S+L +G G G V++ G A+K D E + E+ L P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHV-DGDEEFRKQLLRELKTLRSCESP 59
Query: 585 NVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 644
V+ GA K +S++ EYM+ GSL L+ + K+ + R I +GL +H
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLL---KKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 645 RM-KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP 703
I+HRD+K +N L+N VKI DFG+S+++ ++ + ++ GT +M+PE I+ E
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES 176
Query: 704 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----IPEGPLGRLIAD 759
++ DI+SLG+ + E G P + + S E I +GP L A+
Sbjct: 177 YSYAADIWSLGLTLLECAL------GKFP----FLPPGQPSFFELMQAICDGPPPSLPAE 226
Query: 760 CWA-------------EPQERPSCEEILS 775
++ +P++RPS E+L
Sbjct: 227 EFSPEFRDFISACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 94/269 (34%), Positives = 136/269 (50%), Gaps = 19/269 (7%)
Query: 524 IDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISIL 578
ID S + + +G G FGEV RG VAIK L+ T + DF +E SI+
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKT-LKSGYTEKQRRDFLSEASIM 59
Query: 579 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDIC 637
+ HPN+I G TK + +ITE+ME G+L + + GQ + + + MLR I
Sbjct: 60 GQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ---FTVIQLVGMLRGIA 116
Query: 638 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS---PMRDSSSAGT-P-E 692
G+ + M VHRDL + N LVN + K+ DFGLSR + D P SS G P
Sbjct: 117 AGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176
Query: 693 WMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG 751
W APE I FT D++S G++MWE+ + RP+ + + V+ A+ + +
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDC 236
Query: 752 P--LGRLIADCWA-EPQERPSCEEILSRL 777
P L +L+ DCW + RP +I+S L
Sbjct: 237 PTALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 5e-34
Identities = 84/255 (32%), Positives = 140/255 (54%), Gaps = 10/255 (3%)
Query: 534 RVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 591
R+G G FGEV++GI N T VAIK+ ++ + + +ED EI++LS+ P + + G
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651
+ K +L +I EY+ GS L+ + L +LR+I +GL +H + +HR
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERKIHR 125
Query: 652 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 711
D+K+AN L+++ VK+ DFG++ +TD+ ++ ++ GTP WMAPE+I+ + K DI+
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIW 185
Query: 712 SLGVIMWELCTLNRPWEGVLPERVVYAV-ANEGSRLEIPEG-PLGRLIADCW-AEPQERP 768
SLG+ EL P + P RV++ + N LE P + C +P+ RP
Sbjct: 186 SLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRP 245
Query: 769 SCEEILSRLLDCEYS 783
+ +E+L Y+
Sbjct: 246 TAKELLKHKFITRYT 260
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 85/255 (33%), Positives = 138/255 (54%), Gaps = 28/255 (10%)
Query: 534 RVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 591
R+G G FGEVF+GI N T VAIK+ ++ + + +ED EI++LS+ P V + G
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651
+ K +L +I EY+ GS L+ +G + + ML++I +GL +H K +HR
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLR-AGPFDEF---QIATMLKEILKGLDYLHSEKKIHR 125
Query: 652 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 711
D+K+AN L+++ VK+ DFG++ +TD+ ++ ++ GTP WMAPE+I+ + K DI+
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIW 185
Query: 712 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIAD-----------C 760
SLG+ EL P + P RV++ IP+ L + C
Sbjct: 186 SLGITAIELAKGEPPNSDMHPMRVLF---------LIPKNNPPTLTGEFSKPFKEFIDAC 236
Query: 761 W-AEPQERPSCEEIL 774
+P RP+ +E+L
Sbjct: 237 LNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 92/282 (32%), Positives = 136/282 (48%), Gaps = 34/282 (12%)
Query: 523 NIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEI 575
+ F E +G G FG+V++G G T VAIK L+++ + ++F E
Sbjct: 6 AVRFLE-----ELGEGAFGKVYKGELTGPNERLSATSVAIKT-LKENAEPKVQQEFRQEA 59
Query: 576 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY-HLIHLS------------GQKK 622
++S L+HPN++ LG CTK M+ EY+ G L+ L+ S K
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 623 KLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP- 681
L L + I G+ + VHRDL + NCLV + TVKI DFGLSR I +
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY 179
Query: 682 MRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAV 739
R S + P WM PE I FT + DI+S GV++WE+ + +P+ G + V+ +
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239
Query: 740 ANEGSRLEIPEG---PLGRLIADCWAE-PQERPSCEEILSRL 777
L PE + L+ +CW E P RP ++I +RL
Sbjct: 240 -RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 73/259 (28%), Positives = 127/259 (49%), Gaps = 20/259 (7%)
Query: 532 GTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 589
G ++G G FG+V+ + G +A+K QD + +++ +E+ +L L+HPN++ +
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 590 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 649
G ++ + EY G+L L+ + R L GL +H IV
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL---LEGLAYLHSHGIV 121
Query: 650 HRDLKSANCLVNKHWTVKICDFGLSRIITDS----PMRDSSSAGTPEWMAPELIRNEPFT 705
HRD+K AN ++ + +K+ DFG + + ++ S AGTP +MAPE+I
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181
Query: 706 EK---CDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGSRLEIPE----GPLG-RL 756
DI+SLG ++ E+ T RPW + E ++++ V G + IP+ P G
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG-AGHKPPIPDSLQLSPEGKDF 240
Query: 757 IADCWA-EPQERPSCEEIL 774
+ C +P++RP+ E+L
Sbjct: 241 LDRCLESDPKKRPTASELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 132 bits (331), Expect = 3e-33
Identities = 77/268 (28%), Positives = 127/268 (47%), Gaps = 16/268 (5%)
Query: 528 ELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ-DLTAENMEDFCNEISILSRLRHPNV 586
+ ++G G FGEV+ + VA+KV ++ + ++ +E F EI IL+ L HP
Sbjct: 1 SYRILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 587 IL-FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 645
I+ L ++ EY++ GSL L+ G+K LS L +L I L +H
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 646 MKIVHRDLKSANCLVNKH-WTVKICDFGLSRIITDS------PMRDSSSAGTPEWMAPEL 698
I+HRD+K N L+++ VK+ DFGL++++ D P S+S GTP +MAPE+
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 699 IR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR 755
+ + DI+SLG+ ++EL T P+EG E+ A + + P
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG---EKNSSATSQTLKIILELPTPSLA 236
Query: 756 LIADCWAEPQERPSCEEILSRLLDCEYS 783
+ ++L +LL +
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPK 264
|
Length = 384 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 79/272 (29%), Positives = 129/272 (47%), Gaps = 45/272 (16%)
Query: 535 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 591
+G G +G+V++ T VAIK+ D+ + E+ E +IL + HPN+ F G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKI---MDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 592 ACTKP------PRLSMITEYMELGSLYHLI---HLSGQKKKLSWRRKLKMLRDICRGLMC 642
A K +L ++ E GS+ L+ G++ K W + LR+ RGL
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI--LRETLRGLAY 128
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI--- 699
+H K++HRD+K N L+ K+ VK+ DFG+S + + R ++ GTP WMAPE+I
Sbjct: 129 LHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACD 188
Query: 700 --RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRL- 756
+ + + D++SLG+ EL P + P R ++ +IP P L
Sbjct: 189 EQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF---------KIPRNPPPTLK 239
Query: 757 ------------IADCWAE-PQERPSCEEILS 775
I++C + ++RP EE+L
Sbjct: 240 SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 83/265 (31%), Positives = 136/265 (51%), Gaps = 12/265 (4%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSR 580
W I + + ++G G FGEV+ G + N T VA+K ++ ++ F E +++
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKT 57
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
L+H ++ TK + +ITEYM GSL + S + K+ + + I G+
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLK-SDEGGKVLLPKLIDFSAQIAEGM 116
Query: 641 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 699
I R +HRDL++AN LV++ KI DFGL+R+I D+ A P +W APE I
Sbjct: 117 AYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 176
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGR 755
FT K D++S G++++E+ T + P+ G+ V+ A+ G R+ E L
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-QRGYRMPRMENCPDELYD 235
Query: 756 LIADCWAE-PQERPSCEEILSRLLD 779
++ CW E +ERP+ + + S L D
Sbjct: 236 IMKTCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 5e-32
Identities = 83/250 (33%), Positives = 126/250 (50%), Gaps = 24/250 (9%)
Query: 553 VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL- 611
VA+K+ L D+T DF EI I+SRL++PN+I LG C L MITEYME G L
Sbjct: 47 VAVKM-LRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 612 --------YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH 663
+ +S L M I G+ + + VHRDL + NCLV H
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNH 165
Query: 664 WTVKICDFGLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELC 721
+T+KI DFG+SR + + R A P WMA E I FT D+++ GV +WE+
Sbjct: 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMF 225
Query: 722 TL--NRPWEGVLPERVVYAVA----NEGSRLEIPE-----GPLGRLIADCWA-EPQERPS 769
TL +P+ + E+V+ N+G ++ + + P+ +L+ CW+ + ++RP+
Sbjct: 226 TLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPT 285
Query: 770 CEEILSRLLD 779
+I L +
Sbjct: 286 FNKIHHFLRE 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 80/263 (30%), Positives = 130/263 (49%), Gaps = 21/263 (7%)
Query: 534 RVGIGFFGEVFRGIW---NGT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 588
+G G FG V +G++ +G +VA+K L+Q+ A ++F E S++++L HP ++
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKT-LKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 589 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK-MLRDICRGLMCIHRMK 647
+G C P L ++ E LG L + +K++ LK + + G+ +
Sbjct: 61 LIGVCKGEP-LMLVMELAPLGPLLKYL----KKRREIPVSDLKELAHQVAMGMAYLESKH 115
Query: 648 IVHRDLKSANCL-VNKHWTVKICDFGLSRII-TDSPMRDSSSAGT-P-EWMAPELIRNEP 703
VHRDL + N L VN+H KI DFG+SR + S +++AG P +W APE I
Sbjct: 116 FVHRDLAARNVLLVNRHQ-AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 704 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADC 760
F+ K D++S GV +WE + G + V A+ G RL PE + ++ C
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSC 234
Query: 761 WA-EPQERPSCEEILSRLLDCEY 782
W P++RP+ E+ S
Sbjct: 235 WKYRPEDRPTFSELESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 80/262 (30%), Positives = 137/262 (52%), Gaps = 15/262 (5%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 581
W ++ EL + +G G FG+V G + G VA+K ++ D TA+ F E S++++L
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKC-IKNDATAQA---FLAEASVMTQL 56
Query: 582 RHPNVILFLGACTKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
RH N++ LG + L ++TEYM GSL + G + L LK D+C +
Sbjct: 57 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAM 115
Query: 641 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 700
+ VHRDL + N LV++ K+ DFGL++ S +D+ +W APE +R
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPV-KWTAPEALR 172
Query: 701 NEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGRL 756
+ F+ K D++S G+++WE+ + R P+ + + VV V G +++ P+G + +
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPVVYDV 231
Query: 757 IADCWA-EPQERPSCEEILSRL 777
+ CW + RPS ++ +L
Sbjct: 232 MKQCWHLDAATRPSFLQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 8e-32
Identities = 80/254 (31%), Positives = 133/254 (52%), Gaps = 19/254 (7%)
Query: 535 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 592
+G G FG+++ + + IK + + E E+ +L++++HPN++ F +
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 593 CTKPPRLSMITEYMELGSLYHLIH-----LSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
+ RL ++ EY + G L I+ L + + LSW I GL IH K
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLKHIHDRK 121
Query: 648 IVHRDLKSANCLVNKHWTV-KICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTE 706
I+HRD+KS N ++K+ V K+ DFG++R + DS + GTP +++PE+ +N P+
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNN 181
Query: 707 KCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-A 762
K DI+SLG +++ELCTL P+EG ++V + +G I L LI+ +
Sbjct: 182 KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC-QGYFAPISPNFSRDLRSLISQLFKV 240
Query: 763 EPQERPSCEEILSR 776
P++RPS IL R
Sbjct: 241 SPRDRPSITSILKR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 84/276 (30%), Positives = 140/276 (50%), Gaps = 16/276 (5%)
Query: 517 LAYEE-WNIDFSELTVGTRVGIGFFGEVFRGIWNG---TDVAIKV---FLEQDLTAENME 569
L Y+ W + L+ G +G G FG+V G +D +KV L+ + E
Sbjct: 24 LPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSERE 83
Query: 570 DFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRR 628
+E+ I+S L H N++ LGACT + +ITEY G L + + ++ L+
Sbjct: 84 ALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR-RKRESFLTLED 142
Query: 629 KLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSS 687
L + +G+ + +HRDL + N L+ VKICDFGL+R I+ DS +
Sbjct: 143 LLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGN 202
Query: 688 AGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSR 745
A P +WMAPE I N +T + D++S G+++WE+ +L P+ G+ + Y + EG R
Sbjct: 203 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR 262
Query: 746 LEIPE---GPLGRLIADCWA-EPQERPSCEEILSRL 777
+ PE + ++ CW +P +RP+ ++I+ +
Sbjct: 263 MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 9e-32
Identities = 86/274 (31%), Positives = 137/274 (50%), Gaps = 25/274 (9%)
Query: 529 LTVGTRVGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLTAENMEDFCNEISILSRLRH 583
L +G +G G FG V G + D VA+K T +E+F +E + + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 584 PNVILFLGAC------TKPPRLSMITEYMELGSLYHLI---HLSGQKKKLSWRRKLKMLR 634
PNV+ +G C K P+ +I +M+ G L+ + L G +KL + LK +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 635 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTP-E 692
DI G+ + +HRDL + NC++ + TV + DFGLS+ I + R A P +
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180
Query: 693 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG 751
W+A E + + +T K D+++ GV MWE+ T + P+ GV +Y G+RL+ PE
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV-ENHEIYDYLRHGNRLKQPED 239
Query: 752 PLGRL---IADCW-AEPQERPS---CEEILSRLL 778
L L + CW A+P++RP+ E+L +L
Sbjct: 240 CLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 84/269 (31%), Positives = 131/269 (48%), Gaps = 21/269 (7%)
Query: 529 LTVGTRVGIGFFGEVFRGIWNGTD----VAIKVFLEQDLTAENMEDFCNEISILSRLRHP 584
L +G +G G FG V G N D VA+K T MEDF +E + HP
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 585 NVILFLGACTKP------PRLSMITEYMELGSLYHLI---HLSGQKKKLSWRRKLKMLRD 635
NV+ +G C + P +I +M+ G L+ + L + L + +K + D
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 636 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-MRDSSSAGTP-EW 693
I G+ + +HRDL + NC++N++ V + DFGLS+ I + R A P +W
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 694 MAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEGP 752
+A E + + +T K D++S GV MWE+ T + P+ GV +Y +G+RL+ P
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV-ENSEIYDYLRQGNRLKQPPDC 239
Query: 753 LG---RLIADCWA-EPQERPSCEEILSRL 777
L L++ CW P++RPS E + L
Sbjct: 240 LDGLYSLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 56/197 (28%), Positives = 110/197 (55%), Gaps = 3/197 (1%)
Query: 534 RVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 591
++G G FG VF+ + + A+K + E+ +E +L++L +I +
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651
+ +L+++ EY E G L+ L+ + + L + + I GL +H KI+HR
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLK-MQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHR 125
Query: 652 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 711
D+KS N ++ + VKI D G++++++D+ ++ GTP +++PEL ++P+ EK D++
Sbjct: 126 DIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVW 185
Query: 712 SLGVIMWELCTLNRPWE 728
+LGV+++E CT P++
Sbjct: 186 ALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 79/273 (28%), Positives = 129/273 (47%), Gaps = 35/273 (12%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDV--AIKVFLEQDLTAENMEDFCNEISI 577
+ W I EL G G FG+V++ T + A K+ + E +EDF EI I
Sbjct: 5 DIWEI-IGEL------GDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDI 55
Query: 578 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK------ 631
LS +HPN++ A +L ++ E+ + G+L ++ L R L
Sbjct: 56 LSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIM--------LELERGLTEPQIRY 107
Query: 632 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 691
+ R + L +H K++HRDLK+ N L+ VK+ DFG+S + + + GTP
Sbjct: 108 VCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTP 167
Query: 692 EWMAPELI-----RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSR 745
WMAPE++ ++ P+ K DI+SLG+ + EL + P + P RV+ + +E
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPT 227
Query: 746 LEIPEG---PLGRLIADCWA-EPQERPSCEEIL 774
L+ P + C +P +RP+ E+L
Sbjct: 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 87/265 (32%), Positives = 134/265 (50%), Gaps = 13/265 (4%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSR 580
W I L + ++G G FGEV+ +N T VA+K ++ +E F E +++
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKT 57
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
L+H ++ TK P + +ITE+M GSL + S + K + + I G+
Sbjct: 58 LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLK-SDEGSKQPLPKLIDFSAQIAEGM 115
Query: 641 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 699
I + +HRDL++AN LV+ KI DFGL+R+I D+ A P +W APE I
Sbjct: 116 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGR 755
FT K D++S G+++ E+ T R P+ G+ V+ A+ G R+ PE L
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCPEELYN 234
Query: 756 LIADCW-AEPQERPSCEEILSRLLD 779
++ CW P+ERP+ E I S L D
Sbjct: 235 IMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 5e-31
Identities = 76/265 (28%), Positives = 129/265 (48%), Gaps = 21/265 (7%)
Query: 528 ELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC----NEISILSRL 581
E G ++G G F + R + GT +A+K T+ E+ EI +++RL
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
HP++I LGA + ++ E+M GS+ HL+ G K+ + + RGL
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE---AVIINYTEQLLRGLS 117
Query: 642 CIHRMKIVHRDLKSANCLVNKH-WTVKICDFG----LSRIITDSPMRDSSSAGTPEWMAP 696
+H +I+HRD+K AN L++ ++I DFG L+ T + GT +MAP
Sbjct: 118 YLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 697 ELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER---VVYAVANEGSRLEIPE--G 751
E++R E + CD++S+G ++ E+ T PW +++ +A+ + IPE
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237
Query: 752 PLGRLIA-DCW-AEPQERPSCEEIL 774
P R + C +P++RP E+L
Sbjct: 238 PGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 6e-31
Identities = 83/249 (33%), Positives = 126/249 (50%), Gaps = 23/249 (9%)
Query: 553 VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY 612
VA+K+ L +D DF EI I+SRL+ PN+I L C L MITEYME G L
Sbjct: 49 VAVKM-LREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 613 HLIH--------LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 664
+ +S+ + M I G+ + + VHRDL + NCLV K++
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY 167
Query: 665 TVKICDFGLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCT 722
T+KI DFG+SR + + R A P WM+ E I FT D+++ GV +WE+ T
Sbjct: 168 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
Query: 723 L--NRPWEGVLPERVVYAVA----NEGSRLEIPEGP-----LGRLIADCW-AEPQERPSC 770
L +P+ + E+V+ ++G ++ +P+ L +L+ CW +ERPS
Sbjct: 228 LCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSF 287
Query: 771 EEILSRLLD 779
+EI + LL+
Sbjct: 288 QEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 6e-31
Identities = 82/286 (28%), Positives = 146/286 (51%), Gaps = 32/286 (11%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTD---------VAIKVFLEQDLTAENMEDFC 572
W +LT+G +G G FG+V G D VA+K+ L+ D T +++ D
Sbjct: 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKM-LKDDATEKDLSDLV 68
Query: 573 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSG------------ 619
+E+ ++ + +H N+I LGACT+ L +I EY G+L +
Sbjct: 69 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128
Query: 620 -QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678
++++++ + + RG+ + K +HRDL + N LV ++ +KI DFGL+R +
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVN 188
Query: 679 DSPMRDSSSAG--TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERV 735
+ ++ G +WMAPE + + +T + D++S GV+MWE+ TL P+ G+ P
Sbjct: 189 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 247
Query: 736 VYAVANEGSRLEIP---EGPLGRLIADCW-AEPQERPSCEEILSRL 777
++ + EG R++ P L ++ DCW A P RP+ ++++ L
Sbjct: 248 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 81/262 (30%), Positives = 131/262 (50%), Gaps = 27/262 (10%)
Query: 535 VGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 589
+G G FG V+ G +D A+K L + E +E F E I+ HPNV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKS-LNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 590 LGACTKPPRLSMIT-EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 648
LG C ++ YM+ G L + I + + + + + +G+ + K
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIR--SETHNPTVKDLIGFGLQVAKGMEYLASKKF 119
Query: 649 VHRDLKSANCLVNKHWTVKICDFGLSRIITDS---PMRDSSSAGTP-EWMAPELIRNEPF 704
VHRDL + NC++++ +TVK+ DFGL+R I D + + + A P +WMA E ++ + F
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179
Query: 705 TEKCDIFSLGVIMWELCTLNRPWEGVLPERVV--YAVAN---EGSRLEIPE---GPLGRL 756
T K D++S GV++WEL T G P V + + +G RL PE PL +
Sbjct: 180 TTKSDVWSFGVLLWELMT-----RGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEV 234
Query: 757 IADCW-AEPQERPSCEEILSRL 777
+ CW +P+ RP+ E++SR+
Sbjct: 235 MLSCWHPKPEMRPTFSELVSRI 256
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 9e-31
Identities = 90/279 (32%), Positives = 144/279 (51%), Gaps = 23/279 (8%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNE 574
W + ++T+ +G G FG V+ GI G T VAIK E E +E F NE
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNE 59
Query: 575 ISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKK------LSWR 627
S++ +V+ LG ++ +I E M G L +L L + + S +
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119
Query: 628 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDS 685
+ ++M +I G+ ++ K VHRDL + NC+V + +TVKI DFG++R I TD +
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGS 744
WM+PE +++ FT D++S GV++WE+ TL +P++G+ E+V+ V EG
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-EGG 238
Query: 745 RLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLD 779
L+ P+ L L+ CW P+ RPS EI+S + +
Sbjct: 239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 59/220 (26%), Positives = 109/220 (49%), Gaps = 8/220 (3%)
Query: 535 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC-NEISILSRLRHPNVILFLG 591
+G G FG+V R G A+KV ++ + + E +ILSR+ HP ++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651
A +L ++ EY G L+ + ++ + S R +I L +H + I++R
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLS---KEGRFSEERARFYAAEIVLALEYLHSLGIIYR 117
Query: 652 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 711
DLK N L++ +K+ DFGL++ ++ R ++ GTPE++APE++ + + + D +
Sbjct: 118 DLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWW 177
Query: 712 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG 751
SLGV+++E+ T P+ + + + L PE
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEF 215
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 71/255 (27%), Positives = 124/255 (48%), Gaps = 16/255 (6%)
Query: 535 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 592
+G+G V+ I N VAIK ++ + ++++ E+ +S+ HPNV+ + +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKR-IDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 593 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 652
L ++ Y+ GSL ++ S + L +L+++ +GL +H +HRD
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRD 127
Query: 653 LKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS----AGTPEWMAPELIRNEP-FTEK 707
+K+ N L+ + +VKI DFG+S + D R GTP WMAPE++ + K
Sbjct: 128 IKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFK 187
Query: 708 CDIFSLGVIMWELCTLNRPWEGVLPERV-VYAVANEGSRLEIPE--GPLGR----LIADC 760
DI+S G+ EL T P+ P +V + + N+ LE + +I+ C
Sbjct: 188 ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLC 247
Query: 761 W-AEPQERPSCEEIL 774
+P +RP+ EE+L
Sbjct: 248 LQKDPSKRPTAEELL 262
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 3e-30
Identities = 84/258 (32%), Positives = 119/258 (46%), Gaps = 37/258 (14%)
Query: 553 VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY 612
VA+K+ L D DF E+ ILSRL+ PN+I LG C L MITEYME G L
Sbjct: 49 VAVKI-LRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 613 HLI---HL-------------SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 656
+ HL + +S+ L + I G+ + + VHRDL +
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATR 167
Query: 657 NCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLG 714
NCLV ++ T+KI DFG+SR + R A P WMA E I FT D+++ G
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227
Query: 715 VIMWELCTLNR--PWEGVLPERVVYAVANEG------------SRLEIPEGPLGRLIADC 760
V +WE+ L + P+ + E+V + N G R L L+ C
Sbjct: 228 VTLWEILMLCKEQPYGELTDEQV---IENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQC 284
Query: 761 WA-EPQERPSCEEILSRL 777
W+ + +ERPS +I + L
Sbjct: 285 WSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 76/256 (29%), Positives = 119/256 (46%), Gaps = 17/256 (6%)
Query: 532 GTRVGIGFFGEVF--RGIWNGTDVAIKVF----LEQDLTAENMEDFCNEISILSRLRHPN 585
G +G G FG V+ + G ++A+K + E + EI +L L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKE-VNALECEIQLLKNLQHER 65
Query: 586 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 645
++ + G LS+ EYM GS+ + G L+ K R I G+ +H
Sbjct: 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHS 122
Query: 646 MKIVHRDLKSANCLVNKHWTVKICDFGLSR---IITDSPMRDSSSAGTPEWMAPELIRNE 702
IVHRD+K AN L + VK+ DFG S+ I S S GTP WM+PE+I E
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 703 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG--PLGR-LIAD 759
+ K D++S+G + E+ T PW ++ +A + + ++P P R +
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRR 242
Query: 760 CWAEP-QERPSCEEIL 774
+ E ++RPS EE+L
Sbjct: 243 TFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 74/264 (28%), Positives = 125/264 (47%), Gaps = 27/264 (10%)
Query: 538 GFFGEVFRGIWNGT------DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 591
G FG +F GI +V +K ++ + + E +L L H N++ L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKT-VKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 592 ACTKPPRLSMITE-YMELGSLYHLI----HLSGQKKK-LSWRRKLKMLRDICRGLMCIHR 645
C + + YM G+L + + LS ++ + M I G+ +H+
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 646 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE-----WMAPELIR 700
++H+D+ + NC++++ VKI D LSR + PM D G E WMA E +
Sbjct: 136 RGVIHKDIAARNCVIDEELQVKITDNALSRDLF--PM-DYHCLGDNENRPVKWMALESLV 192
Query: 701 NEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIP---EGPLGRL 756
N+ ++ D++S GV++WEL TL + P+ + P + A +G RL P L +
Sbjct: 193 NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYLKDGYRLAQPINCPDELFAV 251
Query: 757 IADCWA-EPQERPSCEEILSRLLD 779
+A CWA +P+ERPS +++ L D
Sbjct: 252 MACCWALDPEERPSFSQLVQCLTD 275
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 83/270 (30%), Positives = 127/270 (47%), Gaps = 29/270 (10%)
Query: 535 VGIGFFGEVFRG-------IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
+G G FG+VF + VA+K ++ + +DF E +L+ L+H +++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTVLQHQHIV 70
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK------------LSWRRKLKMLRD 635
F G CT+ L M+ EYM G L + G K L+ + L +
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 636 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDSSSAGTPEW 693
I G++ + + VHRDL + NCLV + VKI DFG+SR I TD + W
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 190
Query: 694 MAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE-- 750
M PE I FT + DI+S GV++WE+ T + PW + + + +G LE P
Sbjct: 191 MPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI-TQGRELERPRTC 249
Query: 751 -GPLGRLIADCWA-EPQERPSCEEILSRLL 778
+ ++ CW EPQ+R ++I SRL
Sbjct: 250 PPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 29/207 (14%)
Query: 534 RVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDL-----TAENMEDFCNEISILSRLRHPN 585
++G G +G V++ T VA+K L+ + TA EIS+L L+HPN
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA------LREISLLKELKHPN 59
Query: 586 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 645
++ L +L ++ EY ++ L + + LS ++ + RGL H
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDK--RPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 646 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APELIR 700
+I+HRDLK N L+N+ +K+ DFGL+R P+R T E W APE++
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFG-IPLRTY----THEVVTLWYRAPEILL 171
Query: 701 NEPF-TEKCDIFSLGVIMWELCTLNRP 726
+ DI+S+G I E+ T +P
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMIT-GKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 2e-29
Identities = 83/262 (31%), Positives = 133/262 (50%), Gaps = 22/262 (8%)
Query: 527 SELTVGTRVGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSR 580
+EL +G G FG V++GIW VAIK+ E N+E F +E I++
Sbjct: 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMAS 65
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
+ HP+++ LG C P + ++T+ M G L +H K + + L I +G+
Sbjct: 66 MDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVH--EHKDNIGSQLLLNWCVQIAKGM 122
Query: 641 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT-DSPMRDSSSAGTP-EWMAPEL 698
M + ++VHRDL + N LV VKI DFGL+R++ D ++ P +WMA E
Sbjct: 123 MYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 699 IRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEGPLGRL- 756
I FT + D++S GV +WEL T +P++G+ P R + + +G RL P+ P+ +
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERL--PQPPICTID 239
Query: 757 ----IADCWA-EPQERPSCEEI 773
+ CW + RP +E+
Sbjct: 240 VYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 71/250 (28%), Positives = 130/250 (52%), Gaps = 10/250 (4%)
Query: 534 RVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 591
++G G FG+ + +G IK ++ + E+ E+++LS ++HPN++ +
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKL-SWRRKLKMLRDICRGLMCIHRMKIVH 650
+ + L ++ +Y E G LY I + Q+ L + L IC L +H KI+H
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKI--NAQRGVLFPEDQILDWFVQICLALKHVHDRKILH 124
Query: 651 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 710
RD+KS N + K T+K+ DFG++R++ + + GTP +++PE+ N P+ K DI
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDI 184
Query: 711 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWAE-PQE 766
++LG +++E+CTL +E + +V + GS + L L++ + P++
Sbjct: 185 WALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQLFKRNPRD 243
Query: 767 RPSCEEILSR 776
RPS IL +
Sbjct: 244 RPSVNSILEK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 74/255 (29%), Positives = 126/255 (49%), Gaps = 14/255 (5%)
Query: 526 FSELTVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLR 582
+ + ++G G F EV+R + +G VA+K DL A+ D EI +L +L
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 583 HPNVILFLGACTKPPRLSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLM 641
HPNVI + + + L+++ E + G L +I H QK+ + + K +C L
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 642 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 701
+H +++HRD+K AN + VK+ D GL R + S GTP +M+PE I
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 702 EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-------LG 754
+ K DI+SLG +++E+ L P+ G + +Y++ + + + P P L
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238
Query: 755 RLIADCW-AEPQERP 768
+L+ C +P++RP
Sbjct: 239 QLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 84/286 (29%), Positives = 146/286 (51%), Gaps = 32/286 (11%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTD---------VAIKVFLEQDLTAENMEDFC 572
W + L +G +G G FG+V G D VA+K+ L+ D T +++ D
Sbjct: 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKM-LKSDATEKDLSDLI 71
Query: 573 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHL-------------S 618
+E+ ++ + +H N+I LGACT+ L +I EY G+L +
Sbjct: 72 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131
Query: 619 GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII- 677
+++LS++ + + RG+ + K +HRDL + N LV + +KI DFGL+R I
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191
Query: 678 -TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERV 735
D + ++ +WMAPE + + +T + D++S GV++WE+ TL P+ GV P
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE 250
Query: 736 VYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 777
++ + EG R++ P L ++ DCW A P +RP+ ++++ L
Sbjct: 251 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 84/291 (28%), Positives = 146/291 (50%), Gaps = 35/291 (12%)
Query: 521 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD---------VAIKVFLEQDLTAENMEDF 571
+W L +G +G G FG+V R G D VA+K+ L+ + T +++ D
Sbjct: 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKM-LKDNATDKDLADL 64
Query: 572 CNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHL------------- 617
+E+ ++ + +H N+I LG CT+ L +I EY G+L +
Sbjct: 65 ISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDIT 124
Query: 618 SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677
+++LS++ + + RG+ + + +HRDL + N LV + +KI DFGL+R +
Sbjct: 125 KVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGV 184
Query: 678 TDSPMRDSSSAG--TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPER 734
D +S G +WMAPE + + +T + D++S G++MWE+ TL P+ G+ P
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-PVE 243
Query: 735 VVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPS---CEEILSRLL 778
++ + EG R++ P L L+ +CW A P +RP+ E L ++L
Sbjct: 244 ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 1e-28
Identities = 83/292 (28%), Positives = 151/292 (51%), Gaps = 32/292 (10%)
Query: 516 LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD---------VAIKVFLEQDLTAE 566
L A +W + + LT+G +G G FG+V G D VA+K+ L+ D T +
Sbjct: 1 LPADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKM-LKDDATDK 59
Query: 567 NMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-------------Y 612
++ D +E+ ++ + +H N+I LGACT+ L ++ EY G+L Y
Sbjct: 60 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDY 119
Query: 613 HLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 672
+++L+++ + + RG+ + K +HRDL + N LV + +KI DFG
Sbjct: 120 SFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFG 179
Query: 673 LSRIITDSPMRDSSSAG--TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEG 729
L+R + + ++ G +WMAPE + + +T + D++S GV++WE+ TL P+ G
Sbjct: 180 LARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239
Query: 730 VLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 777
+ P ++ + EG R++ P L ++ +CW A P +RP+ ++++ L
Sbjct: 240 I-PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 75/247 (30%), Positives = 126/247 (51%), Gaps = 17/247 (6%)
Query: 534 RVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 591
R+G G FGEVF G + T VA+K E L + F E IL + HPN++ +G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651
CT+ + ++ E ++ G L L + +L + ++M+ + G+ + +HR
Sbjct: 61 VCTQKQPIYIVMELVQGGDF--LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHR 118
Query: 652 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WMAPELIRNEPFTEK 707
DL + NCLV + +KI DFG+SR D +S+ G + W APE + ++ +
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVY--ASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 708 CDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA- 762
D++S G+++WE +L P+ + ++ A+ +G RL PE + RL+ CW
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-EQGVRLPCPELCPDAVYRLMERCWEY 235
Query: 763 EPQERPS 769
+P +RPS
Sbjct: 236 DPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 75/250 (30%), Positives = 130/250 (52%), Gaps = 11/250 (4%)
Query: 535 VGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 593
+G G FGEVF+G + + T VA+K ++DL E F +E IL + HPN++ +G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKT-CKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 594 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL 653
T+ + ++ E + G L L +K +L ++ +K D G+ + +HRDL
Sbjct: 62 TQRQPIYIVMELVPGGDF--LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDL 119
Query: 654 KSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFS 712
+ NCLV ++ +KI DFG+SR D S P +W APE + ++ + D++S
Sbjct: 120 AARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWS 179
Query: 713 LGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQER 767
G+++WE +L P+ G+ ++ V +G R+ P+ + +++ CW +P+ R
Sbjct: 180 YGILLWETFSLGVCPYPGMTNQQAREQV-EKGYRMSCPQKCPDDVYKVMQRCWDYKPENR 238
Query: 768 PSCEEILSRL 777
P E+ L
Sbjct: 239 PKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 7e-28
Identities = 71/255 (27%), Positives = 129/255 (50%), Gaps = 14/255 (5%)
Query: 526 FSELTVGTRVGIGFFGEVFRG--IWNGTDVAIK-VFLEQDLTAENMEDFCNEISILSRLR 582
+ + ++G G F EV+R + + VA+K V + + + A+ +D EI +L +L
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 583 HPNVILFLGACTKPPRLSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLM 641
HPNVI +L + + L+++ E + G L +I + QK+ + R K +C +
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 642 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 701
+H +++HRD+K AN + VK+ D GL R + S GTP +M+PE I
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 702 EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-------LG 754
+ K DI+SLG +++E+ L P+ G + ++++ + + + P P L
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238
Query: 755 RLIADC-WAEPQERP 768
L++ C + +P +RP
Sbjct: 239 ELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 10/202 (4%)
Query: 534 RVGIGFFGEVFRGIWNGTD--VAIKVFL--EQDLTAENMEDFCNEISILSRLRHPNVILF 589
++G G +G V++ T VAIK + EI +L L HPN+I
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA--LREIKLLKELNHPNIIKL 63
Query: 590 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 649
L L ++ E+M+ LY LI +++ L L + +GL H I+
Sbjct: 64 LDVFRHKGDLYLVFEFMDT-DLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120
Query: 650 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPF-TEKC 708
HRDLK N L+N +K+ DFGL+R + T + APEL+ + +
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180
Query: 709 DIFSLGVIMWELCTLNRPWEGV 730
DI+S+G I EL + + G
Sbjct: 181 DIWSVGCIFAELLSRRPLFPGK 202
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 77/247 (31%), Positives = 123/247 (49%), Gaps = 8/247 (3%)
Query: 535 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 592
VG G FG V R + V IK + +T + NE +L L HPN+I +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 593 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 652
+ L ++ EY G+L I L L I L +H I+HRD
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKLILHRD 126
Query: 653 LKSANCLVNKHWTV-KICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 711
LK+ N L++KH V KI DFG+S+I++ S + + GTP +++PEL +P+ +K DI+
Sbjct: 127 LKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVVGTPCYISPELCEGKPYNQKSDIW 185
Query: 712 SLGVIMWELCTLNRPWEGV-LPERVVYAVANEGSRLEIPEGP-LGRLIADCWA-EPQERP 768
+LG +++EL +L R +E LP V+ ++ + + P L +LI +P +RP
Sbjct: 186 ALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRP 245
Query: 769 SCEEILS 775
+I++
Sbjct: 246 QLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 86/278 (30%), Positives = 134/278 (48%), Gaps = 30/278 (10%)
Query: 523 NIDFSELTVGTRVGIGFFGEVFRG-IWNGTD------VAIKVFLEQDLTAENMEDFCNEI 575
+I ++ + +G G FG+VF +N + VA+K + L A +DF E
Sbjct: 1 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREA 58
Query: 576 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYH---------LIHLSGQ----KK 622
+L+ L+H +++ F G C L M+ EYM+ G L +I + GQ K
Sbjct: 59 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 118
Query: 623 KLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP- 681
+L + L + I G++ + VHRDL + NCLV + VKI DFG+SR + +
Sbjct: 119 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178
Query: 682 MRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAV 739
R P WM PE I FT + D++S GVI+WE+ T + PW + V+ +
Sbjct: 179 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238
Query: 740 ANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEI 773
+G LE P + ++ CW EPQ+R + +EI
Sbjct: 239 -TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 71/218 (32%), Positives = 117/218 (53%), Gaps = 8/218 (3%)
Query: 564 TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK 623
++ +ED E +L++++HPN++ F + L ++ EY + G L I L Q+ K
Sbjct: 38 SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKL--QRGK 95
Query: 624 LSWRRK-LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682
L L+ +C G+ IH +++HRD+KS N + ++ VK+ DFG +R++T
Sbjct: 96 LFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155
Query: 683 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE 742
+ GTP ++ PE+ N P+ K DI+SLG I++ELCTL P++ + ++ V +
Sbjct: 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-Q 214
Query: 743 GSRLEIPEG---PLGRLIADCWAE-PQERPSCEEILSR 776
GS +P L LI + P+ RPS ILSR
Sbjct: 215 GSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 62/236 (26%), Positives = 100/236 (42%), Gaps = 44/236 (18%)
Query: 525 DFSELTVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDF-CNEISILSRL 581
DF G +G G F V + AIK+ ++ L E + E +L+RL
Sbjct: 2 DFK---FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRL 58
Query: 582 -RHPNVI-LFLGACT--KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
HP +I L+ T L + EY G L I G L K R
Sbjct: 59 NGHPGIIKLY---YTFQDEENLYFVLEYAPNGELLQYIRKYG---SLD----EKCTRFYA 108
Query: 638 RGLMC----IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM----------- 682
++ +H I+HRDLK N L++K +KI DFG ++++ +
Sbjct: 109 AEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 683 ---------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
R +S GT E+++PEL+ +P + D+++LG I++++ T P+ G
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 72/264 (27%), Positives = 125/264 (47%), Gaps = 21/264 (7%)
Query: 528 ELTVGTRVGIGFFGEVFRGIWN-GTDVAIK-VFLE---QDLTAENMEDFCNEISILSRLR 582
E T G +G G +G V+ G+ N G +A+K V L+ + E E+ +L L+
Sbjct: 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 583 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
H N++ +LG C +S+ E++ GS+ +++ G + + K + I G+
Sbjct: 61 HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC---KYTKQILDGVAY 117
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII-------TDSPMRDSSSAGTPEWMA 695
+H +VHRD+K N ++ + +K+ DFG +R + T S M S GTP WMA
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH-GTPYWMA 176
Query: 696 PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPE---G 751
PE+I + K DI+S+G ++E+ T P + ++ + + +P+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236
Query: 752 PLGRLIADCWAEPQ-ERPSCEEIL 774
+ C Q ERPS ++L
Sbjct: 237 AAIDFVTSCLTRDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 72/254 (28%), Positives = 118/254 (46%), Gaps = 32/254 (12%)
Query: 550 GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM--ITEYME 607
G VA+K Q TAE++ DF EI IL L+H N++ + G C R ++ + EY+
Sbjct: 33 GEVVAVKKL--QHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLP 90
Query: 608 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 667
GSL +L +++L R+ L IC+G+ + + VHRDL + N LV VK
Sbjct: 91 YGSLRD--YLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVK 148
Query: 668 ICDFGLSRIITDSPMRDSSSAGTPE-----WMAPELIRNEPFTEKCDIFSLGVIMWEL-- 720
I DFGL++++ ++ P W APE + F+ D++S GV+++EL
Sbjct: 149 IGDFGLTKVLPQD--KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
Query: 721 -CTLNRPWEGVLPER---------VVYAVAN---EGSRLEIPEG---PLGRLIADCWA-E 763
+ +VY + RL P G + ++ +CW +
Sbjct: 207 YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNND 266
Query: 764 PQERPSCEEILSRL 777
P +RPS E+ ++
Sbjct: 267 PSQRPSFSELALQV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 78/270 (28%), Positives = 126/270 (46%), Gaps = 31/270 (11%)
Query: 535 VGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENMED--FCNEISILSRLRHPNVILFLG 591
+G G+FG+V G G A V E +A E F E+ L HPNV+ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 592 ACTKPPRLSMITEYMELGSLYHLI-----HLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 646
C + ++ E+ LG L + + ++ +K +M ++ GL+ +H+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK---DVLQRMACEVASGLLWLHQA 119
Query: 647 KIVHRDLKSANCLVNKHWTVKICDFGL--SRIITDSPMRDSSSAGTPEWMAPEL------ 698
+H DL NC + +VKI D+GL + D + A W+APEL
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 699 -IRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEGPLGRL 756
+ + T+K +I+SLGV MWEL T ++P+ + E+V+ V E +++P+ L
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE-QDIKLPKPQLDLK 238
Query: 757 IAD--------CWAEPQERPSCEEILSRLL 778
+D CW +P+ RP+ EE+ LL
Sbjct: 239 YSDRWYEVMQFCWLDPETRPTAEEV-HELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 85/279 (30%), Positives = 140/279 (50%), Gaps = 23/279 (8%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNE 574
W + ++T+ +G G FG V+ G T VA+K E E +E F NE
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNE 59
Query: 575 ISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKK------LSWR 627
S++ +V+ LG +K ++ E M G L +L L + + + +
Sbjct: 60 ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 119
Query: 628 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDS 685
++M +I G+ ++ K VHRDL + NC+V +TVKI DFG++R I TD +
Sbjct: 120 EMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGS 744
WMAPE +++ FT D++S GV++WE+ +L +P++G+ E+V+ V + G
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 239
Query: 745 RLEIPEGPLGR---LIADCWA-EPQERPSCEEILSRLLD 779
L+ P+ R L+ CW P+ RP+ EI++ L D
Sbjct: 240 -LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 78/270 (28%), Positives = 136/270 (50%), Gaps = 22/270 (8%)
Query: 529 LTVGTRVGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLTAENMEDFCNEISILSRLRH 583
T+G +G G FG V D VA+K+ ++ ++E+F E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 584 PNVILFLG------ACTKPPRLSMITEYMELGSLYHLIHLS--GQKK-KLSWRRKLKMLR 634
PNVI +G A + P +I +M+ G L+ + +S G++ L + ++ +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 635 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTP-E 692
DI G+ + +HRDL + NC++N++ TV + DFGLS+ I + R ++ P +
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180
Query: 693 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG 751
W+A E + + +T D+++ GV MWE+ T + P+ GV +Y +G+RL+ P
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV-ENSEIYNYLIKGNRLKQPPD 239
Query: 752 PLG---RLIADCW-AEPQERPSCEEILSRL 777
L L+ CW EP+ RPS + + +L
Sbjct: 240 CLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 80/264 (30%), Positives = 131/264 (49%), Gaps = 18/264 (6%)
Query: 527 SELTVGTRVGIGFFGEVFRGIW--NGTD----VAIKVFLEQDLTAENMEDFCNEISILSR 580
+EL +G G FG V++GIW +G + VAIKV E N E +E +++
Sbjct: 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKE-ILDEAYVMAG 65
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
+ P V LG C + ++T+ M G L L ++ K ++ + L I +G+
Sbjct: 66 VGSPYVCRLLGICLTST-VQLVTQLMPYGCL--LDYVRENKDRIGSQDLLNWCVQIAKGM 122
Query: 641 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII-TDSPMRDSSSAGTP-EWMAPEL 698
+ +++VHRDL + N LV VKI DFGL+R++ D + P +WMA E
Sbjct: 123 SYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 699 IRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIP---EGPLG 754
I + FT + D++S GV +WEL T +P++G+ P R + + +G RL P +
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTIDVY 241
Query: 755 RLIADCWA-EPQERPSCEEILSRL 777
++ CW + + RP E++
Sbjct: 242 MIMVKCWMIDSECRPRFRELVDEF 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 65/211 (30%), Positives = 112/211 (53%), Gaps = 18/211 (8%)
Query: 532 GTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAEN-------MEDFCNEISILSRLR 582
G +G G FG V+ G+ +G +A+K ++A + ++ EI++L L+
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 583 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
H N++ +LG+ L++ EY+ GS+ L++ G ++ R +R I +GL
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR---NFVRQILKGLNY 121
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR------IITDSPMRDSSSAGTPEWMAP 696
+H I+HRD+K AN LV+ +KI DFG+S+ + T + S G+ WMAP
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 697 ELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 727
E+++ +T K DI+SLG ++ E+ T P+
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 19/197 (9%)
Query: 534 RVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 591
VG G +G V R G VAIK F E + + + E+ +L +LRH N++
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 592 ACTKPPRLSMITEYMELGSLYHLIH-----LSGQK-KKLSWRRKLKMLRDICRGLMCIHR 645
A + RL ++ EY+E +L L+ L + W+ + + + H
Sbjct: 68 AFRRKGRLYLVFEYVE-RTLLELLEASPGGLPPDAVRSYIWQ--------LLQAIAYCHS 118
Query: 646 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APE-LIRNEP 703
I+HRD+K N LV++ +K+CDFG +R + P + W APE L+ +
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 704 FTEKCDIFSLGVIMWEL 720
+ + D++++G IM EL
Sbjct: 179 YGKPVDVWAIGCIMAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 78/253 (30%), Positives = 122/253 (48%), Gaps = 21/253 (8%)
Query: 536 GIGFFGEVF--RGIWNGTDVAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 592
G G G V G +A+K + LE + + E+ IL + P ++ F GA
Sbjct: 10 GAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQ--ILRELDILHKCNSPYIVGFYGA 67
Query: 593 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHR 651
+S+ EYM+ GSL + L + ++ R K+ + +GL +H KI+HR
Sbjct: 68 FYNNGDISICMEYMDGGSLDKI--LKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHR 125
Query: 652 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 711
D+K +N LVN +K+CDFG+S + +S + GT +MAPE I+ ++ K DI+
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT--FVGTSSYMAPERIQGNDYSVKSDIW 183
Query: 712 SLGVIMWELCTL-------NRPWEGVLPERVVYAVANEGSRL--EIPEGPLGRLIADCW- 761
SLG+ + EL T N P +G+ E + Y V RL + C
Sbjct: 184 SLGLSLIELATGRFPYPPENDPPDGIF-ELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLI 242
Query: 762 AEPQERPSCEEIL 774
+P+ERPS +E+L
Sbjct: 243 KDPRERPSYKELL 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 7e-26
Identities = 81/280 (28%), Positives = 136/280 (48%), Gaps = 29/280 (10%)
Query: 526 FSELTVGTRVGIGFFGEVFRGI----WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 581
+ ++ +G G FG+V R + + AIK+ L++ + + DF E+ +L +L
Sbjct: 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKM-LKEFASENDHRDFAGELEVLCKL 59
Query: 582 -RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLS-------------GQKKKLSWR 627
HPN+I LGAC L + EY G+L + S G L+ +
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 628 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 687
+ L+ D+ G+ + + +HRDL + N LV ++ KI DFGLSR + ++ +
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-GEEVYVKKTMG 178
Query: 688 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRL 746
WMA E + +T K D++S GV++WE+ +L P+ G+ +Y +G R+
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRM 237
Query: 747 EIP---EGPLGRLIADCWAE-PQERPSCEEI---LSRLLD 779
E P + + L+ CW + P ERP +I LSR+L+
Sbjct: 238 EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 58/196 (29%), Positives = 94/196 (47%), Gaps = 14/196 (7%)
Query: 538 GFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED-FCNEISILSRLRHPNVILFLGACT 594
G +G VF + G AIKV + D+ +N D E ILS+ + P V+ +
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 595 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLK 654
L ++ EY+ G L L+ G + R + +I L +H I+HRDLK
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR---IYIAEIVLALEYLHSNGIIHRDLK 120
Query: 655 SANCLVNKHWTVKICDFGLSRI--------ITDSPMRDSSSAGTPEWMAPELIRNEPFTE 706
N L++ + +K+ DFGLS++ + D D GTP+++APE+I + ++
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSK 180
Query: 707 KCDIFSLGVIMWELCT 722
D +SLG I++E
Sbjct: 181 TVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 74/255 (29%), Positives = 126/255 (49%), Gaps = 22/255 (8%)
Query: 535 VGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 588
+G G FG V++G+W VAIK E N E +E +++ + +P+V
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDEAYVMASVDNPHVCR 73
Query: 589 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 648
LG C + +IT+ M G L L ++ K + + L I +G+ + ++
Sbjct: 74 LLGICLTST-VQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRL 130
Query: 649 VHRDLKSANCLVNKHWTVKICDFGLSRIIT-DSPMRDSSSAGTP-EWMAPELIRNEPFTE 706
VHRDL + N LV VKI DFGL++++ D + P +WMA E I + +T
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTH 190
Query: 707 KCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEGPLGR-----LIADC 760
+ D++S GV +WEL T ++P++G+ P + ++ +G RL P+ P+ ++ C
Sbjct: 191 QSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERL--PQPPICTIDVYMIMVKC 247
Query: 761 WA-EPQERPSCEEIL 774
W + RP E++
Sbjct: 248 WMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 9e-26
Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 27/270 (10%)
Query: 535 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRL-RHPNVILFL 590
+G G FG+V + +G + + ++ +++ DF E+ +L +L HPN+I L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 591 GACTKPPRLSMITEYMELGSLYHLIHLS-------------GQKKKLSWRRKLKMLRDIC 637
GAC L + EY G+L + S LS ++ L D+
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 638 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 697
RG+ + + + +HRDL + N LV +++ KI DFGLSR + ++ + WMA E
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGRLPVRWMAIE 181
Query: 698 LIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP---EGPL 753
+ +T D++S GV++WE+ +L P+ G+ +Y +G RLE P + +
Sbjct: 182 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRLEKPLNCDDEV 240
Query: 754 GRLIADCWAE-PQERPSCEEI---LSRLLD 779
L+ CW E P ERPS +I L+R+L+
Sbjct: 241 YDLMRQCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 76/266 (28%), Positives = 122/266 (45%), Gaps = 25/266 (9%)
Query: 532 GTRVGIGFFGEVFRG--IWNGTDVAIK-VFLEQ-------DLTAENMEDFCNEISILSRL 581
G +G G +G V+ + G +A+K V L + ++ +EI L L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
H N++ +LG T LS+ EY+ GS+ + G+ ++ R + GL
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR---FFTEQVLEGLA 122
Query: 642 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD--SPMRDSSSAGTPEWMAPELI 699
+H I+HRDLK+ N LV+ KI DFG+S+ D ++ S G+ WMAPE+I
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 700 RN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE------G 751
+ + ++ K DI+SLG ++ E+ RPW ++ + N+ S IP
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLS 242
Query: 752 PLGR--LIADCWAEPQERPSCEEILS 775
P+ L A P RP+ E+L
Sbjct: 243 PVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 69/231 (29%), Positives = 96/231 (41%), Gaps = 75/231 (32%)
Query: 535 VGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAENMEDFCN----EISILSRLRHP 584
+G G +G V + G VAIK VF DL EI +L LRH
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLI------DAKRILREIKLLRHLRHE 59
Query: 585 NVI----LFLGACTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 634
N+I + +PP ++TE ME L+ +I S Q L
Sbjct: 60 NIIGLLDIL-----RPPSPEDFNDVYIVTELMET-DLHKVIK-SPQP-----------LT 101
Query: 635 D---------ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685
D I RGL +H ++HRDLK +N LVN + +KICDFGL+R +
Sbjct: 102 DDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE---- 157
Query: 686 SSAGTPEWM----------APELIRNEP-FTEKCDIFSLGVIMWELCTLNR 725
++ APEL+ + +T+ DI+S+G I EL L R
Sbjct: 158 ---DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL--LTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 68/212 (32%), Positives = 111/212 (52%), Gaps = 16/212 (7%)
Query: 534 RVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC---NEISILSRLRHPNVIL 588
R+G G +G+V+ R + G AIKV + E EDF EI ++ +H N++
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKV-----IKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 589 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 648
+ G+ + +L + E+ GSL + H++G LS + + R+ +GL +H
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 649 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI---RNEPFT 705
+HRD+K AN L+ + VK+ DFG+S IT + + S GTP WMAPE+ R +
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 706 EKCDIFSLGVIMWELCTLNRPWEGVLPERVVY 737
+ CDI+++G+ EL L P + P R ++
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALF 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 81/277 (29%), Positives = 135/277 (48%), Gaps = 26/277 (9%)
Query: 524 IDFSELTVGTRVGIGFFGEVFRGIWNG----TDVAIKVFLEQDLTAENMEDFCNEISILS 579
++++++ +G G FG+V + D AIK +++ + ++ DF E+ +L
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEVLC 62
Query: 580 RL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLS-------------GQKKKLS 625
+L HPN+I LGAC L + EY G+L + S LS
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 626 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685
++ L D+ RG+ + + + +HRDL + N LV +++ KI DFGLSR + ++ +
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKT 181
Query: 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGS 744
WMA E + +T D++S GV++WE+ +L P+ G+ +Y +G
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGY 240
Query: 745 RLEIP---EGPLGRLIADCWAE-PQERPSCEEILSRL 777
RLE P + + L+ CW E P ERPS +IL L
Sbjct: 241 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 80/265 (30%), Positives = 128/265 (48%), Gaps = 23/265 (8%)
Query: 535 VGIGFFGEVFRG-IWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 589
+G G FG+VF +N + + V +D + +DF E +L+ L+H +++ F
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 590 LGACTKPPRLSMITEYMELGSLYHLIHLSGQK----------KKLSWRRKLKMLRDICRG 639
G C + L M+ EYM+ G L + G +L+ + L + + I G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 640 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDSSSAGTPEWMAPE 697
++ + VHRDL + NCLV ++ VKI DFG+SR + TD + WM PE
Sbjct: 133 MVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 192
Query: 698 LIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PL 753
I FT + D++SLGV++WE+ T + PW + V+ + +G L+ P +
Sbjct: 193 SIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI-TQGRVLQRPRTCPKEV 251
Query: 754 GRLIADCWA-EPQERPSCEEILSRL 777
L+ CW EP R + +EI S L
Sbjct: 252 YDLMLGCWQREPHMRLNIKEIHSLL 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 54/195 (27%), Positives = 88/195 (45%), Gaps = 7/195 (3%)
Query: 530 TVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
+ R+G G G VF + G VA+K + L EI L +HP V+
Sbjct: 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVV 62
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
L ++ EYM L ++ ++ L + +R + +G+ +H
Sbjct: 63 KLLDVFPHGSGFVLVMEYM-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG 119
Query: 648 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA-GTPEWMAPELIRNEP-FT 705
I+HRDLK AN L++ +KI DFGL+R+ ++ R S T + APEL+ +
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 706 EKCDIFSLGVIMWEL 720
D++++G I EL
Sbjct: 180 PGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 16/215 (7%)
Query: 534 RVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC---NEISILSRLRHPNVIL 588
RVG G +G+V+ R + G A+K+ + E +DF EI ++ +H N++
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKI-----IKLEPGDDFSLIQQEIFMVKECKHCNIVA 70
Query: 589 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 648
+ G+ +L + EY GSL + H++G LS + + R+ +GL +H
Sbjct: 71 YFGSYLSREKLWICMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 649 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI---RNEPFT 705
+HRD+K AN L+ + VK+ DFG++ IT + + S GTP WMAPE+ +N +
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 706 EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA 740
+ CDI+++G+ EL L P + P R ++ ++
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 75/250 (30%), Positives = 128/250 (51%), Gaps = 11/250 (4%)
Query: 535 VGIGFFGEV--FRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 592
VG G +GEV R +G IK ++ + + E +LS+L+HPN++ + +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 593 CT-KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK-LKMLRDICRGLMCIHRMKIVH 650
+ L ++ + E G LYH L QK KL + ++ I L +H I+H
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYH--KLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILH 125
Query: 651 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 710
RDLK+ N + + +K+ D G++R++ + S+ GTP +M+PEL N+P+ K D+
Sbjct: 126 RDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDV 185
Query: 711 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQE 766
++LG ++E+ TL + +VY + EG +P+ LG LIA + P++
Sbjct: 186 WALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGELIATMLSKRPEK 244
Query: 767 RPSCEEILSR 776
RPS + IL +
Sbjct: 245 RPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 80/268 (29%), Positives = 133/268 (49%), Gaps = 42/268 (15%)
Query: 535 VGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 591
VG G +G+V++G + G AIKV D+T + E+ EI++L + H N+ + G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 592 ACTK--PP----RLSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLMCIH 644
A K PP +L ++ E+ GS+ LI + G K W + R+I RGL +H
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI--CREILRGLSHLH 128
Query: 645 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR---- 700
+ K++HRD+K N L+ ++ VK+ DFG+S + + R ++ GTP WMAPE+I
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 188
Query: 701 -NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIAD 759
+ + K D++SLG+ E+ P + P R ++ IP P RL +
Sbjct: 189 PDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---------IPRNPAPRLKSK 239
Query: 760 CWAEP-------------QERPSCEEIL 774
W++ +RP+ E+++
Sbjct: 240 KWSKKFQSFIESCLVKNHSQRPTTEQLM 267
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 67/217 (30%), Positives = 110/217 (50%), Gaps = 19/217 (8%)
Query: 535 VGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 594
+G G FG+V++ T + + + E +ED+ EI IL+ HP ++ LGA
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 595 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK--MLRDICR----GLMCIHRMKI 648
+L ++ E+ G++ ++ L R L ++ ICR L +H MKI
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIM--------LELDRGLTEPQIQVICRQMLEALQYLHSMKI 131
Query: 649 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI-----RNEP 703
+HRDLK+ N L+ +K+ DFG+S + R S GTP WMAPE++ ++ P
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191
Query: 704 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA 740
+ K DI+SLG+ + E+ + P + P RV+ +A
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA 228
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-24
Identities = 74/248 (29%), Positives = 128/248 (51%), Gaps = 13/248 (5%)
Query: 534 RVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 591
++G G G VF + G +VAIK Q + + NEI ++ L++PN++ FL
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKELKNPNIVNFLD 83
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651
+ L ++ EY+ GSL ++ + + + + R+ + L +H +++HR
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECLQALEFLHANQVIHR 139
Query: 652 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 711
D+KS N L+ +VK+ DFG IT + S+ GTP WMAPE++ + + K DI+
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 712 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPE--GPLGR-LIADCWA-EPQE 766
SLG++ E+ P+ P R +Y +A G+ L+ PE P+ R + C + ++
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEK 259
Query: 767 RPSCEEIL 774
R S +E+L
Sbjct: 260 RGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 79/262 (30%), Positives = 137/262 (52%), Gaps = 21/262 (8%)
Query: 535 VGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFL 590
+G G FG V +G++ DVAIKV L+ + ++ E I+ +L +P ++ +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKV-LKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 591 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 650
G C + L ++ E G L LSG+K +++ ++++ + G+ + VH
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKF--LSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 651 RDLKSANCL-VNKHWTVKICDFGLSRII--TDSPMRDSSSAGTP-EWMAPELIRNEPFTE 706
RDL + N L VN+H+ KI DFGLS+ + DS + S+ P +W APE I F+
Sbjct: 119 RDLAARNVLLVNQHYA-KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 707 KCDIFSLGVIMWELCTL-NRPWEGVL-PERVVYAVANEGSRLEIP-EGP--LGRLIADCW 761
+ D++S G+ MWE + +P++ + PE V + +G RL+ P E P + L+ DCW
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIEQGKRLDCPAECPPEMYALMKDCW 235
Query: 762 A-EPQERPSCEEILSRLLDCEY 782
+ ++RP+ ++ R+ Y
Sbjct: 236 IYKWEDRPNFAKVEERMRTYYY 257
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 6e-24
Identities = 77/257 (29%), Positives = 126/257 (49%), Gaps = 18/257 (7%)
Query: 532 GTRVGIGFFGEVF--RGIWNGTDVAIK-VFLEQDL--TAENMEDFCNEISILSRLRHPNV 586
G +G G FGEV+ G ++A+K V + D T++ + EI +L LRH +
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 587 ILFLGACTKPP---RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 643
+ + G C + P +LS+ EYM GS+ + G L+ + R I +G+ +
Sbjct: 67 VQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYL 122
Query: 644 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS---SSAGTPEWMAPELIR 700
H IVHRD+K AN L + VK+ DFG S+ I M + S GTP WM+PE+I
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182
Query: 701 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 757
E + K D++S+ + E+ T PW ++ +A + ++ +P+G +
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFL 242
Query: 758 ADCWAEPQERPSCEEIL 774
+ E + RP+ E +L
Sbjct: 243 KQIFVEEKRRPTAEFLL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 527 SELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED-FCNEISILSRLRH 583
+ +G G FG V R +G A+K+ + + + NE IL +RH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 584 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR----DICRG 639
P ++ G+ L ++ EY+ G L+ + SG R + R +
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG-------RFPEPVARFYAAQVVLA 113
Query: 640 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 699
L +H + IV+RDLK N L++ +KI DFG ++ + R + GTPE++APE+I
Sbjct: 114 LEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG---RTYTLCGTPEYLAPEII 170
Query: 700 RNEPFTEKCDIFSLGVIMWEL 720
++ + + D ++LG++++E+
Sbjct: 171 LSKGYGKAVDWWALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 60/225 (26%), Positives = 114/225 (50%), Gaps = 16/225 (7%)
Query: 566 ENMEDFCNEISIL-SRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKK 623
+++ D +E++I+ +LRHPN++ + + RL ++ + +E L H L +K++
Sbjct: 50 KSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQR 109
Query: 624 LSWRRKLKMLRDICRGLMCIHRMK-IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP- 681
+ R + + L +H+ K IVHRDL N ++ + V I DFGL++ P
Sbjct: 110 FTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPE 167
Query: 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV----LPERVVY 737
+ +S GT + PE+++NEP+ EK D+++ G I++++CTL P+ L ++V
Sbjct: 168 SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE 227
Query: 738 AV---ANEGSRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLD 779
AV EG E + + + + RP ++ + + D
Sbjct: 228 AVYEPLPEGMYSEDVTDVITSCLT---PDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 29/203 (14%)
Query: 534 RVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMED-----FCNEISILSRLRHPNV 586
++G G +G+V++ T VA+K EN ++ EI +L +LRHPN+
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIRM-----ENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 587 ILFLGACTKPPR--LSMITEYME--LGSLYH--LIHLS-GQKKKLSWRRKLKMLRDICRG 639
+ T + + M+ EYM+ L L + + Q K ++ + G
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCY--------MKQLLEG 112
Query: 640 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APEL 698
L +H I+HRD+K +N L+N +K+ DFGL+R T D ++ W PEL
Sbjct: 113 LQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172
Query: 699 IRNEP-FTEKCDIFSLGVIMWEL 720
+ + + D++S+G I+ EL
Sbjct: 173 LLGATRYGPEVDMWSVGCILAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-23
Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 535 VGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 594
+G G FG+V++ T V + + E +ED+ EI IL+ HPN++ L A
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 595 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK--MLRDICR----GLMCIHRMKI 648
L ++ E+ G++ ++ L R L +R +C+ L +H KI
Sbjct: 73 YENNLWILIEFCAGGAVDAVM--------LELERPLTEPQIRVVCKQTLEALNYLHENKI 124
Query: 649 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI-----RNEP 703
+HRDLK+ N L +K+ DFG+S T + R S GTP WMAPE++ ++ P
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 704 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA 740
+ K D++SLG+ + E+ + P + P RV+ +A
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA 221
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-23
Identities = 80/268 (29%), Positives = 131/268 (48%), Gaps = 42/268 (15%)
Query: 535 VGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 591
VG G +G+V++G + G AIKV D+T + E+ EI++L + H N+ + G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVM---DVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 592 ACTK--PP----RLSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLMCIH 644
A K PP +L ++ E+ GS+ L+ + G K W + R+I RGL +H
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI--CREILRGLAHLH 138
Query: 645 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR---- 700
K++HRD+K N L+ ++ VK+ DFG+S + + R ++ GTP WMAPE+I
Sbjct: 139 AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 198
Query: 701 -NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIAD 759
+ + + DI+SLG+ E+ P + P R ++ IP P +L +
Sbjct: 199 PDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL---------IPRNPPPKLKSK 249
Query: 760 CWAEP-------------QERPSCEEIL 774
W++ RPS E++L
Sbjct: 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLL 277
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 4e-23
Identities = 77/270 (28%), Positives = 119/270 (44%), Gaps = 25/270 (9%)
Query: 524 IDFSELTVGTRVGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLTAENMEDFCNEISIL 578
+D + + +G G FGE+ RG VAI L + + F E L
Sbjct: 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHT-LRAGCSDKQRRGFLAEALTL 60
Query: 579 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 638
+ H N++ G T+ + ++TEYM G+L L + +L + + ML +
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSF--LRKHEGQLVAGQLMGMLPGLAS 118
Query: 639 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD------SPMRDSSSAGTPE 692
G+ + M VH+ L + LVN KI F R+ D + M S
Sbjct: 119 GMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPV---L 173
Query: 693 WMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP-- 749
W APE I+ F+ D++S G++MWE+ + RP+ + + V+ AV +G RL P
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-EDGFRLPAPRN 232
Query: 750 -EGPLGRLIADCW-AEPQERPSCEEILSRL 777
L +L+ DCW E ERP +I S L
Sbjct: 233 CPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 7e-23
Identities = 77/258 (29%), Positives = 121/258 (46%), Gaps = 18/258 (6%)
Query: 532 GTRVGIGFFGEVF--RGIWNGTDVAIKVFL---EQDLTAENMEDFCNEISILSRLRHPNV 586
G +G G FG V+ + G ++A K E T++ + EI +L L+H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 587 ILFLGACTK---PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 643
+ + G C + L++ EYM GS+ + G + R K R I G+ +
Sbjct: 67 VQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR---KYTRQILEGMSYL 122
Query: 644 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS---SSAGTPEWMAPELIR 700
H IVHRD+K AN L + VK+ DFG S+ + M + S GTP WM+PE+I
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 701 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE--GPLGRLIA 758
E + K D++SLG + E+ T PW ++ +A + + ++P R
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL 242
Query: 759 DC-WAEPQERPSCEEILS 775
C + E + RPS EE+L
Sbjct: 243 GCIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 535 VGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFC--NEISILSRLRHPNVILF 589
+G G + V++ T VAIK + L + A++ +F EI +L L+HPN+I
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 590 LGACTKPPRLSMITEYMELGSLYHLIH-----LSGQKKKLSWRRKLKMLRDICRGLMCIH 644
L ++++ E+ME L +I L+ K S+ + M RGL +H
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIK-SY---MLMT---LRGLEYLH 119
Query: 645 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EP 703
I+HRDLK N L+ +K+ DFGL+R + + T + APEL+
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARH 179
Query: 704 FTEKCDIFSLGVIMWELCTLNRP 726
+ D++S+G I EL L P
Sbjct: 180 YGVGVDMWSVGCIFAELL-LRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 70/248 (28%), Positives = 111/248 (44%), Gaps = 28/248 (11%)
Query: 549 NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP--RLSMITEYM 606
G A+K D + + E+ I + P ++ + GA + + EY
Sbjct: 25 TGMIFALKTIT-TDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC 83
Query: 607 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC----RGLMCIHRMKIVHRDLKSANCLVNK 662
E GSL + + KK R K+L I +GL +H KI+HRD+K +N L+ +
Sbjct: 84 EGGSLDSIY---KKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR 140
Query: 663 HWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 722
VK+CDFG+S + +S + GT +MAPE I+ +P++ D++SLG+ + E+
Sbjct: 141 KGQVKLCDFGVSGELVNS--LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV-A 197
Query: 723 LNR---PWEGVLP----ERVVYAVANEGSRLEIPEG-------PLGRLIADCWA-EPQER 767
NR P EG P E + Y V L+ G I C +P R
Sbjct: 198 QNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRR 257
Query: 768 PSCEEILS 775
P+ ++L
Sbjct: 258 PTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 75/257 (29%), Positives = 117/257 (45%), Gaps = 16/257 (6%)
Query: 531 VGTRVGIGFFGEVF--RGIWNGTDVAIKVFL---EQDLTAENMEDFCNEISILSRLRHPN 585
+G +G G FG V+ G ++A+K E T++ + EI +L L H
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 586 VILFLGACTKPPR--LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 643
++ + G P LS+ E+M GS+ + G L+ K R I G+ +
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYL 122
Query: 644 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSR---IITDSPMRDSSSAGTPEWMAPELIR 700
H IVHRD+K AN L + VK+ DFG S+ I S S GTP WM+PE+I
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 701 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLI 757
E + K DI+S+G + E+ T PW ++ +A + + +P +
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFL 242
Query: 758 ADCWAEPQERPSCEEIL 774
+ E + RPS +E+L
Sbjct: 243 KRIFVEAKLRPSADELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 76/258 (29%), Positives = 127/258 (49%), Gaps = 33/258 (12%)
Query: 535 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 592
+G G G V++ +A+KV D+T E + +E+ IL + P +I F GA
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIP-LDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 593 CTKPPRLSMITEYMELGSL--YHLI--HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 648
R+S+ TE+M+ GSL Y I H+ G ++ + +GL + +KI
Sbjct: 68 FFVENRISICTEFMDGGSLDVYRKIPEHVLG-----------RIAVAVVKGLTYLWSLKI 116
Query: 649 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKC 708
+HRD+K +N LVN VK+CDFG+S + +S + + GT +MAPE I E +
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK--TYVGTNAYMAPERISGEQYGIHS 174
Query: 709 DIFSLGVIMWELCTLNRPWEGV-------LPERVVYAVANEGSRLEIPEG----PLGRLI 757
D++SLG+ EL P+ + +P +++ + +E + +P G I
Sbjct: 175 DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV-LPVGQFSEKFVHFI 233
Query: 758 ADCW-AEPQERPSCEEIL 774
C +P+ERP+ E ++
Sbjct: 234 TQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 6/158 (3%)
Query: 573 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLK 631
NE IL L HP ++ + + ++ + + G L YHL QK K S +
Sbjct: 49 NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL----SQKVKFSEEQVKF 104
Query: 632 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 691
+ +I L +H I+HRD+K N L+++ V I DF ++ +T + S+S GTP
Sbjct: 105 WICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS-GTP 163
Query: 692 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
+MAPE++ + ++ D +SLGV +E RP+ G
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 3e-22
Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 9/220 (4%)
Query: 534 RVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 591
++G G G V+ I G +VAIK Q + + NEI ++ ++PN++ +L
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLD 83
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651
+ L ++ EY+ GSL ++ + + + + R+ + L +H +++HR
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSNQVIHR 139
Query: 652 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 711
D+KS N L+ +VK+ DFG IT + S+ GTP WMAPE++ + + K DI+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 712 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPE 750
SLG++ E+ P+ P R +Y +A G+ L+ PE
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE 239
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 3e-22
Identities = 78/260 (30%), Positives = 122/260 (46%), Gaps = 30/260 (11%)
Query: 534 RVGIGFFGEVFRGIWNGTDV--AIKVFLE---QDLTAENMEDFCNEISILSRLRHPNVIL 588
R+G G FG V+ +KV E +L E +LS+L HP ++
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 589 FLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
F + + +ITEY E L L L K LS + + + G+ +H+ +
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126
Query: 648 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 707
I+HRDLK+ N + + +KI DFG+SR++ S ++ GTP +M+PE ++++ + K
Sbjct: 127 ILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSK 185
Query: 708 CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA----- 762
DI+SLG I++E+C L +EG VV L I EGP L + ++
Sbjct: 186 SDIWSLGCILYEMCCLAHAFEGQNFLSVV---------LRIVEGPTPSL-PETYSRQLNS 235
Query: 763 --------EPQERPSCEEIL 774
+P RPS EIL
Sbjct: 236 IMQSMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 46/228 (20%)
Query: 531 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFL---EQDL---TAENMEDFCNEISILSRLR 582
+ ++G G FGEV++ I G VA+K L E+D TA EI IL +L+
Sbjct: 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR------EIKILKKLK 65
Query: 583 HPNVILFLG-ACTKPPRLS-------MITEYME--LGSLYH--LIHLSGQKKKLSWRRKL 630
HPNV+ + A +P + M+T YM+ L L + L+ + K
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC------ 119
Query: 631 KMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP--------- 681
+ + G+ +H I+HRD+K+AN L++ +KI DFGL+R P
Sbjct: 120 -YMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 682 -MRDSSSAGTPEWM-APELIRNEP-FTEKCDIFSLGVIMWELCTLNRP 726
R ++ W PEL+ E +T DI+ +G + E+ T RP
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 4e-22
Identities = 75/272 (27%), Positives = 128/272 (47%), Gaps = 34/272 (12%)
Query: 535 VGIGFFGEVFRGIWNGTD------VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 588
+G G FG+V ++ + VA+K L+++ +N + EI+IL L H N++
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKT-LKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 589 FLGACTKP--PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 646
+ G C++ L +I EY+ LGSL + K KL+ + L + IC G+ +H
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 647 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPE-WMAPELIRNEP 703
+HRDL + N L++ VKI DFGL++ + + R +P W A E ++
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186
Query: 704 FTEKCDIFSLGVIMWELCT--------------LNRPWEGVLPERVVYAVANEGSRLEIP 749
F+ D++S GV ++EL T + P +G + + + G RL P
Sbjct: 187 FSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCP 246
Query: 750 EG-PLG--RLIADCW-AEPQERPSCEEILSRL 777
+ P L+ +CW E + RP+ ++ L
Sbjct: 247 KNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 4e-22
Identities = 80/274 (29%), Positives = 131/274 (47%), Gaps = 48/274 (17%)
Query: 535 VGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENMED--FCNEISILSRLRHPNVILFLG 591
+G G+FG+V G + +G A V E ++A E F E L+H N++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR----DICRGLMCIHRMK 647
CT+ ++ E+ LG L +L +K L+ +I GL+ +H+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKG--YLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 648 IVHRDLKSANCLVNKHWTVKICDFGLSR--------IITDS---PMRDSSSAGTPEWMAP 696
+H DL NCL+ TVKI D+GLS + D P+R W+AP
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR---------WIAP 171
Query: 697 ELIRNEPF--------TEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLE 747
EL+ +E T++ +++SLGV +WEL L ++P+ + E+V+ E +L+
Sbjct: 172 ELV-DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE-QQLK 229
Query: 748 IPEGPLGRLIAD--------CWAEPQERPSCEEI 773
+P+ L ++D CW +P++RPS EE+
Sbjct: 230 LPKPRLKLPLSDRWYEVMQFCWLQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-22
Identities = 77/265 (29%), Positives = 120/265 (45%), Gaps = 29/265 (10%)
Query: 540 FGEVFRG--IWNGTD----VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 593
FG++++G G D VAIK L+ + +F E S+++ L HPN++ LG
Sbjct: 18 FGKIYKGHLYLPGMDHAQLVAIKT-LKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV 76
Query: 594 TKPPRLSMITEYMELGSLYHLIHLSGQ--------------KKKLSWRRKLKMLRDICRG 639
T+ + M+ EY+ G L+ + + K L L + I G
Sbjct: 77 TQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAG 136
Query: 640 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-MRDSSSAGTP-EWMAPE 697
+ + VH+DL + N L+ + VKI D GLSR I + R + P WM PE
Sbjct: 137 MEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPE 196
Query: 698 LIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPEGPLGR- 755
I F+ DI+S GV++WE+ + +P+ G + V+ V L E R
Sbjct: 197 AIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR-QLLPCSEDCPPRM 255
Query: 756 --LIADCWAE-PQERPSCEEILSRL 777
L+ +CW E P RP ++I +RL
Sbjct: 256 YSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 5e-22
Identities = 73/261 (27%), Positives = 128/261 (49%), Gaps = 16/261 (6%)
Query: 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLE--QDLTA-ENMEDFCNEISILSRL 581
+EL +G G FG V +GIW G + I V ++ QD + + ++ + + + L
Sbjct: 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL 66
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
H ++ LG C L ++T+ LGSL L H+ + L +R L I +G+
Sbjct: 67 DHAYIVRLLGICPGA-SLQLVTQLSPLGSL--LDHVRQHRDSLDPQRLLNWCVQIAKGMY 123
Query: 642 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII-TDSPMRDSSSAGTP-EWMAPELI 699
+ ++VHR+L + N L+ V+I DFG++ ++ D S TP +WMA E I
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPE---GPLGR 755
+T + D++S GV +WE+ + P+ G+ P V + +G RL P+ +
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-DLLEKGERLAQPQICTIDVYM 242
Query: 756 LIADCWA-EPQERPSCEEILS 775
++ CW + RP+ +E+ +
Sbjct: 243 VMVKCWMIDENVRPTFKELAN 263
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 5e-22
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 8/213 (3%)
Query: 534 RVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 591
++G G G V+ I G +VAIK Q + E NEI ++ +HPN++ +L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK--ELIINEILVMRENKHPNIVNYLD 83
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651
+ L ++ EY+ GSL ++ + + + + R+ + L +H +++HR
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQVIHR 139
Query: 652 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 711
D+KS N L+ +VK+ DFG IT + S+ GTP WMAPE++ + + K DI+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 712 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGS 744
SLG++ E+ P+ P R +Y +A G+
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGT 232
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (241), Expect = 6e-22
Identities = 73/204 (35%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 530 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCN--EISILSRL-RHP 584
V ++G G FG V+ G VAIK ++ + E+ N E+ L +L HP
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKK---FYSWEECMNLREVKSLRKLNEHP 58
Query: 585 NVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 644
N++ + L + EYME G+LY L+ + K S ++ I +GL IH
Sbjct: 59 NIVKLKEVFRENDELYFVFEYME-GNLYQLM-KDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 645 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS-PMRDSSSAGTPEWMAPE-LIRNE 702
+ HRDLK N LV+ VKI DFGL+R I P D S T + APE L+R+
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS--TRWYRAPEILLRST 174
Query: 703 PFTEKCDIFSLGVIMWELCTLNRP 726
++ DI++LG IM EL TL RP
Sbjct: 175 SYSSPVDIWALGCIMAELYTL-RP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 7e-22
Identities = 78/252 (30%), Positives = 120/252 (47%), Gaps = 17/252 (6%)
Query: 533 TRVGIGFFGEVF--RGIWNGTDVAIKVFL-EQDLTAENMEDFCNEISILSRLRHPNVILF 589
+G G FG V+ R + VAIK + E +D E+ L +LRHPN I +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 590 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 649
G + ++ EY LGS ++ + KK L + +GL +H + +
Sbjct: 81 KGCYLREHTAWLVMEYC-LGSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHERI 137
Query: 650 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI--RNE-PFTE 706
HRD+K+ N L+ + TVK+ DFG + ++ SP +S GTP WMAPE+I +E +
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLV--SPA--NSFVGTPYWMAPEVILAMDEGQYDG 193
Query: 707 KCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIPEGPLG--RLIADCWA- 762
K D++SLG+ EL P + +Y +A N+ L + + C
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQK 253
Query: 763 EPQERPSCEEIL 774
PQ+RPS EE+L
Sbjct: 254 IPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 7e-22
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 34/213 (15%)
Query: 533 TRVGIGFFGEVF--RGIWNGTDVAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHP 584
++G G FGEVF R VA+K V +E + +TA EI IL L+H
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA------LREIKILQLLKHE 71
Query: 585 NVILFLGACTKPPRLSMITEYMELGSLYHLI-----H-----LSGQKKKLSWRRKLKMLR 634
NV+ + C T Y ++L+ H LS + K + K+++
Sbjct: 72 NVVNLIEICRTKA-----TPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMK 126
Query: 635 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI----ITDSPMRDSSSAGT 690
+ GL IHR KI+HRD+K+AN L+ K +K+ DFGL+R P R ++ T
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186
Query: 691 PEWMAPELIRNE-PFTEKCDIFSLGVIMWELCT 722
+ PEL+ E + D++ G IM E+ T
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 77/270 (28%), Positives = 125/270 (46%), Gaps = 34/270 (12%)
Query: 535 VGIGFFGEVF------RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 588
+G G FG+V G G VA+K L+ + ++ D EI IL L H N++
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKS-LKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 589 FLGACTKPP--RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 646
+ G CT+ + +I E++ GSL +L K K++ +++LK IC+G+ +
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKE--YLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 647 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP----MRDSSSAGTPEWMAPELIRNE 702
+ VHRDL + N LV VKI DFGL++ I ++D + W APE +
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV-FWYAPECLIQS 187
Query: 703 PFTEKCDIFSLGVIMWELCT--------------LNRPWEGVLPERVVYAVANEGSRLEI 748
F D++S GV ++EL T + P G + + V EG RL
Sbjct: 188 KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPR 247
Query: 749 PEG---PLGRLIADCW-AEPQERPSCEEIL 774
P + +L+ CW +P +R + + ++
Sbjct: 248 PPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 77/259 (29%), Positives = 126/259 (48%), Gaps = 22/259 (8%)
Query: 535 VGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLG 591
+G G +G+VF+ + NG+ A+K+ D + E+ E +IL L HPNV+ F G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKIL---DPIHDIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 592 ACTKPP-----RLSMITEYMELGSLYHLIH-LSGQKKKLSWRRKLKMLRDICRGLMCIHR 645
K +L ++ E GS+ L+ + +++ +L + GL +H
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142
Query: 646 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE--- 702
K +HRD+K N L+ VK+ DFG+S +T + +R ++S GTP WMAPE+I E
Sbjct: 143 NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQL 202
Query: 703 --PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIPE---GPLGRL 756
+ +CD++SLG+ EL + P + P R ++ + N L PE
Sbjct: 203 DSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDF 262
Query: 757 IADCWAEPQE-RPSCEEIL 774
I C + E RP+ ++L
Sbjct: 263 IRKCLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 95.6 bits (237), Expect = 1e-21
Identities = 63/220 (28%), Positives = 113/220 (51%), Gaps = 9/220 (4%)
Query: 534 RVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 591
++G G G V+ + G +VAI+ Q + + NEI ++ ++PN++ +L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLD 84
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651
+ L ++ EY+ GSL ++ + + + + R+ + L +H +++HR
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 652 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 711
D+KS N L+ +VK+ DFG IT + S+ GTP WMAPE++ + + K DI+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 712 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPE 750
SLG++ E+ P+ P R +Y +A G+ L+ PE
Sbjct: 201 SLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 68/258 (26%), Positives = 124/258 (48%), Gaps = 19/258 (7%)
Query: 533 TRVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 588
+G G FG V +G++ VA+K+ + ++ E +++ +L +P ++
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 589 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 648
+G C + ++ E ELG L + + K ++ + +++ + G+ +
Sbjct: 61 MIGIC-EAESWMLVMELAELGPLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 649 VHRDLKSANCL-VNKHWTVKICDFGLSRIIT-DSPMRDSSSAGT-P-EWMAPELIRNEPF 704
VHRDL + N L V +H+ KI DFGLS+ + D + + G P +W APE + F
Sbjct: 117 VHRDLAARNVLLVTQHYA-KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 705 TEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADC 760
+ K D++S GV+MWE + +P++G+ V + + G R+E P+ + L+ C
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-GERMECPQRCPPEMYDLMKLC 234
Query: 761 WA-EPQERPSCEEILSRL 777
W ERP + RL
Sbjct: 235 WTYGVDERPGFAVVELRL 252
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 78/265 (29%), Positives = 131/265 (49%), Gaps = 14/265 (5%)
Query: 521 EWNIDFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISIL 578
E+ ++ E +G G +G V+ R + +AIK E+D + ++ EI++
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALH 59
Query: 579 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 638
S L+H N++ +LG+ ++ + E + GSL L+ K + + + + I
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE 119
Query: 639 GLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAP 696
GL +H +IVHRD+K N LVN + VKI DFG S R+ +P ++ + GT ++MAP
Sbjct: 120 GLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT-GTLQYMAP 178
Query: 697 ELIRNEP--FTEKCDIFSLGVIMWELCTLNRPW-EGVLPERVVYAVANEGSRLEIPE--- 750
E+I P + DI+SLG + E+ T P+ E P+ ++ V EIPE
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLS 238
Query: 751 GPLGRLIADCWA-EPQERPSCEEIL 774
I C+ +P +R S ++L
Sbjct: 239 AEAKNFILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 82/280 (29%), Positives = 126/280 (45%), Gaps = 27/280 (9%)
Query: 524 IDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFCNEIS 576
I+ S + +G FG+V++G GT VAIK L+ E+F +E
Sbjct: 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKT-LKDKAEGPLREEFKHEAM 60
Query: 577 ILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------KKK 623
+ SRL+HPN++ LG TK LSMI Y L+ + + K
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 624 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSP 681
L + ++ I G+ + +VH+DL + N LV VKI D GL R + D
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY 180
Query: 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVA 740
+S WM+PE I F+ DI+S GV++WE+ + +P+ G + V+ +
Sbjct: 181 KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240
Query: 741 NEGSRLEIPEGP--LGRLIADCWAE-PQERPSCEEILSRL 777
N + P + L+ +CW E P RP ++I SRL
Sbjct: 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 7e-21
Identities = 77/259 (29%), Positives = 126/259 (48%), Gaps = 22/259 (8%)
Query: 535 VGIGFFGEVFR--GIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 591
+G G +G+V++ +G+ A+K+ D ++ E+ E +IL L HPNV+ F G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKIL---DPISDVDEEIEAEYNILQSLPNHPNVVKFYG 86
Query: 592 ACTKPPRLS-----MITEYMELGSLYHLIH-LSGQKKKLSWRRKLKMLRDICRGLMCIHR 645
K +L ++ E GS+ L+ L ++L +L GL +H
Sbjct: 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146
Query: 646 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE--- 702
+I+HRD+K N L+ VK+ DFG+S +T + +R ++S GTP WMAPE+I E
Sbjct: 147 NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206
Query: 703 --PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIPEG---PLGRL 756
+ +CD++SLG+ EL + P + P + ++ + N L PE
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHF 266
Query: 757 IADCWAEPQE-RPSCEEIL 774
I+ C + E RPS +L
Sbjct: 267 ISQCLIKDFEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 7e-21
Identities = 50/151 (33%), Positives = 86/151 (56%), Gaps = 7/151 (4%)
Query: 636 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP--MRDSSSAGTPEW 693
+ +G+ + K +HRDL + N L++++ VKICDFGL+R I P +R + +W
Sbjct: 188 VAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 247
Query: 694 MAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPE-- 750
MAPE I + +T + D++S GV++WE+ +L P+ GV + EG+R+ P+
Sbjct: 248 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYT 307
Query: 751 -GPLGRLIADCW-AEPQERPSCEEILSRLLD 779
+ + + DCW EP +RP+ E++ L +
Sbjct: 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 8e-21
Identities = 60/169 (35%), Positives = 93/169 (55%), Gaps = 16/169 (9%)
Query: 626 WRRKLKMLRDIC------RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679
W+ L M IC RG+ + K +HRDL + N L++++ VKICDFGL+R I
Sbjct: 167 WKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 680 SP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVV 736
P +R S+ +WMAPE I ++ +T + D++S GV++WE+ +L P+ GV
Sbjct: 227 DPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF 286
Query: 737 YAVANEGSRLEIPE---GPLGRLIADCW-AEPQERPSCE---EILSRLL 778
+G+R+ PE + R++ CW +P+ERP+ EIL LL
Sbjct: 287 CQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-20
Identities = 71/208 (34%), Positives = 101/208 (48%), Gaps = 29/208 (13%)
Query: 526 FSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMED-----FCNEISIL 578
SEL R+G G G V++ I T A+KV N ED C EI IL
Sbjct: 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYG------NHEDTVRRQICREIEIL 126
Query: 579 SRLRHPNVILFLGACTKPPRLSMITEYMELGSL--YHLIHLSGQKKKLSWRRKLKMLRDI 636
+ HPNV+ + ++ E+M+ GSL H+ ++ L+ + R I
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI----ADEQFLA-----DVARQI 177
Query: 637 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAP 696
G+ +HR IVHRD+K +N L+N VKI DFG+SRI+ + +SS GT +M+P
Sbjct: 178 LSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSP 237
Query: 697 ELIR---NEPFTEKC--DIFSLGVIMWE 719
E I N + DI+SLGV + E
Sbjct: 238 ERINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 49/172 (28%), Positives = 89/172 (51%), Gaps = 8/172 (4%)
Query: 550 GTDVAIKVFLEQDLTAENM-EDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMEL 608
G VA+K + DL + E NE+ I+ +HPN++ + L ++ E++E
Sbjct: 44 GRQVAVK---KMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100
Query: 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKI 668
G+L ++ +++ + + + + L +H ++HRD+KS + L+ VK+
Sbjct: 101 GALTDIV----THTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKL 156
Query: 669 CDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 720
DFG ++ R S GTP WMAPE+I P+ + DI+SLG+++ E+
Sbjct: 157 SDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 79/261 (30%), Positives = 123/261 (47%), Gaps = 18/261 (6%)
Query: 525 DFSELTVGT-RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFCNEISILSR 580
D E+ VG +G G FG V+ + T+ VA+K + T E +D E+ L +
Sbjct: 18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQ 77
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
L+HPN I + G K ++ EY LGS L+ + KK L + +GL
Sbjct: 78 LKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEV--HKKPLQEVEIAAITHGALQGL 134
Query: 641 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI- 699
+H ++HRD+K+ N L+ + VK+ DFG + + + +S GTP WMAPE+I
Sbjct: 135 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----NSFVGTPYWMAPEVIL 190
Query: 700 --RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIPE--GPLG 754
+ K D++SLG+ EL P + +Y +A N+ L+ E
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFR 250
Query: 755 RLIADCWAE-PQERPSCEEIL 774
+ C + PQERP+ E+L
Sbjct: 251 GFVDYCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 65/247 (26%), Positives = 131/247 (53%), Gaps = 18/247 (7%)
Query: 543 VFRGIWNGTDVAIKVFLE-QDLTAENMEDFCNEISILSRLRHPNVI----LFLGACTKPP 597
+++GI+N +V I+ F + ++ NEI L R+ N++ + P
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSA 656
RLS+I EY G L ++ ++K LS++ KL M D C+GL +++ +++L S
Sbjct: 96 RLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSV 152
Query: 657 NCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLG 714
+ LV +++ +KI GL +I++ P ++ + + +++ + +T K DI+SLG
Sbjct: 153 SFLVTENYKLKIICHGLEKILSSPPFKN---VNFMVYFSYKMLNDIFSEYTIKDDIYSLG 209
Query: 715 VIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGP--LGRLIADCWA-EPQERPSC 770
V++WE+ T P+E + + + + N+ + L++P + P + ++ C + + +RP+
Sbjct: 210 VVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNI 269
Query: 771 EEILSRL 777
+EIL L
Sbjct: 270 KEILYNL 276
|
Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 76/265 (28%), Positives = 118/265 (44%), Gaps = 35/265 (13%)
Query: 535 VGIGFFGEVF--RGIWNGTDVAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 591
+G G FG V+ R + N VAIK + + E +D E+ L +LRHPN I + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651
+ ++ EY LGS L+ + KK L + +GL +H ++HR
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 652 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI---RNEPFTEKC 708
D+K+ N L+++ VK+ DFG + I+ + + GTP WMAPE+I + K
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPA----NXFVGTPYWMAPEVILAMDEGQYDGKV 195
Query: 709 DIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAE----- 763
D++SLG+ EL P + +Y +A E P L + W+E
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-------ESPA--LQSGHWSEYFRNF 246
Query: 764 --------PQERPSCEEILSRLLDC 780
PQ+RP+ E +L
Sbjct: 247 VDSCLQKIPQDRPTSEVLLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-20
Identities = 52/151 (34%), Positives = 87/151 (57%), Gaps = 7/151 (4%)
Query: 636 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP--MRDSSSAGTPEW 693
+ RG+ + K +HRDL + N L++++ VKICDFGL+R I P +R + +W
Sbjct: 182 VARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241
Query: 694 MAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPE-- 750
MAPE I ++ +T + D++S GV++WE+ +L P+ GV + EG+R+ PE
Sbjct: 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYA 301
Query: 751 -GPLGRLIADCW-AEPQERPSCEEILSRLLD 779
+ ++ DCW P++RP+ E++ L D
Sbjct: 302 TPEIYSIMLDCWHNNPEDRPTFSELVEILGD 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 3e-20
Identities = 78/263 (29%), Positives = 124/263 (47%), Gaps = 20/263 (7%)
Query: 526 FSELTVGTRVGIGFFGEVF--RGIWNGTDVAIK-VFLEQDLTAENMEDFCNEISILSRLR 582
F++L +G G FG V+ R + VAIK + + E +D E+ L R++
Sbjct: 27 FTDLR---EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK 83
Query: 583 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
HPN I + G + ++ EY LGS L+ + KK L + +GL
Sbjct: 84 HPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEV--HKKPLQEVEIAAITHGALQGLAY 140
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI--- 699
+H ++HRD+K+ N L+ + VK+ DFG + I + + +S GTP WMAPE+I
Sbjct: 141 LHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----NSFVGTPYWMAPEVILAM 196
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIPEGP--LGRL 756
+ K D++SLG+ EL P + +Y +A NE L+ E
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256
Query: 757 IADCWAE-PQERPSCEEILSRLL 778
+ C + PQ+RP+ EE+L +
Sbjct: 257 VDSCLQKIPQDRPTSEELLKHMF 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 531 VGTRVGIGFFGEVFRG--IWNGTDVAIK---VFLEQDLTAENMEDFCNEISILSRLR--- 582
+G G +G V++ + G VA+K V L ++ + EI++L +L
Sbjct: 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLST---LREIALLKQLESFE 59
Query: 583 HPNVILFLGACTKPPR-----LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
HPN++ L C P L+++ E+++ +L K L ++R +
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLL 117
Query: 638 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 697
RG+ +H +IVHRDLK N LV VKI DFGL+RI + M +S T + APE
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE-MALTSVVVTLWYRAPE 176
Query: 698 LIRNEPFTEKCDIFSLGVIMWEL 720
++ + D++S+G I EL
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 8e-20
Identities = 72/209 (34%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 535 VGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFC----NEISILSRLRHPNVIL 588
+G G +G V G VAIK ++ + FC EI IL R +H N+I
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIK-----KISPFEHQTFCQRTLREIKILRRFKHENIIG 67
Query: 589 FLGACTKPPRLSM-----ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 643
L P S + E ME LY LI + + LS L I RGL I
Sbjct: 68 ILDIIRPPSFESFNDVYIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYI 122
Query: 644 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-----AGTPEWMAPEL 698
H ++HRDLK +N L+N + +KICDFGL+RI P D + T + APE+
Sbjct: 123 HSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD--PEHDHTGFLTEYVATRWYRAPEI 180
Query: 699 IRN-EPFTEKCDIFSLGVIMWELCTLNRP 726
+ N + +T+ DI+S+G I+ E+ + NRP
Sbjct: 181 MLNSKGYTKAIDIWSVGCILAEMLS-NRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 9e-20
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 538 GFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRH-PNVILFLGAC 593
G FG V+ + G AIKV + D+ A+N + + E +I+ P V +
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 594 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL 653
L ++ EY+ G LI G W ++ + ++ G+ +H+ I+HRD+
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAKQ--YIAEVVLGVEDLHQRGIIHRDI 123
Query: 654 KSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSL 713
K N L+++ +K+ DFGLSR ++ GTP+++APE I + D +SL
Sbjct: 124 KPENLLIDQTGHLKLTDFGLSRNGLENK----KFVGTPDYLAPETILGVGDDKMSDWWSL 179
Query: 714 GVIMWELCTLNRPWEGVLPERV 735
G +++E P+ P+ V
Sbjct: 180 GCVIFEFLFGYPPFHAETPDAV 201
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 61/201 (30%), Positives = 102/201 (50%), Gaps = 9/201 (4%)
Query: 535 VGIGFFGEVFRGIWNGTD--VAIKVFLEQD--LTAENMEDFCNEISILSRLRHPNVILFL 590
+G G FG+V GTD A+KV L++D L +++E E +L+ + L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKV-LKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 591 GACTKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 649
+C + RL + EY+ G L I SG + R +I GL +H I+
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERGII 118
Query: 650 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 709
+RDLK N L++ +KI DFG+ + + S+ GTP+++APE++ +P+ D
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVD 178
Query: 710 IFSLGVIMWELCTLNRPWEGV 730
++LGV+++E+ P+EG
Sbjct: 179 WWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 3e-19
Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 10/201 (4%)
Query: 535 VGIGFFGEVF-----RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 589
+G G FG+VF G G A+KV + L + E IL+ + HP ++
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 590 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM-LRDICRGLMCIHRMKI 648
A +L +I +++ G L+ LS K+ + +K L ++ L +H + I
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLF--TRLS--KEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 649 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKC 708
++RDLK N L+++ +K+ DFGLS+ D + S GT E+MAPE++ T+
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA 179
Query: 709 DIFSLGVIMWELCTLNRPWEG 729
D +S GV+M+E+ T + P++G
Sbjct: 180 DWWSFGVLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 71/266 (26%), Positives = 122/266 (45%), Gaps = 24/266 (9%)
Query: 535 VGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENME--DFCNEISILSRLRHPNVILFLG 591
+G G+FG+V I+ T VA V E A + E +F + L+HPN++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL-KMLRDICRGLMCIHRMKIVH 650
C + ++ EY ELG L + ++ S L +M +I G+ +H+ +H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLH 122
Query: 651 RDLKSANCLVNKHWTVKICDFGL--SRIITDSPMRDSSSAGTPEWMAPELIRN------- 701
DL NC + TVK+ D+G+ SR D + W+APEL+
Sbjct: 123 SDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLIT 182
Query: 702 EPFTEKCDIFSLGVIMWELC-TLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIAD- 759
T+ ++++LGV +WEL +P+ + V+ V + ++++ + L ++
Sbjct: 183 AEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD-QQVKLFKPQLELPYSER 241
Query: 760 -------CWAEPQERPSCEEILSRLL 778
CW P++R + EE+ RLL
Sbjct: 242 WYEVLQFCWLSPEKRATAEEV-HRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 8e-19
Identities = 66/266 (24%), Positives = 108/266 (40%), Gaps = 35/266 (13%)
Query: 536 GIGFFGEVFRGIW--NGTD----------VAIKVFLEQDLTAENMEDFCNEISILSRLRH 583
G G F +++G+ V +KV L D + F S++S+L H
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKV-LGSDH--RDSLAFFETASLMSQLSH 60
Query: 584 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 643
+++ G C + + M+ EY++ G L +H L W KL + + + L +
Sbjct: 61 KHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYL 117
Query: 644 HRMKIVHRDLKSANCLVNKHWT-------VKICDFGLSRIITDSPMRDSSSAGTPEWMAP 696
K+VH ++ N LV ++ +K+ D G+ + R W+AP
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP----WIAP 173
Query: 697 ELIRNEP--FTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE-GP 752
E IRN T D +S G + E+C+ P + + RL +P+
Sbjct: 174 ECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMPDCAE 232
Query: 753 LGRLIADCWA-EPQERPSCEEILSRL 777
L LI CW +P +RPS IL L
Sbjct: 233 LANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 65/197 (32%), Positives = 94/197 (47%), Gaps = 17/197 (8%)
Query: 535 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 592
VG G +G+V T VAIK +A + + E+ +L + H NVI L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 593 CTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 646
T L ++T M L +++ + +KLS ++ I RGL IH
Sbjct: 83 FTPASSLEDFQDVYLVTHLMG-ADLNNIV----KCQKLSDDHIQFLVYQILRGLKYIHSA 137
Query: 647 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-PFT 705
I+HRDLK +N VN+ +KI DFGL+R TD M T + APE++ N +
Sbjct: 138 GIIHRDLKPSNIAVNEDCELKILDFGLAR-HTDDEMTG--YVATRWYRAPEIMLNWMHYN 194
Query: 706 EKCDIFSLGVIMWELCT 722
+ DI+S+G IM EL T
Sbjct: 195 QTVDIWSVGCIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 50/161 (31%), Positives = 80/161 (49%), Gaps = 18/161 (11%)
Query: 574 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------KKKLSW 626
E+ I+ R P ++ F GA + M E+M+ GSL + G K ++
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAV 112
Query: 627 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 686
L L ++ HR I+HRD+K +N LVN +K+CDFG+S + +S +
Sbjct: 113 VEGLTYLYNV-------HR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA--DT 161
Query: 687 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 727
GT +M+PE I+ +T K D++SLG+ + EL P+
Sbjct: 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 24/203 (11%)
Query: 534 RVGIGFFGEVFRG--IWNGTDVAIK----VF--LEQDLTAENMEDFCNEISILSRLR-HP 584
++G G F EV + G AIK F LEQ EI L RL HP
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-------LREIQALRRLSPHP 58
Query: 585 NVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
N++ + K RL+++ E M++ +LY LI G+K+ L +R + + + L
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELMDM-NLYELIK--GRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE-LIRN 701
+HR I HRD+K N L+ +K+ DFG R I P + T + APE L+ +
Sbjct: 116 MHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY-TEYISTRWYRAPECLLTD 173
Query: 702 EPFTEKCDIFSLGVIMWELCTLN 724
+ K DI+++G + +E+ +L
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLF 196
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 6e-18
Identities = 48/136 (35%), Positives = 79/136 (58%), Gaps = 7/136 (5%)
Query: 649 VHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTE 706
+HRDL + N L+ KICDFGL+R I DS +A P +WMAPE I N +T
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF 295
Query: 707 KCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCW- 761
+ D++S G+++WE+ +L + P+ G+ + Y + EG R+ PE + ++ CW
Sbjct: 296 ESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWD 355
Query: 762 AEPQERPSCEEILSRL 777
A+P +RP+ ++I+ +
Sbjct: 356 ADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 34/214 (15%)
Query: 535 VGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDF----CNEISILSRLRHPNV 586
+G G +G V++ +G + AIK F + D E C EI++L L+H NV
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKF-KGD--KEQYTGISQSACREIALLRELKHENV 64
Query: 587 I----LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSW-RRKLK-MLRDICRGL 640
+ +FL K + ++ +Y E L+ +I Q K++S +K +L I G+
Sbjct: 65 VSLVEVFLEHADK--SVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 641 MCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITDSPMRDSSSAG----TPE 692
+H ++HRDLK AN LV + VKI D GL+R+ ++P++ + T
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPLKPLADLDPVVVTIW 180
Query: 693 WMAPELI---RNEPFTEKCDIFSLGVIMWELCTL 723
+ APEL+ R+ +T+ DI+++G I EL TL
Sbjct: 181 YRAPELLLGARH--YTKAIDIWAIGCIFAELLTL 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-18
Identities = 49/137 (35%), Positives = 82/137 (59%), Gaps = 5/137 (3%)
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIR 700
+H ++HRD+KSAN L+ + VK+ DFG S++ + D + GTP ++APE+ R
Sbjct: 159 VHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR 218
Query: 701 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY-AVANEGSRLEIPEGPLGRLIAD 759
+P+++K D+FSLGV+++EL TL RP++G E V++ +A L P + I
Sbjct: 219 RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVT 278
Query: 760 CW--AEPQERPSCEEIL 774
++P+ RPS ++L
Sbjct: 279 ALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 59/192 (30%), Positives = 93/192 (48%), Gaps = 8/192 (4%)
Query: 535 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 592
VG G +G V + G VAIK FLE + + EI +L +LRH N++ +
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 593 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 652
+ RL ++ E+++ L L L R K L I RG+ H I+HRD
Sbjct: 69 FRRKKRLYLVFEFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHNIIHRD 125
Query: 653 LKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APELIRNEP-FTEKCDI 710
+K N LV++ VK+CDFG +R + +P + W APEL+ + + DI
Sbjct: 126 IKPENILVSQSGVVKLCDFGFARTLA-APGEVYTDYVATRWYRAPELLVGDTKYGRAVDI 184
Query: 711 FSLGVIMWELCT 722
+++G ++ E+ T
Sbjct: 185 WAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-17
Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 525 DFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCN--EISILSR 580
DF+ L V +G G FG+V GTD AIK+ L++D+ ++ + C E +L+
Sbjct: 1 DFNFLMV---LGKGSFGKVMLAERKGTDELYAIKI-LKKDVIIQDDDVECTMVEKRVLAL 56
Query: 581 LRHPNVILFLGAC-TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 639
P + L +C RL + EY+ G L + I G+ K+ + +I G
Sbjct: 57 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKE---PHAVFYAAEIAIG 113
Query: 640 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 699
L +H I++RDLK N +++ +KI DFG+ + + GTP+++APE+I
Sbjct: 114 LFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII 173
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
+P+ + D ++ GV+++E+ P++G
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 65/246 (26%), Positives = 118/246 (47%), Gaps = 17/246 (6%)
Query: 549 NGTDVAIKVFLEQDLTAENMEDFC-NEISILSRLRHPNVILFLGACTKPPRLSMITEYME 607
+G VA+K+ DL + + NE+ I+ +H NV+ + L ++ E+++
Sbjct: 45 SGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101
Query: 608 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 667
G+L ++ + +L+ + + + + L +H ++HRD+KS + L+ VK
Sbjct: 102 GGALTDIV----SQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVK 157
Query: 668 ICDFGL-SRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP 726
+ DFG ++I D P R S GTP WMAPE+I P+ + DI+SLG+++ E+ P
Sbjct: 158 LSDFGFCAQISKDVPKR-KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
Query: 727 WEGVLPERVVYAVANE---GSRLEIPEGPLGRLIADCW--AEPQERPSCEEILSR--LLD 779
+ P + + + + + P+ R + EPQER + +E+L LL
Sbjct: 217 YFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQ 276
Query: 780 CEYSLC 785
C
Sbjct: 277 TGLPEC 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-17
Identities = 55/165 (33%), Positives = 87/165 (52%), Gaps = 13/165 (7%)
Query: 573 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK- 631
+E+ L+ H ++ +L +I EY G L I K++L +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI-----KQRLKEHLPFQE 168
Query: 632 -----MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD-- 684
+ I L +H K++HRDLKSAN + +K+ DFG S+ +DS D
Sbjct: 169 YEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
SS GTP ++APEL + +++K D++SLGVI++EL TL+RP++G
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 15/156 (9%)
Query: 631 KMLRDICRGLMCIH-RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 689
K+ I + L +H ++ ++HRD+K +N L+N++ VK+CDFG+S + DS + + AG
Sbjct: 107 KIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-VAKTIDAG 165
Query: 690 TPEWMAPELIRNE----PFTEKCDIFSLGVIMWELCTLNRPWE--GVLPERVVYAVANEG 743
+MAPE I E + K D++SLG+ M EL T P++ +++ V E
Sbjct: 166 CKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--EE 223
Query: 744 SRLEIPEGPLGRLIAD-----CWAEPQERPSCEEIL 774
++P D +ERP+ E+L
Sbjct: 224 PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELL 259
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 34/203 (16%)
Query: 538 GFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDF----CNEISILSRLRHPNVI--- 587
G +G V+R T VA+K + +E + E F EI+IL +L+HPN++
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKME-----KEKEGFPITSLREINILLKLQHPNIVTVK 70
Query: 588 -LFLGACTKPPRLSMITEYME--LGSLYHLIH---LSGQKKKLSWRRKLKMLRDICRGLM 641
+ +G + ++ M+ EY+E L SL + L + K L + + G+
Sbjct: 71 EVVVG--SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCL--------MLQLLSGVA 120
Query: 642 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APELIR 700
+H I+HRDLK++N L+N +KICDFGL+R SP++ + W APEL+
Sbjct: 121 HLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVVTLWYRAPELLL 179
Query: 701 NEP-FTEKCDIFSLGVIMWELCT 722
++ D++S+G I EL T
Sbjct: 180 GAKEYSTAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 55/190 (28%), Positives = 89/190 (46%), Gaps = 7/190 (3%)
Query: 535 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC-NEISILSRLRHPNVILFLG 591
+G G FGEV + G A K ++ L E NE IL ++ ++
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 592 ACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 650
A L ++ M G L YH+ ++ + R + I GL +H+ +IV+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 651 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 710
RDLK N L++ H V+I D GL+ + + AGTP +MAPE+++ E + D
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGGK-KIKGRAGTPGYMAPEVLQGEVYDFSVDW 177
Query: 711 FSLGVIMWEL 720
F+LG ++E+
Sbjct: 178 FALGCTLYEM 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-17
Identities = 53/159 (33%), Positives = 85/159 (53%), Gaps = 10/159 (6%)
Query: 630 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSA 688
L + RG+ + VHRDL + N L+ + VKICDFGL+R I+ DS S
Sbjct: 240 LSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGST 299
Query: 689 GTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRL 746
P +WMAPE I + +T D++S G+++WE+ +L P+ G++ + Y G R+
Sbjct: 300 FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM 359
Query: 747 EIPE---GPLGRLIADCW-AEPQERPS---CEEILSRLL 778
P+ + ++ CW +EP++RPS +I+ LL
Sbjct: 360 AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 4e-17
Identities = 48/141 (34%), Positives = 78/141 (55%), Gaps = 10/141 (7%)
Query: 649 VHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTE 706
+HRD+ + N L+ KICDFGL+R I+ DS +A P +WMAPE I + +T
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV 293
Query: 707 KCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE-GPLG--RLIADCWA 762
+ D++S G+++WE+ +L + P+ G+L Y + G ++ P+ P ++ CW
Sbjct: 294 QSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWN 353
Query: 763 -EPQERPSCEEI---LSRLLD 779
EP ERP+ +I + R L
Sbjct: 354 LEPTERPTFSQISQLIQRQLG 374
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 29/204 (14%)
Query: 534 RVGIGFFGEVF--RGIWNGTDVAIK-VFLEQDL-----TAENMEDFCNEISILSRLRHPN 585
++G G +G V+ R G VA+K + LE + TA EIS+L L HPN
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA------IREISLLKELNHPN 59
Query: 586 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM-LRDICRGLMCIH 644
++ L +L ++ E+++L ++ +K L + +G+ H
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLD---PPLIKSYLYQLLQGIAYCH 116
Query: 645 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APE-L 698
+++HRDLK N L+++ +K+ DFGL+R P+R T E W APE L
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVR----TYTHEVVTLWYRAPEIL 171
Query: 699 IRNEPFTEKCDIFSLGVIMWELCT 722
+ + ++ DI+S+G I E+
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 6e-17
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 13/214 (6%)
Query: 527 SELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAEN-MEDFCNEISILSRLRH 583
+ + T+VG G +G+VF T VA+K + L N + E IL+ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 584 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 643
++ L A L + EY+ G L++ G + R M + +
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHAR--FYMAEMFE-AVDAL 117
Query: 644 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTPEWMAPELIRNE 702
H + +HRDLK N L++ +K+ DFGLS+ I+T +S G+P++MAPE++R +
Sbjct: 118 HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGK 173
Query: 703 PFTEKCDIFSLGVIMWE-LCTLNRPWEGVLPERV 735
+ D +SLG +++E LC P+ G P
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFP-PFSGSTPNET 206
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 6e-17
Identities = 73/210 (34%), Positives = 101/210 (48%), Gaps = 43/210 (20%)
Query: 535 VGIGFFGEVFRGIWNGTD------VAIK----VFLEQDLTAENMEDFCNEISILSRLRHP 584
+G G FG V W+ TD VA+K VF Q+L + + E+ +L +H
Sbjct: 8 IGYGAFGVV----WSVTDPRDGKRVALKKMPNVF--QNLVS--CKRVFRELKMLCFFKHD 59
Query: 585 NVILFLGA--CTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 636
NV L A +PP + ++TE M+ S H I +S Q LS L I
Sbjct: 60 NV---LSALDILQPPHIDPFEEIYVVTELMQ--SDLHKIIVSPQP--LSSDHVKVFLYQI 112
Query: 637 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE---- 692
RGL +H I+HRD+K N LVN + +KICDFGL+R + P D S T E
Sbjct: 113 LRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLAR--VEEP--DESKHMTQEVVTQ 168
Query: 693 -WMAPELIRNEP-FTEKCDIFSLGVIMWEL 720
+ APE++ +T DI+S+G I EL
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAEL 198
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 6e-17
Identities = 62/210 (29%), Positives = 111/210 (52%), Gaps = 12/210 (5%)
Query: 525 DFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCN--EISILSR 580
DF+ L V +G G FG+V GTD AIK+ L++D+ ++ + C E +L+
Sbjct: 1 DFNFLMV---LGKGSFGKVMLAERKGTDELYAIKI-LKKDVVIQDDDVECTMVEKRVLAL 56
Query: 581 LRHPNVILFLGACTKP-PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 639
P + L +C + RL + EY+ G L + I G+ K+ + + +I G
Sbjct: 57 QDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE---PQAVFYAAEISVG 113
Query: 640 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 699
L +HR I++RDLK N +++ +KI DFG+ + + + GTP+++APE+I
Sbjct: 114 LFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII 173
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
+P+ + D ++ GV+++E+ P++G
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 7e-17
Identities = 63/193 (32%), Positives = 96/193 (49%), Gaps = 18/193 (9%)
Query: 535 VGIGFFGEV--FRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI----L 588
VG+G FG V R G +VAIK ++ T + E+ +L LRH N+I +
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 589 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 648
F+ + +TE + L+ L+ + L + L I RGL +H +
Sbjct: 78 FISPLED---IYFVTELLGT-DLHRLL----TSRPLEKQFIQYFLYQILRGLKYVHSAGV 129
Query: 649 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEK 707
VHRDLK +N L+N++ +KICDFGL+R I D M S T + APE++ + + +
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLAR-IQDPQMTGYVS--TRYYRAPEIMLTWQKYDVE 186
Query: 708 CDIFSLGVIMWEL 720
DI+S G I E+
Sbjct: 187 VDIWSAGCIFAEM 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 8e-17
Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 525 DFSELTVGTRVGIGFFGEVF--RGIWN---GTDVAIKVFLEQDLT--AENMEDFCNEISI 577
+F L V +G G +G+VF R + G A+KV + + A+ E E +
Sbjct: 1 NFELLRV---LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQV 57
Query: 578 LSRLRH-PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 636
L +R P ++ A +L +I +Y+ G L+ HL Q++ + + +I
Sbjct: 58 LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELF--THLY-QREHFTESEVRVYIAEI 114
Query: 637 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI-ITDSPMRDSSSAGTPEWMA 695
L +H++ I++RD+K N L++ V + DFGLS+ + + R S GT E+MA
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 696 PELIRNEP--FTEKCDIFSLGVIMWELCT 722
PE+IR + D +SLGV+ +EL T
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 8e-17
Identities = 56/189 (29%), Positives = 96/189 (50%), Gaps = 9/189 (4%)
Query: 535 VGIGFFGEVF--RGIWNGTDVAIKVFLEQD-LTAENMEDFCNEISILSRLRHPNVILFLG 591
VG G FG V R + A+KV + + + + NE +L + HP +I
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651
L M+ EY+ G L+ + SG + S L +I L +H +IV+R
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKEIVYR 125
Query: 652 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 711
DLK N L++K +K+ DFG ++ + D R + GTPE++APE+I+++ + D +
Sbjct: 126 DLKPENILLDKEGHIKLTDFGFAKKLRD---RTWTLCGTPEYLAPEVIQSKGHNKAVDWW 182
Query: 712 SLGVIMWEL 720
+LG++++E+
Sbjct: 183 ALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 8e-17
Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 12/210 (5%)
Query: 525 DFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCN--EISILSR 580
DF+ L V +G G FG+V GTD AIK+ L++D+ ++ + C E +L+
Sbjct: 1 DFNFLMV---LGKGSFGKVMLAERKGTDELYAIKI-LKKDVVIQDDDVECTMVEKRVLAL 56
Query: 581 LRHPNVILFLGACTKP-PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 639
P + L +C + RL + EY+ G L + I G+ K+ + +I G
Sbjct: 57 SGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKE---PHAVFYAAEIAIG 113
Query: 640 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 699
L +H I++RDLK N +++ +KI DFG+ + + + GTP+++APE+I
Sbjct: 114 LFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII 173
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
+P+ + D ++ GV+++E+ P+EG
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 62/236 (26%), Positives = 115/236 (48%), Gaps = 21/236 (8%)
Query: 549 NGTDVAIKVFLEQDLTAENMEDFC-NEISILSRLRHPNVILFLGACTKPPRLSMITEYME 607
+G VA+K + DL + + NE+ I+ +H NV+ + L ++ E++E
Sbjct: 44 SGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100
Query: 608 LGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTV 666
G+L ++ H +++++ + + + L +H ++HRD+KS + L+ V
Sbjct: 101 GGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRV 155
Query: 667 KICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP 726
K+ DFG ++ R S GTP WMAPELI P+ + DI+SLG+++ E+ P
Sbjct: 156 KLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
Query: 727 WEGVLPERVVYAVA-NEGSRLE-------IPEGPLGRLIADCWAEPQERPSCEEIL 774
+ P + + + N +L+ +G L RL+ +P +R + E+L
Sbjct: 216 YFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV---RDPAQRATAAELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 68/217 (31%), Positives = 102/217 (47%), Gaps = 12/217 (5%)
Query: 536 GIGFFGEVFRGIWNGTD--VAIKVFLEQDLTA-ENMEDFCNEISIL---SRLRHPNVILF 589
G G FG+V + T AIK + D+ A + +E E I + RHP ++
Sbjct: 8 GRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP-FLVN 66
Query: 590 LGACTKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 648
L AC + + + EY G L IH S R + + GL +H KI
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENKI 122
Query: 649 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKC 708
V+RDLK N L++ VKI DFGL + R S+ GTPE++APE++ +T
Sbjct: 123 VYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAV 182
Query: 709 DIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 745
D + LGV+++E+ P+ G E V ++ N+ R
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR 219
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 40/149 (26%), Positives = 83/149 (55%), Gaps = 3/149 (2%)
Query: 574 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 633
E ++L+++ P ++ + P +L ++ ++ G L+H HL + + R +
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFH--HLQREGRFDLSRARFYTA 100
Query: 634 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEW 693
+C L +H+ +++RDLK N L++ + +CDFGL ++ + ++ GTPE+
Sbjct: 101 ELLC-ALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159
Query: 694 MAPELIRNEPFTEKCDIFSLGVIMWELCT 722
+APEL+ +T+ D ++LGV+++E+ T
Sbjct: 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 11/214 (5%)
Query: 535 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCN--EISILS-RLRHPNVI-L 588
+G G FG+V GT+ AIK L++D+ E+ + C E +L+ HP + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKA-LKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 589 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 648
F TK L + EY+ G L I + R +I GL +H+ I
Sbjct: 62 FCTFQTKE-HLFFVMEYLNGGDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHKKGI 117
Query: 649 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKC 708
++RDLK N L++K +KI DFG+ + + + S+ GTP+++APE+++ + + E
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV 177
Query: 709 DIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE 742
D +S GV+++E+ P+ G + + ++ N+
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 533 TRVGIGFFGEVF--RGIWNGTDVAIKVFL--EQDLTAENMEDFCNEISILSRLRHPNVIL 588
+++G G +G VF R G VAIK F+ E D + + EI +L +L+HPN++
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA--LREIRMLKQLKHPNLVN 64
Query: 589 FLGACTKPPRLSMITEYMELGSLYHL-IHLSG----QKKKLSWRRKLKMLRDICRGLMCI 643
+ + +L ++ EY + L L + G KK+ W+ + +
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQ--------TLQAVNFC 116
Query: 644 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE- 702
H+ +HRD+K N L+ K +K+CDFG +RI+T + T + APEL+ +
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 703 PFTEKCDIFSLGVIMWELCTLNRPWEG 729
+ D++++G + EL T W G
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLWPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-16
Identities = 60/190 (31%), Positives = 100/190 (52%), Gaps = 8/190 (4%)
Query: 535 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLG 591
+G G FG+V R +G A+K+ ++ + A++ + E +L RHP +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651
+ RL + EY+ G L+ HLS +++ S R +I L +H KIV+R
Sbjct: 63 SFQTKDRLCFVMEYVNGGELF--FHLS-RERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119
Query: 652 DLKSANCLVNKHWTVKICDFGLSRI-ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 710
DLK N +++K +KI DFGL + ITD+ + GTPE++APE++ + + D
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGITDAATM-KTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 711 FSLGVIMWEL 720
+ LGV+M+E+
Sbjct: 179 WGLGVVMYEM 188
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 5e-16
Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 535 VGIGFFGEVFRGIWNGTDV--AIKVFLEQDLTAENMEDFC-NEISILSRLRHPNVILFLG 591
+G+G FG V + A+K ++ + ++ +E IL HP ++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM-CI------- 643
+ M+ EY G L+ ++ R + R + C+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTIL-----------RDRGLFDEYTARFYIACVVLAFEYL 109
Query: 644 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP 703
H I++RDLK N L++ + VK+ DFG ++ + S + + GTPE++APE+I N+
Sbjct: 110 HNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK-SGQKTWTFCGTPEYVAPEIILNKG 168
Query: 704 FTEKCDIFSLGVIMWELCTLNRP 726
+ D +SLG++++EL T P
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 5e-16
Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 27/211 (12%)
Query: 521 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQD-LTAENMEDFCNEISI 577
W + S+ +G +G G FG V GT AIK +++ L + ++ E SI
Sbjct: 14 SWKL--SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSI 71
Query: 578 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
L L HP ++ + + R+ + E++ G L+ HL R+ + D+
Sbjct: 72 LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELF--THL---------RKAGRFPNDVA 120
Query: 638 R--------GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 689
+ +H I++RDLK N L++ VK+ DFG ++ + D R + G
Sbjct: 121 KFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD---RTFTLCG 177
Query: 690 TPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 720
TPE++APE+I+++ + D +++GV+++E
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEF 208
|
Length = 329 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 6e-16
Identities = 67/202 (33%), Positives = 97/202 (48%), Gaps = 27/202 (13%)
Query: 535 VGIGFFGEVFRGI--WNGTDVAIKVF---LEQDLTAENMEDFCNEISILSRLRHPNVILF 589
VG G +G V + G VAIK + +L A+ E+ +L ++H NVI
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY---RELRLLKHMKHENVIGL 79
Query: 590 LGACTKPPRLSMITEY--------MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
L T L ++ +LG L + +KLS R ++ + +GL
Sbjct: 80 LDVFTPDLSLDRFHDFYLVMPFMGTDLGKLM-------KHEKLSEDRIQFLVYQMLKGLK 132
Query: 642 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 701
IH I+HRDLK N VN+ +KI DFGL+R TDS M + T + APE+I N
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSEM--TGYVVTRWYRAPEVILN 189
Query: 702 -EPFTEKCDIFSLGVIMWELCT 722
+T+ DI+S+G IM E+ T
Sbjct: 190 WMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 7e-16
Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 18/219 (8%)
Query: 535 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCN--EISILSRLR-HPNVILF 589
+G G FG+V GTD AIKV L++D+ ++ + C E IL+ HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKV-LKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 590 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 649
RL + EY+ G L I S +K R ++ LM +HR ++
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHGVI 118
Query: 650 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 709
+RDLK N L++ K+ DFG+ + + + ++ GTP+++APE+++ + D
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVD 178
Query: 710 IFSLGVIMWELCTLNRPWEG---------VLPERVVYAV 739
++LGV+M+E+ P+E +L + V+Y V
Sbjct: 179 WWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV 217
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 48/180 (26%), Positives = 89/180 (49%), Gaps = 8/180 (4%)
Query: 549 NGTDVAIKVFLEQDLTAENMEDFC-NEISILSRLRHPNVILFLGACTKPPRLSMITEYME 607
G VA+K + DL + + NE+ I+ H NV+ + L ++ E++E
Sbjct: 46 TGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102
Query: 608 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 667
G+L ++ +++ + + + R L +H ++HRD+KS + L+ +K
Sbjct: 103 GGALTDIV----THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIK 158
Query: 668 ICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 727
+ DFG ++ + S GTP WMAPE+I P+ + DI+SLG+++ E+ P+
Sbjct: 159 LSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 14/204 (6%)
Query: 527 SELTVGTRVGIGFFGEVFRGIWNGTDV--AIK-VFLEQDLTAENMEDFCNEISILSRLRH 583
E+ V +G G +G V++ + T V A+K + LE D + N E+ IL +
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFN--QIIMELDILHKAVS 58
Query: 584 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 643
P ++ F GA + M EYM+ GSL L + + ++ + +GL +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 644 -HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE 702
I+HRD+K N LVN + VK+CDFG+S + S + ++ G +MAPE I++
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK--TNIGCQSYMAPERIKSG 176
Query: 703 ------PFTEKCDIFSLGVIMWEL 720
+T + D++SLG+ + E+
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 534 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHPN 585
++G G +G V++G T VA+K + LE + TA EIS+L L+HPN
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA------IREISLLKELQHPN 60
Query: 586 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 645
++ + RL +I E++ + +L L + + K L I +G++ H
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVK-SYLYQILQGILFCHS 119
Query: 646 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APELIRNEP- 703
+++HRDLK N L++ +K+ DFGL+R P+R + W APE++ P
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 704 FTEKCDIFSLGVIMWELCTLNRP 726
++ DI+S+G I E+ T +P
Sbjct: 179 YSTPVDIWSIGTIFAEMAT-KKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 48/156 (30%), Positives = 78/156 (50%), Gaps = 3/156 (1%)
Query: 574 EISILSRLRHPNVILFLG-ACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLK 631
E IL+++ H I+ L A L ++ M G L YH+ ++ + R
Sbjct: 43 EKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACF 101
Query: 632 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 691
I GL +H+ +I++RDLK N L++ V+I D GL+ + D + AGTP
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP 161
Query: 692 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 727
+MAPEL++ E + D F+LGV ++E+ P+
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 54/230 (23%), Positives = 95/230 (41%), Gaps = 53/230 (23%)
Query: 531 VGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENME-DFCNEISILSRLRHPNVI 587
V +G G FGEV+ R G A+KV + D+ N E IL+ P ++
Sbjct: 5 VIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIV 64
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD---------ICR 638
+ L ++ EYM G L ++ + + + +
Sbjct: 65 KLYYSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETARFYIAELVL 112
Query: 639 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS------------------ 680
L +H++ +HRD+K N L++ +K+ DFGL + + +
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 681 ----------PMRDSSSA-GTPEWMAPELIRNEPFTEKCDIFSLGVIMWE 719
++S GTP+++APE++R P+ +CD +SLGVI++E
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 10/191 (5%)
Query: 535 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLG 591
+G G FG+V R G A+K+ ++ + A++ + E +L RHP +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651
A RL + EY G L+ HLS +++ + R +I L +H +V+R
Sbjct: 63 AFQTHDRLCFVMEYANGGELF--FHLS-RERVFTEERARFYGAEIVSALEYLHSRDVVYR 119
Query: 652 DLKSANCLVNKHWTVKICDFGLSR--IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 709
D+K N +++K +KI DFGL + I + M+ + GTPE++APE++ + + D
Sbjct: 120 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 710 IFSLGVIMWEL 720
+ LGV+M+E+
Sbjct: 178 WWGLGVVMYEM 188
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-15
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 550 GTDVAIKVFLEQDLTAENM-EDFCNEISILSRLRHPNVILFLGACTKPP-RLSMITEYME 607
G +VAIK+ E+ F E ++ +RL HPN++ L + PP L + EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 608 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-----K 662
+L ++ G L +++ + L C H IVHRDLK N +V+
Sbjct: 63 GRTLREVLAADG---ALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRP 119
Query: 663 HWTVKICDFGLSRIITDSPMRDSSSA-------GTPEWMAPELIRNEPFTEKCDIFSLGV 715
H K+ DFG+ ++ D ++ GTP + APE +R EP T D+++ G+
Sbjct: 120 H--AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 716 IMWELCTLNRPWEGVLPERVVY 737
I E T R +G ++Y
Sbjct: 178 IFLECLTGQRVVQGASVAEILY 199
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 41/147 (27%), Positives = 72/147 (48%), Gaps = 4/147 (2%)
Query: 574 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 633
E +L + HP+VI M+ + LY +L+ + + L + L +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLY--TYLTKRSRPLPIDQALIIE 163
Query: 634 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEW 693
+ I GL +H +I+HRD+K+ N +N V I D G ++ +P AGT E
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA-FLGLAGTVET 222
Query: 694 MAPELIRNEPFTEKCDIFSLGVIMWEL 720
APE++ + + K DI+S G++++E+
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 71/256 (27%), Positives = 122/256 (47%), Gaps = 28/256 (10%)
Query: 535 VGIGFFGEVF-----RGIWNGTDVAIKVFLEQDLT--AENMEDFCNEISILSRLRH-PNV 586
+G G +G+VF G +G A+KV + + A+ E E +L +R P +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 587 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 646
+ A +L +I +Y+ G L+ HLS Q+++ + +I L +H++
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELF--THLS-QRERFKEQEVQIYSGEIVLALEHLHKL 124
Query: 647 KIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTPEWMAPELIR--NEP 703
I++RD+K N L++ + V + DFGLS+ D R S GT E+MAP+++R +
Sbjct: 125 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGG 184
Query: 704 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAE 763
+ D +S+GV+M+EL T P+ + S+ EI R++
Sbjct: 185 HDKAVDWWSMGVLMYELLTGASPFT---------VDGEKNSQAEISR----RILKSEPPY 231
Query: 764 PQE-RPSCEEILSRLL 778
PQE ++I+ RLL
Sbjct: 232 PQEMSALAKDIIQRLL 247
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 7e-15
Identities = 64/201 (31%), Positives = 94/201 (46%), Gaps = 23/201 (11%)
Query: 535 VGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAENMEDFCNEISILSRLRHPNVIL 588
+G G +G V I +G VAIK F L + E+ IL +H N+I
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR----ELKILRHFKHDNIIA 68
Query: 589 FLGACTKPPRLSMITEY--MEL--GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 644
+PP Y M+L L+H+IH S Q R L + RGL IH
Sbjct: 69 IR-DILRPPGADFKDVYVVMDLMESDLHHIIH-SDQPLTEEHIRYF--LYQLLRGLKYIH 124
Query: 645 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS----SSAGTPEWMAPELIR 700
++HRDLK +N LVN+ ++I DFG++R ++ SP T + APEL+
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184
Query: 701 NEP-FTEKCDIFSLGVIMWEL 720
+ P +T D++S+G I E+
Sbjct: 185 SLPEYTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 56/195 (28%), Positives = 101/195 (51%), Gaps = 12/195 (6%)
Query: 535 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLG 591
+G G FG+V++ T A+KV ++++ A+ + E +IL R +G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 592 ---ACTKPPRLSMITEYMELGSLY-HLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
+ L ++T+YM G L+ HL + + S R + ++ L +H+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD 116
Query: 648 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP-FTE 706
IV+RDLK N L++ + +CDFGLS+ ++ GT E++APE++ +E +T+
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTK 176
Query: 707 KCDIFSLGVIMWELC 721
D +SLGV+++E+C
Sbjct: 177 HVDFWSLGVLVFEMC 191
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 51/190 (26%), Positives = 98/190 (51%), Gaps = 7/190 (3%)
Query: 535 VGIGFFGEVF--RGIWNGTDVAIKVFLEQD-LTAENMEDFCNEISILSR-LRHPNVILFL 590
+G G FG+V + +G+ A+KV ++ L + E ++L + L+HP ++
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 591 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 650
+ +L + +Y+ G L+ HL ++ L R + ++ + +H + I++
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELF--FHLQRERCFLEPRARF-YAAEVASAIGYLHSLNIIY 119
Query: 651 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 710
RDLK N L++ V + DFGL + + S+ GTPE++APE++R EP+ D
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179
Query: 711 FSLGVIMWEL 720
+ LG +++E+
Sbjct: 180 WCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-14
Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 33/224 (14%)
Query: 535 VGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAEN---MEDFCNEISILSRLRHPNVILF 589
+G G GEV+ VA+K E DL +EN + F E I + L HP ++
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIRE-DL-SENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 590 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKL--------SWRRKLKMLRDICRGLM 641
C+ + Y+E +L L+ QK+ L S L + IC +
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 642 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT---------DSPMRDSSSA---- 688
+H ++HRDLK N L+ V I D+G + D R+ +
Sbjct: 128 YVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTI 187
Query: 689 -----GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 727
GTP++MAPE + P +E DI++LGVI++++ TL+ P+
Sbjct: 188 PGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 49/132 (37%), Positives = 69/132 (52%), Gaps = 15/132 (11%)
Query: 649 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS--SAGTP----EWMAPELIRNE 702
VHRDL + N L+ + VKICDFGL+R I MRDS+ S G+ +WMAPE I N
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDI----MRDSNYISKGSTFLPLKWMAPESIFNN 316
Query: 703 PFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIA 758
+T D++S G+++WE+ TL P+ + Y G R+ P + ++
Sbjct: 317 LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQ 376
Query: 759 DCWAEPQE-RPS 769
CW E E RP
Sbjct: 377 KCWEEKFEIRPD 388
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 50/156 (32%), Positives = 83/156 (53%), Gaps = 18/156 (11%)
Query: 574 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------KKKLSW 626
E+ +L P ++ F GA +S+ E+M+ GSL ++ +G+ K ++
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108
Query: 627 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 686
R L LR+ KI+HRD+K +N LVN +K+CDFG+S + DS M + S
Sbjct: 109 LRGLTYLREK---------HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MAN-S 157
Query: 687 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 722
GT +M+PE ++ +T + DI+SLG+ + E+
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAI 193
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 53/154 (34%), Positives = 78/154 (50%), Gaps = 12/154 (7%)
Query: 574 EISILSRLRHPNVILFLGACTKPPR------LSMITEYMELGSLYHLIHLSGQKKKLSWR 627
EI +L L H NVI + PP + ++ E M+ L+ +I S Q LS
Sbjct: 54 EIKLLRHLDHENVIA-IKDIMPPPHREAFNDVYIVYELMDT-DLHQIIR-SSQT--LSDD 108
Query: 628 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 687
L + RGL IH ++HRDLK +N L+N + +KICDFGL+R ++ +
Sbjct: 109 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEY 168
Query: 688 AGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWEL 720
T + APEL+ N +T D++S+G I EL
Sbjct: 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 21/157 (13%)
Query: 574 EISILSRLRHPNVILFLGACTKPPRLSMITEY---MEL--GSLYHLIHLSGQKKKLSWRR 628
E+ ++ + H N+I L T L + MEL +L +I + +++S+
Sbjct: 65 ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSY-- 122
Query: 629 KLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 688
+L + G+ +H I+HRDLK +N +V T+KI DFGL+R S M
Sbjct: 123 ---LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----- 174
Query: 689 GTPE-----WMAPELIRNEPFTEKCDIFSLGVIMWEL 720
TP + APE+I + E DI+S+G IM E+
Sbjct: 175 -TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 210
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 9/210 (4%)
Query: 535 VGIGFFGEVFRGIWNGTD--VAIKVFLEQD--LTAENMEDFCNEISILS-RLRHPNVILF 589
+G G FG+VF GT+ AIK L++D L +++E E +LS HP +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKA-LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 590 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 649
L + EY+ G L I S K L R +I GL +H IV
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQ-SCHKFDLP--RATFYAAEIICGLQFLHSKGIV 118
Query: 650 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 709
+RDLK N L++ +KI DFG+ + + + GTP+++APE++ + + D
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVD 178
Query: 710 IFSLGVIMWELCTLNRPWEGVLPERVVYAV 739
+S GV+++E+ P+ G E + ++
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 9/194 (4%)
Query: 534 RVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAE--NMEDFCNEISILSRLRHPNVILF 589
++G G + V++G G VA+K E L AE EIS++ L+H N++
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALK---EIHLDAEEGTPSTAIREISLMKELKHENIVRL 63
Query: 590 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 649
+L ++ EYM+ L + G + L + +G+ H +++
Sbjct: 64 HDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVL 122
Query: 650 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE-LIRNEPFTEKC 708
HRDLK N L+NK +K+ DFGL+R S+ T + AP+ L+ + ++
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSI 182
Query: 709 DIFSLGVIMWELCT 722
DI+S+G IM E+ T
Sbjct: 183 DIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 12/232 (5%)
Query: 531 VGTRVGIGFFGEV--FRGIWNGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVI 587
V + VG G FGEV R G A+KV + L A E + F E ILS P +
Sbjct: 5 VKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIP 64
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
A L ++ EY G L L L+ + + L ++ + +H+M
Sbjct: 65 QLQYAFQDKDNLYLVMEYQPGGDLLSL--LNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 648 IVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIR------ 700
VHRD+K N L+++ +K+ DFG + R+ + + GTP+++APE++
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 701 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP 752
+ +CD +SLGVI +E+ P+ + + N L+ PE P
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP 234
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 33/221 (14%)
Query: 531 VGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCN------------EIS 576
G +G G +G+V + G VAIK +++ + +D E+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 577 ILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 636
I++ ++H N++ + + ++++ + M L + +K +L+ + +L I
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMA----SDLKKVVDRKIRLTESQVKCILLQI 128
Query: 637 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG------- 689
GL +H+ +HRDL AN +N KI DFGL+R P D+ S
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 690 --TPE----WM-APELIRN-EPFTEKCDIFSLGVIMWELCT 722
T + W APEL+ E + D++S+G I EL T
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 57/190 (30%), Positives = 95/190 (50%), Gaps = 8/190 (4%)
Query: 535 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLG 591
+G G FG+V R G A+K+ ++ + A + + E +L RHP +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651
+ RL + EY G L+ HLS +++ S R +I L +H +V+R
Sbjct: 63 SFQTHDRLCFVMEYANGGELF--FHLS-RERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 652 DLKSANCLVNKHWTVKICDFGLSRI-ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 710
DLK N +++K +KI DFGL + I+D + GTPE++APE++ + + D
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 711 FSLGVIMWEL 720
+ LGV+M+E+
Sbjct: 179 WGLGVVMYEM 188
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 44/141 (31%), Positives = 67/141 (47%), Gaps = 19/141 (13%)
Query: 648 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 707
++HRD+K +N L++ VK+CDFG+S + DS + SAG +MAPE I K
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS-KAKTRSAGCAAYMAPERIDPPDPNPK 194
Query: 708 CDI----FSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGSRLEIPEGPLG-------- 754
DI +SLG+ + EL T P++ E V+ + E E P P
Sbjct: 195 YDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE----EPPSLPPNEGFSPDFC 250
Query: 755 RLIADCWA-EPQERPSCEEIL 774
+ C + ++RP E+L
Sbjct: 251 SFVDLCLTKDHRKRPKYRELL 271
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-14
Identities = 54/157 (34%), Positives = 77/157 (49%), Gaps = 17/157 (10%)
Query: 574 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK-------KKLSW 626
E+ +L ++H NVI L T E +Y + HL G +KL+
Sbjct: 66 ELRLLKHMKHENVIGLLDVFTPA------RSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 119
Query: 627 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 686
++ I RGL IH I+HRDLK +N VN+ +KI DFGL+R TD M +
Sbjct: 120 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEM--TG 176
Query: 687 SAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCT 722
T + APE++ N + + DI+S+G IM EL T
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 9e-14
Identities = 54/194 (27%), Positives = 95/194 (48%), Gaps = 14/194 (7%)
Query: 574 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 633
E+ +L P ++ F GA +S+ E+M+ GSL ++ + K++ K+
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---EAKRIPEEILGKVS 109
Query: 634 RDICRGLMCI-HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE 692
+ RGL + + +I+HRD+K +N LVN +K+CDFG+S + DS +S GT
Sbjct: 110 IAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRS 167
Query: 693 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP--------WEGVLPERVVYAVANEGS 744
+M+PE ++ ++ + DI+S+G+ + EL P E + VV E
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPH 227
Query: 745 RLEIPEGPLGRLIA 758
+ P GR ++
Sbjct: 228 SISPRPRPPGRPVS 241
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 48/190 (25%), Positives = 93/190 (48%), Gaps = 7/190 (3%)
Query: 535 VGIGFFGEVFRGIWNGTDV--AIKVFLEQDLTAENMED--FCNEISILSRLRHPNVILFL 590
+G G FG+V + A+KV ++ + + E +L ++HP ++
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 591 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 650
+ +L + +Y+ G L++ HL ++ L R + +I L +H + IV+
Sbjct: 63 FSFQTADKLYFVLDYINGGELFY--HLQRERCFLEPRARF-YAAEIASALGYLHSLNIVY 119
Query: 651 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 710
RDLK N L++ + + DFGL + + S+ GTPE++APE++ +P+ D
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179
Query: 711 FSLGVIMWEL 720
+ LG +++E+
Sbjct: 180 WCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 46/162 (28%), Positives = 85/162 (52%), Gaps = 9/162 (5%)
Query: 571 FCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL 630
F E I++ P V+ A L M+ EYM G L +L +S W +
Sbjct: 90 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNL--MSNYDVPEKWAKFY 147
Query: 631 KMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-RDSSSAG 689
++ L IH M ++HRD+K N L++KH +K+ DFG + ++ M R ++ G
Sbjct: 148 TA--EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVG 205
Query: 690 TPEWMAPELIRNEP----FTEKCDIFSLGVIMWELCTLNRPW 727
TP++++PE+++++ + +CD +S+GV ++E+ + P+
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 45/157 (28%), Positives = 80/157 (50%), Gaps = 4/157 (2%)
Query: 573 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLK 631
NE IL ++ V+ A L ++ M G L +H+ H+ + R +
Sbjct: 49 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG--EAGFEEGRAVF 106
Query: 632 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 691
+IC GL +H+ +IV+RDLK N L++ H ++I D GL+ + + GT
Sbjct: 107 YAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTV 165
Query: 692 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWE 728
+MAPE+++NE +T D ++LG +++E+ P++
Sbjct: 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 50/212 (23%), Positives = 94/212 (44%), Gaps = 30/212 (14%)
Query: 530 TVGTRVGIGFFG----EVFRGIWNGTDVAIKVFLEQDLTAENMEDFC---NEISILSRLR 582
+ T +G F + + T VA+K +L + + ED EI +L+
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKI---NLDSCSKEDLKLLQQEIITSRQLQ 57
Query: 583 HPNVILFLGACTKPPRLSMITEYMELGSLYHLI--HLSGQKKKLSWRRKLKMLRDICRGL 640
HPN++ ++ + L +++ M GS L+ H +L+ +L+D+ L
Sbjct: 58 HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF---ILKDVLNAL 114
Query: 641 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS----------RIITDSPMRDSSSAGT 690
IH +HR +K+++ L++ V + S R++ D P SS
Sbjct: 115 DYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK---SSVKN 171
Query: 691 PEWMAPELIRN--EPFTEKCDIFSLGVIMWEL 720
W++PE+++ + + EK DI+S+G+ EL
Sbjct: 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 57/195 (29%), Positives = 91/195 (46%), Gaps = 14/195 (7%)
Query: 534 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNVILFL 590
R+G G +G V+R + VA+K V ++ + + EI++L LRHPN++
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL-REITLLLNLRHPNIVELK 72
Query: 591 GACTKPPRLS--MITEYME--LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 646
S ++ EY E L SL L S + ++ + RGL +H
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQDLASL-----LDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127
Query: 647 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFT 705
I+HRDLK +N L+ +KI DFGL+R + T + APEL+ +T
Sbjct: 128 FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYT 187
Query: 706 EKCDIFSLGVIMWEL 720
D++++G I+ EL
Sbjct: 188 TAIDMWAVGCILAEL 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 73/268 (27%), Positives = 114/268 (42%), Gaps = 30/268 (11%)
Query: 534 RVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFC--NEISILSRLRHPNVILF 589
++G G + V++GI NG VA+KV + E F E S+L L+H N++L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVI---SMKTEEGVPFTAIREASLLKGLKHANIVLL 68
Query: 590 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 649
L+ + EYM ++I G + R L M + + RGL IH I+
Sbjct: 69 HDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVR--LFMFQ-LLRGLAYIHGQHIL 125
Query: 650 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE--LIRNEPFTEK 707
HRDLK N L++ +K+ DFGL+R P + SS W P L+ ++
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSA 184
Query: 708 CDIFSLGVIMWELCTLNRPWEGV--LPERV-----VYAVANEG-----SRL-----EIPE 750
DI+ G I E+ + GV + E++ V V E S+L E
Sbjct: 185 LDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFL 244
Query: 751 GPLGRLIADCWAEPQERPSCEEILSRLL 778
+ + W P E++ S++L
Sbjct: 245 PCKPQQLRVVWKRLSRPPKAEDLASQML 272
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 46/154 (29%), Positives = 85/154 (55%), Gaps = 6/154 (3%)
Query: 574 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 633
E+ +L P ++ F GA +S+ E+M+ GSL ++ +G ++ + K+
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVS 109
Query: 634 RDICRGLMCI-HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE 692
+ +GL + + KI+HRD+K +N LVN +K+CDFG+S + DS +S GT
Sbjct: 110 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRS 167
Query: 693 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP 726
+M+PE ++ ++ + DI+S+G+ + E+ P
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 534 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNVILFL 590
++G G + V++G TD VA+K + LE + A E+S+L L+H N++
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTA--IREVSLLKDLKHANIVTLH 70
Query: 591 GACTKPPRLSMITEYME------LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 644
L+++ EY++ L + I++ K L + RGL H
Sbjct: 71 DIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKL---------FLFQLLRGLNYCH 121
Query: 645 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE--LIRNE 702
R K++HRDLK N L+N+ +K+ DFGL+R P + S+ W P L+ +
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGST 180
Query: 703 PFTEKCDIFSLGVIMWELCTLNRP 726
++ + D++ +G I +E+ T RP
Sbjct: 181 DYSTQIDMWGVGCIFYEMST-GRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 535 VGIGFFGEV----FRGIWNGTDVAIK----VFLEQDLTAENMEDFCNEISILSRLR-HPN 585
+G G +G V VAIK VF ++ L + E+ +L R H N
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHKN 63
Query: 586 VI-LFLGACTKPPRLSMITEYMEL--GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
+ L+ P + + Y EL L+ +I SGQ L+ + I GL
Sbjct: 64 ITCLYDMDIVFPGNFNELYLYEELMEADLHQIIR-SGQP--LTDAHFQSFIYQILCGLKY 120
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS----SSAGTPEWMAPE- 697
IH ++HRDLK N LVN +KICDFGL+R +++P ++ T + APE
Sbjct: 121 IHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180
Query: 698 LIRNEPFTEKCDIFSLGVIMWEL 720
++ + +T+ D++S+G I+ EL
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAEL 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 6/159 (3%)
Query: 573 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLK 631
NE IL ++ V+ A L ++ M G L +H+ ++ R +
Sbjct: 49 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMG--NPGFDEERAVF 106
Query: 632 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS-PMRDSSSAGT 690
+I GL +HR +IV+RDLK N L++ + ++I D GL+ I + +R GT
Sbjct: 107 YAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR--GRVGT 164
Query: 691 PEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
+MAPE+++NE +T D + LG +++E+ P+
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 5e-13
Identities = 37/128 (28%), Positives = 69/128 (53%), Gaps = 8/128 (6%)
Query: 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN 661
I +Y++ G L+ L+ ++ KLS K++R + L +H+ I+H D+K N L +
Sbjct: 87 IMDYIKDGDLFDLLK---KEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD 143
Query: 662 KH-WTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 720
+ + +CD+GL +II D GT ++ +PE I+ + D +++GV+ +EL
Sbjct: 144 RAKDRIYLCDYGLCKIIGTPSCYD----GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYEL 199
Query: 721 CTLNRPWE 728
T P++
Sbjct: 200 LTGKHPFK 207
|
Length = 267 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 507 ESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD---VAIKVFLEQDL 563
+ P +NK + YE++N + +G G FG V + D VAIK F + +
Sbjct: 19 KEPKRKNK--MKYEDFNFIRT-------LGTGSFGRVILATYKNEDFPPVAIKRFEKSKI 69
Query: 564 TAENMEDFC-NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKK 622
+ D +E IL+ + HP + G+ L ++ E++ G + +
Sbjct: 70 IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL------- 122
Query: 623 KLSWRRKLKMLRD--------ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 674
RR + D I + + IV+RDLK N L++K +K+ DFG +
Sbjct: 123 ----RRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFA 178
Query: 675 RIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 720
+++ R + GTPE++APE++ N + D ++LG+ ++E+
Sbjct: 179 KVVD---TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEI 221
|
Length = 340 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 16/213 (7%)
Query: 525 DFSELTVGTRVGIGFFGEVF-----RGIWNGTDVAIKVFLEQDLT--AENMEDFCNEISI 577
+F L V +G G +G+VF G G A+KV + L A+ +E E ++
Sbjct: 1 NFELLKV---LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNV 57
Query: 578 LSRLRH-PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 636
L +R P ++ A +L +I +Y+ G ++ HL Q+ S +I
Sbjct: 58 LEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMF--THLY-QRDNFSEDEVRFYSGEI 114
Query: 637 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTPEWMA 695
L +H++ IV+RD+K N L++ V + DFGLS+ +++ R S GT E+MA
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 696 PELIRNEPFTEKC-DIFSLGVIMWELCTLNRPW 727
PE+IR + K D +SLG++++EL T P+
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 535 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC-NE---ISILSRLRHPNVIL 588
+G G FGEV+ R G A+K ++ + + E NE +S++S P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 589 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 648
A P +L I + M G L++ HLS Q S + +I GL +H +
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHY--HLS-QHGVFSEKEMRFYATEIILGLEHMHNRFV 118
Query: 649 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI-RNEPFTEK 707
V+RDLK AN L+++H V+I D GL+ S + +S GT +MAPE++ + +
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSS 176
Query: 708 CDIFSLGVIMWELCTLNRPW 727
D FSLG ++++L + P+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 52/189 (27%), Positives = 91/189 (48%), Gaps = 6/189 (3%)
Query: 535 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 592
VG G +G V + T VAIK F + + E E E+ +L L+ N++ A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 593 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 652
+ +L ++ EY+E L L + R + L + + H+ IVHRD
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL---IKAIHWCHKNDIVHRD 125
Query: 653 LKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APELIRNEPFTEKCDIF 711
+K N L++ + +K+CDFG +R +++ + + W +PEL+ P+ + D++
Sbjct: 126 IKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMW 185
Query: 712 SLGVIMWEL 720
S+G I+ EL
Sbjct: 186 SVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 50/191 (26%), Positives = 93/191 (48%), Gaps = 9/191 (4%)
Query: 535 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED---FCNEISILSRLRHPNVILF 589
+G G FG+V + +G A+KV L++ + E +L ++HP ++
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKV-LQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 590 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 649
+ +L + +++ G L+ HL ++ R + +I L +H + IV
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELF--FHLQRERSFPEPRARF-YAAEIASALGYLHSINIV 118
Query: 650 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 709
+RDLK N L++ V + DFGL + ++ GTPE++APE+IR +P+ D
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVD 178
Query: 710 IFSLGVIMWEL 720
+ LG +++E+
Sbjct: 179 WWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 54/201 (26%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 535 VGIGFFGEV--FRGIWNGTDVAIKVFLEQDLTAENMEDF-CNEISILSRLRHPNVILFLG 591
+G G FGEV R A+K+ + ++ + F E I++ P V+
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651
A L M+ EYM G L +L +S W R ++ L IH M +HR
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNL--MSNYDVPEKWARFYTA--EVVLALDAIHSMGFIHR 166
Query: 652 DLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIRNEP----FTE 706
D+K N L++K +K+ DFG ++ + +R ++ GTP++++PE+++++ +
Sbjct: 167 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 226
Query: 707 KCDIFSLGVIMWELCTLNRPW 727
+CD +S+GV ++E+ + P+
Sbjct: 227 ECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 7/225 (3%)
Query: 535 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLG 591
+G G FG+V + G A+K+ ++ + A++ + E +L RHP +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK-IVH 650
+ RL + EY G L+ HLS +++ S R +I L +H K +V+
Sbjct: 63 SFQTHDRLCFVMEYANGGELF--FHLS-RERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119
Query: 651 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 710
RDLK N +++K +KI DFGL + + GTPE++APE++ + + D
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 179
Query: 711 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR 755
+ LGV+M+E+ P+ E++ + E R P +
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAK 224
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 535 VGIGFFGEVFR-----GIWNGTDVAIKVFLEQDLTAENMEDFCN---EISILSRLRHPNV 586
+G G +G+VF+ G G A+KV L++ N +D + E +IL ++HP +
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKV-LKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 587 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM-------LRDICRG 639
+ + A +L +I EY+ G L+ +HL R + M L +I
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELF--MHLE--------REGIFMEDTACFYLSEISLA 112
Query: 640 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 699
L +H+ I++RDLK N L++ VK+ DFGL + + GT E+MAPE++
Sbjct: 113 LEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEIL 172
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
+ D +SLG +M+++ T P+
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 30/87 (34%), Positives = 55/87 (63%), Gaps = 4/87 (4%)
Query: 646 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI---RNE 702
+KI+HRD+K +N L++++ +K+CDFG+S + DS + + AG +MAPE I +
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK-TRDAGCRPYMAPERIDPSARD 185
Query: 703 PFTEKCDIFSLGVIMWELCTLNRPWEG 729
+ + D++SLG+ ++E+ T P+
Sbjct: 186 GYDVRSDVWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 49/190 (25%), Positives = 96/190 (50%), Gaps = 7/190 (3%)
Query: 535 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED-FCNEISIL-SRLRHPNVILFL 590
+G G FG+V + +G A+KV ++ + + + E ++L ++HP ++
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 591 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 650
+ +L + +Y+ G L+ HL ++ R + +I L +H + I++
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFF--HLQRERSFPEPRARF-YAAEIASALGYLHSLNIIY 119
Query: 651 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 710
RDLK N L++ V + DFGL + + S+ GTPE++APE++R +P+ D
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179
Query: 711 FSLGVIMWEL 720
+ LG +++E+
Sbjct: 180 WCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 532 GTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI--- 587
G +VG G +G V++ +G D + + T +M C EI++L L+HPNVI
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA-CREIALLRELKHPNVIALQ 64
Query: 588 -LFLGACTKPPRLSMITEYMELGSLYHLIHL----SGQKKKLSWRRKL--KMLRDICRGL 640
+FL + ++ ++ +Y E L+H+I KK + R + +L I G+
Sbjct: 65 KVFLSHSDR--KVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 641 MCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITD--SPMRDSSSAGTPEWM 694
+H ++HRDLK AN LV + VKI D G +R+ P+ D W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 695 -APELIRN-EPFTEKCDIFSLGVIMWELCT 722
APEL+ +T+ DI+++G I EL T
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 534 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNVILFL 590
++G G + VF+G T+ VA+K + LE + A E+S+L L+H N++
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA--IREVSLLKNLKHANIVTLH 69
Query: 591 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 650
L+++ EY++ L + G + K+ M + + RGL H+ KI+H
Sbjct: 70 DIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMH-NVKIFMFQ-LLRGLSYCHKRKILH 126
Query: 651 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE--LIRNEPFTEKC 708
RDLK N L+N+ +K+ DFGL+R P + S+ W P L+ + ++
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI 185
Query: 709 DIFSLGVIMWELCTLNRP 726
D++ +G I++E+ T RP
Sbjct: 186 DMWGVGCILYEMAT-GRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 54/204 (26%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 525 DFSELTVGTRVGIGFFGEV--FRGIWNGTDVAIKVFLEQDLTAE-NMEDFCNEISILSRL 581
DF + V +G G FGEV R + A+K+ + ++ + F E I++
Sbjct: 44 DFDVIKV---IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
++ A L M+ EYM G L +L +S W R ++ L
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNL--MSNYDIPEKWARFYTA--EVVLALD 156
Query: 642 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIR 700
IH M +HRD+K N L++K +K+ DFG ++ + +R ++ GTP++++PE+++
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLK 216
Query: 701 NE----PFTEKCDIFSLGVIMWEL 720
++ + +CD +S+GV ++E+
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEM 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 532 GTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI--- 587
G +VG G +G V++ +G D + + T +M C EI++L L+HPNVI
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA-CREIALLRELKHPNVISLQ 64
Query: 588 -LFLGACTKPPRLSMITEYMELGSLYHLIHL----SGQKKKLSWRRKL--KMLRDICRGL 640
+FL + ++ ++ +Y E L+H+I KK + R + +L I G+
Sbjct: 65 KVFLSHADR--KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 641 MCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITD--SPMRDSSSAGTPEWM 694
+H ++HRDLK AN LV + VKI D G +R+ P+ D W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 695 -APELIRN-EPFTEKCDIFSLGVIMWELCT 722
APEL+ +T+ DI+++G I EL T
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 52/177 (29%), Positives = 86/177 (48%), Gaps = 13/177 (7%)
Query: 550 GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS------MIT 603
G +VA+K + + E+ +L + H N+I L T L ++
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH 663
E M+ +L +IH+ +++S+ +L + G+ +H I+HRDLK +N +V
Sbjct: 106 ELMD-ANLCQVIHMELDHERMSY-----LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 159
Query: 664 WTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 720
T+KI DFGL+R + M + T + APE+I + E DI+S+G IM EL
Sbjct: 160 CTLKILDFGLARTACTNFMM-TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 3/131 (2%)
Query: 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSAN 657
RL ++ EY+ G L + H+ Q+K L +IC L +H I++RDLK N
Sbjct: 70 RLFLVIEYVNGGDL--MFHMQRQRK-LPEEHARFYAAEICIALNFLHERGIIYRDLKLDN 126
Query: 658 CLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIM 717
L++ +K+ D+G+ + S+ GTP ++APE++R E + D ++LGV+M
Sbjct: 127 VLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLM 186
Query: 718 WELCTLNRPWE 728
+E+ P++
Sbjct: 187 FEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 13/196 (6%)
Query: 534 RVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC-NEISILSRLRHPNVILFL 590
++G G +G V+ R G VA+K + D E + EIS+L L HPN++ L
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 591 GACTKPPRLSMITEYM--ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 648
+L ++ E++ +L LSG L ++L+ GL H ++
Sbjct: 66 DVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQ----GLAFCHSHRV 121
Query: 649 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APE-LIRNEPFTE 706
+HRDLK N L+N +K+ DFGL+R P+R + W APE L+ + ++
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCKYYST 180
Query: 707 KCDIFSLGVIMWELCT 722
DI+SLG I E+ T
Sbjct: 181 AVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 18/217 (8%)
Query: 535 VGIGFFGEVF--RGIWNGTDVAIKVFLEQD--LTAENMEDFCNEISILSRLR-HPNVILF 589
+G G FG+V R +G A+KV L++D L +++E E ILS R HP +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKV-LKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 590 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 649
P RL + E++ G L I S ++ R +I LM +H I+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKGII 118
Query: 650 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 709
+RDLK N L++ K+ DFG+ + + S+ GTP+++APE+++ + D
Sbjct: 119 YRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVD 178
Query: 710 IFSLGVIMWELCTLNRPWEG---------VLPERVVY 737
+++GV+++E+ + P+E +L + VVY
Sbjct: 179 WWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY 215
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 535 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC-NE---ISILSRLRHPNVIL 588
+G G FGEV+ R G A+K ++ + + E NE +S++S P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 589 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 648
A P +LS I + M G L++ HLS Q S +I GL +H +
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHY--HLS-QHGVFSEAEMRFYAAEIILGLEHMHNRFV 118
Query: 649 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE-LIRNEPFTEK 707
V+RDLK AN L+++H V+I D GL+ S + +S GT +MAPE L + +
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS 176
Query: 708 CDIFSLGVIMWELCTLNRPWEG 729
D FSLG ++++L + P+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 554 AIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY 612
A+K +Q+L N ++ E IL+ +P V+ + L M+ EY+E G
Sbjct: 30 AMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCA 89
Query: 613 HLIHLSGQKKKLSWRRKLKMLR----DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKI 668
L+ G + M R + L +H IVHRDLK N L+ +K+
Sbjct: 90 TLLKNIGA-------LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKL 142
Query: 669 CDFGLSRI------------ITDSPMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSL 713
DFGLS+I + R D GTPE++APE+I + + + D +++
Sbjct: 143 TDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAM 202
Query: 714 GVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG 751
G+I++E P+ G PE + V ++ +E PEG
Sbjct: 203 GIILYEFLVGCVPFFGDTPEELFGQVISD--DIEWPEG 238
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 534 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNVILFL 590
++G G + VF+G T+ VA+K + LE + A E+S+L L+H N++
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA--IREVSLLKDLKHANIVTLH 70
Query: 591 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 650
L+++ EY++ L + G +S L I RGL HR K++H
Sbjct: 71 DIVHTDKSLTLVFEYLD-KDLKQYMDDCGNI--MSMHNVKIFLYQILRGLAYCHRRKVLH 127
Query: 651 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE--LIRNEPFTEKC 708
RDLK N L+N+ +K+ DFGL+R P + S+ W P L+ + ++ +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQI 186
Query: 709 DIFSLGVIMWELCTLNRP 726
D++ +G I +E+ + RP
Sbjct: 187 DMWGVGCIFFEMAS-GRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 535 VGIGFFGEVFRGIWNGTD--VAIKVFLEQD--LTAENMEDFCNEISILSRLRHPNVILFL 590
+G G FG+V G A+K L++D L +++E E +L+ L N L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKA-LKKDVVLIDDDVECTMVEKRVLA-LAWENPFLTH 60
Query: 591 GACT--KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 648
CT L + E++ G L I K + R +I GL +H I
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSKGI 117
Query: 649 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKC 708
++RDLK N ++++ +KI DFG+ + R S+ GTP+++APE+++ +T
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV 177
Query: 709 DIFSLGVIMWELCTLNRPWEG 729
D +S GV+++E+ P+ G
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 534 RVGIGFFGEVFRG---IWNGTDVAIKVFLEQD-----LTAENMEDFCNEISILSRLRHPN 585
++G G +G V++ + N T K+ LEQ+ TA EIS+L ++H N
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTA------IREISLLKEMQHGN 62
Query: 586 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM-LRDICRGLMCIH 644
++ RL ++ EY++L H+ K R +K L I RG+ H
Sbjct: 63 IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNP---RLIKTYLYQILRGIAYCH 119
Query: 645 RMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITDSPMRDSSSAGTPEWM-APE-LIRN 701
+++HRDLK N L+++ +K+ DFGL+R P+R + W APE L+ +
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVVTLWYRAPEILLGS 178
Query: 702 EPFTEKCDIFSLGVIMWELCTLNRP 726
++ DI+S+G I E+ +P
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVN-QKP 202
|
Length = 294 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 62/202 (30%), Positives = 94/202 (46%), Gaps = 24/202 (11%)
Query: 533 TRVGIGFFGEVFRGI--WNGTDVAIKVF---LEQDLTAENMEDFCNEISILSRLRHPNVI 587
+VG G +G V I G VAIK + ++ A+ E+++L ++H NVI
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY---RELTLLKHMQHENVI 77
Query: 588 LFLGACTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
L T ++ YM+ L + G LS + ++ + GL
Sbjct: 78 GLLDVFTSAVSGDEFQDFYLVMPYMQT----DLQKIMGHP--LSEDKVQYLVYQMLCGLK 131
Query: 642 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 701
IH I+HRDLK N VN+ +KI DFGL+R D+ M + T + APE+I N
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-HADAEM--TGYVVTRWYRAPEVILN 188
Query: 702 -EPFTEKCDIFSLGVIMWELCT 722
+ + DI+S+G IM E+ T
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 82/297 (27%), Positives = 120/297 (40%), Gaps = 71/297 (23%)
Query: 535 VGIGFFGEVFRGIWN--GTDVAIK----VFLEQDLTAENMED---FCNEISILSRLRHPN 585
+G G +G V I G VAIK VF E++ D EI +L LRHP+
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVF-------EHVSDATRILREIKLLRLLRHPD 60
Query: 586 VILFLGACTKPPR-----LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
++ P R + ++ E ME L+ +I L+ L + R L
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVI---KANDDLTPEHHQFFLYQLLRAL 116
Query: 641 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI-ITDSPMRD--SSSAGTPEWMAPE 697
IH + HRDLK N L N +KICDFGL+R+ D+P + T + APE
Sbjct: 117 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 176
Query: 698 LIRN--EPFTEKCDIFSLGVIMWELCTLNRP----------------WEGVLPERVVYAV 739
L + +T DI+S+G I E+ T +P G + V
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235
Query: 740 ANEGSRLEI----PEGP-----------------LGRLIADCWAEPQERPSCEEILS 775
NE +R + + P L RL+A +P++RP+ EE L+
Sbjct: 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLA---FDPKDRPTAEEALA 289
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 534 RVGIGFFGEVFRGI--WNGTDVAIK-VFLEQDLTAENMEDFC-NEISILSRLRHPNVILF 589
++G G +G VF+ VA+K V L+ D E + EI +L L+H N++
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRL 64
Query: 590 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 649
+L+++ EY + + +G + + + +GL H ++
Sbjct: 65 YDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK---SFMFQLLKGLAFCHSHNVL 121
Query: 650 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE--LIRNEPFTEK 707
HRDLK N L+NK+ +K+ DFGL+R P+R S+ W P L + ++
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 180
Query: 708 CDIFSLGVIMWELCTLNRP 726
D++S G I EL RP
Sbjct: 181 IDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 67/267 (25%), Positives = 119/267 (44%), Gaps = 36/267 (13%)
Query: 535 VGIGFFGEVFRGI---------WNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHP 584
+G G F ++F+GI + T+V +KV D + N E F S++S+L H
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVL---DKSHRNYSESFFEAASMMSQLSHK 59
Query: 585 NVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 644
+++L G C M+ EY++ GSL + + +SW KL++ + + L +
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE 117
Query: 645 RMKIVHRDLKSANCLVNKHWT--------VKICDFGLSRIITDSPMRDSSSAGTPEWMAP 696
+ H ++ + N L+ + +K+ D G+S IT P ++ P W+ P
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLP-KEILLERIP-WVPP 173
Query: 697 ELIRN-EPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE---G 751
E I N + + D +S G +WE+ + ++P + ++ + R ++P
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE---DRHQLPAPKWT 230
Query: 752 PLGRLIADC-WAEPQERPSCEEILSRL 777
L LI C EP RPS I+ L
Sbjct: 231 ELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 4/156 (2%)
Query: 574 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLKM 632
E IL ++ P ++ A L ++ M G L YH+ ++ ++ L R +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVG--ERGLEMERVIHY 100
Query: 633 LRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE 692
I G++ +H M IV+RD+K N L++ ++ D GL+ + D + AGT
Sbjct: 101 SAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNG 159
Query: 693 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWE 728
+MAPE+++ EP++ D F++G ++E+ P++
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 23/201 (11%)
Query: 535 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED-----FCNEISILSRLR---HP 584
+G+G +G V+ R +G VA+K + + ED E+++L RL HP
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALK-----SVRVQTNEDGLPLSTVREVALLKRLEAFDHP 62
Query: 585 NVILFLGACT-----KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 639
N++ + C + +++++ E+++ +L + + L +R RG
Sbjct: 63 NIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDL--MRQFLRG 120
Query: 640 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 699
L +H IVHRDLK N LV VK+ DFGL+RI + M + T + APE++
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS-CQMALTPVVVTLWYRAPEVL 179
Query: 700 RNEPFTEKCDIFSLGVIMWEL 720
+ D++S+G I E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-11
Identities = 68/263 (25%), Positives = 106/263 (40%), Gaps = 44/263 (16%)
Query: 525 DFSELTVGTRVGIGFFGEV--FRGIWNGTDVAIKVFLEQD-LTAENMEDFCNEISILSRL 581
DF L V +G G FGEV + G A+K+ + D L E + E IL
Sbjct: 2 DFESLKV---IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA 58
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
V+ + L +I E++ G + L+ +K LS + + +
Sbjct: 59 DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAID 115
Query: 642 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS------------RIITDSPMRD----- 684
IH++ +HRD+K N L++ VK+ DFGL R +T +P D
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 685 ------------------SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP 726
S+ GTP+++APE+ + + CD +SLGVIM+E+ P
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 727 WEGVLPERVVYAVANEGSRLEIP 749
+ P+ V N L P
Sbjct: 236 FCSETPQETYRKVMNWKETLVFP 258
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-11
Identities = 50/155 (32%), Positives = 76/155 (49%), Gaps = 17/155 (10%)
Query: 574 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK-------KKLSW 626
E+ +L ++H NVI L T + E +Y + +L G +KLS
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPATSIENFNE------VYLVTNLMGADLNNIVKCQKLSD 117
Query: 627 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 686
++ + RGL IH I+HRDLK +N VN+ ++I DFGL+R D M +
Sbjct: 118 EHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR-QADDEM--TG 174
Query: 687 SAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWEL 720
T + APE++ N + + DI+S+G IM EL
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 535 VGIGFFGEVF--RGIWNGTD-VAIKVFLEQDLTAENME-DFCNEISILSRLR---HPNVI 587
+G G +G+VF R + NG VA+K Q E M E+++L L HPNV+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 588 LFLGACT-----KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
CT + +L+++ E+++ +L + + + M+ + RGL
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDF 125
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE 702
+H ++VHRDLK N LV +K+ DFGL+RI + M +S T + APE++
Sbjct: 126 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQS 184
Query: 703 PFTEKCDIFSLGVIMWEL 720
+ D++S+G I E+
Sbjct: 185 SYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 27/84 (32%), Positives = 55/84 (65%), Gaps = 6/84 (7%)
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIR- 700
+H++ VHRD+K N L++K+ +++ DFG R++ D ++ + + GTP++++PE+++
Sbjct: 118 VHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQA 177
Query: 701 ----NEPFTEKCDIFSLGVIMWEL 720
+ +CD +SLGV M+E+
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEM 201
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-11
Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 13/153 (8%)
Query: 574 EISILSRLRHPNVILFLGACTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWR 627
E+ ++ + H N+I L T L ++ E M+ +L +I + +++S+
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY- 123
Query: 628 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 687
+L + G+ +H I+HRDLK +N +V T+KI DFGL+R S M +
Sbjct: 124 ----LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPY 178
Query: 688 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 720
T + APE+I + E DI+S+G IM E+
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 42/148 (28%), Positives = 73/148 (49%), Gaps = 3/148 (2%)
Query: 583 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
HP ++ RL + EY+ G L + H+ Q+K L +I L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRK-LPEEHARFYSAEISLALNY 111
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE 702
+H I++RDLK N L++ +K+ D+G+ + S+ GTP ++APE++R E
Sbjct: 112 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 171
Query: 703 PFTEKCDIFSLGVIMWELCTLNRPWEGV 730
+ D ++LGV+M+E+ P++ V
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIV 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 38/216 (17%)
Query: 535 VGIGFFGEVFRGIWNGTD--VAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHPNV 586
+G G +G+V++ T VA+K V L+ + +TA EI IL +L H N+
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA------IREIKILRQLNHRNI 68
Query: 587 ILFLGACT----------KPPRLSMITEYME---LGSLYH-LIHLSGQKKKLSWRRKLKM 632
+ T ++ EYM+ +G L L+H S K
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-------SF 121
Query: 633 LRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE 692
++ + GL H+ +HRD+K +N L+N +K+ DFGL+R+ R ++
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITL 181
Query: 693 WMAPE--LIRNEPFTEKCDIFSLGVIMWELCTLNRP 726
W P L+ E + D++S G I+ EL T +P
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 6/159 (3%)
Query: 573 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM 632
NE IL ++ V+ A L ++ M G L I+ G R L
Sbjct: 49 NEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFY 107
Query: 633 LRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS--SSAGT 690
+I GL +HR V+RDLK N L++ + ++I D GL+ I P +S GT
Sbjct: 108 AAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKI---PEGESIRGRVGT 164
Query: 691 PEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
+MAPE++ N+ +T D + LG +++E+ P+ G
Sbjct: 165 VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 2e-10
Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 40/169 (23%)
Query: 574 EISILSRLR-HPNVILFLGACTKPPR------LSMITEYMELGSLYHLIHLSGQKKKLSW 626
EI L L HPN++ L + + ++ EYME L+ +I + +
Sbjct: 56 EIMFLQELGDHPNIVKLLNVI----KAENDKDIYLVFEYME-TDLHAVI-----RANI-- 103
Query: 627 RRKLKMLRDI---------CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677
L D+ + L IH ++HRDLK +N L+N VK+ DFGL+R +
Sbjct: 104 ------LEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157
Query: 678 TDSPMRDSSSAGT----PEWM-APE-LIRNEPFTEKCDIFSLGVIMWEL 720
++ + T W APE L+ + +T+ D++S+G I+ E+
Sbjct: 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEM 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 43/150 (28%), Positives = 75/150 (50%), Gaps = 5/150 (3%)
Query: 574 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 633
E IL + HP++I G T +I + LY +L+ K+ ++ L +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLY--CYLAA-KRNIAICDILAIE 188
Query: 634 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD-SPMRDSSSAGTPE 692
R + R + +H +I+HRD+K+ N +N V + DFG + D + + AGT
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIA 248
Query: 693 WMAPELIRNEPFTEKCDIFSLGVIMWELCT 722
APEL+ +P+ DI+S G++++E+ T
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 13/153 (8%)
Query: 574 EISILSRLRHPNVILFLGACTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWR 627
E+ ++ + H N+I L T L ++ E M+ +L +I + +++S+
Sbjct: 73 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY- 130
Query: 628 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 687
+L + G+ +H I+HRDLK +N +V T+KI DFGL+R S M
Sbjct: 131 ----LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 186
Query: 688 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 720
T + APE+I + E DI+S+G IM E+
Sbjct: 187 V-TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 4/156 (2%)
Query: 573 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLK 631
NE IL ++ V+ A L ++ M G L +H+ ++ +R +
Sbjct: 49 NEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG--NPGFDEQRAIF 106
Query: 632 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 691
++C GL + R +IV+RDLK N L++ ++I D GL+ I + GT
Sbjct: 107 YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TVRGRVGTV 165
Query: 692 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 727
+MAPE+I NE +T D + LG +++E+ P+
Sbjct: 166 GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 41/161 (25%), Positives = 66/161 (40%), Gaps = 45/161 (27%)
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLS---RIITDS--------PMRDS------ 685
+H+M +HRD+K N L+++ +K+ DFGL R DS +DS
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 686 --------------------------SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWE 719
S GTP ++APE++ +T+ CD +S+GVI++E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 720 LCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADC 760
+ P+ P V N + L IP +L +
Sbjct: 237 MLVGQPPFLADTPAETQLKVINWETTLHIP--SQAKLSREA 275
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 37/133 (27%), Positives = 69/133 (51%), Gaps = 3/133 (2%)
Query: 596 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKS 655
RL + E++ G L + H+ +++KL +I L +H I++RDLK
Sbjct: 68 ESRLFFVIEFVSGGDL--MFHMQ-RQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKL 124
Query: 656 ANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGV 715
N L++ +K+ D+G+ + S+ GTP ++APE++R E + D ++LGV
Sbjct: 125 DNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 184
Query: 716 IMWELCTLNRPWE 728
+M+E+ P++
Sbjct: 185 LMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 531 VGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 588
+G +G G FG V+ I T VAIK L QD +N E+ I+ L H N+I
Sbjct: 70 LGNIIGNGSFGVVYEAICIDTSEKVAIKKVL-QDPQYKN-----RELLIMKNLNHINIIF 123
Query: 589 ----FLGACTKPPR----LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
+ C K L+++ E++ ++ H + L +CR L
Sbjct: 124 LKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRAL 183
Query: 641 MCIHRMKIVHRDLKSANCLV--NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 698
IH I HRDLK N L+ N H T+K+CDFG ++ + + R S + + APEL
Sbjct: 184 AYIHSKFICHRDLKPQNLLIDPNTH-TLKLCDFGSAKNLL-AGQRSVSYICSRFYRAPEL 241
Query: 699 IRNEP-FTEKCDIFSLGVIMWEL 720
+ +T D++SLG I+ E+
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 31/116 (26%), Positives = 54/116 (46%), Gaps = 38/116 (32%)
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLS------------RIITDSPMRDS----- 685
IH++ +HRD+K N L++ +K+ DFGL RI++ + +
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176
Query: 686 ---------------------SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 720
S+ GTP+++APE+ + ++CD +SLGVIM+E+
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 36/213 (16%)
Query: 535 VGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNV----- 586
+G G G VF + + D VA+K + L ++++ EI I+ RL H N+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYE 69
Query: 587 ILFLGACTKPPRLSMIT---------EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
+L + +T EYME L ++ Q +L M + +
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMET----DLANVLEQGPLSEEHARLFMYQ-LL 124
Query: 638 RGLMCIHRMKIVHRDLKSANCLVNKHWTV-KICDFGLSRIITDSPMRDS---SSAGTPEW 693
RGL IH ++HRDLK AN +N V KI DFGL+RI+ D S +W
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIV-DPHYSHKGYLSEGLVTKW 183
Query: 694 M-APELI---RNEPFTEKCDIFSLGVIMWELCT 722
+P L+ N +T+ D+++ G I E+ T
Sbjct: 184 YRSPRLLLSPNN--YTKAIDMWAAGCIFAEMLT 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 21/197 (10%)
Query: 536 GIGFFGEVFRGIWNGTD--VAIKVF-LEQD----LTAENMEDFCNEISILSRLRHPNVIL 588
G G + V++G T VA+K LE + TA E S+L L+H N++
Sbjct: 14 GEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTA------IREASLLKDLKHANIVT 67
Query: 589 FLGACTKPPRLSMITEYMELG-SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
L+++ EY++ Y G LS L + RGL H+ +
Sbjct: 68 LHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGG----LSMHNVRLFLFQLLRGLAYCHQRR 123
Query: 648 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE--LIRNEPFT 705
++HRDLK N L+++ +K+ DFGL+R P + S+ W P L+ + ++
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 706 EKCDIFSLGVIMWELCT 722
D++ +G I +E+ T
Sbjct: 183 TSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 40/158 (25%), Positives = 74/158 (46%), Gaps = 6/158 (3%)
Query: 574 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 633
EI IL + H +I + A + M+ + L+ + SG L + + +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSG---PLPLEQAITIQ 191
Query: 634 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTP 691
R + L +H I+HRD+K+ N +++ + DFG + + P + +GT
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTL 251
Query: 692 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
E +PEL+ +P+ K DI+S G++++E+ N G
Sbjct: 252 ETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 30/113 (26%), Positives = 61/113 (53%), Gaps = 6/113 (5%)
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIR- 700
+H++ VHRD+K N L++ + +++ DFG +++ D ++ S + GTP++++PE+++
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 701 ----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 749
+ +CD +SLGV M+E+ P+ + N R + P
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 68/274 (24%), Positives = 110/274 (40%), Gaps = 45/274 (16%)
Query: 525 DFSELTVGTRVGIGFFGEV--FRGIWNGTDVAIKVFLEQD-LTAENMEDFCNEISILSRL 581
DF L V +G G FGEV + G A+K+ + D L E + E IL
Sbjct: 2 DFESLKV---IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA 58
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
V+ + L +I E++ G + L+ +K L+ + + +
Sbjct: 59 DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAID 115
Query: 642 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGL---------------------------- 673
IH++ +HRD+K N L++ VK+ DFGL
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 674 --SRIITDSPMRDS-----SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP 726
S+ ++ R+ S+ GTP+++APE+ + + CD +SLGVIM+E+ P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 727 WEGVLPERVVYAVANEGSRLEI-PEGPLGRLIAD 759
+ P+ V N L PE P+ D
Sbjct: 236 FCSETPQETYKKVMNWKETLIFPPEVPISEKAKD 269
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 64/265 (24%), Positives = 106/265 (40%), Gaps = 53/265 (20%)
Query: 535 VGIGFFGEV--FRGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLG 591
+GIG FGEV R + A+K ++D+ N + E IL+ + V+
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651
+ L + +Y+ G + L+ G + R + L C + +H+M +HR
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAEL--TC-AVESVHKMGFIHR 125
Query: 652 DLKSANCLVNKHWTVKICDFGLS---RIITDS--------PMRDS--------------- 685
D+K N L+++ +K+ DFGL R DS +DS
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRC 185
Query: 686 ---------------------SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN 724
S GTP ++APE++ +T+ CD +S+GVI++E+
Sbjct: 186 GDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 245
Query: 725 RPWEGVLPERVVYAVANEGSRLEIP 749
P+ P V N + L IP
Sbjct: 246 PPFLAQTPLETQMKVINWQTSLHIP 270
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-09
Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 573 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK--L 630
NEI L RL H N++ MIT+ + LY ++ + W+ + L
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMY----DEAFDWKDRPLL 266
Query: 631 KMLRDICRGLMC----IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-RDS 685
K R I + L+C IH K++HRD+K N +N + + DFG + D
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 720
GT +PE++ + + E DI+S G+I+ ++
Sbjct: 327 GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
|
Length = 501 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 31/113 (27%), Positives = 60/113 (53%), Gaps = 6/113 (5%)
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIRN 701
IH++ VHRD+K N L++ + +++ DFG ++ D ++ S + GTP++++PE+++
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177
Query: 702 E-----PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 749
+ +CD +SLGV M+E+ P+ + N R + P
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 6e-09
Identities = 60/240 (25%), Positives = 103/240 (42%), Gaps = 32/240 (13%)
Query: 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEIS 576
Y++ +E V ++G G FGEVF T K + L E++
Sbjct: 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN 64
Query: 577 ILSRLRHPNVILFLGACTKPP--RLSMITEYMELGSLYHLIHLSGQK-KKLSWRRKLKML 633
++ L+H N++ ++ +L ++ E+ + G L I + K+ + +
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDIT 124
Query: 634 RDICRGLMCIHRMK-------IVHRDLKSANCLV-----------------NKHWTVKIC 669
R + L H +K ++HRDLK N + N KI
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184
Query: 670 DFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE--PFTEKCDIFSLGVIMWELCTLNRPW 727
DFGLS+ I M S GTP + +PEL+ +E + +K D+++LG I++ELC+ P+
Sbjct: 185 DFGLSKNIGIESMA-HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 8e-09
Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 13/193 (6%)
Query: 534 RVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFC--NEISILSRLRHPNVILF 589
++G G + V++G NG VA+KV Q+ E F E S+L L+H N++L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQE---EEGTPFTAIREASLLKGLKHANIVLL 68
Query: 590 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 649
L+++ EY+ ++ G L L + RGL IH+ I+
Sbjct: 69 HDIIHTKETLTLVFEYVHTDLCQYMDKHPG---GLHPENVKLFLFQLLRGLSYIHQRYIL 125
Query: 650 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE--LIRNEPFTEK 707
HRDLK N L++ +K+ DFGL+R P S+ W P L+ + ++
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTC 184
Query: 708 CDIFSLGVIMWEL 720
D++ +G I E+
Sbjct: 185 LDMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 26/199 (13%)
Query: 550 GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 609
GT V +++ ++ T E+++ NE+ + RHPN++ T L +I+ +M G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 610 SLYHLIHL---SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTV 666
S L+ G + L +L RGL +H+ +HR++K+++ L++ V
Sbjct: 85 SANSLLKTYFPEGMSEALIG----NILFGALRGLNYLHQNGYIHRNIKASHILISGDGLV 140
Query: 667 KICDFGLS------------RIITDSPMRDSSSAGTPEWMAPELIRNE--PFTEKCDIFS 712
+ GLS +++ D P S++ P W++PEL+R + + K DI+S
Sbjct: 141 SLS--GLSHLYSLVRNGQKAKVVYDFP--QFSTSVLP-WLSPELLRQDLYGYNVKSDIYS 195
Query: 713 LGVIMWELCTLNRPWEGVL 731
+G+ EL T P++ +L
Sbjct: 196 VGITACELATGRVPFQDML 214
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 61/266 (22%), Positives = 105/266 (39%), Gaps = 55/266 (20%)
Query: 535 VGIGFFGEV--FRGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLG 591
+GIG FGEV + A+K ++D+ N + E IL+ + V+
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651
+ L + +Y+ G + L+ ++ R + ++ + +H+M +HR
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARF---YIAELTLAIESVHKMGFIHR 125
Query: 652 DLKSANCLVNKHWTVKICDFGL----------------SRIITDSPMRDS---------- 685
D+K N L++ +K+ DFGL S I DS M S
Sbjct: 126 DIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDS-MEPSDLWDDVSNCR 184
Query: 686 ----------------------SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL 723
S GTP ++APE++ + +T+ CD +S+GVI++E+
Sbjct: 185 CGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVG 244
Query: 724 NRPWEGVLPERVVYAVANEGSRLEIP 749
P+ P V N + L IP
Sbjct: 245 QPPFLAPTPTETQLKVINWENTLHIP 270
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 8e-08
Identities = 33/131 (25%), Positives = 59/131 (45%), Gaps = 48/131 (36%)
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-------------RIIT----------- 678
+H++ +HRD+K N L+++ +K+ DFGLS +++
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 679 DSPMRDS-----------------------SSAGTPEWMAPELIRNEPFTEKCDIFSLGV 715
+S DS S+ GTP+++APE+ + + ++CD +SLG
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236
Query: 716 IMWELCTLNRP 726
IM+E C + P
Sbjct: 237 IMFE-CLIGWP 246
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 534 RVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED------FCNEISILSRLRHPN 585
++G G +G+V+ R G VA+K T M++ EIS+L L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKK------TRLEMDEEGIPPTALREISLLQMLSESI 61
Query: 586 VILFLGAC------TKPPRLSMITEYM--ELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
I+ L P L ++ EY+ +L + + G + L + + +
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKK-FMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 638 RGLMCIHRMKIVHRDLKSANCLVNKHWTV-KICDFGLSRIITDSPMRDSSSAGTPEWM-A 695
+G+ H+ ++HRDLK N LV+K + KI D GL R + P++ + W A
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS-IPVKSYTHEIVTLWYRA 179
Query: 696 PE-LIRNEPFTEKCDIFSLGVIMWELCTLN 724
PE L+ + ++ DI+S+G I E+
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 46/206 (22%), Positives = 83/206 (40%), Gaps = 49/206 (23%)
Query: 554 AIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY 612
A+KV ++++ N ++ E IL+ L HP + + L ++ +Y G L+
Sbjct: 30 ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89
Query: 613 HLIHLSGQKKKLSWRRKLKMLRD---------ICRGLMCIHRMKIVHRDLKSANCLVNKH 663
L+ R+ K L + + L +H + IV+RDLK N L+++
Sbjct: 90 RLLQ----------RQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES 139
Query: 664 WTVKICDFGLS----------RIITDSPMRDSSSA-------------------GTPEWM 694
+ + DF LS R SS GT E++
Sbjct: 140 GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYI 199
Query: 695 APELIRNEPFTEKCDIFSLGVIMWEL 720
APE+I + D ++LG++++E+
Sbjct: 200 APEVISGDGHGSAVDWWTLGILLYEM 225
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 21/157 (13%)
Query: 573 NEISILSRLRHPNVILFLG-------ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLS 625
+E +L RL HP V+ L C P+ LY +L + + L
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR--------SDLY--TYLGARLRPLG 258
Query: 626 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG---LSRIITDSPM 682
+ + R + + IH I+HRD+K+ N LVN + + DFG +R +P
Sbjct: 259 LAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 683 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWE 719
AGT + APE++ +P+T DI+S G++++E
Sbjct: 319 H-YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-07
Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 14/153 (9%)
Query: 573 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM 632
+EI+ + +L+HPN++ +G C +I EY+E +L ++ + LSW R+ K+
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL------RNLSWERRRKI 785
Query: 633 LRDICRGLMCIH---RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 689
I + L +H +V +L +++ + L ++ SSA
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA- 843
Query: 690 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 722
++APE + TEK DI+ G+I+ EL T
Sbjct: 844 ---YVAPETRETKDITEKSDIYGFGLILIELLT 873
|
Length = 968 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 7e-07
Identities = 39/142 (27%), Positives = 69/142 (48%), Gaps = 6/142 (4%)
Query: 538 GFFGEVF--RGIWNGTDVAIKVFLEQDLTAENM-EDFCNEISILSRLRHPNVILFLGACT 594
G FG+V+ R N A+KV + D+ +NM E L+ + P ++ +
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 595 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLK 654
+ ++ EY+ G + L+H+ G +K + ++ L +HR I+HRDLK
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGY---FDEEMAVKYISEVALALDYLHRHGIIHRDLK 131
Query: 655 SANCLVNKHWTVKICDFGLSRI 676
N L++ +K+ DFGLS++
Sbjct: 132 PDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 33/100 (33%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFC 572
E+W L G +G G FG+V G VA+K+ L+ + E
Sbjct: 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKM-LKASAHTDEREALM 89
Query: 573 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL 611
+E+ ILS L +H N++ LGACT + +ITEY G L
Sbjct: 90 SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 45/196 (22%), Positives = 85/196 (43%), Gaps = 24/196 (12%)
Query: 549 NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMEL 608
G V ++ + T E + E+ + HPN++ + L ++T +M
Sbjct: 24 TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83
Query: 609 GSLYHLI--HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTV 666
GS LI H +L+ +L+ + + L IH M VHR +K+++ L++
Sbjct: 84 GSAKDLICTHFMDGMSELAIAY---ILQGVLKALDYIHHMGYVHRSVKASHILISVDG-- 138
Query: 667 KICDFGL------------SRIITDSPMRDSSSAGTPEWMAPELIRN--EPFTEKCDIFS 712
K+ GL R++ D P S W++PE+++ + + K DI+S
Sbjct: 139 KVYLSGLRSNLSMINHGQRLRVVHDFP---KYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 195
Query: 713 LGVIMWELCTLNRPWE 728
+G+ EL + P++
Sbjct: 196 VGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 32/103 (31%), Positives = 49/103 (47%), Gaps = 9/103 (8%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNE 574
W + L +G +G G FG V +G VA+K+ ++E + +E
Sbjct: 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEK-QALMSE 90
Query: 575 ISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH 616
+ I+S L H N++ LGACTK + +ITEY G L +H
Sbjct: 91 LKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 24/221 (10%)
Query: 571 FCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL 630
F S++S++ H ++ G C + M+ E++E G L + + ++W K+
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 631 KMLRDICRGLMCIHRMKIVHRDLKSANCLV-------NKHWTVKICDFGLSRIITDSPMR 683
+ + + L + +VH ++ + N L+ +K+ D G+S R
Sbjct: 121 TVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS---R 177
Query: 684 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELC-TLNRPWEGVLP---ERVVYA 738
+ P W+APE + + D +S G + E+C P + P ER
Sbjct: 178 EERVERIP-WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY-- 234
Query: 739 VANEGSRLEIPEGP-LGRLIADCWA-EPQERPSCEEILSRL 777
+ RL P L LI+ C EP +RPS IL L
Sbjct: 235 --EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 10/100 (10%)
Query: 521 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFCN 573
+W L +G +G G FG+V G D VA+K+ L++ TA + +
Sbjct: 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKM-LKEGATASEHKALMS 59
Query: 574 EISILSRL-RHPNVILFLGACTKPP-RLSMITEYMELGSL 611
E+ IL + H NV+ LGACTKP L +I E+ + G+L
Sbjct: 60 ELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNL 99
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 35/159 (22%), Positives = 68/159 (42%), Gaps = 14/159 (8%)
Query: 571 FCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL 630
F S++ ++ H +++L G C + M+ E++E G L +H W K
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KF 108
Query: 631 KMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT-------VKICDFGLSRIITDSPMR 683
K+ + + L + +VH ++ + N L+ + +K+ D G+ + R
Sbjct: 109 KVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS---R 165
Query: 684 DSSSAGTPEWMAPELIRNEP-FTEKCDIFSLGVIMWELC 721
P W+APE + + + D +S G +WE+C
Sbjct: 166 QECVERIP-WIAPECVEDSKNLSIAADKWSFGTTLWEIC 203
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 32/103 (31%), Positives = 50/103 (48%), Gaps = 9/103 (8%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNE 574
W L +G +G G FG+V G G VA+K+ ++E + +E
Sbjct: 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEK-QALMSE 90
Query: 575 ISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH 616
+ I++ L H N++ LGACTK + +ITEY G L + +H
Sbjct: 91 LKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 27/83 (32%), Positives = 41/83 (49%), Gaps = 3/83 (3%)
Query: 640 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 699
L +HR IV RDL N L++ +++ F + DS ++ + APE+
Sbjct: 98 LDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVEN---MYCAPEVG 154
Query: 700 RNEPFTEKCDIFSLGVIMWELCT 722
TE CD +SLG I++EL T
Sbjct: 155 GISEETEACDWWSLGAILFELLT 177
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 35/101 (34%), Positives = 52/101 (51%), Gaps = 12/101 (11%)
Query: 521 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFCN 573
+W L +G +G G FG+V + G + VA+K+ L++ TA +
Sbjct: 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKM-LKEGATASEYKALMT 59
Query: 574 EISILSRL-RHPNVILFLGACTKP--PRLSMITEYMELGSL 611
E+ IL + H NV+ LGACTKP P L +I EY + G+L
Sbjct: 60 ELKILIHIGHHLNVVNLLGACTKPGGP-LMVIVEYCKFGNL 99
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 10/100 (10%)
Query: 521 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFCN 573
+W L +G +G G FG+V G D VA+K+ L++ T +
Sbjct: 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSEHRALMS 59
Query: 574 EISILSRL-RHPNVILFLGACTKP-PRLSMITEYMELGSL 611
E+ IL + H NV+ LGACTKP L +I E+ + G+L
Sbjct: 60 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 99
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 20/41 (48%), Positives = 26/41 (63%)
Query: 632 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 672
++R + GL +HR+ IVHRD+K N LV VKI DFG
Sbjct: 314 VMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 32/150 (21%), Positives = 55/150 (36%), Gaps = 35/150 (23%)
Query: 542 EVFRGIWNGTDVAIKV---------FLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 592
++ + G +K L++ L E E IL++ R G
Sbjct: 11 IIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTR---REARILAKARE------AGV 61
Query: 593 CT------KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 646
P ++ EY+E G L K + +LR++ R + +H+
Sbjct: 62 PVPIVYDVDPDNGLIVMEYIE-GELL---------KDALEEARPDLLREVGRLVGKLHKA 111
Query: 647 KIVHRDLKSANCLVNKHWTVKICDFGLSRI 676
IVH DL ++N +++ I DFGL
Sbjct: 112 GIVHGDLTTSNIILSGGRIYFI-DFGLGEF 140
|
Length = 204 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.004
Identities = 16/34 (47%), Positives = 25/34 (73%)
Query: 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWE 719
S P +MAPE+I+ + +TEK DI+SLG+ ++E
Sbjct: 63 QSRPDPYFMAPEVIQGQSYTEKADIYSLGITLYE 96
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 785 | |||
| PF14381 | 204 | EDR1: Ethylene-responsive protein kinase Le-CTR1 | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.36 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.31 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.18 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.13 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.09 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.03 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.02 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.96 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.89 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.76 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.71 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.62 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.45 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.38 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.35 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.35 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.29 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.21 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.15 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.99 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.9 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.78 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.77 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.77 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.63 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.63 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.6 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.54 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.45 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.33 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.31 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.22 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.18 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.17 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.05 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.04 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.98 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.92 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.81 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.43 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.43 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.38 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.2 | |
| smart00460 | 68 | TGc Transglutaminase/protease-like homologues. Tra | 95.74 | |
| PLN02236 | 344 | choline kinase | 95.6 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.59 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.58 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.52 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.43 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.36 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.04 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.97 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.94 | |
| PF01841 | 113 | Transglut_core: Transglutaminase-like superfamily; | 93.57 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 93.57 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.94 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.57 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 91.92 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 90.47 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 89.89 |
| >PF14381 EDR1: Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-59 Score=477.84 Aligned_cols=195 Identities=39% Similarity=0.619 Sum_probs=180.1
Q ss_pred Cchhhhhhhhhcccccc--cccCCcceEeeccc---hhhhhcCCCCChhhhhhcCCCCceeEEEEEecccchhHHHHHHH
Q 003935 55 LSSQTASQILWSTGMLS--EPIPNGFYSVIPDK---RLKELFDSIPTVDELHALGGEGHRADIILVDSKKDKKLSMLKQL 129 (785)
Q Consensus 55 ~~~~~~s~~~w~~~~~~--~~~~~gfy~~~~~~---~~~~~~~~~p~~~~l~~~~~~~~~~~~i~vd~~~d~~~~~l~~l 129 (785)
+++|++|||||++|+|| |+||||||+|+||+ .|++.++||||+++|++++++++++||||||+..|++|.+|+|.
T Consensus 1 ~~~e~lS~r~W~~~~L~y~dki~DGFYdi~g~~~~~~l~~~~~~~Psl~~L~~~~~~~~~~EvIlVDr~~D~~L~~L~~~ 80 (204)
T PF14381_consen 1 SSAESLSHRYWVNGCLSYDDKIPDGFYDIYGMDCTNSLKEEFGRMPSLEDLQAVPPDDSSREVILVDRRRDPSLKELEQR 80 (204)
T ss_pred CcHHHHHHHHHHcCCCCCCCcCCCCCcccccCCCccccccccCCCCCHHHHhcCCCCCCCeeEEEEccccCHHHHHHHHH
Confidence 47899999999999999 99999999999995 67788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCChHHHHHHHHHHHHhhhCCCCCCChhh--hhHHHHHHHHhh-cceeEeccccccccchhhHHHHHHhhhc
Q 003935 130 IVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAK--AALEETSHMFET-RGVQLLGQIRHGSCRPRAILFKVLADTV 206 (785)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~~a~~v~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~g~i~~g~~r~ra~lfkvlad~~ 206 (785)
+..+.++++++++++|++||++||++|||+ +..++. ..|++.++.|++ +|++|||+|++|+|||||||||||||+|
T Consensus 81 a~~~~~~~~~~~~~~v~~LA~lVa~~MGG~-~~~~~~~~~~w~~~s~~lk~~s~~vplG~l~~G~~rhRALLFKvLAD~i 159 (204)
T PF14381_consen 81 AHELSKGLSTNTKELVQKLAKLVADRMGGP-VSDAEDMLFRWELRSEKLKENSGVVPLGSLRIGLCRHRALLFKVLADRI 159 (204)
T ss_pred HHHHHhccccCHHHHHHHHHHHHHHHhCCC-CCcchhhhHHHHHHHHHHHhCCCeEEEeeecccchHHHHHHHHHHHHhc
Confidence 999999999889999999999999999999 444333 889998876655 4499999999999999999999999999
Q ss_pred CCCceec-ccCCCCcccccccccceeEEeecCceeeeeecccCCCcccc
Q 003935 207 GLESRLM-GLPNDGTMECVDSYKHMSVIVVLNSVELLVDLMRFPGQLIP 254 (785)
Q Consensus 207 ~l~~~~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (785)
||||||| |+...++ +...|+.+|+..+++|||||||++||+|+|
T Consensus 160 glpCrLvrG~~y~g~----~~~~a~~~V~~~~~~eyiVDLm~~PG~L~P 204 (204)
T PF14381_consen 160 GLPCRLVRGCYYCGW----DDDDASNLVKFDDGREYIVDLMGAPGQLIP 204 (204)
T ss_pred CCCceEEeeccCCcc----CCCCceEEEEcCCCcEEEEEcCCCCCCcCC
Confidence 9999999 9988887 677888888889999999999999999998
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=449.37 Aligned_cols=359 Identities=30% Similarity=0.512 Sum_probs=290.8
Q ss_pred HHHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCccc-CCCcccccccccccccccccCCCCCCCC
Q 003935 400 AVRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEIS-GGRSALYNLSRDQMNSQKAISLPSSPHE 478 (785)
Q Consensus 400 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~-~~rs~~~~l~r~~~~sq~~~SlPSsp~~ 478 (785)
-+++|+|.+++++|+++++..|+|++|+|+ +.|+++.+++.+++... +...+||.+.......... .++....
T Consensus 84 f~~~isR~~ae~~ll~p~~~~G~flvR~se----~~~g~yslsv~~~~~~~~~~~v~hyri~~~~~~~~~~--~~~~~~~ 157 (468)
T KOG0197|consen 84 FFGKISREEAERQLLAPENKEGAFLVRESE----SDKGDYSLSVREGDSGGLGAKVKHYRIRQLDGGGLYP--YIDEREL 157 (468)
T ss_pred hhccccHHHHHHhhcCCCCCccceeeeccc----CCcCCeeEEEEeccccCCccceeeeeeeEcCCCCeec--CCCHHHh
Confidence 478999999999999999999999999999 89999999999877554 7788999877642221110 0111111
Q ss_pred CCC------CCC-CCCCCCCCCCCchhhhhhhhhccCCcc------cCCCccccccccccCCCeeEeeEEeeeCcEEEEE
Q 003935 479 YGS------HGS-ERGGSSGYMANSEFVSTWNKVLESPMF------QNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFR 545 (785)
Q Consensus 479 ~~s------~sS-~~~~ssg~~~~s~~~s~~~~il~S~~~------~~~p~~~~ee~~i~~s~y~i~k~LG~G~fG~VYk 545 (785)
+.+ +.+ .+.+.. ..+..++. ...+....+.|+++.+.+++.+.||+|.||+||.
T Consensus 158 F~~l~~lv~~~~~~~~gl~-------------~~l~~p~~~~~~~~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~ 224 (468)
T KOG0197|consen 158 FSSLQQLVNYYSKNADGLC-------------TRLRDPCSKQGHTKPQTPDLARDPWEIPREELKLIRELGSGQFGEVWL 224 (468)
T ss_pred hhhHHHHHhhhhccCcchh-------------hcccCchhccCCCCCCCCccccCCeeecHHHHHHHHHhcCCccceEEE
Confidence 100 000 000000 01111111 1112223788999999999999999999999999
Q ss_pred EEECCe-EEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccchhhHHHHhhcccccc
Q 003935 546 GIWNGT-DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKL 624 (785)
Q Consensus 546 g~~~g~-~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~L 624 (785)
|.+++. +||+|.++...+. .+.|.+|+++|++|+|+|||+++++|..++.+|||||||+.|+|.++|+. ..+..+
T Consensus 225 g~~~~~~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~-~~~~~l 300 (468)
T KOG0197|consen 225 GKWNGSTKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRT-REGGLL 300 (468)
T ss_pred EEEcCCCcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhh-cCCCcc
Confidence 999877 9999999876554 36788999999999999999999999998899999999999999999975 356789
Q ss_pred hHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCC-CCCCCCcccCccccccCC
Q 003935 625 SWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS-SSAGTPEWMAPELIRNEP 703 (785)
Q Consensus 625 s~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~-~~~GT~~Y~APEvl~~~~ 703 (785)
...+.+.++.|||+||+||+++++|||||.+.||||+++..+||+|||||+...+..+... ...-+..|+|||.+..+.
T Consensus 301 ~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~ 380 (468)
T KOG0197|consen 301 NLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGK 380 (468)
T ss_pred chHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCC
Confidence 9999999999999999999999999999999999999999999999999997666555433 334456899999999999
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCh---HHHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003935 704 FTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRLL 778 (785)
Q Consensus 704 ~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip~~---~L~~LI~~CL~-DP~kRPS~~EIL~~L~ 778 (785)
++.|+|||||||+||||+| |+.||.+.++.+++..+ ..+++++.|+. .+.+|+..||. +|++||||+.+...|.
T Consensus 381 FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l-e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~ 459 (468)
T KOG0197|consen 381 FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL-ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLE 459 (468)
T ss_pred cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH-hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHH
Confidence 9999999999999999998 77899999998888876 55778877754 59999999999 9999999999999998
Q ss_pred hhhh
Q 003935 779 DCEY 782 (785)
Q Consensus 779 ~l~~ 782 (785)
++-.
T Consensus 460 ~~~~ 463 (468)
T KOG0197|consen 460 DFFT 463 (468)
T ss_pred Hhhh
Confidence 8754
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=420.47 Aligned_cols=264 Identities=46% Similarity=0.768 Sum_probs=240.1
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEECCeE-EEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~g~~-VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
..+|.++..++.+.+.||+|+||+||+|.+.|+. ||||++..........+.|.+|+.+|.+++|||||+|+|+|.++.
T Consensus 33 ~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 33 LPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred ccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3567778888888899999999999999999998 999999877766666789999999999999999999999999988
Q ss_pred -ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc-cccccCCCCcEEEcCCC-eEEEEecCcc
Q 003935 598 -RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK-IVHRDLKSANCLVNKHW-TVKICDFGLS 674 (785)
Q Consensus 598 -~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~g-IIHrDLKpsNILLd~~g-~VKL~DFGLA 674 (785)
.+.+||||+++|+|.++++.. ....+++..++.++.||+.||.|||+++ |||||||++||||+.++ ++||+|||++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 799999999999999999843 4678999999999999999999999999 99999999999999998 9999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCh-
Q 003935 675 RIITDSPMRDSSSAGTPEWMAPELIR--NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG- 751 (785)
Q Consensus 675 ~~l~~~~~~~~~~~GT~~Y~APEvl~--~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~~- 751 (785)
+.............||+.|||||++. ..+|+.|+||||||++||||+||+.||.+..+..+...+...+.++.+|..
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC 271 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 88765433444578999999999999 669999999999999999999999999999998889999889999998863
Q ss_pred --HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003935 752 --PLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 783 (785)
Q Consensus 752 --~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~s 783 (785)
.+..|+..||. ||.+||++.+|+..|+.+...
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 68999999999 999999999999999987654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=418.01 Aligned_cols=247 Identities=30% Similarity=0.461 Sum_probs=227.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
..|..++.||+|||+.||.+++ .|..||+|++.+..+ .....+.+.+||++.+.|+|||||+++++|++.++.|+|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999976 699999999977654 3345678899999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
|+|..++|..+++ ..+.+++.+++.+++||+.||.|||+++|||||||..|+||+++.+|||+|||||..+..+...
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 9999999999997 5679999999999999999999999999999999999999999999999999999999877677
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-ChHHHHHHHHhhh
Q 003935 684 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLGRLIADCWA 762 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-~~~L~~LI~~CL~ 762 (785)
..+.||||.|+|||++....++..+||||+||+||.|++|++||......+.+..+....+..+-. ..+.++||.++|.
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence 789999999999999999999999999999999999999999999999999999998877665543 3368899999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003935 763 -EPQERPSCEEILSR 776 (785)
Q Consensus 763 -DP~kRPS~~EIL~~ 776 (785)
||.+|||+++||.+
T Consensus 255 ~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDH 269 (592)
T ss_pred CCcccCCCHHHHhcC
Confidence 99999999999976
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=388.91 Aligned_cols=247 Identities=27% Similarity=0.520 Sum_probs=218.5
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
..+|.+.++||.|+||+||+|.+ ++..||||.+.+..+..+..+.+..|+.+|+.++|||||.+++++..++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 46888999999999999999987 5789999999988888888888999999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC------CeEEEEecCccccc
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH------WTVKICDFGLSRII 677 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~------g~VKL~DFGLA~~l 677 (785)
|||.||+|.++++ ..+.+++..++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+.+
T Consensus 89 EyC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999998 45589999999999999999999999999999999999999765 46899999999998
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCh----HH
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG----PL 753 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~~----~L 753 (785)
... ....+.||+|.|||||++..++|+.|+|+||+|++||+|++|+.||...+..++...+.......+.++. ++
T Consensus 166 ~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~ 244 (429)
T KOG0595|consen 166 QPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPL 244 (429)
T ss_pred Cch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCch
Confidence 754 4556889999999999999999999999999999999999999999999999988876655554444332 45
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 754 GRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 754 ~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+|+...++ +|..|.++.+...+
T Consensus 245 ~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 245 RELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred hhhhhHHHhcCccccCchHHhhhh
Confidence 677777777 88888877766543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=388.18 Aligned_cols=246 Identities=32% Similarity=0.516 Sum_probs=219.5
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc-ee
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR-LS 600 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~-l~ 600 (785)
+..+++..++.||+|..|+||++.+ +++.+|+|++. -..+....+++.+|+++++.++|||||.+||+|..+.. ++
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is 154 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS 154 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence 4556788889999999999999988 48899999994 34556677899999999999999999999999999985 99
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-cccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
++||||++|+|.+++. ..+.+++...-.++.+|++||.|||+ ++||||||||+|||++..|.|||||||.+..+.+
T Consensus 155 I~mEYMDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred eehhhcCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999999997 34689999999999999999999995 9999999999999999999999999999998876
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhcCCCCCCCCh---
Q 003935 680 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV-----LPERVVYAVANEGSRLEIPEG--- 751 (785)
Q Consensus 680 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~-----~~~~~v~~i~~~~~~~~ip~~--- 751 (785)
. ...+.+||..|||||.+.+..|+.++||||||++++||++|+.||... ...+++..|.. +..+.+|.+
T Consensus 232 S--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~-~ppP~lP~~~fS 308 (364)
T KOG0581|consen 232 S--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD-EPPPRLPEGEFS 308 (364)
T ss_pred h--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc-CCCCCCCcccCC
Confidence 5 557889999999999999999999999999999999999999999774 55666666655 444555543
Q ss_pred -HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 752 -PLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 752 -~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+++.+|..|++ ||.+||++.++++|
T Consensus 309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 69999999999 99999999999987
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=384.95 Aligned_cols=251 Identities=24% Similarity=0.400 Sum_probs=222.5
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChH-HHHHHHHHHHHHhhcCCCceeeEeccccCCCce
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE-NMEDFCNEISILSRLRHPNVILFLGACTKPPRL 599 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~-~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 599 (785)
.+..++|.+.+.||+|+||+||.+.. +++-||+|++++...... ..+....|..+|..++||+||+++..|++...+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 34578999999999999999999965 688999999988776443 467788999999999999999999999999999
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
|+|+||+.||.|+.+|+ ..+.+++..++-|+.+|+.||.|||++|||||||||+|||||.+|+++|+||||++....
T Consensus 101 ylVld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEEEeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999999997 567899999999999999999999999999999999999999999999999999997655
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-C-CCChHHHHHH
Q 003935 680 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-E-IPEGPLGRLI 757 (785)
Q Consensus 680 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~-~-ip~~~L~~LI 757 (785)
......+.|||+.|||||++.+..|+..+|.||||+++|||++|.+||.+.+....+..+....... + .-....++++
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll 257 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLL 257 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHH
Confidence 5555667899999999999999999999999999999999999999999999999999988766222 1 1345689999
Q ss_pred HHhhh-CCCCCC----CHHHHHHH
Q 003935 758 ADCWA-EPQERP----SCEEILSR 776 (785)
Q Consensus 758 ~~CL~-DP~kRP----S~~EIL~~ 776 (785)
+++++ ||.+|. ++.+|.+|
T Consensus 258 ~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 258 KKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred HHHhccCHHHhcCCCCChHHhhcC
Confidence 99999 999994 55555443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=391.68 Aligned_cols=247 Identities=26% Similarity=0.401 Sum_probs=210.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChH-----HHHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE-----NMEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~-----~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
.+.|.+.+.||+|+||.|-+|.. +|+.||||++.+...... ......+|+++|++|+|||||+++++|..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 35688899999999999999976 699999999987654331 12335699999999999999999999999999
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC---CeEEEEecCccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH---WTVKICDFGLSR 675 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~---g~VKL~DFGLA~ 675 (785)
.||||||+.||.|.+.+- .++.+.+..-+.+++|++.|+.|||++||+||||||+|||+..+ ..+||+|||+|+
T Consensus 251 ~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred eEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 999999999999999986 56788888899999999999999999999999999999999766 789999999999
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCC---CchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCCCC--
Q 003935 676 IITDSPMRDSSSAGTPEWMAPELIRNEPF---TEKCDIFSLGVIMWELCTLNRPWEGVLPER-VVYAVANEGSRLEIP-- 749 (785)
Q Consensus 676 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~---s~ksDVWSLGvILyELLTG~~PF~~~~~~~-~v~~i~~~~~~~~ip-- 749 (785)
..+. .....+.||||.|.|||++.++.+ ..+.|+||+||+||-+++|.+||.+..... ...++..+.+...-+
T Consensus 328 ~~g~-~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 328 VSGE-GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred cccc-ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 8874 345678999999999999986543 348899999999999999999998876666 555555544433322
Q ss_pred ---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 750 ---EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 750 ---~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+...+||.+||. ||++|||+.|+|+|
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 2357889999999 99999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=377.57 Aligned_cols=253 Identities=29% Similarity=0.526 Sum_probs=224.3
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEec-cccCCCc-ee
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG-ACTKPPR-LS 600 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g-~~~d~~~-l~ 600 (785)
...+|.+.++||+|.||+||++.. +|..+|.|.++...++....++...|+.+|++|+|||||++++ -+.+++. ++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 346788999999999999999965 7999999999988888888899999999999999999999998 4444444 99
Q ss_pred EEEEEcccchhhHHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHh--cc--cccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 601 MITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHR--MK--IVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~AL~yLHs--~g--IIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
+|||||.+|+|..+++... ..+.+++..+|+++.|++.||.+||+ .+ |+||||||.||+|+.+|.|||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999999999999987443 45679999999999999999999999 55 9999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC----h
Q 003935 676 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE----G 751 (785)
Q Consensus 676 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~----~ 751 (785)
.+........+.+|||.||+||.+...+|+.|+||||+||++|||+.-+.||.+.+-.++..+|.+. ..+++|+ .
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~~p~~~YS~ 255 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPPLPDEHYST 255 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCCCcHHHhhh
Confidence 9988777777889999999999999999999999999999999999999999999888888887765 4455663 4
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003935 752 PLGRLIADCWA-EPQERPSCEEILSRLL 778 (785)
Q Consensus 752 ~L~~LI~~CL~-DP~kRPS~~EIL~~L~ 778 (785)
.+..||..|+. ||..||+...++..++
T Consensus 256 ~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 256 DLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred HHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 69999999999 9999998655555443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=376.30 Aligned_cols=250 Identities=29% Similarity=0.454 Sum_probs=218.0
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC---hHHHHHHHHHHHHHhhcC-CCceeeEeccccCCC
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT---AENMEDFCNEISILSRLR-HPNVILFLGACTKPP 597 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~---~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~ 597 (785)
.....|.+++.||+|+||+|+.|.+ ++..||+|++.++... ....+.+.+|+.+++.++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999977 6899999987664221 122455668999999999 999999999999999
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC-CeEEEEecCcccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRI 676 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~-g~VKL~DFGLA~~ 676 (785)
.+|+||||+.||.|++++. ..+++.+..++.+++|++.|++|||++||+||||||+|||++.+ +++||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~---~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIV---NKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHH---HcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 9999999999999999997 35789999999999999999999999999999999999999999 9999999999998
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--ChH
Q 003935 677 ITDSPMRDSSSAGTPEWMAPELIRNEP-FT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP--EGP 752 (785)
Q Consensus 677 l~~~~~~~~~~~GT~~Y~APEvl~~~~-~s-~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip--~~~ 752 (785)
.........+.|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.+.+...+...+.......+.- ...
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~ 250 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE 250 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence 843334567899999999999999977 86 78999999999999999999999988888888866554443322 456
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+..|+.+|+. ||.+|+++.+|+.+
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhhC
Confidence 8999999999 99999999999954
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=381.77 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=220.6
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChH-HHHHHHHHHHHHhhc-CCCceeeEeccccCCCc
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE-NMEDFCNEISILSRL-RHPNVILFLGACTKPPR 598 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~-~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~ 598 (785)
.....+|..++.||+|+|++|++|.. .++.||||++.+..+..+ .++-...|-.+|.+| .||.|++|+..|++...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34568999999999999999999976 688999999977665433 345567899999999 79999999999999999
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
+|+|+||+++|+|.++++ +-+.|++..++.++.||+.||+|||++|||||||||+||||+++++++|+|||-|+.+.
T Consensus 149 LYFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred eEEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999999998 55789999999999999999999999999999999999999999999999999999885
Q ss_pred CCCCC---------C----CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Q 003935 679 DSPMR---------D----SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 745 (785)
Q Consensus 679 ~~~~~---------~----~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~ 745 (785)
..... . ..++||..|.+||+|..+..++.+|+|+||||||+|+.|.+||.+.+.--+.++|....+.
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~ 305 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE 305 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc
Confidence 42111 1 3478999999999999999999999999999999999999999999998888888765543
Q ss_pred CCCC-ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 746 LEIP-EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 746 ~~ip-~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+-- +..+.+||+++|. ||.+|+++.+|.+|
T Consensus 306 fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 306 FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred CCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 3211 2468999999999 99999999998876
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=364.59 Aligned_cols=260 Identities=32% Similarity=0.592 Sum_probs=212.0
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccc
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGAC 593 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~ 593 (785)
|.+..++|.+.++||+|+||.||+|.+ .++.||||++.... .....+.+.+|+.+++.+ +||||++++++|
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 667788999999999999999999964 24579999986443 233456789999999999 899999999988
Q ss_pred cCC-CceeEEEEEcccchhhHHHHhhcc----------------------------------------------------
Q 003935 594 TKP-PRLSMITEYMELGSLYHLIHLSGQ---------------------------------------------------- 620 (785)
Q Consensus 594 ~d~-~~l~LV~Ey~~gGSL~dlL~~~~~---------------------------------------------------- 620 (785)
... ..++++|||+++|+|.+++.....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 458999999999999999864211
Q ss_pred -------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCC
Q 003935 621 -------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTP 691 (785)
Q Consensus 621 -------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~ 691 (785)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ......+++
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 13478888999999999999999999999999999999999999999999999986543211 112334567
Q ss_pred cccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCC
Q 003935 692 EWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQE 766 (785)
Q Consensus 692 ~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~k 766 (785)
.|+|||++.+..++.++|||||||+||||++ |..||.+.............+.....+ ...+.+|+.+||. ||.+
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 320 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE 320 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence 8999999999999999999999999999997 999998765544444444444333333 3468999999999 9999
Q ss_pred CCCHHHHHHHHHhhhh
Q 003935 767 RPSCEEILSRLLDCEY 782 (785)
Q Consensus 767 RPS~~EIL~~L~~l~~ 782 (785)
|||+.+|++.|+++..
T Consensus 321 RPs~~el~~~l~~~~~ 336 (338)
T cd05102 321 RPTFSALVEILGDLLQ 336 (338)
T ss_pred CcCHHHHHHHHHHHHh
Confidence 9999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=382.56 Aligned_cols=261 Identities=36% Similarity=0.699 Sum_probs=227.4
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
.++|++..+++.++..||+|.||+||+|.|.| +||||++.......+..+.|++|+.++++-+|.||+-|.|+|..++.
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 48899999999999999999999999999988 58999999999999999999999999999999999999999998875
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
.+|+.+|.|-+|+.+++.. ...|...+.+.|++||++||.|||.++|||||||..||+|.+++.|||+||||+....
T Consensus 463 -AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred -eeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 9999999999999999843 4679999999999999999999999999999999999999999999999999987543
Q ss_pred C--CCCCCCCCCCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----
Q 003935 679 D--SPMRDSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---- 749 (785)
Q Consensus 679 ~--~~~~~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---- 749 (785)
. .........|...|||||+++- .+|++.+|||||||++|||+||..||.....++++..+-++-..+...
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s 619 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRS 619 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhc
Confidence 2 1112234457788999999964 579999999999999999999999999777777776655442223221
Q ss_pred --ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003935 750 --EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 783 (785)
Q Consensus 750 --~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~s 783 (785)
+..+++|+..||. ++++||.+.+|+..|+++..+
T Consensus 620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 620 NCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 1258899999999 999999999999999887764
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=352.59 Aligned_cols=244 Identities=27% Similarity=0.475 Sum_probs=213.0
Q ss_pred eEEeeeCcEEEEEEEECCeEEEEEEeeccccCh-HHHHHHHHHHHHHhhcCCCceeeEeccccC----CCceeEEEEEcc
Q 003935 533 TRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTK----PPRLSMITEYME 607 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d----~~~l~LV~Ey~~ 607 (785)
..||+|+++.||+|.++|+.||||++....... ...+.|.+|+.+|++++||||+++++++.+ ...++++|||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 579999999999999999999999987654332 235778899999999999999999999866 356899999999
Q ss_pred cchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-cccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003935 608 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 686 (785)
Q Consensus 608 gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~ 686 (785)
+|+|.+++. ....+++...+.++.|++.||.|||+ .+++||||||+|||+++++.+||+|||+++.+.... ..
T Consensus 106 ~g~L~~~l~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~~ 179 (283)
T PHA02988 106 RGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FK 179 (283)
T ss_pred CCcHHHHHh---hCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---cc
Confidence 999999997 34578999999999999999999998 499999999999999999999999999998764432 24
Q ss_pred CCCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003935 687 SAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCW 761 (785)
Q Consensus 687 ~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL 761 (785)
..|++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+.....++..+ +..+.+|+.+||
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 259 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACT 259 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHh
Confidence 568899999999976 679999999999999999999999999988888877776666665555 346999999999
Q ss_pred h-CCCCCCCHHHHHHHHHhhhh
Q 003935 762 A-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 762 ~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
+ ||.+|||+.++++.|++++.
T Consensus 260 ~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 260 SHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred cCCcccCcCHHHHHHHHHHHHh
Confidence 9 99999999999999998864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=357.78 Aligned_cols=247 Identities=27% Similarity=0.431 Sum_probs=212.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
+.|..+.++|+|+||+||++.+ +|+-||||++.....++...+-.++||.+|++++|+|+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4677788999999999999976 68999999998777666666777899999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
||+..-|..+-+ ....++...+.++++|++.|+.|||++++|||||||+|||++.+|.+||||||+|+.+..+....
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 999855554433 33468899999999999999999999999999999999999999999999999999998665566
Q ss_pred CCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-------------------C
Q 003935 685 SSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG-------------------S 744 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~-------------------~ 744 (785)
+..+.|.+|.|||.+.+ .+|....||||+||++.||++|.+-|++.+.-..++.|...- .
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 67889999999999987 689999999999999999999999999988877776664311 1
Q ss_pred CCCCCC-------------hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 745 RLEIPE-------------GPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 745 ~~~ip~-------------~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.+.|. ..+-+|++.|++ ||.+|++.++++.|
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111111 136679999999 99999999999875
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=373.61 Aligned_cols=251 Identities=26% Similarity=0.444 Sum_probs=221.5
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCce
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 599 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 599 (785)
.+..++|.++++||+|+||.||+|+. +|..+|+|++++..+ ...+++....|-.+|....+|+||++|..|++..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 34678999999999999999999965 689999999988765 345577888999999999999999999999999999
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
||||||++||++..+|. ..+.|++..++.|+.+++.||+-||+.|+|||||||+|+|||..|++||+||||+.-+..
T Consensus 217 YLiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999999997 567999999999999999999999999999999999999999999999999999853311
Q ss_pred ----------------------CCCC-------------------------CCCCCCCCcccCccccccCCCCchhhHHH
Q 003935 680 ----------------------SPMR-------------------------DSSSAGTPEWMAPELIRNEPFTEKCDIFS 712 (785)
Q Consensus 680 ----------------------~~~~-------------------------~~~~~GT~~Y~APEvl~~~~~s~ksDVWS 712 (785)
.... ....+|||.|+|||++.+..|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0000 02346999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCh-----HHHHHHHHhhhCCCCCC---CHHHHHHH
Q 003935 713 LGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG-----PLGRLIADCWAEPQERP---SCEEILSR 776 (785)
Q Consensus 713 LGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~~-----~L~~LI~~CL~DP~kRP---S~~EIL~~ 776 (785)
||||+||||.|.+||.+.++.+...++.+....+..|.+ ...+||.+|+.||.+|. .++||.+|
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKH 445 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcC
Confidence 999999999999999999999999999988877776643 58899999999999995 56776654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=352.00 Aligned_cols=238 Identities=24% Similarity=0.405 Sum_probs=216.4
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
...++|...+.||.|+||+|.+++. +|..||+|++.++.. .-.+.+...+|..+|+.+.||+++++++.|.+...+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 4567899999999999999999976 688999999977664 3445677889999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
|||||++||.|+.+++ +.+++++..++-++.||+.||+|||+++|++|||||+|||||.+|++||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEeccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999999998 5568999999999999999999999999999999999999999999999999999988664
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-ChHHHHHHHH
Q 003935 681 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLGRLIAD 759 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-~~~L~~LI~~ 759 (785)
..+.||||.|+|||++..++|..++|.|||||++|||+.|..||.+.++..++.+|.......+-- ...+++|+..
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 357899999999999999999999999999999999999999999999999999998776544422 4469999999
Q ss_pred hhh-CCCCC
Q 003935 760 CWA-EPQER 767 (785)
Q Consensus 760 CL~-DP~kR 767 (785)
+++ |-.+|
T Consensus 275 LL~vD~t~R 283 (355)
T KOG0616|consen 275 LLQVDLTKR 283 (355)
T ss_pred HHhhhhHhh
Confidence 998 88888
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=363.42 Aligned_cols=249 Identities=34% Similarity=0.547 Sum_probs=211.3
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC--ceeE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP--RLSM 601 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~--~l~L 601 (785)
..++..++.||+|+||.||++.+. |..+|||........ ..+.+.+|+.+|++++|||||+++|...... .+++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 345677889999999999999874 789999998765322 2677899999999999999999999855444 5999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC-CCeEEEEecCccccccC-
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRIITD- 679 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~-~g~VKL~DFGLA~~l~~- 679 (785)
+|||+++|+|.+++...+ ..+++..++.++.||++||+|||++||||+||||+|||++. ++.+||+|||+++....
T Consensus 94 ~mEy~~~GsL~~~~~~~g--~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYG--GKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred eeeccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 999999999999997432 27999999999999999999999999999999999999999 79999999999987763
Q ss_pred --CCCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCCCCCCCCh---H
Q 003935 680 --SPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEG-VLPERVVYAVANEGSRLEIPEG---P 752 (785)
Q Consensus 680 --~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~-~~~~~~v~~i~~~~~~~~ip~~---~ 752 (785)
.........||+.|||||++.++ ....++|||||||++.||+||+.||.. ......+..+......+.+|+. .
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~ 251 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDE 251 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHH
Confidence 11223457899999999999964 334599999999999999999999998 5666667777766666677754 6
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSRLL 778 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~L~ 778 (785)
.++++..|+. ||.+|||++++|+|.-
T Consensus 252 a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 252 AKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 8999999999 9999999999999843
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=376.99 Aligned_cols=246 Identities=28% Similarity=0.493 Sum_probs=226.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|.+.+.||+|.||+||+|.. +.+.||+|.+.+........+.+.+|++|++.++|||||.++++|+....+++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 6788999999999999999954 67789999998888888788999999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
|+.| +|+.++. ..+.++++.+..++.+++.||.|||+++|+|||+||.|||++.++++|+||||+|+.+.......
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 9987 9999997 56789999999999999999999999999999999999999999999999999999998777777
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-ChHHHHHHHHhhh-
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLGRLIADCWA- 762 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-~~~L~~LI~~CL~- 762 (785)
+...|||.|||||++.+++|+..+|+||+||++|||++|++||....-.+++..|......++.. ...+.+++..++.
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~k 237 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIK 237 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhc
Confidence 78899999999999999999999999999999999999999999988888888887766554432 3469999999999
Q ss_pred CCCCCCCHHHHHHH
Q 003935 763 EPQERPSCEEILSR 776 (785)
Q Consensus 763 DP~kRPS~~EIL~~ 776 (785)
||.+|.+..+++.|
T Consensus 238 dP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 238 DPAQRLTWTDLLGH 251 (808)
T ss_pred ChhhcccHHHHhcC
Confidence 99999999999876
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=370.61 Aligned_cols=265 Identities=32% Similarity=0.541 Sum_probs=214.4
Q ss_pred CCccccccccccCCCeeEeeEEeeeCcEEEEEEEEC-CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEecc
Q 003935 514 KPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 592 (785)
Q Consensus 514 ~p~~~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~-g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~ 592 (785)
...+++.++..++++|...+.||+|+||.||+|... |+.||||++....... ..+|.+|+.++.+++|||+|+|+||
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 345788889999999999999999999999999874 5899999876554432 4569999999999999999999999
Q ss_pred ccCCC-ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc---cccccCCCCcEEEcCCCeEEE
Q 003935 593 CTKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK---IVHRDLKSANCLVNKHWTVKI 668 (785)
Q Consensus 593 ~~d~~-~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~g---IIHrDLKpsNILLd~~g~VKL 668 (785)
|.+.+ ..+|||||+++|+|.++++..... .++|.++.+|+.++|+||+|||... |||||||++|||||+++++||
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 99998 499999999999999999743322 8999999999999999999999854 999999999999999999999
Q ss_pred EecCccccccCCCCCCCCC-CCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---h---HHHHHHHHh
Q 003935 669 CDFGLSRIITDSPMRDSSS-AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL---P---ERVVYAVAN 741 (785)
Q Consensus 669 ~DFGLA~~l~~~~~~~~~~-~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~---~---~~~v~~i~~ 741 (785)
+|||+|+............ .||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+... . .........
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999997654311122222 89999999999999999999999999999999999998876432 1 111111222
Q ss_pred cCCCCC----------CCC-hH---HHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 742 EGSRLE----------IPE-GP---LGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 742 ~~~~~~----------ip~-~~---L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
.+...+ .+. .. +..+..+|++ +|.+||+|.+|++.|+.+.
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 221111 111 12 4567789999 9999999999999996543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=350.06 Aligned_cols=244 Identities=24% Similarity=0.353 Sum_probs=211.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++|.+.+.||+|+||+||+|.+ +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+...+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4688999999999999999987 488999999865433 2234567889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+++|+|.+++. ..+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 81 EYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 9999999999986 3457899999999999999999999999999999999999999999999999999876442
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CChHHHHHHHHhhh
Q 003935 684 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PEGPLGRLIADCWA 762 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i-p~~~L~~LI~~CL~ 762 (785)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+. -...+.+|+.+||.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 22457899999999999998999999999999999999999999998887777776654432221 13468999999999
Q ss_pred -CCCCCCC-----HHHHHHH
Q 003935 763 -EPQERPS-----CEEILSR 776 (785)
Q Consensus 763 -DP~kRPS-----~~EIL~~ 776 (785)
||.+||+ +.++++|
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCHHHccCCccCCHHHHhcC
Confidence 9999995 8998877
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=356.96 Aligned_cols=247 Identities=22% Similarity=0.398 Sum_probs=213.3
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
...++|.+.+.||+|+||.||+|.+ +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 3468899999999999999999987 578999999876533 2234567889999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
+||||+.+|+|.+++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 95 FLLEFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEcCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999999886 3457889999999999999999999999999999999999999999999999999876443
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHH
Q 003935 681 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIAD 759 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~ 759 (785)
. ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..+......+.......+ ..+..+.+|+.+
T Consensus 172 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 248 (329)
T PTZ00263 172 T---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG 248 (329)
T ss_pred c---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHH
Confidence 2 245799999999999999999999999999999999999999998888777776655432211 124468999999
Q ss_pred hhh-CCCCCCC-----HHHHHHH
Q 003935 760 CWA-EPQERPS-----CEEILSR 776 (785)
Q Consensus 760 CL~-DP~kRPS-----~~EIL~~ 776 (785)
||+ ||.+||+ +.+++.|
T Consensus 249 ~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 249 LLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcC
Confidence 999 9999986 7888866
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=377.32 Aligned_cols=252 Identities=37% Similarity=0.629 Sum_probs=227.7
Q ss_pred ccccccccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC
Q 003935 516 LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 595 (785)
Q Consensus 516 ~~~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 595 (785)
....+.|++.|+.+.-++-||.|+.|-||+|+..++.||||.+..- -..+|..|++|+||||+.|.|+|..
T Consensus 113 ~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 113 QQQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred hhhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecC
Confidence 3356889999999999999999999999999999999999986321 1257888999999999999999999
Q ss_pred CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 596 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
...++||||||..|-|...|+ .+.+++......|..+|+.||.|||.+.|||||||.-||||+.+..|||+|||-++
T Consensus 184 sPcyCIiMEfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred CceeEEeeeccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchH
Confidence 999999999999999999997 56789999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCh---H
Q 003935 676 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---P 752 (785)
Q Consensus 676 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~~---~ 752 (785)
...+. ...-.++||..|||||++++.++++|+||||||||||||+||..||.+.+...+++.+-.+...+++|.. .
T Consensus 261 e~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~G 339 (904)
T KOG4721|consen 261 ELSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDG 339 (904)
T ss_pred hhhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchH
Confidence 87654 3345789999999999999999999999999999999999999999999988888877777777777754 5
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
++-|++.||+ .|..||+|.+|+.||.-.
T Consensus 340 fklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 340 FKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 8899999999 999999999999998643
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=342.16 Aligned_cols=247 Identities=24% Similarity=0.364 Sum_probs=205.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|.+.+.||+|+||+||+|.+ +++.||+|++..........+.+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 3689999999999999999988 47789999997665544556778899999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC-C
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-R 683 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~-~ 683 (785)
|++++.+..+.. ....+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 999987765543 235689999999999999999999999999999999999999999999999999987643221 2
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC------------------
Q 003935 684 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR------------------ 745 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~------------------ 745 (785)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 23456899999999999988999999999999999999999999887654443332211000
Q ss_pred --CC-------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 746 --LE-------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 746 --~~-------------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+. .-+..+.+|+.+||. ||.+|||++++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 012348899999999 99999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=372.74 Aligned_cols=251 Identities=26% Similarity=0.401 Sum_probs=222.9
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcC-CCceeeEeccccCCC
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLR-HPNVILFLGACTKPP 597 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~ 597 (785)
..+..++|.+.++||+|.||+|+++.. +++.||||++++... ..+.++..+.|..|+.... ||.+++++.+|+...
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 456788999999999999999999977 577899999988875 4556888999999998885 999999999999999
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
++|+||||+.||++..+. +.+.+++..++-|+..|+.||.|||++||||||||.+|||||.+|++||+|||+++..
T Consensus 443 ~l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred eEEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999999965554 3568999999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-ChHHHHH
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLGRL 756 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-~~~L~~L 756 (785)
-.......+.||||.|+|||++.+..|+..+|.|+|||+||||+.|+.||.+.+.+++...|.+.....++- ..+...|
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~i 598 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAI 598 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHH
Confidence 555556778999999999999999999999999999999999999999999999999999998876555433 4468889
Q ss_pred HHHhhh-CCCCCCC-----HHHHHHH
Q 003935 757 IADCWA-EPQERPS-----CEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS-----~~EIL~~ 776 (785)
+++++. +|.+|-- +++|.+|
T Consensus 599 l~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 599 MRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred HHHHhccCcccccCCCCCCchhhhhC
Confidence 999999 9999963 4555543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=355.99 Aligned_cols=241 Identities=25% Similarity=0.383 Sum_probs=206.6
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccc
Q 003935 533 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 609 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gG 609 (785)
+.||+|+||+||++.+ +|+.||||++.+... .......+.+|+.+++.++||||+++++++...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 588999999876433 2334567889999999999999999999999999999999999999
Q ss_pred hhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCCC
Q 003935 610 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 689 (785)
Q Consensus 610 SL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~G 689 (785)
+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+|
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence 9998886 3457899999999999999999999999999999999999999999999999999764333333345679
Q ss_pred CCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCCC
Q 003935 690 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQER 767 (785)
Q Consensus 690 T~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~kR 767 (785)
|+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.......+ .-...+.+|+.+||. ||.+|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 9999999999999999999999999999999999999998887777666654432221 123468999999999 99999
Q ss_pred C-----CHHHHHHH
Q 003935 768 P-----SCEEILSR 776 (785)
Q Consensus 768 P-----S~~EIL~~ 776 (785)
| ++.++++|
T Consensus 238 ~~~~~~~~~~ll~h 251 (323)
T cd05571 238 LGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCCHHHHHcC
Confidence 9 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=354.32 Aligned_cols=244 Identities=25% Similarity=0.372 Sum_probs=211.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++|.+.+.||+|+||.||+|.+ .++.||||++.+.... ......+.+|+.++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 3689999999999999999987 4789999998765332 234567889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+++|+|.+++. ....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~ 154 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---Y 154 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---c
Confidence 9999999999996 345789999999999999999999999999999999999999999999999999986543 2
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---------ChHHH
Q 003935 684 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---------EGPLG 754 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---------~~~L~ 754 (785)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.........| ...+.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 345679999999999999999999999999999999999999999888877766655433222111 34688
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003935 755 RLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 755 ~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+++.+||. +|.+||++.+++++
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhC
Confidence 99999999 89999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=375.63 Aligned_cols=247 Identities=26% Similarity=0.431 Sum_probs=222.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecc-ccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQ-DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~-~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
.-|++++.||.|+.|.|.+|++ +|+.+|||++.+. .........+.+||-+|+.+.||||+++|++++++..+|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4577899999999999999988 7999999999766 445555677889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+++|.|++++- ..+++++..+.++++||+.|+.|||..+|+||||||+|+||+..+++||+|||+|...... ..
T Consensus 92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-kl 167 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-KL 167 (786)
T ss_pred EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC-cc
Confidence 9999999999997 5678999999999999999999999999999999999999999999999999999876543 45
Q ss_pred CCCCCCCCcccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-ChHHHHHHHHhh
Q 003935 684 DSSSAGTPEWMAPELIRNEPFT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLGRLIADCW 761 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~~~s-~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-~~~L~~LI~~CL 761 (785)
..+.||.|.|.|||++.+.+|. .++||||.|||||.|+||+.||++.+-..++.++..+.+.++-. ....++|+.+|+
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml 247 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRML 247 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHh
Confidence 5688999999999999999985 68999999999999999999999999988988887766655421 336899999999
Q ss_pred h-CCCCCCCHHHHHHHH
Q 003935 762 A-EPQERPSCEEILSRL 777 (785)
Q Consensus 762 ~-DP~kRPS~~EIL~~L 777 (785)
. ||.+|.|++||++|-
T Consensus 248 ~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 248 DVDPSTRITTEEILKHP 264 (786)
T ss_pred ccCccccccHHHHhhCc
Confidence 9 999999999999984
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=359.39 Aligned_cols=248 Identities=27% Similarity=0.478 Sum_probs=227.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
..|.+.+.||+|.||+|-++.. .|+.||||.+.+... +..++-.+.+||+||..|+||||+.+|.+|+..+.+.+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 6788899999999999999965 599999999977765 4455677889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||..+|.|++++. ..+.|++..++.+++||..|+.|||+++++|||||.+|||||+++++||+|||++..+.+.. .
T Consensus 133 EYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k-f 208 (668)
T KOG0611|consen 133 EYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK-F 208 (668)
T ss_pred EecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc-H
Confidence 9999999999998 45689999999999999999999999999999999999999999999999999999887653 4
Q ss_pred CCCCCCCCcccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhh
Q 003935 684 DSSSAGTPEWMAPELIRNEPFT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA 762 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~~~s-~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~~~L~~LI~~CL~ 762 (785)
.+++||+|.|.+||++.+.+|. +..|-|||||+||.|+.|..||++.+...++.++.++.++.+-.+....-||+.|+.
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIRwmLm 288 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGLIRWMLM 288 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHHHHHHHh
Confidence 4689999999999999999985 789999999999999999999999999999999999888877666778889999998
Q ss_pred -CCCCCCCHHHHHHHHH
Q 003935 763 -EPQERPSCEEILSRLL 778 (785)
Q Consensus 763 -DP~kRPS~~EIL~~L~ 778 (785)
||.+|.|+++|..|.+
T Consensus 289 VNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 289 VNPERRATIEDIASHWW 305 (668)
T ss_pred cCcccchhHHHHhhhhe
Confidence 9999999999998854
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=371.21 Aligned_cols=267 Identities=33% Similarity=0.613 Sum_probs=233.4
Q ss_pred CCccccccccccCCCeeEeeEEeeeCcEEEEEEEEC---C--eE-EEEEEeec-cccChHHHHHHHHHHHHHhhcCCCce
Q 003935 514 KPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWN---G--TD-VAIKVFLE-QDLTAENMEDFCNEISILSRLRHPNV 586 (785)
Q Consensus 514 ~p~~~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~---g--~~-VAVKil~~-~~~~~~~~e~f~~EI~iLk~L~HPNI 586 (785)
........|++.-++..+.++||+|+||+||+|... + .. ||+|.... .....+..++|++|+++|+.++||||
T Consensus 144 ~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NV 223 (474)
T KOG0194|consen 144 KRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNV 223 (474)
T ss_pred cccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCE
Confidence 344566789999999999999999999999999762 2 23 89998875 34677889999999999999999999
Q ss_pred eeEeccccCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeE
Q 003935 587 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTV 666 (785)
Q Consensus 587 VkL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~V 666 (785)
|++||++.....+++|||+|.||+|.++|+.. ...++..+...++.+.+.||+|||++++|||||.++|||++.++.+
T Consensus 224 Vr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~v 301 (474)
T KOG0194|consen 224 VRFYGVAVLEEPLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVV 301 (474)
T ss_pred EEEEEEEcCCCccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeE
Confidence 99999999999999999999999999999832 2369999999999999999999999999999999999999999999
Q ss_pred EEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC
Q 003935 667 KICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSR 745 (785)
Q Consensus 667 KL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~ 745 (785)
||+|||+++.............-+..|+|||.+....|+.++|||||||++||+++ |..||.+....++...+...+++
T Consensus 302 KISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r 381 (474)
T KOG0194|consen 302 KISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYR 381 (474)
T ss_pred EeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCcc
Confidence 99999998765422212112235679999999999999999999999999999998 78899999999999999888888
Q ss_pred CCCCCh---HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 746 LEIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 746 ~~ip~~---~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
...|.. .+..++.+||. +|+.||+|.++.+.|+.+..
T Consensus 382 ~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 382 MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 887743 58889999999 99999999999999988754
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=355.61 Aligned_cols=247 Identities=27% Similarity=0.452 Sum_probs=213.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccCh-HHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++|.+.+.||+|+||+||+|.+. ++.||||++....... .....+..|+.++..++||||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999874 8899999997654322 44567889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC--
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-- 681 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~-- 681 (785)
||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 99999999999873 3678999999999999999999999999999999999999999999999999998765432
Q ss_pred ---------------------------CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 003935 682 ---------------------------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER 734 (785)
Q Consensus 682 ---------------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~ 734 (785)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 12234569999999999999999999999999999999999999999988777
Q ss_pred HHHHHHhcCCCCCCC-----ChHHHHHHHHhhhCCCCCCC-HHHHHHH
Q 003935 735 VVYAVANEGSRLEIP-----EGPLGRLIADCWAEPQERPS-CEEILSR 776 (785)
Q Consensus 735 ~v~~i~~~~~~~~ip-----~~~L~~LI~~CL~DP~kRPS-~~EIL~~ 776 (785)
....+.........| +..+.+||.+|+.||.+||+ +.+++++
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~h 285 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcC
Confidence 777666522222222 44689999999999999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=370.39 Aligned_cols=244 Identities=32% Similarity=0.513 Sum_probs=219.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
..|....+||+|+.|.||.+.. .++.||||++....... .+-+++|+.+|+..+|+|||.+++.|...+.+|+|||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 4566778999999999999965 67889999997665544 3567899999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
|++||+|.+.+. ...+++.++..++++++.||+|||.+||||||||.+|||++.+|.+||+|||++..+.......
T Consensus 351 ym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 351 YMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred ecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence 999999999985 3459999999999999999999999999999999999999999999999999999887766566
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----ChHHHHHHHHh
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP----EGPLGRLIADC 760 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip----~~~L~~LI~~C 760 (785)
.+.+|||.|||||++....|++|.||||||++++||+-|++||-..++-+.++.+...+...... ...+++++.+|
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~c 506 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRC 506 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHH
Confidence 78899999999999999999999999999999999999999999999999999988766433322 23699999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003935 761 WA-EPQERPSCEEILSR 776 (785)
Q Consensus 761 L~-DP~kRPS~~EIL~~ 776 (785)
|. |+.+|+++.|+|+|
T Consensus 507 L~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 507 LVVDVEQRASAKELLEH 523 (550)
T ss_pred hhcchhcCCCHHHHhcC
Confidence 99 99999999999987
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=356.44 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=211.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++|++.+.||+|+||+||+|.+ +++.||||++..... .......+.+|+.+++.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4789999999999999999987 588999999976432 2334567889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC-
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 682 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~- 682 (785)
||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999999999986 345799999999999999999999999999999999999999999999999999875432110
Q ss_pred -------------------------------------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 003935 683 -------------------------------------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR 725 (785)
Q Consensus 683 -------------------------------------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~ 725 (785)
.....+||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0112469999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHhhhCCCCCCC---HHHHHHH
Q 003935 726 PWEGVLPERVVYAVANEGSRLEIP-----EGPLGRLIADCWAEPQERPS---CEEILSR 776 (785)
Q Consensus 726 PF~~~~~~~~v~~i~~~~~~~~ip-----~~~L~~LI~~CL~DP~kRPS---~~EIL~~ 776 (785)
||.+.........+.........+ ...+.+++.+|+.+|.+|++ +.++++|
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcC
Confidence 999988887777766544433333 23588999999889999997 9999875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=354.49 Aligned_cols=255 Identities=25% Similarity=0.453 Sum_probs=222.3
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
.+|.++.++|.+...||.|..++||+|.. .+..||||++..+..+.. ++.+.+|+..|+.++||||++++..|..+.
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 45667889999999999999999999976 688999999988877665 789999999999999999999999999999
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+|+||.||.+|++.+++...- ...+++..+..|++++++||.|||++|.||||||+.||||+.+|.|||+|||.+..+
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 9999999999999999997543 345999999999999999999999999999999999999999999999999998777
Q ss_pred cCCCCCC----CCCCCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---
Q 003935 678 TDSPMRD----SSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI--- 748 (785)
Q Consensus 678 ~~~~~~~----~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i--- 748 (785)
.+..... ....||+.|||||++.. .-|+.|+||||||++..||.+|..||....+.+++-..+++......
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~ 256 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG 256 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence 5543221 45689999999999754 35899999999999999999999999999998887766654433111
Q ss_pred -C-------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 749 -P-------EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 749 -p-------~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+ ...++.++..|++ ||.+|||+++++++
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1 1258899999999 99999999999976
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=354.92 Aligned_cols=247 Identities=26% Similarity=0.379 Sum_probs=207.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++|.+.+.||+|+||+||++.+ +++.||||++.+... .......+..|+.++..++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4788999999999999999977 578999999875433 2334567888999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC-
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 682 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~- 682 (785)
||+++|+|.+++. ..+.+++..++.++.|++.||+|||++||+||||||+|||++.++++||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 9999999999987 345799999999999999999999999999999999999999999999999999875432100
Q ss_pred ----------------------------------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003935 683 ----------------------------------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWE 728 (785)
Q Consensus 683 ----------------------------------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~ 728 (785)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 0123579999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHhhh---CCCCCCCHHHHHHH
Q 003935 729 GVLPERVVYAVANEGSRLEIP-----EGPLGRLIADCWA---EPQERPSCEEILSR 776 (785)
Q Consensus 729 ~~~~~~~v~~i~~~~~~~~ip-----~~~L~~LI~~CL~---DP~kRPS~~EIL~~ 776 (785)
+.........+........+| ...+.+++.+++. ++..||++++|++|
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 988888777776544333333 2357777777544 44567999999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=383.74 Aligned_cols=262 Identities=32% Similarity=0.565 Sum_probs=228.6
Q ss_pred ccccccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEe
Q 003935 518 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFL 590 (785)
Q Consensus 518 ~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~ 590 (785)
.....++..++....+.||+|+||+||+|... .+.||||.++.... ....++|.+|++++..++|||||+|+
T Consensus 477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-~~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-NQARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-HHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 34566778899999999999999999999652 45699999976554 33568999999999999999999999
Q ss_pred ccccCCCceeEEEEEcccchhhHHHHhhcc-----------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEE
Q 003935 591 GACTKPPRLSMITEYMELGSLYHLIHLSGQ-----------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCL 659 (785)
Q Consensus 591 g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~-----------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNIL 659 (785)
|+|.+++.++||+|||..|+|..+|..... ..+|+..+.+.|+.|||.||.||-++.+|||||.++|+|
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL 635 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL 635 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence 999999999999999999999999975421 123889999999999999999999999999999999999
Q ss_pred EcCCCeEEEEecCccccccCCCCCC--CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 003935 660 VNKHWTVKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVV 736 (785)
Q Consensus 660 Ld~~g~VKL~DFGLA~~l~~~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v 736 (785)
|+++..|||+|||+++......++. ....-+.+|||||.+..++|+.++|||||||+|||+++ |..||.+..+++++
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 9999999999999999876554442 23456779999999999999999999999999999997 77899999999999
Q ss_pred HHHHhcCCCCCCCCh---HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 737 YAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 737 ~~i~~~~~~~~ip~~---~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
+.+..+.. +..|+. .+..|+..||+ +|.+||+|+||-..|+...
T Consensus 716 e~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 716 ECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred HHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 98866554 777754 59999999999 9999999999999998753
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=340.18 Aligned_cols=254 Identities=32% Similarity=0.524 Sum_probs=206.0
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC------------------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCce
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIWN------------------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV 586 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~~------------------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNI 586 (785)
..++|.+.++||+|+||.||+|.+. +..||+|++.... .......|.+|+.++..++||||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCe
Confidence 4468899999999999999999752 3369999986543 34446789999999999999999
Q ss_pred eeEeccccCCCceeEEEEEcccchhhHHHHhhc----------------ccccchHHHHHHHHHHHHHHHHHHHhccccc
Q 003935 587 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSG----------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 650 (785)
Q Consensus 587 VkL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~----------------~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIH 650 (785)
+++++++.+.+..+++|||+.+|+|.+++.... ....+++..++.++.||+.||+|||+.||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999886421 1134688899999999999999999999999
Q ss_pred ccCCCCcEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh--CCCC
Q 003935 651 RDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT--LNRP 726 (785)
Q Consensus 651 rDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT--G~~P 726 (785)
|||||+|||++.++.+||+|||++..+..... ......++..|+|||++....++.++|||||||++|+|++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986543321 1123345788999999998889999999999999999987 5678
Q ss_pred CCCCChHHHHHHHHh---cC-C-----CCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003935 727 WEGVLPERVVYAVAN---EG-S-----RLEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLD 779 (785)
Q Consensus 727 F~~~~~~~~v~~i~~---~~-~-----~~~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~ 779 (785)
|...........+.. .. . .+...+..+.+|+.+||. ||.+|||+.+|.+.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 887776655443321 11 0 111113468999999999 99999999999988863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=334.36 Aligned_cols=253 Identities=28% Similarity=0.479 Sum_probs=212.4
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
++..+|++.+.||+|+||.||+|.+. +..||+|++..... ......|.+|+.+++.++||||+++++++..++.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 45678999999999999999999752 56899999865432 3345678999999999999999999999999999
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||++|++||||||+|||++.++.++++|||.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999999998632 3578999999999999999999999999999999999999999999999999876543
Q ss_pred CCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003935 679 DSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPL 753 (785)
Q Consensus 679 ~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L 753 (785)
.... ......++..|+|||.+.+..++.++|||||||++||+++ |..||.+.........+.. +...+.+ +..+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 237 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVED-GFRLPAPRNCPNLL 237 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-CCCCCCCCCCCHHH
Confidence 2211 1122345678999999999999999999999999999775 9999998887776666543 3333333 3468
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 754 GRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 754 ~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
.+++.+||+ +|.+||++.+|++.|.++
T Consensus 238 ~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 238 HQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 999999999 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=340.31 Aligned_cols=248 Identities=22% Similarity=0.299 Sum_probs=204.6
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
..++|.+.++||.|+||+||+|.. +++.||+|++...... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 457899999999999999999977 5789999998654322 2235678999999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
|||+.+ +|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~e~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 82 FEYLDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred EeCCCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 999985 88887753 234578999999999999999999999999999999999999999999999999986544333
Q ss_pred CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------------
Q 003935 683 RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL--------------- 746 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~--------------- 746 (785)
......+++.|+|||++.+ ..++.++|||||||++|+|+||+.||.+....+....+......+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 3345678999999999865 568999999999999999999999998877766655443211100
Q ss_pred ----------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 ----------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 ----------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
...+....+|+.+|+. ||.+|||++++++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0012357789999999 99999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=349.97 Aligned_cols=241 Identities=24% Similarity=0.388 Sum_probs=206.2
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccc
Q 003935 533 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 609 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gG 609 (785)
+.||+|+||.||++.+ +|+.||+|++..... .......+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999976 588999999876532 2334567789999999999999999999999999999999999999
Q ss_pred hhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCCC
Q 003935 610 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 689 (785)
Q Consensus 610 SL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~G 689 (785)
+|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..............|
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence 9998886 3457899999999999999999999999999999999999999999999999998764333233345679
Q ss_pred CCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCCC
Q 003935 690 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQER 767 (785)
Q Consensus 690 T~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~kR 767 (785)
|+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.......+ .-...+.+++.+||. ||.+|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 9999999999999999999999999999999999999998888777776654433221 123468999999999 99999
Q ss_pred C-----CHHHHHHH
Q 003935 768 P-----SCEEILSR 776 (785)
Q Consensus 768 P-----S~~EIL~~ 776 (785)
| ++.++++|
T Consensus 238 ~~~~~~~~~~~l~h 251 (323)
T cd05595 238 LGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCCHHHHHcC
Confidence 8 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=355.25 Aligned_cols=261 Identities=28% Similarity=0.528 Sum_probs=216.0
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEe
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 590 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~ 590 (785)
...|.+..++|.+++.||+|+||+||+|++ .+..||||++..... ....+.+.+|+.+++.+ +||||++++
T Consensus 27 ~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~ 105 (375)
T cd05104 27 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLL 105 (375)
T ss_pred ccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeee
Confidence 345677778999999999999999999964 245799999864432 23356788999999999 899999999
Q ss_pred ccccCCCceeEEEEEcccchhhHHHHhhcc--------------------------------------------------
Q 003935 591 GACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------------------------------------------- 620 (785)
Q Consensus 591 g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~-------------------------------------------------- 620 (785)
++|...+..++||||+++|+|.+++.....
T Consensus 106 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 185 (375)
T cd05104 106 GACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK 185 (375)
T ss_pred eeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence 999999999999999999999998864211
Q ss_pred ----------------------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 621 ----------------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 621 ----------------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 1247888999999999999999999999999999999999999999999999998764
Q ss_pred CCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003935 679 DSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 752 (785)
Q Consensus 679 ~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~ 752 (785)
..... .....++..|+|||++.+..++.++|||||||++|||++ |..||...............+.....+ +..
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSE 345 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHH
Confidence 33211 112335567999999999999999999999999999998 888998876655555555555444333 456
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
+.+|+..||+ ||.+||++.+|++.|++.
T Consensus 346 l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 346 MYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 9999999999 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=330.45 Aligned_cols=254 Identities=30% Similarity=0.556 Sum_probs=216.0
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
|.+..++|++.++||+|+||.||+|.. ++..||+|.+..... ..+.+.+|+.+++.++|+||+++++++......+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 567889999999999999999999976 467899998764332 3567899999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
++|||+++++|.+++... ....+++..++.++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++......
T Consensus 78 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 78 IITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEecCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999999999998643 3456888999999999999999999999999999999999999999999999999876543
Q ss_pred CCC-CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003935 681 PMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 755 (785)
Q Consensus 681 ~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~ 755 (785)
... .....++..|+|||++....++.++|||||||++|+|++ |+.||...........+.... ..+.+ +..+.+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 235 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY-RMPRMENCPDELYD 235 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHH
Confidence 221 122345678999999998889999999999999999998 999999887777666655432 22221 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 756 LIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 756 LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
++.+||. +|++||+++++++.|+++
T Consensus 236 li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 236 IMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHccCCcccCcCHHHHHHHHhcC
Confidence 9999999 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=365.35 Aligned_cols=259 Identities=31% Similarity=0.668 Sum_probs=230.6
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 596 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 596 (785)
+++|+....++.+.++||-|.||.||.|+|+ .-.||||.++...+ .+++|+.|+.+|+.++|||+|+|+|+|...
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 5899999999999999999999999999995 55799999876544 368999999999999999999999999999
Q ss_pred CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
..+|||+|||..|+|.++|+.. +...++.-..+.++.||..||+||..+++|||||...|||+.++..||++||||+++
T Consensus 336 pPFYIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999999865 355678888899999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCC-CCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCh---
Q 003935 677 ITDSPMRDSS-SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPEG--- 751 (785)
Q Consensus 677 l~~~~~~~~~-~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip~~--- 751 (785)
+....+.... ..-++.|.|||.+....++.|+|||+|||+|||+.| |..||.+.+..++ +.++.+++++.-|..
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV-Y~LLEkgyRM~~PeGCPp 493 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YGLLEKGYRMDGPEGCPP 493 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH-HHHHhccccccCCCCCCH
Confidence 9877655432 334568999999999999999999999999999987 5569999887655 456678999988865
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 752 PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 752 ~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
.+..|++.||+ .|..||+|.||-+.++.+..
T Consensus 494 kVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 494 KVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 48899999999 99999999999999987653
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=339.57 Aligned_cols=247 Identities=23% Similarity=0.289 Sum_probs=203.3
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
.|.+.+.||+|+||+||+|.+ +|+.||+|++.+..... .....+.+|+.+++.++|+||+++++++.+.+.++++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999976 68899999987554322 233567899999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
|+++|+|.+++... ....+++..+..++.|++.||+|||++||+||||||+|||+++++.++|+|||++....... ..
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 158 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TV 158 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-ee
Confidence 99999998877532 23468999999999999999999999999999999999999999999999999998764322 22
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--cCCCCCC---CChHHHHHHHH
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN--EGSRLEI---PEGPLGRLIAD 759 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~--~~~~~~i---p~~~L~~LI~~ 759 (785)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.. ....... -...+.+|+.+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 238 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRM 238 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHH
Confidence 345789999999999999999999999999999999999999987654322222111 1111112 23468999999
Q ss_pred hhh-CCCCCCC-----HHHHHHH
Q 003935 760 CWA-EPQERPS-----CEEILSR 776 (785)
Q Consensus 760 CL~-DP~kRPS-----~~EIL~~ 776 (785)
||. ||.+||+ ++++++|
T Consensus 239 ~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 239 LLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HhhcCHHHhcCCCCCCHHHHhcC
Confidence 999 9999997 8898876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=335.63 Aligned_cols=245 Identities=34% Similarity=0.644 Sum_probs=203.8
Q ss_pred eEeeEEeeeCcEEEEEEEEC------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 530 TVGTRVGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 530 ~i~k~LG~G~fG~VYkg~~~------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++.+.||.|.||.||+|.+. +..|+||++.. .......+.|.+|++.+++++||||++++|++...+.+++|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccc
Confidence 46789999999999999886 67899999954 344455789999999999999999999999999888899999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC-
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 682 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~- 682 (785)
||+++|+|.+++... ....+++.++..++.||+.||+|||+++++|+||+++|||++.++.+||+|||++........
T Consensus 81 e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp E--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999743 246789999999999999999999999999999999999999999999999999987632211
Q ss_pred -CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHH
Q 003935 683 -RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLI 757 (785)
Q Consensus 683 -~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI 757 (785)
..........|+|||.+.+..++.++||||||+++|||++ |+.||.+.........+ ..+.+...+ +..+.+++
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHHHH
Confidence 1233456678999999999889999999999999999999 68999999888877777 445554444 34699999
Q ss_pred HHhhh-CCCCCCCHHHHHHHH
Q 003935 758 ADCWA-EPQERPSCEEILSRL 777 (785)
Q Consensus 758 ~~CL~-DP~kRPS~~EIL~~L 777 (785)
.+||. ||.+||++.+|++.|
T Consensus 239 ~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHT-SSGGGS--HHHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHhcC
Confidence 99999 999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=347.74 Aligned_cols=239 Identities=22% Similarity=0.405 Sum_probs=204.0
Q ss_pred EeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccchh
Q 003935 535 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 611 (785)
Q Consensus 535 LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL 611 (785)
||+|+||+||+|.+ +++.||+|++..... .......+..|+.+++.++||||+++++++.+.+.+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999987 477899999865432 334456788999999999999999999999999999999999999999
Q ss_pred hHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCCCCC
Q 003935 612 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 691 (785)
Q Consensus 612 ~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~ 691 (785)
.+++. ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus 81 ~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 81 FHHLQ---REGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 99886 345789999999999999999999999999999999999999999999999999986543333334567999
Q ss_pred cccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCCCCC
Q 003935 692 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQERPS 769 (785)
Q Consensus 692 ~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~kRPS 769 (785)
.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+.......+ ..+..+.+++.+||. ||.+||+
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 99999999999999999999999999999999999998888777776665433221 123468999999999 9999974
Q ss_pred ---HHHHHHH
Q 003935 770 ---CEEILSR 776 (785)
Q Consensus 770 ---~~EIL~~ 776 (785)
+.+++.|
T Consensus 238 ~~~~~e~l~h 247 (312)
T cd05585 238 YNGAQEIKNH 247 (312)
T ss_pred CCCHHHHHcC
Confidence 6777765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=353.35 Aligned_cols=249 Identities=20% Similarity=0.368 Sum_probs=214.6
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEEC---CeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIWN---GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~---g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
..+..++|.+.+.||+|+||.||+|.+. +..||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4567789999999999999999999763 35799999865432 2334567889999999999999999999999999
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+++||||+++|+|.+++. ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999999987 3457899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCChHHHHH
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPEGPLGRL 756 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~-~ip~~~L~~L 756 (785)
... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.++......+....... ...+..+.++
T Consensus 182 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 258 (340)
T PTZ00426 182 DTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL 258 (340)
T ss_pred CCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 432 235679999999999999889999999999999999999999999988877777766544322 2224468999
Q ss_pred HHHhhh-CCCCCC-----CHHHHHHH
Q 003935 757 IADCWA-EPQERP-----SCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRP-----S~~EIL~~ 776 (785)
+.+|+. ||.+|+ +++++++|
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 999999 999995 89999876
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=335.15 Aligned_cols=254 Identities=34% Similarity=0.594 Sum_probs=213.6
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEECC-------eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 596 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~~g-------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 596 (785)
+..++|++.+.||+|+||.||+|...+ ..+|+|.+.... .......|.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 345688999999999999999997632 469999886443 334457789999999999999999999999998
Q ss_pred CceeEEEEEcccchhhHHHHhhcc-------------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH 663 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~-------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~ 663 (785)
...+++|||+++++|.+++..... ...+++..++.++.|++.||+|||++|++|+||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 899999999999999999874321 1458889999999999999999999999999999999999999
Q ss_pred CeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 003935 664 WTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVA 740 (785)
Q Consensus 664 g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~ 740 (785)
+.++|+|||++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999986543221 1233456788999999998889999999999999999998 999999888877766654
Q ss_pred hcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003935 741 NEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLD 779 (785)
Q Consensus 741 ~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~ 779 (785)
. ......+ +..+.+|+.+||+ ||.+||++.+|+++|+.
T Consensus 241 ~-~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 241 S-RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred c-CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 3 3333333 3469999999999 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=343.79 Aligned_cols=245 Identities=28% Similarity=0.407 Sum_probs=197.2
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC-----Ccee
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-----PRLS 600 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~-----~~l~ 600 (785)
+|.+.+.||+|+||.||+|.+ ++..||||++............+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 488999999999999999987 578999999865433334456788999999999999999999987543 2479
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
+||||+. ++|.+++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999996 58888876 3457899999999999999999999999999999999999999999999999999865322
Q ss_pred C---CCCCCCCCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-------------
Q 003935 681 P---MRDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE------------- 742 (785)
Q Consensus 681 ~---~~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~------------- 742 (785)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+...
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 11234578999999999876 67899999999999999999999999876543332211110
Q ss_pred -------------CCCCC----C--CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 743 -------------GSRLE----I--PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 743 -------------~~~~~----i--p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..... . -+..+.+++.+||. ||.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000 0 12347789999999 99999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=355.76 Aligned_cols=262 Identities=29% Similarity=0.541 Sum_probs=217.4
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEe
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 590 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~ 590 (785)
.+.|.+..++|.+++.||+|+||.||+|++. +..||||++...... ...+.+.+|+.+++.+ +|+||++++
T Consensus 30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEe
Confidence 3567788889999999999999999998752 247999998754432 3456788999999999 899999999
Q ss_pred ccccCCCceeEEEEEcccchhhHHHHhhcc--------------------------------------------------
Q 003935 591 GACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------------------------------------------- 620 (785)
Q Consensus 591 g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~-------------------------------------------------- 620 (785)
++|...+..++||||+++|+|.+++.....
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 999999999999999999999998864211
Q ss_pred -----------------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC-
Q 003935 621 -----------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 682 (785)
Q Consensus 621 -----------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~- 682 (785)
...+++..+++++.||+.||+|||++||+||||||+|||+++++.+||+|||++........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 12478889999999999999999999999999999999999999999999999976543211
Q ss_pred -CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHH
Q 003935 683 -RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLI 757 (785)
Q Consensus 683 -~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI 757 (785)
......+++.|+|||++.+..++.++|||||||++|+|++ |+.||...............+.....+ +..+.+++
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 348 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIM 348 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHH
Confidence 1112335568999999998899999999999999999997 999998876655555555554444333 35699999
Q ss_pred HHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 758 ADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 758 ~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
.+||+ ||.+||++.+|++.|+++.
T Consensus 349 ~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHh
Confidence 99999 9999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=325.17 Aligned_cols=247 Identities=26% Similarity=0.494 Sum_probs=215.7
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
+|.+.+.||+|+||.||+|.+ +++.|++|.+............+.+|+.+++.++||||+++++++.+.+.++++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 578889999999999999987 588999999877666666678899999999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 685 (785)
+++++|.+++... ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..+........
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~ 159 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence 9999999998743 245789999999999999999999999999999999999999999999999999987755433334
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003935 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 762 (785)
Q Consensus 686 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~ 762 (785)
...+++.|+|||++.+..++.++|+|||||++|+|++|+.||...........+.... ...++ +..+.+++.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08529 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-FPPVSQMYSQQLAQLIDQCLT 238 (256)
T ss_pred ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCccccCHHHHHHHHHHcc
Confidence 5578899999999999989999999999999999999999999888766666554433 33333 3468999999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003935 763 -EPQERPSCEEILSR 776 (785)
Q Consensus 763 -DP~kRPS~~EIL~~ 776 (785)
+|++||++.+++++
T Consensus 239 ~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 239 KDYRQRPDTFQLLRN 253 (256)
T ss_pred CCcccCcCHHHHhhC
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=349.40 Aligned_cols=241 Identities=25% Similarity=0.388 Sum_probs=205.3
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccc
Q 003935 533 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 609 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gG 609 (785)
+.||+|+||.||++.+ +++.||+|++.+... .......+.+|+.+++.++||||+++++++...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999976 588999999976533 2344577889999999999999999999999999999999999999
Q ss_pred hhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCCC
Q 003935 610 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 689 (785)
Q Consensus 610 SL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~G 689 (785)
+|...+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+|
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence 9998886 3457899999999999999999999999999999999999999999999999998764333223345679
Q ss_pred CCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCCC
Q 003935 690 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQER 767 (785)
Q Consensus 690 T~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~kR 767 (785)
|+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.......+ .-...+.+++.+||. ||.+|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 9999999999998999999999999999999999999998877776665544332211 113468999999999 99999
Q ss_pred C-----CHHHHHHH
Q 003935 768 P-----SCEEILSR 776 (785)
Q Consensus 768 P-----S~~EIL~~ 776 (785)
| ++.++++|
T Consensus 238 ~~~~~~~~~~il~h 251 (328)
T cd05593 238 LGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCCHHHHhcC
Confidence 7 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=355.18 Aligned_cols=247 Identities=23% Similarity=0.364 Sum_probs=207.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++|.+.+.||+|+||+||++.+ +++.||||++.+... .....+.+.+|+++++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4789999999999999999977 688999999865432 2334567889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC-
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 682 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~- 682 (785)
||+++|+|.+++. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 9999999999986 345789999999999999999999999999999999999999999999999999864321000
Q ss_pred ----------------------------------------------CCCCCCCCCcccCccccccCCCCchhhHHHHHHH
Q 003935 683 ----------------------------------------------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVI 716 (785)
Q Consensus 683 ----------------------------------------------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvI 716 (785)
.....+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0012469999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC-----hHHHHHHHHhhhCCCC---CCCHHHHHHH
Q 003935 717 MWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE-----GPLGRLIADCWAEPQE---RPSCEEILSR 776 (785)
Q Consensus 717 LyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~-----~~L~~LI~~CL~DP~k---RPS~~EIL~~ 776 (785)
+|||++|..||...........+........+|. ..+.+++.+|+.+|.+ |+++.+++.|
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcC
Confidence 9999999999998887777766665443344432 3688999999986555 5699999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=356.18 Aligned_cols=247 Identities=24% Similarity=0.364 Sum_probs=207.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++|++.+.||+|+||+||++.+ .++.||||++.+... .....+.+.+|+.+++.++||||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 4799999999999999999987 578999999865432 2233567889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC---
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS--- 680 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~--- 680 (785)
||+++|+|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 9999999999986 3457889999999999999999999999999999999999999999999999997532100
Q ss_pred ----------------------------------------CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHH
Q 003935 681 ----------------------------------------PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 720 (785)
Q Consensus 681 ----------------------------------------~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyEL 720 (785)
.......+||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0001234799999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHhhhCCCCCC---CHHHHHHH
Q 003935 721 CTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRLIADCWAEPQERP---SCEEILSR 776 (785)
Q Consensus 721 LTG~~PF~~~~~~~~v~~i~~~~~~~~ip-----~~~L~~LI~~CL~DP~kRP---S~~EIL~~ 776 (785)
++|+.||.+.........+........++ ...+.+++.+|+.+|.+|+ ++.++++|
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCC
Confidence 99999999888777666665433333333 2357788888877999999 99999977
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=335.70 Aligned_cols=247 Identities=25% Similarity=0.357 Sum_probs=201.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE---CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc---CCCceeeEecccc-----C
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL---RHPNVILFLGACT-----K 595 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~---~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L---~HPNIVkL~g~~~-----d 595 (785)
++|.+.+.||+|+||+||+|.+ .++.||+|++............+.+|+.+++.+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688999999999999999976 367899999876544333345567788777766 6999999999874 3
Q ss_pred CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 596 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
...+++||||+. ++|.+++... ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 456899999997 5888888633 33468999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------
Q 003935 676 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL--------- 746 (785)
Q Consensus 676 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~--------- 746 (785)
..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||.+......+..+......+
T Consensus 159 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 159 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred eccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 76543 23345678999999999998899999999999999999999999999887776666654321100
Q ss_pred -------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 -------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 -------------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..-+..+.+|+.+||+ ||++|||+.++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred cccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0012346789999999 99999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=327.59 Aligned_cols=248 Identities=33% Similarity=0.600 Sum_probs=209.5
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC-CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~~-g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
+.++|.+.+.||+|+||.||++.+. +..+|+|.+...... ...|.+|+.+++.++||||+++++++......+++|
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 4567899999999999999999874 568999987654433 356889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+++|+|.++++.. ...+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++.........
T Consensus 79 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 79 EFMENGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EcCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 999999999988632 246889999999999999999999999999999999999999999999999999865433222
Q ss_pred C-CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC--CCCCChHHHHHHHH
Q 003935 684 D-SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSR--LEIPEGPLGRLIAD 759 (785)
Q Consensus 684 ~-~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~--~~ip~~~L~~LI~~ 759 (785)
. ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+...... +......+.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 1 12335568999999998889999999999999999999 89999988887777776553321 22223468999999
Q ss_pred hhh-CCCCCCCHHHHHHHH
Q 003935 760 CWA-EPQERPSCEEILSRL 777 (785)
Q Consensus 760 CL~-DP~kRPS~~EIL~~L 777 (785)
||. +|.+||++.++++.|
T Consensus 237 c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 237 CWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HccCCcccCcCHHHHHHhh
Confidence 999 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=353.82 Aligned_cols=247 Identities=24% Similarity=0.367 Sum_probs=206.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
+.|.+++.||+|+||+||+|.+ +++.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 3688999999999999999987 578999999976543 3345677899999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC--
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-- 681 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~-- 681 (785)
||+++|+|.+++. ....+++..++.++.||+.||+|||+.||+||||||+|||++.++++||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 9999999999986 34578999999999999999999999999999999999999999999999999975431100
Q ss_pred ---------------------------------------------CCCCCCCCCCcccCccccccCCCCchhhHHHHHHH
Q 003935 682 ---------------------------------------------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVI 716 (785)
Q Consensus 682 ---------------------------------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvI 716 (785)
......+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00123479999999999999899999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHhh--h-CCCCCCCHHHHHHH
Q 003935 717 MWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRLIADCW--A-EPQERPSCEEILSR 776 (785)
Q Consensus 717 LyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-----~~~L~~LI~~CL--~-DP~kRPS~~EIL~~ 776 (785)
+|||++|..||...........+........+| ...+.+|+.+|+ . +|..||++.++++|
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999999999888777666665433333333 235788888744 4 66679999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.12 Aligned_cols=254 Identities=27% Similarity=0.491 Sum_probs=212.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccc-cChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQD-LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~-~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++|.+.+.||+|+||.||+|.. +++.||||.+.... ........+.+|+.+++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5789999999999999999976 68899999876533 34445567899999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 604 EYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
||+++++|.+++.... ....+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 9999999998886432 234588999999999999999999999999999999999999999999999999987654332
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCCCCCCC----ChHHHHH
Q 003935 683 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP--ERVVYAVANEGSRLEIP----EGPLGRL 756 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~--~~~v~~i~~~~~~~~ip----~~~L~~L 756 (785)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ......+.. ...+..+ +..+.++
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 240 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ-CDYPPLPTEHYSEKLREL 240 (267)
T ss_pred HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc-CCCCCCChhhcCHHHHHH
Confidence 23345688899999999988899999999999999999999999965432 333333322 2233332 2468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 757 IADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
+.+||. +|.+||++.++++.++++.
T Consensus 241 i~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 241 VSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 999999 9999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=344.85 Aligned_cols=244 Identities=27% Similarity=0.422 Sum_probs=205.2
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHH---hhcCCCceeeEeccccCCCceeEE
Q 003935 529 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISIL---SRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iL---k~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
|.+.+.||+|+||+||+|.+ +++.||||++.+... .....+.+..|+.++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67889999999999999987 578999999975532 223345677776665 566799999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
|||+++++|...+. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 99999999988774 34689999999999999999999999999999999999999999999999999876433333
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhh
Q 003935 683 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCW 761 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~CL 761 (785)
.....+|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.........+.......+ .-+..+.+++.+||
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L 236 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLL 236 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence 33456799999999999999999999999999999999999999999888777777665443222 12346889999999
Q ss_pred h-CCCCCC-----CHHHHHHH
Q 003935 762 A-EPQERP-----SCEEILSR 776 (785)
Q Consensus 762 ~-DP~kRP-----S~~EIL~~ 776 (785)
. ||.+|| ++.+++++
T Consensus 237 ~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 237 RRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred hcCHhHcCCCCCCCHHHHhhC
Confidence 9 999999 57777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=354.41 Aligned_cols=246 Identities=24% Similarity=0.370 Sum_probs=206.7
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
.|.+.++||+|+||+||+|.+ +++.||+|++.+... .......+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588999999999999999987 578899999875433 23345678899999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC---
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP--- 681 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~--- 681 (785)
|+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999999998863 3568899999999999999999999999999999999999999999999999975321000
Q ss_pred --------------------------------------------CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHH
Q 003935 682 --------------------------------------------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIM 717 (785)
Q Consensus 682 --------------------------------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL 717 (785)
......+||+.|+|||++.+..++.++|||||||+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 001234689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHhhhCCCCCCC---HHHHHHH
Q 003935 718 WELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRLIADCWAEPQERPS---CEEILSR 776 (785)
Q Consensus 718 yELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-----~~~L~~LI~~CL~DP~kRPS---~~EIL~~ 776 (785)
|||++|+.||...++.+....+.........| .....+++.+|+.+|.+|++ +.+++.|
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcC
Confidence 99999999999988877777766544444333 23577777777669999987 8888875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=338.43 Aligned_cols=247 Identities=24% Similarity=0.310 Sum_probs=199.1
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
.++|.+.+.||+|+||+||+|.. +++.||||++...... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 46899999999999999999987 5889999998654332 22346778999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+. ++|.+++.. ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 83 EYVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159 (303)
T ss_pred ECCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence 9997 467666652 3356889999999999999999999999999999999999999999999999999765443333
Q ss_pred CCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCC----------------
Q 003935 684 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGSR---------------- 745 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~-~~v~~i~~~~~~---------------- 745 (785)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... .....+......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 345678999999999865 45889999999999999999999999875432 222222110000
Q ss_pred -----CCCC------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 746 -----LEIP------------EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 746 -----~~ip------------~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
...+ ...+.+|+.+|++ ||.+|||+.++++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0000 1246789999999 99999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=327.99 Aligned_cols=254 Identities=31% Similarity=0.655 Sum_probs=215.6
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCce
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 599 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 599 (785)
|++...+|.+.+.||.|+||.||+|.+ .++.+|+|++.... ...+.+.+|+.+++.++||||+++++++...+.+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 567778899999999999999999977 47889999986432 2356789999999999999999999999999999
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
+++|||+++++|.+++... ....+++..++.++.|++.||+|||++|++|+||||+|||+++++.+||+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 78 YIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEEEEeCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999999999998643 345689999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCC-CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHH
Q 003935 680 SPMRDS-SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLG 754 (785)
Q Consensus 680 ~~~~~~-~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~ 754 (785)
...... ...++..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+.. ......+ +..+.
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 235 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-GYRMERPEGCPPKVY 235 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHH
Confidence 322211 2234568999999999999999999999999999998 8999988777666555433 3334433 24699
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 755 RLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 755 ~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
+++.+||. ||.+||++.++++.|+++
T Consensus 236 ~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 236 ELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 99999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=345.59 Aligned_cols=241 Identities=24% Similarity=0.356 Sum_probs=204.5
Q ss_pred eEEeeeCcEEEEEEEE-----CCeEEEEEEeecccc--ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 533 TRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDL--TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~--~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
+.||+|+||.||++.. .++.||+|++..... .......+..|+.+++.++||||+++++++..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 477899999875432 122345678899999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 685 (785)
+++++|.+.+. ..+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence 99999999886 345688889999999999999999999999999999999999999999999999876443333334
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-C
Q 003935 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-E 763 (785)
Q Consensus 686 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~CL~-D 763 (785)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.......+ .-...+.+++.+||. |
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 238 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238 (323)
T ss_pred ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccC
Confidence 56799999999999998899999999999999999999999999888777776655432211 113468999999999 9
Q ss_pred CCCCC-----CHHHHHHH
Q 003935 764 PQERP-----SCEEILSR 776 (785)
Q Consensus 764 P~kRP-----S~~EIL~~ 776 (785)
|.+|| ++.+++++
T Consensus 239 p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 239 PSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HhHcCCCCCCCHHHHhcC
Confidence 99999 88888875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=343.96 Aligned_cols=246 Identities=22% Similarity=0.361 Sum_probs=206.7
Q ss_pred CeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCC-CceeeEeccccCCCceeEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRH-PNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~H-PNIVkL~g~~~d~~~l~LV~ 603 (785)
+|.+.+.||+|+||.||+|.+. ++.||||++.+... .....+.+..|+.++..+.| ++|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999999874 66899999876432 23345678899999999976 46889999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 9999999998886 3456889999999999999999999999999999999999999999999999998754322223
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh
Q 003935 684 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA 762 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~CL~ 762 (785)
....+||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.........+.......+ .....+.+++.+||.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 3456799999999999999999999999999999999999999999888877777665433221 223468899999999
Q ss_pred -CCCCCCCH-----HHHHHH
Q 003935 763 -EPQERPSC-----EEILSR 776 (785)
Q Consensus 763 -DP~kRPS~-----~EIL~~ 776 (785)
||.+|++. .++++|
T Consensus 238 ~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcC
Confidence 99999976 566654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=330.47 Aligned_cols=256 Identities=32% Similarity=0.573 Sum_probs=212.0
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEecccc
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 594 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~ 594 (785)
|.+..++|++.+.||+|+||.||+|.+. +..||+|++..... ......|.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 5667788999999999999999998753 35799998754332 234567899999999999999999999999
Q ss_pred CCCceeEEEEEcccchhhHHHHhhcc-------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEE
Q 003935 595 KPPRLSMITEYMELGSLYHLIHLSGQ-------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 667 (785)
Q Consensus 595 d~~~l~LV~Ey~~gGSL~dlL~~~~~-------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VK 667 (785)
+....++||||+++++|.+++..... ...+++..+..++.|++.||+|||+.|++|+||||+||++++++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 99999999999999999999864321 12467888999999999999999999999999999999999999999
Q ss_pred EEecCccccccCCCCCC--CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Q 003935 668 ICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGS 744 (785)
Q Consensus 668 L~DFGLA~~l~~~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~ 744 (785)
|+|||++.......... ....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.........+.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL 239 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999987654322211 12345778999999999889999999999999999999 6889998887766665554332
Q ss_pred CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003935 745 RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLD 779 (785)
Q Consensus 745 ~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~ 779 (785)
...+ ...+.+++.+||+ ||.+|||+.++++.|++
T Consensus 240 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 240 -LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 2222 3468999999999 99999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=342.44 Aligned_cols=248 Identities=24% Similarity=0.369 Sum_probs=207.2
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeE
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 601 (785)
+..++|.+.+.||+|+||.||++.+ .+..+|+|++.... .....+.+.+|+++++.++||||+++++++...+.+++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 3457899999999999999999987 47789999986542 33445779999999999999999999999999999999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc-ccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~-gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
||||+++++|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 81 CMEHMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EeecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999999986 345689999999999999999999986 6999999999999999999999999999766432
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-------------------
Q 003935 681 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN------------------- 741 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~------------------- 741 (785)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||......+....+..
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 22345789999999999999999999999999999999999999976655433221110
Q ss_pred --------------------------cCCCCCCC----ChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003935 742 --------------------------EGSRLEIP----EGPLGRLIADCWA-EPQERPSCEEILSRL 777 (785)
Q Consensus 742 --------------------------~~~~~~ip----~~~L~~LI~~CL~-DP~kRPS~~EIL~~L 777 (785)
....+..+ ...+.+|+.+||. ||++|||+.+|++|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 01111111 2358899999999 999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=326.30 Aligned_cols=254 Identities=30% Similarity=0.594 Sum_probs=215.0
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
|++..++|++.+.||+|+||.||+|.+ .++.||+|.+...... .+.|.+|+.++++++||||+++++++...+..+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 466778899999999999999999987 4668999998654432 466889999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
++|||+++++|.+++... ....+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 78 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 78 IVTELMKYGSLLEYLQGG-AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeeecccCCcHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999999998633 2346899999999999999999999999999999999999999999999999999877533
Q ss_pred CCCC-CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003935 681 PMRD-SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 755 (785)
Q Consensus 681 ~~~~-~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~ 755 (785)
.... .....+..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.........+... .....+ ...+.+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 235 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMPCPPGCPKELYD 235 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHH
Confidence 2211 11223457999999998899999999999999999999 99999988877776665443 222222 356899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 756 LIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 756 LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
++.+||+ +|.+||++.++++.|+++
T Consensus 236 li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 236 IMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 9999999 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=359.59 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=212.9
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC--Ccee
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRLS 600 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~l~ 600 (785)
..+.|..+.+||+|.||.||++.+ +|+.||+|.+..............+||.||++|+||||++|.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 346678889999999999999987 688999999988877777778888999999999999999999998776 6799
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
||+|||++ +|.-++. ...-.|++.+++.|+.||+.||+|||.+||+|||||.+|||||.+|.+||+|||||+++...
T Consensus 195 lVFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 99999997 7777775 24558999999999999999999999999999999999999999999999999999987654
Q ss_pred CC-CCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--------CC-
Q 003935 681 PM-RDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE--------IP- 749 (785)
Q Consensus 681 ~~-~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~--------ip- 749 (785)
.. ..+..+-|.+|.|||++.+. .|+.+.|+||.||||.||++|++.|.+.+..+.+..|...-..+. +|
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 33 25677889999999999874 699999999999999999999999999988888877764322111 11
Q ss_pred ---------------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 750 ---------------------EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 750 ---------------------~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+...-+|+..+|. ||.+|.|+.++|..
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0123468889999 99999999998864
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=342.79 Aligned_cols=246 Identities=22% Similarity=0.365 Sum_probs=207.4
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCceeEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
+|.+.+.||+|+||+||+|.+ +++.||||++.+... .....+.+..|..++..+ +|++|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 578899999999999999987 467899999876432 223345677888888877 5899999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+++|+|.+.+. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 9999999998886 3456899999999999999999999999999999999999999999999999999765433333
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh
Q 003935 684 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA 762 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~CL~ 762 (785)
....+||+.|+|||++.+..++.++|||||||++|||+||+.||.+.........+.......+ .....+.+++.+|++
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 4456799999999999999999999999999999999999999999888887777765443222 123468899999999
Q ss_pred -CCCCCCCH-----HHHHHH
Q 003935 763 -EPQERPSC-----EEILSR 776 (785)
Q Consensus 763 -DP~kRPS~-----~EIL~~ 776 (785)
||.+|++. .+++++
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcC
Confidence 99999984 666544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=346.92 Aligned_cols=241 Identities=26% Similarity=0.380 Sum_probs=205.5
Q ss_pred eEEeeeCcEEEEEEEE-----CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcc
Q 003935 533 TRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME 607 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~ 607 (785)
+.||+|+||.||++.. .|+.||+|++............+..|++++++++||||+++++++.+++.+|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 47899999997655444445667889999999999999999999999999999999999
Q ss_pred cchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCC
Q 003935 608 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 687 (785)
Q Consensus 608 gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~ 687 (785)
+|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 999999886 34578999999999999999999999999999999999999999999999999998765443333456
Q ss_pred CCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCC
Q 003935 688 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQ 765 (785)
Q Consensus 688 ~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~ 765 (785)
.|++.|+|||.+.+..++.++|||||||++|+|++|+.||...........+.......+ .-+..+.+|+.+||+ ||.
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~ 238 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPA 238 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHh
Confidence 799999999999998899999999999999999999999998888777777655433221 123468999999999 999
Q ss_pred CCCC-----HHHHHHH
Q 003935 766 ERPS-----CEEILSR 776 (785)
Q Consensus 766 kRPS-----~~EIL~~ 776 (785)
+||+ +.+++.+
T Consensus 239 ~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 239 NRLGAGPDGVEEIKRH 254 (318)
T ss_pred HcCCCCCCCHHHHhCC
Confidence 9999 5555543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=358.47 Aligned_cols=247 Identities=27% Similarity=0.412 Sum_probs=211.4
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccCCC-cee
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPP-RLS 600 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~-~l~ 600 (785)
..++|.+.++||.|.||.||+|+. .|..||||.++++....+. -.=++|+..|++|+ |||||++.+++.+++ .+|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 347899999999999999999976 6889999998776655432 22368999999998 999999999999988 899
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
+|||||+. +|+++++.+ ++.+++..++.|++||++||+|+|.+|+.|||+||+|||+..+..|||+|||+|+.....
T Consensus 87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence 99999985 999999743 788999999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCCCCCCCcccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------------
Q 003935 681 PMRDSSSAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE------------ 747 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~------------ 747 (785)
+ ..+..+.|.+|+|||++. .+-|+.+.|+||+|||++|+++-++-|++.+....++++..--..+.
T Consensus 164 p-PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 164 P-PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred C-CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 3 235778999999999875 56799999999999999999999999999988888887754222221
Q ss_pred --------CC-----------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 --------IP-----------EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 --------ip-----------~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+ .....++|.+|+. ||.+|||+.+++++
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11 1246678999999 99999999999876
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=346.80 Aligned_cols=248 Identities=27% Similarity=0.392 Sum_probs=211.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++|.+.+.||+|+||+||++.+ +++.||+|++..... .....+.+..|+.+++.++||||+++++++.+...+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4689999999999999999977 588999999976543 2334567889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC-
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 682 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~- 682 (785)
||+++|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 999999999998732 35789999999999999999999999999999999999999999999999999987654322
Q ss_pred CCCCCCCCCcccCccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----Ch
Q 003935 683 RDSSSAGTPEWMAPELIR------NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EG 751 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~------~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-----~~ 751 (785)
......||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+.........| ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence 223457899999999986 4567899999999999999999999999888877777666544333322 34
Q ss_pred HHHHHHHHhhhCCCCCCCHHHHHHH
Q 003935 752 PLGRLIADCWAEPQERPSCEEILSR 776 (785)
Q Consensus 752 ~L~~LI~~CL~DP~kRPS~~EIL~~ 776 (785)
.+.+|+.+|+.+|.+||++.++++|
T Consensus 239 ~~~~li~~ll~~p~~R~t~~~l~~h 263 (330)
T cd05601 239 DFLDLIQSLLCGQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHHHHHccChhhCCCHHHHhCC
Confidence 6889999999999999999999876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=343.98 Aligned_cols=241 Identities=22% Similarity=0.364 Sum_probs=205.8
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCceeEEEEEccc
Q 003935 533 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
+.||+|+||+||+|.+ .++.||+|++.+... .....+.+..|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3699999999999987 467899999876433 233456678899998866 799999999999999999999999999
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 688 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 688 (785)
|+|...+. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence 99998886 345789999999999999999999999999999999999999999999999999976543333344567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003935 689 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 766 (785)
Q Consensus 689 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 766 (785)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.......+ .-...+.+++.+||. ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 99999999999999999999999999999999999999999988888877765443222 124568899999999 9999
Q ss_pred CC-------CHHHHHHH
Q 003935 767 RP-------SCEEILSR 776 (785)
Q Consensus 767 RP-------S~~EIL~~ 776 (785)
|| ++.+++++
T Consensus 238 R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 238 RLGCVASQGGEDAIKQH 254 (321)
T ss_pred cCCCCCCCCCHHHHhcC
Confidence 99 88888866
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=325.96 Aligned_cols=252 Identities=37% Similarity=0.596 Sum_probs=212.7
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCce
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 599 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 599 (785)
..++|++.+.||+|+||+||+|.+. ...||+|++.... .......|.+|+.+++.++||||+++++++...+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 3467999999999999999999873 3479999876543 334457789999999999999999999999999999
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
+++|||+++++|.+++... ...+++..++.++.|++.||+|||++||+|+||||+|||+++++.++|+|||++.....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 81 MIITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999999998632 34789999999999999999999999999999999999999999999999999988752
Q ss_pred CC--CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003935 680 SP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPL 753 (785)
Q Consensus 680 ~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L 753 (785)
.. .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+... ...+.+ +..+
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 237 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-YRLPPPMDCPSAL 237 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHH
Confidence 21 11222345678999999998889999999999999999998 99999888877776665432 222222 3468
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 754 GRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 754 ~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
.+++.+||+ +|.+||++.+|+++|.++
T Consensus 238 ~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 238 YQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=325.46 Aligned_cols=244 Identities=26% Similarity=0.546 Sum_probs=206.7
Q ss_pred EEeeeCcEEEEEEEE----CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccc
Q 003935 534 RVGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 609 (785)
Q Consensus 534 ~LG~G~fG~VYkg~~----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gG 609 (785)
+||+|+||.||+|.+ ++..+|+|++..........+.+.+|+.+++.++||||+++++++.. ...+++|||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999965 46789999987665555567889999999999999999999998864 4678999999999
Q ss_pred hhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC---CCC
Q 003935 610 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR---DSS 686 (785)
Q Consensus 610 SL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~---~~~ 686 (785)
+|.+++. ....+++..+..++.|++.||+|||++||+||||||.||+++.++.+||+|||++......... ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9999986 3346899999999999999999999999999999999999999999999999999876443221 122
Q ss_pred CCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003935 687 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 762 (785)
Q Consensus 687 ~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~ 762 (785)
..++..|+|||.+....++.++|+|||||++|||++ |+.||...........+.. +..+..| +..+.++|.+||+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~~~ 236 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-GERMECPQRCPPEMYDLMKLCWT 236 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHHhc
Confidence 334578999999988889999999999999999998 9999998877766665543 3334444 3468999999999
Q ss_pred -CCCCCCCHHHHHHHHHhhhh
Q 003935 763 -EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 763 -DP~kRPS~~EIL~~L~~l~~ 782 (785)
||++||++.+|.+.|+++.|
T Consensus 237 ~~p~~Rp~~~~i~~~l~~~~~ 257 (257)
T cd05116 237 YGVDERPGFAVVELRLRNYYY 257 (257)
T ss_pred cCchhCcCHHHHHHHHhcccC
Confidence 99999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=346.48 Aligned_cols=241 Identities=24% Similarity=0.380 Sum_probs=205.0
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccc
Q 003935 533 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 609 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gG 609 (785)
+.||+|+||+||++.+ +|+.||+|++.+... .......+..|+.+++.++||||+++++++.....+++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999986 588999999976543 2334567788999999999999999999999999999999999999
Q ss_pred hhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-cccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003935 610 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 688 (785)
Q Consensus 610 SL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 688 (785)
+|..++. ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence 9998886 34578999999999999999999997 7999999999999999999999999999876433322334567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003935 689 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 766 (785)
Q Consensus 689 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 766 (785)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+ .-...+.+|+.+||. ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 99999999999999999999999999999999999999998887776666554332221 123468999999999 9999
Q ss_pred CC-----CHHHHHHH
Q 003935 767 RP-----SCEEILSR 776 (785)
Q Consensus 767 RP-----S~~EIL~~ 776 (785)
|+ ++.++++|
T Consensus 238 R~~~~~~~~~~il~h 252 (325)
T cd05594 238 RLGGGPDDAKEIMQH 252 (325)
T ss_pred hCCCCCCCHHHHhcC
Confidence 96 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=351.76 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=213.9
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 521 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 521 e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
.+.+..++|.+.+.||+|+||+||++.+ +++.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 4456778999999999999999999987 578999999865432 2233456788999999999999999999999999
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999999998852 35788899999999999999999999999999999999999999999999999876
Q ss_pred cCCCC-CCCCCCCCCcccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---
Q 003935 678 TDSPM-RDSSSAGTPEWMAPELIRNE----PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP--- 749 (785)
Q Consensus 678 ~~~~~-~~~~~~GT~~Y~APEvl~~~----~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip--- 749 (785)
..... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+.........|
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI 272 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcC
Confidence 44322 23356799999999998653 47889999999999999999999999988877777776544433333
Q ss_pred --ChHHHHHHHHhhh-CCCC--CCCHHHHHHH
Q 003935 750 --EGPLGRLIADCWA-EPQE--RPSCEEILSR 776 (785)
Q Consensus 750 --~~~L~~LI~~CL~-DP~k--RPS~~EIL~~ 776 (785)
...+.+|+.+|+. +|.+ |++++++++|
T Consensus 273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 3468899999999 8887 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=328.09 Aligned_cols=254 Identities=31% Similarity=0.603 Sum_probs=216.4
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeE
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 601 (785)
+....+|++.++||.|+||.||+|.+ .+..+|+|++..... .....+..|+.+++.++||||+++++++.....+++
T Consensus 2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 34456799999999999999999987 467899999865433 234678899999999999999999999999999999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
+|||+++++|.+++... ....+++..++.++.|++.||+|||+.||+|+||||+||++++++.+||+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 80 ITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred EEeecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999999999743 34568999999999999999999999999999999999999999999999999998765443
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHH
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLI 757 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI 757 (785)
.......++..|+|||.+....++.++||||||+++|+|++ |+.||......+....+.. ......+ +..+.+++
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA-GYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh-CCcCCCCCCCCHHHHHHH
Confidence 33334456778999999998889999999999999999998 8999988887777666553 3333332 34689999
Q ss_pred HHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 758 ADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 758 ~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
.+||+ ||.+|||+.+|++.|+++
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 238 LECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHcCCCchhCcCHHHHHHHHhcC
Confidence 99999 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=343.90 Aligned_cols=241 Identities=24% Similarity=0.383 Sum_probs=204.4
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCceeEEEEEccc
Q 003935 533 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
+.||+|+||+||+|.+ +++.||||++.+... .....+.+..|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 478899999875432 223456778899998876 699999999999999999999999999
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 688 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 688 (785)
|+|.+++. ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..............
T Consensus 81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 99998886 345789999999999999999999999999999999999999999999999999876433333334567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003935 689 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 766 (785)
Q Consensus 689 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 766 (785)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.......+ .....+.+++.+||. ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 99999999999999999999999999999999999999999888887777765433221 224468999999999 9999
Q ss_pred CCCH------HHHHHH
Q 003935 767 RPSC------EEILSR 776 (785)
Q Consensus 767 RPS~------~EIL~~ 776 (785)
||++ ++++.|
T Consensus 238 R~~~~~~~~~~~~~~h 253 (320)
T cd05590 238 RLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCCCCCCHHHHHcC
Confidence 9998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=322.95 Aligned_cols=247 Identities=28% Similarity=0.469 Sum_probs=210.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh---HHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA---ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~---~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 601 (785)
++|.+.+.||+|++|.||++.. .++.+|+|.+....... ...+.+.+|++++++++||||+++++++.+...+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999976 58899999986544322 234678899999999999999999999999999999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
++||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||++++++.++|+|||++.......
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 9999999999998863 3468899999999999999999999999999999999999999999999999987654321
Q ss_pred CCC---CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003935 682 MRD---SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 755 (785)
Q Consensus 682 ~~~---~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~ 755 (785)
... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||....................++ +..+.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHH
Confidence 111 23457889999999999889999999999999999999999998877766666655554444444 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHH
Q 003935 756 LIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 756 LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
++..||. +|.+||++.+++++
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhC
Confidence 9999999 99999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=327.41 Aligned_cols=255 Identities=31% Similarity=0.576 Sum_probs=214.6
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEecccc
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 594 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~ 594 (785)
|++..++|.+.+.||+|+||.||+|.+. +..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 5667789999999999999999999763 2679999975443 3334567889999999999999999999999
Q ss_pred CCCceeEEEEEcccchhhHHHHhhcc-------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEE
Q 003935 595 KPPRLSMITEYMELGSLYHLIHLSGQ-------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 667 (785)
Q Consensus 595 d~~~l~LV~Ey~~gGSL~dlL~~~~~-------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VK 667 (785)
.....+++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.||+|+||||+|||++.++.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 99999999999999999999864321 23478889999999999999999999999999999999999999999
Q ss_pred EEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Q 003935 668 ICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGS 744 (785)
Q Consensus 668 L~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~ 744 (785)
|+|||+++........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||...........+. .+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~ 238 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGG 238 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCC
Confidence 9999999866443221 223456788999999988889999999999999999998 899999888777766665 333
Q ss_pred CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003935 745 RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLL 778 (785)
Q Consensus 745 ~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~ 778 (785)
....| +..+.+++.+||+ +|.+|||+.++++.|+
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 33333 3468999999999 9999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=325.00 Aligned_cols=251 Identities=31% Similarity=0.560 Sum_probs=206.7
Q ss_pred eeEeeEEeeeCcEEEEEEEEC--Ce--EEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC------Cc
Q 003935 529 LTVGTRVGIGFFGEVFRGIWN--GT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------PR 598 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~~--g~--~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~------~~ 598 (785)
|.+++.||+|+||.||+|.+. +. .+|+|.+..........+.|.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 356789999999999999873 32 689999876655556678899999999999999999999976432 24
Q ss_pred eeEEEEEcccchhhHHHHhhc---ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 599 LSMITEYMELGSLYHLIHLSG---QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~---~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
.++++||+.+|+|.+++.... ....+++..+..++.|++.||+|||++||+||||||+|||+++++.++|+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 689999999999998874321 23458999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---
Q 003935 676 IITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP--- 749 (785)
Q Consensus 676 ~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip--- 749 (785)
.+...... .....+++.|++||.+.+..++.++|||||||++|+|++ |+.||.+....+....+..... ...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~ 239 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR-LKQPPDC 239 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-CCCCCCC
Confidence 76443221 123346678999999999999999999999999999999 7899988877766666554332 2222
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 750 EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 750 ~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
...+.+++.+||+ ||.+|||+.+|++.|.++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 240 LDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 3468999999999 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=353.90 Aligned_cols=250 Identities=28% Similarity=0.416 Sum_probs=211.5
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChH------------HHHHHHHHHHHHhhcCCCceeeEe
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE------------NMEDFCNEISILSRLRHPNVILFL 590 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~------------~~e~f~~EI~iLk~L~HPNIVkL~ 590 (785)
..++|.+.+.||+|.||+|-++.+ +++.||||++.+..+... ..+...+||.+|+++.|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 467899999999999999999977 688999999976543221 146788999999999999999999
Q ss_pred ccccCC--CceeEEEEEcccchhhHHHHhhccccc-chHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEE
Q 003935 591 GACTKP--PRLSMITEYMELGSLYHLIHLSGQKKK-LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 667 (785)
Q Consensus 591 g~~~d~--~~l~LV~Ey~~gGSL~dlL~~~~~~~~-Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VK 667 (785)
.+..++ +.+|||+|||..|.+...= ..+. +++.+++.|+++++.||+|||.+|||||||||+|+||+++|+||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence 998765 4699999999998887542 2334 99999999999999999999999999999999999999999999
Q ss_pred EEecCccccccCCC-----CCCCCCCCCCcccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 003935 668 ICDFGLSRIITDSP-----MRDSSSAGTPEWMAPELIRNEP----FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYA 738 (785)
Q Consensus 668 L~DFGLA~~l~~~~-----~~~~~~~GT~~Y~APEvl~~~~----~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~ 738 (785)
|+|||.+....... ......+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||-+....++..+
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 99999998763221 1123478999999999987632 35688999999999999999999999999999999
Q ss_pred HHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003935 739 VANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLL 778 (785)
Q Consensus 739 i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~ 778 (785)
|.+.....+.. .+.+++||++||. ||.+|.++.+|..|..
T Consensus 331 Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 331 IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 98766444333 2369999999999 9999999999988754
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.60 Aligned_cols=241 Identities=23% Similarity=0.404 Sum_probs=200.7
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCceeEEEEEccc
Q 003935 533 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
+.||+|+||+||+|.+ +++.||+|++..... .....+.+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 467899999876432 223345566777777654 799999999999999999999999999
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 688 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 688 (785)
|+|..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+
T Consensus 81 g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence 99998886 345789999999999999999999999999999999999999999999999999986544333344567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCChHHHHHHHHhhh-CCCC
Q 003935 689 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPEGPLGRLIADCWA-EPQE 766 (785)
Q Consensus 689 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~-~ip~~~L~~LI~~CL~-DP~k 766 (785)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....... ..-...+.+++.+||. ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999999999999999999999999999999999988877777665432211 1123468899999999 9999
Q ss_pred CCCHH-HHHHH
Q 003935 767 RPSCE-EILSR 776 (785)
Q Consensus 767 RPS~~-EIL~~ 776 (785)
||++. +++++
T Consensus 238 R~~~~~~l~~h 248 (316)
T cd05592 238 RLGVDGDIRQH 248 (316)
T ss_pred cCCChHHHHcC
Confidence 99875 56543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=327.52 Aligned_cols=254 Identities=28% Similarity=0.521 Sum_probs=211.5
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
+.+++|++.+.||+|+||+||+|.+ .+..+|+|.+.... .......|.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4567899999999999999999974 35689999986433 3344578899999999999999999999999999
Q ss_pred ceeEEEEEcccchhhHHHHhhcc--------------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQ--------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH 663 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~--------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~ 663 (785)
..+++|||+++++|.+++..... ...+++.+++.++.|++.||+|||++||+|+||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 99999999999999998853211 2357889999999999999999999999999999999999999
Q ss_pred CeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 003935 664 WTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVA 740 (785)
Q Consensus 664 g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~ 740 (785)
+.+||+|||++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999986543221 1233446678999999988889999999999999999998 899998887766655554
Q ss_pred hcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003935 741 NEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLD 779 (785)
Q Consensus 741 ~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~ 779 (785)
. ...+..+ +..+.+++.+||+ ||.+||++.+|+++|..
T Consensus 241 ~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 K-RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred c-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 3 3333333 3468999999999 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=321.18 Aligned_cols=251 Identities=31% Similarity=0.639 Sum_probs=215.0
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeE
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 601 (785)
|.+...+|++.+.||.|+||.||+|...|+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+....++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 345667899999999999999999999999999999865432 45789999999999999999999999998889999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
||||+++++|.+++... ....+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 78 VTEYMAKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999999998633 22368999999999999999999999999999999999999999999999999998764321
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHH
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLI 757 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI 757 (785)
.....+..|+|||.+....++.++||||||+++|+|++ |..||...........+.. ......+ +..+.+++
T Consensus 157 ---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li 232 (256)
T cd05039 157 ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-GYRMEAPEGCPPEVYKVM 232 (256)
T ss_pred ---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCCCCccCCCHHHHHHH
Confidence 13344568999999988889999999999999999997 9999988877766655443 3333333 34689999
Q ss_pred HHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 758 ADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 758 ~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
.+||. +|.+||++.++++.|+++
T Consensus 233 ~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 233 KDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHhccChhhCcCHHHHHHHHhcC
Confidence 99999 999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=357.06 Aligned_cols=249 Identities=29% Similarity=0.483 Sum_probs=227.4
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc-eeEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR-LSMI 602 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~-l~LV 602 (785)
.++|.+++++|+|+||.++.+.+ +++.|++|.+..............+|+.++++++|||||.+.+.|.+++. +++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 46788999999999999998866 57899999998877766666788999999999999999999999999998 9999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
|+||+||+|.+.+.... +..++++.+..|+.|++.|+.|||+++|+|||||+.||+++.++.|+|+|||+|+.+.....
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 99999999999998653 67899999999999999999999999999999999999999999999999999999987765
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHH
Q 003935 683 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIAD 759 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~ 759 (785)
...+..||+.|++||++.+.+|..|+|||||||++|||++-+++|...+...++.++.+... .++| ...++.||..
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~-~Plp~~ys~el~~lv~~ 240 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLY-SPLPSMYSSELRSLVKS 240 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccC-CCCCccccHHHHHHHHH
Confidence 66788999999999999999999999999999999999999999999999999999887663 3333 3479999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003935 760 CWA-EPQERPSCEEILSR 776 (785)
Q Consensus 760 CL~-DP~kRPS~~EIL~~ 776 (785)
|+. +|..||++.++|.+
T Consensus 241 ~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 241 MLRKNPEHRPSALELLRR 258 (426)
T ss_pred HhhcCCccCCCHHHHhhC
Confidence 999 99999999999976
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=342.19 Aligned_cols=243 Identities=31% Similarity=0.428 Sum_probs=197.6
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
.+++|...++||+|+||+||+|.+ +++.||||++.... .....+.+.+|+++++.++|+||+++++++...+.+++|
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 456788889999999999999987 48899999986543 334457789999999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
|||+.+++|.... ...+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 151 ~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 151 LEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred EecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999999986432 345677889999999999999999999999999999999999999999999987654332
Q ss_pred CCCCCCCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhcCCCCCCC---Ch
Q 003935 683 RDSSSAGTPEWMAPELIRN-----EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER---VVYAVANEGSRLEIP---EG 751 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~-----~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~---~v~~i~~~~~~~~ip---~~ 751 (785)
......||..|+|||++.. ...+.++|||||||++|||++|+.||....... ....+. .......+ ..
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 302 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-MSQPPEAPATASR 302 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-ccCCCCCCCccCH
Confidence 3345679999999998853 234568999999999999999999997433222 222121 11222222 34
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 752 PLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 752 ~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+.+||.+||. ||.+||++.++++|
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 68999999999 99999999999987
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=349.94 Aligned_cols=261 Identities=30% Similarity=0.547 Sum_probs=216.9
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEec
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLG 591 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g 591 (785)
..|+++.++|.+++.||+|+||.||+|.+. +..||||++.... .....+.|.+|+.+++++. ||||+++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 467788899999999999999999999762 2369999986543 3344578999999999996 999999999
Q ss_pred cccCCCceeEEEEEcccchhhHHHHhhcc---------------------------------------------------
Q 003935 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQ--------------------------------------------------- 620 (785)
Q Consensus 592 ~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~--------------------------------------------------- 620 (785)
+|.+...+|+||||+++|+|.+++.....
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 99999999999999999999998864311
Q ss_pred ------------------------------------------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcE
Q 003935 621 ------------------------------------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANC 658 (785)
Q Consensus 621 ------------------------------------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNI 658 (785)
...+++..++.++.|++.||+|||+.+|+|+||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 12478888999999999999999999999999999999
Q ss_pred EEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 003935 659 LVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERV 735 (785)
Q Consensus 659 LLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~ 735 (785)
|++.++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 999999999999999987643221 1223456788999999999899999999999999999997 9999987765555
Q ss_pred HHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 736 VYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 736 v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
.......+..+..+ +..+.+++.+||+ ||.+||++.+|.+.|.++.
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 FYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 55545545444433 2368999999999 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=357.22 Aligned_cols=252 Identities=24% Similarity=0.411 Sum_probs=215.1
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC----
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP---- 597 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~---- 597 (785)
...++|.+.+.||+|+||+||++.+ +|+.||||++............+.+|+.++..++|+||++++..+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457999999999999999999976 6889999999877666666778899999999999999999988765332
Q ss_pred ----ceeEEEEEcccchhhHHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecC
Q 003935 598 ----RLSMITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 672 (785)
Q Consensus 598 ----~l~LV~Ey~~gGSL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFG 672 (785)
.+++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 3689999999999999886432 34578999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC--CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-
Q 003935 673 LSRIITDS--PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP- 749 (785)
Q Consensus 673 LA~~l~~~--~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip- 749 (785)
+++.+... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+...... .++
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~ 267 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD-PLPP 267 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC-CCCC
Confidence 99876432 11233567999999999999999999999999999999999999999998887777766554332 232
Q ss_pred --ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 750 --EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 750 --~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
...+.+|+..||. ||.+||++.+++++
T Consensus 268 ~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 268 SISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 3469999999999 99999999999875
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=324.29 Aligned_cols=245 Identities=33% Similarity=0.533 Sum_probs=206.5
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEc
Q 003935 529 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 606 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 606 (785)
|++++.||+|+||+||++.. +++.||+|++...............|+.+++.++||||+++++++.+....+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 78899999999999999988 4668999999877665555555567999999999999999999999999999999999
Q ss_pred ccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003935 607 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 686 (785)
Q Consensus 607 ~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~ 686 (785)
.+++|.+++. ....+++..++.++.|+++||++||+.||+|+||||+||+++.++.++|+|||.+............
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred cccccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999997 4567899999999999999999999999999999999999999999999999999864333334456
Q ss_pred CCCCCcccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhcCCCCCCC-----ChHHHHHH
Q 003935 687 SAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERV---VYAVANEGSRLEIP-----EGPLGRLI 757 (785)
Q Consensus 687 ~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~---v~~i~~~~~~~~ip-----~~~L~~LI 757 (785)
..++..|+|||++. +..++.++||||||+++|+|++|..||........ .............. ...+.+++
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 67899999999998 78899999999999999999999999998733222 22222111111111 25799999
Q ss_pred HHhhh-CCCCCCCHHHHHHH
Q 003935 758 ADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 758 ~~CL~-DP~kRPS~~EIL~~ 776 (785)
..||+ ||++||++.+++++
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTS
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999 99999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=322.70 Aligned_cols=251 Identities=29% Similarity=0.538 Sum_probs=209.6
Q ss_pred eeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc-----
Q 003935 529 LTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR----- 598 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~----- 598 (785)
|++++.||+|+||.||+|... +..||+|++............+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999762 3679999987766555667789999999999999999999998866543
Q ss_pred -eeEEEEEcccchhhHHHHhhc---ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcc
Q 003935 599 -LSMITEYMELGSLYHLIHLSG---QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 674 (785)
Q Consensus 599 -l~LV~Ey~~gGSL~dlL~~~~---~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 674 (785)
.++++||+++++|..++.... ....+++..++.++.|++.||+|||+.||+|+||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 799999999999998885432 2246899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCC--CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 003935 675 RIITDSPMRD--SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP-- 749 (785)
Q Consensus 675 ~~l~~~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip-- 749 (785)
+.+....... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+... .....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 239 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG-NRLKQPED 239 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCcC
Confidence 8765432211 12335678999999988889999999999999999999 88999888877776655443 333333
Q ss_pred -ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 750 -EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 750 -~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
...+.+++.+||+ ||.+||++.+++++|+++
T Consensus 240 ~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 240 CLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2468899999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=334.62 Aligned_cols=252 Identities=27% Similarity=0.552 Sum_probs=208.4
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCe----EEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~----~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
...+|++.+.||+|+||+||+|.+ ++. .||+|++.... .....+.|.+|+.+++.++||||++++++|... .
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 346799999999999999999976 333 48999986432 334457899999999999999999999998775 5
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
.++++||+++|+|.+++.. ....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.+.
T Consensus 83 ~~~v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 83 VQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred ceeeeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 7899999999999999873 23468889999999999999999999999999999999999999999999999998765
Q ss_pred CCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003935 679 DSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 752 (785)
Q Consensus 679 ~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~ 752 (785)
..... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+... +...+.....+ ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 239 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQPPICTID 239 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhCCCCCCCCCCCCHH
Confidence 43221 122334678999999999999999999999999999997 999998877665443 33444333333 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
+..++..||. +|.+||++.+++..|.++.
T Consensus 240 ~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 240 VYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 8899999999 9999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=379.77 Aligned_cols=257 Identities=32% Similarity=0.599 Sum_probs=223.0
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE---CCe----EEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW---NGT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 596 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~---~g~----~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 596 (785)
++.+..++.+.||+|+||.||.|.. .|. .||||.+.+.. +.....+|++|..+|+.++|||||+++|+|.+.
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 4567788899999999999999976 233 48888876543 455678999999999999999999999999999
Q ss_pred CceeEEEEEcccchhhHHHHhhcc----cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecC
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQ----KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 672 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~----~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFG 672 (785)
...++++|||.||+|..+|+.... ...++....+.++.|||+|+.|||++++|||||.++||||+....|||+|||
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999999985421 3568999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCC--CCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003935 673 LSRIITDSPMRDSSS--AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP 749 (785)
Q Consensus 673 LA~~l~~~~~~~~~~--~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip 749 (785)
+|+.+.+..+..... .-+..|||||.+..+.++.|+|||||||+|||++| |..||.+..+.++...+...+ +++.|
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~P 926 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDPP 926 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCCC
Confidence 999665554443332 34468999999999999999999999999999998 678999999999988777766 77776
Q ss_pred C---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 750 E---GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 750 ~---~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
. +.+.+||..||+ +|++||+|..|++.+.++.+
T Consensus 927 ~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 927 SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 4 468899999999 99999999999998887654
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=328.34 Aligned_cols=259 Identities=29% Similarity=0.582 Sum_probs=217.1
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEec
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 591 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g 591 (785)
..|.+..++|.+.+.||+|+||.||++.+. ...+|+|++..... ......+.+|+.+++.+ +|+||+++++
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 357778889999999999999999999763 25799999865433 34456789999999999 7999999999
Q ss_pred cccCCCceeEEEEEcccchhhHHHHhh-------------cccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcE
Q 003935 592 ACTKPPRLSMITEYMELGSLYHLIHLS-------------GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANC 658 (785)
Q Consensus 592 ~~~d~~~l~LV~Ey~~gGSL~dlL~~~-------------~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNI 658 (785)
++...+.++++|||+++|+|..+++.. .....+++..++.++.|++.||+|||++||+|+||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999999999998642 1245689999999999999999999999999999999999
Q ss_pred EEcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 003935 659 LVNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERV 735 (785)
Q Consensus 659 LLd~~g~VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~ 735 (785)
|++.++.+||+|||+++.+...... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 9999999999999999876543221 122335578999999998889999999999999999997 9999998877666
Q ss_pred HHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 736 VYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 736 v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
...+.. +.....+ ...+.+|+.+||. ||.+|||+.++++.|.++
T Consensus 244 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 244 FKLLKE-GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHHHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 655443 3333333 3468899999999 999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=340.15 Aligned_cols=241 Identities=24% Similarity=0.419 Sum_probs=204.3
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCceeEEEEEccc
Q 003935 533 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
+.||+|+||+||+|.+ +++.||||++.+... .......+..|+.++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999987 467899999976532 223456678899999888 699999999999999999999999999
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 688 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 688 (785)
|+|...+. ....+++..+..++.|++.||+|||++||+||||||+|||+++++.+||+|||++.............+
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 99998886 345799999999999999999999999999999999999999999999999999875433222334457
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003935 689 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 766 (785)
Q Consensus 689 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 766 (785)
|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+ ..+..+.+|+.+||. ||.+
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 89999999999999999999999999999999999999998887777766654433222 124568999999999 9999
Q ss_pred CCCH-----HHHHHH
Q 003935 767 RPSC-----EEILSR 776 (785)
Q Consensus 767 RPS~-----~EIL~~ 776 (785)
||++ .+++++
T Consensus 238 R~s~~~~~~~~ll~~ 252 (318)
T cd05570 238 RLGCLPTGEQDIKGH 252 (318)
T ss_pred cCCCCCCCHHHHhcC
Confidence 9999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=327.17 Aligned_cols=254 Identities=30% Similarity=0.549 Sum_probs=212.7
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
...+|.+.+.||+|+||.||+|.+. +..||+|++..... .+..+.|.+|+++++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4567889999999999999999752 36799999865433 334578999999999999999999999999999
Q ss_pred ceeEEEEEcccchhhHHHHhhc-----------ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeE
Q 003935 598 RLSMITEYMELGSLYHLIHLSG-----------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTV 666 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~-----------~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~V 666 (785)
..+++|||+++++|.+++.... ....+++..+..++.|++.||+|||++|++|+||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999987432 12457899999999999999999999999999999999999999999
Q ss_pred EEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC
Q 003935 667 KICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEG 743 (785)
Q Consensus 667 KL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~ 743 (785)
+|+|||++........ ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR 241 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999976533221 1223345788999999999999999999999999999998 999998888877777665433
Q ss_pred CCCC--CCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003935 744 SRLE--IPEGPLGRLIADCWA-EPQERPSCEEILSRLLD 779 (785)
Q Consensus 744 ~~~~--ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~ 779 (785)
.... ..+..+.+++.+||. ||.+||++.++++.|.+
T Consensus 242 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 242 LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 2221 123569999999999 99999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=349.70 Aligned_cols=253 Identities=25% Similarity=0.392 Sum_probs=212.4
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCC
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKP 596 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 596 (785)
..+....++|.+.+.||+|+||.||++.+ +++.+|+|++.+... .....+.+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 34455678999999999999999999987 477899999865332 223345678899999999999999999999999
Q ss_pred CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
..+|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 999999999999999998852 3588899999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC-CCCCCCCCCcccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC-
Q 003935 677 ITDSPM-RDSSSAGTPEWMAPELIRNE----PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE- 750 (785)
Q Consensus 677 l~~~~~-~~~~~~GT~~Y~APEvl~~~----~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~- 750 (785)
...... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+........+|.
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 271 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED 271 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCc
Confidence 643322 22356799999999999764 378899999999999999999999999888777777766554444443
Q ss_pred ----hHHHHHHHHhhh-CCC--CCCCHHHHHHH
Q 003935 751 ----GPLGRLIADCWA-EPQ--ERPSCEEILSR 776 (785)
Q Consensus 751 ----~~L~~LI~~CL~-DP~--kRPS~~EIL~~ 776 (785)
..+.+++.+|+. ++. .|+++.++++|
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 358889999997 443 38899999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=347.00 Aligned_cols=247 Identities=27% Similarity=0.393 Sum_probs=208.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++|.+.+.||+|+||+||++.. .++.||+|++..... .......+..|+.++..++||||+++++++.+...+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688999999999999999987 578999999875432 2334567889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC--
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-- 681 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~-- 681 (785)
||+++|+|.+++. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 9999999999986 34578999999999999999999999999999999999999999999999999987542210
Q ss_pred ---------------------------------CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003935 682 ---------------------------------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWE 728 (785)
Q Consensus 682 ---------------------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~ 728 (785)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00123579999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHhhhCCCCCC---CHHHHHHH
Q 003935 729 GVLPERVVYAVANEGSRLEIP-----EGPLGRLIADCWAEPQERP---SCEEILSR 776 (785)
Q Consensus 729 ~~~~~~~v~~i~~~~~~~~ip-----~~~L~~LI~~CL~DP~kRP---S~~EIL~~ 776 (785)
+..+......+........+| ...+.+|+.+|+.||.+|+ ++.++++|
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcC
Confidence 988888777776544333333 2357888888766999998 47788766
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=322.48 Aligned_cols=253 Identities=34% Similarity=0.596 Sum_probs=213.5
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
|++..++|++.++||+|+||.||+|.. +++.||+|.+...... ...|.+|+.+++.++|+||+++++++. ....+
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 456678899999999999999999976 5788999998755443 357889999999999999999999874 45689
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
++|||+.+++|.+++... ....+++.++..++.|++.||+|||+.|++|+||||+||++++++.++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 77 IITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEcCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999999988643 3457899999999999999999999999999999999999999999999999999876532
Q ss_pred CCC-CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003935 681 PMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 755 (785)
Q Consensus 681 ~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~ 755 (785)
... .....++..|+|||++....++.++||||||+++|+|++ |+.||.+.+.......+.. ....+.+ +..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER-GYRMPRPDNCPEELYE 234 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHc-CCCCCCCCCCCHHHHH
Confidence 221 223345678999999998889999999999999999999 9999998877766665543 3333333 346999
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 756 LIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 756 LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
++.+||. +|++||++++++..|+++
T Consensus 235 li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 235 LMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred HHHHHccCChhhCCCHHHHHHHhhcC
Confidence 9999999 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=326.95 Aligned_cols=247 Identities=27% Similarity=0.466 Sum_probs=204.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
..+|.+.+.||+|+||.||+|.. +++.||+|++..... .....+.+|+.+++.++||||+++++++...+.+++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 46799999999999999999986 578899999865432 23456789999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+++++|.++++ ....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..+......
T Consensus 86 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 86 EYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 9999999999886 3457899999999999999999999999999999999999999999999999999876443322
Q ss_pred CCCCCCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC------ChHHH
Q 003935 684 DSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP------EGPLG 754 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip------~~~L~ 754 (785)
.....+++.|+|||.+. ...++.++|+|||||++|+|++|+.||....+......+.......... ...+.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence 33456889999999884 3457889999999999999999999997665544433332222222111 24688
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHHH
Q 003935 755 RLIADCWA-EPQERPSCEEILSRL 777 (785)
Q Consensus 755 ~LI~~CL~-DP~kRPS~~EIL~~L 777 (785)
+++.+||. +|++||++++|+++|
T Consensus 243 ~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 243 NFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHhhCChhhCcCHHHHhcCC
Confidence 99999999 999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=324.06 Aligned_cols=249 Identities=31% Similarity=0.600 Sum_probs=209.3
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEECC-eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~~g-~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
+.++|++.+.||+|+||+||.+.+.+ ..+|+|.+...... ...|.+|+.+++.++||||+++++++......+++|
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 45679999999999999999998754 46999988654332 356899999999999999999999999988999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+.+++|.+++... ...+++..++.++.||+.||+|||+.|++|+||||+|||++.++.+||+|||+++........
T Consensus 79 e~~~~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 79 EYMSNGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EcCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 999999999998632 236899999999999999999999999999999999999999999999999998866443221
Q ss_pred -CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC--CCCCChHHHHHHHH
Q 003935 684 -DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSR--LEIPEGPLGRLIAD 759 (785)
Q Consensus 684 -~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~--~~ip~~~L~~LI~~ 759 (785)
.....++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+...... .......+.+++.+
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYS 236 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 112335668999999998889999999999999999998 99999888777666666543221 12234579999999
Q ss_pred hhh-CCCCCCCHHHHHHHHH
Q 003935 760 CWA-EPQERPSCEEILSRLL 778 (785)
Q Consensus 760 CL~-DP~kRPS~~EIL~~L~ 778 (785)
||. +|.+||++.+|++.|+
T Consensus 237 cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 237 CWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HcCCCcccCCCHHHHHHhhC
Confidence 999 9999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.48 Aligned_cols=247 Identities=24% Similarity=0.316 Sum_probs=213.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
.+|...++||+|.||.||+|.+ +|+.||||.++.............+||..|+.++|+||+.++++|...+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4577788999999999999987 68999999997765544434567899999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
|++. +|...++ .+...++..+++.|+.++++||+|||++.|+||||||.|+|++.+|.+||+|||+|+.+.......
T Consensus 82 fm~t-dLe~vIk--d~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMPT-DLEVVIK--DKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred eccc-cHHHHhc--ccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 9985 8888886 356789999999999999999999999999999999999999999999999999999998765555
Q ss_pred CCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---C------C-----
Q 003935 685 SSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---I------P----- 749 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~---i------p----- 749 (785)
...+-|.+|.|||.+.+ +.|+...|+||.|||+.||+-|.+-|.+.+.-+.+..+.+.-..+. . |
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 55688999999999876 5799999999999999999999999999888777777665333222 1 1
Q ss_pred ---------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 750 ---------------EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 750 ---------------~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+..-+|+.++|. ||.+|+++.|++++
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1235678999999 99999999999976
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=342.59 Aligned_cols=261 Identities=32% Similarity=0.589 Sum_probs=213.3
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEecc
Q 003935 521 EWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGA 592 (785)
Q Consensus 521 e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~ 592 (785)
.|++..++|++.+.||.|+||.||+|.+. ++.||+|++.... .....+.+.+|+.++.++ +|+||++++++
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 37777889999999999999999999642 3679999986443 233456788999999999 79999999998
Q ss_pred ccC-CCceeEEEEEcccchhhHHHHhhcc---------------------------------------------------
Q 003935 593 CTK-PPRLSMITEYMELGSLYHLIHLSGQ--------------------------------------------------- 620 (785)
Q Consensus 593 ~~d-~~~l~LV~Ey~~gGSL~dlL~~~~~--------------------------------------------------- 620 (785)
|.. ...+++++||+++++|.+++.....
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 764 4568899999999999998863211
Q ss_pred -------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCC
Q 003935 621 -------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTP 691 (785)
Q Consensus 621 -------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~ 691 (785)
...+++..+..++.|++.||+|||++||+||||||+|||+++++.++|+|||++..+..... ......++.
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 13688999999999999999999999999999999999999999999999999987643221 122334567
Q ss_pred cccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCC
Q 003935 692 EWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQE 766 (785)
Q Consensus 692 ~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~k 766 (785)
.|+|||++.+..++.++|||||||++|||++ |..||.+....+........+.....+ ...+.+++.+||+ +|.+
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 319 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPED 319 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhh
Confidence 8999999999999999999999999999998 999998765555444444444443333 3468999999999 9999
Q ss_pred CCCHHHHHHHHHhhhh
Q 003935 767 RPSCEEILSRLLDCEY 782 (785)
Q Consensus 767 RPS~~EIL~~L~~l~~ 782 (785)
||++.+|+++|.++.-
T Consensus 320 RPs~~ell~~l~~~~~ 335 (337)
T cd05054 320 RPTFSELVEILGDLLQ 335 (337)
T ss_pred CcCHHHHHHHHHHHHh
Confidence 9999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.78 Aligned_cols=257 Identities=30% Similarity=0.537 Sum_probs=214.8
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 596 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 596 (785)
++.++|.+.+.||+|+||+||++.. ++..+|+|.+... .....+.+.+|++++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4567899999999999999999974 2356889987543 234457799999999999999999999999999
Q ss_pred CceeEEEEEcccchhhHHHHhhc----------ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeE
Q 003935 597 PRLSMITEYMELGSLYHLIHLSG----------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTV 666 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~----------~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~V 666 (785)
..++++|||+++++|.+++.... ....+++..++.++.|++.||+|||++|++||||||+|||+++++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999986432 12358999999999999999999999999999999999999999999
Q ss_pred EEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC
Q 003935 667 KICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEG 743 (785)
Q Consensus 667 KL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~ 743 (785)
+|+|||++........ ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...........+....
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999986543221 1223345778999999998889999999999999999998 899999888777776665433
Q ss_pred CCCC--CCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 744 SRLE--IPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 744 ~~~~--ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
.... ..+..+.+|+.+||+ ||.+|||+.++++.|+++..
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 2211 123469999999999 99999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=319.26 Aligned_cols=254 Identities=28% Similarity=0.510 Sum_probs=212.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++|++.+.||+|+||.||+|.. +|+.||+|.+..... .....+.+.+|+.+++.++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999987 588999998865333 3344678999999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 604 EYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
||+++++|..++.... ....+++.+++.++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 9999999999886432 245689999999999999999999999999999999999999999999999999887654333
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcCCCCCCC----ChHHHHH
Q 003935 683 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL--PERVVYAVANEGSRLEIP----EGPLGRL 756 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~--~~~~v~~i~~~~~~~~ip----~~~L~~L 756 (785)
......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||.... .......+.. +.....+ ...+.++
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 240 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-CDYPPLPADHYSEELRDL 240 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-CCCCCCChhhcCHHHHHH
Confidence 3334568889999999998889999999999999999999999996543 2233333322 3333333 2368999
Q ss_pred HHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 757 IADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
+.+||. +|.+||++.+|++.|+++.
T Consensus 241 i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 241 VSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 999999 9999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=336.95 Aligned_cols=246 Identities=25% Similarity=0.396 Sum_probs=220.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|.+-+.||+|.|+.||++.+ .|+.+|+|++....+.....+++.+|+.|.+.|+|||||++.+.+......|+|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 5688889999999999999976 68999999998877777778899999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEc---CCCeEEEEecCccccccCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN---KHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd---~~g~VKL~DFGLA~~l~~~~ 681 (785)
++.|+.|..-+- ..-.+++..+-.+++||+++|.|||.+||||||+||.|+||- ...-+||+|||+|..+. ..
T Consensus 91 ~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g 166 (355)
T KOG0033|consen 91 LVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DG 166 (355)
T ss_pred cccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-Cc
Confidence 999999985443 224689999999999999999999999999999999999995 44579999999999987 44
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 756 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-----~~~L~~L 756 (785)
......+|||.|||||+++..+|+..+|||+.||+||-|+.|.+||.+.+...+++++....+..+-| ....++|
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L 246 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL 246 (355)
T ss_pred cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence 45567899999999999999999999999999999999999999999999999999998877655443 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003935 757 IADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~ 776 (785)
+++|+. ||.+|.|+.|.|+|
T Consensus 247 vrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 247 IRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HHHHhccChhhhccHHHHhCC
Confidence 999999 99999999999976
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=320.96 Aligned_cols=250 Identities=29% Similarity=0.572 Sum_probs=211.5
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccc-cCCCcee
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC-TKPPRLS 600 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~-~d~~~l~ 600 (785)
|.++..+|++.+.||+|+||.||++...|..+|+|.+.... ..+.|.+|+.+++.++|+||+++++++ ......+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 55678899999999999999999999999999999975432 246788999999999999999999975 4556789
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
+++||+++++|.+++... ....+++..++.++.|++.||+|||++||+||||||+||++++++.+||+|||++......
T Consensus 77 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEECCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 999999999999998643 2345889999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHH
Q 003935 681 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRL 756 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~L 756 (785)
. ....++..|+|||++.+..++.++|||||||++|+|++ |+.||...........+.. ......+ +..+.++
T Consensus 156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 231 (256)
T cd05082 156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPVVYDV 231 (256)
T ss_pred C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCCHHHHHH
Confidence 1 23345678999999998889999999999999999997 9999988777666655533 3333332 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 757 IADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
+.+||. +|.+|||+.++++.|+++
T Consensus 232 i~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 232 MKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHhcCChhhCcCHHHHHHHHhcC
Confidence 999999 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=330.86 Aligned_cols=240 Identities=25% Similarity=0.383 Sum_probs=198.2
Q ss_pred EeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccchh
Q 003935 535 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 611 (785)
Q Consensus 535 LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL 611 (785)
||+|+||+||++.+ +++.||+|.+....... ...+.+..|+.+++.++|+||+++++++.....+++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999976 57899999986544322 2346778899999999999999999999999999999999999999
Q ss_pred hHHHHhh-cccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCCCC
Q 003935 612 YHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGT 690 (785)
Q Consensus 612 ~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT 690 (785)
.+.+... .....+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++..+...........||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 8877532 234578999999999999999999999999999999999999999999999999998765443333456789
Q ss_pred CcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-
Q 003935 691 PEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE----RVVYAVANEGSRLEIP---EGPLGRLIADCWA- 762 (785)
Q Consensus 691 ~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~----~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~- 762 (785)
+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+... ....+ ...+.+++.+||+
T Consensus 161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~ 238 (280)
T cd05608 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFCEALLAK 238 (280)
T ss_pred cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHHHHHhcC
Confidence 9999999999999999999999999999999999999765432 222222211 11222 3468999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 003935 763 EPQERP-----SCEEILSR 776 (785)
Q Consensus 763 DP~kRP-----S~~EIL~~ 776 (785)
||.+|| +++++++|
T Consensus 239 ~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 239 DPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CHHHhcCCCCCCHHHHhcC
Confidence 999999 77888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=339.76 Aligned_cols=241 Identities=22% Similarity=0.369 Sum_probs=200.2
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCceeEEEEEccc
Q 003935 533 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
+.||+|+||+||+|.+ +|+.||+|++..... .....+.+..|+.++..+ +||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999987 578999999876432 122345677788888754 899999999999999999999999999
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 688 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 688 (785)
|+|..++. ....+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||+++............+
T Consensus 81 g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence 99998886 345789999999999999999999999999999999999999999999999999875432222334567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCChHHHHHHHHhhh-CCCC
Q 003935 689 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPEGPLGRLIADCWA-EPQE 766 (785)
Q Consensus 689 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~-~ip~~~L~~LI~~CL~-DP~k 766 (785)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+....... ..-...+.+++.+||. ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999999999999999999999999999999999888777666654432211 1123468999999999 9999
Q ss_pred CCCHH-HHHHH
Q 003935 767 RPSCE-EILSR 776 (785)
Q Consensus 767 RPS~~-EIL~~ 776 (785)
||++. ++++|
T Consensus 238 R~~~~~~~~~h 248 (316)
T cd05620 238 RLGVVGNIRGH 248 (316)
T ss_pred cCCChHHHHcC
Confidence 99984 66643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=339.04 Aligned_cols=240 Identities=24% Similarity=0.383 Sum_probs=200.3
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCceeEEEEEccc
Q 003935 533 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
+.||+|+||+||+|.+ .++.||||++..... .....+.+..|..++..+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999987 467899999876532 122345677788888764 899999999999999999999999999
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 688 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 688 (785)
|+|..++. ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..............
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 99999886 335688999999999999999999999999999999999999999999999999875432222334567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCChHHHHHHHHhhh-CCCC
Q 003935 689 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPEGPLGRLIADCWA-EPQE 766 (785)
Q Consensus 689 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~-~ip~~~L~~LI~~CL~-DP~k 766 (785)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+....... ......+.+++.+||. ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 8999999999999999999999999999999999999999888777766654433221 1224468899999999 9999
Q ss_pred CCCHH-HHHH
Q 003935 767 RPSCE-EILS 775 (785)
Q Consensus 767 RPS~~-EIL~ 775 (785)
||++. ++++
T Consensus 238 R~~~~~~l~~ 247 (316)
T cd05619 238 RLGVKGDIRQ 247 (316)
T ss_pred cCCChHHHHc
Confidence 99997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=340.98 Aligned_cols=236 Identities=22% Similarity=0.396 Sum_probs=198.3
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHH-HHhhcCCCceeeEeccccCCCceeEEEEEccc
Q 003935 533 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEIS-ILSRLRHPNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~-iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
+.||+|+||+||+|.+ +|+.||+|++.+.... ....+.+..|.. +++.++||||+++++++...+.+++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999987 5889999998754332 223345566655 46789999999999999999999999999999
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 688 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 688 (785)
|+|..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 99998886 345789999999999999999999999999999999999999999999999999876433333334567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003935 689 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 766 (785)
Q Consensus 689 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 766 (785)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+........ .....+.+++.+||+ ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 99999999999999999999999999999999999999999888777777665432221 124468999999999 9999
Q ss_pred CCCHH
Q 003935 767 RPSCE 771 (785)
Q Consensus 767 RPS~~ 771 (785)
||++.
T Consensus 238 R~~~~ 242 (323)
T cd05575 238 RLGAK 242 (323)
T ss_pred CCCCC
Confidence 99874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.00 Aligned_cols=246 Identities=30% Similarity=0.525 Sum_probs=211.3
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
+|.+.+.||.|+||.||++.+ ++..+|+|.+..... ....+.+.+|+.+++.++|+||+++++++.....++++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 578899999999999999987 588999999865433 33457788999999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 685 (785)
+++++|.+++... ....+++..++.++.|++.||.|||++||+|+||||+||++++++.++|+|||++...........
T Consensus 80 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 80 CDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence 9999999888632 345688999999999999999999999999999999999999999999999999987755443344
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003935 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 762 (785)
Q Consensus 686 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~ 762 (785)
...+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+.... ...++ ...+.+++.+||.
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~ 237 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS-YKPLPSHYSYELRSLIKQMFK 237 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC-CCCCCcccCHHHHHHHHHHHh
Confidence 5678899999999998889999999999999999999999999887776666654433 22233 3468899999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003935 763 -EPQERPSCEEILSR 776 (785)
Q Consensus 763 -DP~kRPS~~EIL~~ 776 (785)
||.+||++.+|+..
T Consensus 238 ~~P~~Rp~~~~il~~ 252 (255)
T cd08219 238 RNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCCCHHHHhhc
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=339.04 Aligned_cols=246 Identities=26% Similarity=0.363 Sum_probs=200.3
Q ss_pred CeeEeeEEeeeCcEEEEEEEE-----CCeEEEEEEeecccc--ChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCce
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDL--TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 599 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~--~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l 599 (785)
+|.+.+.||+|+||+||++.. .++.||+|++.+... .....+.+..|+.+++.+ +||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588999999999999999865 478899999865432 223346678899999999 499999999999999999
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
++||||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 99999999999999886 345789999999999999999999999999999999999999999999999999986543
Q ss_pred CC-CCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCCC-CCCChH
Q 003935 680 SP-MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVL----PERVVYAVANEGSRL-EIPEGP 752 (785)
Q Consensus 680 ~~-~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~----~~~~v~~i~~~~~~~-~ip~~~ 752 (785)
.. ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .......+....... ......
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPE 237 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence 22 122345799999999999865 47889999999999999999999996432 223333333222111 112346
Q ss_pred HHHHHHHhhh-CCCCCC-----CHHHHHHH
Q 003935 753 LGRLIADCWA-EPQERP-----SCEEILSR 776 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRP-----S~~EIL~~ 776 (785)
+.+++.+||. ||.+|| +++++++|
T Consensus 238 ~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 8999999999 999999 78888876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=341.05 Aligned_cols=243 Identities=21% Similarity=0.356 Sum_probs=200.2
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHH-HHhhcCCCceeeEeccccCCCceeEEEEEccc
Q 003935 533 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEIS-ILSRLRHPNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~-iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
+.||+|+||+||+|.+ +++.||+|++...... ......+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999987 4678999998754322 122334555544 56788999999999999999999999999999
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 688 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 688 (785)
++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 81 GELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred CcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 99999886 345688889999999999999999999999999999999999999999999999976543333334567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003935 689 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 766 (785)
Q Consensus 689 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 766 (785)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+........ .-...+.+++.+|++ ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 99999999999999999999999999999999999999999888777776655432221 123468999999999 9999
Q ss_pred CCCHHHHHHHHH
Q 003935 767 RPSCEEILSRLL 778 (785)
Q Consensus 767 RPS~~EIL~~L~ 778 (785)
||++.+.+..+.
T Consensus 238 R~~~~~~~~~i~ 249 (325)
T cd05602 238 RLGAKDDFMEIK 249 (325)
T ss_pred CCCCCCCHHHHh
Confidence 998875444443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.36 Aligned_cols=258 Identities=30% Similarity=0.544 Sum_probs=213.3
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEecccc
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 594 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~ 594 (785)
|++..++|++.+.||+|+||.||+|... +..||+|.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 6678889999999999999999998642 44799998764432 233456889999999999999999999999
Q ss_pred CCCceeEEEEEcccchhhHHHHhhcc-------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEE
Q 003935 595 KPPRLSMITEYMELGSLYHLIHLSGQ-------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 667 (785)
Q Consensus 595 d~~~l~LV~Ey~~gGSL~dlL~~~~~-------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VK 667 (785)
+....+++|||+++|+|.+++..... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999999974321 23456778899999999999999999999999999999999999999
Q ss_pred EEecCccccccCCCCCC--CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Q 003935 668 ICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGS 744 (785)
Q Consensus 668 L~DFGLA~~l~~~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~ 744 (785)
|+|||+++......... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+.....
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 239 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999998654322211 12345678999999998889999999999999999998 7889998887776665544332
Q ss_pred CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 745 RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 745 ~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
...+ +..+.+++.+||+ ||.+|||+.++++.|++..
T Consensus 240 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 240 -LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 2222 3469999999999 9999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=325.36 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=202.8
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
+|++.+.||.|+||.||+|.+ ++..||+|++..........+.+.+|+.+++.++||||+++++++.++..+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 588999999999999999987 588999999865544444456788999999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 685 (785)
+. ++|.+++.....+..+++..++.++.||+.||+|||++||+|+||||+|||++.++.++|+|||++...........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 98 57888876544446799999999999999999999999999999999999999999999999999976644332233
Q ss_pred CCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-------------------
Q 003935 686 SSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR------------------- 745 (785)
Q Consensus 686 ~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~------------------- 745 (785)
...+++.|+|||.+.+. .++.++|||||||++|+|+||+.||.+.........+......
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence 44678899999988654 5789999999999999999999999876654433332211100
Q ss_pred -----------CCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 746 -----------LEIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 746 -----------~~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
....+..+.+++.+||. ||.+|||+.+|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00012356789999999 99999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=328.25 Aligned_cols=254 Identities=31% Similarity=0.490 Sum_probs=211.6
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 596 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 596 (785)
+++++|.+.+.||+|+||+||+|.+. +..||+|++..... ....+.|..|+.++..++||||+++++++...
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 45677888999999999999999763 46799999864432 33456788999999999999999999999999
Q ss_pred CceeEEEEEcccchhhHHHHhhc-------------ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC
Q 003935 597 PRLSMITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH 663 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~-------------~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~ 663 (785)
...++++||+.+++|.+++.... ....+++..++.++.|++.||+|||++||+||||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 99999999999999999985321 12357888999999999999999999999999999999999999
Q ss_pred CeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 003935 664 WTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVA 740 (785)
Q Consensus 664 g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~ 740 (785)
+.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999886543221 1123345778999999988889999999999999999998 888999888877776665
Q ss_pred hcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003935 741 NEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLD 779 (785)
Q Consensus 741 ~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~ 779 (785)
.... ...+ +..+.+|+..||+ +|.+||++.+|+..|++
T Consensus 241 ~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 NRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred cCCc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 5432 2233 3358999999999 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=337.78 Aligned_cols=247 Identities=23% Similarity=0.381 Sum_probs=205.0
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeE
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 601 (785)
+..++|.+.++||.|+||.||++.+ .+..+|+|++.... .....+.+.+|+++++.++||||++++++|.+.+.+++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 3457899999999999999999987 47789999886543 33445778999999999999999999999999999999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc-ccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~-gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
||||+++++|.+++. ..+.+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++..+...
T Consensus 81 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999999986 345688999999999999999999975 7999999999999999999999999999765432
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---------------------
Q 003935 681 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV--------------------- 739 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i--------------------- 739 (785)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 223457899999999999988999999999999999999999999765443322111
Q ss_pred ----------------------HhcCCCCCCC----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 740 ----------------------ANEGSRLEIP----EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 740 ----------------------~~~~~~~~ip----~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
......+..+ +..+.+|+.+||+ ||++|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0011111111 2357899999999 99999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.11 Aligned_cols=261 Identities=30% Similarity=0.569 Sum_probs=215.5
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeE
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILF 589 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL 589 (785)
..|++..++|.+++.||+|+||.||++.+. ...+|+|.+.... .......+..|+.+++.+ +||||+++
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 356677789999999999999999999752 2469999986543 234456788999999999 79999999
Q ss_pred eccccCCCceeEEEEEcccchhhHHHHhhcc-------------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCC
Q 003935 590 LGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 656 (785)
Q Consensus 590 ~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~-------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKps 656 (785)
++++......|+||||+++|+|.+++..... ...+++..++.++.|++.||+|||++|++||||||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 9999999999999999999999999974321 235889999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCCCC--CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 003935 657 NCLVNKHWTVKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 733 (785)
Q Consensus 657 NILLd~~g~VKL~DFGLA~~l~~~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~ 733 (785)
|||++.++.++|+|||++.......... ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 9999999999999999987664322111 12234568999999998889999999999999999998 88899887766
Q ss_pred HHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 734 RVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 734 ~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
.....+ ........+ ...+.+|+.+||. +|.+||++.++++.|.++..
T Consensus 250 ~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 250 ELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 655544 334344443 3468899999999 99999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=320.18 Aligned_cols=253 Identities=33% Similarity=0.587 Sum_probs=212.0
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
|.+..++|.+.++||+|+||.||+|.. .+..+|+|.+...... .+.|.+|+.+++.++|+||+++++++.. ...+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIY 76 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcE
Confidence 456677899999999999999999976 4668999998655443 3568899999999999999999998854 4589
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
++|||+++++|.+++... ....+++..++.++.|++.||+|||+.||+|+||||+||++++++.++|+|||++..+...
T Consensus 77 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 999999999999998642 3446899999999999999999999999999999999999999999999999999876543
Q ss_pred CCCC-CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003935 681 PMRD-SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 755 (785)
Q Consensus 681 ~~~~-~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~ 755 (785)
.... ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.........+... ...+.+ +..+.+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMPCPQDCPISLHE 234 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHH
Confidence 2211 22345668999999988889999999999999999999 88999888777766666543 233333 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 756 LIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 756 LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
|+.+||. +|.+|||+.++++.|+++
T Consensus 235 li~~~l~~~p~~Rpt~~~l~~~l~~~ 260 (260)
T cd05070 235 LMLQCWKKDPEERPTFEYLQSFLEDY 260 (260)
T ss_pred HHHHHcccCcccCcCHHHHHHHHhcC
Confidence 9999999 999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=322.70 Aligned_cols=253 Identities=28% Similarity=0.506 Sum_probs=211.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++|++.+.||+|+||.||++.+ +++.+|||.+..... .....+.+.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5788899999999999999986 688999998865432 3344578899999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 604 EYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
||+++++|.+++.... ....+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 9999999999886422 345689999999999999999999999999999999999999999999999999887654433
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhcCCCCCCC----ChHHHHH
Q 003935 683 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE--RVVYAVANEGSRLEIP----EGPLGRL 756 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~--~~v~~i~~~~~~~~ip----~~~L~~L 756 (785)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.... .....+.. ...+..+ +..+.++
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 240 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYPPLPSDHYSEELRQL 240 (267)
T ss_pred ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc-CCCCCCCcccccHHHHHH
Confidence 333457889999999999888999999999999999999999999755332 22222222 2222222 3469999
Q ss_pred HHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 757 IADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
+.+||. ||.+|||+.+|++.++++
T Consensus 241 i~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 241 VNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HHHhcCCCcccCCCHHHHHHHHhhh
Confidence 999999 999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=316.45 Aligned_cols=247 Identities=28% Similarity=0.477 Sum_probs=210.4
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC-CCceeEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-PPRLSMITE 604 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d-~~~l~LV~E 604 (785)
.|++.+.||.|++|.||++.+ +++.+|+|.+..........+.+.+|+.+++.++|+||+++++.+.. ...++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 488999999999999999977 57789999987666555556778999999999999999999988764 445899999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
|+++++|.+++... ....+++.+++.++.|++.||+|||++||+|+||||+||+++.++.++|+|||++..+.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 159 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA 159 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence 99999999988642 34568999999999999999999999999999999999999999999999999998775443333
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCW 761 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL 761 (785)
....+++.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+.... ....+ +..+.+++.+||
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l 238 (257)
T cd08223 160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK-LPPMPKDYSPELGELIATML 238 (257)
T ss_pred ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-CCCCccccCHHHHHHHHHHh
Confidence 45568899999999999999999999999999999999999998877766666554432 22222 346899999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003935 762 A-EPQERPSCEEILSR 776 (785)
Q Consensus 762 ~-DP~kRPS~~EIL~~ 776 (785)
. ||.+||++.+++++
T Consensus 239 ~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 239 SKRPEKRPSVKSILRQ 254 (257)
T ss_pred ccCcccCCCHHHHhcC
Confidence 9 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=337.02 Aligned_cols=240 Identities=23% Similarity=0.374 Sum_probs=203.2
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcC-CCceeeEeccccCCCceeEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~ 603 (785)
+|...+.||+|+||+||+|.+ +|+.||+|++.+... .....+.+..|+.++..+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 467889999999999999987 578999999875432 2334567788999998886 577888999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+++|+|.+++. ....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 9999999999886 3457999999999999999999999999999999999999999999999999998765433333
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh
Q 003935 684 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA 762 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~CL~ 762 (785)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+ .....+.+++.+||.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 3456799999999999999999999999999999999999999999888877777765443221 123468899999999
Q ss_pred -CCCCCCCH
Q 003935 763 -EPQERPSC 770 (785)
Q Consensus 763 -DP~kRPS~ 770 (785)
+|.+|++.
T Consensus 238 ~~p~~R~~~ 246 (323)
T cd05615 238 KHPSKRLGC 246 (323)
T ss_pred cCHhhCCCC
Confidence 99999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=318.23 Aligned_cols=254 Identities=32% Similarity=0.595 Sum_probs=214.8
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
|++..++|.+.++||.|+||.||++.+ +++.+|||.+...... .+++.+|+.+++.++|+||+++++++......+
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 567788999999999999999999977 4568999998754433 467889999999999999999999999888999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
++|||+++++|.+++... ....+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++..+...
T Consensus 78 ~v~e~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEeccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 999999999999998632 2356899999999999999999999999999999999999999999999999999876432
Q ss_pred CCC-CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003935 681 PMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 755 (785)
Q Consensus 681 ~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~ 755 (785)
... .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.........+... .....+ +..+.+
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 235 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRMPRPPNCPEELYD 235 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHH
Confidence 111 112334568999999998889999999999999999998 99999888777766666543 222222 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 756 LIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 756 LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
++.+||. +|.+||+++++++.|+++
T Consensus 236 ~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 236 LMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred HHHHHcccCcccCCCHHHHHHHHhcC
Confidence 9999999 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=320.70 Aligned_cols=247 Identities=35% Similarity=0.642 Sum_probs=207.2
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC-CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~~-g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
+..+|++.+.||+|+||.||+|.+. +..+|+|++...... ...|.+|+.+++.++||||+++++++......+++|
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 3457889999999999999999874 557999998654433 246888999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+++++|.+++... ...+++..++.++.|++.||+|||+.||+|+||||+||+++.++.+||+|||+++...+....
T Consensus 79 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 79 EYMANGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred ecCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 999999999998632 346899999999999999999999999999999999999999999999999999866443221
Q ss_pred C-CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCC---CChHHHHHHH
Q 003935 684 D-SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEI---PEGPLGRLIA 758 (785)
Q Consensus 684 ~-~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~i---p~~~L~~LI~ 758 (785)
. ....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.. ...... .+..+.+++.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA-GYRLYRPKLAPTEVYTIMY 235 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHH
Confidence 1 12234457999999998889999999999999999999 7999988877766665543 322222 2457999999
Q ss_pred Hhhh-CCCCCCCHHHHHHHH
Q 003935 759 DCWA-EPQERPSCEEILSRL 777 (785)
Q Consensus 759 ~CL~-DP~kRPS~~EIL~~L 777 (785)
+||. +|++|||+.++++.|
T Consensus 236 ~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 236 SCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHhcCChhhCcCHHHHHHHh
Confidence 9999 999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=328.93 Aligned_cols=247 Identities=24% Similarity=0.283 Sum_probs=204.3
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
.|++.+.||+|+||+||++.+ +++.||+|++....... .....+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999986 58899999986544322 223567889999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
|+.+|+|.+++... ....+++..+..++.|++.||.|||+.||+|+||||+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~ 158 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TI 158 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-cc
Confidence 99999999887632 23568999999999999999999999999999999999999999999999999998764322 22
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCCCC---CChHHHHHHHH
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE--GSRLEI---PEGPLGRLIAD 759 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~--~~~~~i---p~~~L~~LI~~ 759 (785)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+... ...... -+..+.+|+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQ 238 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHH
Confidence 3457899999999999888999999999999999999999999876554332222111 111122 23468999999
Q ss_pred hhh-CCCCCC-----CHHHHHHH
Q 003935 760 CWA-EPQERP-----SCEEILSR 776 (785)
Q Consensus 760 CL~-DP~kRP-----S~~EIL~~ 776 (785)
||. ||.+|| ++++++++
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 239 LLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HccCCHHHhcCCCCCCHHHHhcC
Confidence 999 999999 88899876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=339.63 Aligned_cols=239 Identities=23% Similarity=0.372 Sum_probs=197.3
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCceeEEEEEccc
Q 003935 533 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
+.||+|+||+||++.+ +++.||+|++.+.... ......+..|+.++..+ +||||+++++++.+...+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999987 5789999999765432 23456688899999988 699999999999999999999999999
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 688 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 688 (785)
|+|..++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence 99998886 345799999999999999999999999999999999999999999999999999875333223334567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------hHH-HHHHHHhcCCCCCCC---ChHHHHH
Q 003935 689 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL--------PER-VVYAVANEGSRLEIP---EGPLGRL 756 (785)
Q Consensus 689 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~--------~~~-~v~~i~~~~~~~~ip---~~~L~~L 756 (785)
||+.|+|||++.+..++.++|+|||||++|+|++|+.||.... ... ....+.... ..+| ...+.++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~l 235 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKASSV 235 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--CCCCCCCCHHHHHH
Confidence 9999999999999999999999999999999999999996321 112 222233222 2233 3468899
Q ss_pred HHHhhh-CCCCCCC------HHHHHHH
Q 003935 757 IADCWA-EPQERPS------CEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS------~~EIL~~ 776 (785)
+.+||. ||.+|++ +.++++|
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 236 LKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 999999 9999997 6787765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.10 Aligned_cols=244 Identities=26% Similarity=0.348 Sum_probs=199.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC------
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------ 597 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------ 597 (785)
.++|.+.+.||+|+||.||++.+ .|..||+|++............+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 47899999999999999999977 5889999998765555555678889999999999999999999886543
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+|+||||+.+ +|...+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 100 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 47999999986 4555543 24788889999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--------------
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG-------------- 743 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~-------------- 743 (785)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 174 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 174 CTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred ccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 432 22334678999999999999999999999999999999999999998766543322221100
Q ss_pred ---------CCC--------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 744 ---------SRL--------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 744 ---------~~~--------------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
... ......+.+|+.+||. ||.+|||+.|+++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 0012357899999999 99999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=316.81 Aligned_cols=249 Identities=29% Similarity=0.424 Sum_probs=216.0
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
.|++.+.||.|+||.||.+.. ++..+++|.+............+.+|++++++++|+||+++++++.+...++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478899999999999988866 588899999877666666677899999999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 685 (785)
+++++|.+++... ....+++.++..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 81 ANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred cCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 9999999998643 245689999999999999999999999999999999999999999999999999987655433334
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--ChHHHHHHHHhhh-
Q 003935 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP--EGPLGRLIADCWA- 762 (785)
Q Consensus 686 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip--~~~L~~LI~~CL~- 762 (785)
...+++.|+|||.+.+..++.++||||||+++|+|++|..||......+....+.........+ ...+.+++..||.
T Consensus 160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQ 239 (256)
T ss_pred ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccc
Confidence 5678999999999988888999999999999999999999999888877777766544333221 3468899999998
Q ss_pred CCCCCCCHHHHHHHH
Q 003935 763 EPQERPSCEEILSRL 777 (785)
Q Consensus 763 DP~kRPS~~EIL~~L 777 (785)
+|.+||++.++++++
T Consensus 240 ~p~~R~s~~~ll~~~ 254 (256)
T cd08221 240 DPEKRPTADEVLDQP 254 (256)
T ss_pred CcccCCCHHHHhhCc
Confidence 999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=352.64 Aligned_cols=248 Identities=27% Similarity=0.371 Sum_probs=211.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--C-CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--N-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~-g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
...|.+.+.||+|+||.||++.. + +..||+|.+.... ......+..|+.+++.++|||||+++++|...+.+|+|
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 45599999999999999999976 3 5678888764432 33446678899999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhh-cccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 603 TEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
|||+++|+|.+++... .....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999999887532 234568999999999999999999999999999999999999999999999999998765432
Q ss_pred C--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHH
Q 003935 682 M--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRL 756 (785)
Q Consensus 682 ~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~L 756 (785)
. .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...... ..+ ...+.+|
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~l 302 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-PFPCPVSSGMKAL 302 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCccCCHHHHHH
Confidence 1 233567999999999999999999999999999999999999999988887777776654432 222 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003935 757 IADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~ 776 (785)
+..||. ||.+||++.+++.+
T Consensus 303 i~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 303 LDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHHhccChhhCcCHHHHHhC
Confidence 999999 99999999999864
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=320.90 Aligned_cols=254 Identities=33% Similarity=0.594 Sum_probs=211.4
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEEC-CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~-g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
|.+..++|++.++||+|+||.||+|.++ ...||+|++...... .+.|.+|+++++.++||||+++++++.+ ...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 4566788999999999999999999874 457999998654432 3568899999999999999999998754 4589
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
++|||+++|+|.+++... ....+++..++.++.|++.||+|||+.+|+|+||||+||++++++.++|+|||++..+...
T Consensus 77 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEEcCCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999999999998632 2346789999999999999999999999999999999999999999999999999876543
Q ss_pred CCCC-CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003935 681 PMRD-SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 755 (785)
Q Consensus 681 ~~~~-~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~ 755 (785)
.... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+.... ....+ +..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 234 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMPCPPECPESLHD 234 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-CCCCccccCHHHHH
Confidence 2211 23346678999999988889999999999999999999 888998887777666554322 22222 346889
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 756 LIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 756 LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
|+.+||+ +|.+||++.++++.|+++.
T Consensus 235 li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 235 LMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 9999999 9999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=340.55 Aligned_cols=241 Identities=22% Similarity=0.356 Sum_probs=199.6
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHH-HHhhcCCCceeeEeccccCCCceeEEEEEccc
Q 003935 533 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEIS-ILSRLRHPNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~-iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
+.||+|+||+||++.+ +|+.||+|++.+... .......+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999987 588999999865432 2233455666665 46778999999999999999999999999999
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 688 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 688 (785)
|+|...+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 99998876 345789999999999999999999999999999999999999999999999999876433323334567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003935 689 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 766 (785)
Q Consensus 689 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 766 (785)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+........ .....+.+++..|+. +|.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 99999999999999999999999999999999999999998888777776665432211 123468899999999 9999
Q ss_pred CCCHHHHHHH
Q 003935 767 RPSCEEILSR 776 (785)
Q Consensus 767 RPS~~EIL~~ 776 (785)
||++.+.++.
T Consensus 238 R~~~~~~~~~ 247 (325)
T cd05604 238 RLGAKEDFLE 247 (325)
T ss_pred cCCCCCCHHH
Confidence 9987543333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=355.39 Aligned_cols=245 Identities=33% Similarity=0.542 Sum_probs=217.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
..|+....||+|.||.||+|.+ .++.||+|++...... ..++++.+|+.+|.+++++||.++|+.+..+..++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 4566668999999999999987 4789999999765443 346889999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
||.||++.++++ .+..+.+..+..++++++.|+.|||..+.+|||||+.|||+..+|.+||+|||.+..+.......
T Consensus 92 y~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 92 YCGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HhcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 999999999997 44566888888999999999999999999999999999999999999999999999988776666
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCW 761 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL 761 (785)
.+++|||.|||||++++..|+.|+||||||++.+||++|.+||.+..+..+++.|.... ++.+. ...++++|..|+
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~-PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSA-PPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCC-CCccccccCHHHHHHHHHHh
Confidence 78999999999999999899999999999999999999999999998877776654433 22222 225999999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003935 762 A-EPQERPSCEEILSR 776 (785)
Q Consensus 762 ~-DP~kRPS~~EIL~~ 776 (785)
+ ||+.||++.++|+|
T Consensus 248 ~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 248 DKNPEFRPSAKELLKH 263 (467)
T ss_pred hcCcccCcCHHHHhhh
Confidence 9 99999999999987
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=345.57 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=213.1
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCC
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKP 596 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 596 (785)
..+.+..++|.+.+.||+|+||.||++.+ .++.+|+|++.+... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 45566778999999999999999999987 578899999865332 223345678899999999999999999999999
Q ss_pred CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
..+++||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||++..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 999999999999999998862 3578889999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC-CCCCCCCCCcccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 003935 677 ITDSPM-RDSSSAGTPEWMAPELIRNEP----FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-- 749 (785)
Q Consensus 677 l~~~~~-~~~~~~GT~~Y~APEvl~~~~----~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-- 749 (785)
...... .....+||+.|+|||++.... ++.++|||||||++|||++|..||...+.......+........+|
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 271 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCc
Confidence 654322 223567999999999997543 7889999999999999999999999988877777776654443333
Q ss_pred ---ChHHHHHHHHhhhCCCC---CCCHHHHHHHH
Q 003935 750 ---EGPLGRLIADCWAEPQE---RPSCEEILSRL 777 (785)
Q Consensus 750 ---~~~L~~LI~~CL~DP~k---RPS~~EIL~~L 777 (785)
...+.+++..|+.+|.. |+++.+|++|.
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 272 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 23588999999984433 78999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=338.17 Aligned_cols=236 Identities=22% Similarity=0.381 Sum_probs=196.3
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHH-HHhhcCCCceeeEeccccCCCceeEEEEEccc
Q 003935 533 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEIS-ILSRLRHPNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~-iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
+.||+|+||+||+|.+ +++.||+|++.+... .......+..|+. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 578999999875433 2223345556654 57889999999999999999999999999999
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 688 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 688 (785)
++|...+. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 99988876 345788999999999999999999999999999999999999999999999999876433333334567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003935 689 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 766 (785)
Q Consensus 689 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 766 (785)
||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+.......+ .....+.+++.+||+ ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 99999999999999999999999999999999999999998887777766654432221 113368899999999 9999
Q ss_pred CCCHH
Q 003935 767 RPSCE 771 (785)
Q Consensus 767 RPS~~ 771 (785)
||++.
T Consensus 238 R~~~~ 242 (321)
T cd05603 238 RLGAK 242 (321)
T ss_pred cCCCC
Confidence 98754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=321.85 Aligned_cols=258 Identities=27% Similarity=0.480 Sum_probs=214.5
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEEC------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC-
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK- 595 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~~------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d- 595 (785)
.+..++|.+.+.||+|+||.||+|.+. +..|++|++.. .......+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 356688999999999999999999873 47789998753 3344556788999999999999999999998765
Q ss_pred CCceeEEEEEcccchhhHHHHhhccc-----ccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEe
Q 003935 596 PPRLSMITEYMELGSLYHLIHLSGQK-----KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICD 670 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL~dlL~~~~~~-----~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~D 670 (785)
+...+++++|+++++|.+++...... ..+++..++.++.|++.||+|||+++++|+||||+||++++++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 46789999999999999998653222 4689999999999999999999999999999999999999999999999
Q ss_pred cCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCC
Q 003935 671 FGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLE 747 (785)
Q Consensus 671 FGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ 747 (785)
||+++.+...... .....++..|+|||++.+..++.++|||||||++||+++ |+.||....+......+.. .....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~ 239 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD-GYRLA 239 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc-CCCCC
Confidence 9999866433221 122345678999999998889999999999999999999 9999998877665554433 33332
Q ss_pred CC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 748 IP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 748 ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
.+ +..+.+++.+||. ||++|||+.++++.|.++..
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 22 3468999999999 99999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=315.06 Aligned_cols=244 Identities=37% Similarity=0.682 Sum_probs=209.5
Q ss_pred eEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcc
Q 003935 533 TRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME 607 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~ 607 (785)
+.||+|+||.||+|... +..+|+|++....... ..+.+.+|+.+++.++|+||+++++++.....++++|||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 46899999999999874 7789999987654433 46789999999999999999999999999999999999999
Q ss_pred cchhhHHHHhhcc------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 608 LGSLYHLIHLSGQ------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 608 gGSL~dlL~~~~~------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
+++|.+++..... ...+++..++.++.|++.||+|||++|++|+||+|+||++++++.++|+|||.+.......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 9999999874311 3679999999999999999999999999999999999999999999999999998775432
Q ss_pred --CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003935 682 --MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 755 (785)
Q Consensus 682 --~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~ 755 (785)
.......+++.|+|||.+....++.++||||||+++|+|++ |..||...........+.. +.....+ +..+.+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 238 (262)
T cd00192 160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDELYE 238 (262)
T ss_pred ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCChHHHH
Confidence 12234567889999999988889999999999999999999 5999999888777776665 3333333 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHH
Q 003935 756 LIADCWA-EPQERPSCEEILSRLL 778 (785)
Q Consensus 756 LI~~CL~-DP~kRPS~~EIL~~L~ 778 (785)
++.+||. +|.+|||+.+++++|+
T Consensus 239 li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 239 LMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHccCCcccCcCHHHHHHhhC
Confidence 9999999 9999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=316.69 Aligned_cols=241 Identities=29% Similarity=0.588 Sum_probs=201.6
Q ss_pred EEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccchh
Q 003935 534 RVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 611 (785)
Q Consensus 534 ~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL 611 (785)
.||+|+||.||+|.+ +++.+|+|.+... ...+....|.+|+++++.++||||+++++++......++||||+++++|
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 689999999999976 6889999987543 3344557799999999999999999999999999999999999999999
Q ss_pred hHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC--CCCCC
Q 003935 612 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD--SSSAG 689 (785)
Q Consensus 612 ~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~--~~~~G 689 (785)
.+++.. ....+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+|||++.......... .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 999863 23468899999999999999999999999999999999999999999999999987654321111 11123
Q ss_pred CCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CC
Q 003935 690 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EP 764 (785)
Q Consensus 690 T~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP 764 (785)
+..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.. ......+ +..+.+|+.+||+ +|
T Consensus 159 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-GVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-CCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 457999999999889999999999999999998 8889988777665555443 2233333 3468899999999 99
Q ss_pred CCCCCHHHHHHHHH
Q 003935 765 QERPSCEEILSRLL 778 (785)
Q Consensus 765 ~kRPS~~EIL~~L~ 778 (785)
.+||++.++++.|+
T Consensus 238 ~~Rps~~~~~~~l~ 251 (252)
T cd05084 238 GQRPSFSTVHQELQ 251 (252)
T ss_pred hhCcCHHHHHHHHh
Confidence 99999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=345.63 Aligned_cols=262 Identities=29% Similarity=0.523 Sum_probs=219.0
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEe
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFL 590 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~ 590 (785)
..+|.+..++|.++++||+|+||.||+|.+. +..||||++..... ....+.+.+|+.+|..+. ||||++++
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~ 107 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLL 107 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence 3568889999999999999999999999863 35799999975433 333467899999999997 99999999
Q ss_pred ccccCCCceeEEEEEcccchhhHHHHhhcc--------------------------------------------------
Q 003935 591 GACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------------------------------------------- 620 (785)
Q Consensus 591 g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~-------------------------------------------------- 620 (785)
++|...+..++||||+++|+|.++++....
T Consensus 108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 999999999999999999999999864311
Q ss_pred ---------------------------------------------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCC
Q 003935 621 ---------------------------------------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKS 655 (785)
Q Consensus 621 ---------------------------------------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKp 655 (785)
...+++..++.++.|++.||+|||+.+|+||||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp 267 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA 267 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence 12467778899999999999999999999999999
Q ss_pred CcEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 003935 656 ANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLP 732 (785)
Q Consensus 656 sNILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~ 732 (785)
+|||+++++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999986533211 1123456788999999998889999999999999999998 8899988766
Q ss_pred HHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 733 ERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 733 ~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
.+........+.++..| ...+.+|+.+||. +|.+||++.+|+..|+++.
T Consensus 348 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 66655555555544444 3468999999999 9999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=325.01 Aligned_cols=254 Identities=35% Similarity=0.586 Sum_probs=209.0
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEECC------------------eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCce
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIWNG------------------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV 586 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~~g------------------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNI 586 (785)
+..+|.+.++||+|+||.||++.+.+ ..||+|++..... ....+.+.+|+++++.++||||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCE
Confidence 45688999999999999999987632 4589999865433 3456789999999999999999
Q ss_pred eeEeccccCCCceeEEEEEcccchhhHHHHhhc--------ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcE
Q 003935 587 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSG--------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANC 658 (785)
Q Consensus 587 VkL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~--------~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNI 658 (785)
+++++++..+...++++||+.+++|.+++.... ....+++..++.++.|++.||+|||++||+|+||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999986432 112689999999999999999999999999999999999
Q ss_pred EEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCChHH
Q 003935 659 LVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT--LNRPWEGVLPER 734 (785)
Q Consensus 659 LLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT--G~~PF~~~~~~~ 734 (785)
+++.++.++|+|||++........ ......+++.|+|||.+.+..++.++|||||||++|||++ +..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999976543321 1223456778999999988889999999999999999998 677998777666
Q ss_pred HHHHHHhc----CCCC--CCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003935 735 VVYAVANE----GSRL--EIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLD 779 (785)
Q Consensus 735 ~v~~i~~~----~~~~--~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~ 779 (785)
........ .... ..+ +..+.+++.+||+ ||.+|||+.+|++.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 242 VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 65554432 1111 111 2469999999999 99999999999998864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=325.61 Aligned_cols=254 Identities=30% Similarity=0.555 Sum_probs=208.6
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC--Ce--EEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCcee
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIWN--GT--DVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~~--g~--~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~ 600 (785)
+++|++.+.||+|+||.||+|... +. .+++|.+... ......+.|.+|+.++.++ +||||+++++++.....++
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 368999999999999999999763 33 4688877532 2334457789999999999 7999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhc-------------ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEE
Q 003935 601 MITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 667 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~-------------~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VK 667 (785)
+++||+++++|.+++.... ....+++..++.++.|++.||+|||++||+||||||+|||+++++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999986422 113588999999999999999999999999999999999999999999
Q ss_pred EEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC
Q 003935 668 ICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRL 746 (785)
Q Consensus 668 L~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~ 746 (785)
|+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||...........+... ...
T Consensus 160 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~-~~~ 237 (297)
T cd05089 160 IADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRM 237 (297)
T ss_pred ECCcCCCccccce-eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCC
Confidence 9999998643221 11112233557999999998889999999999999999997 99999988887776665442 223
Q ss_pred CCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 747 EIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 747 ~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
..+ +..+.+|+.+||. +|.+||+++++++.|.++..
T Consensus 238 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 238 EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 223 3468999999999 99999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=338.02 Aligned_cols=239 Identities=23% Similarity=0.374 Sum_probs=196.1
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCceeEEEEEccc
Q 003935 533 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
+.||+|+||+||+|.+ +++.||+|++.+... .......+..|+.++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999987 577899999976543 233456678899988776 799999999999999999999999999
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 688 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 688 (785)
|+|..++. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.............
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence 99988876 345789999999999999999999999999999999999999999999999999976433333334567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------C-hHHHHHHHHhcCCCCCCC---ChHHHHH
Q 003935 689 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV--------L-PERVVYAVANEGSRLEIP---EGPLGRL 756 (785)
Q Consensus 689 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~--------~-~~~~v~~i~~~~~~~~ip---~~~L~~L 756 (785)
||+.|+|||++.+..++.++|||||||++|+|++|+.||... . .......+.... ..+| ...+.++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~l 235 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKAASV 235 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--CCCCCCCCHHHHHH
Confidence 999999999999999999999999999999999999999521 1 112222232222 2233 3468899
Q ss_pred HHHhhh-CCCCCCC------HHHHHHH
Q 003935 757 IADCWA-EPQERPS------CEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS------~~EIL~~ 776 (785)
+.+||. ||.+||+ +.++++|
T Consensus 236 l~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 236 LKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 999999 9999998 5677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=325.10 Aligned_cols=256 Identities=31% Similarity=0.549 Sum_probs=213.5
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 596 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 596 (785)
+...+|.+.+.||+|+||.||+|.+. +..+++|.+.... ....+.+.+|+++++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 34567999999999999999999742 3458888875432 33346788999999999999999999999999
Q ss_pred CceeEEEEEcccchhhHHHHhhc-------------ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC
Q 003935 597 PRLSMITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH 663 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~-------------~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~ 663 (785)
...++||||+++++|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999986432 12358899999999999999999999999999999999999999
Q ss_pred CeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 003935 664 WTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVA 740 (785)
Q Consensus 664 g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~ 740 (785)
+.++|+|||++........ ......++..|+|||.+.+..++.++|||||||++|+|+| |..||...........+.
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 9999999999976543221 1233456788999999999999999999999999999998 999998888777666554
Q ss_pred hcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 741 NEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 741 ~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
... ....+ +..+.+++.+||+ +|.+||++.++++.|.++..
T Consensus 240 ~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 240 QGR-VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred CCC-CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 332 22222 3468999999999 99999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=316.96 Aligned_cols=253 Identities=35% Similarity=0.610 Sum_probs=210.1
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEEC-CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~-g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
|++..++|.+...||.|+||.||++.+. +..+|+|.+...... .+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIY 76 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcE
Confidence 4455678999999999999999999874 457999987644332 3568899999999999999999998754 4689
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
++|||+.+++|.+++... ....+++..+..++.|++.||+|||+.|++|+||||+||++++++.++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEcCCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 999999999999998643 3345889999999999999999999999999999999999999999999999999876443
Q ss_pred CCC-CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003935 681 PMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 755 (785)
Q Consensus 681 ~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~ 755 (785)
... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.........+.. ......+ +..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-GYRMPCPQGCPESLHE 234 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHHHH
Confidence 221 122345678999999998889999999999999999999 8999998877766665543 3333333 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 756 LIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 756 LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
++.+||. ||.+||+++++++.|+++
T Consensus 235 li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 235 LMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred HHHHHccCCcccCcCHHHHHHHHhcC
Confidence 9999999 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=326.41 Aligned_cols=260 Identities=28% Similarity=0.580 Sum_probs=216.3
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEE---------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEe
Q 003935 521 EWNIDFSELTVGTRVGIGFFGEVFRGIW---------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 590 (785)
Q Consensus 521 e~~i~~s~y~i~k~LG~G~fG~VYkg~~---------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~ 590 (785)
.|.+...+|.+.+.||+|+||.||++.+ ++..+|+|.+.... .......+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 3567788999999999999999999964 23468999876432 334457889999999999 799999999
Q ss_pred ccccCCCceeEEEEEcccchhhHHHHhhc-------------ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCc
Q 003935 591 GACTKPPRLSMITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSAN 657 (785)
Q Consensus 591 g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~-------------~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsN 657 (785)
+++......+++|||+++|+|.+++.... ....+++..+..++.||+.||.|||++||+||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 99999999999999999999999987432 12357888999999999999999999999999999999
Q ss_pred EEEcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 003935 658 CLVNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPER 734 (785)
Q Consensus 658 ILLd~~g~VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~ 734 (785)
||++.++.+||+|||+++.+...... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+...
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 99999999999999999876443221 123345678999999998889999999999999999998 788998887777
Q ss_pred HHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 735 VVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 735 ~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
....+.. ......+ ...+.+|+.+||. +|.+||++.++++.|+++..
T Consensus 248 ~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 248 LFKLLKE-GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHHHHc-CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 6665543 3333333 3468999999999 99999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=328.50 Aligned_cols=260 Identities=29% Similarity=0.581 Sum_probs=215.7
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEe
Q 003935 521 EWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 590 (785)
Q Consensus 521 e~~i~~s~y~i~k~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~ 590 (785)
.|.+..++|.+.++||+|+||.||+|... ...+|+|++.... .......+.+|+.+++.+ +||||++++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 46667789999999999999999999642 3468999876443 334467789999999999 699999999
Q ss_pred ccccCCCceeEEEEEcccchhhHHHHhhc-------------ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCc
Q 003935 591 GACTKPPRLSMITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSAN 657 (785)
Q Consensus 591 g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~-------------~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsN 657 (785)
+++.....++++|||+++|+|.+++.... ....+++..+..++.|++.||.|||++||+|+||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 99999999999999999999999986432 12458899999999999999999999999999999999
Q ss_pred EEEcCCCeEEEEecCccccccCCCCCC--CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 003935 658 CLVNKHWTVKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPER 734 (785)
Q Consensus 658 ILLd~~g~VKL~DFGLA~~l~~~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~ 734 (785)
||++.++.+||+|||+++......... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999998764322211 12234467999999999899999999999999999999 889998887766
Q ss_pred HHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 735 VVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 735 ~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
....+.. ......+ ...+.+++.+||. +|.+||++.++++.|.++..
T Consensus 245 ~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 245 LFKLLRE-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 6665543 3333333 2468899999999 99999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=329.14 Aligned_cols=248 Identities=23% Similarity=0.313 Sum_probs=202.2
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
..++|.+.+.||+|+||+||+|.+ .++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 357899999999999999999977 5778999998654332 2234677899999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
|||+.+ +|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 83 ~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 83 FEYLDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred EeCCCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 999986 77776653 234688999999999999999999999999999999999999999999999999986544333
Q ss_pred CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----------------
Q 003935 683 RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS----------------- 744 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~----------------- 744 (785)
......+++.|+|||.+.+ ..++.++|||||||++|+|+||+.||.+.+.......+.....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 3344568899999998865 4688999999999999999999999988766554443322100
Q ss_pred ----CCC----------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 745 ----RLE----------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 745 ----~~~----------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
... .-+..+.+|+.+|+. ||.+|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000 012357789999999 99999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=320.63 Aligned_cols=247 Identities=26% Similarity=0.438 Sum_probs=204.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|++.+.||+|+||.||+|.+ +++.||+|++..........+.+.+|+.+++.++||||+++++++.....++++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4688999999999999999987 48899999986554333334567899999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
|++++.|..++. ....+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 999988888765 34468999999999999999999999999999999999999999999999999998775543223
Q ss_pred CCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------------
Q 003935 685 SSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS------------------- 744 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~------------------- 744 (785)
....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+....+....+.....
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34567889999999876 5578999999999999999999999988766554443321100
Q ss_pred CCC-------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 745 RLE-------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 745 ~~~-------------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
... -.+..+.+|+.+||+ +|++||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000 012357899999999 99999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=322.33 Aligned_cols=252 Identities=27% Similarity=0.526 Sum_probs=206.6
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCe----EEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~----~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
...+|++.+.||+|+||+||+|.+ ++. .+++|.+... .......++..|+.+++.+.||||+++++++.. ..
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 346788899999999999999987 444 4777776432 223345678889999999999999999998764 45
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
.++++||+++|+|.+++.. ....+++..++.++.||+.||+|||+.|++|+||||+|||+++++.+||+|||+++...
T Consensus 83 ~~~i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred cEEEEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 7899999999999999863 23578999999999999999999999999999999999999999999999999998764
Q ss_pred CCC--CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003935 679 DSP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 752 (785)
Q Consensus 679 ~~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~ 752 (785)
... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+ ..+.....+ ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 239 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLAQPQICTID 239 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCCCCCCCCHH
Confidence 322 12233456778999999998889999999999999999998 99999888776554443 444443332 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
+..++.+||. ||.+|||+.++++.|..+.
T Consensus 240 ~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 240 VYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 8889999999 9999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=315.97 Aligned_cols=247 Identities=27% Similarity=0.523 Sum_probs=213.3
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
+|++.+.||+|+||.||++.. +|+.||+|.+..........+++.+|+.+++.++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 488999999999999999976 588999999876655555567899999999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 685 (785)
+.+++|.+++... ....+++.+++.++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++...........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 9999999988632 234578999999999999999999999999999999999999999999999999987654333333
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003935 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 762 (785)
Q Consensus 686 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~ 762 (785)
...|++.|+|||++.+..++.++|+|||||++|+|++|+.||...........+..... ...+ ...+.+++.+||+
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08218 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-PPVSSHYSYDLRNLVSQLFK 238 (256)
T ss_pred hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC-CCCcccCCHHHHHHHHHHhh
Confidence 45688899999999988899999999999999999999999988887777776655443 2233 3468999999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003935 763 -EPQERPSCEEILSR 776 (785)
Q Consensus 763 -DP~kRPS~~EIL~~ 776 (785)
+|.+||++.+++++
T Consensus 239 ~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 239 RNPRDRPSVNSILEK 253 (256)
T ss_pred CChhhCcCHHHHhhC
Confidence 99999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=335.34 Aligned_cols=248 Identities=21% Similarity=0.327 Sum_probs=206.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++|.+.+.||+|+||+||++.. +++.||+|++.+... .....+.|.+|+.+++.++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4789999999999999999987 478999999865332 2334566889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+++|+|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 99999999999863 2456899999999999999999999999999999999999999999999999998766443222
Q ss_pred -CCCCCCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC------Ch
Q 003935 684 -DSSSAGTPEWMAPELIRN-----EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP------EG 751 (785)
Q Consensus 684 -~~~~~GT~~Y~APEvl~~-----~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip------~~ 751 (785)
.....||+.|+|||++.. ..++.++|||||||++|+|++|+.||......+....+........++ ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence 223569999999999863 457889999999999999999999999888777776665544333332 34
Q ss_pred HHHHHHHHhhh---CCCCCCCHHHHHHH
Q 003935 752 PLGRLIADCWA---EPQERPSCEEILSR 776 (785)
Q Consensus 752 ~L~~LI~~CL~---DP~kRPS~~EIL~~ 776 (785)
.+.+++.+|+. ++..|+++.++++|
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 68899999876 34448899999987
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=320.24 Aligned_cols=253 Identities=29% Similarity=0.557 Sum_probs=208.8
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCe----EEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~----~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
...+|.+.+.||+|+||+||+|.+ ++. .||+|++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 446889999999999999999976 444 48999986543 344457889999999999999999999998764 4
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
.++++||+++|+|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||+++++.+||+|||+++...
T Consensus 83 ~~l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred cEEEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 7899999999999999863 23568999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003935 679 DSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 752 (785)
Q Consensus 679 ~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~ 752 (785)
..... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+ ..+.....+ ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 239 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL-EKGERLPQPPICTID 239 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCCCCccCCHH
Confidence 33221 122345678999999998889999999999999999998 89999887766655443 334333333 236
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
+.+++.+||. ||+.||++.++++.|.++..
T Consensus 240 ~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 240 VYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 8899999999 99999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=321.42 Aligned_cols=254 Identities=30% Similarity=0.562 Sum_probs=207.8
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 596 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 596 (785)
+..++|.+.+.||+|+||.||+|.+. +..||+|.+.... .......|.+|+.+++.++|+||+++++++.+.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34567999999999999999999874 3578888875432 233446789999999999999999999999998
Q ss_pred CceeEEEEEcccchhhHHHHhhcc----cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC---eEEEE
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQ----KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKIC 669 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~----~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g---~VKL~ 669 (785)
...+++|||+++++|.+++..... ...+++..++.++.||+.||+|||+++++|+||||+|||++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 899999999999999999874421 13589999999999999999999999999999999999998654 69999
Q ss_pred ecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC
Q 003935 670 DFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRL 746 (785)
Q Consensus 670 DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~ 746 (785)
|||+++........ ......++.|+|||++.+..++.++|||||||++|+|++ |..||...........+.. ....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~~ 240 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG-GGRL 240 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CCcC
Confidence 99999876432211 112233568999999998889999999999999999997 9999998877766655443 2223
Q ss_pred CCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003935 747 EIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLD 779 (785)
Q Consensus 747 ~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~ 779 (785)
..+ +..+.+++.+||+ +|.+||++.+++++|++
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 322 2468899999999 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=315.95 Aligned_cols=247 Identities=30% Similarity=0.526 Sum_probs=209.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
.++|.+.+.||.|+||.||+|.+ .++.+++|++...... ..+.+.+|+.+++.++||||+++++++.....++++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 36799999999999999999987 4678999998755432 4578899999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+++++|.+++... ...+++..+..++.|++.||+|||+.||+|+||+|+||++++++.++|+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred eCCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 999999999988632 257899999999999999999999999999999999999999999999999999876543223
Q ss_pred CCCCCCCCcccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC------ChHHH
Q 003935 684 DSSSAGTPEWMAPELIRNE---PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP------EGPLG 754 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~---~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip------~~~L~ 754 (785)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||....+......+.......... +..+.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence 3445688899999999776 88999999999999999999999999887766666554443222211 23588
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003935 755 RLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 755 ~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+++.+||. +|..||++.+|+.+
T Consensus 238 ~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 238 DFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHhcC
Confidence 99999999 99999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=322.84 Aligned_cols=253 Identities=33% Similarity=0.595 Sum_probs=209.8
Q ss_pred CeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 528 ELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
+|++.+.||+|+||.||+|... ...+|+|.+..... ......+.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 4778899999999999999763 24688888764433 344578999999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhc---------------------ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEE
Q 003935 601 MITEYMELGSLYHLIHLSG---------------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCL 659 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~---------------------~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNIL 659 (785)
+++||+.+++|.+++.... ....+++..++.++.|++.||+|||++||+||||||+|||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 9999999999999886421 1235789999999999999999999999999999999999
Q ss_pred EcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 003935 660 VNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVV 736 (785)
Q Consensus 660 Ld~~g~VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v 736 (785)
+++++.+||+|||+++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..+....
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999999999765332211 122345678999999988889999999999999999998 99999888777665
Q ss_pred HHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 737 YAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 737 ~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
..+ ........+ ...+.+++..||+ +|.+||++.++++.|+++..
T Consensus 240 ~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 240 NLL-KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHH-hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 544 333333333 2468999999999 99999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=318.94 Aligned_cols=252 Identities=35% Similarity=0.584 Sum_probs=210.5
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCce
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 599 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 599 (785)
...+|++.+.||+|+||.||+|.+. +..+|+|.+..... ....+.|.+|+.+++.++||||+++++++...+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3467899999999999999999762 33689998865433 34457889999999999999999999999999999
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
+++|||+++++|.+++... ...+++.++..++.|++.||+|||++|++|+||||+|||++.++.++|+|||++..+..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999999998632 35689999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCC---CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003935 680 SPMRD---SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 752 (785)
Q Consensus 680 ~~~~~---~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~ 752 (785)
..... ....++..|+|||.+.+..++.++|+|||||++|++++ |..||......+....+... ...+.+ +..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPAPMDCPAA 237 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcCCCCCCCCHH
Confidence 32211 12223568999999998889999999999999999886 99999888776666655443 333322 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
+.+++.+||+ +|.+||++.++++.|.++
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 238 LHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 8999999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.82 Aligned_cols=245 Identities=26% Similarity=0.385 Sum_probs=201.4
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC-----cee
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP-----RLS 600 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~-----~l~ 600 (785)
+|.+.+.||+|+||+||++.+ +++.||||++..........+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999986 6889999998654444445678899999999999999999999998776 789
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
+|+||+. ++|...+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999997 46777664 3457999999999999999999999999999999999999999999999999999865432
Q ss_pred C-CCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc----------------
Q 003935 681 P-MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE---------------- 742 (785)
Q Consensus 681 ~-~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~---------------- 742 (785)
. .......+++.|+|||++.+. .++.++|||||||++|||++|+.||.+.++......+...
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 2 122344678999999998874 4789999999999999999999999887766554443321
Q ss_pred -------CCCCC----------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 743 -------GSRLE----------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 743 -------~~~~~----------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
...+. .....+.+|+.+||. ||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 11110 012357889999999 99999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=335.20 Aligned_cols=245 Identities=25% Similarity=0.328 Sum_probs=200.3
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC------
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------ 596 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~------ 596 (785)
-.++|.+.+.||+|+||.||++.+ .++.||||++..........+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 357899999999999999999976 588999999876555555567888999999999999999999987543
Q ss_pred CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
...|++|||+.+ ++.+.+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 347999999976 5555553 2478889999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----------
Q 003935 677 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR----------- 745 (785)
Q Consensus 677 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~----------- 745 (785)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......
T Consensus 169 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 169 AGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred CCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 5443 2233567899999999999999999999999999999999999999876654433322111000
Q ss_pred --------------C------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 746 --------------L------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 746 --------------~------------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
. ......+.+|+.+|+. ||.+|||+.++++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 0011347889999999 99999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=321.61 Aligned_cols=246 Identities=24% Similarity=0.334 Sum_probs=197.2
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc---CCCceeeEeccccC-----CC
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL---RHPNVILFLGACTK-----PP 597 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L---~HPNIVkL~g~~~d-----~~ 597 (785)
+|.+.+.||+|+||+||+|.+ +++.||+|.+............+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 478899999999999999987 578999999865443332234566777777665 69999999998764 23
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.++++|||+.+ +|.+++... ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 58999999985 788777633 2345899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------- 746 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~----------- 746 (785)
.... ......+++.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 159 SCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred cCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 5332 2234568899999999998889999999999999999999999998876665554443211000
Q ss_pred -----------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 -----------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 -----------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..-+..+.+++.+|++ ||.+|||+.+++.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0012347899999999 99999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=335.76 Aligned_cols=244 Identities=25% Similarity=0.305 Sum_probs=201.6
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC------C
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------P 597 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~------~ 597 (785)
.++|.+.+.||+|+||.||++.+ .++.||||++..........+.+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 47899999999999999999987 578899999876554455567788999999999999999999987543 3
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+|+||||+.+ +|...+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 57999999976 5666553 24788889999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC------------
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR------------ 745 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~------------ 745 (785)
.... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 177 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 177 GTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred CCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 4432 233557899999999999999999999999999999999999999887766555444321110
Q ss_pred --------CC-----------------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 746 --------LE-----------------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 746 --------~~-----------------------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+. .....+.+|+.+|+. ||.+|||+.++++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 011247889999999 99999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=325.89 Aligned_cols=258 Identities=29% Similarity=0.558 Sum_probs=215.2
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEecc
Q 003935 521 EWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGA 592 (785)
Q Consensus 521 e~~i~~s~y~i~k~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~ 592 (785)
.|.+..++|.+.+.||+|+||.||++.+ .+..+|+|++..... ....+.+.+|+.+++++ +||||++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 4566778899999999999999999964 234799998865432 33457789999999999 79999999999
Q ss_pred ccCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecC
Q 003935 593 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 672 (785)
Q Consensus 593 ~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFG 672 (785)
+...+..+++|||+++|+|.++++.. ....+++.++..++.|++.||+|||+++|+|+||||+|||++.++.++|+|||
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence 99999999999999999999998632 23348999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003935 673 LSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP 749 (785)
Q Consensus 673 LA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip 749 (785)
++........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...............+.....+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 266 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP 266 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCC
Confidence 9986543221 1122345678999999999889999999999999999998 999998877666555555544433322
Q ss_pred ---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 750 ---EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 750 ---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
+..+.+++.+||. +|++||++.++++.|.+.
T Consensus 267 ~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 267 EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 3468999999999 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=316.05 Aligned_cols=253 Identities=36% Similarity=0.582 Sum_probs=210.6
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEEC--C---eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIWN--G---TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~~--g---~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
+..++|+..+.||+|+||.||+|... + ..+|+|.+.... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 34567889999999999999999762 3 368999875443 23445789999999999999999999999999999
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
.+++|||+++++|.+++.. ....+++.++..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 81 AMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred cEEEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999999863 33578999999999999999999999999999999999999999999999999998664
Q ss_pred CCCCCC---CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---Ch
Q 003935 679 DSPMRD---SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EG 751 (785)
Q Consensus 679 ~~~~~~---~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~ 751 (785)
...... .....++.|+|||++.+..++.++|||||||++|||++ |+.||...........+... ...+.+ +.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~ 237 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLPAPMDCPS 237 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC-CCCCCCCCCCH
Confidence 322111 11223457999999998889999999999999999997 99999888777766666543 232222 34
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 752 PLGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 752 ~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
.+.+++.+||+ +|.+||++.+|++.|.++
T Consensus 238 ~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 238 AVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 68899999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=334.68 Aligned_cols=260 Identities=32% Similarity=0.573 Sum_probs=210.3
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccc
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGAC 593 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~ 593 (785)
|.+..++|.+.+.||+|+||+||+|.+ .++.||||++..... ......+.+|+.++.++ +||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 667778999999999999999999974 367899999865433 33456788999999999 689999999988
Q ss_pred cCC-CceeEEEEEcccchhhHHHHhhcc----------------------------------------------------
Q 003935 594 TKP-PRLSMITEYMELGSLYHLIHLSGQ---------------------------------------------------- 620 (785)
Q Consensus 594 ~d~-~~l~LV~Ey~~gGSL~dlL~~~~~---------------------------------------------------- 620 (785)
... ..++++|||+++|+|.+++.....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 468899999999999999864210
Q ss_pred ------------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC--CCCC
Q 003935 621 ------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSS 686 (785)
Q Consensus 621 ------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--~~~~ 686 (785)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........ ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 12467888999999999999999999999999999999999999999999999986533211 1112
Q ss_pred CCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003935 687 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 762 (785)
Q Consensus 687 ~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~ 762 (785)
..+++.|+|||.+.+..++.++||||||+++|+|++ |..||...............+.....+ ...+.+++..||+
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~ 320 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 320 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence 345678999999988889999999999999999997 899998765444333434444333333 3468899999999
Q ss_pred -CCCCCCCHHHHHHHHHhhhh
Q 003935 763 -EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 763 -DP~kRPS~~EIL~~L~~l~~ 782 (785)
||.+||++.+|+++|+++..
T Consensus 321 ~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 321 GEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=312.06 Aligned_cols=248 Identities=29% Similarity=0.501 Sum_probs=212.0
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC--CCceeEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--PPRLSMIT 603 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d--~~~l~LV~ 603 (785)
+|.+.+.||.|+||.||++.+ +++.+|+|++..........+.+..|+++++.++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478899999999999999976 57889999998776666667889999999999999999999997753 45589999
Q ss_pred EEcccchhhHHHHhh-cccccchHHHHHHHHHHHHHHHHHHH-----hcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 604 EYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIH-----RMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~AL~yLH-----s~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
||+++++|.+++... .....+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998643 22457899999999999999999999 889999999999999999999999999999887
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHH
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLG 754 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~ 754 (785)
...........+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.. +....++ ...+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 239 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE-GKFRRIPYRYSSELN 239 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc-CCCCCCccccCHHHH
Confidence 6544323455789999999999988899999999999999999999999998876665555544 3333333 34689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003935 755 RLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 755 ~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+++.+|+. +|.+||++.+|+++
T Consensus 240 ~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 240 EVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHccCCcccCCCHHHHhhC
Confidence 99999999 99999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=312.74 Aligned_cols=248 Identities=31% Similarity=0.633 Sum_probs=208.6
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
+.++|++.+.||.|+||.||++.+ +++.+|+|++...... ...|.+|+++++.++||||+++++++......++++
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 456889999999999999999977 4788999998654443 356889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+.+++|.+++.. ....+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 79 EFMEHGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EcCCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999998863 2346889999999999999999999999999999999999999999999999998765433211
Q ss_pred -CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC--CCCCCChHHHHHHHH
Q 003935 684 -DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGS--RLEIPEGPLGRLIAD 759 (785)
Q Consensus 684 -~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~--~~~ip~~~L~~LI~~ 759 (785)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||...........+..... .+......+.+|+.+
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQH 236 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 122335678999999998889999999999999999998 8999988777766666543221 122234569999999
Q ss_pred hhh-CCCCCCCHHHHHHHH
Q 003935 760 CWA-EPQERPSCEEILSRL 777 (785)
Q Consensus 760 CL~-DP~kRPS~~EIL~~L 777 (785)
||+ +|.+||++.+++++|
T Consensus 237 ~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 237 CWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HcccChhhCCCHHHHHHhh
Confidence 999 999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=321.05 Aligned_cols=246 Identities=27% Similarity=0.475 Sum_probs=205.3
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
.++|.+.+.||+|+||.||+|.+ +++.||+|++..... .....+.+|+.+++.++||||+++++++...+.+++++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 35788889999999999999987 578999999865432 23456788999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+++++|.+++. ..+.+++.+++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.........
T Consensus 86 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 86 EFCGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred eccCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 9999999999886 3457899999999999999999999999999999999999999999999999998766543333
Q ss_pred CCCCCCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC------ChHHH
Q 003935 684 DSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP------EGPLG 754 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip------~~~L~ 754 (785)
.....|++.|+|||++. ...++.++|+|||||++|+|++|+.||....+.............+... +..+.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence 34557899999999974 4568899999999999999999999997766555444433333222111 23588
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003935 755 RLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 755 ~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+++.+||. +|++||++.+|+++
T Consensus 243 ~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 243 HFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhcC
Confidence 99999999 99999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.33 Aligned_cols=253 Identities=32% Similarity=0.562 Sum_probs=212.0
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
|++..++|.+.++||+|+||.||++.+ .+..+|+|.+.... ...+.|.+|+.+++.++|+||+++++++.+ ...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 667788999999999999999999976 46679999876432 235678899999999999999999999887 6789
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
++|||+++++|.+++... ....+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 77 IITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEeCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999999998643 3456888999999999999999999999999999999999999999999999999876443
Q ss_pred CCC-CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003935 681 PMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 755 (785)
Q Consensus 681 ~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~ 755 (785)
... .....++..|+|||++....++.++|+|||||++|++++ |+.||...........+.. +...+.+ +..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRPENCPEELYN 234 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC-CCCCCCcccCCHHHHH
Confidence 221 122345678999999998889999999999999999998 8999998877666655443 3232222 246889
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 756 LIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 756 LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
++.+||+ +|++||++.++++.|+++
T Consensus 235 ~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 235 IMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred HHHHHcccCcccCcCHHHHHHHHhcC
Confidence 9999999 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=321.07 Aligned_cols=252 Identities=32% Similarity=0.577 Sum_probs=209.7
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 596 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 596 (785)
++..+|.+.++||+|+||.||++.. ++..+|+|.+... .....+.|.+|+++++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 4567889999999999999999963 3557889987543 334457899999999999999999999999999
Q ss_pred CceeEEEEEcccchhhHHHHhhcc------------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQ------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 664 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g 664 (785)
...+++|||+++++|.+++..... ...+++..++.++.|++.||+|||++|++|+||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 999999999999999999874321 13588999999999999999999999999999999999999999
Q ss_pred eEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 003935 665 TVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVAN 741 (785)
Q Consensus 665 ~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~ 741 (785)
.+||+|||++........ ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...........+..
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 999999999976543221 1122345678999999999999999999999999999998 8999988877776666544
Q ss_pred cCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003935 742 EGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLL 778 (785)
Q Consensus 742 ~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~ 778 (785)
.. ....+ +..+.+|+.+||+ ||.+||++.+|++.|+
T Consensus 240 ~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 240 GR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred Cc-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 32 22222 3468899999999 9999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=316.48 Aligned_cols=244 Identities=27% Similarity=0.536 Sum_probs=202.3
Q ss_pred EEeeeCcEEEEEEEEC----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccc
Q 003935 534 RVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 609 (785)
Q Consensus 534 ~LG~G~fG~VYkg~~~----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gG 609 (785)
.||+|+||.||+|.+. +..||+|++.... .....+.|.+|+.+++.++||||+++++++.. ...++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 3899999999999763 4569999986543 34445779999999999999999999998864 4689999999999
Q ss_pred hhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC---CC
Q 003935 610 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD---SS 686 (785)
Q Consensus 610 SL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~---~~ 686 (785)
+|.+++.. ....+++..++.++.|++.||+|||++|++|+||||+|||++.++.+||+|||++..+....... ..
T Consensus 80 ~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 80 PLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99998863 24578999999999999999999999999999999999999999999999999998654332111 12
Q ss_pred CCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003935 687 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 762 (785)
Q Consensus 687 ~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~ 762 (785)
..+++.|+|||.+....++.++|||||||++|+|++ |..||...........+. .+.....+ ...+.+++.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c~~ 236 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCWI 236 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHcC
Confidence 233578999999998889999999999999999996 999999887776655443 33334433 3468999999999
Q ss_pred -CCCCCCCHHHHHHHHHhhhh
Q 003935 763 -EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 763 -DP~kRPS~~EIL~~L~~l~~ 782 (785)
+|++||++.+|++.|+++.|
T Consensus 237 ~~~~~Rp~~~~i~~~l~~~~~ 257 (257)
T cd05115 237 YKWEDRPNFAKVEERMRTYYY 257 (257)
T ss_pred CChhhCcCHHHHHHHHhhhcC
Confidence 99999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=333.48 Aligned_cols=240 Identities=24% Similarity=0.401 Sum_probs=197.0
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCceeEEEEEccc
Q 003935 533 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
+.||+|+||+||+|.. +++.||+|++.+.... ....+.+..|+.++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999987 5788999999765432 33456788999999888 699999999999999999999999999
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 688 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 688 (785)
|+|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence 99998876 345799999999999999999999999999999999999999999999999999975433223334567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHHhcCCCCCCC---ChHHHHHHHH
Q 003935 689 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV------LPERVVYAVANEGSRLEIP---EGPLGRLIAD 759 (785)
Q Consensus 689 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~------~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~ 759 (785)
||+.|+|||++.+..++.++|||||||++|+|++|+.||... ............. ...+| +..+.+++.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~ 236 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-PIRIPRFLSVKASHVLKG 236 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-CCCCCCCCCHHHHHHHHH
Confidence 999999999999999999999999999999999999999532 2222233322222 22233 3468899999
Q ss_pred hhh-CCCCCCC------HHHHHHH
Q 003935 760 CWA-EPQERPS------CEEILSR 776 (785)
Q Consensus 760 CL~-DP~kRPS------~~EIL~~ 776 (785)
||. ||.+|++ +.++++|
T Consensus 237 ~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 237 FLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HhccCHHHcCCCCCCCCHHHHHcC
Confidence 999 9999997 4677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=325.49 Aligned_cols=256 Identities=31% Similarity=0.574 Sum_probs=208.5
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCe--EEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCc
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGT--DVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPR 598 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~--~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~ 598 (785)
+.+++|.+.+.||+|+||.||+|.+ ++. .+|+|.+... ........|.+|+.++.++ +||||+++++++...+.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 4567899999999999999999986 344 3566665432 2334457888999999999 89999999999999999
Q ss_pred eeEEEEEcccchhhHHHHhhc-------------ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCe
Q 003935 599 LSMITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 665 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~-------------~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~ 665 (785)
+|++|||+++++|.+++.... ....+++..++.++.|++.||+|||++||+||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 999999999999999987432 1236889999999999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Q 003935 666 VKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGS 744 (785)
Q Consensus 666 VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~ 744 (785)
+||+|||++...... .......++..|+|||.+.+..++.++|||||||++|+|+| |..||......+....+.. ..
T Consensus 163 ~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~ 240 (303)
T cd05088 163 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GY 240 (303)
T ss_pred EEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc-CC
Confidence 999999998643211 11112234567999999988889999999999999999998 9999988777666555432 22
Q ss_pred CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 745 RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 745 ~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
....+ ...+.+|+.+||+ +|.+||++.+++..|.++..
T Consensus 241 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 241 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 22222 3468899999999 99999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=320.55 Aligned_cols=254 Identities=31% Similarity=0.559 Sum_probs=210.6
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 596 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 596 (785)
++.++|.+.+.||+|+||.||+|.+ .+..+|+|++.... .......|.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 3457899999999999999999976 35689999986443 334456789999999999999999999999999
Q ss_pred CceeEEEEEcccchhhHHHHhhc-------------------ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCc
Q 003935 597 PRLSMITEYMELGSLYHLIHLSG-------------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSAN 657 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~-------------------~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsN 657 (785)
...++++||+++++|.+++.... ....+++..++.++.|++.||+|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999986321 11347888999999999999999999999999999999
Q ss_pred EEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 003935 658 CLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPER 734 (785)
Q Consensus 658 ILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~ 734 (785)
||++.++.++|+|||++........ .......+..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876533221 1122345667999999998899999999999999999997 888998888777
Q ss_pred HHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003935 735 VVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLD 779 (785)
Q Consensus 735 ~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~ 779 (785)
....+.... ....+ +..+.+++.+||+ +|.+||++.|+++.|++
T Consensus 241 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 VIYYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 766654433 22222 3468999999999 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=314.43 Aligned_cols=243 Identities=26% Similarity=0.545 Sum_probs=202.6
Q ss_pred eEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcc
Q 003935 533 TRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME 607 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~ 607 (785)
++||+|+||.||+|.+. +..+|+|.+...... ...+.+.+|+.+++.+.||||+++++++.. ...+++|||+.
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence 46999999999999762 257999998765543 445789999999999999999999998764 46899999999
Q ss_pred cchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCC--
Q 003935 608 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS-- 685 (785)
Q Consensus 608 gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~-- 685 (785)
+++|.+++.. ...+++..+..++.|++.||+|||..|++|+||||+|||++.++.+||+|||+++.+........
T Consensus 79 ~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 79 LGPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 9999999973 34789999999999999999999999999999999999999999999999999987644322111
Q ss_pred -CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHh
Q 003935 686 -SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADC 760 (785)
Q Consensus 686 -~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~C 760 (785)
...++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+.. ......+ +..+.+++.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES-GERLPRPEECPQEIYSIMLSC 234 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHH
Confidence 1223467999999998899999999999999999998 9999988877666555543 3333333 24688999999
Q ss_pred hh-CCCCCCCHHHHHHHHHhhh
Q 003935 761 WA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 761 L~-DP~kRPS~~EIL~~L~~l~ 781 (785)
|. +|.+||++.++++.|+++.
T Consensus 235 l~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 235 WKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred hcCChhhCcCHHHHHHHHHhcc
Confidence 99 9999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=322.31 Aligned_cols=250 Identities=25% Similarity=0.430 Sum_probs=220.0
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 601 (785)
..++|.+++.||+|.||.||.|.. ++.-||+|++.+..+.. ....++.+|++|-..|+||||+++|++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 457999999999999999999976 46689999997765432 234678899999999999999999999999999999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
++||.+.|.++..|... ....+++.....++.|++.|+.|||..+||||||||+|+|++..+.+||+|||.+..-. .
T Consensus 100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--~ 176 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--S 176 (281)
T ss_pred EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--C
Confidence 99999999999998633 45679999999999999999999999999999999999999999999999999987643 3
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHh
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADC 760 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~C 760 (785)
....+.|||..|++||+..+..++...|+|++|++.||++.|..||...+..+.+..+.......+ .-....+++|..|
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~l 256 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRL 256 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHH
Confidence 345678999999999999999999999999999999999999999999998888888875443332 2244689999999
Q ss_pred hh-CCCCCCCHHHHHHHH
Q 003935 761 WA-EPQERPSCEEILSRL 777 (785)
Q Consensus 761 L~-DP~kRPS~~EIL~~L 777 (785)
+. +|.+|.+..++++|-
T Consensus 257 l~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 257 LVKNPIERLALTEVMDHP 274 (281)
T ss_pred hccCccccccHHHHhhhH
Confidence 99 999999999999874
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=314.01 Aligned_cols=249 Identities=27% Similarity=0.468 Sum_probs=210.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|++.+.||.|+||+||+|.. ++..+|+|++....... ....+.+|+.+++.++|+||+++++.+.....+++++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4789999999999999999976 57789999987655444 56789999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC-
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR- 683 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~- 683 (785)
|+++++|.+++........+++..+..++.|++.||+|||+.||+|+||+|+||++++++.++|+|||++..+......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 9999999999975433357899999999999999999999999999999999999999999999999999876543222
Q ss_pred ---CCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CC------ChH
Q 003935 684 ---DSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IP------EGP 752 (785)
Q Consensus 684 ---~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip------~~~ 752 (785)
.....++..|+|||.+... .++.++|+|||||++|+|++|+.||.................... .. ...
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKS 239 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHH
Confidence 1334688999999998776 789999999999999999999999988777666655544322111 10 235
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.+++.+||. ||.+||++.+|+++
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 240 FRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhhC
Confidence 7899999999 99999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=337.85 Aligned_cols=239 Identities=25% Similarity=0.414 Sum_probs=198.7
Q ss_pred EeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhc---CCCceeeEeccccCCCceeEEEEEccc
Q 003935 535 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL---RHPNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 535 LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L---~HPNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
||+|+||+||+|.+ .++.||||++.+... .......+..|..++..+ .||||+++++++.+...+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999987 588999999865433 222344566677777665 699999999999999999999999999
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 688 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 688 (785)
|+|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.............+
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 99998886 345789999999999999999999999999999999999999999999999999976433333334567
Q ss_pred CCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CChHHHHHHHHhhh-CC
Q 003935 689 GTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI--PEGPLGRLIADCWA-EP 764 (785)
Q Consensus 689 GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i--p~~~L~~LI~~CL~-DP 764 (785)
||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+......... -...+.+++.+||. ||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P 237 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCH
Confidence 99999999998764 4889999999999999999999999998887777766554433322 24568899999999 99
Q ss_pred CCCC----CHHHHHHH
Q 003935 765 QERP----SCEEILSR 776 (785)
Q Consensus 765 ~kRP----S~~EIL~~ 776 (785)
.+|| ++.++++|
T Consensus 238 ~~R~~~~~~~~~ll~h 253 (330)
T cd05586 238 QHRLGAHRDAVELKEH 253 (330)
T ss_pred HHCCCCCCCHHHHhcC
Confidence 9998 57777664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.24 Aligned_cols=247 Identities=29% Similarity=0.464 Sum_probs=205.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc---ChHHHHHHHHHHHHHhhcCCCceeeEeccccCC--Cce
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL---TAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRL 599 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~---~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~l 599 (785)
.+|++.+.||+|+||.||+|.+ ++..||||.+..... .....+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5789999999999999999986 478999998754322 233457888999999999999999999988764 458
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
+++|||+++++|.+++.. ...+++..++.++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 899999999999998863 34678889999999999999999999999999999999999999999999999886542
Q ss_pred CCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC---hHH
Q 003935 680 SPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---GPL 753 (785)
Q Consensus 680 ~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~---~~L 753 (785)
... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||..................+..|. ..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHC 238 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHH
Confidence 211 12234588899999999888899999999999999999999999988766665555544433444442 357
Q ss_pred HHHHHHhhhCCCCCCCHHHHHHH
Q 003935 754 GRLIADCWAEPQERPSCEEILSR 776 (785)
Q Consensus 754 ~~LI~~CL~DP~kRPS~~EIL~~ 776 (785)
.+++.+||.+|..||++++|+++
T Consensus 239 ~~~i~~~l~~p~~Rp~~~~il~~ 261 (265)
T cd06652 239 RDFLKRIFVEAKLRPSADELLRH 261 (265)
T ss_pred HHHHHHHhcChhhCCCHHHHhcC
Confidence 88999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=341.55 Aligned_cols=246 Identities=28% Similarity=0.481 Sum_probs=219.6
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHhhcC-CCceeeEeccccCCCceeE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~L 601 (785)
...|.+++.||+|.||.||+++. +|+.+|+|++.+..... ...+.+.+|+.+|+++. |||||.++++|++...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 35788999999999999999987 58899999997766532 34578899999999998 9999999999999999999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC----CCeEEEEecCccccc
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK----HWTVKICDFGLSRII 677 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~----~g~VKL~DFGLA~~l 677 (785)
|||++.||.|++.+... .+++..+..++.|++.+++|||+.||+||||||+|+|+.. ++.+|++|||++...
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999998743 3999999999999999999999999999999999999963 357999999999988
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChH
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGP 752 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-----~~~ 752 (785)
.. .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.+.+.......+.........+ ...
T Consensus 190 ~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 190 KP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred cC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 77 556678899999999999999999999999999999999999999999999888888887766543322 246
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
++++|..|+. ||.+|+|+.++|+|
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcC
Confidence 8999999999 99999999999997
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=318.35 Aligned_cols=257 Identities=28% Similarity=0.494 Sum_probs=208.3
Q ss_pred ccccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEecccc
Q 003935 518 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACT 594 (785)
Q Consensus 518 ~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~ 594 (785)
..+.+....++|.+.+.||+|+||+||++.+ .++.+|+|++..... ....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 4466666788999999999999999999977 578999998754322 235677899999999 6999999999873
Q ss_pred -----CCCceeEEEEEcccchhhHHHHhh-cccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEE
Q 003935 595 -----KPPRLSMITEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKI 668 (785)
Q Consensus 595 -----d~~~l~LV~Ey~~gGSL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL 668 (785)
..+.++++|||+++++|.+++... .....+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEE
Confidence 445689999999999999887532 23456889999999999999999999999999999999999999999999
Q ss_pred EecCccccccCCCCCCCCCCCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Q 003935 669 CDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-----EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG 743 (785)
Q Consensus 669 ~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~ 743 (785)
+|||++..+...........|++.|+|||++.. ..++.++|||||||++|+|++|+.||....+...........
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (286)
T cd06638 166 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP 245 (286)
T ss_pred ccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC
Confidence 999999876543333345578999999999853 457889999999999999999999998776654444332221
Q ss_pred C-CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003935 744 S-RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRL 777 (785)
Q Consensus 744 ~-~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L 777 (785)
. ....+ ...+.+|+.+||+ ||.+||++.+++++.
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1 11112 3468999999999 999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=316.99 Aligned_cols=247 Identities=28% Similarity=0.477 Sum_probs=203.0
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccCC------
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKP------ 596 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~------ 596 (785)
...|.+.+.||+|+||+||+|.+ .++.+|+|++..... ....+.+|+.+++.+ +||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35678889999999999999977 578899999865432 235678999999998 699999999998643
Q ss_pred CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
..++++|||+++++|.+++... ....+++..+..++.|++.||+|||+++|+|+||||+||++++++.++|+|||++..
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 4589999999999999998742 345689999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---
Q 003935 677 ITDSPMRDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI--- 748 (785)
Q Consensus 677 l~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i--- 748 (785)
............|++.|+|||++. +..++.++|||||||++|+|++|+.||.....................
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCC
Confidence 644322334567899999999986 345788999999999999999999999877666555544433222211
Q ss_pred CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 749 PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 749 p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
....+.+|+.+||. +|.+|||+.+++++
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 241 WSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 13468999999999 99999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=332.95 Aligned_cols=248 Identities=21% Similarity=0.335 Sum_probs=207.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++|.+.++||+|+||+||++.+ .++.+|+|++.+... .......+..|+.++..++|+||+++++++.+...+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4789999999999999999987 467899999865332 2223455788999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC-
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 682 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~- 682 (785)
||+++|+|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 999999999999732 35689999999999999999999999999999999999999999999999999876533222
Q ss_pred CCCCCCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC------Ch
Q 003935 683 RDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP------EG 751 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip------~~ 751 (785)
.....+||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+........+| ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence 223457999999999986 3468899999999999999999999999988888888776655443333 33
Q ss_pred HHHHHHHHhhh-C--CCCCCCHHHHHHH
Q 003935 752 PLGRLIADCWA-E--PQERPSCEEILSR 776 (785)
Q Consensus 752 ~L~~LI~~CL~-D--P~kRPS~~EIL~~ 776 (785)
.+.+|+.+|+. + +..|+++.++++|
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 58899999886 3 4447899999987
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=333.81 Aligned_cols=248 Identities=21% Similarity=0.334 Sum_probs=206.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++|.+.+.||+|+||+||++.+ .++.||+|++.+... .......+..|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4789999999999999999987 577899999865322 2233456788999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC-
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 682 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~- 682 (785)
||+++|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 999999999999732 35688999999999999999999999999999999999999999999999999987654322
Q ss_pred CCCCCCCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC------Ch
Q 003935 683 RDSSSAGTPEWMAPELIRN-----EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP------EG 751 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~-----~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip------~~ 751 (785)
......||+.|+|||++.+ +.++.++|||||||+||+|++|+.||......+....+.....+..+| ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 2223579999999999875 567889999999999999999999999888877777776554444333 24
Q ss_pred HHHHHHHHhhh-CCCC--CCCHHHHHHH
Q 003935 752 PLGRLIADCWA-EPQE--RPSCEEILSR 776 (785)
Q Consensus 752 ~L~~LI~~CL~-DP~k--RPS~~EIL~~ 776 (785)
.+.+++.+|+. ++.+ |++++++++|
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 68899999988 4433 5689988876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.55 Aligned_cols=246 Identities=28% Similarity=0.507 Sum_probs=207.5
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
+|.+.+.||+|+||.||+|.. +++.||+|.+..........+.+..|+.+++.++|+||+++++++...+.+++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 478899999999999999976 578999999987766555678899999999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC-
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD- 684 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~- 684 (785)
+++++|.+++. ....+++..+..++.|++.||+|||+.||+|+||+|+||++++++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLE---HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHh---hcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 99999999986 34468899999999999999999999999999999999999999999999999998765432221
Q ss_pred ---CCCCCCCcccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHH
Q 003935 685 ---SSSAGTPEWMAPELIRNEP---FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPL 753 (785)
Q Consensus 685 ---~~~~GT~~Y~APEvl~~~~---~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-----~~~L 753 (785)
....+++.|+|||++.+.. ++.++||||||+++|+|++|+.||..................+.+| ...+
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHH
Confidence 1356788999999998766 8899999999999999999999997664333333222333333333 2358
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 754 GRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 754 ~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+++..||+ +|.+||++.+++.+
T Consensus 238 ~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 238 KDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHHHHHccCCcccCCCHHHHhcC
Confidence 899999999 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=328.52 Aligned_cols=260 Identities=28% Similarity=0.573 Sum_probs=216.2
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeE
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILF 589 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL 589 (785)
.+|++...+|++++.||+|+||.||++.+. +..||+|++... ......+.+.+|+.+++++ +||||+++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 457777788999999999999999999652 236899987643 3334567899999999999 79999999
Q ss_pred eccccCCCceeEEEEEcccchhhHHHHhhc-------------ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCC
Q 003935 590 LGACTKPPRLSMITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 656 (785)
Q Consensus 590 ~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~-------------~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKps 656 (785)
+++|...+.+++++||+++|+|.+++.... ....+++..++.++.|++.||+|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 999999999999999999999999986432 1235788999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 003935 657 NCLVNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 733 (785)
Q Consensus 657 NILLd~~g~VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~ 733 (785)
|||++.++.+||+|||+++........ .....++..|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999999876443211 122334567999999999999999999999999999998 88999988777
Q ss_pred HHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 734 RVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 734 ~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
.....+.. ......+ ...+.+++.+||+ +|.+||++.+++++|.++.
T Consensus 244 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 244 ELFKLLKE-GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 76665543 3333333 3468899999999 9999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.25 Aligned_cols=245 Identities=28% Similarity=0.534 Sum_probs=205.1
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-------HHHHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-------ENMEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-------~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
.|.+++.||.|+||.||+|.+ .++.+|+|.+....... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 366788999999999999976 57889999886543321 234678899999999999999999999999999
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
.++++||+++++|.+++. ....+++..+..++.|++.||+|||+.|++|+||+|+||++++++.++|+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 999999999999999996 33578899999999999999999999999999999999999999999999999998765
Q ss_pred CCCC------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---
Q 003935 679 DSPM------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP--- 749 (785)
Q Consensus 679 ~~~~------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip--- 749 (785)
.... ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...........+.. ...+.++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 236 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPEIPSNI 236 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCCcCCccc
Confidence 3211 11234578899999999988899999999999999999999999988766555544433 2233333
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 750 EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 750 ~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+..+.+++.+||+ ||.+||++.+++++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 237 SSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 3468899999999 99999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=322.88 Aligned_cols=244 Identities=23% Similarity=0.327 Sum_probs=196.7
Q ss_pred EeeeCcEEEEEEEE--CCeEEEEEEeeccccChH-HHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccchh
Q 003935 535 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE-NMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 611 (785)
Q Consensus 535 LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~-~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL 611 (785)
||+|+||+||++.. .|+.||+|.+........ ....+..|+++++.++||||+++++++..+..+++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999976 588999999865443221 234556799999999999999999999999999999999999999
Q ss_pred hHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCCCCC
Q 003935 612 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 691 (785)
Q Consensus 612 ~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~ 691 (785)
.+++... ....+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||++....... ......|++
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~ 158 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTN 158 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCC
Confidence 9887533 33458899999999999999999999999999999999999999999999999998765432 223456899
Q ss_pred cccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHhcCCCC--CCCChHHHHHHHHhhh-CC
Q 003935 692 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE----RVVYAVANEGSRL--EIPEGPLGRLIADCWA-EP 764 (785)
Q Consensus 692 ~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~----~~v~~i~~~~~~~--~ip~~~L~~LI~~CL~-DP 764 (785)
.|+|||++.+..++.++|||||||++|+|++|+.||...... ............. ......+.+|+.+||+ ||
T Consensus 159 ~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P 238 (277)
T cd05607 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKP 238 (277)
T ss_pred CccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCH
Confidence 999999999988999999999999999999999999765332 2222222211111 1124468999999999 99
Q ss_pred CCCCCHHHHHHHHHhh
Q 003935 765 QERPSCEEILSRLLDC 780 (785)
Q Consensus 765 ~kRPS~~EIL~~L~~l 780 (785)
.+||++.++++++...
T Consensus 239 ~~R~~~~~~~~~~~~h 254 (277)
T cd05607 239 EDRLGSREKNDDPRKH 254 (277)
T ss_pred hhCCCCccchhhhhcC
Confidence 9999997766555443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.97 Aligned_cols=246 Identities=27% Similarity=0.476 Sum_probs=205.1
Q ss_pred CeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccC----hHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLT----AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~----~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
+|++++.||.|+||+||+|.. +++.+|+|.+...... ......+.+|+++++.++|+||+++++++.+...++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999976 6888999988654321 23346788999999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC--
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS-- 680 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~-- 680 (785)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999999999863 346889999999999999999999999999999999999999999999999998765321
Q ss_pred ----CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCCCCCC---ChH
Q 003935 681 ----PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE-GSRLEIP---EGP 752 (785)
Q Consensus 681 ----~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~-~~~~~ip---~~~ 752 (785)
........++..|+|||++.+..++.++|||||||++|+|++|..||...........+... ...+.++ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHH
Confidence 11122356889999999999988999999999999999999999999877655544443332 2222233 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.+++.+||. +|.+||++.+++++
T Consensus 238 ~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 238 AIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcC
Confidence 8899999999 99999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.69 Aligned_cols=243 Identities=31% Similarity=0.570 Sum_probs=206.4
Q ss_pred eEEeeeCcEEEEEEEEC---C--eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcc
Q 003935 533 TRVGIGFFGEVFRGIWN---G--TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME 607 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~~---g--~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~ 607 (785)
+.||+|+||.||+|.+. + ..+|||.+...... ...+.|.+|+.++++++||||+++++++.. ..+++++||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 36899999999999762 2 26899998765544 556789999999999999999999999988 88999999999
Q ss_pred cchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC---C
Q 003935 608 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR---D 684 (785)
Q Consensus 608 gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~---~ 684 (785)
+++|.+.+..... ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||++..+...... .
T Consensus 79 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 79 LGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 9999999874322 57899999999999999999999999999999999999999999999999999876442211 1
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHh
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADC 760 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~C 760 (785)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+.........+ +..+.+++.+|
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 237 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQC 237 (257)
T ss_pred cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHH
Confidence 13456788999999999899999999999999999998 999998888877777666544444333 34689999999
Q ss_pred hh-CCCCCCCHHHHHHHHH
Q 003935 761 WA-EPQERPSCEEILSRLL 778 (785)
Q Consensus 761 L~-DP~kRPS~~EIL~~L~ 778 (785)
|+ +|.+||++.++++.|.
T Consensus 238 l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 238 WAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCCcccCCCHHHHHHHhc
Confidence 99 9999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=321.92 Aligned_cols=254 Identities=33% Similarity=0.566 Sum_probs=206.1
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEECC----------------eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceee
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIWNG----------------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 588 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~~g----------------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVk 588 (785)
...+|.+.++||+|+||.||++...+ ..||+|++... ........|.+|+++++.++||||++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 44689999999999999999986532 24899998654 33444567999999999999999999
Q ss_pred EeccccCCCceeEEEEEcccchhhHHHHhhcc---------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEE
Q 003935 589 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQ---------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCL 659 (785)
Q Consensus 589 L~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~---------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNIL 659 (785)
+++++......++||||+++++|.+++..... ...+++..++.++.|++.||+|||++|++|+||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 99999999999999999999999999864321 124688899999999999999999999999999999999
Q ss_pred EcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCChHHH
Q 003935 660 VNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT--LNRPWEGVLPERV 735 (785)
Q Consensus 660 Ld~~g~VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT--G~~PF~~~~~~~~ 735 (785)
++.++.+||+|||++......... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 999999999999999765432211 122345678999999998889999999999999999998 6679988777665
Q ss_pred HHHHHh---c-CC--C---CCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003935 736 VYAVAN---E-GS--R---LEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLD 779 (785)
Q Consensus 736 v~~i~~---~-~~--~---~~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~ 779 (785)
...+.. . .. . ...-+..+.+|+.+||. ||.+||++.+|++.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 544322 1 11 1 11113469999999999 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=318.64 Aligned_cols=247 Identities=28% Similarity=0.399 Sum_probs=203.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|.+.+.||+|+||.||+|.+ .++.||+|++..........+.+.+|+++++.++||||+++++++.....+++++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4688999999999999999987 47899999986654444445678899999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
|+++++|..+.. ....+++..++.++.||+.||+|||+.||+|+||+|+||++++++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 999999988765 23458999999999999999999999999999999999999999999999999998765443333
Q ss_pred CCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC------------------
Q 003935 685 SSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR------------------ 745 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~------------------ 745 (785)
....++..|+|||++.+ ..++.++||||||+++|+|++|+.||...........+......
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 34567889999999875 45788999999999999999999999866554433332211000
Q ss_pred --CC------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 746 --LE------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 746 --~~------------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+. -.+..+.+++.+||. +|.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 012358899999999 99999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=322.96 Aligned_cols=244 Identities=28% Similarity=0.489 Sum_probs=207.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
.+|.+.+.||+|+||.||+|.+ +++.+|+|.+...... ..+.+.+|+.+++.+.||||+++++.+......++|||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 5789999999999999999986 5789999998765443 24678899999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
|+++++|.+++. ...+++.++..++.|++.||+|||+.||+|+||||+|||++.++.++|+|||++..........
T Consensus 98 ~~~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 173 (296)
T cd06654 98 YLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (296)
T ss_pred ccCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccccc
Confidence 999999999885 2357889999999999999999999999999999999999999999999999988664433233
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCC---ChHHHHHHHHh
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIP---EGPLGRLIADC 760 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~-~~ip---~~~L~~LI~~C 760 (785)
....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+......+...... ...+ ...+.+++.+|
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 253 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHH
Confidence 3457889999999999888999999999999999999999999887765544444332221 1122 23588999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003935 761 WA-EPQERPSCEEILSR 776 (785)
Q Consensus 761 L~-DP~kRPS~~EIL~~ 776 (785)
|. +|.+||++.+++++
T Consensus 254 l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 254 LDMDVEKRGSAKELLQH 270 (296)
T ss_pred CcCCcccCcCHHHHhhC
Confidence 99 99999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.25 Aligned_cols=252 Identities=36% Similarity=0.591 Sum_probs=209.3
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC--C---eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCce
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIWN--G---TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 599 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~~--g---~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 599 (785)
...+|++.+.||+|+||.||+|.+. + ..||||++... ......+.|..|+.+++.++||||+++++++.+....
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 3467899999999999999999763 3 35999998654 2344567899999999999999999999999999999
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
+++|||+++++|.+++... ...+++.+++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 81 MIITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEEEecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999999988632 35689999999999999999999999999999999999999999999999999876543
Q ss_pred CCCC---CCCC--CCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---C
Q 003935 680 SPMR---DSSS--AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---E 750 (785)
Q Consensus 680 ~~~~---~~~~--~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~ 750 (785)
.... .... ..+..|+|||.+.+..++.++|||||||++|||++ |..||...........+.. ....+.+ +
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~ 237 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-DYRLPPPMDCP 237 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-CCcCCCcccCC
Confidence 2211 1111 12457999999999899999999999999999886 9999988877766666543 2222222 2
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 751 GPLGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 751 ~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
..+.+++.+||. +|.+||++.+|+..|+++
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 238 TALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 368899999999 999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=317.47 Aligned_cols=244 Identities=34% Similarity=0.556 Sum_probs=209.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|.+.+.||.|+||.||+|.+ +++.+|+|++.... .......+.+|+.+++.++|+||+++++++.+...+++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 3678889999999999999987 57899999986543 23345678899999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
|+++++|.+++.. ..+++..++.++.|++.||.|||+.+++|+||+|+||++++++.++|+|||++..+.......
T Consensus 80 ~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 80 YCGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred eeCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 9999999999862 278999999999999999999999999999999999999999999999999998876543333
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----ChHHHHHHHHh
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP----EGPLGRLIADC 760 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip----~~~L~~LI~~C 760 (785)
....+++.|+|||.+.+..++.++|||||||++|+|+||+.||....+......+.... .+.++ +..+.+++.+|
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN-PPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC-CCCCcccccCHHHHHHHHHH
Confidence 45678889999999998889999999999999999999999998877666555544332 22222 23589999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003935 761 WA-EPQERPSCEEILSR 776 (785)
Q Consensus 761 L~-DP~kRPS~~EIL~~ 776 (785)
|. +|.+||++++++++
T Consensus 235 l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 235 LNKDPKERPSAKELLKH 251 (274)
T ss_pred hhCChhhCcCHHHHhhC
Confidence 98 99999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.14 Aligned_cols=245 Identities=31% Similarity=0.513 Sum_probs=207.8
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc---ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL---TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~---~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
+|+..+.||+|+||+||+|.. ++..|++|.+..... ..+..+.+.+|+.+++.++|+||+++++++.....++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 366778999999999999987 588999999865432 234567899999999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
+||+++++|.+++. ....+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 99999999999986 33468899999999999999999999999999999999999999999999999988764432
Q ss_pred CCCCCCCCCcccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHH
Q 003935 683 RDSSSAGTPEWMAPELIRNEP-FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIA 758 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~~~-~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~ 758 (785)
......+++.|++||.+.... ++.++|+|||||++|+|++|+.||...........+........++ +..+.+++.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 236 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFIL 236 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHH
Confidence 223556889999999987766 8999999999999999999999998877655555544433333443 346899999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003935 759 DCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 759 ~CL~-DP~kRPS~~EIL~~ 776 (785)
+||. +|.+||++.+++.+
T Consensus 237 ~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 237 KCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHhhcCcccCcCHHHHhcC
Confidence 9999 99999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=312.52 Aligned_cols=244 Identities=30% Similarity=0.580 Sum_probs=207.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|.+.+.||.|+||.||+|.+. ++.+++|.+.... ..+.+.+|+.+++.++||||+++++++.....+|+++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 57888999999999999999873 6889999985432 15789999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
|+.+++|.+++.. ....+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..........
T Consensus 79 ~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 79 YCGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred cCCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 9999999999863 24578999999999999999999999999999999999999999999999999998775543233
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCC---ChHHHHHHHHh
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIP---EGPLGRLIADC 760 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~-~~ip---~~~L~~LI~~C 760 (785)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||....+......+...... ...+ ...+.+++.+|
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHH
Confidence 3455788999999999989999999999999999999999999887665554443322111 1111 23688999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003935 761 WA-EPQERPSCEEILSR 776 (785)
Q Consensus 761 L~-DP~kRPS~~EIL~~ 776 (785)
|+ ||.+||++.+++++
T Consensus 237 l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 237 LVKDPEERPSAIQLLQH 253 (256)
T ss_pred HhcChhhCcCHHHHhcC
Confidence 99 99999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=320.58 Aligned_cols=245 Identities=30% Similarity=0.503 Sum_probs=209.0
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
...|++.+.||.|+||.||+|.+ +++.||+|.+...... ..+.+.+|+.+++.++||||+++++++.....+++|+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 35799999999999999999976 6889999998654433 3467889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+++++|..++. ...+++.++..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 96 e~~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 96 EYLAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred EecCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 9999999999885 235899999999999999999999999999999999999999999999999998876544333
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCC---ChHHHHHHHH
Q 003935 684 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIP---EGPLGRLIAD 759 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~-~~~ip---~~~L~~LI~~ 759 (785)
.....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+......+..... ....+ ...+.+++.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR 251 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence 3345688999999999988899999999999999999999999998877665554443222 11122 2358899999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003935 760 CWA-EPQERPSCEEILSR 776 (785)
Q Consensus 760 CL~-DP~kRPS~~EIL~~ 776 (785)
||. ||.+||++.+|+++
T Consensus 252 ~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 252 CLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HhhcChhhCCCHHHHhhC
Confidence 999 99999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=313.57 Aligned_cols=254 Identities=30% Similarity=0.544 Sum_probs=210.5
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEECC-----eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~~g-----~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
+...+|++.+.||+|+||.||+|.+.. ..+|+|...... .....+.|.+|+.+++.++||||+++++++.+. .
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~ 80 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-P 80 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-C
Confidence 455779999999999999999997632 368899875433 244567899999999999999999999998764 5
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
.+++|||+++++|.+++.. ....+++..++.++.|++.||+|||+.|++|+||||+|||++.++.++|+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 81 VWIVMELAPLGELRSYLQV--NKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred cEEEEEcCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 7899999999999999863 23468999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCC-CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003935 679 DSPMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPL 753 (785)
Q Consensus 679 ~~~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L 753 (785)
..... .....++..|+|||.+....++.++||||||+++|+|++ |..||...........+.... ....+ +..+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTL 237 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-cCCCCCCCCHHH
Confidence 43222 122334568999999988889999999999999999986 999998888776666554432 33332 3469
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 754 GRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 754 ~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
.+++.+||. +|.+|||+.++++.|.++..
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 999999999 99999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.14 Aligned_cols=249 Identities=29% Similarity=0.490 Sum_probs=206.9
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeE
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 601 (785)
...+.|++.++||.|+||.||+|.+ .+..+|+|++... .....+.+.+|+.+++.++||||+++++++..++.+++
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 3446799999999999999999987 4788999998644 34456788999999999999999999999999999999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
||||+++++|..++.. ....+++..++.++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 87 MIEFCPGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred EEecCCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 9999999999887753 23468999999999999999999999999999999999999999999999999987654332
Q ss_pred CCCCCCCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCC---ChH
Q 003935 682 MRDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIP---EGP 752 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~-~~ip---~~~ 752 (785)
.......+++.|+|||++. ...++.++|||||||++|+|++|..||...........+...... ...+ ...
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSME 244 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHH
Confidence 3333456888999999984 345788999999999999999999999887766655554432221 1112 236
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.+++.+||. +|.+||++.+++++
T Consensus 245 ~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 245 FRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhcC
Confidence 8899999999 99999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=318.90 Aligned_cols=246 Identities=23% Similarity=0.301 Sum_probs=197.9
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
+|.+.+.||+|+||.||+|.+ +|..+|+|.+............+.+|+.+++.++||||+++++++.+...+++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 478889999999999999987 588999999876544433445678899999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 685 (785)
+.+ +|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+........
T Consensus 81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 985 67766652 245689999999999999999999999999999999999999999999999999986644322233
Q ss_pred CCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHhcCC------------------C
Q 003935 686 SSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPW-EGVLPERVVYAVANEGS------------------R 745 (785)
Q Consensus 686 ~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF-~~~~~~~~v~~i~~~~~------------------~ 745 (785)
...+++.|+|||.+.+. .++.++|||||||++|+|+||..|| .+.+.......+..... .
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 45678899999998764 4789999999999999999999885 44443333332211000 0
Q ss_pred C------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 746 L------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 746 ~------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
. ......+.+++.+||. ||.+|||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0 0112357889999999 99999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=343.67 Aligned_cols=244 Identities=25% Similarity=0.349 Sum_probs=194.3
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC------
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------ 596 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~------ 596 (785)
...+|.+++.||+|+||+||+|.+ .++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 346799999999999999999987 57899999875432 2234799999999999999998876321
Q ss_pred --CceeEEEEEcccchhhHHHHh-hcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC-eEEEEecC
Q 003935 597 --PRLSMITEYMELGSLYHLIHL-SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFG 672 (785)
Q Consensus 597 --~~l~LV~Ey~~gGSL~dlL~~-~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g-~VKL~DFG 672 (785)
..+++||||+++ +|.+++.. ......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 246789999986 66655542 22456789999999999999999999999999999999999998664 79999999
Q ss_pred ccccccCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----
Q 003935 673 LSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----- 746 (785)
Q Consensus 673 LA~~l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~----- 746 (785)
+++.+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+......+..+......+
T Consensus 217 la~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 295 (440)
T PTZ00036 217 SAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295 (440)
T ss_pred cchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 998764432 2234578999999999876 468999999999999999999999999877665555443211100
Q ss_pred ----------------------CCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 ----------------------EIP---EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 ----------------------~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+| +..+.+|+.+||. ||.+|||+.++++|
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 011 2357889999999 99999999999976
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=313.17 Aligned_cols=247 Identities=30% Similarity=0.556 Sum_probs=208.1
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
-+...+|++.+.||+|+||.||++...++.+|+|.+.... ..+.+.+|+.+++.++||||+++++++..+. .+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v 76 (254)
T cd05083 2 LLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIV 76 (254)
T ss_pred cccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEE
Confidence 3456789999999999999999999899999999985432 2357889999999999999999999987654 7999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
|||+++++|.+++... ....+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 77 MELMSKGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EECCCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 9999999999998643 3346889999999999999999999999999999999999999999999999998765332
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHH
Q 003935 683 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIA 758 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~ 758 (785)
......+..|+|||.+.+..++.++|+|||||++|+|++ |+.||...........+.. +.....+ +..+.+++.
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 231 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-GYRMEPPEGCPADVYVLMT 231 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-CCCCCCCCcCCHHHHHHHH
Confidence 122334568999999998889999999999999999997 9999998887766555433 3333322 246889999
Q ss_pred Hhhh-CCCCCCCHHHHHHHHHh
Q 003935 759 DCWA-EPQERPSCEEILSRLLD 779 (785)
Q Consensus 759 ~CL~-DP~kRPS~~EIL~~L~~ 779 (785)
+||+ +|.+||++.++++.|++
T Consensus 232 ~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 232 SCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHcCCChhhCcCHHHHHHHHcc
Confidence 9999 99999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=321.05 Aligned_cols=248 Identities=22% Similarity=0.326 Sum_probs=202.0
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
..++|.+.+.||.|+||.||+|.+ +++.||+|.+...... .....+.+|+.+++.++||||+++++++.....+++|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 457899999999999999999977 4788999998654322 2234677899999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
|||+. ++|..++.. ....+++..+..++.|++.||+|||+.||+|+||||+|||++.++.++|+|||++........
T Consensus 83 ~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 83 FEYLD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred Eeccc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 99998 488877753 234688999999999999999999999999999999999999999999999999976544332
Q ss_pred CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----------------
Q 003935 683 RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS----------------- 744 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~----------------- 744 (785)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+...-.
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 3334567889999999865 4578899999999999999999999988776554433321100
Q ss_pred CCCC--------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 745 RLEI--------------PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 745 ~~~i--------------p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.... -+..+.+|+.+|+. ||.+|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 12357899999999 99999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.87 Aligned_cols=248 Identities=31% Similarity=0.532 Sum_probs=210.1
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
+|.+.+.||.|+||.||+|.. .|..+|+|.+..........+.+.+|+.+++.++|+||+++++.+......++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 478899999999999999987 578899999876554444556788999999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC-eEEEEecCccccccCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g-~VKL~DFGLA~~l~~~~~~~ 684 (785)
+++++|.+++... ....+++..++.++.|++.||.|||+.+++|+||||+||++++++ .++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence 9999999988632 234579999999999999999999999999999999999999875 56999999998775443333
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--ChHHHHHHHHhhh
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP--EGPLGRLIADCWA 762 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip--~~~L~~LI~~CL~ 762 (785)
....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.........+ ...+.+++.+||.
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFK 239 (257)
T ss_pred cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhc
Confidence 34568899999999988889999999999999999999999998877766666554433222111 3469999999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003935 763 -EPQERPSCEEILSR 776 (785)
Q Consensus 763 -DP~kRPS~~EIL~~ 776 (785)
+|.+|||+.+++++
T Consensus 240 ~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 240 VSPRDRPSITSILKR 254 (257)
T ss_pred cChhhCcCHHHHhhC
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=332.01 Aligned_cols=243 Identities=26% Similarity=0.329 Sum_probs=198.8
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC------C
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------P 597 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~------~ 597 (785)
.++|.+.+.||.|+||+||+|.+ .++.||||++..........+.+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 37899999999999999999976 577899999875544444456788999999999999999999987543 3
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+|++++++ +++|.+++. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 94 ~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 468899987 678888774 346899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----------
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR----------- 745 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~----------- 745 (785)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..+......
T Consensus 169 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 169 DDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred CCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 442 234578999999999877 56899999999999999999999999876655444433221100
Q ss_pred ----------CCCC-----------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 746 ----------LEIP-----------EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 746 ----------~~ip-----------~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
...+ ...+.+|+.+|+. ||.+|||+.++++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0011 1236789999999 99999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=317.35 Aligned_cols=248 Identities=28% Similarity=0.491 Sum_probs=199.3
Q ss_pred eeEeeEEeeeCcEEEEEEEE------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC--Ccee
Q 003935 529 LTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRLS 600 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~l~ 600 (785)
|++.+.||+|+||+||++.+ .+..||+|++..... ....+.|.+|+++++.++||||+++++++... ..++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 37889999999999988653 467899999865432 23456788999999999999999999987653 4589
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
++|||+++++|.+++.. ..+++.+++.++.|++.||+|||++||+|+||||+|||+++++.++|+|||++......
T Consensus 85 lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 99999999999999862 35899999999999999999999999999999999999999999999999999876543
Q ss_pred CCC---CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--------------HHHHHHhcC
Q 003935 681 PMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER--------------VVYAVANEG 743 (785)
Q Consensus 681 ~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~--------------~v~~i~~~~ 743 (785)
... .....++..|+|||.+.+..++.++||||||+++|+|+||..||....... .........
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 211 122345667999999998889999999999999999999999986543211 111111112
Q ss_pred CCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 744 SRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 744 ~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
.....+ +..+.+++..||+ +|++|||+.++++.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 222222 3468999999999 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=308.74 Aligned_cols=241 Identities=29% Similarity=0.561 Sum_probs=202.3
Q ss_pred EEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccchhh
Q 003935 534 RVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY 612 (785)
Q Consensus 534 ~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL~ 612 (785)
.||+|+||.||+|.. +++.+|+|++.... .......|.+|+++++.++||||+++++++......++||||+++++|.
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 689999999999976 57789999876543 3344457889999999999999999999999999999999999999999
Q ss_pred HHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCC-CCCCCC
Q 003935 613 HLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS-SSAGTP 691 (785)
Q Consensus 613 dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~-~~~GT~ 691 (785)
+++.. ....+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++........... ...+++
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05085 81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI 158 (250)
T ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence 98863 234688999999999999999999999999999999999999999999999999976543322111 223456
Q ss_pred cccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCC
Q 003935 692 EWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQE 766 (785)
Q Consensus 692 ~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~k 766 (785)
.|+|||++.+..++.++||||||+++|++++ |..||...........+.. ..+...+ +..+.+++.+||. +|++
T Consensus 159 ~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (250)
T cd05085 159 KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-GYRMSCPQKCPDDVYKVMQRCWDYKPEN 237 (250)
T ss_pred cccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcccCccc
Confidence 7999999998889999999999999999998 9999998877766665543 3333333 2468999999999 9999
Q ss_pred CCCHHHHHHHHH
Q 003935 767 RPSCEEILSRLL 778 (785)
Q Consensus 767 RPS~~EIL~~L~ 778 (785)
||++.++++.|.
T Consensus 238 Rp~~~~l~~~l~ 249 (250)
T cd05085 238 RPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHhc
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=339.18 Aligned_cols=241 Identities=26% Similarity=0.354 Sum_probs=194.5
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeE
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 601 (785)
+....|.+.+.||+|+||.||++.+ .++.||+|... ...+.+|+.+++.++||||+++++++......++
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 4557899999999999999999987 57889999743 2346789999999999999999999999999999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
++|++. ++|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 161 v~e~~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 161 ILPRYK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEecCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 999996 57877775 34568899999999999999999999999999999999999999999999999997543221
Q ss_pred -CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHh------------
Q 003935 682 -MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL-------PERVVYAVAN------------ 741 (785)
Q Consensus 682 -~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~-------~~~~v~~i~~------------ 741 (785)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+..
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 12234679999999999999999999999999999999999998764321 1111111110
Q ss_pred --------------cCCCCC--CC--------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 742 --------------EGSRLE--IP--------EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 742 --------------~~~~~~--ip--------~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
...... .+ +..+.+|+.+||. ||.+|||+.|++++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 00 1247789999999 99999999999975
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=319.16 Aligned_cols=247 Identities=29% Similarity=0.524 Sum_probs=209.1
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
.++|.+.+.||.|+||+||+|.+ ++..+|+|++... .....+.|..|+.+++.++||||+++++++..+...++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 35688999999999999999987 4788999998643 3344678999999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+++++|.+++... ...+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.........
T Consensus 82 e~~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 82 EFCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999999999988632 356899999999999999999999999999999999999999999999999998765443333
Q ss_pred CCCCCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCC---ChHHH
Q 003935 684 DSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIP---EGPLG 754 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~-~~ip---~~~L~ 754 (785)
.....+++.|+|||.+. ...++.++|+||||+++|+|++|+.||...........+...... ...+ ...+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence 34456889999999975 345778999999999999999999999988777766665543221 1122 34689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003935 755 RLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 755 ~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+++..||. +|.+||++.+++++
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 240 DFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHhccChhhCcCHHHHhcC
Confidence 99999999 99999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.73 Aligned_cols=244 Identities=25% Similarity=0.380 Sum_probs=203.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|.+.++||+|+||.||++.+ ++..+|+|.+.... .......+.+|++++++++||||++++++|.+++.++++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 3689999999999999999987 47789999876432 33445678899999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-cccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
|+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.++|+|||++...... .
T Consensus 80 y~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~ 154 (308)
T cd06615 80 HMDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--M 154 (308)
T ss_pred ccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--c
Confidence 9999999999873 3578999999999999999999997 69999999999999999999999999998765432 2
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---------------------
Q 003935 684 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE--------------------- 742 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~--------------------- 742 (785)
.....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 23457889999999998888999999999999999999999999765443322221110
Q ss_pred --------------CCCCCCC----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 743 --------------GSRLEIP----EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 743 --------------~~~~~ip----~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
...+..| +..+.+++.+||. +|.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111 2358899999999 99999999999987
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=313.23 Aligned_cols=244 Identities=29% Similarity=0.513 Sum_probs=194.9
Q ss_pred EEeeeCcEEEEEEEE-C---CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccc
Q 003935 534 RVGIGFFGEVFRGIW-N---GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 609 (785)
Q Consensus 534 ~LG~G~fG~VYkg~~-~---g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gG 609 (785)
.||+|+||+||+|.. . ...+|+|.+.... .......|.+|+.+++.++||||+++++++.+...+++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 589999999999964 2 3468888765432 3444567889999999999999999999999999999999999999
Q ss_pred hhhHHHHhhcc--cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC--CCC
Q 003935 610 SLYHLIHLSGQ--KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDS 685 (785)
Q Consensus 610 SL~dlL~~~~~--~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--~~~ 685 (785)
+|.+++..... ....++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 99999874322 23456788899999999999999999999999999999999999999999999876433221 112
Q ss_pred CCCCCCcccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC-CCCC------C
Q 003935 686 SSAGTPEWMAPELIRN-------EPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSR-LEIP------E 750 (785)
Q Consensus 686 ~~~GT~~Y~APEvl~~-------~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~-~~ip------~ 750 (785)
...+++.|+|||++.. ..++.++|||||||++|||++ |..||....+............. ...+ .
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYS 240 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCC
Confidence 3345678999998743 456889999999999999999 78899888776666555443321 1111 2
Q ss_pred hHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 003935 751 GPLGRLIADCWAEPQERPSCEEILSRLL 778 (785)
Q Consensus 751 ~~L~~LI~~CL~DP~kRPS~~EIL~~L~ 778 (785)
..+..++..||.||.+||++++|++.|.
T Consensus 241 ~~~~~~~~~~~~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 241 DRWYEVMQFCWLDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHHHHHHHHhcCcccccCHHHHHHHhc
Confidence 3577899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=308.30 Aligned_cols=246 Identities=30% Similarity=0.462 Sum_probs=210.7
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
+|.+.+.||+|+||.||++.. +++.+|+|.+............+.+|+.+++.++||||+++++.+...+.+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 488899999999999999876 578899999977666556678899999999999999999999999988999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC-CeEEEEecCccccccCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~-g~VKL~DFGLA~~l~~~~~~~ 684 (785)
+++++|.+++... ....+++..+..++.|++.||+|||++||+|+||+|+||+++++ +.++|+|||++....... ..
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~ 158 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KA 158 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-cc
Confidence 9999999999643 24468999999999999999999999999999999999999854 468999999998765432 22
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCW 761 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL 761 (785)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+..... ..++ ...+.+++..||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l 237 (256)
T cd08220 159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-APISDRYSPDLRQLILSML 237 (256)
T ss_pred cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-CCCCCCcCHHHHHHHHHHc
Confidence 345688899999999988899999999999999999999999988877766666554332 2233 346899999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003935 762 A-EPQERPSCEEILSR 776 (785)
Q Consensus 762 ~-DP~kRPS~~EIL~~ 776 (785)
. +|.+|||+.+++++
T Consensus 238 ~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 238 NLDPSKRPQLSQIMAQ 253 (256)
T ss_pred cCChhhCCCHHHHhhC
Confidence 9 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=318.17 Aligned_cols=246 Identities=23% Similarity=0.264 Sum_probs=203.1
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChH-HHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 529 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE-NMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~-~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
|+..+.||.|+||+||++.+ +++.+|+|.+........ ....+.+|+++++.++|+||+.+++++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 67788999999999999987 578999999866543322 245678899999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 685 (785)
+++++|.+++... ....+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++....... ...
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 159 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIR 159 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-ccc
Confidence 9999999887633 23469999999999999999999999999999999999999999999999999997654322 223
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCC---CChHHHHHHHHh
Q 003935 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS--RLEI---PEGPLGRLIADC 760 (785)
Q Consensus 686 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~--~~~i---p~~~L~~LI~~C 760 (785)
...|++.|+|||++.+..++.++|+|||||++|+|++|..||...........+..... .... -...+.+|+..|
T Consensus 160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239 (285)
T ss_pred CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHH
Confidence 45789999999999988899999999999999999999999987765543333322111 1111 234688999999
Q ss_pred hh-CCCCCCC-----HHHHHHH
Q 003935 761 WA-EPQERPS-----CEEILSR 776 (785)
Q Consensus 761 L~-DP~kRPS-----~~EIL~~ 776 (785)
|+ ||.+||+ +.+++.+
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 240 LTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccCCHhHcCCCcccChHHHHcC
Confidence 99 9999999 7777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=313.43 Aligned_cols=245 Identities=28% Similarity=0.462 Sum_probs=195.7
Q ss_pred eEEeeeCcEEEEEEEEC----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEccc
Q 003935 533 TRVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~~----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
+.||+|+||.||+|.+. +..+|+|.+..... ......|.+|+.+++.++||||+++++++.+...+++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 35899999999999753 35689998765443 23345788999999999999999999999999899999999999
Q ss_pred chhhHHHHhhcc--cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC--CC
Q 003935 609 GSLYHLIHLSGQ--KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RD 684 (785)
Q Consensus 609 GSL~dlL~~~~~--~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--~~ 684 (785)
|+|.+++..... ....++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........ ..
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 999999864321 23567778889999999999999999999999999999999999999999999976543221 12
Q ss_pred CCCCCCCcccCccccccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC-CCCCC------C
Q 003935 685 SSSAGTPEWMAPELIRNE-------PFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEG-SRLEI------P 749 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~-------~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~-~~~~i------p 749 (785)
....+++.|+|||++.+. .++.++|+||||+++|||++ |+.||......+......... ..... .
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPL 239 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCC
Confidence 234577889999998642 35789999999999999996 999998877666544433222 11111 1
Q ss_pred ChHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 003935 750 EGPLGRLIADCWAEPQERPSCEEILSRLL 778 (785)
Q Consensus 750 ~~~L~~LI~~CL~DP~kRPS~~EIL~~L~ 778 (785)
...+.+++.+||.+|.+|||+.+|+..|.
T Consensus 240 ~~~~~~l~~~c~~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 240 SDRWYEVMQFCWLQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ChHHHHHHHHHhcCcccCCCHHHHHHHhc
Confidence 23578899999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=318.86 Aligned_cols=253 Identities=34% Similarity=0.565 Sum_probs=204.5
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC------------------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCcee
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIWN------------------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~~------------------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIV 587 (785)
.++|++.++||+|+||+||++.+. +..+|+|++.... .......|.+|+.+++.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 457999999999999999998532 3368999986442 334457899999999999999999
Q ss_pred eEeccccCCCceeEEEEEcccchhhHHHHhhcc--------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEE
Q 003935 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ--------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCL 659 (785)
Q Consensus 588 kL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~--------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNIL 659 (785)
++++++......+++|||+++++|.+++..... ...+++.++..++.|++.||+|||+.||+|+||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 999999999999999999999999999864321 134778899999999999999999999999999999999
Q ss_pred EcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCChHHH
Q 003935 660 VNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT--LNRPWEGVLPERV 735 (785)
Q Consensus 660 Ld~~g~VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT--G~~PF~~~~~~~~ 735 (785)
++.++.++|+|||++..+...... .....+++.|++||+..+..++.++|||||||++|||++ |..||......+.
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 999999999999999865432211 112334678999999888889999999999999999998 7789987766555
Q ss_pred HHHHHh---c---CCCCCC---CChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003935 736 VYAVAN---E---GSRLEI---PEGPLGRLIADCWA-EPQERPSCEEILSRLLD 779 (785)
Q Consensus 736 v~~i~~---~---~~~~~i---p~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~ 779 (785)
...... . ....+. .+..+.+|+.+||+ ||.+||++.+|++.|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 243 IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 443211 0 111111 13568999999999 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.15 Aligned_cols=246 Identities=29% Similarity=0.473 Sum_probs=202.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc---ChHHHHHHHHHHHHHhhcCCCceeeEeccccC--CCce
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL---TAENMEDFCNEISILSRLRHPNVILFLGACTK--PPRL 599 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~---~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d--~~~l 599 (785)
.+|++.+.||+|+||.||++.+ .++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3678899999999999999976 578999998865432 22345678899999999999999999998765 3568
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
++++||+++++|.+++. ....+++...+.++.|++.||+|||+.+|+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLK---AYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 89999999999999986 334688999999999999999999999999999999999999999999999999876532
Q ss_pred CC---CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003935 680 SP---MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPL 753 (785)
Q Consensus 680 ~~---~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L 753 (785)
.. .......++..|+|||.+.+..++.++|||||||++|+|++|+.||..................+.++ ...+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHA 238 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHH
Confidence 11 11123457889999999998889999999999999999999999998877666665555444444444 3457
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 754 GRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 754 ~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..++ .||. +|.+||++++|+.|
T Consensus 239 ~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 239 RDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHH-HHhcCChhhCcCHHHHhcC
Confidence 7788 5666 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=315.78 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=202.4
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
+|.+.+.||.|+||.||+|.+ +++.||||++............+.+|++++++++||||+++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478899999999999999987 588999999865544444456788999999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 685 (785)
+. ++|..++... ....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 158 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence 96 5788887643 345789999999999999999999999999999999999999999999999999876644322233
Q ss_pred CCCCCCcccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------------
Q 003935 686 SSAGTPEWMAPELIRNEP-FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------------ 746 (785)
Q Consensus 686 ~~~GT~~Y~APEvl~~~~-~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~------------------ 746 (785)
...+++.|+|||.+.+.. ++.++|||||||++|+|+||+.||...........+......+
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence 445788999999887644 6889999999999999999999998776554444433211110
Q ss_pred ------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 ------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 ------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..-...+.++|.+||+ ||.+||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0112357789999999 99999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=317.53 Aligned_cols=244 Identities=28% Similarity=0.476 Sum_probs=204.8
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEc
Q 003935 529 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 606 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 606 (785)
|++.+.||.|+||.||+|.+ .+..+++|.+.... ....+.+.+|+++++.++||||+++++++......++|+||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 56778999999999999987 46778888875432 345678899999999999999999999999999999999999
Q ss_pred ccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003935 607 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 686 (785)
Q Consensus 607 ~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~ 686 (785)
++++|..++.. ....+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++............
T Consensus 85 ~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 85 AGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence 99999888753 2457899999999999999999999999999999999999999999999999999766443333345
Q ss_pred CCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCC---ChHHHHHH
Q 003935 687 SAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIP---EGPLGRLI 757 (785)
Q Consensus 687 ~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~-~~~ip---~~~L~~LI 757 (785)
..+++.|+|||++. +..++.++|||||||++|+|++|+.||......+....+..... ....+ +..+.+++
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL 242 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHH
Confidence 57889999999984 45578899999999999999999999998877666665543322 11122 34699999
Q ss_pred HHhhh-CCCCCCCHHHHHHH
Q 003935 758 ADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 758 ~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+||. ||.+||++.+++++
T Consensus 243 ~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 243 KKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHccCChhhCcCHHHHhcC
Confidence 99999 99999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=333.71 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=218.9
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEECC--eEEEEEEeeccccC-hHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNG--TDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~g--~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
..+.++.|.+.+.||+|.-|+||++...+ ..+|+|++.+..+. .....+...|-+||+.++||.+..||..|+.+..
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 45667889999999999999999998854 78999999877654 3446678889999999999999999999999999
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
.+++||||+||+|..+++.+ .++.+++..++-|+.+|+-||+|||.+|||+|||||+||||.++|+|-|+||.|+....
T Consensus 152 ~cl~meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred eEEEEecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999999999998754 57789999999999999999999999999999999999999999999999999864331
Q ss_pred CC----------------------------------C----------------------CCCCCCCCCCcccCccccccC
Q 003935 679 DS----------------------------------P----------------------MRDSSSAGTPEWMAPELIRNE 702 (785)
Q Consensus 679 ~~----------------------------------~----------------------~~~~~~~GT~~Y~APEvl~~~ 702 (785)
-. . ......+||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 00 0 011234689999999999999
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCC----HHHHH
Q 003935 703 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPS----CEEIL 774 (785)
Q Consensus 703 ~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPS----~~EIL 774 (785)
-.+.++|+|+|||+||||+.|..||.+.+..+....++......+-.. ..+++||+++|. ||++|.- +.||.
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 999999999999999999999999999999999999886554443322 468999999998 9999987 77776
Q ss_pred HH
Q 003935 775 SR 776 (785)
Q Consensus 775 ~~ 776 (785)
+|
T Consensus 391 ~H 392 (459)
T KOG0610|consen 391 RH 392 (459)
T ss_pred cC
Confidence 54
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=311.88 Aligned_cols=249 Identities=30% Similarity=0.489 Sum_probs=205.4
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCC----
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPP---- 597 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~---- 597 (785)
..++|.+.+.||.|+||.||+|.+ +++.+++|++..... ..+.|.+|+.+++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 357899999999999999999987 467899999865432 346788999999999 6999999999986544
Q ss_pred --ceeEEEEEcccchhhHHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcc
Q 003935 598 --RLSMITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 674 (785)
Q Consensus 598 --~l~LV~Ey~~gGSL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 674 (785)
.++++|||+++++|.+++.... ....+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 4899999999999999886432 2457899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-
Q 003935 675 RIITDSPMRDSSSAGTPEWMAPELIRN-----EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI- 748 (785)
Q Consensus 675 ~~l~~~~~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i- 748 (785)
..............+++.|+|||++.. ..++.++|||||||++|+|++|+.||...........+.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS 240 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCc
Confidence 776543333345568899999998753 34678999999999999999999999877666666555443221111
Q ss_pred C---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 749 P---EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 749 p---~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+ ...+.+|+.+||. ||++|||+.+++++
T Consensus 241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 241 PENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 2368899999999 99999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=318.14 Aligned_cols=244 Identities=23% Similarity=0.395 Sum_probs=208.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++|++.+.||+|+||.||++.+ +++.+|+|++..... .....+.+.+|++++++++||||+++++++.+...++++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4789999999999999999987 578999999865443 2334577889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.||+|+||+|+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 99999999999863 357899999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh
Q 003935 684 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA 762 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~CL~ 762 (785)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+........ .-+..+.+++.+||.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 2345788999999999888889999999999999999999999988876666665553322211 124578999999999
Q ss_pred -CCCCCC-----CHHHHHHH
Q 003935 763 -EPQERP-----SCEEILSR 776 (785)
Q Consensus 763 -DP~kRP-----S~~EIL~~ 776 (785)
||.+|+ ++++++++
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred CCHHHccCcccCCHHHHHcC
Confidence 999999 77777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=309.69 Aligned_cols=245 Identities=31% Similarity=0.564 Sum_probs=198.2
Q ss_pred eEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEecccc-CCCceeEEEEEc
Q 003935 533 TRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT-KPPRLSMITEYM 606 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~-d~~~l~LV~Ey~ 606 (785)
+.||+|+||.||+|.+. +..+|+|.+... ......+.+.+|+.+++.++||||+++++++. .+...++++||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 36899999999999752 357999987532 23344678899999999999999999999775 455689999999
Q ss_pred ccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC----
Q 003935 607 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM---- 682 (785)
Q Consensus 607 ~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~---- 682 (785)
.+++|.+++... ...+++..+..++.|++.||+|||+.+++||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 80 KHGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999998632 33467778889999999999999999999999999999999999999999999976543211
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHH
Q 003935 683 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIA 758 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG-~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~ 758 (785)
......+++.|+|||.+.+..++.++|||||||++|||++| ..||...........+.. +..+..+ +..+.+++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 236 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ-GRRLLQPEYCPDPLYEVML 236 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-CCCCCCCCcCCHHHHHHHH
Confidence 11233456789999999888899999999999999999995 567777766665555443 2233222 346889999
Q ss_pred Hhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 759 DCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 759 ~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
+||. +|++||++.+|++.|+++.
T Consensus 237 ~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 237 SCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HHcCCChhhCCCHHHHHHHHHHHh
Confidence 9999 9999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=320.76 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=210.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
.+|.+.+.||+|+||+||+|.. .++.||+|.+....... ...+.+..|+++++.++||||+++++.+.+....+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3688999999999999999987 47899999997665443 35677899999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC-
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 682 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~- 682 (785)
||+.+++|.+++... ....+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 999999999998632 345789999999999999999999999999999999999999999999999999875432110
Q ss_pred ----------------------------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 003935 683 ----------------------------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER 734 (785)
Q Consensus 683 ----------------------------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~ 734 (785)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 1113357889999999999889999999999999999999999999888777
Q ss_pred HHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCC----HHHHHHH
Q 003935 735 VVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPS----CEEILSR 776 (785)
Q Consensus 735 ~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS----~~EIL~~ 776 (785)
....+.......... +..+.+++.+||. ||.+||+ +++++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 666665444333222 4569999999999 9999999 8888775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=316.80 Aligned_cols=239 Identities=29% Similarity=0.455 Sum_probs=198.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|.+.+.||+|+||.||+|.+ +++.||+|++.... .......|.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 3677889999999999999986 57889999986543 33445679999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
|+++++|..+. .+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++...... ..
T Consensus 80 ~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~ 150 (279)
T cd06619 80 FMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IA 150 (279)
T ss_pred cCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cc
Confidence 99999986542 4678888999999999999999999999999999999999999999999999866433 22
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcCCCCCC----CChHH
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP-------ERVVYAVANEGSRLEI----PEGPL 753 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~-------~~~v~~i~~~~~~~~i----p~~~L 753 (785)
....++..|+|||++.+..++.++|+|||||++|+|++|+.||..... ......+... ..... ....+
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 229 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-DPPVLPVGQFSEKF 229 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-CCCCCCCCcCCHHH
Confidence 346789999999999998899999999999999999999999965322 1222222221 11221 23468
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 754 GRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 754 ~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+++.+||+ +|.+||++.+++++
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcC
Confidence 899999999 99999999999977
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=313.31 Aligned_cols=245 Identities=33% Similarity=0.582 Sum_probs=200.1
Q ss_pred EEeeeCcEEEEEEEEC--Ce--EEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCceeEEEEEccc
Q 003935 534 RVGIGFFGEVFRGIWN--GT--DVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 534 ~LG~G~fG~VYkg~~~--g~--~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
.||+|+||.||+|.+. +. .+|+|.+... ......+.+.+|++++.++ +||||+++++++...+.++++|||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 5899999999999863 33 4678877532 2334456789999999999 799999999999999999999999999
Q ss_pred chhhHHHHhhc-------------ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 609 GSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 609 GSL~dlL~~~~-------------~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
|+|.+++.... ....+++.+++.++.|++.||+|||+.|++|+||||+|||+++++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 99999986432 12357899999999999999999999999999999999999999999999999986
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---Ch
Q 003935 676 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EG 751 (785)
Q Consensus 676 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~ 751 (785)
..... ........+..|+|||++....++.++|||||||++|||++ |..||.+.........+.. ......+ +.
T Consensus 161 ~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (270)
T cd05047 161 GQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEKPLNCDD 238 (270)
T ss_pred ccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC-CCCCCCCCcCCH
Confidence 43211 11112234567999999998889999999999999999997 9999988777666655533 2232222 34
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 752 PLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 752 ~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
.+.+|+.+||. +|.+|||+.++++.|.++.
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 239 EVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 68899999999 9999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=312.90 Aligned_cols=254 Identities=32% Similarity=0.551 Sum_probs=210.5
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
+.++|.+.+.||.|+||+||+|... ...+++|.+..... ....+.+.+|+.++++++|+||+++++++.+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4578899999999999999999752 45699998754332 234578999999999999999999999999989
Q ss_pred ceeEEEEEcccchhhHHHHhhccc------ccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEec
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQK------KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 671 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~------~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DF 671 (785)
..++||||+++++|.+++...... ..+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999998743321 16899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003935 672 GLSRIITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP 749 (785)
Q Consensus 672 GLA~~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip 749 (785)
|++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||........+..+.........+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP 241 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence 99875433221 2223456778999999988888999999999999999998 788998877776666655433322222
Q ss_pred ---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003935 750 ---EGPLGRLIADCWA-EPQERPSCEEILSRLLD 779 (785)
Q Consensus 750 ---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~ 779 (785)
+..+.+++.+||. +|.+||++.++++.|.+
T Consensus 242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 3468999999999 99999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=339.15 Aligned_cols=246 Identities=25% Similarity=0.387 Sum_probs=220.7
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
=|.+.+.||+|.|++|-++.+ .|..||||++.+..++.-....+++|+..|+.++|||||++|.+......+|+|+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 466778999999999999865 899999999999888877778899999999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEc-CCCeEEEEecCccccccCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd-~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
-.+|+|++++-. ....+.+..+.+|+.||+.|+.|||+..+|||||||+||++. +-|-|||.|||++..+... ...
T Consensus 99 GD~GDl~DyImK--He~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-~kL 175 (864)
T KOG4717|consen 99 GDGGDLFDYIMK--HEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-KKL 175 (864)
T ss_pred cCCchHHHHHHh--hhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc-chh
Confidence 999999999864 456799999999999999999999999999999999999875 6789999999999887654 345
Q ss_pred CCCCCCCcccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CChHHHHHHHHhhh
Q 003935 685 SSSAGTPEWMAPELIRNEPFT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PEGPLGRLIADCWA 762 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s-~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i-p~~~L~~LI~~CL~ 762 (785)
.+.||...|-|||++.+..|+ ++.||||||||||.|++|+.||...+..+.+-.|....+..+- .....++||..|+.
T Consensus 176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLv 255 (864)
T KOG4717|consen 176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLV 255 (864)
T ss_pred hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHh
Confidence 688999999999999999887 5789999999999999999999999999999888887765543 24479999999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003935 763 -EPQERPSCEEILSR 776 (785)
Q Consensus 763 -DP~kRPS~~EIL~~ 776 (785)
||.+|.+.++|...
T Consensus 256 RdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 256 RDPKKRASLEEIVST 270 (864)
T ss_pred cCchhhccHHHHhcc
Confidence 99999999999864
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=315.97 Aligned_cols=244 Identities=34% Similarity=0.582 Sum_probs=208.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
..|+..+.||.|+||.||+|.+ .+..+|+|++..... ....+.+.+|+.+++.+.||||+++++++.++...++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 3567788999999999999987 578999999875433 3346789999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
|+++++|.+++. ...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 83 YLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 999999999885 2358889999999999999999999999999999999999999999999999998765443333
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCW 761 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL 761 (785)
....++..|+|||.+.+..++.++|+|||||++|+|++|..||....+......+.. ...+.++ +..+.+++.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK-NNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc-CCCCCCchhhhHHHHHHHHHHc
Confidence 345678899999999988899999999999999999999999988777666554432 2223332 235889999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003935 762 A-EPQERPSCEEILSR 776 (785)
Q Consensus 762 ~-DP~kRPS~~EIL~~ 776 (785)
. +|.+||++.+++++
T Consensus 238 ~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 238 NKDPSFRPTAKELLKH 253 (277)
T ss_pred ccCcccCcCHHHHHhC
Confidence 9 99999999999887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.87 Aligned_cols=244 Identities=29% Similarity=0.482 Sum_probs=206.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
.+|.+.+.||.|+||.||++.. +++.||+|.+...... ..+.+.+|+.+++.++||||+++++++.....+++|||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 6789999999999999999986 5889999998755433 24668899999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
|+++++|.+++. ...+++.++..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++..........
T Consensus 97 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 172 (297)
T cd06656 97 YLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (297)
T ss_pred ccCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence 999999999885 2357889999999999999999999999999999999999999999999999998765443333
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCC---ChHHHHHHHHh
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIP---EGPLGRLIADC 760 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~-~ip---~~~L~~LI~~C 760 (785)
....+++.|+|||.+.+..++.++|+|||||++|+|++|..||....+......+...+... ..+ ...+.+++.+|
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 252 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC 252 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHH
Confidence 44578899999999999889999999999999999999999998766544433333222111 111 24588999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003935 761 WA-EPQERPSCEEILSR 776 (785)
Q Consensus 761 L~-DP~kRPS~~EIL~~ 776 (785)
|. +|.+||++.+++++
T Consensus 253 l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 253 LEMDVDRRGSAKELLQH 269 (297)
T ss_pred ccCChhhCcCHHHHhcC
Confidence 99 99999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=314.96 Aligned_cols=247 Identities=26% Similarity=0.399 Sum_probs=204.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|.+.+.||+|+||.||+|.+ +++.||+|++..........+.+.+|+++++.++|+||+++++++...+.+++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3689999999999999999987 47789999987655444556788999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC-C
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-R 683 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~-~ 683 (785)
|++++.+..+.. ....+++..+..++.||+.||+|||+.|++|+||+|+||++++++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 999877776654 345689999999999999999999999999999999999999999999999999987655432 2
Q ss_pred CCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC------------------
Q 003935 684 DSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS------------------ 744 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~------------------ 744 (785)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||.+.........+.....
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 2345678899999999887 789999999999999999999999987655443333221000
Q ss_pred ---------------CCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 745 ---------------RLEIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 745 ---------------~~~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+..-+..+.+++.+||. +|.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000113458899999999 99999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=313.23 Aligned_cols=246 Identities=25% Similarity=0.332 Sum_probs=205.9
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
+|.+.+.||.|+||.||+|.+ +|+.||+|++..........+.+.+|+.+++.++||||+++++++.....+++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 588999999999999999987 588999999977665455567899999999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC-CC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-RD 684 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~-~~ 684 (785)
+ +++|.+++... ...+++.+++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 9 99999988633 35789999999999999999999999999999999999999999999999999987654321 12
Q ss_pred CCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------------
Q 003935 685 SSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------------- 746 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~----------------- 746 (785)
....++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.........+......+
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 345688999999998654 46899999999999999999988888776655544433211100
Q ss_pred --------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 --------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 --------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
...+..+.+++.+|+. +|.+||++++++.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0012457889999999 99999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=319.07 Aligned_cols=247 Identities=25% Similarity=0.316 Sum_probs=202.1
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
.|.+.+.||+|+||+||++.+ .++.||+|.+....... .....+.+|+.+++.++|+||+.+++.+.+.+.++++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 367788999999999999987 57899999986554332 234567889999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
|+++++|.+++... ....+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~ 158 (285)
T cd05630 81 LMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TI 158 (285)
T ss_pred ecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-cc
Confidence 99999999888533 23468999999999999999999999999999999999999999999999999987654322 22
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCC--CCCCCChHHHHHHHH
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE---RVVYAVANEGS--RLEIPEGPLGRLIAD 759 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~---~~v~~i~~~~~--~~~ip~~~L~~LI~~ 759 (785)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ........... ........+.+|+..
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKM 238 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHH
Confidence 3457899999999999999999999999999999999999999865432 22222211111 111123468999999
Q ss_pred hhh-CCCCCCC-----HHHHHHH
Q 003935 760 CWA-EPQERPS-----CEEILSR 776 (785)
Q Consensus 760 CL~-DP~kRPS-----~~EIL~~ 776 (785)
||+ ||.+||| +.++++|
T Consensus 239 ~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 239 LLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HhhcCHHHccCCCCCchHHHHcC
Confidence 999 9999999 8899875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=355.62 Aligned_cols=259 Identities=27% Similarity=0.483 Sum_probs=214.2
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE-CC-eEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccc-cC
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIW-NG-TDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGAC-TK 595 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~-~g-~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~-~d 595 (785)
..+.+...+++|.+.|.+|||+.||+|+. .+ ..||+|++... ++...+.+.+||++|+.|+ |+|||.|++.. ..
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 45567778899999999999999999987 34 89999998765 5677889999999999997 99999999932 21
Q ss_pred ---C---CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc--cccccCCCCcEEEcCCCeEE
Q 003935 596 ---P---PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVK 667 (785)
Q Consensus 596 ---~---~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~g--IIHrDLKpsNILLd~~g~VK 667 (785)
+ -.++|.||||.||.|-+++...... .|++.++++|++|+++|+++||... |||||||-+||||+.+++.|
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence 1 2478999999999999999755444 4999999999999999999999987 99999999999999999999
Q ss_pred EEecCccccccCCCCCC---------CCCCCCCcccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 003935 668 ICDFGLSRIITDSPMRD---------SSSAGTPEWMAPELI---RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERV 735 (785)
Q Consensus 668 L~DFGLA~~l~~~~~~~---------~~~~GT~~Y~APEvl---~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~ 735 (785)
|||||.+.......... -....|+.|+|||++ .+.+.++|+|||+|||+||-||....||.+.....
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la- 265 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA- 265 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-
Confidence 99999987643322111 123478999999987 56789999999999999999999999998864432
Q ss_pred HHHHHhcCCCCCC-C--ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhccC
Q 003935 736 VYAVANEGSRLEI-P--EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSLC 785 (785)
Q Consensus 736 v~~i~~~~~~~~i-p--~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~sLc 785 (785)
|++..+..+. | ...+.+||..||+ ||.+||++-+++.++..+...-|
T Consensus 266 ---Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 266 ---ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred ---EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 3444544433 2 2369999999999 99999999999999988876544
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=313.01 Aligned_cols=252 Identities=30% Similarity=0.575 Sum_probs=210.3
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCe----EEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~----~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
...+|++.+.||+|+||+||+|.+ +|. .+|+|.+..... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 346789999999999999999976 232 589998765433 4455788999999999999999999999887 67
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
.++++||+++|+|.+++.. ....+++..+..++.|++.||+|||+.||+|+||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred eEEEEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999999863 23468999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003935 679 DSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 752 (785)
Q Consensus 679 ~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~ 752 (785)
..... .....++..|+|||.+....++.++|+|||||++||+++ |+.||.+....+....+.. +.....+ ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 239 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK-GERLPQPPICTID 239 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC-CCCCCCCCCCCHH
Confidence 33211 112234568999999988889999999999999999998 9999999887776665543 3333333 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
+..++.+||. ||.+||++.++++.|.++.
T Consensus 240 ~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 240 VYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 8899999999 9999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=327.59 Aligned_cols=248 Identities=25% Similarity=0.300 Sum_probs=210.0
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC--CCceeE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--PPRLSM 601 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d--~~~l~L 601 (785)
.++|..+++|++|.||.||+|++ +++.||+|.++.........-.-++||.+|.+++|||||.+-.+..- -+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 46788899999999999999987 57889999997665433333456799999999999999998877543 345999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
|||||+. +|..+++.. ..++...+++.++.|+++|++|||.+.|+|||||++|+|++..|.+||+|||+|+.++.+.
T Consensus 155 VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 9999987 888888732 3589999999999999999999999999999999999999999999999999999998876
Q ss_pred CCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---------C---
Q 003935 682 MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---------I--- 748 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~---------i--- 748 (785)
...+..+-|.+|.|||.+.+. .|+...|+||+|||+.||+++++-|.+......+++|...-..+. +
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 667788899999999998874 699999999999999999999999999988888888765332221 0
Q ss_pred --------CC-------------hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 749 --------PE-------------GPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 749 --------p~-------------~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
|. +.-.+|+..++. ||.+|.|+++.|+|
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 10 123468899999 99999999999976
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=312.09 Aligned_cols=250 Identities=30% Similarity=0.538 Sum_probs=199.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC--CCc
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--PPR 598 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d--~~~ 598 (785)
..|++.+.||+|+||.||++.. ++..||+|.+... .....+.|.+|+++++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 5788899999999999999864 4678999998643 23446788999999999999999999998643 346
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
+++|+||+++++|.+++.. ....+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred eEEEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 8999999999999999863 23468999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCC---CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---------------HHHHHH
Q 003935 679 DSPMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER---------------VVYAVA 740 (785)
Q Consensus 679 ~~~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~---------------~v~~i~ 740 (785)
..... .....++..|+|||++.+..++.++|||||||++|||++|..|+....... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 33211 112233456999999998889999999999999999999887754332110 011122
Q ss_pred hcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 741 NEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 741 ~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
........+ +..+.+|+.+||. +|++|||+.+|++.|.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 222222222 2368999999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.16 Aligned_cols=234 Identities=27% Similarity=0.511 Sum_probs=191.6
Q ss_pred eEEeeeCcEEEEEEEECCe------------EEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 533 TRVGIGFFGEVFRGIWNGT------------DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~~g~------------~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
+.||+|+||.||+|.+.+. .+++|++...... ...|.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 3689999999999987422 4778876543321 5788899999999999999999999888 7789
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC-------eEEEEecCc
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-------TVKICDFGL 673 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g-------~VKL~DFGL 673 (785)
+||||+++|+|.+++... ...+++..+..++.||+.||+|||++||+|+||||+|||++.++ .+||+|||+
T Consensus 77 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 77 MVEEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999998732 22688999999999999999999999999999999999999887 899999999
Q ss_pred cccccCCCCCCCCCCCCCcccCccccccC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC-
Q 003935 674 SRIITDSPMRDSSSAGTPEWMAPELIRNE--PFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP- 749 (785)
Q Consensus 674 A~~l~~~~~~~~~~~GT~~Y~APEvl~~~--~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip- 749 (785)
+..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||............. .......+
T Consensus 155 a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~ 229 (259)
T cd05037 155 PITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMPD 229 (259)
T ss_pred cccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCCC
Confidence 987543 2234567789999999876 78999999999999999999 577887775444333332 22222222
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003935 750 EGPLGRLIADCWA-EPQERPSCEEILSRL 777 (785)
Q Consensus 750 ~~~L~~LI~~CL~-DP~kRPS~~EIL~~L 777 (785)
...+.+++.+||. +|.+||++.++++.|
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 230 CAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 3578999999999 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=306.87 Aligned_cols=245 Identities=29% Similarity=0.438 Sum_probs=209.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|.+.+.||.|++|.||++.+ .++.|++|++...... .....+.+|+..+..++|+||+++++++.....+++++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 3688899999999999999987 4889999998665433 446789999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-cccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
|+++++|.+++.. ...+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 80 YMDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred ecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999873 3678999999999999999999999 99999999999999999999999999999877554333
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcCCCCCCC----ChHHHHH
Q 003935 684 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL---PERVVYAVANEGSRLEIP----EGPLGRL 756 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~---~~~~v~~i~~~~~~~~ip----~~~L~~L 756 (785)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... ..+....+. .......+ +..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHHHH
Confidence 334567889999999999989999999999999999999999998773 334444433 23333333 2369999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003935 757 IADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~ 776 (785)
+..||. +|.+||++.+++++
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHccCChhhCCCHHHHHhC
Confidence 999999 99999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=316.38 Aligned_cols=247 Identities=26% Similarity=0.459 Sum_probs=204.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|++.+.||+|+||.||++.+ .+..||+|.+... ........+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 4688899999999999999987 4889999988643 233445788999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-cccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
|+++++|..++........+++..+..++.|++.||.|||+ .||+|+||||+||+++.++.++|+|||++..+... .
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~ 157 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--L 157 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--c
Confidence 99999999888643223478999999999999999999996 59999999999999999999999999999766432 2
Q ss_pred CCCCCCCCcccCccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--hcCCCCCCC---ChH
Q 003935 684 DSSSAGTPEWMAPELIRNE------PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA--NEGSRLEIP---EGP 752 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~------~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~--~~~~~~~ip---~~~ 752 (785)
.....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...........+. ..+....++ +..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence 2345678899999998654 35789999999999999999999997665544433322 122223333 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.+++.+||. +|.+||++.+++.+
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 238 AQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHHHHHHcccCcccCCCHHHHhcC
Confidence 8899999999 99999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=324.72 Aligned_cols=245 Identities=20% Similarity=0.317 Sum_probs=196.7
Q ss_pred EeeEEeee--CcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEc
Q 003935 531 VGTRVGIG--FFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 606 (785)
Q Consensus 531 i~k~LG~G--~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 606 (785)
+.++||+| +|++||++.. +|+.||+|++..........+.+.+|+.+++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7889999976 5889999998766555555567788999999999999999999999999999999999
Q ss_pred ccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC----
Q 003935 607 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM---- 682 (785)
Q Consensus 607 ~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~---- 682 (785)
++|+|.+++... ....+++..++.++.|++.||+|||++||+||||||+|||++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999998633 234589999999999999999999999999999999999999999999999987544322111
Q ss_pred ---CCCCCCCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----------
Q 003935 683 ---RDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---------- 747 (785)
Q Consensus 683 ---~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~---------- 747 (785)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||....................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 1122356778999999976 4689999999999999999999999987655444333222111000
Q ss_pred -------------------------------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 -------------------------------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 -------------------------------------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.-+..+.+++.+||+ ||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 001247789999999 99999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.43 Aligned_cols=243 Identities=33% Similarity=0.580 Sum_probs=205.7
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
.|+..+.||+|+||.||+|.+ .+..||+|.+..... ....+.+.+|+.+++.++||||+++++++..+..+++|+||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 456678899999999999987 578899999864433 23457889999999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 685 (785)
+++++|.+++. ...+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++..+........
T Consensus 84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence 99999998885 24688999999999999999999999999999999999999999999999999987654433333
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003935 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 762 (785)
Q Consensus 686 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~ 762 (785)
...++..|+|||.+.+..++.++|||||||++|+|++|+.||....+......+.. .....++ ...+.+++.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK-NSPPTLEGQYSKPFKEFVEACLN 238 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc-CCCCCCCcccCHHHHHHHHHHcc
Confidence 45678899999999998899999999999999999999999987766555544332 2222222 2468899999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003935 763 -EPQERPSCEEILSR 776 (785)
Q Consensus 763 -DP~kRPS~~EIL~~ 776 (785)
+|.+||++.+++++
T Consensus 239 ~~p~~Rp~~~~il~~ 253 (277)
T cd06642 239 KDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCcCHHHHHHh
Confidence 99999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=310.40 Aligned_cols=251 Identities=28% Similarity=0.445 Sum_probs=201.5
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCce
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 599 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 599 (785)
++++++++.....||+|+||.||+|.+ ++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++..++..
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF 80 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence 344556666667899999999999976 46789999876543 33456889999999999999999999999999999
Q ss_pred eEEEEEcccchhhHHHHhhcccccc--hHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC-CCeEEEEecCcccc
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKL--SWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRI 676 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~L--s~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~-~g~VKL~DFGLA~~ 676 (785)
++++||+++++|.+++.... ..+ ++..+..++.||+.||+|||++||+|+||||+||+++. ++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKW--GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEEecCCCCCHHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 99999999999999987322 334 78888999999999999999999999999999999976 67999999999876
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCC---C
Q 003935 677 ITDSPMRDSSSAGTPEWMAPELIRNEP--FTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGSRLEIP---E 750 (785)
Q Consensus 677 l~~~~~~~~~~~GT~~Y~APEvl~~~~--~s~ksDVWSLGvILyELLTG~~PF~~~~~~-~~v~~i~~~~~~~~ip---~ 750 (785)
............+++.|+|||.+.... ++.++||||||+++|+|++|+.||...... ............+.++ .
T Consensus 159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06624 159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLS 238 (268)
T ss_pred cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccC
Confidence 644332333456889999999986643 788999999999999999999999765432 2222221112223333 3
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 751 GPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 751 ~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..+.+++.+||. +|.+||++.+++.+
T Consensus 239 ~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 239 AEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 468899999999 99999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=306.35 Aligned_cols=246 Identities=36% Similarity=0.687 Sum_probs=206.3
Q ss_pred eeEeeEEeeeCcEEEEEEEECC------eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 529 LTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~~g------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
+++.+.||.|+||.||++.+.. ..+|+|++..... ....+.+..|+.+++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567899999999999998743 7899999865433 22467899999999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
|||+++++|.+++.... ...+++.++..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 80 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 80 MEYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EeccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999986322 12289999999999999999999999999999999999999999999999999987654422
Q ss_pred CCC-CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHH
Q 003935 683 RDS-SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLI 757 (785)
Q Consensus 683 ~~~-~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI 757 (785)
... ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+..... ...+ +..+.+++
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i 237 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR-LPKPENCPPEIYKLM 237 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-CCCCCcCCHHHHHHH
Confidence 221 2336789999999988889999999999999999998 7889988777777666654332 2222 34688999
Q ss_pred HHhhh-CCCCCCCHHHHHHHH
Q 003935 758 ADCWA-EPQERPSCEEILSRL 777 (785)
Q Consensus 758 ~~CL~-DP~kRPS~~EIL~~L 777 (785)
.+||. ||.+|||+.++++.|
T Consensus 238 ~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 238 LQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHCcCChhhCcCHHHHHhhC
Confidence 99999 999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=333.87 Aligned_cols=247 Identities=19% Similarity=0.257 Sum_probs=194.1
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCC------CceeeEec
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH------PNVILFLG 591 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~H------PNIVkL~g 591 (785)
+++.....+|.+.++||+|+||+||+|.+ .++.||||++.... .....+..|+.+++.++| .+|+++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 44455668899999999999999999987 57889999985422 223445667777776654 56889988
Q ss_pred cccCC-CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-cccccccCCCCcEEEcCCC-----
Q 003935 592 ACTKP-PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHW----- 664 (785)
Q Consensus 592 ~~~d~-~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-~gIIHrDLKpsNILLd~~g----- 664 (785)
++... ..+++||+++ +++|.+++. ....+++..+..++.||+.||+|||+ .|||||||||+|||++.++
T Consensus 199 ~~~~~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 199 YFQNETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EEEcCCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccc
Confidence 88654 4688888887 667887775 34579999999999999999999998 5999999999999998665
Q ss_pred -----------eEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Q 003935 665 -----------TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE 733 (785)
Q Consensus 665 -----------~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~ 733 (785)
.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 499999998864322 234568999999999999999999999999999999999999999887765
Q ss_pred HHHHHHHhcCCCC-------------------------------------------CCCChHHHHHHHHhhh-CCCCCCC
Q 003935 734 RVVYAVANEGSRL-------------------------------------------EIPEGPLGRLIADCWA-EPQERPS 769 (785)
Q Consensus 734 ~~v~~i~~~~~~~-------------------------------------------~ip~~~L~~LI~~CL~-DP~kRPS 769 (785)
.....+......+ .+....+.+||.+||. ||.+|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 5443332211000 0012236689999999 9999999
Q ss_pred HHHHHHH
Q 003935 770 CEEILSR 776 (785)
Q Consensus 770 ~~EIL~~ 776 (785)
++|+|+|
T Consensus 432 a~e~L~H 438 (467)
T PTZ00284 432 ARQMTTH 438 (467)
T ss_pred HHHHhcC
Confidence 9999986
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=313.57 Aligned_cols=255 Identities=28% Similarity=0.451 Sum_probs=207.3
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccC
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTK 595 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d 595 (785)
...+.-..++|.+.+.||+|+||.||++.. .++.+|+|++..... ....+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 344444568899999999999999999987 578899999864322 235677899999998 79999999999864
Q ss_pred C-----CceeEEEEEcccchhhHHHHhh-cccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEE
Q 003935 596 P-----PRLSMITEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKIC 669 (785)
Q Consensus 596 ~-----~~l~LV~Ey~~gGSL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~ 669 (785)
. ..+++|+||+++++|.++++.. .....+++..++.++.|++.||+|||+.|++|+||||+||+++.++.+||+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence 3 3589999999999999988632 234578999999999999999999999999999999999999999999999
Q ss_pred ecCccccccCCCCCCCCCCCCCcccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 003935 670 DFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-----PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS 744 (785)
Q Consensus 670 DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~-----~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~ 744 (785)
|||++..............++..|+|||.+... .++.++|||||||++|+|++|+.||........+..+.....
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~ 250 (291)
T cd06639 171 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP 250 (291)
T ss_pred ecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC
Confidence 999998765433333445688999999998643 367899999999999999999999988776665555443322
Q ss_pred CC-CCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 745 RL-EIP---EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 745 ~~-~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.. ..+ ...+.+++.+||+ +|++||++.+++++
T Consensus 251 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 251 PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11 111 2358899999999 99999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=313.24 Aligned_cols=236 Identities=22% Similarity=0.435 Sum_probs=190.5
Q ss_pred eEEeeeCcEEEEEEEEC--------------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 533 TRVGIGFFGEVFRGIWN--------------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~~--------------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
+.||+|+||.||+|+.. ...+++|++.... ....+.|..|+.+++.++||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 36899999999999742 2258888875432 2334678899999999999999999999999989
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCe-------EEEEec
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT-------VKICDF 671 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~-------VKL~DF 671 (785)
.+++|||+++++|..++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++. ++++||
T Consensus 79 ~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CEEEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999888763 2356899999999999999999999999999999999999986654 899999
Q ss_pred CccccccCCCCCCCCCCCCCcccCccccc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003935 672 GLSRIITDSPMRDSSSAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELC-TLNRPWEGVLPERVVYAVANEGSRLEIP 749 (785)
Q Consensus 672 GLA~~l~~~~~~~~~~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvILyELL-TG~~PF~~~~~~~~v~~i~~~~~~~~ip 749 (785)
|++...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......+... ..........+
T Consensus 157 g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~ 231 (262)
T cd05077 157 GIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLVTP 231 (262)
T ss_pred CCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccCCCC
Confidence 998765322 2345788999999887 467899999999999999997 5888887765444322 22222222222
Q ss_pred -ChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003935 750 -EGPLGRLIADCWA-EPQERPSCEEILSRL 777 (785)
Q Consensus 750 -~~~L~~LI~~CL~-DP~kRPS~~EIL~~L 777 (785)
...+.+|+.+||+ ||.+||++.+|+.+|
T Consensus 232 ~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 232 SCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 2468899999999 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=313.20 Aligned_cols=248 Identities=29% Similarity=0.469 Sum_probs=202.7
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccC------
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTK------ 595 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d------ 595 (785)
..+.|++.+.||.|+||.||+|.+ .++.+|+|++.... .....+..|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 456788899999999999999987 57899999985432 2345688899999998 69999999999853
Q ss_pred CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 596 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
...++++|||+++|+|.+++... ....+++..+..++.||+.||+|||+.||+|+||+|+||++++++.++|+|||++.
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 45689999999999999988643 34468888899999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--
Q 003935 676 IITDSPMRDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-- 748 (785)
Q Consensus 676 ~l~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i-- 748 (785)
.............|++.|+|||.+. ...++.++|||||||++|+|++|..||....+......+.........
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 249 (282)
T cd06636 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSK 249 (282)
T ss_pred hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCccc
Confidence 6543322334566889999999886 346788999999999999999999999877665555444332222111
Q ss_pred -CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 749 -PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 749 -p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
-+..+.+++.+||. ||.+||++.+|+++
T Consensus 250 ~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 13468999999999 99999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=360.95 Aligned_cols=257 Identities=26% Similarity=0.428 Sum_probs=210.7
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC-
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK- 595 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d- 595 (785)
+........+|.+.+.||.|+||+||++.+ .+..+|+|++............|..|+.+++.++|||||+++++|..
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 344555678999999999999999999987 47789999998766666667889999999999999999999998854
Q ss_pred -CCceeEEEEEcccchhhHHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhc-------ccccccCCCCcEEEcC----
Q 003935 596 -PPRLSMITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRM-------KIVHRDLKSANCLVNK---- 662 (785)
Q Consensus 596 -~~~l~LV~Ey~~gGSL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~AL~yLHs~-------gIIHrDLKpsNILLd~---- 662 (785)
...+|+||||+++|+|.+++.... ....+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 456899999999999999886432 235799999999999999999999985 4999999999999964
Q ss_pred -------------CCeEEEEecCccccccCCCCCCCCCCCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 003935 663 -------------HWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPW 727 (785)
Q Consensus 663 -------------~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvILyELLTG~~PF 727 (785)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||+||+|+||..||
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 2358999999998765432 2235579999999999864 45889999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCC--ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 728 EGVLPERVVYAVANEGSRLEIP--EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 728 ~~~~~~~~v~~i~~~~~~~~ip--~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
........+...........++ ...+.+||..||. +|.+||++.++|.+
T Consensus 244 ~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 244 HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 8765544444444433333322 3469999999999 99999999999954
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=315.27 Aligned_cols=246 Identities=23% Similarity=0.274 Sum_probs=201.9
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC---hHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT---AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~---~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
+|.+.+.||+|+||.||+|.+ +++.||+|.+...... ......+..|+.+++.++|+||+++++++.+...+++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999999987 5789999998765543 23345677899999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
|||+ +++|.+++... ...+++..++.++.||++||.|||++||+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 9999 88999998632 23799999999999999999999999999999999999999999999999999987755433
Q ss_pred CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------------
Q 003935 683 RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL--------------- 746 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~--------------- 746 (785)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...........+......+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 3334456788999998865 467899999999999999999988887766555444433211000
Q ss_pred ------CC--------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 ------EI--------PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 ------~i--------p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.. -...+.+++.+||. ||.+|||+.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 02357789999999 99999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=309.10 Aligned_cols=251 Identities=28% Similarity=0.527 Sum_probs=205.5
Q ss_pred eeEeeEEeeeCcEEEEEEEE-----CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC------
Q 003935 529 LTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------ 597 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------ 597 (785)
|.+.+.||+|+||.||+|.+ .+..+|||++..+.......+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 56788999999999999975 2578999999766655666788999999999999999999999875432
Q ss_pred ceeEEEEEcccchhhHHHHhhc---ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcc
Q 003935 598 RLSMITEYMELGSLYHLIHLSG---QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 674 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~---~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 674 (785)
..+++++|+.+|+|.+++.... ....+++..++.++.|++.||+|||+.||+|+||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 2478899999999988775321 1235788999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 003935 675 RIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP-- 749 (785)
Q Consensus 675 ~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip-- 749 (785)
+....... ......+++.|++||.+....++.++|||||||++|+|++ |+.||...........+.... ....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 239 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RLKQPPD 239 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-cCCCCCC
Confidence 87643221 1123345678999999998889999999999999999999 889998877766555554332 22222
Q ss_pred -ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 750 -EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 750 -~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
...+.+++.+||+ +|.+||++.++++.|+++
T Consensus 240 ~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 240 CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2468999999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=305.10 Aligned_cols=242 Identities=29% Similarity=0.589 Sum_probs=203.0
Q ss_pred eEEeeeCcEEEEEEEEC-CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccchh
Q 003935 533 TRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 611 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~~-g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL 611 (785)
++||.|+||.||++.+. ++.||+|.+...... ...+.|.+|+.+++.++|+||+++++++.+....+++|||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 36899999999999874 889999988655443 4567899999999999999999999999999999999999999999
Q ss_pred hHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC--CCCCC
Q 003935 612 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD--SSSAG 689 (785)
Q Consensus 612 ~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~--~~~~G 689 (785)
.+++... ...+++..+..++.|++.||+|||+++++||||+|+|||++.++.++|+|||++.......... .....
T Consensus 80 ~~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 9998632 3468899999999999999999999999999999999999999999999999998654322111 12233
Q ss_pred CCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CC
Q 003935 690 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EP 764 (785)
Q Consensus 690 T~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP 764 (785)
+..|+|||.+.+..++.++|+|||||++|+|+| |..||...........+.. ......+ +..+.+++.+||. +|
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-GYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-CCCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999998889999999999999999999 7889988877665555543 2222222 3468999999999 99
Q ss_pred CCCCCHHHHHHHHH
Q 003935 765 QERPSCEEILSRLL 778 (785)
Q Consensus 765 ~kRPS~~EIL~~L~ 778 (785)
.+||++.++++.|+
T Consensus 237 ~~Rp~~~ell~~l~ 250 (251)
T cd05041 237 ENRPSFSEIYNELQ 250 (251)
T ss_pred hhCcCHHHHHHHhh
Confidence 99999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=326.40 Aligned_cols=256 Identities=23% Similarity=0.323 Sum_probs=213.5
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCc-eeeEeccccCCC-----
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN-VILFLGACTKPP----- 597 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN-IVkL~g~~~d~~----- 597 (785)
+..|...++||+|+||+||+|.. +|+.||+|.+......+.......+|+.+|+.++|+| ||.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45566778899999999999976 6889999998665443333456689999999999999 999999998776
Q ss_pred -ceeEEEEEcccchhhHHHHhhccc-ccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 598 -RLSMITEYMELGSLYHLIHLSGQK-KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 598 -~l~LV~Ey~~gGSL~dlL~~~~~~-~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
.+++|+||+.. +|..++...... ..++...++.+++||+.||+|||++||+||||||.||||++.|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 79999999975 888888754322 357778999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---C--
Q 003935 676 IITDSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI---P-- 749 (785)
Q Consensus 676 ~l~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i---p-- 749 (785)
.+.-+....+...+|.+|.|||++.+. .|+...||||+|||++||++++.-|.+.........+...-..+.. |
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 876554445677899999999999886 7999999999999999999999999999888887777653333310 0
Q ss_pred --------------------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH--HHhhhh
Q 003935 750 --------------------------EGPLGRLIADCWA-EPQERPSCEEILSR--LLDCEY 782 (785)
Q Consensus 750 --------------------------~~~L~~LI~~CL~-DP~kRPS~~EIL~~--L~~l~~ 782 (785)
.....+++..|++ +|.+|.|+..++.| +.+...
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 0135678999999 99999999999988 555443
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=300.41 Aligned_cols=246 Identities=35% Similarity=0.578 Sum_probs=210.1
Q ss_pred CeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC--CceeEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRLSMIT 603 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~l~LV~ 603 (785)
+|++.+.||+|++|.||+|... ++.+++|++..........+.+.+|+.++++++||||+++++.+... ..+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999874 88999999876665455678899999999999999999999999888 8899999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC-
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 682 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~- 682 (785)
||+++++|.+++.. ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 99999999999873 33889999999999999999999999999999999999999999999999999987765432
Q ss_pred -CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCC---ChHHHHHH
Q 003935 683 -RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIP---EGPLGRLI 757 (785)
Q Consensus 683 -~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~-~~~~v~~i~~~~~~~~ip---~~~L~~LI 757 (785)
......++..|+|||.+.+..++.++||||||+++|+|++|..||.... .......+........++ +..+.+++
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 237 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence 1334568889999999998889999999999999999999999998765 333333333323333333 34699999
Q ss_pred HHhhh-CCCCCCCHHHHHHH
Q 003935 758 ADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 758 ~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+|+. +|.+||++.+++.+
T Consensus 238 ~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 238 RKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHhCcCChhhCCCHHHHhhC
Confidence 99999 99999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=309.53 Aligned_cols=245 Identities=32% Similarity=0.598 Sum_probs=201.7
Q ss_pred eEEeeeCcEEEEEEEECC--------eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 533 TRVGIGFFGEVFRGIWNG--------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~~g--------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
+.||+|+||.||+|.+.. ..+|+|.+..... ......|.+|+.+++.++||||+++++++......+++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 358999999999997632 5789998754322 2345678999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhc----ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC-----eEEEEecCccc
Q 003935 605 YMELGSLYHLIHLSG----QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-----TVKICDFGLSR 675 (785)
Q Consensus 605 y~~gGSL~dlL~~~~----~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g-----~VKL~DFGLA~ 675 (785)
|+++++|.+++.... ....+++..++.++.|++.||+|||+.+++|+||||+||+++.++ .++|+|||++.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 999999999986432 223578899999999999999999999999999999999999877 89999999997
Q ss_pred cccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---
Q 003935 676 IITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP--- 749 (785)
Q Consensus 676 ~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip--- 749 (785)
........ .....++..|+|||.+.+..++.++|||||||++|+|++ |+.||......+....+... .....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 238 (269)
T cd05044 160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-GRLQKPENC 238 (269)
T ss_pred ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-CccCCcccc
Confidence 65432211 122345678999999999999999999999999999998 99999887776665554432 222222
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003935 750 EGPLGRLIADCWA-EPQERPSCEEILSRLLD 779 (785)
Q Consensus 750 ~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~ 779 (785)
+..+.+++.+||. +|.+||++.+|++.|++
T Consensus 239 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 239 PDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred hHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 3468899999999 99999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=309.84 Aligned_cols=246 Identities=28% Similarity=0.471 Sum_probs=203.1
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC--------hHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT--------AENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~--------~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
+|.+.+.||.|+||.||+|.. +++.+|+|.+...... ....+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999976 5889999987543211 112456888999999999999999999999999
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+++|+||+++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 99999999999999999863 357899999999999999999999999999999999999999999999999999765
Q ss_pred cCCC--CCCCCCCCCCcccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----
Q 003935 678 TDSP--MRDSSSAGTPEWMAPELIRNEP--FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---- 749 (785)
Q Consensus 678 ~~~~--~~~~~~~GT~~Y~APEvl~~~~--~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---- 749 (785)
.... .......++..|+|||.+.... ++.++|+||||+++|+|++|..||...........+........++
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 4321 1122346788999999987654 7899999999999999999999998766655544443333222222
Q ss_pred ---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 750 ---EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 750 ---~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
...+.+++..||. +|.+||++.+++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 2368899999999 99999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=315.80 Aligned_cols=248 Identities=25% Similarity=0.352 Sum_probs=205.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++|.+.+.||+|+||.||++.+ .++.||+|.+...... ....+.+.+|+.+++.++||||+++++.+..+..++++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3688999999999999999987 4678999998765432 233567889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC--
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-- 681 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~-- 681 (785)
||+++++|.+++. ....+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||+++......
T Consensus 81 e~~~g~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLK---NIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 9999999999986 33578999999999999999999999999999999999999999999999999986421100
Q ss_pred -------------CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 003935 682 -------------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI 748 (785)
Q Consensus 682 -------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i 748 (785)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||.+..+.+....+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 0111245788999999998888999999999999999999999999988887777766554322211
Q ss_pred ----CChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003935 749 ----PEGPLGRLIADCWA-EPQERPSCEEILSRL 777 (785)
Q Consensus 749 ----p~~~L~~LI~~CL~-DP~kRPS~~EIL~~L 777 (785)
.+..+.+++.+||+ ||.+||++.++++.|
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 13458999999999 999999854444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=308.50 Aligned_cols=251 Identities=24% Similarity=0.433 Sum_probs=209.3
Q ss_pred CeeEeeEEeeeCcEEEEEEEEC---CeEEEEEEeeccc--------cChHHHHHHHHHHHHHhh-cCCCceeeEeccccC
Q 003935 528 ELTVGTRVGIGFFGEVFRGIWN---GTDVAIKVFLEQD--------LTAENMEDFCNEISILSR-LRHPNVILFLGACTK 595 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~~---g~~VAVKil~~~~--------~~~~~~e~f~~EI~iLk~-L~HPNIVkL~g~~~d 595 (785)
.|++.+.||+|+||.||+|.+. ++.+|+|.+.... .......++..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4778899999999999999874 5789999875432 223345677889988865 799999999999999
Q ss_pred CCceeEEEEEcccchhhHHHHhh-cccccchHHHHHHHHHHHHHHHHHHHh-cccccccCCCCcEEEcCCCeEEEEecCc
Q 003935 596 PPRLSMITEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGL 673 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGL 673 (785)
.+..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ .|++|+||+|+|||++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999999887542 234568999999999999999999996 7899999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---CC
Q 003935 674 SRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI---PE 750 (785)
Q Consensus 674 A~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i---p~ 750 (785)
+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+......+.. ..
T Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd08528 161 AKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239 (269)
T ss_pred eeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCC
Confidence 98765443 334556888999999999988999999999999999999999999887776666655544333221 23
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003935 751 GPLGRLIADCWA-EPQERPSCEEILSRLLD 779 (785)
Q Consensus 751 ~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~ 779 (785)
..+.+++.+||+ ||.+||++.++.+++.+
T Consensus 240 ~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 240 EDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred HHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 469999999999 99999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=312.69 Aligned_cols=249 Identities=21% Similarity=0.272 Sum_probs=200.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccCCCc-----
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPR----- 598 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~----- 598 (785)
++|.+.+.||+|+||.||+|.+ +++.||||++............+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688999999999999999987 5889999998655433333467889999999995 6999999999877655
Q ss_pred eeEEEEEcccchhhHHHHhhcc--cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC-CCeEEEEecCccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQ--KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSR 675 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~--~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~-~g~VKL~DFGLA~ 675 (785)
+|++|||+++ +|.+++..... ...+++..++.++.||+.||.|||++||+||||+|+||+++. ++.+||+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999986 78777754322 346899999999999999999999999999999999999998 8899999999998
Q ss_pred cccCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------
Q 003935 676 IITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-------- 746 (785)
Q Consensus 676 ~l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~-------- 746 (785)
.+...........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.........+......+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 66433222234457889999998865 457899999999999999999999998876665554443211000
Q ss_pred ---------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 ---------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 ---------------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.-...+.++|.+||. ||.+||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0012358889999999 99999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=317.65 Aligned_cols=240 Identities=26% Similarity=0.405 Sum_probs=185.0
Q ss_pred eeEEeeeCcEEEEEEEE----CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC--CCceeEEEEE
Q 003935 532 GTRVGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--PPRLSMITEY 605 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d--~~~l~LV~Ey 605 (785)
+++||+|+||+||+|.+ .++.||+|.+...... ..+.+|+.+++.++||||+++++++.. ...++++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 46899999999999975 3568999998654332 346789999999999999999998854 4568899999
Q ss_pred cccchhhHHHHhhc------ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEE----cCCCeEEEEecCccc
Q 003935 606 MELGSLYHLIHLSG------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSR 675 (785)
Q Consensus 606 ~~gGSL~dlL~~~~------~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILL----d~~g~VKL~DFGLA~ 675 (785)
+.+ +|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||+ +..+.+||+|||++.
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 875 7777765321 12358999999999999999999999999999999999999 456789999999998
Q ss_pred cccCCCC---CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHHhc
Q 003935 676 IITDSPM---RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE---------RVVYAVANE 742 (785)
Q Consensus 676 ~l~~~~~---~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~---------~~v~~i~~~ 742 (785)
.+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 7643221 1234578999999999876 45899999999999999999999999643221 111111110
Q ss_pred CC---------------------------C------------CCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 743 GS---------------------------R------------LEIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 743 ~~---------------------------~------------~~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.. . ...++..+.+|+.+||+ ||.+|||++|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0 00112346789999999 99999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=310.03 Aligned_cols=242 Identities=24% Similarity=0.344 Sum_probs=204.5
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
+|.+.+.||.|+||.||+|.+ .++.||+|++.+.... ....+.+.+|++++++++||||+++++++......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 488999999999999999987 4889999999765432 2456789999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
|+.+++|.+++.. ...+++..+..++.|+++||.|||++|++|+||+|+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 156 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LT 156 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cc
Confidence 9999999999863 3578999999999999999999999999999999999999999999999999988765432 22
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCCCC---ChHHHHHHH
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP---ERVVYAVANEGSRLEIP---EGPLGRLIA 758 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~---~~~v~~i~~~~~~~~ip---~~~L~~LI~ 758 (785)
....|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ......... .....+ +..+.+++.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAIN 234 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHHH
Confidence 345688899999999988899999999999999999999999987763 333332221 222222 346889999
Q ss_pred Hhhh-CCCCCCCH--HHHHH
Q 003935 759 DCWA-EPQERPSC--EEILS 775 (785)
Q Consensus 759 ~CL~-DP~kRPS~--~EIL~ 775 (785)
+||. ||.+||++ .++++
T Consensus 235 ~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 235 KLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHccCChhHcCCccHHHHhc
Confidence 9999 99999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=310.24 Aligned_cols=252 Identities=31% Similarity=0.543 Sum_probs=205.1
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC--CC
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--PP 597 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~~------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d--~~ 597 (785)
...|++.+.||+|+||.||++.++ +..+|||++...... ...+.|.+|+.+++.++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 356788899999999999999753 678999998755443 346789999999999999999999999877 55
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
..+++|||+++++|.+++... ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 789999999999999998632 336899999999999999999999999999999999999999999999999999877
Q ss_pred cCCCCC---CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--------------HHHHHH
Q 003935 678 TDSPMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER--------------VVYAVA 740 (785)
Q Consensus 678 ~~~~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~--------------~v~~i~ 740 (785)
...... .....++..|++||.+.+..++.++||||||+++|||++|..||....... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 532111 112344567999999988889999999999999999999999986543221 112222
Q ss_pred hcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 741 NEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 741 ~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
........+ +..+.+|+.+||. +|.+||++.+|++.|.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 223222222 2468899999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=301.11 Aligned_cols=245 Identities=31% Similarity=0.567 Sum_probs=211.9
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
+|.+.+.||+|++|.||++.+ .++.|++|.+..........+.+.+|++++++++|||++++++++.+...+++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 478899999999999999977 577899999987766556678899999999999999999999999998999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 685 (785)
+++++|.+++.. ...+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 999999999863 35789999999999999999999999999999999999999999999999999987765433333
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003935 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 762 (785)
Q Consensus 686 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~ 762 (785)
...++..|+|||.+.+..++.++|||+||+++|+|++|..||................. ..++ ...+.+++.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH-PPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCC-CCCCCCCCHHHHHHHHHHHh
Confidence 45688899999999888889999999999999999999999988776655555543322 2222 3468999999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003935 763 -EPQERPSCEEILSR 776 (785)
Q Consensus 763 -DP~kRPS~~EIL~~ 776 (785)
+|++||++.+++.+
T Consensus 237 ~~p~~R~~~~~~l~~ 251 (254)
T cd06627 237 KDPNLRPTAKQLLKH 251 (254)
T ss_pred CChhhCcCHHHHhcC
Confidence 99999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=306.63 Aligned_cols=247 Identities=29% Similarity=0.485 Sum_probs=207.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccc---cChHHHHHHHHHHHHHhhcCCCceeeEeccccCC--Cce
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQD---LTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRL 599 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~---~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~l 599 (785)
.+|.+.+.||+|+||.||++.+ ++..||+|++.... ........+.+|+++++.++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5789999999999999999976 58899999875432 2234457889999999999999999999998654 458
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
++++||+++++|.+++. ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 89999999999999886 234588999999999999999999999999999999999999999999999999986532
Q ss_pred CC---CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC---hHH
Q 003935 680 SP---MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---GPL 753 (785)
Q Consensus 680 ~~---~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~---~~L 753 (785)
.. .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...........+......+.+|. ..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 238 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDAC 238 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHH
Confidence 11 111234688899999999988899999999999999999999999988776666666554444444443 468
Q ss_pred HHHHHHhhhCCCCCCCHHHHHHH
Q 003935 754 GRLIADCWAEPQERPSCEEILSR 776 (785)
Q Consensus 754 ~~LI~~CL~DP~kRPS~~EIL~~ 776 (785)
.+++.+||.+|.+||++.+++.|
T Consensus 239 ~~~i~~~l~~~~~r~~~~~~~~~ 261 (264)
T cd06653 239 RDFLKQIFVEEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHHHHhcCcccCccHHHHhcC
Confidence 99999999988999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=315.75 Aligned_cols=252 Identities=31% Similarity=0.596 Sum_probs=205.9
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCe----EEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~----~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
...+|+..+.||+|+||.||+|.+ ++. .+|+|.+..... ......+.+|+.+++.++||||++++++|... .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 346788889999999999999976 343 578888764432 33345788999999999999999999998764 4
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
.++++||+++|+|.+++.. ....+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+|||+++.+.
T Consensus 83 ~~~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred ceeeehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 7899999999999998863 23468899999999999999999999999999999999999999999999999998764
Q ss_pred CCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003935 679 DSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 752 (785)
Q Consensus 679 ~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~ 752 (785)
.... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.+.........+ ..+.....+ ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 239 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGERLPQPPICTID 239 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCCCCCCCCCHH
Confidence 3221 1223345678999999999999999999999999999997 89999887665544443 333333332 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
+..++..||. +|++||++.++++.|.++.
T Consensus 240 ~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 240 VYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 8899999999 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=315.05 Aligned_cols=247 Identities=26% Similarity=0.420 Sum_probs=205.5
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeE
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 601 (785)
++.++|++.+.||+|+||+||++.+ .++.||+|++..... ....+.+.+|+++++.++||||+++++++.....+++
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 3457889999999999999999987 488999998865432 3345788999999999999999999999999999999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-cccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
||||+++++|.+++. ..+.+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 81 CMEFMDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEecCCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999999886 34578999999999999999999997 68999999999999999999999999998765332
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHHhcCCCCCCC
Q 003935 681 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-----------RVVYAVANEGSRLEIP 749 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~-----------~~v~~i~~~~~~~~ip 749 (785)
......|+..|+|||++.+..++.++|+|||||++|+|++|+.||...... .....+... ....++
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 234 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-PPPRLP 234 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-cCCCCC
Confidence 123457899999999998888999999999999999999999999865442 222222221 122222
Q ss_pred ----ChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003935 750 ----EGPLGRLIADCWA-EPQERPSCEEILSRL 777 (785)
Q Consensus 750 ----~~~L~~LI~~CL~-DP~kRPS~~EIL~~L 777 (785)
+..+.+|+.+||+ ||.+||++.+++++.
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 2358899999999 999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=313.00 Aligned_cols=237 Identities=22% Similarity=0.372 Sum_probs=190.2
Q ss_pred EEeeeCcEEEEEEEEC--------------------------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCcee
Q 003935 534 RVGIGFFGEVFRGIWN--------------------------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587 (785)
Q Consensus 534 ~LG~G~fG~VYkg~~~--------------------------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIV 587 (785)
+||+|+||.||+|... ...||+|++.... ......|.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 5999999999998631 1358888875432 23346788999999999999999
Q ss_pred eEeccccCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC---
Q 003935 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW--- 664 (785)
Q Consensus 588 kL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g--- 664 (785)
+++++|.+....++||||+++|+|..++.. ....+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999988863 345688999999999999999999999999999999999997643
Q ss_pred ----eEEEEecCccccccCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHH
Q 003935 665 ----TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELC-TLNRPWEGVLPERVVYA 738 (785)
Q Consensus 665 ----~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELL-TG~~PF~~~~~~~~v~~ 738 (785)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||....+......
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred CccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 4899999998654322 23457788999998865 56899999999999999985 78999987766554333
Q ss_pred HHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003935 739 VANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSRLL 778 (785)
Q Consensus 739 i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~ 778 (785)
.......+......+.+++.+||+ +|.+||++.+|++.|.
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 234 YEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 222111111122468899999999 9999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=307.40 Aligned_cols=246 Identities=28% Similarity=0.528 Sum_probs=202.6
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc----ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL----TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~----~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 601 (785)
+|+..+.||+|+||.||++.. +++.+|+|++..... .....+.+.+|+.+++.++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467789999999999999976 688999999864432 12245788999999999999999999999999999999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC-eEEEEecCccccccCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITDS 680 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g-~VKL~DFGLA~~l~~~ 680 (785)
|+||+++++|.+++.. ...+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||++..+...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 9999999999999863 35788999999999999999999999999999999999998765 6999999999876543
Q ss_pred CCC----CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCCCCCCC---C
Q 003935 681 PMR----DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE---RVVYAVANEGSRLEIP---E 750 (785)
Q Consensus 681 ~~~----~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~---~~v~~i~~~~~~~~ip---~ 750 (785)
... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...... .....+........++ +
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 211 12346788999999998888999999999999999999999999754432 2222222223333343 2
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 751 GPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 751 ~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..+.+++.+||. +|.+||++.+++++
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 468899999998 99999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.07 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=202.8
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
+|.+.++||.|++|.||+|.+ +|..||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 588999999999999999987 5889999998755432 2345677899999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 685 (785)
+++ +|.+++........+++..+..++.|++.||+|||+.|++|+||||+||++++++.++|+|||++...........
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence 985 7888776444445789999999999999999999999999999999999999999999999999976644322333
Q ss_pred CCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------------C-
Q 003935 686 SSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------------E- 747 (785)
Q Consensus 686 ~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~----------------~- 747 (785)
...+++.|++||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......+ .
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF 238 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence 45678899999988664 57889999999999999999999998877665555443211000 0
Q ss_pred -------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 -------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 -------------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..+..+.+++.+|++ ||.+||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 012347789999999 99999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=301.48 Aligned_cols=248 Identities=30% Similarity=0.547 Sum_probs=215.6
Q ss_pred CeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
+|.+.+.||.|+||.||++.+. +..+|+|++..........+.+.+|+++++.++|||++++++.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788999999999999999874 88999999977666656677899999999999999999999999998999999999
Q ss_pred cccchhhHHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 606 MELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 606 ~~gGSL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
+++++|.+++.... ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 99999999887432 24679999999999999999999999999999999999999999999999999998765543333
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCW 761 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL 761 (785)
....+++.|+|||.+.+..++.++|+||||+++|+|++|..||................ ...++ ...+.+++..||
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l 239 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-YPPIPSQYSSELRNLVSSLL 239 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHc
Confidence 44578899999999998889999999999999999999999998887777666655433 33333 346899999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003935 762 A-EPQERPSCEEILSR 776 (785)
Q Consensus 762 ~-DP~kRPS~~EIL~~ 776 (785)
. +|.+||++.+++++
T Consensus 240 ~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 240 QKDPEERPSIAQILQS 255 (258)
T ss_pred CCChhhCcCHHHHhcC
Confidence 9 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=302.47 Aligned_cols=246 Identities=31% Similarity=0.547 Sum_probs=212.3
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
+|++.+.||.|+||.||++.+ ++..+|+|.+............+.+|+.+++.++|+||+++++++.+....++++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478899999999999999976 577899999877665555667888999999999999999999999999999999999
Q ss_pred cccchhhHHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 606 MELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 606 ~~gGSL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
+++++|..++.... ....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~~ 158 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MA 158 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--Cc
Confidence 99999999886422 2356899999999999999999999999999999999999999999999999999877554 22
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCW 761 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL 761 (785)
....+++.|++||.+.+..++.++|+||||+++|+|++|+.||......+....+.... ...++ ...+.+++.+||
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l 237 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK-YPPIPPIYSQDLQNFIRSML 237 (256)
T ss_pred ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCchhhCHHHHHHHHHHc
Confidence 34568889999999999999999999999999999999999999888776665554433 23332 245899999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003935 762 A-EPQERPSCEEILSR 776 (785)
Q Consensus 762 ~-DP~kRPS~~EIL~~ 776 (785)
. +|.+||++.+++++
T Consensus 238 ~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 238 QVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCcccCCCHHHHhcC
Confidence 8 99999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=311.91 Aligned_cols=251 Identities=29% Similarity=0.499 Sum_probs=201.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC--Cc
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PR 598 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~ 598 (785)
.-|++.+.||+|+||.||++.+ .+..||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3467889999999999999974 36789999986443 234457899999999999999999999998775 56
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
.+++|||+++++|.+++... ...+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++..+.
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 89999999999999998632 3468999999999999999999999999999999999999999999999999998764
Q ss_pred CCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------------hHHHHHHHHh
Q 003935 679 DSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL--------------PERVVYAVAN 741 (785)
Q Consensus 679 ~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~--------------~~~~v~~i~~ 741 (785)
.... ......++..|+|||++.+..++.++|||||||++|+|+++..|+.... ..........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 4321 1123456678999999988889999999999999999999876643211 1111111222
Q ss_pred cCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 742 EGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 742 ~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
.+.....+ ...+.+|+.+||+ +|.+||++.++++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 23333322 2468999999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=298.08 Aligned_cols=243 Identities=32% Similarity=0.601 Sum_probs=208.1
Q ss_pred CeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
+|.+.+.||+|++|.||++.+. +..+++|++..... ...+.+.+|+.+++.++|+||+++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4788899999999999999874 88899999865543 3457889999999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 685 (785)
+++++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||.+........ ..
T Consensus 79 ~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 155 (253)
T cd05122 79 CSGGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RN 155 (253)
T ss_pred CCCCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-cc
Confidence 9999999998632 25789999999999999999999999999999999999999999999999999987654322 33
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHh
Q 003935 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRLIADC 760 (785)
Q Consensus 686 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-----~~~L~~LI~~C 760 (785)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.||................ ....+ ...+.+++.+|
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~ 234 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG-PPGLRNPEKWSDEFKDFLKKC 234 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC-CCCcCcccccCHHHHHHHHHH
Confidence 5568889999999998889999999999999999999999998876655555444322 22222 34689999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003935 761 WA-EPQERPSCEEILSR 776 (785)
Q Consensus 761 L~-DP~kRPS~~EIL~~ 776 (785)
|+ ||.+|||+.+++++
T Consensus 235 l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 235 LQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccCChhhCCCHHHHhcC
Confidence 99 99999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=311.80 Aligned_cols=236 Identities=25% Similarity=0.432 Sum_probs=190.3
Q ss_pred EEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 534 RVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 534 ~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
.||.|+||.||+|.+. ...+|+|.+.... ....+.+..|+.+++.++||||+++++++..+...++|||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 5899999999999763 2247888764332 2335678899999999999999999999999889999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCe--------EEEEecCcccc
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT--------VKICDFGLSRI 676 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~--------VKL~DFGLA~~ 676 (785)
|+++|+|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. ++++|||++..
T Consensus 80 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 80 YVKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred cCCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999998632 346889999999999999999999999999999999999987664 69999999876
Q ss_pred ccCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHhcCCCCCCCChHHH
Q 003935 677 ITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPEGPLG 754 (785)
Q Consensus 677 l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~-~PF~~~~~~~~v~~i~~~~~~~~ip~~~L~ 754 (785)
.... ....+++.|+|||++.+ ..++.++|||||||++|+|++|. .||..................+......+.
T Consensus 158 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (258)
T cd05078 158 VLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELA 233 (258)
T ss_pred cCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHHHH
Confidence 5432 23467889999999986 45789999999999999999995 677666555443322221111112224689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHHH
Q 003935 755 RLIADCWA-EPQERPSCEEILSRL 777 (785)
Q Consensus 755 ~LI~~CL~-DP~kRPS~~EIL~~L 777 (785)
+|+.+||+ ||.+|||+.+|++.|
T Consensus 234 ~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 234 NLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHHhccChhhCCCHHHHHHhc
Confidence 99999999 999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.06 Aligned_cols=243 Identities=34% Similarity=0.599 Sum_probs=206.8
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
-|.+.+.||.|+||.||+|.+ ++..+|+|++..... ....+.+.+|+.+++.++||||+++++++..+..+++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 366788999999999999976 578999999764433 23456788999999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 685 (785)
+++++|..++. ...+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++..+........
T Consensus 84 ~~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 84 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 99999999885 24688999999999999999999999999999999999999999999999999877654332333
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003935 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 762 (785)
Q Consensus 686 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~ 762 (785)
...++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+.. .....++ +..+.+++.+||+
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~ 238 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK-NNPPTLEGNYSKPLKEFVEACLN 238 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc-CCCCCCCcccCHHHHHHHHHHcc
Confidence 45678899999999888899999999999999999999999988776665555433 2233232 3468999999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003935 763 -EPQERPSCEEILSR 776 (785)
Q Consensus 763 -DP~kRPS~~EIL~~ 776 (785)
+|.+||++.+++++
T Consensus 239 ~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 239 KEPSFRPTAKELLKH 253 (277)
T ss_pred CChhhCcCHHHHHhC
Confidence 99999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=309.51 Aligned_cols=247 Identities=25% Similarity=0.316 Sum_probs=195.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
..+|.+.+.||+|+||.||+|.. +++.||+|++...... .....+.+|+.+++.++|+||+++++++......++|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 46899999999999999999976 5889999998654332 22345778999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+. +++.+.+.. ....+++..+..++.|++.||+|||+.||+|+||||+|||++.++.++|+|||++.........
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 9996 566655542 2346788889999999999999999999999999999999999999999999999765443323
Q ss_pred CCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhc-C---------------CC
Q 003935 684 DSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANE-G---------------SR 745 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~-~~v~~i~~~-~---------------~~ 745 (785)
.....+++.|+|||.+.+. .++.++|||||||++|+|++|..||...... +....+... + ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 3345678999999998764 5788999999999999999999999765432 221111110 0 00
Q ss_pred CC-----------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 746 LE-----------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 746 ~~-----------------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.. .....+.+++.+|+. ||.+|||+.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00 012357889999999 99999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=323.99 Aligned_cols=246 Identities=28% Similarity=0.364 Sum_probs=204.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC-----CCce
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-----PPRL 599 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d-----~~~l 599 (785)
..|...+.||.|+||.|..+.+ +|..||||.+.......-..++..+|+.+|+.++|+||+.+++++.. -..+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 4455578999999999999987 68899999987655566667889999999999999999999998865 2358
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
|+|+|+|. .+|...++ .+..|+...+..+++|++.||.|+|+.+|+||||||.|+|++.+..+||||||+|+....
T Consensus 102 YiV~elMe-tDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 102 YLVFELME-TDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred EEehhHHh-hHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 99999994 58888887 455699999999999999999999999999999999999999999999999999998853
Q ss_pred C--CCCCCCCCCCCcccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---------
Q 003935 680 S--PMRDSSSAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE--------- 747 (785)
Q Consensus 680 ~--~~~~~~~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~--------- 747 (785)
. ....+..+.|.+|.|||++. ...|+...||||+|||+.||++|+.-|.+.+....+..+..--..+.
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 2 22335678899999999875 46799999999999999999999999988766655555443222111
Q ss_pred ---------------CC--------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 ---------------IP--------EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 ---------------ip--------~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.| ....-+|+.+||. ||.+|+|++|.|+|
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11 1235578999999 99999999999987
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=313.85 Aligned_cols=248 Identities=26% Similarity=0.329 Sum_probs=203.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC--CceeE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRLSM 601 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~l~L 601 (785)
.++|.+.+.||.|+||.||+|.+ +++.+|+|.+............+.+|+.+++.++||||+++++++... ...|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 45788999999999999999988 478899999876554444445678899999999999999999998776 78999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
++||+.+ +|.+++... ...+++..++.++.||+.||+|||+.|++|+||||+|||++.++.++|+|||++.......
T Consensus 84 v~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 84 VMEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9999985 888887632 3468999999999999999999999999999999999999999999999999998775543
Q ss_pred CCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC----------------
Q 003935 682 MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS---------------- 744 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~---------------- 744 (785)
.......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...........+...-.
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 233345678899999998764 468899999999999999999999987766555444322100
Q ss_pred -------------CCCC----CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 745 -------------RLEI----PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 745 -------------~~~i----p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
...+ -...+.+++.+||+ +|++|||+.|++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0001 13357899999999 99999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=310.09 Aligned_cols=247 Identities=22% Similarity=0.318 Sum_probs=197.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
.++|.+.+.||.|+||.||+|.. +++.||+|.+....... ....+.+|+++++.++||||+++++++.+....++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 57899999999999999999987 57899999986543221 2345678999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+.+ +|.+++... ...+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.........
T Consensus 83 e~~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 83 EYLDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred ecCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 99985 888887632 346889999999999999999999999999999999999999999999999998765432222
Q ss_pred CCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCC----------------
Q 003935 684 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSR---------------- 745 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~-~~~~v~~i~~~~~~---------------- 745 (785)
.....++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+.. .......+...-..
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 223456789999999875 458899999999999999999999997655 22222222110000
Q ss_pred ----------------CCCC-ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 746 ----------------LEIP-EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 746 ----------------~~ip-~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..+. ...+.+++.+|+. +|.+|||+.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000 1346789999999 99999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.80 Aligned_cols=238 Identities=24% Similarity=0.406 Sum_probs=203.6
Q ss_pred EeeeCcEEEEEEEEC--CeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccchh
Q 003935 535 VGIGFFGEVFRGIWN--GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 611 (785)
Q Consensus 535 LG~G~fG~VYkg~~~--g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL 611 (785)
||.|+||.||++.+. ++.+|+|++.+... .....+.+.+|+.+++.++||||+++++++.++..+++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999885 88999999876543 234457799999999999999999999999999999999999999999
Q ss_pred hHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCCCCC
Q 003935 612 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 691 (785)
Q Consensus 612 ~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~ 691 (785)
.+++. ....+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++....... ......+++
T Consensus 81 ~~~l~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~ 156 (262)
T cd05572 81 WTILR---DRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTP 156 (262)
T ss_pred HHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCc
Confidence 99986 33468999999999999999999999999999999999999999999999999998775432 223456889
Q ss_pred cccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCC
Q 003935 692 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL--PERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQ 765 (785)
Q Consensus 692 ~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~--~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~ 765 (785)
.|++||.+.+..++.++|+||||+++|+|++|..||.... .......+.........| +..+.+++.+||. +|.
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 9999999988889999999999999999999999998776 555555555333333333 3468999999999 999
Q ss_pred CCCC-----HHHHHHH
Q 003935 766 ERPS-----CEEILSR 776 (785)
Q Consensus 766 kRPS-----~~EIL~~ 776 (785)
+||+ +.+++++
T Consensus 237 ~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 237 ERLGNLKGGIKDIKKH 252 (262)
T ss_pred hCcCCcccCHHHHhcC
Confidence 9999 8888874
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=308.48 Aligned_cols=243 Identities=29% Similarity=0.454 Sum_probs=204.3
Q ss_pred CeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
+|.+.+.||.|+||.||++.+. ++.+|+|.+..... ....+.+.+|+++++.++||||+++++++.....+++++||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 5777889999999999999874 78899999876543 34567889999999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-cccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
+++++|.+++... ...+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 81 MDGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred cCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 9999999998743 2678999999999999999999999 9999999999999999999999999999876643321
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhcCCCCCCC----ChHHHH
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL-----PERVVYAVANEGSRLEIP----EGPLGR 755 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~-----~~~~v~~i~~~~~~~~ip----~~~L~~ 755 (785)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... .......+.. ...+..+ +..+.+
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (265)
T cd06605 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-EPPPRLPSGKFSPDFQD 235 (265)
T ss_pred hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc-CCCCCCChhhcCHHHHH
Confidence 12668889999999999999999999999999999999999997542 2233333322 2223332 336889
Q ss_pred HHHHhhh-CCCCCCCHHHHHHH
Q 003935 756 LIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 756 LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+|..||. ||.+||++.+++.+
T Consensus 236 li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 236 FVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHcCCCchhCcCHHHHhhC
Confidence 9999999 99999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.53 Aligned_cols=246 Identities=22% Similarity=0.316 Sum_probs=200.6
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEc
Q 003935 529 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 606 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 606 (785)
|.+.+.||.|++|+||+|.+ +|+.||+|++............+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56778999999999999976 5889999998765544444467889999999999999999999999999999999999
Q ss_pred ccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003935 607 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 686 (785)
Q Consensus 607 ~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~ 686 (785)
. ++|.+++... ....+++..++.++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++..+.........
T Consensus 81 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 81 D-LDLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred C-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 5 5888888632 2246899999999999999999999999999999999999999999999999999765433222233
Q ss_pred CCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------------------
Q 003935 687 SAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------------- 746 (785)
Q Consensus 687 ~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~------------------- 746 (785)
..+++.|+|||++.+. .++.++|+||||+++|+|++|+.||...........+......+
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP 238 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence 4568899999988664 57899999999999999999999998776654444432211100
Q ss_pred -----------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 -----------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 -----------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
......+.+++.+||+ ||.+||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0012357889999999 99999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=337.36 Aligned_cols=257 Identities=33% Similarity=0.613 Sum_probs=222.7
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC----Ce--EEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccc
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN----GT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 593 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~----g~--~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~ 593 (785)
..+++..+...+.+.||.|-||.||+|++. |. .||||..+... ..+..+.|+.|.-+|+.++||||++++|+|
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 355677778888899999999999999873 33 48888876544 345578999999999999999999999999
Q ss_pred cCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCc
Q 003935 594 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGL 673 (785)
Q Consensus 594 ~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGL 673 (785)
.+.+ .++|||.++.|.|..+++. +...|+......+++||+.||+|||+.++|||||..+|||+.....|||+|||+
T Consensus 461 ~e~P-~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 461 VEQP-MWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred eccc-eeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccch
Confidence 8876 8999999999999999974 456788899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCC-CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCh
Q 003935 674 SRIITDSPMRDS-SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPEG 751 (785)
Q Consensus 674 A~~l~~~~~~~~-~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip~~ 751 (785)
++.+.+..+... ...-+..|||||.+....++.++|||.|||.+||++. |..||.+..+..++-.+ ..+.+++.|+.
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-EnGeRlP~P~n 616 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-ENGERLPCPPN 616 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-cCCCCCCCCCC
Confidence 999988765543 3445668999999999999999999999999999875 78899998887776655 55777777765
Q ss_pred ---HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 752 ---PLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 752 ---~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
.+..|+.+||. +|.+||.+.+|...|.++.
T Consensus 617 CPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 617 CPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred CChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 48899999999 9999999999998887754
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.13 Aligned_cols=249 Identities=25% Similarity=0.314 Sum_probs=203.2
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC--Ccee
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRLS 600 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~l~ 600 (785)
..++|.+.+.||.|+||.||+|.+ +|+.||+|++............+.+|+.+++.++|+||+++++++... +.++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 457899999999999999999987 588999999865543333334567899999999999999999998654 4689
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
+||||+.+ +|.+++... ...+++..++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 85 lv~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99999975 787777532 356899999999999999999999999999999999999999999999999999877543
Q ss_pred CCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--------------
Q 003935 681 PMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-------------- 745 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~-------------- 745 (785)
........+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 222233446788999999865 55789999999999999999999999988877766655432110
Q ss_pred ---CC--------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 746 ---LE--------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 746 ---~~--------------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.. .....+.++|.+|++ ||++|||+.+++.|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 012346789999999 99999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=339.20 Aligned_cols=250 Identities=25% Similarity=0.450 Sum_probs=228.8
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
......|.+.+.||+|.|++|.++.+ .++.||||++.+...+....+.+.+|+++|+.++|||||+++.+......+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 34567899999999999999999987 6999999999999888888788999999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
+||||+.+|.+++++. +.+.+.+..+..++.|+..|++|||+++|+|||||++||||+.+.++||+|||++..+..
T Consensus 132 lV~eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~- 207 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY- 207 (596)
T ss_pred EEEEeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc-
Confidence 9999999999999997 455777799999999999999999999999999999999999999999999999998874
Q ss_pred CCCCCCCCCCCcccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-ChHHHHHHH
Q 003935 681 PMRDSSSAGTPEWMAPELIRNEPFT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLGRLIA 758 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~~~~s-~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-~~~L~~LI~ 758 (785)
.....+.||++.|.|||++.+..|. +.+|+||+|++||.|++|..||++.+-.......+...++.+.. ....++|++
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLr 287 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLR 287 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHH
Confidence 3456789999999999999998774 78999999999999999999999998888888888888888766 446999999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003935 759 DCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 759 ~CL~-DP~kRPS~~EIL~~ 776 (785)
+++- +|.+|+++++|.++
T Consensus 288 k~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred HhhccCccccCCHHHhhhh
Confidence 9998 99999999999876
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=308.96 Aligned_cols=248 Identities=22% Similarity=0.310 Sum_probs=200.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|.+.+.||+|++|+||+|.+ +++.||+|.+............+.+|+.+++.++||||+++++++.....+++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 5799999999999999999986 57889999986554444445678899999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC-CCeEEEEecCccccccCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~-~g~VKL~DFGLA~~l~~~~~~ 683 (785)
|+++ +|.+.+... ....+++..++.++.||+.||+|||++|++|+||+|+||+++. ++.+||+|||++.........
T Consensus 82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 9974 777766432 2334688889999999999999999999999999999999985 567999999999765433222
Q ss_pred CCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------------
Q 003935 684 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL---------------- 746 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~---------------- 746 (785)
.....+++.|+|||++.+ ..++.++|||||||++|+|+||+.||...........+......+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 234467889999998866 457899999999999999999999998877665555443211000
Q ss_pred --------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 --------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 --------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..-...+.+++.+|++ +|.+||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0012347889999999 99999999999975
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.47 Aligned_cols=246 Identities=27% Similarity=0.424 Sum_probs=196.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHH-HhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISI-LSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~i-Lk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++|.+.+.||+|+||.||++.+ +|+.||+|++........ ...+..|+.+ ++.++||||+++++++..++..+++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 4788999999999999999987 588999999876543333 3456666665 66678999999999999999999999
Q ss_pred EEcccchhhHHHHhh-cccccchHHHHHHHHHHHHHHHHHHHhc-ccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 604 EYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~-gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
||++ |+|.+++... .....+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++..+....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9997 5787777532 2345789999999999999999999997 99999999999999999999999999998764322
Q ss_pred CCCCCCCCCCcccCcccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCC----ChH
Q 003935 682 MRDSSSAGTPEWMAPELIRN----EPFTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIP----EGP 752 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~----~~~s~ksDVWSLGvILyELLTG~~PF~~~~-~~~~v~~i~~~~~~~~ip----~~~ 752 (785)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.... ..+....... .....++ +..
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (283)
T cd06617 159 -AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQLPAEKFSPE 236 (283)
T ss_pred -ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh-cCCCCCCccccCHH
Confidence 2223567889999998865 456889999999999999999999997543 2233333322 2223232 246
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.+++.+||. +|.+||++.+++++
T Consensus 237 l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 237 FQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 8899999999 99999999999974
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=313.57 Aligned_cols=240 Identities=26% Similarity=0.416 Sum_probs=184.1
Q ss_pred eeEEeeeCcEEEEEEEEC----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEecccc--CCCceeEEEEE
Q 003935 532 GTRVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT--KPPRLSMITEY 605 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~~----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~--d~~~l~LV~Ey 605 (785)
+.+||+|+||+||+|... +..||+|.+..... ...+.+|+.+++.++||||+++++++. .+..+++++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 468999999999999862 46899998865432 235778999999999999999999884 35578999999
Q ss_pred cccchhhHHHHhhc------ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEE----cCCCeEEEEecCccc
Q 003935 606 MELGSLYHLIHLSG------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSR 675 (785)
Q Consensus 606 ~~gGSL~dlL~~~~------~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILL----d~~g~VKL~DFGLA~ 675 (785)
+.+ +|.+++.... ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 875 6766664221 12358899999999999999999999999999999999999 566799999999998
Q ss_pred cccCCCC---CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHHhc
Q 003935 676 IITDSPM---RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE---------RVVYAVANE 742 (785)
Q Consensus 676 ~l~~~~~---~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~---------~~v~~i~~~ 742 (785)
....... ......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||...... .....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 7644321 1234568899999999876 45899999999999999999999999643221 000000000
Q ss_pred -C--------------------------------------CCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 743 -G--------------------------------------SRLEIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 743 -~--------------------------------------~~~~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+ .....++..+.+|+.+|+. ||.+|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 0000122347789999999 99999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=316.67 Aligned_cols=242 Identities=24% Similarity=0.408 Sum_probs=203.2
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
.|.....||.|+||.||++.. ++..||||.+.... ....+.+.+|+.+++.++|+||+++++.+...+..+++|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 344456799999999999976 57899999986433 23456788999999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 685 (785)
+++++|.+++. ...+++..+..++.||+.||+|||++||+||||||+||++++++.++|+|||++...........
T Consensus 101 ~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 101 LEGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence 99999998874 23588999999999999999999999999999999999999999999999999876544332233
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHHHHHh
Q 003935 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRLIADC 760 (785)
Q Consensus 686 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i-----p~~~L~~LI~~C 760 (785)
...+++.|+|||.+.+..++.++||||||+++|||++|+.||...........+... ..... ....+.+++..|
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN-LPPRVKDSHKVSSVLRGFLDLM 255 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCccccccccCHHHHHHHHHH
Confidence 456889999999999888999999999999999999999999887776655544322 11111 134688999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003935 761 WA-EPQERPSCEEILSR 776 (785)
Q Consensus 761 L~-DP~kRPS~~EIL~~ 776 (785)
|. ||.+|||+.+++++
T Consensus 256 l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 256 LVREPSQRATAQELLQH 272 (292)
T ss_pred ccCChhHCcCHHHHhhC
Confidence 99 99999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=328.80 Aligned_cols=240 Identities=24% Similarity=0.336 Sum_probs=194.7
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~~----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 601 (785)
..+|.+.+.||.|+||.||++... +..||+|.+... ..+.+|+.+++.++||||+++++++.....+++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 357999999999999999999753 467999987532 234579999999999999999999999999999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
+||++. ++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+++.+....
T Consensus 164 v~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 164 VMPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999996 57777774 44679999999999999999999999999999999999999999999999999998765432
Q ss_pred CC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhc--------------
Q 003935 682 MR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE---RVVYAVANE-------------- 742 (785)
Q Consensus 682 ~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~---~~v~~i~~~-------------- 742 (785)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ..+..+...
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 21 22457999999999999999999999999999999999999999764321 111111110
Q ss_pred -----------CCCCC--CC--------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 743 -----------GSRLE--IP--------EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 743 -----------~~~~~--ip--------~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..+.. .+ ...+.++|.+||. ||.+||++.+++.+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00110 11 1246789999999 99999999999976
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.55 Aligned_cols=243 Identities=33% Similarity=0.587 Sum_probs=204.0
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC---CCceeeEeccccCCCceeEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR---HPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~---HPNIVkL~g~~~d~~~l~LV 602 (785)
.|++.+.||.|+||.||+|.+ +++.+|+|.+..... ....+.+.+|+.+++.++ ||||+++++++......+++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 467788999999999999987 578999999865432 334567889999999996 99999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
|||+++++|.+++.. ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..+.....
T Consensus 81 ~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 81 MEYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999998852 3689999999999999999999999999999999999999999999999999987755433
Q ss_pred CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----ChHHHHHH
Q 003935 683 RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP----EGPLGRLI 757 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip----~~~L~~LI 757 (785)
......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+... ..+.++ ...+.+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i 235 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLEDNGYSKLLREFV 235 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCCcccCCHHHHHHH
Confidence 3344578899999998865 45788999999999999999999999887665554433222 222222 23689999
Q ss_pred HHhhh-CCCCCCCHHHHHHH
Q 003935 758 ADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 758 ~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+||. ||.+||++.+++.+
T Consensus 236 ~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 236 AACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHcCCCcccCcCHHHHhhC
Confidence 99999 99999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=341.69 Aligned_cols=244 Identities=26% Similarity=0.477 Sum_probs=212.1
Q ss_pred eeEeeEEeeeCcEEEEEEEECC--eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEc
Q 003935 529 LTVGTRVGIGFFGEVFRGIWNG--TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 606 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~~g--~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 606 (785)
|.|+..||.|+||+||+++... -..|-|++..+ ..+.+++|+-||+||..+.||+||++++.|...+.++++.|||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 4456789999999999998753 34567887544 3456899999999999999999999999999999999999999
Q ss_pred ccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003935 607 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 686 (785)
Q Consensus 607 ~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~ 686 (785)
.||.+..++-.. +..|++.++..+++|++.||.|||+++|||||||+.|||++-+|.|+|+|||.+............
T Consensus 112 ~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs 189 (1187)
T KOG0579|consen 112 GGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS 189 (1187)
T ss_pred CCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence 999999887643 468999999999999999999999999999999999999999999999999998765444444567
Q ss_pred CCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC----hHHHHHH
Q 003935 687 SAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE----GPLGRLI 757 (785)
Q Consensus 687 ~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~----~~L~~LI 757 (785)
+.|||+|||||+.. ..+|++++||||||++|.||..+.+|-...++..++.++.....+..+.+ ..+.+++
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfL 269 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFL 269 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHH
Confidence 89999999999874 57899999999999999999999999999999999998876554333332 2589999
Q ss_pred HHhhh-CCCCCCCHHHHHHH
Q 003935 758 ADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 758 ~~CL~-DP~kRPS~~EIL~~ 776 (785)
..||. ||..||++.+|++|
T Consensus 270 k~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 270 KRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHhcCCccCCCHHHHhhC
Confidence 99999 99999999999987
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=305.07 Aligned_cols=244 Identities=24% Similarity=0.467 Sum_probs=193.4
Q ss_pred EEeeeCcEEEEEEEE-CCe---EEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccc
Q 003935 534 RVGIGFFGEVFRGIW-NGT---DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 609 (785)
Q Consensus 534 ~LG~G~fG~VYkg~~-~g~---~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gG 609 (785)
.||+|+||+||++.. ++. .+++|.+..... ....+.|.+|+.+++.++||||+++++.|.+....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 599999999999964 332 355666543322 334578999999999999999999999999999999999999999
Q ss_pred hhhHHHHhhcc-cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC--CCCCC
Q 003935 610 SLYHLIHLSGQ-KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP--MRDSS 686 (785)
Q Consensus 610 SL~dlL~~~~~-~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~--~~~~~ 686 (785)
+|.++++.... ...+++..++.++.||+.||+|||+.+++|+||||+|||++.++.++|+|||++....... .....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 99999874321 2456777888999999999999999999999999999999999999999999986532221 12234
Q ss_pred CCCCCcccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC----CCCC---Ch
Q 003935 687 SAGTPEWMAPELIRN-------EPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSR----LEIP---EG 751 (785)
Q Consensus 687 ~~GT~~Y~APEvl~~-------~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~----~~ip---~~ 751 (785)
..++..|+|||++.. ..++.++|||||||++|||++ |..||......+....+...... +.++ ..
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSE 240 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcH
Confidence 567889999998753 245789999999999999997 46789887776666665443321 1111 33
Q ss_pred HHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 003935 752 PLGRLIADCWAEPQERPSCEEILSRLL 778 (785)
Q Consensus 752 ~L~~LI~~CL~DP~kRPS~~EIL~~L~ 778 (785)
.+.+++..||.+|.+||++.+|++.|.
T Consensus 241 ~~~~l~~~c~~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 241 RWYEVLQFCWLSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHHHhhCcccCCCHHHHHHHhc
Confidence 578899999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.51 Aligned_cols=244 Identities=30% Similarity=0.490 Sum_probs=206.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
..+|.+.+.||+|+||.||++.. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..|+|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 36889999999999999999976 578899999854432 23467889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+++++|.+++.. ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 96 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 96 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred ecCCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999999998852 35788899999999999999999999999999999999999999999999998766544333
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--C---ChHHHHHHH
Q 003935 684 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI--P---EGPLGRLIA 758 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i--p---~~~L~~LI~ 758 (785)
.....+++.|+|||.+....++.++|+|||||++|+|++|+.||...........+.... .+.. + ...+.+++.
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~ 250 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLN 250 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC-CCCCCCccccCHHHHHHHH
Confidence 344568889999999988889999999999999999999999998776654444333222 1111 1 235889999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003935 759 DCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 759 ~CL~-DP~kRPS~~EIL~~ 776 (785)
.||. +|.+||++.+++.+
T Consensus 251 ~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 251 RCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHccCChhhCcCHHHHhcC
Confidence 9999 99999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=315.65 Aligned_cols=241 Identities=25% Similarity=0.407 Sum_probs=202.8
Q ss_pred eEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcc
Q 003935 530 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME 607 (785)
Q Consensus 530 ~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~ 607 (785)
.....||.|+||.||++.. .++.||+|++...... ..+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 3445799999999999976 5889999998654332 24668899999999999999999999999999999999999
Q ss_pred cchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCC
Q 003935 608 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 687 (785)
Q Consensus 608 gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~ 687 (785)
+++|..++. ...+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++..+..........
T Consensus 102 ~~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 102 GGALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred CCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence 999998774 2468899999999999999999999999999999999999999999999999987654433333446
Q ss_pred CCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----CCChHHHHHHHHhhh-
Q 003935 688 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----IPEGPLGRLIADCWA- 762 (785)
Q Consensus 688 ~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~----ip~~~L~~LI~~CL~- 762 (785)
.+++.|+|||++.+..++.++|||||||++|+|++|+.||...........+........ .....+.+++.+||+
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~ 257 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTR 257 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcC
Confidence 788999999999988899999999999999999999999987776666555433221111 113468999999999
Q ss_pred CCCCCCCHHHHHHH
Q 003935 763 EPQERPSCEEILSR 776 (785)
Q Consensus 763 DP~kRPS~~EIL~~ 776 (785)
+|.+||++.+++++
T Consensus 258 ~P~~Rps~~~ll~~ 271 (297)
T cd06659 258 EPQERATAQELLDH 271 (297)
T ss_pred CcccCcCHHHHhhC
Confidence 99999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=309.37 Aligned_cols=247 Identities=30% Similarity=0.498 Sum_probs=209.7
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
....|.+.+.||.|+||.||+|.+. +..+++|++..... ..+.+.+|+++++.++|+||+++++++......+++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 3456888899999999999999884 88999999865433 456788999999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
+||+++++|.+++.... ..+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 94 MEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 99999999999997422 3799999999999999999999999999999999999999999999999999876544322
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC----CChHHHHHHH
Q 003935 683 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI----PEGPLGRLIA 758 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i----p~~~L~~LI~ 758 (785)
......+++.|++||.+.+..++.++|+|||||++|+|++|+.||....+......+......... .+..+.+++.
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence 223445788999999999888999999999999999999999999988776665555443322111 1346899999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003935 759 DCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 759 ~CL~-DP~kRPS~~EIL~~ 776 (785)
.||+ +|.+||++.+++.+
T Consensus 252 ~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 252 KCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHhccChhhCcCHHHHhhC
Confidence 9999 99999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=305.69 Aligned_cols=246 Identities=25% Similarity=0.427 Sum_probs=201.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC--CCceeEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--PPRLSMI 602 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d--~~~l~LV 602 (785)
++|...+.||.|++|.||+|.+ .++.+|+|.+..... ......+.+|+++++.++||||++++++|.. ...+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 3688899999999999999987 578999999875433 2445778999999999999999999998854 3468999
Q ss_pred EEEcccchhhHHHHhh-cccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 603 TEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
|||+++++|.+++... .....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 9999999999887532 234568899999999999999999999999999999999999999999999999987654321
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhcCCCCCCC-------
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV-----LPERVVYAVANEGSRLEIP------- 749 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~-----~~~~~v~~i~~~~~~~~ip------- 749 (785)
.....++..|+|||.+.+..++.++|||||||++|+|++|..||... ...+....+.. .....++
T Consensus 160 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (287)
T cd06621 160 --AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPELKDEPGNGI 236 (287)
T ss_pred --cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhhccCCCCCC
Confidence 12345788999999999989999999999999999999999999765 22333333222 1111111
Q ss_pred --ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 750 --EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 750 --~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
...+.+++.+||. +|.+|||+.|++.+
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred chHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1358899999999 99999999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=351.69 Aligned_cols=254 Identities=26% Similarity=0.335 Sum_probs=204.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
.+|.+.++||+|+||.||+|.+ .++.||+|++..... .....+.|.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999999987 488999999865433 2334567999999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcc--------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 604 EYMELGSLYHLIHLSGQ--------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~--------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
||++|++|.+++..... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 99999999998864211 2345677889999999999999999999999999999999999999999999998
Q ss_pred cccCCC------------------CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 003935 676 IITDSP------------------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY 737 (785)
Q Consensus 676 ~l~~~~------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~ 737 (785)
...... ......+||+.|+|||.+.+..++.++|||||||++|||+||..||..........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~ 241 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY 241 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh
Confidence 662110 01112469999999999999999999999999999999999999998765544333
Q ss_pred HHHhcCCCCC----CCChHHHHHHHHhhh-CCCCCC-CHHHHHHHHHhh
Q 003935 738 AVANEGSRLE----IPEGPLGRLIADCWA-EPQERP-SCEEILSRLLDC 780 (785)
Q Consensus 738 ~i~~~~~~~~----ip~~~L~~LI~~CL~-DP~kRP-S~~EIL~~L~~l 780 (785)
.......... .-+..+.+++.+|+. ||.+|| +++++++.|++.
T Consensus 242 ~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 242 RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2111111000 112358899999999 999996 667777777654
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.20 Aligned_cols=247 Identities=26% Similarity=0.409 Sum_probs=212.8
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc------ChHHHHHHHHHHHHHhhc-CCCceeeEeccccCC
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL------TAENMEDFCNEISILSRL-RHPNVILFLGACTKP 596 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~------~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~ 596 (785)
+..|...+.||.|..++|.++.+ .|..+|+|++..... ..+-.+.-.+|+.||+++ .||||+++.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 35566678899999999999876 588999998843221 222345667899999998 599999999999999
Q ss_pred CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
..+++|+|.|+.|.|+++|. ..-+++++..++|+.|+++|++|||.++|+||||||+|||++++.+++|+|||+++.
T Consensus 96 sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred chhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeec
Confidence 99999999999999999997 556899999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCCCCCcccCccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 003935 677 ITDSPMRDSSSAGTPEWMAPELIRNE------PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE 750 (785)
Q Consensus 677 l~~~~~~~~~~~GT~~Y~APEvl~~~------~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~ 750 (785)
+... ......||||+|+|||.+... .|+...|+|++|||||.|+.|.+||......-++..+..+.+...-|.
T Consensus 173 l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe 251 (411)
T KOG0599|consen 173 LEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE 251 (411)
T ss_pred cCCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence 8654 344678999999999998753 467789999999999999999999998877777777777666554442
Q ss_pred -----hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 751 -----GPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 751 -----~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
...++||.+|++ ||.+|.|++|+|.|
T Consensus 252 Wadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 252 WADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred hhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 358899999999 99999999999987
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=304.13 Aligned_cols=247 Identities=25% Similarity=0.400 Sum_probs=208.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcC-CCceeeEeccccCCCceeEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV 602 (785)
++|.+.+.||+|+||.||++.. ++..||+|++..... .....+.+..|+.++++++ ||||+++++++......+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4789999999999999999987 688999999876443 2334567889999999998 99999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
|||+.+++|.+++. ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~---~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999999999987 334799999999999999999999999999999999999999999999999999887644321
Q ss_pred --------------------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 003935 683 --------------------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE 742 (785)
Q Consensus 683 --------------------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~ 742 (785)
......++..|+|||.+....++.++|+||||++++++++|+.||...........+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 112345788999999998888999999999999999999999999988766655555432
Q ss_pred CCCCC-CCChHHHHHHHHhhh-CCCCCCCH----HHHHHH
Q 003935 743 GSRLE-IPEGPLGRLIADCWA-EPQERPSC----EEILSR 776 (785)
Q Consensus 743 ~~~~~-ip~~~L~~LI~~CL~-DP~kRPS~----~EIL~~ 776 (785)
..... .-+..+.+++..||+ +|.+||++ .+++++
T Consensus 238 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 238 EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 22221 113468999999999 99999999 777764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=301.76 Aligned_cols=238 Identities=28% Similarity=0.419 Sum_probs=201.4
Q ss_pred EeeeCcEEEEEEEEC--CeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccchh
Q 003935 535 VGIGFFGEVFRGIWN--GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 611 (785)
Q Consensus 535 LG~G~fG~VYkg~~~--g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL 611 (785)
||.|+||.||++.+. |+.+++|++..... .....+.+.+|+++++.++||||+++++.+......|+++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999884 88999999865543 234467889999999999999999999999999999999999999999
Q ss_pred hHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC--------C
Q 003935 612 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--------R 683 (785)
Q Consensus 612 ~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--------~ 683 (785)
.+++.. ...+++..+..++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 999873 23789999999999999999999999999999999999999999999999999876543211 2
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHh
Q 003935 684 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADC 760 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~C 760 (785)
.....++..|++||.+....++.++||||||+++|+|++|..||...........+.......... +..+.+++.+|
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 237 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKL 237 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHH
Confidence 234467889999999988889999999999999999999999999888877776665533332222 45689999999
Q ss_pred hh-CCCCCCCH---HHHHH
Q 003935 761 WA-EPQERPSC---EEILS 775 (785)
Q Consensus 761 L~-DP~kRPS~---~EIL~ 775 (785)
|+ +|.+||++ .++++
T Consensus 238 l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 238 LVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred hcCCHhhcCCCccHHHHhc
Confidence 99 99999999 55554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=307.69 Aligned_cols=249 Identities=27% Similarity=0.373 Sum_probs=197.3
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC-----
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP----- 597 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~----- 597 (785)
..++|.+.+.||+|+||.||+|.. +++.||||.+............+.+|+.+++.++||||+++++++...+
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 356899999999999999999987 5889999998654433333345678999999999999999999886543
Q ss_pred ---ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcc
Q 003935 598 ---RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 674 (785)
Q Consensus 598 ---~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 674 (785)
..++||||+.+ +|.+.+.. ....+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 35999999975 77776652 2346899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC----CCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----
Q 003935 675 RIITDSPMR----DSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR---- 745 (785)
Q Consensus 675 ~~l~~~~~~----~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~---- 745 (785)
..+...... .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||.+.........+......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 876433211 1234577889999988664 4788999999999999999999999877665443332221100
Q ss_pred -----------------------------CCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 746 -----------------------------LEIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 746 -----------------------------~~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..+....+.+||.+||. ||.+|||+++++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00112346789999999 99999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=317.79 Aligned_cols=244 Identities=25% Similarity=0.335 Sum_probs=199.6
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC------C
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------P 597 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~------~ 597 (785)
..+|++.+.||+|+||.||+|.+ +++.||+|++............+.+|+.+++.++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 36799999999999999999986 688999999865544445566788999999999999999999987643 3
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
..|+||||+.+ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred cEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 47999999975 77777641 2888999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------- 746 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~----------- 746 (785)
.... ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...-..+
T Consensus 169 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T cd07850 169 GTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247 (353)
T ss_pred CCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence 4432 2234567889999999999999999999999999999999999998766544333332110000
Q ss_pred ---------------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 ---------------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 ---------------------------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
......+.+++.+||+ ||++|||+.++|.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0011246789999999 99999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=308.08 Aligned_cols=241 Identities=24% Similarity=0.419 Sum_probs=204.0
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEc
Q 003935 529 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 606 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 606 (785)
|...+.||.|++|.||++.. .++.+++|++.... ....+.+.+|+.+++.++||||+++++++...+..++++||+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 44457899999999999976 57889999875433 233466889999999999999999999999999999999999
Q ss_pred ccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003935 607 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 686 (785)
Q Consensus 607 ~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~ 686 (785)
++++|.+++.. ..+++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||++............
T Consensus 99 ~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 174 (285)
T cd06648 99 EGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS 174 (285)
T ss_pred CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence 99999998863 46889999999999999999999999999999999999999999999999988765443222334
Q ss_pred CCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHHHHHhh
Q 003935 687 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRLIADCW 761 (785)
Q Consensus 687 ~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i-----p~~~L~~LI~~CL 761 (785)
..|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+......+.... .... .+..+.+++.+||
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CCCCcccccCCHHHHHHHHHHc
Confidence 568899999999998889999999999999999999999998877766666554432 1111 1246999999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003935 762 A-EPQERPSCEEILSR 776 (785)
Q Consensus 762 ~-DP~kRPS~~EIL~~ 776 (785)
. +|.+||++.+++++
T Consensus 254 ~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 254 VRDPAQRATAAELLNH 269 (285)
T ss_pred ccChhhCcCHHHHccC
Confidence 9 99999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=309.89 Aligned_cols=242 Identities=30% Similarity=0.472 Sum_probs=202.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccc-cChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQD-LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~-~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
..|.+.+.||+|+||+||+|.. .++.||+|++.... ......+.+.+|+.+++.++||||++++++|.+....++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4588889999999999999986 58899999986543 33445577899999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+.+ ++.+++.. ....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~g-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 95 EYCLG-SASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred HhhCC-CHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 99984 66666542 2346899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----ChHHHHH
Q 003935 684 DSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP----EGPLGRL 756 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip----~~~L~~L 756 (785)
....+++.|+|||++. ...++.++||||||+++|+|++|+.||...........+..... +..+ ...+.++
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 246 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS-PTLSSNDWSDYFRNF 246 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-CCCCchhhCHHHHHH
Confidence 2456788999999874 45688999999999999999999999988777666655543322 2221 2368999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003935 757 IADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.+||. +|.+||++.+|+.+
T Consensus 247 i~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 247 VDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHhcCChhhCcCHHHHhcC
Confidence 999999 99999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=302.91 Aligned_cols=245 Identities=26% Similarity=0.351 Sum_probs=203.6
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEc
Q 003935 529 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 606 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 606 (785)
|.+.+.||.|++|.||++.. +++.+++|.+............+.+|+.+++.++|+||+++++++..+...++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56678999999999999987 5888999998766554445677889999999999999999999999999999999999
Q ss_pred ccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003935 607 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 686 (785)
Q Consensus 607 ~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~ 686 (785)
++ +|.+++.. ....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+............
T Consensus 81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 86 77777753 2357899999999999999999999999999999999999999999999999999877554322334
Q ss_pred CCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------------------
Q 003935 687 SAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------------- 746 (785)
Q Consensus 687 ~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~------------------- 746 (785)
..++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+.......
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 5678899999998876 78999999999999999999999998877655544443211110
Q ss_pred ------C------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 ------E------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 ------~------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
. ..+..+.+++.+||. ||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 012358899999999 99999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=301.26 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=200.7
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC--CceeEEEE
Q 003935 529 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRLSMITE 604 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~l~LV~E 604 (785)
|.+.+.||.|+||.||+|.+ +++.+|+|++............+.+|+.+++.++||||+++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 67889999999999999987 478999999976653344456788999999999999999999999887 78999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC-C
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-R 683 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~-~ 683 (785)
|+++ +|..++.. ....+++..++.++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 9985 78877752 225789999999999999999999999999999999999999999999999999987654321 1
Q ss_pred CCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------------
Q 003935 684 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL---------------- 746 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~---------------- 746 (785)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+......+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 223456788999998765 457899999999999999999999998877665555443311100
Q ss_pred ----------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 ----------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 ----------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
......+.+++.+||. +|.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0012357789999999 99999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=320.46 Aligned_cols=240 Identities=25% Similarity=0.316 Sum_probs=189.4
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
....|.+.+.||+|+||.||+|.+ .+..||+|+.... ....|+.+++.++||||+++++++......++|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 345799999999999999999988 4568999975322 234699999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
+||+. ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 136 ~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred EEccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 99996 577777753 34578999999999999999999999999999999999999999999999999997543321
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCC-CCCChH---------HHHHHHHhc-CC-CCCCC-
Q 003935 683 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW-EGVLPE---------RVVYAVANE-GS-RLEIP- 749 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF-~~~~~~---------~~v~~i~~~-~~-~~~ip- 749 (785)
......||+.|+|||++.+..++.++|||||||++|||+++..|+ ...... ..+..+... +. ...++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 223457899999999999999999999999999999999876554 322110 111111110 00 00000
Q ss_pred --------------------------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 750 --------------------------------EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 750 --------------------------------~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
...+.+||.+||+ ||.+|||+.|+++|
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 1235569999999 99999999999976
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=308.42 Aligned_cols=248 Identities=25% Similarity=0.389 Sum_probs=193.7
Q ss_pred CeeEeeEEeeeCcEEEEEEEE----CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCC--Ccee
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW----NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRLS 600 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~----~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~l~ 600 (785)
.|.+.++||+|+||.||+|.+ .++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 478889999999999999987 468999999876431 122235678899999999999999999999888 7899
Q ss_pred EEEEEcccchhhHHHHhhc--ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC----CCeEEEEecCcc
Q 003935 601 MITEYMELGSLYHLIHLSG--QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK----HWTVKICDFGLS 674 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~--~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~----~g~VKL~DFGLA 674 (785)
+||||+.+ +|.+++.... ....+++..++.++.|++.||+|||+.+|+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999986 5655554322 1237899999999999999999999999999999999999999 999999999999
Q ss_pred ccccCCCC---CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---------HHHHHHh
Q 003935 675 RIITDSPM---RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER---------VVYAVAN 741 (785)
Q Consensus 675 ~~l~~~~~---~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~---------~v~~i~~ 741 (785)
........ ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..... ....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 87644322 1234467889999998876 457899999999999999999999997554321 0000000
Q ss_pred ------------------------cCCCCCCC--------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 742 ------------------------EGSRLEIP--------------EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 742 ------------------------~~~~~~ip--------------~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.......+ ...+.+++.+|+. ||.+|||+.+++++
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00011111 2247789999999 99999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=300.90 Aligned_cols=242 Identities=26% Similarity=0.388 Sum_probs=194.2
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccCC--CceeEEE
Q 003935 529 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKP--PRLSMIT 603 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~--~~l~LV~ 603 (785)
|++.+.||+|+||.||+|.. +++.||+|++........ .....+|+.++.++. |+||+++++++.+. +.+++|+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 67889999999999999987 578999999865433322 234567899999885 99999999999887 8899999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+.+ +|.+.+.. ....+++..++.++.|++.||+|||+.|++|+||+|+||+++. +.+||+|||++........
T Consensus 80 e~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 80 ELMDM-NLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred ecCCc-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 99975 77776652 2357899999999999999999999999999999999999999 9999999999987644322
Q ss_pred CCCCCCCCcccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC----------------CC
Q 003935 684 DSSSAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS----------------RL 746 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~----------------~~ 746 (785)
.....+++.|+|||.+. +..++.++|||||||++|||++|..||.+.+....+..+..... ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 23346788999999764 45578899999999999999999999987766554443322100 00
Q ss_pred CC--------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 EI--------------PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 ~i--------------p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.. -...+.+++.+||. +|.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 01 12458899999999 99999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=307.50 Aligned_cols=260 Identities=26% Similarity=0.330 Sum_probs=209.3
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
...-++-++|.+.++||+|||+.||+++. +++.||+|++.... .+..+..++|++..++++|||++++++++..+.
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE 91 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence 44567778999999999999999999975 78899999987665 355788899999999999999999999875544
Q ss_pred c-----eeEEEEEcccchhhHHHHhhcc-cccchHHHHHHHHHHHHHHHHHHHhcc--cccccCCCCcEEEcCCCeEEEE
Q 003935 598 R-----LSMITEYMELGSLYHLIHLSGQ-KKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKIC 669 (785)
Q Consensus 598 ~-----l~LV~Ey~~gGSL~dlL~~~~~-~~~Ls~~~~l~Ia~QIa~AL~yLHs~g--IIHrDLKpsNILLd~~g~VKL~ 669 (785)
. .|+++.|...|+|.+.+..... +..+++.+++.|+.+|++||++||... ++||||||.|||+++.+.++|.
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence 3 9999999999999998876543 447999999999999999999999998 9999999999999999999999
Q ss_pred ecCccccccCCCCC---------CCCCCCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 003935 670 DFGLSRIITDSPMR---------DSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY 737 (785)
Q Consensus 670 DFGLA~~l~~~~~~---------~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~ 737 (785)
|||.+....-.... ......|..|+|||.+.- ...++++|||||||+||+|+.|..||...-...---
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl 251 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL 251 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence 99998765321110 012347889999999864 457889999999999999999999996321110000
Q ss_pred HHHhcCCCCCCC-----ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 738 AVANEGSRLEIP-----EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 738 ~i~~~~~~~~ip-----~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
.+........+| .+.+.++|+.|++ ||.+||++.+++.++.++.
T Consensus 252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 000111122223 3468999999999 9999999999999998764
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=306.68 Aligned_cols=246 Identities=24% Similarity=0.396 Sum_probs=195.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++|...+.||+|+||.||++.+ +++.+|+|.+...... .....+.+|+.++.++. |+||+++++++..+...+++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 4566778899999999999987 5789999998655433 44567889999999996 999999999999988999999
Q ss_pred EEcccchhhHHHHh--hcccccchHHHHHHHHHHHHHHHHHHHh-cccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 604 EYMELGSLYHLIHL--SGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 604 Ey~~gGSL~dlL~~--~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
||+.. ++.++... ......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++..+...
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 99874 44443321 1123578999999999999999999997 49999999999999999999999999999766443
Q ss_pred CCCCCCCCCCCcccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCC-------
Q 003935 681 PMRDSSSAGTPEWMAPELIRNE---PFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGSRLEIP------- 749 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~~---~~s~ksDVWSLGvILyELLTG~~PF~~~~~~-~~v~~i~~~~~~~~ip------- 749 (785)
. ......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||...... .....+.. +..+.++
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (288)
T cd06616 162 I-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK-GDPPILSNSEEREF 239 (288)
T ss_pred C-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcC-CCCCcCCCcCCCcc
Confidence 2 22344688899999999776 6899999999999999999999999765421 12222211 1111111
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 750 EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 750 ~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
...+.+|+.+||+ +|.+|||+++|+++
T Consensus 240 ~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 240 SPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2358899999999 99999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=324.50 Aligned_cols=256 Identities=32% Similarity=0.532 Sum_probs=216.1
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEECC-eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeE
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~~g-~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 601 (785)
++..+.+.++++||+|-||+|.++..++ ..||||+++.... .....+|.+||.+|.+|+|||||+++|+|..++.+++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 4566788899999999999999998865 8999999876543 3446899999999999999999999999999999999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
++||+++|+|.+++.... ...+......+|+.||+.||+||.+.++|||||.+.|||++.++++||+|||+++.+....
T Consensus 613 I~EYmEnGDLnqFl~ahe-apt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHE-LPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHhcCcHHHHHHhcc-CcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999999997542 2335566677899999999999999999999999999999999999999999999775554
Q ss_pred CCCC--CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHhc---CC------CCCC
Q 003935 682 MRDS--SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELC--TLNRPWEGVLPERVVYAVANE---GS------RLEI 748 (785)
Q Consensus 682 ~~~~--~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELL--TG~~PF~~~~~~~~v~~i~~~---~~------~~~i 748 (785)
++.. ..+.+.+|||+|.+.-++++.++|||+||++|||++ +...||.....++++.....- .. ++.+
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~ 771 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPA 771 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCc
Confidence 4322 345678999999999999999999999999999985 567899999888887765321 11 1111
Q ss_pred CChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 749 PEGPLGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 749 p~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
-+..+.+++..||. |..+||+|+++..+|++.
T Consensus 772 cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 772 CPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 23468899999999 999999999999999874
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=305.67 Aligned_cols=250 Identities=23% Similarity=0.324 Sum_probs=200.5
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC----
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP---- 597 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~---- 597 (785)
...++|.+.+.||+|+||.||+|.+ +++.||+|++............+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 3457899999999999999999987 5789999998765443334456788999999999999999999887654
Q ss_pred ------ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEec
Q 003935 598 ------RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 671 (785)
Q Consensus 598 ------~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DF 671 (785)
.+++++||+++ ++...+.. ....+++..++.++.|++.||+|||+.||+|+||||+||++++++.+||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 78999999986 66666542 2346899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCC-CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----
Q 003935 672 GLSRIITDSPM-RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR---- 745 (785)
Q Consensus 672 GLA~~l~~~~~-~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~---- 745 (785)
|++........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........+..+......
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 99987654321 1123356788999998865 45788999999999999999999999876655544333321100
Q ss_pred ---------------------------CCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 746 ---------------------------LEIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 746 ---------------------------~~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
...-+..+.+++.+||. ||.+||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00113468899999999 99999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=308.29 Aligned_cols=244 Identities=29% Similarity=0.462 Sum_probs=204.4
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
.|...+.||+|+||.||++.+ ++..+|+|++..... ..+..+.+.+|+++++.++|||++++++++.+....++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 366788999999999999986 578999999865432 33445678999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
|+.+ +|.+++.. ....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 9975 77776653 2456899999999999999999999999999999999999999999999999998754332
Q ss_pred CCCCCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHH
Q 003935 685 SSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIA 758 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~ 758 (785)
....+++.|+|||.+. .+.++.++|||||||++|+|++|+.||...........+.........+ ...+.+++.
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 258 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 258 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHH
Confidence 2456888999999973 4568899999999999999999999998887776666665544332222 335899999
Q ss_pred Hhhh-CCCCCCCHHHHHHHHH
Q 003935 759 DCWA-EPQERPSCEEILSRLL 778 (785)
Q Consensus 759 ~CL~-DP~kRPS~~EIL~~L~ 778 (785)
+||+ +|.+||++.++++++.
T Consensus 259 ~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 259 SCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred HHccCCcccCcCHHHHHhChh
Confidence 9999 9999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=341.24 Aligned_cols=255 Identities=36% Similarity=0.597 Sum_probs=223.4
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEEC--C---eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIWN--G---TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~~--g---~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
+++.+..+|.++||.|-||+||+|..+ | ..||||.++.. ..+.+..+|+.|+.||.++.||||++|-|+.....
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 456678899999999999999999762 3 46999998654 45566789999999999999999999999999999
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
...+|+|||++|+|..+|+.. .+.+++.+...+++.|+.||+||-++|+|||||.+.|||++.+...|++|||+++.+
T Consensus 704 PvMIiTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 999999999999999999854 467999999999999999999999999999999999999999999999999999988
Q ss_pred cCCCCCC-CCC--CCCCcccCccccccCCCCchhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhcCCCCCCCCh--
Q 003935 678 TDSPMRD-SSS--AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELC-TLNRPWEGVLPERVVYAVANEGSRLEIPEG-- 751 (785)
Q Consensus 678 ~~~~~~~-~~~--~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELL-TG~~PF~~~~~~~~v~~i~~~~~~~~ip~~-- 751 (785)
.+..... ++. .-+.+|.|||.+...+++.++||||||++|||.+ .|.+||-+.++.+++..+ ..+++++-|-+
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI-e~gyRLPpPmDCP 860 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-EQGYRLPPPMDCP 860 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH-HhccCCCCCCCCc
Confidence 6654222 222 2346899999999999999999999999999976 589999999999888876 45777766644
Q ss_pred -HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 752 -PLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 752 -~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
.|.+|+..||+ |-.+||.|.+|+..|.++.
T Consensus 861 ~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 861 AALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred HHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 59999999999 9999999999999998764
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=313.89 Aligned_cols=246 Identities=26% Similarity=0.373 Sum_probs=199.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC----CCcee
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK----PPRLS 600 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d----~~~l~ 600 (785)
++|.+.+.||.|+||.||+|.. +|+.||+|++..........+.+.+|+.+++.++||||+++++++.. ...++
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6789999999999999999976 58899999987654444446778899999999999999999998753 34689
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
+|+||+. ++|.+++. ....+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 85 lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 85 VVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999996 58888875 3456999999999999999999999999999999999999999999999999999876432
Q ss_pred CCC----CCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-------------
Q 003935 681 PMR----DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE------------- 742 (785)
Q Consensus 681 ~~~----~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~------------- 742 (785)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 211 123468889999999865 46889999999999999999999999876544333222211
Q ss_pred -----------CCCCCC--------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 743 -----------GSRLEI--------PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 743 -----------~~~~~i--------p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
...... .+..+.+++.+||+ +|.+||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 001111 13458899999999 99999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=310.73 Aligned_cols=245 Identities=28% Similarity=0.375 Sum_probs=205.0
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC-----cee
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP-----RLS 600 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~-----~l~ 600 (785)
+|.+.+.||.|+||.||+|.. .+..+|||++..........+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 478899999999999999987 4789999998765443445678899999999999999999999988775 789
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
++|||+.+ +|.+++. ....+++..++.++.|++.||+|||+.||+|+||||+|||++.++.++|+|||++......
T Consensus 81 lv~e~~~~-~l~~~l~---~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELMET-DLHKVIK---SPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchhh-hHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99999984 7888876 3448999999999999999999999999999999999999999999999999999887554
Q ss_pred C---CCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---------
Q 003935 681 P---MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE--------- 747 (785)
Q Consensus 681 ~---~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~--------- 747 (785)
. .......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||.+....+....+......+.
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 3 122345678899999999887 789999999999999999999999988776665554443211110
Q ss_pred ---------------------C--CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 ---------------------I--PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 ---------------------i--p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
. -...+.+++.+||. +|.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 12347789999999 99999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=303.47 Aligned_cols=240 Identities=25% Similarity=0.340 Sum_probs=194.6
Q ss_pred EeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccchh
Q 003935 535 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 611 (785)
Q Consensus 535 LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL 611 (785)
||+|+||+||++.+ +|+.||+|++...... ......+..|+.+++.++||||+++++++...+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999976 5889999998754432 22345677899999999999999999999999999999999999999
Q ss_pred hHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCCCCC
Q 003935 612 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 691 (785)
Q Consensus 612 ~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~ 691 (785)
.+++... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .......++.
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~ 158 (277)
T cd05577 81 KYHIYNV-GEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTP 158 (277)
T ss_pred HHHHHHc-CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCCC
Confidence 9988633 2246899999999999999999999999999999999999999999999999998766432 2223456788
Q ss_pred cccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCCCCC---ChHHHHHHHHhhh-CCC
Q 003935 692 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE--GSRLEIP---EGPLGRLIADCWA-EPQ 765 (785)
Q Consensus 692 ~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~--~~~~~ip---~~~L~~LI~~CL~-DP~ 765 (785)
.|+|||.+.+..++.++|||||||++|+|++|+.||...........+... ......+ +..+.+++.+||+ ||.
T Consensus 159 ~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 238 (277)
T cd05577 159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPE 238 (277)
T ss_pred CcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChh
Confidence 999999998888999999999999999999999999765442111111111 1111222 3468999999999 999
Q ss_pred CCC-----CHHHHHHH
Q 003935 766 ERP-----SCEEILSR 776 (785)
Q Consensus 766 kRP-----S~~EIL~~ 776 (785)
+|| ++.+++.+
T Consensus 239 ~R~~~~~~~~~~ll~h 254 (277)
T cd05577 239 KRLGCRGGSADEVREH 254 (277)
T ss_pred HccCCCcccHHHHHhC
Confidence 999 66667654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.38 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=196.8
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC------
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------ 597 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------ 597 (785)
.++|.+.++||.|+||.||+|.+ +++.+|+|++............+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999987 5788999998655443333356778999999999999999999875433
Q ss_pred --ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 598 --RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 598 --~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
.+++++||+.+ ++...+.. ....+++..+..++.|+++||+|||++||+|+||||+||++++++.++|+|||++.
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 46999999976 56555542 34579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCC-----------CCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Q 003935 676 IITDSPMR-----------DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG 743 (785)
Q Consensus 676 ~l~~~~~~-----------~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~ 743 (785)
........ .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 65432211 112356788999998865 458899999999999999999999998877665554443211
Q ss_pred CCC---------------------CCC----------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 744 SRL---------------------EIP----------EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 744 ~~~---------------------~ip----------~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..+ ..+ ...+.+++.+|+. ||.+|||+.+++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 110 000 1246789999999 99999999999865
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.64 Aligned_cols=246 Identities=20% Similarity=0.320 Sum_probs=198.1
Q ss_pred eEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccc
Q 003935 530 TVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 609 (785)
Q Consensus 530 ~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gG 609 (785)
.+++.+|.|+++.||++..+++.||||++..........+.+.+|+.+++.++|+||+++++++.+....+++|||++++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 34556666777777777778999999999776555666788999999999999999999999999999999999999999
Q ss_pred hhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC-------
Q 003935 610 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM------- 682 (785)
Q Consensus 610 SL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~------- 682 (785)
+|.+++... ....+++..+..++.|++.||+|||+++|+|+||||+||+++.++.++|+|||.+........
T Consensus 85 ~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 85 SCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred CHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 999998743 234688999999999999999999999999999999999999999999999998876532211
Q ss_pred CCCCCCCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------------C
Q 003935 683 RDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE------------I 748 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~------------i 748 (785)
......++..|+|||++.. ..++.++|+|||||++|+|++|..||.................... .
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 1123456778999999876 3578899999999999999999999987665444332221110000 0
Q ss_pred C-----------------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 749 P-----------------------EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 749 p-----------------------~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
. ...+.+++..||. ||++|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0 1246789999999 99999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=329.59 Aligned_cols=240 Identities=22% Similarity=0.290 Sum_probs=192.5
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
...|.+.+.||+|+||.||++.+ .++.||||... ...+.+|+.+|++++|+|||++++++...+..+++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 45799999999999999999988 46789999632 234568999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC-
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 682 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~- 682 (785)
|++. ++|..++.. ....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 240 e~~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 240 PKYR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EccC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 9996 578777752 234799999999999999999999999999999999999999999999999999987643221
Q ss_pred -CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcCCC--------
Q 003935 683 -RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL--------PERVVYAVANEGSR-------- 745 (785)
Q Consensus 683 -~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~--------~~~~v~~i~~~~~~-------- 745 (785)
......||+.|+|||++.+..++.++|||||||+||||++|..|+.... ...+...+......
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 1224579999999999999999999999999999999999886543211 12222221111100
Q ss_pred -----------------CC----------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 746 -----------------LE----------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 746 -----------------~~----------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.. ..+..+.+||.+||. ||.+|||+.|+|++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 001247789999999 99999999999986
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=303.88 Aligned_cols=250 Identities=16% Similarity=0.187 Sum_probs=184.4
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHH---------HHHHHHHHHHHhhcCCCceeeE
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAEN---------MEDFCNEISILSRLRHPNVILF 589 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~---------~e~f~~EI~iLk~L~HPNIVkL 589 (785)
+.-.+|.+.++||+|+||+||+|.+. +..+|+|+.......... ......+...+..+.|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 34478999999999999999999874 335677764322211100 0112234445666789999999
Q ss_pred eccccCCC----ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCe
Q 003935 590 LGACTKPP----RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 665 (785)
Q Consensus 590 ~g~~~d~~----~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~ 665 (785)
++++.... ..+++++++.. ++.+.+.. ....++..++.++.|++.||+|||+.+|+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc
Confidence 98765443 23567776643 55555542 234578888999999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCC-------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHH--
Q 003935 666 VKICDFGLSRIITDSPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP-ERV-- 735 (785)
Q Consensus 666 VKL~DFGLA~~l~~~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~-~~~-- 735 (785)
++|+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ...
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999987642211 11234699999999999999999999999999999999999999987632 221
Q ss_pred ------HHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003935 736 ------VYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSRL 777 (785)
Q Consensus 736 ------v~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~L 777 (785)
...+..........+..+.+++..||. +|.+||++.+|++.|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 122222222222234568999999999 999999999999875
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=298.42 Aligned_cols=245 Identities=27% Similarity=0.344 Sum_probs=199.1
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc---CCCceeeEeccccCCCc-----
Q 003935 529 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL---RHPNVILFLGACTKPPR----- 598 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L---~HPNIVkL~g~~~d~~~----- 598 (785)
|++.+.||+|+||.||+|.+ +++.||+|++............+.+|+.+++.+ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 67889999999999999987 478999999875544333345677788877666 59999999999988776
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
++++|||+.+ +|.+++... ....+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999985 788887643 23368999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------
Q 003935 679 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------ 746 (785)
Q Consensus 679 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~------------ 746 (785)
... ......++..|+|||.+.+..++.++|+|||||++|+|++|..||.+....+....+.......
T Consensus 159 ~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 159 FEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred CCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 432 2223457889999999999889999999999999999999999998887766655544311100
Q ss_pred -----C---C------C--ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 -----E---I------P--EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 -----~---i------p--~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
. . + ...+.+++.+||+ ||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 0 0 1246789999999 99999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=311.68 Aligned_cols=246 Identities=26% Similarity=0.331 Sum_probs=198.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC-----Cce
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-----PRL 599 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~-----~~l 599 (785)
.+|.+.+.||+|+||+||++.+ +++.||||.+............+.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 4799999999999999999987 588999999865443444456778999999999999999999987654 347
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
++++||+. ++|.+++. ....+++..+..++.|++.||.|||+++++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 85 YIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 99999996 57887775 345799999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC---------------
Q 003935 680 SPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG--------------- 743 (785)
Q Consensus 680 ~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~--------------- 743 (785)
.........++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence 3333344567889999998865 468899999999999999999999998765433222221100
Q ss_pred ---------CCC--------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 744 ---------SRL--------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 744 ---------~~~--------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
... .-....+.+++.+||+ +|++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000 0012347899999999 99999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=302.88 Aligned_cols=252 Identities=23% Similarity=0.403 Sum_probs=202.8
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccCC
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKP 596 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~ 596 (785)
..+.+..++|.+.+.||+|+||+||+|.+. ++.||||++....... ....+..|+.++..+. ||||+++++++.+.
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 456778899999999999999999999885 8899999987554332 3456777887777775 99999999999999
Q ss_pred CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-cccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
...|++|||+.+ ++.+++... ...+++..+..++.|++.||+|||+ .||+||||+|+||++++++.+||+|||++.
T Consensus 87 ~~~~~v~e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 87 SDVFICMELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred CeEEEEeeccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccch
Confidence 999999999864 666666532 3478999999999999999999997 599999999999999999999999999997
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCC-
Q 003935 676 IITDSPMRDSSSAGTPEWMAPELIRNEP----FTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGSRLEIP- 749 (785)
Q Consensus 676 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~----~s~ksDVWSLGvILyELLTG~~PF~~~~~~-~~v~~i~~~~~~~~ip- 749 (785)
.+..... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... +....+.... ....+
T Consensus 164 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 241 (296)
T cd06618 164 RLVDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE-PPSLPP 241 (296)
T ss_pred hccCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-CCCCCC
Confidence 7644322 22345778999999987553 788999999999999999999999764332 3333333322 22222
Q ss_pred ----ChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003935 750 ----EGPLGRLIADCWA-EPQERPSCEEILSRL 777 (785)
Q Consensus 750 ----~~~L~~LI~~CL~-DP~kRPS~~EIL~~L 777 (785)
...+.+|+.+||. ||.+||++.+++.+-
T Consensus 242 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 3468999999999 999999999999763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=296.13 Aligned_cols=237 Identities=25% Similarity=0.372 Sum_probs=194.4
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHH-hhcCCCceeeEeccccCCCceeEEEEEccc
Q 003935 533 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISIL-SRLRHPNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iL-k~L~HPNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
+.||.|+||.||+|.+ .++.||+|++.+.... ......+..|..++ ...+|+||+++++++...+.+|+++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5689999999999987 5789999998654432 22233455565544 445899999999999999999999999999
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 688 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 688 (785)
++|.+++. ....+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++..... .....
T Consensus 82 ~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~ 154 (260)
T cd05611 82 GDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFV 154 (260)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCC
Confidence 99999986 335689999999999999999999999999999999999999999999999999876533 23456
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--CC---CChHHHHHHHHhhh-
Q 003935 689 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL--EI---PEGPLGRLIADCWA- 762 (785)
Q Consensus 689 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~--~i---p~~~L~~LI~~CL~- 762 (785)
+++.|+|||.+.+..++.++||||||+++|+|++|..||...........+....... .. -+..+.+++.+||.
T Consensus 155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 7889999999988888999999999999999999999999888777666554433211 11 13468999999999
Q ss_pred CCCCCCCH---HHHHHH
Q 003935 763 EPQERPSC---EEILSR 776 (785)
Q Consensus 763 DP~kRPS~---~EIL~~ 776 (785)
+|.+||++ .+++++
T Consensus 235 ~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 235 DPAKRLGANGYQEIKSH 251 (260)
T ss_pred CHHHccCCCcHHHHHcC
Confidence 99999965 566544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=309.56 Aligned_cols=244 Identities=29% Similarity=0.405 Sum_probs=194.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC-----Cce
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-----PRL 599 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~-----~~l 599 (785)
++|.+.+.||+|+||.||+|.+ +|+.||+|++..... ......+.+|+.+++.++||||+++++++... ...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 6899999999999999999976 588999999854322 23356788999999999999999999886543 347
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
++++||+.+ +|..++. ...+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 999999975 7776664 34689999999999999999999999999999999999999999999999999987643
Q ss_pred CCC---CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC------------
Q 003935 680 SPM---RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG------------ 743 (785)
Q Consensus 680 ~~~---~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~------------ 743 (785)
... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+...-
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 221 1123568899999998754 568999999999999999999999997655433222211100
Q ss_pred ------------CCCCC--------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 744 ------------SRLEI--------PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 744 ------------~~~~i--------p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..... ....+.+++.+||. +|.+||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 12357899999999 99999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=295.71 Aligned_cols=247 Identities=30% Similarity=0.479 Sum_probs=202.7
Q ss_pred CeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeecc---ccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQ---DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~---~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
+|.+.+.||+|+||+||++.+. +..+++|+++.- .........+..|+.+++.++||||+++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788999999999999999774 445666665432 22333345677899999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhh-cccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 603 TEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
+||+++++|.+++... .....+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 9999999999888642 23457899999999999999999999999999999999999975 569999999998765443
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHH
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIA 758 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~ 758 (785)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+.. +..+..+ +..+.+++.
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 238 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-GPTPSLPETYSRQLNSIMQ 238 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-CCCCCCcchhcHHHHHHHH
Confidence 333455688899999999888889999999999999999999999987766665555443 2232333 246889999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003935 759 DCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 759 ~CL~-DP~kRPS~~EIL~~ 776 (785)
+||. +|.+||++.+++++
T Consensus 239 ~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 239 SMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHhcCChhhCcCHHHHhhC
Confidence 9999 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=329.50 Aligned_cols=241 Identities=26% Similarity=0.343 Sum_probs=203.2
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-C-----CceeeEeccccCCCce
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-H-----PNVILFLGACTKPPRL 599 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-H-----PNIVkL~g~~~d~~~l 599 (785)
+|.+.+.||+|.||.|.+|.+ +++.||||+++.+ .....+...|+.+|..|+ | -|||+++++|...+++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 889999999999999999987 5889999999654 334566778999999997 4 3899999999999999
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC--eEEEEecCccccc
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW--TVKICDFGLSRII 677 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g--~VKL~DFGLA~~l 677 (785)
+||+|.+. -+|+++++.. +...++...++.++.||+.||.+||+.||||+||||+||||.+.. .|||+|||.|+..
T Consensus 264 ciVfELL~-~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 264 CIVFELLS-TNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeehhhh-hhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999996 5999999754 456799999999999999999999999999999999999997543 7999999999987
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------- 746 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~----------- 746 (785)
....+ ..+.+..|.|||++.+.+|+.+.||||||||++||++|.+-|.+.+....+..|..--..+
T Consensus 342 ~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~ 418 (586)
T KOG0667|consen 342 SQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA 418 (586)
T ss_pred CCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc
Confidence 65433 5667889999999999999999999999999999999998898877766555543210000
Q ss_pred ---------------------------------------CCC--------------ChHHHHHHHHhhh-CCCCCCCHHH
Q 003935 747 ---------------------------------------EIP--------------EGPLGRLIADCWA-EPQERPSCEE 772 (785)
Q Consensus 747 ---------------------------------------~ip--------------~~~L~~LI~~CL~-DP~kRPS~~E 772 (785)
..| ...+.+++++|+. ||.+|+|..+
T Consensus 419 ~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~q 498 (586)
T KOG0667|consen 419 HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQ 498 (586)
T ss_pred ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHH
Confidence 011 0136789999999 9999999999
Q ss_pred HHHH
Q 003935 773 ILSR 776 (785)
Q Consensus 773 IL~~ 776 (785)
.|+|
T Consensus 499 al~H 502 (586)
T KOG0667|consen 499 ALNH 502 (586)
T ss_pred HhcC
Confidence 9987
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=352.88 Aligned_cols=255 Identities=24% Similarity=0.353 Sum_probs=224.2
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHhhcCCCceeeEeccccC
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTK 595 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 595 (785)
..++....++|.+++.||+|+||.|..+.+ .++.||+|++.+-.+- .....-|..|-.+|..-+.+-|+.++.+|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 456677889999999999999999999987 5778999998764332 2234567889999999999999999999999
Q ss_pred CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 596 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
+.++|+||||++||+|..++. +...+++..++-|+..|+.||.-||+.|+|||||||+|||||..|++||+|||.+.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlS---k~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLS---KFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred ccceEEEEecccCchHHHHHh---hcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHH
Confidence 999999999999999999997 33489999999999999999999999999999999999999999999999999988
Q ss_pred cccCC-CCCCCCCCCCCcccCccccc----c-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003935 676 IITDS-PMRDSSSAGTPEWMAPELIR----N-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 749 (785)
Q Consensus 676 ~l~~~-~~~~~~~~GT~~Y~APEvl~----~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip 749 (785)
.+... .......+|||.|++||++. + +.|+..+|.||+||++|||++|..||+..+..+.+-+|.+-.....+|
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP 303 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP 303 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC
Confidence 87644 44556778999999999995 2 568999999999999999999999999999999999998877677777
Q ss_pred C-----hHHHHHHHHhhhCCCCCCC---HHHHHHH
Q 003935 750 E-----GPLGRLIADCWAEPQERPS---CEEILSR 776 (785)
Q Consensus 750 ~-----~~L~~LI~~CL~DP~kRPS---~~EIL~~ 776 (785)
+ ...++||.+++.+|..|-. +++|..|
T Consensus 304 ~~~~VSeeakdLI~~ll~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 304 DETDVSEEAKDLIEALLCDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred cccccCHHHHHHHHHHhcChhhhcccccHHHHHhC
Confidence 3 3589999999999999987 8888776
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=297.87 Aligned_cols=245 Identities=25% Similarity=0.336 Sum_probs=202.3
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEc
Q 003935 529 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 606 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 606 (785)
|.+.+.||+|+||.||+|+. +++.+|+|++..........+.+..|+.+++.++|+||+++++++.....+++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 56678899999999999987 4889999998766544444567889999999999999999999999999999999999
Q ss_pred ccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003935 607 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 686 (785)
Q Consensus 607 ~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~ 686 (785)
. ++|.+++.... ..+++..++.++.|++.||+|||+.||+|+||+|+||++++++.++|+|||++............
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 8 48999887431 46899999999999999999999999999999999999999999999999999876544323334
Q ss_pred CCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------------CC
Q 003935 687 SAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-------------------RL 746 (785)
Q Consensus 687 ~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~-------------------~~ 746 (785)
..++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+..... ..
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 4567889999998766 789999999999999999999999987765554443322100 00
Q ss_pred ---------CCC--ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 ---------EIP--EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 ---------~ip--~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..+ +..+.+++.+||. ||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 001 2358899999999 99999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=291.82 Aligned_cols=236 Identities=28% Similarity=0.448 Sum_probs=201.7
Q ss_pred EeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccchh
Q 003935 535 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 611 (785)
Q Consensus 535 LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL 611 (785)
||.|+||.||++.+ +++.+|+|++...... ......+..|+.+++.++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999987 4789999998765442 23567889999999999999999999999999999999999999999
Q ss_pred hHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCCCCC
Q 003935 612 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 691 (785)
Q Consensus 612 ~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~ 691 (785)
.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..............++.
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 999863 34689999999999999999999999999999999999999999999999999987654433334566888
Q ss_pred cccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCC
Q 003935 692 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQER 767 (785)
Q Consensus 692 ~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kR 767 (785)
.|++||.+.+..++.++|+||||+++|+|++|..||...........+.... ..++ +..+.+++.+||. ||.+|
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~i~~~l~~~p~~R 235 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP--LRFPEFLSPEARDLISGLLQKDPTKR 235 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence 9999999988888999999999999999999999998877766666655422 2232 4468999999999 99999
Q ss_pred CCH---HHHHH
Q 003935 768 PSC---EEILS 775 (785)
Q Consensus 768 PS~---~EIL~ 775 (785)
|++ +++++
T Consensus 236 ~~~~~~~~l~~ 246 (250)
T cd05123 236 LGSGGAEEIKA 246 (250)
T ss_pred CCcccHHHHHh
Confidence 999 55554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=329.69 Aligned_cols=241 Identities=30% Similarity=0.465 Sum_probs=210.5
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 529 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
|.-++.||.|+||-||.+.+ +...||||.+..... ..+...++++|+..|+.++|||++.+.|||....+.|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 33457799999999999976 677899999865543 345578999999999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 685 (785)
|-| +-.|++.. ..+++.+..+..|..+.+.||+|||+++.||||||+.||||++.|.|||+|||.|....+. .
T Consensus 108 ClG-SAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----n 180 (948)
T KOG0577|consen 108 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----N 180 (948)
T ss_pred Hhc-cHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch----h
Confidence 974 88888864 4578999999999999999999999999999999999999999999999999999876543 5
Q ss_pred CCCCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHH
Q 003935 686 SSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIAD 759 (785)
Q Consensus 686 ~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~ 759 (785)
.++|||.|||||++. .+.|+-|+||||||+++.||...++|+-..+....++.|..+..+.... .+.+.+++..
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~ 260 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDS 260 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHH
Confidence 789999999999985 4789999999999999999999999999999999999887655433222 2358999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003935 760 CWA-EPQERPSCEEILSR 776 (785)
Q Consensus 760 CL~-DP~kRPS~~EIL~~ 776 (785)
|++ -|.+|||.++++.|
T Consensus 261 CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 261 CLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHhhCcccCCcHHHHhhc
Confidence 999 89999999999876
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=300.64 Aligned_cols=237 Identities=26% Similarity=0.358 Sum_probs=188.0
Q ss_pred EEeeeCcEEEEEEEE--CCeEEEEEEeeccccChH-HHHHHHHHHHHHhh---cCCCceeeEeccccCCCceeEEEEEcc
Q 003935 534 RVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE-NMEDFCNEISILSR---LRHPNVILFLGACTKPPRLSMITEYME 607 (785)
Q Consensus 534 ~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~-~~e~f~~EI~iLk~---L~HPNIVkL~g~~~d~~~l~LV~Ey~~ 607 (785)
.||+|+||.||++.+ +++.+|+|.+.+...... ....+.+|..+++. .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 389999999999977 578999999866543322 22334455544433 479999999999998889999999999
Q ss_pred cchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCC
Q 003935 608 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 687 (785)
Q Consensus 608 gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~ 687 (785)
+++|.+++. ....+++..+..++.|++.||+|||+.||+|+||||+|||++.++.++|+|||++....... ....
T Consensus 81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (279)
T cd05633 81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHAS 155 (279)
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--ccCc
Confidence 999998886 34579999999999999999999999999999999999999999999999999987654332 2345
Q ss_pred CCCCcccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003935 688 AGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE--RVVYAVANEGSRLEIP---EGPLGRLIADCW 761 (785)
Q Consensus 688 ~GT~~Y~APEvl~-~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~--~~v~~i~~~~~~~~ip---~~~L~~LI~~CL 761 (785)
.|++.|+|||.+. +..++.++|||||||++|+|++|..||...... ....... ......++ ...+.+++.+||
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 234 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTVNVELPDSFSPELKSLLEGLL 234 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-hcCCcCCccccCHHHHHHHHHHh
Confidence 6899999999986 456899999999999999999999999754321 1122111 11222222 346899999999
Q ss_pred h-CCCCCC-----CHHHHHHH
Q 003935 762 A-EPQERP-----SCEEILSR 776 (785)
Q Consensus 762 ~-DP~kRP-----S~~EIL~~ 776 (785)
. ||.+|| ++.++++|
T Consensus 235 ~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 235 QRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCCHHHhcCCCCCCHHHHHhC
Confidence 9 999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=325.17 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=207.7
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccCCC
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPP 597 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~ 597 (785)
+-+.++...|.++++||+||.+.||++.. +.+.||+|.+.....+...+..|.+|+..|.+|+ |.+||++|+|-..++
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 34566778999999999999999999987 4667888877666667777899999999999996 999999999999999
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+||||||=+ .+|..+|+... ..++...++.|..|++.++.++|++||||.||||.|+|+-. |.+||+|||+|..+
T Consensus 434 ~lYmvmE~Gd-~DL~kiL~k~~--~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 434 YLYMVMECGD-IDLNKILKKKK--SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred eEEEEeeccc-ccHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 9999999865 58999997432 22332378889999999999999999999999999999964 69999999999987
Q ss_pred cCCC--CCCCCCCCCCcccCccccccC-----------CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhcC
Q 003935 678 TDSP--MRDSSSAGTPEWMAPELIRNE-----------PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERV-VYAVANEG 743 (785)
Q Consensus 678 ~~~~--~~~~~~~GT~~Y~APEvl~~~-----------~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~-v~~i~~~~ 743 (785)
.... ......+||+.||+||.+... +.+.++||||||||||+|+.|+.||....+... +..+.+-+
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~ 589 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPN 589 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCC
Confidence 6542 234567899999999998642 256789999999999999999999988764433 33333333
Q ss_pred CCCC---CCCh-HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 744 SRLE---IPEG-PLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 744 ~~~~---ip~~-~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
...+ ++.. ++.++++.||. ||.+||++.++|+|
T Consensus 590 ~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 590 HEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 3333 3333 48999999999 99999999999986
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=330.93 Aligned_cols=250 Identities=31% Similarity=0.568 Sum_probs=216.7
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC---Ce--EEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCce
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIWN---GT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 599 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~~---g~--~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 599 (785)
..+++.+.++||+|.||.|++|.|+ |+ .||||.+....... ...+|++|+.+|.+|+|||+++|||+..+ ..+
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 3456777889999999999999884 43 69999997666654 57899999999999999999999999988 558
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
.||+|+++.|+|.+.|+. .....|.......|+.||+.||.||..+++|||||...|+||-....|||+||||.+.+..
T Consensus 186 mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999999986 4667788889999999999999999999999999999999999999999999999998865
Q ss_pred CCCCC---CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCh---H
Q 003935 680 SPMRD---SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPEG---P 752 (785)
Q Consensus 680 ~~~~~---~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip~~---~ 752 (785)
...+. ....-...|+|||.++...++.++|||+|||+||||+| |..||.+.....++..+- .+.+++.|.. .
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~csed 343 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYCSED 343 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCChHH
Confidence 43222 22345568999999999999999999999999999998 567999999998888876 6777776643 6
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSRLL 778 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~L~ 778 (785)
+.++++.||. +|++||+|..|.+.+-
T Consensus 344 IY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 344 IYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred HHHHHHHhccCCccccccHHHHHHhHH
Confidence 9999999999 9999999999985543
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=307.10 Aligned_cols=243 Identities=23% Similarity=0.393 Sum_probs=194.7
Q ss_pred eEEeee--CcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEccc
Q 003935 533 TRVGIG--FFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 533 k~LG~G--~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
..||+| +||+||++.+ .|+.||+|++..........+.+.+|+.+++.++||||++++++|...+.+++++||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 9999999987 689999999876665555668889999999999999999999999999999999999999
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC-----
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR----- 683 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~----- 683 (785)
++|.+++... ....+++..+..++.|++.||+|||+.||+||||||+|||++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 84 GSANSLLKTY-FPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 9999988743 2345899999999999999999999999999999999999999999999999865433221110
Q ss_pred --CCCCCCCCcccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------------
Q 003935 684 --DSSSAGTPEWMAPELIRNE--PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------- 746 (785)
Q Consensus 684 --~~~~~GT~~Y~APEvl~~~--~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~------------- 746 (785)
.....++..|+|||++.+. .++.++|||||||++|+|++|+.||...................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 0112345679999999764 47899999999999999999999998776555443332211100
Q ss_pred ------------------------------CCC-----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 ------------------------------EIP-----EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 ------------------------------~ip-----~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..+ ...+.+|+.+||. ||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 1247889999999 99999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.16 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=218.2
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCce
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 599 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 599 (785)
.+..++|..+++||+|.||+|-++.. .++.||+|++++... ..+.+..-+.|-.+|+..+||.+..+...|+.++++
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 34678889999999999999999965 689999999987764 344466677899999999999999999999999999
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
++||||..||.|+.+|. ..+.+++...+-+-.+|+.||.|||+++||+||||.+|+|||++|++||+|||+++.--.
T Consensus 244 CFVMeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999999998886 466899999999999999999999999999999999999999999999999999987544
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-ChHHHHHHH
Q 003935 680 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLGRLIA 758 (785)
Q Consensus 680 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-~~~L~~LI~ 758 (785)
......+.||||.|+|||++....|..+.|.|.+||++|||++|+.||+..+...+...+..+..+.+-. ....+.|+.
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLs 400 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLS 400 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHH
Confidence 4455678999999999999999999999999999999999999999999999888888777655443322 335788999
Q ss_pred Hhhh-CCCCCC-----CHHHHHHH
Q 003935 759 DCWA-EPQERP-----SCEEILSR 776 (785)
Q Consensus 759 ~CL~-DP~kRP-----S~~EIL~~ 776 (785)
.++. ||.+|. .+.||..+
T Consensus 401 GLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 401 GLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred HHhhcChHhhcCCCchhHHHHHhh
Confidence 9998 999993 45555543
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=308.90 Aligned_cols=245 Identities=24% Similarity=0.365 Sum_probs=198.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccCC--CceeE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKP--PRLSM 601 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~--~~l~L 601 (785)
++|.+.+.||+|+||.||+|.+ .++.+|+|.+............+.+|+.+++++ +||||++++++|... ..+++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 5788899999999999999987 578999998865443444456788899999999 999999999988643 35899
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
||||+. ++|..++. . ..+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 87 v~e~~~-~~L~~~~~---~-~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 87 VFEYME-TDLHAVIR---A-NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred Eecccc-cCHHHHHh---c-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 999998 48888775 2 278889999999999999999999999999999999999999999999999998764332
Q ss_pred C-----CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------
Q 003935 682 M-----RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL--------- 746 (785)
Q Consensus 682 ~-----~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~--------- 746 (785)
. ......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.........+.......
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 1 1123458889999998765 457889999999999999999999998766554443332221100
Q ss_pred -----------------C----C--CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 -----------------E----I--PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 -----------------~----i--p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
. . ....+.+++.+||+ ||.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 0 12357889999999 99999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=312.21 Aligned_cols=241 Identities=27% Similarity=0.397 Sum_probs=195.1
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC-----Ccee
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-----PRLS 600 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~-----~~l~ 600 (785)
.|...+++|.|+||.||+|+. .+..||||.......-. -+|+++|+.++|||||++..+|... -...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 366678999999999999976 57899999864433211 2699999999999999999887432 2467
Q ss_pred EEEEEcccchhhHHHHh-hcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC-CeEEEEecCcccccc
Q 003935 601 MITEYMELGSLYHLIHL-SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIIT 678 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~-~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~-g~VKL~DFGLA~~l~ 678 (785)
+||||++. +|...++. ...+..++...++-+++||++||+|||+.||+||||||.|+|+|.+ |.+||||||.|+.+.
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 89999996 88877763 2235678888899999999999999999999999999999999965 999999999999886
Q ss_pred CCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----------
Q 003935 679 DSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---------- 747 (785)
Q Consensus 679 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~---------- 747 (785)
... .......|..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.+....+..++.--..+.
T Consensus 178 ~~e-pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 178 KGE-PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred cCC-CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 542 3345667899999999877 4699999999999999999999999999887777666654222221
Q ss_pred -----CC---------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 -----IP---------------EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 -----ip---------------~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.| +...-+|+.+++. +|.+|.++.+++.|
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 00 1246689999999 99999999999876
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=302.53 Aligned_cols=238 Identities=25% Similarity=0.415 Sum_probs=199.9
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccch
Q 003935 533 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGS 610 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGS 610 (785)
.+||+|+||.||++.. ++..+|+|.+.... ......+.+|+.+++.++|+||+++++++...+..+++|||+++++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 5799999999999977 58899999875332 2345678899999999999999999999999999999999999999
Q ss_pred hhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCCCC
Q 003935 611 LYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGT 690 (785)
Q Consensus 611 L~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT 690 (785)
|.+++. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++..............++
T Consensus 104 L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 179 (292)
T cd06657 104 LTDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT 179 (292)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence 998874 2357899999999999999999999999999999999999999999999999987664432223345688
Q ss_pred CcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----CCCChHHHHHHHHhhh-CCC
Q 003935 691 PEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----EIPEGPLGRLIADCWA-EPQ 765 (785)
Q Consensus 691 ~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~----~ip~~~L~~LI~~CL~-DP~ 765 (785)
+.|+|||.+.+..++.++|+||||+++|+|++|..||...........+....... ...+..+.+++.+||. +|.
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~ 259 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPA 259 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcc
Confidence 99999999988889999999999999999999999998877665554443221111 1123468899999999 999
Q ss_pred CCCCHHHHHHH
Q 003935 766 ERPSCEEILSR 776 (785)
Q Consensus 766 kRPS~~EIL~~ 776 (785)
+||++.+++.+
T Consensus 260 ~R~~~~~ll~~ 270 (292)
T cd06657 260 QRATAAELLKH 270 (292)
T ss_pred cCcCHHHHhcC
Confidence 99999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=294.77 Aligned_cols=244 Identities=30% Similarity=0.404 Sum_probs=198.0
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccCCCceeEEEEE
Q 003935 529 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
|++.+.||.|+||+||+|.. .++.||||.+....... ......+|+..+++++ ||||+++++++..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 67889999999999999987 47789999986543322 2234567999999999 99999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 685 (785)
+ +|+|.+.+.... ...+++..++.++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 80 ~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 156 (283)
T cd07830 80 M-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-YT 156 (283)
T ss_pred C-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-cC
Confidence 9 778988886332 34789999999999999999999999999999999999999999999999999987654322 23
Q ss_pred CCCCCCcccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------------
Q 003935 686 SSAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------------ 746 (785)
Q Consensus 686 ~~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~------------------ 746 (785)
...++..|+|||++. ...++.++|+||||+++|+|++|+.||...........+......+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence 456788999999875 4557899999999999999999999998776555444332211100
Q ss_pred -------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 -------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 -------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
......+.+++.+||+ +|.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0012458899999999 99999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=306.04 Aligned_cols=246 Identities=24% Similarity=0.312 Sum_probs=197.2
Q ss_pred CCee-EeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHH------------HHHHHHHHHHHhhcCCCceeeEec
Q 003935 527 SELT-VGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAEN------------MEDFCNEISILSRLRHPNVILFLG 591 (785)
Q Consensus 527 s~y~-i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~------------~e~f~~EI~iLk~L~HPNIVkL~g 591 (785)
++|. +.+.||.|+||+||+|.+ .++.||||++......... ...+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3444 457799999999999986 5889999998654332210 124778999999999999999999
Q ss_pred cccCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEec
Q 003935 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 671 (785)
Q Consensus 592 ~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DF 671 (785)
++...+..+++|||+. ++|.+++. ....+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 9999999999999997 58888876 3456899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCC--------------CCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 003935 672 GLSRIITDSP--------------MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVV 736 (785)
Q Consensus 672 GLA~~l~~~~--------------~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v 736 (785)
|++....... .......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9998765111 111233467889999998764 4689999999999999999999999988776655
Q ss_pred HHHHhcCCCC-----------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 737 YAVANEGSRL-----------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 737 ~~i~~~~~~~-----------------------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..+......+ ......+.+++..||. +|.+||++++++.+
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 4443211000 0012357889999999 99999999999976
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.90 Aligned_cols=243 Identities=26% Similarity=0.327 Sum_probs=197.8
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC------
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------ 597 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------ 597 (785)
.++|++.+.||+|+||.||++.. ++..||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 46799999999999999999976 5889999998654433444567889999999999999999999987654
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+++||||+ +++|.+++. ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred eEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 358999998 678887774 346899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL---------- 746 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~---------- 746 (785)
... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.........+.......
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 169 DSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred ccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 432 223467889999999876 458899999999999999999999998776544433332211100
Q ss_pred ----------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 ----------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 ----------------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
......+.+++.+|+. ||.+|||+.+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0012247789999999 99999999999964
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=298.90 Aligned_cols=244 Identities=24% Similarity=0.390 Sum_probs=196.9
Q ss_pred CeeEeeEEeeeCcEEEEEEEE-----CCeEEEEEEeecccc--ChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCce
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDL--TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 599 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~--~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l 599 (785)
+|++.+.||.|+||.||++.. +|..||+|++..... .....+.+.+|+.+++.+ +|+||+++++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999975 578899999865432 122346678899999999 599999999999999899
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+|||++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 999999999999998863 45688999999999999999999999999999999999999999999999999987643
Q ss_pred CCC-CCCCCCCCCcccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcCCCCCCC---
Q 003935 680 SPM-RDSSSAGTPEWMAPELIRNE--PFTEKCDIFSLGVIMWELCTLNRPWEGVLP----ERVVYAVANEGSRLEIP--- 749 (785)
Q Consensus 680 ~~~-~~~~~~GT~~Y~APEvl~~~--~~s~ksDVWSLGvILyELLTG~~PF~~~~~----~~~v~~i~~~~~~~~ip--- 749 (785)
... ......|+..|+|||.+... .++.++||||||+++|+|++|..||..... ......+.... ...+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 235 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPYPQEM 235 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC--CCCCccC
Confidence 221 12245688999999998753 467899999999999999999999974322 22222222221 2222
Q ss_pred ChHHHHHHHHhhh-CCCCCC-----CHHHHHHH
Q 003935 750 EGPLGRLIADCWA-EPQERP-----SCEEILSR 776 (785)
Q Consensus 750 ~~~L~~LI~~CL~-DP~kRP-----S~~EIL~~ 776 (785)
...+.+++.+||. ||.+|| ++.+++.+
T Consensus 236 ~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 3458899999999 999997 77888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.35 Aligned_cols=241 Identities=29% Similarity=0.440 Sum_probs=200.2
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 529 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
|...+.||+|+||+||+|.+ .+..||+|++..... .....+.+.+|+.+++.++|||++++++++.+....|++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 45567899999999999986 588999999865433 334456788999999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 685 (785)
+.+ ++.+++.. ....+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 103 ~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~~ 175 (313)
T cd06633 103 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----AN 175 (313)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----CC
Confidence 974 67776652 345689999999999999999999999999999999999999999999999999865322 23
Q ss_pred CCCCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---CChHHHHHHHH
Q 003935 686 SSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI---PEGPLGRLIAD 759 (785)
Q Consensus 686 ~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i---p~~~L~~LI~~ 759 (785)
...|+..|+|||++. ...++.++|||||||++|+|++|..||...........+......... ....+.+++.+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 255 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY 255 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 456888999999984 456888999999999999999999999887776666655443322211 12468999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003935 760 CWA-EPQERPSCEEILSR 776 (785)
Q Consensus 760 CL~-DP~kRPS~~EIL~~ 776 (785)
||+ +|.+||++.+++.+
T Consensus 256 ~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 256 CLQKIPQERPASAELLRH 273 (313)
T ss_pred HccCChhhCcCHHHHhcC
Confidence 999 99999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=330.09 Aligned_cols=240 Identities=30% Similarity=0.529 Sum_probs=201.7
Q ss_pred EeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccc--cChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc--eeEEEE
Q 003935 531 VGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQD--LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR--LSMITE 604 (785)
Q Consensus 531 i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~--~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~--l~LV~E 604 (785)
....||+|+|-+||+|.++ |-.||--.++... ..+...+.|..|+.+|+.|+||||++||.++.+..+ +.+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4568999999999999874 5555532222222 234556899999999999999999999999977655 889999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc--cccccCCCCcEEEc-CCCeEEEEecCccccccCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~g--IIHrDLKpsNILLd-~~g~VKL~DFGLA~~l~~~~ 681 (785)
.+..|+|..+++ +.+.++.+.++.|++||++||.|||++. |||||||.+||+|+ ..|.|||+|+|||..+...
T Consensus 124 L~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 124 LFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred cccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence 999999999998 4568889999999999999999999985 99999999999997 4589999999999988765
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----CCChHHHHHH
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----IPEGPLGRLI 757 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~----ip~~~L~~LI 757 (785)
+.....|||.|||||++. ..|++.+||||||+.|+||+|+.+||....+...+++-+..|..+. +.+..+++||
T Consensus 200 -~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fI 277 (632)
T KOG0584|consen 200 -HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFI 277 (632)
T ss_pred -ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHH
Confidence 444578999999999998 6699999999999999999999999988766655555555554443 3455799999
Q ss_pred HHhhhCCCCCCCHHHHHHH
Q 003935 758 ADCWAEPQERPSCEEILSR 776 (785)
Q Consensus 758 ~~CL~DP~kRPS~~EIL~~ 776 (785)
.+|+.-...|||+.|+|++
T Consensus 278 ekCl~~~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 278 EKCLATKSERLSAKELLKD 296 (632)
T ss_pred HHHhcCchhccCHHHHhhC
Confidence 9999988999999999975
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=307.84 Aligned_cols=243 Identities=28% Similarity=0.352 Sum_probs=201.1
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc-----
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR----- 598 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~----- 598 (785)
.++|.+.+.||+|+||.||+|.+ .++.||+|++..........+.+.+|+.+++.++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 46899999999999999999987 47889999986554444455678899999999999999999998866554
Q ss_pred -eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 599 -LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 599 -l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.++|+||+ +++|.+++. ...+++..++.++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999998 568988885 246899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---------
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE--------- 747 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~--------- 747 (785)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+......+..+......+.
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 169 DDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred ccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 432 234567889999999865 3678999999999999999999999987776655554433211000
Q ss_pred -----------------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 -----------------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 -----------------------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.....+.+++.+||. ||.+|||+.+|+.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 013457899999999 99999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.07 Aligned_cols=236 Identities=26% Similarity=0.352 Sum_probs=189.2
Q ss_pred EEeeeCcEEEEEEEE--CCeEEEEEEeeccccChH-HHHHHHHHHHH---HhhcCCCceeeEeccccCCCceeEEEEEcc
Q 003935 534 RVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE-NMEDFCNEISI---LSRLRHPNVILFLGACTKPPRLSMITEYME 607 (785)
Q Consensus 534 ~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~-~~e~f~~EI~i---Lk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~ 607 (785)
.||+|+||.||++.+ .++.||+|.+.+...... ....+..|..+ ++...||||+++++++...+.+++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 389999999999976 578999999876543321 12234444443 444579999999999999999999999999
Q ss_pred cchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCC
Q 003935 608 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 687 (785)
Q Consensus 608 gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~ 687 (785)
+++|..++. ....+++..++.++.|++.||+|||+.+|+|+||||+||+++.++.++|+|||++..+... .....
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 155 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHAS 155 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCc
Confidence 999998886 3457999999999999999999999999999999999999999999999999998765432 22345
Q ss_pred CCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcCCCCCCC---ChHHHHHHHHh
Q 003935 688 AGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVL---PERVVYAVANEGSRLEIP---EGPLGRLIADC 760 (785)
Q Consensus 688 ~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~---~~~~v~~i~~~~~~~~ip---~~~L~~LI~~C 760 (785)
.|+..|+|||.+.++ .++.++|||||||++|+|++|+.||.... ........ ......++ ...+.+++.+|
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~ 233 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELRSLLEGL 233 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--hccCCCCCCcCCHHHHHHHHHH
Confidence 789999999999754 68999999999999999999999998763 22222221 11222232 34689999999
Q ss_pred hh-CCCCCC-----CHHHHHHH
Q 003935 761 WA-EPQERP-----SCEEILSR 776 (785)
Q Consensus 761 L~-DP~kRP-----S~~EIL~~ 776 (785)
+. +|.+|| ++.+++++
T Consensus 234 l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 234 LQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred hhcCHHhccCCCCCCHHHHHhC
Confidence 99 999999 99999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=296.27 Aligned_cols=236 Identities=22% Similarity=0.359 Sum_probs=187.7
Q ss_pred CCeeEeeE--EeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCceeE
Q 003935 527 SELTVGTR--VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 527 s~y~i~k~--LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~L 601 (785)
++|.+.+. ||.|+||.||++.. ++..+|+|++........ |+.....+ +||||+++++++...+.+++
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34555555 49999999999976 578899999865433221 22222222 69999999999999999999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC-eEEEEecCccccccCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITDS 680 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g-~VKL~DFGLA~~l~~~ 680 (785)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 87 v~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 87 IMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 9999999999999873 34899999999999999999999999999999999999999988 9999999998776433
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhc-CCCCCC---CChHHHH
Q 003935 681 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVV-YAVANE-GSRLEI---PEGPLGR 755 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v-~~i~~~-~~~~~i---p~~~L~~ 755 (785)
....++..|+|||++.+..++.++||||||+++|+|++|+.||......... ..+... ...... .+..+.+
T Consensus 164 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAND 239 (267)
T ss_pred ----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHH
Confidence 2346889999999999988999999999999999999999999865433221 111111 111111 2346899
Q ss_pred HHHHhhh-CCCCCCC-HHHHHHH
Q 003935 756 LIADCWA-EPQERPS-CEEILSR 776 (785)
Q Consensus 756 LI~~CL~-DP~kRPS-~~EIL~~ 776 (785)
++.+||+ +|.+||+ ++++++|
T Consensus 240 li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 240 FVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHHhccChhhCCchHHHHhcC
Confidence 9999999 9999995 6999864
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.28 Aligned_cols=245 Identities=29% Similarity=0.453 Sum_probs=202.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
..|...+.||+|+||.||+|.+ ++..+|+|.+..... .......+.+|+.+++.++|+|++++++++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3466778899999999999987 577899998864322 3344567889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+. |++.+.+.. ....+++..+..++.|++.||.|||+.+++|+||+|+|||++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 9997 577776642 2346899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---CCChHHHHHH
Q 003935 684 DSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---IPEGPLGRLI 757 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~---ip~~~L~~LI 757 (785)
....+++.|+|||.+. ...++.++|||||||++|+|++|..||...........+........ ..+..+.+|+
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHH
Confidence 2446788999999974 35678899999999999999999999988776665555544332221 1234688999
Q ss_pred HHhhh-CCCCCCCHHHHHHHHH
Q 003935 758 ADCWA-EPQERPSCEEILSRLL 778 (785)
Q Consensus 758 ~~CL~-DP~kRPS~~EIL~~L~ 778 (785)
.+||. +|.+||++.+++.+-.
T Consensus 248 ~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 248 DSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHHhhCCcccCCCHHHHhhCcc
Confidence 99999 9999999999998744
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=328.29 Aligned_cols=238 Identities=31% Similarity=0.487 Sum_probs=204.4
Q ss_pred EEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccchh
Q 003935 534 RVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 611 (785)
Q Consensus 534 ~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL 611 (785)
+||+|.||+||.|.+ +...+|||.+.... ....+-+..||.+.+.|+|.|||+++|.|.+++.+-++||-++||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 699999999999977 45678899886544 33456678899999999999999999999999999999999999999
Q ss_pred hHHHHhhcccccc--hHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEc-CCCeEEEEecCccccccCCCCCCCCCC
Q 003935 612 YHLIHLSGQKKKL--SWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMRDSSSA 688 (785)
Q Consensus 612 ~dlL~~~~~~~~L--s~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd-~~g~VKL~DFGLA~~l~~~~~~~~~~~ 688 (785)
.++++.. =+++ .+..+-.+..||++||.|||.+.|||||||-+|||++ -.|.+||+|||-++.+..-+....++.
T Consensus 660 SsLLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 660 SSLLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred HHHHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 9999743 2455 7888889999999999999999999999999999996 678999999999998765444556788
Q ss_pred CCCcccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCCCh---HHHHHHHHhhh
Q 003935 689 GTPEWMAPELIRNEP--FTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIPEG---PLGRLIADCWA 762 (785)
Q Consensus 689 GT~~Y~APEvl~~~~--~s~ksDVWSLGvILyELLTG~~PF~~~~-~~~~v~~i~~~~~~~~ip~~---~L~~LI~~CL~ 762 (785)
||..|||||++..++ |..++|||||||++.||.||++||.... +.....++-.-+..+++|.+ ..+++|.+|+.
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFe 817 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFE 817 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence 999999999998754 7889999999999999999999998664 45555555555567777765 57889999999
Q ss_pred -CCCCCCCHHHHHH
Q 003935 763 -EPQERPSCEEILS 775 (785)
Q Consensus 763 -DP~kRPS~~EIL~ 775 (785)
||.+||++.++|.
T Consensus 818 pd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 818 PDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcccCccHHHhcc
Confidence 9999999999985
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=315.50 Aligned_cols=242 Identities=28% Similarity=0.515 Sum_probs=215.4
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEc
Q 003935 529 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 606 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 606 (785)
|.++.+||+|+||.||++++ .|+.+|||.... ..+++++.+|+.+|++++.|++|++||.|..+..+++|||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 56788999999999999987 589999998743 345788999999999999999999999999999999999999
Q ss_pred ccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003935 607 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 686 (785)
Q Consensus 607 ~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~ 686 (785)
..|++.++++. .+++|++..+..+++..++||+|||...-||||||+.||||+.+|+.||+|||.|-.+.+.-....+
T Consensus 111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT 188 (502)
T KOG0574|consen 111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT 188 (502)
T ss_pred CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence 99999999974 4679999999999999999999999999999999999999999999999999999988776555567
Q ss_pred CCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----CCChHHHHHHHHhhh
Q 003935 687 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----IPEGPLGRLIADCWA 762 (785)
Q Consensus 687 ~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~----ip~~~L~~LI~~CL~ 762 (785)
..|||.|||||++..-.|+.++||||||++..||..|++||.+.-+.+.+..+..+..... .-.+.+.++++.|+.
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLi 268 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLI 268 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhc
Confidence 8899999999999998899999999999999999999999999988887776654332221 113468899999998
Q ss_pred -CCCCCCCHHHHHHH
Q 003935 763 -EPQERPSCEEILSR 776 (785)
Q Consensus 763 -DP~kRPS~~EIL~~ 776 (785)
+|++|-|+.++++|
T Consensus 269 K~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 269 KKPEERKTALRLCEH 283 (502)
T ss_pred CCHHHHHHHHHHhhh
Confidence 99999999999987
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=354.69 Aligned_cols=246 Identities=28% Similarity=0.461 Sum_probs=213.5
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
++.-+..||.|.||.||.+.. +|...|+|.+..+.........+.+|..++..++|||+|++||+-.+.+..+|+|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 345577899999999999976 688999999877776666667788999999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC--
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR-- 683 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~-- 683 (785)
|.+|+|.+++. .++-.++.....+..|++.|++|||+.|||||||||.||+|+.+|.+|++|||.|..+.+....
T Consensus 1316 C~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1316 CEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred hccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 99999999997 4556788888899999999999999999999999999999999999999999999887654211
Q ss_pred --CCCCCCCCcccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCh---HHHH
Q 003935 684 --DSSSAGTPEWMAPELIRNEP---FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGR 755 (785)
Q Consensus 684 --~~~~~GT~~Y~APEvl~~~~---~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~~---~L~~ 755 (785)
.....||+.|||||++.+.. ...+.||||||||+.||+||+.||...+..-.+-..+..+..+.+|.. .-++
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~d 1472 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRD 1472 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHH
Confidence 23567999999999998654 456899999999999999999999988776655555667888888865 4678
Q ss_pred HHHHhhh-CCCCCCCHHHHHHH
Q 003935 756 LIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 756 LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
++..|+. ||.+|.++.+|+++
T Consensus 1473 Fle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1473 FLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHHHHhcCchhhhHHHHHHHh
Confidence 9999999 99999999998876
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=305.04 Aligned_cols=241 Identities=27% Similarity=0.333 Sum_probs=194.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC------c
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------R 598 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------~ 598 (785)
.+|.+.+.||+|+||.||+|++ +|+.||||++............+.+|+.+++.++||||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 5799999999999999999986 5889999998754433334466889999999999999999999986543 4
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
+++++||+.. +|..+. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus 95 ~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 95 FYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred EEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 6899999974 565543 2358899999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------
Q 003935 679 DSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS------------- 744 (785)
Q Consensus 679 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~------------- 744 (785)
.. .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.........+.....
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 169 AE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred CC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence 22 234467889999999876 4688999999999999999999999988765544443322110
Q ss_pred --------CCC-----------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 745 --------RLE-----------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 745 --------~~~-----------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+. ..+..+.+++.+||+ ||.+||++.+++.|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 012347799999999 99999999999976
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=328.12 Aligned_cols=250 Identities=20% Similarity=0.290 Sum_probs=185.3
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC---CeEEEEEE--------------eec-cccChHHHHHHHHHHHHHhhcCCCcee
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIWN---GTDVAIKV--------------FLE-QDLTAENMEDFCNEISILSRLRHPNVI 587 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~~---g~~VAVKi--------------l~~-~~~~~~~~e~f~~EI~iLk~L~HPNIV 587 (785)
.++|.+.+.||+|+||+||++... +...++|. +.+ ..........+.+|+.+|+.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998652 11222221 111 111223345688999999999999999
Q ss_pred eEeccccCCCceeEEEEEcccchhhHHHHhhc--ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCe
Q 003935 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSG--QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 665 (785)
Q Consensus 588 kL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~--~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~ 665 (785)
++++++...+..|++++++.+ +|..++.... .........++.++.||+.||+|||++|||||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 999999999999999999864 6666554221 1223345677889999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCC--ChHHHHHHHHh
Q 003935 666 VKICDFGLSRIITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGV--LPERVVYAVAN 741 (785)
Q Consensus 666 VKL~DFGLA~~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~-PF~~~--~~~~~v~~i~~ 741 (785)
+||+|||++..+..... ......||+.|+|||++.+..++.++|||||||++|||++|.. ||... .+...+..+..
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~ 385 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID 385 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence 99999999987754322 2234679999999999999999999999999999999999986 44322 22222222211
Q ss_pred cCC--CCCC-------------------------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 742 EGS--RLEI-------------------------------PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 742 ~~~--~~~i-------------------------------p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
... ...+ .+..+.+++.+|++ ||.+|||+.|++++
T Consensus 386 ~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 0000 01235667889999 99999999999976
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=331.46 Aligned_cols=259 Identities=32% Similarity=0.614 Sum_probs=222.3
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEe
Q 003935 521 EWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 590 (785)
Q Consensus 521 e~~i~~s~y~i~k~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~ 590 (785)
.|++..+++.+.+.||.|.||.|++|... ...||||.++..... ...+.+..|+++|+.+ +|+||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 68888888899999999999999999642 347999998766655 5678999999999999 599999999
Q ss_pred ccccCCCceeEEEEEcccchhhHHHHhhc-----------cc--ccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCc
Q 003935 591 GACTKPPRLSMITEYMELGSLYHLIHLSG-----------QK--KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSAN 657 (785)
Q Consensus 591 g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~-----------~~--~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsN 657 (785)
|+|...+.+++|+||+..|+|.++++... .. ..++....+.+++||+.||+||++.++|||||.++|
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 99999999999999999999999997543 00 238999999999999999999999999999999999
Q ss_pred EEEcCCCeEEEEecCccccccCCCCCC-CCCC--CCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 003935 658 CLVNKHWTVKICDFGLSRIITDSPMRD-SSSA--GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 733 (785)
Q Consensus 658 ILLd~~g~VKL~DFGLA~~l~~~~~~~-~~~~--GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~ 733 (785)
||++++..+||+|||+++...+..... .... -+..|||||.+....|+.++||||||++||||+| |..||.+....
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999999999999999999765543332 2233 3457999999999999999999999999999998 56799987733
Q ss_pred HHHHHHHhcCCCCCCCCh---HHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 734 RVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 734 ~~v~~i~~~~~~~~ip~~---~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
..+...+..+.+...|.. .+..+++.||+ +|.+||++.++.+.+...
T Consensus 529 ~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 529 EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 444557888888888854 58899999999 999999999999998874
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=301.62 Aligned_cols=245 Identities=25% Similarity=0.315 Sum_probs=193.6
Q ss_pred CeeEeeEEeeeCcEEEEEEEEC----CeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccC----CCc
Q 003935 528 ELTVGTRVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTK----PPR 598 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~~----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d----~~~ 598 (785)
+|.+.+.||+|+||.||++.+. +..||+|.+..........+.+.+|+.+++++ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788999999999999999874 66899999865433333456788999999999 59999999987532 245
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
+|++++|+. ++|...+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 788888886 58888875 45578999999999999999999999999999999999999999999999999998664
Q ss_pred CCCC----CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC----------
Q 003935 679 DSPM----RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG---------- 743 (785)
Q Consensus 679 ~~~~----~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~---------- 743 (785)
.... ......|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+...-
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 3211 1223468899999998765 568999999999999999999999998765433332222100
Q ss_pred ----------------CCCC------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 744 ----------------SRLE------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 744 ----------------~~~~------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.... .....+.+++.+|++ ||.+|||+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 113468899999999 99999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.28 Aligned_cols=246 Identities=25% Similarity=0.351 Sum_probs=197.6
Q ss_pred CeeEeeEEeeeCcEEEEEEEE-----CCeEEEEEEeeccccC--hHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCce
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLT--AENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 599 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~~--~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l 599 (785)
+|++.+.||+|+||.||++.. +++.||||++.+.... ....+.+.+|+.++..+ +||||+++++++.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478899999999999999864 4678999998654321 22346788999999999 599999999999999999
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
++||||+.+++|.+.+. ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+..
T Consensus 81 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHh---hcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 99999999999998886 335688999999999999999999999999999999999999999999999999876543
Q ss_pred CCC-CCCCCCCCCcccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcCCCCCCC---
Q 003935 680 SPM-RDSSSAGTPEWMAPELIRNEP--FTEKCDIFSLGVIMWELCTLNRPWEGVLP----ERVVYAVANEGSRLEIP--- 749 (785)
Q Consensus 680 ~~~-~~~~~~GT~~Y~APEvl~~~~--~s~ksDVWSLGvILyELLTG~~PF~~~~~----~~~v~~i~~~~~~~~ip--- 749 (785)
... ......|+..|+|||.+.+.. ++.++||||||+++|+|++|..||..... ......+.... ...+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 235 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK--PPFPKTM 235 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC--CCCCccc
Confidence 321 122346889999999987654 78899999999999999999999964322 22222222221 1222
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003935 750 EGPLGRLIADCWA-EPQERPSCEEILSRLL 778 (785)
Q Consensus 750 ~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~ 778 (785)
+..+.+++.+||+ ||++|||+.++.+.|.
T Consensus 236 ~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 236 SAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred CHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 3468999999999 9999999776655544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=303.56 Aligned_cols=244 Identities=26% Similarity=0.319 Sum_probs=196.8
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC------
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------ 596 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~------ 596 (785)
..++|.+.+.||+|+||.||+|.+ +++.||+|++..........+.+.+|+.++++++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 347899999999999999999976 588999999876443344456788999999999999999999987543
Q ss_pred CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
...+++++++ +++|.+++. ...+++..++.++.|++.||+|||+.||+||||||+||++++++.++|+|||++..
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred ccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 3467777776 778888775 23589999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----------
Q 003935 677 ITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS----------- 744 (785)
Q Consensus 677 l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~----------- 744 (785)
.... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+.....
T Consensus 170 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 170 TDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred cccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 5332 234567889999999866 5688999999999999999999999987665444333222110
Q ss_pred -------------CCC--------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 745 -------------RLE--------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 745 -------------~~~--------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+. .....+.+++..|++ ||.+||++.+++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 112357889999999 99999999999976
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=301.24 Aligned_cols=244 Identities=27% Similarity=0.363 Sum_probs=196.9
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC-CCceeE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-PPRLSM 601 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d-~~~l~L 601 (785)
..++|.+.+.||.|+||.||++.. +++.||+|++.+........+.+..|+.+++.++||||++++++|.. ....++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 346799999999999999999976 57889999886554444445778899999999999999999998865 557899
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
++||+. ++|..++. ...+++..+..++.|++.||+|||+.||+|+||+|+|||+++++.++|+|||++......
T Consensus 88 v~e~~~-~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 88 VTELLG-TDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred Eeehhc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 999984 58887775 345788888999999999999999999999999999999999999999999998754322
Q ss_pred CCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc------------------
Q 003935 682 MRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE------------------ 742 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~------------------ 742 (785)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+...
T Consensus 162 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 162 --MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred --cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 234467889999998766 56899999999999999999999999876543322211110
Q ss_pred ------CCCCC--------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 743 ------GSRLE--------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 743 ------~~~~~--------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..... ..+..+.++|.+||+ +|.+||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 012468899999999 99999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=303.43 Aligned_cols=243 Identities=25% Similarity=0.342 Sum_probs=193.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC--------
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-------- 596 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~-------- 596 (785)
.+|.+.+.||.|+||.||+|.. +++.||+|.+..... ...+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 6799999999999999999987 578999999865543 3456788999999999999999999876554
Q ss_pred ------CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEc-CCCeEEEE
Q 003935 597 ------PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKIC 669 (785)
Q Consensus 597 ------~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd-~~g~VKL~ 669 (785)
...++++||+. ++|.+++. ...+++..++.++.||+.||.|||+.||+||||||+||+++ .++.++|+
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 34789999997 48887774 24688999999999999999999999999999999999997 45678999
Q ss_pred ecCccccccCCCC---CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--
Q 003935 670 DFGLSRIITDSPM---RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG-- 743 (785)
Q Consensus 670 DFGLA~~l~~~~~---~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~-- 743 (785)
|||++........ ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...........+....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999976533211 1123457889999998754 567889999999999999999999998776554444332211
Q ss_pred ---------------------CCCC--------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 744 ---------------------SRLE--------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 744 ---------------------~~~~--------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.... .....+.+++.+||. ||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000 012347789999999 99999999999965
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=325.71 Aligned_cols=147 Identities=24% Similarity=0.409 Sum_probs=132.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
+++|.+.++||+|+||+||+|.+. ++.||||++..... .......+..|+.+++.++||||+++++++.....+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 578999999999999999999884 88999999875443 344457788999999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
|||+.+++|.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999863 3468899999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=314.68 Aligned_cols=360 Identities=20% Similarity=0.232 Sum_probs=249.0
Q ss_pred hhhHhhhhccccccCccchhHHHHHHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccc
Q 003935 377 SEARRIRRRSISITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSAL 456 (785)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~ 456 (785)
-..+||-+-...++.|+.-.+-+-|++|+...-+|||.+ |.||.--|...+--.--+|+. -...+.++.+
T Consensus 194 ~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~--~~~~~~eik~h~f~~~i~~~~--------l~~r~~~~~f 263 (612)
T KOG0603|consen 194 DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGA--GPDGVDEIKQHEFFQSIDWNE--------LEARSRPPPF 263 (612)
T ss_pred HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhcc--CcchhHHHhccchheeeeHhh--------HhhcCCCCCC
Confidence 678999999999999999999999999999999999865 344444443332111011110 0111111111
Q ss_pred cccc-ccccccccccCCCCCCCCCCCC----CCCCCCCCCCCCCchhhhhhhhhccCCcccCCCccccccccccCCCeeE
Q 003935 457 YNLS-RDQMNSQKAISLPSSPHEYGSH----GSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELTV 531 (785)
Q Consensus 457 ~~l~-r~~~~sq~~~SlPSsp~~~~s~----sS~~~~ssg~~~~s~~~s~~~~il~S~~~~~~p~~~~ee~~i~~s~y~i 531 (785)
-.-. +...+.+-...+++........ .+.....+++. |+.. .++.. -.-.-.+++|.+
T Consensus 264 kp~~~~e~~~~~fd~eft~~~P~dsp~~~~~~s~~~if~g~s----fva~--~il~~-----------~~~~~~~~~y~~ 326 (612)
T KOG0603|consen 264 KPGSITERDVAQFDPEFTSQVPADSPLLSASGSDHTIFSGPS----FVAP--GVLED-----------AVTAPFTESYEF 326 (612)
T ss_pred CCcccchhhhhhcCchhccCCcccCCCCCCCccccchhcCCC----ccCh--HHhhc-----------cccCCcchhhcc
Confidence 1111 1111111111121111111000 00000011110 0000 00000 000013567888
Q ss_pred eeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCceeEEEEEccc
Q 003935 532 GTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
...+|.|+|+.|..+.+ +++..++|++.+...+ -.+|+.++... +||||+++++.+.+....|+|||++.|
T Consensus 327 ~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g 400 (612)
T KOG0603|consen 327 REELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG 400 (612)
T ss_pred ccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence 88899999999999976 6888999999765222 23577666555 699999999999999999999999999
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEE-cCCCeEEEEecCccccccCCCCCCCCC
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV-NKHWTVKICDFGLSRIITDSPMRDSSS 687 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILL-d~~g~VKL~DFGLA~~l~~~~~~~~~~ 687 (785)
+-+.+.+. ..+.+. ..+..|+.+|+.|+.|||.+|||||||||+|||+ ++.++++|+|||.++..... ....
T Consensus 401 ~ell~ri~---~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~~tp 473 (612)
T KOG0603|consen 401 GELLRRIR---SKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---CDTP 473 (612)
T ss_pred cHHHHHHH---hcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---hccc
Confidence 98888775 233334 7778899999999999999999999999999999 69999999999999887654 2345
Q ss_pred CCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCC
Q 003935 688 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQE 766 (785)
Q Consensus 688 ~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~k 766 (785)
+-|..|.|||++....|++++|+||||++||+|++|+.||........+...+..+..........++|+.+||+ ||.+
T Consensus 474 ~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~ 553 (612)
T KOG0603|consen 474 ALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPAL 553 (612)
T ss_pred chhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHHHhccCChhh
Confidence 778899999999999999999999999999999999999988776633333333332224445679999999999 9999
Q ss_pred CCCHHHHHHH
Q 003935 767 RPSCEEILSR 776 (785)
Q Consensus 767 RPS~~EIL~~ 776 (785)
||++.+++.|
T Consensus 554 Rl~~~~i~~h 563 (612)
T KOG0603|consen 554 RLGADEIGAH 563 (612)
T ss_pred CcChhhhccC
Confidence 9999999876
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=317.03 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=224.6
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEECCeE--EEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCC
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKP 596 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~g~~--VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 596 (785)
+.-++.++++..+..||-|+||.|-++..+++. +|+|++++... +..+.+.+..|-.+|..++.|.||++|..|.+.
T Consensus 413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ 492 (732)
T KOG0614|consen 413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS 492 (732)
T ss_pred hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc
Confidence 344567788888999999999999999886655 89999877654 455567889999999999999999999999999
Q ss_pred CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
...||+||-|-||.|+..++ ..+.++...++-++..+++|++|||++|||+|||||+|++|+.+|-+||.|||+|+.
T Consensus 493 kyvYmLmEaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKk 569 (732)
T KOG0614|consen 493 KYVYMLMEACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKK 569 (732)
T ss_pred hhhhhhHHhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHH
Confidence 99999999999999999997 567899999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCh---HH
Q 003935 677 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PL 753 (785)
Q Consensus 677 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~~---~L 753 (785)
+.... ...++||||.|.|||++.++-.+.++|.||||+++|||++|.+||.+.++...+..++.+.....+|.. ..
T Consensus 570 i~~g~-KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a 648 (732)
T KOG0614|consen 570 IGSGR-KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTA 648 (732)
T ss_pred hccCC-ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhH
Confidence 87653 446899999999999999999999999999999999999999999999999999999988888887743 35
Q ss_pred HHHHHHhhh-CCCCCCC-----HHHHHHHH
Q 003935 754 GRLIADCWA-EPQERPS-----CEEILSRL 777 (785)
Q Consensus 754 ~~LI~~CL~-DP~kRPS-----~~EIL~~L 777 (785)
.+||+++.. +|.+|-- +.+|.+|-
T Consensus 649 ~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 649 TDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred HHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 667776655 9999964 67777663
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=302.78 Aligned_cols=243 Identities=23% Similarity=0.369 Sum_probs=207.6
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEECC--eEEEEEEeecccc-ChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCc
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIWNG--TDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPR 598 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~~g--~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~ 598 (785)
.+...+|..+.+||+|+||+|.++...| ..||||++++... +.++++--+.|..+|... +-|.+++++.+|+.-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 3456788899999999999999997755 4699999987754 334455566788888765 47899999999999999
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
+|+||||+.||+|...++ +-+.+.+..+.-++.+|+.||-+||++|||+||||.+||||+.+|++||+|||+++.--
T Consensus 425 LyFVMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred eeeEEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999999998887 44578889999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-ChHHHHHH
Q 003935 679 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLGRLI 757 (785)
Q Consensus 679 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-~~~L~~LI 757 (785)
-......+.||||.|+|||++..++|...+|.|||||+||||+.|+.||.+.+.+++.+.|.......+.. ..+...+.
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ic 581 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAIC 581 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHH
Confidence 44445668999999999999999999999999999999999999999999999999999887655433322 23466777
Q ss_pred HHhhh-CCCCCC
Q 003935 758 ADCWA-EPQERP 768 (785)
Q Consensus 758 ~~CL~-DP~kRP 768 (785)
+..+. +|.+|.
T Consensus 582 kg~ltK~P~kRL 593 (683)
T KOG0696|consen 582 KGLLTKHPGKRL 593 (683)
T ss_pred HHHhhcCCcccc
Confidence 88787 999984
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=317.64 Aligned_cols=248 Identities=30% Similarity=0.588 Sum_probs=213.2
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CC----eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 529 LTVGTRVGIGFFGEVFRGIW--NG----TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~--~g----~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
++..++||.|+||+||+|.| +| -+||+|++......+ .-.+|+.|+-+|.++.|||+++++++|.... +.||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~-~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK-ASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch-hhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 34467899999999999987 43 369999987655443 3578999999999999999999999998876 8999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
++|+++|+|.++++. ++..+-.+..+.|.+||++||.|||.++++||||.++||||....++||.|||+++.+.....
T Consensus 776 tq~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999999985 456788889999999999999999999999999999999999999999999999998865432
Q ss_pred --CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCh---HHHHH
Q 003935 683 --RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRL 756 (785)
Q Consensus 683 --~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip~~---~L~~L 756 (785)
......-.+.|||-|.+...+|+.++|||||||++||++| |..||.+....++... +..+.++..|+. .+..+
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl-le~geRLsqPpiCtiDVy~~ 932 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL-LEKGERLSQPPICTIDVYMV 932 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-HhccccCCCCCCccHHHHHH
Confidence 3334455678999999999999999999999999999987 7889999988776654 566667777765 57889
Q ss_pred HHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 757 IADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
+.+||. |+..||+|+++...+..+.
T Consensus 933 mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 933 MVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred HHHHhccCcccCccHHHHHHHHHHHh
Confidence 999999 9999999999999887653
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=318.47 Aligned_cols=249 Identities=27% Similarity=0.456 Sum_probs=199.5
Q ss_pred EeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC------ceeEE
Q 003935 531 VGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------RLSMI 602 (785)
Q Consensus 531 i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------~l~LV 602 (785)
..+.||+|+||.||+|.+ .|+.||||.+.+.. .....+...+|+++|++++|+|||+++++-++.. ...+|
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 456899999999999986 69999999987654 3344678899999999999999999999865543 36899
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEc--CCC--eEEEEecCcccccc
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN--KHW--TVKICDFGLSRIIT 678 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd--~~g--~VKL~DFGLA~~l~ 678 (785)
||||.||+|...+....+...|++.+.+.++..+..||.|||++||+||||||.||++- .+| ..||+|||.|+.+.
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~ 175 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD 175 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCC
Confidence 99999999999998777778899999999999999999999999999999999999984 333 47999999999987
Q ss_pred CCCCCCCCCCCCCcccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCCC-------
Q 003935 679 DSPMRDSSSAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVL----PERVVYAVANEGSRL------- 746 (785)
Q Consensus 679 ~~~~~~~~~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvILyELLTG~~PF~~~~----~~~~v~~i~~~~~~~------- 746 (785)
+.. .....+||..|++||++. .+.|+..+|.|||||++|+++||..||.... +.+....+..+....
T Consensus 176 d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~ 254 (732)
T KOG4250|consen 176 DNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQE 254 (732)
T ss_pred CCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeec
Confidence 764 556889999999999998 4889999999999999999999999995432 233444444322111
Q ss_pred ------------CCCCh-------HHHHHHHHhhh-CCCCCC--CHHHHHHHHHhhh
Q 003935 747 ------------EIPEG-------PLGRLIADCWA-EPQERP--SCEEILSRLLDCE 781 (785)
Q Consensus 747 ------------~ip~~-------~L~~LI~~CL~-DP~kRP--S~~EIL~~L~~l~ 781 (785)
+.|.. .+..++..++. +|++|. .+.+.-..+.++.
T Consensus 255 ~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 255 EENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred ccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 11111 24455666777 899998 6666666655543
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=283.96 Aligned_cols=250 Identities=24% Similarity=0.427 Sum_probs=206.6
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccCCC
Q 003935 521 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPP 597 (785)
Q Consensus 521 e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~ 597 (785)
....+.++++.+..||.|.-|+|+++.+ .|..+|||.+.... +.+..++++..+.++...+ +|+||+.+|+|..+.
T Consensus 86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~ 164 (391)
T KOG0983|consen 86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT 164 (391)
T ss_pred ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence 3445667777888999999999999987 47899999987654 4555788888898877665 999999999999999
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-cccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
..++.||.|.. .+..+++. -.+++++..+-++...++.||.||.. +||||||+||+|||+|+.|++||||||++-.
T Consensus 165 dV~IcMelMs~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGr 241 (391)
T KOG0983|consen 165 DVFICMELMST-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGR 241 (391)
T ss_pred hHHHHHHHHHH-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccce
Confidence 99999998853 55555553 24568999999999999999999986 6899999999999999999999999999988
Q ss_pred ccCCCCCCCCCCCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCCCh-
Q 003935 677 ITDSPMRDSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIPEG- 751 (785)
Q Consensus 677 l~~~~~~~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvILyELLTG~~PF~~~~-~~~~v~~i~~~~~~~~ip~~- 751 (785)
+.+.. ..+..+|-+.|||||.+.- ..|+-++||||||++|+||.||+.||.+.. .-+++..+.+ ...+-++..
T Consensus 242 lvdSk-AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~ 319 (391)
T KOG0983|consen 242 LVDSK-AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHM 319 (391)
T ss_pred eeccc-ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCccc
Confidence 86643 3345678999999999864 468899999999999999999999999854 4455555655 333444432
Q ss_pred ----HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 752 ----PLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 752 ----~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+.+++..||. |+.+||...++++|
T Consensus 320 gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 320 GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 58899999999 99999999999976
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=292.70 Aligned_cols=242 Identities=24% Similarity=0.410 Sum_probs=199.2
Q ss_pred CCCeeEe-eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccC----CC
Q 003935 526 FSELTVG-TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTK----PP 597 (785)
Q Consensus 526 ~s~y~i~-k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d----~~ 597 (785)
+++|++- ++||-|-.|.|..+.+ ++.++|+|++... ....+|+++.-.. .|||||.++++|+. ..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 4666665 4689999999999976 5889999997422 3456889886655 59999999999864 35
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEc---CCCeEEEEecCcc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN---KHWTVKICDFGLS 674 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd---~~g~VKL~DFGLA 674 (785)
.+.+|||.|+||.|++.++.. ....+++.++-.|+.||+.|+.|||+.+|.||||||+|+|.+ .+..+||+|||+|
T Consensus 133 cLLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 688999999999999999754 356799999999999999999999999999999999999996 4557999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhcCCCCCCC-
Q 003935 675 RIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV----LPERVVYAVANEGSRLEIP- 749 (785)
Q Consensus 675 ~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~----~~~~~v~~i~~~~~~~~ip- 749 (785)
+.-... ....+.|-||.|.|||++...+|+..+|+||+||++|-|++|.+||+.. .......+|..+.+..+-|
T Consensus 212 K~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE 290 (400)
T KOG0604|consen 212 KETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE 290 (400)
T ss_pred cccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh
Confidence 876532 3445778999999999999999999999999999999999999999754 2334455555544444333
Q ss_pred ----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 750 ----EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 750 ----~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+..+++|+.+|. +|.+|.|+.+++++
T Consensus 291 Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 291 WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred HhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 2357889999999 99999999999876
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=304.65 Aligned_cols=245 Identities=25% Similarity=0.305 Sum_probs=203.7
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHH-HHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~-~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
+.+..+.|..-++||+|+||.||-++. +|+-||+|.+.++...... ..-.++|..+|.+++.+.||.+-.+|+..+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 445667888999999999999998854 7889999998776654333 2345789999999999999999999999999
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
+++|+..|.||+|..++... .++.+++..++-|+.+|+-||++||+.+||+|||||+|||||+.|+|.|+|+|||..+.
T Consensus 260 LClVLtlMNGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred eEEEEEeecCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 99999999999999877644 34689999999999999999999999999999999999999999999999999999887
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCCCC---ChH
Q 003935 679 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP---ERVVYAVANEGSRLEIP---EGP 752 (785)
Q Consensus 679 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~---~~~v~~i~~~~~~~~ip---~~~ 752 (785)
... .....+||.+|||||++.++.|+...|.|+|||+||||+.|+.||..... .+.+.+... ......+ ...
T Consensus 339 ~g~-~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~-~~~~ey~~kFS~e 416 (591)
T KOG0986|consen 339 EGK-PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL-EDPEEYSDKFSEE 416 (591)
T ss_pred CCC-ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh-cchhhcccccCHH
Confidence 653 33456999999999999999999999999999999999999999975432 222222221 1122222 236
Q ss_pred HHHHHHHhhh-CCCCCCC
Q 003935 753 LGRLIADCWA-EPQERPS 769 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS 769 (785)
.+.|.+.+|. ||.+|--
T Consensus 417 akslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 417 AKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred HHHHHHHHHccCHHHhcc
Confidence 8889999998 9999853
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=326.37 Aligned_cols=242 Identities=29% Similarity=0.459 Sum_probs=189.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEecccc----------
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT---------- 594 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~---------- 594 (785)
.+|.....||+||||.||+++. +|+.||||++.... .......+.+|+..|.+|+|||||++|..+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 4566778899999999999976 79999999997765 4555677899999999999999999874320
Q ss_pred -------------------------------------------------C-------------------C----------
Q 003935 595 -------------------------------------------------K-------------------P---------- 596 (785)
Q Consensus 595 -------------------------------------------------d-------------------~---------- 596 (785)
. .
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0 0
Q ss_pred -------------------------------CceeEEEEEcccchhhHHHHhhcccccc-hHHHHHHHHHHHHHHHHHHH
Q 003935 597 -------------------------------PRLSMITEYMELGSLYHLIHLSGQKKKL-SWRRKLKMLRDICRGLMCIH 644 (785)
Q Consensus 597 -------------------------------~~l~LV~Ey~~gGSL~dlL~~~~~~~~L-s~~~~l~Ia~QIa~AL~yLH 644 (785)
-.+||-||||+..++.++++... .. ....++++++||++||+|+|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~---~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH---FNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc---cchhhHHHHHHHHHHHHHHHHHH
Confidence 12588999999988888887332 22 46778999999999999999
Q ss_pred hcccccccCCCCcEEEcCCCeEEEEecCcccccc------C------------CCCCCCCCCCCCcccCccccccC---C
Q 003935 645 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT------D------------SPMRDSSSAGTPEWMAPELIRNE---P 703 (785)
Q Consensus 645 s~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~------~------------~~~~~~~~~GT~~Y~APEvl~~~---~ 703 (785)
++|||||||||.||+|++++.|||+|||+|+... + .....+..+||.-|+|||++.+. +
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999999998721 0 01123456899999999999765 4
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC----h---HHHHHHHHhhh-CCCCCCCHHHHHH
Q 003935 704 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE----G---PLGRLIADCWA-EPQERPSCEEILS 775 (785)
Q Consensus 704 ~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~----~---~L~~LI~~CL~-DP~kRPS~~EIL~ 775 (785)
|+.|+|+||||+|++||+. ||.........-.-++.+. .+.+. + .=..+|.+|++ ||.+|||+.|+|+
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~-iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGS-IPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCC-CCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 9999999999999999987 6766544333322233222 22221 1 24578999999 9999999999986
Q ss_pred H
Q 003935 776 R 776 (785)
Q Consensus 776 ~ 776 (785)
.
T Consensus 871 s 871 (1351)
T KOG1035|consen 871 S 871 (1351)
T ss_pred c
Confidence 4
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=277.69 Aligned_cols=214 Identities=22% Similarity=0.249 Sum_probs=175.8
Q ss_pred eCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccchhhHHH
Q 003935 538 GFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLI 615 (785)
Q Consensus 538 G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL~dlL 615 (785)
|.||.||++.+ +++.||+|++.... .+..|...+....||||+++++++.+....+++|||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 89999999987 68899999986542 2334555555667999999999999999999999999999999988
Q ss_pred HhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccC
Q 003935 616 HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMA 695 (785)
Q Consensus 616 ~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~A 695 (785)
.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++...... .....++..|+|
T Consensus 77 ~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~a 150 (237)
T cd05576 77 SK---FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCA 150 (237)
T ss_pred HH---hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccC
Confidence 63 346899999999999999999999999999999999999999999999999988665432 223456778999
Q ss_pred ccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCH
Q 003935 696 PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSC 770 (785)
Q Consensus 696 PEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~ 770 (785)
||.+.+..++.++|+||+|+++|+|++|+.||....... .......+| ...+.+++.+||+ ||.+||++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------ccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 999988889999999999999999999998876432211 111112222 3468999999999 99999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=265.57 Aligned_cols=232 Identities=31% Similarity=0.475 Sum_probs=195.0
Q ss_pred CcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccchhhHHHH
Q 003935 539 FFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH 616 (785)
Q Consensus 539 ~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL~dlL~ 616 (785)
+||.||+|.+. ++.+|+|++........ .+.+.+|++.++.++|+||+++++++......++++||+.+++|..++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999884 68999999876544322 5789999999999999999999999999889999999999999999886
Q ss_pred hhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCc
Q 003935 617 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAP 696 (785)
Q Consensus 617 ~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~AP 696 (785)
.. ..+++..++.++.+++.++.|||+.+++|+||+|.||+++.++.++|+|||.+....... ......++..|++|
T Consensus 80 ~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~p 155 (244)
T smart00220 80 KR---GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAP 155 (244)
T ss_pred hc---cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCH
Confidence 32 238899999999999999999999999999999999999999999999999998775532 23356688899999
Q ss_pred cccccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCCCCCC-----CChHHHHHHHHhhh-CCCCCCC
Q 003935 697 ELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG-VLPERVVYAVANEGSRLEI-----PEGPLGRLIADCWA-EPQERPS 769 (785)
Q Consensus 697 Evl~~~~~s~ksDVWSLGvILyELLTG~~PF~~-~~~~~~v~~i~~~~~~~~i-----p~~~L~~LI~~CL~-DP~kRPS 769 (785)
|.+....++.++|||+||+++|+|++|..||.. .........+ ........ -...+.+++.+||. +|.+||+
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKI-GKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH-hccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 999988899999999999999999999999988 4444444433 33322221 23468899999999 9999999
Q ss_pred HHHHHHH
Q 003935 770 CEEILSR 776 (785)
Q Consensus 770 ~~EIL~~ 776 (785)
+.+++++
T Consensus 235 ~~~~~~~ 241 (244)
T smart00220 235 AEEALQH 241 (244)
T ss_pred HHHHhhC
Confidence 9999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=330.09 Aligned_cols=238 Identities=23% Similarity=0.394 Sum_probs=188.3
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
.|...+.||+|+||.||+|.+ ++..||||.+...... ...|++++++++|||||+++++|.+....++||||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 455667899999999999986 6889999988543221 12468899999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHH---hcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH---RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLH---s~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
+++|+|.++++ .++|..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.......
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 99999999985 3789999999999999999999 6699999999999999998888775 665543321
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhcC-----CCC------
Q 003935 683 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP-----ERVVYAVANEG-----SRL------ 746 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~-----~~~v~~i~~~~-----~~~------ 746 (785)
.....+++.|+|||++.+..++.++|||||||++|||+||+.||..... ........... ..+
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 1234678999999999999999999999999999999999999853211 11111000000 000
Q ss_pred CCCCh---HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 747 EIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 747 ~ip~~---~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
..+.. .+.+++.+||+ ||++||++.++++.|+++..
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 11111 35678899999 99999999999999998754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-32 Score=284.35 Aligned_cols=246 Identities=21% Similarity=0.364 Sum_probs=204.5
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHhhc-CCCceeeEeccccC
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRL-RHPNVILFLGACTK 595 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d 595 (785)
..|.+...+|.++++||+|+|++|..+.+ +.+-||+|++++.-.+ .+.+.....|..+..+. +||.+|.++.+|+.
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 45677889999999999999999999866 5778999999876553 34456667788887766 69999999999999
Q ss_pred CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 596 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
...+++|.||++||+|...++ ..+.++++.++-+..+|+.||.|||++|||+||||.+|||++..|++||+|||+++
T Consensus 323 esrlffvieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred cceEEEEEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhh
Confidence 999999999999999987776 45689999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CChHHHHHH-HHhcCCCCC
Q 003935 676 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG-------VLPERVVYA-VANEGSRLE 747 (785)
Q Consensus 676 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~-------~~~~~~v~~-i~~~~~~~~ 747 (785)
.--.+....++.||||.|.|||++++..|....|.|+|||+++||+.|+.||.- .+.+..+.+ ++.+..+.+
T Consensus 400 e~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip 479 (593)
T KOG0695|consen 400 EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP 479 (593)
T ss_pred cCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc
Confidence 765555667789999999999999999999999999999999999999999962 222333333 333333332
Q ss_pred CCCh-HHHHHHHHhhh-CCCCCC
Q 003935 748 IPEG-PLGRLIADCWA-EPQERP 768 (785)
Q Consensus 748 ip~~-~L~~LI~~CL~-DP~kRP 768 (785)
-.-. ....+++..++ ||.+|.
T Consensus 480 rslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 480 RSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ceeehhhHHHHHHhhcCCcHHhc
Confidence 2211 34567788888 999884
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=303.56 Aligned_cols=241 Identities=29% Similarity=0.448 Sum_probs=205.0
Q ss_pred eeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccc
Q 003935 532 GTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 609 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gG 609 (785)
.+.||.|.||+||-|++ +|+.||||++.+-.........+.+|+.||+++.||.||.+-..|+..+.+++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 46899999999999987 6999999999888887777788999999999999999999999999999999999999876
Q ss_pred hhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC---eEEEEecCccccccCCCCCCCC
Q 003935 610 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLSRIITDSPMRDSS 686 (785)
Q Consensus 610 SL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g---~VKL~DFGLA~~l~~~~~~~~~ 686 (785)
-|.-+|. ...++|++...+-++.||+.||+|||-++|+|+||||+||||.... ++||||||+|+.++.... ...
T Consensus 649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-Rrs 725 (888)
T KOG4236|consen 649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-RRS 725 (888)
T ss_pred HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh-hhh
Confidence 6666654 3567899999999999999999999999999999999999997543 799999999999876543 357
Q ss_pred CCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CC----ChHHHHHHHHhh
Q 003935 687 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IP----EGPLGRLIADCW 761 (785)
Q Consensus 687 ~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip----~~~L~~LI~~CL 761 (785)
.+|||.|+|||+++++-|...-|+||.|||+|--++|..||.... ++..++.+..+..+ -| .....+||..++
T Consensus 726 VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn~LL 803 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLINNLL 803 (888)
T ss_pred hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHHHHH
Confidence 899999999999999999999999999999999999999997542 23344444333221 11 124667899999
Q ss_pred h-CCCCCCCHHHHHHHH
Q 003935 762 A-EPQERPSCEEILSRL 777 (785)
Q Consensus 762 ~-DP~kRPS~~EIL~~L 777 (785)
+ .-.+|.|.+..+.|-
T Consensus 804 qVkm~kRysvdk~lsh~ 820 (888)
T KOG4236|consen 804 QVKMRKRYSVDKSLSHP 820 (888)
T ss_pred HHHHHHhcchHhhccch
Confidence 9 999999999988773
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=290.54 Aligned_cols=247 Identities=33% Similarity=0.592 Sum_probs=201.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhh--cCCCceeeEeccccCCC----cee
Q 003935 527 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR--LRHPNVILFLGACTKPP----RLS 600 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~--L~HPNIVkL~g~~~d~~----~l~ 600 (785)
.+.++.+.||+|.||+||+|.|.|..||||+|.... ...+.+|.+|++- |+|+||+.|++.-..+. .++
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 567889999999999999999999999999986433 3567788888765 59999999998754433 489
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc--------ccccccCCCCcEEEcCCCeEEEEecC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM--------KIVHRDLKSANCLVNKHWTVKICDFG 672 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~--------gIIHrDLKpsNILLd~~g~VKL~DFG 672 (785)
||++|.+.|+|+|+|. ..+++...+++++..++.||++||.. .|.|||||..|||+.+++...|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 9999999999999996 35899999999999999999999953 49999999999999999999999999
Q ss_pred ccccccCCC----CCCCCCCCCCcccCccccccCC----CC--chhhHHHHHHHHHHHHh----------CCCCCCCC--
Q 003935 673 LSRIITDSP----MRDSSSAGTPEWMAPELIRNEP----FT--EKCDIFSLGVIMWELCT----------LNRPWEGV-- 730 (785)
Q Consensus 673 LA~~l~~~~----~~~~~~~GT~~Y~APEvl~~~~----~s--~ksDVWSLGvILyELLT----------G~~PF~~~-- 730 (785)
||....... ......+||.+|||||++...- +. ..+||||||+++||++. .+.||++.
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 998765431 2345678999999999997542 21 36899999999999874 25688754
Q ss_pred ---ChHHHHHHHHhcCCCCCCCCh--------HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 731 ---LPERVVYAVANEGSRLEIPEG--------PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 731 ---~~~~~v~~i~~~~~~~~ip~~--------~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
+.+++..-+.....++.+|.- .+.+|++.||. +|.-|-|+--|.+.|.++..
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 333444444456667777642 36789999999 99999999999999988764
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=285.42 Aligned_cols=238 Identities=26% Similarity=0.462 Sum_probs=193.0
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccCCCceeEEEEEcccc
Q 003935 533 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEYMELG 609 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~Ey~~gG 609 (785)
+.||+|+|+.|-.++. +|..||||++.++. ........+|++++..++ |+||++++++|+++.++|+|||-|.||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 4799999999998854 89999999998763 345678999999999996 999999999999999999999999999
Q ss_pred hhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC---eEEEEecCccccccCCC-----
Q 003935 610 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLSRIITDSP----- 681 (785)
Q Consensus 610 SL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g---~VKL~DFGLA~~l~~~~----- 681 (785)
+|...++ +.+.+++..+.++..+|+.||.|||.+||.||||||+|||-.... -||||||.+..-+....
T Consensus 162 plLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 162 PLLSHIQ---KRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred hHHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 9998887 456899999999999999999999999999999999999997654 48999998875432111
Q ss_pred --CCCCCCCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------------ChHHHHHHHH
Q 003935 682 --MRDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGV--------------LPERVVYAVA 740 (785)
Q Consensus 682 --~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTG~~PF~~~--------------~~~~~v~~i~ 740 (785)
....+.+|+..|||||+.. ...|+.++|.||||||||-|++|++||.+. ...+.+..-+
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI 318 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI 318 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence 1123457889999999873 246899999999999999999999999642 1122333333
Q ss_pred hcCCCCCCCCh-------HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 741 NEGSRLEIPEG-------PLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 741 ~~~~~~~ip~~-------~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.++ ..++|+. ..++++..++. |+..|-++..++.+
T Consensus 319 QEG-kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 319 QEG-KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred hcc-CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 333 2344543 46778899988 99999999988873
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=303.11 Aligned_cols=241 Identities=24% Similarity=0.362 Sum_probs=203.3
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccc-cChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQD-LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~-~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
.+.+-|..++.||-|+||+|.++.. +...||+|.+.+.+ +...++...+.|-.||.....+-||+||..|++.+++|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 4557789999999999999999854 56679999986655 34555677888999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
+||+|++||++..+|. ..+-+.+..++.|+.++.-|+++.|..|+|||||||+|||||.+|+|||+||||+.-+.-.
T Consensus 706 FVMdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EEEeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999999987 4458999999999999999999999999999999999999999999999999998644210
Q ss_pred --------CC----------------------------------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHH
Q 003935 681 --------PM----------------------------------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMW 718 (785)
Q Consensus 681 --------~~----------------------------------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILy 718 (785)
.. .....+||+.|+|||++...-|+..+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 00 002346999999999999988999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCh-----HHHHHHHHhhhCCCCC
Q 003935 719 ELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG-----PLGRLIADCWAEPQER 767 (785)
Q Consensus 719 ELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~~-----~L~~LI~~CL~DP~kR 767 (785)
||+.|+.||....+.+...++++....+.++.. +..++|.++..++..|
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~R 916 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSR 916 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhh
Confidence 999999999999998888888877776666632 3555666655555565
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=292.99 Aligned_cols=247 Identities=28% Similarity=0.531 Sum_probs=205.6
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhc--CCCceeeEeccccCCC----ce
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL--RHPNVILFLGACTKPP----RL 599 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L--~HPNIVkL~g~~~d~~----~l 599 (785)
.....+.+.||+|.||.||+|+.+++.||||++. .+..+.|.+|-+|++.. +|+||++|+++-.... .+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 3445567889999999999999999999999985 34567899999887764 7999999999865544 79
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc---------ccccccCCCCcEEEcCCCeEEEEe
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM---------KIVHRDLKSANCLVNKHWTVKICD 670 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~---------gIIHrDLKpsNILLd~~g~VKL~D 670 (785)
+||++|.+.|+|.++|+ ...++|....+++.-+++||+|||+- .|+|||||..||||.++++..|+|
T Consensus 284 wLVt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred eEEeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 99999999999999996 44799999999999999999999963 499999999999999999999999
Q ss_pred cCccccccCCCC--CCCCCCCCCcccCccccccCC-CC-----chhhHHHHHHHHHHHHhC------------CCCCC--
Q 003935 671 FGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEP-FT-----EKCDIFSLGVIMWELCTL------------NRPWE-- 728 (785)
Q Consensus 671 FGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~-~s-----~ksDVWSLGvILyELLTG------------~~PF~-- 728 (785)
||||..+..... .....+||.+|||||++.+.. +. .+.||||+|.+||||++. +.||.
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 999998764321 122468999999999997642 22 368999999999999973 23453
Q ss_pred ---CCChHHHHHHHHhcCCCCCCCCh--------HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 729 ---GVLPERVVYAVANEGSRLEIPEG--------PLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 729 ---~~~~~~~v~~i~~~~~~~~ip~~--------~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
....+++...++.++.++.+|+. .+.+.+..||. ||+-|.|+.=+-+++.++.
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 34556777777888899998864 47889999999 9999999998888887764
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=284.32 Aligned_cols=203 Identities=30% Similarity=0.467 Sum_probs=170.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC-CCc
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-PPR 598 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~~------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d-~~~ 598 (785)
...|.+...||+|.||.||+++.. ...+|||.++.+......-....+|+.+++.++||||+.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 356788899999999999999542 2369999987653322333567899999999999999999999987 778
Q ss_pred eeEEEEEcccchhhHHHHhhc--ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC----CeEEEEecC
Q 003935 599 LSMITEYMELGSLYHLIHLSG--QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH----WTVKICDFG 672 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~--~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~----g~VKL~DFG 672 (785)
+++++||.+. +|+++++... ..+.++...++.|++||+.|+.|||++-|+||||||.|||+..+ |.|||+|||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999999997 8888887543 34579999999999999999999999999999999999999877 899999999
Q ss_pred ccccccCCCC---CCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003935 673 LSRIITDSPM---RDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEG 729 (785)
Q Consensus 673 LA~~l~~~~~---~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~ 729 (785)
+++.+.+.-. .....+-|.+|.|||.+.+. .|+.+.|||++|||+.||+|-.+-|.+
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999876422 23455688999999999875 689999999999999999998776643
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=261.45 Aligned_cols=246 Identities=22% Similarity=0.297 Sum_probs=204.1
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
+|.-.++||+|.||+||++.. .+.-||+|.......++......++||.+++.++|.|||+++++...++.+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 455667899999999999976 577899999877666555566788999999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 685 (785)
|.. .|..+... -++.++.+.++.++.|+++||.|||++++.||||||.|+|++.+|.+||+|||+++.++-+..-..
T Consensus 83 cdq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 83 CDQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred hhH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 975 77777653 356899999999999999999999999999999999999999999999999999998876544445
Q ss_pred CCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCC---------CCC----
Q 003935 686 SSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLE---------IPE---- 750 (785)
Q Consensus 686 ~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~---------ip~---- 750 (785)
..+-|.+|.+|.++.+. -|+...|+||.||++.|+.. |++-|++.+....+..+...-..+. +|+
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 66789999999999875 58899999999999999986 4555888888877777654222111 111
Q ss_pred -----------------hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 751 -----------------GPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 751 -----------------~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..=++|+..++. +|..|.+++..+++
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 013468888888 99999999998875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=300.80 Aligned_cols=251 Identities=29% Similarity=0.489 Sum_probs=213.7
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccC---
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTK--- 595 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d--- 595 (785)
+....+.|.+...||.|.+|.||+++. +++..|+|++...... -+++..|.++|+.+ .|||++.+||+|..
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---EEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---cHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 334456788899999999999999854 7999999998654332 35666789999887 59999999999853
Q ss_pred --CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCc
Q 003935 596 --PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGL 673 (785)
Q Consensus 596 --~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGL 673 (785)
++.+|||||||.+|++.|+++... +..+.|..+..|++.++.|+.+||+..+||||||-.|||++.++.|||+|||+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence 457999999999999999998654 77899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 003935 674 SRIITDSPMRDSSSAGTPEWMAPELIRN-----EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI 748 (785)
Q Consensus 674 A~~l~~~~~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i 748 (785)
+..+...-....+..|||.|||||++.. ..|+..+|+||||++..||.-|.+|+-+.-+...+..+.+.......
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLk 249 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK 249 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcccc
Confidence 9988766556667899999999999964 35778999999999999999999999999998888877654433333
Q ss_pred -CC---hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 749 -PE---GPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 749 -p~---~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
|. ..+.++|..|+. |-.+||++.++++|
T Consensus 250 rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 250 RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 22 257889999998 99999999999875
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=275.97 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=201.4
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHH-hhcCCCceeeEeccccCC
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISIL-SRLRHPNVILFLGACTKP 596 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iL-k~L~HPNIVkL~g~~~d~ 596 (785)
.-|.+..++++-...||.|+||+|++-.+ .|+..|||.+....... ..++++.|.+.. +.-++||||+|||++..+
T Consensus 57 ~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~k-eq~rll~e~d~~mks~~cp~IVkfyGa~F~E 135 (361)
T KOG1006|consen 57 HLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEK-EQKRLLMEHDTVMKSSNCPNIVKFYGALFSE 135 (361)
T ss_pred cccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchH-HHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence 34555666777778999999999999887 48899999997766533 457888888765 445799999999999999
Q ss_pred CceeEEEEEcccchhhHHHHh--hcccccchHHHHHHHHHHHHHHHHHHHh-cccccccCCCCcEEEcCCCeEEEEecCc
Q 003935 597 PRLSMITEYMELGSLYHLIHL--SGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGL 673 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~--~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGL 673 (785)
+..|+.||.|.- +|..+.+. ..+...+++.-.-.|..-++.||.||.. ..|||||+||+||||+..|.|||||||+
T Consensus 136 GdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGI 214 (361)
T KOG1006|consen 136 GDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGI 214 (361)
T ss_pred CceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccc
Confidence 999999999973 55443321 2245678999888999999999999985 6899999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CC
Q 003935 674 SRIITDSPMRDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PE 750 (785)
Q Consensus 674 A~~l~~~~~~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i-p~ 750 (785)
+-.+.+. ...+..+|...|||||.+.. .-|+-++||||||++|||+.||+.||..++..-....++..+..+.+ .+
T Consensus 215 cGqLv~S-iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~ 293 (361)
T KOG1006|consen 215 CGQLVDS-IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFD 293 (361)
T ss_pred hHhHHHH-HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCc
Confidence 9776543 22345578889999999964 34899999999999999999999999988764333333333433332 21
Q ss_pred -------hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 751 -------GPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 751 -------~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..+..+|.-|+. |-+.||.+.+++++
T Consensus 294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 257889999998 99999999998864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=277.68 Aligned_cols=262 Identities=23% Similarity=0.457 Sum_probs=219.2
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEec
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 591 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g 591 (785)
..++.+...+++....+-+|.||.||+|+|. .+.|.+|.++.+. ..-+...|+.|...+..+.|||+..+.+
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 3556667778888889999999999999763 2346667764433 3345678899999999999999999999
Q ss_pred cccCC-CceeEEEEEcccchhhHHHHh-----hcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCe
Q 003935 592 ACTKP-PRLSMITEYMELGSLYHLIHL-----SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 665 (785)
Q Consensus 592 ~~~d~-~~l~LV~Ey~~gGSL~dlL~~-----~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~ 665 (785)
++.+. ...++++.++.-|+|..++.. ......++..+...++.|++.|++|||++||||.||.++|+++++..+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee
Confidence 98654 567889999999999999973 233456888899999999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCCCC--CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 003935 666 VKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANE 742 (785)
Q Consensus 666 VKL~DFGLA~~l~~~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~ 742 (785)
|||+|=.+++.+....++. ...-.+..||+||.+.+..|+.++|||||||+||||+| |+.||...++.++... +..
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y-lkd 513 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY-LKD 513 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH-Hhc
Confidence 9999999999876554432 23345678999999999999999999999999999987 7889999999776654 466
Q ss_pred CCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 743 GSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 743 ~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
+++...| ++.+..++..||. +|++||+++++...|.++--
T Consensus 514 GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 514 GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 8888777 4468899999999 99999999999999998754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=296.22 Aligned_cols=248 Identities=19% Similarity=0.233 Sum_probs=170.1
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE--C----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEecc---
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIW--N----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA--- 592 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~--~----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~--- 592 (785)
.....++|.+.++||+|+||.||+|.+ + +..||+|++...... +.+..| .+....+.+++.++..
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 445678999999999999999999987 3 678999987543211 111111 1222223333332222
Q ss_pred ---ccCCCceeEEEEEcccchhhHHHHhhcc-----------------cccchHHHHHHHHHHHHHHHHHHHhccccccc
Q 003935 593 ---CTKPPRLSMITEYMELGSLYHLIHLSGQ-----------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 652 (785)
Q Consensus 593 ---~~d~~~l~LV~Ey~~gGSL~dlL~~~~~-----------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrD 652 (785)
+.....+++|+||+.+++|.+++..... ........+..++.||+.||+|||++||+|||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD 280 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD 280 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence 2455679999999999999998863211 01122345678999999999999999999999
Q ss_pred CCCCcEEEcC-CCeEEEEecCccccccCC-CCCCCCCCCCCcccCccccccC----------------------CCCchh
Q 003935 653 LKSANCLVNK-HWTVKICDFGLSRIITDS-PMRDSSSAGTPEWMAPELIRNE----------------------PFTEKC 708 (785)
Q Consensus 653 LKpsNILLd~-~g~VKL~DFGLA~~l~~~-~~~~~~~~GT~~Y~APEvl~~~----------------------~~s~ks 708 (785)
|||+|||++. ++.+||+|||+++.+... ........+++.|+|||.+... .++.++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999985 579999999999865432 2233456789999999966322 234567
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------CCC---------CCChHHHHHHHHhhh-CCC
Q 003935 709 DIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-------------RLE---------IPEGPLGRLIADCWA-EPQ 765 (785)
Q Consensus 709 DVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~-------------~~~---------ip~~~L~~LI~~CL~-DP~ 765 (785)
|||||||+||||+++..|+..... .....+...+. ... .......+|+.+|+. ||.
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLI-QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHH-HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 999999999999998776543211 11111111110 000 001124479999999 999
Q ss_pred CCCCHHHHHHH
Q 003935 766 ERPSCEEILSR 776 (785)
Q Consensus 766 kRPS~~EIL~~ 776 (785)
+|||+.++++|
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999987
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=284.79 Aligned_cols=246 Identities=23% Similarity=0.383 Sum_probs=196.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccc-cCh----HHHHHHHHHHHHHhhcCCCceeeEecccc-CCCc
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQD-LTA----ENMEDFCNEISILSRLRHPNVILFLGACT-KPPR 598 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~-~~~----~~~e~f~~EI~iLk~L~HPNIVkL~g~~~-d~~~ 598 (785)
+.|-+++.||+|+|++||++.+ ..+.||||+-.... +.. ...+...+|..|.+.|.||.||++|++|. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 5788889999999999999965 68889999865432 211 22456778999999999999999999985 4567
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc--ccccccCCCCcEEEc---CCCeEEEEecCc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM--KIVHRDLKSANCLVN---KHWTVKICDFGL 673 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~--gIIHrDLKpsNILLd---~~g~VKL~DFGL 673 (785)
++-|+|||+|.+|..+|+ ..+.++++.++.|+.||+.||.||... .|||-||||.||||- .-|.+||+|||+
T Consensus 543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 899999999999999997 567899999999999999999999986 499999999999994 447899999999
Q ss_pred cccccCCCCC-------CCCCCCCCcccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHH-HH
Q 003935 674 SRIITDSPMR-------DSSSAGTPEWMAPELIRNE----PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERV-VYA-VA 740 (785)
Q Consensus 674 A~~l~~~~~~-------~~~~~GT~~Y~APEvl~~~----~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~-v~~-i~ 740 (785)
++.+.+..+. .....||.+|++||.+.-+ +.+.|+||||+|||+|.++.|+.||......+. ++. .+
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 9999765433 2346799999999988543 467899999999999999999999986543322 211 11
Q ss_pred hcCCCCCCC-----ChHHHHHHHHhhh-CCCCCCCHHHHHH
Q 003935 741 NEGSRLEIP-----EGPLGRLIADCWA-EPQERPSCEEILS 775 (785)
Q Consensus 741 ~~~~~~~ip-----~~~L~~LI~~CL~-DP~kRPS~~EIL~ 775 (785)
-+.....+| ....+++|++||+ --+.|....++..
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 112222222 3468899999998 7778887777653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=239.38 Aligned_cols=210 Identities=40% Similarity=0.641 Sum_probs=183.8
Q ss_pred EeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccchhh
Q 003935 535 VGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY 612 (785)
Q Consensus 535 LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL~ 612 (785)
||.|.+|.||++... ++.+++|++....... ..+.+.+|+..++.++|++|+++++++......++++||+.+++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999886 8899999987654432 3467899999999999999999999999989999999999999999
Q ss_pred HHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC-CCeEEEEecCccccccCCCCCCCCCCCCC
Q 003935 613 HLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRIITDSPMRDSSSAGTP 691 (785)
Q Consensus 613 dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~-~g~VKL~DFGLA~~l~~~~~~~~~~~GT~ 691 (785)
+++... ...+++..++.++.+++.++++||+.|++|+||+|.||+++. ++.++|+|||.+..............+..
T Consensus 80 ~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 80 DLLKEN--EGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 998632 146889999999999999999999999999999999999999 89999999999987755432233456778
Q ss_pred cccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCC
Q 003935 692 EWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPS 769 (785)
Q Consensus 692 ~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPS 769 (785)
.|++||.+... .++.+.|+|++|+++++| ..+.+++..|+. +|.+||+
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------~~~~~~l~~~l~~~p~~R~~ 207 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------PELKDLIRKMLQKDPEKRPS 207 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------HHHHHHHHHHhhCCcccCcC
Confidence 99999999887 788999999999999999 457889999998 9999999
Q ss_pred HHHHHHHH
Q 003935 770 CEEILSRL 777 (785)
Q Consensus 770 ~~EIL~~L 777 (785)
+.++++++
T Consensus 208 ~~~l~~~~ 215 (215)
T cd00180 208 AKEILEHL 215 (215)
T ss_pred HHHHhhCC
Confidence 99998763
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-31 Score=271.22 Aligned_cols=248 Identities=28% Similarity=0.434 Sum_probs=199.0
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC-------
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------- 596 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~------- 596 (785)
.+.|.-..+||+|.||+||++.. .|+.||+|++...+.........++|+.+|..++|+|++.+++.|...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 35566678899999999999865 578899987654443333445678999999999999999999988532
Q ss_pred -CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 597 -PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 597 -~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
..+|+||.+|+. +|.-++. +....++...+.+++.++..||.|+|+..|+|||+|+.|+|++.+|.+||+|||+++
T Consensus 96 r~t~ylVf~~ceh-DLaGlLs--n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLS--NRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhc--CccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 348999999986 7777775 334679999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC----CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--cCCCCC-
Q 003935 676 IITDSPM----RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN--EGSRLE- 747 (785)
Q Consensus 676 ~l~~~~~----~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~--~~~~~~- 747 (785)
.+..... ..+..+-|.+|++||.+.+ ..|+++.|||..|||+.||+|+.+-+.+.+....+..+.. +...++
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 7643321 2345667999999998876 5799999999999999999999999988877766655532 111111
Q ss_pred -----------------CC----------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 -----------------IP----------------EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 -----------------ip----------------~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+| +....+|+..++. ||.+|+++.+++.|
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 11 1134568999999 99999999999976
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=281.91 Aligned_cols=254 Identities=19% Similarity=0.252 Sum_probs=179.8
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE------------------CCeEEEEEEeeccccCh------------HHHHHHH
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW------------------NGTDVAIKVFLEQDLTA------------ENMEDFC 572 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~------------------~g~~VAVKil~~~~~~~------------~~~e~f~ 572 (785)
....++|.+.++||+|+||+||+|.+ .++.||||.+....... ...+.+.
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 34678999999999999999999863 24679999985432110 0012234
Q ss_pred HHHHHHhhcCCCce-----eeEeccccC--------CCceeEEEEEcccchhhHHHHhhcc-------------------
Q 003935 573 NEISILSRLRHPNV-----ILFLGACTK--------PPRLSMITEYMELGSLYHLIHLSGQ------------------- 620 (785)
Q Consensus 573 ~EI~iLk~L~HPNI-----VkL~g~~~d--------~~~l~LV~Ey~~gGSL~dlL~~~~~------------------- 620 (785)
.|+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 46677777766554 677777653 3468999999999999998863210
Q ss_pred --cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC-CCCCCCCCCcccCcc
Q 003935 621 --KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-RDSSSAGTPEWMAPE 697 (785)
Q Consensus 621 --~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~-~~~~~~GT~~Y~APE 697 (785)
...+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++..+..... ......+++.|+|||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 12346778899999999999999999999999999999999999999999999976543221 111234578999999
Q ss_pred ccccCC--------------------C--CchhhHHHHHHHHHHHHhCCC-CCCCCChHHHHHH--------H-HhcCCC
Q 003935 698 LIRNEP--------------------F--TEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYA--------V-ANEGSR 745 (785)
Q Consensus 698 vl~~~~--------------------~--s~ksDVWSLGvILyELLTG~~-PF~~~~~~~~v~~--------i-~~~~~~ 745 (785)
.+.... + ..+.||||+||++|+|++|.. ||.+......... + ......
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 885422 1 124799999999999999986 7754321111100 0 001111
Q ss_pred CCCC-----ChHHHHHHHHhhh-CC---CCCCCHHHHHHH
Q 003935 746 LEIP-----EGPLGRLIADCWA-EP---QERPSCEEILSR 776 (785)
Q Consensus 746 ~~ip-----~~~L~~LI~~CL~-DP---~kRPS~~EIL~~ 776 (785)
..++ .+...+|+.+|+. +| .+|+|+.++|+|
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 1111 3457889999997 54 689999999987
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=273.34 Aligned_cols=244 Identities=22% Similarity=0.290 Sum_probs=198.2
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcC--CC----ceeeEeccccCC
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLR--HP----NVILFLGACTKP 596 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~--HP----NIVkL~g~~~d~ 596 (785)
-...|.+...+|+|.||.|-.+.+. +..||||+++.- ....+..+-|+++|+++. .| -+|.+.++|...
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 3578999999999999999999874 678999997532 233456678999999994 23 378899999999
Q ss_pred CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEc---------------
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN--------------- 661 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd--------------- 661 (785)
++.++|+|.+ |-++++++.. ++..+++..+++.+++|++++++|||+.+++|.||||+|||+.
T Consensus 164 ghiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred CceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence 9999999988 4599999973 3556899999999999999999999999999999999999993
Q ss_pred -----CCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 003935 662 -----KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVV 736 (785)
Q Consensus 662 -----~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v 736 (785)
++..|+|+|||.|..-.. .....+.|..|.|||++.+-.++.++||||+||||+||+||..-|++..+.+.+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e---~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHE---HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred eeccCCCcceEEEecCCcceecc---CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence 134689999999976543 335678899999999999999999999999999999999999999887766643
Q ss_pred HHHHhcCC-------------------CCCCC----------------------------ChHHHHHHHHhhh-CCCCCC
Q 003935 737 YAVANEGS-------------------RLEIP----------------------------EGPLGRLIADCWA-EPQERP 768 (785)
Q Consensus 737 ~~i~~~~~-------------------~~~ip----------------------------~~~L~~LI~~CL~-DP~kRP 768 (785)
..+..--. ++..+ ...+.+|+++||. ||.+|+
T Consensus 319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri 398 (415)
T KOG0671|consen 319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI 398 (415)
T ss_pred HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence 32211000 11100 0147789999999 999999
Q ss_pred CHHHHHHH
Q 003935 769 SCEEILSR 776 (785)
Q Consensus 769 S~~EIL~~ 776 (785)
|+.|+|.|
T Consensus 399 Tl~EAL~H 406 (415)
T KOG0671|consen 399 TLREALSH 406 (415)
T ss_pred cHHHHhcC
Confidence 99999976
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=292.96 Aligned_cols=236 Identities=34% Similarity=0.526 Sum_probs=188.3
Q ss_pred eEEeeeCcEE-EEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCceeEEEEEcccch
Q 003935 533 TRVGIGFFGE-VFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGS 610 (785)
Q Consensus 533 k~LG~G~fG~-VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~Ey~~gGS 610 (785)
+.+|.|+-|+ ||+|.++|+.||||.+... ...-..+||..|+.- .|||||++|+.-.+....|++.|.|. .+
T Consensus 515 eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~s 588 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYEGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CS 588 (903)
T ss_pred HHcccCCCCcEEEEEeeCCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hh
Confidence 4688998875 7999999999999997532 234557899999988 49999999999999999999999997 49
Q ss_pred hhHHHHhhcc-cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC---C--CeEEEEecCccccccCCCC--
Q 003935 611 LYHLIHLSGQ-KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---H--WTVKICDFGLSRIITDSPM-- 682 (785)
Q Consensus 611 L~dlL~~~~~-~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~---~--g~VKL~DFGLA~~l~~~~~-- 682 (785)
|.+++..... .....-...+.++.|+++||++||+.+||||||||.||||+. + .+++|+|||+++.+.....
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~ 668 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF 668 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh
Confidence 9999975311 111111445788999999999999999999999999999975 2 4789999999998865432
Q ss_pred -CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcCCCCC----CCChHHHHH
Q 003935 683 -RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLE----IPEGPLGRL 756 (785)
Q Consensus 683 -~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG-~~PF~~~~~~~~v~~i~~~~~~~~----ip~~~L~~L 756 (785)
...+..||-+|+|||.+....-+.++|||||||++|+.++| ..||.+....+. .|.+...... .++....+|
T Consensus 669 ~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d~eA~dL 746 (903)
T KOG1027|consen 669 SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPDCEAKDL 746 (903)
T ss_pred hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCchHHHHHH
Confidence 23456799999999999998888899999999999999987 779987644332 2333333222 122268899
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003935 757 IADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~ 776 (785)
|.+|+. +|..||++.+||.|
T Consensus 747 I~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 747 ISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred HHHhcCCCcccCCCHHHHhCC
Confidence 999999 99999999999975
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-28 Score=238.80 Aligned_cols=212 Identities=34% Similarity=0.540 Sum_probs=179.0
Q ss_pred eeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEc
Q 003935 529 LTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 606 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 606 (785)
|.+.+.||.|++|.||++... ++.+|+|.+...... ...+.+.+|++.++.++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 567889999999999999884 689999998765433 24678899999999999999999999999889999999999
Q ss_pred ccchhhHHHHhhccccc-chHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC-CCC
Q 003935 607 ELGSLYHLIHLSGQKKK-LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-MRD 684 (785)
Q Consensus 607 ~gGSL~dlL~~~~~~~~-Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~-~~~ 684 (785)
++++|.+++... .. +++..+..++.+++.++.+||+.+++|+||++.||+++.++.++|+|||++....... ...
T Consensus 80 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 80 EGGDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 999999998732 23 8899999999999999999999999999999999999999999999999998775432 112
Q ss_pred CCCCCCCcccCcccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCC
Q 003935 685 SSSAGTPEWMAPELI-RNEPFTEKCDIFSLGVIMWELCTLNRPWEG-VLPERVVYAVANEGS 744 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl-~~~~~s~ksDVWSLGvILyELLTG~~PF~~-~~~~~~v~~i~~~~~ 744 (785)
....++..|++||.+ ....++.++|+|+||+++++|++|+.||.. ..+...+...+..+.
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 345677889999998 667788899999999999999999999987 455544444444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=249.16 Aligned_cols=224 Identities=27% Similarity=0.405 Sum_probs=179.4
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEE--EECCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCc
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPR 598 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg--~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~ 598 (785)
+++.-+++..+..||+|+||.|-+- ..+|+..|+|.+...-. ....++.++|+.+..+. .+|.+|+|||.......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 4555567777889999999987655 45899999999865543 44567888999886555 79999999999999999
Q ss_pred eeEEEEEcccchhhHHHHh-hcccccchHHHHHHHHHHHHHHHHHHHh-cccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 599 LSMITEYMELGSLYHLIHL-SGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~-~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
.++.||.|.- +|..+... ...+..+++..+-+|+..+.+||+|||+ ..+||||+||+|||++.+|+||+||||.+-.
T Consensus 120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 9999999974 66655432 2356789999999999999999999997 5899999999999999999999999999988
Q ss_pred ccCCCCCCCCCCCCCcccCcccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCC
Q 003935 677 ITDSPMRDSSSAGTPEWMAPELIRN----EPFTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIP 749 (785)
Q Consensus 677 l~~~~~~~~~~~GT~~Y~APEvl~~----~~~s~ksDVWSLGvILyELLTG~~PF~~~~-~~~~v~~i~~~~~~~~ip 749 (785)
+.+.. ..+...|...|||||.+.. ..|+-|+||||||++++||.+++.||.... +-+.+.++.. ...+.+|
T Consensus 199 L~dSi-Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe-ep~P~Lp 274 (282)
T KOG0984|consen 199 LVDSI-AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE-EPSPQLP 274 (282)
T ss_pred ehhhh-HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc-CCCCCCc
Confidence 76642 2223567788999998853 468999999999999999999999998764 4455555443 3344444
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-29 Score=277.98 Aligned_cols=200 Identities=26% Similarity=0.435 Sum_probs=175.0
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChH------HHHHHHHHHHHHhhcC---CCceeeEeccc
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE------NMEDFCNEISILSRLR---HPNVILFLGAC 593 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~------~~e~f~~EI~iLk~L~---HPNIVkL~g~~ 593 (785)
++++|+..+.||.|+||.|+.+++ +...|+||.+.+.+.-.+ ..-..-.||+||..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 578899999999999999999988 456799999877654211 1224557999999997 99999999999
Q ss_pred cCCCceeEEEEEcc-cchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecC
Q 003935 594 TKPPRLSMITEYME-LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 672 (785)
Q Consensus 594 ~d~~~l~LV~Ey~~-gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFG 672 (785)
++++++|++||--. +.+|++++. -.+.+++..+..|+.||+.|+++||+.||||||||-+||.++.+|-+||+|||
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeecc
Confidence 99999999999754 568889887 45689999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCcccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCC
Q 003935 673 LSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT-EKCDIFSLGVIMWELCTLNRPWEG 729 (785)
Q Consensus 673 LA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s-~ksDVWSLGvILyELLTG~~PF~~ 729 (785)
.+...... ....+.||..|.|||++.+.+|- ..-|||++|++||.++....||+.
T Consensus 716 saa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 716 SAAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred chhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99876554 34578999999999999998885 567999999999999999999975
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=248.76 Aligned_cols=240 Identities=23% Similarity=0.381 Sum_probs=192.5
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccCC--Cce
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKP--PRL 599 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~--~~l 599 (785)
..++|.+.+++|+|.|++||.|.. ++.+++||+++. -..+.+.+|+.||..|. ||||++++++..++ ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 568899999999999999999974 788999999863 23467889999999997 99999999998775 457
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC-CCeEEEEecCcccccc
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRIIT 678 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~-~g~VKL~DFGLA~~l~ 678 (785)
.+++||+.+.+...+. ++++...++.++.+++.||.|||++||+|||+||.|++++. ...++|+|+|+|.++.
T Consensus 111 aLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 8999999987766554 36888899999999999999999999999999999999985 4579999999999876
Q ss_pred CCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHh-----------cCCC
Q 003935 679 DSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPW-EGVLPERVVYAVAN-----------EGSR 745 (785)
Q Consensus 679 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF-~~~~~~~~v~~i~~-----------~~~~ 745 (785)
... ...-.+.+..|-.||.+.. +.|+..-|+|||||+|..|+..+.|| .+.++...+.++.. ..+.
T Consensus 185 p~~-eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 185 PGK-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred CCc-eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 543 2234566778999999875 56899999999999999999999987 44444433333321 0111
Q ss_pred CCCC---------------------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 746 LEIP---------------------------EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 746 ~~ip---------------------------~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..++ ....-+|+..++. |-++|+|+.|.+.|
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 1111 1245678999999 99999999998875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=270.93 Aligned_cols=244 Identities=21% Similarity=0.353 Sum_probs=202.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC------CCceeeEeccccCCCc
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR------HPNVILFLGACTKPPR 598 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~------HPNIVkL~g~~~d~~~ 598 (785)
..|.+....|+|-|++|.+|.+ .|..||||+|..+.. -.+.=+.|+++|++|+ --|+++|+..|...++
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 5688888899999999999977 478999999965432 2345568999999996 3589999999999999
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC-CeEEEEecCccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRII 677 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~-g~VKL~DFGLA~~l 677 (785)
+|||||.+. .+|.++|+.-+.+..|....++.|++|++.||..|...||+|.||||+|||+++. ..+||||||.|...
T Consensus 509 LClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~ 587 (752)
T KOG0670|consen 509 LCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFA 587 (752)
T ss_pred eEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccc
Confidence 999999886 5999999988888889999999999999999999999999999999999999865 46899999999877
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----------
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---------- 747 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~---------- 747 (785)
..... +...-+..|.|||++.+-+|+...|+||+||+||||+||+.-|++.++..++..........+
T Consensus 588 ~enei--tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~ 665 (752)
T KOG0670|consen 588 SENEI--TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFK 665 (752)
T ss_pred ccccc--cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchh
Confidence 55432 223345579999999999999999999999999999999999999888776655432211111
Q ss_pred ------------------------------CC---------------Ch------HHHHHHHHhhh-CCCCCCCHHHHHH
Q 003935 748 ------------------------------IP---------------EG------PLGRLIADCWA-EPQERPSCEEILS 775 (785)
Q Consensus 748 ------------------------------ip---------------~~------~L~~LI~~CL~-DP~kRPS~~EIL~ 775 (785)
.| ++ .+.+|+..||. ||++|.|..+.|+
T Consensus 666 dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 666 DQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred hhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 01 11 36778999999 9999999999997
Q ss_pred H
Q 003935 776 R 776 (785)
Q Consensus 776 ~ 776 (785)
|
T Consensus 746 H 746 (752)
T KOG0670|consen 746 H 746 (752)
T ss_pred C
Confidence 6
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-29 Score=261.67 Aligned_cols=246 Identities=28% Similarity=0.393 Sum_probs=192.6
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC-----ceeE
Q 003935 529 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP-----RLSM 601 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~-----~l~L 601 (785)
..-.+.||.|+||.||.+.+ +|+.||+|.+..-..+-...+.+.+|+.+|...+|.|++..+++.+... .+|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 33457899999999999987 6999999987544333444678999999999999999999988765443 3678
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
++|.|.. +|..++- ....++...++-+++||++||+|||+.||.||||||.|+|++.+..+||||||+++.-....
T Consensus 135 ~TELmQS-DLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHh-hhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 8888763 6666654 45678999999999999999999999999999999999999999999999999998764332
Q ss_pred -CCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----------
Q 003935 682 -MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI----------- 748 (785)
Q Consensus 682 -~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i----------- 748 (785)
.+.+..+-|..|.|||++.+. .|+.+.||||.|||+.||+..+.-|....+.+.++.+...-..+.+
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 223344578899999999874 6899999999999999999999899887777766665432222211
Q ss_pred ----------CC-----------h---HHHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003935 749 ----------PE-----------G---PLGRLIADCWA-EPQERPSCEEILSRLL 778 (785)
Q Consensus 749 ----------p~-----------~---~L~~LI~~CL~-DP~kRPS~~EIL~~L~ 778 (785)
|+ . ..-.+...++. ||.+|.+.++.+.++-
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 10 0 12234555667 9999999999887753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=278.45 Aligned_cols=246 Identities=30% Similarity=0.507 Sum_probs=217.7
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
.++|.+..++|.|.||.||++.+ .+...|+|+++.... ....-+.+|+.+++.++|||||.++|.+.....++++|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 46788999999999999999976 688999999876543 33566778999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
|||.+|+|.+.-+ -.+.+++.++....++.+.|++|||+.|=+|||||-.|||+++.|.+|++|||.+..++.....
T Consensus 92 EycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK 168 (829)
T ss_pred EecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence 9999999999886 4578999999999999999999999999999999999999999999999999999888766555
Q ss_pred CCCCCCCCcccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC------hHHH
Q 003935 684 DSSSAGTPEWMAPELI---RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE------GPLG 754 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl---~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~------~~L~ 754 (785)
...+.||+.|||||+. +.+-|...+|||++|+...|+-.-+.|.-+.-+.+..+.....++.+..-. ..+.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh 248 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFH 248 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHH
Confidence 6688999999999976 355689999999999999999999999888888888888877777665433 2588
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003935 755 RLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 755 ~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
++++.|+. +|.+||+++.+|.|
T Consensus 249 ~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred HHHHHHhcCCCccCCChhhheec
Confidence 99999998 99999999988764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-26 Score=249.67 Aligned_cols=131 Identities=27% Similarity=0.378 Sum_probs=110.6
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-----C---CceeeEecccc
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-----H---PNVILFLGACT 594 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-----H---PNIVkL~g~~~ 594 (785)
+..+|.+.++||.|.|++||++.+ ..+.||+|+.+.. ....+..+.||.+|++++ | .+||+|++.|.
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 346899999999999999999987 5778999997543 233466788999999984 2 47999999996
Q ss_pred C----CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-cccccccCCCCcEEE
Q 003935 595 K----PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLV 660 (785)
Q Consensus 595 d----~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-~gIIHrDLKpsNILL 660 (785)
. +.+++||+|++ |.+|..++... ..+.++...+++|++||+.||.|||. .||||.||||+|||+
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 5 34699999998 56888888755 45679999999999999999999997 599999999999999
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-27 Score=246.81 Aligned_cols=242 Identities=25% Similarity=0.318 Sum_probs=193.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC------c
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------R 598 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------~ 598 (785)
.+|.-++.+|.|.- .|..+.+ .++.||+|.......+....+...+|..++..++|+||++++.+|.-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666677888888 6666644 6899999988666555555678889999999999999999999986554 4
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
.|+|||||.. +|...+. ..++-..+..+++|.+.|++|||+.||+||||||+||++..++.+||.|||+|+.-.
T Consensus 96 ~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 7999999974 7777765 346777889999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------
Q 003935 679 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------ 746 (785)
Q Consensus 679 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~------------ 746 (785)
.. ...+..+.|..|.|||++.+-.|.+.+||||+||++.||++|+.-|.+.+.-....++...-..+
T Consensus 170 ~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 170 TD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred cc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 43 45567788999999999998889999999999999999999999887654433333222111000
Q ss_pred -----------------CCCC--------------hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 -----------------EIPE--------------GPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 -----------------~ip~--------------~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+|+ +..++++.+||. ||++|.|+.++|.|
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0111 136788999998 99999999999976
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-26 Score=273.77 Aligned_cols=193 Identities=19% Similarity=0.168 Sum_probs=140.9
Q ss_pred hhcCC-CceeeEeccc-------cCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccccc
Q 003935 579 SRLRH-PNVILFLGAC-------TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 650 (785)
Q Consensus 579 k~L~H-PNIVkL~g~~-------~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIH 650 (785)
+.++| +||++++++| .+...+++++||+ +++|.+++.. ....+++.+++.++.||+.||+|||++||+|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~gIvH 103 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQGIVV 103 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 34556 6888888877 3334678889987 5599999962 2456999999999999999999999999999
Q ss_pred ccCCCCcEEEcCC-------------------CeEEEEecCccccccCCC----------------CCCCCCCCCCcccC
Q 003935 651 RDLKSANCLVNKH-------------------WTVKICDFGLSRIITDSP----------------MRDSSSAGTPEWMA 695 (785)
Q Consensus 651 rDLKpsNILLd~~-------------------g~VKL~DFGLA~~l~~~~----------------~~~~~~~GT~~Y~A 695 (785)
|||||+||||+.. +.+|++|||+++...... .......||+.|+|
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 9999999999654 445566666665321100 00112458889999
Q ss_pred ccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CChHHHHHHHHhhh-CCCCCCCHHH
Q 003935 696 PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI--PEGPLGRLIADCWA-EPQERPSCEE 772 (785)
Q Consensus 696 PEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i--p~~~L~~LI~~CL~-DP~kRPS~~E 772 (785)
||++.+..|+.++|||||||+||||++|..|+..... ....+......... .......++..||. +|.+||++.+
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~e 261 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSE 261 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHH
Confidence 9999999999999999999999999999888764321 12222111111111 11235678889999 9999999999
Q ss_pred HHHH
Q 003935 773 ILSR 776 (785)
Q Consensus 773 IL~~ 776 (785)
++++
T Consensus 262 il~h 265 (793)
T PLN00181 262 LLQS 265 (793)
T ss_pred Hhhc
Confidence 9875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-25 Score=213.84 Aligned_cols=159 Identities=23% Similarity=0.298 Sum_probs=127.9
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 688 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 688 (785)
|+|.++++. .+..+++.+++.++.||+.||+|||+.+ ||+|||++.++.+|+ ||++...... ...
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~ 65 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSR 65 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCC
Confidence 688888863 2456999999999999999999999998 999999999999999 9999876442 236
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCC-----CC---Ch--HHHHHH
Q 003935 689 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGSRLE-----IP---EG--PLGRLI 757 (785)
Q Consensus 689 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~-~~v~~i~~~~~~~~-----ip---~~--~L~~LI 757 (785)
||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+........ .+ .. .+.+++
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 889999999999999999999999999999999999999765432 22222222111110 00 11 488999
Q ss_pred HHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 758 ADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 758 ~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
.+||. +|.+||++.++++++.....
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHHH
Confidence 99999 99999999999999877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-23 Score=210.53 Aligned_cols=247 Identities=31% Similarity=0.470 Sum_probs=202.2
Q ss_pred eeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChH-HHHHHHHHHHHHhhcCCC-ceeeEeccccCCCceeEEEEEc
Q 003935 529 LTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE-NMEDFCNEISILSRLRHP-NVILFLGACTKPPRLSMITEYM 606 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~-~~e~f~~EI~iLk~L~HP-NIVkL~g~~~d~~~l~LV~Ey~ 606 (785)
|.+...||.|+|+.||++.+. ..+++|.+........ ....|.+|+.++..+.|+ +|+++++.+......+++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 678899999999999999887 7889999876655443 568899999999999988 7999999997777789999999
Q ss_pred ccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC-eEEEEecCccccccCCCC---
Q 003935 607 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITDSPM--- 682 (785)
Q Consensus 607 ~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g-~VKL~DFGLA~~l~~~~~--- 682 (785)
.++++.+++........++......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.+..+.....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS 160 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccc
Confidence 9999997665221112688999999999999999999999999999999999999988 799999999986654332
Q ss_pred ---CCCCCCCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcCCC---CCCC
Q 003935 683 ---RDSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVLP----ERVVYAVANEGSR---LEIP 749 (785)
Q Consensus 683 ---~~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvILyELLTG~~PF~~~~~----~~~v~~i~~~~~~---~~ip 749 (785)
......|+..|++||.+.+ ..+....|+|++|++++++++|..||..... ......+...... ....
T Consensus 161 ~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (384)
T COG0515 161 IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240 (384)
T ss_pred ccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccC
Confidence 2356789999999999987 5788999999999999999999999887763 4444444433322 1222
Q ss_pred C-------hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 750 E-------GPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 750 ~-------~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
. ..+.+++..|+. +|..|.+..+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 241 PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 2 257889999998 99999998887764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.8e-25 Score=226.97 Aligned_cols=231 Identities=21% Similarity=0.333 Sum_probs=175.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEecc-ccCCCceeEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGA-CTKPPRLSMI 602 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~-~~d~~~l~LV 602 (785)
+.|.+.+.||+|.||.+-++.+. ++.+++|.+..... ..++|.+|..---.| .|.||+.-|++ |+..+.+.++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 67899999999999999999884 67899998865433 357899998765556 49999988765 6777888999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEc--CCCeEEEEecCccccccCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN--KHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd--~~g~VKL~DFGLA~~l~~~ 680 (785)
+||++.|+|...+. ...+.+...+.++.|+++||.|+|++++||||||.+|||+- +..+|||||||+.+..+..
T Consensus 101 qE~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred eccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 99999999998774 24577888899999999999999999999999999999994 3458999999998765432
Q ss_pred CCCCCCCCCCCcccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhcCCCCCCCCh-
Q 003935 681 PMRDSSSAGTPEWMAPELIRNE-----PFTEKCDIFSLGVIMWELCTLNRPWEGV---LPERVVYAVANEGSRLEIPEG- 751 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~~-----~~s~ksDVWSLGvILyELLTG~~PF~~~---~~~~~v~~i~~~~~~~~ip~~- 751 (785)
. .....+..|.+||+.... ...+.+|+|.||+++|.++||..||... ++....+.....+..+..|..
T Consensus 177 V---~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F 253 (378)
T KOG1345|consen 177 V---KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF 253 (378)
T ss_pred e---hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh
Confidence 1 122335568899876432 3567899999999999999999999732 222222222333434444432
Q ss_pred -----HHHHHHHHhhh-CCCCC
Q 003935 752 -----PLGRLIADCWA-EPQER 767 (785)
Q Consensus 752 -----~L~~LI~~CL~-DP~kR 767 (785)
.+..+.++-+. +|++|
T Consensus 254 ~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 254 NPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred cccCHHHHHHHHHhcCCccccc
Confidence 24455566666 78777
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=220.54 Aligned_cols=251 Identities=19% Similarity=0.235 Sum_probs=194.9
Q ss_pred CeeEeeEEeeeCcEEEEEEEECC---eEEEEEEeeccccChHHHHHHHHHHHHHhhcCC----CceeeEeccc-cCCCce
Q 003935 528 ELTVGTRVGIGFFGEVFRGIWNG---TDVAIKVFLEQDLTAENMEDFCNEISILSRLRH----PNVILFLGAC-TKPPRL 599 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~~g---~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~H----PNIVkL~g~~-~d~~~l 599 (785)
.|.+.++||+|+||.||.|.... ..+|+|+-........ ..+..|+.++..+.. +++..+++.. ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 89999999999999999998743 4688888654432221 156788999888873 6888888888 467778
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC-----CeEEEEecCcc
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-----WTVKICDFGLS 674 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~-----g~VKL~DFGLA 674 (785)
++||+.+ |.+|.++..... .+.++..++..++.|++.+|++||+.|++||||||.|++++.. ..++|.|||++
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 9999877 679999886443 6789999999999999999999999999999999999999855 46999999999
Q ss_pred c--cccCCCC------C--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 003935 675 R--IITDSPM------R--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS 744 (785)
Q Consensus 675 ~--~l~~~~~------~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~ 744 (785)
+ .+..... . .....||..|+++.+..+...+.+.|+||++.++.+++.|..||.................
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8 3322111 0 1235599999999999999999999999999999999999999977654332332222111
Q ss_pred CC------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 745 RL------EIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 745 ~~------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
.. ..++..+..+...+-. +...+|....+...|++...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 11 1233456777777766 89999999999998876543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-24 Score=235.33 Aligned_cols=192 Identities=29% Similarity=0.438 Sum_probs=161.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE-----CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccCCCcee
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLS 600 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~ 600 (785)
..|.+.++||.|.|++||++.+ ..+.||+|.+..... ...+.+|+++|..+. +.||+++.+++..++...
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 5688899999999999999954 356899998865443 345889999999995 999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEc-CCCeEEEEecCccccccC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKICDFGLSRIITD 679 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd-~~g~VKL~DFGLA~~l~~ 679 (785)
+|+||++...-.++.. .++...++.+++.++.||+++|.+|||||||||.|+|.+ ..++-.|+|||+|.....
T Consensus 112 ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred EEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 9999999988888875 467889999999999999999999999999999999997 456788999999972210
Q ss_pred C---------------C-------------------C----------CCCCCCCCCcccCcccccc-CCCCchhhHHHHH
Q 003935 680 S---------------P-------------------M----------RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLG 714 (785)
Q Consensus 680 ~---------------~-------------------~----------~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLG 714 (785)
. . + ......||++|.|||++.. ...+.++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 0 0 0 0013469999999999865 4568899999999
Q ss_pred HHHHHHHhCCCCCC
Q 003935 715 VIMWELCTLNRPWE 728 (785)
Q Consensus 715 vILyELLTG~~PF~ 728 (785)
||++-++++..||-
T Consensus 266 VI~Lslls~~~PFf 279 (418)
T KOG1167|consen 266 VILLSLLSRRYPFF 279 (418)
T ss_pred ceeehhhccccccc
Confidence 99999999999984
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=217.92 Aligned_cols=250 Identities=31% Similarity=0.616 Sum_probs=213.9
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
.++++++.+..+|.....|+.|+|.|+|..+++|++.........-.+|..|.-.|+.+.||||+.+++.|..++++.++
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred CcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 45677788889999999999999999999999999988777776678899999999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc--cccccCCCCcEEEcCCCeEEEE--ecCcccccc
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKIC--DFGLSRIIT 678 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~g--IIHrDLKpsNILLd~~g~VKL~--DFGLA~~l~ 678 (785)
..||+.|+|+..++.. .+-..+..++.+++.++++|++|||+.. |----|....++++++.+.+|. |--++..
T Consensus 266 sq~mp~gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq-- 342 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-- 342 (448)
T ss_pred eeeccchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee--
Confidence 9999999999999843 3445788899999999999999999974 4444588899999998877664 3222211
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCC---chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCh---H
Q 003935 679 DSPMRDSSSAGTPEWMAPELIRNEPFT---EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---P 752 (785)
Q Consensus 679 ~~~~~~~~~~GT~~Y~APEvl~~~~~s---~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~~---~ 752 (785)
.....-.|.|++||.+..++-+ .++|+|||.++||||.|...||.+.++.+.-.++.-++.+..+|+. .
T Consensus 343 -----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~h 417 (448)
T KOG0195|consen 343 -----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRH 417 (448)
T ss_pred -----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHH
Confidence 1234456899999999887654 4789999999999999999999999999999999999999999976 4
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
..+|+.-|+. ||.+||.+..|+--|+++
T Consensus 418 m~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 418 MNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred HHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 7889999999 999999999998887765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=219.93 Aligned_cols=163 Identities=20% Similarity=0.201 Sum_probs=128.4
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE---CCeEEEEEEeecccc---ChHHHHHHHHHHHHHhhcCCCceee-EeccccCCC
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDL---TAENMEDFCNEISILSRLRHPNVIL-FLGACTKPP 597 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~---~g~~VAVKil~~~~~---~~~~~e~f~~EI~iLk~L~HPNIVk-L~g~~~d~~ 597 (785)
-.+.|.+.+.||+|+||+||+|.+ +++.+|||++..... .....+.|.+|+++|+.++|+||+. ++++ +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 457899999999999999999976 467789998753311 2234567899999999999999985 5442 4
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccC-CCCcEEEcCCCeEEEEecCcccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL-KSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDL-KpsNILLd~~g~VKL~DFGLA~~ 676 (785)
..|+||||++|++|... . ... ...++.|+++||.|||++||+|||| ||+|||++.++.+||+|||+++.
T Consensus 92 ~~~LVmE~~~G~~L~~~-~---~~~------~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-R---PHG------DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred CcEEEEEccCCCCHHHh-C---ccc------hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 57999999999999632 1 111 1467899999999999999999999 99999999999999999999997
Q ss_pred ccCCCCCC--------CCCCCCCcccCcccccc
Q 003935 677 ITDSPMRD--------SSSAGTPEWMAPELIRN 701 (785)
Q Consensus 677 l~~~~~~~--------~~~~GT~~Y~APEvl~~ 701 (785)
+....... ....+++.|+|||.+..
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 75432111 24567888999998864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7e-22 Score=230.98 Aligned_cols=247 Identities=23% Similarity=0.326 Sum_probs=185.8
Q ss_pred EeeEEeeeCcEEEEEEEE--CCeEEEEEEeec---cccCh-HHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 531 VGTRVGIGFFGEVFRGIW--NGTDVAIKVFLE---QDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 531 i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~---~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
-...+|.|++|.|+.... ....++.|.+.. ..... .....+..|..+-..+.|||++..+..+.+....+..||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 456799999997776654 233334443221 11222 222236678888888999999998888888777777799
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC---
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP--- 681 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~--- 681 (785)
||++ +|+.++. ....++...+..++.|++.|++|||..||.|||+|++|++++.+|.+||+|||.+..+....
T Consensus 402 ~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 402 YCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred cccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 9999 9999886 33578889999999999999999999999999999999999999999999999998765432
Q ss_pred -CCCCCCCCCCcccCccccccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHh-cCCCCCCC--------
Q 003935 682 -MRDSSSAGTPEWMAPELIRNEPFTE-KCDIFSLGVIMWELCTLNRPWEGVLPERVVY-AVAN-EGSRLEIP-------- 749 (785)
Q Consensus 682 -~~~~~~~GT~~Y~APEvl~~~~~s~-ksDVWSLGvILyELLTG~~PF~~~~~~~~v~-~i~~-~~~~~~ip-------- 749 (785)
......+|+..|+|||++.+..|++ ..||||.|++++.|++|+.||.........+ .... ........
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 557 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL 557 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence 2345678999999999999999986 5799999999999999999997654433321 1111 11111111
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHH--HHhhh
Q 003935 750 EGPLGRLIADCWA-EPQERPSCEEILSR--LLDCE 781 (785)
Q Consensus 750 ~~~L~~LI~~CL~-DP~kRPS~~EIL~~--L~~l~ 781 (785)
+..-+.+|.++++ ||.+|.|+++|++. ++.+.
T Consensus 558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 558 PRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred hhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 1235678999999 99999999999964 44443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.3e-22 Score=233.03 Aligned_cols=241 Identities=23% Similarity=0.302 Sum_probs=186.7
Q ss_pred CeeEeeEEeeeCcEEEEEEEECCeEEEEEEeecccc--ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDL--TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~--~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
+|...+.||.+.|=+|.+++++...|+||++.++.. .-...++-+.|+. ...++|||.+.+.-+...+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 788889999999999999998666699999977653 2222333444455 5556899999999998888889999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc---CC--
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT---DS-- 680 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~---~~-- 680 (785)
+.+ +|+|.+. ..+.+...+.+.|+.|++.||..||..||+|||||.+|||++.-..+.|+||..-+... +.
T Consensus 103 vkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 103 VKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred Hhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 986 8999886 56678888999999999999999999999999999999999999999999998765431 11
Q ss_pred --CCCCCCCCCCCcccCcccccc----------CC-CCchhhHHHHHHHHHHHHhC-CCCCCC-----------CChHHH
Q 003935 681 --PMRDSSSAGTPEWMAPELIRN----------EP-FTEKCDIFSLGVIMWELCTL-NRPWEG-----------VLPERV 735 (785)
Q Consensus 681 --~~~~~~~~GT~~Y~APEvl~~----------~~-~s~ksDVWSLGvILyELLTG-~~PF~~-----------~~~~~~ 735 (785)
.+...+......|+|||.+.. .+ .+++.||||+||+++||++- ++||.- ..++.+
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence 111223334457999998753 12 57789999999999999874 666631 111111
Q ss_pred HHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 736 VYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 736 v~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
+. .+++..+++++..|++ ||.+|.++++.|+.-+-..|
T Consensus 259 Le---------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F 297 (1431)
T KOG1240|consen 259 LE---------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF 297 (1431)
T ss_pred HH---------hCcCccHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence 11 2455579999999999 99999999999998655444
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-20 Score=198.04 Aligned_cols=211 Identities=19% Similarity=0.301 Sum_probs=175.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~ 603 (785)
-.|.++++||+|+||+.+.|+. ++..||||.-..+.. .-++..|...++.|. .++|-..|-+-.+..+-.||+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 4688999999999999999965 899999998543322 245677888888885 789999888888888888999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC-----CeEEEEecCcccccc
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-----WTVKICDFGLSRIIT 678 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~-----g~VKL~DFGLA~~l~ 678 (785)
|.+ |-+|.|+..-. ++.++.+++..++.|++.-++|+|++.+|.|||||+|+||... ..|.|+|||+|+.+.
T Consensus 104 dLL-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhh-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 987 67999988754 4689999999999999999999999999999999999999743 468999999999887
Q ss_pred CCCCC-------CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhcCC
Q 003935 679 DSPMR-------DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV---LPERVVYAVANEGS 744 (785)
Q Consensus 679 ~~~~~-------~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~---~~~~~v~~i~~~~~ 744 (785)
++... .....||.+||+-....+..-+.+-|+=|||-++++.+-|..||.+. +..+.+++|-..+.
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr 256 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR 256 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence 65322 23457999999999888888899999999999999999999999875 45555555544433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.1e-20 Score=189.85 Aligned_cols=248 Identities=18% Similarity=0.275 Sum_probs=188.7
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCC-CceeeEeccccCCCcee
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH-PNVILFLGACTKPPRLS 600 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~H-PNIVkL~g~~~d~~~l~ 600 (785)
+...+|.++++||.|+||.+|.|.. .|..||||+-...... -++.-|..+.+.|++ ..|..+..+..+...-.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 3457899999999999999999976 7999999985443322 346678999999874 66777777788888889
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC---CeEEEEecCccccc
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH---WTVKICDFGLSRII 677 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~---g~VKL~DFGLA~~l 677 (785)
+||+.+ |.+|.+++... .+.++..+++.++-|++.-++|+|.+++|||||||+|+|..-+ ..+.|+|||+|+.+
T Consensus 88 lVMdLL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeecc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 999987 67999988754 4679999999999999999999999999999999999999643 46899999999987
Q ss_pred cCCCC-------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCCCCC
Q 003935 678 TDSPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE---RVVYAVANEGSRLE 747 (785)
Q Consensus 678 ~~~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~---~~v~~i~~~~~~~~ 747 (785)
.+... ......||.+|.+-....+..-+.+.|+=|+|.+|.++.-|..||.+.... +.+..+........
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 54321 124567999999888777777788999999999999999999999987543 33444444333332
Q ss_pred CC------ChHHHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003935 748 IP------EGPLGRLIADCWA-EPQERPSCEEILSRLL 778 (785)
Q Consensus 748 ip------~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~ 778 (785)
+. +.++.-.+.-|-. --.+-|...-+.+.++
T Consensus 245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 21 1234445555655 4445566555544443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.3e-20 Score=187.47 Aligned_cols=140 Identities=17% Similarity=0.134 Sum_probs=107.6
Q ss_pred eeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHH------------------------HHHHHHHHHHHhhcCCCce
Q 003935 532 GTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAEN------------------------MEDFCNEISILSRLRHPNV 586 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~------------------------~e~f~~EI~iLk~L~HPNI 586 (785)
...||+|+||.||+|.. +|+.||||++......... ......|+.++..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999987 6899999998654321111 1122359999999987766
Q ss_pred eeEeccccCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHH-HhcccccccCCCCcEEEcCCCe
Q 003935 587 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI-HRMKIVHRDLKSANCLVNKHWT 665 (785)
Q Consensus 587 VkL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yL-Hs~gIIHrDLKpsNILLd~~g~ 665 (785)
.....+.. ...++||||++++++..... ....++...+..++.|++.+|.|| |+.||+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 43322211 22489999999987765432 235688999999999999999999 799999999999999998 478
Q ss_pred EEEEecCccccc
Q 003935 666 VKICDFGLSRII 677 (785)
Q Consensus 666 VKL~DFGLA~~l 677 (785)
++|+|||++...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.7e-21 Score=218.48 Aligned_cols=221 Identities=25% Similarity=0.379 Sum_probs=183.2
Q ss_pred EeeeCcEEEEEEE-----ECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccCCCceeEEEEEccc
Q 003935 535 VGIGFFGEVFRGI-----WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 535 LG~G~fG~VYkg~-----~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
+|+|.||.|+++. +.|..||+|++.+.............|..++..++ ||.+|++...++.+...+++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7899999999763 35778999998776553333335567888888887 99999999999999999999999999
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 688 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 688 (785)
|.|...+. +...+++.....+...++-+++++|+.+|+|||+|++||+++.+|++++.|||+++..-.... .|
T Consensus 82 g~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----~c 154 (612)
T KOG0603|consen 82 GDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----AC 154 (612)
T ss_pred chhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----cc
Confidence 99998876 566788888899999999999999999999999999999999999999999999988755432 29
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CC
Q 003935 689 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA-EP 764 (785)
Q Consensus 689 GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP 764 (785)
||..|||||+++ ......|.||||++++||+||..||.. ++...|.... +.+|. ...+.++..++. +|
T Consensus 155 gt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~--~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 155 GTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE--LEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred cchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc--cCCchhhhHHHHHHHHHHHhhCH
Confidence 999999999999 467889999999999999999999998 4444454422 22332 247778888887 89
Q ss_pred CCCCCH
Q 003935 765 QERPSC 770 (785)
Q Consensus 765 ~kRPS~ 770 (785)
..|--.
T Consensus 227 ~nrLg~ 232 (612)
T KOG0603|consen 227 ENRLGA 232 (612)
T ss_pred HHHhcc
Confidence 888543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.5e-20 Score=190.99 Aligned_cols=171 Identities=17% Similarity=0.108 Sum_probs=133.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChH-HHHH------HHHHHHHHhhcCCCceeeEeccccCC---
Q 003935 527 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE-NMED------FCNEISILSRLRHPNVILFLGACTKP--- 596 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~-~~e~------f~~EI~iLk~L~HPNIVkL~g~~~d~--- 596 (785)
.+|++.+.||.|+||.||+...++..+|||++.......+ ..+. +.+|+..+.++.|++|..+..++...
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~ 110 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERK 110 (232)
T ss_pred CceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccc
Confidence 6899999999999999999877788999999976544332 2233 57899999999999999988875533
Q ss_pred -----CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEec
Q 003935 597 -----PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 671 (785)
Q Consensus 597 -----~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DF 671 (785)
...+++|||++|.+|.++.. +++ ....+++.+|..||+.|++|||+||+||+++.++ ++|+||
T Consensus 111 ~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 111 TLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred cccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 35799999999999987642 222 2456999999999999999999999999999988 999999
Q ss_pred CccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHH
Q 003935 672 GLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELC 721 (785)
Q Consensus 672 GLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELL 721 (785)
|........... ..++....|..++|+|+||+++..+.
T Consensus 179 g~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 988654321100 11344455777999999999887654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-19 Score=190.76 Aligned_cols=233 Identities=22% Similarity=0.291 Sum_probs=150.2
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCC----------CceeeEeccc-
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRH----------PNVILFLGAC- 593 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~H----------PNIVkL~g~~- 593 (785)
.+..+..||.|+++.||.+++ +|+.+|||++..... .....+.+.+|.-....+.+ -.++.-++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 466788999999999999999 479999999855443 23346777777755555322 1111111111
Q ss_pred --------cCC---C-----ceeEEEEEcccchhhHHHHhh---c-ccccchHHHHHHHHHHHHHHHHHHHhcccccccC
Q 003935 594 --------TKP---P-----RLSMITEYMELGSLYHLIHLS---G-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL 653 (785)
Q Consensus 594 --------~d~---~-----~l~LV~Ey~~gGSL~dlL~~~---~-~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDL 653 (785)
... . +.+++|+-+. ++|.+++... . ....+....+..+..|+++.+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 111 1 2456777664 5777765421 1 1234556666778899999999999999999999
Q ss_pred CCCcEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCcccccc--------CCCCchhhHHHHHHHHHHHHhCCC
Q 003935 654 KSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN--------EPFTEKCDIFSLGVIMWELCTLNR 725 (785)
Q Consensus 654 KpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~--------~~~s~ksDVWSLGvILyELLTG~~ 725 (785)
+|+|++++.+|.++|+||+.....+.... ....+..|.+||.... -.++.+.|.|+||+++|.|+||..
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYR---CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEE---GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceee---ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999999999999988766543211 1233477999997744 257889999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCC
Q 003935 726 PWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQER 767 (785)
Q Consensus 726 PF~~~~~~~~v~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kR 767 (785)
||....+...... .-.... .+ ++.++.||..+++ ||.+|
T Consensus 249 Pf~~~~~~~~~~~-~f~~C~-~~-Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW-DFSRCR-DM-PEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG-GGTTSS-----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc-cchhcC-Cc-CHHHHHHHHHHccCCcccC
Confidence 9986544322221 111222 23 4569999999999 99887
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.2e-19 Score=179.39 Aligned_cols=142 Identities=15% Similarity=0.134 Sum_probs=110.3
Q ss_pred eeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccCh----------------------H--HHHHHHHHHHHHhhcCCCce
Q 003935 532 GTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTA----------------------E--NMEDFCNEISILSRLRHPNV 586 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~----------------------~--~~e~f~~EI~iLk~L~HPNI 586 (785)
...||+|+||.||+|.+ +|+.||||++....... . ....+..|...+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999987 59999999987653210 0 01234578999999999887
Q ss_pred eeEeccccCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-cccccccCCCCcEEEcCCCe
Q 003935 587 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWT 665 (785)
Q Consensus 587 VkL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-~gIIHrDLKpsNILLd~~g~ 665 (785)
.....+.... .++||||++|+++..... ....++...+..++.|++.++.+||+ .||+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 5433332222 489999999886543321 22457788899999999999999999 9999999999999999 789
Q ss_pred EEEEecCccccccC
Q 003935 666 VKICDFGLSRIITD 679 (785)
Q Consensus 666 VKL~DFGLA~~l~~ 679 (785)
++|+|||++.....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=178.96 Aligned_cols=187 Identities=18% Similarity=0.108 Sum_probs=140.7
Q ss_pred eEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChH--HHHHHHHHHHHHhhcC-CCceeeEeccccCCCceeEEEEEc
Q 003935 530 TVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE--NMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEYM 606 (785)
Q Consensus 530 ~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~--~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~Ey~ 606 (785)
.+...|++|+||+||.+...+.+++.+.+........ ....|.+|+++|++|. |++|.+++++ ...+++|||+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 3567899999999998877888988887754443211 1235789999999995 5888888886 3479999999
Q ss_pred ccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccC-CCCcEEEcCCCeEEEEecCccccccCCCCC--
Q 003935 607 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL-KSANCLVNKHWTVKICDFGLSRIITDSPMR-- 683 (785)
Q Consensus 607 ~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDL-KpsNILLd~~g~VKL~DFGLA~~l~~~~~~-- 683 (785)
.|.+|..... .. ...++.|++.+|+++|++||+|||| ||.|||++.++.++|+|||++.........
T Consensus 81 ~G~~L~~~~~----~~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 81 AGAAMYQRPP----RG------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred cCccHHhhhh----hh------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 9999875432 11 1357889999999999999999999 799999999999999999999855432210
Q ss_pred --C---------CCCCCCCcccCccccccC-CCC-chhhHHHHHHHHHHHHhCCCCCCCC
Q 003935 684 --D---------SSSAGTPEWMAPELIRNE-PFT-EKCDIFSLGVIMWELCTLNRPWEGV 730 (785)
Q Consensus 684 --~---------~~~~GT~~Y~APEvl~~~-~~s-~ksDVWSLGvILyELLTG~~PF~~~ 730 (785)
. .-...++.|++|+.-.-- ..+ ...+.++.|+-+|.++|+..|.-+.
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 011256777777654321 223 5678999999999999999986543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=209.12 Aligned_cols=243 Identities=20% Similarity=0.269 Sum_probs=186.2
Q ss_pred ccccccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC---CCceeeEeccc
Q 003935 518 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR---HPNVILFLGAC 593 (785)
Q Consensus 518 ~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~---HPNIVkL~g~~ 593 (785)
+..+.++..+.|.|.+.||+|+||+||+|.. +|+.||||+=...... +|.-=.+++.+|+ -+.|.++..++
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~ 763 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW-----EFYICLQVMERLKPQMLPSIMHISSAH 763 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce-----eeeehHHHHHhhchhhhcchHHHHHHH
Confidence 3455667778999999999999999999976 6899999985443321 1222334455555 34566666666
Q ss_pred cCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEc-------CCCeE
Q 003935 594 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-------KHWTV 666 (785)
Q Consensus 594 ~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd-------~~g~V 666 (785)
.-.+.-++|+||.+.|+|.+++. ..+.+++..+..++.|++..++.||..+|||+||||+|+||. ..--+
T Consensus 764 ~~~~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 764 VFQNASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred ccCCcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccce
Confidence 77777899999999999999996 678899999999999999999999999999999999999995 23468
Q ss_pred EEEecCcccccc--CCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 003935 667 KICDFGLSRIIT--DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS 744 (785)
Q Consensus 667 KL~DFGLA~~l~--~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~ 744 (785)
+|+|||.+..+. .........++|-.+-.+|+..+.++++.+|.|.|..+++-|+.|++-= ...+.
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------~~~g~ 908 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------VKNGS 908 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------hcCCc
Confidence 999999987653 2233455678899999999999999999999999999999999997521 11122
Q ss_pred CCCCC--------ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 745 RLEIP--------EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 745 ~~~ip--------~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
...+. .+.+.+++..+|+ |-..=|...+|...++..
T Consensus 909 ~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~ 953 (974)
T KOG1166|consen 909 SWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEV 953 (974)
T ss_pred ceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHH
Confidence 22111 2245667777777 555567777777776654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-18 Score=187.53 Aligned_cols=192 Identities=22% Similarity=0.325 Sum_probs=140.3
Q ss_pred CCCceeeEeccccC---------------------------CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHH
Q 003935 582 RHPNVILFLGACTK---------------------------PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 634 (785)
Q Consensus 582 ~HPNIVkL~g~~~d---------------------------~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~ 634 (785)
+|||||++.++|.+ +..+|+||.-.+. +|..++- ....+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh----cCCCchHHHHHHHH
Confidence 59999999988742 2357899987764 8888885 23466677788999
Q ss_pred HHHHHHHHHHhcccccccCCCCcEEEc--CCC--eEEEEecCccccccCCC----C--CCCCCCCCCcccCccccccCCC
Q 003935 635 DICRGLMCIHRMKIVHRDLKSANCLVN--KHW--TVKICDFGLSRIITDSP----M--RDSSSAGTPEWMAPELIRNEPF 704 (785)
Q Consensus 635 QIa~AL~yLHs~gIIHrDLKpsNILLd--~~g--~VKL~DFGLA~~l~~~~----~--~~~~~~GT~~Y~APEvl~~~~~ 704 (785)
|+++|+.|||++||.|||+|.+|||+. +++ .+.|+|||++---.... + ..-...|....||||+....+-
T Consensus 349 QlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 349 QLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 999999999999999999999999993 333 67899999874332211 1 1223457788999999875321
Q ss_pred ------CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHH
Q 003935 705 ------TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEIL 774 (785)
Q Consensus 705 ------s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPS~~EIL 774 (785)
-.|+|.|+.|.+.||+++...||+......+-..-..+...+.+|+ ..+++|+..+++ ||++|++..-..
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 2489999999999999999999987333222222223333444443 358999999999 999999877665
Q ss_pred HHHH
Q 003935 775 SRLL 778 (785)
Q Consensus 775 ~~L~ 778 (785)
..|.
T Consensus 509 Nvl~ 512 (598)
T KOG4158|consen 509 NVLN 512 (598)
T ss_pred hHHH
Confidence 5543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-17 Score=168.10 Aligned_cols=136 Identities=25% Similarity=0.346 Sum_probs=114.6
Q ss_pred eEEeeeCcEEEEEEEECCeEEEEEEeeccccChH------HHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEc
Q 003935 533 TRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE------NMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 606 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~------~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 606 (785)
+.||+|++|.||+|.+.|..+++|+......... ....+.+|+.++..+.|++|.....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5799999999999999999999998754332211 1246788999999999999877776766777889999999
Q ss_pred ccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 607 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 607 ~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
+|++|.+++... .+ ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999988622 11 7788999999999999999999999999999999 78999999999865
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=189.66 Aligned_cols=202 Identities=37% Similarity=0.659 Sum_probs=161.3
Q ss_pred HhhcCCCceeeEeccccCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccc-ccccCCCC
Q 003935 578 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI-VHRDLKSA 656 (785)
Q Consensus 578 Lk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gI-IHrDLKps 656 (785)
|+.+.|.|+.+|+|.+.+++..+.|.+||..|+|.+.+.. ....+++.....++.+|+.||+|||.-.| +|+.++..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 4578999999999999999999999999999999999973 45678999999999999999999998655 99999999
Q ss_pred cEEEcCCCeEEEEecCccccccCC--CCCCCCCCCCCcccCccccccCC-------CCchhhHHHHHHHHHHHHhCCCCC
Q 003935 657 NCLVNKHWTVKICDFGLSRIITDS--PMRDSSSAGTPEWMAPELIRNEP-------FTEKCDIFSLGVIMWELCTLNRPW 727 (785)
Q Consensus 657 NILLd~~g~VKL~DFGLA~~l~~~--~~~~~~~~GT~~Y~APEvl~~~~-------~s~ksDVWSLGvILyELLTG~~PF 727 (785)
|++++....+||+|||+....... ........-..-|.|||.+.... .+.++|+||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998876431 11111222345699999997641 466799999999999999999999
Q ss_pred CC----CChHHHHHHHHhcCC---CCCCCC-----hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 728 EG----VLPERVVYAVANEGS---RLEIPE-----GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 728 ~~----~~~~~~v~~i~~~~~---~~~ip~-----~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
.. ..+.+++..+...+. ++.+.. ..+..++..||. +|.+||++++|-..++.+.
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 75 233456655544233 222221 147789999999 9999999999998877653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.9e-18 Score=199.84 Aligned_cols=200 Identities=28% Similarity=0.397 Sum_probs=150.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|..++.|-.|+||-||.+.++ .+.+|+|+ +++++-.. + ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~lilR------n---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLILR------N---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccchhhh------c---cccccCCccee-----------------
Confidence 56778899999999999999775 77899955 33322111 0 23333344433
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC----
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS---- 680 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~---- 680 (785)
|+-..+++ .-+.++... +.+++|||+.||+|||+||+|++|+.-|++|+.|||+++.....
T Consensus 136 ----gDc~tllk---~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ----GDCATLLK---NIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ----chhhhhcc---cCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 44444444 334455443 77999999999999999999999999999999999998754211
Q ss_pred -----------CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003935 681 -----------PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 749 (785)
Q Consensus 681 -----------~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip 749 (785)
.......||||.|.|||++..+-|...+|+|++|+|+||.+.|..||.+.++++++..++......+-.
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE 280 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence 112345689999999999999889999999999999999999999999999999988877544332211
Q ss_pred ----ChHHHHHHHHhhh-CCCCCC
Q 003935 750 ----EGPLGRLIADCWA-EPQERP 768 (785)
Q Consensus 750 ----~~~L~~LI~~CL~-DP~kRP 768 (785)
..+.++++..++. +|..|-
T Consensus 281 dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 281 DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred CcCCCHHHHHHHHHHHHhChHhhc
Confidence 2258899999998 999983
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=3e-17 Score=164.32 Aligned_cols=132 Identities=27% Similarity=0.343 Sum_probs=108.0
Q ss_pred EeeeCcEEEEEEEECCeEEEEEEeeccccCh------HHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEccc
Q 003935 535 VGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA------ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 535 LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~------~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
||+|+||.||+|.+.+..+++|+........ .....+.+|+.++..++|+++.....++......+++|||++|
T Consensus 2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g 81 (199)
T TIGR03724 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG 81 (199)
T ss_pred CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence 7999999999999999999999975433211 1235677899999999988765544445556668999999999
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
++|.+++... .. .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++...
T Consensus 82 ~~l~~~~~~~---~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 82 KPLKDVIEEG---ND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ccHHHHHhhc---HH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999887521 11 7899999999999999999999999999999 789999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.7e-17 Score=169.39 Aligned_cols=134 Identities=15% Similarity=0.206 Sum_probs=103.9
Q ss_pred eeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-----CCCceeeEeccccCCC---c-eeEE
Q 003935 532 GTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-----RHPNVILFLGACTKPP---R-LSMI 602 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-----~HPNIVkL~g~~~d~~---~-l~LV 602 (785)
.+.||+|+|+.||....++.. +||++...... ..+.+.+|+.+++.+ .||||++++|+++++. . +.+|
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEECCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 467999999999963334444 68988654322 346789999999999 5799999999998873 3 3378
Q ss_pred EEE--cccchhhHHHHhhcccccchHHHHHHHHHHHHHHH-HHHHhcccccccCCCCcEEEcC----CCeEEEEecCcc
Q 003935 603 TEY--MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL-MCIHRMKIVHRDLKSANCLVNK----HWTVKICDFGLS 674 (785)
Q Consensus 603 ~Ey--~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL-~yLHs~gIIHrDLKpsNILLd~----~g~VKL~DFGLA 674 (785)
+|| +.+++|.+++.. ..+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||+.+
T Consensus 84 ~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999 558999999963 235555 35678888887 9999999999999999999974 348999994444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.6e-17 Score=169.15 Aligned_cols=144 Identities=19% Similarity=0.193 Sum_probs=111.5
Q ss_pred CeeEeeEEeeeCcEEEEEEE-E--CCeEEEEEEeeccccCh----------------------HHHHHHHHHHHHHhhcC
Q 003935 528 ELTVGTRVGIGFFGEVFRGI-W--NGTDVAIKVFLEQDLTA----------------------ENMEDFCNEISILSRLR 582 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~-~--~g~~VAVKil~~~~~~~----------------------~~~e~f~~EI~iLk~L~ 582 (785)
-|.+.+.||+|+||.||+|. + +|+.||||++....... .....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46788999999999999998 3 68999999986543210 01134568999999997
Q ss_pred CCc--eeeEeccccCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc-cccccCCCCcEE
Q 003935 583 HPN--VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK-IVHRDLKSANCL 659 (785)
Q Consensus 583 HPN--IVkL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~g-IIHrDLKpsNIL 659 (785)
+.+ +.+++++ ...++||||+.+++|..... ....+....+..++.|++.+|.+||+.| |+|+||||+||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 533 3344443 23589999999988876542 2334566677899999999999999999 999999999999
Q ss_pred EcCCCeEEEEecCccccccC
Q 003935 660 VNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 660 Ld~~g~VKL~DFGLA~~l~~ 679 (785)
++ ++.++|+|||.+.....
T Consensus 182 i~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EE-CCCEEEEEChhhhccCC
Confidence 99 88999999999875543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=183.86 Aligned_cols=137 Identities=22% Similarity=0.302 Sum_probs=113.8
Q ss_pred eeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccCh------HHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 529 LTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA------ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~------~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
|...+.||+|+||+||+|.+.+..+++|+........ ...+.+.+|+.+++.++|++|+..+.++......++|
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 4557899999999999999887777777643322111 1235688999999999999998877777777778999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
|||+++++|.+++. ....++.|++.+|.|||+.||+||||||+|||+ .++.++|+|||+++..
T Consensus 415 ~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 415 MEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999998874 246789999999999999999999999999999 6789999999999653
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=3e-16 Score=158.23 Aligned_cols=139 Identities=21% Similarity=0.246 Sum_probs=108.3
Q ss_pred CeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccCh--------------------HHHHHHHHHHHHHhhcCCCc-
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTA--------------------ENMEDFCNEISILSRLRHPN- 585 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~--------------------~~~e~f~~EI~iLk~L~HPN- 585 (785)
.|.+.+.||+|+||.||++.. +|+.+|||++....... .....+..|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 367788999999999999977 68999999876432110 01123667889999888774
Q ss_pred -eeeEeccccCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC
Q 003935 586 -VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 664 (785)
Q Consensus 586 -IVkL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g 664 (785)
+...++. ...+++|||++|++|..+... .....++.+++.++.++|+.||+|+||||+||++++++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 4444432 345899999999998765420 23457889999999999999999999999999999999
Q ss_pred eEEEEecCccccccC
Q 003935 665 TVKICDFGLSRIITD 679 (785)
Q Consensus 665 ~VKL~DFGLA~~l~~ 679 (785)
.++|+|||++.....
T Consensus 163 ~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 KIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEEECCccccCCC
Confidence 999999999966543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.9e-15 Score=137.69 Aligned_cols=132 Identities=20% Similarity=0.185 Sum_probs=112.2
Q ss_pred EeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCC--CceeeEeccccCCCceeEEEEEccc
Q 003935 531 VGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH--PNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 531 i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~H--PNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
+.+.||.|.++.||++..++..+++|....... ...+..|+.+++.++| .++.+++.++...+..++++||+.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 357899999999999999888999999754432 3568899999999976 5889999888887889999999998
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc---ccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM---KIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~---gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
+.+..+ +......++.+++.+|++||.. +++|+|++|.||++++.+.++++|||.+..
T Consensus 78 ~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777543 3445567889999999999985 799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.3e-15 Score=147.08 Aligned_cols=138 Identities=21% Similarity=0.251 Sum_probs=98.1
Q ss_pred eeEEeeeCcEEEEEEEEC-CeEEEEEEeeccccChHHHHHH----------------------HHHHHHHhhcCCCc--e
Q 003935 532 GTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDF----------------------CNEISILSRLRHPN--V 586 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~~-g~~VAVKil~~~~~~~~~~e~f----------------------~~EI~iLk~L~HPN--I 586 (785)
++.||+|+||+||+|.+. ++.||||++............+ ..|...+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999874 8999999986543322111111 24555565554332 3
Q ss_pred eeEeccccCCCceeEEEEEcccchhhH-HHHhhcccccchHHHHHHHHHHHHHHHHHHHh-cccccccCCCCcEEEcCCC
Q 003935 587 ILFLGACTKPPRLSMITEYMELGSLYH-LIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHW 664 (785)
Q Consensus 587 VkL~g~~~d~~~l~LV~Ey~~gGSL~d-lL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-~gIIHrDLKpsNILLd~~g 664 (785)
.+.+++ ...+++|||++++.+.. .+... ... ..+..++.+++.++.++|. .||+|+||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 344433 23589999999954431 12110 011 5678899999999999999 9999999999999999 88
Q ss_pred eEEEEecCccccccC
Q 003935 665 TVKICDFGLSRIITD 679 (785)
Q Consensus 665 ~VKL~DFGLA~~l~~ 679 (785)
.++|+|||.+.....
T Consensus 152 ~~~liDfg~a~~~~~ 166 (187)
T cd05119 152 KVYIIDVPQAVEIDH 166 (187)
T ss_pred cEEEEECcccccccC
Confidence 999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.3e-16 Score=174.77 Aligned_cols=169 Identities=27% Similarity=0.417 Sum_probs=130.7
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
++|+.|++|...+|.+++.........++...+.++.|++.|++| +|.+|+|+||.||++..+..+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 588999999999999999755566678888999999999999999 99999999999999999999999999998876
Q ss_pred cCCC------CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC-C-C
Q 003935 678 TDSP------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRL-E-I 748 (785)
Q Consensus 678 ~~~~------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~-~-i 748 (785)
.... ...+...||..||+||.+.+..|+.|+||||||++|+||++ -..+|... .....++.+..+ . +
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----~t~~d~r~g~ip~~~~ 482 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----ATLTDIRDGIIPPEFL 482 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----HhhhhhhcCCCChHHh
Confidence 5443 12345679999999999999999999999999999999998 33333221 111111222212 1 1
Q ss_pred CChH-HHHHHHHhhh-CCCCCCCHHHH
Q 003935 749 PEGP-LGRLIADCWA-EPQERPSCEEI 773 (785)
Q Consensus 749 p~~~-L~~LI~~CL~-DP~kRPS~~EI 773 (785)
-+.+ -..|+.+++. .|.+||++.+.
T Consensus 483 ~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 483 QDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 1222 3368888888 99999954443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.2e-14 Score=152.25 Aligned_cols=137 Identities=18% Similarity=0.174 Sum_probs=106.3
Q ss_pred eeEEe-eeCcEEEEEEEECCeEEEEEEeecccc-----------ChHHHHHHHHHHHHHhhcCCCce--eeEeccccCCC
Q 003935 532 GTRVG-IGFFGEVFRGIWNGTDVAIKVFLEQDL-----------TAENMEDFCNEISILSRLRHPNV--ILFLGACTKPP 597 (785)
Q Consensus 532 ~k~LG-~G~fG~VYkg~~~g~~VAVKil~~~~~-----------~~~~~e~f~~EI~iLk~L~HPNI--VkL~g~~~d~~ 597 (785)
+..|| .|+.|+||.+...+..++||.+..... .......+.+|+.++..+.|++| ...+++.....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 34687 899999999988899999998854321 11223567889999999998875 56666543322
Q ss_pred c----eeEEEEEccc-chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecC
Q 003935 598 R----LSMITEYMEL-GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 672 (785)
Q Consensus 598 ~----l~LV~Ey~~g-GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFG 672 (785)
. .++|+||++| .+|.+++.. ..++.. .+.||+.+|.+||++||+|+||||.|||++.++.++|+|||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 2 2599999997 688888752 234443 35789999999999999999999999999998999999999
Q ss_pred cccc
Q 003935 673 LSRI 676 (785)
Q Consensus 673 LA~~ 676 (785)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=8.5e-16 Score=180.11 Aligned_cols=248 Identities=23% Similarity=0.346 Sum_probs=188.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE---CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccCCCceeEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~---~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV 602 (785)
..|.+.+.||+|+|+.|-.... ....+|+|.+..........+....|..+-+.+. |+|++++++...+....+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 4566777799999999987754 2445677766554433444556667888888887 99999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHH-hcccccccCCCCcEEEcCCC-eEEEEecCccccccC-
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH-RMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITD- 679 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLH-s~gIIHrDLKpsNILLd~~g-~VKL~DFGLA~~l~~- 679 (785)
++|..|++++..+. .......+...+..++.|+..++.|+| ..++.|+|+||+|.+++..+ .++++|||+|..+..
T Consensus 100 ~~~s~g~~~f~~i~-~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 100 LSYSDGGSLFSKIS-HPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cCcccccccccccc-cCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999998772 112225666677889999999999999 99999999999999999999 999999999988765
Q ss_pred CC--CCCCCCCC-CCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCC-CCCC----
Q 003935 680 SP--MRDSSSAG-TPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY-AVANEGSR-LEIP---- 749 (785)
Q Consensus 680 ~~--~~~~~~~G-T~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~-~i~~~~~~-~~ip---- 749 (785)
.. ......+| ++.|+|||...+. ...+..|+||.|+++..+++|..||.........+ .+...... ...+
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSI 258 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccC
Confidence 22 22335678 9999999999884 45678899999999999999999997654433222 12221111 1111
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHH
Q 003935 750 EGPLGRLIADCWA-EPQERPSCEEILS 775 (785)
Q Consensus 750 ~~~L~~LI~~CL~-DP~kRPS~~EIL~ 775 (785)
.....+++.+++. +|..|.+.+++..
T Consensus 259 ~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 259 SDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ChhhhhcccccccCCchhccccccccc
Confidence 2246677888887 9999999887754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.6e-11 Score=137.81 Aligned_cols=141 Identities=21% Similarity=0.236 Sum_probs=97.4
Q ss_pred eEEeeeCcEEEEEEEE-CCeEEEEEEeeccccCh----------------------------HH----------HHHHHH
Q 003935 533 TRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTA----------------------------EN----------MEDFCN 573 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~----------------------------~~----------~e~f~~ 573 (785)
+.||.|++|.||+|+. +|+.||||+........ .. .-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999987 79999999975431100 00 013555
Q ss_pred HHHHHhhcC-----CCceeeEeccccCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHH-HHHHHHhcc
Q 003935 574 EISILSRLR-----HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR-GLMCIHRMK 647 (785)
Q Consensus 574 EI~iLk~L~-----HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~-AL~yLHs~g 647 (785)
|+..+.++. +++|.-..-+.......++||||++|++|.++...... .. ....++.+++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 666665552 34332211112223346999999999999987653211 11 12345666665 468899999
Q ss_pred cccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 648 IVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 648 IIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
++|+|+||.||+++.+++++|+|||++..+.
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.4e-11 Score=140.82 Aligned_cols=145 Identities=19% Similarity=0.218 Sum_probs=94.0
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE-C-CeEEEEEEeecccc---------------------------C-h----HHHH--
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW-N-GTDVAIKVFLEQDL---------------------------T-A----ENME-- 569 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~-~-g~~VAVKil~~~~~---------------------------~-~----~~~e-- 569 (785)
|.+|.. +.||.|++|.||+|+. + |+.||||+..+... . . +..+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 455555 7899999999999987 4 89999999864311 0 0 0111
Q ss_pred ----HHHHHHHHHhhcC----CCceeeEecccc-CCCceeEEEEEcccchhhHHHHhhccc---ccchHHHHHHHHHHHH
Q 003935 570 ----DFCNEISILSRLR----HPNVILFLGACT-KPPRLSMITEYMELGSLYHLIHLSGQK---KKLSWRRKLKMLRDIC 637 (785)
Q Consensus 570 ----~f~~EI~iLk~L~----HPNIVkL~g~~~-d~~~l~LV~Ey~~gGSL~dlL~~~~~~---~~Ls~~~~l~Ia~QIa 637 (785)
+|.+|+..+.+++ +.+.+.+-.++. .....++||||+.|+.+.++......+ ..+....+..++.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 2334444444442 322222222221 123457999999999998753211111 2355555555555554
Q ss_pred HHHHHHHhcccccccCCCCcEEEcCCC----eEEEEecCcccccc
Q 003935 638 RGLMCIHRMKIVHRDLKSANCLVNKHW----TVKICDFGLSRIIT 678 (785)
Q Consensus 638 ~AL~yLHs~gIIHrDLKpsNILLd~~g----~VKL~DFGLA~~l~ 678 (785)
..|++|+|+||.||+++.++ +++++|||++..+.
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 58999999999999999888 99999999997664
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.4e-12 Score=145.64 Aligned_cols=241 Identities=24% Similarity=0.211 Sum_probs=177.8
Q ss_pred CeeEeeEEee--eCcEEEEEEEE----CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccCCCcee
Q 003935 528 ELTVGTRVGI--GFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLS 600 (785)
Q Consensus 528 ~y~i~k~LG~--G~fG~VYkg~~----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~ 600 (785)
.+.+.+.+|. |.+|.||.+.. .+..+|+|.-+........-..=.+|+...+.++ |+|.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3456678999 99999998754 5778999874332222222223345676666674 999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHH----HHHHHHhcccccccCCCCcEEEcCC-CeEEEEecCccc
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR----GLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSR 675 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~----AL~yLHs~gIIHrDLKpsNILLd~~-g~VKL~DFGLA~ 675 (785)
+-+|++. .+|..+.+ .....++...++..+.+... ||.++|+.+++|-|+||.||+...+ ...+++|||+..
T Consensus 195 iqtE~~~-~sl~~~~~--~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCH--TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred eeecccc-chhHHhhh--cccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 9999997 57776665 23445788888899999999 9999999999999999999999999 889999999999
Q ss_pred cccCCCCCCCCC-----CCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHhcCC-CCC
Q 003935 676 IITDSPMRDSSS-----AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV--LPERVVYAVANEGS-RLE 747 (785)
Q Consensus 676 ~l~~~~~~~~~~-----~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~--~~~~~v~~i~~~~~-~~~ 747 (785)
.+.+........ .|...|++||..++- ++...|+|++|.+..+..++..+.... +.-... +..+ ..+
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~----r~~~ip~e 346 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL----RQGYIPLE 346 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcccc----ccccCchh
Confidence 887765443333 678899999998765 789999999999999999887654322 110000 1111 000
Q ss_pred ---CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 ---IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 ---ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
-....+...+..+++ +|-.|+++..++.+
T Consensus 347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred hhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 112245667778888 89999998887754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1e-11 Score=120.59 Aligned_cols=128 Identities=15% Similarity=0.096 Sum_probs=96.7
Q ss_pred eeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCcee-eEeccccCCCceeEEEEEcccch
Q 003935 532 GTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI-LFLGACTKPPRLSMITEYMELGS 610 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIV-kL~g~~~d~~~l~LV~Ey~~gGS 610 (785)
.+.|+.|.++.||++...+..|++|+...... ....+..|+.+++.+.+.+++ +++.+.. ...++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 35688999999999999999999999754321 123456899999988655544 4444433 33589999999988
Q ss_pred hhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhccc-----ccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 611 LYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI-----VHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 611 L~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gI-----IHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
+.... . ....++.+++.+|+.||..++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 76431 0 112456789999999999885 9999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=5.2e-10 Score=129.43 Aligned_cols=164 Identities=21% Similarity=0.233 Sum_probs=123.2
Q ss_pred CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccchhhHHHHhhcccccchHHH
Q 003935 549 NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRR 628 (785)
Q Consensus 549 ~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~ 628 (785)
.+.+|.|..+..... .......+-+..|+.++||||++++..+...+.+|+|+|-+. .|...++. +....
T Consensus 36 ~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred cCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 567777777654443 334556677888999999999999999999999999999986 56666652 33555
Q ss_pred HHHHHHHHHHHHHHHH-hcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCch
Q 003935 629 KLKMLRDICRGLMCIH-RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 707 (785)
Q Consensus 629 ~l~Ia~QIa~AL~yLH-s~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~k 707 (785)
+..-+.||+.||.||| ..+++|++|...-|+++..|+.||++|-++...............--.|..|+.+.... -.
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s 183 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WS 183 (690)
T ss_pred HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cc
Confidence 6677899999999998 57899999999999999999999999988765443321111111222456666543322 34
Q ss_pred hhHHHHHHHHHHHHhCC
Q 003935 708 CDIFSLGVIMWELCTLN 724 (785)
Q Consensus 708 sDVWSLGvILyELLTG~ 724 (785)
.|.|-|||++++++.|.
T Consensus 184 ~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 184 IDSWGLGCLIEELFNGS 200 (690)
T ss_pred hhhhhHHHHHHHHhCcc
Confidence 69999999999999993
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.7e-10 Score=118.00 Aligned_cols=137 Identities=17% Similarity=0.098 Sum_probs=96.9
Q ss_pred eEEeeeCcEEEEEEEEC--------CeEEEEEEeecccc-----------C---------hHHHHHHH----HHHHHHhh
Q 003935 533 TRVGIGFFGEVFRGIWN--------GTDVAIKVFLEQDL-----------T---------AENMEDFC----NEISILSR 580 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~~--------g~~VAVKil~~~~~-----------~---------~~~~e~f~----~EI~iLk~ 580 (785)
..||.|.-+.||.|... +..+|||++..... + ....+.+. +|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999753 37899998743210 0 01122333 79999988
Q ss_pred cCC--CceeeEeccccCCCceeEEEEEcccchhh-HHHHhhcccccchHHHHHHHHHHHHHHHHHH-HhcccccccCCCC
Q 003935 581 LRH--PNVILFLGACTKPPRLSMITEYMELGSLY-HLIHLSGQKKKLSWRRKLKMLRDICRGLMCI-HRMKIVHRDLKSA 656 (785)
Q Consensus 581 L~H--PNIVkL~g~~~d~~~l~LV~Ey~~gGSL~-dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yL-Hs~gIIHrDLKps 656 (785)
+.. -++-..+++ ..-++||||+.++.+. ..++ ...++......+..+++.+|.+| |+.||||+||++.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 852 233344433 3468999999875442 2222 12345556677889999999999 8999999999999
Q ss_pred cEEEcCCCeEEEEecCcccccc
Q 003935 657 NCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 657 NILLd~~g~VKL~DFGLA~~l~ 678 (785)
|||++ ++.++|+|||.+....
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCC
Confidence 99997 4689999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.8e-11 Score=127.48 Aligned_cols=201 Identities=25% Similarity=0.325 Sum_probs=141.8
Q ss_pred HHhhcCCCceeeEeccccCC-----CceeEEEEEcccchhhHHHHhhcc-cccchHHHHHHHHHHHHHHHHHHHhcc--c
Q 003935 577 ILSRLRHPNVILFLGACTKP-----PRLSMITEYMELGSLYHLIHLSGQ-KKKLSWRRKLKMLRDICRGLMCIHRMK--I 648 (785)
Q Consensus 577 iLk~L~HPNIVkL~g~~~d~-----~~l~LV~Ey~~gGSL~dlL~~~~~-~~~Ls~~~~l~Ia~QIa~AL~yLHs~g--I 648 (785)
.|-.+.|.|||+++.|+.+. ....++.||+..|++..+|++... ...+......+|+.||+.||.|||+.. |
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 34456799999999998654 457899999999999999986543 356788888999999999999999874 9
Q ss_pred ccccCCCCcEEEcCCCeEEEEecCccccccCC---C--CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhC
Q 003935 649 VHRDLKSANCLVNKHWTVKICDFGLSRIITDS---P--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL 723 (785)
Q Consensus 649 IHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~---~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG 723 (785)
+|+++..+.|++..+|-+|+.--.-. ..... . .......+-++|.+||.=.....+..+|||+||...++|.-+
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 99999999999999998887522111 11000 0 001122356889999987777778899999999999999887
Q ss_pred CCC-CCCCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 724 NRP-WEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 724 ~~P-F~~~~~~~~v~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
..- -.+......-..+.+- ......+.-+.++..|+. .|+.||++.+++-|...+
T Consensus 279 Eiq~tnseS~~~~ee~ia~~--i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANV--IIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred eeccCCCcceeehhhhhhhh--eeeccCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 653 3222221111111111 111122223458899999 999999999999775544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.5e-11 Score=143.81 Aligned_cols=247 Identities=21% Similarity=0.257 Sum_probs=186.1
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
+...++.+.+.+-+-+|.++.++.+.- .|...+.|+...... ...+.+....+-.++-...+|.++...-.+.....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 446678888889999999999997754 244445554432221 11123334444445544567888877776666677
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
.+++++|+.+++|...++ ..+..+.+..+.++..+..+++|||...+.|+|++|.|+|...+++.++.|||......
T Consensus 879 ~~L~~~~~~~~~~~Skl~---~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLH---NSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred cchhhHHhccCCchhhhh---cCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccc
Confidence 999999999999999987 34467777788889999999999999999999999999999999999999998432211
Q ss_pred CC------------------------C-------CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003935 679 DS------------------------P-------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 727 (785)
Q Consensus 679 ~~------------------------~-------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF 727 (785)
.- . .......+|+.|.+||.+.+......+|+|++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 0 0012345899999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCC----hHHHHHHHHhhh-CCCCCCCHH
Q 003935 728 EGVLPERVVYAVANEGSRLEIPE----GPLGRLIADCWA-EPQERPSCE 771 (785)
Q Consensus 728 ~~~~~~~~v~~i~~~~~~~~ip~----~~L~~LI~~CL~-DP~kRPS~~ 771 (785)
....+.+....+.+.......-. ...++++...+. +|.+|..+.
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99999998888776554443322 246788888887 888886654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=6.7e-10 Score=112.09 Aligned_cols=132 Identities=21% Similarity=0.279 Sum_probs=102.0
Q ss_pred EEeeeCcEEEEEEEECCeEEEEEEeeccccChHH------HHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcc
Q 003935 534 RVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAEN------MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME 607 (785)
Q Consensus 534 ~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~------~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~ 607 (785)
.+++|+-+.+|.+.+-|.++++|.-.++...... .+.-.+|+.++..++--.|...+=+..+.+...++|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 5789999999999888888888875444332221 2456689999998865454444444556677899999999
Q ss_pred cchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 608 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 608 gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
|..|.+.+... ...++..+-.-+.-||..||+|+||.++||++..++ +.++||||+..
T Consensus 83 G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA----------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc----------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999888632 245677788888999999999999999999998764 99999999964
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.7e-11 Score=136.46 Aligned_cols=245 Identities=22% Similarity=0.195 Sum_probs=175.6
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE---CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCce
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 599 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~---~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l 599 (785)
....+|..+..||.|.|+.|+.+.. .+..|++|.+.+.......-..-..|+.+...+ .|.|++.++..+....+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3456788999999999999998754 467899998765443332222234566666666 499999998888888888
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC-CeEEEEecCcccccc
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIIT 678 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~-g~VKL~DFGLA~~l~ 678 (785)
|+-.|||.++++..... -...+.+...+++..|++.++.++|+..++|+|+||+||++..+ +..++.|||+...+.
T Consensus 342 ~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred cCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 99999999998876553 33467888899999999999999999999999999999999876 788999999986532
Q ss_pred CCCCCCCCCCCCCcc-cCccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHhcCCCCCCCC--hHHH
Q 003935 679 DSPMRDSSSAGTPEW-MAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE--GPLG 754 (785)
Q Consensus 679 ~~~~~~~~~~GT~~Y-~APEvl~~~~~s~ksDVWSLGvILyELLTG~~-PF~~~~~~~~v~~i~~~~~~~~ip~--~~L~ 754 (785)
-.. ......+..| .+++......+..+.|+|+||..+.+.+++.. ++.+.... .+..+..+..+. ..+.
T Consensus 419 ~~~--~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~-----~i~~~~~p~~~~~~~~~q 491 (524)
T KOG0601|consen 419 FSS--GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL-----TIRSGDTPNLPGLKLQLQ 491 (524)
T ss_pred eec--ccccccccccccchhhccccccccccccccccccccccccCcccCcccccce-----eeecccccCCCchHHhhh
Confidence 211 1111223334 35666667788899999999999999999875 33322111 112233333333 2345
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHHHH
Q 003935 755 RLIADCWA-EPQERPSCEEILSRLL 778 (785)
Q Consensus 755 ~LI~~CL~-DP~kRPS~~EIL~~L~ 778 (785)
.+.+.+.. ++..||++.++..+..
T Consensus 492 ~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 492 VLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred hhhhhhcCCccccchhhhhhcccch
Confidence 55666666 8888999888776543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.3e-09 Score=109.54 Aligned_cols=139 Identities=19% Similarity=0.236 Sum_probs=102.5
Q ss_pred eEEeeeCcEEEEEEEECC-eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCC--ceeeEeccccCC---CceeEEEEEc
Q 003935 533 TRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHP--NVILFLGACTKP---PRLSMITEYM 606 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~~g-~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HP--NIVkL~g~~~d~---~~l~LV~Ey~ 606 (785)
+.|+.|.++.||++...+ ..+++|+....... .....+..|+++++.+.+. ++.+++.+.... +..+++|||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998754 89999997544321 1235678999999998753 345666666553 3678999999
Q ss_pred ccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 003935 607 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR----------------------------------------- 645 (785)
Q Consensus 607 ~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs----------------------------------------- 645 (785)
+|.++.+.+. ...++......++.+++.+|.+||+
T Consensus 83 ~G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 83 DGRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CCEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9988876542 0245566666667777777777763
Q ss_pred ---------------cccccccCCCCcEEEcC--CCeEEEEecCcccc
Q 003935 646 ---------------MKIVHRDLKSANCLVNK--HWTVKICDFGLSRI 676 (785)
Q Consensus 646 ---------------~gIIHrDLKpsNILLd~--~g~VKL~DFGLA~~ 676 (785)
..++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.1e-09 Score=107.22 Aligned_cols=146 Identities=18% Similarity=0.169 Sum_probs=107.1
Q ss_pred EeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChH------HHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 531 VGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE------NMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 531 i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~------~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
....|-+|+-+.|+++.+.|+.+.||.-..+..... ..+..++|+.+|.++.--.|.-..-++.+...-.++||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 356788999999999999999999986544333221 23567789999988864444433334455556789999
Q ss_pred Eccc-chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC---eEEEEecCccccc
Q 003935 605 YMEL-GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLSRII 677 (785)
Q Consensus 605 y~~g-GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g---~VKL~DFGLA~~l 677 (785)
|++| .++.+++....... ........++.+|-+.+.-||..+|||+||.++||+|..++ .+.++|||++..-
T Consensus 91 ~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9987 46777776443222 22333378899999999999999999999999999996544 4689999998653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.1e-08 Score=113.20 Aligned_cols=247 Identities=17% Similarity=0.239 Sum_probs=160.6
Q ss_pred eEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceee--------EeccccCCCcee
Q 003935 530 TVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVIL--------FLGACTKPPRLS 600 (785)
Q Consensus 530 ~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVk--------L~g~~~d~~~l~ 600 (785)
..+..||+|+-+.+|-.-.-+.. +-|+++........ +.+..|... .||-+-. ++|- .....+-
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d~-VAKIYh~Pppa~~a-----qk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iG 86 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRDQ-VAKIYHAPPPAAQA-----QKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIG 86 (637)
T ss_pred CCCccccCCccceeeecchhhch-hheeecCCCchHHH-----HHHHHhccCCCCcchhhhhcccHHHhhCC-CccceeE
Confidence 35678999999999965332333 44888765432221 223334443 4554322 2221 1122366
Q ss_pred EEEEEcccch-hhHHHH---hhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 601 MITEYMELGS-LYHLIH---LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 601 LV~Ey~~gGS-L~dlL~---~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
+.|..+.+.- ...++. +........|...++.++.++.+.+.||..|.+-+|+.++|+|+++++.|.|.|-..-..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee
Confidence 7777776532 222221 122335678999999999999999999999999999999999999999999998654443
Q ss_pred ccCCCCCCCCCCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCCCC-------hHHH-HH-----
Q 003935 677 ITDSPMRDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTL-NRPWEGVL-------PERV-VY----- 737 (785)
Q Consensus 677 l~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTG-~~PF~~~~-------~~~~-v~----- 737 (785)
. .........+|.+.|++||.-+ +-.-+...|.|.||+++++++.| +.||.+.. +-+. +.
T Consensus 167 ~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 167 N-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred c-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 3 2233444667899999999765 23346678999999999999887 78997532 1110 00
Q ss_pred --HHHhcCCCCC---CC----ChHHHHHHHHhhh---CCCCCCCHHHHHHHHHhhhhcc
Q 003935 738 --AVANEGSRLE---IP----EGPLGRLIADCWA---EPQERPSCEEILSRLLDCEYSL 784 (785)
Q Consensus 738 --~i~~~~~~~~---ip----~~~L~~LI~~CL~---DP~kRPS~~EIL~~L~~l~~sL 784 (785)
.....+..+. +| ...++.|..+|+. ++.-||+++..+..|-.+..+|
T Consensus 246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 0001111111 11 2358889999997 4679999999998887766544
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.2e-08 Score=107.15 Aligned_cols=141 Identities=16% Similarity=0.053 Sum_probs=98.9
Q ss_pred EEeeeCcEEEEEEEECCeEEEEEEeeccccChHHH----------HHHHHHHHHHhhcC-----CCceeeEeccccC--C
Q 003935 534 RVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENM----------EDFCNEISILSRLR-----HPNVILFLGACTK--P 596 (785)
Q Consensus 534 ~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~----------e~f~~EI~iLk~L~-----HPNIVkL~g~~~d--~ 596 (785)
.+-......|+++..+|+.|.||........ +.. ..+.+|...+..|. .|.+|-+...-.. .
T Consensus 29 ~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFELAGKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEECCEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 3444444457788888999999976433321 111 14778998888874 3444333211011 2
Q ss_pred CceeEEEEEcccc-hhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC-------CCeEEE
Q 003935 597 PRLSMITEYMELG-SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-------HWTVKI 668 (785)
Q Consensus 597 ~~l~LV~Ey~~gG-SL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~-------~g~VKL 668 (785)
..-++|+|++++. +|.+++.... ....+......++.+++..+..||..||+|+|+++.|||++. +..+.|
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L 186 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV 186 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence 3468999999986 7888875221 234556677889999999999999999999999999999975 468999
Q ss_pred EecCcccc
Q 003935 669 CDFGLSRI 676 (785)
Q Consensus 669 ~DFGLA~~ 676 (785)
+||+.+..
T Consensus 187 IDl~r~~~ 194 (268)
T PRK15123 187 IDLHRAQI 194 (268)
T ss_pred EECCcccc
Confidence 99998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.76 E-value=7.8e-08 Score=97.93 Aligned_cols=127 Identities=28% Similarity=0.306 Sum_probs=83.4
Q ss_pred EEEEEEE-CCeEEEEEEeecccc------------------------ChHHHHHHHHHHHHHhhcCCCc--eeeEecccc
Q 003935 542 EVFRGIW-NGTDVAIKVFLEQDL------------------------TAENMEDFCNEISILSRLRHPN--VILFLGACT 594 (785)
Q Consensus 542 ~VYkg~~-~g~~VAVKil~~~~~------------------------~~~~~e~f~~EI~iLk~L~HPN--IVkL~g~~~ 594 (785)
.||.|.. +|..+|||+...... .........+|...|.++..-+ +-+.+.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899987 788999998753210 0011245678999999997553 34444432
Q ss_pred CCCceeEEEEEcc--cchhhHHHHhhcccccchHHHHHHHHHHHHHHHHH-HHhcccccccCCCCcEEEcCCCeEEEEec
Q 003935 595 KPPRLSMITEYME--LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC-IHRMKIVHRDLKSANCLVNKHWTVKICDF 671 (785)
Q Consensus 595 d~~~l~LV~Ey~~--gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~y-LHs~gIIHrDLKpsNILLd~~g~VKL~DF 671 (785)
.-++||||+. |..+..+... .++......++.+++..+.. +|..||+|+||.+.|||++++ .+.|+||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 2479999999 7666655431 12234456677888886665 579999999999999999987 9999999
Q ss_pred Ccccccc
Q 003935 672 GLSRIIT 678 (785)
Q Consensus 672 GLA~~l~ 678 (785)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.71 E-value=5.2e-07 Score=102.45 Aligned_cols=214 Identities=16% Similarity=0.231 Sum_probs=149.2
Q ss_pred CcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC----CCceeEEEEEccc-chh
Q 003935 539 FFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK----PPRLSMITEYMEL-GSL 611 (785)
Q Consensus 539 ~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d----~~~l~LV~Ey~~g-GSL 611 (785)
.-.+.|++.. +|..|++|+++-...... .....-+++++++.|+|||+|.+++.. +..+++||+|.++ ++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST--NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc--ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 3467899865 799999999843322111 112345789999999999999998863 3468999999985 566
Q ss_pred hHHHHhh------------cccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 612 YHLIHLS------------GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 612 ~dlL~~~------------~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
.++.-.. ..+...++...|.|+.|+..||.++|+.|+..+-|.+.+||++.+-+++|...|....+..
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 6543211 1234578899999999999999999999999999999999999988999988887766543
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCChHHH-HHHHHhcCCCCCCCChHHHHHH
Q 003935 680 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERV-VYAVANEGSRLEIPEGPLGRLI 757 (785)
Q Consensus 680 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~-PF~~~~~~~~-v~~i~~~~~~~~ip~~~L~~LI 757 (785)
.. . |-+.. -.+-|.=.||.+++.|.||.. -+........ ...+ .. .....+++++
T Consensus 446 d~------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-~~-----~yS~D~rn~v 502 (655)
T KOG3741|consen 446 DP------------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-TT-----TYSTDLRNVV 502 (655)
T ss_pred CC------------C--cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-hh-----hhhHHHHHHH
Confidence 32 0 11111 235688899999999999965 3444433333 2222 11 1223567777
Q ss_pred HHhhh-CCCCCCCHHHHHHHHH
Q 003935 758 ADCWA-EPQERPSCEEILSRLL 778 (785)
Q Consensus 758 ~~CL~-DP~kRPS~~EIL~~L~ 778 (785)
.-+.. ++++ -++.+++.++-
T Consensus 503 ~yl~s~~~~~-ksI~~llp~~~ 523 (655)
T KOG3741|consen 503 EYLESLNFRE-KSIQDLLPMIG 523 (655)
T ss_pred HHHHhcCccc-ccHHHHHHHHH
Confidence 77776 6665 67777776643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.8e-07 Score=95.86 Aligned_cols=127 Identities=21% Similarity=0.182 Sum_probs=88.1
Q ss_pred ECCeEEEEEEeeccccCh-----HHHHHHHHHHHHHhhcCCCce--eeEeccccCC----CceeEEEEEcccc-hhhHHH
Q 003935 548 WNGTDVAIKVFLEQDLTA-----ENMEDFCNEISILSRLRHPNV--ILFLGACTKP----PRLSMITEYMELG-SLYHLI 615 (785)
Q Consensus 548 ~~g~~VAVKil~~~~~~~-----~~~e~f~~EI~iLk~L~HPNI--VkL~g~~~d~----~~l~LV~Ey~~gG-SL~dlL 615 (785)
..++.+.+|.+....... -....+.+|...+..|..-+| .+.+++.... ...++|+|++++. +|.+++
T Consensus 30 ~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~ 109 (206)
T PF06293_consen 30 LVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLL 109 (206)
T ss_pred ccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHH
Confidence 355666666543221111 123456778887777743222 2333333221 2358999999974 788888
Q ss_pred HhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC---eEEEEecCccccc
Q 003935 616 HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLSRII 677 (785)
Q Consensus 616 ~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g---~VKL~DFGLA~~l 677 (785)
... ..++......++.+++..++-||.+||+|+|+++.|||++.++ .+.|+||+.++..
T Consensus 110 ~~~---~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 110 QQW---EQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred Hhh---cccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 632 2266677889999999999999999999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.1e-06 Score=93.71 Aligned_cols=136 Identities=26% Similarity=0.290 Sum_probs=99.0
Q ss_pred eEeeEEeeeCcEEEEEEEE-CCeEEEEEEeecccc------------------C--hHHHHHHHHHHHHHhhcCCC--ce
Q 003935 530 TVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDL------------------T--AENMEDFCNEISILSRLRHP--NV 586 (785)
Q Consensus 530 ~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~------------------~--~~~~e~f~~EI~iLk~L~HP--NI 586 (785)
.++++||-|.-+.||.|.. +|.++|||.-..... . .-......+|.++|.+|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4578999999999999988 699999997422110 0 11134566888999888643 44
Q ss_pred eeEeccccCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeE
Q 003935 587 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTV 666 (785)
Q Consensus 587 VkL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~V 666 (785)
-+.+++ +...+||||+.|-.|...- ++......++..|+.-+.-+-..||||+|+.+=||+++++|.+
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCE
Confidence 444443 4578999999986665432 1334445566677777776678999999999999999999999
Q ss_pred EEEecCccccc
Q 003935 667 KICDFGLSRII 677 (785)
Q Consensus 667 KL~DFGLA~~l 677 (785)
.++||--+...
T Consensus 242 ~vIDwPQ~v~~ 252 (304)
T COG0478 242 VVIDWPQAVPI 252 (304)
T ss_pred EEEeCcccccC
Confidence 99999877544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.9e-06 Score=87.55 Aligned_cols=138 Identities=17% Similarity=0.154 Sum_probs=93.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChH-HHHHH------HHHHHHHhhcC---CCceeeEecccc--
Q 003935 527 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE-NMEDF------CNEISILSRLR---HPNVILFLGACT-- 594 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~-~~e~f------~~EI~iLk~L~---HPNIVkL~g~~~-- 594 (785)
.+|.+.+.+-......|.+-..+|+.+.+|.........+ ....| .+++..+..++ ...+..++.+..
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk 110 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK 110 (229)
T ss_pred CCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence 5788888888888888888888999999998755432221 11112 23444444443 222333222221
Q ss_pred ---CCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEec
Q 003935 595 ---KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 671 (785)
Q Consensus 595 ---d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DF 671 (785)
-....+++|||++|..|.++.. +++ .+...+.+++..||+.|++|+|++|.|++++++ .++++||
T Consensus 111 ~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~ 178 (229)
T PF06176_consen 111 IFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT 178 (229)
T ss_pred eccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence 2234578999999988877643 222 244567788999999999999999999999965 4999999
Q ss_pred Ccccc
Q 003935 672 GLSRI 676 (785)
Q Consensus 672 GLA~~ 676 (785)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 87653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.35 E-value=5e-06 Score=86.33 Aligned_cols=140 Identities=15% Similarity=0.059 Sum_probs=100.8
Q ss_pred eeeCcEEEEEEEECCeEEEEEEeeccc---cC-hHHHHHHHHHHHHHhhcCCCc--eeeEecc--ccCC--CceeEEEEE
Q 003935 536 GIGFFGEVFRGIWNGTDVAIKVFLEQD---LT-AENMEDFCNEISILSRLRHPN--VILFLGA--CTKP--PRLSMITEY 605 (785)
Q Consensus 536 G~G~fG~VYkg~~~g~~VAVKil~~~~---~~-~~~~e~f~~EI~iLk~L~HPN--IVkL~g~--~~d~--~~l~LV~Ey 605 (785)
|+||-+.|++...+|..+-+|.-.... +. +.-...|.+|...|..|..-+ +.+...+ -..+ -.-+||+|-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 578899999998888888888743111 10 223467999999999885322 3333311 1111 236889997
Q ss_pred ccc-chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCe--EEEEecCcccc
Q 003935 606 MEL-GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT--VKICDFGLSRI 676 (785)
Q Consensus 606 ~~g-GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~--VKL~DFGLA~~ 676 (785)
+.+ -+|.+++... .-.+.+......++.+|+..++-||+.|+.|+|+.+.|||++.++. ++++||--++.
T Consensus 107 L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 107 MAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 764 5777777522 2335677888899999999999999999999999999999986666 99999987654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.4e-07 Score=110.15 Aligned_cols=140 Identities=20% Similarity=0.282 Sum_probs=96.5
Q ss_pred HHHHHHHHHHHh-cccccccCCCCcEEEcCCCeEEEEecCccccccCCCC-CC--------CCCCCCCcccCccccccCC
Q 003935 634 RDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-RD--------SSSAGTPEWMAPELIRNEP 703 (785)
Q Consensus 634 ~QIa~AL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~-~~--------~~~~GT~~Y~APEvl~~~~ 703 (785)
.+++.|+.|+|+ .++||++|.|++|.++.++..||+.|+++........ .. ....-...|.|||++.+..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 345599999997 5899999999999999999999999998765443111 10 0112345799999999988
Q ss_pred CCchhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHh------cCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHH
Q 003935 704 FTEKCDIFSLGVIMWELCTLNRP-WEGVLPERVVYAVAN------EGSRLEIPEGPLGRLIADCWA-EPQERPSCEEIL 774 (785)
Q Consensus 704 ~s~ksDVWSLGvILyELLTG~~P-F~~~~~~~~v~~i~~------~~~~~~ip~~~L~~LI~~CL~-DP~kRPS~~EIL 774 (785)
.+.++|+||+||++|.+..|..+ +.............. .++...+|. .+.+-+.+++. ++..||++..++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~-el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPS-ELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcH-HHHHHHHHHhcCCcccCcchhhhh
Confidence 89999999999999999955444 433222111111111 112223333 46666777777 999999777665
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.5e-05 Score=80.28 Aligned_cols=141 Identities=18% Similarity=0.199 Sum_probs=83.1
Q ss_pred eeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCc--eeeEeccc---cCCCceeEEEEEc
Q 003935 532 GTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--VILFLGAC---TKPPRLSMITEYM 606 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN--IVkL~g~~---~d~~~l~LV~Ey~ 606 (785)
++.|+.|..+.||++...+..+++|+.... .....+..|..+++.+.... +.+++.++ ......+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 467999999999999987789999996433 34566778888888875322 34444432 2233478999999
Q ss_pred ccchhhH----------------HHHh---hc-ccccch-HH--------HHHHH------------HHHHHH-HHHHHH
Q 003935 607 ELGSLYH----------------LIHL---SG-QKKKLS-WR--------RKLKM------------LRDICR-GLMCIH 644 (785)
Q Consensus 607 ~gGSL~d----------------lL~~---~~-~~~~Ls-~~--------~~l~I------------a~QIa~-AL~yLH 644 (785)
+|..+.. .+.. .. ....+. .. ..... ...+.. .++.++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9987766 1111 10 000000 00 00000 112222 333333
Q ss_pred h-------cccccccCCCCcEEEc-CCCeEEEEecCcccc
Q 003935 645 R-------MKIVHRDLKSANCLVN-KHWTVKICDFGLSRI 676 (785)
Q Consensus 645 s-------~gIIHrDLKpsNILLd-~~g~VKL~DFGLA~~ 676 (785)
. ..++|+|+.+.|||++ +++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 4599999999999999 667778999988753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=4.1e-06 Score=97.28 Aligned_cols=142 Identities=19% Similarity=0.231 Sum_probs=89.6
Q ss_pred eEEeeeCcEEEEEEEE-CCeEEEEEEeecccc---------------------------ChH-HH----------HHHHH
Q 003935 533 TRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDL---------------------------TAE-NM----------EDFCN 573 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~---------------------------~~~-~~----------e~f~~ 573 (785)
+.|+.++-|.||+|+. +|+.||||+....-. ... .. -++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6799999999999988 499999999643211 000 01 12334
Q ss_pred HHHHHhhcC-----CCceeeEeccccCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHH-HHHHHhcc
Q 003935 574 EISILSRLR-----HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG-LMCIHRMK 647 (785)
Q Consensus 574 EI~iLk~L~-----HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~A-L~yLHs~g 647 (785)
|...+.+++ .++|.--.=+++-...-.++|||++|..+.+...... ..++.+.+ +..++.+ +..+=..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~i---a~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKEL---AELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHH---HHHHHHHHHHHHHhcC
Confidence 555444442 3333221112222344689999999999998753221 22332222 2222222 22333479
Q ss_pred cccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 648 IVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 648 IIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
++|.|.+|.||+++.+|++.+.|||+...+..
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999876643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.3e-05 Score=83.69 Aligned_cols=136 Identities=15% Similarity=0.109 Sum_probs=81.5
Q ss_pred eEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCc--eeeEeccccCCCceeEEEEEcccch
Q 003935 533 TRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--VILFLGACTKPPRLSMITEYMELGS 610 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN--IVkL~g~~~d~~~l~LV~Ey~~gGS 610 (785)
.+||.|..+.||+. .+..+++|...... . .....+|.++++.+..-+ +.+.+++....+...++||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-D---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC-C---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 46899999999984 35577889875422 2 244678999998875332 3455666666777889999999863
Q ss_pred -hhHHH--------------Hh----hcc--cccchHHHH-HHHHH----------HHHH-HHHHHHh----cccccccC
Q 003935 611 -LYHLI--------------HL----SGQ--KKKLSWRRK-LKMLR----------DICR-GLMCIHR----MKIVHRDL 653 (785)
Q Consensus 611 -L~dlL--------------~~----~~~--~~~Ls~~~~-l~Ia~----------QIa~-AL~yLHs----~gIIHrDL 653 (785)
+...+ .. ... ......... ..+.. .+.. ...+|.. ..++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 11111 00 000 001111110 01100 0111 1223321 24789999
Q ss_pred CCCcEEEcCCCeEEEEecCccc
Q 003935 654 KSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 654 KpsNILLd~~g~VKL~DFGLA~ 675 (785)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.99 E-value=4.4e-05 Score=79.43 Aligned_cols=137 Identities=18% Similarity=0.080 Sum_probs=82.3
Q ss_pred EEeeeCc-EEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccCCCceeEEEEEcccchh
Q 003935 534 RVGIGFF-GEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEYMELGSL 611 (785)
Q Consensus 534 ~LG~G~f-G~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL 611 (785)
.|-.|.+ +.||+....+..+.||+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.++
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 3444555 7899997777788889864332 234567888888874 32344666666666678999999998776
Q ss_pred hHHH-------------------Hhhcc-cccchHH--HHHHHHH--------------------HHHHHHHHHH-----
Q 003935 612 YHLI-------------------HLSGQ-KKKLSWR--RKLKMLR--------------------DICRGLMCIH----- 644 (785)
Q Consensus 612 ~dlL-------------------~~~~~-~~~Ls~~--~~l~Ia~--------------------QIa~AL~yLH----- 644 (785)
.... +.... ...+... ....... .+...+..|-
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 5331 10000 0011100 0000000 0111122221
Q ss_pred --hcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 645 --RMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 645 --s~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2348999999999999998778899999774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.90 E-value=8.9e-05 Score=78.64 Aligned_cols=136 Identities=18% Similarity=0.160 Sum_probs=91.0
Q ss_pred EEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHH----------------------HHHHHHHHHHHhhcCCC--ceee
Q 003935 534 RVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAEN----------------------MEDFCNEISILSRLRHP--NVIL 588 (785)
Q Consensus 534 ~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~----------------------~e~f~~EI~iLk~L~HP--NIVk 588 (785)
.|.+|.-+.||+|.. ++..+|+|++......-.. .....+|...|+++..- .+-+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 677888889999975 6899999998654322111 11233566667666322 2222
Q ss_pred EeccccCCCceeEEEEEcccchh-hHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-cccccccCCCCcEEEcCCCeE
Q 003935 589 FLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTV 666 (785)
Q Consensus 589 L~g~~~d~~~l~LV~Ey~~gGSL-~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-~gIIHrDLKpsNILLd~~g~V 666 (785)
-+.+. .-.+||||+..... .-.|+ ...+.......+..++++.+.-|-. .|+||+||..=|||+. ++.+
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 23322 23799999975311 11111 1123333677888899999998876 8999999999999999 7899
Q ss_pred EEEecCcccccc
Q 003935 667 KICDFGLSRIIT 678 (785)
Q Consensus 667 KL~DFGLA~~l~ 678 (785)
.|+|||-|....
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999987654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.0001 Score=85.86 Aligned_cols=141 Identities=23% Similarity=0.228 Sum_probs=89.1
Q ss_pred eEEeeeCcEEEEEEEE-CCeEEEEEEeeccccCh-----------------------------HH------HHHHHHHHH
Q 003935 533 TRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTA-----------------------------EN------MEDFCNEIS 576 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~-----------------------------~~------~e~f~~EI~ 576 (785)
+.||.-+.|.||+++. +|+.||||+-+..-... +. .-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999976 78999999853321100 00 013555655
Q ss_pred HHhhc----CCCc------eeeEeccccCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc
Q 003935 577 ILSRL----RHPN------VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 646 (785)
Q Consensus 577 iLk~L----~HPN------IVkL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~ 646 (785)
...++ .|-+ |-++|..+. ....|+||||+|..+.++-.-. ...++...+...+.++.. +-+=..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~--~~gi~~~~i~~~l~~~~~--~qIf~~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAID--KRGISPHDILNKLVEAYL--EQIFKT 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHH--HcCCCHHHHHHHHHHHHH--HHHHhc
Confidence 54443 3444 333333322 3468999999999888764322 223444433333333221 122246
Q ss_pred ccccccCCCCcEEEcC----CCeEEEEecCccccccC
Q 003935 647 KIVHRDLKSANCLVNK----HWTVKICDFGLSRIITD 679 (785)
Q Consensus 647 gIIHrDLKpsNILLd~----~g~VKL~DFGLA~~l~~ 679 (785)
|++|+|-+|.||+++. ++.+.+-|||+...+..
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 8999999999999983 67899999999877654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00023 Score=73.69 Aligned_cols=127 Identities=23% Similarity=0.338 Sum_probs=92.4
Q ss_pred CCeeEeeEEeeeCc-EEEEEEEECCeEEEEEEeec---ccc-------Ch---------HHHHHHHHHHHHHhhcC---C
Q 003935 527 SELTVGTRVGIGFF-GEVFRGIWNGTDVAIKVFLE---QDL-------TA---------ENMEDFCNEISILSRLR---H 583 (785)
Q Consensus 527 s~y~i~k~LG~G~f-G~VYkg~~~g~~VAVKil~~---~~~-------~~---------~~~e~f~~EI~iLk~L~---H 583 (785)
.+++..+.||.|.- |.||++...|+.||+|++.. ... .. ....-|..|.....+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 78889999999999 99999999999999999321 110 00 12346888988877775 5
Q ss_pred Cce--eeEeccccCC------------------CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHH
Q 003935 584 PNV--ILFLGACTKP------------------PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 643 (785)
Q Consensus 584 PNI--VkL~g~~~d~------------------~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yL 643 (785)
.++ |+.+||..-. ....||.||++... .+.. +-+.++.+-|..+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKIL 180 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHHH
Confidence 566 8998886211 12467888877533 1222 2355677788899
Q ss_pred HhcccccccCCCCcEEEcCCCeEEEEecCcc
Q 003935 644 HRMKIVHRDLKSANCLVNKHWTVKICDFGLS 674 (785)
Q Consensus 644 Hs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 674 (785)
|..||+-+|+++.|.. .=+|+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999986 3478999865
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00019 Score=88.31 Aligned_cols=78 Identities=19% Similarity=0.158 Sum_probs=56.5
Q ss_pred eeEEeeeCcEEEEEEEECC----eEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCce--eeEeccccCC---CceeE
Q 003935 532 GTRVGIGFFGEVFRGIWNG----TDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNV--ILFLGACTKP---PRLSM 601 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~~g----~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNI--VkL~g~~~d~---~~l~L 601 (785)
.++|+.|.++.+|+....+ ..+++|+........ ....+.+|+.+|+.+. |.+| .+++.+|.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 4778999999999987643 467888754332211 2346789999999995 6665 6777777664 46789
Q ss_pred EEEEcccch
Q 003935 602 ITEYMELGS 610 (785)
Q Consensus 602 V~Ey~~gGS 610 (785)
||||++|..
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999999864
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00012 Score=74.54 Aligned_cols=102 Identities=23% Similarity=0.268 Sum_probs=81.5
Q ss_pred HHHHHHHhhcCC-CceeeEeccccCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh---cc
Q 003935 572 CNEISILSRLRH-PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR---MK 647 (785)
Q Consensus 572 ~~EI~iLk~L~H-PNIVkL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs---~g 647 (785)
..|.-+++.+++ +++.+++|+|-. +++.||...+++.........-...+|..+.+++.++++.+.+|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888888876 699999999953 7899999977665321000112346899999999999999999997 45
Q ss_pred cccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 648 IVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 648 IIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
+...|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 889999999999999999999999876554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.63 E-value=6.3e-06 Score=95.81 Aligned_cols=179 Identities=22% Similarity=0.190 Sum_probs=130.5
Q ss_pred eEEeeeCcEEEEEEEECCe-EEEEEEeeccccChHHHHHHHHHHHHHhhcCCCc-eeeEeccccCCCceeEEEEEcccc-
Q 003935 533 TRVGIGFFGEVFRGIWNGT-DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN-VILFLGACTKPPRLSMITEYMELG- 609 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~~g~-~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN-IVkL~g~~~d~~~l~LV~Ey~~gG- 609 (785)
+.+++|+++++|+.....+ ....+.+... ....-++++|.+++||| .+..++-++.+...++.++++.++
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 4468999999998754322 2223333211 34556899999999999 777788788888899999999877
Q ss_pred hhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCCC
Q 003935 610 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 689 (785)
Q Consensus 610 SL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~G 689 (785)
+...... ...-.+..-+...+.+.-+++++|||+.-=+|+| ||+..+ +..+..||+....+.... ......+
T Consensus 321 s~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~~~ 392 (829)
T KOG0576|consen 321 SSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRTAIG 392 (829)
T ss_pred cccccCC--hhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-ccccCCC
Confidence 2222111 0112334444556677778899999988778998 777665 689999999988776543 3456789
Q ss_pred CCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 003935 690 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP 726 (785)
Q Consensus 690 T~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~P 726 (785)
++.++|||+.....+..+.|+|++|+--.++.-|-.|
T Consensus 393 ~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 393 TPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred CCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 9999999999999999999999999877777766555
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00024 Score=72.09 Aligned_cols=130 Identities=22% Similarity=0.202 Sum_probs=91.8
Q ss_pred eEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceee-EeccccCCCceeEEEEEccc
Q 003935 530 TVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL-FLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 530 ~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVk-L~g~~~d~~~l~LV~Ey~~g 608 (785)
.+.+.||+|.+|.||+|.+.|..+|+|+-..+. ....+..|+++|..++-.++.. +|.|-. .++.|||+.|
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G 96 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDG 96 (201)
T ss_pred hhhhhhhcccccEEEEeeccCceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcC
Confidence 345679999999999999999999999854332 2466889999999998666643 333322 2455999999
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCC-CCcEEEcCCCeEEEEecCccccc
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLK-SANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLK-psNILLd~~g~VKL~DFGLA~~l 677 (785)
-.|...-.. .+. +-+..+++..--|-..||-|+-|. |...+|..++.+.|+||.-|...
T Consensus 97 ~~L~~~~~~------~~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 97 RPLGKLEIG------GDR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred cchhhhhhc------ccH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 888766531 122 234456666666778899999886 44444444559999999988743
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00026 Score=87.37 Aligned_cols=195 Identities=19% Similarity=0.228 Sum_probs=136.0
Q ss_pred HHHHHHHHHhhcCCCceeeEeccccCCCc----eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh
Q 003935 570 DFCNEISILSRLRHPNVILFLGACTKPPR----LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 645 (785)
Q Consensus 570 ~f~~EI~iLk~L~HPNIVkL~g~~~d~~~----l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs 645 (785)
...-|...+..+.|+|++.++.|-.+... ..+..+++...++...+. .....+....+.+..++.+||+|+|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHH
Confidence 33446667788899999999988655432 345567888888888876 45678889999999999999999999
Q ss_pred cccccccCCCC---cEEEcCCCeEEEE--ecCccccccCCCCCCCCCCCCCcccCccccccCCCCch--hhHHHHHHHHH
Q 003935 646 MKIVHRDLKSA---NCLVNKHWTVKIC--DFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK--CDIFSLGVIMW 718 (785)
Q Consensus 646 ~gIIHrDLKps---NILLd~~g~VKL~--DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~k--sDVWSLGvILy 718 (785)
....|.-|... +.-.+..+.+.+. ||+.+..+.+.... .....+..+.++|......+..+ .|+|.+|..+.
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccc-hhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 86555555444 3334555667766 89888877654332 23344566788888877666554 79999999999
Q ss_pred HHHhCCCCCCC-CChHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003935 719 ELCTLNRPWEG-VLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSRL 777 (785)
Q Consensus 719 ELLTG~~PF~~-~~~~~~v~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~L 777 (785)
.+..|..+-.. ......... . -.....+....|+. ++++|+++.+++.+.
T Consensus 384 ~~~~~~~i~~~~~~~~~~l~~----~-----~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 384 QLSQGEDISEKSAVPVSLLDV----L-----STSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhcCcccccccchhhhhcc----c-----cchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 99988764221 111111110 0 01135677888988 999999999999874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00066 Score=70.61 Aligned_cols=73 Identities=21% Similarity=0.153 Sum_probs=44.1
Q ss_pred eEEeeeCcE-EEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCC---ceeeEeccccCC---CceeEEEEE
Q 003935 533 TRVGIGFFG-EVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHP---NVILFLGACTKP---PRLSMITEY 605 (785)
Q Consensus 533 k~LG~G~fG-~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HP---NIVkL~g~~~d~---~~l~LV~Ey 605 (785)
+.|+.|+.. .||+. +..+++|+..... ....+..|++++..+... -+-++++..... ...+++|++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 457766665 58876 3467788754321 234678899988877521 222333333322 235889999
Q ss_pred cccchhh
Q 003935 606 MELGSLY 612 (785)
Q Consensus 606 ~~gGSL~ 612 (785)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9986653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0016 Score=67.15 Aligned_cols=73 Identities=15% Similarity=0.139 Sum_probs=46.4
Q ss_pred eeEEeeeCcEEEEEEEEC---CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCce-eeEeccccCCCceeEEEEEcc
Q 003935 532 GTRVGIGFFGEVFRGIWN---GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTKPPRLSMITEYME 607 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~~---g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNI-VkL~g~~~d~~~l~LV~Ey~~ 607 (785)
.+.|..|-...+|++... +..|++|+....... .....+|+.+++.+...++ .++++.+. . .++|||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeC
Confidence 356778888999998764 578999976532211 1122368888888853333 33444332 2 47999999
Q ss_pred cchh
Q 003935 608 LGSL 611 (785)
Q Consensus 608 gGSL 611 (785)
|.++
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 8665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0015 Score=67.37 Aligned_cols=134 Identities=16% Similarity=0.181 Sum_probs=93.2
Q ss_pred eEEeeeCcEEEEEEEECCeEEEEEEeeccc--------------cChHHHHHHHHHHHHHhhcC------CCceeeEecc
Q 003935 533 TRVGIGFFGEVFRGIWNGTDVAIKVFLEQD--------------LTAENMEDFCNEISILSRLR------HPNVILFLGA 592 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~~g~~VAVKil~~~~--------------~~~~~~e~f~~EI~iLk~L~------HPNIVkL~g~ 592 (785)
..||+|+.=.||.--. +....||+..... .......++.+|+.....+. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 5699999999986433 3445788876554 11112456667777666665 8899999999
Q ss_pred ccCCCceeEEEEEccc------chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC--
Q 003935 593 CTKPPRLSMITEYMEL------GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-- 664 (785)
Q Consensus 593 ~~d~~~l~LV~Ey~~g------GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g-- 664 (785)
.+++-...+|+|.+.. -+|.+++. ...++. .+...+-+-..||-..+|+.+|++|.||++..+.
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999889999998753 35667764 234554 2333444556788899999999999999996332
Q ss_pred --eEEEEe-cCccc
Q 003935 665 --TVKICD-FGLSR 675 (785)
Q Consensus 665 --~VKL~D-FGLA~ 675 (785)
.+.|+| ||...
T Consensus 158 ~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 158 EFRLVLIDGLGEKE 171 (199)
T ss_pred ceEEEEEeCCCCcc
Confidence 577776 55443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0034 Score=68.24 Aligned_cols=77 Identities=13% Similarity=-0.074 Sum_probs=54.8
Q ss_pred EeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCC---CceeeEeccccC---CCceeEEEE
Q 003935 531 VGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH---PNVILFLGACTK---PPRLSMITE 604 (785)
Q Consensus 531 i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~H---PNIVkL~g~~~d---~~~l~LV~E 604 (785)
-.+.||.|..+.||+....+..+.+|..+. ... ...|..|...|+.|.- -.+.+++++|.. .+..++|||
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~-~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGNPMPLMARS-FST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred eeeecCCccceeEEEEEcCCCCEEEEEecc-ccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 456799999999999876555677787432 111 2467889999988752 245667766643 366899999
Q ss_pred Ecccchh
Q 003935 605 YMELGSL 611 (785)
Q Consensus 605 y~~gGSL 611 (785)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998754
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.002 Score=68.84 Aligned_cols=139 Identities=17% Similarity=0.207 Sum_probs=83.4
Q ss_pred eeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCc--eeeEeccc------cCCCceeEEE
Q 003935 532 GTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--VILFLGAC------TKPPRLSMIT 603 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN--IVkL~g~~------~d~~~l~LV~ 603 (785)
.+.|..|....+|+...++..+++|+... .. ...+..|+.++..+.+.+ +.+++... ...+..++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~--~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK--VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC--CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 45677788889999877777899998753 11 244566777777774322 33443321 2234578999
Q ss_pred EEcccchhhH----H----------HHhhccc--------ccchHHHHH----------HHHHHHHHHHHHHHh------
Q 003935 604 EYMELGSLYH----L----------IHLSGQK--------KKLSWRRKL----------KMLRDICRGLMCIHR------ 645 (785)
Q Consensus 604 Ey~~gGSL~d----l----------L~~~~~~--------~~Ls~~~~l----------~Ia~QIa~AL~yLHs------ 645 (785)
+|++|..+.. . +|..... ....|.... .....+..++.++.+
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999865421 0 1110000 001111100 011123344455543
Q ss_pred -cccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 646 -MKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 646 -~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
.+++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998777899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.001 Score=69.94 Aligned_cols=135 Identities=17% Similarity=0.102 Sum_probs=76.9
Q ss_pred EeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCcee-eEeccccCCCceeEEEEEcccchhhH
Q 003935 535 VGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI-LFLGACTKPPRLSMITEYMELGSLYH 613 (785)
Q Consensus 535 LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIV-kL~g~~~d~~~l~LV~Ey~~gGSL~d 613 (785)
+..|-.+.+|+...++..+++|+........ .-...+|..+++.+...+++ +++..+. -++|+||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 4568888999998888889999854322110 01245788888888533222 2333322 368999999866532
Q ss_pred --------------HH---Hhhc-ccccchHH-HHHHHHHHH---------HHHHHHHHh--------cccccccCCCCc
Q 003935 614 --------------LI---HLSG-QKKKLSWR-RKLKMLRDI---------CRGLMCIHR--------MKIVHRDLKSAN 657 (785)
Q Consensus 614 --------------lL---~~~~-~~~~Ls~~-~~l~Ia~QI---------a~AL~yLHs--------~gIIHrDLKpsN 657 (785)
.+ |... ....++.. ....+..++ ...+..+-. ..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 11 1111 01112211 111222111 111222221 258999999999
Q ss_pred EEEcCCCeEEEEecCcccc
Q 003935 658 CLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 658 ILLd~~g~VKL~DFGLA~~ 676 (785)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998743
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.009 Score=64.78 Aligned_cols=139 Identities=20% Similarity=0.271 Sum_probs=75.9
Q ss_pred eeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-----CCCceeeEe-c--cccCCCceeEEE
Q 003935 532 GTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-----RHPNVILFL-G--ACTKPPRLSMIT 603 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-----~HPNIVkL~-g--~~~d~~~l~LV~ 603 (785)
.+.|+.|....+|+...++..+++|++. ..... .+..|+.++..| ..|.++.-. | +....+..++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~--~~~~~---~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~ 101 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQGEYVLTLFE--RLTAE---DLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV 101 (319)
T ss_pred cchhccccccceEEEEeCCCcEEEEEec--cCChH---HhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence 3457778888999998766689999875 22222 233345555444 244444311 0 112245578999
Q ss_pred EEcccchhh-----------HHH---Hhhccc--------ccchH-HHHH------------HHHHH-HHHHHHHHH---
Q 003935 604 EYMELGSLY-----------HLI---HLSGQK--------KKLSW-RRKL------------KMLRD-ICRGLMCIH--- 644 (785)
Q Consensus 604 Ey~~gGSL~-----------dlL---~~~~~~--------~~Ls~-~~~l------------~Ia~Q-Ia~AL~yLH--- 644 (785)
+|++|..+. ..+ |..... ..+.+ .... ..+.+ +...++.+.
T Consensus 102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 181 (319)
T PRK05231 102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA 181 (319)
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence 999986431 111 111000 01111 1111 01111 111223332
Q ss_pred ----hcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 645 ----RMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 645 ----s~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
..++||+|+++.|||++.+...-|+||+.+.
T Consensus 182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2379999999999999976556899999874
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0079 Score=65.17 Aligned_cols=143 Identities=15% Similarity=0.167 Sum_probs=82.4
Q ss_pred eeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCc--eeeEeccc------cCCCcee
Q 003935 529 LTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--VILFLGAC------TKPPRLS 600 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN--IVkL~g~~------~d~~~l~ 600 (785)
..-.+.++.|....+|++..++..+++|+..... . ...+..|++++..|...+ +.+++... ...+..+
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ceeccccCCccccceEEEEeCCCcEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 3345667778778999987766678899865421 1 233445667666663221 33333321 2235578
Q ss_pred EEEEEcccchhh-----------H---HHHhhccc---------ccchHHHHH------------HHHHHHHHHHHHHHh
Q 003935 601 MITEYMELGSLY-----------H---LIHLSGQK---------KKLSWRRKL------------KMLRDICRGLMCIHR 645 (785)
Q Consensus 601 LV~Ey~~gGSL~-----------d---lL~~~~~~---------~~Ls~~~~l------------~Ia~QIa~AL~yLHs 645 (785)
++++|++|..+. . .+|..... ..-.|.... .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999885431 0 11111010 001111100 011123344555542
Q ss_pred -------cccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 646 -------MKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 646 -------~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
.+++|+|+++.||++++++.+.|+||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 589999999999999988877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.00056 Score=75.07 Aligned_cols=136 Identities=15% Similarity=0.170 Sum_probs=93.6
Q ss_pred CeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeecccc------------------ChH--HHHHHHHHHHHHhhcC-CCc
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDL------------------TAE--NMEDFCNEISILSRLR-HPN 585 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~------------------~~~--~~e~f~~EI~iLk~L~-HPN 585 (785)
-+.++++||-|.-+-||.+-+ +|++.++|+-..... .+- ..-...+|...|+.|. |-.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 466789999999999999977 599999986321110 000 0123457888888775 322
Q ss_pred -eeeEeccccCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC
Q 003935 586 -VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 664 (785)
Q Consensus 586 -IVkL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g 664 (785)
+.+.+ +.+..++|||++.|-.|...-+.. +.. .+...+..-+--|-.+|+||+|+.-=||++++++
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v~------d~~---~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHVE------DPP---TLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeeecC------ChH---HHHHHHHHHHHHHHHcCceecccchheeEEecCC
Confidence 22222 345678999999998887654311 122 2344445556678889999999999999999999
Q ss_pred eEEEEecCcccc
Q 003935 665 TVKICDFGLSRI 676 (785)
Q Consensus 665 ~VKL~DFGLA~~ 676 (785)
.++++||--...
T Consensus 240 ~i~vIDFPQmvS 251 (465)
T KOG2268|consen 240 KIVVIDFPQMVS 251 (465)
T ss_pred CEEEeechHhhc
Confidence 999999976543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.00022 Score=89.45 Aligned_cols=160 Identities=16% Similarity=0.102 Sum_probs=121.0
Q ss_pred HHHHHHHHHHhhcCCCceeeEeccccC--CCceeEEEEEcccchhhHHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHh
Q 003935 569 EDFCNEISILSRLRHPNVILFLGACTK--PPRLSMITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHR 645 (785)
Q Consensus 569 e~f~~EI~iLk~L~HPNIVkL~g~~~d--~~~l~LV~Ey~~gGSL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~AL~yLHs 645 (785)
+-...|...++...|++++....-... ....|..++|+.+|.+++.+-..- +...+....+.....+.+.+..-+|+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 344556666677789999887665433 334688999999999999886442 23345555555555555777777775
Q ss_pred c-----ccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHH
Q 003935 646 M-----KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 720 (785)
Q Consensus 646 ~-----gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyEL 720 (785)
. -.+|+++|+.|.++..+.++|++++|+.+...+.........+++.|+.|+....-.++.++|+|..|+.+|+.
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 3 27999999999999999999999999998554433334456788889999998888889899999999999999
Q ss_pred HhCCCCCC
Q 003935 721 CTLNRPWE 728 (785)
Q Consensus 721 LTG~~PF~ 728 (785)
..|..+|-
T Consensus 1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred hcccHHHH
Confidence 98887763
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0057 Score=65.81 Aligned_cols=73 Identities=18% Similarity=0.256 Sum_probs=46.0
Q ss_pred eEEeeeCcEEEEEEEEC--------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCcee-eEeccccCCCceeEEE
Q 003935 533 TRVGIGFFGEVFRGIWN--------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI-LFLGACTKPPRLSMIT 603 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~~--------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIV-kL~g~~~d~~~l~LV~ 603 (785)
+.|..|-...||++... ++.+++|+...... ......+|..++..+...++. ++++++. + .+|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~ 76 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIE 76 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchh
Confidence 45666777899998764 47899999654321 123456788888887533332 3444443 2 3588
Q ss_pred EEcccchhh
Q 003935 604 EYMELGSLY 612 (785)
Q Consensus 604 Ey~~gGSL~ 612 (785)
||++|..+.
T Consensus 77 e~i~G~~l~ 85 (302)
T cd05156 77 EFIPSRTLT 85 (302)
T ss_pred heeCCCcCC
Confidence 998886653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.03 Score=60.14 Aligned_cols=29 Identities=24% Similarity=0.328 Sum_probs=25.4
Q ss_pred cccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 646 MKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 646 ~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
.+++|+|+++.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.038 Score=62.88 Aligned_cols=76 Identities=17% Similarity=0.034 Sum_probs=51.4
Q ss_pred eeEEeeeCcEEEEEEEEC-C-eEEEEEEeecccc---C--hHHHHHHHHHHHHHhhcC---CCceeeEeccccCCCceeE
Q 003935 532 GTRVGIGFFGEVFRGIWN-G-TDVAIKVFLEQDL---T--AENMEDFCNEISILSRLR---HPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~~-g-~~VAVKil~~~~~---~--~~~~e~f~~EI~iLk~L~---HPNIVkL~g~~~d~~~l~L 601 (785)
.+.||.|.+..||++... | +.++||.-..... . .-..+.+..|.+.|+.+. -.++.+++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 367999999999999874 4 4899997431100 0 123456777888888763 2356666665 3355789
Q ss_pred EEEEcccc
Q 003935 602 ITEYMELG 609 (785)
Q Consensus 602 V~Ey~~gG 609 (785)
||||+++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99999863
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.022 Score=63.86 Aligned_cols=138 Identities=17% Similarity=0.182 Sum_probs=92.4
Q ss_pred eEEeeeCcEEEEEEEE-CCeEEEEEEeecccc----------------------ChH-HH-HHHHHHHHHHhhcCCCcee
Q 003935 533 TRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDL----------------------TAE-NM-EDFCNEISILSRLRHPNVI 587 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~----------------------~~~-~~-e~f~~EI~iLk~L~HPNIV 587 (785)
..|..|.-+.||.+.. +|..+|||+++..-+ ++. -+ -..-.|+..|++|+.-.|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 3577899999999976 788999998754321 010 01 1234678888887643322
Q ss_pred eEeccccCCCceeEEEEEcccchhh-HHHHhhcccccchHHHHHHHHHHHHHHHHHHH-hcccccccCCCCcEEEcCCCe
Q 003935 588 LFLGACTKPPRLSMITEYMELGSLY-HLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH-RMKIVHRDLKSANCLVNKHWT 665 (785)
Q Consensus 588 kL~g~~~d~~~l~LV~Ey~~gGSL~-dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLH-s~gIIHrDLKpsNILLd~~g~ 665 (785)
-.--+.. ....|||+|+...... -.| +...++...+..+-.|++.-|.-|- ..++||.||.-=|+|+.+ |.
T Consensus 230 ~PePIlL--k~hVLVM~FlGrdgw~aPkL----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~ 302 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFLGRDGWAAPKL----KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GK 302 (520)
T ss_pred CCCceee--ecceEeeeeccCCCCcCccc----ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CE
Confidence 1100001 1257899999742221 222 2345677778888889998888874 579999999999999975 69
Q ss_pred EEEEecCccccc
Q 003935 666 VKICDFGLSRII 677 (785)
Q Consensus 666 VKL~DFGLA~~l 677 (785)
+.|+|.+-+...
T Consensus 303 lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 303 LYIIDVSQSVEH 314 (520)
T ss_pred EEEEEccccccC
Confidence 999999987654
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.047 Score=60.42 Aligned_cols=146 Identities=14% Similarity=0.164 Sum_probs=83.8
Q ss_pred EeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCC--CceeeEeccccCCC--ceeEEEEEc
Q 003935 531 VGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH--PNVILFLGACTKPP--RLSMITEYM 606 (785)
Q Consensus 531 i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~H--PNIVkL~g~~~d~~--~l~LV~Ey~ 606 (785)
+.+.+-.|....+|.....++.++|. ...............+|..+|+.+.- --+-..+++|.+.. ..+.||+|+
T Consensus 29 ~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 34445445555566666668888888 33222333445666778888877642 12234456666654 779999999
Q ss_pred ccchhhH------------------HHHhhcc---------c--ccchHHHHHHHHHH--------------HHHHHHHH
Q 003935 607 ELGSLYH------------------LIHLSGQ---------K--KKLSWRRKLKMLRD--------------ICRGLMCI 643 (785)
Q Consensus 607 ~gGSL~d------------------lL~~~~~---------~--~~Ls~~~~l~Ia~Q--------------Ia~AL~yL 643 (785)
.|..+.. .|..... . ......++..+..+ ......||
T Consensus 108 eGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl 187 (321)
T COG3173 108 EGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWL 187 (321)
T ss_pred cceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHH
Confidence 9843221 1111000 0 00001111111111 12224455
Q ss_pred Hhc--------ccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 644 HRM--------KIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 644 Hs~--------gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
+.+ .++|+|+++.|+++++++.+-|.||+++..-
T Consensus 188 ~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 188 EANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 543 3799999999999999988999999998653
|
|
| >smart00460 TGc Transglutaminase/protease-like homologues | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.016 Score=48.42 Aligned_cols=58 Identities=26% Similarity=0.300 Sum_probs=41.9
Q ss_pred ccccccchhhHHHHHHhhhcCCCceec-ccCC-CCccc--ccccccceeEEeecCceeeeee
Q 003935 187 IRHGSCRPRAILFKVLADTVGLESRLM-GLPN-DGTME--CVDSYKHMSVIVVLNSVELLVD 244 (785)
Q Consensus 187 i~~g~~r~ra~lfkvlad~~~l~~~~~-g~~~-~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 244 (785)
-+.|.|.+.|.||+.|.-.+|+|||+| |+.. ++... -.....|.=+.|-.+.+=+.+|
T Consensus 4 ~~~G~C~~~a~l~~~llr~~GIpar~v~g~~~~~~~~~~~~~~~~~H~W~ev~~~~~W~~~D 65 (68)
T smart00460 4 TKYGTCGEFAALFVALLRSLGIPARVVSGYLKAPDTIGGLRSIWEAHAWAEVYLEGGWVPVD 65 (68)
T ss_pred ccceeeHHHHHHHHHHHHHCCCCeEEEeeeecCCCCCcccccCCCcEEEEEEEECCCeEEEe
Confidence 468999999999999999999999998 9722 22210 0235677777776665555555
|
Transglutaminases are enzymes that establish covalent links between proteins. A subset of transglutaminase homologues appear to catalyse the reverse reaction, the hydrolysis of peptide bonds. Proteins with this domain are both extracellular and intracellular, and it is likely that the eukaryotic intracellular proteins are involved in signalling events. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.053 Score=60.34 Aligned_cols=142 Identities=20% Similarity=0.308 Sum_probs=80.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEEC------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCcee-eEeccccCCCce
Q 003935 527 SELTVGTRVGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI-LFLGACTKPPRL 599 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~~------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIV-kL~g~~~d~~~l 599 (785)
+.+.+ +.|-.|-...+|++... ++.|++|+...... ..-.-.+|..+++.+..-++. ++++.+.. +
T Consensus 37 ~~~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~---~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g-- 109 (344)
T PLN02236 37 EALQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE---LFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G-- 109 (344)
T ss_pred CcEEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC---eeechHHHHHHHHHHHHcCCCCceEEEECC-c--
Confidence 34444 45545888999998752 35789998754321 111225688888888643333 34454432 2
Q ss_pred eEEEEEcccchhhHH-----------------HHhhc-c--cccchHHHHHHHHHHH-----------------HHHHHH
Q 003935 600 SMITEYMELGSLYHL-----------------IHLSG-Q--KKKLSWRRKLKMLRDI-----------------CRGLMC 642 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dl-----------------L~~~~-~--~~~Ls~~~~l~Ia~QI-----------------a~AL~y 642 (785)
.|.+|+++.++... +|... . .....+..+..++.++ ...+..
T Consensus 110 -~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~ 188 (344)
T PLN02236 110 -RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL 188 (344)
T ss_pred -eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence 57999987665311 11111 0 0012233333333222 111222
Q ss_pred H----H----hcccccccCCCCcEEEcC-CCeEEEEecCcccc
Q 003935 643 I----H----RMKIVHRDLKSANCLVNK-HWTVKICDFGLSRI 676 (785)
Q Consensus 643 L----H----s~gIIHrDLKpsNILLd~-~g~VKL~DFGLA~~ 676 (785)
| . ...++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2 1 235899999999999986 46899999988753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.063 Score=57.93 Aligned_cols=30 Identities=20% Similarity=0.432 Sum_probs=25.2
Q ss_pred ccccccCCCCcEEEcCCCe-EEEEecCcccc
Q 003935 647 KIVHRDLKSANCLVNKHWT-VKICDFGLSRI 676 (785)
Q Consensus 647 gIIHrDLKpsNILLd~~g~-VKL~DFGLA~~ 676 (785)
.++|+|+++.|||+++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 46999998854
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.1 Score=59.65 Aligned_cols=75 Identities=17% Similarity=0.002 Sum_probs=50.8
Q ss_pred eeEEeeeCcEEEEEEEECCeEEEEEEeecccc--C---hHHHHHHHHHHHHHhhcC---CCceeeEeccccCCCceeEEE
Q 003935 532 GTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDL--T---AENMEDFCNEISILSRLR---HPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~--~---~~~~e~f~~EI~iLk~L~---HPNIVkL~g~~~d~~~l~LV~ 603 (785)
.+.||.|....||++...+..++||.-..... . +.....-..|...|+.+. ..++.+++.++.+. .+++|
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlvM 114 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIGM 114 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEEE
Confidence 57899999999999987777899997531111 0 012344445677776653 24677788887744 57889
Q ss_pred EEccc
Q 003935 604 EYMEL 608 (785)
Q Consensus 604 Ey~~g 608 (785)
||+++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99976
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.11 Score=56.83 Aligned_cols=74 Identities=22% Similarity=0.151 Sum_probs=46.6
Q ss_pred EeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC---CCceeeEeccccCCCceeEEEEEcc
Q 003935 531 VGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR---HPNVILFLGACTKPPRLSMITEYME 607 (785)
Q Consensus 531 i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~---HPNIVkL~g~~~d~~~l~LV~Ey~~ 607 (785)
-.+.|+-|....+|+...+++.+.||+-.... ...|..|.+-|+.|. --.+.+.+++....+..++++||++
T Consensus 21 ~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLDTDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp EEEEE--SSSSEEEEEETTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeEecCCCChhheEEEECCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 45678889999999988888999999965221 245778888888883 3345567776665666799999998
Q ss_pred cc
Q 003935 608 LG 609 (785)
Q Consensus 608 gG 609 (785)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 66
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.43 E-value=0.16 Score=55.28 Aligned_cols=30 Identities=17% Similarity=0.219 Sum_probs=27.3
Q ss_pred ccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 647 KIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 647 gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
+++|+|+.+.|||+++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999998999999987753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.094 Score=57.95 Aligned_cols=142 Identities=18% Similarity=0.253 Sum_probs=78.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEECC-----eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCcee-eEeccccCCCcee
Q 003935 527 SELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI-LFLGACTKPPRLS 600 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~~g-----~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIV-kL~g~~~d~~~l~ 600 (785)
+++++ +.|..|-...+|++...+ ..|++|+...... ..-.-.+|..+++.+..-++- ++++++. .+
T Consensus 15 ~~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G--- 86 (330)
T PLN02421 15 SDFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG--- 86 (330)
T ss_pred CceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---
Confidence 44544 445448888999986543 3788998754321 112234688888888644442 4454442 22
Q ss_pred EEEEEcccchhhH--------------HHHhhcc-----cc-cchHHHHHHHHHHH----------------------HH
Q 003935 601 MITEYMELGSLYH--------------LIHLSGQ-----KK-KLSWRRKLKMLRDI----------------------CR 638 (785)
Q Consensus 601 LV~Ey~~gGSL~d--------------lL~~~~~-----~~-~Ls~~~~l~Ia~QI----------------------a~ 638 (785)
+|.+|+++.++.. .+..... .. .-.+..+..+..++ ..
T Consensus 87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 166 (330)
T PLN02421 87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD 166 (330)
T ss_pred EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence 5888887765421 1111000 01 11233333333222 11
Q ss_pred HHHHHH----hc----ccccccCCCCcEEEcC-CCeEEEEecCcccc
Q 003935 639 GLMCIH----RM----KIVHRDLKSANCLVNK-HWTVKICDFGLSRI 676 (785)
Q Consensus 639 AL~yLH----s~----gIIHrDLKpsNILLd~-~g~VKL~DFGLA~~ 676 (785)
-+..+. .. -++|+|+.+.|||+++ ++.++++||..|..
T Consensus 167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 122221 11 3799999999999975 57899999998743
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.04 E-value=0.26 Score=55.59 Aligned_cols=73 Identities=19% Similarity=0.076 Sum_probs=46.0
Q ss_pred EEeeeCcEEEEEEEECC--eEEEEEEeec-----cccChHHHHHHHHHHHHHhhcC--CC-ceeeEeccccCCCceeEEE
Q 003935 534 RVGIGFFGEVFRGIWNG--TDVAIKVFLE-----QDLTAENMEDFCNEISILSRLR--HP-NVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 534 ~LG~G~fG~VYkg~~~g--~~VAVKil~~-----~~~~~~~~e~f~~EI~iLk~L~--HP-NIVkL~g~~~d~~~l~LV~ 603 (785)
.||.|....||++...+ +.++||.-.. ....+-...+..-|...|+... .| ++.++|.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 47999999999998753 5799986321 1011122345567788887663 34 34445543 444567999
Q ss_pred EEccc
Q 003935 604 EYMEL 608 (785)
Q Consensus 604 Ey~~g 608 (785)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99864
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.97 E-value=0.55 Score=51.74 Aligned_cols=70 Identities=11% Similarity=0.022 Sum_probs=40.9
Q ss_pred eCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCc--eeeE---ec--cccCCCceeEEEEEcccc
Q 003935 538 GFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--VILF---LG--ACTKPPRLSMITEYMELG 609 (785)
Q Consensus 538 G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN--IVkL---~g--~~~d~~~l~LV~Ey~~gG 609 (785)
+.-..||+... ++..+++|+....... ..++..|++.+..|.... ++.. -| ....++..+.++++++|.
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~---~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~ 112 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPERWS---DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR 112 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcccCC---HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence 45577999876 4678999987543333 344556777776663111 2221 11 112234577899998875
Q ss_pred h
Q 003935 610 S 610 (785)
Q Consensus 610 S 610 (785)
.
T Consensus 113 ~ 113 (325)
T PRK11768 113 A 113 (325)
T ss_pred C
Confidence 4
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.94 E-value=0.58 Score=52.13 Aligned_cols=137 Identities=19% Similarity=0.248 Sum_probs=81.7
Q ss_pred EEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCc------eeeEecc----ccCCCceeEEE
Q 003935 534 RVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN------VILFLGA----CTKPPRLSMIT 603 (785)
Q Consensus 534 ~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN------IVkL~g~----~~d~~~l~LV~ 603 (785)
.|.. .-..||+....+..+++|+.... ... .++..|+..|..|.-.+ +..+-|- .......+.++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRYILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred cccc-ccCceEEEEecCCCeEEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 3444 55679999887667799998665 333 45566777777763211 2222222 22223678899
Q ss_pred EEcccchhhH---------------HHHhhccc---------ccchHHH----H---------HHHHHHHHHHHHHHHh-
Q 003935 604 EYMELGSLYH---------------LIHLSGQK---------KKLSWRR----K---------LKMLRDICRGLMCIHR- 645 (785)
Q Consensus 604 Ey~~gGSL~d---------------lL~~~~~~---------~~Ls~~~----~---------l~Ia~QIa~AL~yLHs- 645 (785)
+|++|..+.. .++..... ....|.. . .....++...+..+..
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999877662 11111100 1122320 0 1133444555555553
Q ss_pred -------cc--cccccCCCCcEEEcCCCe-EEEEecCccc
Q 003935 646 -------MK--IVHRDLKSANCLVNKHWT-VKICDFGLSR 675 (785)
Q Consensus 646 -------~g--IIHrDLKpsNILLd~~g~-VKL~DFGLA~ 675 (785)
.+ +||+|+.+.||+++.+.. +-++||+.+.
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 24 999999999999998875 8899999874
|
|
| >PF01841 Transglut_core: Transglutaminase-like superfamily; InterPro: IPR002931 This domain is found in many proteins known to have transglutaminase activity, i | Back alignment and domain information |
|---|
Probab=93.57 E-value=0.086 Score=48.05 Aligned_cols=99 Identities=22% Similarity=0.302 Sum_probs=53.7
Q ss_pred HHHHHHHHhcCCCChHHHHHHHHHHHHhhhCCC-CCCChhhhhHHHHHHHHhhcceeEeccccccccchhhHHHHHHhhh
Q 003935 127 KQLIVALVKGLNSNPAAMIKKIAGLVADFYKRP-SVESPAKAALEETSHMFETRGVQLLGQIRHGSCRPRAILFKVLADT 205 (785)
Q Consensus 127 ~~l~~~~~~~~~~~~~~~~~~~a~~v~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~g~i~~g~~r~ra~lfkvlad~ 205 (785)
|+|...++.+.. ++.+.++.|...|.+.+.-- ......... -...|+ -+.|.|..-|.||..|+-.
T Consensus 1 ~~la~~i~~~~~-~~~~~~~~i~~~v~~~~~y~~~~~~~~~~~---~~~~l~---------~~~G~C~~~a~l~~allr~ 67 (113)
T PF01841_consen 1 RALAREITANSK-TPLEKAKAIYDWVRSNIRYDDPNYSPGPRD---ASEVLR---------SGRGDCEDYASLFVALLRA 67 (113)
T ss_dssp --------TTSH-CHHCCCCCCCCCCCCCCCEC-TCCCCCCTT---HHHHHH---------CEEESHHHHHHHHHHHHHH
T ss_pred CCcccccCCCCC-CHHHHHHHHHHHHHhCcEEeCCCCCCCCCC---HHHHHH---------cCCCccHHHHHHHHHHHhh
Confidence 355666665555 56666666666666555433 011111100 112222 3459999999999999999
Q ss_pred cCCCceec-ccCCC----CcccccccccceeEEeecCc
Q 003935 206 VGLESRLM-GLPND----GTMECVDSYKHMSVIVVLNS 238 (785)
Q Consensus 206 ~~l~~~~~-g~~~~----~~~~~~~~~~~~~~~~~~~~ 238 (785)
.|+|||+| |...+ +...-.+...|.-+-|-+++
T Consensus 68 ~Gipar~v~g~~~~~~~~~~~~~~~~~~H~w~ev~~~~ 105 (113)
T PF01841_consen 68 LGIPARVVSGYVKGPDPDGDYSVDGNDNHAWVEVYLPG 105 (113)
T ss_dssp HT--EEEEEEEEEECSSTTCTSTSSEEEEEEEEEEETT
T ss_pred CCCceEEEEEEcCCccccccccCCCCCCEEEEEEEEcC
Confidence 99999999 87332 22334455668888877733
|
e. which cross-link proteins through an acyl-transfer reaction between the gamma-carboxamide group of peptide-bound glutamine and the epsilon-amino group of peptide-bound lysine, resulting in a epsilon-(gamma-glutamyl)lysine isopeptide bond. Tranglutaminases have been found in a diverse range of species, from bacteria through to mammals. The enzymes require calcium binding and their activity leads to post-translational modification of proteins through acyl-transfer reactions, involving peptidyl glutamine residues as acyl donors and a variety of primary amines as acyl acceptors, with the generation of proteinase resistant isopeptide bonds []. Sequence conservation in this superfamily primarily involves three motifs that centre around conserved cysteine, histidine, and aspartate residues that form the catalytic triad in the structurally characterised transglutaminase, the human blood clotting factor XIIIa' []. On the basis of the experimentally demonstrated activity of the Methanobacterium phage psiM2 pseudomurein endoisopeptidase [], it is proposed that many, if not all, microbial homologs of the transglutaminases are proteases and that the eukaryotic transglutaminases have evolved from an ancestral protease []. A subunit of plasma Factor XIII revealed that each Factor XIIIA subunit is composed of four domains (termed N-terminal beta-sandwich, core domain (containing the catalytic and the regulatory sites), and C-terminal beta-barrels 1 and 2) and that two monomers assemble into the native dimer through the surfaces in domains 1 and 2, in opposite orientation. This organisation in four domains is highly conserved during evolution among transglutaminase isoforms [].; PDB: 2F4M_A 2F4O_A 1GGY_B 1FIE_B 1GGU_B 1GGT_B 1F13_A 1QRK_B 1EVU_A 1EX0_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=93.57 E-value=0.21 Score=56.98 Aligned_cols=75 Identities=17% Similarity=0.035 Sum_probs=49.1
Q ss_pred eeEEeeeCcEEEEEEEEC--CeEEEEEEeec----cccChHHHHHHHHHHHHHhhcC--CC-ceeeEeccccCCCceeEE
Q 003935 532 GTRVGIGFFGEVFRGIWN--GTDVAIKVFLE----QDLTAENMEDFCNEISILSRLR--HP-NVILFLGACTKPPRLSMI 602 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~~--g~~VAVKil~~----~~~~~~~~e~f~~EI~iLk~L~--HP-NIVkL~g~~~d~~~l~LV 602 (785)
.+.||.|.-..||++... ++.++||.-.. ...-+-...+..-|.+.|+... .| ++.++|.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 578999999999999874 56789986321 1111123456677888888764 44 34445553 44456788
Q ss_pred EEEccc
Q 003935 603 TEYMEL 608 (785)
Q Consensus 603 ~Ey~~g 608 (785)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 988864
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.94 E-value=0.89 Score=57.80 Aligned_cols=31 Identities=26% Similarity=0.420 Sum_probs=26.2
Q ss_pred cccccccCCCCcEEEcCCC--eEE-EEecCcccc
Q 003935 646 MKIVHRDLKSANCLVNKHW--TVK-ICDFGLSRI 676 (785)
Q Consensus 646 ~gIIHrDLKpsNILLd~~g--~VK-L~DFGLA~~ 676 (785)
.++||+|+.+.|||++.++ ++. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999775 565 999998753
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.57 E-value=1 Score=51.21 Aligned_cols=78 Identities=17% Similarity=0.123 Sum_probs=45.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEECC---eE-----EEEEEeeccccChHHHHHHHHHHHHHhhcCCCcee-eEeccccCCC
Q 003935 527 SELTVGTRVGIGFFGEVFRGIWNG---TD-----VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI-LFLGACTKPP 597 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~~g---~~-----VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIV-kL~g~~~d~~ 597 (785)
+++.+ +.|..|-...+|++...+ .. |.+++.... ....-+-.+|+.+++.+...++- ++++.+.
T Consensus 51 ~~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~---~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~--- 123 (383)
T PTZ00384 51 EFIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY---NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG--- 123 (383)
T ss_pred ccEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC---CceEeccHHHHHHHHHHHhCCCCCeEEEecC---
Confidence 34444 455558889999986532 22 344432111 11111224689999998755554 4455543
Q ss_pred ceeEEEEEcccchhh
Q 003935 598 RLSMITEYMELGSLY 612 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~ 612 (785)
-+++.||++|-+|.
T Consensus 124 -~g~l~efIeGr~l~ 137 (383)
T PTZ00384 124 -DFTIQEWVEGNTMG 137 (383)
T ss_pred -CEEEEEEeccccCC
Confidence 26999999987664
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=91.92 E-value=0.73 Score=49.23 Aligned_cols=76 Identities=20% Similarity=0.150 Sum_probs=55.9
Q ss_pred eeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCC---CceeeEeccccCCCceeEEEEEccc
Q 003935 532 GTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH---PNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~H---PNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
.+.+.-|.--..|...+...++.||+-. .+....|..|+.-|..+.- -.+-+++.+-....+.|+|+||++-
T Consensus 21 r~~v~gG~inea~~v~dg~~~~FvK~n~-----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~ 95 (286)
T COG3001 21 REEVSGGDINEAWRLRDGTDPFFVKCNQ-----REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT 95 (286)
T ss_pred ccccCCccccceeEeecCCcceEEEecc-----hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence 3456667777788888888899999832 3345678888887777743 4466777777888889999999997
Q ss_pred chhh
Q 003935 609 GSLY 612 (785)
Q Consensus 609 GSL~ 612 (785)
+.+.
T Consensus 96 ~~~d 99 (286)
T COG3001 96 GPLD 99 (286)
T ss_pred CCCC
Confidence 6554
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.47 E-value=0.64 Score=54.48 Aligned_cols=152 Identities=22% Similarity=0.253 Sum_probs=90.0
Q ss_pred HHHHHHHHHHhhcCCCceeeEeccccCC-CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc
Q 003935 569 EDFCNEISILSRLRHPNVILFLGACTKP-PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647 (785)
Q Consensus 569 e~f~~EI~iLk~L~HPNIVkL~g~~~d~-~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~g 647 (785)
.+++-..+.++.+.|+|...++++.... .+..+|+|++. .+|.+.+.... .... +++ -+|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~-------------s~~----~~~ 87 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDE-------------SLL----AHG 87 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchh-------------hhc----ccc
Confidence 4566778889999999999999886543 45788999885 58888886332 1110 011 222
Q ss_pred cccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003935 648 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 727 (785)
Q Consensus 648 IIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF 727 (785)
+.|- |+ ++.+| - .... | | .+..+|+|||++|.++.+++-|..-|
T Consensus 88 ~~~~-----~~-------~~~td-~---~~t~-------------~--~-----~~~~pKsdVwsl~~i~~el~L~~~l~ 131 (725)
T KOG1093|consen 88 VLHL-----NI-------IYITD-H---FLTK-------------Y--P-----SPIGPKSDVWSLGFIILELYLGISLE 131 (725)
T ss_pred ccee-----hh-------hhccc-c---cccc-------------C--C-----CCCCcchhhhhHHHHHHHHHHhhHHH
Confidence 2222 12 22333 0 0000 0 0 01124999999999999999998877
Q ss_pred CCCChHHHHHHHHhcCCCCCC-------------CChHHHHHHHHhhh-CCCCCCCHHHHHH
Q 003935 728 EGVLPERVVYAVANEGSRLEI-------------PEGPLGRLIADCWA-EPQERPSCEEILS 775 (785)
Q Consensus 728 ~~~~~~~~v~~i~~~~~~~~i-------------p~~~L~~LI~~CL~-DP~kRPS~~EIL~ 775 (785)
......+....+..-.....- .+..+..+...|+. .|..||...++.+
T Consensus 132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 766665555544332211110 11224456777877 8888887666554
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=89.89 E-value=0.78 Score=51.90 Aligned_cols=56 Identities=23% Similarity=0.282 Sum_probs=47.7
Q ss_pred chHHHHHHHHHHHHHHHHHHHhc-ccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 624 LSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 624 Ls~~~~l~Ia~QIa~AL~yLHs~-gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
-.++++..++++.+..+.-+... .+-|||+...||||+ +|+|.|+||-+++.-...
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~~~q 374 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSYSQ 374 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecccCC
Confidence 45788899999988888888754 799999999999999 899999999999865443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 785 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-71 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-71 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-40 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-39 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-39 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-39 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-38 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-37 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-37 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-37 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-37 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-37 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-37 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-37 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-37 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-37 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-37 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-37 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-37 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-37 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-37 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-36 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-36 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-36 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-36 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-36 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-36 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-36 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-36 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-36 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-36 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-36 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-36 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-36 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-36 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-36 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-36 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-36 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-36 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-36 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-36 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-36 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-36 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-35 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-35 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-35 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-35 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-35 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-35 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-35 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-34 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-34 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-34 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-34 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-33 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-33 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-33 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-33 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-33 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-33 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-33 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-33 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-33 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-32 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-32 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-32 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-32 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-32 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-32 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-32 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-32 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-32 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-32 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-32 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-32 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-32 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-32 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-32 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-32 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-32 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-32 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-32 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-32 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-32 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-32 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-32 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-32 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-32 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-31 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-31 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-31 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-31 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-31 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-31 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-31 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-31 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-31 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-31 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-31 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-31 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-31 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-31 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-31 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-31 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-31 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-30 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-30 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-30 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-30 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-30 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-30 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-30 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-30 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-30 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-30 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-30 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-30 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-29 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-29 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-29 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-29 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-29 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-29 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-29 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-29 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-29 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-29 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-29 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-29 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-29 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-29 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-29 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-29 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-29 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-29 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-29 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-29 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-29 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-28 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-28 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-28 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-28 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-28 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-28 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-28 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-28 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-28 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-28 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-28 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-28 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-28 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-28 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-28 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-28 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-28 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-28 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-28 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-28 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-28 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-28 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-28 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-28 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-27 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-27 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-27 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-27 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-27 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-27 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-27 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-27 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-27 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-27 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-27 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-27 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-27 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-27 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-27 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-26 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-26 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-26 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-26 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-26 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-26 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-26 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-26 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-26 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-26 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-26 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-26 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-26 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-26 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-26 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-26 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-26 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-26 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-26 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-26 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-26 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-25 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-25 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-25 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-25 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-25 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-25 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-25 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-25 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-25 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-25 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-25 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-25 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-25 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-25 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-25 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-25 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-25 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-25 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-25 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-25 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-24 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-24 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-24 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-24 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-24 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-24 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-24 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-24 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-24 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-24 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-24 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-24 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-24 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-24 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-24 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-24 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-24 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-24 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-23 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-23 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-23 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-23 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-23 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-23 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-23 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-23 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-23 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-23 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-23 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-23 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-23 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-23 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-23 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-23 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-23 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-23 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-23 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-23 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-23 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-23 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-23 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-23 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-23 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-23 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-23 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-23 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-23 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-22 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-22 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-22 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-22 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-22 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-22 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-22 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-22 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-22 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-22 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-22 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-22 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-22 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-22 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-22 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-22 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-22 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-22 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-22 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-22 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-21 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-21 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-21 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-21 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-21 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-21 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-21 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-21 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-21 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-21 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-21 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-21 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-21 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-21 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-21 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-21 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-21 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-21 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-21 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-21 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-21 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-21 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-21 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-21 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-21 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-21 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-21 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-21 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-21 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-21 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-21 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-21 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-21 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-21 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-21 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-21 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-21 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-20 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-20 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-20 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-20 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-20 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-20 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-20 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-20 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-20 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-20 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-20 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-20 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-20 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-20 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-20 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-20 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-20 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-20 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-20 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-20 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-20 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-20 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-20 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-20 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-20 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-20 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-20 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-20 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-20 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-20 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-20 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-20 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-20 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-20 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-19 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-19 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-19 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-19 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-19 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-19 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-19 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-19 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-18 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-18 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-18 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-18 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-18 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-18 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-18 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-18 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-18 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-18 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-18 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-18 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-18 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-17 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-17 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-17 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-17 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-17 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-17 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-17 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-17 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-17 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-17 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-17 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-17 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-17 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-17 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-17 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-17 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-17 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-17 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-17 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-17 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-17 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-17 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-17 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-17 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-17 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-17 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-17 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-17 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-17 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-17 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-16 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-16 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-16 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-16 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-16 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-16 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-16 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-16 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-16 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-16 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-16 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-16 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-15 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-15 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-15 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-15 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-15 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-15 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-15 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-15 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-15 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-15 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-15 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-14 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-14 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-14 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-14 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-14 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-14 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-14 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-14 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-13 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-13 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-13 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-13 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-13 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-13 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-13 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-13 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-13 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-13 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-13 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-13 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-13 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-13 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-13 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-13 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-13 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-13 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-13 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-11 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-11 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-10 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-10 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-10 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 9e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 420 bits (1082), Expect = e-142
Identities = 125/289 (43%), Positives = 187/289 (64%), Gaps = 6/289 (2%)
Query: 495 NSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVA 554
+ + + + + + ++ +I + +L + ++G G FG V R W+G+DVA
Sbjct: 5 HHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVA 64
Query: 555 IKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHL 614
+K+ +EQD AE + +F E++I+ RLRHPN++LF+GA T+PP LS++TEY+ GSLY L
Sbjct: 65 VKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRL 124
Query: 615 IHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFG 672
+H SG +++L RR+L M D+ +G+ +H IVHR+LKS N LV+K +TVK+CDFG
Sbjct: 125 LHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFG 184
Query: 673 LSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP 732
LSR+ + + S+AGTPEWMAPE++R+EP EK D++S GVI+WEL TL +PW + P
Sbjct: 185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP 244
Query: 733 ERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 777
+VV AV + RLEIP + +I CW EP +RPS I+ L
Sbjct: 245 AQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 381 bits (981), Expect = e-128
Identities = 94/273 (34%), Positives = 142/273 (52%), Gaps = 23/273 (8%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLE--QDLTAENMEDFCNEISILS 579
IDF+ELT+ +GIG FG+V+R W G +VA+K + ++ +E+ E + +
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 580 RLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 639
L+HPN+I G C K P L ++ E+ G L ++ K++ + I RG
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARG 117
Query: 640 LMCIHRMK---IVHRDLKSANCLVNK--------HWTVKICDFGLSRIITDSPMRDSSSA 688
+ +H I+HRDLKS+N L+ + + +KI DFGL+R + S+A
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAA 175
Query: 689 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI 748
G WMAPE+IR F++ D++S GV++WEL T P+ G+ V Y VA L I
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235
Query: 749 PEG---PLGRLIADCWA-EPQERPSCEEILSRL 777
P P +L+ DCW +P RPS IL +L
Sbjct: 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 379 bits (975), Expect = e-127
Identities = 76/269 (28%), Positives = 128/269 (47%), Gaps = 17/269 (6%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILS 579
+ IDF +L T++ GE+++G W G D+ +KV +D + DF E L
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLR 62
Query: 580 RLRHPNVILFLGACTKPP--RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
HPNV+ LGAC PP ++IT +M GSLY+++H G + + +K D+
Sbjct: 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMA 121
Query: 638 RGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMA 695
RG+ +H ++ I L S + ++++ T +I + + P W+A
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS-----FQSPGRMYAPAWVA 176
Query: 696 PELIRNEP---FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG- 751
PE ++ +P D++S V++WEL T P+ + + VA EG R IP G
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGI 236
Query: 752 --PLGRLIADCW-AEPQERPSCEEILSRL 777
+ +L+ C +P +RP + I+ L
Sbjct: 237 SPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 373 bits (959), Expect = e-124
Identities = 81/290 (27%), Positives = 145/290 (50%), Gaps = 24/290 (8%)
Query: 507 ESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE 566
P ++ + +EW+I F +L +G +G G FG+V+ G W+G +VAI++ + +
Sbjct: 13 SFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNED 71
Query: 567 NMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSW 626
++ F E+ + RH NV+LF+GAC PP L++IT + +LY ++ K L
Sbjct: 72 QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR--DAKIVLDV 129
Query: 627 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD-- 684
+ ++ ++I +G+ +H I+H+DLKS N + + V I DFGL I
Sbjct: 130 NKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE 188
Query: 685 ---SSSAGTPEWMAPELIRN---------EPFTEKCDIFSLGVIMWELCTLNRPWEGVLP 732
G +APE+IR PF++ D+F+LG I +EL P++
Sbjct: 189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA 248
Query: 733 ERVVYAVANEGSRLEIPEG----PLGRLIADCWA-EPQERPSCEEILSRL 777
E +++ + G + + + + ++ CWA E +ERP+ +++ L
Sbjct: 249 EAIIWQMGT-GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 371 bits (955), Expect = e-123
Identities = 75/279 (26%), Positives = 124/279 (44%), Gaps = 21/279 (7%)
Query: 518 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISI 577
+ S+L G +G G FG+ + T + + E F E+ +
Sbjct: 1 SMPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKV 60
Query: 578 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
+ L HPNV+ F+G K RL+ ITEY++ G+L +I + W +++ +DI
Sbjct: 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK--SMDSQYPWSQRVSFAKDIA 118
Query: 638 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS------------ 685
G+ +H M I+HRDL S NCLV ++ V + DFGL+R++ D +
Sbjct: 119 SGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 686 --SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NE 742
+ G P WMAPE+I + EK D+FS G+++ E+ LP + + +
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238
Query: 743 GSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 777
P + C +P++RPS ++ L
Sbjct: 239 FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 370 bits (953), Expect = e-123
Identities = 87/273 (31%), Positives = 154/273 (56%), Gaps = 17/273 (6%)
Query: 518 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISI 577
A ++W I ++TVG R+G G FG V++G W+G DVA+K+ T + ++ F NE+ +
Sbjct: 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGV 73
Query: 578 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
L + RH N++LF+G T P L+++T++ E SLYH +H + K ++ + + R
Sbjct: 74 LRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTA 130
Query: 638 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDSSSAGTPEWMA 695
RG+ +H I+HRDLKS N +++ TVKI DFGL+ + +G+ WMA
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 696 PELIRNE---PFTEKCDIFSLGVIMWELCTLNRPWEGVLP-ERVVYAVANEGSRLEIPEG 751
PE+IR + P++ + D+++ G++++EL T P+ + ++++ V ++ +
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV 250
Query: 752 P------LGRLIADCWA-EPQERPSCEEILSRL 777
+ RL+A+C + ERPS IL+ +
Sbjct: 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 358 bits (921), Expect = e-119
Identities = 83/287 (28%), Positives = 131/287 (45%), Gaps = 29/287 (10%)
Query: 513 NKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-----TA 565
+ +E+ ++G G FG V +G + + VAIK + D
Sbjct: 5 GSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 566 ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLS 625
E ++F E+ I+S L HPN++ G PP M+ E++ G LYH + + +
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLL--DKAHPIK 120
Query: 626 WRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLV-----NKHWTVKICDFGLSRIIT 678
W KL+++ DI G+ + IVHRDL+S N + N K+ DFGLS+
Sbjct: 121 WSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV 180
Query: 679 DSPMRDSSSAGTPEWMAPELI--RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE--R 734
S G +WMAPE I E +TEK D +S +I++ + T P++ +
Sbjct: 181 HSVS---GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237
Query: 735 VVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 777
+ + EG R IPE L +I CW+ +P++RP I+ L
Sbjct: 238 FINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 354 bits (911), Expect = e-117
Identities = 87/270 (32%), Positives = 139/270 (51%), Gaps = 18/270 (6%)
Query: 524 IDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH 583
ID+ E+ V VG G FG V + W DVAIK + + F E+ LSR+ H
Sbjct: 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES----ERKAFIVELRQLSRVNH 60
Query: 584 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 643
PN++ GAC P + ++ EY E GSLY+++H + + + +G+ +
Sbjct: 61 PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 644 HRMK---IVHRDLKSANCLVNKHWTV-KICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 699
H M+ ++HRDLK N L+ TV KICDFG + I ++ G+ WMAPE+
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT---NNKGSAAWMAPEVF 175
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGV-LPERVVYAVANEGSRLEIPEG---PLGR 755
++EKCD+FS G+I+WE+ T +P++ + P + + G+R + + P+
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235
Query: 756 LIADCWA-EPQERPSCEEILSRLLDCEYSL 784
L+ CW+ +P +RPS EEI+ +
Sbjct: 236 LMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 316 bits (812), Expect = e-102
Identities = 81/300 (27%), Positives = 132/300 (44%), Gaps = 53/300 (17%)
Query: 528 ELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
++T+ VG G +GEV+RG W G +VA+K+F +D + E E+ LRH N++
Sbjct: 9 DITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRE---TELYNTVMLRHENIL 65
Query: 588 LFLGACTK----PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 643
F+ + +L +IT Y E+GSLY + L L+++ I GL +
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHL 121
Query: 644 H--------RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP----MRDSSSAGTP 691
H + I HRDLKS N LV K+ I D GL+ + + S + ++ GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 692 EWMAPELIRNEP------FTEKCDIFSLGVIMWELCT----------LNRPWEGVLP--- 732
+MAPE++ ++ DI++ G+++WE+ P+ V+P
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241
Query: 733 --ERVVYAVANEGSRLEIPE--------GPLGRLIADCW-AEPQERPSCEEILSRLLDCE 781
E + V + R IP L +L+ +CW P R + I L +
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 301
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 317 bits (815), Expect = e-102
Identities = 78/307 (25%), Positives = 124/307 (40%), Gaps = 53/307 (17%)
Query: 517 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEIS 576
L ++ + ++G G +GEV+ G W G VA+KVF + + E EI
Sbjct: 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRE---TEIY 83
Query: 577 ILSRLRHPNVILFLGACTKP----PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM 632
+RH N++ F+ A K +L +IT+Y E GSLY + L + LK+
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKL 139
Query: 633 LRDICRGLMCIH--------RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684
GL +H + I HRDLKS N LV K+ T I D GL+
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199
Query: 685 ----SSSAGTPEWMAPELI------RNEPFTEKCDIFSLGVIMWELCT----------LN 724
++ GT +M PE++ + D++S G+I+WE+
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259
Query: 725 RPWEGVLP-----ERVVYAVANEGSRLEIPEGP--------LGRLIADCW-AEPQERPSC 770
P+ ++P E + V + R P +G+L+ +CW P R +
Sbjct: 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319
Query: 771 EEILSRL 777
+ L
Sbjct: 320 LRVKKTL 326
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = 2e-96
Identities = 75/307 (24%), Positives = 130/307 (42%), Gaps = 53/307 (17%)
Query: 517 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEIS 576
L + + +G G FGEV+RG W G +VA+K+F ++ + E EI
Sbjct: 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIY 88
Query: 577 ILSRLRHPNVILFLGACTK----PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM 632
LRH N++ F+ A K +L ++++Y E GSL+ ++ + ++ +K+
Sbjct: 89 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKL 144
Query: 633 LRDICRGLMCIH--------RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684
GL +H + I HRDLKS N LV K+ T I D GL+ +
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204
Query: 685 ----SSSAGTPEWMAPELIRNE------PFTEKCDIFSLGVIMWELCTLNR--------- 725
+ GT +MAPE++ + ++ DI+++G++ WE+
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264
Query: 726 -PWEGVLP-----ERVVYAVANEGSRLEIPEG--------PLGRLIADCW-AEPQERPSC 770
P+ ++P E + V + R IP + +++ +CW A R +
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324
Query: 771 EEILSRL 777
I L
Sbjct: 325 LRIKKTL 331
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 8e-92
Identities = 78/320 (24%), Positives = 127/320 (39%), Gaps = 68/320 (21%)
Query: 517 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEIS 576
A E ++D L + +G G +G V++G + VA+KVF + ++F NE +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKN 57
Query: 577 I--LSRLRHPNVILFLGACTKPP-----RLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 629
I + + H N+ F+ + ++ EY GSL + W
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS----LHTSDWVSS 113
Query: 630 LKMLRDICRGLMCIH---------RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680
++ + RGL +H + I HRDL S N LV T I DFGLS +T +
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 681 PMRDSSS--------AGTPEWMAPELIRN-------EPFTEKCDIFSLGVIMWEL---CT 722
+ GT +MAPE++ E ++ D+++LG+I WE+ CT
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 723 LNRPWEGVLPERVVYA---------------VANEGSRLEIPEG---------PLGRLIA 758
P E V ++ + V+ E R + PE L I
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 759 DCW-AEPQERPSCEEILSRL 777
DCW + + R + + R+
Sbjct: 294 DCWDQDAEARLTAQXAEERM 313
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 278 bits (712), Expect = 2e-87
Identities = 67/305 (21%), Positives = 117/305 (38%), Gaps = 53/305 (17%)
Query: 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISIL 578
E L + G FG V++ VA+K+F QD + E+ L
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSL 72
Query: 579 SRLRHPNVILFLGACTKPPRLSM----ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 634
++H N++ F+GA + + + IT + E GSL + +SW +
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK----ANVVSWNELCHIAE 128
Query: 635 DICRGLMCIH----------RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684
+ RGL +H + I HRD+KS N L+ + T I DFGL+
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 685 SSS--AGTPEWMAPELIRNEP-----FTEKCDIFSLGVIMWELCTLNRPWEGVLP----- 732
+ GT +MAPE++ + D++++G+++WEL + +G +
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 733 -----------ERVVYAVANEGSRLEIPE--------GPLGRLIADCWAE-PQERPSCEE 772
E + V ++ R + + L I +CW + R S
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
Query: 773 ILSRL 777
+ R+
Sbjct: 309 VGERI 313
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 2e-73
Identities = 80/274 (29%), Positives = 131/274 (47%), Gaps = 16/274 (5%)
Query: 517 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDF 571
+ ++ I ++ + +G GFFGEV+ G++ +VA+K ++D T +N E F
Sbjct: 2 MGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKT-CKKDCTLDNKEKF 60
Query: 572 CNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK 631
+E I+ L HP+++ +G + P +I E G L +L K L +
Sbjct: 61 MSEAVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGEL--GHYLERNKNSLKVLTLVL 117
Query: 632 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 691
IC+ + + + VHRD+ N LV VK+ DFGLSR I D +S P
Sbjct: 118 YSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP 177
Query: 692 -EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP 749
+WM+PE I FT D++ V MWE+ + +P+ + + V+ + +G RL P
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-EKGDRLPKP 236
Query: 750 EG---PLGRLIADCWA-EPQERPSCEEILSRLLD 779
+ L L+ CW +P +RP E++ L D
Sbjct: 237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 6e-73
Identities = 90/270 (33%), Positives = 140/270 (51%), Gaps = 13/270 (4%)
Query: 517 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEI 575
L Y W ID +LT +G G FG V G W G DVAIK+ +++ +E ++F E
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKM-IKEGSMSE--DEFIEEA 70
Query: 576 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 635
++ L H ++ G CTK + +ITEYM G L L +L + + ++ L+M +D
Sbjct: 71 KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL--LNYLREMRHRFQTQQLLEMCKD 128
Query: 636 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWM 694
+C + + + +HRDL + NCLVN VK+ DFGLSR + D S + P W
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 188
Query: 695 APELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG-- 751
PE++ F+ K DI++ GV+MWE+ +L P+E + +G RL P
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRLYRPHLAS 247
Query: 752 -PLGRLIADCW-AEPQERPSCEEILSRLLD 779
+ ++ CW + ERP+ + +LS +LD
Sbjct: 248 EKVYTIMYSCWHEKADERPTFKILLSNILD 277
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 1e-72
Identities = 82/270 (30%), Positives = 134/270 (49%), Gaps = 13/270 (4%)
Query: 517 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG--TDVAIKVFLEQDLTAENMEDFCNE 574
+ ++W ++ +L +G ++G G FGEVF G T VA+K + L + F E
Sbjct: 104 VPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKS-CRETLPPDLKAKFLQE 162
Query: 575 ISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 634
IL + HPN++ +G CT+ + ++ E ++ G L L + +L + L+M+
Sbjct: 163 ARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF--LTFLRTEGARLRVKTLLQMVG 220
Query: 635 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGT-P-E 692
D G+ + +HRDL + NCLV + +KI DFG+SR D S P +
Sbjct: 221 DAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
Query: 693 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG 751
W APE + ++ + D++S G+++WE +L P+ + ++ V G RL PE
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK-GGRLPCPEL 339
Query: 752 ---PLGRLIADCWA-EPQERPSCEEILSRL 777
+ RL+ CWA EP +RPS I L
Sbjct: 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 4e-72
Identities = 81/265 (30%), Positives = 143/265 (53%), Gaps = 13/265 (4%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSR 580
+ E+T+ +G G FG V G W G DVA+K+ +++ +E ++F E + +
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKM-IKEGSMSE--DEFFQEAQTMMK 59
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
L HP ++ F G C+K + ++TEY+ G L L +L K L + L+M D+C G+
Sbjct: 60 LSHPKLVKFYGVCSKEYPIYIVTEYISNGCL--LNYLRSHGKGLEPSQLLEMCYDVCEGM 117
Query: 641 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 699
+ + +HRDL + NCLV++ VK+ DFG++R + D S P +W APE+
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVF 177
Query: 700 RNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGR 755
++ K D+++ G++MWE+ +L P++ VV V ++G RL P + +
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV-SQGHRLYRPHLASDTIYQ 236
Query: 756 LIADCW-AEPQERPSCEEILSRLLD 779
++ CW P++RP+ +++LS +
Sbjct: 237 IMYSCWHELPEKRPTFQQLLSSIEP 261
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 5e-72
Identities = 81/275 (29%), Positives = 127/275 (46%), Gaps = 16/275 (5%)
Query: 517 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDF 571
+ ++ I + +G +G G FG+V +GI+ VAIK + + E F
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKF 63
Query: 572 CNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK 631
E + + HP+++ +G T+ P +I E LG L L +K L +
Sbjct: 64 LQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGEL--RSFLQVRKYSLDLASLIL 120
Query: 632 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 691
+ L + + VHRD+ + N LV+ + VK+ DFGLSR + DS +S P
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 180
Query: 692 -EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP 749
+WMAPE I FT D++ GV MWE+ +P++GV V+ + G RL +P
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMP 239
Query: 750 EG---PLGRLIADCWA-EPQERPSCEEILSRLLDC 780
L L+ CWA +P RP E+ ++L
Sbjct: 240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 8e-72
Identities = 84/267 (31%), Positives = 146/267 (54%), Gaps = 13/267 (4%)
Query: 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG--TDVAIKVFLEQDLTAENMEDFCNEIS 576
Y++W ++ +++T+ ++G G +GEV+ G+W VA+K L++D E+F E +
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTMEV--EEFLKEAA 61
Query: 577 ILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 636
++ ++HPN++ LG CT+ P +ITE+M G+L + ++++S L M I
Sbjct: 62 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQI 120
Query: 637 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMA 695
+ + + +HRDL + NCLV ++ VK+ DFGLSR++T + A P +W A
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 696 PELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG--- 751
PE + F+ K D+++ GV++WE+ T P+ G+ +V + + R+E PEG
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPE 239
Query: 752 PLGRLIADCW-AEPQERPSCEEILSRL 777
+ L+ CW P +RPS EI
Sbjct: 240 KVYELMRACWQWNPSDRPSFAEIHQAF 266
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 1e-71
Identities = 83/266 (31%), Positives = 138/266 (51%), Gaps = 13/266 (4%)
Query: 521 EWNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILS 579
+W ID SELT +G G FG V G W VAIK + + +E EDF E ++
Sbjct: 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSE--EDFIEEAEVMM 58
Query: 580 RLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 639
+L HP ++ G C + + ++TE+ME G L +L Q+ + L M D+C G
Sbjct: 59 KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCL--SDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 640 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPEL 698
+ + ++HRDL + NCLV ++ +K+ DFG++R + D S+ P +W +PE+
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 176
Query: 699 IRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLG 754
++ K D++S GV+MWE+ + P+E VV + + G RL P +
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFRLYKPRLASTHVY 235
Query: 755 RLIADCW-AEPQERPSCEEILSRLLD 779
+++ CW P++RP+ +L +L +
Sbjct: 236 QIMNHCWRERPEDRPAFSRLLRQLAE 261
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 2e-71
Identities = 95/294 (32%), Positives = 141/294 (47%), Gaps = 20/294 (6%)
Query: 503 NKVLESPMFQNKPLLAYEE--WNIDFSELTVGTRVGIGFFGEVFRGIWNG------TDVA 554
+ + P A + I S +T +G G FGEV++G+ VA
Sbjct: 18 ENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVA 77
Query: 555 IKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHL 614
IK L+ T + DF E I+ + H N+I G +K + +ITEYME G+L
Sbjct: 78 IKT-LKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL--D 134
Query: 615 IHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 674
L + + S + + MLR I G+ + M VHRDL + N LVN + K+ DFGLS
Sbjct: 135 KFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194
Query: 675 RIITDSPMRDSSSAGT--P-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGV 730
R++ D P +++G P W APE I FT D++S G++MWE+ T RP+ +
Sbjct: 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254
Query: 731 LPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDC 780
V+ A+ N+G RL P + +L+ CW E RP +I+S L
Sbjct: 255 SNHEVMKAI-NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 2e-70
Identities = 81/279 (29%), Positives = 141/279 (50%), Gaps = 20/279 (7%)
Query: 516 LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEI 575
W ++ EL + +G G FG+V G + G VA+K ++ D TA+ F E
Sbjct: 10 EFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKC-IKNDATAQ---AFLAEA 65
Query: 576 SILSRLRHPNVILFLGACTK-PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 634
S++++LRH N++ LG + L ++TEYM GSL + S + L LK
Sbjct: 66 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSL 124
Query: 635 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EW 693
D+C + + VHRDL + N LV++ K+ DFGL++ + + + P +W
Sbjct: 125 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKW 180
Query: 694 MAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG- 751
APE +R + F+ K D++S G+++WE+ + R P+ + + VV V +G +++ P+G
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGC 239
Query: 752 --PLGRLIADCW-AEPQERPSCEEI---LSRLLDCEYSL 784
+ ++ +CW + RPS ++ L + E L
Sbjct: 240 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHELHL 278
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 4e-70
Identities = 79/275 (28%), Positives = 125/275 (45%), Gaps = 17/275 (6%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLT-AENMEDFCN 573
I +L + ++G G FG V RG W+ VA+K L+ E M+DF
Sbjct: 11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 70
Query: 574 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 633
E++ + L H N+I G PP + M+TE LGSL L L + +
Sbjct: 71 EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSL--LDRLRKHQGHFLLGTLSRYA 127
Query: 634 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGT--P 691
+ G+ + + +HRDL + N L+ VKI DFGL R + + P
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187
Query: 692 -EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP 749
W APE ++ F+ D + GV +WE+ T PW G+ ++++ + EG RL P
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 247
Query: 750 EG---PLGRLIADCWA-EPQERPSCEEILSRLLDC 780
E + ++ CWA +P++RP+ + LL+
Sbjct: 248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 4e-70
Identities = 93/289 (32%), Positives = 138/289 (47%), Gaps = 19/289 (6%)
Query: 504 KVLESPMFQNKPLLAYEE--WNIDFSELTVGTRVGIGFFGEVFRGIW-----NGTDVAIK 556
+ P +P A I+ S + + +G G GEV G VAIK
Sbjct: 24 QFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIK 83
Query: 557 VFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH 616
L+ T DF +E SI+ + HPN+I G T+ ++TEYME GSL
Sbjct: 84 A-LKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL--DTF 140
Query: 617 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676
L + + + + MLR + G+ + + VHRDL + N LV+ + K+ DFGLSR+
Sbjct: 141 LRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
Query: 677 ITDSPMRDSSSAGT--P-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLP 732
+ D P ++ G P W APE I F+ D++S GV+MWE+ RP+ +
Sbjct: 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260
Query: 733 ERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 777
V+ +V EG RL P G L +L+ DCW + +RP +I+S L
Sbjct: 261 RDVISSV-EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 5e-70
Identities = 91/268 (33%), Positives = 143/268 (53%), Gaps = 15/268 (5%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISIL 578
+EW + L + R+G G FGEV+ G +NG T VA+K L+Q + + F E +++
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSP--DAFLAEANLM 62
Query: 579 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHL-SGQKKKLSWRRKLKMLRDIC 637
+L+H ++ T+ P +ITEYME GSL + L + KL+ + L M I
Sbjct: 63 KQLQHQRLVRLYAVVTQEPIY-IITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 638 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAP 696
G+ I +HRDL++AN LV+ + KI DFGL+R+I D+ A P +W AP
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
Query: 697 ELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---P 752
E I FT K D++S G+++ E+ T R P+ G+ V+ + G R+ P+
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-ERGYRMVRPDNCPEE 238
Query: 753 LGRLIADCW-AEPQERPSCEEILSRLLD 779
L +L+ CW P++RP+ + + S L D
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 5e-70
Identities = 85/282 (30%), Positives = 149/282 (52%), Gaps = 15/282 (5%)
Query: 507 ESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG--TDVAIKVFLEQDLT 564
+ Y++W ++ +++T+ ++G G +GEV+ G+W VA+K L++D
Sbjct: 200 RNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTM 258
Query: 565 AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHL-SGQKKK 623
E+F E +++ ++HPN++ LG CT+ P +ITE+M G+L L +L +++
Sbjct: 259 EV--EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL--LDYLRECNRQE 314
Query: 624 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683
+S L M I + + + +HR+L + NCLV ++ VK+ DFGLSR++T
Sbjct: 315 VSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374
Query: 684 DSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVAN 741
+ A P +W APE + F+ K D+++ GV++WE+ T P+ G+ +V +
Sbjct: 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-E 433
Query: 742 EGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLD 779
+ R+E PEG + L+ CW P +RPS EI
Sbjct: 434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 475
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 5e-70
Identities = 98/299 (32%), Positives = 147/299 (49%), Gaps = 21/299 (7%)
Query: 492 YMANSEFVSTWNKVLESPMFQNKP---LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW 548
Y +++ + L + +KP LA + W I L + ++G G FGEV+ G W
Sbjct: 149 YSKHADGLCH---RLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 205
Query: 549 NG-TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME 607
NG T VAIK + E F E ++ +LRH ++ ++ P ++TEYM
Sbjct: 206 NGTTRVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMS 261
Query: 608 LGSLYHLIHL-SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTV 666
GSL L L K L + + M I G+ + RM VHRDL++AN LV ++
Sbjct: 262 KGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 319
Query: 667 KICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-N 724
K+ DFGL+R+I D+ A P +W APE FT K D++S G+++ EL T
Sbjct: 320 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379
Query: 725 RPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLD 779
P+ G++ V+ V G R+ P L L+ CW EP+ERP+ E + + L D
Sbjct: 380 VPYPGMVNREVLDQV-ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 6e-70
Identities = 96/304 (31%), Positives = 143/304 (47%), Gaps = 19/304 (6%)
Query: 492 YMANSEFVSTWNKVLESPMFQNKPLLAYEE--WNIDFSELTVGTRVGIGFFGEVFRGIWN 549
+ N + P P E +D + +++ VG G FGEV G
Sbjct: 8 HFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLK 67
Query: 550 G-----TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604
VAIK L+ T + DF E SI+ + HPN+I G TK + ++TE
Sbjct: 68 LPSKKEISVAIKT-LKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE 126
Query: 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 664
YME GSL L + + + + MLR I G+ + M VHRDL + N L+N +
Sbjct: 127 YMENGSL--DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL 184
Query: 665 TVKICDFGLSRIITDSPMRDSSSAGT--P-EWMAPELIRNEPFTEKCDIFSLGVIMWELC 721
K+ DFGL R++ D P ++ G P W +PE I FT D++S G+++WE+
Sbjct: 185 VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
Query: 722 TL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSR 776
+ RP+ + + V+ AV +EG RL P L +L+ DCW + RP E+I+S
Sbjct: 245 SYGERPYWEMSNQDVIKAV-DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 777 LLDC 780
L
Sbjct: 304 LDKL 307
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 6e-70
Identities = 70/267 (26%), Positives = 128/267 (47%), Gaps = 18/267 (6%)
Query: 524 IDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCNEISI 577
+ +E +G G FG V++G+W VAIK L + + + ++ +E +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEAYV 70
Query: 578 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
++ + +P+V LG C + +IT+ M G L L ++ K + + L I
Sbjct: 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIA 127
Query: 638 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII-TDSPMRDSSSAGTP-EWMA 695
+G+ + ++VHRDL + N LV VKI DFGL++++ + + P +WMA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 696 PELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG--- 751
E I + +T + D++S GV +WEL T ++P++G+ + + +G RL P
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTI 246
Query: 752 PLGRLIADCWA-EPQERPSCEEILSRL 777
+ ++ CW + RP E++
Sbjct: 247 DVYMIMRKCWMIDADSRPKFRELIIEF 273
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 1e-69
Identities = 76/278 (27%), Positives = 133/278 (47%), Gaps = 18/278 (6%)
Query: 520 EEWNIDFSELTVG-TRVGIGFFGEVFRGIWNG----TDVAIKVFLEQDLTAENMEDFCNE 574
++ + L + +G G FG V +G++ DVAIKV L+Q + E+ E
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMRE 60
Query: 575 ISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 634
I+ +L +P ++ +G C L ++ E G L L G+++++ ++L
Sbjct: 61 AQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPL--HKFLVGKREEIPVSNVAELLH 117
Query: 635 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGT--P- 691
+ G+ + VHRDL + N L+ KI DFGLS+ + ++ + P
Sbjct: 118 QVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 177
Query: 692 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPE 750
+W APE I F+ + D++S GV MWE + +P++ + V+ + +G R+E P
Sbjct: 178 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMECPP 236
Query: 751 G---PLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 784
L L++DCW + ++RP + R+ C YSL
Sbjct: 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 7e-69
Identities = 88/279 (31%), Positives = 137/279 (49%), Gaps = 15/279 (5%)
Query: 509 PMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAEN 567
+ + + W I L + ++G G FGEV+ +N T VA+K + +
Sbjct: 170 MSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP---GSMS 226
Query: 568 MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHL-SGQKKKLSW 626
+E F E +++ L+H ++ TK P + +ITE+M GSL L L S + K
Sbjct: 227 VEAFLAEANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSL--LDFLKSDEGSKQPL 283
Query: 627 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 686
+ + I G+ I + +HRDL++AN LV+ KI DFGL+R+I D+
Sbjct: 284 PKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343
Query: 687 SAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGS 744
A P +W APE I FT K D++S G+++ E+ T P+ G+ V+ A+ G
Sbjct: 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGY 402
Query: 745 RLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLD 779
R+ PE L ++ CW P+ERP+ E I S L D
Sbjct: 403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 441
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 2e-68
Identities = 85/331 (25%), Positives = 137/331 (41%), Gaps = 24/331 (7%)
Query: 461 RDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYE 520
+ + S+P + S + + P +
Sbjct: 332 PQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMP--------STR 383
Query: 521 EWNIDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDFCNEI 575
++ I + +G +G G FG+V +GI+ VAIK + + E F E
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT-CKNCTSDSVREKFLQEA 442
Query: 576 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 635
+ + HP+++ +G T+ P +I E LG L L +K L +
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGEL--RSFLQVRKFSLDLASLILYAYQ 499
Query: 636 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWM 694
+ L + + VHRD+ + N LV+ + VK+ DFGLSR + DS +S P +WM
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 559
Query: 695 APELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG-- 751
APE I FT D++ GV MWE+ +P++GV V+ + G RL +P
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCP 618
Query: 752 -PLGRLIADCWA-EPQERPSCEEILSRLLDC 780
L L+ CWA +P RP E+ ++L
Sbjct: 619 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 3e-68
Identities = 79/281 (28%), Positives = 143/281 (50%), Gaps = 19/281 (6%)
Query: 505 VLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLT 564
+ + W ++ EL + +G G FG+V G + G VA+K ++ D T
Sbjct: 171 KVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKC-IKNDAT 229
Query: 565 AENMEDFCNEISILSRLRHPNVILFLGACTK-PPRLSMITEYMELGSLYHLIHL-SGQKK 622
A+ F E S++++LRH N++ LG + L ++TEYM GSL + +L S +
Sbjct: 230 AQ---AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL--VDYLRSRGRS 284
Query: 623 KLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682
L LK D+C + + VHRDL + N LV++ K+ DFGL++ + +
Sbjct: 285 VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342
Query: 683 RDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVA 740
+ P +W APE +R + F+ K D++S G+++WE+ + R P+ + + VV V
Sbjct: 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV- 399
Query: 741 NEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 777
+G +++ P+G + ++ +CW + RP+ ++ +L
Sbjct: 400 EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQL 440
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 5e-68
Identities = 95/284 (33%), Positives = 141/284 (49%), Gaps = 16/284 (5%)
Query: 506 LESPMFQNKP---LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQ 561
L + +KP LA + W I L + ++G G FGEV+ G WNG T VAIK
Sbjct: 243 LTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP- 301
Query: 562 DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK 621
+ E F E ++ +LRH ++ ++ P ++TEYM GSL +
Sbjct: 302 --GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLK-GETG 357
Query: 622 KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681
K L + + M I G+ + RM VHRDL++AN LV ++ K+ DFGL+R+I D+
Sbjct: 358 KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417
Query: 682 MRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAV 739
A P +W APE FT K D++S G+++ EL T P+ G++ V+ V
Sbjct: 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477
Query: 740 ANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLD 779
G R+ P L L+ CW EP+ERP+ E + + L D
Sbjct: 478 -ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 520
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 5e-68
Identities = 69/281 (24%), Positives = 126/281 (44%), Gaps = 18/281 (6%)
Query: 517 LAYEEWNIDFSELTVGTRV-GIGFFGEVFRGIWNG----TDVAIKVFLEQDLTAENMEDF 571
+ +E +D LT+ + G G FG V +G + VA+K+ + ++
Sbjct: 6 IRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL 65
Query: 572 CNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK 631
E +++ +L +P ++ +G C ++ E ELG L + Q + + + ++
Sbjct: 66 LAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQ---QNRHVKDKNIIE 121
Query: 632 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGT- 690
++ + G+ + VHRDL + N L+ KI DFGLS+ + +
Sbjct: 122 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 691 -P-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLE 747
P +W APE I F+ K D++S GV+MWE + +P+ G+ V + +G R+
Sbjct: 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-EKGERMG 240
Query: 748 IPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 784
P G + L+ CW + + RP + RL + Y +
Sbjct: 241 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 7e-68
Identities = 61/284 (21%), Positives = 117/284 (41%), Gaps = 40/284 (14%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNG---------TDVAIKVFLEQDLTAENMEDFC 572
I +L +G G F ++F+G+ T+V +KV E F
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL--DKAHRNYSESFF 60
Query: 573 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM 632
S++S+L H +++L G C ++ E+++ GSL +L K ++ KL++
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSL--DTYLKKNKNCINILWKLEV 118
Query: 633 LRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT--------VKICDFGLSRIITDS---- 680
+ + + + ++H ++ + N L+ + +K+ D G+S +
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178
Query: 681 -PMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVY 737
+ W+ PE I N + D +S G +WE+C+ ++P + +R +
Sbjct: 179 ERIP---------WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ 229
Query: 738 AVANEGSRLEIPEG-PLGRLIADCWA-EPQERPSCEEILSRLLD 779
+ +L P+ L LI +C EP RPS I+ L
Sbjct: 230 FY-EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNS 272
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 2e-67
Identities = 83/290 (28%), Positives = 126/290 (43%), Gaps = 30/290 (10%)
Query: 518 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMED 570
+I ++ + +G G FG+VF VA+K + L A D
Sbjct: 6 GIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--D 63
Query: 571 FCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-------------YHLIHL 617
F E +L+ L+H +++ F G C L M+ EYM+ G L
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 618 SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677
K +L + L + I G++ + VHRDL + NCLV + VKI DFG+SR +
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV 183
Query: 678 TDSPM-RDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPER 734
+ R P WM PE I FT + D++S GVI+WE+ T +PW +
Sbjct: 184 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 243
Query: 735 VVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 780
V+ + +G LE P + ++ CW EPQ+R + +EI L
Sbjct: 244 VIECI-TQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHAL 292
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 6e-67
Identities = 73/291 (25%), Positives = 129/291 (44%), Gaps = 36/291 (12%)
Query: 518 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDF 571
+ + L ++G G FG V ++ VA+K L+ T E++ DF
Sbjct: 1 GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHS-TEEHLRDF 58
Query: 572 CNEISILSRLRHPNVILFLGACTKPPRLS--MITEYMELGSLYHLIHLSGQKKKLSWRRK 629
EI IL L+H N++ + G C R + +I EY+ GSL +L K+++ +
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL--RDYLQKHKERIDHIKL 116
Query: 630 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSS 687
L+ IC+G+ + + +HRDL + N LV VKI DFGL++++ +
Sbjct: 117 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEP 176
Query: 688 AGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR----------------PWEGV 730
+P W APE + F+ D++S GV+++EL T +
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236
Query: 731 LPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 777
+ ++ + RL P+G + ++ +CW +RPS ++ R+
Sbjct: 237 IVFHLIELL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 1e-66
Identities = 73/269 (27%), Positives = 126/269 (46%), Gaps = 18/269 (6%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCNEI 575
+EL +G G FG V +G+W V IKV +E ++ + + +
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV-IEDKSGRQSFQAVTDHM 66
Query: 576 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 635
+ L H +++ LG C L ++T+Y+ LGSL L H+ + L + L
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSL--LDHVRQHRGALGPQLLLNWGVQ 123
Query: 636 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII-TDSPMRDSSSAGTP-EW 693
I +G+ + +VHR+L + N L+ V++ DFG++ ++ D S A TP +W
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 694 MAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG- 751
MA E I +T + D++S GV +WEL T P+ G+ V + +G RL P+
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-EKGERLAQPQIC 242
Query: 752 --PLGRLIADCWA-EPQERPSCEEILSRL 777
+ ++ CW + RP+ +E+ +
Sbjct: 243 TIDVYMVMVKCWMIDENIRPTFKELANEF 271
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 2e-66
Identities = 78/307 (25%), Positives = 135/307 (43%), Gaps = 39/307 (12%)
Query: 505 VLESPMFQNKPLLAY---EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAI 555
E+ FQ A+ + + L ++G G FG V ++ VA+
Sbjct: 16 TTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAV 75
Query: 556 KVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR--LSMITEYMELGSLYH 613
K L+ T E++ DF EI IL L+H N++ + G C R L +I EY+ GSL
Sbjct: 76 KK-LQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL-- 131
Query: 614 LIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGL 673
+L K+++ + L+ IC+G+ + + +HRDL + N LV VKI DFGL
Sbjct: 132 RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 191
Query: 674 SRIITDSPM--RDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR----- 725
++++ + +P W APE + F+ D++S GV+++EL T
Sbjct: 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 251
Query: 726 -----------PWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSC 770
++ ++ + RL P+G + ++ +CW +RPS
Sbjct: 252 PAEFMRMIGNDKQGQMIVFHLIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 310
Query: 771 EEILSRL 777
++ R+
Sbjct: 311 RDLALRV 317
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-66
Identities = 86/292 (29%), Positives = 145/292 (49%), Gaps = 23/292 (7%)
Query: 510 MFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQD 562
F + +EW + ++T+ +G G FG V+ G+ G T VAIK + +
Sbjct: 8 YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT-VNEA 66
Query: 563 LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY-------HLI 615
+ +F NE S++ +V+ LG ++ +I E M G L +
Sbjct: 67 ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAM 126
Query: 616 HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675
+ S + ++M +I G+ ++ K VHRDL + NC+V + +TVKI DFG++R
Sbjct: 127 ANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
Query: 676 IITDSPM-RDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLP 732
I ++ R P WM+PE +++ FT D++S GV++WE+ TL +P++G+
Sbjct: 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246
Query: 733 ERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 780
E+V+ V EG L+ P+ L L+ CW P+ RPS EI+S + +
Sbjct: 247 EQVLRFV-MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 2e-66
Identities = 79/296 (26%), Positives = 127/296 (42%), Gaps = 34/296 (11%)
Query: 512 QNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTA 565
+ KP + + + L +G G FG+V + G VA+K L+ +
Sbjct: 6 EKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS-LKPESGG 64
Query: 566 ENMEDFCNEISILSRLRHPNVILFLGACTKPPR--LSMITEYMELGSLYHLIHLSGQKKK 623
++ D EI IL L H N++ + G CT+ + +I E++ GSL +L K K
Sbjct: 65 NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL--KEYLPKNKNK 122
Query: 624 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 682
++ +++LK IC+G+ + + VHRDL + N LV VKI DFGL++ I
Sbjct: 123 INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY 182
Query: 683 -RDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL---------------NR 725
+P W APE + F D++S GV + EL T
Sbjct: 183 YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP 242
Query: 726 PWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 777
+ R+V + EG RL P + +L+ CW +P R S + ++
Sbjct: 243 THGQMTVTRLVNTL-KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 2e-66
Identities = 83/292 (28%), Positives = 122/292 (41%), Gaps = 47/292 (16%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNE 574
I S + +G FG+V++G G VAIK L+ E+F +E
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT-LKDKAEGPLREEFRHE 62
Query: 575 ISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-------------YHLIHLSGQK 621
+ +RL+HPNV+ LG TK LSMI Y G L K
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 622 KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS- 680
L + ++ I G+ + +VH+DL + N LV VKI D GL R + +
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182
Query: 681 ----------PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEG 729
P+R WMAPE I F+ DI+S GV++WE+ + +P+ G
Sbjct: 183 YYKLLGNSLLPIR---------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 233
Query: 730 VLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 777
+ VV + L P+ + L+ +CW P RP ++I SRL
Sbjct: 234 YSNQDVVEMI-RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-66
Identities = 85/333 (25%), Positives = 143/333 (42%), Gaps = 51/333 (15%)
Query: 483 GSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGE 542
G+ GSS + ++E+P + + +I ++ + +G G FG+
Sbjct: 1 GAMGSGSSLSPTEGKGSGLQGHIIENPQYFSDA----CVHHIKRRDIVLKWELGEGAFGK 56
Query: 543 VFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 595
VF + VA+K ++ + +DF E +L+ L+H +++ F G CT+
Sbjct: 57 VFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHIVRFFGVCTE 114
Query: 596 PPRLSMITEYMELGSL------------YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 643
L M+ EYM G L L + L + + G++ +
Sbjct: 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL 174
Query: 644 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS-----------PMRDSSSAGTPE 692
+ VHRDL + NCLV + VKI DFG+SR I + P+R
Sbjct: 175 AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR--------- 225
Query: 693 WMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG 751
WM PE I FT + D++S GV++WE+ T +PW + + + +G LE P
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI-TQGRELERPRA 284
Query: 752 ---PLGRLIADCW-AEPQERPSCEEILSRLLDC 780
+ ++ CW EPQ+R S +++ +RL
Sbjct: 285 CPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 4e-66
Identities = 70/267 (26%), Positives = 128/267 (47%), Gaps = 18/267 (6%)
Query: 524 IDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCNEISI 577
+ +E +G G FG V++G+W VAIK L + + + ++ +E +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEAYV 70
Query: 578 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
++ + +P+V LG C + +IT+ M G L L ++ K + + L I
Sbjct: 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIA 127
Query: 638 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII-TDSPMRDSSSAGTP-EWMA 695
+G+ + ++VHRDL + N LV VKI DFGL++++ + + P +WMA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 696 PELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG--- 751
E I + +T + D++S GV +WEL T ++P++G+ + + +G RL P
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTI 246
Query: 752 PLGRLIADCWA-EPQERPSCEEILSRL 777
+ ++ CW + RP E++
Sbjct: 247 DVYMIMVKCWMIDADSRPKFRELIIEF 273
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 1e-65
Identities = 76/275 (27%), Positives = 131/275 (47%), Gaps = 21/275 (7%)
Query: 520 EEWNI--DFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDFC 572
++ I + +G G FG V+ G + AIK L + + +E F
Sbjct: 12 KDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKS-LSRITEMQQVEAFL 70
Query: 573 NEISILSRLRHPNVILFLGACTKP-PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK 631
E ++ L HPNV+ +G P ++ YM G L L + ++ + + +
Sbjct: 71 REGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDL--LQFIRSPQRNPTVKDLIS 128
Query: 632 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS---PMRDSSSA 688
+ RG+ + K VHRDL + NC++++ +TVK+ DFGL+R I D ++ A
Sbjct: 129 FGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA 188
Query: 689 GTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRL 746
P +W A E ++ FT K D++S GV++WEL T P+ + P + + + +G RL
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-AQGRRL 247
Query: 747 EIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 777
PE L +++ CW A+P RP+ ++ +
Sbjct: 248 PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEV 282
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 1e-65
Identities = 81/281 (28%), Positives = 131/281 (46%), Gaps = 21/281 (7%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDFCNE 574
E+ ID + L +G +G G FG V G VA+K + + +E+F +E
Sbjct: 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 575 ISILSRLRHPNVILFLGACTK-----PPRLSMITEYMELGSLYHLI---HLSGQKKKLSW 626
+ + HPNVI LG C + P+ +I +M+ G L+ + L K +
Sbjct: 87 AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146
Query: 627 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-RDS 685
+ LK + DI G+ + +HRDL + NC++ TV + DFGLS+ I R
Sbjct: 147 QTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206
Query: 686 SSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEG 743
A P +W+A E + + +T K D+++ GV MWE+ T P+ GV + + G
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL-LHG 265
Query: 744 SRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 780
RL+ PE L ++ CW +P +RP+ + +L
Sbjct: 266 HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-65
Identities = 80/282 (28%), Positives = 129/282 (45%), Gaps = 23/282 (8%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFC 572
+ + +T+ +G G FGEV+ G +G VA+K L + + ++ DF
Sbjct: 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFL 81
Query: 573 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY----HLIHLSGQKKKLSWRR 628
E I+S+ H N++ +G + ++ E M G L Q L+
Sbjct: 82 MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 629 KLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLSR-IITDSPMRD 684
L + RDI G + +HRD+ + NCL+ KI DFG++R I S R
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201
Query: 685 SSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANE 742
A P +WM PE FT K D +S GV++WE+ +L P+ + V+ V
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-TS 260
Query: 743 GSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 780
G R++ P+ P+ R++ CW +P++RP+ IL R+ C
Sbjct: 261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 7e-65
Identities = 78/277 (28%), Positives = 132/277 (47%), Gaps = 21/277 (7%)
Query: 518 AYEEWNIDFSE--LTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMED 570
A + I S + +G G FG V+ G A+K L + +
Sbjct: 14 AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ 72
Query: 571 FCNEISILSRLRHPNVILFLGACTKP-PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 629
F E I+ HPNV+ LG C + ++ YM+ G L + + + + +
Sbjct: 73 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDL 130
Query: 630 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS---PMRDSS 686
+ + +G+ + K VHRDL + NC++++ +TVK+ DFGL+R + D + + +
Sbjct: 131 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 190
Query: 687 SAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGS 744
A P +WMA E ++ + FT K D++S GV++WEL T P+ V + + +G
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGR 249
Query: 745 RLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 777
RL PE PL ++ CW + + RPS E++SR+
Sbjct: 250 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 286
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 8e-65
Identities = 73/294 (24%), Positives = 134/294 (45%), Gaps = 22/294 (7%)
Query: 505 VLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFL 559
+L+S ++ E+ I + T+G +G G FG V VA+K+
Sbjct: 1 MLDSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLK 60
Query: 560 EQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK------PPRLSMITEYMELGSLYH 613
+ + ++E+F E + + HP+V +G + P +I +M+ G L+
Sbjct: 61 ADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHA 120
Query: 614 LI---HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICD 670
+ + L + ++ + DI G+ + +HRDL + NC++ + TV + D
Sbjct: 121 FLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD 180
Query: 671 FGLSRIITDSPM-RDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPW 727
FGLSR I R ++ P +W+A E + + +T D+++ GV MWE+ T P+
Sbjct: 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240
Query: 728 EGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 777
G+ + + G+RL+ P + L+ CW A+P++RPS + L
Sbjct: 241 AGIENAEIYNYL-IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 2e-64
Identities = 82/287 (28%), Positives = 134/287 (46%), Gaps = 27/287 (9%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFC 572
E+W + L G +G G FG+V G VA+K+ L+ A+ E
Sbjct: 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM-LKSTAHADEKEALM 97
Query: 573 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-----------YHLIHLSGQ 620
+E+ I+S L +H N++ LGACT + +ITEY G L +
Sbjct: 98 SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 621 KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITD 679
S R L + +G+ + +HRD+ + N L+ KI DFGL+R I+ D
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217
Query: 680 SPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVY 737
S +A P +WMAPE I + +T + D++S G+++WE+ +L P+ G+L Y
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277
Query: 738 AVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 780
+ +G ++ P + ++ CW EP RP+ ++I S L +
Sbjct: 278 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 3e-64
Identities = 83/290 (28%), Positives = 131/290 (45%), Gaps = 31/290 (10%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFC 572
+W + L+ G +G G FG+V G VA+K+ L+ E
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALM 74
Query: 573 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL---------------YHLIH 616
+E+ +LS L H N++ LGACT +ITEY G L
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 617 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR- 675
+ + L L + +G+ + +HRDL + N L+ KICDFGL+R
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 676 IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPE 733
I DS +A P +WMAPE I N +T + D++S G+ +WEL +L P+ G+ +
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 734 RVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLD 779
Y + EG R+ PE + ++ CW A+P +RP+ ++I+ +
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 3e-64
Identities = 72/288 (25%), Positives = 120/288 (41%), Gaps = 36/288 (12%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCN 573
+ L +G G FG+V ++ VA+K L+ D ++ +
Sbjct: 24 DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA-LKADAGPQHRSGWKQ 82
Query: 574 EISILSRLRHPNVILFLGACTKPPR--LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK 631
EI IL L H ++I + G C L ++ EY+ LGSL + + + + L
Sbjct: 83 EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLL 138
Query: 632 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAG 689
+ IC G+ +H +HRDL + N L++ VKI DFGL++ + + R
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198
Query: 690 TP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL---------------NRPWEGVLPE 733
+P W APE ++ F D++S GV ++EL T +
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258
Query: 734 RVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 777
R+ + G RL P+ + L+ +CW E RP+ E ++ L
Sbjct: 259 RLTELLE-RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 3e-64
Identities = 90/305 (29%), Positives = 146/305 (47%), Gaps = 32/305 (10%)
Query: 507 ESPMFQNKPLLAYE--EWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKV 557
E P+ ++ L Y+ +W L +G +G G FG+V G VA+K+
Sbjct: 5 ELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM 64
Query: 558 FLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPR-LSMITEYMELGSL---- 611
L++ T +E+ IL + H NV+ LGACTKP L +I E+ + G+L
Sbjct: 65 -LKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 612 ---------YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK 662
Y + K L+ + + +G+ + K +HRDL + N L+++
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183
Query: 663 HWTVKICDFGLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWEL 720
VKICDFGL+R I D A P +WMAPE I + +T + D++S GV++WE+
Sbjct: 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
Query: 721 CTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILS 775
+L P+ GV + EG+R+ P+ + + + DCW EP +RP+ E++
Sbjct: 244 FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303
Query: 776 RLLDC 780
L +
Sbjct: 304 HLGNL 308
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 4e-64
Identities = 79/282 (28%), Positives = 128/282 (45%), Gaps = 23/282 (8%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFC 572
+ + +T+ +G G FGEV+ G +G VA+K L + + ++ DF
Sbjct: 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFL 122
Query: 573 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY----HLIHLSGQKKKLSWRR 628
E I+S+ H N++ +G + ++ E M G L Q L+
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 629 KLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLSR-IITDSPMRD 684
L + RDI G + +HRD+ + NCL+ KI DFG++R I R
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242
Query: 685 SSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANE 742
A P +WM PE FT K D +S GV++WE+ +L P+ + V+ V
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-TS 301
Query: 743 GSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 780
G R++ P+ P+ R++ CW +P++RP+ IL R+ C
Sbjct: 302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 5e-64
Identities = 88/339 (25%), Positives = 149/339 (43%), Gaps = 27/339 (7%)
Query: 461 RDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMA----NSEFVSTWNKVLESPMFQNKPL 516
R + + SP G E +S Y N F ++ + +
Sbjct: 17 RRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELV 76
Query: 517 LAYEEWNIDFSE--LTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENME 569
A + I S + +G G FG V+ G A+K L + +
Sbjct: 77 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVS 135
Query: 570 DFCNEISILSRLRHPNVILFLGACTK--PPRLSMITEYMELGSLYHLIHLSGQKKKLSWR 627
F E I+ HPNV+ LG C + L ++ YM+ G L + + + + +
Sbjct: 136 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRN--FIRNETHNPTVK 192
Query: 628 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS---PMRD 684
+ + +G+ + K VHRDL + NC++++ +TVK+ DFGL+R + D + +
Sbjct: 193 DLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 252
Query: 685 SSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANE 742
+ A P +WMA E ++ + FT K D++S GV++WEL T P+ V + + +
Sbjct: 253 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQ 311
Query: 743 GSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 777
G RL PE PL ++ CW + + RPS E++SR+
Sbjct: 312 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 350
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-63
Identities = 85/293 (29%), Positives = 140/293 (47%), Gaps = 37/293 (12%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFC 572
+W L +G +G G FG+V + T VA+K+ L+++ + + D
Sbjct: 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM-LKENASPSELRDLL 74
Query: 573 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL--------------------- 611
+E ++L ++ HP+VI GAC++ L +I EY + GSL
Sbjct: 75 SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 612 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 671
++ L+ + I +G+ + MK+VHRDL + N LV + +KI DF
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDF 194
Query: 672 GLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWE 728
GLSR + + S P +WMA E + + +T + D++S GV++WE+ TL P+
Sbjct: 195 GLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254
Query: 729 GVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 777
G+ PER+ + G R+E P+ + RL+ CW EP +RP +I L
Sbjct: 255 GIPPERLFNLL-KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 2e-63
Identities = 91/325 (28%), Positives = 144/325 (44%), Gaps = 58/325 (17%)
Query: 503 NKVLESPMFQNKPLLA---YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TD 552
+++ +PM+Q PLL + + +G G FG VF+ G T
Sbjct: 20 DRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTM 79
Query: 553 VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL- 611
VA+K+ L+++ +A+ DF E ++++ +PN++ LG C + ++ EYM G L
Sbjct: 80 VAVKM-LKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 138
Query: 612 --------------------YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651
S LS +L + R + G+ + K VHR
Sbjct: 139 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198
Query: 652 DLKSANCLVNKHWTVKICDFGLSRIITDS-----------PMRDSSSAGTPEWMAPELIR 700
DL + NCLV ++ VKI DFGLSR I + P+R WM PE I
Sbjct: 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR---------WMPPESIF 249
Query: 701 NEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRL 756
+T + D+++ GV++WE+ + +P+ G+ E V+Y V +G+ L PE L L
Sbjct: 250 YNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV-RDGNILACPENCPLELYNL 308
Query: 757 IADCW-AEPQERPSCEEILSRLLDC 780
+ CW P +RPS I L
Sbjct: 309 MRLCWSKLPADRPSFCSIHRILQRM 333
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 7e-63
Identities = 83/288 (28%), Positives = 148/288 (51%), Gaps = 32/288 (11%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG---------TDVAIKVFLEQDLTAENMED 570
+W +LT+G +G G FG+V G VA+K+ L+ D T +++ D
Sbjct: 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM-LKDDATEKDLSD 86
Query: 571 FCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-------------YHLIH 616
+E+ ++ + +H N+I LGACT+ L +I EY G+L Y
Sbjct: 87 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 617 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR- 675
+++++++ + + RG+ + K +HRDL + N LV ++ +KI DFGL+R
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 676 IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPE 733
I + +++ P +WMAPE + + +T + D++S GV+MWE+ TL P+ G+ E
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266
Query: 734 RVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 777
+ + EG R++ P L ++ DCW A P +RP+ ++++ L
Sbjct: 267 ELFKLL-KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 1e-62
Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 36/296 (12%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFC 572
+W L G +G G FG+V G VA+K+ L++ + E
Sbjct: 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM-LKEKADSSEREALM 96
Query: 573 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-------------------- 611
+E+ ++++L H N++ LGACT + +I EY G L
Sbjct: 97 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 612 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 671
+ L++ L + +G+ + VHRDL + N LV VKICDF
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 216
Query: 672 GLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWE 728
GL+R I++DS +A P +WMAPE + +T K D++S G+++WE+ +L P+
Sbjct: 217 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276
Query: 729 GVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 780
G+ + Y + G +++ P + ++ CW + ++RPS + S L
Sbjct: 277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 1e-62
Identities = 80/282 (28%), Positives = 131/282 (46%), Gaps = 28/282 (9%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG----TDVAIKVFLEQDLTAENMEDFCNEI 575
+D++++ +G G FG+V + D AIK +++ + ++ DF E+
Sbjct: 18 IYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGEL 76
Query: 576 SILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-------------YHLIHLSGQK 621
+L +L HPN+I LGAC L + EY G+L +
Sbjct: 77 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 622 KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681
LS ++ L D+ RG+ + + + +HRDL + N LV +++ KI DFGLSR
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEV 194
Query: 682 MRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAV 739
+ P WMA E + +T D++S GV++WE+ +L P+ G+ + +
Sbjct: 195 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254
Query: 740 ANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 777
+G RLE P + L+ CW +P ERPS +IL L
Sbjct: 255 -PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-62
Identities = 90/391 (23%), Positives = 165/391 (42%), Gaps = 28/391 (7%)
Query: 417 RGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSP 476
+ + + L + L I + A N S + A +LP+ P
Sbjct: 215 QDKAGKYCIPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHP 274
Query: 477 HE--YGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAY--------EEWNIDF 526
+ + S GY +++ +K PM + + ++ +
Sbjct: 275 STLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKR 334
Query: 527 SELTVG-TRVGIGFFGEVFRGIWNG----TDVAIKVFLEQDLTAENMEDFCNEISILSRL 581
L + +G G FG V +G++ DVAIKV L+Q + E+ E I+ +L
Sbjct: 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREAQIMHQL 393
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
+P ++ +G C + ++ E G L L G+++++ ++L + G+
Sbjct: 394 DNPYIVRLIGVCQAEALM-LVMEMAGGGPL--HKFLVGKREEIPVSNVAELLHQVSMGMK 450
Query: 642 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGT--P-EWMAPEL 698
+ VHR+L + N L+ KI DFGLS+ + ++ + P +W APE
Sbjct: 451 YLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 510
Query: 699 IRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLG 754
I F+ + D++S GV MWE + +P++ + V+ + +G R+E P L
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMECPPECPPELY 569
Query: 755 RLIADCWA-EPQERPSCEEILSRLLDCEYSL 784
L++DCW + ++RP + R+ C YSL
Sbjct: 570 ALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 3e-62
Identities = 85/291 (29%), Positives = 145/291 (49%), Gaps = 32/291 (10%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG---------TDVAIKVFLEQDLTAENMED 570
W + L +G +G G FG+V G T VA+K+ L+ D T +++ D
Sbjct: 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEKDLSD 120
Query: 571 FCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-------------YHLIH 616
+E+ ++ + +H N+I LGACT+ L +I EY G+L Y
Sbjct: 121 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 180
Query: 617 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676
+++LS + + + RG+ + K +HRDL + N LV + +KI DFGL+R
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 240
Query: 677 I-TDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPE 733
I + +++ P +WMAPE + + +T + D++S GV++WE+ TL P+ GV E
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300
Query: 734 RVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 780
+ + EG R++ P L ++ DCW A P +RP+ ++++ L
Sbjct: 301 ELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 3e-62
Identities = 75/287 (26%), Positives = 121/287 (42%), Gaps = 33/287 (11%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCN 573
+ + L +++G G FG V ++ VA+K L+ + DF
Sbjct: 16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQ-LQHSGP-DQQRDFQR 73
Query: 574 EISILSRLRHPNVILFLGACTKPPRLS--MITEYMELGSLYHLIHLSGQKKKLSWRRKLK 631
EI IL L ++ + G P R S ++ EY+ G L L + +L R L
Sbjct: 74 EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL--RDFLQRHRARLDASRLLL 131
Query: 632 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAG 689
IC+G+ + + VHRDL + N LV VKI DFGL++++
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191
Query: 690 TP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERV------------ 735
+P W APE + + F+ + D++S GV+++EL T ++
Sbjct: 192 SPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251
Query: 736 -VYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 777
+ + EG RL P + L+ CWA PQ+RPS + +L
Sbjct: 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 1e-61
Identities = 83/288 (28%), Positives = 148/288 (51%), Gaps = 32/288 (11%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG---------TDVAIKVFLEQDLTAENMED 570
+W +LT+G +G G FG+V G VA+K+ L+ D T +++ D
Sbjct: 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM-LKDDATEKDLSD 132
Query: 571 FCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-------------YHLIH 616
+E+ ++ + +H N+I LGACT+ L +I EY G+L Y
Sbjct: 133 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 617 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR- 675
+++++++ + + RG+ + K +HRDL + N LV ++ +KI DFGL+R
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 252
Query: 676 IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPE 733
I + +++ P +WMAPE + + +T + D++S GV+MWE+ TL P+ G+ E
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312
Query: 734 RVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 777
+ + EG R++ P L ++ DCW A P +RP+ ++++ L
Sbjct: 313 ELFKLL-KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-59
Identities = 75/280 (26%), Positives = 131/280 (46%), Gaps = 14/280 (5%)
Query: 508 SPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRG--IWNGTDVAIK-VFLEQDLT 564
P FQ + L + + + ++G G F EV+R + +G VA+K V + +
Sbjct: 13 VPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD 72
Query: 565 AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK- 623
A+ D EI +L +L HPNVI + + + L+++ E + G L +I ++K+
Sbjct: 73 AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL 132
Query: 624 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683
+ R K +C L +H +++HRD+K AN + VK+ D GL R +
Sbjct: 133 IPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 192
Query: 684 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG 743
S GTP +M+PE I + K DI+SLG +++E+ L P+ G +Y++ +
Sbjct: 193 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKI 250
Query: 744 SRLEIPEGPLGR-------LIADCWA-EPQERPSCEEILS 775
+ + P P L+ C +P++RP +
Sbjct: 251 EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 3e-59
Identities = 66/257 (25%), Positives = 114/257 (44%), Gaps = 20/257 (7%)
Query: 532 GTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 589
+G G F V++G+ +VA ++ LT + F E +L L+HPN++ F
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 590 LGA----CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 645
+ + ++TE M G+L + + K + + R I +GL +H
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 646 MK--IVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE 702
I+HRDLK N + +VKI D GL+ + S + + GTPE+MAPE+ +
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAPEMYEEK 205
Query: 703 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGR-LIA 758
+ E D+++ G+ M E+ T P+ +Y G + + P + +I
Sbjct: 206 -YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 264
Query: 759 DCWA-EPQERPSCEEIL 774
C ER S +++L
Sbjct: 265 GCIRQNKDERYSIKDLL 281
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 6e-59
Identities = 70/263 (26%), Positives = 133/263 (50%), Gaps = 11/263 (4%)
Query: 523 NIDFSEL---TVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISI 577
N+ F + ++G G FG+ +G IK ++++ E+ E+++
Sbjct: 17 NLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAV 76
Query: 578 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
L+ ++HPN++ + + + L ++ +Y E G L+ I+ + + L IC
Sbjct: 77 LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQIC 135
Query: 638 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 697
L +H KI+HRD+KS N + K TV++ DFG++R++ + + GTP +++PE
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195
Query: 698 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLG 754
+ N+P+ K DI++LG +++ELCTL +E + +V + GS + L
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI-ISGSFPPVSLHYSYDLR 254
Query: 755 RLIADCWA-EPQERPSCEEILSR 776
L++ + P++RPS IL +
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEK 277
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 8e-56
Identities = 72/261 (27%), Positives = 119/261 (45%), Gaps = 15/261 (5%)
Query: 530 TVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
V +G G +G R +G + K +T + +E+++L L+HPN++
Sbjct: 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 68
Query: 588 LFLGA--CTKPPRLSMITEYMELGSLYHLIHLSGQKKK-LSWRRKLKMLRDICRGLMCIH 644
+ L ++ EY E G L +I ++++ L L+++ + L H
Sbjct: 69 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 645 RMK-----IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 699
R ++HRDLK AN ++ VK+ DFGL+RI+ + GTP +M+PE +
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRL 756
+ EK DI+SLG +++ELC L P+ + + + EG IP L +
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIPYRYSDELNEI 247
Query: 757 IADCWA-EPQERPSCEEILSR 776
I + RPS EEIL
Sbjct: 248 ITRMLNLKDYHRPSVEEILEN 268
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 7e-53
Identities = 65/268 (24%), Positives = 115/268 (42%), Gaps = 36/268 (13%)
Query: 530 TVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
+G G FG+VF+ +G IK E E E+ L++L H N++
Sbjct: 14 KEIELIGSGGFGQVFKAKHRIDGKTYVIK---RVKYNNEKAE---REVKALAKLDHVNIV 67
Query: 588 LFLGA----------------CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK 631
+ G +K L + E+ + G+L I + +KL L+
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALE 126
Query: 632 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 691
+ I +G+ IH K+++RDLK +N + VKI DFGL + + R + S GT
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-TRSKGTL 185
Query: 692 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG 751
+M+PE I ++ + ++ D+++LG+I+ EL + + I +
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE------TSKFFTDLRDGIISDI 239
Query: 752 ---PLGRLIADCWA-EPQERPSCEEILS 775
L+ + +P++RP+ EIL
Sbjct: 240 FDKKEKTLLQKLLSKKPEDRPNTSEILR 267
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-52
Identities = 66/329 (20%), Positives = 118/329 (35%), Gaps = 46/329 (13%)
Query: 465 NSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQ-NKPLLAYEEWN 523
+ + + + F ++ L+SP + ++P +++
Sbjct: 4 HHHHSSGVDLGTENLYFQSMHQLQPRR----VSFRGEASETLQSPGYDPSRPESFFQQ-- 57
Query: 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 581
F L+ +G G +GEVF+ +G A+K + ++ E+ ++
Sbjct: 58 -SFQRLSR---LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 582 -RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
+HP + A + L + TE SL H L + LRD L
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQ--HCEAWGASLPEAQVWGYLRDTLLAL 170
Query: 641 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 700
+H +VH D+K AN + K+ DFGL + + G P +MAPEL+
Sbjct: 171 AHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQEGDPRYMAPELL- 228
Query: 701 NEPFTEKCDIFSLGVIMWELCTLNRPW----------EGVLPERVVYAVANEGSRLEIPE 750
+ D+FSLG+ + E+ +G LP E
Sbjct: 229 QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPP-------------EFTA 275
Query: 751 G---PLGRLIADCWA-EPQERPSCEEILS 775
G L ++ +P+ R + E +L+
Sbjct: 276 GLSSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 7e-52
Identities = 64/273 (23%), Positives = 113/273 (41%), Gaps = 28/273 (10%)
Query: 530 TVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
++G G F V G+ +G A+K L + ++ E+ E + HPN++
Sbjct: 32 LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ--QDREEAQREADMHRLFNHPNIL 89
Query: 588 LFLGACTKPP----RLSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLMC 642
+ C + ++ + + G+L++ I L + L+ + L +L ICRGL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA---------GTPEW 693
IH HRDLK N L+ + D G + T +
Sbjct: 150 IHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 694 MAPELI---RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE 750
APEL + E+ D++SLG +++ + P++ V + A+A + +L IP+
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-QLSIPQ 268
Query: 751 GP-----LGRLIADCWAE-PQERPSCEEILSRL 777
P L +L+ P +RP +LS+L
Sbjct: 269 SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-51
Identities = 89/271 (32%), Positives = 145/271 (53%), Gaps = 17/271 (6%)
Query: 513 NKPLLAYEEWNIDFSEL-TVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENME 569
L + D EL T ++G G FGEVF+GI N T VAIK+ ++ + + +E
Sbjct: 7 QSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI-IDLEEAEDEIE 65
Query: 570 DFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 629
D EI++LS+ P V + G+ K +L +I EY+ GS L+ + L +
Sbjct: 66 DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQI 121
Query: 630 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 689
+LR+I +GL +H K +HRD+K+AN L+++H VK+ DFG++ +TD+ ++ ++ G
Sbjct: 122 ATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVG 181
Query: 690 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEI 748
TP WMAPE+I+ + K DI+SLG+ EL P + P +V++ + L
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL-- 239
Query: 749 PEGPLGRLIADCWA-----EPQERPSCEEIL 774
EG + + + EP RP+ +E+L
Sbjct: 240 -EGNYSKPLKEFVEACLNKEPSFRPTAKELL 269
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-51
Identities = 61/268 (22%), Positives = 125/268 (46%), Gaps = 28/268 (10%)
Query: 530 TVGTRVGIGFFGEVFRGI-WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--V 586
++ ++G G +VF+ + AIK ++ + ++ + NEI+ L++L+ + +
Sbjct: 31 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90
Query: 587 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 646
I + M+ E L + +KK + + +++ + IH+
Sbjct: 91 IRLYDYEITDQYIYMVMECGN-IDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 647 KIVHRDLKSANCLVNKHWTVKICDFGLSRII---TDSPMRDSSSAGTPEWMAPELIRNEP 703
IVH DLK AN L+ +K+ DFG++ + T S ++D S GT +M PE I++
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD-SQVGTVNYMPPEAIKDMS 204
Query: 704 -----------FTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIPEG 751
+ K D++SLG I++ + P++ ++ ++A+ + +E P+
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 752 P---LGRLIADCWA-EPQERPSCEEILS 775
P L ++ C +P++R S E+L+
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 6e-51
Identities = 61/268 (22%), Positives = 125/268 (46%), Gaps = 28/268 (10%)
Query: 530 TVGTRVGIGFFGEVFRGI-WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--V 586
++ ++G G +VF+ + AIK ++ + ++ + NEI+ L++L+ + +
Sbjct: 12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71
Query: 587 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 646
I + M+ E L + +KK + + +++ + IH+
Sbjct: 72 IRLYDYEITDQYIYMVMECGN-IDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 647 KIVHRDLKSANCLVNKHWTVKICDFGLSRII---TDSPMRDSSSAGTPEWMAPELIRNEP 703
IVH DLK AN L+ +K+ DFG++ + T S ++D S GT +M PE I++
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD-SQVGTVNYMPPEAIKDMS 185
Query: 704 -----------FTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIPEG 751
+ K D++SLG I++ + P++ ++ ++A+ + +E P+
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 752 P---LGRLIADCWA-EPQERPSCEEILS 775
P L ++ C +P++R S E+L+
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 6e-50
Identities = 82/317 (25%), Positives = 125/317 (39%), Gaps = 25/317 (7%)
Query: 471 SLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELT 530
S+ S + S S A + + + E + K E+ + +T
Sbjct: 4 SVSSGQAHSLA--SLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61
Query: 531 VGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 588
RVG G FGEV R G A+K + L +E E+ + L P ++
Sbjct: 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRVE----ELVACAGLSSPRIVP 114
Query: 589 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 648
GA + P +++ E +E GSL LI G L R L L GL +H +I
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 649 VHRDLKSANCLVNKH-WTVKICDFGLSRIITD-----SPMRDSSSAGTPEWMAPELIRNE 702
+H D+K+ N L++ +CDFG + + S + GT MAPE++ +
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 703 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG-SRLEIPEG--PLGR-LIA 758
P K DI+S +M + PW + +A+E EIP PL I
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQ 291
Query: 759 DCWA-EPQERPSCEEIL 774
+ EP R S E+
Sbjct: 292 EGLRKEPVHRASAMELR 308
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-49
Identities = 60/268 (22%), Positives = 124/268 (46%), Gaps = 28/268 (10%)
Query: 530 TVGTRVGIGFFGEVFRGI-WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--V 586
++ ++G G +VF+ + AIK ++ + ++ + NEI+ L++L+ + +
Sbjct: 59 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 118
Query: 587 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 646
I + M+ E L + +KK + + +++ + IH+
Sbjct: 119 IRLYDYEITDQYIYMVMECGN-IDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 647 KIVHRDLKSANCLVNKHWTVKICDFGLSRII---TDSPMRDSSSAGTPEWMAPELIRNEP 703
IVH DLK AN L+ +K+ DFG++ + T S ++D S G +M PE I++
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD-SQVGAVNYMPPEAIKDMS 232
Query: 704 -----------FTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIPEG 751
+ K D++SLG I++ + P++ ++ ++A+ + +E P+
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292
Query: 752 P---LGRLIADCWA-EPQERPSCEEILS 775
P L ++ C +P++R S E+L+
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-49
Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 30/280 (10%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENMEDFCNEISIL 578
W+I+ + + +G G V VAIK LE+ +M++ EI +
Sbjct: 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAM 67
Query: 579 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK------M 632
S+ HPN++ + + L ++ + + GS+ +I K L +
Sbjct: 68 SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIK-HIVAKGEHKSGVLDESTIATI 126
Query: 633 LRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS----- 687
LR++ GL +H+ +HRD+K+ N L+ + +V+I DFG+S + +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 688 AGTPEWMAPELI-RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-R 745
GTP WMAPE++ + + K DI+S G+ EL T P+ P +V+
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246
Query: 746 LEIPEGPLGR----------LIADCWA-EPQERPSCEEIL 774
LE +I+ C +P++RP+ E+L
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-49
Identities = 71/251 (28%), Positives = 124/251 (49%), Gaps = 15/251 (5%)
Query: 533 TRVGIGFFGEVFRG--IWNGTDVAIKVF-LEQDLTAENMEDFCNEISILSRLRHPNVILF 589
++G G +G V++ G VAIK +E DL ++ EISI+ + P+V+ +
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-----QEIIKEISIMQQCDSPHVVKY 89
Query: 590 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 649
G+ K L ++ EY GS+ +I L K L+ +L+ +GL +H M+ +
Sbjct: 90 YGSYFKNTDLWIVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMRKI 147
Query: 650 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 709
HRD+K+ N L+N K+ DFG++ +TD+ + ++ GTP WMAPE+I+ + D
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVAD 207
Query: 710 IFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIADCWA-EP 764
I+SLG+ E+ P+ + P R ++ + PE + C P
Sbjct: 208 IWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSP 267
Query: 765 QERPSCEEILS 775
++R + ++L
Sbjct: 268 EQRATATQLLQ 278
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-48
Identities = 57/277 (20%), Positives = 99/277 (35%), Gaps = 34/277 (12%)
Query: 530 TVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
+G G FG VF + + + AIK + E E+ L++L HP ++
Sbjct: 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 588 LFLGAC------------TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 635
+ A + L + + +L ++ ++ L +
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 636 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS------------PMR 683
I + +H ++HRDLK +N VK+ DFGL + R
Sbjct: 127 IAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 684 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG 743
+ GT +M+PE I ++ K DIFSLG+I++EL P+ +
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNL 243
Query: 744 SRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSR 776
+ ++ D + P ERP I+
Sbjct: 244 KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-48
Identities = 55/273 (20%), Positives = 101/273 (36%), Gaps = 36/273 (13%)
Query: 530 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNV 586
++G G FG VF+ + +G AIK + + + ++ E+ + L +H +V
Sbjct: 14 HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73
Query: 587 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK-LSWRRKLKMLRDICRGLMCIHR 645
+ + A + + + EY GSL I + + +L + RGL IH
Sbjct: 74 VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133
Query: 646 MKIVHRDLKSANCLVNKH-------------------WTVKICDFGLSRIITDSPMRDSS 686
M +VH D+K +N +++ KI D G I+
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----QV 189
Query: 687 SAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 745
G ++A E+++ N K DIF+L + + + +G
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----WHEIRQGRL 245
Query: 746 LEIPEG---PLGRLIADCWA-EPQERPSCEEIL 774
IP+ L+ +P+ RPS ++
Sbjct: 246 PRIPQVLSQEFTELLKVMIHPDPERRPSAMALV 278
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-48
Identities = 72/264 (27%), Positives = 127/264 (48%), Gaps = 12/264 (4%)
Query: 521 EWNIDFSELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISIL 578
E++ ++ E +G G +G V+ G N +AIK E+D + + EI++
Sbjct: 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALH 73
Query: 579 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 638
L+H N++ +LG+ ++ + + E + GSL L+ K + + + I
Sbjct: 74 KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE 133
Query: 639 GLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 697
GL +H +IVHRD+K N L+N + +KI DFG S+ + + GT ++MAPE
Sbjct: 134 GLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE 193
Query: 698 LIRNEP--FTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIPEG--P 752
+I P + + DI+SLG + E+ T P+ + P+ ++ V EIPE
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA 253
Query: 753 LGR-LIADCWA-EPQERPSCEEIL 774
+ I C+ +P +R ++L
Sbjct: 254 EAKAFILKCFEPDPDKRACANDLL 277
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-48
Identities = 71/276 (25%), Positives = 127/276 (46%), Gaps = 19/276 (6%)
Query: 514 KPLLAYEEWNIDFSEL-TVGTRVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENME 569
+ ++D +E+ + +G G FG+V++ T A KV + + E +E
Sbjct: 5 SREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELE 61
Query: 570 DFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 629
D+ EI IL+ HP ++ LGA +L ++ E+ G++ ++ + L+ +
Sbjct: 62 DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL--DRGLTEPQI 119
Query: 630 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 689
+ R + L +H +I+HRDLK+ N L+ +++ DFG+S + + S G
Sbjct: 120 QVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG 179
Query: 690 TPEWMAPELIRNEPFTE-----KCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS 744
TP WMAPE++ E + K DI+SLG+ + E+ + P + P RV+ +A
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP 239
Query: 745 -RLEIPEG---PLGRLIADCWA-EPQERPSCEEILS 775
L P + P+ RPS ++L
Sbjct: 240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-48
Identities = 70/249 (28%), Positives = 124/249 (49%), Gaps = 15/249 (6%)
Query: 534 RVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENMEDFCNEISILSRLRHPNVILFL 590
++G G G V+ + T VAI+ L+Q E NEI ++ ++PN++ +L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYL 83
Query: 591 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 650
+ L ++ EY+ GSL ++ + + + + R+ + L +H +++H
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 651 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 710
RD+KS N L+ +VK+ DFG IT + S+ GTP WMAPE++ + + K DI
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 711 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIADCWA-EPQ 765
+SLG++ E+ P+ P R +Y +A G+ L+ PE + C + +
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVE 259
Query: 766 ERPSCEEIL 774
+R S +E+L
Sbjct: 260 KRGSAKELL 268
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-47
Identities = 75/266 (28%), Positives = 128/266 (48%), Gaps = 34/266 (12%)
Query: 534 RVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 590
VG G +G+V++G G AIKV D+T + E+ EI++L + H N+ +
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKV---MDVTGDEEEEIKQEINMLKKYSHHRNIATYY 87
Query: 591 GA------CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK------MLRDICR 638
GA +L ++ E+ GS+ LI K + LK + R+I R
Sbjct: 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-------KNTKGNTLKEEWIAYICREILR 140
Query: 639 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 698
GL +H+ K++HRD+K N L+ ++ VK+ DFG+S + + R ++ GTP WMAPE+
Sbjct: 141 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 200
Query: 699 IRNEPFTE-----KCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPE-- 750
I + + K D++SLG+ E+ P + P R ++ + + RL+ +
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 260
Query: 751 GPLGRLIADCWA-EPQERPSCEEILS 775
I C +RP+ E+++
Sbjct: 261 KKFQSFIESCLVKNHSQRPATEQLMK 286
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-47
Identities = 60/249 (24%), Positives = 116/249 (46%), Gaps = 15/249 (6%)
Query: 534 RVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENMEDFCNEISILSRLRHPNVILFL 590
++G G G V + VA+K+ L + + E NE+ I+ +H NV+
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMY 108
Query: 591 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 650
+ L ++ E+++ G+L ++ + +L+ + + + + L +H ++H
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQGVIH 164
Query: 651 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 710
RD+KS + L+ VK+ DFG I+ + S GTP WMAPE+I + + DI
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDI 224
Query: 711 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIADCWA-EPQ 765
+SLG+++ E+ P+ P + + + + +L+ L + +PQ
Sbjct: 225 WSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQ 284
Query: 766 ERPSCEEIL 774
ER + +E+L
Sbjct: 285 ERATAQELL 293
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 6e-46
Identities = 72/252 (28%), Positives = 111/252 (44%), Gaps = 17/252 (6%)
Query: 534 RVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENMEDFCNEISILSRLRHPNVILFL 590
+G G FG V+ VAIK + E +D E+ L +LRHPN I +
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 591 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 650
G + ++ EY GS L+ + KK L + +GL +H ++H
Sbjct: 121 GCYLREHTAWLVMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIH 177
Query: 651 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE---PFTEK 707
RD+K+ N L+++ VK+ DFG + I+ +S GTP WMAPE+I + K
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSASIMA----PANSFVGTPYWMAPEVILAMDEGQYDGK 233
Query: 708 CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPE--GPLGRLIADCWA-E 763
D++SLG+ EL P + +Y +A S L+ + C
Sbjct: 234 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI 293
Query: 764 PQERPSCEEILS 775
PQ+RP+ E +L
Sbjct: 294 PQDRPTSEVLLK 305
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 8e-46
Identities = 70/287 (24%), Positives = 116/287 (40%), Gaps = 47/287 (16%)
Query: 527 SELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHP 584
S+ +G G FG+V R + AIK T E + +E+ +L+ L H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNHQ 62
Query: 585 NVILFLGA-------------CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK 631
V+ + A K L + EY E G+LY LIH + +
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWR 120
Query: 632 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD------- 684
+ R I L IH I+HRDLK N +++ VKI DFGL++ + S
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 685 -------SSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVV 736
+S+ GT ++A E++ EK D++SLG+I +E+ G+ ++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNIL 238
Query: 737 YAVANEGSRLEIPEG-------PLGRLIADC-WAEPQERPSCEEILS 775
+ + +E P ++I +P +RP +L+
Sbjct: 239 KKLRS--VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 6e-45
Identities = 77/282 (27%), Positives = 118/282 (41%), Gaps = 41/282 (14%)
Query: 529 LTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPN 585
L V + G F V+ + + +G + A+K L + E+ + +L HPN
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI--IQEVCFMKKLSGHPN 87
Query: 586 VILFLGACTKPPRLSMITEY-----MEL--GSLYHLIHLSGQKKKLSWRRKLKMLRDICR 638
++ F A + S + EL G L + + LS LK+ CR
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 639 GLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA-------- 688
+ +HR K I+HRDLK N L++ T+K+CDFG + I+ P S+
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 689 ----GTPEWMAPELI---RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN 741
TP + PE+I N P EK DI++LG I++ LC P+E R+V
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG--- 264
Query: 742 EGSRLEIPEGP-----LGRLIADCWAE-PQERPSCEEILSRL 777
+ IP LI P+ER S E++ +L
Sbjct: 265 ---KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 18/216 (8%)
Query: 530 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
+ +G G VFRG G AIKVF ++ E +L +L H N++
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 588 LFLGA--CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 645
T +I E+ GSLY ++ L L +LRD+ G+ +
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 646 MKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR- 700
IVHR++K N + + K+ DFG +R + D S GT E++ P++
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF-VSLYGTEEYLHPDMYER 189
Query: 701 -------NEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
+ + D++S+GV + T + P+
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-44
Identities = 66/231 (28%), Positives = 100/231 (43%), Gaps = 13/231 (5%)
Query: 530 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
+ R+G G FG V R I G VAIK Q+L+ +N E +C EI I+ +L HPNV+
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQC-RQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 588 -LF-----LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
L + EY E G L ++ L +L DI L
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 642 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 698
+H +I+HRDLK N ++ + KI D G ++ + + GT +++APEL
Sbjct: 136 YLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF-VGTLQYLAPEL 194
Query: 699 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 749
+ + +T D +S G + +E T RP+ + E S I
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-42
Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 18/216 (8%)
Query: 530 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
+ +G G VFRG G AIKVF ++ E +L +L H N++
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 588 LFLGA--CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 645
T +I E+ GSLY ++ L L +LRD+ G+ +
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 646 MKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR- 700
IVHR++K N + + K+ DFG +R + D S GT E++ P++
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF-VSLYGTEEYLHPDMYER 189
Query: 701 -------NEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
+ + D++S+GV + T + P+
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 63/281 (22%), Positives = 122/281 (43%), Gaps = 15/281 (5%)
Query: 507 ESPMFQNKPLLAYEEWNIDFS--ELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQD 562
E + + L ++ + + + +G G G VF+ +G +A K+ + +
Sbjct: 11 EQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL-IHLE 69
Query: 563 LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ-- 620
+ E+ +L P ++ F GA +S+ E+M+ GSL ++ +G+
Sbjct: 70 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP 129
Query: 621 KKKLSWRRKLKMLRDICRGLMCIH-RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679
++ L K+ + +GL + + KI+HRD+K +N LVN +K+CDFG+S + D
Sbjct: 130 EQILG-----KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184
Query: 680 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV 739
S M + S GT +M+PE ++ ++ + DI+S+G+ + E+ P + +
Sbjct: 185 S-MAN-SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242
Query: 740 ANEGSRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDC 780
+ P R + + LLD
Sbjct: 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDY 283
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-42
Identities = 48/277 (17%), Positives = 101/277 (36%), Gaps = 35/277 (12%)
Query: 512 QNKPLLAYEEWNIDFSELTVGTRVGIGF--FGEVFRGI--WNGTDVAIKVFLEQDLTAEN 567
+N + + + T +G GF V G V ++ + + E
Sbjct: 10 ENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEM 69
Query: 568 MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWR 627
+ E+ + HPN++ + L ++T +M GS LI +
Sbjct: 70 VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI-------CTHFM 122
Query: 628 RKLK------MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681
+ +L+ + + L IH M VHR +K+++ L++ V + + +
Sbjct: 123 DGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182
Query: 682 MR-------DSSSAGTPEWMAPELIR--NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP 732
R S W++PE+++ + + K DI+S+G+ EL + P++ +
Sbjct: 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242
Query: 733 ERVVYAVANEGSRLEIPEGPLGRLIADCWAEPQERPS 769
+++ E G + L+ +E
Sbjct: 243 TQMLL---------EKLNGTVPCLLDTSTIPAEELTM 270
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 70/227 (30%), Positives = 115/227 (50%), Gaps = 17/227 (7%)
Query: 526 FSELTVGTR-------VGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENMEDFCNEISI 577
+L T +G G FG+V++G + +G VA+K + E+F EI
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGI--EEFETEIET 88
Query: 578 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSG---QKKKLSWRRKLKMLR 634
LS RHP+++ +G C + + +I +YME G+L HL G +SW ++L++
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKR--HLYGSDLPTMSMSWEQRLEICI 146
Query: 635 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS--AGTPE 692
RGL +H I+HRD+KS N L+++++ KI DFG+S+ T+ S+ GT
Sbjct: 147 GAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLG 206
Query: 693 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV 739
++ PE TEK D++S GV+++E+ LP +V
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 3e-41
Identities = 68/261 (26%), Positives = 106/261 (40%), Gaps = 31/261 (11%)
Query: 536 GIGFFGE-VFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGAC 593
G G G V+RG+++ DVA+K L + + + E+ +L HPNVI +
Sbjct: 33 GHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHPNVIRYFCTE 87
Query: 594 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL 653
+ E +L + + +L+ GL +H + IVHRDL
Sbjct: 88 KDRQFQYIAIELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDL 144
Query: 654 KSANCLV-----NKHWTVKICDFGLSRIITD---SPMRDSSSAGTPEWMAPELIR---NE 702
K N L+ + I DFGL + + S R S GT W+APE++ E
Sbjct: 145 KPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKE 204
Query: 703 PFTEKCDIFSLGVIMWE-LCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR------ 755
T DIFS G + + + + P+ L +R + S L+
Sbjct: 205 NPTYTVDIFSAGCVFYYVISEGSHPFGKSL-QRQANILLGACS-LDCLHPEKHEDVIARE 262
Query: 756 LIADCWA-EPQERPSCEEILS 775
LI A +PQ+RPS + +L
Sbjct: 263 LIEKMIAMDPQKRPSAKHVLK 283
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-41
Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 525 DFSEL-TVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRL 581
FS+ V +G G F V R + T + A K+ + L+A + + E I +L
Sbjct: 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
+HPN++ + + ++ + + G L+ I ++ S ++ I +
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESIA 119
Query: 642 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEWMAPE 697
H IVHR+LK N L+ K VK+ DFGL+ + D AGTP +++PE
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPGYLSPE 177
Query: 698 LIRNEPFTEKCDIFSLGVIM 717
+++ +P+++ DI++ GVI+
Sbjct: 178 VLKKDPYSKPVDIWACGVIL 197
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-41
Identities = 58/273 (21%), Positives = 115/273 (42%), Gaps = 21/273 (7%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISI 577
+ W+ +L +G G +G V + + +G +A+K + + + + ++ +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKR-IRSTVDEKEQKQLLMDLDV 73
Query: 578 LSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL--KMLR 634
+ R P ++ F GA + + E M S ++ K+
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITL 132
Query: 635 DICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEW 693
+ L + +KI+HRD+K +N L+++ +K+CDFG+S + DS + + AG +
Sbjct: 133 ATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS-IAKTRDAGCRPY 191
Query: 694 MAPELI----RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGS-RLE 747
MAPE I + + + D++SLG+ ++EL T P+ + V +L
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS 251
Query: 748 IPEG-----PLGRLIADC-WAEPQERPSCEEIL 774
E + C + +RP +E+L
Sbjct: 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 14/210 (6%)
Query: 526 FSELTVGTR-------VGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENMEDFCNEISI 577
EL V + +G G FG+V++G + +GT VA+K E+ ++ F E+ +
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ-FQTEVEM 80
Query: 578 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLKMLRDI 636
+S H N++ G C P ++ YM GS+ L + L W ++ ++
Sbjct: 81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGS 140
Query: 637 CRGLMCIH---RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-AGTPE 692
RGL +H KI+HRD+K+AN L+++ + + DFGL++++ +++ GT
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 200
Query: 693 WMAPELIRNEPFTEKCDIFSLGVIMWELCT 722
+APE + +EK D+F GV++ EL T
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELIT 230
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 48/250 (19%), Positives = 89/250 (35%), Gaps = 25/250 (10%)
Query: 544 FRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603
++ + + + + M+ +I + N + L + L +
Sbjct: 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140
Query: 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH 663
+ +L ++ + L + I + +H ++HRDLK +N
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD 200
Query: 664 WTVKICDFGLSRIITDSPMRDSSSA------------GTPEWMAPELIRNEPFTEKCDIF 711
VK+ DFGL + + GT +M+PE I ++ K DIF
Sbjct: 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIF 260
Query: 712 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP------LGRLIADCWA-EP 764
SLG+I++EL ERV + + L+ P ++ D + P
Sbjct: 261 SLGLILFELLYSFSTQM----ERV--RIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSP 314
Query: 765 QERPSCEEIL 774
ERP +I+
Sbjct: 315 TERPEATDII 324
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 18/216 (8%)
Query: 521 EWNI-DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED-FCNEIS 576
+W + DF +G +G G FG V+ R + +A+KV + L +E E+
Sbjct: 5 QWALEDF---EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 577 ILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 636
I S LRHPN++ G R+ +I EY LG++Y + + K +R + ++
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITEL 118
Query: 637 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAP 696
L H +++HRD+K N L+ +KI DFG S S R + GT +++ P
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPP 176
Query: 697 ELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP 732
E+I EK D++SLGV+ +E G P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLV------GKPP 206
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 76/353 (21%), Positives = 134/353 (37%), Gaps = 82/353 (23%)
Query: 509 PMFQNKPLLAYE--EWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFL 559
P+ ++ L Y+ +W L +G +G G FG+V G VA+K+ L
Sbjct: 2 PLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-L 60
Query: 560 EQDLTAENMEDFCNEIS---------------------------ILSRLRHPNVILFLGA 592
++ T +E+ I+ + N+ +L +
Sbjct: 61 KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 120
Query: 593 CTK--PPRLSMITEYMELGSLYHLIHLS-------------------------------- 618
P + + + I +
Sbjct: 121 KRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180
Query: 619 ----GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 674
K L+ + + +G+ + K +HRDL + N L+++ VKICDFGL+
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
Query: 675 R-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVL 731
R I D A P +WMAPE I + +T + D++S GV++WE+ +L P+ GV
Sbjct: 241 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300
Query: 732 PERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDC 780
+ EG+R+ P+ + + + DCW EP +RP+ E++ L +
Sbjct: 301 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 69/218 (31%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 526 FSELTVGTR-------------VGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENM---E 569
F EL T +G G FG V++G N T VA+K L + +
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKK-LAAMVDITTEELKQ 75
Query: 570 DFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 629
F EI ++++ +H N++ LG + L ++ YM GSL + LSW +
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 630 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-- 687
K+ + G+ +H +HRD+KSAN L+++ +T KI DFGL+R S +
Sbjct: 136 CKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLAR---ASEKFAQTVMT 192
Query: 688 ---AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 722
GT +MAPE +R E T K DI+S GV++ E+ T
Sbjct: 193 SRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIIT 229
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-39
Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 525 DFSEL-TVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRL 581
FS+ V +G G F V R + T + A K+ + L+A + + E I +L
Sbjct: 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 85
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
+HPN++ + + ++ + + G L+ I ++ S ++ I +
Sbjct: 86 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESIA 142
Query: 642 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEWMAPE 697
H IVHR+LK N L+ K VK+ DFGL+ + D AGTP +++PE
Sbjct: 143 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPGYLSPE 200
Query: 698 LIRNEPFTEKCDIFSLGVIM 717
+++ +P+++ DI++ GVI+
Sbjct: 201 VLKKDPYSKPVDIWACGVIL 220
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-39
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 16/215 (7%)
Query: 521 EWNIDFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED-FCNEISI 577
++ ID ++ G +G G FG V+ R N +A+KV + L E +E EI I
Sbjct: 10 KFTIDDFDI--GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI 67
Query: 578 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
S LRHPN++ R+ ++ E+ G LY + + + +R + ++
Sbjct: 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ---KHGRFDEQRSATFMEELA 124
Query: 638 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 697
L H K++HRD+K N L+ +KI DFG S + S R + GT +++ PE
Sbjct: 125 DALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRR-TMCGTLDYLPPE 182
Query: 698 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP 732
+I + EK D++ GV+ +E G+ P
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLV------GMPP 211
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-39
Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 525 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF----LEQDLTAENMEDFCNEISI 577
+ +G +G G F V + G + A K L + E+ E++I
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 578 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
L +RHPN+I + +I E + G L+ + +K+ L+ + L+ I
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA---EKESLTEDEATQFLKQIL 118
Query: 638 RGLMCIHRMKIVHRDLKSANCL-VNKHW---TVKICDFGLSRII-TDSPMRDSSSAGTPE 692
G+ +H +I H DLK N + ++K+ +K+ DFG++ I + ++ GTPE
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI--FGTPE 176
Query: 693 WMAPELIRNEPFTEKCDIFSLGVIM 717
++APE++ EP + D++S+GVI
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-38
Identities = 66/298 (22%), Positives = 114/298 (38%), Gaps = 51/298 (17%)
Query: 520 EEWNIDFSELTVGTRV-GIGFFGEV-FRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISI 577
+ L V ++ G G G V F+G + G VA+K L + + EI +
Sbjct: 7 PNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML-----IDFCDIALMEIKL 61
Query: 578 LSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLI----HLSGQKKKLSWRRKLKM 632
L+ HPNVI + + T L + E +L L+ K + +
Sbjct: 62 LTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 633 LRDICRGLMCIHRMKIVHRDLKSANCLV-------------NKHWTVKICDFGLSRIITD 679
LR I G+ +H +KI+HRDLK N LV ++ + I DFGL + +
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 680 SPMRDSSS----AGTPEWMAPELIRN-------EPFTEKCDIFSLGVIMWELCTLNRP-- 726
++ +GT W APEL+ T DIFS+G + + + + +
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 727 WEGVLPERVVYAVANEGSRLEIPEGP---------LGRLIADCWAEPQERPSCEEILS 775
+ E + ++ + ++I +P +RP+ ++L
Sbjct: 241 GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMID---HDPLKRPTAMKVLR 295
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 63/270 (23%), Positives = 119/270 (44%), Gaps = 23/270 (8%)
Query: 523 NIDFSELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISI-LS 579
+ +L +G G +G V + +G +A+K + + ++ + ++ I +
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKR-IRATVNSQEQKRLLMDLDISMR 61
Query: 580 RLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 639
+ P + F GA + + + E M+ + + + + K+ I +
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 640 LMCIH-RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 698
L +H ++ ++HRD+K +N L+N VK+CDFG+S + D + AG +MAPE
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD-VAKDIDAGCKPYMAPER 180
Query: 699 IRNE----PFTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIPEGPL 753
I E ++ K DI+SLG+ M EL L P++ P + + V E P+ P
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE----PSPQLPA 236
Query: 754 GR-------LIADC-WAEPQERPSCEEILS 775
+ + C +ERP+ E++
Sbjct: 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 525 DFSEL-TVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRL 581
F+E + +G G FGEV + T + A+KV + ++ E+ +L +L
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
HPN++ ++ E G L+ I ++K+ S ++++ + G+
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGIT 135
Query: 642 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIIT-DSPMRDSSSAGTPEWMAPE 697
+H+ IVHRDLK N L+ K +KI DFGLS ++ M+D GT ++APE
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPE 193
Query: 698 LIRNEPFTEKCDIFSLGVIM 717
++R + EKCD++S GVI+
Sbjct: 194 VLR-GTYDEKCDVWSAGVIL 212
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 47/193 (24%), Positives = 90/193 (46%), Gaps = 12/193 (6%)
Query: 530 TVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
+G G F EVF T A+K + + NEI++L +++H N++
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIAVLKKIKHENIV 69
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
++ + + G L+ I ++ + + +++ + + +H
Sbjct: 70 TLEDIYESTTHYYLVMQLVSGGELFDRIL---ERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 648 IVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPF 704
IVHRDLK N L ++ + I DFGLS++ + M + GTP ++APE++ +P+
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA--CGTPGYVAPEVLAQKPY 184
Query: 705 TEKCDIFSLGVIM 717
++ D +S+GVI
Sbjct: 185 SKAVDCWSIGVIT 197
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-38
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 525 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF----LEQDLTAENMEDFCNEISI 577
+ +G +G G F V + G + A K + E+ E+SI
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 578 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
L ++ H NVI + +I E + G L+ + QK+ LS ++ I
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA---QKESLSEEEATSFIKQIL 125
Query: 638 RGLMCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPE 692
G+ +H KI H DLK N ++ +K+ DFGL+ I D ++ GTPE
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI--FGTPE 183
Query: 693 WMAPELIRNEPFTEKCDIFSLGVIM 717
++APE++ EP + D++S+GVI
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-38
Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 525 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF----LEQDLTAENMEDFCNEISI 577
+ + G +G G F V + G A K + + ED E+SI
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 578 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
L ++HPNVI + +I E + G L+ + +K+ L+ + L+ I
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQIL 124
Query: 638 RGLMCIHRMKIVHRDLKSANCL-VNKHW---TVKICDFGLSRIIT-DSPMRDSSSAGTPE 692
G+ +H ++I H DLK N + ++++ +KI DFGL+ I + ++ GTPE
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI--FGTPE 182
Query: 693 WMAPELIRNEPFTEKCDIFSLGVIM 717
++APE++ EP + D++S+GVI
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 9e-38
Identities = 50/199 (25%), Positives = 95/199 (47%), Gaps = 9/199 (4%)
Query: 525 DFSEL-TVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRL 581
F+E + +G G F V R + + A + + L+A + + E I L
Sbjct: 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
+HPN++ + ++ +I + + G L+ I ++ S ++ I ++
Sbjct: 68 KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV---AREYYSEADASHCIQQILEAVL 124
Query: 642 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 698
H+M +VHR+LK N L+ K VK+ DFGL+ + AGTP +++PE+
Sbjct: 125 HCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 184
Query: 699 IRNEPFTEKCDIFSLGVIM 717
+R +P+ + D+++ GVI+
Sbjct: 185 LRKDPYGKPVDLWACGVIL 203
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 58/270 (21%), Positives = 115/270 (42%), Gaps = 20/270 (7%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISI 577
+ + + ++L +G G G+V++ G +A+K + + E + ++ +
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ-MRRSGNKEENKRILMDLDV 76
Query: 578 LSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 636
+ + P ++ G + + E M + + G + R KM I
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG---PIPERILGKMTVAI 133
Query: 637 CRGLMCIH-RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMA 695
+ L + + ++HRD+K +N L+++ +K+CDFG+S + D SAG +MA
Sbjct: 134 VKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD-KAKDRSAGCAAYMA 192
Query: 696 PELI-----RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGS-RLEI 748
PE I + + D++SLG+ + EL T P++ + V+ V E L
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG 252
Query: 749 PEG---PLGRLIADC-WAEPQERPSCEEIL 774
G + DC + ++RP ++L
Sbjct: 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLL 282
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 68/262 (25%), Positives = 107/262 (40%), Gaps = 32/262 (12%)
Query: 531 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMED-FCNEISILSRLRHPNVI 587
G +G G F + F A K+ + L + + EISI L H +V+
Sbjct: 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 78
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
F G + ++ E SL L ++K L+ LR I G +HR +
Sbjct: 79 GFHGFFEDNDFVFVVLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR 135
Query: 648 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 707
++HRDLK N +N+ VKI DFGL+ + R GTP ++APE++ + + +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 708 CDIFSLGVIMWELCTLNRPWEGVLP----------ERVVYAVANEGSRLEIPE---GPLG 754
D++S+G IM+ L G P R+ IP+
Sbjct: 196 VDVWSIGCIMYTLLV------GKPPFETSCLKETYLRIKKN------EYSIPKHINPVAA 243
Query: 755 RLIADC-WAEPQERPSCEEILS 775
LI +P RP+ E+L+
Sbjct: 244 SLIQKMLQTDPTARPTINELLN 265
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 56/272 (20%), Positives = 102/272 (37%), Gaps = 31/272 (11%)
Query: 536 GIGFFGEVFRGIWNGTDVAIKVF---------------LEQDLTAENMEDFCNEISILSR 580
G F ++ + A+K + ++ +DF NE+ I++
Sbjct: 40 NQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD 99
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSG-----QKKKLSWRRKLKMLRD 635
+++ + G T + +I EYME S+ + + +++
Sbjct: 100 IKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKS 159
Query: 636 ICRGLMCIHRMK-IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM 694
+ IH K I HRD+K +N L++K+ VK+ DFG S + D ++ S GT E+M
Sbjct: 160 VLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--GSRGTYEFM 217
Query: 695 APELIRNEPFT--EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP 752
PE NE K DI+SLG+ ++ + P+ + ++ +E P
Sbjct: 218 PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK-NIEYPLDR 276
Query: 753 LGRLIADCWAEPQER-----PSCEEILSRLLD 779
L + + L L
Sbjct: 277 NHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLR 308
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-37
Identities = 53/189 (28%), Positives = 92/189 (48%), Gaps = 10/189 (5%)
Query: 536 GIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH-PNVILFLGA 592
G G F V + I G + A K ++ + + +EI++L + P VI
Sbjct: 38 GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97
Query: 593 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 652
+ +I EY G ++ L L + +S +++++ I G+ +H+ IVH D
Sbjct: 98 YENTSEIILILEYAAGGEIFSLC-LPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLD 156
Query: 653 LKSANCLV---NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEWMAPELIRNEPFTEKC 708
LK N L+ +KI DFG+SR I +R+ GTPE++APE++ +P T
Sbjct: 157 LKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI--MGTPEYLAPEILNYDPITTAT 214
Query: 709 DIFSLGVIM 717
D++++G+I
Sbjct: 215 DMWNIGIIA 223
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-37
Identities = 65/266 (24%), Positives = 120/266 (45%), Gaps = 23/266 (8%)
Query: 525 DFSEL-TVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRL 581
SE+ ++G G +GEV T AIK+ + ++ + E+++L L
Sbjct: 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
HPN++ ++ E + G L+ I + K + +++ + G+
Sbjct: 94 DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVT 150
Query: 642 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 698
+H+ IVHRDLK N L+ K +KI DFGLS + + + GT ++APE+
Sbjct: 151 YLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-KMKERLGTAYYIAPEV 209
Query: 699 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP------ 752
+R + + EKCD++S+GVI++ L P+ G + ++ V + PE
Sbjct: 210 LR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268
Query: 753 ---LGRLIADCWAEPQERPSCEEILS 775
+ +++ + Q R S ++ L
Sbjct: 269 KDLIKQMLQ---FDSQRRISAQQALE 291
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-37
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 525 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF----LEQDLTAENMEDFCNEISI 577
+ +G +G G F V + G + A K E+ E+SI
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 578 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
L ++ HPN+I + +I E + G L+ + QK+ LS ++ I
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA---QKESLSEEEATSFIKQIL 125
Query: 638 RGLMCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPE 692
G+ +H KI H DLK N ++ +K+ DFGL+ I D ++ GTPE
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI--FGTPE 183
Query: 693 WMAPELIRNEPFTEKCDIFSLGVIM 717
++APE++ EP + D++S+GVI
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-37
Identities = 67/275 (24%), Positives = 112/275 (40%), Gaps = 41/275 (14%)
Query: 525 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 581
F+E + +G G FGEV + + A+KV + ++ E+ +L +L
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
HPN++ ++ E G L+ I ++K+ S ++++ + G+
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGIT 135
Query: 642 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRII-TDSPMRDSSSAGTPEWMAPE 697
+H+ IVHRDLK N L+ K +KI DFGLS ++ M+D GT ++APE
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPE 193
Query: 698 LIRNEPFTEKCDIFSLGVIMWE-LCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRL 756
++R + EKCD++S GVI++ L G P Y + G
Sbjct: 194 VLR-GTYDEKCDVWSAGVILYILLS-------GTPP---FYGKNEYDILKRVETGKY-AF 241
Query: 757 IADCWAE----------------PQERPSCEEILS 775
W P R + + L
Sbjct: 242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 7e-37
Identities = 48/194 (24%), Positives = 88/194 (45%), Gaps = 14/194 (7%)
Query: 530 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
T+ +G G +GEV + A K + + E+++ F EI I+ L HPN+I
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNII 69
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
+ ++ E G L+ + K+ ++++D+ + H++
Sbjct: 70 RLYETFEDNTDIYLVMELCTGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 648 IVHRDLKSANCLV---NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEWMAPELIRNEP 703
+ HRDLK N L + +K+ DFGL+ MR GTP +++P+++
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSPQVLEG-L 183
Query: 704 FTEKCDIFSLGVIM 717
+ +CD +S GV+M
Sbjct: 184 YGPECDEWSAGVMM 197
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 59/269 (21%), Positives = 113/269 (42%), Gaps = 29/269 (10%)
Query: 531 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAEN--MEDFCNEISILSRLRHPNV 586
+ ++G G V+ VAIK + + ++ F E+ S+L H N+
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKA-IFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 587 --ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 644
++ + L M EY+E +L I LS + I G+ H
Sbjct: 74 VSMIDVDEEDDCYYLVM--EYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAH 128
Query: 645 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA-GTPEWMAPELIRNEP 703
M+IVHRD+K N L++ + T+KI DFG+++ ++++ + ++ GT ++ +PE + E
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 704 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP----------L 753
E DI+S+G++++E+ P+ G + + +P L
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD----SVPNVTTDVRKDIPQSL 244
Query: 754 GRLIADCWA-EPQERP-SCEEILSRLLDC 780
+I + R + +E+ L
Sbjct: 245 SNVILRATEKDKANRYKTIQEMKDDLSSV 273
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 68/257 (26%), Positives = 108/257 (42%), Gaps = 22/257 (8%)
Query: 531 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMED-FCNEISILSRLRHPNVI 587
G +G G F + F A K+ + L + + EISI L H +V+
Sbjct: 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 104
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
F G + ++ E SL L ++K L+ LR I G +HR +
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR 161
Query: 648 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 707
++HRDLK N +N+ VKI DFGL+ + R GTP ++APE++ + + +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 708 CDIFSLGVIMWELCTLNRPWEGVLP-----ERVVYAVANEGSRLEIPE---GPLGRLIAD 759
D++S+G IM+ L G P + Y + IP+ LI
Sbjct: 222 VDVWSIGCIMYTLLV------GKPPFETSCLKETYLRIKKN-EYSIPKHINPVAASLIQK 274
Query: 760 C-WAEPQERPSCEEILS 775
+P RP+ E+L+
Sbjct: 275 MLQTDPTARPTINELLN 291
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 59/194 (30%), Positives = 90/194 (46%), Gaps = 15/194 (7%)
Query: 530 TVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
V + +G G V+R GT A+KV + + EI +L RL HPN+I
Sbjct: 56 EVESELGRGATSIVYRCKQKGTQKPYALKVLK----KTVDKKIVRTEIGVLLRLSHPNII 111
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
P +S++ E + G L+ I +K S R ++ I + +H
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 648 IVHRDLKSANCLV---NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEWMAPELIRNEP 703
IVHRDLK N L +KI DFGLS+I+ M+ GTP + APE++R
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV--CGTPGYCAPEILRGCA 226
Query: 704 FTEKCDIFSLGVIM 717
+ + D++S+G+I
Sbjct: 227 YGPEVDMWSVGIIT 240
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-36
Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 11/195 (5%)
Query: 530 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
++G G FG+V +G + IK + +D + ME EI +L L HPN+I
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKT-INKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 588 LFLGACTKPPRLSMITEYMELGSLYH-LIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 646
+ ++ E E G L ++ + K LS ++++ + L H
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 647 KIVHRDLKSANCLV---NKHWTVKICDFGLSRIIT-DSPMRDSSSAGTPEWMAPELIRNE 702
+VH+DLK N L + H +KI DFGL+ + D + +AGT +MAPE+ +
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN--AAGTALYMAPEVFK-R 200
Query: 703 PFTEKCDIFSLGVIM 717
T KCDI+S GV+M
Sbjct: 201 DVTFKCDIWSAGVVM 215
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-36
Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 5/193 (2%)
Query: 531 VGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED-FCNEISILSRLRHPNVI 587
VG +G G F V+ I G +VAIK+ ++ + M NE+ I +L+HP+++
Sbjct: 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSIL 74
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
+ ++ E G + + + K S + I G++ +H
Sbjct: 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMHQIITGMLYLHSHG 132
Query: 648 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 707
I+HRDL +N L+ ++ +KI DFGL+ + + + GTP +++PE+ +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLE 192
Query: 708 CDIFSLGVIMWEL 720
D++SLG + + L
Sbjct: 193 SDVWSLGCMFYTL 205
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 64/305 (20%), Positives = 108/305 (35%), Gaps = 62/305 (20%)
Query: 530 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDL---TAENMEDFCNEISILSRLRHP 584
+ +G G +G V I AIK+ + + +++E E+ ++ +L HP
Sbjct: 29 HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 585 NVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL-------------- 630
N+ + ++ E G L +++ +
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 631 -----------------------KMLRDICRGLMCIHRMKIVHRDLKSANCLV--NKHWT 665
++R I L +H I HRD+K N L NK +
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFE 208
Query: 666 VKICDFGLSRIITDSPMRD----SSSAGTPEWMAPELIR--NEPFTEKCDIFSLGVIMWE 719
+K+ DFGLS+ + ++ AGTP ++APE++ NE + KCD +S GV++
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 720 LCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP---------LGRLIADCWAEPQERPSC 770
L P+ GV + V N+ E P L L+ ER
Sbjct: 269 LLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLN---RNVDERFDA 325
Query: 771 EEILS 775
L
Sbjct: 326 MRALQ 330
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-36
Identities = 70/279 (25%), Positives = 126/279 (45%), Gaps = 13/279 (4%)
Query: 446 HDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKV 505
H SG NL M + S +E S + S+ S
Sbjct: 6 HHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVD 65
Query: 506 LESP--MFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQ 561
+ +P F ++ + A + F ++ +G G FG+V + T +A K+ +
Sbjct: 66 IPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR 125
Query: 562 DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK 621
+ ++ E+ NEIS++++L H N+I A + ++ EY++ G L+ I +
Sbjct: 126 GM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI--IDES 181
Query: 622 KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT--VKICDFGLSRIIT- 678
L+ + ++ IC G+ +H+M I+H DLK N L +KI DFGL+R
Sbjct: 182 YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241
Query: 679 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIM 717
++ + GTPE++APE++ + + D++S+GVI
Sbjct: 242 REKLKVN--FGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 47/199 (23%), Positives = 86/199 (43%), Gaps = 13/199 (6%)
Query: 525 DFSEL-TVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRL 581
+ E + +G G FG V R + + K + + EISIL+
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVLVKKEISILNIA 58
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
RH N++ + L MI E++ ++ I+ S + L+ R + + +C L
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQ 116
Query: 642 CIHRMKIVHRDLKSAN--CLVNKHWTVKICDFGLSRIIT-DSPMRDSSSAGTPEWMAPEL 698
+H I H D++ N + T+KI +FG +R + R PE+ APE+
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEV 174
Query: 699 IRNEPFTEKCDIFSLGVIM 717
+++ + D++SLG ++
Sbjct: 175 HQHDVVSTATDMWSLGTLV 193
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-35
Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 21/203 (10%)
Query: 530 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF------LEQDLTAENMEDFCNEISILSRL 581
+ +G G GEV VAI++ + A+ + EI IL +L
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
HP +I ++ E ME G L+ + K+L + +
Sbjct: 198 NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKV---VGNKRLKEATCKLYFYQMLLAVQ 253
Query: 642 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEWMAPE 697
+H I+HRDLK N L+ + +KI DFG S+I+ + S MR GTP ++APE
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPE 311
Query: 698 LIRN---EPFTEKCDIFSLGVIM 717
++ + + D +SLGVI+
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-35
Identities = 71/268 (26%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 525 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDL-TAENMEDFCNEISILSR 580
FS+ +G G FGEV G + A+KV ++ + + E E+ +L +
Sbjct: 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 82
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
L HPN++ ++ E G L+ I +K+ S +++R + G+
Sbjct: 83 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGI 139
Query: 641 MCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDS-PMRDSSSAGTPEWMAP 696
+H+ KIVHRDLK N L+ +K ++I DFGLS S M+D GT ++AP
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAP 197
Query: 697 ELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP---- 752
E++ + EKCD++S GVI++ L + P+ G ++ V E+P+
Sbjct: 198 EVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256
Query: 753 -----LGRLIADCWAEPQERPSCEEILS 775
+ +++ P R S + L
Sbjct: 257 SAKDLIRKMLT---YVPSMRISARDALD 281
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 49/210 (23%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 525 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF------LEQDLTAENMEDFCNEI 575
+F + +G G V R + G + A+K+ L + E E E
Sbjct: 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRET 150
Query: 576 SILSRLR-HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 634
IL ++ HP++I + + + ++ + M G L+ + +K LS + ++R
Sbjct: 151 HILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT---EKVALSEKETRSIMR 207
Query: 635 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEW 693
+ + +H IVHRDLK N L++ + +++ DFG S + +R+ GTP +
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE--LCGTPGY 265
Query: 694 MAPELIR------NEPFTEKCDIFSLGVIM 717
+APE+++ + + ++ D+++ GVI+
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 525 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF-------LEQDLTAENMEDFCNE 574
F E +G G V R I + A+K+ + E E E
Sbjct: 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 575 ISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 633
+ IL ++ HPN+I ++ + M+ G L+ + +K LS + K++
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIM 130
Query: 634 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD-SPMRDSSSAGTPE 692
R + + +H++ IVHRDLK N L++ +K+ DFG S + +R+ GTP
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE--VCGTPS 188
Query: 693 WMAPELIR------NEPFTEKCDIFSLGVIM 717
++APE+I + + ++ D++S GVIM
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 21/203 (10%)
Query: 530 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF------LEQDLTAENMEDFCNEISILSRL 581
+ +G G GEV VAIK+ + A+ + EI IL +L
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
HP +I ++ E ME G L+ + K+L + +
Sbjct: 73 NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQ 128
Query: 642 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEWMAPE 697
+H I+HRDLK N L+ + +KI DFG S+I+ + S MR GTP ++APE
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPE 186
Query: 698 LIRN---EPFTEKCDIFSLGVIM 717
++ + + D +SLGVI+
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 56/193 (29%), Positives = 90/193 (46%), Gaps = 11/193 (5%)
Query: 530 TVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
+ +G G FG V R + T K + NEISI+++L HP +I
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLI 111
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
A + +I E++ G L+ I + + K+S + +R C GL +H
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 648 IVHRDLKSAN--CLVNKHWTVKICDFGLSRIIT-DSPMRDSSSAGTPEWMAPELIRNEPF 704
IVH D+K N C K +VKI DFGL+ + D ++ + T E+ APE++ EP
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDREPV 227
Query: 705 TEKCDIFSLGVIM 717
D++++GV+
Sbjct: 228 GFYTDMWAIGVLG 240
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-35
Identities = 57/251 (22%), Positives = 99/251 (39%), Gaps = 15/251 (5%)
Query: 473 PSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSEL-TV 531
G E+G + +P+ + + +
Sbjct: 105 DERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHD---HVLDHYDI 161
Query: 532 GTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 589
+G G FG V R T + A K + + E EI +S LRHP ++
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 590 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 649
A + MI E+M G L+ + + + K+S ++ +R +C+GL +H V
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKV--ADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 277
Query: 650 HRDLKSAN--CLVNKHWTVKICDFGLSRIIT-DSPMRDSSSAGTPEWMAPELIRNEPFTE 706
H DLK N + +K+ DFGL+ + ++ + GT E+ APE+ +P
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGY 335
Query: 707 KCDIFSLGVIM 717
D++S+GV+
Sbjct: 336 YTDMWSVGVLS 346
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-35
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 10/213 (4%)
Query: 515 PLLAYEEWNIDFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAE---NM 568
+L + ++ F ++ + +G G F V R I G A+K+ T+ +
Sbjct: 11 GILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST 70
Query: 569 EDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK-KKLSWR 627
ED E SI L+HP+++ L + L M+ E+M+ L I S
Sbjct: 71 EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 130
Query: 628 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRD 684
+R I L H I+HRD+K L+ VK+ FG++ + +S +
Sbjct: 131 VASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA 190
Query: 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIM 717
GTP +MAPE+++ EP+ + D++ GVI+
Sbjct: 191 GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 43/291 (14%), Positives = 92/291 (31%), Gaps = 44/291 (15%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFC 572
E+ + + V +G G F +V+ + +KV + +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT-- 115
Query: 573 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ--KKKLSWRRKL 630
+ L + F A ++ E G+L + I+L +K + +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 631 KMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT-----------VKICDFGLSRIITD 679
+ + +H +I+H D+K N ++ + + + D G S +
Sbjct: 176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 680 SP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY 737
P ++ T + E++ N+P+ + D F + ++ + G +
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF------GTYMK---- 285
Query: 738 AVANEGSRLEIPEGPLGRLIADCWAE---------PQERPSCEEILSRLLD 779
V NEG + D W E ++L + L
Sbjct: 286 -VKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK 335
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 48/188 (25%), Positives = 82/188 (43%), Gaps = 14/188 (7%)
Query: 536 GIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGA 592
G G F + + + A+K+ ++ + EI+ L HPN++
Sbjct: 20 GEGSFSICRKCVHKKSNQAFAVKIISKRME-----ANTQKEITALKLCEGHPNIVKLHEV 74
Query: 593 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 652
++ E + G L+ I +KK S ++R + + +H + +VHRD
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIK---KKKHFSETEASYIMRKLVSAVSHMHDVGVVHRD 131
Query: 653 LKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 709
LK N L N + +KI DFG +R+ + T + APEL+ + E CD
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCD 191
Query: 710 IFSLGVIM 717
++SLGVI+
Sbjct: 192 LWSLGVIL 199
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-33
Identities = 72/279 (25%), Positives = 114/279 (40%), Gaps = 49/279 (17%)
Query: 530 TVGTRVGIGFFGEVFRGIWNGTD--VAIKV-----------FLEQDLTAENMEDFCNEIS 576
++G G +GEV AIKV + + E+ NEIS
Sbjct: 39 FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 577 ILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 636
+L L HPN+I ++TE+ E G L+ I + K +++ I
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQI 155
Query: 637 CRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRII-TDSPMRDSSSAGTPE 692
G+ +H+ IVHRD+K N L+ N +KI DFGLS D +RD GT
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD--RLGTAY 213
Query: 693 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP 752
++APE+++ + + EKCD++S GVIM+ L G P ++ ++ +G
Sbjct: 214 YIAPEVLK-KKYNEKCDVWSCGVIMYILLC------GYPP---FGGQNDQDIIKKVEKGK 263
Query: 753 LGRLIADCWAE----------------PQERPSCEEILS 775
+ W +R + EE L+
Sbjct: 264 Y-YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 6e-33
Identities = 35/292 (11%), Positives = 71/292 (24%), Gaps = 48/292 (16%)
Query: 529 LTVGTRVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENMEDFCNEISILSRLRHPN 585
L + + +G VF A+KVF + + + +E +RL +
Sbjct: 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123
Query: 586 V-----------------------ILFLGACTKPPRLSMITEYMEL--GSLYHLIHL--- 617
L ++ M L L
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183
Query: 618 -SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676
+ + + R + +VH N + + + D
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK 243
Query: 677 ITDSPMRDSSSAGTPEWMAPELI--RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP-- 732
+ R +S+ + E + FT + + LG+ ++ + L P+ V P
Sbjct: 244 VGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 733 -ERVVYAVANEGSRLEIPEGPLGRLIADCWA--------EPQERPSCEEILS 775
+ G L + + R E +
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-33
Identities = 41/288 (14%), Positives = 82/288 (28%), Gaps = 43/288 (14%)
Query: 529 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVF-LEQDLTAENMEDFCNEISILSRLR--- 582
L GT +G G + V + + ++ E+ L LR
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 583 ----------------------HPNVILFLGACTKPPRLS----MITEYMELGSLY-HLI 615
+I LS L + L+
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 616 HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675
S K L +L++ + R L +H +VH L+ + ++++ V + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 676 IITDSPMRDSSSA-GTPEWMAPELIRNEP-----FTEKCDIFSLGVIMWELCTLNRPWEG 729
S + PE A ++ T D ++LG+ ++ + + P
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319
Query: 730 VLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSR 776
+ IP+ P+ L+ ++R + +
Sbjct: 320 DAALGGSEWIFRS--CKNIPQ-PVRALLEGFLRYPKEDRLLPLQAMET 364
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 68/271 (25%), Positives = 126/271 (46%), Gaps = 28/271 (10%)
Query: 531 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAEN--MEDFCNEISILSRLRHPNV 586
+G +G G EV + + DVA+KV L DL + F E + L HP +
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKV-LRADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 587 I------LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
+ P + M EY++ +L ++H + ++ +R ++++ D C+ L
Sbjct: 75 VAVYDTGEAETPAGPLPYIVM--EYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQAL 129
Query: 641 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS--PMRDSSSA-GTPEWMAPE 697
H+ I+HRD+K AN +++ VK+ DFG++R I DS + +++ GT ++++PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 698 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE------GSRLEIPEG 751
R + + D++SLG +++E+ T P+ G P V Y E +
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA- 248
Query: 752 PLGRLIADCWA-EPQERP-SCEEILSRLLDC 780
L ++ A P+ R + E+ + L+
Sbjct: 249 DLDAVVLKALAKNPENRYQTAAEMRADLVRV 279
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 536 GIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGA 592
G G V I + A+K+ +Q E+ +L + + H NV+ +
Sbjct: 22 GEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 593 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 652
+ R ++ E M GS+ IH +++ + +++D+ L +H I HRD
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIH---KRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 653 LKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSS-------AGTPEWMAPELIR-- 700
LK N L N+ VKICDF L I + S G+ E+MAPE++
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196
Query: 701 ---NEPFTEKCDIFSLGVIM 717
+ ++CD++SLGVI+
Sbjct: 197 SEEASIYDKRCDLWSLGVIL 216
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-32
Identities = 58/260 (22%), Positives = 99/260 (38%), Gaps = 27/260 (10%)
Query: 531 VGTRVGIGFFGEVFRG---IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
V + G G ++ NG V +K L AE E L+ + HP+++
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKG-LVHSGDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 588 LFLGACTKPPRLSMITEY--MEL---GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
R Y ME SL +KL + L +I L
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSY 197
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE 702
+H + +V+ DLK N ++ + +K+ D G I GTP + APE++R
Sbjct: 198 LHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRTG 252
Query: 703 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA 762
P T DI+++G + L G + + + L+ + GRL+
Sbjct: 253 P-TVATDIYTVGRTLAALTLDLPTRNGRYVD----GLPEDDPVLKTYD-SYGRLLRRAID 306
Query: 763 -EPQERP-SCEEILSRLLDC 780
+P++R + EE+ ++L
Sbjct: 307 PDPRQRFTTAEEMSAQLTGV 326
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 53/195 (27%), Positives = 91/195 (46%), Gaps = 16/195 (8%)
Query: 530 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNV 586
V +G+G + R I + A+K+ ++ D EI IL R +HPN+
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTEEIEILLRYGQHPNI 78
Query: 587 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 646
I + ++TE M+ G L I ++K S R +L I + + +H
Sbjct: 79 ITLKDVYDDGKYVYVVTELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 647 KIVHRDLKSANCLVNKH----WTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE 702
+VHRDLK +N L +++ICDFG ++ + + T ++APE++ +
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ 195
Query: 703 PFTEKCDIFSLGVIM 717
+ CDI+SLGV++
Sbjct: 196 GYDAACDIWSLGVLL 210
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 51/192 (26%), Positives = 86/192 (44%), Gaps = 20/192 (10%)
Query: 536 GIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGA 592
G+G G+V G A+K+ + E+ + P+++ L
Sbjct: 38 GLGVNGKVLECFHRRTGQKCALKLL-------YDSPKARQEVDHHWQASGGPHIVCILDV 90
Query: 593 C----TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 648
L +I E ME G L+ I G + + R +++RDI + +H I
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQA-FTEREAAEIMRDIGTAIQFLHSHNI 149
Query: 649 VHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT 705
HRD+K N L K +K+ DFG ++ T + ++ TP ++APE++ E +
Sbjct: 150 AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP--CYTPYYVAPEVLGPEKYD 207
Query: 706 EKCDIFSLGVIM 717
+ CD++SLGVIM
Sbjct: 208 KSCDMWSLGVIM 219
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 68/255 (26%), Positives = 114/255 (44%), Gaps = 29/255 (11%)
Query: 536 GIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 593
G G F +V I G +VAIK+ + L +++ E+ I+ L HPN++
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83
Query: 594 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL 653
L +I EY G ++ + ++ + R I + H+ +IVHRDL
Sbjct: 84 ETEKTLYLIMEYASGGEVFDYLV---AHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDL 140
Query: 654 KSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT-EKCDIFS 712
K+ N L++ +KI DFG S T + G P + APEL + + + + D++S
Sbjct: 141 KAENLLLDADMNIKIADFGFSNEFTVGGKL-DAFCGAPPYAAPELFQGKKYDGPEVDVWS 199
Query: 713 LGVIMWELCTLNRPWEG----VLPERVVYAVANEGSRLEIPEGPLGRLIADCW------- 761
LGVI++ L + + P++G L ERV+ + IP + DC
Sbjct: 200 LGVILYTLVSGSLPFDGQNLKELRERVLRG------KYRIPFY----MSTDCENLLKRFL 249
Query: 762 -AEPQERPSCEEILS 775
P +R + E+I+
Sbjct: 250 VLNPIKRGTLEQIMK 264
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 64/270 (23%), Positives = 111/270 (41%), Gaps = 31/270 (11%)
Query: 530 TVGTRVGIGFFGEVFRGIWNGTD------VAIKVFLEQDLTAENM--EDFCNEISILSRL 581
+ VG G G+V+ D VA+K+ + + L+++ + E RL
Sbjct: 37 RLRRLVGRGGMGDVYEA----EDTVRERIVALKL-MSETLSSDPVFRTRMQREARTAGRL 91
Query: 582 RHPNV--ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 639
+ P+V I G + M + L ++ G L+ R + ++R I
Sbjct: 92 QEPHVVPIHDFGEIDGQLYVDM--RLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSA 146
Query: 640 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA-GTPEWMAPEL 698
L H HRD+K N LV+ + DFG++ TD + + GT +MAPE
Sbjct: 147 LDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206
Query: 699 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE------GSRLEIPEGP 752
T + DI++L +++E T + P++G V+ A N+ R IP
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPPYQGD-QLSVMGAHINQAIPRPSTVRPGIPVA- 264
Query: 753 LGRLIADCWA-EPQER-PSCEEILSRLLDC 780
+IA A P++R +C ++ +
Sbjct: 265 FDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 66/287 (22%), Positives = 115/287 (40%), Gaps = 61/287 (21%)
Query: 530 TVGTRVGIGFFGEVF--RGIWNGTDVAIKVF-----------------------LEQDLT 564
T+ +G G +G V + T A+KV +
Sbjct: 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 565 AENMEDFC-NEISILSRLRHPNVI-LF--LGACTKPPRLSMITEYMELGSLYHLIHLSGQ 620
+ EI+IL +L HPNV+ L L + L M+ E + G + +
Sbjct: 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVP----T 130
Query: 621 KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680
K LS + +D+ +G+ +H KI+HRD+K +N LV + +KI DFG+S S
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 681 PMRDSSSAGTPEWMAPELIRNEPFT---EKCDIFSLGVIMWELCTLNRPWEGVLP----- 732
S++ GTP +MAPE + + D++++GV ++ G P
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF------GQCPFMDER 244
Query: 733 ERVVYAVANEGSRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLD 779
+++ LE P+ +P +++++R+LD
Sbjct: 245 IMCLHSKIKSQ-ALEFPD------------QPDIAEDLKDLITRMLD 278
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 56/249 (22%), Positives = 100/249 (40%), Gaps = 22/249 (8%)
Query: 536 GIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 593
G G +GEV VA+K+ ++ + E+ EI I L H NV+ F G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 594 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL 653
+ + EY G L+ I + + + G++ +H + I HRD+
Sbjct: 75 REGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 131
Query: 654 KSANCLVNKHWTVKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIRNEPFT-EKCDI 710
K N L+++ +KI DFGL+ + + + GT ++APEL++ F E D+
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 711 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAEPQERPSC 770
+S G+++ + PW+ Y+ E P + +
Sbjct: 192 WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID-------------SAP 238
Query: 771 EEILSRLLD 779
+L ++L
Sbjct: 239 LALLHKILV 247
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 48/256 (18%), Positives = 104/256 (40%), Gaps = 30/256 (11%)
Query: 473 PSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELTVG 532
P+ P + + + + ++ + +N + Y+
Sbjct: 17 PAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYK---------VTS 67
Query: 533 TRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILF 589
+G+G G+V + A+K+ ++ E+ + R + P+++
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRI 120
Query: 590 LGAC----TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 645
+ L ++ E ++ G L+ I G + + R ++++ I + +H
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHS 179
Query: 646 MKIVHRDLKSANCLV---NKHWTVKICDFGLSRIIT-DSPMRDSSSAGTPEWMAPELIRN 701
+ I HRD+K N L + +K+ DFG ++ T + + TP ++APE++
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAPEVLGP 237
Query: 702 EPFTEKCDIFSLGVIM 717
E + + CD++SLGVIM
Sbjct: 238 EKYDKSCDMWSLGVIM 253
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 43/293 (14%), Positives = 85/293 (29%), Gaps = 52/293 (17%)
Query: 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVF-LEQDLTAENMEDFCNEISILSRLR-- 582
L GT +G G + V + + ++ E+ L LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 583 -----------------------HPNVILFLGACTKPPRLS----MITEYMELGSLY-HL 614
+I LS L + L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 615 IHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 674
+ S K L +L++ + R L +H +VH L+ + ++++ V + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 675 RIITDSPMRDSSSAGTPEWMAPELI-----------RNEPFTEKCDIFSLGVIMWELCTL 723
S+ + + PEL R T D ++LG++++ +
Sbjct: 254 VRDG----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 724 NRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILS 775
+ P + S IP+ P+ L+ ++R + +
Sbjct: 310 DLPITKDAALGGSEWIFR--SCKNIPQ-PVRALLEGFLRYPKEDRLLPLQAME 359
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 56/249 (22%), Positives = 100/249 (40%), Gaps = 22/249 (8%)
Query: 536 GIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 593
G G +GEV VA+K+ ++ + E+ EI I L H NV+ F G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 594 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL 653
+ + EY G L+ I + + + G++ +H + I HRD+
Sbjct: 75 REGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 131
Query: 654 KSANCLVNKHWTVKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIRNEPFT-EKCDI 710
K N L+++ +KI DFGL+ + + + GT ++APEL++ F E D+
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 711 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAEPQERPSC 770
+S G+++ + PW+ Y+ E P + +
Sbjct: 192 WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID-------------SAP 238
Query: 771 EEILSRLLD 779
+L ++L
Sbjct: 239 LALLHKILV 247
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 14/207 (6%)
Query: 530 TVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCN-EISILSRLRHPNV 586
+G +G+G FG+V G G VA+K+ Q + + ++ EI L RHP++
Sbjct: 14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 587 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 646
I + P M+ EY+ G L+ I + ++ ++ + I + HR
Sbjct: 74 IKLYQVISTPTDFFMVMEYVSGGELFDYI---CKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 647 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT- 705
+VHRDLK N L++ H KI DFGLS +++D +S G+P + APE+I +
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR-TSCGSPNYAAPEVISGRLYAG 189
Query: 706 EKCDIFSLGVIMWELCTLNRPWEGVLP 732
+ DI+S GVI++ L G LP
Sbjct: 190 PEVDIWSCGVILYALLC------GTLP 210
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 29/212 (13%)
Query: 525 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDF-CNEISILSRL 581
DF + +G G F V R + + AIK+ ++ + EN + E ++SRL
Sbjct: 31 DFKFGKI---LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD------ 635
HP + +L Y + G L ++ RK+ +
Sbjct: 88 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK--YI----------RKIGSFDETCTRFY 135
Query: 636 ---ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD--SPMRDSSSAGT 690
I L +H I+HRDLK N L+N+ ++I DFG +++++ R +S GT
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
Query: 691 PEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 722
++++PEL+ + + D+++LG I+++L
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 46/201 (22%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 530 TVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCN------EISILSRL 581
+ + +G G FG V+ +V +K ++ + + + EI+ILSR+
Sbjct: 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGS-LYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
H N+I L ++ E G L+ I + +L + R + +
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAV 143
Query: 641 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 700
+ I+HRD+K N ++ + +T+K+ DFG + + + + GT E+ APE++
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY-TFCGTIEYCAPEVLM 202
Query: 701 NEPFT-EKCDIFSLGVIMWEL 720
P+ + +++SLGV ++ L
Sbjct: 203 GNPYRGPELEMWSLGVTLYTL 223
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 58/261 (22%), Positives = 107/261 (40%), Gaps = 28/261 (10%)
Query: 530 TVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCN----EISILSRLRH 583
VG +G G FG V+ G + + VAIK + ++ E+ +L ++
Sbjct: 46 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105
Query: 584 --PNVILFLGACTKPPRLSMITEYME-LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
VI L +P +I E E + L+ I ++ L + +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAV 162
Query: 641 MCIHRMKIVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 699
H ++HRD+K N L++ +K+ DFG ++ D+ D GT + PE I
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD--FDGTRVYSPPEWI 220
Query: 700 RNEPFT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP---LGR 755
R + ++SLG++++++ + P+E E ++ ++ +
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRG------QVFFRQRVSSECQH 272
Query: 756 LIADC-WAEPQERPSCEEILS 775
LI C P +RP+ EEI +
Sbjct: 273 LIRWCLALRPSDRPTFEEIQN 293
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 530 TVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
+G G FG R VA+K EN++ EI LRHPN++
Sbjct: 23 DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNIV 79
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
F P L++I EY G LY I + S + + G+ H M+
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERI---CNAGRFSEDEARFFFQQLLSGVSYCHSMQ 136
Query: 648 IVHRDLKSANCLVNKHWT--VKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT 705
I HRDLK N L++ +KICDFG S+ S+ GTP ++APE++ + +
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRQEYD 195
Query: 706 -EKCDIFSLGVIMWELCTLNRPWEGVLP 732
+ D++S GV ++ + G P
Sbjct: 196 GKIADVWSCGVTLYVMLV------GAYP 217
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-28
Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 9/210 (4%)
Query: 525 DFSELTVGTRVGIGFFGEVFRGIWNGTDV--AIKVFLEQDLTAENMEDFC--NEISILSR 580
F + V +G G FGEVF T A K L + + E IL++
Sbjct: 186 WFLDFRV---LGRGGFGEVFACQMKATGKLYACKK-LNKKRLKKRKGYQGAMVEKKILAK 241
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLKMLRDICRG 639
+ ++ A L ++ M G + YH+ ++ R + I G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 640 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 699
L +H+ I++RDLK N L++ V+I D GL+ + + AGTP +MAPEL+
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
E + D F+LGV ++E+ P+
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRA 391
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 531 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCN-EISILSRLRHPNVI 587
+ +G G FG+V VA+K Q L +M EIS L LRHP++I
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
T P + M+ EY G L+ I +KK+++ + + I + HR K
Sbjct: 73 KLYDVITTPTDIVMVIEYAG-GELFDYI---VEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 648 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT-E 706
IVHRDLK N L++ + VKI DFGLS I+TD +S G+P + APE+I + +
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK-TSCGSPNYAAPEVINGKLYAGP 187
Query: 707 KCDIFSLGVIMWELCTLNRPWEGVLP 732
+ D++S G++++ + G LP
Sbjct: 188 EVDVWSCGIVLYVMLV------GRLP 207
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 65/263 (24%), Positives = 107/263 (40%), Gaps = 30/263 (11%)
Query: 530 TVGTRVGIGFFGEVFRG--IWNGTDVAIKVFL-EQDLTAENMEDFCN---EISILSRLR- 582
+G +G G FG VF G + + VAIKV + L + D E+++L ++
Sbjct: 34 RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 583 ---HPNVILFLGACTKPPRLSMITEYMELGS-LYHLIHLSGQKKKLSWRRKLKMLRDICR 638
HP VI L ++ E L+ I +K L +
Sbjct: 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT---EKGPLGEGPSRCFFGQVVA 150
Query: 639 GLMCIHRMKIVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 697
+ H +VHRD+K N L++ + K+ DFG ++ D P D GT + PE
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD--FDGTRVYSPPE 208
Query: 698 LIRNEPFT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP---L 753
I + ++SLG++++++ + P+E + ++ + L P
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERD--QEIL------EAELHFPAHVSPDC 260
Query: 754 GRLIADC-WAEPQERPSCEEILS 775
LI C +P RPS EEIL
Sbjct: 261 CALIRRCLAPKPSSRPSLEEILL 283
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 62/194 (31%), Positives = 101/194 (52%), Gaps = 8/194 (4%)
Query: 531 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCN-EISILSRLRHPNVI 587
+G +G+G FG+V G G VA+K+ Q + + ++ EI L RHP++I
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
+ P + M+ EY+ G L+ I + +L + ++ + I G+ HR
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 648 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT-E 706
+VHRDLK N L++ H KI DFGLS +++D +S G+P + APE+I +
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR-TSCGSPNYAAPEVISGRLYAGP 195
Query: 707 KCDIFSLGVIMWEL 720
+ DI+S GVI++ L
Sbjct: 196 EVDIWSSGVILYAL 209
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 28/207 (13%)
Query: 534 RVGIGFFGEVFRG--IWNGTDVAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHPN 585
++G G +G VF+ VA+K V L+ D +A EI +L L+H N
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA------LREICLLKELKHKN 62
Query: 586 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 645
++ +L+++ E+ + L + L + +GL H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSF--LFQLLKGLGFCHS 119
Query: 646 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APE-LI 699
++HRDLK N L+N++ +K+ +FGL+R P+R + E W P+ L
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVR----CYSAEVVTLWYRPPDVLF 174
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLNRP 726
+ ++ D++S G I EL RP
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-27
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 10/209 (4%)
Query: 525 DFSELTVGTRVGIGFFGEVFRGIWNGTDV--AIKVFLEQDLTAENMEDFC--NEISILSR 580
F + V +G G FGEV T A K LE+ + + NE IL +
Sbjct: 185 TFRQYRV---LGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEK 240
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
+ V+ A L ++ M G L I+ G + R + +IC GL
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGL 299
Query: 641 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 700
+HR +IV+RDLK N L++ H ++I D GL+ + + GT +MAPE+++
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVK 358
Query: 701 NEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
NE +T D ++LG +++E+ P++
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSPFQQ 387
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 531 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLT-AENMEDFCN-EISILSRLRHPNV 586
+G +G G +G+V A+K+ ++ L N E EI +L RLRH NV
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 587 I-LF--LGACTKPPRLSMITEYMELGS--LYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
I L L K ++ M+ EY G + + +K+ + + GL
Sbjct: 69 IQLVDVLYNEEKQ-KMYMVMEYCVCGMQEMLDSV----PEKRFPVCQAHGYFCQLIDGLE 123
Query: 642 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELI 699
+H IVH+D+K N L+ T+KI G++ + D +S G+P + PE+
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 700 RN-EPFT-EKCDIFSLGVIMWELCTLNRPWEGVLP 732
+ F+ K DI+S GV ++ + T G+ P
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITT------GLYP 212
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-26
Identities = 56/263 (21%), Positives = 109/263 (41%), Gaps = 25/263 (9%)
Query: 525 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRL 581
DF L V +G G FGEV + A+K+ + ++ F E +L
Sbjct: 75 DFEILKV---IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG 131
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
+ A L ++ +Y G L LS + +L L ++ +
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLT--LLSKFEDRLPEEMARFYLAEMVIAID 189
Query: 642 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIR 700
+H++ VHRD+K N L++ + +++ DFG +++ D ++ S + GTP++++PE+++
Sbjct: 190 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 701 NEPFTEK-----CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR 755
+ CD +SLGV M+E+ P+ + N R + P
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV--- 306
Query: 756 LIADCWAEPQERPSCEEILSRLL 778
+ ++++ RL+
Sbjct: 307 --------TDVSENAKDLIRRLI 321
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 28/203 (13%)
Query: 534 RVGIGFFGEVFRGIWNGTD--VAIKVF-LEQD-----LTAENMEDFCNEISILSRLRHPN 585
++G G +G VF+ T VAIK F +D A EI +L +L+HPN
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA------LREIRMLKQLKHPN 63
Query: 586 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 645
++ L + RL ++ EY + ++ H + + + + + + H+
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSI--TWQTLQAVNFCHK 120
Query: 646 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APE-LI 699
+HRD+K N L+ KH +K+CDFG +R++T P E W +PE L+
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSD----YYDDEVATRWYRSPELLV 175
Query: 700 RNEPFTEKCDIFSLGVIMWELCT 722
+ + D++++G + EL +
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLS 198
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 36/213 (16%)
Query: 534 RVGIGFFGEVFRG--IWNGTDVAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHPN 585
++G G FGEVF+ G VA+K V +E + +TA EI IL L+H N
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA------LREIKILQLLKHEN 77
Query: 586 VILFLGACT--------KPPRLSMITEYME--LGSLYHLIHLSGQKKKLSWRRKLKMLRD 635
V+ + C + ++ ++ E L L LS K + ++++
Sbjct: 78 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL-----LSNVLVKFTLSEIKRVMQM 132
Query: 636 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE--- 692
+ GL IHR KI+HRD+K+AN L+ + +K+ DFGL+R + T
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF-SLAKNSQPNRYTNRVVT 191
Query: 693 -WM-APELIRNEP-FTEKCDIFSLGVIMWELCT 722
W PEL+ E + D++ G IM E+ T
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 56/236 (23%), Positives = 106/236 (44%), Gaps = 15/236 (6%)
Query: 525 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRL 581
D+ + V +G G FGEV R A+K+ + ++ + F E I++
Sbjct: 70 DYEVVKV---IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 126
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
P V+ A L M+ EYM G L +L+ + + ++ L
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWARFYTAEVVLALD 182
Query: 642 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIR 700
IH M +HRD+K N L++K +K+ DFG ++ + +R ++ GTP++++PE+++
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242
Query: 701 NEPFTEK----CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP 752
++ CD +S+GV ++E+ + P+ + N + L P+
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 298
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 55/243 (22%), Positives = 102/243 (41%), Gaps = 24/243 (9%)
Query: 525 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRL 581
DF L V +G G F EV + G A+K+ + D+ + F E +L
Sbjct: 62 DFEILKV---IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG 118
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR----DIC 637
+ A L ++ EY G L LS +++ +M R +I
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLT--LLSKFGERIP----AEMARFYLAEIV 172
Query: 638 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAP 696
+ +HR+ VHRD+K N L+++ +++ DFG ++ D +R + GTP++++P
Sbjct: 173 MAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
Query: 697 ELIRNE-------PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 749
E+++ + +CD ++LGV +E+ P+ + + L +P
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP 292
Query: 750 EGP 752
Sbjct: 293 LVD 295
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 28/203 (13%)
Query: 534 RVGIGFFGEVFRGIWNGTD--VAIKVF-LEQD-----LTAENMEDFCNEISILSRLRHPN 585
VG G +G V + T VAIK F D A EI +L +LRH N
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA------MREIKLLKQLRHEN 85
Query: 586 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 645
++ L C K R ++ E+++ ++ + L L ++ K L I G+ H
Sbjct: 86 LVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHS 142
Query: 646 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APE-LI 699
I+HRD+K N LV++ VK+CDFG +R + +P E W APE L+
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGE----VYDDEVATRWYRAPELLV 197
Query: 700 RNEPFTEKCDIFSLGVIMWELCT 722
+ + + D++++G ++ E+
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFM 220
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 534 RVGIGFFGEVFRG--IWNGTDVAIK-VFLEQD----LTAENMEDFCNEISILSRLRHPNV 586
++G G + V++G G VA+K V L+ + TA EIS++ L+H N+
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA------IREISLMKELKHENI 65
Query: 587 ILFLGACTKPPRLSMITEYME--LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 644
+ +L+++ E+M+ L + + L + +GL H
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 645 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APELI 699
KI+HRDLK N L+NK +K+ DFGL+R P+ + E W AP+++
Sbjct: 126 ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVN----TFSSEVVTLWYRAPDVL 180
Query: 700 RNEPF-TEKCDIFSLGVIMWELCTLNRP 726
+ DI+S G I+ E+ T +P
Sbjct: 181 MGSRTYSTSIDIWSCGCILAEMIT-GKP 207
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 39/225 (17%)
Query: 521 EWNIDFSELTVGTRVGIGFFGEVFRGI--WNGTDVAIK---VFLEQDLTAENMEDFCN-- 573
+NI S+ + + +G G +G V G VAIK F F
Sbjct: 6 VYNIS-SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPL------FALRT 56
Query: 574 --EISILSRLRHPNVILFLGACTKPPRLSM-----ITEYMELGSLYHLIHLSGQKKKLSW 626
EI IL +H N+I + I E M+ L+ +I S Q LS
Sbjct: 57 LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI--STQM--LSD 111
Query: 627 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 686
+ R + +H ++HRDLK +N L+N + +K+CDFGL+RII +S +S
Sbjct: 112 DHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 687 SAGTPEWM----------APELIRN-EPFTEKCDIFSLGVIMWEL 720
G M APE++ ++ D++S G I+ EL
Sbjct: 172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 30/207 (14%)
Query: 534 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHPN 585
++G G +G V++ N A+K + LE++ T EISIL L+H N
Sbjct: 9 KIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTT------IREISILKELKHSN 61
Query: 586 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 645
++ RL ++ E+++ L L+ + + + L + G+ H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSF--LLQLLNGIAYCHD 118
Query: 646 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APELIR 700
+++HRDLK N L+N+ +KI DFGL+R P+R T E W AP+++
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVR----KYTHEIVTLWYRAPDVLM 173
Query: 701 NEPF-TEKCDIFSLGVIMWELCTLNRP 726
+ DI+S+G I E+ P
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVN-GTP 199
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 73/303 (24%), Positives = 114/303 (37%), Gaps = 56/303 (18%)
Query: 475 SPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELTVGTR 534
S HE + G+ ++ S+ K S + +W I +
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIP-DRYEIRHL 60
Query: 535 VGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAENMEDFCN----EISILSRLRHP 584
+G G +G V VAIK VF +DL C EI+IL+RL H
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVF--EDLI------DCKRILREIAILNRLNHD 112
Query: 585 NVILFLGACTKPPRLS-----MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 639
+V+ L ++ E + L + L+ +L ++ G
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFR-TPVY--LTELHIKTLLYNLLVG 168
Query: 640 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM----- 694
+ +H I+HRDLK ANCLVN+ +VK+CDFGL+R + +S +P
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 695 ----------------------APELIRNEP-FTEKCDIFSLGVIMWELCTLNRPWEGVL 731
APELI + +TE D++S+G I EL + +
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 732 PER 734
+R
Sbjct: 289 ADR 291
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 29/203 (14%)
Query: 534 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHPN 585
+VG G +G V++ + VA+K + L+ + TA EIS+L L HPN
Sbjct: 28 KVGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTA------IREISLLKELHHPN 80
Query: 586 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 645
++ + L+++ E+ME L ++ + + S + L + RG+ H+
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIY--LYQLLRGVAHCHQ 137
Query: 646 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APE-LI 699
+I+HRDLK N L+N +K+ DFGL+R P+R T E W AP+ L+
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSY----THEVVTLWYRAPDVLM 192
Query: 700 RNEPFTEKCDIFSLGVIMWELCT 722
++ ++ DI+S+G I E+ T
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMIT 215
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 41/208 (19%)
Query: 534 RVGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAENMEDFCN----EISILSRLRH 583
+G G G V +VAIK F Q+ T E+ ++ + H
Sbjct: 32 PIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQT------HAKRAYRELVLMKCVNH 83
Query: 584 PNVILFLGACTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
N+I L T L ++ E M+ +L +I + +L R +L +
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI-----QMELDHERMSYLLYQML 137
Query: 638 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM--- 694
G+ +H I+HRDLK +N +V T+KI DFGL+R +S TP +
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA------GTSFMMTPYVVTRY 191
Query: 695 --APELIRNEPFTEKCDIFSLGVIMWEL 720
APE+I + E DI+S+G IM E+
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEM 219
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 65/241 (26%), Positives = 99/241 (41%), Gaps = 47/241 (19%)
Query: 507 ESPMFQNKPLLAYEEWNIDFSELTVGTR------VGIGFFGEVFRGI--WNGTDVAIK-- 556
M ++K + + S TV R +G G G V +VAIK
Sbjct: 36 HYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL 95
Query: 557 --VFLEQDLTAENMEDFCN----EISILSRLRHPNVILFLGACTKPPRLS------MITE 604
F Q+ T E+ ++ + H N+I L T L ++ E
Sbjct: 96 SRPF--QNQT------HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 147
Query: 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 664
M+ +L +I + +L R +L + G+ +H I+HRDLK +N +V
Sbjct: 148 LMD-ANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
Query: 665 TVKICDFGLSRIITDSPMRDSSSAGTPEWM-----APELIRNEPFTEKCDIFSLGVIMWE 719
T+KI DFGL+R S M TP + APE+I + E DI+S+G IM E
Sbjct: 202 TLKILDFGLARTAGTSFMM------TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 255
Query: 720 L 720
+
Sbjct: 256 M 256
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 15/212 (7%)
Query: 525 DFSELTVGTRVGIGFFGEVF---RGIWNGTDV--AIKVFLEQDLTAENMEDFCNEISILS 579
F L V +G G FG+VF + + A+KV + L + E IL
Sbjct: 25 QFELLKV---LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 580 RLRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
+ HP I+ L T +L +I +++ G L+ LS ++ + L ++
Sbjct: 82 EVNHP-FIVKLHYAFQT-EGKLYLILDFLRGGDLFT--RLS-KEVMFTEEDVKFYLAELA 136
Query: 638 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 697
L +H + I++RDLK N L+++ +K+ DFGLS+ D + S GT E+MAPE
Sbjct: 137 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 196
Query: 698 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
++ T+ D +S GV+M+E+ T P++G
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 534 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQD----LTAENMEDFCNEISILSRLRHPNV 586
++G G + V++G TD VA+K + LE + TA E+S+L L+H N+
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA------IREVSLLKDLKHANI 62
Query: 587 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 646
+ L+++ EY++ L + G + + L + RGL HR
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLF--LFQLLRGLAYCHRQ 119
Query: 647 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APELIRN 701
K++HRDLK N L+N+ +K+ DFGL+R + P + E W P+++
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTY----DNEVVTLWYRPPDILLG 174
Query: 702 EP-FTEKCDIFSLGVIMWELCTLNRP 726
++ + D++ +G I +E+ T RP
Sbjct: 175 STDYSTQIDMWGVGCIFYEMAT-GRP 199
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 54/210 (25%), Positives = 84/210 (40%), Gaps = 36/210 (17%)
Query: 535 VGIGFFGEVFRGI-WNGTDVAIKVFLEQDLTAENMEDFCN---------EISILSRLRHP 584
+ G +G V G+ G VAIK + + EI +L+ HP
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 585 NVILFLGACTKPPRLS-----MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 639
N++ + ++TE M L +IH Q+ +S + + I G
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH--DQRIVISPQHIQYFMYHILLG 146
Query: 640 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-------RDSSSAGTPE 692
L +H +VHRDL N L+ + + ICDF L+R T R
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR--------- 197
Query: 693 WM-APELIRN-EPFTEKCDIFSLGVIMWEL 720
W APEL+ + FT+ D++S G +M E+
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 34/210 (16%)
Query: 535 VGIGFFGEVFRGIW--NGTDVAIK-VFLEQDLTAENMEDFCN-EISILSRLRHPNVILFL 590
+G G FG V++ +G VAIK V ++ F N E+ I+ +L H N++ L
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIV-RL 112
Query: 591 GACTKPPR-------LSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLMC 642
L+++ +Y+ ++Y + H S K+ L + + R L
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 643 IHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIIT-DSPMRD--SSSAGTPEWM-APE 697
IH I HRD+K N L++ +K+CDFG ++ + P S + APE
Sbjct: 172 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS-----RYYRAPE 226
Query: 698 LI-RNEPFTEKCDIFSLGVIMWELCTLNRP 726
LI +T D++S G ++ EL L +P
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELL-LGQP 255
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 51/220 (23%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 525 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRL 581
F L +G G FG+V + A+K +Q N + + E+ I+ L
Sbjct: 16 HFEILRA---IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLKMLRDICR-- 638
HP ++ + + M+ + + G L YHL ++ + + +
Sbjct: 73 EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL------------QQNVHFKEETVKLF 120
Query: 639 ------GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE 692
L + +I+HRD+K N L+++H V I DF ++ ++ + ++ AGT
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKP 179
Query: 693 WMAPELIRNEPF---TEKCDIFSLGVIMWELCTLNRPWEG 729
+MAPE+ + + D +SLGV +EL RP+
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 525 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRL 581
F + +G G FG V + +G A+K+ +Q + +E NE IL +
Sbjct: 42 QFDRIKT---LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR--- 638
P ++ + L M+ EY+ G ++ HL RR + R
Sbjct: 99 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HL---------RRIGRFSEPHARFYA 147
Query: 639 -----GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEW 693
+H + +++RDLK N L+++ +++ DFG ++ + R + GTPE
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---RTWTLCGTPEA 204
Query: 694 MAPELIRNEPFTEKCDIFSLGVIMWELCT 722
+APE+I ++ + + D ++LGV+++E+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 17/214 (7%)
Query: 525 DFSELTVGTRVGIGFFGEVF---RGIWNGTDV--AIKVFLEQDLTAENMEDFC--NEISI 577
F L V +G G +G+VF + T A+KV + + + E +I
Sbjct: 18 CFELLRV---LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI 74
Query: 578 LSRLRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 635
L ++HP I+ L T +L +I EY+ G L+ L ++ L +
Sbjct: 75 LEEVKHP-FIVDLIYAFQT-GGKLYLILEYLSGGELFM--QLE-REGIFMEDTACFYLAE 129
Query: 636 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMA 695
I L +H+ I++RDLK N ++N VK+ DFGL + + GT E+MA
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMA 189
Query: 696 PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
PE++ D +SLG +M+++ T P+ G
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-24
Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 17/206 (8%)
Query: 525 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 580
DFS + +G G FGEV+ R G A+K L++ + NE +LS
Sbjct: 190 DFSVHRI---IGRGGFGEVYGCRKADTGKMYAMKC-LDKKRIKMKQGETLALNERIMLSL 245
Query: 581 L---RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
+ P ++ A P +LS I + M G L++ HLS Q S +I
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHY--HLS-QHGVFSEADMRFYAAEII 302
Query: 638 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 697
GL +H +V+RDLK AN L+++H V+I D GL+ + + +S GT +MAPE
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPE 360
Query: 698 LI-RNEPFTEKCDIFSLGVIMWELCT 722
++ + + D FSLG ++++L
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLR 386
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 7e-24
Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 531 VGTRVGIGFFGEVFRG----IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV 586
G +VG G +G V++ + D A+K ++ C EI++L L+HPNV
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA----CREIALLRELKHPNV 80
Query: 587 ILFLGACT--KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL------KMLRDICR 638
I ++ ++ +Y E L+H+I K +L +L I
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 639 GLMCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITDSPMRDSSSAGTPE-- 692
G+ +H ++HRDLK AN LV + VKI D G +R+ SP++ + P
Sbjct: 140 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN-SPLK-PLADLDPVVV 197
Query: 693 --WM-APELIRNEPF-TEKCDIFSLGVIMWELCTLNRP 726
W APEL+ T+ DI+++G I EL T P
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EP 234
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-24
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 29/207 (14%)
Query: 535 VGIGFFGEVFRGIWNGTD-VAIK-VFLEQDLTAENMEDFCN-EISILSRLRHPNVILFLG 591
+G G FG VF+ +D VAIK V + + F N E+ I+ ++HPNV+ L
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQD--------KRFKNRELQIMRIVKHPNVVD-LK 98
Query: 592 ACTKPP-------RLSMITEYMELGSLYHLI-HLSGQKKKLSWRR-KLKMLRDICRGLMC 642
A L+++ EY+ ++Y H + K+ + KL M + + R L
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQ-LLRSLAY 156
Query: 643 IHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APELI- 699
IH + I HRD+K N L++ +K+ DFG ++I+ + S + APELI
Sbjct: 157 IHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRYYRAPELIF 214
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLNRP 726
+T DI+S G +M EL +P
Sbjct: 215 GATNYTTNIDIWSTGCVMAELM-QGQP 240
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 9e-24
Identities = 62/254 (24%), Positives = 98/254 (38%), Gaps = 51/254 (20%)
Query: 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAENMEDFC 572
+ ++ + +G G +G V+ +VAIK +F +DL C
Sbjct: 19 IKNVHVP-DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF--EDLI------DC 69
Query: 573 N----EISILSRLRHPNVILFLGACTKPPRLS-----MITEYMELGSLYHLIHLSGQKKK 623
EI+IL+RL+ +I L ++ E + L L +
Sbjct: 70 KRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFK-TPIF-- 125
Query: 624 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683
L+ +L ++ G IH I+HRDLK ANCL+N+ +VK+CDFGL+R I
Sbjct: 126 LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 684 DSSSAGTPEWM----------------------APELIRNEP-FTEKCDIFSLGVIMWEL 720
+ + APELI + +T+ DI+S G I EL
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 721 CTLNRPWEGVLPER 734
+ + R
Sbjct: 246 LNMLQSHINDPTNR 259
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 73/238 (30%), Positives = 99/238 (41%), Gaps = 44/238 (18%)
Query: 509 PMFQNKPLLAYEEWNIDFSELTVGTR------VGIGFFGEVFRGI--WNGTDVAIK---V 557
M F VG R +G G +G V N VAIK
Sbjct: 6 HMAAAAAAGPEMVRGQVF---DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP 62
Query: 558 FLEQDLTAENMEDFCN----EISILSRLRHPNVILFLGACTKPPRLSM-----ITEYMEL 608
F + T +C EI IL R RH N+I P M + + ME
Sbjct: 63 F--EHQT------YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 114
Query: 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKI 668
LY L+ + LS L I RGL IH ++HRDLK +N L+N +KI
Sbjct: 115 -DLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKI 169
Query: 669 CDFGLSRIITDSPMRDSSSAGTPE----WM-APELIRN-EPFTEKCDIFSLGVIMWEL 720
CDFGL+R+ P D + T W APE++ N + +T+ DI+S+G I+ E+
Sbjct: 170 CDFGLARVA--DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 61/230 (26%), Positives = 98/230 (42%), Gaps = 50/230 (21%)
Query: 519 YEEWNIDFSELTVGTR------VGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAE 566
+ + +++ + + VG G +G V I +G VAIK F Q
Sbjct: 10 FYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEI-- 65
Query: 567 NMEDFCN----EISILSRLRHPNVILFLGACTKPPRLS------MITEYMELGSLYHLIH 616
F E+ +L ++H NVI L T L ++ +M+ L ++
Sbjct: 66 ----FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM- 119
Query: 617 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676
K S + ++ + +GL IH +VHRDLK N VN+ +KI DFGL+R
Sbjct: 120 ----GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR- 174
Query: 677 ITDSPMRDSSSAGTPEWM-----APELIRN-EPFTEKCDIFSLGVIMWEL 720
D+ M T + APE+I + + + DI+S+G IM E+
Sbjct: 175 HADAEM-------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEM 217
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 30/210 (14%)
Query: 525 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRL 581
DF L +G G FG V R NG A+KV ++ + +E +E +LS +
Sbjct: 7 DFQILRT---LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 582 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD------ 635
HP +I G ++ MI +Y+E G L+ L RK + +
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFS--LL----------RKSQRFPNPVAKFY 111
Query: 636 ---ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE 692
+C L +H I++RDLK N L++K+ +KI DFG ++ + D + GTP+
Sbjct: 112 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPD 168
Query: 693 WMAPELIRNEPFTEKCDIFSLGVIMWELCT 722
++APE++ +P+ + D +S G++++E+
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-23
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 30/209 (14%)
Query: 534 RVGIGFFGEVFRG--IWNGTDVAIK-VFLEQDLTAENMEDFCN----EISILSRLR---H 583
+G+G +G V++ +G VA+K V + E+++L RL H
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNG--GGGGGGLPISTVREVALLRRLEAFEH 73
Query: 584 PNV-----ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 638
PNV + + +++++ E+++ L + + + K ++R R
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK-DLMRQFLR 131
Query: 639 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM 694
GL +H IVHRDLK N LV TVK+ DFGL+RI M TP W
Sbjct: 132 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY-SYQMA-----LTPVVVTLWY 185
Query: 695 -APELIRNEPFTEKCDIFSLGVIMWELCT 722
APE++ + D++S+G I E+
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEMFR 214
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 6e-23
Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 534 RVGIGFFGEVFRGI---WNGTDVAIK-VFLEQD-----LTAENMEDFCNEISILSRLR-- 582
+G G +G+VF+ G VA+K V ++ L+ E+++L L
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST------IREVAVLRHLETF 71
Query: 583 -HPNV-----ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 636
HPNV + + + +L+++ E+++ L + + + K M+ +
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK-DMMFQL 129
Query: 637 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE---- 692
RGL +H ++VHRDLK N LV +K+ DFGL+RI M T
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMA-----LTSVVVTL 183
Query: 693 WM-APELIRNEPFTEKCDIFSLGVIMWELCTLNRP 726
W APE++ + D++S+G I E+ +P
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 217
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 39/198 (19%), Positives = 76/198 (38%), Gaps = 40/198 (20%)
Query: 530 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNV 586
+G+G G+V + A+K+ ++ E+ + R + P++
Sbjct: 21 VTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHI 73
Query: 587 ILFLGAC----TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
+ + L ++ E ++ G L+ I + + R ++++ I +
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 643 IHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 699
+H + I HRD+K N L + +K+ DFG A E
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------AKETT 171
Query: 700 RNEPFTEKCDIFSLGVIM 717
E + + CD++SLGVIM
Sbjct: 172 G-EKYDKSCDMWSLGVIM 188
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-23
Identities = 66/204 (32%), Positives = 91/204 (44%), Gaps = 33/204 (16%)
Query: 534 RVGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAENMEDFCN----EISILSRLRH 583
VG G +G V + G VAIK F Q F E+ +L +RH
Sbjct: 32 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSEL------FAKRAYRELRLLKHMRH 83
Query: 584 PNVILFLGACTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
NVI L T L ++ +M L L+ +KL R ++ +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMG-TDLGKLMK----HEKLGEDRIQFLVYQML 138
Query: 638 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 697
+GL IH I+HRDLK N VN+ +KI DFGL+R DS M T + APE
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEMTGYVV--TRWYRAPE 195
Query: 698 LIRN-EPFTEKCDIFSLGVIMWEL 720
+I N +T+ DI+S+G IM E+
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEM 219
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 534 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFCN----EISILSRLRHPNV 586
+G G F V++ T+ VAIK + L +E + EI +L L HPN+
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHR--SEAKDGINRTALREIKLLQELSHPNI 74
Query: 587 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 646
I L A +S++ ++ME L +I + S + + +GL +H+
Sbjct: 75 IGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAY--MLMTLQGLEYLHQH 131
Query: 647 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APELIRN 701
I+HRDLK N L++++ +K+ DFGL++ P R T + W APEL+
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAY----THQVVTRWYRAPELLFG 186
Query: 702 EPF-TEKCDIFSLGVIMWELCTLNRP 726
D++++G I+ EL P
Sbjct: 187 ARMYGVGVDMWAVGCILAELLL-RVP 211
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 525 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 580
DF L + +G G FG+V R G A+K+ L +++ E E +L
Sbjct: 6 DFDYLKL---LGKGTFGKVILVREKATGRYYAMKI-LRKEVIIAKDEVAHTVTESRVLQN 61
Query: 581 LRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 638
RHP + L T RL + EY G L+ HLS +++ + R +I
Sbjct: 62 TRHP-FLTALKYAFQT-HDRLCFVMEYANGGELFF--HLS-RERVFTEERARFYGAEIVS 116
Query: 639 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 698
L +H +V+RD+K N +++K +KI DFGL + + GTPE++APE+
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176
Query: 699 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
+ + + D + LGV+M+E+ P+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 49/220 (22%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 519 YEEWNIDFSEL---TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCN 573
YE +++ + ++G G + EVF I N V +K+ L +
Sbjct: 25 YESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI-----LKPVKKKKIKR 79
Query: 574 EISILSRLR-HPNVILFLGACTKPP---RLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 629
EI IL LR PN+I K P +++ E++ L + L+
Sbjct: 80 EIKILENLRGGPNIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDI 132
Query: 630 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMRD-SSS 687
+ +I + L H M I+HRD+K N +++ +H +++ D+GL+ P ++ +
Sbjct: 133 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPGQEYNVR 190
Query: 688 AGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRP 726
+ + PEL+ + + + D++SLG ++ + P
Sbjct: 191 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 34/213 (15%)
Query: 535 VGIGFFGEVFRGIW--NGTDVAIK-VFLEQDLTAENMEDFCN----EISILSRLRHPNVI 587
G G FG V G G VAIK V QD F N + L+ L HPN++
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVI--QDPR------FRNRELQIMQDLAVLHHPNIV 82
Query: 588 LFLGACTKPPR--------LSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICR 638
L + L+++ EY+ +L+ + ++ L + R
Sbjct: 83 Q-LQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140
Query: 639 GLMCIHR--MKIVHRDLKSANCLVNKH-WTVKICDFGLSRIITDSPMRDSSSAGTPEWM- 694
+ C+H + + HRD+K N LVN+ T+K+CDFG ++ + SP + + +
Sbjct: 141 SIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPSEPNVAYICSRYYR 198
Query: 695 APELIRN-EPFTEKCDIFSLGVIMWELCTLNRP 726
APELI + +T DI+S+G I E+ L P
Sbjct: 199 APELIFGNQHYTTAVDIWSVGCIFAEMM-LGEP 230
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 6e-22
Identities = 64/232 (27%), Positives = 99/232 (42%), Gaps = 39/232 (16%)
Query: 512 QNKPLLAYEEWNIDFSELTVGTR------VGIGFFGEVFRGI--WNGTDVAIK----VFL 559
++ + ++ + V R VG G +G V G VA+K F
Sbjct: 8 HSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF- 66
Query: 560 EQDLTAENMEDFCN----EISILSRLRHPNVILFLGACTKPPRLS------MITEYMELG 609
Q + E+ +L ++H NVI L T L ++T M
Sbjct: 67 -QSII------HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-A 118
Query: 610 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKIC 669
L +++ +KL+ ++ I RGL IH I+HRDLK +N VN+ +KI
Sbjct: 119 DLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174
Query: 670 DFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWEL 720
DFGL+R T M + T + APE++ N + + DI+S+G IM EL
Sbjct: 175 DFGLAR-HTADEMTGYVA--TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 7e-22
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 12/210 (5%)
Query: 525 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 580
+F L + +G G FG+V + G A+K+ L++++ E E +L
Sbjct: 149 EFEYLKL---LGKGTFGKVILVKEKATGRYYAMKI-LKKEVIVAKDEVAHTLTENRVLQN 204
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
RHP + + RL + EY G L+ HLS +++ S R +I L
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFF--HLS-RERVFSEDRARFYGAEIVSAL 261
Query: 641 MCIHRMK-IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 699
+H K +V+RDLK N +++K +KI DFGL + + GTPE++APE++
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 321
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
+ + D + LGV+M+E+ P+
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 7e-22
Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 34/208 (16%)
Query: 534 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHPN 585
++G G +GEV++ I T+ VAIK + LE + TA E+S+L L+H N
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA------IREVSLLKELQHRN 94
Query: 586 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 645
+I RL +I EY E L + + +S R L + G+ H
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 646 MKIVHRDLKSANCLVNKHWT-----VKICDFGLSRIITDSPMRDSSSAGTPE----WM-A 695
+ +HRDLK N L++ +KI DFGL+R P+R T E W
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQF----THEIITLWYRP 205
Query: 696 PELIRNEP-FTEKCDIFSLGVIMWELCT 722
PE++ ++ DI+S+ I E+
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLM 233
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 8e-22
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 16/212 (7%)
Query: 525 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 580
DF + +G G FG+VF AIK L++D+ + + C E +LS
Sbjct: 18 DFILHKM---LGKGSFGKVFLAEFKKTNQFFAIKA-LKKDVVLMDDDVECTMVEKRVLSL 73
Query: 581 -LRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
HP + + T L + EY+ G L + I K R +I
Sbjct: 74 AWEHP-FLTHMFCTFQT-KENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEII 128
Query: 638 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 697
GL +H IV+RDLK N L++K +KI DFG+ + + ++ GTP+++APE
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 188
Query: 698 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
++ + + D +S GV+++E+ P+ G
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 1e-21
Identities = 75/341 (21%), Positives = 140/341 (41%), Gaps = 22/341 (6%)
Query: 404 MNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQ 463
++ L E E F +D L ++ L + ++ G S + +
Sbjct: 211 QKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKA 270
Query: 464 MNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWN 523
L EY + GS G + + + K +++
Sbjct: 271 GVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFD 330
Query: 524 I----------DFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDF 571
DF+ L V +G G FG+V GTD A+K+ L++D+ ++ +
Sbjct: 331 NNGNRDRMKLTDFNFLMV---LGKGSFGKVMLSERKGTDELYAVKI-LKKDVVIQDDDVE 386
Query: 572 C--NEISILSRLRHPNVILFLGACTKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWRR 628
C E +L+ P + L +C + RL + EY+ G L + H+ Q +
Sbjct: 387 CTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY--HIQ-QVGRFKEPH 443
Query: 629 KLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 688
+ +I GL + I++RDLK N +++ +KI DFG+ + + +
Sbjct: 444 AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC 503
Query: 689 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
GTP+++APE+I +P+ + D ++ GV+++E+ P+EG
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 21/218 (9%)
Query: 525 DFSELTVGTRVGIGFFGEVF---RGIWNGTDV--AIKVFLEQDLTAENMEDFC---NEIS 576
+F L V +G G +G+VF + + T A+KV L++ + + E
Sbjct: 55 NFELLKV---LGTGAYGKVFLVRKISGHDTGKLYAMKV-LKKATIVQKAKTTEHTRTERQ 110
Query: 577 ILSRLRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 634
+L +R ++ L T +L +I +Y+ G L+ HLS Q+++ + +
Sbjct: 111 VLEHIRQSPFLVTLHYAFQT-ETKLHLILDYINGGELFT--HLS-QRERFTEHEVQIYVG 166
Query: 635 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEW 693
+I L +H++ I++RD+K N L++ + V + DFGLS + D R GT E+
Sbjct: 167 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 694 MAPELIRNEP--FTEKCDIFSLGVIMWELCTLNRPWEG 729
MAP+++R + D +SLGV+M+EL T P+
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 54/216 (25%), Positives = 83/216 (38%), Gaps = 44/216 (20%)
Query: 534 RVGIGFFGEVFRGI--WNGTDVAIK--VFLEQDLTAENMEDFCN----EISILSRLRHPN 585
+G G G VF + VAIK V D EI I+ RL H N
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVL--TDPQ------SVKHALREIKIIRRLDHDN 69
Query: 586 VILFLGACTKPPRLS--------------MITEYMELGSLYHLIHLSGQKKKLSWRRKLK 631
++ ++ EYME L +++ + L
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLE----QGPLLEEHARL 124
Query: 632 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITDSPMRDSSSAGT 690
+ + RGL IH ++HRDLK AN +N +KI DFGL+RI+ P +
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIM--DPHYSHKGHLS 182
Query: 691 PE----WM-APELIRN-EPFTEKCDIFSLGVIMWEL 720
W +P L+ + +T+ D+++ G I E+
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-21
Identities = 58/211 (27%), Positives = 107/211 (50%), Gaps = 14/211 (6%)
Query: 525 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 580
+F + V +G G FG+V R G A+KV L++D+ ++ + C E ILS
Sbjct: 24 NFEFIRV---LGKGSFGKVMLARVKETGDLYAVKV-LKKDVILQDDDVECTMTEKRILSL 79
Query: 581 LRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 638
R+ + L C T P RL + E++ G L H+ + ++ R +I
Sbjct: 80 ARNHPFLTQLFCCFQT-PDRLFFVMEFVNGGDLMF--HIQ-KSRRFDEARARFYAAEIIS 135
Query: 639 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 698
LM +H I++RDLK N L++ K+ DFG+ + + + ++ GTP+++APE+
Sbjct: 136 ALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEI 195
Query: 699 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
++ + D +++GV+++E+ + P+E
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 5e-21
Identities = 55/220 (25%), Positives = 102/220 (46%), Gaps = 14/220 (6%)
Query: 525 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 580
DF L V +G G + +V R A+KV ++++L ++ + E + +
Sbjct: 10 DFDLLRV---IGRGSYAKVLLVRLKKTDRIYAMKV-VKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 581 LRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 638
+ ++ L +C T RL + EY+ G L H+ +++KL +I
Sbjct: 66 ASNHPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMF--HMQ-RQRKLPEEHARFYSAEISL 121
Query: 639 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 698
L +H I++RDLK N L++ +K+ D+G+ + S+ GTP ++APE+
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 181
Query: 699 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYA 738
+R E + D ++LGV+M+E+ P++ V
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 221
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 8e-21
Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 14/211 (6%)
Query: 525 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 580
DF+ L V +G G FG+V A+K+ L++D+ ++ + C E +L+
Sbjct: 21 DFNFLMV---LGKGSFGKVMLSERKGTDELYAVKI-LKKDVVIQDDDVECTMVEKRVLAL 76
Query: 581 LRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 638
P + L +C T RL + EY+ G L + H+ Q + + +I
Sbjct: 77 PGKPPFLTQLHSCFQT-MDRLYFVMEYVNGGDLMY--HIQ-QVGRFKEPHAVFYAAEIAI 132
Query: 639 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 698
GL + I++RDLK N +++ +KI DFG+ + + + GTP+++APE+
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEI 192
Query: 699 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
I +P+ + D ++ GV+++E+ P+EG
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 9e-21
Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 14/220 (6%)
Query: 525 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 580
DF L V +G G + +V R A++V ++++L ++ + E + +
Sbjct: 53 DFDLLRV---IGRGSYAKVLLVRLKKTDRIYAMRV-VKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 581 LRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 638
+ ++ L +C T RL + EY+ G L H+ +++KL +I
Sbjct: 109 ASNHPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMF--HMQ-RQRKLPEEHARFYSAEISL 164
Query: 639 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 698
L +H I++RDLK N L++ +K+ D+G+ + S+ GTP ++APE+
Sbjct: 165 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 224
Query: 699 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYA 738
+R E + D ++LGV+M+E+ P++ V
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 54/238 (22%), Positives = 91/238 (38%), Gaps = 58/238 (24%)
Query: 535 VGIGFFGEVFRGIWN--GTDVAIK-VFLEQDLTAENMEDFCN-EISILSRLRHPNVI--- 587
+G G FG V G A+K V + + N E+ I+ L H N+I
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPR--------YKNRELDIMKVLDHVNIIKLV 66
Query: 588 -----------------------------LFLGACTKPPR------LSMITEYMELGSLY 612
+ + L++I EY+ +L+
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH 125
Query: 613 HLI-HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKICD 670
++ + + + + R + IH + I HRD+K N LVN K T+K+CD
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 671 FGLSRIITDSPMRDSSSAGTPEWM-APELIRN-EPFTEKCDIFSLGVIMWELCTLNRP 726
FG ++ + P S + + APEL+ +T D++S+G + EL L +P
Sbjct: 186 FGSAKKL--IPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI-LGKP 240
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 53/239 (22%), Positives = 99/239 (41%), Gaps = 57/239 (23%)
Query: 521 EWNIDFSELTVGTRVGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAENMEDFCN- 573
+ ++ + + ++G G +G V++ I G VA+K F Q+ T
Sbjct: 4 DRHVL-RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF--QNST------DAQR 54
Query: 574 ---EISILSRLR-HPNVILFLGACTKPPRLS---MITEYMELGSLYHLIH---LSGQKKK 623
EI IL+ L H N++ L + ++ +YME L+ +I L K+
Sbjct: 55 TFREIMILTELSGHENIVNLLNVL-RADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQ 112
Query: 624 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683
++ + + + +H ++HRD+K +N L+N VK+ DFGLSR +
Sbjct: 113 Y-------VVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165
Query: 684 DSSSAGTPEWM---------------------APELIRN-EPFTEKCDIFSLGVIMWEL 720
++ + APE++ +T+ D++SLG I+ E+
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-20
Identities = 57/212 (26%), Positives = 104/212 (49%), Gaps = 16/212 (7%)
Query: 525 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 580
DF L V +G G FG+V R A+KV L++ + E+ +E ++L +
Sbjct: 39 DFHFLKV---IGKGSFGKVLLARHKAEEVFYAVKV-LQKKAILKKKEEKHIMSERNVLLK 94
Query: 581 -LRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
++HP ++ L T +L + +Y+ G L++ HL +++ R +I
Sbjct: 95 NVKHP-FLVGLHFSFQT-ADKLYFVLDYINGGELFY--HLQ-RERCFLEPRARFYAAEIA 149
Query: 638 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 697
L +H + IV+RDLK N L++ + + DFGL + + S+ GTPE++APE
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE 209
Query: 698 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
++ +P+ D + LG +++E+ P+
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 30/261 (11%), Positives = 70/261 (26%), Gaps = 46/261 (17%)
Query: 531 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENM-EDFCNEISILSRLRHPNVI 587
+ G + ++ VA+ Q + +++ ++ + LSR+ P V
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
L ++ E++ GSL + S ++ ++ + HR
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVAD-----TSPSPVGAIRAMQSLAAAADAAHRAG 149
Query: 648 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 707
+ + V+ V + M +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPAT--------------------MPDA-------NPQ 182
Query: 708 CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS------RLEIPEGP--LGRLIAD 759
DI +G ++ L P + + + + P + + A
Sbjct: 183 DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAAR 242
Query: 760 CWA-EPQERPSCEEILSRLLD 779
+ R + L L+
Sbjct: 243 SVQGDGGIRSAST--LLNLMQ 261
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 57/202 (28%), Positives = 83/202 (41%), Gaps = 26/202 (12%)
Query: 535 VGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCN----EISILSRLRH----- 583
+G G FG+V + VA+K+ N + F EI IL LR
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKM-------VRNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 584 -PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
NVI L T + M E + + +LY LI + + S K I + L
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSM-NLYELIK-KNKFQGFSLPLVRKFAHSILQCLDA 215
Query: 643 IHRMKIVHRDLKSANCLVN--KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 700
+H+ +I+H DLK N L+ +K+ DFG S S + APE+I
Sbjct: 216 LHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR---FYRAPEVIL 272
Query: 701 NEPFTEKCDIFSLGVIMWELCT 722
+ D++SLG I+ EL T
Sbjct: 273 GARYGMPIDMWSLGCILAELLT 294
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 74.5 bits (182), Expect = 2e-14
Identities = 38/198 (19%), Positives = 58/198 (29%), Gaps = 50/198 (25%)
Query: 527 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENME------DFCNEISILSR 580
+L ++G G FGEVF+ I + T VAIK+ + N + EI I
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKE 79
Query: 581 L---------RHPNVILFLGAC------------------------------TKPPRLSM 601
L R I K +L +
Sbjct: 80 LSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFI 139
Query: 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH-RMKIVHRDLKSANCLV 660
+ E+ G + K S +L + L ++ HRDL N L+
Sbjct: 140 VLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 661 NKHWTVKICDFGLSRIIT 678
K K+ + T
Sbjct: 196 KKTSLKKLHYTLNGKSST 213
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 47/219 (21%), Positives = 85/219 (38%), Gaps = 48/219 (21%)
Query: 536 GIGFFGEVFRG--IWNGTDVAIKV------FLEQDLTAENMEDFCNEISILSRLR----- 582
G G F V+ + N T VA+K+ + E EI +L R+
Sbjct: 28 GWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---------EIKLLQRVNDADNT 78
Query: 583 ------HPNVILFL------GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL 630
+++ L G + M+ E + +L LI + +
Sbjct: 79 KEDSMGANHILKLLDHFNHKGPNGVH--VVMVFEVLGE-NLLALIKKYEHRG-IPLIYVK 134
Query: 631 KMLRDICRGLMCIHRM-KIVHRDLKSANCLVN------KHWTVKICDFGLSRIITDSPMR 683
++ + + GL +HR I+H D+K N L+ +KI D G + +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---H 191
Query: 684 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 722
++S T E+ +PE++ P+ DI+S +++EL T
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 47/210 (22%), Positives = 85/210 (40%), Gaps = 32/210 (15%)
Query: 531 VGTRVGIGFFGEVFRGIW--NGTDVAIKV------FLEQDLTAENMEDFCNEISILSRLR 582
+ + +G G FG+V + VAIK+ FL Q E+ +L +
Sbjct: 58 IDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI---------EVRLLELMN 108
Query: 583 HP------NVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 636
++ L ++ E + +LY L+ + + +S K + +
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTN-FRGVSLNLTRKFAQQM 166
Query: 637 CRGLMCIH--RMKIVHRDLKSANCLV--NKHWTVKICDFGLSRIITDSPMRDSSSAGTPE 692
C L+ + + I+H DLK N L+ K +KI DFG S + +
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI---YQYIQSRF 223
Query: 693 WMAPELIRNEPFTEKCDIFSLGVIMWELCT 722
+ +PE++ P+ D++SLG I+ E+ T
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 61/227 (26%), Positives = 93/227 (40%), Gaps = 46/227 (20%)
Query: 531 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH----P 584
VG ++G G FGE+ G ++ VAIK LE + E +L P
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIK--LEPMKSRAPQ--LHLEYRFYKQLGSGDGIP 68
Query: 585 NVILFLGACTKPPRLSMITEYMELG-SLYHLIHLSGQKKKLSWRRKLK---MLRD--ICR 638
V F G C K +M+ E LG SL L L + S LK M+ I R
Sbjct: 69 QVYYF-GPCGK--YNAMVLEL--LGPSLEDLFDLCD--RTFS----LKTVLMIAIQLISR 117
Query: 639 GLMCIHRMKIVHRDLKSANCLVNKHWT-----VKICDFGLSRIITDS------PMRDSSS 687
+ +H +++RD+K N L+ + + I DF L++ D P R+ S
Sbjct: 118 -MEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKS 176
Query: 688 -AGTPEWMAPELIRNEPFTE---KCDIFSLGVIMWELCTLNRPWEGV 730
GT +M+ I E + D+ +LG + + PW+G+
Sbjct: 177 LTGTARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 8e-11
Identities = 51/236 (21%), Positives = 80/236 (33%), Gaps = 78/236 (33%)
Query: 536 GIGFFGEVFRGI---WNGTDVAIKV------FLEQDLTAENMEDFCNEISILSRLRHP-- 584
G G FG+V I G VA+K+ + E + EI +L L
Sbjct: 23 GEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS---------EIQVLEHLNTTDP 73
Query: 585 ----NVILFLGA-------CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 633
+ L C ++ E + L S Y I +G KM
Sbjct: 74 NSTFRCVQMLEWFEHHGHIC-------IVFELLGL-STYDFIKENG-FLPFRLDHIRKMA 124
Query: 634 RDICRGLMCIHRMKIVHRDLKSANCLVN-------------------KHWTVKICDFG-- 672
IC+ + +H K+ H DLK N L + +K+ DFG
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 673 ------LSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 722
S +++ R APE+I +++ CD++S+G I+ E
Sbjct: 185 TYDDEHHSTLVSTRHYR-----------APEVILALGWSQPCDVWSIGCILIEYYL 229
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 40/235 (17%), Positives = 78/235 (33%), Gaps = 74/235 (31%)
Query: 535 VGIGFFGEVFR---GIWNGTDVAIKVFLEQDLTAENMEDFCN----EISILSRLRHP--- 584
+G G FG+V + VA+K+ N+ + EI++L +++
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKII-------RNVGKYREAARLEINVLKKIKEKDKE 79
Query: 585 ---NVILFLGA-------CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 634
+L C + E + + + + + M
Sbjct: 80 NKFLCVLMSDWFNFHGHMC-------IAFELLGK-NTFEFLK-ENNFQPYPLPHVRHMAY 130
Query: 635 DICRGLMCIHRMKIVHRDLKSANCLVN-------------------KHWTVKICDFG--- 672
+C L +H ++ H DLK N L K+ ++++ DFG
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 673 -----LSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 722
+ I+ R PE+I + + CD++S+G I++E
Sbjct: 191 FDHEHHTTIVATRHYR-----------PPEVILELGWAQPCDVWSIGCILFEYYR 234
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 49/240 (20%), Positives = 77/240 (32%), Gaps = 82/240 (34%)
Query: 536 GIGFFGEVFRGI--WNGTDVAIKV------FLEQDLTAENMEDFCNEISILSRLRH---- 583
G G FG V N A+KV + E IL ++++
Sbjct: 44 GDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI---------EADILKKIQNDDIN 94
Query: 584 -PNVILFLGA-------CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 635
N++ + G C +I E + SLY +I + +
Sbjct: 95 NNNIVKYHGKFMYYDHMC-------LIFEPLGP-SLYEIITRNN-YNGFHIEDIKLYCIE 145
Query: 636 ICRGLMCIHRMKIVHRDLKSANCLVN-------------------------KHWTVKICD 670
I + L + +M + H DLK N L++ K +K+ D
Sbjct: 146 ILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 671 FG--------LSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 722
FG II R APE+I N + D++S G ++ EL T
Sbjct: 206 FGCATFKSDYHGSIINTRQYR-----------APEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 59/231 (25%), Positives = 93/231 (40%), Gaps = 54/231 (23%)
Query: 531 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMED----FCNEISILSRLRH- 583
VG R+G G FG +F G + N VAIK E +E L
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKF--------EPRRSDAPQLRDEYRTYKLLAGC 65
Query: 584 ---PNVILFLGACTKPPRLSMITEYMELG-SLYHLIHLSGQKKKLSWRRKLK---MLRD- 635
PNV F G ++ + LG SL L+ L G +K S +K M
Sbjct: 66 TGIPNVYYF-GQEGL--HNVLVIDL--LGPSLEDLLDLCG--RKFS----VKTVAMAAKQ 114
Query: 636 -ICRGLMCIHRMKIVHRDLKSANCLVNKHWT-----VKICDFGLSRIITDS------PMR 683
+ R + IH +V+RD+K N L+ + + + + DFG+ + D P R
Sbjct: 115 MLAR-VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173
Query: 684 DSSS-AGTPEWMAPELIRNEPFTEKC---DIFSLGVIMWELCTLNRPWEGV 730
+ + +GT +M+ I E+ D+ +LG + + PW+G+
Sbjct: 174 EKKNLSGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 42/224 (18%)
Query: 531 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMED----FCNEISILSRLRH- 583
+G ++G G FG+++ G I G +VAIK+ E ++ E I ++
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKL--------ECVKTKHPQLHIESKIYKMMQGG 64
Query: 584 ---PNVILFLGACTKPPRLSMITEYMELG-SLYHLIHLSGQKKKLSWRRKLKMLRDICRG 639
P + GA M+ E LG SL L + +K S + L + +
Sbjct: 65 VGIPTIRWC-GAEGD--YNVMVMEL--LGPSLEDLFNFCS--RKFSLKTVLLLADQMISR 117
Query: 640 LMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDS------PMRDSSS-AG 689
+ IH +HRD+K N L+ K V I DFGL++ D+ P R++ + G
Sbjct: 118 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177
Query: 690 TPEWMAPELIRNEPFTEKC---DIFSLGVIMWELCTLNRPWEGV 730
T + + I E+ D+ SLG ++ + PW+G+
Sbjct: 178 TARYAS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 48/239 (20%), Positives = 76/239 (31%), Gaps = 46/239 (19%)
Query: 531 VGTRVGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 589
VG +G G FG ++ + + V + + E+ R P I
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQK 98
Query: 590 LGACTKPPRLSM------------ITEY----ME-LG-SLYHLIHLSGQKKKLSWRRKLK 631
K L + Y M+ G L + + K+ S K
Sbjct: 99 WIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA--KRFS----RK 152
Query: 632 ---MLRD--ICRGLMCIHRMKIVHRDLKSANCLVN--KHWTVKICDFGLSRIITDS---- 680
L + L IH + VH D+K++N L+N V + D+GL+
Sbjct: 153 TVLQLSLRILDI-LEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
Query: 681 --PMRDSSS-AGTPEWMAPELIRNEPFTEKC---DIFSLGVIMWELCTLNRPWEGVLPE 733
GT E+ + I D+ LG M + T + PWE L +
Sbjct: 212 AYAADPKRCHDGTIEFTS---IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 42/224 (18%)
Query: 531 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMED----FCNEISILSRLRH- 583
+G ++G G FGE++ G I +VAIK+ EN++ E I L+
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLLYESKIYRILQGG 62
Query: 584 ---PNVILFLGACTKPPRLSMITEYMELG-SLYHLIHLSGQKKKLSWRRKLKMLRDICRG 639
PNV F G ++ + LG SL L + +KLS + L + +
Sbjct: 63 TGIPNVRWF-GVEGD--YNVLVMDL--LGPSLEDLFNF--CSRKLSLKTVLMLADQMINR 115
Query: 640 LMCIHRMKIVHRDLKSANCLVNKHWT---VKICDFGLSRIITDS------PMRDSSS-AG 689
+ +H +HRD+K N L+ V I DFGL++ D+ P R++ + G
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
Query: 690 TPEWMAPELIRNEPFTEKC---DIFSLGVIMWELCTLNRPWEGV 730
T + + + E+ D+ SLG ++ + PW+G+
Sbjct: 176 TARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 50/263 (19%), Positives = 84/263 (31%), Gaps = 86/263 (32%)
Query: 531 VGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-----H 583
V ++G G F V+ I VA+KV E +EI +L +R
Sbjct: 41 VIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK---SAEHYTETALDEIRLLKSVRNSDPND 97
Query: 584 PN---VILFLGA-----------CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 629
PN V+ L C M+ E + L I S + L
Sbjct: 98 PNREMVVQLLDDFKISGVNGTHIC-------MVFEVLGH-HLLKWIIKSNYQG-LPLPCV 148
Query: 630 LKMLRDICRGLMCIHR-MKIVHRDLKSANCLVN--------------------------- 661
K+++ + +GL +H +I+H D+K N L++
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 662 ----------------------KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 699
+ VKI D G + + D T ++ + E++
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ---TRQYRSLEVL 265
Query: 700 RNEPFTEKCDIFSLGVIMWELCT 722
+ DI+S + +EL T
Sbjct: 266 IGSGYNTPADIWSTACMAFELAT 288
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 41/244 (16%), Positives = 76/244 (31%), Gaps = 56/244 (22%)
Query: 531 VGTRVGIGFFGEVFRGI----------WNGTDVAIKVFLEQDLTAENME-DFCNEISILS 579
+ + G ++ ++K+ + + NE +
Sbjct: 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL--------DAKDGRLFNEQNFFQ 97
Query: 580 RLRHPNVILFLGACTKPPRLSMITEY-------------ME-LG-SLYHLIHLSGQKKKL 624
R P + P L++ T + LG SL + +S K L
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSP-KHVL 156
Query: 625 SWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV--NKHWTVKICDFGLSRIITDS-- 680
S R L++ + L +H + VH ++ + N V V + +G + S
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
Query: 681 --PMRDSSSA---GTPEWMA------PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
+ S + G E+++ R + D+ SLG M + PW
Sbjct: 217 HVAYVEGSRSPHEGDLEFISMDLHKGCGPSR------RSDLQSLGYCMLKWLYGFLPWTN 270
Query: 730 VLPE 733
LP
Sbjct: 271 CLPN 274
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 51/245 (20%), Positives = 78/245 (31%), Gaps = 57/245 (23%)
Query: 531 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 588
+G ++G G FG ++ A V + EN F +E+ R+ + I
Sbjct: 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHV--VKVEYQENGPLF-SELKFYQRVAKKDCIK 97
Query: 589 FLGACTKPPRLSMITEY----------------ME-LG-SLYHLIHLSGQKKKLSWRRKL 630
+ L + Y ME LG L + +G
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG---TFK----K 150
Query: 631 K---MLRD--ICRGLMCIHRMKIVHRDLKSANCLV--NKHWTVKICDFGLSRIITDS--- 680
L + L IH + VH D+K+AN L+ V + D+GLS +
Sbjct: 151 STVLQLGIRMLDV-LEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 681 ---PMRDSSS-AGTPEWMA------PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV 730
GT E+ + L R + D+ LG M PWE
Sbjct: 210 KQYQENPRKGHNGTIEFTSLDAHKGVALSR------RSDVEILGYCMLRWLCGKLPWEQN 263
Query: 731 LPERV 735
L + V
Sbjct: 264 LKDPV 268
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 785 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.03 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.87 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.62 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.4 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.29 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.22 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.03 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.0 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.91 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.8 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.39 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.39 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.32 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.17 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 97.17 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.02 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.96 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.81 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.74 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.67 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.59 | |
| 3kd4_A | 506 | Putative protease; structural genomics, joint cent | 96.57 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.44 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.05 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.05 | |
| 3maz_A | 125 | Signal-transducing adaptor protein 1; modular doma | 96.03 | |
| 1aot_F | 106 | FYN protein-tyrosine kinase; SH2 domain, signal tr | 95.65 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.37 | |
| 1blj_A | 114 | P55 BLK protein tyrosine kinase; signal transducti | 95.06 | |
| 1lkk_A | 105 | Human P56 tyrosine kinase; complex (tyrosine kinas | 94.55 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.43 | |
| 2el8_A | 118 | Signal-transducing adaptor protein 2; SH2 domain, | 93.95 | |
| 1rja_A | 100 | Tyrosine-protein kinase 6; human protein tyrosine | 93.32 | |
| 1nrv_A | 105 | Growth factor receptor-bound protein 10; dimer, si | 92.92 | |
| 2dly_A | 121 | FYN-related kinase; BRK family kinase, structural | 92.45 | |
| 4d8k_A | 175 | Tyrosine-protein kinase LCK; protein kinases, SH2 | 92.3 | |
| 3isr_A | 293 | Transglutaminase-like enzymes, putative cysteine; | 92.27 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.2 | |
| 3pqz_A | 117 | Growth factor receptor-bound protein 7; SH2, binds | 91.56 | |
| 2aug_A | 126 | Growth factor receptor-bound protein 14; phosphory | 91.24 | |
| 3ov1_A | 117 | Growth factor receptor-bound protein 2; GRB2 SH2 d | 89.73 | |
| 1d4t_A | 104 | T cell signal transduction molecule SAP; SH2 domai | 89.08 | |
| 2ekx_A | 110 | Cytoplasmic tyrosine-protein kinase BMX; SH2 domai | 89.03 | |
| 2dx0_A | 138 | Phospholipase C, gamma 2; phosphoric diester hydro | 88.98 | |
| 2cia_A | 102 | Cytoplasmic protein NCK2; SH2-domain, SH3 domain, | 88.96 | |
| 1i3z_A | 103 | EWS/FLI1 activated transcript 2; SH2 domain phosph | 88.77 | |
| 2gsb_A | 119 | RAS GTPase-activating protein 1; GAP, RAS P21 prot | 88.37 | |
| 3tkz_A | 109 | Tyrosine-protein phosphatase non-receptor type 11; | 88.07 | |
| 1ka6_A | 128 | SH2 domain protein 1A; SH2 domain, protein-peptide | 87.94 | |
| 1jyr_A | 96 | Growth factor receptor-bound protein 2; receptor b | 87.86 | |
| 4fbn_A | 246 | 1-phosphatidylinositol 4,5-bisphosphate phosphodi | 87.65 | |
| 2hdv_A | 111 | SH2-B PH domain containing signaling mediator 1 ga | 87.26 | |
| 1r1p_A | 100 | GRB2-related adaptor protein 2; SH2, GADS, phospho | 86.01 | |
| 2ge9_A | 125 | Tyrosine-protein kinase BTK; SH2 domain, structure | 85.92 | |
| 2ysx_A | 119 | Signaling inositol polyphosphate phosphatase SHIP | 85.78 | |
| 2eo6_A | 141 | B-cell linker protein; SH2, cytoplasmic adapter pr | 85.56 | |
| 2eo3_A | 111 | CRK-like protein; phosphorylation, repeat, SH2 dom | 85.45 | |
| 3us4_A | 98 | Megakaryocyte-associated tyrosine-protein kinase; | 85.25 | |
| 2dm0_A | 125 | Tyrosine-protein kinase TXK; TEC family kinase, st | 85.25 | |
| 1ju5_A | 109 | CRK; CRK, SH2, SH3, adaptor protein, phosphopeptid | 84.5 | |
| 3qwx_X | 174 | Cell death abnormality protein 2; cell engulfment, | 84.17 | |
| 2oq1_A | 254 | Tyrosine-protein kinase ZAP-70; tandem SH2 domains | 83.6 | |
| 2bbu_A | 164 | Suppressor of cytokine signaling 3; SH2 domain, ex | 83.23 | |
| 1a81_A | 254 | SYK kinase; complex (transferase-peptide), SYK, ki | 82.89 | |
| 3k2m_A | 112 | Proto-oncogene tyrosine-protein kinase ABL1; engin | 82.06 | |
| 2dvj_A | 230 | V-CRK sarcoma virus CT10 oncogene homolog, isoform | 81.87 | |
| 2lnw_A | 122 | VAV-2, guanine nucleotide exchange factor VAV2; si | 81.68 | |
| 2f4m_A | 295 | Peptide N-glycanase; glycoproteins, ubiquitin-depe | 81.6 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 81.54 | |
| 3eaz_A | 106 | Tyrosine-protein kinase CSK; SH2, disulfide, oxidi | 81.54 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 81.54 | |
| 2cs0_A | 119 | Hematopoietic SH2 domain containing; ALX, FLJ14886 | 81.4 | |
| 2dlz_A | 118 | Protein VAV-2; RHO family guanine nucleotide excha | 81.17 | |
| 2c9w_A | 169 | Suppressor of cytokine signaling 2; growth regulat | 80.37 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=457.32 Aligned_cols=262 Identities=35% Similarity=0.620 Sum_probs=222.8
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
...|+++.++|.+.++||+|+||+||+|++++ .||||+++.........+.|.+|+.+|++++|||||+++++|.+ +.
T Consensus 28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN 105 (307)
T ss_dssp -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence 35689999999999999999999999998766 58999998777777778899999999999999999999999865 46
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
+++|||||++|+|.++++. ....+++.+++.|+.||+.||+|||+++||||||||+||||++++++||+|||+|+...
T Consensus 106 ~~iVmEy~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp CEEEEECCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred EEEEEEcCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 8999999999999999973 34579999999999999999999999999999999999999999999999999998764
Q ss_pred CCC--CCCCCCCCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----CC
Q 003935 679 DSP--MRDSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----IP 749 (785)
Q Consensus 679 ~~~--~~~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~----ip 749 (785)
... ......+||+.|||||++.+ .+|+.++|||||||+||||+||+.||.+.+....+..+...+...+ ++
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 263 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLY 263 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSC
T ss_pred cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Confidence 322 22345689999999999964 4699999999999999999999999998877666666655543322 22
Q ss_pred ---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhcc
Q 003935 750 ---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 784 (785)
Q Consensus 750 ---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~sL 784 (785)
+..+.+|+.+||+ ||.+|||+.+|+++|+.++.++
T Consensus 264 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 264 KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 2368999999999 9999999999999999887654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-52 Score=449.41 Aligned_cols=258 Identities=31% Similarity=0.565 Sum_probs=218.6
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccc
Q 003935 521 EWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 593 (785)
Q Consensus 521 e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~ 593 (785)
.+.+..++|.+.++||+|+||+||+|.+. ++.||||++... .....++|.+|+.+|++++|||||+++|+|
T Consensus 35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 112 (329)
T 4aoj_A 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVC 112 (329)
T ss_dssp SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34567789999999999999999999863 678999998643 345568899999999999999999999999
Q ss_pred cCCCceeEEEEEcccchhhHHHHhhcc------------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEc
Q 003935 594 TKPPRLSMITEYMELGSLYHLIHLSGQ------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN 661 (785)
Q Consensus 594 ~d~~~l~LV~Ey~~gGSL~dlL~~~~~------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd 661 (785)
.+.+.+|+|||||++|+|.++++.... ..++++.+++.|+.||+.||+|||+++||||||||+||||+
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 999999999999999999999974321 24689999999999999999999999999999999999999
Q ss_pred CCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 003935 662 KHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYA 738 (785)
Q Consensus 662 ~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~ 738 (785)
+++++||+|||+++....... .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..++...
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999999987644322 2235679999999999999999999999999999999999 8999999998888877
Q ss_pred HHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 739 VANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 739 i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
+.. +.+++.|. ..+.+|+.+||+ ||.+|||+.+|+++|+.+.
T Consensus 273 i~~-g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 273 ITQ-GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp HHH-TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHc-CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 655 44555553 469999999999 9999999999999998864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-53 Score=462.91 Aligned_cols=250 Identities=26% Similarity=0.512 Sum_probs=218.3
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
..++|.++++||+|+||+||+|.+ +|+.||||++.+........+.|.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 357899999999999999999988 589999999988877777788999999999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
||||+||+|.+++... ....+++.+++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+.+.....
T Consensus 102 mEy~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp EECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred EeCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 9999999999999643 345689999999999999999999999999999999999999999999999999987654322
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHH
Q 003935 683 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIAD 759 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~ 759 (785)
.....+||+.|+|||++.+..|+.++|||||||+||||+||+.||.+.+..++...+...... .++ +..+.+||.+
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-~~~~~~s~~~~~li~~ 259 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-PVSLHYSYDLRSLVSQ 259 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHH
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCccCCHHHHHHHHH
Confidence 233567999999999999999999999999999999999999999999999988888776543 232 3469999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003935 760 CWA-EPQERPSCEEILSR 776 (785)
Q Consensus 760 CL~-DP~kRPS~~EIL~~ 776 (785)
||. ||.+|||+.|+++|
T Consensus 260 ~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 260 LFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HTCSSGGGSCCHHHHHTS
T ss_pred HccCChhHCcCHHHHhcC
Confidence 999 99999999999975
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=447.62 Aligned_cols=258 Identities=31% Similarity=0.492 Sum_probs=223.0
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEecccc
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 594 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~ 594 (785)
.++..+++++.++||+|+||+||+|.+ +++.||||++..... ....++|.+|+.++++++|||||+++|+|.
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-C-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-hHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 346678899999999999999999986 357899999865432 334578999999999999999999999999
Q ss_pred CCCceeEEEEEcccchhhHHHHhhcc-------------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEc
Q 003935 595 KPPRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN 661 (785)
Q Consensus 595 d~~~l~LV~Ey~~gGSL~dlL~~~~~-------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd 661 (785)
+++.+++|||||++|+|.+++..... ...+++..++.|+.||+.||+|||+++||||||||+||||+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 99999999999999999999964321 24689999999999999999999999999999999999999
Q ss_pred CCCeEEEEecCccccccCCC--CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 003935 662 KHWTVKICDFGLSRIITDSP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYA 738 (785)
Q Consensus 662 ~~g~VKL~DFGLA~~l~~~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~ 738 (785)
+++++||+|||+++...... ......+||+.|+|||++.++.|+.++|||||||+||||+| |..||.+.+..++...
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999998764332 22345689999999999999999999999999999999998 8999999998888877
Q ss_pred HHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 739 VANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 739 i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
+.. +.+++.|+ ..+.+|+.+||+ ||.+||||.+|+++|+.+.
T Consensus 260 i~~-~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 260 IRN-RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHc-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 654 44555554 368999999999 9999999999999998763
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=446.52 Aligned_cols=257 Identities=30% Similarity=0.568 Sum_probs=222.4
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 595 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 595 (785)
.+..++|.+.++||+|+||+||+|.+ +++.||||++... .....++|.+|+.+|++++|||||+++|+|.+
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 46678999999999999999999976 3678999998643 34556889999999999999999999999999
Q ss_pred CCceeEEEEEcccchhhHHHHhhc----------ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCe
Q 003935 596 PPRLSMITEYMELGSLYHLIHLSG----------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 665 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL~dlL~~~~----------~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~ 665 (785)
++.+|+|||||++|+|.++++... ....+++.+++.++.||+.||+|||+++||||||||+||||++++.
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence 999999999999999999997532 2347999999999999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 003935 666 VKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANE 742 (785)
Q Consensus 666 VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~ 742 (785)
+||+|||+|+........ .....||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+..
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~- 245 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ- 245 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH-
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-
Confidence 999999999876443222 223468999999999999999999999999999999998 8999999999888877765
Q ss_pred CCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 743 GSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 743 ~~~~~ip~---~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
+.++..|. ..+.+|+.+||+ ||.+|||+.+|++.|+++..
T Consensus 246 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 246 GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 44444443 469999999999 99999999999999988753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=450.80 Aligned_cols=262 Identities=31% Similarity=0.573 Sum_probs=226.5
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEECC-------eEEEEEEeeccccChHHHHHHHHHHHHHhhcCC-CceeeEe
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRH-PNVILFL 590 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~g-------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~H-PNIVkL~ 590 (785)
..+|+++.++|+++++||+|+||+||+|.+.+ +.||||++..... ....+.|.+|+.+|++++| ||||+++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-hHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 35799999999999999999999999998732 5799999875443 3446789999999999965 9999999
Q ss_pred ccccCC-CceeEEEEEcccchhhHHHHhhcc-------------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCC
Q 003935 591 GACTKP-PRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 656 (785)
Q Consensus 591 g~~~d~-~~l~LV~Ey~~gGSL~dlL~~~~~-------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKps 656 (785)
|+|.+. ..+++|||||++|+|.++++.... ...+++..++.|+.||+.||+|||+++||||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 998764 568999999999999999975322 245899999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 003935 657 NCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 733 (785)
Q Consensus 657 NILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~ 733 (785)
||||++++.+||+|||+|+.+..... .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+....
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654322 2234578999999999999999999999999999999998 89999988766
Q ss_pred HHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 734 RVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 734 ~~v~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
+.+......+.++..|+ ..+.+|+..||+ ||.+|||+.+|+++|.++.
T Consensus 295 ~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 295 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 66666667777777664 369999999999 9999999999999998874
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=448.90 Aligned_cols=243 Identities=25% Similarity=0.400 Sum_probs=217.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
+.|.+.++||+|+||+||+|.+ +|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+++.+|+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5699999999999999999988 58899999997654432 3568899999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
||+||+|.+++.. ..+++.+++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+.+.......
T Consensus 152 y~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 227 (346)
T 4fih_A 152 FLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 227 (346)
T ss_dssp CCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred CCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcc
Confidence 9999999999862 469999999999999999999999999999999999999999999999999999876655555
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHH
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRLIAD 759 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-----~~~L~~LI~~ 759 (785)
...+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+....+..... +.++ ...+.+||.+
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCGGGSCHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccccCCHHHHHHHHH
Confidence 678999999999999999999999999999999999999999999988888877765432 2221 3468999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003935 760 CWA-EPQERPSCEEILSR 776 (785)
Q Consensus 760 CL~-DP~kRPS~~EIL~~ 776 (785)
||. ||.+|||+.|+++|
T Consensus 307 ~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 307 LLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HSCSSTTTSCCHHHHTTC
T ss_pred HcCCChhHCcCHHHHhcC
Confidence 999 99999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-52 Score=445.29 Aligned_cols=247 Identities=21% Similarity=0.346 Sum_probs=218.6
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
.++|.+++.||+|+||+||+|.+ +|+.||||++.+... .....+.+.+|+++|+.++|||||++++++++++.+|+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999988 588999999976543 223357789999999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC-
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP- 681 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~- 681 (785)
||||+||+|.+++. ..+.+++..++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+.+....
T Consensus 111 mEy~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999999997 34579999999999999999999999999999999999999999999999999999875432
Q ss_pred -CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHH
Q 003935 682 -MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIAD 759 (785)
Q Consensus 682 -~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~ 759 (785)
....+.+||+.|+|||++.+..|+.++|||||||+||+|+||+.||.+.+..++...+.......+ .-...+.+||.+
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 267 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHH
Confidence 234567999999999999999999999999999999999999999999999998888877654322 113468999999
Q ss_pred hhh-CCCCCCCHHHHHH
Q 003935 760 CWA-EPQERPSCEEILS 775 (785)
Q Consensus 760 CL~-DP~kRPS~~EIL~ 775 (785)
||. ||.+|||++|++.
T Consensus 268 lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 268 LLVLDATKRLGCEEMEG 284 (311)
T ss_dssp HSCSSGGGSTTSGGGTC
T ss_pred HccCCHhHCcChHHHcC
Confidence 999 9999999998643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=434.79 Aligned_cols=242 Identities=27% Similarity=0.470 Sum_probs=208.7
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC----CCceeEE
Q 003935 529 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK----PPRLSMI 602 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d----~~~l~LV 602 (785)
|++.++||+|+||+||+|.+ ++..||+|++..........+.|.+|+.+|+.++|||||+++++|.+ ...+|+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 46788999999999999988 47899999998877777778899999999999999999999999864 3568999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc--cccccCCCCcEEEc-CCCeEEEEecCccccccC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVN-KHWTVKICDFGLSRIITD 679 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~g--IIHrDLKpsNILLd-~~g~VKL~DFGLA~~l~~ 679 (785)
||||+||+|.+++.. ...+++..++.|+.||+.||+|||++| ||||||||+||||+ .++.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999973 457999999999999999999999998 99999999999997 479999999999986543
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CC---ChHHHH
Q 003935 680 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IP---EGPLGR 755 (785)
Q Consensus 680 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip---~~~L~~ 755 (785)
. .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+......+......+..+. .+ ...+.+
T Consensus 185 ~--~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (290)
T 3fpq_A 185 S--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261 (290)
T ss_dssp T--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred C--ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHH
Confidence 2 3346789999999999875 599999999999999999999999987666555555554443322 22 236899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHH
Q 003935 756 LIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 756 LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
||.+||. ||.+|||+.++++|
T Consensus 262 li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 262 IIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999 99999999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-52 Score=445.00 Aligned_cols=250 Identities=25% Similarity=0.350 Sum_probs=212.3
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE-----CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
++.++|.+++.||+|+||+||+|.+ .++.||||++.+..........+.+|+.+|+.++|||||++++++.+++.
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 3457899999999999999999976 36789999997665444444568899999999999999999999999999
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
+|+|||||+||+|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||++.++++||+|||+|+...
T Consensus 101 ~~ivmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEEECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEEEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999999973 4579999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHH
Q 003935 679 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLI 757 (785)
Q Consensus 679 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI 757 (785)
.........+||+.|+|||++.+..|+.++|||||||+||||+||+.||.+.+..++...+.......+ .-+..+.+||
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 257 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL 257 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 554455678999999999999999999999999999999999999999999999998888876543322 1234699999
Q ss_pred HHhhh-CCCCCCC-----HHHHHHH
Q 003935 758 ADCWA-EPQERPS-----CEEILSR 776 (785)
Q Consensus 758 ~~CL~-DP~kRPS-----~~EIL~~ 776 (785)
.+||. ||.+||| ++|+++|
T Consensus 258 ~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 258 RMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHcccCHHHCCCCCcCCHHHHHcC
Confidence 99999 9999998 5788765
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=442.89 Aligned_cols=249 Identities=27% Similarity=0.397 Sum_probs=215.0
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
....+.|.+.++||+|+||+||+|.+ +|+.||||++..+... .+|+.+++.++|||||++++++.+++.+|
T Consensus 54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34567899999999999999999988 4889999999765432 36999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC-eEEEEecCccccccC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITD 679 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g-~VKL~DFGLA~~l~~ 679 (785)
+|||||+||+|.++++. .+.+++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+..
T Consensus 127 ivmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp EEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred EEEeccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 99999999999999973 45799999999999999999999999999999999999999887 699999999987754
Q ss_pred CCC-----CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCC---C
Q 003935 680 SPM-----RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIP---E 750 (785)
Q Consensus 680 ~~~-----~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~-~ip---~ 750 (785)
... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+...+...+....... .++ +
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s 283 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA 283 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSC
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCC
Confidence 321 1234689999999999999999999999999999999999999999887777777777655332 233 3
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 751 GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 751 ~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
..+.+||.+||. ||.+|||+.||+++|....
T Consensus 284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 468999999999 9999999999999987653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=427.50 Aligned_cols=246 Identities=30% Similarity=0.458 Sum_probs=200.7
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
.++|++.+.||+|+||+||+|.+ +|+.||||++.+..... ...+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 46899999999999999999987 58999999997665432 3356789999999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
|||+ +|+|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+......
T Consensus 92 mEy~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 92 IEYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp EECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EeCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 9999 678998886 34579999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHh
Q 003935 683 RDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADC 760 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~C 760 (785)
...+.+||+.|+|||++.+..| +.++|||||||++|+|+||+.||.+.+.......+.......+ .-+..+.+|+.+|
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 246 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM 246 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 3346789999999999998876 5799999999999999999999999988888887776544322 1234689999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003935 761 WA-EPQERPSCEEILSR 776 (785)
Q Consensus 761 L~-DP~kRPS~~EIL~~ 776 (785)
|. ||.+|||++|+++|
T Consensus 247 L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 247 LIVNPLNRISIHEIMQD 263 (275)
T ss_dssp SCSSGGGSCCHHHHHHC
T ss_pred ccCChhHCcCHHHHHcC
Confidence 99 99999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=450.79 Aligned_cols=244 Identities=25% Similarity=0.397 Sum_probs=217.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
+.|.+.++||+|+||+||+|.+ +|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+.+.+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 5699999999999999999998 58899999997654332 3568899999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
||+||+|.+++.. ..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.......
T Consensus 229 y~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 304 (423)
T 4fie_A 229 FLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 304 (423)
T ss_dssp CCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred CCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence 9999999999862 369999999999999999999999999999999999999999999999999999876655555
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCC---ChHHHHHHHHh
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIP---EGPLGRLIADC 760 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~-~~ip---~~~L~~LI~~C 760 (785)
...+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+...... ...+ ...+.+||.+|
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 384 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 384 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHH
Confidence 6789999999999999999999999999999999999999999999988888877654321 1111 34699999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003935 761 WA-EPQERPSCEEILSR 776 (785)
Q Consensus 761 L~-DP~kRPS~~EIL~~ 776 (785)
|. ||.+|||+.|+|+|
T Consensus 385 L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 385 LVRDPAQRATAAELLKH 401 (423)
T ss_dssp SCSSTTTSCCHHHHTTC
T ss_pred cCCChhHCcCHHHHhcC
Confidence 99 99999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=420.35 Aligned_cols=249 Identities=29% Similarity=0.477 Sum_probs=200.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC----ceeEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP----RLSMI 602 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~----~l~LV 602 (785)
.+|.+.++||+|+||+||+|+++|+.||||++.... .....+..|+..+..++|||||+++++|.+++ .+|+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 368899999999999999999999999999986432 11122334566667889999999999997654 47999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc--------ccccccCCCCcEEEcCCCeEEEEecCcc
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM--------KIVHRDLKSANCLVNKHWTVKICDFGLS 674 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~--------gIIHrDLKpsNILLd~~g~VKL~DFGLA 674 (785)
||||++|+|.++++. ..+++..+.+++.|++.||+|||++ +||||||||+||||+.++++||+|||+|
T Consensus 80 ~Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999963 3689999999999999999999987 8999999999999999999999999999
Q ss_pred ccccCCCC----CCCCCCCCCcccCccccccC------CCCchhhHHHHHHHHHHHHhCCCCCC----------CC----
Q 003935 675 RIITDSPM----RDSSSAGTPEWMAPELIRNE------PFTEKCDIFSLGVIMWELCTLNRPWE----------GV---- 730 (785)
Q Consensus 675 ~~l~~~~~----~~~~~~GT~~Y~APEvl~~~------~~s~ksDVWSLGvILyELLTG~~PF~----------~~---- 730 (785)
+....... .....+||+.|+|||++.+. .++.++|||||||+||||+||..||. +.
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 87754322 12345799999999999764 36789999999999999999976543 22
Q ss_pred -ChHHHHHHHHhcCCCCCCCCh--------HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 731 -LPERVVYAVANEGSRLEIPEG--------PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 731 -~~~~~v~~i~~~~~~~~ip~~--------~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
........+.....++.+|.. .+.+|+.+||. ||.+|||+.+|++.|+++..
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 223444445556666666642 47789999999 99999999999999998753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=419.22 Aligned_cols=245 Identities=24% Similarity=0.362 Sum_probs=192.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC-------
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------- 597 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------- 597 (785)
++|.+.+.||+|+||+||+|.+ +|+.||||++.... .....+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 4689999999999999999988 58899999987654 3444578999999999999999999999986544
Q ss_pred -----ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecC
Q 003935 598 -----RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 672 (785)
Q Consensus 598 -----~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFG 672 (785)
.+|+|||||++|+|.+++.........++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 379999999999999999754444456677889999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC------------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHH
Q 003935 673 LSRIITDSPM------------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAV 739 (785)
Q Consensus 673 LA~~l~~~~~------------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~-~~v~~i 739 (785)
+|+.+..... .....+||+.|||||++.+..|+.++|||||||+||||++ ||.+.... .....+
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~ 240 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV 240 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHH
Confidence 9987654321 1234579999999999999999999999999999999996 88654322 222222
Q ss_pred HhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 740 ANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 740 ~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.. ...++.. ...+.+|+.+||+ ||.+|||+.++++|
T Consensus 241 ~~-~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 241 RN-LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HT-TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hc-CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 22 2222111 1246789999999 99999999999985
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=424.37 Aligned_cols=246 Identities=25% Similarity=0.344 Sum_probs=211.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC------CCc
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK------PPR 598 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d------~~~ 598 (785)
++|.+++.||+|+||+||+|.+ +|+.||||++..........+.+.+|+.+|+.++|||||++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999988 58999999998776666677889999999999999999999998653 467
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
+|+|||||. |+|.+++. ..+.+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 899999996 57888886 45689999999999999999999999999999999999999999999999999998764
Q ss_pred CC----CCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------
Q 003935 679 DS----PMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE------ 747 (785)
Q Consensus 679 ~~----~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~------ 747 (785)
.. .......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.+....+..+......+.
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 32 2233467899999999998875 569999999999999999999999999988888777754322111
Q ss_pred ------------------C--------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 ------------------I--------PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 ------------------i--------p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
. .+..+.+||.+||. ||.+|||+.|+|+|
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 12357889999999 99999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=426.24 Aligned_cols=355 Identities=27% Similarity=0.464 Sum_probs=277.7
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCcccccccccccccccccCCCCCCCCCC
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYG 480 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~~~~sq~~~SlPSsp~~~~ 480 (785)
.+.|+|.++++.|+..++.+|+|++|.|+ +.++.|.+|+...++..++..+||.+.+..... -.+. +.. .
T Consensus 74 ~g~i~r~~ae~~L~~~~~~~G~FLvR~s~----~~~g~y~lsv~~~~~~~~~~v~H~~I~~~~~g~-~~i~-~~~--~-- 143 (454)
T 1qcf_A 74 FKGISRKDAERQLLAPGNMLGSFMIRDSE----TTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGG-FYIS-PRS--T-- 143 (454)
T ss_dssp ETTCCHHHHHHHHHSTTCCTTCEEEEECS----SSTTSEEEEEEEEETTTEEEEEEEEEEECTTSC-EESS-SSS--C--
T ss_pred ccccchhhhhhhhhcCCCCCceEEEEECc----CCCCeEEEEEEecccCCCCceEEEEEEEcCCCc-EEEe-Ccc--c--
Confidence 56789999999999999999999999998 677889999887666667788899887632110 0000 000 0
Q ss_pred CCCCCCCCCCCCCCCchhhhhhhhh-------ccCCcccCC--CccccccccccCCCeeEeeEEeeeCcEEEEEEEEC-C
Q 003935 481 SHGSERGGSSGYMANSEFVSTWNKV-------LESPMFQNK--PLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-G 550 (785)
Q Consensus 481 s~sS~~~~ssg~~~~s~~~s~~~~i-------l~S~~~~~~--p~~~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~-g 550 (785)
+..-...+..+.+. +..+..... .....+.|++..++|.+.+.||+|+||+||+|.++ +
T Consensus 144 -----------F~sl~eLv~~y~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~ 212 (454)
T 1qcf_A 144 -----------FSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKH 212 (454)
T ss_dssp -----------BSSHHHHHHHHTSSCTTSSSCCCSBCCCCCCCCCCCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTT
T ss_pred -----------cCCHHHHHHHHHhccCCccccccccccccCccccccccceeechHHeEEEEEcccCCceEEEEEEECCc
Confidence 00001111111100 001111111 12335778999999999999999999999999984 7
Q ss_pred eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccchhhHHHHhhcccccchHHHHH
Q 003935 551 TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL 630 (785)
Q Consensus 551 ~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l 630 (785)
..||||++..... ..+.|.+|+.+|+.++||||+++++++. .+.+++||||+.+|+|.+++... ....+++..++
T Consensus 213 ~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~ 287 (454)
T 1qcf_A 213 TKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLI 287 (454)
T ss_dssp EEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSH-HHHTCCHHHHH
T ss_pred cEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhc-cCCCCCHHHHH
Confidence 8899999976543 2578999999999999999999999987 55689999999999999999732 23468889999
Q ss_pred HHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC-CCCCCCCCcccCccccccCCCCchhh
Q 003935 631 KMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR-DSSSAGTPEWMAPELIRNEPFTEKCD 709 (785)
Q Consensus 631 ~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~-~~~~~GT~~Y~APEvl~~~~~s~ksD 709 (785)
.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .....+++.|+|||++....++.++|
T Consensus 288 ~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 367 (454)
T 1qcf_A 288 DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367 (454)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHH
Confidence 99999999999999999999999999999999999999999999876542211 22345678999999999999999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 710 IFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 710 VWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
||||||+||||+| |+.||.+....+....+.. +.+.+.| +..+.+|+.+||. ||.+|||+.+|++.|+++..
T Consensus 368 vwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 368 VWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred HHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 9999999999999 9999999988887777654 4444444 3469999999999 99999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=424.74 Aligned_cols=356 Identities=28% Similarity=0.485 Sum_probs=273.1
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCcccccccccccccccccCCCCCCCCCC
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYG 480 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~~~~sq~~~SlPSsp~~~~ 480 (785)
.+.|.|.++++.|+..++.+|+|++|.|+ +.++.|.+|+...+...+++.+||.+.+.... .+-+.. ...+
T Consensus 69 ~g~~~r~~ae~~L~~~~~~~G~FLvR~s~----~~~g~y~lsv~~~~~~~~~~v~h~~I~~~~~g---~~~~~~-~~~F- 139 (452)
T 1fmk_A 69 FGKITRRESERLLLNAENPRGTFLVRESE----TTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSG---GFYITS-RTQF- 139 (452)
T ss_dssp EETCCHHHHHHHHTCTTSCTTEEEEEECS----SSTTCEEEEEEEEETTTEEEEEEEEEEECTTS---CEESST-TSEE-
T ss_pred cCCccHHHHHHHhccCCCCCceEEEEeCC----CCCCceEEEEEeeccCCCCcEEEEEEEEcCCC---CEEEec-Cccc-
Confidence 46789999999999999999999999998 56788999998766666778899988874211 010000 0000
Q ss_pred CCCCCCCCCCCCCCCchhhhhhhhh-------ccCCccc---CCCccccccccccCCCeeEeeEEeeeCcEEEEEEEEC-
Q 003935 481 SHGSERGGSSGYMANSEFVSTWNKV-------LESPMFQ---NKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWN- 549 (785)
Q Consensus 481 s~sS~~~~ssg~~~~s~~~s~~~~i-------l~S~~~~---~~p~~~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~- 549 (785)
.+-...+..+... +..+... .......+.|++..++|.+.+.||+|+||+||+|.++
T Consensus 140 ------------~Sl~~Li~~y~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~ 207 (452)
T 1fmk_A 140 ------------NSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG 207 (452)
T ss_dssp ------------SSHHHHHHHHTTCCTTSSSCCCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETT
T ss_pred ------------CCHHHHHHHhhhccccchhhccccccccccccCCCCccccccChhHceeeeeecCCCCeEEEEEEECC
Confidence 0001111111100 0000000 1112235778999999999999999999999999985
Q ss_pred CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccchhhHHHHhhcccccchHHHH
Q 003935 550 GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 629 (785)
Q Consensus 550 g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~ 629 (785)
+..||||++...... .+.|.+|+.+|+.++||||+++++++.+ +.+++||||+++|+|.+++... ....+++..+
T Consensus 208 ~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~-~~~~~~~~~~ 282 (452)
T 1fmk_A 208 TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQL 282 (452)
T ss_dssp TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH-HHTTCCHHHH
T ss_pred CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhc-CCCCCCHHHH
Confidence 467999998765443 4678999999999999999999999877 6689999999999999999632 2346899999
Q ss_pred HHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC-CCCCCCCCcccCccccccCCCCchh
Q 003935 630 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR-DSSSAGTPEWMAPELIRNEPFTEKC 708 (785)
Q Consensus 630 l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~-~~~~~GT~~Y~APEvl~~~~~s~ks 708 (785)
+.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .....+++.|+|||++.+..++.++
T Consensus 283 ~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~s 362 (452)
T 1fmk_A 283 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362 (452)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccc
Confidence 999999999999999999999999999999999999999999999876543222 2234577899999999999999999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003935 709 DIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 783 (785)
Q Consensus 709 DVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~s 783 (785)
|||||||++|||++ |+.||.+....+....+.. +.+...| +..+.+|+.+||. ||.+|||+.+|++.|+++..+
T Consensus 363 DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred cHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 99999999999999 9999999988887776654 4444444 3468999999999 999999999999999987543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=408.84 Aligned_cols=345 Identities=24% Similarity=0.442 Sum_probs=261.4
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCcccccccccccccccccCCCCCCCCCC
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYG 480 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~~~~sq~~~SlPSsp~~~~ 480 (785)
.+.|.|.++++.|+ .+|+|++|.|++ .. .+.+|+.. .++.+||.+.+... ...+
T Consensus 17 hg~i~r~~a~~lL~----~~G~flvR~s~~----~~-~~~lsv~~-----~~~~~h~~i~~~~~----~~~~-------- 70 (377)
T 3cbl_A 17 HGAIPRAEVAELLV----HSGDFLVRESQG----KQ-EYVLSVLW-----DGLPRHFIIQSLDN----LYRL-------- 70 (377)
T ss_dssp CTTCCHHHHHHHCC----STTEEEEEECC------C-CEEEEC----------CCEEEC----C----CCCC--------
T ss_pred CCCCCHHHHHHHHh----cCCCEEEEEeCC----CC-cEEEEEEE-----CCCccchhhccccc----eEEe--------
Confidence 46788999999887 479999999973 23 67778875 24678888765311 0000
Q ss_pred CCCCCCCCCCCCCCCchhhhhhhhhccC----CcccCCCccccccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEE
Q 003935 481 SHGSERGGSSGYMANSEFVSTWNKVLES----PMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVA 554 (785)
Q Consensus 481 s~sS~~~~ssg~~~~s~~~s~~~~il~S----~~~~~~p~~~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VA 554 (785)
....+..-...+..+...... ...........+.|.++.++|.+.+.||+|+||+||+|.+ +++.||
T Consensus 71 -------~~~~F~sl~~LI~~y~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va 143 (377)
T 3cbl_A 71 -------EGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVA 143 (377)
T ss_dssp -----------CCSHHHHHHHHHHHTCCC-----CCCCEECCCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEE
T ss_pred -------cceeccchHHHHHHHhhccCCcccccCcccccCccccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEE
Confidence 000111122222222211110 0111112234567889999999999999999999999998 488999
Q ss_pred EEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHH
Q 003935 555 IKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 634 (785)
Q Consensus 555 VKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~ 634 (785)
||++... ......+.|.+|+.+++.++||||+++++++...+.+++||||+++|+|.+++.. ....+++..++.++.
T Consensus 144 vK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~ 220 (377)
T 3cbl_A 144 VKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVG 220 (377)
T ss_dssp EEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHH
T ss_pred EEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHH
Confidence 9998644 3344556789999999999999999999999999999999999999999999973 234689999999999
Q ss_pred HHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC--CCCCCCCcccCccccccCCCCchhhHHH
Q 003935 635 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIRNEPFTEKCDIFS 712 (785)
Q Consensus 635 QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDVWS 712 (785)
||+.||+|||++||+||||||+|||++.++.+||+|||+++......... ....+++.|+|||++.+..++.++||||
T Consensus 221 qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 300 (377)
T 3cbl_A 221 DAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWS 300 (377)
T ss_dssp HHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHH
T ss_pred HHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHH
Confidence 99999999999999999999999999999999999999998654432111 1223567899999999989999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 713 LGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 713 LGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
|||++|||++ |..||.+.........+.. +.+...| +..+.+|+.+||. ||.+|||+.+|++.|+++..
T Consensus 301 lG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 301 FGILLWETFSLGASPYPNLSNQQTREFVEK-GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp HHHHHHHHHTTSCCSSTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 9999999998 9999999888777665543 4444444 3468999999999 99999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=393.36 Aligned_cols=266 Identities=47% Similarity=0.898 Sum_probs=224.8
Q ss_pred cccccccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC
Q 003935 517 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 596 (785)
Q Consensus 517 ~~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 596 (785)
.....+.+..++|.+.+.||+|+||+||+|.++|+.||||++..........+.|.+|+.++++++||||+++++++.+.
T Consensus 27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp -----CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CCcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 34567788889999999999999999999999999999999988777777788999999999999999999999999999
Q ss_pred CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc--cccccCCCCcEEEcCCCeEEEEecCcc
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLS 674 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~g--IIHrDLKpsNILLd~~g~VKL~DFGLA 674 (785)
..+++||||+++|+|.+++........+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 999999999999999999974433345999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC---h
Q 003935 675 RIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---G 751 (785)
Q Consensus 675 ~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~---~ 751 (785)
+.............||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+........++. .
T Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (309)
T 3p86_A 187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence 8765543344567899999999999999999999999999999999999999999998888877766665555553 4
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 752 PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 752 ~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
.+.+|+.+||. ||.+|||+.++++.|+.+..
T Consensus 267 ~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 69999999999 99999999999999998764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=428.62 Aligned_cols=356 Identities=28% Similarity=0.474 Sum_probs=278.3
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCcccccccccccccccccCCCCCCCCCC
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYG 480 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~~~~sq~~~SlPSsp~~~~ 480 (785)
.+.|.|.++++.|+..++.+|+|++|.|+ +.++.|.+++...+...+++.+||.+.+..... -.+.. ..
T Consensus 152 ~g~i~r~~ae~~L~~~~~~~G~FLvR~S~----~~~g~y~lsv~~~~~~~~~~v~h~~I~~~~~g~-~~i~~---~~--- 220 (535)
T 2h8h_A 152 FGKITRRESERLLLNAENPRGTFLVRESE----TTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGG-FYITS---RT--- 220 (535)
T ss_dssp CCSCCHHHHHHHHTCTTCCTTEEEEEECS----SSTTCEEEEEEEEETTTEEEEEEEEEBC-CCSC-EEEET---TE---
T ss_pred ccccCHHHHHHHhccCCCCCCeEEEEecC----CCCCcEEEEEEeeccCCCCceEEEEEEEcCCCc-EEeec---cc---
Confidence 56789999999999999999999999998 567889999987776667788999888742110 00000 00
Q ss_pred CCCCCCCCCCCCCCCchhhhhhhhhcc-------CCccc---CCCccccccccccCCCeeEeeEEeeeCcEEEEEEEEC-
Q 003935 481 SHGSERGGSSGYMANSEFVSTWNKVLE-------SPMFQ---NKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWN- 549 (785)
Q Consensus 481 s~sS~~~~ssg~~~~s~~~s~~~~il~-------S~~~~---~~p~~~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~- 549 (785)
.+..-...+..+..... .+... ....+..+.|++..++|.+.++||+|+||+||+|.+.
T Consensus 221 ----------~F~SL~eLv~~y~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~ 290 (535)
T 2h8h_A 221 ----------QFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG 290 (535)
T ss_dssp ----------EESSHHHHHHHHHHCCTTSSSCCCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETT
T ss_pred ----------cccChHHhheeeccccCccccccccccccccccccccCccceecchhhhhhheecccCCCeEEEEEEECC
Confidence 00001111111111000 00000 1112335789999999999999999999999999985
Q ss_pred CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccchhhHHHHhhcccccchHHHH
Q 003935 550 GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 629 (785)
Q Consensus 550 g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~ 629 (785)
+..||||++...... .+.|.+|+.+|+.++||||+++++++.+ +.+++||||+.+|+|.+++... ....+++..+
T Consensus 291 ~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~ 365 (535)
T 2h8h_A 291 TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQL 365 (535)
T ss_dssp TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHH-HHTTCCHHHH
T ss_pred CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhc-CCCCCCHHHH
Confidence 468999999765443 4679999999999999999999999877 6799999999999999999632 2346899999
Q ss_pred HHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC-CCCCCCCCCcccCccccccCCCCchh
Q 003935 630 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKC 708 (785)
Q Consensus 630 l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ks 708 (785)
+.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ......++..|+|||++.+..++.++
T Consensus 366 ~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~s 445 (535)
T 2h8h_A 366 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445 (535)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchh
Confidence 99999999999999999999999999999999999999999999987643211 12234567899999999999999999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003935 709 DIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 783 (785)
Q Consensus 709 DVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~s 783 (785)
|||||||+||||++ |+.||.+....+....+.. +.+...+ ...+.+||.+||. ||.+|||+.+|++.|+++..+
T Consensus 446 DvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp HHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 99999999999999 8999999988887776654 4444444 3469999999999 999999999999999987543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=408.76 Aligned_cols=344 Identities=23% Similarity=0.444 Sum_probs=263.2
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCcccccccccccccccccCCCCCCCCCC
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYG 480 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~~~~sq~~~SlPSsp~~~~ 480 (785)
.+.|.|.++++.|+. ..+|+|++|.|+ ...+.+.+++.. +++.+||.+..... ...+... ..+
T Consensus 84 hg~i~r~~ae~~L~~--~~~G~FlvR~S~----~~~g~~~Lsv~~-----~~~v~H~~I~~~~~----~~~i~~~-~~F- 146 (450)
T 1k9a_A 84 HGKITREQAERLLYP--PETGLFLVREST----NYPGDYTLCVSC-----EGKVEHYRIMYHAS----KLSIDEE-VYF- 146 (450)
T ss_dssp CTTCCHHHHHHHTCS--CCTTEEEEEECS----SSTTSEEEEEEC-----SSSEEEEEEEEETT----EEESSSS-SCB-
T ss_pred ccCcCHHHhhhhhcc--CCCceEEEEecC----CCCCceEEEEEe-----CCeeeEEEEEecCC----ceEeccc-ccc-
Confidence 567899999999964 345999999998 556677777744 55677887743211 1111000 000
Q ss_pred CCCCCCCCCCCCCCCchhhhhhhhhcc-------CCcccCCC-----ccccccccccCCCeeEeeEEeeeCcEEEEEEEE
Q 003935 481 SHGSERGGSSGYMANSEFVSTWNKVLE-------SPMFQNKP-----LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW 548 (785)
Q Consensus 481 s~sS~~~~ssg~~~~s~~~s~~~~il~-------S~~~~~~p-----~~~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~ 548 (785)
..-..++..+..... .+.....+ .+....|.+..++|.+.+.||+|+||+||+|.+
T Consensus 147 ------------~sl~eLv~~y~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~ 214 (450)
T 1k9a_A 147 ------------ENLMQLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY 214 (450)
T ss_dssp ------------SSHHHHHHHHHHCCTTSSSCCCEECCCTTCEEHHHHHHHTTCBCCGGGEEEEEEEEECSSEEEEEEEE
T ss_pred ------------ccHHHHHhhhcccccchhhhccccccccCcccchhhhcccccccChHHeEEEeeecCcCCeeEEEEEe
Confidence 001111111111000 00000001 012467889999999999999999999999999
Q ss_pred CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC-ceeEEEEEcccchhhHHHHhhcccccchHH
Q 003935 549 NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWR 627 (785)
Q Consensus 549 ~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~-~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~ 627 (785)
+++.||||++.... ..+.|.+|+.+|+.++||||+++++++.+.. .+++||||+++|+|.+++... ....+++.
T Consensus 215 ~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~-~~~~~~~~ 289 (450)
T 1k9a_A 215 RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGD 289 (450)
T ss_dssp TTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHH-CTTTCCHH
T ss_pred cCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhc-CCCCCCHH
Confidence 99999999987543 2467999999999999999999999986654 799999999999999999743 23357899
Q ss_pred HHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCch
Q 003935 628 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 707 (785)
Q Consensus 628 ~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~k 707 (785)
.++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .....+++.|+|||++.+..++.+
T Consensus 290 ~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~ 366 (450)
T 1k9a_A 290 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTK 366 (450)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCCTTTSCHHHHHSSCCCHH
T ss_pred HHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---ccCCCCCcceeCHHHhcCCCCCcH
Confidence 99999999999999999999999999999999999999999999999865332 223467889999999999999999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 708 CDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 708 sDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
+|||||||+||||++ |+.||.+....+....+.. +.+...|. ..+.+||..||. ||.+|||+.+|++.|+++..
T Consensus 367 sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 367 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp HHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 999999999999998 9999998887777666543 44555543 469999999999 99999999999999998754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=424.83 Aligned_cols=246 Identities=25% Similarity=0.412 Sum_probs=217.5
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
.++|.+++.||+|+||+||+|.+ +|+.||+|++.... ....+.+.+|+.+|+.++|||||+++++|.+...+|+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 46899999999999999999988 58899999987644 334577889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC--CeEEEEecCccccccCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH--WTVKICDFGLSRIITDSP 681 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~--g~VKL~DFGLA~~l~~~~ 681 (785)
|||.||+|.+++.. ....+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 234 E~~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 234 EFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp ECCCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred eecCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999998852 34579999999999999999999999999999999999999854 899999999999875432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 756 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-----~~~L~~L 756 (785)
.....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+....+.........+ ...+.+|
T Consensus 312 -~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dl 390 (573)
T 3uto_A 312 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390 (573)
T ss_dssp -EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred -ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 2345689999999999999999999999999999999999999999999999888887655433221 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003935 757 IADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~ 776 (785)
|.+||. ||.+|||+.|+|+|
T Consensus 391 i~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 391 IRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999 99999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=400.08 Aligned_cols=240 Identities=23% Similarity=0.326 Sum_probs=196.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE-----CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCcee
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~ 600 (785)
+.|.+.++||+|+||+||+|.+ .++.||||++..... ...+.+|+++|+.+ +|||||++++++.+.+.+|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 5799999999999999999976 267899999865432 35678999999998 6999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC-CeEEEEecCccccccC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIITD 679 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~-g~VKL~DFGLA~~l~~ 679 (785)
+||||+++|+|.+++. .+++.+++.++.||+.||+|||++|||||||||+|||++.+ +++||+|||+|+...+
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999999999884 48999999999999999999999999999999999999876 7999999999986543
Q ss_pred CCC----------------------------CCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003935 680 SPM----------------------------RDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGV 730 (785)
Q Consensus 680 ~~~----------------------------~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~ 730 (785)
... .....+||+.|+|||++.+. .|+.++||||+||++|||+||+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 211 12345799999999999875 4899999999999999999999999543
Q ss_pred -ChHHHHHHHHhcC------------------------------------C-------------------CCCCCChHHH
Q 003935 731 -LPERVVYAVANEG------------------------------------S-------------------RLEIPEGPLG 754 (785)
Q Consensus 731 -~~~~~v~~i~~~~------------------------------------~-------------------~~~ip~~~L~ 754 (785)
+....+..+.... . .....+..+.
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 3333333322100 0 0001123577
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003935 755 RLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 755 ~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+|+.+||. ||.+|||++|+|+|
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHCcCChhHCcCHHHHhcC
Confidence 89999999 99999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=416.12 Aligned_cols=348 Identities=27% Similarity=0.546 Sum_probs=267.3
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCcccccccccccccccccCCCCCCCCCC
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYG 480 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~~~~sq~~~SlPSsp~~~~ 480 (785)
.+.|.|.+++..|.. +.+|+|++|.|+ ..++.+.+|+.. +++.+||.+.+..... +-.... ..
T Consensus 109 hg~i~r~~ae~ll~~--~~~G~fLvR~s~----~~~~~~~lsv~~-----~~~v~h~~I~~~~~g~---~~~~~~-~~-- 171 (495)
T 1opk_A 109 HGPVSRNAAEYLLSS--GINGSFLVRESE----SSPGQRSISLRY-----EGRVYHYRINTASDGK---LYVSSE-SR-- 171 (495)
T ss_dssp EEECCHHHHHHHGGG--CCTTEEEEEECS----SSTTCEEEEEEE-----TTEEEEEECEECTTSC---EESSTT-SC--
T ss_pred ccCCCHHHHHHHhhC--CCCceEEEEeCC----CCCCceEEEEee-----CCeEEEEEEEecCCCc---eEeccC-cc--
Confidence 356788899876643 678999999998 556778888875 4578888876531110 000000 00
Q ss_pred CCCCCCCCCCCCCCCchhhhhhhhhcc-------CCcc-cCCC-----ccccccccccCCCeeEeeEEeeeCcEEEEEEE
Q 003935 481 SHGSERGGSSGYMANSEFVSTWNKVLE-------SPMF-QNKP-----LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGI 547 (785)
Q Consensus 481 s~sS~~~~ssg~~~~s~~~s~~~~il~-------S~~~-~~~p-----~~~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~ 547 (785)
+..-.+.+..+..... .+.. ...+ ...++.|++..++|.+.+.||+|+||+||+|.
T Consensus 172 -----------F~sl~eLv~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~ 240 (495)
T 1opk_A 172 -----------FNTLAELVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGV 240 (495)
T ss_dssp -----------BSSHHHHHHHHTTCCTTSSSCCCEECCCCSCCCCSSSCSSSSCCBCCGGGEEEEEESGGGTTSSEEEEE
T ss_pred -----------chhHHHHhhhhcccccccchhccccccccccccccccCccccccccCHHHceeeeEecCCCCeEEEEEE
Confidence 0000111111110000 0000 0000 11356789999999999999999999999999
Q ss_pred EC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcccchhhHHHHhhcccccch
Q 003935 548 WN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLS 625 (785)
Q Consensus 548 ~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls 625 (785)
+. +..||||++...... .+.|.+|+.+|+.++||||++++++|.+...+++||||+++|+|.+++... ....++
T Consensus 241 ~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~~~~ 316 (495)
T 1opk_A 241 WKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVS 316 (495)
T ss_dssp EGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHS-CTTTSC
T ss_pred EcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhc-CcCCCC
Confidence 84 789999998755433 577999999999999999999999999999999999999999999999743 345689
Q ss_pred HHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC-CCCCCCCCcccCccccccCCC
Q 003935 626 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR-DSSSAGTPEWMAPELIRNEPF 704 (785)
Q Consensus 626 ~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~-~~~~~GT~~Y~APEvl~~~~~ 704 (785)
+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .....+++.|+|||++.+..+
T Consensus 317 ~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 396 (495)
T 1opk_A 317 AVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396 (495)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCC
Confidence 9999999999999999999999999999999999999999999999999876543222 234456789999999999999
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003935 705 TEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLD 779 (785)
Q Consensus 705 s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~ 779 (785)
+.++|||||||+||||+| |..||.+.....+...+ ..+.+...+ +..+.+||.+||+ ||.+|||+.+|++.|++
T Consensus 397 ~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 475 (495)
T 1opk_A 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 475 (495)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 999999999999999999 99999988877666554 344444444 3469999999999 99999999999999988
Q ss_pred hh
Q 003935 780 CE 781 (785)
Q Consensus 780 l~ 781 (785)
+.
T Consensus 476 ~~ 477 (495)
T 1opk_A 476 MF 477 (495)
T ss_dssp SC
T ss_pred HH
Confidence 64
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=422.49 Aligned_cols=248 Identities=24% Similarity=0.315 Sum_probs=206.0
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh----HHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA----ENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~----~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
+..++|.+++.||+|+||+||+|.+ +|+.||||++.+..... ........++.+++.++|||||+++++|.+.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 4568999999999999999999988 58899999997654321 11222334466777889999999999999999
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+|+|||||+||+|.+++.. .+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+
T Consensus 266 ~lylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999999973 457999999999999999999999999999999999999999999999999999887
Q ss_pred cCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhcCCCCC-CCChH
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGV---LPERVVYAVANEGSRLE-IPEGP 752 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~---~~~~~v~~i~~~~~~~~-ip~~~ 752 (785)
... ...+.+||+.|+|||++.. ..|+.++|||||||+||||++|+.||.+. ....+...+.......+ .-...
T Consensus 343 ~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~ 420 (689)
T 3v5w_A 343 SKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 420 (689)
T ss_dssp SSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred CCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHH
Confidence 554 3346799999999999964 57999999999999999999999999754 23334444443332211 12346
Q ss_pred HHHHHHHhhh-CCCCCCC-----HHHHHHH
Q 003935 753 LGRLIADCWA-EPQERPS-----CEEILSR 776 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS-----~~EIL~~ 776 (785)
+.+||.+||. ||.+|++ +++|++|
T Consensus 421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred HHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 9999999999 9999998 7888875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=417.68 Aligned_cols=260 Identities=26% Similarity=0.514 Sum_probs=218.4
Q ss_pred ccccccCCCeeEe-eEEeeeCcEEEEEEEE----CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEecccc
Q 003935 520 EEWNIDFSELTVG-TRVGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 594 (785)
Q Consensus 520 ee~~i~~s~y~i~-k~LG~G~fG~VYkg~~----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~ 594 (785)
.++.+....+.+. ++||+|+||+||+|.+ .++.||||++..........+.|.+|+.+|+.++|||||+++++|.
T Consensus 361 ~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 440 (635)
T 4fl3_A 361 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE 440 (635)
T ss_dssp SSSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3455555666664 4899999999999965 3578999999876665566788999999999999999999999996
Q ss_pred CCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcc
Q 003935 595 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 674 (785)
Q Consensus 595 d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 674 (785)
. +.+++||||+.+|+|.+++. ....+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++
T Consensus 441 ~-~~~~lv~E~~~~g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla 516 (635)
T 4fl3_A 441 A-ESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 516 (635)
T ss_dssp S-SSEEEEEECCTTEEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHH
T ss_pred c-CCEEEEEEccCCCCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCc
Confidence 5 45899999999999999996 3457999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC-
Q 003935 675 RIITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP- 749 (785)
Q Consensus 675 ~~l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip- 749 (785)
+.+..... ......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+....+.. +.....+
T Consensus 517 ~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~-~~~~~~p~ 595 (635)
T 4fl3_A 517 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPA 595 (635)
T ss_dssp HHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCT
T ss_pred cccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCC
Confidence 87654321 1223456789999999999999999999999999999998 9999999988877776654 4444444
Q ss_pred --ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhcc
Q 003935 750 --EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 784 (785)
Q Consensus 750 --~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~sL 784 (785)
+..+.+||..||. ||.+||++.+|++.|+++.+.+
T Consensus 596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 596 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 3469999999999 9999999999999999987764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=384.13 Aligned_cols=249 Identities=25% Similarity=0.439 Sum_probs=223.1
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeE
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 601 (785)
....+|.+.+.||+|+||+||+|.+ +|+.||||++..........+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3467899999999999999999987 68899999998877777777889999999999999999999999999999999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
||||+++|+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 92 v~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EECCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EEECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 9999999999999873 3579999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCCCCcccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CChHHHHHHHH
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PEGPLGRLIAD 759 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s-~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i-p~~~L~~LI~~ 759 (785)
.....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+.......+.......+. ....+.+|+.+
T Consensus 169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 247 (328)
T 3fe3_A 169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKR 247 (328)
T ss_dssp -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 33567899999999999988775 7999999999999999999999999998888888776554432 24568999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003935 760 CWA-EPQERPSCEEILSR 776 (785)
Q Consensus 760 CL~-DP~kRPS~~EIL~~ 776 (785)
||. ||.+|||+.++++|
T Consensus 248 ~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 248 FLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HCCSSTTTSCCHHHHTTC
T ss_pred HCCCChhHCcCHHHHhcC
Confidence 999 99999999999976
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=363.47 Aligned_cols=254 Identities=29% Similarity=0.561 Sum_probs=225.7
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC--Cce
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRL 599 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~l 599 (785)
+.+..++|.+.+.||+|+||+||+|.++++.||||++..........+.|.+|+.+++.++||||+++++++.+. ..+
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 466788999999999999999999999999999999988777777778899999999999999999999999877 778
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc--cccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~g--IIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
++||||+++|+|.+++... ....+++..++.++.|++.||+|||++| |+||||||+|||++.++.++|+|||++...
T Consensus 85 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEEEECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred EeeecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999999999732 2336899999999999999999999999 999999999999999999999999987653
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC---h
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRNEPFTE---KCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---G 751 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~---ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~---~ 751 (785)
.. ....||+.|+|||.+.+..++. ++|||||||++|+|++|+.||.+.........+......+..+. .
T Consensus 164 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3kmu_A 164 QS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238 (271)
T ss_dssp SC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred cc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence 32 3457899999999998765444 89999999999999999999999998888888877776666553 4
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 752 PLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 752 ~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
.+.+++..||. ||.+|||+.++++.|+++.
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 239 HVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 69999999999 9999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=413.79 Aligned_cols=260 Identities=27% Similarity=0.525 Sum_probs=217.1
Q ss_pred ccccccCCCeeEee-EEeeeCcEEEEEEEE----CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEecccc
Q 003935 520 EEWNIDFSELTVGT-RVGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 594 (785)
Q Consensus 520 ee~~i~~s~y~i~k-~LG~G~fG~VYkg~~----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~ 594 (785)
..+.+..+++.+.. .||+|+||+||+|.+ ++..||||++..... ....+.|.+|+.+|+.++|||||+++++|.
T Consensus 328 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 406 (613)
T 2ozo_A 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQ 406 (613)
T ss_dssp CCSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-STTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEec
Confidence 34566677888777 899999999999976 355799999876532 334678999999999999999999999997
Q ss_pred CCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcc
Q 003935 595 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 674 (785)
Q Consensus 595 d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 674 (785)
. +.+++||||+.+|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++
T Consensus 407 ~-~~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 407 A-EALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp S-SSEEEEEECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred c-CCeEEEEEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 6 569999999999999999862 3456999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC---CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 003935 675 RIITDSPMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE 750 (785)
Q Consensus 675 ~~l~~~~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip~ 750 (785)
+.+...... .....+++.|+|||++.+..++.++|||||||+||||++ |+.||.+....++...+.. +.+...|.
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~-~~~~~~p~ 562 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRMECPP 562 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT-TCCCCCCT
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCCCCCC
Confidence 876433211 122345689999999999999999999999999999998 9999999888887776654 44455443
Q ss_pred ---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhcc
Q 003935 751 ---GPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 784 (785)
Q Consensus 751 ---~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~sL 784 (785)
..+.+||..||. ||.+||++.+|++.|+++..++
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 469999999999 9999999999999999876643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=385.24 Aligned_cols=261 Identities=29% Similarity=0.583 Sum_probs=223.5
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeE
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILF 589 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL 589 (785)
..|.+..++|.+++.||+|+||+||+|.+. +..||||++.... .....+.+.+|+.+++.+ +||||+++
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~ 152 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL 152 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 346677889999999999999999999762 3569999986543 445567899999999999 89999999
Q ss_pred eccccCCCceeEEEEEcccchhhHHHHhhcc-------------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCC
Q 003935 590 LGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 656 (785)
Q Consensus 590 ~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~-------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKps 656 (785)
+++|.+.+.+|+||||+++|+|.+++..... ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 232 (370)
T 2psq_A 153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 232 (370)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence 9999999999999999999999999975421 235899999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 003935 657 NCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 733 (785)
Q Consensus 657 NILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~ 733 (785)
|||++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999999987654322 2234567889999999999999999999999999999999 99999998877
Q ss_pred HHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 734 RVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 734 ~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
+....+.. +.....+ ...+.+|+.+||. ||.+||++.+++++|+++..
T Consensus 313 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 313 ELFKLLKE-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp GHHHHHHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 76665544 4444444 3469999999999 99999999999999998754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=362.00 Aligned_cols=252 Identities=37% Similarity=0.688 Sum_probs=210.2
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccC--hHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLT--AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~--~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
++..++|.+.+.||+|+||+||+|.+.++.||||++...... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 467789999999999999999999999999999998654322 223577899999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc---cccccCCCCcEEEcC--------CCeEEEE
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK---IVHRDLKSANCLVNK--------HWTVKIC 669 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~g---IIHrDLKpsNILLd~--------~g~VKL~ 669 (785)
+||||+++++|.+++. ...+++..++.++.|++.||+|||++| |+||||||+|||++. ++.+||+
T Consensus 83 lv~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 9999999999999884 457999999999999999999999999 999999999999986 7789999
Q ss_pred ecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003935 670 DFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 749 (785)
Q Consensus 670 DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip 749 (785)
|||++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.........+.........+
T Consensus 159 Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3dtc_A 159 DFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236 (271)
T ss_dssp CCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC
T ss_pred cCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC
Confidence 999998765432 234578999999999999999999999999999999999999999998888887777666555554
Q ss_pred C---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 750 E---GPLGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 750 ~---~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
. ..+.+++.+||. ||.+|||+.+++++|+++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 3 469999999999 999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=362.70 Aligned_cols=257 Identities=31% Similarity=0.627 Sum_probs=223.4
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
..|.+..++|.+.+.||+|+||+||+|.+ +++.||+|++....... +.+.+|+.++++++||||+++++++.+...
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 35778889999999999999999999988 68889999997655443 568899999999999999999999999999
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
.++||||+++++|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp EEEEEECCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred eEEEEEeCCCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccc
Confidence 9999999999999999963 34568999999999999999999999999999999999999999999999999998764
Q ss_pred CCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003935 679 DSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPL 753 (785)
Q Consensus 679 ~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L 753 (785)
.... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+.... ....+ +..+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 236 (269)
T 4hcu_A 158 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-RLYKPRLASTHV 236 (269)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCCCTTSCHHH
T ss_pred ccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc-cCCCCCcCCHHH
Confidence 3221 2234557788999999999999999999999999999999 999999998888877766542 22222 4569
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 754 GRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 754 ~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
.+++..||. ||.+|||+.+++++|+++..
T Consensus 237 ~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 237 YQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 999999999 99999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=371.87 Aligned_cols=245 Identities=28% Similarity=0.466 Sum_probs=215.7
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
..+|.+.+.||+|+||+||+|.+ +++.||||++....... .+.+.+|+.+++.++||||+++++++...+.+++||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 36789999999999999999986 68899999987654433 467889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+.+|+|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 97 e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp ECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred ECCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 99999999999863 35899999999999999999999999999999999999999999999999999887665555
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCC---ChHHHHHHHH
Q 003935 684 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIP---EGPLGRLIAD 759 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~-~ip---~~~L~~LI~~ 759 (785)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+....... ..+ +..+.+|+.+
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 252 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHH
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHH
Confidence 556789999999999999999999999999999999999999999988877777665544322 222 3358999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003935 760 CWA-EPQERPSCEEILSR 776 (785)
Q Consensus 760 CL~-DP~kRPS~~EIL~~ 776 (785)
||. ||.+|||+.+++++
T Consensus 253 ~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 253 CLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HSCSSTTTSCCHHHHTTC
T ss_pred HccCChhHCcCHHHHhhC
Confidence 999 99999999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=381.29 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=218.8
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
+..++|.+.+.||+|+||+||+|.+ +|+.||||++.+... .....+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 3467899999999999999999988 588999999975432 2233567889999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 82 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999999998873 457899999999999999999999999999999999999999999999999999875444
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHH
Q 003935 681 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIAD 759 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~ 759 (785)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.......+ .-...+.+||.+
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 238 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 4444567899999999999999999999999999999999999999999888888877776543322 124568999999
Q ss_pred hhh-CCCCCC-----CHHHHHHH
Q 003935 760 CWA-EPQERP-----SCEEILSR 776 (785)
Q Consensus 760 CL~-DP~kRP-----S~~EIL~~ 776 (785)
||. ||.+|| ++.+|++|
T Consensus 239 lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 239 LLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HhhcCHHHhcCCCCCCHHHHHcC
Confidence 999 999999 89999876
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=377.54 Aligned_cols=266 Identities=31% Similarity=0.560 Sum_probs=223.9
Q ss_pred cccccccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceee
Q 003935 517 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVIL 588 (785)
Q Consensus 517 ~~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVk 588 (785)
.....|++..++|.+.+.||+|+||.||+|.+ +++.||||++.... .....+.+.+|+.+++.+ +||||++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceee
Confidence 34567888999999999999999999999974 24789999996543 344567899999999999 7999999
Q ss_pred EeccccCCCc-eeEEEEEcccchhhHHHHhhcc-----------------------------------------------
Q 003935 589 FLGACTKPPR-LSMITEYMELGSLYHLIHLSGQ----------------------------------------------- 620 (785)
Q Consensus 589 L~g~~~d~~~-l~LV~Ey~~gGSL~dlL~~~~~----------------------------------------------- 620 (785)
+++++.+.+. +++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999887654 8999999999999999974321
Q ss_pred ----------------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC--
Q 003935 621 ----------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-- 682 (785)
Q Consensus 621 ----------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~-- 682 (785)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence 11289999999999999999999999999999999999999999999999999987643322
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHH
Q 003935 683 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIA 758 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~ 758 (785)
......||+.|+|||++.+..++.++|||||||++|+|+| |..||.+.............+.....+ ...+.+++.
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 330 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 330 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHH
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 2234568889999999999999999999999999999998 999998877655555555555555444 346999999
Q ss_pred Hhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003935 759 DCWA-EPQERPSCEEILSRLLDCEYS 783 (785)
Q Consensus 759 ~CL~-DP~kRPS~~EIL~~L~~l~~s 783 (785)
.||. ||.+|||+.+++++|+++...
T Consensus 331 ~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 331 DCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHccCChhhCCCHHHHHHHHHHHHHH
Confidence 9999 999999999999999987653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=362.22 Aligned_cols=259 Identities=31% Similarity=0.601 Sum_probs=221.6
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC-CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~-g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
...|.+..++|.+.+.||+|+||+||++.+. +..||+|++....... +.+.+|+.+++.++||||+++++++.+..
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 4677888899999999999999999999884 6689999997655443 56889999999999999999999999999
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+++||||+.+++|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred CeEEEEeccCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence 99999999999999999973 2456999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC--CCCCChHH
Q 003935 678 TDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSR--LEIPEGPL 753 (785)
Q Consensus 678 ~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~--~~ip~~~L 753 (785)
..... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+...... +...+..+
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 250 (283)
T 3gen_A 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV 250 (283)
T ss_dssp CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHH
Confidence 43211 1234457788999999999999999999999999999998 99999999888877776654321 22234579
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 754 GRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 754 ~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
.+|+..||. ||.+|||+.+++++|+++..
T Consensus 251 ~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 251 YTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 999999999 99999999999999998754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=358.68 Aligned_cols=257 Identities=28% Similarity=0.581 Sum_probs=222.1
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEEC-CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCce
Q 003935 521 EWNIDFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 599 (785)
Q Consensus 521 e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 599 (785)
.+++..++|.+.+.||+|+||+||+|.+. +..||+|++....... +.+.+|+.+++.++||||+++++++.+....
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 45677889999999999999999999884 5689999997655443 5688999999999999999999999999999
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
++||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred EEEEEccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 9999999999999999743 34699999999999999999999999999999999999999999999999999987654
Q ss_pred CCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC--CCCChHHHH
Q 003935 680 SPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRL--EIPEGPLGR 755 (785)
Q Consensus 680 ~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~--~ip~~~L~~ 755 (785)
... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...........+....... ...+..+.+
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQ 236 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHH
Confidence 322 2234456778999999999889999999999999999999 999999988888777765543221 122457999
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 756 LIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 756 LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
++..||. ||.+|||+.+++++|+.+..
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 237 IMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 9999999 99999999999999998754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=364.68 Aligned_cols=263 Identities=32% Similarity=0.586 Sum_probs=225.1
Q ss_pred ccccccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEe
Q 003935 518 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFL 590 (785)
Q Consensus 518 ~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~ 590 (785)
....|.+..++|.+.+.||+|+||.||+|.+ .++.||||++.... .....+.+.+|+.+++.++||||++++
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~ 92 (314)
T 2ivs_A 14 EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLY 92 (314)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEE
Confidence 4456788889999999999999999999976 24789999986543 455568899999999999999999999
Q ss_pred ccccCCCceeEEEEEcccchhhHHHHhhcc---------------------cccchHHHHHHHHHHHHHHHHHHHhcccc
Q 003935 591 GACTKPPRLSMITEYMELGSLYHLIHLSGQ---------------------KKKLSWRRKLKMLRDICRGLMCIHRMKIV 649 (785)
Q Consensus 591 g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~---------------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gII 649 (785)
+++.+.+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||++||+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv 172 (314)
T 2ivs_A 93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV 172 (314)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 999999999999999999999999975432 23589999999999999999999999999
Q ss_pred cccCCCCcEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCC
Q 003935 650 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRP 726 (785)
Q Consensus 650 HrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~P 726 (785)
||||||+|||++.++.+||+|||++........ ......+++.|+|||.+.+..++.++|||||||++|+|++ |..|
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987654322 2234567889999999999999999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 727 WEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 727 F~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
|.+.........+... .....+ +..+.+|+.+||. ||.+||++.+++++|+++..
T Consensus 253 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 253 YPGIPPERLFNLLKTG-HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp STTCCGGGHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHhhcC-CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9988877766655443 333333 3469999999999 99999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=371.19 Aligned_cols=263 Identities=31% Similarity=0.537 Sum_probs=223.7
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEECC-------eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEecc
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 592 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~g-------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~ 592 (785)
..+.+..++|.+.+.||+|+||.||+|.+.+ +.||||++.... .....+.|.+|+.+++.++||||++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 4566778999999999999999999998753 789999987543 34456789999999999999999999999
Q ss_pred ccCCCceeEEEEEcccchhhHHHHhhcc---------------------cccchHHHHHHHHHHHHHHHHHHHhcccccc
Q 003935 593 CTKPPRLSMITEYMELGSLYHLIHLSGQ---------------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651 (785)
Q Consensus 593 ~~d~~~l~LV~Ey~~gGSL~dlL~~~~~---------------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHr 651 (785)
+.+.+.+++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++||+||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 9999999999999999999999975321 2578999999999999999999999999999
Q ss_pred cCCCCcEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 003935 652 DLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWE 728 (785)
Q Consensus 652 DLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~ 728 (785)
||||+|||++.++.+||+|||++........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999987643221 2234567899999999999999999999999999999999 999999
Q ss_pred CCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhcc
Q 003935 729 GVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 784 (785)
Q Consensus 729 ~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~sL 784 (785)
+.........+.... ....+ +..+.+|+.+||. ||.+||++.+++++|+++...+
T Consensus 279 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 279 GMAHEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TSCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCChHHHHHHHhCCC-cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 998888777665543 33333 3469999999999 9999999999999999876543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=363.01 Aligned_cols=248 Identities=22% Similarity=0.283 Sum_probs=209.7
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
+++|.+.+.||+|+||+||+|.+ +++.||||++............+.+|+.+++.++||||+++++++.+...+++||
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 36899999999999999999988 5889999999877666666788999999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+.++.+..+.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 81 EFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred ecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 9998754444443 3467999999999999999999999999999999999999999999999999999887655444
Q ss_pred CCCCCCCCcccCccccccCC-CCchhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHhcCCCCC--------------
Q 003935 684 DSSSAGTPEWMAPELIRNEP-FTEKCDIFSLGVIMWELCTLNRP-WEGVLPERVVYAVANEGSRLE-------------- 747 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~~-~s~ksDVWSLGvILyELLTG~~P-F~~~~~~~~v~~i~~~~~~~~-------------- 747 (785)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.........+......+.
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 55678999999999998765 89999999999999999998887 566666666555543211100
Q ss_pred ----------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 ----------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 ----------------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..+..+.+|+.+||. ||.+|||++++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 012357899999999 99999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=366.59 Aligned_cols=256 Identities=30% Similarity=0.558 Sum_probs=213.6
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
.+..++|.+++.||+|+||+||+|.+ +++.||+|++.. ......+.|.+|+.+++.++||||+++++++.+.+..+
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 34568999999999999999999988 488999998854 34556788999999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp EEEECCTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEecCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 99999999999999974 2457999999999999999999999999999999999999999999999999999876443
Q ss_pred CCCC--------------CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHh
Q 003935 681 PMRD--------------SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER-----VVYAVAN 741 (785)
Q Consensus 681 ~~~~--------------~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~-----~v~~i~~ 741 (785)
.... ....||+.|+|||++.+..++.++|||||||++|+|++|..||....... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 2211 14579999999999999999999999999999999999999986532211 1111112
Q ss_pred cCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003935 742 EGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 783 (785)
Q Consensus 742 ~~~~~~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~s 783 (785)
....... +..+.+|+.+||. ||.+|||+.++++.|+++...
T Consensus 242 ~~~~~~~-~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 242 RYCPPNC-PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp HTCCTTC-CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCCCC-CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 2222222 3458999999999 999999999999999987643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=378.53 Aligned_cols=246 Identities=24% Similarity=0.398 Sum_probs=219.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|.+.+.||+|+||+||+|.+ +|+.||+|++..........+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 5799999999999999999988 48899999998877777777889999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC---CeEEEEecCccccccCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH---WTVKICDFGLSRIITDSP 681 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~---g~VKL~DFGLA~~l~~~~ 681 (785)
|+.+|+|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 109 ~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 109 LVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp CCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred cCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 999999999886 44579999999999999999999999999999999999999765 459999999998775432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 756 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-----~~~L~~L 756 (785)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.........+ +..+.+|
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 264 (362)
T 2bdw_A 186 -AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264 (362)
T ss_dssp -SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHH
T ss_pred -ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 2345689999999999999999999999999999999999999999998888888777655444332 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003935 757 IADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.+||. ||.+||++.++++|
T Consensus 265 i~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 265 IDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHcCCChhhCcCHHHHhcC
Confidence 999999 99999999999976
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=382.50 Aligned_cols=250 Identities=23% Similarity=0.371 Sum_probs=212.2
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCce
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 599 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l 599 (785)
+..++|.+.+.||+|+||+||+|.+ +++.||||++.+... .....+.+..|+.+++.+ +||||+++++++.+...+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 4568999999999999999999987 488999999976432 223456788999999988 699999999999999999
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++....
T Consensus 100 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999999873 45799999999999999999999999999999999999999999999999999986544
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CChHHHHHHH
Q 003935 680 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PEGPLGRLIA 758 (785)
Q Consensus 680 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i-p~~~L~~LI~ 758 (785)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.......+. -...+.+|+.
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 256 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILK 256 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 444455678999999999999989999999999999999999999999999999888888775543322 2456899999
Q ss_pred Hhhh-CCCCCCCH------HHHHHH
Q 003935 759 DCWA-EPQERPSC------EEILSR 776 (785)
Q Consensus 759 ~CL~-DP~kRPS~------~EIL~~ 776 (785)
+||. ||.+||++ .+|++|
T Consensus 257 ~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 257 SFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHhhhCHHHccCCcccCCHHHHhhC
Confidence 9999 99999998 788765
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=361.36 Aligned_cols=264 Identities=28% Similarity=0.520 Sum_probs=225.0
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEe
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 590 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~ 590 (785)
...|++..++|.+.+.||+|+||+||+|.+ .++.||||++.... .....+.+.+|+.+++.+ +||||++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 456888889999999999999999999975 35789999987543 334467899999999999 899999999
Q ss_pred ccccCCCceeEEEEEcccchhhHHHHhhcc---------------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCC
Q 003935 591 GACTKPPRLSMITEYMELGSLYHLIHLSGQ---------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKS 655 (785)
Q Consensus 591 g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~---------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKp 655 (785)
+++.+.+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++||+||||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 999999999999999999999999975421 12589999999999999999999999999999999
Q ss_pred CcEEEcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 003935 656 ANCLVNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLP 732 (785)
Q Consensus 656 sNILLd~~g~VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~ 732 (785)
+|||++.++.+||+|||++......... .....+|+.|+|||.+.+..++.++|||||||++|+|+| |..||.+...
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 9999999999999999999876543221 223457788999999999999999999999999999999 9999988776
Q ss_pred HHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003935 733 ERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 783 (785)
Q Consensus 733 ~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~s 783 (785)
................+ +..+.+|+.+||. ||.+|||+.+++++|+++...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 65555555555444333 3469999999999 999999999999999987643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=389.82 Aligned_cols=247 Identities=24% Similarity=0.381 Sum_probs=220.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|.+.+.||+|+||+||+|.+ +|+.+|+|++..........+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 5799999999999999999987 68999999998877766667889999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEc---CCCeEEEEecCccccccCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN---KHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd---~~g~VKL~DFGLA~~l~~~~ 681 (785)
|+.+|+|.+.+. ....+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||++.......
T Consensus 91 ~~~gg~L~~~i~---~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 91 LVTGGELFEDIV---AREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp CCBCCBHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred eCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 999999999887 345799999999999999999999999999999999999998 46789999999998876654
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 756 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-----~~~L~~L 756 (785)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.........+ +..+.+|
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 247 (444)
T 3soa_A 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247 (444)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 44556789999999999999999999999999999999999999999999988888887765544332 3469999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003935 757 IADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.+||. ||.+|||+.++++|
T Consensus 248 i~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 248 INKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHcCCChhHCCCHHHHhcC
Confidence 999999 99999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=372.64 Aligned_cols=263 Identities=28% Similarity=0.514 Sum_probs=220.4
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEec
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 591 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g 591 (785)
.+|++..++|.+.+.||+|+||+||+|.+ .+..||||++.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 35788889999999999999999999986 35579999987543 233457889999999999 8999999999
Q ss_pred cccCCCceeEEEEEcccchhhHHHHhhcc--------------------cccchHHHHHHHHHHHHHHHHHHHhcccccc
Q 003935 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQ--------------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651 (785)
Q Consensus 592 ~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~--------------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHr 651 (785)
++...+.+++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 99999999999999999999999974321 1347999999999999999999999999999
Q ss_pred cCCCCcEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 003935 652 DLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWE 728 (785)
Q Consensus 652 DLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~ 728 (785)
||||+|||++.++.+||+|||++........ ......+|+.|+|||.+.+..++.++|||||||++|+|+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999987644322 1223457789999999999999999999999999999998 999999
Q ss_pred CCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003935 729 GVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 783 (785)
Q Consensus 729 ~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~s 783 (785)
+.............+.....+ +..+.+|+.+||. ||.+|||+.+++++|+++...
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 887666666666666555444 3479999999999 999999999999999987653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=367.32 Aligned_cols=264 Identities=25% Similarity=0.451 Sum_probs=207.1
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC--Ce---EEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccc
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN--GT---DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 593 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~--g~---~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~ 593 (785)
.+.+.+..++|.+.+.||+|+||+||+|.+. +. .||||++..........+.+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 3556677889999999999999999999763 22 799999977665556678899999999999999999999999
Q ss_pred cCCCce------eEEEEEcccchhhHHHHhhccc---ccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC
Q 003935 594 TKPPRL------SMITEYMELGSLYHLIHLSGQK---KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 664 (785)
Q Consensus 594 ~d~~~l------~LV~Ey~~gGSL~dlL~~~~~~---~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g 664 (785)
...... ++||||+.+|+|.+++...... ..+++..++.++.|++.||+|||++||+||||||+|||++.++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence 876654 9999999999999998644322 2589999999999999999999999999999999999999999
Q ss_pred eEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 003935 665 TVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVAN 741 (785)
Q Consensus 665 ~VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~ 741 (785)
.+||+|||+++........ .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 254 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence 9999999999876443221 223456789999999999999999999999999999999 8999999888877777665
Q ss_pred cCCCCCCC--ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 742 EGSRLEIP--EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 742 ~~~~~~ip--~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
.......+ ...+.+|+.+||. ||.+|||+.++++.|+++..
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 44322222 3469999999999 99999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=365.09 Aligned_cols=248 Identities=26% Similarity=0.383 Sum_probs=207.7
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh------------------------HHHHHHHHHHHHH
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA------------------------ENMEDFCNEISIL 578 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~------------------------~~~e~f~~EI~iL 578 (785)
..++|.+.+.||+|+||+||+|.+ +++.||||++....... ...+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 457899999999999999999987 58899999987654221 1235688999999
Q ss_pred hhcCCCceeeEeccccC--CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCC
Q 003935 579 SRLRHPNVILFLGACTK--PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 656 (785)
Q Consensus 579 k~L~HPNIVkL~g~~~d--~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKps 656 (785)
+.++||||+++++++.+ ...+++||||+++++|.+++ ....+++..++.++.||+.||+|||++||+||||||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 99999999999999876 56789999999999998765 3457999999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCChH
Q 003935 657 NCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP---FTEKCDIFSLGVIMWELCTLNRPWEGVLPE 733 (785)
Q Consensus 657 NILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~---~s~ksDVWSLGvILyELLTG~~PF~~~~~~ 733 (785)
|||++.++.+||+|||++..............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 99999999999999999988765444445678999999999998765 378899999999999999999999988877
Q ss_pred HHHHHHHhcCCCCCC---CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 734 RVVYAVANEGSRLEI---PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 734 ~~v~~i~~~~~~~~i---p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.....+......... -...+.+|+.+||. ||.+|||+.++++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 776666554433322 13469999999999 99999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=353.24 Aligned_cols=256 Identities=31% Similarity=0.636 Sum_probs=222.4
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCce
Q 003935 521 EWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 599 (785)
Q Consensus 521 e~~i~~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 599 (785)
+|.++.++|.+.+.||+|+||.||+|.+ +++.||+|++....... +.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 4778889999999999999999999988 67899999997655433 5788999999999999999999999999999
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus 79 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp EEEECCCTTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEEEeCCCCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999999999999863 235689999999999999999999999999999999999999999999999999987643
Q ss_pred CCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHH
Q 003935 680 SPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLG 754 (785)
Q Consensus 680 ~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~ 754 (785)
... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||...........+.... ....+ +..+.
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~ 235 (267)
T 3t9t_A 157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-RLYKPRLASTHVY 235 (267)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCCCTTSCHHHH
T ss_pred ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC-cCCCCccCcHHHH
Confidence 211 1234567889999999999999999999999999999999 899999988888777765532 22222 45699
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 755 RLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 755 ~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
+++.+||. ||.+||++.+++++|+++..
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 236 QIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999 99999999999999998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=369.00 Aligned_cols=257 Identities=33% Similarity=0.542 Sum_probs=219.1
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
++..++|.+.+.||+|+||+||+|.+. +..||||++.... .....+.|.+|+.+++.++||||+++++++.+..
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 455688999999999999999999872 4469999986543 4455678999999999999999999999999999
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred ccEEEeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999963 3457999999999999999999999999999999999999999999999999999877
Q ss_pred cCCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---C
Q 003935 678 TDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---E 750 (785)
Q Consensus 678 ~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~ 750 (785)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+... .....+ +
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 280 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPAPMGCP 280 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CCCCCCCCcC
Confidence 54322 1223456788999999999999999999999999999999 99999999888887776554 333333 3
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003935 751 GPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 783 (785)
Q Consensus 751 ~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~s 783 (785)
..+.+|+..||. ||.+|||+.+|++.|+.+..+
T Consensus 281 ~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 281 HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 469999999999 999999999999999987643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=376.50 Aligned_cols=246 Identities=26% Similarity=0.408 Sum_probs=216.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChH----HHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE----NMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~----~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
+.|.+++.||+|+||+||+|.+ +|+.||+|++.+...... ..+.+.+|+.+++.++||||+++++++.+...++
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 5799999999999999999988 488999999976554221 3467899999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC----eEEEEecCcccc
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW----TVKICDFGLSRI 676 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g----~VKL~DFGLA~~ 676 (785)
+||||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 92 lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 92 LILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 9999999999999986 456799999999999999999999999999999999999998776 799999999987
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----CCCh
Q 003935 677 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-----IPEG 751 (785)
Q Consensus 677 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-----ip~~ 751 (785)
..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+........ ....
T Consensus 169 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 247 (361)
T 2yab_A 169 IEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247 (361)
T ss_dssp CCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred cCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 75532 33467899999999999999999999999999999999999999999988888887766543322 1234
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 752 PLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 752 ~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+.+||.+||. ||.+|||+.++++|
T Consensus 248 ~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 248 LAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 68999999999 99999999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=367.20 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=206.4
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
-.++|.+.++||+|+||+||+|.+ +|+.||+|++............+.+|+.+++.++||||+++++++.+...+++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 347899999999999999999988 6889999999766555555678899999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+.+ +|.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 99985 77777652 3456999999999999999999999999999999999999999999999999999887654444
Q ss_pred CCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---C-----------
Q 003935 684 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---I----------- 748 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~---i----------- 748 (785)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......+. .
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence 456688999999999876 5689999999999999999999999988776665555443111100 0
Q ss_pred -----------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 749 -----------------PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 749 -----------------p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
-...+.+|+.+||. ||.+|||+.++++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 01357789999999 99999999999985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=361.93 Aligned_cols=248 Identities=22% Similarity=0.317 Sum_probs=206.1
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
+++|.+.+.||+|+||+||+|.+ .++.||+|++..........+.+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 36899999999999999999988 48899999997655444344678899999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
|+.+ +|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 81 HLDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp CCSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ecCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 9986 88888863 23578999999999999999999999999999999999999999999999999998775443334
Q ss_pred CCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------------
Q 003935 685 SSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------------- 746 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~----------------- 746 (785)
....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 45678999999999976 458999999999999999999999999988777666654321100
Q ss_pred -------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 -------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 -------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..-+..+.+|+.+||. ||.+|||+.++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0012357899999999 99999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=359.22 Aligned_cols=260 Identities=33% Similarity=0.661 Sum_probs=208.7
Q ss_pred ccccccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 518 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 518 ~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
..+.+++..++|++.++||+|+||+||+|.+.+ .+|+|++..........+.|.+|+.+++.++||||+++++++ ...
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 345667888999999999999999999998765 599999987776777778899999999999999999999965 455
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+++||||+.+++|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred ccEEEEEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccc
Confidence 68999999999999999853 3457999999999999999999999999999999999999999999999999999865
Q ss_pred cCC--CCCCCCCCCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCC--
Q 003935 678 TDS--PMRDSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIP-- 749 (785)
Q Consensus 678 ~~~--~~~~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~-~ip-- 749 (785)
... ........||+.|+|||++. +..++.++||||||+++|+|++|+.||.+.............+... ...
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV 250 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSS
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhc
Confidence 432 11223457899999999986 6678999999999999999999999998876665555554443322 211
Q ss_pred ----ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 750 ----EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 750 ----~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
+..+.+|+.+||. ||.+|||+.++++.|+++.
T Consensus 251 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 2468999999999 9999999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=373.04 Aligned_cols=262 Identities=29% Similarity=0.543 Sum_probs=225.2
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceee
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVIL 588 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVk 588 (785)
...|++..++|.+++.||+|+||+||+|.+. +..||||++... ......+.+.+|+.+++.+ +||||++
T Consensus 61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 3456788899999999999999999999862 257999998654 3445568899999999999 8999999
Q ss_pred EeccccCCCceeEEEEEcccchhhHHHHhhcc-------------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCC
Q 003935 589 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKS 655 (785)
Q Consensus 589 L~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~-------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKp 655 (785)
+++++.+.+..++||||+.+|+|.+++..... ...+++..++.++.||+.||+|||++||+||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 99999999999999999999999999975431 24599999999999999999999999999999999
Q ss_pred CcEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 003935 656 ANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLP 732 (785)
Q Consensus 656 sNILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~ 732 (785)
+|||++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654322 2234567889999999999999999999999999999999 9999999888
Q ss_pred HHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 733 ERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 733 ~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
......+... .....+ ...+.+|+.+||. ||.+|||+.+|+++|+++..
T Consensus 300 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 300 EELFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp HHHHHHHHTT-CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcC-CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 7777666543 333333 3469999999999 99999999999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=369.26 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=206.4
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE-----CCeEEEEEEeecccc--ChHHHHHHHHHHHHHhhcCCCceeeEeccccC
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDL--TAENMEDFCNEISILSRLRHPNVILFLGACTK 595 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~--~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 595 (785)
.+..++|.+.+.||+|+||+||++.+ +++.||+|++.+... .......+.+|+.+++.++||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 34567899999999999999999986 578999999976543 22334667899999999999999999999999
Q ss_pred CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 596 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
.+.+|+||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred CCEEEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999999873 3568999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHH
Q 003935 676 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLG 754 (785)
Q Consensus 676 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~ 754 (785)
............+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+ .-...+.
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 249 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEAR 249 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 654443344567899999999999999999999999999999999999999999988888877776543222 1235699
Q ss_pred HHHHHhhh-CCCCCC-----CHHHHHHH
Q 003935 755 RLIADCWA-EPQERP-----SCEEILSR 776 (785)
Q Consensus 755 ~LI~~CL~-DP~kRP-----S~~EIL~~ 776 (785)
+|+.+||. ||.+|| ++.++++|
T Consensus 250 ~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 250 DLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 99999999 999999 78888875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=371.04 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=212.1
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc-
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR- 598 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~- 598 (785)
.++.+..++|.+.+.||+|+||+||+|.+.++.||||++.... .....+..|+.+++.++||||+++++++.....
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred cccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence 4567788899999999999999999999999999999986542 233456679999999999999999999977543
Q ss_pred ---eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc----------ccccccCCCCcEEEcCCCe
Q 003935 599 ---LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM----------KIVHRDLKSANCLVNKHWT 665 (785)
Q Consensus 599 ---l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~----------gIIHrDLKpsNILLd~~g~ 665 (785)
+++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+. ||+||||||+|||++.++.
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred CceEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence 6999999999999999963 3599999999999999999999999 9999999999999999999
Q ss_pred EEEEecCccccccCCCC--CCCCCCCCCcccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCC--------
Q 003935 666 VKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNE-----PFTEKCDIFSLGVIMWELCTLNRPWEGV-------- 730 (785)
Q Consensus 666 VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~-----~~s~ksDVWSLGvILyELLTG~~PF~~~-------- 730 (785)
+||+|||+++.+..... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||.+.
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 99999999987654322 22346799999999999873 4567899999999999999999999653
Q ss_pred --------ChHHHHHHHHhcCCCCCCCC--------hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 731 --------LPERVVYAVANEGSRLEIPE--------GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 731 --------~~~~~v~~i~~~~~~~~ip~--------~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
........+......+.++. ..+.+|+.+||. ||.+|||+.++++.|+++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 22233333333333443332 138899999999 99999999999999998764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=360.93 Aligned_cols=248 Identities=25% Similarity=0.426 Sum_probs=206.4
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
.++|.+.+.||+|+||+||+|.+ +|+.||||++..........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 36899999999999999999988 4889999999776666666778899999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+++++|.+++. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 82 e~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 82 EYCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp ECCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 9999999999886 4467999999999999999999999999999999999999999999999999999887654444
Q ss_pred CCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC------------------
Q 003935 684 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS------------------ 744 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~------------------ 744 (785)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 456689999999999976 6789999999999999999999999998887766655432110
Q ss_pred -CCC-------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 745 -RLE-------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 745 -~~~-------------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
... -.+..+.+|+.+||. ||.+|||+.++++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 012347889999999 99999999999976
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=363.15 Aligned_cols=265 Identities=31% Similarity=0.549 Sum_probs=225.3
Q ss_pred CccccccccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCcee
Q 003935 515 PLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587 (785)
Q Consensus 515 p~~~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIV 587 (785)
..+..++|++..++|.+.+.||+|+||+||+|.+. ++.||||++.... .......+.+|+.+++.++||||+
T Consensus 13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~ 91 (322)
T 1p4o_A 13 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVV 91 (322)
T ss_dssp SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBC
T ss_pred cccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 34456788899999999999999999999999753 5789999986543 334456799999999999999999
Q ss_pred eEeccccCCCceeEEEEEcccchhhHHHHhhcc-------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEE
Q 003935 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV 660 (785)
Q Consensus 588 kL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~-------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILL 660 (785)
++++++.+....++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 92 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli 171 (322)
T 1p4o_A 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 171 (322)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred eeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE
Confidence 999999999999999999999999999874321 1456899999999999999999999999999999999999
Q ss_pred cCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 003935 661 NKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVY 737 (785)
Q Consensus 661 d~~g~VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~ 737 (785)
+.++.+||+|||++......... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+........
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 251 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence 99999999999999866433221 223456889999999999999999999999999999999 899999988887777
Q ss_pred HHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 738 AVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 738 ~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
.+..... ...+ +..+.+|+.+||. ||.+|||+.+++++|++..
T Consensus 252 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 252 FVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 7665443 2222 3469999999999 9999999999999998763
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=353.66 Aligned_cols=247 Identities=24% Similarity=0.391 Sum_probs=219.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
.++|.+.+.||+|+||+||+|.+ +++.||+|++..........+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 36899999999999999999987 4889999999887777777788999999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCe---EEEEecCccccccCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT---VKICDFGLSRIITDS 680 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~---VKL~DFGLA~~l~~~ 680 (785)
||+.+++|.+.+.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||++......
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 99999999988863 357899999999999999999999999999999999999976655 999999999876543
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHH
Q 003935 681 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGR 755 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-----~~~L~~ 755 (785)
. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.........+.........+ +..+.+
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 162 E-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240 (284)
T ss_dssp C-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred c-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence 2 2345679999999999999999999999999999999999999999998888888777655444332 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHH
Q 003935 756 LIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 756 LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
|+.+||. ||.+|||+.+++++
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 241 LIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHcccChhhCCCHHHHhcC
Confidence 9999999 99999999999986
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=358.97 Aligned_cols=253 Identities=23% Similarity=0.365 Sum_probs=213.5
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
.++|.+.+.||+|+||+||+|.+ .++.||+|++..... .....+.|.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 36899999999999999999987 588999999865443 445567899999999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
|||+++++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 999999999999973 35799999999999999999999999999999999999999999999999999987654322
Q ss_pred -CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---C---CChHHHH
Q 003935 683 -RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---I---PEGPLGR 755 (785)
Q Consensus 683 -~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~---i---p~~~L~~ 755 (785)
......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.................. . -+..+.+
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 246 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN 246 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHH
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHH
Confidence 22345799999999999999999999999999999999999999999888777666554432211 1 1346899
Q ss_pred HHHHhhh-CCCCCC-CHHHHHHHHHhhh
Q 003935 756 LIADCWA-EPQERP-SCEEILSRLLDCE 781 (785)
Q Consensus 756 LI~~CL~-DP~kRP-S~~EIL~~L~~l~ 781 (785)
++.+||. ||.+|| ++.++++.|..+.
T Consensus 247 li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 247 VILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred HHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 9999999 999998 9999999998764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=370.60 Aligned_cols=250 Identities=22% Similarity=0.364 Sum_probs=211.7
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCce
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 599 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l 599 (785)
+..++|.+.+.||+|+||+||+|.+ +++.||||++.+... .....+.+.+|+.+++.+ +||||+++++++.+...+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 3467899999999999999999988 488999999986654 344567788999999988 899999999999999999
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++....
T Consensus 86 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999999999873 35799999999999999999999999999999999999999999999999999986544
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHhcCCCCC-CC
Q 003935 680 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV---------LPERVVYAVANEGSRLE-IP 749 (785)
Q Consensus 680 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~---------~~~~~v~~i~~~~~~~~-ip 749 (785)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ .-
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 242 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 242 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS
T ss_pred CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC
Confidence 434455678999999999999999999999999999999999999999752 23334444444332221 12
Q ss_pred ChHHHHHHHHhhh-CCCCCCCH------HHHHHH
Q 003935 750 EGPLGRLIADCWA-EPQERPSC------EEILSR 776 (785)
Q Consensus 750 ~~~L~~LI~~CL~-DP~kRPS~------~EIL~~ 776 (785)
...+.+|+.+||. ||.+||++ .++++|
T Consensus 243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 3468999999999 99999995 677765
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=355.93 Aligned_cols=258 Identities=30% Similarity=0.536 Sum_probs=208.0
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEecccc
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 594 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~ 594 (785)
.++++..++|.+.+.||+|+||+||+|.+. +..||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 456777889999999999999999999873 4569999976432 3445678999999999999999999999985
Q ss_pred CCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcc
Q 003935 595 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 674 (785)
Q Consensus 595 d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 674 (785)
+ +..++||||+++++|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 87 ~-~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 87 E-NPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp S-SSCEEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred c-CccEEEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccc
Confidence 4 568999999999999999973 2346899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---
Q 003935 675 RIITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP--- 749 (785)
Q Consensus 675 ~~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip--- 749 (785)
........ ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+.... ....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~ 242 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNC 242 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTC
T ss_pred cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-CCCCCCCC
Confidence 87654322 2233457789999999999999999999999999999996 999999888777776665433 23333
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 750 EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 750 ~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
+..+.+++.+||. ||.+|||+.+++++|+++..
T Consensus 243 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 243 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 3469999999999 99999999999999998753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=364.21 Aligned_cols=263 Identities=29% Similarity=0.556 Sum_probs=223.8
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEECC-------eEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEe
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 590 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~g-------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~ 590 (785)
.+.|++..++|.+.+.||+|+||+||+|.+.+ ..||+|++.... .....+.+.+|+.+++.+ +||||++++
T Consensus 38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 116 (333)
T 2i1m_A 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLL 116 (333)
T ss_dssp CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 35688889999999999999999999998732 379999986543 344567899999999999 899999999
Q ss_pred ccccCCCceeEEEEEcccchhhHHHHhhcc-----------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEE
Q 003935 591 GACTKPPRLSMITEYMELGSLYHLIHLSGQ-----------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCL 659 (785)
Q Consensus 591 g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~-----------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNIL 659 (785)
+++.+.+.+++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196 (333)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence 999999999999999999999999974321 345799999999999999999999999999999999999
Q ss_pred EcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 003935 660 VNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVV 736 (785)
Q Consensus 660 Ld~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v 736 (785)
++.++.+||+|||++........ ......+|+.|+|||++.+..++.++|||||||++|+|+| |..||.+.......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 99999999999999987643322 1233456789999999999999999999999999999998 89999987766666
Q ss_pred HHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 737 YAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 737 ~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
..+.........+ +..+.+|+..||. ||.+|||+.+++++|+++..
T Consensus 277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 6666655544433 3569999999999 99999999999999998753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=357.98 Aligned_cols=258 Identities=28% Similarity=0.505 Sum_probs=209.1
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC-
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK- 595 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d- 595 (785)
++..++|++.+.||+|+||+||+|.+ +++.||||++... .....+.|.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 34567899999999999999999984 5789999998643 34556789999999999999999999998854
Q ss_pred -CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcc
Q 003935 596 -PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 674 (785)
Q Consensus 596 -~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 674 (785)
...+++||||+++|+|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 35689999999999999999742 346999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---------------HH
Q 003935 675 RIITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER---------------VV 736 (785)
Q Consensus 675 ~~l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~---------------~v 736 (785)
........ ......+++.|+|||.+.+..++.++||||||+++|+|+||..||....... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 87654321 1223457778999999999999999999999999999999999986532211 11
Q ss_pred HHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhcc
Q 003935 737 YAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 784 (785)
Q Consensus 737 ~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~sL 784 (785)
............+ +..+.+|+..||. ||.+|||+.++++.|+++...+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 2222333333333 3469999999999 9999999999999999987653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=374.90 Aligned_cols=250 Identities=20% Similarity=0.335 Sum_probs=216.0
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeecccc-ChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCce
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 599 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l 599 (785)
+..++|.+.+.||+|+||+||+|.+. ++.||||++.+... .....+.+..|..++..+ +||||+++++++.+.+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 45689999999999999999999984 67899999976532 122356788999999988 799999999999999999
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++....
T Consensus 97 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999999999999999973 35799999999999999999999999999999999999999999999999999987544
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHH
Q 003935 680 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIA 758 (785)
Q Consensus 680 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~ 758 (785)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.......+ .-+..+.+|+.
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 253 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 253 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 44445577899999999999999999999999999999999999999999998888888876543322 12346899999
Q ss_pred Hhhh-CCCCCCC-----HHHHHHH
Q 003935 759 DCWA-EPQERPS-----CEEILSR 776 (785)
Q Consensus 759 ~CL~-DP~kRPS-----~~EIL~~ 776 (785)
+||. ||.+||+ +.+|++|
T Consensus 254 ~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 254 GLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999 9999995 5777765
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=368.96 Aligned_cols=246 Identities=24% Similarity=0.440 Sum_probs=216.4
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 601 (785)
..++|.+.+.||+|+||+||+|.+ +|+.||+|++.+.... ....+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 457899999999999999999987 5889999999754321 1235678899999999999999999999999999999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
||||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 84 v~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp EECCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EEeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 999999999999997 3457899999999999999999999999999999999999999999999999999876542
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHh
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADC 760 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~C 760 (785)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.......+ .-...+.+|+.+|
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~l 237 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL 237 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 3456899999999999999999999999999999999999999999988888888776543322 1245799999999
Q ss_pred hh-CCCCCC-----CHHHHHHH
Q 003935 761 WA-EPQERP-----SCEEILSR 776 (785)
Q Consensus 761 L~-DP~kRP-----S~~EIL~~ 776 (785)
|. ||.+|| +++++++|
T Consensus 238 L~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 238 ITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTS
T ss_pred hccCHHHcCCCcCCCHHHHhcC
Confidence 99 999999 89999865
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=376.95 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=215.7
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCC
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPP 597 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~ 597 (785)
..+..++|.+.+.||+|+||+||+|.+ +|+.||||++.+... .....+.+..|..++..+ +||||+++++++.+..
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 345678999999999999999999988 488999999976432 122346678899999877 8999999999999999
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++..
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999999973 357899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHH
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRL 756 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~L 756 (785)
..........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.......+ .-+..+.+|
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 248 (345)
T 1xjd_A 169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 248 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred ccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHH
Confidence 4433345577899999999999999999999999999999999999999999998888887766543222 123569999
Q ss_pred HHHhhh-CCCCCCCHH-HHHHH
Q 003935 757 IADCWA-EPQERPSCE-EILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~-EIL~~ 776 (785)
+.+||. ||.+||++. +|++|
T Consensus 249 i~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 249 LVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHhcCCHhHcCCChHHHHcC
Confidence 999999 999999997 77644
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=371.12 Aligned_cols=249 Identities=26% Similarity=0.379 Sum_probs=210.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc---ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL---TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~---~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 601 (785)
+.|.+.+.||+|+||+||+|.+ +++.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 5799999999999999999987 588999999864322 11135678999999999999999999999999999999
Q ss_pred EEEEcccchhhHHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCe---EEEEecCccccc
Q 003935 602 ITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT---VKICDFGLSRII 677 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~---VKL~DFGLA~~l 677 (785)
||||+++++|.+.+.... ....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++...
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 999999999988775432 3345899999999999999999999999999999999999986654 999999999887
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----CCChH
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-----IPEGP 752 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-----ip~~~ 752 (785)
..........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+. .......+........ .....
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~ 262 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHISES 262 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccCCHH
Confidence 66544455678999999999999999999999999999999999999999885 3445555554433222 12346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.+|+.+||. ||.+|||+.++++|
T Consensus 263 ~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 263 AKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcC
Confidence 8999999999 99999999999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=364.46 Aligned_cols=246 Identities=26% Similarity=0.418 Sum_probs=214.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh----HHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA----ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~----~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
+.|.+.+.||+|+||+||+|.+ +|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+...++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 5699999999999999999988 48899999997654322 13577899999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC----eEEEEecCcccc
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW----TVKICDFGLSRI 676 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g----~VKL~DFGLA~~ 676 (785)
+||||+++++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 91 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 9999999999999986 456799999999999999999999999999999999999999887 899999999987
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----CCCh
Q 003935 677 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-----IPEG 751 (785)
Q Consensus 677 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-----ip~~ 751 (785)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+........ ..+.
T Consensus 168 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (326)
T 2y0a_A 168 IDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246 (326)
T ss_dssp CCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred CCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCH
Confidence 75432 23456799999999999999999999999999999999999999999888887777665443322 1234
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 752 PLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 752 ~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+.+|+.+||. ||.+|||+.++++|
T Consensus 247 ~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 247 LAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 68899999999 99999999999985
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=357.32 Aligned_cols=261 Identities=25% Similarity=0.504 Sum_probs=217.7
Q ss_pred cccccccCCCeeEee-EEeeeCcEEEEEEEE----CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccc
Q 003935 519 YEEWNIDFSELTVGT-RVGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 593 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k-~LG~G~fG~VYkg~~----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~ 593 (785)
..++.++.++|.+.+ .||+|+||+||+|.+ .++.||||++..........+.+.+|+.+++.++||||+++++++
T Consensus 8 ~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 87 (291)
T 1xbb_A 8 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 87 (291)
T ss_dssp ---CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 356677788999998 999999999999965 367899999976655555578899999999999999999999999
Q ss_pred cCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCc
Q 003935 594 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGL 673 (785)
Q Consensus 594 ~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGL 673 (785)
..+.+++||||+++++|.+++.. ...+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+|||+
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 163 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 163 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCc
Confidence 55678999999999999999973 45699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCC---CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003935 674 SRIITDSPMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP 749 (785)
Q Consensus 674 A~~l~~~~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip 749 (785)
+......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.+.........+.. +.....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 242 (291)
T 1xbb_A 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCP 242 (291)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCC
T ss_pred ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCC
Confidence 9876543221 123456789999999998889999999999999999999 9999999888777666544 3333333
Q ss_pred ---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhcc
Q 003935 750 ---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 784 (785)
Q Consensus 750 ---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~sL 784 (785)
+..+.+++.+||. ||.+||++.++++.|+++..+.
T Consensus 243 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 243 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 3469999999999 9999999999999999886543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=358.10 Aligned_cols=253 Identities=23% Similarity=0.431 Sum_probs=209.1
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEEC--C-------eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEecccc
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIWN--G-------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 594 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~~--g-------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~ 594 (785)
+..++|.+.+.||+|+||+||+|.+. + ..||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 45678999999999999999999763 3 569999986543 234578999999999999999999999999
Q ss_pred CCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCe--------E
Q 003935 595 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT--------V 666 (785)
Q Consensus 595 d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~--------V 666 (785)
+.+..++||||+.+++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred eCCCCEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 999999999999999999999742 345899999999999999999999999999999999999998877 9
Q ss_pred EEEecCccccccCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHhcCC
Q 003935 667 KICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGS 744 (785)
Q Consensus 667 KL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~-~PF~~~~~~~~v~~i~~~~~ 744 (785)
||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|. .||.................
T Consensus 161 kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (289)
T 4fvq_A 161 KLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ 236 (289)
T ss_dssp EECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred eeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCC
Confidence 99999999765332 22357889999999987 77999999999999999999965 45656555554444333222
Q ss_pred CCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhcc
Q 003935 745 RLEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 784 (785)
Q Consensus 745 ~~~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~sL 784 (785)
.+......+.+|+.+||. ||.+|||+.+++++|+++..+-
T Consensus 237 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 237 LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 222224469999999999 9999999999999999987654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=356.88 Aligned_cols=247 Identities=32% Similarity=0.590 Sum_probs=203.6
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhh--cCCCceeeEeccccC----CCce
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR--LRHPNVILFLGACTK----PPRL 599 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~--L~HPNIVkL~g~~~d----~~~l 599 (785)
.++|.+.+.||+|+||+||+|.++++.||||++... ....+..|.+++.. ++||||+++++++.. ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 468999999999999999999999999999998543 23556677777766 789999999998644 3458
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHH--------hcccccccCCCCcEEEcCCCeEEEEec
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH--------RMKIVHRDLKSANCLVNKHWTVKICDF 671 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLH--------s~gIIHrDLKpsNILLd~~g~VKL~DF 671 (785)
++||||+++|+|.++++ ...+++..++.++.|++.||+||| +.||+||||||+|||++.++.+||+||
T Consensus 82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 99999999999999994 347999999999999999999999 999999999999999999999999999
Q ss_pred CccccccCCCCC----CCCCCCCCcccCccccccC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCCC
Q 003935 672 GLSRIITDSPMR----DSSSAGTPEWMAPELIRNE------PFTEKCDIFSLGVIMWELCTL----------NRPWEGVL 731 (785)
Q Consensus 672 GLA~~l~~~~~~----~~~~~GT~~Y~APEvl~~~------~~s~ksDVWSLGvILyELLTG----------~~PF~~~~ 731 (785)
|+++........ .....||+.|+|||++.+. .++.++|||||||++|||+|| ..||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 999876543222 2345799999999999876 455799999999999999999 88886432
Q ss_pred -----hHHHHHHHHhcCCCCCCCC--------hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 732 -----PERVVYAVANEGSRLEIPE--------GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 732 -----~~~~v~~i~~~~~~~~ip~--------~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
.......+......+.++. ..+.+|+.+||. ||.+|||+.+|++.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 301 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 301 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhccC
Confidence 2233333333344444443 248899999999 9999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=352.98 Aligned_cols=258 Identities=28% Similarity=0.532 Sum_probs=220.4
Q ss_pred cccccCCCeeEee-EEeeeCcEEEEEEEE----CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC
Q 003935 521 EWNIDFSELTVGT-RVGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 595 (785)
Q Consensus 521 e~~i~~s~y~i~k-~LG~G~fG~VYkg~~----~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 595 (785)
++.+..++|.+.. .||+|+||+||+|.+ .+..||||++.... .....+.+.+|+.+++.++||||+++++++ .
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 4566778888887 999999999999975 47789999987543 345578899999999999999999999999 4
Q ss_pred CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 596 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
.+.+++||||+++++|.+++.. ....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 158 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK 158 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCcEEEEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccccee
Confidence 5569999999999999999862 34569999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCC---CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 003935 676 IITDSPMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP-- 749 (785)
Q Consensus 676 ~l~~~~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip-- 749 (785)
........ .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+.. +.....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~ 237 (287)
T 1u59_A 159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRMECPPE 237 (287)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-TCCCCCCTT
T ss_pred eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc-CCcCCCCCC
Confidence 77543221 223456889999999998889999999999999999998 9999999888777766554 3333333
Q ss_pred -ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003935 750 -EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 783 (785)
Q Consensus 750 -~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~s 783 (785)
+..+.+++..||. ||.+||++.+++++|+++..+
T Consensus 238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 3469999999999 999999999999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=350.71 Aligned_cols=259 Identities=32% Similarity=0.559 Sum_probs=221.3
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC-CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~-g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
.++|++..++|.+.+.||+|+||+||+|.+. +..||||++...... .+.+.+|+.+++.++||||+++++++.. +
T Consensus 5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 3678899999999999999999999999885 668999998765433 4678899999999999999999999875 4
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
..++||||+++++|.+++... ....+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CcEEEEecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 589999999999999998632 2236899999999999999999999999999999999999999999999999999877
Q ss_pred cCCCCC-CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003935 678 TDSPMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 752 (785)
Q Consensus 678 ~~~~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~ 752 (785)
...... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.+.........+... .....+ +..
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRPDNCPEE 238 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHH
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-cCCCCcccccHH
Confidence 543222 234457789999999998889999999999999999999 89999998887777666543 333333 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSRLLDCEYS 783 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~s 783 (785)
+.+|+..||. ||.+|||+.++++.|+++...
T Consensus 239 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 9999999999 999999999999999987543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=366.66 Aligned_cols=245 Identities=21% Similarity=0.313 Sum_probs=214.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
.++|.+.+.||+|+||+||+|.+ +++.||+|++... ......+.+|+.+++.++||||+++++++.+...+++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 47899999999999999999988 4889999998643 234567889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC--CCeEEEEecCccccccCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK--HWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~--~g~VKL~DFGLA~~l~~~~ 681 (785)
||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..+....
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 81 EFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EeCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999999862 2347999999999999999999999999999999999999987 7899999999998775432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHH
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRL 756 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i-----p~~~L~~L 756 (785)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+......... .+..+.+|
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHH
Confidence 223456899999999999988999999999999999999999999999988888887765544321 23468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003935 757 IADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.+||. ||.+|||+.++++|
T Consensus 238 i~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 238 VDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHcCCChhHCcCHHHHhcC
Confidence 999999 99999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=357.99 Aligned_cols=263 Identities=31% Similarity=0.566 Sum_probs=220.3
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEe
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 590 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~ 590 (785)
..+|.+..++|.+.+.||+|+||+||+|.+ +++.||||++.... .....+.+.+|+.+++.+ +||||++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 456778889999999999999999999975 35789999987543 344567899999999999 699999999
Q ss_pred ccccCCC-ceeEEEEEcccchhhHHHHhhcc-------------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCC
Q 003935 591 GACTKPP-RLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 656 (785)
Q Consensus 591 g~~~d~~-~l~LV~Ey~~gGSL~dlL~~~~~-------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKps 656 (785)
+++...+ .+++||||+++++|.+++..... ...+++..++.++.|++.||+|||++||+||||||+
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~ 177 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence 9987654 48999999999999999974322 122899999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 003935 657 NCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 733 (785)
Q Consensus 657 NILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~ 733 (785)
|||++.++.+||+|||++........ ......+|+.|+|||++.+..++.++|||||||++|+|+| |..||.+....
T Consensus 178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 99999999999999999987644322 1223457889999999999999999999999999999998 99999887655
Q ss_pred HHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 734 RVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 734 ~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
.........+.....+ ...+.+++.+||. ||.+|||+.+++++|+++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 5444444444444443 3469999999999 99999999999999998754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=384.48 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=208.9
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCce
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 599 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 599 (785)
.+..++|.+.+.||+|+||+||+|.+ +|+.||||++..... .......+.+|+.+++.++||||++++++|.+.+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 34567899999999999999999987 588999999975432 233456788999999999999999999999999999
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-cccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+++...
T Consensus 224 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EEEECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEEEeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999999873 4579999999999999999999998 999999999999999999999999999998755
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHH
Q 003935 679 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLI 757 (785)
Q Consensus 679 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI 757 (785)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+.......+ .-+..+.+||
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 380 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL 380 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 444445567899999999999999999999999999999999999999999988888887776554332 1234689999
Q ss_pred HHhhh-CCCCCC-----CHHHHHHH
Q 003935 758 ADCWA-EPQERP-----SCEEILSR 776 (785)
Q Consensus 758 ~~CL~-DP~kRP-----S~~EIL~~ 776 (785)
.+||. ||.+|| ++.++++|
T Consensus 381 ~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 381 SGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHcccCHHHhCCCCCCCHHHHHhC
Confidence 99999 999999 99999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=356.18 Aligned_cols=259 Identities=31% Similarity=0.653 Sum_probs=223.8
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 596 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 596 (785)
++.|++..++|.+.+.||+|+||+||+|.+. +..||+|++.... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 4678889999999999999999999999884 8899999986543 3457789999999999999999999999999
Q ss_pred CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
..+++||||+.+++|.+++... ....+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++..
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred CCEEEEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 9999999999999999999743 345689999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---Ch
Q 003935 677 ITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EG 751 (785)
Q Consensus 677 l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~ 751 (785)
...... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...........+... .....+ +.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 239 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERPEGCPE 239 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCCTTCCH
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc-CCCCCCCCCCH
Confidence 654322 1223456788999999999999999999999999999999 99999988877666655443 333333 34
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 752 PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 752 ~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
.+.+|+..||. ||.+|||+.++++.|+++..
T Consensus 240 ~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 69999999999 99999999999999987643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=371.97 Aligned_cols=259 Identities=29% Similarity=0.511 Sum_probs=219.3
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEecccc
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 594 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~ 594 (785)
.++..++|.+.+.||+|+||+||+|.+ .++.||||++... ........+.+|+.+++.++||||+++++++.
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 455678899999999999999999984 3568999998643 33445678999999999999999999999999
Q ss_pred CCCceeEEEEEcccchhhHHHHhhcc----cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC---eEE
Q 003935 595 KPPRLSMITEYMELGSLYHLIHLSGQ----KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVK 667 (785)
Q Consensus 595 d~~~l~LV~Ey~~gGSL~dlL~~~~~----~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g---~VK 667 (785)
+....++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999999999975431 24589999999999999999999999999999999999999554 599
Q ss_pred EEecCccccccCCC--CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Q 003935 668 ICDFGLSRIITDSP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGS 744 (785)
Q Consensus 668 L~DFGLA~~l~~~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~ 744 (785)
|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++ |..||...........+....
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~- 303 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG- 303 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-
Confidence 99999998653221 12233567899999999999999999999999999999998 999999998888777766544
Q ss_pred CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 745 RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 745 ~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
....+ +..+.+|+.+||+ ||.+|||+.+|+++|+.+..
T Consensus 304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 23222 3469999999999 99999999999999987653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=377.05 Aligned_cols=251 Identities=21% Similarity=0.364 Sum_probs=209.7
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCc
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRL-RHPNVILFLGACTKPPR 598 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~ 598 (785)
.+..++|.+.+.||+|+||+||+|.+ +++.||||++.+.... ....+.+..|+.++..+ +||||+++++++.+...
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 35668999999999999999999988 4789999999766543 23345678899999887 89999999999999999
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
+|+||||+++|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++...
T Consensus 128 ~~lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999999999873 4579999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHhcCCCCC-C
Q 003935 679 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV---------LPERVVYAVANEGSRLE-I 748 (785)
Q Consensus 679 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~---------~~~~~v~~i~~~~~~~~-i 748 (785)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ .
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 284 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence 4444556788999999999999999999999999999999999999999643 22233444444332221 1
Q ss_pred CChHHHHHHHHhhh-CCCCCCCH------HHHHHH
Q 003935 749 PEGPLGRLIADCWA-EPQERPSC------EEILSR 776 (785)
Q Consensus 749 p~~~L~~LI~~CL~-DP~kRPS~------~EIL~~ 776 (785)
-...+.+||.+||+ ||.+||++ .+|++|
T Consensus 285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 23468999999999 99999985 677765
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=353.09 Aligned_cols=255 Identities=28% Similarity=0.561 Sum_probs=211.2
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC-C
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-P 597 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~-~ 597 (785)
...|.+..++|.+.+.||+|+||+||++.++|+.||||++.... ..+.+.+|+.+++.++||||+++++++.+. +
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence 34577888999999999999999999999999999999986443 346789999999999999999999986554 5
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+++||||+++++|.+++... ....+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++...
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred ceEEEEecCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 799999999999999999743 2234889999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPL 753 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L 753 (785)
... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+.. +.....+ +..+
T Consensus 168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 243 (278)
T 1byg_A 168 SST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPAV 243 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-TCCCCCCTTCCHHH
T ss_pred ccc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCcccCCHHH
Confidence 432 223467889999999999999999999999999999998 9999998877666655533 3333333 3469
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 754 GRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 754 ~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
.+++..||. ||.+|||+.++++.|+++..
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 999999999 99999999999999998865
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=361.59 Aligned_cols=261 Identities=28% Similarity=0.570 Sum_probs=222.3
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeE
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILF 589 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL 589 (785)
..|.+..++|.+.+.||+|+||+||+|.+. +..||||++.... .....+.+.+|+.+++.+ +||||+++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 456778899999999999999999999863 5679999986543 345567899999999999 89999999
Q ss_pred eccccCCCceeEEEEEcccchhhHHHHhhcc-------------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCC
Q 003935 590 LGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 656 (785)
Q Consensus 590 ~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~-------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKps 656 (785)
++++.+.+.+++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 9999999999999999999999999974321 234899999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 003935 657 NCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 733 (785)
Q Consensus 657 NILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~ 733 (785)
|||++.++.+||+|||++........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 99999999999999999987654322 1234467889999999999889999999999999999999 99999998887
Q ss_pred HHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 734 RVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 734 ~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
+....+.... ....+ ...+.+++..||. ||.+|||+.+++++|+++..
T Consensus 267 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 267 ELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhcCC-CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 7776655433 33333 3469999999999 99999999999999998753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=353.32 Aligned_cols=249 Identities=27% Similarity=0.455 Sum_probs=212.4
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHhhcCCCceeeEeccccCCCce
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 599 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 599 (785)
...+++|.+.+.||+|+||+||+|.+ ++..||||++....... .....+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 34568999999999999999999988 46789999986543221 2246788999999999999999999999999999
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999999999873 35689999999999999999999999999999999999999999999999999866543
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHH
Q 003935 680 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIA 758 (785)
Q Consensus 680 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~ 758 (785)
. ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...........+.......+ .....+.+|+.
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (279)
T 3fdn_A 162 S--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 239 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred c--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence 2 23456789999999999999999999999999999999999999999888887777665443322 23456999999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003935 759 DCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 759 ~CL~-DP~kRPS~~EIL~~ 776 (785)
+||. ||.+|||+.++++|
T Consensus 240 ~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 240 RLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHCCSSGGGSCCHHHHHHC
T ss_pred HHhccChhhCCCHHHHhhC
Confidence 9999 99999999999987
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=360.57 Aligned_cols=243 Identities=25% Similarity=0.388 Sum_probs=212.1
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
.|...+.||+|+||+||+|.+ +|+.||||++...... ..+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 367778999999999999987 5899999998755432 346788999999999999999999999999999999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCC
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 685 (785)
+++++|.+++. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 124 ~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 124 LQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp CCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred CCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence 99999999885 34699999999999999999999999999999999999999999999999999987765433445
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC----CChHHHHHHHHhh
Q 003935 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI----PEGPLGRLIADCW 761 (785)
Q Consensus 686 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i----p~~~L~~LI~~CL 761 (785)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+......... .+..+.+++.+||
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 678999999999999999999999999999999999999999998887777766554322111 1345899999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003935 762 A-EPQERPSCEEILSR 776 (785)
Q Consensus 762 ~-DP~kRPS~~EIL~~ 776 (785)
. ||.+|||+.+++++
T Consensus 280 ~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 280 VRDPQERATAQELLDH 295 (321)
T ss_dssp CSSTTTSCCHHHHHTS
T ss_pred cCChhhCcCHHHHhcC
Confidence 9 99999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=371.61 Aligned_cols=247 Identities=21% Similarity=0.356 Sum_probs=216.9
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
...++|.+.+.||+|+||+||+|.+ +|+.||||++.+... .....+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 3567899999999999999999988 588999999965532 1233567889999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 118 lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999999999973 346999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHH
Q 003935 681 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIAD 759 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~ 759 (785)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+ .-...+.+||.+
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 271 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 2356899999999999999999999999999999999999999999988888888776543322 123569999999
Q ss_pred hhh-CCCCCCC-----HHHHHHH
Q 003935 760 CWA-EPQERPS-----CEEILSR 776 (785)
Q Consensus 760 CL~-DP~kRPS-----~~EIL~~ 776 (785)
||. ||.+||+ +.+|++|
T Consensus 272 lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 272 LLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HhhcCHHhccCCccCCHHHHHhC
Confidence 999 9999998 8888865
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=357.73 Aligned_cols=265 Identities=29% Similarity=0.515 Sum_probs=214.9
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccc
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 593 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~ 593 (785)
.+.+.+..++|.+.+.||+|+||+||+|.+. +..||+|++..........+.+.+|+.+++.++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3566677889999999999999999999762 34799999987766666778899999999999999999999998
Q ss_pred cCCC-----ceeEEEEEcccchhhHHHHhhc---ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCe
Q 003935 594 TKPP-----RLSMITEYMELGSLYHLIHLSG---QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 665 (785)
Q Consensus 594 ~d~~-----~l~LV~Ey~~gGSL~dlL~~~~---~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~ 665 (785)
.+.. ..++||||+.+++|.+++.... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence 7654 3599999999999999985432 3457999999999999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 003935 666 VKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANE 742 (785)
Q Consensus 666 VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~ 742 (785)
+||+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+...
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 265 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC
Confidence 99999999987644321 1223457889999999999999999999999999999999 88999988887777666554
Q ss_pred CCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhcc
Q 003935 743 GSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 784 (785)
Q Consensus 743 ~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~sL 784 (785)
. ....+ ...+.+|+.+||. ||.+|||+.+++++|+++..++
T Consensus 266 ~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 266 H-RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp C-CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred C-CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 3 33333 3469999999999 9999999999999999987654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=371.16 Aligned_cols=253 Identities=19% Similarity=0.289 Sum_probs=211.7
Q ss_pred cccCCCeeEeeEEeee--CcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 523 NIDFSELTVGTRVGIG--FFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G--~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
....++|.+.+.||+| +||+||+|.+ +|+.||||++..........+.+.+|+.+++.++|||||++++++.+.+.
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 3456789999999999 9999999998 48899999998877667777889999999999999999999999999999
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
+++||||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999999999743 23569999999999999999999999999999999999999999999999999986543
Q ss_pred CCC-------CCCCCCCCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----
Q 003935 679 DSP-------MRDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR---- 745 (785)
Q Consensus 679 ~~~-------~~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~---- 745 (785)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 211 11233578999999999987 67999999999999999999999999876555444333221110
Q ss_pred -------------------------------------------CCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 746 -------------------------------------------LEIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 746 -------------------------------------------~~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
...-...+.+|+.+||. ||.+|||+.++++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00012358889999999 99999999999976
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=363.63 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=199.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC-------
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------- 597 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------- 597 (785)
++|.+.+.||+|+||+||+|.+ +|+.||||++..... ....+.+.+|+.+++.++||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST-TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 5789999999999999999988 588999999975542 334678999999999999999999999885543
Q ss_pred --------------------------------------------------ceeEEEEEcccchhhHHHHhhcccccchHH
Q 003935 598 --------------------------------------------------RLSMITEYMELGSLYHLIHLSGQKKKLSWR 627 (785)
Q Consensus 598 --------------------------------------------------~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~ 627 (785)
.+++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 279999999999999999865555567778
Q ss_pred HHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC------------CCCCCCCCCCcccC
Q 003935 628 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP------------MRDSSSAGTPEWMA 695 (785)
Q Consensus 628 ~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~------------~~~~~~~GT~~Y~A 695 (785)
.++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 899999999999999999999999999999999999999999999998775432 12234579999999
Q ss_pred ccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHH
Q 003935 696 PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCE 771 (785)
Q Consensus 696 PEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~ 771 (785)
||++.+..++.++|||||||++|+|++|..|+... ......+.. ...+... ...+.+|+.+||. ||.+|||+.
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 321 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRN-LKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT 321 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHT-TCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhc-cCCCcccccCChhHHHHHHHHccCCCCcCCCHH
Confidence 99999999999999999999999999987765321 112222222 1111111 2357889999999 999999999
Q ss_pred HHHHH
Q 003935 772 EILSR 776 (785)
Q Consensus 772 EIL~~ 776 (785)
+++++
T Consensus 322 ~~l~~ 326 (332)
T 3qd2_B 322 DIIEN 326 (332)
T ss_dssp HHHHS
T ss_pred HHhhc
Confidence 99975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=374.77 Aligned_cols=253 Identities=20% Similarity=0.339 Sum_probs=208.9
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHH-HhhcCCCceeeEeccccCCCce
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISI-LSRLRHPNVILFLGACTKPPRL 599 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~i-Lk~L~HPNIVkL~g~~~d~~~l 599 (785)
+..++|.+.+.||+|+||+||+|.+ +++.||||++.+.... ......+..|..+ ++.++||||+++++++.+.+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 3557899999999999999999988 4778999999776543 2334567778777 5778999999999999999999
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++....
T Consensus 115 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999999873 45789999999999999999999999999999999999999999999999999987554
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHH
Q 003935 680 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIA 758 (785)
Q Consensus 680 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~ 758 (785)
........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+........ .-...+.+|+.
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 271 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLE 271 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Confidence 44445567899999999999999999999999999999999999999999998888888876543322 12346899999
Q ss_pred Hhhh-CCCCCCCHHHHHHHHHh
Q 003935 759 DCWA-EPQERPSCEEILSRLLD 779 (785)
Q Consensus 759 ~CL~-DP~kRPS~~EIL~~L~~ 779 (785)
+||. ||.+||++.+.++.+.+
T Consensus 272 ~lL~~dp~~R~~~~~~~~~i~~ 293 (373)
T 2r5t_A 272 GLLQKDRTKRLGAKDDFMEIKS 293 (373)
T ss_dssp HHTCSSGGGSTTTTTTHHHHHT
T ss_pred HHcccCHHhCCCCCCCHHHHhC
Confidence 9999 99999998544444443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=373.51 Aligned_cols=255 Identities=34% Similarity=0.587 Sum_probs=207.0
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
++..++|.+.+.||+|+||+||+|.+. +..||||++.... .....+.|.+|+.+++.++||||+++++++.+..
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 455678999999999999999999763 6679999986543 4455678999999999999999999999999999
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred ceEEEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999999973 3457999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCC---CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---C
Q 003935 678 TDSPMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---E 750 (785)
Q Consensus 678 ~~~~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~ 750 (785)
...... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||...........+.. +.....+ +
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~ 276 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYRLPPPMDCP 276 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT-TEECCCCTTCB
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcccc
Confidence 543221 122345778999999999999999999999999999998 9999999888777766544 3333333 3
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 751 GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 751 ~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
..+.+|+..||. ||.+||++.+|++.|+++.
T Consensus 277 ~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 277 AALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 469999999999 9999999999999998874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=351.05 Aligned_cols=250 Identities=33% Similarity=0.605 Sum_probs=209.9
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHH-----HHHHHHHHHHHhhcCCCceeeEeccccCC
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAEN-----MEDFCNEISILSRLRHPNVILFLGACTKP 596 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~-----~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 596 (785)
+..++|.+.+.||+|+||+||+|.+ +++.||+|++......... .+.+.+|+.+++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 4558899999999999999999988 5889999998655433221 16789999999999999999999999776
Q ss_pred CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc--cccccCCCCcEEEcCCCe-----EEEE
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWT-----VKIC 669 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~g--IIHrDLKpsNILLd~~g~-----VKL~ 669 (785)
. ++||||+++++|.+.+.. ....+++..++.++.|++.||+|||++| |+||||||+|||++.++. +||+
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred C--eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 5 799999999999988863 3457999999999999999999999999 999999999999987776 9999
Q ss_pred ecCccccccCCCCCCCCCCCCCcccCcccc--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhcCCC
Q 003935 670 DFGLSRIITDSPMRDSSSAGTPEWMAPELI--RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERV--VYAVANEGSR 745 (785)
Q Consensus 670 DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl--~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~--v~~i~~~~~~ 745 (785)
|||+++.... ......||+.|+|||++ ....++.++|||||||++|+|++|+.||........ ...+......
T Consensus 172 Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 248 (287)
T 4f0f_A 172 DFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248 (287)
T ss_dssp CCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC
T ss_pred CCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC
Confidence 9999975443 23456799999999998 445678999999999999999999999986654333 4444455555
Q ss_pred CCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 746 LEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 746 ~~ip~---~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
..++. ..+.+|+.+||. ||.+|||+.++++.|+++
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 55543 369999999999 999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=361.99 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=196.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
.++|.+.+.||+|+||+||+|.+ +|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 46799999999999999999987 488999999875542 223467889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhc---ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 604 EYMELGSLYHLIHLSG---QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~---~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
||+. ++|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 9998 58888886432 1245899999999999999999999999999999999999999999999999999887544
Q ss_pred CCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------------
Q 003935 681 PMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------- 746 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~------------- 746 (785)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (317)
T 2pmi_A 162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241 (317)
T ss_dssp CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence 444456689999999999976 468999999999999999999999999988877776664321100
Q ss_pred ----------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 ----------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 ----------------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
...+..+.+|+.+||. ||.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0112368899999999 99999999999975
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=357.35 Aligned_cols=253 Identities=23% Similarity=0.380 Sum_probs=210.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC--ceeE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP--RLSM 601 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~--~l~L 601 (785)
.++|.+.+.||+|+||+||+|.+. ++.||||++...... ...+.+.+|+.+++.++||||+++++++.... .+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 467999999999999999999984 889999998754432 23567889999999999999999999987655 6899
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEE----cCCCeEEEEecCccccc
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRII 677 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILL----d~~g~VKL~DFGLA~~l 677 (785)
||||+++++|.+++........+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 99999999999999855444459999999999999999999999999999999999999 78889999999999877
Q ss_pred cCCCCCCCCCCCCCcccCccccc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCC
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIR--------NEPFTEKCDIFSLGVIMWELCTLNRPWEGVL----PERVVYAVANEGSR 745 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~--------~~~~s~ksDVWSLGvILyELLTG~~PF~~~~----~~~~v~~i~~~~~~ 745 (785)
.... ......||+.|+|||++. +..++.++|||||||++|||++|+.||.... .......+......
T Consensus 167 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~ 245 (319)
T 4euu_A 167 EDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245 (319)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCT
T ss_pred CCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCc
Confidence 5543 234567999999999986 5778999999999999999999999996432 34445555443321
Q ss_pred C-----------------CCC---------ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 746 L-----------------EIP---------EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 746 ~-----------------~ip---------~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
. .++ ...+.+++.+||. ||.+|||+.|++++..+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1 111 1247889999999 999999999999998874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=365.75 Aligned_cols=247 Identities=23% Similarity=0.357 Sum_probs=204.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
.++|.+.+.||+|+||+||+|.+ +++.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 47899999999999999999987 5889999998655432 23467889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC--C
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS--P 681 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~--~ 681 (785)
||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+... .
T Consensus 85 e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 85 EYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp ECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EcCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999999999885 4557999999999999999999999999999999999999999999999999999865422 1
Q ss_pred CCCCCCCCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhcCCCCCC---CChHHHHH
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERV-VYAVANEGSRLEI---PEGPLGRL 756 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvILyELLTG~~PF~~~~~~~~-v~~i~~~~~~~~i---p~~~L~~L 756 (785)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ...+......... ....+.+|
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 22345689999999999988765 7799999999999999999999987655422 2222222222211 23468899
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003935 757 IADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.+||. ||.+|||+.+++++
T Consensus 242 i~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 242 LHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHccCChhhCcCHHHHhhC
Confidence 999999 99999999999876
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=363.39 Aligned_cols=251 Identities=23% Similarity=0.385 Sum_probs=208.3
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCC--CceeeEeccccCCCc
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH--PNVILFLGACTKPPR 598 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~H--PNIVkL~g~~~d~~~ 598 (785)
..+....|.+.+.||+|+||+||++.+ +++.||||++..........+.+.+|+.+++.++| |||+++++++.+...
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 455667899999999999999999987 57889999998777777777889999999999986 999999999999999
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
+++||| +.+++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++..+.
T Consensus 84 ~~lv~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEEEEC-CCSEEHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEEEEe-CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999999 56789999997 345789999999999999999999999999999999999997 5789999999998765
Q ss_pred CCCC--CCCCCCCCCcccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCC
Q 003935 679 DSPM--RDSSSAGTPEWMAPELIRN-----------EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGS 744 (785)
Q Consensus 679 ~~~~--~~~~~~GT~~Y~APEvl~~-----------~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~-~~v~~i~~~~~ 744 (785)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+.....
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence 4322 2235679999999999865 67899999999999999999999999875443 44444444444
Q ss_pred CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003935 745 RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRL 777 (785)
Q Consensus 745 ~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L 777 (785)
....+ ...+.+|+.+||. ||.+|||+.++++|-
T Consensus 239 ~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 239 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 44333 3469999999999 999999999999873
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=350.65 Aligned_cols=257 Identities=30% Similarity=0.526 Sum_probs=214.7
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC
Q 003935 521 EWNIDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 595 (785)
Q Consensus 521 e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 595 (785)
.+.+..++|.+.+.||+|+||+||+|.+. +..||+|++.... .....+.|.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 45677889999999999999999999762 2359999986543 34456889999999999999999999999876
Q ss_pred CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 596 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
+ ..++||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 85 ~-~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 85 E-PTWIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred C-CCEEEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCc
Confidence 4 578999999999999999742 3568999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---C
Q 003935 676 IITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---E 750 (785)
Q Consensus 676 ~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~ 750 (785)
....... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||...........+.... ....+ +
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 240 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-RLPKPDLCP 240 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC-CCCCCTTCC
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC-CCCCCCCCC
Confidence 7654322 2234567889999999999999999999999999999998 999998877766666554433 23332 3
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 751 GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 751 ~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
..+.+++.+||. ||.+|||+.+++++|+++..
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 241 PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 469999999999 99999999999999998753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=360.43 Aligned_cols=251 Identities=25% Similarity=0.419 Sum_probs=205.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCce---
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL--- 599 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l--- 599 (785)
.++|.+.+.||+|+||+||+|.+ +++.||||++..... .......+.+|+.+++.++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 36899999999999999999987 688999999976543 344567889999999999999999999998765543
Q ss_pred -eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 600 -SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 600 -~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
|+||||+++++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 999999999999999973 3579999999999999999999999999999999999999999999999999998765
Q ss_pred CCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CC
Q 003935 679 DSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PE 750 (785)
Q Consensus 679 ~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i-----p~ 750 (785)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+................+.. .+
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 247 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCC
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCC
Confidence 4321 223456899999999999999999999999999999999999999999888877776665443321 23
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHH-HHh
Q 003935 751 GPLGRLIADCWA-EPQERPSCEEILSR-LLD 779 (785)
Q Consensus 751 ~~L~~LI~~CL~-DP~kRPS~~EIL~~-L~~ 779 (785)
..+.+|+.+||. ||.+||+..+++.+ +.+
T Consensus 248 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 248 ADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 468999999999 99999976666644 443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=353.13 Aligned_cols=253 Identities=28% Similarity=0.457 Sum_probs=215.3
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccc--cCCCceeE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC--TKPPRLSM 601 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~--~d~~~l~L 601 (785)
.++|.+.+.||+|+||+||++.+ +++.||+|++..........+.+.+|+.+++.++||||+++++++ .....+++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46899999999999999999988 588999999987776677778899999999999999999999987 44667999
Q ss_pred EEEEcccchhhHHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhcc-----cccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 602 ITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMK-----IVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~AL~yLHs~g-----IIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.| |+|+||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999987432 2345899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003935 676 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGP 752 (785)
Q Consensus 676 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~ 752 (785)
.............|++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+.... ...++ +..
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~ 243 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIPYRYSDE 243 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCCTTSCHH
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc-cccCCcccCHH
Confidence 76543222223468999999999999999999999999999999999999999988877776665543 33333 357
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSRLLD 779 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~L~~ 779 (785)
+.+++.+||. ||.+||++.+|++++..
T Consensus 244 l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 244 LNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 9999999999 99999999999987653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=364.99 Aligned_cols=248 Identities=23% Similarity=0.299 Sum_probs=200.1
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
..++|.+.+.||+|+||+||+|.+ +++.||||++..........+.+.+|+.+++.++||||+++++++.+...+++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 356899999999999999999987 588999999976655555567788999999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEE-----cCCCeEEEEecCccccc
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV-----NKHWTVKICDFGLSRII 677 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILL-----d~~g~VKL~DFGLA~~l 677 (785)
|||+.+ +|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||+ +..+.+||+|||++...
T Consensus 112 ~e~~~~-~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 112 FEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EECCSE-EHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EecCCC-CHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 999985 8998886 34569999999999999999999999999999999999999 45556999999999887
Q ss_pred cCCCCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---------
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE--------- 747 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~--------- 747 (785)
...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+......+.
T Consensus 188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 6544444566789999999999874 589999999999999999999999999888777776654211111
Q ss_pred -------C---------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 -------I---------------PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 -------i---------------p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
. .+..+.+|+.+||. ||.+|||+.++++|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0 12457899999999 99999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=355.71 Aligned_cols=249 Identities=35% Similarity=0.665 Sum_probs=204.1
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++.++|.+.+.||+|+||+||++.+.++.||||++... ...+.|.+|+.++++++||||+++++++.+ ..++||
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence 46688999999999999999999999999999998532 335789999999999999999999999874 479999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh---cccccccCCCCcEEEcCCCe-EEEEecCccccccC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR---MKIVHRDLKSANCLVNKHWT-VKICDFGLSRIITD 679 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs---~gIIHrDLKpsNILLd~~g~-VKL~DFGLA~~l~~ 679 (785)
||+++|+|.+++........+++..++.++.|++.||+|||+ +||+||||||+|||++.++. +||+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 999999999999754333457899999999999999999999 89999999999999988876 79999999976543
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCCCCCCC---ChHHH
Q 003935 680 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP--ERVVYAVANEGSRLEIP---EGPLG 754 (785)
Q Consensus 680 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~--~~~v~~i~~~~~~~~ip---~~~L~ 754 (785)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+. .+..+..+ +..+.
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 234 (307)
T 2eva_A 159 H---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-NGTRPPLIKNLPKPIE 234 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH-TTCCCCCBTTCCHHHH
T ss_pred c---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh-cCCCCCcccccCHHHH
Confidence 2 2345689999999999999999999999999999999999999986432 22333332 23333332 34699
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 755 RLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 755 ~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
+|+.+||. ||.+|||+.+++++|+++..
T Consensus 235 ~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 235 SLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 99999999 99999999999999998754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=351.97 Aligned_cols=256 Identities=28% Similarity=0.479 Sum_probs=210.5
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 596 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 596 (785)
.+....|++.+.||+|+||.||+|.+ +++.||||++..... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 34456799999999999999999984 588999999875432 23457789999999999999999999999876
Q ss_pred --CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcc
Q 003935 597 --PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 674 (785)
Q Consensus 597 --~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 674 (785)
..+++||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCceEEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence 6689999999999999999632 356899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC--------------CChHHHHH
Q 003935 675 RIITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG--------------VLPERVVY 737 (785)
Q Consensus 675 ~~l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~--------------~~~~~~v~ 737 (785)
........ ......||..|+|||++.+..++.++|||||||++|+|++|..|+.. ........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 87754432 23355688899999999999999999999999999999999987532 22222333
Q ss_pred HHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 738 AVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 738 ~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
.....+.....+ +..+.+|+.+||. ||.+|||+.++++.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 333444444444 2469999999999 9999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=357.89 Aligned_cols=257 Identities=34% Similarity=0.552 Sum_probs=213.9
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEEC------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 595 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 595 (785)
.++..++|.+.+.||+|+||+||+|.+. +..||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 3567789999999999999999999763 2359999986543 34456789999999999999999999999999
Q ss_pred CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 596 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
.+..++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CCCcEEEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 9999999999999999999863 34578999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 003935 676 IITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP-- 749 (785)
Q Consensus 676 ~l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip-- 749 (785)
....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+... .....+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~ 274 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPTPMD 274 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTT
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC-CcCCCccc
Confidence 7654321 1223456788999999999999999999999999999999 99999998888777766543 333333
Q ss_pred -ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 750 -EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 750 -~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
+..+.+|+.+||. ||.+||++.+++++|+++..
T Consensus 275 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 275 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 3469999999999 99999999999999988653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=348.17 Aligned_cols=252 Identities=17% Similarity=0.229 Sum_probs=211.6
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCceeE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~L 601 (785)
..++|.+.+.||+|+||+||+|.+ +++.||||++...... +.+.+|+.+++.+ +|+||+++++++.+....++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 347899999999999999999986 6899999998654332 3577899999999 79999999999999999999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCe-----EEEEecCcccc
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT-----VKICDFGLSRI 676 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~-----VKL~DFGLA~~ 676 (785)
||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 84 v~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99999 99999999743 346999999999999999999999999999999999999987766 99999999987
Q ss_pred ccCCCC-------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhcCCCC
Q 003935 677 ITDSPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV---LPERVVYAVANEGSRL 746 (785)
Q Consensus 677 l~~~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~---~~~~~v~~i~~~~~~~ 746 (785)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+. ........+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 754322 124567999999999999999999999999999999999999999874 3334444333222111
Q ss_pred C------CCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003935 747 E------IPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 783 (785)
Q Consensus 747 ~------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~s 783 (785)
. --+..+.+|+..||. ||.+||++.+|++.|+++...
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 1 113469999999999 999999999999999987654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=347.85 Aligned_cols=254 Identities=29% Similarity=0.540 Sum_probs=211.2
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CC---eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCce-eE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NG---TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL-SM 601 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g---~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l-~L 601 (785)
.|.+.+.||+|+||+||+|.+ ++ ..+|+|++... ......+.+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 466789999999999999976 22 36999998643 3345568899999999999999999999999876655 99
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
+|||+.+++|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 101 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999999999963 34678999999999999999999999999999999999999999999999999998654321
Q ss_pred ----CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003935 682 ----MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIP---EGPL 753 (785)
Q Consensus 682 ----~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~-PF~~~~~~~~v~~i~~~~~~~~ip---~~~L 753 (785)
.......+++.|+|||.+.+..++.++|||||||++|+|++|.. ||...........+.. ......+ +..+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 257 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ-GRRLPQPEYCPDSL 257 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT-TCCCCCCTTCCHHH
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc-CCCCCCCccchHHH
Confidence 22234567889999999999999999999999999999999555 5666666555555443 3333333 3469
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhhhhccC
Q 003935 754 GRLIADCWA-EPQERPSCEEILSRLLDCEYSLC 785 (785)
Q Consensus 754 ~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~sLc 785 (785)
.+|+.+||. ||.+|||+.++++.|+++...++
T Consensus 258 ~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 258 YQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 999999999 99999999999999999877654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=360.38 Aligned_cols=248 Identities=19% Similarity=0.253 Sum_probs=209.7
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCceeEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV 602 (785)
.++|.+.+.||+|+||+||+|.+ +++.||||++...... +.+.+|+.+++.+ +||||+++++++......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 37899999999999999999986 6899999998755332 3578999999999 899999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCe-----EEEEecCccccc
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT-----VKICDFGLSRII 677 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~-----VKL~DFGLA~~l 677 (785)
|||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.+
T Consensus 84 ~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 84 LELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 9999 89999999743 457999999999999999999999999999999999999998887 999999999876
Q ss_pred cCCCCC-------CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcCCCCC
Q 003935 678 TDSPMR-------DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL---PERVVYAVANEGSRLE 747 (785)
Q Consensus 678 ~~~~~~-------~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~---~~~~v~~i~~~~~~~~ 747 (785)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+....+........
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 543221 245689999999999999999999999999999999999999998743 3333333322211111
Q ss_pred -------CCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 748 -------IPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 748 -------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
.| .+.+|+..||. ||.+||++.+|++.|+++..
T Consensus 241 ~~~~~~~~p--~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 241 IEVLCENFP--EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp HHHHTTTCH--HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHhccCh--HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 22 79999999999 99999999999999987653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=361.32 Aligned_cols=252 Identities=27% Similarity=0.548 Sum_probs=207.0
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCe----EEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~----~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
..++|.+.+.||+|+||+||+|.+ +++ +||+|.+.... .....+.|.+|+.+++.++||||++++++|.+..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 457899999999999999999987 344 35778765432 2334578999999999999999999999998764
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
.++++||+.+|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~~~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred eEEEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 8899999999999999874 34579999999999999999999999999999999999999999999999999998775
Q ss_pred CCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003935 679 DSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 752 (785)
Q Consensus 679 ~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~ 752 (785)
.... ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.........+.. +.....+ ...
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 247 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GERLPQPPICTID 247 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TCCCCCCTTBCHH
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc-CCCCCCCccCCHH
Confidence 4322 2234456889999999999999999999999999999999 9999998887766655544 3333333 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
+.+|+.+||+ ||.+||++.+++++|+.+.
T Consensus 248 ~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 248 VYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 8999999999 9999999999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=351.75 Aligned_cols=258 Identities=27% Similarity=0.466 Sum_probs=204.5
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccc-cChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQD-LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~-~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 601 (785)
...+|.+.+.||+|+||.||+|.+ +|+.||||++.... ......+.+.+|+.+++.++||||+++++++...+.+++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 456899999999999999999987 58899999987543 345556789999999999999999999999999999999
Q ss_pred EEEEcccchhhHHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 602 ITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
||||+.+++|.+++.... ....+++..++.++.|++.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 999999999999986432 3456899999999999999999999999999999999999999999999999999876554
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHhcCCCCCC---CChHHHH
Q 003935 681 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV--LPERVVYAVANEGSRLEI---PEGPLGR 755 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~--~~~~~v~~i~~~~~~~~i---p~~~L~~ 755 (785)
........|++.|+|||++.+..++.++||||||+++|+|++|+.||.+. ........+......... .+..+.+
T Consensus 190 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 269 (310)
T 2wqm_A 190 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269 (310)
T ss_dssp ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHH
T ss_pred CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHH
Confidence 33344567899999999999999999999999999999999999999754 233344444333322211 1346999
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 756 LIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 756 LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
|+.+||. ||.+|||+.++++.|+++..
T Consensus 270 li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 270 LVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 9999999 99999999999999998864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=383.45 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=217.6
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHhhcCCCceeeEeccccCC
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKP 596 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 596 (785)
..+.+..++|.+.+.||+|+||+||+|.+ +++.||+|++.+.... ....+.+.+|+.+++.++|||||+++++|.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 45667788999999999999999999988 4789999998653221 11224578899999999999999999999999
Q ss_pred CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
..+|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 999999999999999999862 3589999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC-CCCCCCCCCcccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 003935 677 ITDSPM-RDSSSAGTPEWMAPELIRNEP----FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-- 749 (785)
Q Consensus 677 l~~~~~-~~~~~~GT~~Y~APEvl~~~~----~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-- 749 (785)
...... .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.......+.........|
T Consensus 218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 297 (410)
T 3v8s_A 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 297 (410)
T ss_dssp CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTT
T ss_pred eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCc
Confidence 654332 234678999999999998765 7889999999999999999999999999988888887643322222
Q ss_pred ---ChHHHHHHHHhhh-CCCC--CCCHHHHHHH
Q 003935 750 ---EGPLGRLIADCWA-EPQE--RPSCEEILSR 776 (785)
Q Consensus 750 ---~~~L~~LI~~CL~-DP~k--RPS~~EIL~~ 776 (785)
...+.+||.+||. +|.+ ||++++|++|
T Consensus 298 ~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 298 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 3469999999999 8888 9999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=360.55 Aligned_cols=255 Identities=24% Similarity=0.362 Sum_probs=213.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc---ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL---TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~---~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 601 (785)
++|.+.+.||+|+||+||+|.+ ++..||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 6799999999999999999988 477899999865432 33456789999999999999999999999999999999
Q ss_pred EEEEcccchhhHHHHhhc-------------------------------------ccccchHHHHHHHHHHHHHHHHHHH
Q 003935 602 ITEYMELGSLYHLIHLSG-------------------------------------QKKKLSWRRKLKMLRDICRGLMCIH 644 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~-------------------------------------~~~~Ls~~~~l~Ia~QIa~AL~yLH 644 (785)
||||+++|+|.+++.... ....+++..++.++.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 999999999999884110 1234578889999999999999999
Q ss_pred hcccccccCCCCcEEEcCCC--eEEEEecCccccccCCC----CCCCCCCCCCcccCcccccc--CCCCchhhHHHHHHH
Q 003935 645 RMKIVHRDLKSANCLVNKHW--TVKICDFGLSRIITDSP----MRDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVI 716 (785)
Q Consensus 645 s~gIIHrDLKpsNILLd~~g--~VKL~DFGLA~~l~~~~----~~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvI 716 (785)
++||+||||||+|||++.++ .+||+|||++..+.... .......||+.|+|||++.+ ..++.++|||||||+
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 99999999999999998776 89999999998764321 12345679999999999975 678999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHhhh-CCCCCCCHHHHHHH--HHhhh
Q 003935 717 MWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRLIADCWA-EPQERPSCEEILSR--LLDCE 781 (785)
Q Consensus 717 LyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-----~~~L~~LI~~CL~-DP~kRPS~~EIL~~--L~~l~ 781 (785)
+|+|++|+.||.+.........+.........+ ...+.+|+.+||. ||.+||++.+++++ ++++.
T Consensus 266 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 999999999999999988888887766554433 3468999999999 99999999999986 45444
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=350.74 Aligned_cols=249 Identities=27% Similarity=0.361 Sum_probs=217.2
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 601 (785)
...+|.+.+.||+|+||+||++.+. ++.+|+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 3468999999999999999999884 78899999876543 34456788999999999999999999999999999999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
||||+.+++|.+++.. ...+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 93 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 93 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999998863 3578999999999999999999999999999999999999999999999999998775444
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHh
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADC 760 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~C 760 (785)
.......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........+........ ..+..+.+|+.+|
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 249 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM 249 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHH
Confidence 444566799999999999998899999999999999999999999999888777766655433221 1234689999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003935 761 WA-EPQERPSCEEILSR 776 (785)
Q Consensus 761 L~-DP~kRPS~~EIL~~ 776 (785)
|. ||.+|||+.+++++
T Consensus 250 l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 250 LQTDPTARPTINELLND 266 (294)
T ss_dssp TCSSGGGSCCGGGGGGS
T ss_pred cccChhhCcCHHHHhhC
Confidence 99 99999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=354.60 Aligned_cols=246 Identities=26% Similarity=0.401 Sum_probs=215.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChH----HHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE----NMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~----~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
+.|.+.+.||+|+||.||+|.+ +|+.||+|++........ ..+.+.+|+.+++.++||||+++++++.+...++
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 5699999999999999999988 488999999976543221 3577899999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC----eEEEEecCcccc
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW----TVKICDFGLSRI 676 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g----~VKL~DFGLA~~ 676 (785)
+||||+++++|.+++. ....+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 92 LILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEECCCCSCBHHHHHH---TCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 9999999999999997 456799999999999999999999999999999999999999887 899999999987
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----CCCh
Q 003935 677 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-----IPEG 751 (785)
Q Consensus 677 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-----ip~~ 751 (785)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+........ ..+.
T Consensus 169 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (321)
T 2a2a_A 169 IEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247 (321)
T ss_dssp CCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred cCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCH
Confidence 75432 23456799999999999999999999999999999999999999999888887777665443221 1234
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 752 PLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 752 ~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+.+|+.+||. ||.+|||+.++++|
T Consensus 248 ~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 248 LAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 68999999999 99999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=369.88 Aligned_cols=246 Identities=23% Similarity=0.325 Sum_probs=198.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccCCC--cee
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPP--RLS 600 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~--~l~ 600 (785)
.++|.+.+.||+|+||+||+|.+ +|+.||||++..........+.+.+|+.+++.+. ||||+++++++...+ .+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 36899999999999999999987 5889999999766566666788999999999997 999999999986543 689
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
+||||+. ++|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 88 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 9999998 588888862 46899999999999999999999999999999999999999999999999999865321
Q ss_pred ---------------------CCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 003935 681 ---------------------PMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYA 738 (785)
Q Consensus 681 ---------------------~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~ 738 (785)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 111234679999999999986 6789999999999999999999999999888777666
Q ss_pred HHhcCCCCC------------------------------------------------CCChHHHHHHHHhhh-CCCCCCC
Q 003935 739 VANEGSRLE------------------------------------------------IPEGPLGRLIADCWA-EPQERPS 769 (785)
Q Consensus 739 i~~~~~~~~------------------------------------------------ip~~~L~~LI~~CL~-DP~kRPS 769 (785)
+......+. .....+.+|+.+||. ||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 643211110 113358899999999 9999999
Q ss_pred HHHHHHH
Q 003935 770 CEEILSR 776 (785)
Q Consensus 770 ~~EIL~~ 776 (785)
+.++++|
T Consensus 323 ~~e~l~H 329 (388)
T 3oz6_A 323 ANDALKH 329 (388)
T ss_dssp HHHHTTS
T ss_pred HHHHhCC
Confidence 9999987
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=360.84 Aligned_cols=253 Identities=26% Similarity=0.513 Sum_probs=209.5
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeE----EEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTD----VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~----VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
+..++|.+.+.||+|+||+||+|.+ +++. ||+|++..... ....+.+.+|+.+++.++||||+++++++.. .
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~ 87 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-S 87 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-S
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-C
Confidence 3457899999999999999999987 3443 77787754322 2223567789999999999999999999864 5
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
..++||||+.+|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred ccEEEEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 68999999999999999863 3457899999999999999999999999999999999999999999999999999887
Q ss_pred cCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---Ch
Q 003935 678 TDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EG 751 (785)
Q Consensus 678 ~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~ 751 (785)
..... ......+++.|+|||++.+..++.++|||||||++|+|+| |+.||.+.........+.. +.....+ ..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 244 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK-GERLAQPQICTI 244 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT-TCBCCCCTTBCT
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc-CCCCCCCCcCcH
Confidence 54322 2234567889999999999999999999999999999999 9999998877776665544 3333333 33
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 752 PLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 752 ~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
.+.+|+.+||. ||.+||++.+++++|+.+.
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 245 DVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 58899999999 9999999999999998764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=372.45 Aligned_cols=252 Identities=21% Similarity=0.325 Sum_probs=211.4
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 521 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 521 e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
...+.+++|.+.+.||+|+||+||+|.+ +++.||+|++.+... .....+.+.+|+.+++.++|||||+++++|.+..
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 4566788999999999999999999988 478899999865432 2233567889999999999999999999999999
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+|+||||+.+|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++..+
T Consensus 89 ~~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp EEEEEECCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 9999999999999999997 4567999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhcCCCC-CCCC
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGV---LPERVVYAVANEGSRL-EIPE 750 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvILyELLTG~~PF~~~---~~~~~v~~i~~~~~~~-~ip~ 750 (785)
... ......+||+.|+|||++.. ..++.++|||||||++|+|++|+.||... ........+....... ..-.
T Consensus 166 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s 244 (384)
T 4fr4_A 166 PRE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWS 244 (384)
T ss_dssp CTT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSC
T ss_pred cCC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCC
Confidence 543 23456789999999999974 45899999999999999999999999743 3334444433322221 1123
Q ss_pred hHHHHHHHHhhh-CCCCCCC-HHHHHHH
Q 003935 751 GPLGRLIADCWA-EPQERPS-CEEILSR 776 (785)
Q Consensus 751 ~~L~~LI~~CL~-DP~kRPS-~~EIL~~ 776 (785)
..+.+||.+||. ||.+||+ +.++++|
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 469999999999 9999998 7777653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=348.34 Aligned_cols=256 Identities=27% Similarity=0.489 Sum_probs=211.3
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccc-cCCCce
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC-TKPPRL 599 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~-~d~~~l 599 (785)
...|.+.+.||+|+||+||+|.+. ...+|+|.+... ......+.+.+|+.+++.++||||+++++++ ...+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 356889999999999999999862 235889988643 3445567899999999999999999999985 455678
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
++||||+.+|+|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 103 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999999963 345689999999999999999999999999999999999999999999999999987644
Q ss_pred CCC----CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCC--CCChH
Q 003935 680 SPM----RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLE--IPEGP 752 (785)
Q Consensus 680 ~~~----~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~--ip~~~ 752 (785)
... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...........+........ ..+..
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 260 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHH
Confidence 321 1234567789999999999999999999999999999999 5667777766666655554332221 12456
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhcc
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 784 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~sL 784 (785)
+.+++.+||. ||.+|||+.++++.|+++...+
T Consensus 261 l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 261 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 9999999999 9999999999999999987654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=343.96 Aligned_cols=243 Identities=22% Similarity=0.373 Sum_probs=212.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|.+.+.||+|+||+||+|.+. +..+|+|++...... ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 56999999999999999999884 668999998765432 25678999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEE---cCCCeEEEEecCccccccCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILL---d~~g~VKL~DFGLA~~l~~~~ 681 (785)
|+++++|.+++.. ...+++..++.++.|++.||+|||++||+|+||||+|||+ +.++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999999998863 4568999999999999999999999999999999999999 788999999999998765432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHH
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRL 756 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i-----p~~~L~~L 756 (785)
......||+.|+|||++.+. ++.++||||||+++|+|++|+.||...........+......... .+..+.+|
T Consensus 164 -~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (277)
T 3f3z_A 164 -MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241 (277)
T ss_dssp -CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHH
T ss_pred -chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHH
Confidence 33456799999999998765 899999999999999999999999998888888777665443321 23468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003935 757 IADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.+||. ||.+|||+.+++++
T Consensus 242 i~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 242 IRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999 99999999999975
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=355.36 Aligned_cols=252 Identities=29% Similarity=0.455 Sum_probs=207.7
Q ss_pred eEeeEEeeeCcEEEEEEEECCeEEEEEEeeccc--cChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEcc
Q 003935 530 TVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQD--LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME 607 (785)
Q Consensus 530 ~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~--~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~ 607 (785)
..++.||+|+||+||+|.++++.||||++.... ......+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 113 (307)
T 2nru_A 34 VGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP 113 (307)
T ss_dssp TTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred ccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecC
Confidence 345899999999999999999999999986543 223446789999999999999999999999999999999999999
Q ss_pred cchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC--CCC
Q 003935 608 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDS 685 (785)
Q Consensus 608 gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--~~~ 685 (785)
+++|.+++........+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+|||++........ ...
T Consensus 114 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 193 (307)
T 2nru_A 114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS 193 (307)
T ss_dssp TCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECS
T ss_pred CCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccccccc
Confidence 999999997555556799999999999999999999999999999999999999999999999999987644221 123
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHhcC---------CCCCCCC--
Q 003935 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERV----VYAVANEG---------SRLEIPE-- 750 (785)
Q Consensus 686 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~----v~~i~~~~---------~~~~ip~-- 750 (785)
...||+.|+|||.+.+. ++.++||||||+++|+|++|..||........ ...+.... .....+.
T Consensus 194 ~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (307)
T 2nru_A 194 RIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS 272 (307)
T ss_dssp SCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHH
T ss_pred ccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHH
Confidence 45799999999998764 88999999999999999999999976543221 11111111 0111111
Q ss_pred -hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 751 -GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 751 -~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
..+.+++.+||. ||.+|||+.+++++|+++.-
T Consensus 273 ~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 273 VEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 247889999999 99999999999999998764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=360.53 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=209.0
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
..++|.+.+.||+|+||.||+|.+. |+.||||++..........+.+.+|+.+++.++||||+++++++.+...+++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 4678999999999999999999884 88999999977766666677888999999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
|||+.+++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 103 ~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 103 FEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999999998875 345799999999999999999999999999999999999999999999999999987655444
Q ss_pred CCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----------------
Q 003935 683 RDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR---------------- 745 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~---------------- 745 (785)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+......
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 44566799999999999875 7899999999999999999999999988877666555421110
Q ss_pred ----CC------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 746 ----LE------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 746 ----~~------------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+. .-+..+.+|+.+||. ||.+|||+.++++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 013458899999999 99999999999976
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=362.63 Aligned_cols=266 Identities=26% Similarity=0.425 Sum_probs=214.3
Q ss_pred CccccccccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccc
Q 003935 515 PLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 593 (785)
Q Consensus 515 p~~~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~ 593 (785)
..++..++.+..++|.+.+.||+|+||+||+|.+ +++.||||++....... ....+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEE
Confidence 3456677888899999999999999999999976 58899999986544322 123688999999999999999999999
Q ss_pred cCCCceeEEEEEcccchhhHHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhc---ccccccCCCCcEEEcCCCeEEEE
Q 003935 594 TKPPRLSMITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRM---KIVHRDLKSANCLVNKHWTVKIC 669 (785)
Q Consensus 594 ~d~~~l~LV~Ey~~gGSL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~AL~yLHs~---gIIHrDLKpsNILLd~~g~VKL~ 669 (785)
.+....++||||+.+|+|.+++.... ....+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997433 234599999999999999999999999 99999999999999999999999
Q ss_pred ecCccccccCCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHh---
Q 003935 670 DFGLSRIITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV----LPERVVYAVAN--- 741 (785)
Q Consensus 670 DFGLA~~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~----~~~~~v~~i~~--- 741 (785)
|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||... ...........
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 9999987653322 233456999999999999988999999999999999999999999521 00001111111
Q ss_pred -cCCCC---------CCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 742 -EGSRL---------EIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 742 -~~~~~---------~ip~---~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
..... ..+. ..+.+++..||+ ||.+|||+.+|+++|+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 11100 1111 248889999999 9999999999999998643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=352.56 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=207.7
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccC
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTK 595 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d 595 (785)
..++....++|.+.+.||+|+||.||+|.+ +++.||||++...... .+.+.+|+.+++.+ +||||+++++++..
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 445555678999999999999999999998 6889999998754432 35788999999999 79999999999876
Q ss_pred ------CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEE
Q 003935 596 ------PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKIC 669 (785)
Q Consensus 596 ------~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~ 669 (785)
...+++||||+.+++|.+++... ....+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEe
Confidence 45789999999999999999743 34578999999999999999999999999999999999999999999999
Q ss_pred ecCccccccCCCCCCCCCCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 003935 670 DFGLSRIITDSPMRDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS 744 (785)
Q Consensus 670 DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~ 744 (785)
|||++..............|++.|+|||++. +..++.++|||||||++|+|++|..||.+.........+.....
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 251 (326)
T 2x7f_A 172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA 251 (326)
T ss_dssp CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc
Confidence 9999987654333334567999999999987 56789999999999999999999999998888777766655443
Q ss_pred CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 745 RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 745 ~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
....+ +..+.+|+.+||. ||.+||++.+++++
T Consensus 252 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 252 PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 22222 3469999999999 99999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=352.33 Aligned_cols=250 Identities=23% Similarity=0.397 Sum_probs=187.4
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 601 (785)
..++|.+.+.||+|+||.||+|.+ +|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 456899999999999999999987 6889999998654321 1224678899999999999999999999999999999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
||||+++++|.+++.. ....+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 89 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999873 33578999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCCChHHHHHHHHh
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIPEGPLGRLIADC 760 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~-~~ip~~~L~~LI~~C 760 (785)
.......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........+...... +...+..+.+|+.+|
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 246 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQL 246 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHH
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHH
Confidence 3334567899999999999988999999999999999999999999876655444433222211 111234689999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003935 761 WA-EPQERPSCEEILSR 776 (785)
Q Consensus 761 L~-DP~kRPS~~EIL~~ 776 (785)
|. ||.+|||+.+++++
T Consensus 247 l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 247 LRRNPADRLSLSSVLDH 263 (278)
T ss_dssp SCSSGGGSCCHHHHTTS
T ss_pred cccCHhhCCCHHHHhcC
Confidence 99 99999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=347.49 Aligned_cols=246 Identities=27% Similarity=0.458 Sum_probs=209.5
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC----CCc
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK----PPR 598 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d----~~~ 598 (785)
....|.+.+.||+|+||+||+|.+ ++..||+|++..........+.+.+|+.+++.++||||+++++++.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 345689999999999999999988 47789999998777777778889999999999999999999998754 456
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc--cccccCCCCcEEEc-CCCeEEEEecCccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVN-KHWTVKICDFGLSR 675 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~g--IIHrDLKpsNILLd-~~g~VKL~DFGLA~ 675 (785)
+++||||+++++|.+++.. ...+++..++.++.||+.||+|||+.| |+|+||||+|||++ .++.+||+|||++.
T Consensus 104 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 8999999999999999973 357899999999999999999999999 99999999999997 78999999999997
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-C---CCh
Q 003935 676 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-I---PEG 751 (785)
Q Consensus 676 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-i---p~~ 751 (785)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...............+..+. . ...
T Consensus 181 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (290)
T 1t4h_A 181 LKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp GCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred ccccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence 65433 2335679999999998875 489999999999999999999999988665555554444433222 1 234
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 752 PLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 752 ~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+.+|+.+||. ||.+|||+.++++|
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhC
Confidence 69999999999 99999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=358.63 Aligned_cols=249 Identities=27% Similarity=0.362 Sum_probs=217.7
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 601 (785)
...+|.+.+.||+|+||.||++.+ +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 346899999999999999999988 477899999876543 34556788999999999999999999999999999999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
||||+.+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 119 v~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 119 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp EECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999999998863 3578999999999999999999999999999999999999999999999999998775444
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHh
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADC 760 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~C 760 (785)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+........ .....+.+|+.+|
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 275 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM 275 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHH
Confidence 444567799999999999999999999999999999999999999999887777766655443322 2234689999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003935 761 WA-EPQERPSCEEILSR 776 (785)
Q Consensus 761 L~-DP~kRPS~~EIL~~ 776 (785)
|. ||.+|||+.+++++
T Consensus 276 l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 276 LQTDPTARPTINELLND 292 (335)
T ss_dssp TCSSGGGSCCGGGGGGS
T ss_pred ccCChhHCcCHHHHhcC
Confidence 99 99999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=374.83 Aligned_cols=246 Identities=27% Similarity=0.373 Sum_probs=188.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC-----CCce
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-----PPRL 599 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d-----~~~l 599 (785)
++|.+.+.||+|+||+||+|.+ +++.||||++..........+.+.+|+.+|+.++||||+++++++.. ...+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 7899999999999999999987 58899999997766666667889999999999999999999999843 3568
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
|+||||+. ++|.+++. ....+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++....
T Consensus 133 ~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEECCCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEeccc-cchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 99999985 68888886 456799999999999999999999999999999999999999999999999999987643
Q ss_pred CCC---------------------------CCCCCCCCCcccCcccc-ccCCCCchhhHHHHHHHHHHHHh---------
Q 003935 680 SPM---------------------------RDSSSAGTPEWMAPELI-RNEPFTEKCDIFSLGVIMWELCT--------- 722 (785)
Q Consensus 680 ~~~---------------------------~~~~~~GT~~Y~APEvl-~~~~~s~ksDVWSLGvILyELLT--------- 722 (785)
... .....+||+.|+|||++ .+..++.++|||||||+||||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 211 12345789999999986 56679999999999999999999
Q ss_pred --CCCCCCCCCh--------------------HHHHHHHHhcCCC--------------------------------CCC
Q 003935 723 --LNRPWEGVLP--------------------ERVVYAVANEGSR--------------------------------LEI 748 (785)
Q Consensus 723 --G~~PF~~~~~--------------------~~~v~~i~~~~~~--------------------------------~~i 748 (785)
|+.+|.+... ...+..+...... ...
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 6667765431 1111111110000 001
Q ss_pred CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 749 PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 749 p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
....+.+|+.+||. ||.+|||++|+|+|
T Consensus 369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 13458899999999 99999999999987
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=347.81 Aligned_cols=248 Identities=24% Similarity=0.419 Sum_probs=214.4
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
+..++|.+.+.||+|+||.||+|.+ +++.||||++....... ...+.+.+|+.+++.++||||+++++++.+.+.++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 4567899999999999999999988 47889999986543221 12467889999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
+||||+++++|.+++.. ...+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999999873 346899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCChHHHHHHHH
Q 003935 681 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPEGPLGRLIAD 759 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~-~ip~~~L~~LI~~ 759 (785)
......|++.|+|||++.+..++.++||||||+++|+|++|..||...........+....... ..-+..+.+++.+
T Consensus 168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 245 (284)
T 2vgo_A 168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISK 245 (284)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHH
Confidence 2345679999999999999999999999999999999999999999988877777666543322 1224579999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003935 760 CWA-EPQERPSCEEILSR 776 (785)
Q Consensus 760 CL~-DP~kRPS~~EIL~~ 776 (785)
||. ||.+||++.++++|
T Consensus 246 ~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 246 LLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HSCSSGGGSCCHHHHHTC
T ss_pred HhhcCHhhCCCHHHHhhC
Confidence 999 99999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=354.22 Aligned_cols=259 Identities=29% Similarity=0.465 Sum_probs=194.3
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccc---
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGAC--- 593 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~--- 593 (785)
+.+++...+|.+.+.||+|+||+||+|.+ +++.||||++... .....+.+.+|+.+++.+. ||||+++++++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 45566677899999999999999999998 6889999998554 3445678899999999996 99999999988
Q ss_pred -----cCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc--cccccCCCCcEEEcCCCeE
Q 003935 594 -----TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTV 666 (785)
Q Consensus 594 -----~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~g--IIHrDLKpsNILLd~~g~V 666 (785)
.....++++|||+. |+|.+++........+++..++.++.||+.||+|||++| |+||||||+|||++.++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 34445899999996 688888875545667999999999999999999999999 9999999999999999999
Q ss_pred EEEecCccccccCCCCC------------CCCCCCCCcccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003935 667 KICDFGLSRIITDSPMR------------DSSSAGTPEWMAPELI---RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL 731 (785)
Q Consensus 667 KL~DFGLA~~l~~~~~~------------~~~~~GT~~Y~APEvl---~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~ 731 (785)
||+|||++......... .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 99999999876543211 1144689999999998 56778999999999999999999999998765
Q ss_pred hHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 732 PERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 732 ~~~~v~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
........... .........+.+|+.+||. ||.+|||+.+++++|+++..
T Consensus 258 ~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 258 KLRIVNGKYSI-PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp --------CCC-CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhhcCcccC-CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 54433221111 1111123458999999999 99999999999999998754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=368.12 Aligned_cols=257 Identities=20% Similarity=0.217 Sum_probs=203.7
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHH---------HHHHHHHHHHHhhcCCCcee
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAEN---------MEDFCNEISILSRLRHPNVI 587 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~---------~e~f~~EI~iLk~L~HPNIV 587 (785)
+..++|.+.+.||+|+||+||+|.+. ++.||||++......... ...+..|+..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 45678999999999999999999873 468999998655321111 12344566677888999999
Q ss_pred eEeccccCC----CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEc--
Q 003935 588 LFLGACTKP----PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-- 661 (785)
Q Consensus 588 kL~g~~~d~----~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd-- 661 (785)
++++++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC
Confidence 999998764 4589999999 9999999974 346799999999999999999999999999999999999999
Q ss_pred CCCeEEEEecCccccccCCCC-------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 003935 662 KHWTVKICDFGLSRIITDSPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER 734 (785)
Q Consensus 662 ~~g~VKL~DFGLA~~l~~~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~ 734 (785)
.++.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 889999999999987643211 1134569999999999999999999999999999999999999998543222
Q ss_pred HHHHHHhcCC------------CCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003935 735 VVYAVANEGS------------RLEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 783 (785)
Q Consensus 735 ~v~~i~~~~~------------~~~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~s 783 (785)
.......... ...-.+..+.+|+..||. ||.+||++.+|++.|+++...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 2211111110 001224569999999999 999999999999999987654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=382.81 Aligned_cols=256 Identities=20% Similarity=0.328 Sum_probs=217.9
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHhhcCCCceeeEeccccC
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTK 595 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 595 (785)
...+.+..++|.+.++||+|+||+||+|.+ .++.||||++.+..... ...+.+.+|+.++..++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 345567788999999999999999999988 47899999986532211 112347899999999999999999999999
Q ss_pred CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 596 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
...+|+||||+++|+|.+++.. ....+++..++.++.||+.||+|||++|||||||||+||||+.++++||+|||+++
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 9999999999999999999973 24679999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC-CCCCCCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003935 676 IITDSPM-RDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 749 (785)
Q Consensus 676 ~l~~~~~-~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip 749 (785)
....... .....+||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+..+....+........+|
T Consensus 224 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 303 (437)
T 4aw2_A 224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 303 (437)
T ss_dssp ECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred hcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCC
Confidence 7654332 234568999999999997 5678999999999999999999999999999988888876543322222
Q ss_pred ------ChHHHHHHHHhhh-CCCC--CCCHHHHHHH
Q 003935 750 ------EGPLGRLIADCWA-EPQE--RPSCEEILSR 776 (785)
Q Consensus 750 ------~~~L~~LI~~CL~-DP~k--RPS~~EIL~~ 776 (785)
...+.+||.+||. +|.+ ||+++++++|
T Consensus 304 ~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 304 TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 3468999999998 7777 9999999976
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=346.76 Aligned_cols=253 Identities=25% Similarity=0.368 Sum_probs=196.2
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCce
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 599 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 599 (785)
+++..++|.+.+.||+|+||+||+|.+ +|+.||||++..........+.+..+...++.++||||+++++++.+.+..
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 456778999999999999999999998 689999999876544444444455566668889999999999999999999
Q ss_pred eEEEEEcccchhhHHHHhh-cccccchHHHHHHHHHHHHHHHHHHHhc-ccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 600 SMITEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~-gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
++||||+++ +|.+++... .....+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999985 777766532 2456799999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCcccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCCCCCC---
Q 003935 678 TDSPMRDSSSAGTPEWMAPELI----RNEPFTEKCDIFSLGVIMWELCTLNRPWEGV-LPERVVYAVANEGSRLEIP--- 749 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl----~~~~~s~ksDVWSLGvILyELLTG~~PF~~~-~~~~~v~~i~~~~~~~~ip--- 749 (785)
.... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||... ..................+
T Consensus 161 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T 3fme_A 161 VDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF 239 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTS
T ss_pred cccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccC
Confidence 5432 22345799999999996 5667899999999999999999999999864 4444444444433322221
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 750 EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 750 ~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+..+.+|+.+||. ||.+|||+.++++|
T Consensus 240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 240 SAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 3468999999999 99999999999985
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=349.30 Aligned_cols=245 Identities=34% Similarity=0.591 Sum_probs=215.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
+.|.+.+.||+|+||+||+|.+ +++.||||++...... ...+.+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 5699999999999999999987 5889999999765433 345789999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
|+++++|.+++. ...+++..++.++.|++.||.|||++||+|+||||+|||++.++.+||+|||++..........
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 999999999985 3578999999999999999999999999999999999999999999999999998876554444
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCW 761 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~~CL 761 (785)
....|++.|+|||++.+..++.++||||||+++|+|++|+.||...........+.... ...++ +..+.+|+.+||
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l 255 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACL 255 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCCCCSSCCHHHHHHHHHHC
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC-CCCCccccCHHHHHHHHHHc
Confidence 56789999999999999999999999999999999999999999888877766655433 22222 346999999999
Q ss_pred h-CCCCCCCHHHHHHHH
Q 003935 762 A-EPQERPSCEEILSRL 777 (785)
Q Consensus 762 ~-DP~kRPS~~EIL~~L 777 (785)
. ||.+|||+.+++++.
T Consensus 256 ~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 256 NKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CSSGGGSCCHHHHTTCH
T ss_pred CCChhhCcCHHHHhhCh
Confidence 9 999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=380.15 Aligned_cols=256 Identities=20% Similarity=0.335 Sum_probs=218.3
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccC
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTK 595 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 595 (785)
.+++.+..++|.+.+.||+|+||+||+|.+ +|+.||||++.+... .....+.+.+|+.++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 456667789999999999999999999988 588999999975432 12223457899999999999999999999999
Q ss_pred CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 596 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
.+.+|+||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 99999999999999999999743 3479999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC-CCCCCCCCCcccCccccc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Q 003935 676 IITDSPM-RDSSSAGTPEWMAPELIR-------NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE 747 (785)
Q Consensus 676 ~l~~~~~-~~~~~~GT~~Y~APEvl~-------~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ 747 (785)
....... .....+||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+..+....+........
T Consensus 211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~ 290 (412)
T 2vd5_A 211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS 290 (412)
T ss_dssp ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC
Confidence 7754332 233568999999999997 35689999999999999999999999999998888887765332222
Q ss_pred CC------ChHHHHHHHHhhhCCCCC---CCHHHHHHH
Q 003935 748 IP------EGPLGRLIADCWAEPQER---PSCEEILSR 776 (785)
Q Consensus 748 ip------~~~L~~LI~~CL~DP~kR---PS~~EIL~~ 776 (785)
.| +..+.+||.+||.+|.+| |++++|++|
T Consensus 291 ~p~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 291 LPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTH 328 (412)
T ss_dssp CC----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTS
T ss_pred CCccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcC
Confidence 22 346899999999988887 699999876
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.94 Aligned_cols=250 Identities=22% Similarity=0.284 Sum_probs=210.9
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-----CCceeeEec
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-----HPNVILFLG 591 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-----HPNIVkL~g 591 (785)
+++..+-.++|.+.++||+|+||+||+|.+ +++.||||++... ......+..|+.+++.++ ||||+++++
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 344455568999999999999999999998 6889999998632 334567788999999996 999999999
Q ss_pred cccCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC---------
Q 003935 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK--------- 662 (785)
Q Consensus 592 ~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~--------- 662 (785)
++...+.+++||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccc
Confidence 999999999999999 89999999743 3346899999999999999999999999999999999999975
Q ss_pred ----------------CCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 003935 663 ----------------HWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP 726 (785)
Q Consensus 663 ----------------~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~P 726 (785)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 258 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence 789999999999875432 2456799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCC------------------------CC-----------------------ChHHHHHHHH
Q 003935 727 WEGVLPERVVYAVANEGSRLE------------------------IP-----------------------EGPLGRLIAD 759 (785)
Q Consensus 727 F~~~~~~~~v~~i~~~~~~~~------------------------ip-----------------------~~~L~~LI~~ 759 (785)
|...........+.......+ .| ...+.+|+.+
T Consensus 259 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 338 (360)
T 3llt_A 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS 338 (360)
T ss_dssp CCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence 998887776665543221111 00 1346689999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003935 760 CWA-EPQERPSCEEILSR 776 (785)
Q Consensus 760 CL~-DP~kRPS~~EIL~~ 776 (785)
||+ ||.+|||+.++++|
T Consensus 339 ~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 339 ILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HCCSSGGGSCCHHHHTTS
T ss_pred HhcCChhhCCCHHHHhcC
Confidence 999 99999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=378.84 Aligned_cols=245 Identities=26% Similarity=0.474 Sum_probs=214.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|.+.++||+|+||+||+|.+ +++.||||++............+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 6799999999999999999988 48899999997654433345788999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEc---CCCeEEEEecCccccccCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN---KHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd---~~g~VKL~DFGLA~~l~~~~ 681 (785)
|+.+|+|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+....
T Consensus 102 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 102 LYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 9999999998863 35799999999999999999999999999999999999995 55689999999998765432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 756 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-----~~~L~~L 756 (785)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+.........+ +..+.+|
T Consensus 179 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 179 -KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred -ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 2345679999999999986 49999999999999999999999999999988888887766555443 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003935 757 IADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~ 776 (785)
|.+||. ||.+|||+.++++|
T Consensus 257 i~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 257 IRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHcCCChhhCcCHHHHhcC
Confidence 999999 99999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=361.42 Aligned_cols=261 Identities=29% Similarity=0.501 Sum_probs=213.3
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
..++....++|.+.+.||+|+||+||+|.+ +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 445556778999999999999999999987 488999999865433 34678999999999999999999999999999
Q ss_pred ceeEEEEEcccchhhHHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
.+++||||+++|+|.+++.... ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999999999885322 123589999999999999999999999999999999999999999999999999987
Q ss_pred ccCCC--CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhcCCC---
Q 003935 677 ITDSP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERV------VYAVANEGSR--- 745 (785)
Q Consensus 677 l~~~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~------v~~i~~~~~~--- 745 (785)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....+... ..........
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 54321 122344589999999999999999999999999999999999999975433211 1111111110
Q ss_pred ------CCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 746 ------LEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 746 ------~~ip~---~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
..++. ..+.+++.+||. ||.+|||+.+++++|+++.
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11111 247889999999 9999999999999998764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=345.35 Aligned_cols=246 Identities=24% Similarity=0.423 Sum_probs=210.2
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChH----HHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE----NMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~----~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
++|.+.+.||+|+||+||+|.+ +++.||+|++........ ..+.+.+|+.+++.++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 4689999999999999999988 488999999876543321 3578899999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC----eEEEEecCcccc
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW----TVKICDFGLSRI 676 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g----~VKL~DFGLA~~ 676 (785)
+||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+|+||||+||+++.++ .+||+|||++..
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 99999999999999963 45789999999999999999999999999999999999998877 899999999987
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----CCCh
Q 003935 677 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-----IPEG 751 (785)
Q Consensus 677 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-----ip~~ 751 (785)
..... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.+.........+........ ..+.
T Consensus 162 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T 3bhy_A 162 IEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240 (283)
T ss_dssp CC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred ccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence 65432 22355789999999999999999999999999999999999999999888777776655433221 1234
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 752 PLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 752 ~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+.+|+.+||. ||.+|||+.+++++
T Consensus 241 ~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 68999999999 99999999999985
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=360.52 Aligned_cols=244 Identities=30% Similarity=0.462 Sum_probs=210.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
+.|.+.+.||+|+||+||+|.+ +++.||||++..... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588999999999999999986 688999999976543 3344578999999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+. |+|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 9998 577777753 2457899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCCCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHH
Q 003935 684 DSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLI 757 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI 757 (785)
....||+.|+|||++. ...++.++|||||||++|||++|+.||.+.........+.........+ +..+.+|+
T Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 286 (348)
T 1u5q_A 208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 286 (348)
T ss_dssp -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 3567999999999984 5678999999999999999999999999988877777766654333222 34689999
Q ss_pred HHhhh-CCCCCCCHHHHHHHH
Q 003935 758 ADCWA-EPQERPSCEEILSRL 777 (785)
Q Consensus 758 ~~CL~-DP~kRPS~~EIL~~L 777 (785)
.+||. ||.+|||+.+++++.
T Consensus 287 ~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 287 DSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp HHHTCSSGGGSCCHHHHTTCH
T ss_pred HHHcccChhhCcCHHHHhhCh
Confidence 99999 999999999999763
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=366.11 Aligned_cols=249 Identities=23% Similarity=0.379 Sum_probs=207.9
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC--CCceeeEeccccCCCce
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR--HPNVILFLGACTKPPRL 599 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~--HPNIVkL~g~~~d~~~l 599 (785)
.+....|.+.+.||+|+||+||+|.+ .++.||||++..........+.+.+|+.+|+.++ ||||+++++++.....+
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 34456799999999999999999987 4788999999877666777789999999999996 59999999999999999
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
|+||| +.+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.+..
T Consensus 132 ~lv~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred EEEEe-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99999 678899999873 34788999999999999999999999999999999999995 57999999999987654
Q ss_pred CCC--CCCCCCCCCcccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCCC
Q 003935 680 SPM--RDSSSAGTPEWMAPELIRN-----------EPFTEKCDIFSLGVIMWELCTLNRPWEGVLP-ERVVYAVANEGSR 745 (785)
Q Consensus 680 ~~~--~~~~~~GT~~Y~APEvl~~-----------~~~s~ksDVWSLGvILyELLTG~~PF~~~~~-~~~v~~i~~~~~~ 745 (785)
... .....+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||..... ......+......
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~ 286 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc
Confidence 321 2345679999999999875 4689999999999999999999999987643 3445555544444
Q ss_pred CCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 746 LEIP---EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 746 ~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
...+ ...+.+|+.+||. ||.+|||+.+++++
T Consensus 287 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 3333 4579999999999 99999999999976
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.66 Aligned_cols=247 Identities=28% Similarity=0.438 Sum_probs=206.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
+.|.+.+.||+|+||+||++.+ ++..+|+|++...... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 5799999999999999999987 4889999998765432 235778999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhh-cccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEE---cCCCeEEEEecCccccccCC
Q 003935 605 YMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 605 y~~gGSL~dlL~~~-~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILL---d~~g~VKL~DFGLA~~l~~~ 680 (785)
|+++|+|.+.+... .....+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++..+...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 99999999888543 234679999999999999999999999999999999999999 45678999999999876543
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----ChHHHHH
Q 003935 681 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP----EGPLGRL 756 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip----~~~L~~L 756 (785)
. ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.................... ...+.+|
T Consensus 181 ~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (285)
T 3is5_A 181 E-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDL 258 (285)
T ss_dssp -------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHH
T ss_pred c-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHH
Confidence 2 234567999999999986 458999999999999999999999999988877777665544333221 3468899
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003935 757 IADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.+||. ||.+|||+.+++++
T Consensus 259 i~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 259 LKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999 99999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=377.64 Aligned_cols=244 Identities=25% Similarity=0.329 Sum_probs=202.3
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC------
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------ 597 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------ 597 (785)
.++|.+.+.||+|+||+||+|.+ +++.||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999987 5889999999876666667788999999999999999999999986554
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+|+||||+.++ |.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 469999999875 555543 24889999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------- 746 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~----------- 746 (785)
... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+....+..+......+
T Consensus 215 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~ 293 (464)
T 3ttj_A 215 GTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293 (464)
T ss_dssp --C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred CCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence 543 23346789999999999999999999999999999999999999999988777766654421111
Q ss_pred ------------C------CC--------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 ------------E------IP--------------EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 ------------~------ip--------------~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
. .+ ...+.+|+.+||. ||.+|||++|+++|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00 1247889999999 99999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=369.87 Aligned_cols=247 Identities=29% Similarity=0.433 Sum_probs=206.0
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 601 (785)
...+|.+.+.||+|+||+||+|.+ +++.||||++....... .....+.+|+.+++.++||||+++++++.+...+++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 357899999999999999999998 68899999986543221 123568899999999999999999999999999999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
||||+ +|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 87 v~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 99999 6788888763 3579999999999999999999999999999999999999999999999999998765543
Q ss_pred CCCCCCCCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCCChHHHHHHHH
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIPEGPLGRLIAD 759 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~-~~ip~~~L~~LI~~ 759 (785)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.........+...... +...+..+.+|+.+
T Consensus 163 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 241 (336)
T 3h4j_B 163 -FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRR 241 (336)
T ss_dssp -TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHT
T ss_pred -ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 3346689999999999988776 78999999999999999999999876543332222111111 11123468999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003935 760 CWA-EPQERPSCEEILSR 776 (785)
Q Consensus 760 CL~-DP~kRPS~~EIL~~ 776 (785)
||. ||.+|||+.+++++
T Consensus 242 ~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 242 MIVADPMQRITIQEIRRD 259 (336)
T ss_dssp TSCSSGGGSCCHHHHTTC
T ss_pred HcCCChhHCcCHHHHHhC
Confidence 999 99999999999876
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=347.95 Aligned_cols=256 Identities=30% Similarity=0.561 Sum_probs=209.3
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEEC---Ce--EEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIWN---GT--DVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~~---g~--~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
+..++|.+.+.||+|+||+||+|.+. ++ .||||++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 45578999999999999999999862 22 689999865543 2345678999999999999999999999998765
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.++|+||+++++|.+++... ...+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+|||++...
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred -ceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 89999999999999998743 356899999999999999999999999999999999999999999999999999877
Q ss_pred cCCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---C
Q 003935 678 TDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---E 750 (785)
Q Consensus 678 ~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~ 750 (785)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.........+.........+ +
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 251 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence 54322 1224467889999999999889999999999999999999 999999999888888877665554443 3
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 751 GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 751 ~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
..+.+++.+||. ||.+|||+.+++++|++...
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 469999999999 99999999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=362.87 Aligned_cols=246 Identities=27% Similarity=0.379 Sum_probs=197.6
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeE
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 601 (785)
...++|.+.+.||+|+||+||++.+ +++.||||++....... +.+.+|+.+++.++||||+++++++.+...+++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 3567899999999999999999988 58899999997654332 557899999999999999999999999999999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCe--EEEEecCccccccC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT--VKICDFGLSRIITD 679 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~--VKL~DFGLA~~l~~ 679 (785)
||||+.+|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 94 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 94 IMEYASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 9999999999999863 357999999999999999999999999999999999999987765 99999999975433
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcCCCCCC---CCh
Q 003935 680 SPMRDSSSAGTPEWMAPELIRNEPFTEK-CDIFSLGVIMWELCTLNRPWEGVLP----ERVVYAVANEGSRLEI---PEG 751 (785)
Q Consensus 680 ~~~~~~~~~GT~~Y~APEvl~~~~~s~k-sDVWSLGvILyELLTG~~PF~~~~~----~~~v~~i~~~~~~~~i---p~~ 751 (785)
.. ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+... ......+.......+. ...
T Consensus 171 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (361)
T 3uc3_A 171 HS-QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred cC-CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence 21 2345679999999999988887765 8999999999999999999986533 3444444443332222 134
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 752 PLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 752 ~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+.+|+.+||. ||.+|||+.++++|
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhHCcCHHHHHhC
Confidence 68999999999 99999999999987
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=343.69 Aligned_cols=249 Identities=26% Similarity=0.467 Sum_probs=206.0
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
+..++|.+.+.||+|+||.||+|.+ +|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+...++
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF 87 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence 4567899999999999999999988 4889999998654321 223567889999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
+||||+++++|.+++.. ...+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999999973 346899999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCCCCCCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHH
Q 003935 681 PMRDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIA 758 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~ 758 (785)
. ......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...........+.......+ .-+..+.+++.
T Consensus 165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 243 (276)
T 2h6d_A 165 E-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLM 243 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred c-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHH
Confidence 2 2235578999999999988765 6899999999999999999999998888777776655432221 12456999999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003935 759 DCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 759 ~CL~-DP~kRPS~~EIL~~ 776 (785)
+||. ||.+|||+.+++++
T Consensus 244 ~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 244 HMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHTCSSGGGSCCHHHHHHS
T ss_pred HHccCChhhCCCHHHHHhC
Confidence 9999 99999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=344.69 Aligned_cols=242 Identities=23% Similarity=0.323 Sum_probs=204.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++|.+.+.||+|+||+||+|.+ +++.||||++............+.+|+..+..+ +||||+++++++.+.+.+++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999988 588999999987666556678899999999999 8999999999999999999999
Q ss_pred EEcccchhhHHHHhhcc-cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC-------------------
Q 003935 604 EYMELGSLYHLIHLSGQ-KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH------------------- 663 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~-~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~------------------- 663 (785)
||+++++|.+++..... ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 99999999999974322 2568999999999999999999999999999999999999844
Q ss_pred CeEEEEecCccccccCCCCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 003935 664 WTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE 742 (785)
Q Consensus 664 g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~ 742 (785)
..+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|..|+..... ...+. .
T Consensus 171 ~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~-~ 242 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIR-Q 242 (289)
T ss_dssp CCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHH-T
T ss_pred eEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHH-c
Confidence 47999999999876543 234689999999999876 567899999999999999999987755432 22222 2
Q ss_pred CCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 743 GSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 743 ~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+..+.++ +..+.+|+.+||. ||.+|||+.++++|
T Consensus 243 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 243 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 3333333 3579999999999 99999999999876
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=357.42 Aligned_cols=253 Identities=27% Similarity=0.540 Sum_probs=206.5
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeE----EEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTD----VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~----VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
+..++|.+.+.||+|+||+||+|.+ +++. ||+|.+.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 3457899999999999999999987 4544 5677664332 2334578999999999999999999999998765
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+++++|+.+|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 91 -~~~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred -ceEEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 8899999999999999874 2456899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---Ch
Q 003935 678 TDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EG 751 (785)
Q Consensus 678 ~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~ 751 (785)
..... ......+|+.|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+... .....+ ..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 246 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQPPICTI 246 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-CCCCCCTTBCH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCccCCH
Confidence 44322 2234457789999999999999999999999999999999 99999998877766655443 333333 34
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 752 PLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 752 ~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
.+.+|+.+||. ||.+||++.++++.|+++.
T Consensus 247 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 247 DVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 68999999999 9999999999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=356.02 Aligned_cols=242 Identities=23% Similarity=0.267 Sum_probs=198.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++|.+.++||+|+||+||+|.+ +|+.||||++............+..|+..+..+ +||||++++++|.+.+.+++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 6799999999999999999988 588999999876655555566677777776666 8999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-~ 212 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-A 212 (311)
T ss_dssp ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-C
Confidence 999 56888877643 4569999999999999999999999999999999999999999999999999998765432 2
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---CCChHHHHHHHHh
Q 003935 684 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---IPEGPLGRLIADC 760 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~---ip~~~L~~LI~~C 760 (785)
.....||+.|+|||++.+ .++.++|||||||++|||++|..||..... ...+........ ..+..+.+|+.+|
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~ 288 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMM 288 (311)
T ss_dssp --CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHHH
Confidence 345679999999999886 699999999999999999999776654322 222222221111 1234689999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003935 761 WA-EPQERPSCEEILSR 776 (785)
Q Consensus 761 L~-DP~kRPS~~EIL~~ 776 (785)
|. ||.+|||+.+++++
T Consensus 289 L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 289 LEPDPKLRATAEALLAL 305 (311)
T ss_dssp SCSSTTTSCCHHHHHTS
T ss_pred cCCChhhCcCHHHHHhC
Confidence 99 99999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=354.65 Aligned_cols=253 Identities=30% Similarity=0.488 Sum_probs=199.7
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHH--HhhcCCCceeeEeccc-----
Q 003935 521 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISI--LSRLRHPNVILFLGAC----- 593 (785)
Q Consensus 521 e~~i~~s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~i--Lk~L~HPNIVkL~g~~----- 593 (785)
+..+..++|.+.+.||+|+||+||+|.++++.||||++.... ...+..|.++ +..++||||+++++++
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 81 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTA 81 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence 345678999999999999999999999999999999986432 2344555555 4458999999999743
Q ss_pred cCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc---------ccccccCCCCcEEEcCCC
Q 003935 594 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM---------KIVHRDLKSANCLVNKHW 664 (785)
Q Consensus 594 ~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~---------gIIHrDLKpsNILLd~~g 664 (785)
.....+++||||+++|+|.+++.. ...++..++.++.||+.||+|||+. ||+||||||+|||++.++
T Consensus 82 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 82 DGRMEYLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp TSCEEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred CCCceEEEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC
Confidence 334467999999999999999963 2458889999999999999999999 999999999999999999
Q ss_pred eEEEEecCccccccCCC--------CCCCCCCCCCcccCcccccc-------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003935 665 TVKICDFGLSRIITDSP--------MRDSSSAGTPEWMAPELIRN-------EPFTEKCDIFSLGVIMWELCTLNRPWEG 729 (785)
Q Consensus 665 ~VKL~DFGLA~~l~~~~--------~~~~~~~GT~~Y~APEvl~~-------~~~s~ksDVWSLGvILyELLTG~~PF~~ 729 (785)
.+||+|||++..+.... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||..
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 99999999998765321 11234579999999999987 3566789999999999999999776532
Q ss_pred C------------------ChHHHHHHHHhcCCCCCCCCh---------HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 730 V------------------LPERVVYAVANEGSRLEIPEG---------PLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 730 ~------------------~~~~~v~~i~~~~~~~~ip~~---------~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
. ........+.....++.++.. .+.+|+.+||. ||.+|||+.++++.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 1 112222223333444444432 58999999999 9999999999999999876
Q ss_pred h
Q 003935 782 Y 782 (785)
Q Consensus 782 ~ 782 (785)
.
T Consensus 318 ~ 318 (336)
T 3g2f_A 318 M 318 (336)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=360.59 Aligned_cols=247 Identities=21% Similarity=0.314 Sum_probs=199.5
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
+++|.+.+.||+|+||+||+|.+ +++.||||++...... .....+.+|+.+++.++||||+++++++.+...+++||
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 36899999999999999999988 5889999998644321 11224567999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+.+ +|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 80 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 80 EYLDK-DLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp ECCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred ccccc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence 99985 88887763 3456899999999999999999999999999999999999999999999999999876544444
Q ss_pred CCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---------------
Q 003935 684 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE--------------- 747 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~--------------- 747 (785)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......+.
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 455678999999999876 5689999999999999999999999999888777766654211110
Q ss_pred ----------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 ----------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 ----------------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..+..+.+|+.+||. ||.+|||+.++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 012357899999999 99999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=361.83 Aligned_cols=243 Identities=26% Similarity=0.365 Sum_probs=193.1
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
.+.|.+.+.||+|+||+||+|.+ .++.||||++.... ..+.+.+|+.+++.++||||+++++++.+...+++||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 46799999999999999999998 46789999987543 2356789999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC---CCeEEEEecCccccccCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLSRIITDS 680 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~---~g~VKL~DFGLA~~l~~~ 680 (785)
||+++++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 128 e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 128 ELVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EeCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 9999999999986 4457999999999999999999999999999999999999975 889999999999876543
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCCC-----CChHHH
Q 003935 681 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER-VVYAVANEGSRLEI-----PEGPLG 754 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~-~v~~i~~~~~~~~i-----p~~~L~ 754 (785)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+......... ....+.
T Consensus 205 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 283 (349)
T 2w4o_A 205 V-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAK 283 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred c-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHH
Confidence 2 2345679999999999999999999999999999999999999998766555 44444443332221 134689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003935 755 RLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 755 ~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+|+.+||. ||.+|||+.+++++
T Consensus 284 ~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 284 DLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999 99999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=362.77 Aligned_cols=241 Identities=25% Similarity=0.419 Sum_probs=206.8
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++|.+.+.||+|+||+||+|.+ +++.||||++.+.... +.+|++++.++ +||||+++++++.+...+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 5799999999999999999988 4889999999765432 34688888888 7999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC----CeEEEEecCccccccC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH----WTVKICDFGLSRIITD 679 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~----g~VKL~DFGLA~~l~~ 679 (785)
||+.+|+|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||+.+. +.+||+|||++.....
T Consensus 96 E~~~gg~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 96 ELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCCSCBHHHHHH---TCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred eCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 9999999999986 44679999999999999999999999999999999999998543 3599999999988765
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC---CChHHHHHHHHhcCCCCCC-----CCh
Q 003935 680 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG---VLPERVVYAVANEGSRLEI-----PEG 751 (785)
Q Consensus 680 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~---~~~~~~v~~i~~~~~~~~i-----p~~ 751 (785)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+ ....+....+......... -..
T Consensus 173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 252 (342)
T 2qr7_A 173 ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252 (342)
T ss_dssp TTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCH
T ss_pred CCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCH
Confidence 54445567899999999999988899999999999999999999999975 4555666666554433221 234
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 752 PLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 752 ~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+.+|+.+||. ||.+||++.++++|
T Consensus 253 ~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 253 TAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 68999999999 99999999999976
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=353.15 Aligned_cols=255 Identities=28% Similarity=0.459 Sum_probs=212.0
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEecccc--C
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT--K 595 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~--d 595 (785)
++.++|++.+.||+|+||+||+|.+ .++.||||++... .....+.+.+|+.+++.++||||+++++++. +
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 3457899999999999999999984 5788999998654 3445677999999999999999999999876 4
Q ss_pred CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 596 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
...+++||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred CceEEEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 55689999999999999999742 3469999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--------------HHHHH
Q 003935 676 IITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE--------------RVVYA 738 (785)
Q Consensus 676 ~l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~--------------~~v~~ 738 (785)
....... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||...... .....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 7654322 223456888999999999999999999999999999999999998654322 22233
Q ss_pred HHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 739 VANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 739 i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
....+.....+ +..+.+|+.+||. ||.+|||+.+++++|+.+..
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 33334444333 3469999999999 99999999999999997753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=378.98 Aligned_cols=249 Identities=27% Similarity=0.485 Sum_probs=217.2
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
+..++|.+++.||+|+||+||+|.+ +|+.||||++....... ...+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3457899999999999999999988 58899999997543221 23567889999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
+||||+++|+|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 93 lv~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 93 MVMEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999999986 4567999999999999999999999999999999999999999999999999999887553
Q ss_pred CCCCCCCCCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHH
Q 003935 681 PMRDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIA 758 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~ 758 (785)
. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.........+.......+ .-...+.+|+.
T Consensus 170 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 248 (476)
T 2y94_A 170 E-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLK 248 (476)
T ss_dssp C-CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHH
T ss_pred c-cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHH
Confidence 2 3346789999999999998765 6899999999999999999999999888888777765543322 12346999999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003935 759 DCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 759 ~CL~-DP~kRPS~~EIL~~ 776 (785)
+||. ||.+|||+.++++|
T Consensus 249 ~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 249 HMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHTCSSTTTSCCHHHHHTC
T ss_pred HHcCCCchhCcCHHHHHhC
Confidence 9999 99999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=375.88 Aligned_cols=245 Identities=25% Similarity=0.443 Sum_probs=209.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
+.|.+.+.||+|+||+||+|.+ ++..||||++............+.+|+.+++.++||||++++++|.+...+|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4699999999999999999988 57899999997765544445778999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC---CCeEEEEecCccccccCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~---~g~VKL~DFGLA~~l~~~~ 681 (785)
|+.+|+|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 117 ~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 117 CYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 9999999988863 357899999999999999999999999999999999999975 4559999999998776542
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 756 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-----~~~L~~L 756 (785)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+.........+ +..+.+|
T Consensus 194 -~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 271 (494)
T 3lij_A 194 -KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271 (494)
T ss_dssp -CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHH
T ss_pred -cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHH
Confidence 3345689999999999874 59999999999999999999999999999988888887765544332 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003935 757 IADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.+||. ||.+|||+.++++|
T Consensus 272 i~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 272 IKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHCCCChhhCccHHHHhcC
Confidence 999999 99999999999976
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=366.72 Aligned_cols=246 Identities=25% Similarity=0.383 Sum_probs=213.3
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
.+.|.+.+.||+|+||+||+|.+ +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+...+++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 46899999999999999999988 58899999986543 233467889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC--CCeEEEEecCccccccCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK--HWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~--~g~VKL~DFGLA~~l~~~~ 681 (785)
||+.+|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 128 E~~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 128 EFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp ECCCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EcCCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999998862 2347999999999999999999999999999999999999974 5789999999998775432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHH
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRL 756 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i-----p~~~L~~L 756 (785)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+......... .+..+.+|
T Consensus 206 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 284 (387)
T 1kob_A 206 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284 (387)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred -ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 223457999999999999999999999999999999999999999998888877777665433221 13468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003935 757 IADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~ 776 (785)
|.+||. ||.+|||+.+++++
T Consensus 285 i~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 285 IKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHcCCChhHCcCHHHHhhC
Confidence 999999 99999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=353.20 Aligned_cols=258 Identities=29% Similarity=0.518 Sum_probs=214.1
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 595 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 595 (785)
++..++|.+.+.||+|+||+||+|.+ .+..||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 35567899999999999999999973 35689999986433 34456789999999999999999999999999
Q ss_pred CCceeEEEEEcccchhhHHHHhhcc----cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC---CCeEEE
Q 003935 596 PPRLSMITEYMELGSLYHLIHLSGQ----KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKI 668 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL~dlL~~~~~----~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~---~g~VKL 668 (785)
....++||||+++++|.+++..... ...+++..++.++.||+.||.|||++||+||||||+|||++. +..+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999999975431 145899999999999999999999999999999999999984 456999
Q ss_pred EecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC
Q 003935 669 CDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSR 745 (785)
Q Consensus 669 ~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~ 745 (785)
+|||++......... .....+++.|+|||++.+..++.++|||||||++|+|+| |..||...........+.... .
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~ 263 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-R 263 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-C
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC-C
Confidence 999999865433221 223457889999999999999999999999999999998 999999988877776665543 2
Q ss_pred CCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 746 LEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 746 ~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
...+ +..+.+|+.+||. ||.+||++.+++++|+.+..
T Consensus 264 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 2222 3469999999999 99999999999999987653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=345.33 Aligned_cols=254 Identities=28% Similarity=0.434 Sum_probs=207.3
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 521 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 521 e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
++....++|.....||+|+||+||+|.+ +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp CEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch--HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 3445566677777999999999999987 578999999876532 335778999999999999999999999999999
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC-CCeEEEEecCccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRII 677 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~-~g~VKL~DFGLA~~l 677 (785)
+++||||+++++|.+++........+++..++.++.|++.||+|||++||+|+||||+|||++. ++.+||+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 9999999999999999975444456778999999999999999999999999999999999987 899999999999877
Q ss_pred cCCCCCCCCCCCCCcccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCC---Ch
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRNEP--FTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGSRLEIP---EG 751 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~~~--~s~ksDVWSLGvILyELLTG~~PF~~~~~~-~~v~~i~~~~~~~~ip---~~ 751 (785)
...........|++.|+|||++.+.. ++.++||||||+++|+|++|+.||...... ..............++ +.
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (295)
T 2clq_A 174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA 253 (295)
T ss_dssp CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCH
T ss_pred CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCH
Confidence 54433344567999999999997654 889999999999999999999999765433 2222222223333333 34
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 752 PLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 752 ~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+.+|+.+||. ||.+||++.+++++
T Consensus 254 ~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 254 EAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 68999999999 99999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=376.16 Aligned_cols=245 Identities=28% Similarity=0.472 Sum_probs=216.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++|.+.+.||+|+||+||+|.+ +|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+...+++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 5799999999999999999988 5889999999765432 334578899999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEE---cCCCeEEEEecCccccccCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILL---d~~g~VKL~DFGLA~~l~~~ 680 (785)
||+.+|+|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+...
T Consensus 106 e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 106 EVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp CCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred ecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 9999999999886 45679999999999999999999999999999999999999 56789999999999877543
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHH
Q 003935 681 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGR 755 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-----~~~L~~ 755 (785)
. .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+.........+ +..+.+
T Consensus 183 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 260 (484)
T 3nyv_A 183 K-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260 (484)
T ss_dssp C-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred c-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence 2 2234579999999999976 59999999999999999999999999999988888887766555443 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHH
Q 003935 756 LIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 756 LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
|+.+||. ||.+|||+.++++|
T Consensus 261 li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 261 LIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHCCCChhHCcCHHHHhhC
Confidence 9999999 99999999999976
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=363.34 Aligned_cols=243 Identities=27% Similarity=0.405 Sum_probs=206.2
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEc
Q 003935 529 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 606 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 606 (785)
|...+.||+|+||+||+|.+ +|+.||+|++..... ...+.|.+|+.+++.++||||+++++++.+.+.+++||||+
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 33467899999999999987 588999999876432 34578999999999999999999999999999999999999
Q ss_pred ccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEE--cCCCeEEEEecCccccccCCCCCC
Q 003935 607 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV--NKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 607 ~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILL--d~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+.... ..
T Consensus 169 ~~~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~ 245 (373)
T 2x4f_A 169 DGGELFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KL 245 (373)
T ss_dssp TTCEEHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BC
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-cc
Confidence 99999988863 34568999999999999999999999999999999999999 567899999999998775432 23
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHHHHH
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRLIAD 759 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i-----p~~~L~~LI~~ 759 (785)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......... -...+.+|+.+
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 325 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK 325 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHT
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHH
Confidence 4567999999999999999999999999999999999999999999888888877765443321 13468999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003935 760 CWA-EPQERPSCEEILSR 776 (785)
Q Consensus 760 CL~-DP~kRPS~~EIL~~ 776 (785)
||. ||.+|||+.+++++
T Consensus 326 ~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 326 LLIKEKSWRISASEALKH 343 (373)
T ss_dssp TSCSSGGGSCCHHHHHHS
T ss_pred HcCCChhhCCCHHHHhcC
Confidence 999 99999999999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=349.71 Aligned_cols=255 Identities=22% Similarity=0.275 Sum_probs=204.7
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~L 601 (785)
.+++|.+.+.||+|+||+||+|.+ +++.||||++..... .....+.+.+|+.+++.++||||+++++++...+.+++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 457899999999999999999987 588999999865543 33445788999999999999999999999999999999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
||||+++++|.+++.. ...+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 9999999999999973 3578999999999999999999999999999999999999999999999999998765432
Q ss_pred C-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CC---CChHHHHH
Q 003935 682 M-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EI---PEGPLGRL 756 (785)
Q Consensus 682 ~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~-~i---p~~~L~~L 756 (785)
. ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+......+ .. -+..+.+|
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 268 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAV 268 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHH
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHH
Confidence 1 2234578999999999999999999999999999999999999999877654444333322211 11 13469999
Q ss_pred HHHhhh-CCCCCC-CHHHHHHHHHhhhh
Q 003935 757 IADCWA-EPQERP-SCEEILSRLLDCEY 782 (785)
Q Consensus 757 I~~CL~-DP~kRP-S~~EIL~~L~~l~~ 782 (785)
+.+||. ||.+|| +++++++.|++...
T Consensus 269 i~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 269 IARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred HHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 999999 999999 99999999987643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=356.97 Aligned_cols=249 Identities=23% Similarity=0.252 Sum_probs=203.9
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh---HHHHHHHHHHHHHhhcCCCceeeEeccccCCCce
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA---ENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 599 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~---~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 599 (785)
..++|.+.+.||+|+||+||+|.+ +|+.||||++....... ...+.+.+|+.+++.++||||+++++++.+...+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 347899999999999999999987 48899999986543221 1124678999999999999999999999999999
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
++||||+.+ +|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 999999986 78877752 345688999999999999999999999999999999999999999999999999988765
Q ss_pred CCCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----------
Q 003935 680 SPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----------- 747 (785)
Q Consensus 680 ~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~----------- 747 (785)
.........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+......+.
T Consensus 165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244 (346)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence 54444567899999999999764 589999999999999999999999999888777776654211110
Q ss_pred ------------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 ------------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 ------------------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.....+.+|+.+||. ||.+|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 012468899999999 99999999999976
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=363.63 Aligned_cols=257 Identities=19% Similarity=0.205 Sum_probs=201.0
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE-----CCeEEEEEEeeccccChH---------HHHHHHHHHHHHhhcCCCceeeE
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLTAE---------NMEDFCNEISILSRLRHPNVILF 589 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~~~~---------~~e~f~~EI~iLk~L~HPNIVkL 589 (785)
+..++|.+.+.||+|+||+||+|.+ .+..+|||++........ ....+.+|+.+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 3457899999999999999999988 457899999875532111 11346788899999999999999
Q ss_pred eccccC----CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC-
Q 003935 590 LGACTK----PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW- 664 (785)
Q Consensus 590 ~g~~~d----~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g- 664 (785)
++++.. ...+++||||+ +++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISG---QNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCB---GGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence 999877 67899999999 999999986 334899999999999999999999999999999999999999887
Q ss_pred -eEEEEecCccccccCCCC-------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--ChHH
Q 003935 665 -TVKICDFGLSRIITDSPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV--LPER 734 (785)
Q Consensus 665 -~VKL~DFGLA~~l~~~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~--~~~~ 734 (785)
.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ....
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 999999999987643211 113457999999999999999999999999999999999999999652 2222
Q ss_pred HHHHHH--hcCCCC--------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhcc
Q 003935 735 VVYAVA--NEGSRL--------EIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 784 (785)
Q Consensus 735 ~v~~i~--~~~~~~--------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~sL 784 (785)
...... ...... ...+..+.+++.+||. ||.+||++.+|++.|++....+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 330 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL 330 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence 211111 111110 0123469999999999 9999999999999999877654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=357.48 Aligned_cols=261 Identities=30% Similarity=0.561 Sum_probs=216.8
Q ss_pred ccccccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 518 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 518 ~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
..++|.+..++|.+.+.||+|+||.||+|.+.+ .+|+|++..........+.|.+|+.+++.++||||+++++++.+.+
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 457788999999999999999999999998866 5999998765544444566788999999999999999999999999
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.++++|||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred ceEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 99999999999999999862 234689999999999999999999999999999999999998 679999999998765
Q ss_pred cCC-----CCCCCCCCCCCcccCcccccc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Q 003935 678 TDS-----PMRDSSSAGTPEWMAPELIRN---------EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG 743 (785)
Q Consensus 678 ~~~-----~~~~~~~~GT~~Y~APEvl~~---------~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~ 743 (785)
... ........|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 259 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM 259 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC
Confidence 321 112234568899999999874 457899999999999999999999999988887777665543
Q ss_pred CCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 744 SRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 744 ~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
.....+ +..+.+|+..||. ||.+|||+.++++.|+++..
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 260 KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp CCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred CCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 322221 3469999999999 99999999999999988764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=358.68 Aligned_cols=249 Identities=26% Similarity=0.412 Sum_probs=206.9
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC-------
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK------- 595 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d------- 595 (785)
..++|.+.+.||+|+||+||+|.+ +|+.||||++............+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 357899999999999999999988 58899999987665544445678899999999999999999999876
Q ss_pred -CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcc
Q 003935 596 -PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 674 (785)
Q Consensus 596 -~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 674 (785)
.+.+++||||+.+ +|.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 3468999999986 66666642 3456999999999999999999999999999999999999999999999999999
Q ss_pred ccccCC----CCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--
Q 003935 675 RIITDS----PMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-- 747 (785)
Q Consensus 675 ~~l~~~----~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-- 747 (785)
..+... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+........
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 876422 122345678999999999876 4589999999999999999999999999888777666654221111
Q ss_pred C-C------------------------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 I-P------------------------------EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 i-p------------------------------~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
. + +..+.+|+.+||. ||.+|||+.++++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0 0 2347789999999 99999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=351.77 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=204.1
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC---hHHHHHHHHHHHHHhhcC---CCceeeEeccccCC
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT---AENMEDFCNEISILSRLR---HPNVILFLGACTKP 596 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~---~~~~e~f~~EI~iLk~L~---HPNIVkL~g~~~d~ 596 (785)
..++|.+.+.||+|+||+||+|.+ +++.||||++...... ......+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999986 6889999998654321 111245667777777664 99999999998765
Q ss_pred C-----ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEec
Q 003935 597 P-----RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 671 (785)
Q Consensus 597 ~-----~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DF 671 (785)
. .++++|||+. ++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 5 4799999998 5999988633 2344999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----
Q 003935 672 GLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---- 747 (785)
Q Consensus 672 GLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~---- 747 (785)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......+.
T Consensus 165 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (308)
T 3g33_A 165 GLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 243 (308)
T ss_dssp SCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 9998765432 23456789999999999999999999999999999999999999999988887777654211110
Q ss_pred ------------------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 ------------------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 ------------------------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.-...+.+|+.+||. ||.+|||+.++++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 012357899999999 99999999999976
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=348.36 Aligned_cols=243 Identities=24% Similarity=0.402 Sum_probs=209.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|.+.+.||+|+||+||++.+ +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 5799999999999999999988 588999999875432 223568899999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEE---cCCCeEEEEecCccccccCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILL---d~~g~VKL~DFGLA~~l~~~~ 681 (785)
|+++++|.+++.. ...+++..++.++.|++.||+|||++||+|+||||+|||+ +.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 87 LVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred cCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 9999999998863 3578999999999999999999999999999999999999 78899999999999765432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 756 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-----~~~L~~L 756 (785)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.........+ +..+.+|
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 241 (304)
T 2jam_A 163 -IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241 (304)
T ss_dssp -TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHH
T ss_pred -ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHH
Confidence 1223468999999999999999999999999999999999999999988888777776654433221 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003935 757 IADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.+||. ||.+|||+.+++++
T Consensus 242 i~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 242 ICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHcCCChhHCcCHHHHhcC
Confidence 999999 99999999999975
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=359.20 Aligned_cols=236 Identities=22% Similarity=0.367 Sum_probs=181.0
Q ss_pred eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccCCCceeEEEEEcccc
Q 003935 533 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEYMELG 609 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~Ey~~gG 609 (785)
+.||+|+||+||+|.+ +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....|+||||+++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 6899999999999988 4889999998643 2456788999999997 999999999999999999999999999
Q ss_pred hhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC---eEEEEecCccccccCCCCCCCC
Q 003935 610 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLSRIITDSPMRDSS 686 (785)
Q Consensus 610 SL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g---~VKL~DFGLA~~l~~~~~~~~~ 686 (785)
+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++............
T Consensus 92 ~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 168 (325)
T 3kn6_A 92 ELFERIK---KKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT 168 (325)
T ss_dssp BHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccc
Confidence 9999997 346799999999999999999999999999999999999998765 8999999999876654444456
Q ss_pred CCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcCCCCCC-----CChHHH
Q 003935 687 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP-------ERVVYAVANEGSRLEI-----PEGPLG 754 (785)
Q Consensus 687 ~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~-------~~~v~~i~~~~~~~~i-----p~~~L~ 754 (785)
.+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .+....+......... ....+.
T Consensus 169 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 248 (325)
T 3kn6_A 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAK 248 (325)
T ss_dssp ---------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHH
T ss_pred cCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHH
Confidence 7789999999999999999999999999999999999999986433 3444444333322221 134689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003935 755 RLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 755 ~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+|+..||. ||.+|||+.+++++
T Consensus 249 ~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 249 DLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHHHCCCChhHCCCHHHHhcC
Confidence 99999999 99999999999865
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=353.48 Aligned_cols=256 Identities=31% Similarity=0.574 Sum_probs=211.8
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEE--EEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCc
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDV--AIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPR 598 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~V--AVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~ 598 (785)
+.+++|.+.+.||+|+||.||+|.+ ++..+ |+|.+.... .....+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 3457899999999999999999976 56654 899886432 233456789999999999 89999999999999999
Q ss_pred eeEEEEEcccchhhHHHHhhc-------------ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCe
Q 003935 599 LSMITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 665 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~-------------~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~ 665 (785)
+++||||+++++|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe
Confidence 999999999999999997432 1246899999999999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Q 003935 666 VKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGS 744 (785)
Q Consensus 666 VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~ 744 (785)
+||+|||++...... .......+++.|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+.. +.
T Consensus 181 ~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~-~~ 258 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GY 258 (327)
T ss_dssp EEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-TC
T ss_pred EEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc-CC
Confidence 999999999754322 12234457889999999999889999999999999999998 9999999888777666543 33
Q ss_pred CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 745 RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 745 ~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
....+ +..+.+|+.+||. ||.+|||+.+++++|.++..
T Consensus 259 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 259 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 33333 3469999999999 99999999999999987653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=342.00 Aligned_cols=246 Identities=23% Similarity=0.357 Sum_probs=206.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|.+.+.||+|+||.||+|.+ +++.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 5799999999999999999988 4889999998755432 345788999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC--C
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP--M 682 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~--~ 682 (785)
|+++++|.+++. ....+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++....... .
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 999999999885 44579999999999999999999999999999999999999999999999999998654321 1
Q ss_pred CCCCCCCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCCC---CChHHHHHH
Q 003935 683 RDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPER-VVYAVANEGSRLEI---PEGPLGRLI 757 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvILyELLTG~~PF~~~~~~~-~v~~i~~~~~~~~i---p~~~L~~LI 757 (785)
......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||....... ....+......... .+..+.+|+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 2345678999999999987765 779999999999999999999998765432 22333322222111 234689999
Q ss_pred HHhhh-CCCCCCCHHHHHHH
Q 003935 758 ADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 758 ~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+||. ||.+|||+.+++++
T Consensus 243 ~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 243 HKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHSCSSTTTSCCHHHHTTC
T ss_pred HHHCCCCchhCCCHHHHhcC
Confidence 99999 99999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=342.14 Aligned_cols=247 Identities=26% Similarity=0.415 Sum_probs=207.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC---------
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--------- 595 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d--------- 595 (785)
.+|.+.+.||+|+||.||+|.+ +++.||+|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 5789999999999999999988 48899999987543 246689999999999999999998754
Q ss_pred -------CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEE
Q 003935 596 -------PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKI 668 (785)
Q Consensus 596 -------~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL 668 (785)
...+++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 34589999999999999999743 3457899999999999999999999999999999999999999999999
Q ss_pred EecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 003935 669 CDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI 748 (785)
Q Consensus 669 ~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i 748 (785)
+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||... ......+ ........
T Consensus 164 ~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~-~~~~~~~~ 239 (284)
T 2a19_B 164 GDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDL-RDGIISDI 239 (284)
T ss_dssp CCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHH-HTTCCCTT
T ss_pred Ccchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHh-hccccccc
Confidence 9999998775532 234567999999999999999999999999999999999999987532 2222222 22333333
Q ss_pred CChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhcc
Q 003935 749 PEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 784 (785)
Q Consensus 749 p~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~sL 784 (785)
.+..+.+|+.+||. ||.+|||+.+++++|..+..+.
T Consensus 240 ~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 240 FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 45579999999999 9999999999999999887653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=348.00 Aligned_cols=249 Identities=31% Similarity=0.556 Sum_probs=201.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhc--CCCceeeEeccccCC----Cce
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL--RHPNVILFLGACTKP----PRL 599 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L--~HPNIVkL~g~~~d~----~~l 599 (785)
.++|.+.+.||+|+||+||+|.++++.||||++.... ...+..|.+++..+ +||||+++++++... ..+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred ccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 3689999999999999999999999999999985432 24455666666655 899999999998776 678
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc--------ccccccCCCCcEEEcCCCeEEEEec
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM--------KIVHRDLKSANCLVNKHWTVKICDF 671 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~--------gIIHrDLKpsNILLd~~g~VKL~DF 671 (785)
++||||+++|+|.++++. ..+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+||
T Consensus 111 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 999999999999999963 3689999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCCCC----CCCCCCCCcccCccccccCCCCch------hhHHHHHHHHHHHHhC----------CCCCCCCC
Q 003935 672 GLSRIITDSPMR----DSSSAGTPEWMAPELIRNEPFTEK------CDIFSLGVIMWELCTL----------NRPWEGVL 731 (785)
Q Consensus 672 GLA~~l~~~~~~----~~~~~GT~~Y~APEvl~~~~~s~k------sDVWSLGvILyELLTG----------~~PF~~~~ 731 (785)
|++..+...... .....||+.|+|||++.+..+..+ +|||||||++|||+|| +.||....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 999776443221 224579999999999988766554 9999999999999999 77776432
Q ss_pred -----hHHHHHHHHhcCCCCCCCC--------hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003935 732 -----PERVVYAVANEGSRLEIPE--------GPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 783 (785)
Q Consensus 732 -----~~~~v~~i~~~~~~~~ip~--------~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~s 783 (785)
.......+......+..+. ..+.+|+.+||. ||.+|||+.+++++|+++..+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 2223333333333444442 248899999999 999999999999999988653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=346.36 Aligned_cols=246 Identities=28% Similarity=0.511 Sum_probs=208.1
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
..++|.+.+.||+|+||.||+|.+. |+.||||++..... .+.+.+|+.+++.++||||+++++++...+.+++|
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 3467999999999999999999884 88999999875432 35688999999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
|||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++........
T Consensus 103 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 103 MEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp EECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred eecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 999999999999863 245789999999999999999999999999999999999999999999999999987765443
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CC---CChHHHHHHH
Q 003935 683 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EI---PEGPLGRLIA 758 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~-~i---p~~~L~~LI~ 758 (785)
......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+....... .. -+..+.+|+.
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 260 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVK 260 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHH
Confidence 4456679999999999999999999999999999999999999999888776666554433211 11 1346899999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003935 759 DCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 759 ~CL~-DP~kRPS~~EIL~~ 776 (785)
+||. ||.+|||+.+++++
T Consensus 261 ~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 261 QCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHTCSCTTTSCCHHHHTTS
T ss_pred HHccCChhhCcCHHHHHhC
Confidence 9999 99999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=374.67 Aligned_cols=246 Identities=28% Similarity=0.451 Sum_probs=211.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-----------HHHHHHHHHHHHHhhcCCCceeeEecc
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-----------ENMEDFCNEISILSRLRHPNVILFLGA 592 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-----------~~~e~f~~EI~iLk~L~HPNIVkL~g~ 592 (785)
.++|.+.++||+|+||+||+|.+ .++.||||++....... ...+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 46899999999999999999988 47899999997654322 235678999999999999999999999
Q ss_pred ccCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC---eEEEE
Q 003935 593 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKIC 669 (785)
Q Consensus 593 ~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g---~VKL~ 669 (785)
+.+...+++||||+++|+|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 9999999999999999999998863 35799999999999999999999999999999999999998776 69999
Q ss_pred ecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-
Q 003935 670 DFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI- 748 (785)
Q Consensus 670 DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i- 748 (785)
|||++....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+.........
T Consensus 192 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 269 (504)
T 3q5i_A 192 DFGLSSFFSKDY-KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269 (504)
T ss_dssp CCTTCEECCTTS-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred ECCCCEEcCCCC-ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 999998775432 3346689999999999875 5899999999999999999999999999998888888776544332
Q ss_pred ----CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 749 ----PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 749 ----p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+..+.+|+.+||. ||.+|||+.++++|
T Consensus 270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 23468999999999 99999999999976
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=360.15 Aligned_cols=243 Identities=27% Similarity=0.327 Sum_probs=203.0
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC------
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------ 597 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------ 597 (785)
.+.|.+.+.||+|+||+||+|.+ +|+.||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 36899999999999999999987 5889999998766555666788999999999999999999999987653
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+|+||||+ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 469999999 7899999863 46899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL---------- 746 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~---------- 746 (785)
... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+......+
T Consensus 179 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 179 DSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp CSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred ccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 432 345678999999999887 679999999999999999999999999888776666554321111
Q ss_pred ----------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 ----------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 ----------------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
......+.+|+.+||. ||.+|||+.++++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0113458899999999 99999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=342.18 Aligned_cols=247 Identities=25% Similarity=0.420 Sum_probs=213.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc---C----hHHHHHHHHHHHHHhhcC-CCceeeEeccccC
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL---T----AENMEDFCNEISILSRLR-HPNVILFLGACTK 595 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~---~----~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d 595 (785)
.++|.+.+.||+|+||.||+|.+ +++.||||++..... . ....+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 57899999999999999999988 578999999975531 1 123467889999999996 9999999999999
Q ss_pred CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 596 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
....++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 9999999999999999999973 3578999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCcccCccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003935 676 IITDSPMRDSSSAGTPEWMAPELIR------NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 749 (785)
Q Consensus 676 ~l~~~~~~~~~~~GT~~Y~APEvl~------~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip 749 (785)
...... ......|++.|+|||++. ...++.++||||||+++|+|++|+.||...........+.........+
T Consensus 173 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 1phk_A 173 QLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 251 (298)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred hcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc
Confidence 765432 234567899999999985 4568899999999999999999999999988887777776655444332
Q ss_pred -----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 750 -----EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 750 -----~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+..+.+|+.+||. ||.+|||+.+++++
T Consensus 252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 252 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 2468999999999 99999999999874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=347.94 Aligned_cols=247 Identities=28% Similarity=0.482 Sum_probs=205.8
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
.+.|.+.+.||+|+||+||+|.+. ++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+.+++||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 367999999999999999999984 88999999865432 33578899999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+++++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.........
T Consensus 96 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 96 EFCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp ECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC
T ss_pred EeCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccc
Confidence 999999999988642 356899999999999999999999999999999999999999999999999997644222112
Q ss_pred CCCCCCCCcccCcccc-----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-C---ChHHH
Q 003935 684 DSSSAGTPEWMAPELI-----RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-P---EGPLG 754 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl-----~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i-p---~~~L~ 754 (785)
.....||+.|+|||++ .+..++.++||||||+++|+|++|..||...........+......... + +..+.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHH
Confidence 2345789999999998 4677899999999999999999999999998887777766654432221 1 33689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003935 755 RLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 755 ~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+|+..||. ||.+|||+.++++|
T Consensus 254 ~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 254 DFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHHcccChhhCCCHHHHhcC
Confidence 99999999 99999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=349.91 Aligned_cols=247 Identities=29% Similarity=0.533 Sum_probs=208.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhh--cCCCceeeEeccccCCC----cee
Q 003935 527 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR--LRHPNVILFLGACTKPP----RLS 600 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~--L~HPNIVkL~g~~~d~~----~l~ 600 (785)
++|.+.+.||+|+||+||+|.++++.||||++... ....+.+|++++.. ++||||+++++++.... .++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 67999999999999999999999999999998543 24567889999887 78999999999998775 789
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHH--------hcccccccCCCCcEEEcCCCeEEEEecC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH--------RMKIVHRDLKSANCLVNKHWTVKICDFG 672 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLH--------s~gIIHrDLKpsNILLd~~g~VKL~DFG 672 (785)
+||||+++|+|.+++.. ..+++..++.++.|++.||+||| +.||+||||||+|||++.++.+||+|||
T Consensus 117 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp EEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 99999999999999963 36899999999999999999999 8999999999999999999999999999
Q ss_pred ccccccCCCC----CCCCCCCCCcccCccccccCC------CCchhhHHHHHHHHHHHHhC----------CCCCCCC--
Q 003935 673 LSRIITDSPM----RDSSSAGTPEWMAPELIRNEP------FTEKCDIFSLGVIMWELCTL----------NRPWEGV-- 730 (785)
Q Consensus 673 LA~~l~~~~~----~~~~~~GT~~Y~APEvl~~~~------~s~ksDVWSLGvILyELLTG----------~~PF~~~-- 730 (785)
++........ ......||+.|+|||++.+.. ++.++|||||||++|+|+|| ..||...
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 9987754432 124557999999999998762 33689999999999999999 7898764
Q ss_pred ---ChHHHHHHHHhcCCCCCCCC--------hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 731 ---LPERVVYAVANEGSRLEIPE--------GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 731 ---~~~~~v~~i~~~~~~~~ip~--------~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
........+......+.++. ..+.+|+.+||. ||.+|||+.+|+++|+++..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 23344444444445555553 258899999999 99999999999999998764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=357.98 Aligned_cols=244 Identities=25% Similarity=0.313 Sum_probs=199.4
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC------
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------ 597 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------ 597 (785)
.++|.+.+.||+|+||+||+|.+ +++.||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 47899999999999999999987 5889999999876666666788999999999999999999999987665
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+++||||+.+ +|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 68999999985 6777764 35889999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------- 746 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~----------- 746 (785)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+
T Consensus 178 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 178 GTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred cccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 5432 2345679999999999999999999999999999999999999999988877766665422111
Q ss_pred ---------C--------------CC---------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 ---------E--------------IP---------EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 ---------~--------------ip---------~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
. .+ ...+.+|+.+||. ||.+|||+.++++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0 01 1247889999999 99999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=356.16 Aligned_cols=248 Identities=23% Similarity=0.373 Sum_probs=208.9
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
++..++|.+.+.||+|+||+||++.+. +..||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.++
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 345678999999999999999999984 8899999987653 4455678999999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc-ccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~-gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 108 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEECCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999999973 34689999999999999999999996 999999999999999999999999999976543
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--------------------
Q 003935 680 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV-------------------- 739 (785)
Q Consensus 680 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i-------------------- 739 (785)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+
T Consensus 185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 185 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp H--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred c--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 2 223567999999999999999999999999999999999999999876655432211
Q ss_pred ---------------------HhcCCCCCCC----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 740 ---------------------ANEGSRLEIP----EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 740 ---------------------~~~~~~~~ip----~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.........+ +..+.+|+.+||. ||.+|||+.++++|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0111112222 3368899999999 99999999999976
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=350.08 Aligned_cols=251 Identities=27% Similarity=0.481 Sum_probs=208.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC--Cc
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PR 598 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~--~~ 598 (785)
..|++.+.||+|+||+||++.+ +++.||||++... ......+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 3458999999999999998865 5788999998755 3345567899999999999999999999999774 56
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
+++||||+++++|.+++.. ..+++..++.++.|++.||+|||+.||+|+||||+|||++.++.+||+|||++....
T Consensus 110 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 8999999999999999852 348999999999999999999999999999999999999999999999999998775
Q ss_pred CCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--------------HHHHHHHh
Q 003935 679 DSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE--------------RVVYAVAN 741 (785)
Q Consensus 679 ~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~--------------~~v~~i~~ 741 (785)
.... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||...... ........
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 4322 123456888999999999989999999999999999999999999754322 11222333
Q ss_pred cCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 742 EGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 742 ~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
.......+ +..+.+|+.+||. ||.+|||+.++++.|+++..
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 34344333 2469999999999 99999999999999998754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=362.67 Aligned_cols=254 Identities=29% Similarity=0.537 Sum_probs=202.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--C-C--eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC-CCcee
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--N-G--TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-PPRLS 600 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~-g--~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d-~~~l~ 600 (785)
..|.+.+.||+|+||+||+|.+ + + ..||+|.+.... .....+.|.+|+.+++.++||||+++++++.+ .+..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 3578899999999999999976 2 2 358999886433 33456889999999999999999999998654 56789
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
+||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 168 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999999963 3456889999999999999999999999999999999999999999999999999876443
Q ss_pred CCC----CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003935 681 PMR----DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 752 (785)
Q Consensus 681 ~~~----~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~ 752 (785)
... .....+|+.|+|||++.+..++.++|||||||++|||+| |..||.+....+....+... .....| +..
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~-~~~~~p~~~~~~ 324 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLLQPEYCPDP 324 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT-CCCCCCTTCCHH
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHH
Confidence 211 123457789999999999999999999999999999999 67788877666555555443 333333 356
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhcc
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 784 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~sL 784 (785)
+.+++.+||. ||.+|||+.+++++|+++..++
T Consensus 325 l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 325 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 9999999999 9999999999999999886544
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=390.63 Aligned_cols=251 Identities=20% Similarity=0.353 Sum_probs=217.3
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCc
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPR 598 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~ 598 (785)
.+..++|.+.+.||+|+||+||+|.+ +++.||||++.+... .....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 45678999999999999999999988 477899999975432 222356788999999988 69999999999999999
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
+|+||||+++|+|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+++...
T Consensus 417 ~~lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999999973 3579999999999999999999999999999999999999999999999999998755
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CChHHHHHH
Q 003935 679 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PEGPLGRLI 757 (785)
Q Consensus 679 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i-p~~~L~~LI 757 (785)
.........+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..++...+.......+. -...+.+||
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 573 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 573 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHH
T ss_pred cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 4444556788999999999999999999999999999999999999999999999888888765533321 234699999
Q ss_pred HHhhh-CCCCCCCH-----HHHHHH
Q 003935 758 ADCWA-EPQERPSC-----EEILSR 776 (785)
Q Consensus 758 ~~CL~-DP~kRPS~-----~EIL~~ 776 (785)
.+||. ||.+||++ ++|++|
T Consensus 574 ~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 574 KGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHccCCHHHCCCCCCCcHHHHhcC
Confidence 99999 99999997 777754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=339.17 Aligned_cols=250 Identities=20% Similarity=0.286 Sum_probs=204.8
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccc-cCCCceeEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC-TKPPRLSMI 602 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~-~d~~~l~LV 602 (785)
.++|.+.+.||+|+||+||+|.+ +++.||||++...... ..+.+|+.+++.++|++++..+.++ ......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 36899999999999999999986 6899999998655432 3578999999999988866666555 566778999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEE---cCCCeEEEEecCccccccC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILL---d~~g~VKL~DFGLA~~l~~ 679 (785)
|||+ +++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 84 ~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 9999 89999998632 3579999999999999999999999999999999999999 4888999999999987755
Q ss_pred CCC-------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCC---
Q 003935 680 SPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP---ERVVYAVANEGSRL--- 746 (785)
Q Consensus 680 ~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~---~~~v~~i~~~~~~~--- 746 (785)
... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+... ......+.......
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 422 12456799999999999999999999999999999999999999986432 12222222211111
Q ss_pred ---CCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 747 ---EIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 747 ---~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
..-+..+.+|+..||. ||.+|||+.+|++.|+++..
T Consensus 241 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 1123568999999999 99999999999999998754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=351.91 Aligned_cols=248 Identities=25% Similarity=0.403 Sum_probs=210.3
Q ss_pred CCeeEe-eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccCCCceeEE
Q 003935 527 SELTVG-TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 527 s~y~i~-k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV 602 (785)
+.|.+. +.||+|+||+||+|.+ +++.||+|++............+.+|+.+++.+. ||||+++++++.+...+++|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 456666 8899999999999988 4889999999776655555678999999999995 69999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC---CCeEEEEecCccccccC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLSRIITD 679 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~---~g~VKL~DFGLA~~l~~ 679 (785)
|||+.+|+|.+++.. .....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 999999999998752 23467999999999999999999999999999999999999987 78999999999987754
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHH
Q 003935 680 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLG 754 (785)
Q Consensus 680 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-----~~~L~ 754 (785)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.........+ ...+.
T Consensus 187 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 265 (327)
T 3lm5_A 187 AC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLAT 265 (327)
T ss_dssp --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred cc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHH
Confidence 32 2345679999999999999999999999999999999999999999998888777766544333221 34689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003935 755 RLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 755 ~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+|+.+||. ||.+|||+++++++
T Consensus 266 ~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 266 DFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHcCCChhhCcCHHHHhCC
Confidence 99999999 99999999999976
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=342.00 Aligned_cols=249 Identities=20% Similarity=0.292 Sum_probs=201.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccc-cCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC-TKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~-~d~~~l~LV~ 603 (785)
++|.+.+.||+|+||+||+|.+ +++.||||++...... ..+.+|+.+++.++|++++..+..+ ......++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 6799999999999999999986 6889999987654332 3477899999999988877666655 5667789999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEE---cCCCeEEEEecCccccccCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILL---d~~g~VKL~DFGLA~~l~~~ 680 (785)
||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 999 89999998732 4569999999999999999999999999999999999999 78899999999999876543
Q ss_pred CC-------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCCCCC---
Q 003935 681 PM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE---RVVYAVANEGSRLE--- 747 (785)
Q Consensus 681 ~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~---~~v~~i~~~~~~~~--- 747 (785)
.. ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.... .....+........
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence 22 223567999999999999999999999999999999999999999764322 22222221111111
Q ss_pred ---CCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 748 ---IPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 748 ---ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
--+..+.+|+..||. ||.+|||+.++++.|+++..
T Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 114569999999999 99999999999999998754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=347.80 Aligned_cols=245 Identities=24% Similarity=0.359 Sum_probs=198.0
Q ss_pred CCeeEe-eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCceeEE
Q 003935 527 SELTVG-TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 527 s~y~i~-k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV 602 (785)
+.|.+. +.||+|+||+||+|.+ +++.||||++..... ...+.+.+|+.++.++ +||||+++++++.+.+.+++|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 567774 7899999999999986 588999999976533 2346788999999885 799999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCe---EEEEecCccccccC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT---VKICDFGLSRIITD 679 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~---VKL~DFGLA~~l~~ 679 (785)
|||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 90 FEKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999999973 357899999999999999999999999999999999999988776 99999999976542
Q ss_pred CCC-------CCCCCCCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------------
Q 003935 680 SPM-------RDSSSAGTPEWMAPELIRN-----EPFTEKCDIFSLGVIMWELCTLNRPWEGVLP--------------- 732 (785)
Q Consensus 680 ~~~-------~~~~~~GT~~Y~APEvl~~-----~~~s~ksDVWSLGvILyELLTG~~PF~~~~~--------------- 732 (785)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 211 1124569999999999975 5588999999999999999999999986542
Q ss_pred HHHHHHHHhcCCCCC-----CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 733 ERVVYAVANEGSRLE-----IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 733 ~~~v~~i~~~~~~~~-----ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
......+.......+ .-+..+.+|+.+||. ||.+|||+.++++|
T Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 233344433332221 113468999999999 99999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=341.62 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=206.3
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC--hHHHHHHHHHHHHHhhcCCCceeeEeccc--cCCCce
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT--AENMEDFCNEISILSRLRHPNVILFLGAC--TKPPRL 599 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~--~~~~e~f~~EI~iLk~L~HPNIVkL~g~~--~d~~~l 599 (785)
.++|.+.+.||+|+||.||++.+ +++.||+|++...... ....+.+.+|+.+++.++||||+++++++ .+...+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 36799999999999999999987 5789999998654321 23457899999999999999999999998 455679
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
++||||+.++ |.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 9999999987 66666533 356799999999999999999999999999999999999999999999999999987643
Q ss_pred CC--CCCCCCCCCCcccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHH
Q 003935 680 SP--MRDSSSAGTPEWMAPELIRNEP--FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLG 754 (785)
Q Consensus 680 ~~--~~~~~~~GT~~Y~APEvl~~~~--~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~ 754 (785)
.. .......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.+.........+........ .-...+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 241 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHH
Confidence 21 1223557899999999998654 37899999999999999999999999888777777665443221 1234689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003935 755 RLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 755 ~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+|+.+||. ||.+|||+.+++++
T Consensus 242 ~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 242 DLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHHccCChhhCCCHHHHhcC
Confidence 99999999 99999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=362.02 Aligned_cols=196 Identities=31% Similarity=0.421 Sum_probs=169.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC-----Cce
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-----PRL 599 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~-----~~l 599 (785)
++|.+.+.||+|+||+||+|.+ +++.||||++..........+.+.+|+.+|+.++||||+++++++... ..+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 7899999999999999999988 578999999976655666678899999999999999999999998766 568
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
|+||||+. ++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 99999987 59999886 456799999999999999999999999999999999999999999999999999987643
Q ss_pred CCC----------------------CCCCCCCCCcccCcccc-ccCCCCchhhHHHHHHHHHHHHhCCCC
Q 003935 680 SPM----------------------RDSSSAGTPEWMAPELI-RNEPFTEKCDIFSLGVIMWELCTLNRP 726 (785)
Q Consensus 680 ~~~----------------------~~~~~~GT~~Y~APEvl-~~~~~s~ksDVWSLGvILyELLTG~~P 726 (785)
... .....+||+.|+|||++ ....++.++|||||||++|||++|..|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 251 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence 321 12466899999999986 566799999999999999999985433
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=347.68 Aligned_cols=255 Identities=25% Similarity=0.437 Sum_probs=192.6
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 521 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 521 e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
.|.+..++|.+.+.||+|+||+||+|.+ +++.||||++..... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 3567789999999999999999999976 688999999865432 2335678899999999999999999999999999
Q ss_pred eeEEEEEcccchhhHHHHhhc-----ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCc
Q 003935 599 LSMITEYMELGSLYHLIHLSG-----QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGL 673 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~-----~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGL 673 (785)
.++||||+++++|.+++.... ....+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 999999999999999986421 235689999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-----CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Q 003935 674 SRIITDSPM-----RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE 747 (785)
Q Consensus 674 A~~l~~~~~-----~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ 747 (785)
+........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....................
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 976643211 1234578999999999876 5689999999999999999999999998776665554443322110
Q ss_pred -----------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 -----------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 -----------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..+..+.+|+.+||. ||.+|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 112368899999999 99999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=357.67 Aligned_cols=257 Identities=15% Similarity=0.151 Sum_probs=209.5
Q ss_pred ccccccccCCCeeEeeEEeeeCcEEEEEEE-------ECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC---CCcee
Q 003935 518 AYEEWNIDFSELTVGTRVGIGFFGEVFRGI-------WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR---HPNVI 587 (785)
Q Consensus 518 ~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~-------~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~---HPNIV 587 (785)
...++++..++|.+.+.||+|+||+||+|. ..++.||||++.... ..++..|+.+++.++ |+||+
T Consensus 56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv 130 (365)
T 3e7e_A 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFM 130 (365)
T ss_dssp SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBC
T ss_pred cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhh
Confidence 446677888999999999999999999993 258899999986432 356778888888887 99999
Q ss_pred eEeccccCCCceeEEEEEcccchhhHHHHhhc--ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC---
Q 003935 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSG--QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK--- 662 (785)
Q Consensus 588 kL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~--~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~--- 662 (785)
++++++...+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 131 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp CEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGT
T ss_pred hhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEeccccc
Confidence 99999999999999999999999999997532 2457999999999999999999999999999999999999998
Q ss_pred --------CCeEEEEecCccccccC--CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 003935 663 --------HWTVKICDFGLSRIITD--SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP 732 (785)
Q Consensus 663 --------~g~VKL~DFGLA~~l~~--~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~ 732 (785)
++.+||+|||+++.+.. ........+||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 89999999999976532 22233467899999999999999999999999999999999999999964322
Q ss_pred HHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCC-CCHHHHHHHHHhhhh
Q 003935 733 ERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQER-PSCEEILSRLLDCEY 782 (785)
Q Consensus 733 ~~~v~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kR-PS~~EIL~~L~~l~~ 782 (785)
.... .............+.+++..|++ +|.+| |++.++.+.|+++..
T Consensus 291 ~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 291 GECK---PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp TEEE---ECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred Ccee---echhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 1100 00011111123468899999999 88888 688888888877643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.85 Aligned_cols=256 Identities=23% Similarity=0.382 Sum_probs=209.4
Q ss_pred ccccccccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC--CCceeeEecc
Q 003935 516 LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR--HPNVILFLGA 592 (785)
Q Consensus 516 ~~~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~--HPNIVkL~g~ 592 (785)
.+.++.+.+...+|.+.+.||+|+||.||++.+ +++.||||++..........+.+.+|+.+++.++ ||||++++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 344566777788999999999999999999987 5788999999877666677788999999999997 5999999999
Q ss_pred ccCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecC
Q 003935 593 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 672 (785)
Q Consensus 593 ~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFG 672 (785)
+.....+++||| +.+++|.+++. ....+++..++.++.|++.||+|||++||+||||||+|||+++ +.+||+|||
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHH---HCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred eecCCEEEEEEe-cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeecc
Confidence 999999999999 66789999997 3457899999999999999999999999999999999999965 899999999
Q ss_pred ccccccCCCC--CCCCCCCCCcccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHH
Q 003935 673 LSRIITDSPM--RDSSSAGTPEWMAPELIRN-----------EPFTEKCDIFSLGVIMWELCTLNRPWEGVLP-ERVVYA 738 (785)
Q Consensus 673 LA~~l~~~~~--~~~~~~GT~~Y~APEvl~~-----------~~~s~ksDVWSLGvILyELLTG~~PF~~~~~-~~~v~~ 738 (785)
++........ ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ......
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 251 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHH
Confidence 9987644321 1234578999999999875 4688999999999999999999999987643 334444
Q ss_pred HHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 739 VANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 739 i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.........+ +..+.+|+.+||. ||.+||++.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 252 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 44444443333 4569999999999 99999999999976
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=367.68 Aligned_cols=248 Identities=15% Similarity=0.141 Sum_probs=194.9
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHH---HHHhhcCCCceeeEe----
Q 003935 521 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEI---SILSRLRHPNVILFL---- 590 (785)
Q Consensus 521 e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI---~iLk~L~HPNIVkL~---- 590 (785)
++....++|.+.+.||+|+||+||+|.+ +|+.||||++..... .....+.|.+|+ .+++.++|||||+++
T Consensus 67 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp SSSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred ecCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 3444567899999999999999999986 589999999975532 334567889999 455556899999998
Q ss_pred ---ccccCCC-----------------ceeEEEEEcccchhhHHHHhhc----ccccchHHHHHHHHHHHHHHHHHHHhc
Q 003935 591 ---GACTKPP-----------------RLSMITEYMELGSLYHLIHLSG----QKKKLSWRRKLKMLRDICRGLMCIHRM 646 (785)
Q Consensus 591 ---g~~~d~~-----------------~l~LV~Ey~~gGSL~dlL~~~~----~~~~Ls~~~~l~Ia~QIa~AL~yLHs~ 646 (785)
+++.+.+ ..|++|||+ +|+|.+++.... ....+++..++.++.||+.||+|||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 225 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 225 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 4444332 378999999 679999997432 123456788999999999999999999
Q ss_pred ccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccC-----------CCCchhhHHHHHH
Q 003935 647 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-----------PFTEKCDIFSLGV 715 (785)
Q Consensus 647 gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~-----------~~s~ksDVWSLGv 715 (785)
||+||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+. .++.++|||||||
T Consensus 226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred CeecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999999999999999999986433 2335567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 716 IMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 716 ILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
++|||++|+.||.+.........+... ...-+..+.+|+.+||. ||.+|||+.+++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWIFRS---CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGGGSS---CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCcccccccchhhhhhh---ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 999999999999876544333322211 11223569999999999 99999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.98 Aligned_cols=246 Identities=22% Similarity=0.402 Sum_probs=211.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc--Ch----HHHHHHHHHHHHHhhc-CCCceeeEeccccCCC
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL--TA----ENMEDFCNEISILSRL-RHPNVILFLGACTKPP 597 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~--~~----~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~ 597 (785)
++|.+.+.||+|+||.||+|.+ +|+.||||++..... .. ...+.+.+|+.+++.+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999988 488999999865432 11 2245678999999999 7999999999999999
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 99999999999999999873 357999999999999999999999999999999999999999999999999999877
Q ss_pred cCCCCCCCCCCCCCcccCcccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRN------EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-- 749 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~------~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-- 749 (785)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.........+
T Consensus 251 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 251 EPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 5432 3345789999999999863 358889999999999999999999999988877777766554433221
Q ss_pred ---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 750 ---EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 750 ---~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+..+.+|+.+||. ||.+|||+.+++++
T Consensus 330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 3358999999999 99999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=361.26 Aligned_cols=252 Identities=24% Similarity=0.382 Sum_probs=204.7
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE-----CCeEEEEEEeecccc--ChHHHHHHHHHHHHHhhc-CCCceeeEecccc
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDL--TAENMEDFCNEISILSRL-RHPNVILFLGACT 594 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~--~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~ 594 (785)
.+..++|.+.+.||+|+||+||+|.+ +++.||||++..... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 45568999999999999999999987 588999999865432 112234567899999999 6999999999999
Q ss_pred CCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcc
Q 003935 595 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 674 (785)
Q Consensus 595 d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 674 (785)
....+++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eCceEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999999973 347899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC-CCCCCCCCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhcCCCC-
Q 003935 675 RIITDSP-MRDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGV----LPERVVYAVANEGSRL- 746 (785)
Q Consensus 675 ~~l~~~~-~~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvILyELLTG~~PF~~~----~~~~~v~~i~~~~~~~- 746 (785)
+.+.... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... ........+.......
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 286 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 286 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC
Confidence 8654321 12234579999999999986 35789999999999999999999999743 2333333333322111
Q ss_pred CCCChHHHHHHHHhhh-CCCCCC-----CHHHHHHHH
Q 003935 747 EIPEGPLGRLIADCWA-EPQERP-----SCEEILSRL 777 (785)
Q Consensus 747 ~ip~~~L~~LI~~CL~-DP~kRP-----S~~EIL~~L 777 (785)
..-...+.+|+.+||. ||.+|| ++.+++++.
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1123468999999999 999999 999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=354.72 Aligned_cols=250 Identities=17% Similarity=0.185 Sum_probs=203.5
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEEC----------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceee------
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIWN----------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL------ 588 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~~----------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVk------ 588 (785)
..++|.+.+.||+|+||+||+|.+. ++.||||++... +.+.+|+.+++.++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 3478999999999999999999873 678999998644 35779999999999999998
Q ss_pred ---------EeccccC-CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcE
Q 003935 589 ---------FLGACTK-PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANC 658 (785)
Q Consensus 589 ---------L~g~~~d-~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNI 658 (785)
+++++.. ...+++||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 4455544 66789999999 99999999743 246799999999999999999999999999999999999
Q ss_pred EEcCCC--eEEEEecCccccccCCCC-------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003935 659 LVNKHW--TVKICDFGLSRIITDSPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 729 (785)
Q Consensus 659 LLd~~g--~VKL~DFGLA~~l~~~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~ 729 (785)
|++.++ .+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 999999999987643211 12345799999999999999999999999999999999999999987
Q ss_pred CC--hHHHHHHHH--hcCCCCC--------CCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003935 730 VL--PERVVYAVA--NEGSRLE--------IPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 783 (785)
Q Consensus 730 ~~--~~~~v~~i~--~~~~~~~--------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~s 783 (785)
.. ......... ....... ..+..+.+|+..||. ||.+|||+.+|++.|+++...
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 53 222222221 1111110 114579999999999 999999999999999987643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=358.89 Aligned_cols=241 Identities=22% Similarity=0.389 Sum_probs=204.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChH------HHHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE------NMEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~------~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
++|.+.+.||+|+||+||+|.+ +++.||||++........ ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 5799999999999999999987 688999999976543221 23457789999999999999999999999999
Q ss_pred eeEEEEEcccc-hhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 599 LSMITEYMELG-SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 599 l~LV~Ey~~gG-SL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
+++||||+.+| +|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 104 ~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999776 9999886 4557999999999999999999999999999999999999999999999999999877
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCChHHHHH
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRL 756 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~~~L~~L 756 (785)
.... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... .......+...+..+.+|
T Consensus 181 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~l~~l 254 (335)
T 3dls_A 181 ERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----VEAAIHPPYLVSKELMSL 254 (335)
T ss_dssp CTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----TTTCCCCSSCCCHHHHHH
T ss_pred CCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----HhhccCCCcccCHHHHHH
Confidence 5432 2335679999999999988876 88999999999999999999999764321 001111122234579999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003935 757 IADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.+||. ||.+|||+.+++++
T Consensus 255 i~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 255 VSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999 99999999999987
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=377.90 Aligned_cols=254 Identities=22% Similarity=0.300 Sum_probs=214.5
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-HHHHHHHHHHHHHhhcCCCceeeEeccccCCCce
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 599 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 599 (785)
.+..++|.+.+.||+|+||+||+|.+ +|+.||||++.+..... ...+.+.+|+.+++.++||||+++++++.+...+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 35568899999999999999999988 58899999997654321 2356788999999999999999999999999999
Q ss_pred eEEEEEcccchhhHHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 600 SMITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
|+||||++||+|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.+.
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999999986432 24469999999999999999999999999999999999999999999999999998876
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhcCCCCC-CCChHH
Q 003935 679 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV----LPERVVYAVANEGSRLE-IPEGPL 753 (785)
Q Consensus 679 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~----~~~~~v~~i~~~~~~~~-ip~~~L 753 (785)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+. ........+.......+ .-+..+
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~ 420 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHH
Confidence 5444444568999999999999999999999999999999999999999865 34555555554332221 124468
Q ss_pred HHHHHHhhh-CCCCCCCH-----HHHHHH
Q 003935 754 GRLIADCWA-EPQERPSC-----EEILSR 776 (785)
Q Consensus 754 ~~LI~~CL~-DP~kRPS~-----~EIL~~ 776 (785)
.+|+.+||. ||.+||++ .+|++|
T Consensus 421 ~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp HHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred HHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 999999999 99999965 677654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=361.58 Aligned_cols=242 Identities=21% Similarity=0.358 Sum_probs=193.2
Q ss_pred CCCeeEe-eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHh-hcCCCceeeEeccccC----CC
Q 003935 526 FSELTVG-TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILS-RLRHPNVILFLGACTK----PP 597 (785)
Q Consensus 526 ~s~y~i~-k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk-~L~HPNIVkL~g~~~d----~~ 597 (785)
.++|.+. +.||+|+||+||++.+ +++.||||++... ..+.+|+.++. ..+||||+++++++.. ..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 4678776 7899999999999988 4889999998532 34668888874 4589999999998865 56
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC---CCeEEEEecCcc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLS 674 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~---~g~VKL~DFGLA 674 (785)
.+|+||||+.+|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 789999999999999999732 2346999999999999999999999999999999999999997 789999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHhcCCCCCC--
Q 003935 675 RIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER----VVYAVANEGSRLEI-- 748 (785)
Q Consensus 675 ~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~----~v~~i~~~~~~~~i-- 748 (785)
+...... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..... ....+.........
T Consensus 212 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 290 (400)
T 1nxk_A 212 KETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 290 (400)
T ss_dssp EECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred cccCCCC-ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence 8765432 2346689999999999999999999999999999999999999997654321 23333333333222
Q ss_pred ---CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 749 ---PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 749 ---p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
-...+.+||.+||. ||.+|||+.++++|
T Consensus 291 ~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 13468999999999 99999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=340.26 Aligned_cols=245 Identities=26% Similarity=0.470 Sum_probs=212.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|.+.+.||+|+||+||+|.+ +++.||||++..........+.+.+|+.+++.++||||+++++++.+...+++|+|
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 6799999999999999999988 58899999997665544556789999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC---CeEEEEecCccccccCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH---WTVKICDFGLSRIITDSP 681 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~---g~VKL~DFGLA~~l~~~~ 681 (785)
|+.+++|.+.+.. ...+++..++.++.||+.||+|||++||+|+||||+|||++.+ +.+||+|||++.......
T Consensus 102 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 102 LYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred ccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 9999999988863 3478999999999999999999999999999999999999754 479999999998765432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 756 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-----~~~L~~L 756 (785)
......+++.|+|||.+.+. ++.++||||||+++|+|++|..||.+.........+.........+ +..+.++
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (287)
T 2wei_A 179 -KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (287)
T ss_dssp -SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHH
T ss_pred -ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHH
Confidence 22344578899999998765 8999999999999999999999999988888777776655444332 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003935 757 IADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.+||. ||.+|||+.+++++
T Consensus 257 i~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 257 IRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHcccChhhCcCHHHHhcC
Confidence 999999 99999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.12 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=206.2
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE---CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc---CCCceeeEecccc----
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL---RHPNVILFLGACT---- 594 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~---~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L---~HPNIVkL~g~~~---- 594 (785)
..++|.+.+.||+|+||+||+|.+ +++.||||++............+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 347899999999999999999987 378899999875543332234566788777766 8999999999986
Q ss_pred -CCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCc
Q 003935 595 -KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGL 673 (785)
Q Consensus 595 -d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGL 673 (785)
....+++||||+. |+|.+++... ....+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 5567899999998 5999988643 234589999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------
Q 003935 674 SRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------- 746 (785)
Q Consensus 674 A~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~------- 746 (785)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 167 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (326)
T 1blx_A 167 ARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245 (326)
T ss_dssp CCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred cccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence 98764322 2345678999999999999999999999999999999999999999988877776665321100
Q ss_pred ---------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 ---------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 ---------------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..-+..+.+|+.+||. ||.+|||+.++++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0112357899999999 99999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=364.85 Aligned_cols=246 Identities=25% Similarity=0.362 Sum_probs=195.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC------hHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT------AENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~------~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
.++|.+.+.||+|+||+||+|.+ +++.||||++...... ......+.+|+.+|++++||||+++++++...
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~- 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 36899999999999999999988 4789999999765422 11223578999999999999999999998654
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC---eEEEEecCcc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLS 674 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g---~VKL~DFGLA 674 (785)
.+++||||+++|+|.+++. ....+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 213 ~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred ceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 5899999999999998875 456799999999999999999999999999999999999997544 5999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---
Q 003935 675 RIITDSPMRDSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI--- 748 (785)
Q Consensus 675 ~~l~~~~~~~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i--- 748 (785)
+...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...............+.....
T Consensus 290 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 368 (419)
T 3i6u_A 290 KILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368 (419)
T ss_dssp TSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred eecCCCc-cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence 8775432 2345689999999999853 66889999999999999999999999875443333333333322222
Q ss_pred ---CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 749 ---PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 749 ---p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
....+.+|+.+||. ||.+|||+.++++|
T Consensus 369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 13468999999999 99999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=351.63 Aligned_cols=247 Identities=25% Similarity=0.347 Sum_probs=206.3
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
..|++. ++|.+.+.||+|+||+||+|.+ +|+.||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 36 ~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 114 (371)
T 4exu_A 36 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 114 (371)
T ss_dssp EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred ceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence 344443 7899999999999999999987 5899999999876666666788999999999999999999999998776
Q ss_pred ce------eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEec
Q 003935 598 RL------SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 671 (785)
Q Consensus 598 ~l------~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DF 671 (785)
.. ++||||+. ++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 115 SLRNFYDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp SSTTCCCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECST
T ss_pred CcccceeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEec
Confidence 54 99999998 57777653 34899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----
Q 003935 672 GLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL---- 746 (785)
Q Consensus 672 GLA~~l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~---- 746 (785)
|+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 189 g~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 189 GLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp TCC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CcccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 999866432 235678999999999987 678999999999999999999999999988777666654321111
Q ss_pred ----------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 ----------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 ----------------------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
......+.+|+.+||. ||.+|||+.++++|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0113468899999999 99999999999976
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=347.55 Aligned_cols=260 Identities=23% Similarity=0.315 Sum_probs=207.4
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEecccc---
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT--- 594 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~--- 594 (785)
+.+.+..++|.+.+.||+|+||.||++.+ +++.||||++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRER 99 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence 44556778999999999999999999987 6889999998653 3445678999999999999999999999986
Q ss_pred -CCCceeEEEEEcccchhhHHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecC
Q 003935 595 -KPPRLSMITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 672 (785)
Q Consensus 595 -d~~~l~LV~Ey~~gGSL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFG 672 (785)
.....++||||+.+|+|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecC
Confidence 3446899999999999999887432 34679999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCC---------CCCCCCCCcccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHH
Q 003935 673 LSRIITDSPMR---------DSSSAGTPEWMAPELIRNEP---FTEKCDIFSLGVIMWELCTLNRPWEGVLP--ERVVYA 738 (785)
Q Consensus 673 LA~~l~~~~~~---------~~~~~GT~~Y~APEvl~~~~---~s~ksDVWSLGvILyELLTG~~PF~~~~~--~~~v~~ 738 (785)
++......... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..... ......
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 98765321100 01234689999999997654 68899999999999999999999953211 111111
Q ss_pred HHhcCCCCCC---CChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 739 VANEGSRLEI---PEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 739 i~~~~~~~~i---p~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
+ ......+. .+..+.+|+.+||. ||.+|||+.+++++|+++..
T Consensus 260 ~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 260 V-QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp H-HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred h-hccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 2 22222221 13469999999999 99999999999999998764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=357.13 Aligned_cols=242 Identities=26% Similarity=0.344 Sum_probs=190.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC------Cc
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------PR 598 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~------~~ 598 (785)
++|.+.+.||+|+||.||+|.+ +|+.||||++..........+.+.+|+.+++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 7899999999999999999987 588999999976655556678899999999999999999999998654 56
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
+|+++||+ +++|.+++. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 109 ~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 89999999 689999885 2469999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 003935 679 DSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------- 746 (785)
Q Consensus 679 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~----------- 746 (785)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+......+
T Consensus 184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 184 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred cc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 32 235679999999999987 678999999999999999999999999988776666554321110
Q ss_pred ----------CC-----------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 ----------EI-----------PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 ----------~i-----------p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.. .+..+.+|+.+||. ||.+|||+.++++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00 12357899999999 99999999999976
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=352.84 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=212.3
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChH---------------HHHHHHHHHHHHhhcCCCceee
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE---------------NMEDFCNEISILSRLRHPNVIL 588 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~---------------~~e~f~~EI~iLk~L~HPNIVk 588 (785)
...++|.+.+.||+|+||.||+|.++++.||||++........ ..+.+.+|+.+++.++||||++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 4468999999999999999999999999999999865433211 1277899999999999999999
Q ss_pred EeccccCCCceeEEEEEcccchhhHH------HHhhcccccchHHHHHHHHHHHHHHHHHHHh-cccccccCCCCcEEEc
Q 003935 589 FLGACTKPPRLSMITEYMELGSLYHL------IHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVN 661 (785)
Q Consensus 589 L~g~~~d~~~l~LV~Ey~~gGSL~dl------L~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-~gIIHrDLKpsNILLd 661 (785)
+++++.+.+.+++||||+++++|.++ +.. .....+++..++.++.|++.||+|||+ +||+|+||||+|||++
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 99999999999999999999999988 531 125679999999999999999999999 9999999999999999
Q ss_pred CCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHH
Q 003935 662 KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-PFTE-KCDIFSLGVIMWELCTLNRPWEGVLP-ERVVYA 738 (785)
Q Consensus 662 ~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~-ksDVWSLGvILyELLTG~~PF~~~~~-~~~v~~ 738 (785)
.++.+||+|||++...... ......|++.|+|||++.+. .++. ++|||||||++|+|++|+.||..... ......
T Consensus 187 ~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 264 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264 (348)
T ss_dssp TTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred CCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 9999999999999876543 33456799999999999887 6666 99999999999999999999988776 555555
Q ss_pred HHhcCCCCC--------------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 739 VANEGSRLE--------------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 739 i~~~~~~~~--------------------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.......+ ..+..+.+|+.+||. ||.+|||+.++++|
T Consensus 265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 544332222 123468999999999 99999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=342.70 Aligned_cols=250 Identities=23% Similarity=0.290 Sum_probs=206.6
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE---CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCC------ceeeEeccccCC
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHP------NVILFLGACTKP 596 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~---~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HP------NIVkL~g~~~d~ 596 (785)
.++|.+.+.||+|+||+||+|.+ +++.||||++... ....+.+.+|+.+++.++|+ +|+++++++...
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 46899999999999999999987 4789999998643 34457788999999988765 499999999999
Q ss_pred CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC--------------
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-------------- 662 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~-------------- 662 (785)
+.+++||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred CcEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 9999999999 78999988643 2346899999999999999999999999999999999999987
Q ss_pred -----CCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 003935 663 -----HWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY 737 (785)
Q Consensus 663 -----~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~ 737 (785)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||..........
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 244 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred cccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 668999999999875432 235678999999999999999999999999999999999999999887766554
Q ss_pred HHHhcCCCCC------------------------------------------CC---ChHHHHHHHHhhh-CCCCCCCHH
Q 003935 738 AVANEGSRLE------------------------------------------IP---EGPLGRLIADCWA-EPQERPSCE 771 (785)
Q Consensus 738 ~i~~~~~~~~------------------------------------------ip---~~~L~~LI~~CL~-DP~kRPS~~ 771 (785)
.+.......+ .+ ...+.+|+.+||. ||.+|||+.
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 324 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR 324 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence 4432111000 00 1247799999999 999999999
Q ss_pred HHHHH--HHhhhhc
Q 003935 772 EILSR--LLDCEYS 783 (785)
Q Consensus 772 EIL~~--L~~l~~s 783 (785)
+++++ ++++..+
T Consensus 325 ell~hp~f~~~~~~ 338 (339)
T 1z57_A 325 EALKHPFFDLLKKS 338 (339)
T ss_dssp HHTTSGGGGGGGC-
T ss_pred HHhcCHHHHHHhcc
Confidence 99976 5554433
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=345.77 Aligned_cols=257 Identities=28% Similarity=0.505 Sum_probs=210.9
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 596 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 596 (785)
.+..++|.+.+.||+|+||.||++.+ +++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 34557899999999999999999984 5789999998654 334567899999999999999999999998665
Q ss_pred C--ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcc
Q 003935 597 P--RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 674 (785)
Q Consensus 597 ~--~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 674 (785)
+ .+++||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred CCCceEEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 4 789999999999999999742 346899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------------H---HH
Q 003935 675 RIITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE------------R---VV 736 (785)
Q Consensus 675 ~~l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~------------~---~v 736 (785)
........ ......++..|+|||.+.+..++.++|||||||++|+|+||..||...... . ..
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 87754322 123345778899999999988999999999999999999999988643111 0 11
Q ss_pred HHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003935 737 YAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 783 (785)
Q Consensus 737 ~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~s 783 (785)
............+ +..+.+|+.+||. ||.+|||+.++++.|+++.-.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1222333333333 3469999999999 999999999999999987643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=352.36 Aligned_cols=252 Identities=27% Similarity=0.353 Sum_probs=200.1
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeecccc---------ChHHHHHHHHHHHHHhhcCCCceeeEe
Q 003935 521 EWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDL---------TAENMEDFCNEISILSRLRHPNVILFL 590 (785)
Q Consensus 521 e~~i~~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~---------~~~~~e~f~~EI~iLk~L~HPNIVkL~ 590 (785)
++..-.++|.+.+.||+|+||.||+|.+ +|+.||||++..... .....+.+.+|+.+++.++||||++++
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 95 (362)
T 3pg1_A 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR 95 (362)
T ss_dssp HHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred HHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence 3444568899999999999999999977 688999999855332 223347899999999999999999999
Q ss_pred cccc-----CCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCe
Q 003935 591 GACT-----KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 665 (785)
Q Consensus 591 g~~~-----d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~ 665 (785)
+++. ....+++||||+. |+|.+.+. .....+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 172 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMR-TDLAQVIH--DQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND 172 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCS-EEHHHHHH--CTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred eeEEeccCCCcceEEEEEccCC-CCHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC
Confidence 9983 3346899999998 57777775 23457999999999999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 003935 666 VKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS 744 (785)
Q Consensus 666 VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~ 744 (785)
+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 173 ~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 251 (362)
T 3pg1_A 173 ITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251 (362)
T ss_dssp EEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEEEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 9999999998654332 2345678999999999877 6789999999999999999999999999887777666543211
Q ss_pred CCC----------------------C-----------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 745 RLE----------------------I-----------PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 745 ~~~----------------------i-----------p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+. . .+..+.+|+.+||. ||.+|||+.++++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 111 0 12358899999999 99999999999976
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=353.74 Aligned_cols=246 Identities=24% Similarity=0.311 Sum_probs=200.7
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC-----
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK----- 595 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d----- 595 (785)
+....+|.+.+.||+|+||+||+|.+ +|+.||||++...... +.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 44567899999999999999999987 5889999998654322 2369999999999999999999833
Q ss_pred ---------------------------------CCceeEEEEEcccchhhHHHHh-hcccccchHHHHHHHHHHHHHHHH
Q 003935 596 ---------------------------------PPRLSMITEYMELGSLYHLIHL-SGQKKKLSWRRKLKMLRDICRGLM 641 (785)
Q Consensus 596 ---------------------------------~~~l~LV~Ey~~gGSL~dlL~~-~~~~~~Ls~~~~l~Ia~QIa~AL~ 641 (785)
...+++||||+++ +|.+.+.. ......+++..++.++.||+.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3348899999985 77766643 224567999999999999999999
Q ss_pred HHHhcccccccCCCCcEEEc-CCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHH
Q 003935 642 CIHRMKIVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWE 719 (785)
Q Consensus 642 yLHs~gIIHrDLKpsNILLd-~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyE 719 (785)
|||++||+||||||+|||++ .++.+||+|||+++.+.... ......||+.|+|||++.+. .++.++|||||||++|+
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 99999999999999999998 68999999999998765432 33456789999999998775 48999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHhcCCCC------------------------------CCCChHHHHHHHHhhh-CCCCCC
Q 003935 720 LCTLNRPWEGVLPERVVYAVANEGSRL------------------------------EIPEGPLGRLIADCWA-EPQERP 768 (785)
Q Consensus 720 LLTG~~PF~~~~~~~~v~~i~~~~~~~------------------------------~ip~~~L~~LI~~CL~-DP~kRP 768 (785)
|++|+.||.+.........+......+ ...+..+.+|+.+||. ||.+||
T Consensus 235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 314 (383)
T 3eb0_A 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI 314 (383)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence 999999999988877776665321111 0012358899999999 999999
Q ss_pred CHHHHHHH
Q 003935 769 SCEEILSR 776 (785)
Q Consensus 769 S~~EIL~~ 776 (785)
|+.++++|
T Consensus 315 t~~e~l~h 322 (383)
T 3eb0_A 315 NPYEAMAH 322 (383)
T ss_dssp CHHHHHTS
T ss_pred CHHHHhcC
Confidence 99999965
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=359.77 Aligned_cols=255 Identities=23% Similarity=0.368 Sum_probs=210.5
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC--ceeE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP--RLSM 601 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~--~l~L 601 (785)
.++|.+.+.||+|+||+||+|.+. |+.||||++...... ...+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 467999999999999999999884 889999998754332 23567889999999999999999999987655 6899
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEE----cCCCeEEEEecCccccc
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRII 677 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILL----d~~g~VKL~DFGLA~~l 677 (785)
||||+++|+|.+++........+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 99999999999999754444459999999999999999999999999999999999999 78888999999999876
Q ss_pred cCCCCCCCCCCCCCcccCcccccc--------CCCCchhhHHHHHHHHHHHHhCCCCCCC----CChHHHHHHHHhcCCC
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRN--------EPFTEKCDIFSLGVIMWELCTLNRPWEG----VLPERVVYAVANEGSR 745 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~--------~~~s~ksDVWSLGvILyELLTG~~PF~~----~~~~~~v~~i~~~~~~ 745 (785)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. .........+......
T Consensus 167 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~ 245 (396)
T 4eut_A 167 EDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245 (396)
T ss_dssp CCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCT
T ss_pred cCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCc
Confidence 5432 2345679999999999865 5678899999999999999999999964 2344555555543321
Q ss_pred C-----------------CCC---------ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 746 L-----------------EIP---------EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 746 ~-----------------~ip---------~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
. .++ ...+.+++..||. ||.+||++.++++.+.++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 1 011 1247789999999 99999999999999987653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.31 Aligned_cols=239 Identities=20% Similarity=0.308 Sum_probs=198.4
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccC--CCcee
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTK--PPRLS 600 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d--~~~l~ 600 (785)
.++|.+.+.||+|+||+||+|.+ +++.||||++.... .+.+.+|+.+++.++ ||||+++++++.+ ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 47899999999999999999987 58899999986432 367889999999997 9999999999987 56789
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC-eEEEEecCccccccC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITD 679 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g-~VKL~DFGLA~~l~~ 679 (785)
+||||+.+++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 110 lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999998874 488999999999999999999999999999999999999776 899999999987654
Q ss_pred CCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHh-------------cCC
Q 003935 680 SPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGV-LPERVVYAVAN-------------EGS 744 (785)
Q Consensus 680 ~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~-~~~~~v~~i~~-------------~~~ 744 (785)
.. ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||... ........+.. ...
T Consensus 184 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 184 GQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp TC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 32 2345678999999999987 67899999999999999999999999543 33222222111 000
Q ss_pred CC-------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 745 RL-------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 745 ~~-------------------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.. ..-+..+.+|+.+||. ||.+|||+.++++|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 0023468999999999 99999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=344.70 Aligned_cols=245 Identities=25% Similarity=0.328 Sum_probs=202.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC-----Cc
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-----PR 598 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~-----~~ 598 (785)
.++|.+.+.||+|+||+||+|.+. |+.||||++.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 378999999999999999999884 8899999986432 344567788999999999999999999987654 67
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
.++||||+. ++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 899999998 588888862 468999999999999999999999999999999999999999999999999998765
Q ss_pred CCCC----------CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-
Q 003935 679 DSPM----------RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL- 746 (785)
Q Consensus 679 ~~~~----------~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~- 746 (785)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 3211 1123578999999998764 678999999999999999999999999887665554443211100
Q ss_pred --------------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 --------------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 --------------------------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..-+..+.+|+.+||. ||.+|||+.++++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0112357899999999 99999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=338.07 Aligned_cols=243 Identities=26% Similarity=0.345 Sum_probs=196.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEecccc----------
Q 003935 527 SELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT---------- 594 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~---------- 594 (785)
++|.+.+.||+|+||.||+|.+. ++.||||++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 68999999999999999999884 889999998654 3455678999999999999999999998863
Q ss_pred ----CCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEc-CCCeEEEE
Q 003935 595 ----KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKIC 669 (785)
Q Consensus 595 ----d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd-~~g~VKL~ 669 (785)
+...+++||||+. |+|.+++. ...+++..++.++.|++.||+|||++||+||||||+|||++ +++.+||+
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred ccccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 4467899999998 59998885 35689999999999999999999999999999999999997 56799999
Q ss_pred ecCccccccCCCC---CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Q 003935 670 DFGLSRIITDSPM---RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 745 (785)
Q Consensus 670 DFGLA~~l~~~~~---~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~ 745 (785)
|||++........ ......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+......
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999987643211 1223457899999998865 67899999999999999999999999988877666655432211
Q ss_pred C-------------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 746 L-------------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 746 ~-------------------------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
. ..-+..+.+|+.+||. ||.+|||+.++++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0 0113468899999999 99999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=340.47 Aligned_cols=252 Identities=24% Similarity=0.402 Sum_probs=191.7
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
..+....++|.+.+.||+|+||.||+|.+ +|+.||||++..........+.+..+..+++.++||||+++++++.+.+
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 45667789999999999999999999988 5889999999766544444444555566788889999999999999999
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc-ccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~-gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
.+++||||+ ++.+..+... ....+++..++.++.|++.||.|||++ ||+|+||||+|||++.++.+||+|||++..
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred cEEEEEecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 999999999 4555555542 245789999999999999999999995 999999999999999999999999999977
Q ss_pred ccCCCCCCCCCCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCCCCCC-
Q 003935 677 ITDSPMRDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGV-LPERVVYAVANEGSRLEIP- 749 (785)
Q Consensus 677 l~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTG~~PF~~~-~~~~~v~~i~~~~~~~~ip- 749 (785)
..... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||... ........+.... ....+
T Consensus 175 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~ 252 (318)
T 2dyl_A 175 LVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE-PPLLPG 252 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC-CCCCCS
T ss_pred ccCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC-CCCCCc
Confidence 65432 223457899999999994 556889999999999999999999999874 4444444444432 22222
Q ss_pred ----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 750 ----EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 750 ----~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+..+.+|+.+||. ||.+||++.+++++
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 3469999999999 99999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=349.15 Aligned_cols=245 Identities=26% Similarity=0.369 Sum_probs=197.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC------hHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT------AENMEDFCNEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~------~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
++|.+.+.||+|+||.||+|.+ +++.||||++...... ......+.+|+.+++.++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5799999999999999999988 4789999998654321 122346889999999999999999999987655
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCe---EEEEecCccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT---VKICDFGLSR 675 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~---VKL~DFGLA~ 675 (785)
+++||||+++++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus 89 ~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 899999999999999886 4567999999999999999999999999999999999999987664 9999999998
Q ss_pred cccCCCCCCCCCCCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC----
Q 003935 676 IITDSPMRDSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI---- 748 (785)
Q Consensus 676 ~l~~~~~~~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i---- 748 (785)
...... ......||+.|+|||++. ...++.++|||||||++|+|++|..||...............+.....
T Consensus 166 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T 2ycf_A 166 ILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244 (322)
T ss_dssp ECCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred eccccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence 764321 112346899999999974 567899999999999999999999999765443222222222222211
Q ss_pred --CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 749 --PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 749 --p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
-...+.+|+.+||. ||.+||++.+++++
T Consensus 245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 13468999999999 99999999999865
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=348.53 Aligned_cols=244 Identities=28% Similarity=0.373 Sum_probs=203.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC-----Cce
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-----PRL 599 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~-----~~l 599 (785)
.+|.+.+.||+|+||+||+|.+ +++.||||++.... .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 6899999999999999999987 58899999986433 344567899999999999999999999998654 368
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
++||||+.+ +|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 106 ~iv~e~~~~-~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEECCSE-EHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEcccCc-CHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 999999984 88888852 4689999999999999999999999999999999999999999999999999987643
Q ss_pred CCC---CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------
Q 003935 680 SPM---RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL--------- 746 (785)
Q Consensus 680 ~~~---~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~--------- 746 (785)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 221 1245689999999998754 558999999999999999999999999887666655554211110
Q ss_pred -----------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 -----------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 -----------------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.-.+..+.+|+.+||. ||.+|||+.++++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0113458899999999 99999999999976
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=355.13 Aligned_cols=243 Identities=25% Similarity=0.299 Sum_probs=200.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC------ce
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------RL 599 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~------~l 599 (785)
.+|.+.+.||+|+||+||+|.+ .+..+|+|++...... ..+|+.+++.++||||+++++++.... .+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 5799999999999999999988 5666999887544322 236999999999999999999985433 38
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEc-CCCeEEEEecCcccccc
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKICDFGLSRIIT 678 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd-~~g~VKL~DFGLA~~l~ 678 (785)
++||||++++.+..+.........+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 89999999876655554444466899999999999999999999999999999999999999 79999999999998764
Q ss_pred CCCCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 003935 679 DSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------- 746 (785)
Q Consensus 679 ~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~----------- 746 (785)
... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+......+
T Consensus 194 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 272 (394)
T 4e7w_A 194 AGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN 272 (394)
T ss_dssp TTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGG
T ss_pred CCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence 432 23456789999999998765 58999999999999999999999999988777666655421100
Q ss_pred -------C------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 -------E------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 -------~------------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
. ..+..+.+|+.+||. ||.+|||+.++++|
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0 012368899999999 99999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=345.20 Aligned_cols=241 Identities=26% Similarity=0.345 Sum_probs=202.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc------
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR------ 598 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~------ 598 (785)
++|.+.+.||+|+||+||+|.+ +|+.||||++..........+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 6899999999999999999987 58999999997766566667889999999999999999999999987654
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
+++||||+. ++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 499999998 58877663 348999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------
Q 003935 679 DSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS------------- 744 (785)
Q Consensus 679 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~------------- 744 (785)
.. .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 178 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 254 (353)
T 3coi_A 178 AE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred CC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence 32 234678999999999887 6789999999999999999999999998877666555433110
Q ss_pred -------------CCC------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 745 -------------RLE------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 745 -------------~~~------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
... .....+.+|+.+||. ||.+|||+.++++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 113468999999999 99999999999976
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=358.54 Aligned_cols=243 Identities=24% Similarity=0.274 Sum_probs=205.1
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc------CCCceeeEeccccCCC
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL------RHPNVILFLGACTKPP 597 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L------~HPNIVkL~g~~~d~~ 597 (785)
..+|.+.+.||+|+||+||+|.+ .++.||||++... ......+.+|+.+++.+ +|+||+++++++....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 36799999999999999999988 4789999998643 33446778888888887 5779999999999999
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCe--EEEEecCccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT--VKICDFGLSR 675 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~--VKL~DFGLA~ 675 (785)
.+++||||+. ++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred eEEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 9999999997 5888888643 3345899999999999999999999999999999999999999887 9999999997
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--------
Q 003935 676 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-------- 747 (785)
Q Consensus 676 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-------- 747 (785)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+......+.
T Consensus 251 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~ 327 (429)
T 3kvw_A 251 YEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327 (429)
T ss_dssp ETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBT
T ss_pred ecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhh
Confidence 65432 2356899999999999999999999999999999999999999999888777665543211000
Q ss_pred ----------------------------------------------------CCChHHHHHHHHhhh-CCCCCCCHHHHH
Q 003935 748 ----------------------------------------------------IPEGPLGRLIADCWA-EPQERPSCEEIL 774 (785)
Q Consensus 748 ----------------------------------------------------ip~~~L~~LI~~CL~-DP~kRPS~~EIL 774 (785)
..+..+.+||.+||. ||.+|||+.|++
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L 407 (429)
T 3kvw_A 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407 (429)
T ss_dssp THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHh
Confidence 012347899999999 999999999999
Q ss_pred HH
Q 003935 775 SR 776 (785)
Q Consensus 775 ~~ 776 (785)
+|
T Consensus 408 ~H 409 (429)
T 3kvw_A 408 RH 409 (429)
T ss_dssp TS
T ss_pred CC
Confidence 86
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=375.61 Aligned_cols=251 Identities=25% Similarity=0.330 Sum_probs=211.6
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
+..++|.+.+.||+|+||+||+|.+ +|+.||||++.+.... ......+.+|+.+|+.++||||+++++++.+...+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 5567899999999999999999988 5889999999764331 123466889999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
+||||++||+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 261 lVmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EEECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 999999999999998632 2345999999999999999999999999999999999999999999999999999877543
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCCC-CCCChHHHH
Q 003935 681 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL----PERVVYAVANEGSRL-EIPEGPLGR 755 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~----~~~~v~~i~~~~~~~-~ip~~~L~~ 755 (785)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+....... ..-...+.+
T Consensus 340 ~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~d 418 (576)
T 2acx_A 340 Q-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARS 418 (576)
T ss_dssp C-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred c-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHH
Confidence 2 2235689999999999999999999999999999999999999998753 334444443322211 112346999
Q ss_pred HHHHhhh-CCCCCC-----CHHHHHHH
Q 003935 756 LIADCWA-EPQERP-----SCEEILSR 776 (785)
Q Consensus 756 LI~~CL~-DP~kRP-----S~~EIL~~ 776 (785)
||.+||. ||.+|| ++.+|++|
T Consensus 419 LI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 419 LCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 9999999 999999 78999876
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=343.95 Aligned_cols=255 Identities=22% Similarity=0.365 Sum_probs=186.3
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHHH-HHhhcCCCceeeEeccccC
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEIS-ILSRLRHPNVILFLGACTK 595 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI~-iLk~L~HPNIVkL~g~~~d 595 (785)
...|.+..++|.+.+.||+|+||.||+|.+. |+.||||++..... ......+..|+. +++.++||||+++++++.+
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 4677888999999999999999999999884 89999999976543 334456666666 7778899999999999999
Q ss_pred CCceeEEEEEcccchhhHHHHhh--cccccchHHHHHHHHHHHHHHHHHHHhc-ccccccCCCCcEEEcCCCeEEEEecC
Q 003935 596 PPRLSMITEYMELGSLYHLIHLS--GQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHWTVKICDFG 672 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL~dlL~~~--~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~-gIIHrDLKpsNILLd~~g~VKL~DFG 672 (785)
.+..++||||+.+ +|.+++... .....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 9999999999986 777766532 1246789999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCcccCcccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 003935 673 LSRIITDSPMRDSSSAGTPEWMAPELI----RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI 748 (785)
Q Consensus 673 LA~~l~~~~~~~~~~~GT~~Y~APEvl----~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i 748 (785)
++....... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||...............+..+.+
T Consensus 172 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3aln_A 172 ISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250 (327)
T ss_dssp SSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred Cceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence 998765432 22344799999999998 4567899999999999999999999999875432111111111212222
Q ss_pred C-------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 749 P-------EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 749 p-------~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+ ...+.+|+.+||. ||.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 1 3468999999999 99999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=356.87 Aligned_cols=242 Identities=23% Similarity=0.305 Sum_probs=196.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC------CCc
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK------PPR 598 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d------~~~ 598 (785)
.+|.+.+.||+|+||+||+|.+ +|+.||||++..... .+.+|+++|+.++|||||+++++|.. ...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 4699999999999999999998 588999999865432 13369999999999999999998743 223
Q ss_pred eeEEEEEcccchhhHHHH-hhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC-CeEEEEecCcccc
Q 003935 599 LSMITEYMELGSLYHLIH-LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRI 676 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~-~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~-g~VKL~DFGLA~~ 676 (785)
+++||||+++ +|.+.+. .......+++..++.++.||+.||+|||++||+||||||+||||+.+ +.+||+|||+++.
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 6799999987 4554443 22345679999999999999999999999999999999999999954 6789999999987
Q ss_pred ccCCCCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----------
Q 003935 677 ITDSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR---------- 745 (785)
Q Consensus 677 l~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~---------- 745 (785)
+.... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||.+......+..+......
T Consensus 207 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~ 285 (420)
T 1j1b_A 207 LVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285 (420)
T ss_dssp CCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred cccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 65432 23456789999999999764 7999999999999999999999999998877666655431100
Q ss_pred -----CCC---------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 746 -----LEI---------------PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 746 -----~~i---------------p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..+ .+..+.+|+.+||. ||.+||++.++++|
T Consensus 286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 001 13468899999999 99999999999976
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=346.96 Aligned_cols=250 Identities=23% Similarity=0.281 Sum_probs=194.1
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc--
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR-- 598 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~-- 598 (785)
....++|.+.+.||+|+||+||+|.+ +|+.||||++...... ...+.+++..++.++||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34568999999999999999999988 4889999998654332 2346678888899999999999999865333
Q ss_pred -----eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHH--hcccccccCCCCcEEEcC-CCeEEEEe
Q 003935 599 -----LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH--RMKIVHRDLKSANCLVNK-HWTVKICD 670 (785)
Q Consensus 599 -----l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLH--s~gIIHrDLKpsNILLd~-~g~VKL~D 670 (785)
+++||||+.++.+..+.........+++..++.++.|++.||.||| ++||+||||||+|||++. ++.+||+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 7899999997654444433345667899999999999999999999 999999999999999996 89999999
Q ss_pred cCccccccCCCCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--
Q 003935 671 FGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-- 747 (785)
Q Consensus 671 FGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-- 747 (785)
||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+......+.
T Consensus 176 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3e3p_A 176 FGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254 (360)
T ss_dssp CTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence 99998775432 23456789999999998665 489999999999999999999999999888777776654211110
Q ss_pred ----------------------------C---CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 ----------------------------I---PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 ----------------------------i---p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
. ....+.+|+.+||+ ||.+|||+.++++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 11358899999999 99999999999976
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=332.55 Aligned_cols=242 Identities=27% Similarity=0.439 Sum_probs=192.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC---------
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--------- 595 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d--------- 595 (785)
++|.+.+.||+|+||+||+|.+ +++.||||++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 5789999999999999999987 5889999998542 3456788999999999999999999998754
Q ss_pred ----CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEec
Q 003935 596 ----PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 671 (785)
Q Consensus 596 ----~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DF 671 (785)
...+++||||+++++|.+++.. ....+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 3568999999999999999973 3456888999999999999999999999999999999999999999999999
Q ss_pred CccccccCCC--------------CCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHH
Q 003935 672 GLSRIITDSP--------------MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVL-PERV 735 (785)
Q Consensus 672 GLA~~l~~~~--------------~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~-~~~~ 735 (785)
|++....... .......||+.|+|||++.+. .++.++|||||||++|+|++ ||.... ....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 9998764321 112345689999999999864 68999999999999999998 665432 2233
Q ss_pred HHHHHhcCC--CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 736 VYAVANEGS--RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 736 v~~i~~~~~--~~~ip---~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
...+..... ....+ ...+.+|+.+||. ||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 333332221 11122 2248999999999 99999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=348.50 Aligned_cols=243 Identities=21% Similarity=0.289 Sum_probs=196.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC--------CCceeeEecccc-
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR--------HPNVILFLGACT- 594 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~--------HPNIVkL~g~~~- 594 (785)
.++|.+.++||+|+||+||+|.+ +++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 47899999999999999999987 5889999998643 344577889999999985 788999999987
Q ss_pred ---CCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc-ccccccCCCCcEEEcCCC------
Q 003935 595 ---KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHW------ 664 (785)
Q Consensus 595 ---d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~-gIIHrDLKpsNILLd~~g------ 664 (785)
....+++||||+.+ +|.+.+... ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGH-HLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp EETTEEEEEEEECCCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred cCCCCceEEEEEeccCc-cHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence 56679999999955 555444322 335699999999999999999999998 999999999999999775
Q ss_pred -------------------------------------------eEEEEecCccccccCCCCCCCCCCCCCcccCcccccc
Q 003935 665 -------------------------------------------TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 701 (785)
Q Consensus 665 -------------------------------------------~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~ 701 (785)
.+||+|||++...... .....||+.|+|||++.+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHT
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcC
Confidence 7999999999876543 345679999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCCCC-----------------------------
Q 003935 702 EPFTEKCDIFSLGVIMWELCTLNRPWEGVLP------ERVVYAVANEGSRL----------------------------- 746 (785)
Q Consensus 702 ~~~s~ksDVWSLGvILyELLTG~~PF~~~~~------~~~v~~i~~~~~~~----------------------------- 746 (785)
..++.++|||||||+||+|++|+.||..... ......+.......
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 9999999999999999999999999976542 22222221100000
Q ss_pred -----------CCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 -----------EIPE---GPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 -----------~ip~---~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..+. ..+.+|+.+||. ||.+|||+.++++|
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0111 247789999999 99999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=356.78 Aligned_cols=248 Identities=15% Similarity=0.107 Sum_probs=182.5
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhc--CCCceeeEeccc----
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL--RHPNVILFLGAC---- 593 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L--~HPNIVkL~g~~---- 593 (785)
.....+|.+.+.||+|+||+||+|.+ +|+.||||++..... .....+.+.+|+.+++.+ +||||++++..+
T Consensus 58 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 58 SQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137 (371)
T ss_dssp TCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCC
T ss_pred CCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeee
Confidence 33445699999999999999999987 588999999987665 334456777885555444 699988855333
Q ss_pred ---cCC-----------------CceeEEEEEcccchhhHHHHhhcccccchHHHH------HHHHHHHHHHHHHHHhcc
Q 003935 594 ---TKP-----------------PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK------LKMLRDICRGLMCIHRMK 647 (785)
Q Consensus 594 ---~d~-----------------~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~------l~Ia~QIa~AL~yLHs~g 647 (785)
... ..+|+||||++ |+|.+++.... ..+.+..+ +.++.||+.||+|||++|
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ 214 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG 214 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC
Confidence 221 33799999999 89999997532 23344444 677799999999999999
Q ss_pred cccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCC
Q 003935 648 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNR 725 (785)
Q Consensus 648 IIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvILyELLTG~~ 725 (785)
|+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||+||+|++|+.
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999998764321 13456799999999987 679999999999999999999999
Q ss_pred CCCCCChHHHHH--H---HHhcCCCCCCC-----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 726 PWEGVLPERVVY--A---VANEGSRLEIP-----EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 726 PF~~~~~~~~v~--~---i~~~~~~~~ip-----~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
||.+..+..... . ..........+ +..+.+|+.+||. ||.+|||+.++++|
T Consensus 292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 998764321100 0 00001111111 3469999999999 99999999999865
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=353.64 Aligned_cols=244 Identities=26% Similarity=0.396 Sum_probs=181.6
Q ss_pred CeeE-eeEEeeeCcEEEEEEEEC----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccc--cCCCcee
Q 003935 528 ELTV-GTRVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC--TKPPRLS 600 (785)
Q Consensus 528 ~y~i-~k~LG~G~fG~VYkg~~~----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~--~d~~~l~ 600 (785)
.|.+ +++||+|+||+||+|.+. ++.||||++...... ..+.+|+.+|+.++||||+++++++ .....++
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 3554 568999999999999863 678999998755433 4578999999999999999999999 4567899
Q ss_pred EEEEEcccchhhHHHHhhc------ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEE----cCCCeEEEEe
Q 003935 601 MITEYMELGSLYHLIHLSG------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV----NKHWTVKICD 670 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~------~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILL----d~~g~VKL~D 670 (785)
+||||+.+ +|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99999975 7777665322 12248999999999999999999999999999999999999 6788999999
Q ss_pred cCccccccCCC---CCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChH---------HHHH
Q 003935 671 FGLSRIITDSP---MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPE---------RVVY 737 (785)
Q Consensus 671 FGLA~~l~~~~---~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~---------~~v~ 737 (785)
||+++.+.... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.... ..+.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 99998765421 122356799999999999874 5899999999999999999999999765432 2222
Q ss_pred HHHhcCCCCC---------------------------------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 738 AVANEGSRLE---------------------------------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 738 ~i~~~~~~~~---------------------------------------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+......+. .+...+.+||.+||. ||.+|||+.++|+|
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 2221111000 013457889999999 99999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=337.40 Aligned_cols=243 Identities=19% Similarity=0.318 Sum_probs=200.1
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC--C-eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCc------eeeEeccccCC
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIWN--G-TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN------VILFLGACTKP 596 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~~--g-~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN------IVkL~g~~~d~ 596 (785)
.++|.+.+.||+|+||+||+|.+. + +.||+|++... ....+.+.+|+.+++.++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 478999999999999999999873 3 78999998643 334567888999999997665 99999999999
Q ss_pred CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEE----------------
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---------------- 660 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILL---------------- 660 (785)
+.+++||||+. ++|.+.+... ....+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 95 ~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 95 GHMCIAFELLG-KNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp TEEEEEEECCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred CeEEEEEeccC-CChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999995 5565555432 33569999999999999999999999999999999999999
Q ss_pred ---cCCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 003935 661 ---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY 737 (785)
Q Consensus 661 ---d~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~ 737 (785)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 56789999999999875432 235679999999999999999999999999999999999999999887766554
Q ss_pred HHHhcCCCCC-----------------------------------------CC----ChHHHHHHHHhhh-CCCCCCCHH
Q 003935 738 AVANEGSRLE-----------------------------------------IP----EGPLGRLIADCWA-EPQERPSCE 771 (785)
Q Consensus 738 ~i~~~~~~~~-----------------------------------------ip----~~~L~~LI~~CL~-DP~kRPS~~ 771 (785)
.+.......+ .. ...+.+|+.+||. ||.+|||+.
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 329 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA 329 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence 4432111100 00 1247799999999 999999999
Q ss_pred HHHHH
Q 003935 772 EILSR 776 (785)
Q Consensus 772 EIL~~ 776 (785)
++++|
T Consensus 330 e~l~h 334 (355)
T 2eu9_A 330 EALLH 334 (355)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99865
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=370.44 Aligned_cols=257 Identities=30% Similarity=0.541 Sum_probs=216.3
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEecccc
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 594 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~ 594 (785)
..+.+..++|.+.+.||+|+||+||+|.+. +..||||++.... .....+.|.+|+.+++.++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 456677789999999999999999999873 4569999876432 3445678999999999999999999999985
Q ss_pred CCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcc
Q 003935 595 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 674 (785)
Q Consensus 595 d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 674 (785)
+ +..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 462 ~-~~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 462 E-NPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred c-CceEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCC
Confidence 4 568999999999999999973 2346899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---
Q 003935 675 RIITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP--- 749 (785)
Q Consensus 675 ~~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip--- 749 (785)
+....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+.... ....+
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~ 617 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNC 617 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC-CCCCCTTC
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCCCCccc
Confidence 87654322 2223457789999999999999999999999999999997 999999998888777765543 33333
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 750 EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 750 ~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
+..+.+|+.+||. ||.+|||+.+|++.|+++.
T Consensus 618 ~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2469999999999 9999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=342.23 Aligned_cols=246 Identities=25% Similarity=0.385 Sum_probs=202.8
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh----HHHHHHHHHHHHHhhcC--CCceeeEec
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA----ENMEDFCNEISILSRLR--HPNVILFLG 591 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~----~~~e~f~~EI~iLk~L~--HPNIVkL~g 591 (785)
.+...-.++|.+.+.||+|+||+||+|.+ +++.||||++....... ...+.+.+|+.+++.++ ||||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 44445568899999999999999999987 68899999997654322 12245678999999996 599999999
Q ss_pred cccCCCceeEEEEEccc-chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEc-CCCeEEEE
Q 003935 592 ACTKPPRLSMITEYMEL-GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKIC 669 (785)
Q Consensus 592 ~~~d~~~l~LV~Ey~~g-GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd-~~g~VKL~ 669 (785)
++...+.+++|+||+.+ ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++ +++.+||+
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999999986 899999873 45789999999999999999999999999999999999999 78999999
Q ss_pred ecCccccccCCCCCCCCCCCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CCCC
Q 003935 670 DFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG-SRLE 747 (785)
Q Consensus 670 DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~-~~~~ 747 (785)
|||++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... +.... ....
T Consensus 193 Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~~~~~ 264 (320)
T 3a99_A 193 DFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ 264 (320)
T ss_dssp CCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCCCCCSS
T ss_pred eCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcccccccc
Confidence 99999877543 2335679999999999987765 6789999999999999999999976421 11211 1112
Q ss_pred CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..+..+.+|+.+||. ||.+|||+.+++++
T Consensus 265 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 265 RVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 224579999999999 99999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=334.28 Aligned_cols=241 Identities=26% Similarity=0.392 Sum_probs=193.6
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh----HHHHHHHHHHHHHhhc----CCCceeeEecccc
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA----ENMEDFCNEISILSRL----RHPNVILFLGACT 594 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~----~~~e~f~~EI~iLk~L----~HPNIVkL~g~~~ 594 (785)
-.++|.+.+.||+|+||.||+|.+ +++.||||++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 347899999999999999999987 58899999986654322 1234456799999998 8999999999999
Q ss_pred CCCceeEEEEE-cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEc-CCCeEEEEecC
Q 003935 595 KPPRLSMITEY-MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKICDFG 672 (785)
Q Consensus 595 d~~~l~LV~Ey-~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd-~~g~VKL~DFG 672 (785)
..+..++|+|| +.+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred cCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 99999999999 789999999973 34689999999999999999999999999999999999999 88999999999
Q ss_pred ccccccCCCCCCCCCCCCCcccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCCC
Q 003935 673 LSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPE 750 (785)
Q Consensus 673 LA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s-~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~-~~~ip~ 750 (785)
++....... .....|++.|+|||++.+..+. .++|||||||++|+|++|+.||..... +..... ......
T Consensus 186 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~ 257 (312)
T 2iwi_A 186 SGALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFPAHVS 257 (312)
T ss_dssp SCEECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTCCCCCTTSC
T ss_pred hhhhcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------HhhhccCCcccCC
Confidence 998775432 3456799999999999877664 589999999999999999999976321 112111 112224
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 751 GPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 751 ~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
..+.+|+.+||. ||.+|||+.+++++
T Consensus 258 ~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 258 PDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 568999999999 99999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=342.52 Aligned_cols=244 Identities=21% Similarity=0.313 Sum_probs=203.9
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CC-----ceeeEeccccCC
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HP-----NVILFLGACTKP 596 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HP-----NIVkL~g~~~d~ 596 (785)
-.++|.+.+.||+|+||+||+|.+ +++.||||++... ......+..|+.+++.++ |+ +|+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 357999999999999999999987 4889999998643 334567788999988885 54 499999999999
Q ss_pred CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHH--hcccccccCCCCcEEEc--CCCeEEEEecC
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH--RMKIVHRDLKSANCLVN--KHWTVKICDFG 672 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLH--s~gIIHrDLKpsNILLd--~~g~VKL~DFG 672 (785)
+.+++||||+.+ +|.+++... ....+++..++.++.|++.||.||| +.||+||||||+|||++ .++.+||+|||
T Consensus 129 ~~~~lv~e~~~~-~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 129 NHLCLVFEMLSY-NLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TEEEEEEECCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CceEEEEecCCC-CHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 999999999975 999988743 2356899999999999999999999 57999999999999995 47789999999
Q ss_pred ccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----
Q 003935 673 LSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----- 747 (785)
Q Consensus 673 LA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~----- 747 (785)
+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.........+......+.
T Consensus 207 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (382)
T 2vx3_A 207 SSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283 (382)
T ss_dssp TCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred Cceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99877543 2356799999999999999999999999999999999999999999888777666553211100
Q ss_pred -----------CCC-------------------------------------------------hHHHHHHHHhhh-CCCC
Q 003935 748 -----------IPE-------------------------------------------------GPLGRLIADCWA-EPQE 766 (785)
Q Consensus 748 -----------ip~-------------------------------------------------~~L~~LI~~CL~-DP~k 766 (785)
++. ..+.+||.+||. ||.+
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 363 (382)
T 2vx3_A 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKT 363 (382)
T ss_dssp TCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTT
T ss_pred hhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhh
Confidence 000 147899999999 9999
Q ss_pred CCCHHHHHHH
Q 003935 767 RPSCEEILSR 776 (785)
Q Consensus 767 RPS~~EIL~~ 776 (785)
|||+.++|+|
T Consensus 364 Rpta~e~L~h 373 (382)
T 2vx3_A 364 RIQPYYALQH 373 (382)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhcC
Confidence 9999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=339.85 Aligned_cols=245 Identities=20% Similarity=0.313 Sum_probs=196.8
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-----------CCceeeEe
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-----------HPNVILFL 590 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-----------HPNIVkL~ 590 (785)
+...+|.+.+.||+|+||+||+|.+ +++.||||++... ....+.+.+|+.+++.++ ||||++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 3457899999999999999999987 6889999998643 234567889999999886 89999999
Q ss_pred ccccCCC----ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc-ccccccCCCCcEEEc----
Q 003935 591 GACTKPP----RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVN---- 661 (785)
Q Consensus 591 g~~~d~~----~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~-gIIHrDLKpsNILLd---- 661 (785)
+++...+ .++++|||+ +++|.+++... ....+++..++.++.||+.||+|||++ ||+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 9987644 689999999 88999998743 345689999999999999999999998 999999999999994
Q ss_pred --CCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------H
Q 003935 662 --KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP------E 733 (785)
Q Consensus 662 --~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~------~ 733 (785)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4458999999999876542 2355789999999999999999999999999999999999999986542 2
Q ss_pred HHHHHHHhcCC----------------------------------------CCCCC---ChHHHHHHHHhhh-CCCCCCC
Q 003935 734 RVVYAVANEGS----------------------------------------RLEIP---EGPLGRLIADCWA-EPQERPS 769 (785)
Q Consensus 734 ~~v~~i~~~~~----------------------------------------~~~ip---~~~L~~LI~~CL~-DP~kRPS 769 (785)
.....+..... ...++ ...+.+||.+||. ||.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 22222221000 00111 1247789999999 9999999
Q ss_pred HHHHHHH
Q 003935 770 CEEILSR 776 (785)
Q Consensus 770 ~~EIL~~ 776 (785)
+.++++|
T Consensus 328 ~~ell~h 334 (373)
T 1q8y_A 328 AGGLVNH 334 (373)
T ss_dssp HHHHHTC
T ss_pred HHHHhhC
Confidence 9999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=354.53 Aligned_cols=249 Identities=19% Similarity=0.274 Sum_probs=205.5
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCC-CceeeEeccccCCCceeEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH-PNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~H-PNIVkL~g~~~d~~~l~LV 602 (785)
.++|.+.++||+|+||+||+|.+ +++.||||++...... ..+..|+.+++.++| ++|..+..++......++|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 36899999999999999999987 4889999998655433 347789999999986 5666666667777889999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEE---cCCCeEEEEecCccccccC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILL---d~~g~VKL~DFGLA~~l~~ 679 (785)
|||+ +++|.+++... ...+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+++.+..
T Consensus 82 me~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EECC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 9999 89999999742 4579999999999999999999999999999999999999 6889999999999987755
Q ss_pred CCCC-------CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCC---
Q 003935 680 SPMR-------DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP---ERVVYAVANEGSRL--- 746 (785)
Q Consensus 680 ~~~~-------~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~---~~~v~~i~~~~~~~--- 746 (785)
.... .....||+.|+|||++.+..++.++|||||||+||||++|+.||.+... ...+..+.......
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 3221 2256799999999999999999999999999999999999999987543 33333332221111
Q ss_pred ---CCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 747 ---EIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 747 ---~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
.-.+..+.+|+..||. ||.+||++.+|++.|+++.
T Consensus 239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1113468999999999 9999999999999998874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=335.81 Aligned_cols=241 Identities=23% Similarity=0.383 Sum_probs=170.7
Q ss_pred CCCeeEee-EEeeeCcEEEEEEEEC--CeEEEEEEeeccccChHHHHHHHHHH-HHHhhcCCCceeeEeccccC----CC
Q 003935 526 FSELTVGT-RVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEI-SILSRLRHPNVILFLGACTK----PP 597 (785)
Q Consensus 526 ~s~y~i~k-~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~~~~~e~f~~EI-~iLk~L~HPNIVkL~g~~~d----~~ 597 (785)
.++|.+.+ .||+|+||+||+|.+. ++.||||++... .. ..+|+ ..++.++||||+++++++.. ..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 36788865 6999999999999884 889999998643 11 22233 34566789999999999865 44
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC---CCeEEEEecCcc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLS 674 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~---~g~VKL~DFGLA 674 (785)
.+++||||+.+|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred eEEEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 589999999999999999733 2357999999999999999999999999999999999999976 455999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHhcCCCCC---
Q 003935 675 RIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYA----VANEGSRLE--- 747 (785)
Q Consensus 675 ~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~----i~~~~~~~~--- 747 (785)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... +........
T Consensus 179 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (336)
T 3fhr_A 179 KETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256 (336)
T ss_dssp EEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTT
T ss_pred eecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchh
Confidence 876543 23356789999999999988899999999999999999999999987655433211 111111111
Q ss_pred --CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 --IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 --ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.-+..+.+|+.+||. ||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 113468999999999 99999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=341.98 Aligned_cols=246 Identities=26% Similarity=0.398 Sum_probs=186.6
Q ss_pred cccCCC-eeEeeEEeeeCcEEEEEE-EECCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCce
Q 003935 523 NIDFSE-LTVGTRVGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 599 (785)
Q Consensus 523 ~i~~s~-y~i~k~LG~G~fG~VYkg-~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l 599 (785)
+..+.+ |.+.+.||+|+||+||.+ ..+|+.||||++.... .+.+.+|+.+++.+ +||||+++++++.+...+
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 84 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFL 84 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeE
Confidence 334444 455688999999999754 4579999999986432 35678999999886 899999999999999999
Q ss_pred eEEEEEcccchhhHHHHhhcccc----cchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC------------
Q 003935 600 SMITEYMELGSLYHLIHLSGQKK----KLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH------------ 663 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~----~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~------------ 663 (785)
|+||||+. |+|.+++....... ..++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 85 ~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 85 YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence 99999996 69999997432111 11333467899999999999999999999999999999754
Q ss_pred -CeEEEEecCccccccCCCCC----CCCCCCCCcccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003935 664 -WTVKICDFGLSRIITDSPMR----DSSSAGTPEWMAPELIRN-------EPFTEKCDIFSLGVIMWELCT-LNRPWEGV 730 (785)
Q Consensus 664 -g~VKL~DFGLA~~l~~~~~~----~~~~~GT~~Y~APEvl~~-------~~~s~ksDVWSLGvILyELLT-G~~PF~~~ 730 (785)
+.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|||+| |..||.+.
T Consensus 164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 48999999999887543221 234579999999999975 678999999999999999999 89999876
Q ss_pred ChHHHHHHHHhcCCCCCC----CC----hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 731 LPERVVYAVANEGSRLEI----PE----GPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 731 ~~~~~v~~i~~~~~~~~i----p~----~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.... ..+......... .. ..+.+|+.+||. ||.+|||+.++++|
T Consensus 244 ~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 244 YSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp TTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 5443 223332222211 11 358899999999 99999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=346.28 Aligned_cols=247 Identities=26% Similarity=0.395 Sum_probs=190.4
Q ss_pred ccccCCCeeEeeEEeeeCcEEE-EEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCce
Q 003935 522 WNIDFSELTVGTRVGIGFFGEV-FRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 599 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~V-Ykg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l 599 (785)
+.+...+|.+.+.||+|+||+| |++..+++.||||++...... .+.+|+.+|+.+ +|||||++++++.+....
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 4455567999999999999985 555668999999998654332 345799999999 799999999999999999
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC-----CCeEEEEecCcc
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-----HWTVKICDFGLS 674 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~-----~g~VKL~DFGLA 674 (785)
|+||||+. |+|.+++... ...+.+..++.++.||+.||+|||++||+||||||+|||++. ...+||+|||++
T Consensus 94 ~lv~E~~~-g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEECCS-EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEECCC-CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 99999997 5999988632 234455566789999999999999999999999999999953 236889999999
Q ss_pred ccccCCC---CCCCCCCCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCC
Q 003935 675 RIITDSP---MRDSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLE 747 (785)
Q Consensus 675 ~~l~~~~---~~~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ 747 (785)
+...... ......+||+.|+|||++. ...++.++|||||||++|||++ |..||....................
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~ 250 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL 250 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc
Confidence 8765332 1234567999999999997 4567889999999999999999 8899977655444332211111111
Q ss_pred CCC----hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 IPE----GPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 ip~----~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+. ..+.+|+.+||. ||.+|||+.++++|
T Consensus 251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 111 237889999999 99999999999965
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=316.51 Aligned_cols=223 Identities=13% Similarity=0.058 Sum_probs=183.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeeccccC-hHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
.+|.+.+.||+|+||.||+|.+. ++.||||++...... ....+.|.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 67999999999999999999984 899999999765443 455688999999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||++|++|.+++.. . .....+..++.|++.||+|||++||+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 99999999999852 2 3445688899999999999999999999999999999999999998443
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHhcCCCC-----CCCChHHHH
Q 003935 684 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY---AVANEGSRL-----EIPEGPLGR 755 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~---~i~~~~~~~-----~ip~~~L~~ 755 (785)
|++ +++.++|||||||++|+|+||+.||.+......+. ......... .--+..+.+
T Consensus 175 ---------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (286)
T 3uqc_A 175 ---------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238 (286)
T ss_dssp ---------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHH
T ss_pred ---------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHH
Confidence 333 37899999999999999999999998765432110 000111000 011346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 756 LIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 756 LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
|+.+||. ||.+| |+.++++.|++...
T Consensus 239 li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 239 VAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp HHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred HHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 9999999 99999 99999999998653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=313.99 Aligned_cols=221 Identities=22% Similarity=0.388 Sum_probs=177.8
Q ss_pred CCCeeEe-eEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHH-hhcCCCceeeEeccccC----CC
Q 003935 526 FSELTVG-TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISIL-SRLRHPNVILFLGACTK----PP 597 (785)
Q Consensus 526 ~s~y~i~-k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iL-k~L~HPNIVkL~g~~~d----~~ 597 (785)
.++|.+. +.||+|+||.||++.+ +++.||||++... ..+.+|+.++ +.++||||+++++++.. ..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 3677777 7899999999999988 5889999998532 3467888887 55689999999999876 66
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC---CCeEEEEecCcc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLS 674 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~---~g~VKL~DFGLA 674 (785)
.+++||||+++|+|.+++... ....+++..++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred eEEEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 799999999999999999743 3347999999999999999999999999999999999999998 789999999998
Q ss_pred ccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCC---
Q 003935 675 RIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS--RLEIP--- 749 (785)
Q Consensus 675 ~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~--~~~ip--- 749 (785)
..... ..++.++|||||||++|+|++|+.||.+.........+..... ....+
T Consensus 168 ~~~~~----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (299)
T 3m2w_A 168 KETTG----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225 (299)
T ss_dssp EECTT----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred ccccc----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence 65432 3467899999999999999999999987654433221111111 11111
Q ss_pred ----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 750 ----EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 750 ----~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+..+.+|+.+||. ||.+|||+.++++|
T Consensus 226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 3468999999999 99999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=335.32 Aligned_cols=248 Identities=16% Similarity=0.127 Sum_probs=188.5
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEEC--CeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCC-CceeeE-------
Q 003935 521 EWNIDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRH-PNVILF------- 589 (785)
Q Consensus 521 e~~i~~s~y~i~k~LG~G~fG~VYkg~~~--g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~H-PNIVkL------- 589 (785)
++.....+|..++.||+|+||+||+|.+. |+.||||++..... .....+.|.+|+.+++.++| +|+...
T Consensus 72 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~ 151 (413)
T 3dzo_A 72 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151 (413)
T ss_dssp SSSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred cCCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence 34455667999999999999999999984 89999999873332 22335778999999999987 322111
Q ss_pred --------------eccccC-----CCceeEEEEEcccchhhHHHHhh----cccccchHHHHHHHHHHHHHHHHHHHhc
Q 003935 590 --------------LGACTK-----PPRLSMITEYMELGSLYHLIHLS----GQKKKLSWRRKLKMLRDICRGLMCIHRM 646 (785)
Q Consensus 590 --------------~g~~~d-----~~~l~LV~Ey~~gGSL~dlL~~~----~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~ 646 (785)
..++.. ...++++|+++ +++|.+++... .....+++..++.++.||+.||+|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 230 (413)
T 3dzo_A 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 230 (413)
T ss_dssp CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 111111 12355666654 67999888522 2355789999999999999999999999
Q ss_pred ccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCcccc----------ccCCCCchhhHHHHHHH
Q 003935 647 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI----------RNEPFTEKCDIFSLGVI 716 (785)
Q Consensus 647 gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl----------~~~~~s~ksDVWSLGvI 716 (785)
||+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||+
T Consensus 231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred CcccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 9999999999999999999999999999876443 345577 999999999 55568899999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 717 MWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 717 LyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+|||+||+.||...........+.... ..+ +..+.+|+.+||. ||.+||++.+++++
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~~~~~~--~~~-~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEWIFRSC--KNI-PQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGGGGSSC--CCC-CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHCCCCCCCcchhhhHHHHHhhc--ccC-CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999999998766544333322211 122 3569999999999 99999998888764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=326.79 Aligned_cols=238 Identities=21% Similarity=0.245 Sum_probs=187.1
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeecccc------ChHHHHHHHHHHHHHhhcC---------------
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDL------TAENMEDFCNEISILSRLR--------------- 582 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~------~~~~~e~f~~EI~iLk~L~--------------- 582 (785)
+..++|.+.+.||+|+||+||+|.++|+.||||++..... .....+.+.+|+.+++.++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 3457899999999999999999999999999999976542 2233477889999998886
Q ss_pred -----------CCceeeEeccccC-------------CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHH
Q 003935 583 -----------HPNVILFLGACTK-------------PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 638 (785)
Q Consensus 583 -----------HPNIVkL~g~~~d-------------~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~ 638 (785)
||||+++++++.+ ...+|+||||+++|++.+.+. ...+++..++.++.||+.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHH
Confidence 5555555555554 678999999999997766653 256899999999999999
Q ss_pred HHHHHH-hcccccccCCCCcEEEcCCC--------------------eEEEEecCccccccCCCCCCCCCCCCCcccCcc
Q 003935 639 GLMCIH-RMKIVHRDLKSANCLVNKHW--------------------TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 697 (785)
Q Consensus 639 AL~yLH-s~gIIHrDLKpsNILLd~~g--------------------~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APE 697 (785)
||+||| ++||+||||||+|||++.++ .+||+|||+++..... ..+||+.|+|||
T Consensus 173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE 247 (336)
T 2vuw_A 173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSG
T ss_pred HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChh
Confidence 999999 99999999999999999887 9999999999877543 347999999999
Q ss_pred ccccCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCh-HHHHHHHHhcCCCCCC-C-------ChHHHHHHHHhhh-CCCC
Q 003935 698 LIRNEPFTEKCDIFSLGVI-MWELCTLNRPWEGVLP-ERVVYAVANEGSRLEI-P-------EGPLGRLIADCWA-EPQE 766 (785)
Q Consensus 698 vl~~~~~s~ksDVWSLGvI-LyELLTG~~PF~~~~~-~~~v~~i~~~~~~~~i-p-------~~~L~~LI~~CL~-DP~k 766 (785)
++.+.. +.++||||||++ .+++++|..||.+... ......+......... + +..+.+||.+||. |
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--- 323 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--- 323 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence 998776 899999998777 7788999999854321 1222233322111111 1 1248899999999 6
Q ss_pred CCCHHHHH-HH
Q 003935 767 RPSCEEIL-SR 776 (785)
Q Consensus 767 RPS~~EIL-~~ 776 (785)
|+.+++ +|
T Consensus 324 --sa~e~l~~H 332 (336)
T 2vuw_A 324 --SATDLLCQH 332 (336)
T ss_dssp --SHHHHHHHC
T ss_pred --CHHHHHhcC
Confidence 999998 64
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=353.20 Aligned_cols=234 Identities=24% Similarity=0.345 Sum_probs=192.8
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE---CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCc----
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR---- 598 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~---~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~---- 598 (785)
.++|.+.+.||+|+||+||+|.+ +|+.||||++.... .....+.|.+|+.+++.++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 47899999999999999999987 47899999986533 34556788999999999999999999999987665
Q ss_pred -eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 599 -LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 599 -l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.|+||||++|++|.+++. ..+++.+++.++.||+.||.|||++|||||||||+|||++.+ .+||+|||+++..
T Consensus 158 ~~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eeEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 799999999999998774 269999999999999999999999999999999999999985 9999999999876
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----ChHH
Q 003935 678 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP----EGPL 753 (785)
Q Consensus 678 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip----~~~L 753 (785)
... ....||+.|+|||++.+.. +.++|||||||+||+|++|..||.+..... .....+ ...+
T Consensus 232 ~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------~~~~~~~~~~~~~l 297 (681)
T 2pzi_A 232 NSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG---------LPEDDPVLKTYDSY 297 (681)
T ss_dssp TCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS---------CCTTCHHHHHCHHH
T ss_pred ccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc---------ccccccccccCHHH
Confidence 543 4567999999999998764 899999999999999999999886531110 000001 2358
Q ss_pred HHHHHHhhh-CCCCCCC-HHHHHHHHHhh
Q 003935 754 GRLIADCWA-EPQERPS-CEEILSRLLDC 780 (785)
Q Consensus 754 ~~LI~~CL~-DP~kRPS-~~EIL~~L~~l 780 (785)
.+||.+||. ||.+||+ ++++...|..+
T Consensus 298 ~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 298 GRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 899999999 9999995 56666656544
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=354.84 Aligned_cols=247 Identities=28% Similarity=0.360 Sum_probs=197.1
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC------CC
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK------PP 597 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d------~~ 597 (785)
.++|.+.+.||+|+||+||+|.+ +|+.||||++... ......+.+.+|+.+++.++||||+++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 46899999999999999999987 5889999998654 345556789999999999999999999998765 66
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCe---EEEEecCcc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT---VKICDFGLS 674 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~---VKL~DFGLA 674 (785)
..++||||+++|+|.+++........+++..++.++.|++.||+|||+.||+||||||+|||++.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 78999999999999999985444457999999999999999999999999999999999999997664 999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---------H-h---
Q 003935 675 RIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV---------A-N--- 741 (785)
Q Consensus 675 ~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i---------~-~--- 741 (785)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||............ . .
T Consensus 172 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l 250 (676)
T 3qa8_A 172 KELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250 (676)
T ss_dssp CBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred ccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence 8775432 334568999999999999999999999999999999999999999765332211000 0 0
Q ss_pred -c----CCCCCCC-------ChHHHHHHHHhhh-CCCCCCCHHHHH
Q 003935 742 -E----GSRLEIP-------EGPLGRLIADCWA-EPQERPSCEEIL 774 (785)
Q Consensus 742 -~----~~~~~ip-------~~~L~~LI~~CL~-DP~kRPS~~EIL 774 (785)
. ....+.+ +..+.+|+..||. ||.+|||+.+++
T Consensus 251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 0 0000111 1358899999999 999999998854
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-30 Score=297.18 Aligned_cols=186 Identities=16% Similarity=0.101 Sum_probs=133.9
Q ss_pred EEeeeCcEEEEEEE--ECCeEEEEEEeecccc--------ChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCceeEE
Q 003935 534 RVGIGFFGEVFRGI--WNGTDVAIKVFLEQDL--------TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 534 ~LG~G~fG~VYkg~--~~g~~VAVKil~~~~~--------~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~l~LV 602 (785)
..+.|+.|.+..+. +-|..||+|++.+... ...+.++|.+|+++|+++ .|+||++++++++++..+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45667777666553 3689999999976532 123457899999999999 699999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
|||++|++|.+++. ..+++++. +|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.......
T Consensus 321 MEyv~G~~L~d~i~---~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLA---AGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EECCCSEEHHHHHH---TTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred EecCCCCcHHHHHH---hCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 99999999999997 34566654 5889999999999999999999999999999999999999999988765544
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 003935 683 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP 726 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~P 726 (785)
...+.+||+.|+|||++.+. +..++|+|++|+++++|.++..|
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 44566899999999999875 67789999999999888766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.7e-27 Score=267.28 Aligned_cols=185 Identities=16% Similarity=0.168 Sum_probs=148.5
Q ss_pred EeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChH------HHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 531 VGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE------NMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 531 i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~------~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
..+.||+|+||+||+|...++.+++|+......... ..+.|.+|+.++++++||||+++..++......|+|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 356899999999999988899999998755443221 23568999999999999999965555556677899999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC-
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR- 683 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~- 683 (785)
|+++++|.+++.. ++.++.|++.||+|||++||+||||||+|||++. ++||+|||+++........
T Consensus 420 ~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 420 YINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp CCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred CCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999862 5689999999999999999999999999999998 9999999999987542111
Q ss_pred ------CCCCCCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003935 684 ------DSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWE 728 (785)
Q Consensus 684 ------~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvILyELLTG~~PF~ 728 (785)
....+||+.|+|||++.. ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 124579999999999987 567888999999999999888887774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-22 Score=214.02 Aligned_cols=146 Identities=20% Similarity=0.183 Sum_probs=116.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccCh----------------HHHHHHHHHHHHHhhcCCCceeeE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTA----------------ENMEDFCNEISILSRLRHPNVILF 589 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~----------------~~~e~f~~EI~iLk~L~HPNIVkL 589 (785)
.-|.+++.||+|+||.||+|.+ +|+.||||++....... .....+.+|+.+++.++ | +++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 3455669999999999999998 58899999986433211 13567899999999999 5 666
Q ss_pred eccccCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEE
Q 003935 590 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKIC 669 (785)
Q Consensus 590 ~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~ 669 (785)
.+++.. +..++||||++|++|.+ +.. .....++.|++.||+|||++||+||||||+|||++ ++.+||+
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEEC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEE
Confidence 665543 56799999999999988 421 12346999999999999999999999999999999 9999999
Q ss_pred ecCccccccCCCCCCCCCCCCCcccCccccc
Q 003935 670 DFGLSRIITDSPMRDSSSAGTPEWMAPELIR 700 (785)
Q Consensus 670 DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~ 700 (785)
|||+++.. ..+.|||++.
T Consensus 235 DFG~a~~~-------------~~~~a~e~l~ 252 (282)
T 1zar_A 235 DFPQSVEV-------------GEEGWREILE 252 (282)
T ss_dssp CCTTCEET-------------TSTTHHHHHH
T ss_pred ECCCCeEC-------------CCCCHHHHHH
Confidence 99999643 3467899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5e-19 Score=183.76 Aligned_cols=138 Identities=17% Similarity=0.177 Sum_probs=106.3
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeE--EEEEEeeccccCh----------------------HHHHHHHHHHHHHhhc
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTD--VAIKVFLEQDLTA----------------------ENMEDFCNEISILSRL 581 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~--VAVKil~~~~~~~----------------------~~~e~f~~EI~iLk~L 581 (785)
-|.+.+.||+|+||.||+|.+ +|+. ||||++....... .....+.+|+.+|+.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999987 7999 9999975432110 1123678999999999
Q ss_pred CCCce--eeEeccccCCCceeEEEEEccc-c----hhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHH-hcccccccC
Q 003935 582 RHPNV--ILFLGACTKPPRLSMITEYMEL-G----SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH-RMKIVHRDL 653 (785)
Q Consensus 582 ~HPNI--VkL~g~~~d~~~l~LV~Ey~~g-G----SL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLH-s~gIIHrDL 653 (785)
.|++| ..++++ ...++||||+.+ | +|.++.. ..++..+..++.|++.||.||| +.||+||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~givHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR------ELKELDVEGIFNDVVENVKRLYQEAELVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG------GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh------ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 87754 333332 357899999942 3 5555432 1335567889999999999999 999999999
Q ss_pred CCCcEEEcCCCeEEEEecCccccc
Q 003935 654 KSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 654 KpsNILLd~~g~VKL~DFGLA~~l 677 (785)
||+|||++. .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.1e-16 Score=177.28 Aligned_cols=137 Identities=13% Similarity=0.215 Sum_probs=97.7
Q ss_pred CeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccC------------hHHHHH--------HHHHHHHHhhcCCCce
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLT------------AENMED--------FCNEISILSRLRHPNV 586 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~------------~~~~e~--------f~~EI~iLk~L~HPNI 586 (785)
=|.++++||+|+||.||+|.. +|+.||||++...... ...... ..+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 388999999999999999987 6899999997532110 000111 2245555555543332
Q ss_pred e--eEeccccCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC
Q 003935 587 I--LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 664 (785)
Q Consensus 587 V--kL~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g 664 (785)
. ..+++ ...++||||+.|++|..+.. . .....++.||+.+|.|||++|||||||||.|||+++++
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCC
Confidence 1 11111 12479999999999876532 1 12356889999999999999999999999999998776
Q ss_pred ----------eEEEEecCccccc
Q 003935 665 ----------TVKICDFGLSRII 677 (785)
Q Consensus 665 ----------~VKL~DFGLA~~l 677 (785)
.+.|+||+-+...
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 4899999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=2.1e-11 Score=124.93 Aligned_cols=140 Identities=12% Similarity=0.016 Sum_probs=110.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccCCCceeEEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
..|.+...++.|+.+.||++...++.+++|+....... ....+.+|+.+++.+. +..+.++++++.+.+..|+||||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 46788888888999999999878889999998643211 1235788999999885 66677888888888889999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR---------------------------------------- 645 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs---------------------------------------- 645 (785)
++|.+|.+.+. +......++.+++.+|+.||+
T Consensus 92 i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 92 ADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred cCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999876531 111234678899999999998
Q ss_pred -------------------cccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 646 -------------------MKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 646 -------------------~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
..++|+|+++.|||++++..+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998766667999997743
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.07 E-value=1.9e-10 Score=116.08 Aligned_cols=135 Identities=16% Similarity=0.100 Sum_probs=96.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCc--eeeEeccccCCCceeEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--VILFLGACTKPPRLSMI 602 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN--IVkL~g~~~d~~~l~LV 602 (785)
...+.+....+.|..+.||++.. +|..+++|+..... ...+..|+.+++.+.+.+ +.+++++....+..++|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 34555533334555699999976 46789999975431 235678999999886444 44588887777789999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc-----------------------------------
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK----------------------------------- 647 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~g----------------------------------- 647 (785)
|||++|.+|. .. . .+ ...++.+++..|+.||+..
T Consensus 94 ~e~i~G~~l~--~~---~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 94 LGEVPGQDLL--SS---H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EECCSSEETT--TS---C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEecCCcccC--cC---c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9999998884 21 0 11 1245667777777777643
Q ss_pred -----------------------cccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 648 -----------------------IVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 648 -----------------------IIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
++|+|++|.|||+++++.+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.03 E-value=5.1e-10 Score=120.46 Aligned_cols=140 Identities=16% Similarity=0.218 Sum_probs=106.0
Q ss_pred EeeEEeeeCcEEEEEEEECCeEEEEEEee--ccccChHHHHHHHHHHHHHhhcC--CCceeeEeccccCC---CceeEEE
Q 003935 531 VGTRVGIGFFGEVFRGIWNGTDVAIKVFL--EQDLTAENMEDFCNEISILSRLR--HPNVILFLGACTKP---PRLSMIT 603 (785)
Q Consensus 531 i~k~LG~G~fG~VYkg~~~g~~VAVKil~--~~~~~~~~~e~f~~EI~iLk~L~--HPNIVkL~g~~~d~---~~l~LV~ 603 (785)
..+.|+.|.++.||++...+..+++|+.. ..... .....+.+|+.+++.+. +..+.+++.++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35778999999999998878889999865 32211 12356778999999987 34567788887766 4589999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-------------------------------------- 645 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-------------------------------------- 645 (785)
||++|..+.+.. -..++......++.+++.+|+.||+
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998875421 2246778888899999999999997
Q ss_pred --------------------cccccccCCCCcEEEcCCCe--EEEEecCcccc
Q 003935 646 --------------------MKIVHRDLKSANCLVNKHWT--VKICDFGLSRI 676 (785)
Q Consensus 646 --------------------~gIIHrDLKpsNILLd~~g~--VKL~DFGLA~~ 676 (785)
..++|+|+++.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36999999999999997653 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.87 E-value=3.6e-09 Score=111.38 Aligned_cols=182 Identities=18% Similarity=0.118 Sum_probs=119.7
Q ss_pred eEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCc--eeeEeccccCCC---ceeEEEEEc
Q 003935 533 TRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPN--VILFLGACTKPP---RLSMITEYM 606 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPN--IVkL~g~~~d~~---~l~LV~Ey~ 606 (785)
+.++.|.+..||++. ..+++|+... ......+.+|+.+|+.+. +.. +.+++....... ..|+||+++
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 458999999999863 6789998542 234567889999998873 322 233444433332 358899999
Q ss_pred ccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 003935 607 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR----------------------------------------- 645 (785)
Q Consensus 607 ~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs----------------------------------------- 645 (785)
+|.+|..... ..++..+...++.+++..|+.||+
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9998875432 246667777788888888888885
Q ss_pred -----------------cccccccCCCCcEEEcC--CCeEEEEecCccccccCCCCCCCCCCCCCcccCccccc----c-
Q 003935 646 -----------------MKIVHRDLKSANCLVNK--HWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR----N- 701 (785)
Q Consensus 646 -----------------~gIIHrDLKpsNILLd~--~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~----~- 701 (785)
..++|+|+++.||++++ +..+.|+||+.+............ .....-..|+... .
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~-~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISL-MEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTT-CCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHH-HhhccccCHHHHHHHHHHc
Confidence 13799999999999998 566889999998754221000000 0000002232211 1
Q ss_pred CCC---------CchhhHHHHHHHHHHHHhCCCCC
Q 003935 702 EPF---------TEKCDIFSLGVIMWELCTLNRPW 727 (785)
Q Consensus 702 ~~~---------s~ksDVWSLGvILyELLTG~~PF 727 (785)
+.. ....+.|++|.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 12368999999999999998876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=3.7e-06 Score=89.07 Aligned_cols=132 Identities=17% Similarity=0.116 Sum_probs=88.6
Q ss_pred eEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCC---ceeeEecccc-CCCceeEEEEEccc
Q 003935 533 TRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHP---NVILFLGACT-KPPRLSMITEYMEL 608 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HP---NIVkL~g~~~-d~~~l~LV~Ey~~g 608 (785)
+.++.|....||+. |..+++|+.. .......+..|+.+|+.+.+. .+.+.+.++. ..+..+++|+|++|
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eecCCCcceeEEEE---CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 46888999999998 7788999842 223456788999999998642 2344444442 44567899999999
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR------------------------------------------- 645 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs------------------------------------------- 645 (785)
.++....- ..++......++.++...|+.||+
T Consensus 98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88865321 112333333344444444444442
Q ss_pred -----------------cccccccCCCCcEEEcC---CCe-EEEEecCcccc
Q 003935 646 -----------------MKIVHRDLKSANCLVNK---HWT-VKICDFGLSRI 676 (785)
Q Consensus 646 -----------------~gIIHrDLKpsNILLd~---~g~-VKL~DFGLA~~ 676 (785)
..++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 24699999999999987 455 48999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=8.2e-06 Score=83.48 Aligned_cols=131 Identities=15% Similarity=0.155 Sum_probs=90.0
Q ss_pred EEeeeCcE-EEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccCCCceeEEEEEcccc
Q 003935 534 RVGIGFFG-EVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEYMELG 609 (785)
Q Consensus 534 ~LG~G~fG-~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~Ey~~gG 609 (785)
.+..|..+ .||+... .+..+++|+-.. .....+..|...|+.+. +--+-++++++.+.+..++|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 34445554 6898765 366799998542 23456788999998885 222456677777888899999999998
Q ss_pred hhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 003935 610 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM------------------------------------------- 646 (785)
Q Consensus 610 SL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~------------------------------------------- 646 (785)
++.+..... ......+..++...|+.||..
T Consensus 106 ~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 106 TAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp EHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 877654311 111223444555555555531
Q ss_pred ---------------ccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 647 ---------------KIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 647 ---------------gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
.++|+|+++.|||++.++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 268999999999999877777999998754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.03 E-value=2.8e-05 Score=81.64 Aligned_cols=137 Identities=13% Similarity=0.099 Sum_probs=78.6
Q ss_pred eEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-----CCceeeEe-c--cccCCCceeEEEE
Q 003935 533 TRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-----HPNVILFL-G--ACTKPPRLSMITE 604 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-----HPNIVkL~-g--~~~d~~~l~LV~E 604 (785)
+.|+.|..+.||++...+..+++|+.... . ..+..|+.+++.|. .|.++... | +....+..+++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 45666778999999887777999998642 2 22334555555442 34444321 1 1123556789999
Q ss_pred Ecccchhh--------------HHHHhhccc---c--------cchHHH-------------------------------
Q 003935 605 YMELGSLY--------------HLIHLSGQK---K--------KLSWRR------------------------------- 628 (785)
Q Consensus 605 y~~gGSL~--------------dlL~~~~~~---~--------~Ls~~~------------------------------- 628 (785)
|++|..+. ..+|..... . ...|..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986442 111211110 0 001110
Q ss_pred HHHHHHHHHHHHHHHHh-------------cccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 629 KLKMLRDICRGLMCIHR-------------MKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 629 ~l~Ia~QIa~AL~yLHs-------------~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
...+..++..++.+|+. ..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11122234445666652 579999999999999888899999999774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=6.1e-05 Score=80.48 Aligned_cols=83 Identities=12% Similarity=-0.031 Sum_probs=53.5
Q ss_pred eEeeEE-eeeCcEEEEEEEEC--------CeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcC-C--CceeeEeccccCC
Q 003935 530 TVGTRV-GIGFFGEVFRGIWN--------GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLR-H--PNVILFLGACTKP 596 (785)
Q Consensus 530 ~i~k~L-G~G~fG~VYkg~~~--------g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~-H--PNIVkL~g~~~d~ 596 (785)
...+.| +.|..+.+|++... +..+++|+...... .......+..|+.+++.+. + -.+.+++.++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345678 88889999998654 67899998643220 0000134567888887774 2 2345566666554
Q ss_pred ---CceeEEEEEcccchhh
Q 003935 597 ---PRLSMITEYMELGSLY 612 (785)
Q Consensus 597 ---~~l~LV~Ey~~gGSL~ 612 (785)
+..++||||++|..+.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 3568999999986653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.80 E-value=4.9e-05 Score=82.79 Aligned_cols=76 Identities=16% Similarity=0.060 Sum_probs=48.1
Q ss_pred eeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc--Ch---HHHHHHHHHHHHHhhcCC--Cce-eeEeccccCCCceeE
Q 003935 532 GTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL--TA---ENMEDFCNEISILSRLRH--PNV-ILFLGACTKPPRLSM 601 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~--~~---~~~e~f~~EI~iLk~L~H--PNI-VkL~g~~~d~~~l~L 601 (785)
.+.||.|.++.||++.. .++.++||....... .. .....+..|+++++.+.. +.. .+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 46799999999999954 567899998643211 00 112456778888887742 333 345543 3345689
Q ss_pred EEEEcccc
Q 003935 602 ITEYMELG 609 (785)
Q Consensus 602 V~Ey~~gG 609 (785)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999863
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00055 Score=73.40 Aligned_cols=76 Identities=17% Similarity=0.063 Sum_probs=59.6
Q ss_pred EeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC---CCceeeEeccccCCCceeEEEEEcc
Q 003935 531 VGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR---HPNVILFLGACTKPPRLSMITEYME 607 (785)
Q Consensus 531 i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~---HPNIVkL~g~~~d~~~l~LV~Ey~~ 607 (785)
-.+.|+.|.+..+|+....+..+++|+.... ....|..|...|+.|. ...+.+.+.++...+..++||||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3567899999999999877889999986532 2456788999888874 2456677777777778999999999
Q ss_pred cchh
Q 003935 608 LGSL 611 (785)
Q Consensus 608 gGSL 611 (785)
+..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00035 Score=73.31 Aligned_cols=143 Identities=14% Similarity=0.133 Sum_probs=79.9
Q ss_pred eEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-----CCceeeEe-c--cccCCCceeE
Q 003935 530 TVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-----HPNVILFL-G--ACTKPPRLSM 601 (785)
Q Consensus 530 ~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-----HPNIVkL~-g--~~~d~~~l~L 601 (785)
.-.+.|+.|....+|++...+..+++|+..... . .+.+..|+.+++.+. .|.++... | +....+..++
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~-~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV-E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 100 (322)
T ss_dssp EEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred eEeeccCCCcccceEEEEeCCccEEEEEeCCCC-C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence 345678888889999998766689999976421 1 133456777776663 23333211 1 0112345789
Q ss_pred EEEEcccchhhH--------------HHHhhccc---------ccchHHHHHH------------HHHHHHHHHHHHHh-
Q 003935 602 ITEYMELGSLYH--------------LIHLSGQK---------KKLSWRRKLK------------MLRDICRGLMCIHR- 645 (785)
Q Consensus 602 V~Ey~~gGSL~d--------------lL~~~~~~---------~~Ls~~~~l~------------Ia~QIa~AL~yLHs- 645 (785)
+++|++|..+.. .++..... ....|..... +...+...+++++.
T Consensus 101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~ 180 (322)
T 2ppq_A 101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 180 (322)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 999999864311 11211000 0011221100 00113445555553
Q ss_pred ------cccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 646 ------MKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 646 ------~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
.+++|+|+++.|||+++++.+.|+||+.+..
T Consensus 181 ~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 181 WPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 4699999999999999876668999997753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00058 Score=75.22 Aligned_cols=78 Identities=14% Similarity=0.051 Sum_probs=47.1
Q ss_pred HhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCCCC--CCCcccCccccccC---CCCchhhHHHHHHHHH
Q 003935 644 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA--GTPEWMAPELIRNE---PFTEKCDIFSLGVIMW 718 (785)
Q Consensus 644 Hs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~--GT~~Y~APEvl~~~---~~s~ksDVWSLGvILy 718 (785)
+...++|+|+++.|||++.++ ++|+||+.+..-....... ... -...|.+|+..... .-....++..+...+|
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIG-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHH-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHH-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 356799999999999998876 9999999886542110000 000 01235555544311 1122355567777888
Q ss_pred HHHhC
Q 003935 719 ELCTL 723 (785)
Q Consensus 719 ELLTG 723 (785)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00074 Score=70.70 Aligned_cols=135 Identities=18% Similarity=0.134 Sum_probs=74.0
Q ss_pred eeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCce-eeEeccccCCCceeEEEEEc-ccc
Q 003935 532 GTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTKPPRLSMITEYM-ELG 609 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNI-VkL~g~~~d~~~l~LV~Ey~-~gG 609 (785)
.+.|+.|....+|++ ..+++|+....... .....+|+.+++.+...++ .++++++. ..-++++||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCc
Confidence 577988999999998 67889987542111 1122457777776642222 34444433 3347899999 665
Q ss_pred hhhHH---------------H---Hhhcc--cccc-hHHHHHHHHHH--------------HHHHHHHHH----h----c
Q 003935 610 SLYHL---------------I---HLSGQ--KKKL-SWRRKLKMLRD--------------ICRGLMCIH----R----M 646 (785)
Q Consensus 610 SL~dl---------------L---~~~~~--~~~L-s~~~~l~Ia~Q--------------Ia~AL~yLH----s----~ 646 (785)
++... + |.... .... ....+..+..+ +...+..|. . .
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 55320 0 10000 0000 11111111111 111122221 1 2
Q ss_pred ccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 647 KIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 647 gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
.++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4899999999999 5667889999998754
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=97.17 E-value=7.9e-06 Score=92.27 Aligned_cols=146 Identities=8% Similarity=0.110 Sum_probs=62.8
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCcccccccccccccccccCCCCCCCCCC
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYG 480 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~~~~sq~~~SlPSsp~~~~ 480 (785)
.+.|+|.+++..|+. .+|+|++|.|+ +.++.|.+|+.. +++.+||.+.++ .. .-+
T Consensus 55 hg~i~r~~ae~lL~~---~~G~FLvR~S~----~~~g~~~Lsv~~-----~~~v~H~~I~~~---g~--~~~-------- 109 (463)
T 3cxl_A 55 HGMISREAADQLLIV---AEGSYLIRESQ----RQPGTYTLALRF-----GSQTRNFRLYYD---GK--HFV-------- 109 (463)
T ss_dssp CCSCCHHHHHHHHTT---STTEEEEEECS----SSTTCEEEEEEC-----SSSEEEEECEES---SS--EES--------
T ss_pred ccCCCHHHHHHHHcC---CCCeEEEeccC----CCCCCEEEEEEE-----CCEEEEEEEecC---Ce--EEE--------
Confidence 467899999998853 58999999998 567778888887 567889988652 11 100
Q ss_pred CCCCCCCCCCCCCCCchhhh-----hhhhhccCCcccCCCccccccccccCCCeeEeeEEeeeCcEEEEEEEECC--eEE
Q 003935 481 SHGSERGGSSGYMANSEFVS-----TWNKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG--TDV 553 (785)
Q Consensus 481 s~sS~~~~ssg~~~~s~~~s-----~~~~il~S~~~~~~p~~~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~g--~~V 553 (785)
. ...+.+-.+.+. .+.....++..... .+. .+.+.|| ||+||+|.+.+ .+|
T Consensus 110 ---~----~~~F~sl~~Lv~dGl~~~~~~~~~~~~~l~~--------~i~----~l~~~lG---fG~v~~g~~~~~~~~V 167 (463)
T 3cxl_A 110 ---G----EKRFESIHDLVTDGLITLYIETKAAEYIAKM--------TIN----PIYEHVG---YTTLNREPAYKKHMPV 167 (463)
T ss_dssp ---S----SCCBSCHHHHHHHHHHHHHHHHHTHHHHHHT--------TSS----CSTTTSS---BCCC---------CCB
T ss_pred ---C----CCccCCHHHHHHHHHHhhhccCCCcchhhcc--------ccc----cccccCC---chhhhcccccccCCch
Confidence 0 011222233333 22221111100000 011 3345566 99999998854 578
Q ss_pred EE------EEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccc
Q 003935 554 AI------KVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 593 (785)
Q Consensus 554 AV------Kil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~ 593 (785)
|+ |.........+....|.+|..+++.++|||+++.+++.
T Consensus 168 av~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 168 LKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp GGGC-----------------------------------CBCCCEE
T ss_pred hhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 88 77655555555567889999999999999999988764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0039 Score=64.72 Aligned_cols=78 Identities=17% Similarity=0.117 Sum_probs=53.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCC---ceeeEeccccCCCceeEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHP---NVILFLGACTKPPRLSMI 602 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HP---NIVkL~g~~~d~~~l~LV 602 (785)
.++.-.+.+|.|..+.||++.. +|+.|++|+........ ...|..|+..|+.|.-. -+.+.+++. .-+++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv 88 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA 88 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence 4556678899999999999987 68999999864332221 23467899988887421 123334332 24789
Q ss_pred EEEcccch
Q 003935 603 TEYMELGS 610 (785)
Q Consensus 603 ~Ey~~gGS 610 (785)
|||+.++.
T Consensus 89 ~e~l~~~~ 96 (288)
T 3f7w_A 89 MEWVDERP 96 (288)
T ss_dssp EECCCCCC
T ss_pred EEeecccC
Confidence 99988654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0018 Score=68.44 Aligned_cols=32 Identities=31% Similarity=0.373 Sum_probs=27.7
Q ss_pred cccccccCCCCcEEEcCC----CeEEEEecCccccc
Q 003935 646 MKIVHRDLKSANCLVNKH----WTVKICDFGLSRII 677 (785)
Q Consensus 646 ~gIIHrDLKpsNILLd~~----g~VKL~DFGLA~~l 677 (785)
..++|+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 479999999999999874 68999999988654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0024 Score=71.03 Aligned_cols=72 Identities=18% Similarity=0.281 Sum_probs=48.8
Q ss_pred eeEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCce-eeEeccccCCCceeE
Q 003935 532 GTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTKPPRLSM 601 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNI-VkL~g~~~d~~~l~L 601 (785)
.+.|+.|....||++... +..+++|+..... . ...+..|..+++.+...++ .++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 467888999999999764 4689999874321 1 1345579988888853333 456665542 38
Q ss_pred EEEEcccchh
Q 003935 602 ITEYMELGSL 611 (785)
Q Consensus 602 V~Ey~~gGSL 611 (785)
|+||++|.+|
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999987444
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0019 Score=69.59 Aligned_cols=73 Identities=12% Similarity=0.177 Sum_probs=43.1
Q ss_pred eeEEeeeCcEEEEEEEECC----------eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCce-eeEeccccCCCcee
Q 003935 532 GTRVGIGFFGEVFRGIWNG----------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTKPPRLS 600 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~~g----------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNI-VkL~g~~~d~~~l~ 600 (785)
.+.|+.|....+|++...+ ..+++|+..... ........|..+++.+...++ .++++.. . -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence 4567888889999998754 688889864321 111123568888877753233 3455443 2 37
Q ss_pred EEEEEcccchh
Q 003935 601 MITEYMELGSL 611 (785)
Q Consensus 601 LV~Ey~~gGSL 611 (785)
+||+|++|.++
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999987543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.67 E-value=0.014 Score=61.21 Aligned_cols=138 Identities=12% Similarity=0.127 Sum_probs=78.1
Q ss_pred eEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCc--eeeEecc-----ccCCCceeEEEE
Q 003935 533 TRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--VILFLGA-----CTKPPRLSMITE 604 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN--IVkL~g~-----~~d~~~l~LV~E 604 (785)
..|+ |....||++.. +|+.+++|+....... ...+..|..+++.+.... +.+++.. ....+..+++|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCC---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 3566 88889999866 4668999998643332 245566888777764212 3333332 112345678999
Q ss_pred Ecccchhh-----------HH---HHhhcc------cccchHHHH----------------------HHHHHHHHHHHHH
Q 003935 605 YMELGSLY-----------HL---IHLSGQ------KKKLSWRRK----------------------LKMLRDICRGLMC 642 (785)
Q Consensus 605 y~~gGSL~-----------dl---L~~~~~------~~~Ls~~~~----------------------l~Ia~QIa~AL~y 642 (785)
|++|..+. .. ++.... ...+++... ...+.+++..++-
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 99985432 01 111110 011221110 0111122222222
Q ss_pred H----HhcccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 643 I----HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 643 L----Hs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
+ +...++|+|+++.|||++ + .+.|+||+.+..
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 2 234589999999999999 4 899999988754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.59 E-value=0.028 Score=57.75 Aligned_cols=103 Identities=21% Similarity=0.201 Sum_probs=68.5
Q ss_pred cchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHH-hcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003935 608 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH-RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 686 (785)
Q Consensus 608 gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLH-s~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~ 686 (785)
.-+|.++|.. .+.++++.++|.++.|.+.+|.-+- ++.-..+=+.|..|+|..+|.|.+.+ +.+.
T Consensus 32 ~vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 32 ALSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 4578899974 3578999999999999999987762 11111233456889999999987753 1110
Q ss_pred CCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 003935 687 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP 726 (785)
Q Consensus 687 ~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~P 726 (785)
.....+.|||... ...+.+.=|||||++||.-+-...|
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123466888764 3457889999999999999986665
|
| >3kd4_A Putative protease; structural genomics, joint center for STR genomics, JCSG, protein structure initiative, PSI-2, hydrol; HET: MSE; 2.00A {Parabacteroides distasonis atcc 8503} | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0055 Score=69.90 Aligned_cols=114 Identities=11% Similarity=0.147 Sum_probs=82.6
Q ss_pred cchhHHHHHHHHHHHHhcCCCChHHHHHHHHHHHHhhhCCCCCCChhhhhHH--HHHHHHhhcceeEeccccccccchhh
Q 003935 119 KDKKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALE--ETSHMFETRGVQLLGQIRHGSCRPRA 196 (785)
Q Consensus 119 ~d~~~~~l~~l~~~~~~~~~~~~~~~~~~~a~~v~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~g~i~~g~~r~ra 196 (785)
.++. +++++..+..+.. ++.+.++.|-..|.+++.--.+..+.. .|. ..+.-|++ +.|-|+-.|
T Consensus 226 ~~~~---i~~~a~~l~~~~~-~~~ek~~~iy~~V~~~i~y~~~~~~~~-g~~~~~a~~vl~~---------~~G~C~d~a 291 (506)
T 3kd4_A 226 QGYE---SKTFAQFLTDKSG-NEQEKVNIIRDHILNNLSTCPIPMAMT-GYTVRDIDTVLRS---------AYGTPLEIA 291 (506)
T ss_dssp CCHH---HHHHHHHHHSSCS-SHHHHHHHHHHHHHHHCEECCCCGGGG-TTCCCCHHHHHHH---------TEECHHHHH
T ss_pred CCHH---HHHHHHHHHhcCC-CHHHHHHHHHHHHHhccEecceecccC-CCCCCCHHHHHHh---------CCcchHHHH
Confidence 3555 8999999998887 999999999999999885221111110 000 01133333 369999999
Q ss_pred HHHHHHhhhcCCCceec-ccC-CCCcc-cccccccceeEEeecCceeeeeecc
Q 003935 197 ILFKVLADTVGLESRLM-GLP-NDGTM-ECVDSYKHMSVIVVLNSVELLVDLM 246 (785)
Q Consensus 197 ~lfkvlad~~~l~~~~~-g~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (785)
+||.+|+-..|+|||+| +.. +.+.. .-+.+.+|+-|.|.++...|++|-=
T Consensus 292 ~Ll~AllRa~GIpA~~v~~~t~~~~~~~~~lp~~nh~i~~v~~~g~~y~lDat 344 (506)
T 3kd4_A 292 QLLNVMLNAAGIPSEVLAVYPGHLDTDACGLAAIQTLAVKATVDGKDQYLSAS 344 (506)
T ss_dssp HHHHHHHHHTTCCEEEEEEEETTSCGGGCCSTTCCEEEEEEEETTEEEEESSS
T ss_pred HHHHHHHHHCCCCcEEEEEEcCCCCCccCCCCCCCEEEEEEEECCEEEEEecC
Confidence 99999999999999997 663 33322 2345569999999999999999984
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0082 Score=66.01 Aligned_cols=137 Identities=15% Similarity=0.206 Sum_probs=81.6
Q ss_pred eEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccCCCceeEE
Q 003935 533 TRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV 602 (785)
+.|..|-...+|++... ++.+++|+..... .....+.+|..+++.|. +.-..++++++.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 56777888899998763 4689999863211 12355668999988874 2222455666554 399
Q ss_pred EEEcccchhhH--------------HH---Hhhcc--cccc--hHHHHHHHHHHHHH-------------------HHHH
Q 003935 603 TEYMELGSLYH--------------LI---HLSGQ--KKKL--SWRRKLKMLRDICR-------------------GLMC 642 (785)
Q Consensus 603 ~Ey~~gGSL~d--------------lL---~~~~~--~~~L--s~~~~l~Ia~QIa~-------------------AL~y 642 (785)
+||++|.+|.. .| |.... .+.. -+.++.+++.++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 99999865531 11 11100 1111 34556666554422 2333
Q ss_pred HHh--------cccccccCCCCcEEEcCC----CeEEEEecCcccc
Q 003935 643 IHR--------MKIVHRDLKSANCLVNKH----WTVKICDFGLSRI 676 (785)
Q Consensus 643 LHs--------~gIIHrDLKpsNILLd~~----g~VKL~DFGLA~~ 676 (785)
|.. ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 332 259999999999999876 7899999988753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.05 E-value=0.05 Score=61.20 Aligned_cols=73 Identities=15% Similarity=0.032 Sum_probs=47.7
Q ss_pred eeEEeeeCcEEEEEEEECC--eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCce-eeEeccccCCCceeEEEEEccc
Q 003935 532 GTRVGIGFFGEVFRGIWNG--TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~~g--~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNI-VkL~g~~~d~~~l~LV~Ey~~g 608 (785)
.+.|+.|-...+|++...+ ..+++|+....... .-.-..|..+++.|...++ .++++++. + .+|+||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---IINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCC
Confidence 4678889999999998865 88999987432211 0112478888988865444 45666663 2 359999987
Q ss_pred chh
Q 003935 609 GSL 611 (785)
Q Consensus 609 GSL 611 (785)
.+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.05 E-value=0.019 Score=61.55 Aligned_cols=32 Identities=22% Similarity=0.383 Sum_probs=28.0
Q ss_pred cccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 646 MKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 646 ~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
..++|+|+.+.||+++.++.+.|+||+.+..-
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 36999999999999998888999999887653
|
| >3maz_A Signal-transducing adaptor protein 1; modular domain, phosphotyrosine, specificity, cytoplasm, phosphoprotein, SH2 domain, signaling protein; HET: PTR; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.03 E-value=0.00041 Score=65.13 Aligned_cols=54 Identities=7% Similarity=0.022 Sum_probs=44.2
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
++.|+|++||+ ||..++.+|+|++|+++ +.+ .|.+|++.+++ ++..+||++.+.
T Consensus 19 f~~isR~eAE~-lL~~~~~~GaFLVR~Se----~~~-~ySLSVR~~~~--~~~VKHYkI~~~ 72 (125)
T 3maz_A 19 FYTVSRKEATE-MLQKNPSLGNMILRPGS----DSR-NYSITIRQEID--IPRIKHYKVMSV 72 (125)
T ss_dssp BCCCCHHHHHH-HHHHCGGGCSEEEEECT----TSS-SEEEEEEECSS--SCEEEEEEEEEE
T ss_pred cCCCCHHHHHH-HHhccCCCCcEEEEeCC----CCC-CEEEEEEecCC--CCCEeeeEEEEe
Confidence 56789999996 45668889999999997 333 68899988654 789999999886
|
| >1aot_F FYN protein-tyrosine kinase; SH2 domain, signal transduction, peptide complex, complex (proto-oncogene/early protein); HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1aou_F* | Back alignment and structure |
|---|
Probab=95.65 E-value=0.0024 Score=57.27 Aligned_cols=57 Identities=14% Similarity=0.240 Sum_probs=48.5
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.+++..|+..++.+|+|++|.|+ +.++.+.+|+...++..+++.+|+.+.+.
T Consensus 10 g~isR~~Ae~lL~~~g~~~G~FLVR~S~----~~~g~~~LSv~~~~~~~~~~v~H~~I~~~ 66 (106)
T 1aot_F 10 GKLGRKDAERQLLSFGNPRGTFLIRESE----TTKGAYSLSIRDWDDMKGDHVKHYKIRKL 66 (106)
T ss_dssp BSCCHHHHHHHHHTTTCCTTEECCBCBS----SSSSBBCCEEECCBTTTBCCEEECCBEEE
T ss_pred CCCCHHHHHHHHhhCCCCCcEEEEEeCC----CCCCCEEEEEEecccCCCCcEEEEEEEEe
Confidence 4689999999999999999999999998 45678899998766666788999988764
|
| >1blj_A P55 BLK protein tyrosine kinase; signal transduction, transferase, phosphotransferase, phosphorylation; NMR {Mus musculus} SCOP: d.93.1.1 PDB: 1blk_A | Back alignment and structure |
|---|
Probab=95.06 E-value=0.006 Score=55.44 Aligned_cols=56 Identities=14% Similarity=0.171 Sum_probs=46.8
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.++++.|+..++.+|+|++|.|+ +..+.+.+|+...+.. +++.+|+.+.+.
T Consensus 17 g~isR~~Ae~lL~~~g~~~G~FLVR~S~----~~~g~y~LSv~~~~~~-~~~v~H~~I~~~ 72 (114)
T 1blj_A 17 RTISRKDAERQLLAPMNKAGSFLIRESE----SNKGAFSLSVKDITTQ-GEVVKHYKIRSL 72 (114)
T ss_dssp CSCCHHHHHHHHSSTTCCTTCEEBCBCT----TCSSCEEEEECBCCTT-TCBCCCEEEEEE
T ss_pred CCCCHHHHHHHHhhCCCCCceEEEEeCC----CCCCCEEEEEEEecCC-CCcEEEEEEEEc
Confidence 5689999999999999999999999998 4567888898875433 678899988764
|
| >1lkk_A Human P56 tyrosine kinase; complex (tyrosine kinase/peptide); HET: PTR; 1.00A {Homo sapiens} SCOP: d.93.1.1 PDB: 1lcj_A* 1bhf_A* 1bhh_A 1lkl_A* 1bhh_B 1fbz_A* 1ijr_A* 1cwd_L* 1cwe_A* | Back alignment and structure |
|---|
Probab=94.55 E-value=0.003 Score=56.60 Aligned_cols=57 Identities=11% Similarity=0.180 Sum_probs=47.3
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.+|++.|+..++.+|+|++|.|+ +..+.+.+|+...++..+++.+|+.+.+.
T Consensus 9 g~isR~~Ae~lL~~~~~~~G~FLVR~S~----~~~g~~~LSv~~~~~~~~~~v~H~~I~~~ 65 (105)
T 1lkk_A 9 KNLSRKDAERQLLAPGNTHGSFLIRESE----STAGSFSLSVRDFDQNQGEVVKHYKIRNL 65 (105)
T ss_dssp TTCCHHHHHHHHTSTTCCTTCEEEEECS----SSTTCEEEEEEEEETTTEEEEEEEEEEEC
T ss_pred CCCCHHHHHHHHHhcCCCCceEEEEECC----CCCCcEEEEEEEcccCCCCcEEEEEEEEC
Confidence 5689999999999999999999999998 45677888888765555678888888764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.43 E-value=0.21 Score=55.71 Aligned_cols=73 Identities=12% Similarity=0.139 Sum_probs=46.3
Q ss_pred eeEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCce-eeEeccccCCCceeE
Q 003935 532 GTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTKPPRLSM 601 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNI-VkL~g~~~d~~~l~L 601 (785)
.+.|..|-...+|++... +..+++|+...... ..-+..+|..+++.+...+| .++++.+. -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~---~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG---KFYDSKVELDVFRYLSNINIAPNIIADFP----EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc---hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCE
Confidence 456777888999999875 57899998643221 11123468888877742222 34444332 278
Q ss_pred EEEEcccchh
Q 003935 602 ITEYMELGSL 611 (785)
Q Consensus 602 V~Ey~~gGSL 611 (785)
|++|++|.+|
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998664
|
| >2el8_A Signal-transducing adaptor protein 2; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.95 E-value=0.013 Score=54.04 Aligned_cols=55 Identities=9% Similarity=-0.066 Sum_probs=45.8
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCcccccccc
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 461 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r 461 (785)
.+.|+|.+|++.|++.+ .+|+|++|.|+ +.++.+.+|+...+ ..+++.+|+.+.+
T Consensus 25 hG~isR~eAe~lL~~~~-~~G~FLVR~S~----~~~g~y~LSv~~~~-~~~~~v~H~~I~~ 79 (118)
T 2el8_A 25 FLKVSRLEAQLLLERYP-ECGNLLLRPSG----DGADGVSVTTRQMH-NGTHVVRHYKVKR 79 (118)
T ss_dssp CCCCCHHHHHHHHHHSS-TTCSBEEEECC----SSSSSEEEEECCCB-TTBCCCEEECBCC
T ss_pred ecCCCHHHHHHHHhhCC-CCcEEEEeeCC----CCCCceEEEEEEec-CCCCcEEEEEEEE
Confidence 56789999999998887 99999999998 55788999998754 3367889998876
|
| >1rja_A Tyrosine-protein kinase 6; human protein tyrosine kinase-6 (PTK6/BRK), SRC homology 2(S domain, solution structure, backbone dynamics, transferase; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=93.32 E-value=0.016 Score=51.43 Aligned_cols=52 Identities=13% Similarity=0.163 Sum_probs=43.6
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.+++..|...|..+|+|++|.|+ +.++.+.+|+.. +++.+|+.+.+.
T Consensus 7 g~isR~~Ae~lL~~~g~~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~~ 58 (100)
T 1rja_A 7 GCISRSEAVRRLQAEGNATGAFLIRVSE----KPSADYVLSVRD-----TQAVRHYKIWRR 58 (100)
T ss_dssp TTCCHHHHHHHHSSTTCSSCCEEEEECS----SSSSCEEEEECT-----TSSCEEEEEEEC
T ss_pred CCCCHHHHHHHHhccCCCCCEEEEEeCC----CCCCCEEEEEEE-----CCEEEEEEEEEc
Confidence 5689999999999999999999999998 446778888876 467888888763
|
| >1nrv_A Growth factor receptor-bound protein 10; dimer, signaling protein; 1.65A {Homo sapiens} SCOP: d.93.1.1 PDB: 3m7f_A | Back alignment and structure |
|---|
Probab=92.92 E-value=0.017 Score=51.65 Aligned_cols=52 Identities=10% Similarity=-0.005 Sum_probs=43.3
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.+|++.|...|+.+|+|++|.|+ +..+.+.+|+.. +++.+|+.+.+.
T Consensus 10 g~isR~~Ae~lL~~~g~~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~~ 61 (105)
T 1nrv_A 10 GRISREESHRIIKQQGLVDGLFLLRDSQ----SNPKAFVLTLCH-----HQKIKNFQILPC 61 (105)
T ss_dssp TTCCHHHHHHHHHHTTCCTTEEEEEECS----SCTTCEEEEEEE-----TTEEEEEEEEEC
T ss_pred CCCCHHHHHHHHHhcCCCCceEEEEeCC----CCCCCEEEEEEe-----CCEEEEEEEEEE
Confidence 5689999999999999999999999998 446778888876 367888887763
|
| >2dly_A FYN-related kinase; BRK family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=92.45 E-value=0.018 Score=53.10 Aligned_cols=53 Identities=15% Similarity=0.196 Sum_probs=44.1
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
.+.|+|.+++..|+..++.+|+|++|.|+ ...+.+.+|+.. +++.+|+.+.+.
T Consensus 20 hG~isR~eAe~lL~~~~~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 72 (121)
T 2dly_A 20 FGAIKRADAEKQLLYSENQTGAFLIRESE----SQKGDFSLSVLD-----EGVVKHYRIRRL 72 (121)
T ss_dssp CSSCCHHHHHHHHTSSSCCTTCEEEEECS----SSSSCEEEEEES-----SSCEEEEEEEEC
T ss_pred ccCCCHHHHHHHHhcCCCCCCEEEEEcCC----CCCCceEEEEEE-----CCeEEEEEEEEc
Confidence 35789999999999999999999999998 456778888876 467888888763
|
| >4d8k_A Tyrosine-protein kinase LCK; protein kinases, SH2 domain, SH3 domain, structural genomics center for structural genomics, JCSG; 2.36A {Homo sapiens} PDB: 1lck_A* 1x27_A* | Back alignment and structure |
|---|
Probab=92.30 E-value=0.015 Score=56.72 Aligned_cols=58 Identities=10% Similarity=0.178 Sum_probs=49.0
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
.+.|+|.++++.|+..++.+|+|++|.|+ +..+.|.+|+...++..+++.+|+.+.+.
T Consensus 78 ~g~isr~~ae~lL~~~~~~~G~FLVR~S~----~~~g~y~LSv~~~~~~~~~~v~H~~I~~~ 135 (175)
T 4d8k_A 78 FKNLSRKDAERQLLAPGNTHGSFLIRESE----STAGSFSLSVRDFDQNQGEVVKHYKIRNL 135 (175)
T ss_dssp CSSCCHHHHHHHHHSTTCCTTCEEEEECS----SSTTCEEEEEEEECTTSCEEEEEEEEEEC
T ss_pred cCcccHHHHHHHHhcCCCCCCEEEEEECC----CCCCeEEEEEEeCcccCCCceEEEEEEEC
Confidence 35689999999999999999999999998 56778888988766666788999988764
|
| >3isr_A Transglutaminase-like enzymes, putative cysteine; protease, hutchinsoni MCSG, structural genomics; 1.90A {Cytophaga hutchinsonii} | Back alignment and structure |
|---|
Probab=92.27 E-value=0.4 Score=50.95 Aligned_cols=122 Identities=17% Similarity=0.172 Sum_probs=82.0
Q ss_pred HHHHHHHHHhcCCCChHHHHHHHHHHHHhhhCCC-CCCChhhhhHHHHHHHHhhcceeEeccccccccchhhHHHHHHhh
Q 003935 126 LKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRP-SVESPAKAALEETSHMFETRGVQLLGQIRHGSCRPRAILFKVLAD 204 (785)
Q Consensus 126 l~~l~~~~~~~~~~~~~~~~~~~a~~v~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~g~i~~g~~r~ra~lfkvlad 204 (785)
++++...+..+.. ++.+.++.|...|.+.+.=- ......... ..-|+ -+.|.|+.-|.||-+|+-
T Consensus 128 i~~~A~~~~~~~~-~~~~~~~ai~~~v~~~~~Y~~~~~~~~~~a----~~~l~---------~~~G~C~d~A~l~val~R 193 (293)
T 3isr_A 128 LQKLAYKEFGKIE-NVYSKVLAITDWIYNNVEYISGSTNSQTSA----FDTIT---------ERAGVCRDFAHLGIALCR 193 (293)
T ss_dssp SHHHHHHHHTTCC-SHHHHHHHHHHHHHHHSEECTTSCCTTCCH----HHHHH---------HCEECHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCC-CHHHHHHHHHHHHHhhcEEeccCCCCCCCH----HHhhc---------CCcEehHHHHHHHHHHHH
Confidence 7888888876665 77789999999999876422 111111111 12222 368999999999999999
Q ss_pred hcCCCceec-ccCCCCcccccccccceeEEeecCceeeeeecccCCCccccCchhhhhhhcccccCCCCccC
Q 003935 205 TVGLESRLM-GLPNDGTMECVDSYKHMSVIVVLNSVELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAE 275 (785)
Q Consensus 205 ~~~l~~~~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (785)
..|||||+| |+-.+.. ..-.|.=+-|-++..=+.+|--. + .|. ..||--|.--|-++
T Consensus 194 a~GIPAR~VsGy~~~~~----~~~~HAW~Evyl~ggWv~~DpT~--~--~~~------~~~I~vA~GRD~~D 251 (293)
T 3isr_A 194 ALSIPARYFTGYAFKLN----PPDFHACFEAYIGGNWIIFDATR--L--VPL------NGLVKIATGRDAAD 251 (293)
T ss_dssp HTTCCEEEEEEEETTCS----SCCEEEEEEEEETTEEEEECTTC--C--SCG------GGEEEEEEESSGGG
T ss_pred HCCCCEEEEEEECCCCC----CCCeEEEEEEEECCcEEEEECCC--C--CCC------CCeEEEEECCCHHH
Confidence 999999999 9843321 23368878777777666666432 2 221 45887776667665
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.20 E-value=0.45 Score=52.04 Aligned_cols=30 Identities=23% Similarity=0.378 Sum_probs=25.0
Q ss_pred ccccccCCCCcEEE------cCCCeEEEEecCcccc
Q 003935 647 KIVHRDLKSANCLV------NKHWTVKICDFGLSRI 676 (785)
Q Consensus 647 gIIHrDLKpsNILL------d~~g~VKL~DFGLA~~ 676 (785)
.++|+|+.+.|||+ +++..+.++||-.|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36899999999999 4566799999988754
|
| >3pqz_A Growth factor receptor-bound protein 7; SH2, binds phosphotyrosine, tyrosine kinases, cytoplasmic, P binding; 2.41A {Homo sapiens} PDB: 1mw4_A* 2l4k_A* 2qms_A | Back alignment and structure |
|---|
Probab=91.56 E-value=0.029 Score=51.15 Aligned_cols=53 Identities=11% Similarity=-0.024 Sum_probs=42.9
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
.+.|+|.++++.|...+..+|+|++|.|+ +..+.+.+|+.. +++.+|+.+.+.
T Consensus 18 hg~isR~~Ae~lL~~~g~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 70 (117)
T 3pqz_A 18 HGRISREESQRLIGQQGLVDGLFLVRESQ----RNPQGFVLSLCH-----LQKVKHYLILPS 70 (117)
T ss_dssp CCSCCHHHHHHHHHHTTCCTTEEEEEECC----C-CCCEEEEEEE-----TTEEEEEEEEEE
T ss_pred cCCCCHHHHHHHHhcCCCCCCEEEEEecC----CCCCcEEEEEEe-----CCeeEEEEEEEe
Confidence 35689999999999989999999999998 445678888876 567888888763
|
| >2aug_A Growth factor receptor-bound protein 14; phosphorylation, SH2 domain, signaling protein; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.24 E-value=0.024 Score=52.82 Aligned_cols=53 Identities=9% Similarity=0.095 Sum_probs=44.0
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
.+.|+|.+|++.|+..|+.+|+|++|.|+ +..+.|.+|+.. +++.+++.+.+.
T Consensus 30 hG~isR~eAe~lL~~~g~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 82 (126)
T 2aug_A 30 HHKISRDEAQRLIIQQGLVDGVFLVRDSQ----SNPKTFVLSMSH-----GQKIKHFQIIPV 82 (126)
T ss_dssp ETTCCHHHHHHHHHTTTCCTTEEEEEECS----SSSCCEEEEEEE-----TTEEEEEEEEEE
T ss_pred cCCCCHHHHHHHHhccCCCCCEEEEeecC----CCCCCEEEEEEc-----CCeEEEEEEEEE
Confidence 46789999999999999999999999998 456778888876 457888888763
|
| >3ov1_A Growth factor receptor-bound protein 2; GRB2 SH2 domain, phosphotyrosine binding, signaling protein, signaling protein-antagonist complex; HET: PTR; 1.60A {Homo sapiens} SCOP: d.93.1.1 PDB: 3imj_A* 3in7_A* 3imd_A* 3kfj_A* 3n8m_A* 3in8_A* 3s8l_A* 3s8n_A* 3s8o_A* 2huy_A* 2h5k_A* 2huw_A* 2h46_E* 3c7i_A* 3n84_A* 1fhs_A 1bm2_A* 1bmb_A* 3ove_A* 1fyr_A* ... | Back alignment and structure |
|---|
Probab=89.73 E-value=0.038 Score=50.76 Aligned_cols=51 Identities=12% Similarity=0.195 Sum_probs=41.0
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.++++.|.. ++.+|+|++|.|+ +..+.|.+|+.. +++.+++.+.+.
T Consensus 11 G~isR~eAe~lL~~-~~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 61 (117)
T 3ov1_A 11 GKIPRAKAEEMLSK-QRHDGAFLIRESE----SAPGDFSLSVKF-----GNDVQHFKVLRD 61 (117)
T ss_dssp CSCCHHHHHHHHHT-CCSTTBEEEEECS----SSTTCEEEEEEE-----TTEEEEEECEEC
T ss_pred CCCCHHHHHHHHhC-CCCCCcEEEEeCC----CCCCCEEEEEec-----CCceEEEEEEEC
Confidence 46889999998777 8899999999998 556778888875 567888887653
|
| >1d4t_A T cell signal transduction molecule SAP; SH2 domain, tyrosine kinase, signal transduction, peptide recognition, signaling protein; 1.10A {Homo sapiens} SCOP: d.93.1.1 PDB: 1d1z_A 1d4w_A* 1m27_A* | Back alignment and structure |
|---|
Probab=89.08 E-value=0.038 Score=49.31 Aligned_cols=51 Identities=12% Similarity=0.093 Sum_probs=40.6
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.++++.|...+ .+|+|++|.|+ +..+.+.+|+.. +++.+|+.+.+.
T Consensus 9 g~isR~~Ae~lL~~~~-~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~~ 59 (104)
T 1d4t_A 9 GKISRETGEKLLLATG-LDGSYLLRDSE----SVPGVYCLCVLY-----HGYIYTYRVSQT 59 (104)
T ss_dssp CSCCHHHHHHHHHHHC-CTTEEEEEECS----SSTTCEEEEEEE-----TTEEEEEEEEEC
T ss_pred cCCCHHHHHHHHHhcC-CCCEEEEeeCC----CCCCCEEEEEEE-----CCeEEEEEEEEC
Confidence 4688999999887765 88999999998 456778888876 457888887763
|
| >2ekx_A Cytoplasmic tyrosine-protein kinase BMX; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.03 E-value=0.078 Score=47.80 Aligned_cols=55 Identities=11% Similarity=0.158 Sum_probs=42.4
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCC-cccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHD-EISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d-~~~~~rs~~~~l~r~ 462 (785)
+.|+|.+++..|...+ .+|+|++|.|+ .++.+.+|+...+ ...+++.+|+.+.+.
T Consensus 16 g~isR~~Ae~lL~~~~-~~G~FLVR~S~-----~~g~y~LSv~~~~~~~~~~~v~H~~I~~~ 71 (110)
T 2ekx_A 16 GNISRSQSEQLLRQKG-KEGAFMVRNSS-----QVGMYTVSLFSKAVNDKKGTVKHYHVHTN 71 (110)
T ss_dssp CSCCHHHHHHHHHHTC-CTTEEEEEECS-----STTCEEEEECCCCSSCSSCCCEEEECEEC
T ss_pred CCCCHHHHHHHHhccC-CCceEEEEecC-----CCCCEEEEEEeccccCCCCcEEEEEEEEC
Confidence 5688999999776664 88999999994 2678888988754 234678899988764
|
| >2dx0_A Phospholipase C, gamma 2; phosphoric diester hydrolase, structural genomics, NPPSFA, national project on protein structural and functional analyses; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=88.98 E-value=0.057 Score=50.95 Aligned_cols=53 Identities=13% Similarity=0.150 Sum_probs=43.6
Q ss_pred HHHH-HHHHHHhhhhhh----cCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 401 VRAM-NETLKQNRLLQE----RGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 401 ~~~~-~~~~~~~~l~~~----~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
.+.| +|.+|++.|+.. ++.+|+|++|.|+ +..+.|.+|+.. +++.+|+.+.+.
T Consensus 26 hG~i~sR~eAe~lL~~~c~~~g~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 83 (138)
T 2dx0_A 26 HKKVESRTSAEKLLQEYCAETGAKDGTFLVRESE----TFPNDYTLSFWR-----SGRVQHCRIRST 83 (138)
T ss_dssp CTTCCCHHHHHHHHHHHHTTTTCCTTCEEEEECS----SSTTCEEEEEEE-----TTEEEEEEEEEE
T ss_pred cCCCCCHHHHHHHHHhhccccCCCCCEEEEEeCC----CCCCCeEEEEEE-----CCeEEEEEEEEe
Confidence 4678 899999999876 8999999999998 456778888875 467889988765
|
| >2cia_A Cytoplasmic protein NCK2; SH2-domain, SH3 domain, phosphorylation, binding specificity; HET: PTR MPD; 1.45A {Homo sapiens} PDB: 1z3k_A 2ci9_A* 2ci8_A* | Back alignment and structure |
|---|
Probab=88.96 E-value=0.062 Score=47.91 Aligned_cols=50 Identities=8% Similarity=0.138 Sum_probs=39.4
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCcccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 461 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r 461 (785)
+.|+|.++++.|++.+ .+|+|++|.|+ +..+.+.+|+.. +++.+|+.+..
T Consensus 10 g~isR~~Ae~lL~~~~-~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~ 59 (102)
T 2cia_A 10 GNVTRHQAECALNERG-VEGDFLIRDSE----SSPSDFSVSLKA-----SGKNKHFKVQL 59 (102)
T ss_dssp CSCCHHHHHHHHHHHC-CTTEEEEEECS----SSTTCEEEEECC-----SSSCEEEEEEE
T ss_pred CCCCHHHHHHHHhhCC-CCcEEEEEECC----CCCCCEEEEEEe-----CCeeEEEEEEe
Confidence 4689999999876665 88999999998 445678888886 35778887763
|
| >1i3z_A EWS/FLI1 activated transcript 2; SH2 domain phosphotyrosine signal transduction lymphocyte, signaling protein; HET: PTR; 2.15A {Mus musculus} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=88.77 E-value=0.051 Score=48.30 Aligned_cols=51 Identities=14% Similarity=0.094 Sum_probs=39.8
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.++++.|...+ .+|+|++|.|+ ...+.+.+|+.. +++.+|+.+.+.
T Consensus 8 g~isR~~Ae~lL~~~~-~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~~ 58 (103)
T 1i3z_A 8 GCLTKRECEALLLKGG-VDGNFLIRDSE----SVPGALCLCVSF-----KKLVYSYRIFRE 58 (103)
T ss_dssp SSCCHHHHHHHHHTTC-STTEEEEEECS----SSTTCEEEEEEC-----SSSEEEEEEEEC
T ss_pred CCCCHHHHHHHHhhcC-CCceEEEEeCC----CCCCCEEEEEEE-----CCEEEEEEEEEC
Confidence 4688999999877655 89999999998 445668888876 467888888763
|
| >2gsb_A RAS GTPase-activating protein 1; GAP, RAS P21 protein activator, P120GAP, rasgap, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.37 E-value=0.073 Score=48.93 Aligned_cols=52 Identities=10% Similarity=0.071 Sum_probs=41.2
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
.+.|+|.++++.|+..+ .+|+|++|.|+ +.++.|.+|+.. .++.+|+.+.+.
T Consensus 20 hG~isR~~Ae~lL~~~g-~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 71 (119)
T 2gsb_A 20 HGKISKQEAYNLLMTVG-QVCSFLVRPSD----NTPGDYSLYFRT-----NENIQRFKICPT 71 (119)
T ss_dssp CCSSCHHHHHHHHHHTC-CSSEEEEEECS----SSTTCEEEEEEC-----SSCBCCCCEEEE
T ss_pred cCCCCHHHHHHHHhhcC-CCCeEEEEeCC----CCCCceEEEEEE-----CCEEEEEEEEEc
Confidence 35789999999888766 57999999998 456778888876 357888888764
|
| >3tkz_A Tyrosine-protein phosphatase non-receptor type 11; SH2 domain, protein protein interactions, PTR residues, HYDR peptide complex; HET: PTR; 1.80A {Homo sapiens} PDB: 3tl0_A* 1aya_A* 1ayb_A* 1ayc_A* 1ayd_A | Back alignment and structure |
|---|
Probab=88.07 E-value=0.057 Score=48.56 Aligned_cols=50 Identities=12% Similarity=0.145 Sum_probs=40.4
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCcccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 461 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r 461 (785)
+.|+|.+|++.|...+ .+|+|++|.|+ +.++.+.+|+.. +++.+|+.+.+
T Consensus 12 g~isr~~Ae~lL~~~~-~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~ 61 (109)
T 3tkz_A 12 PNITGVEAENLLLTRG-VDGSFLARPSK----SNPGDFTLSVRR-----NGAVTHIKIQN 61 (109)
T ss_dssp TTCCHHHHHHHHHHHC-CTTEEEEEECS----SSTTCEEEEEEE-----TTEEEEEEEEE
T ss_pred cCCCHHHHHHHHhcCC-CCCEEEEEecC----CCCCCEEEEEEE-----CCEEEEEEEEe
Confidence 5689999998887765 89999999998 456778888875 56788888765
|
| >1ka6_A SH2 domain protein 1A; SH2 domain, protein-peptide complex, immune system; HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1ka7_A | Back alignment and structure |
|---|
Probab=87.94 E-value=0.074 Score=49.47 Aligned_cols=51 Identities=12% Similarity=0.093 Sum_probs=40.6
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.++++.|...+ .+|+|++|.|+ ...+.+.+|+.. +++.+|+.+.+.
T Consensus 9 G~isR~eAe~lL~~~~-~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 59 (128)
T 1ka6_A 9 GKISRETGEKLLLATG-LDGSYLLRDSE----SVPGVYCLCVLY-----HGYIYTYRVSQT 59 (128)
T ss_dssp CSCCHHHHHHHHHHHC-CTTCEEEEECS----SSTTCEEEEEES-----SSCEEEEEEEEC
T ss_pred CCCCHHHHHHHHhcCC-CCCEEEEeecC----CCCCCEEEEEEe-----CCEEEEEEEEEC
Confidence 4688999999887655 88999999998 456678888876 457888888763
|
| >1jyr_A Growth factor receptor-bound protein 2; receptor binding, regulatory, inhibitor, signaling protein-I complex; HET: PTR; 1.55A {Homo sapiens} SCOP: d.93.1.1 PDB: 1jyq_A* 1jyu_A 1qg1_E* 1x0n_A* 2aob_A* 2aoa_A* 3n7y_A* 1tze_E* 1zfp_E* 3mxc_A* 3mxy_A* 1cj1_A* | Back alignment and structure |
|---|
Probab=87.86 E-value=0.056 Score=47.72 Aligned_cols=51 Identities=14% Similarity=0.233 Sum_probs=40.2
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.+++..|...+ .+|+|++|.|+ ...+.+.+|+.. +++.+|+.+.+.
T Consensus 8 g~isR~~Ae~lL~~~~-~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~~ 58 (96)
T 1jyr_A 8 GKIPRAKAEEMLSKQR-HDGAFLIRESE----SAPGDFSLSVKF-----GNDVQHFKVLRD 58 (96)
T ss_dssp CSCCHHHHHHHHHTCC-STTBEEEEECS----SSTTCEEEEEEE-----TTEEEEEECEEC
T ss_pred cCCCHHHHHHHHhcCC-CCcEEEEEecC----CCCCCEEEEEEe-----CCeEEEEEEEEc
Confidence 4688999999888766 59999999998 445678888876 357888887663
|
| >4fbn_A 1-phosphatidylinositol 4,5-bisphosphate phosphodi gamma-1; SH2 domain, plcgamma specific array, interaction domain, FIB growth factor receptor 1; 2.40A {Homo sapiens} PDB: 4ey0_A* 3gqi_B* 2fci_A* 2pld_A* 2ple_A* | Back alignment and structure |
|---|
Probab=87.65 E-value=0.11 Score=53.72 Aligned_cols=50 Identities=8% Similarity=0.098 Sum_probs=42.0
Q ss_pred HHHHHHHhhhhh----hcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 404 MNETLKQNRLLQ----ERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 404 ~~~~~~~~~l~~----~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
|.|.+||+.|+. .++.||+|++|+|+ +.++.|.+|+.. +++.+|+.+.+.
T Consensus 16 ~sR~~AE~lL~~~~~~~~~~dG~FLVR~S~----s~~G~y~LSv~~-----~~~v~H~~I~~~ 69 (246)
T 4fbn_A 16 DGRHIAERLLTEYCIETGAPDGSFLVRESE----TFVGDYTLSFWR-----NGKVQHCRIHSR 69 (246)
T ss_dssp CHHHHHHHHHHHHHHHHTCCTTCEEEEECS----SSTTCEEEEEEE-----TTEEEEEEEEEE
T ss_pred CCHHHHHHHHHHhhhccCCCCCEEEEEcCC----CCCCCEEEEEEE-----CCEEEEEEEEEE
Confidence 479999999864 68999999999998 778889999875 578889988764
|
| >2hdv_A SH2-B PH domain containing signaling mediator 1 gamma isoform; adapter protein, signaling protein; 2.00A {Mus musculus} PDB: 2hdx_A* 1rpy_A 1rqq_C* | Back alignment and structure |
|---|
Probab=87.26 E-value=0.067 Score=48.50 Aligned_cols=52 Identities=10% Similarity=0.136 Sum_probs=42.1
Q ss_pred HHHHHHHHHhhhhhhcC-CCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERG-EDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~-~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.++++.|+..|+ .+|+|++|.|+ ...+.+.+|+.. +++.+|+.+.+.
T Consensus 14 G~isR~~Ae~lL~~~g~~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 66 (111)
T 2hdv_A 14 GMLSRLKAAQLVLEGGTGSHGVFLVRQSE----TRRGECVLTFNF-----QGKAKHLRLSLN 66 (111)
T ss_dssp EECCHHHHHHHHHTTGGGGTTEEEEEECS----SCTTEEEEEEEE-----TTEEEEEEEEEC
T ss_pred CCCCHHHHHHHHHHcCCCCCCeEEEEecC----CCCCCEEEEEEe-----CCeEEEEEEEEc
Confidence 46889999999998885 99999999998 445668888876 467888887763
|
| >1r1p_A GRB2-related adaptor protein 2; SH2, GADS, phosphopeptide, peptide binding protein; HET: PTR; 1.80A {Mus musculus} SCOP: d.93.1.1 PDB: 1r1q_A* 1r1s_A* | Back alignment and structure |
|---|
Probab=86.01 E-value=0.12 Score=45.92 Aligned_cols=50 Identities=10% Similarity=0.153 Sum_probs=40.0
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.++++.|... .+|+|++|.|+ +..+.+.+|+.. +++.+|+.+.+.
T Consensus 14 g~isR~~Ae~lL~~~--~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~~ 63 (100)
T 1r1p_A 14 EGLSRHQAENLLMGK--DIGFFIIRASQ----SSPGDFSISVRH-----EDDVQHFKVMRD 63 (100)
T ss_dssp TTCCHHHHHHHHHTS--CTTBEEEEECS----SSTTCEEEEEEC-----SSSEEEEECEEC
T ss_pred cCCCHHHHHHHhcCC--CCCEEEEEecC----CCCCCEEEEEEE-----CCEEEEEEEEEc
Confidence 578999999999865 79999999998 445668888876 357888887763
|
| >2ge9_A Tyrosine-protein kinase BTK; SH2 domain, structure, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.92 E-value=0.11 Score=48.16 Aligned_cols=55 Identities=13% Similarity=0.125 Sum_probs=42.6
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCc-ccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDE-ISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~-~~~~rs~~~~l~r~ 462 (785)
+.|+|.++++.|...+ .+|+|++|.|+ .++.+.+|+...++ ..+++.+++.+.+.
T Consensus 16 G~isR~eAe~lL~~~g-~~G~FLVR~Ss-----~~g~y~LSv~~~~~~~~~~~v~H~~I~~~ 71 (125)
T 2ge9_A 16 KHMTRSQAEQLLKQEG-KEGGFIVRDSS-----KAGKYTVSVFAKSTGDPQGVIRHYVVCST 71 (125)
T ss_dssp TTCCHHHHHHHHHHHT-CTTEEEEEECS-----SSCCEEEEEEESSSSSTTCEEEEEECEEE
T ss_pred cCCCHHHHHHHHhhcC-CCceEEEEecC-----CCCCEEEEEEeccccCCCCeEEEEEEEEc
Confidence 5789999999887765 88999999994 26778888886542 24578889988764
|
| >2ysx_A Signaling inositol polyphosphate phosphatase SHIP II; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.78 E-value=0.093 Score=48.08 Aligned_cols=51 Identities=10% Similarity=0.082 Sum_probs=40.3
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.++++.|...+ .+|+|++|.|+ +..+.+.+|+.. +++.+|+.+.+.
T Consensus 15 G~isR~eAe~lL~~~~-~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 65 (119)
T 2ysx_A 15 GNITRSKAEELLSRTG-KDGSFLVRASE----SISRAYALCVLY-----RNCVYTYRILPN 65 (119)
T ss_dssp ESCCHHHHHHHHHHHC-CTTEEEEEECS----SCTTSEEEEEEC-----SSCEEEEEEEEC
T ss_pred CCCCHHHHHHHHhhcC-CCCEEEEEeCC----CCCCCEEEEEEE-----CCEEEEEEEEEc
Confidence 4688999999876555 89999999998 456778888876 357888888763
|
| >2eo6_A B-cell linker protein; SH2, cytoplasmic adapter protein, B-cell adapter containing SH2 domain protein; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=85.56 E-value=0.11 Score=49.13 Aligned_cols=54 Identities=11% Similarity=-0.007 Sum_probs=40.8
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
.+.|+|.++++.|++. +.+|+|++|.|+++ ..++.|.+|+.. +++.+|+.+.+.
T Consensus 27 hG~isR~eAe~lL~~~-~~~G~FLVR~S~~~--~~~g~y~LSv~~-----~~~v~H~~I~~~ 80 (141)
T 2eo6_A 27 AGACDRKSAEEALHRS-NKDGSFLIRKSSGH--DSKQPYTLVAFF-----NKRVYNIPVRFI 80 (141)
T ss_dssp EESCCHHHHHHHHHHH-CCTTCBCEEECSTT--CSSCSEEEEEEE-----TTEEEEEEECEE
T ss_pred ecCCCHHHHHHHhhcc-CCCceEEEEECCCC--CCCCCEEEEEEE-----CCEEEEEEEEEe
Confidence 3568999999987654 46999999999831 146778888876 457888887753
|
| >2eo3_A CRK-like protein; phosphorylation, repeat, SH2 domain, SH3 domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.45 E-value=0.091 Score=47.61 Aligned_cols=50 Identities=12% Similarity=0.127 Sum_probs=40.3
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCcccccccc
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 461 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r 461 (785)
.+.|+|.++++.|. ++.+|+|++|.|+ ...+.+.+|+.. +++.+|+.+.+
T Consensus 23 hg~isR~~Ae~lL~--~~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~ 72 (111)
T 2eo3_A 23 MGPVSRQEAQTRLQ--GQRHGMFLVRDSS----TCPGDYVLSVSE-----NSRVSHYIINS 72 (111)
T ss_dssp EESCCHHHHHHHHS--SCCTTCEEEEECS----SSSSCEEEEEEE-----TTEEEEEEEEE
T ss_pred cCCCCHHHHHHHhc--CCCCceEEEEeec----CCCCCEEEEEEe-----CCeEEEEEEEE
Confidence 35789999999885 7899999999998 445678888875 46788888776
|
| >3us4_A Megakaryocyte-associated tyrosine-protein kinase; SH2 domain, signaling protein, structural genomics, joint CE structural genomics, JCSG; 1.50A {Homo sapiens} SCOP: d.93.1.1 PDB: 1jwo_A | Back alignment and structure |
|---|
Probab=85.25 E-value=0.093 Score=46.18 Aligned_cols=50 Identities=12% Similarity=0.072 Sum_probs=39.4
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.++++.|. +..+|+|++|.|+ +..+.+.+|+.. +++.+|+.+.+.
T Consensus 10 g~isr~~Ae~lL~--~~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 59 (98)
T 3us4_A 10 GKISGQEAVQQLQ--PPEDGLFLVRESA----RHPGDYVLCVSF-----GRDVIHYRVLHR 59 (98)
T ss_dssp CSCCHHHHHHHTC--SCCTTCEEEEECS----SSTTCEEEEEEE-----TTEEEEEEEEEE
T ss_pred CCCCHHHHHHHcc--CCCCcEEEEEeCC----CCCCcEEEEEEE-----CCceEEEEEEEe
Confidence 4688999999886 3589999999997 556677888776 567888887764
|
| >2dm0_A Tyrosine-protein kinase TXK; TEC family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.25 E-value=0.1 Score=48.27 Aligned_cols=56 Identities=11% Similarity=0.150 Sum_probs=43.0
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCC-cccCCCccccccccc
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHD-EISGGRSALYNLSRD 462 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d-~~~~~rs~~~~l~r~ 462 (785)
.+.|+|.++++.|...+ .+|+|++|.|+ .++.|.+|+...+ ...+++.+|+.+.+.
T Consensus 20 hG~isR~eAe~lL~~~~-~~G~FLVR~S~-----~~g~y~LSv~~~~~~~~~~~v~H~~I~~~ 76 (125)
T 2dm0_A 20 HRNITRNQAEHLLRQES-KEGAFIVRDSR-----HLGSYTISVFMGARRSTEAAIKHYQIKKN 76 (125)
T ss_dssp CCSCCHHHHHHHHHHHC-STTCBCEEEET-----TEEEEEEEEECCCSSSSSCCEEEEEEEEC
T ss_pred cCCCCHHHHHHHHhhcC-CCCEEEEEecC-----CCCCEEEEEEeccccCCCCcEEEEEEEEc
Confidence 35689999999776665 88999999994 2677888888754 334678899988764
|
| >1ju5_A CRK; CRK, SH2, SH3, adaptor protein, phosphopeptide, protein binding/transferase complex; HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=84.50 E-value=0.13 Score=46.38 Aligned_cols=50 Identities=8% Similarity=0.070 Sum_probs=39.3
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.+++..|. ++.+|+|++|.|+ +..+.+.+|+.. +++.+|+.+.+.
T Consensus 5 g~isr~~Ae~lL~--~~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 54 (109)
T 1ju5_A 5 GRLSRQEAVALLQ--GQRHGVFLVRDSS----TSPGDYVLSVSE-----NSRVSHYIINSS 54 (109)
T ss_dssp TTCCHHHHHHHHT--TCCTTEEEEEECS----SSTTEEEEEEEC-----SSCEEEEEEECC
T ss_pred cCCCHHHHHHHhc--CCCCCEEEEEecC----CCCCCEEEEEEE-----CCeEEEEEEEEC
Confidence 4689999999875 5789999999998 446678888876 456788877654
|
| >3qwx_X Cell death abnormality protein 2; cell engulfment, signaling protein; 2.01A {Caenorhabditis elegans} | Back alignment and structure |
|---|
Probab=84.17 E-value=0.15 Score=49.49 Aligned_cols=53 Identities=13% Similarity=0.129 Sum_probs=41.9
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCcccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 461 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r 461 (785)
+.|+|.++++.|+..++.+|+|++|.| +.++.|.+|+...+ .++..+|+.+.+
T Consensus 17 g~isR~~Ae~lL~~~~~~~G~FLVR~S-----~~~g~y~LSv~~~~--~~~~v~H~~I~~ 69 (174)
T 3qwx_X 17 PGMSREEAHKLLGEPQVSIGTFLMRDS-----SRPGEYSLTVREAD--EGNAVCHYLIER 69 (174)
T ss_dssp TTCCHHHHHHHHHSTTCCTTEEEEEEC-----SSTTCEEEEEECCS--SSSCEEEEEEEE
T ss_pred CCCCHHHHHHHHhccCCCCCeEEEEec-----CCCCCEEEEEEECC--CCCceEEEEEEe
Confidence 578999999999999999999999998 34667888887722 133488888765
|
| >2oq1_A Tyrosine-protein kinase ZAP-70; tandem SH2 domains, ZAP-70, tyrosine kinase, transferase; HET: PTR; 1.90A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1m61_A | Back alignment and structure |
|---|
Probab=83.60 E-value=0.15 Score=52.86 Aligned_cols=51 Identities=12% Similarity=0.018 Sum_probs=43.6
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCcccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 461 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r 461 (785)
+.|+|.++++.|+..+..+|+|++|.|+ +.++.|.+|+.. +++.+|+.+.+
T Consensus 11 g~isR~~Ae~lL~~~~~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~ 61 (254)
T 2oq1_A 11 GSISRAEAEEHLKLAGMADGLFLLRQCL----RSLGGYVLSLVH-----DVRFHHFPIER 61 (254)
T ss_dssp BSCCHHHHHHHHHHTTCCTTCEEEEECS----SSTTCEEEEEEE-----TTEEEEEEEEE
T ss_pred CCCCHHHHHHHHhccCCCCcEEEEEeCC----CCCCCEEEEEEE-----CCeEEEEEEEE
Confidence 4689999999999999999999999998 456778888875 56788888876
|
| >2bbu_A Suppressor of cytokine signaling 3; SH2 domain, extended SH2 subdomain, PEST motif, protein complex, cytokine regulator; HET: PTR; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=83.23 E-value=0.3 Score=47.61 Aligned_cols=49 Identities=8% Similarity=-0.021 Sum_probs=39.9
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCcccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 461 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r 461 (785)
+.|+|.++++.|.. +.+|+|++|.|+ +..+.+.+|+.. +++.+|+.+.+
T Consensus 28 G~IsR~eAe~lL~~--~~~GtFLVR~S~----s~~g~y~LSvr~-----~~~v~H~rI~~ 76 (164)
T 2bbu_A 28 SAVTGGEANLLLSA--EPAGTFLIRDSS----DQRHFFTLSVKT-----QSGTKNLRIQC 76 (164)
T ss_dssp TTSCHHHHHHHHHH--SSTTCCEEEECS----TTSCCEEEEECC-----TTCCEEEECEE
T ss_pred CCCCHHHHHHHhcC--CCCCCEEEEECC----CCCCCEEEEEEE-----CCceEEEEEEe
Confidence 56789999998743 889999999998 456788888876 56788888875
|
| >1a81_A SYK kinase; complex (transferase-peptide), SYK, kinase, SH2 domain; HET: PTR; 3.00A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=82.89 E-value=0.14 Score=52.91 Aligned_cols=51 Identities=12% Similarity=0.159 Sum_probs=43.5
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCcccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 461 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r 461 (785)
+.|+|.++++.|+..++.+|+|++|.|+ +..+.+.+|+.. +++.+|+.+.+
T Consensus 10 g~isR~~Ae~lL~~~g~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~ 60 (254)
T 1a81_A 10 GNITREEAEDYLVQGGMSDGLYLLRQSR----NYLGGFALSVAH-----GRKAHHYTIER 60 (254)
T ss_dssp SSCCHHHHHHHHHHTTCCTTEEEEEECS----SSTTCEEEEEEE-----TTEEEEEEEEE
T ss_pred CCCCHHHHHHHHhcCCCCCcEEEEEecC----CCCCCEEEEEEE-----CCeeEEEEEEE
Confidence 4689999999999999999999999998 556778888875 56788888876
|
| >3k2m_A Proto-oncogene tyrosine-protein kinase ABL1; engineered binding protein, antibody mimic, protein-protein SH2 domain, ATP-binding, phosphoprotein; 1.75A {Homo sapiens} PDB: 3uyo_A 3t04_A 1ab2_A | Back alignment and structure |
|---|
Probab=82.06 E-value=0.13 Score=46.46 Aligned_cols=50 Identities=14% Similarity=0.208 Sum_probs=39.0
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.++++.|. ++.+|+|++|.|+ +..+.+.+|+.. +++.+|+.+.+.
T Consensus 10 g~isR~~Ae~lL~--~~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 59 (112)
T 3k2m_A 10 GPVSRNAAEYLLS--SGINGSFLVRESE----SSPGQRSISLRY-----EGRVYHYRINTA 59 (112)
T ss_dssp ESCCHHHHHHHTT--TCCTTEEEEEECS----SSTTCEEEEEEE-----TTEEEEEEEEEC
T ss_pred eCCCHHHHHHHhc--cCCCceEEEEeCC----CCCCCEEEEEEe-----CCcEEEEEEEEC
Confidence 4688999998664 4689999999998 456778888776 467888888764
|
| >2dvj_A V-CRK sarcoma virus CT10 oncogene homolog, isoform A; SH3, SH2, signal transduction, adapter molecule, signaling protein; HET: PTR; NMR {Homo sapiens} PDB: 2eyy_A 2eyv_A 2eyw_A | Back alignment and structure |
|---|
Probab=81.87 E-value=0.35 Score=49.18 Aligned_cols=50 Identities=8% Similarity=0.070 Sum_probs=40.3
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.++++.|. ++.+|+|++|.|+ +..+.|.+|+.. +++.+|+.+.+.
T Consensus 18 G~isR~eAe~lL~--~~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 67 (230)
T 2dvj_A 18 GRLSRQEAVALLQ--GQRHGVFLVRDSS----TSPGDYVLSVSE-----NSRVSHYIINSS 67 (230)
T ss_dssp SSCCTTHHHHHHT--TSSSSCBEEECCS----SCTTSCEEECCC-----SSSCCCEECBCC
T ss_pred CCCCHHHHHHHhc--CCCCceEEEEeCC----CCCCCEEEEEEE-----CCEEEEEEEEeC
Confidence 5688999999885 4789999999998 556788888887 467888887764
|
| >2lnw_A VAV-2, guanine nucleotide exchange factor VAV2; signaling protein; HET: PTR; NMR {Homo sapiens} PDB: 2lnx_A | Back alignment and structure |
|---|
Probab=81.68 E-value=0.16 Score=46.86 Aligned_cols=51 Identities=6% Similarity=0.012 Sum_probs=40.9
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
.+.|+|.+|++.|.. +.+|+|++|.|+ +..+.|.+|+.. +++.+++.+.+.
T Consensus 26 hG~isR~eAe~lL~~--~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 76 (122)
T 2lnw_A 26 AGNMERQQTDNLLKS--HASGTYLIRERP----AEAERFAISIKF-----NDEVKHIKVVEK 76 (122)
T ss_dssp CCSCCHHHHHHHHHH--SCTTBEEEEECC----CSSEEEEEEEEC-----SSCEEEEEEEEE
T ss_pred CcCCCHHHHHHHhcC--CCCCeEEEEeCC----CCCCcEEEEEEe-----CCcEEEEEEEEc
Confidence 467899999998876 579999999997 556778888877 467888887754
|
| >2f4m_A Peptide N-glycanase; glycoproteins, ubiquitin-dependent protein degradation, NUCL excision repair, peptide:N-glycanase; 1.85A {Mus musculus} SCOP: d.3.1.4 PDB: 2f4o_A* | Back alignment and structure |
|---|
Probab=81.60 E-value=1 Score=47.85 Aligned_cols=49 Identities=27% Similarity=0.329 Sum_probs=37.8
Q ss_pred cccccccchhhHHHHHHhhhcCCCceec-ccCCCCcccccccccceeEEeecCc--eeeeeec
Q 003935 186 QIRHGSCRPRAILFKVLADTVGLESRLM-GLPNDGTMECVDSYKHMSVIVVLNS--VELLVDL 245 (785)
Q Consensus 186 ~i~~g~~r~ra~lfkvlad~~~l~~~~~-g~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 245 (785)
.-+.|.|++-|.||-+|+-.+|+|+|+| |+ ..|.=+-|-++. .=+-||-
T Consensus 137 ~~r~G~C~d~A~lf~al~Ra~GIpAR~V~Gy-----------~~HaW~Evy~~g~~gWv~~Dp 188 (295)
T 2f4m_A 137 ETRCGRCGEWANCFTLCCRALGFEARYVWDY-----------TDHVWTEVYSPSQQRWLHCDA 188 (295)
T ss_dssp HHCEESHHHHHHHHHHHHHHTTCCEEEEEET-----------TTEEEEEEEETTTTEEEEEET
T ss_pred HcCCEeeHHHHHHHHHHHHHCCCCEEEEcCC-----------CCEEEEEEEECCCCeEEEEeC
Confidence 4589999999999999999999999999 98 456655555544 3344443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.54 E-value=0.17 Score=58.64 Aligned_cols=52 Identities=12% Similarity=0.024 Sum_probs=44.7
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.+|++.|+..++.||+|++|.|+ +.++.|.+|+.. +++.+|+.+.+.
T Consensus 13 g~i~r~~ae~~L~~~~~~~G~fLvR~s~----~~~g~~~ls~~~-----~~~~~h~~i~~~ 64 (613)
T 2ozo_A 13 GSISRAEAEEHLKLAGMADGLFLLRQCL----RSLGGYVLSLVH-----DVRFHHFPIERQ 64 (613)
T ss_dssp BSCCHHHHHHHHHTTTCCTTEEEEEECT----TBTTCEEEEEEE-----TTEEEEEEEEEC
T ss_pred ccCCHHHHHHHHhccCCCCCeEEEEecC----CCCCCEEEEEEE-----CCeEEEEEEEEC
Confidence 5789999999999999999999999998 678889998876 557888887753
|
| >3eaz_A Tyrosine-protein kinase CSK; SH2, disulfide, oxidized reduced, ATP-binding, cell membrane, cytoplasm, membrane, nucleotide-binding, phosphoprotein; 1.31A {Homo sapiens} PDB: 3eac_A | Back alignment and structure |
|---|
Probab=81.54 E-value=0.15 Score=45.62 Aligned_cols=50 Identities=10% Similarity=0.116 Sum_probs=39.3
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.++++.|. +..+|+|++|.|+ +.++.+.+|+.. +++.+|+.+.+.
T Consensus 13 g~isr~~Ae~lL~--~~~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~~ 62 (106)
T 3eaz_A 13 GKITREQAERLLY--PPETGLFLVREST----NYPGDYTLCVSS-----DGKVEHYRIMYH 62 (106)
T ss_dssp CSCCHHHHHHHTC--SCCTTEEEEEECT----TSTTCEEEEEEE-----TTEEEEEECEEE
T ss_pred CCCCHHHHHHHhC--CCCCCEEEEEECC----CCCCcEEEEEEe-----CCceEEEEEEec
Confidence 4688999998886 3589999999998 556777888865 567888887753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=81.54 E-value=0.18 Score=58.66 Aligned_cols=53 Identities=11% Similarity=0.171 Sum_probs=45.4
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
++.|+|.+||+.|+..++.+|+|++|.|+ +..+.|.+|+.. +++.+|+.+.+.
T Consensus 17 ~g~isr~~Ae~~L~~~~~~~G~FLvR~S~----~~~g~y~lsv~~-----~~~v~h~~i~~~ 69 (635)
T 4fl3_A 17 FGNITREEAEDYLVQGGMSDGLYLLRQSR----NYLGGFALSVAH-----GRKAHHYTIERE 69 (635)
T ss_dssp CBSCCHHHHHHHHHHTTCCTTEEEEEECT----TSSSCEEEEEEE-----TTEEEEEEEEEC
T ss_pred CCCCCHHHHHHHHhcCCCCCceEEEeecc----cCCCCEEEEEEe-----CCEEEeEEEEEc
Confidence 45789999999999999999999999998 778889998877 567888888654
|
| >2cs0_A Hematopoietic SH2 domain containing; ALX, FLJ14886, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=81.40 E-value=0.29 Score=44.79 Aligned_cols=50 Identities=8% Similarity=-0.029 Sum_probs=39.0
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
.+.|+|.++++.|. ++.+|+|++|.|++ ..+ +.+|+.. .++.+|+.+.+.
T Consensus 20 hG~isR~~Ae~lL~--~~~~G~FLVR~S~~----~~~-y~LSv~~-----~~~v~H~~I~~~ 69 (119)
T 2cs0_A 20 HGAISREDAENLLE--SQPLGSFLIRVSHS----HVG-YTLSYKA-----QSSCCHFMVKLL 69 (119)
T ss_dssp CSSCCHHHHHHHHH--TSCTTCEEEEECSS----SSS-EEEEECC-----SSSCEEEEEEEC
T ss_pred ccCCCHHHHHHHhc--CCCCCEEEEEecCC----CCC-EEEEEEE-----CCEEEEEEEEEc
Confidence 35688999999884 67899999999983 344 8888876 357888887764
|
| >2dlz_A Protein VAV-2; RHO family guanine nucleotide exchange factor, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.17 E-value=0.23 Score=45.51 Aligned_cols=51 Identities=6% Similarity=0.024 Sum_probs=41.0
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
.+.|+|.++++.|... .+|+|++|.|+ +.++.+.+|+.. +++.+|+.+.+.
T Consensus 20 hG~isR~~Ae~lL~~~--~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 70 (118)
T 2dlz_A 20 AGNMERQQTDNLLKSH--ASGTYLIRERP----AEAERFAISIKF-----NDEVKHIKVVEK 70 (118)
T ss_dssp EESCCHHHHHHHHHHS--CTTBEEEECCS----CSSCCEEEEEEC-----SSSEEEEEEEEE
T ss_pred ecCCCHHHHHHHhcCC--CCCEEEEEeCC----CCCCCEEEEEEE-----CCcEEEEEEEEc
Confidence 3578999999998763 89999999998 456778888886 467888888764
|
| >2c9w_A Suppressor of cytokine signaling 2; growth regulation, SH2 domain, signal transduction inhibitor nuclear protein; 1.9A {Homo sapiens} SCOP: a.271.1.1 d.93.1.1 | Back alignment and structure |
|---|
Probab=80.37 E-value=0.25 Score=48.11 Aligned_cols=50 Identities=8% Similarity=0.093 Sum_probs=39.8
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.+|++.|. ++.+|+|++|.|+ ..++.+.+|+.. +++.+|+.+.+.
T Consensus 22 G~isR~eAe~lL~--~~~~G~FLVR~S~----~~~~~~~LSv~~-----~~~v~H~rI~~~ 71 (169)
T 2c9w_A 22 GSMTVNEAKEKLK--EAPEGTFLIRDSS----HSDYLLTISVKT-----SAGPTNLRIEYQ 71 (169)
T ss_dssp TTCCHHHHHHHHT--TSCTTCEEEEECC----STTCSEEEEEEE-----TTEEEEEEEEEE
T ss_pred cCCCHHHHHHHcC--CCCCcEEEEecCC----CCCCeEEEEEEE-----CCeeEEEEEEEe
Confidence 5689999999884 5899999999998 457778888876 356788887764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 785 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-78 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-72 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-71 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-70 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-68 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-68 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-66 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-66 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-66 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-65 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-65 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-64 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-63 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-63 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-63 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-62 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-62 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-61 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-60 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-59 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-59 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-58 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-57 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-56 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-55 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-55 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-53 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-52 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-51 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-51 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-48 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-47 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-44 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-42 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-41 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-37 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-36 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-20 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 251 bits (641), Expect = 4e-78
Identities = 84/271 (30%), Positives = 148/271 (54%), Gaps = 17/271 (6%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILS 579
++W I ++TVG R+G G FG V++G W+G DVA+K+ T + ++ F NE+ +L
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 580 RLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 639
+ RH N++LF+G T P L+++T++ E SLYH +H + K + + + R +G
Sbjct: 60 KTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQG 116
Query: 640 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS--AGTPEWMAPE 697
+ +H I+HRDLKS N +++ TVKI DFGL+ + + +G+ WMAPE
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
Query: 698 LIRNE---PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-- 752
+IR + P++ + D+++ G++++EL T P+ + + + G
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236
Query: 753 -----LGRLIADCWA-EPQERPSCEEILSRL 777
+ RL+A+C + ERP +IL+ +
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (599), Expect = 3e-72
Identities = 73/261 (27%), Positives = 130/261 (49%), Gaps = 13/261 (4%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 581
W ++ EL + +G G FG+V G + G VA+K + F E S++++L
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQL 57
Query: 582 RHPNVILFLGACTKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
RH N++ LG + L ++TEYM GSL + G + L LK D+C +
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAM 116
Query: 641 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 700
+ VHRDL + N LV++ K+ DFGL++ + + + +W APE +R
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALR 173
Query: 701 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 757
+ F+ K D++S G+++WE+ + R +P + V +G +++ P+G + ++
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 233
Query: 758 ADCWA-EPQERPSCEEILSRL 777
+CW + RPS ++ +L
Sbjct: 234 KNCWHLDAAMRPSFLQLREQL 254
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 9e-71
Identities = 82/264 (31%), Positives = 131/264 (49%), Gaps = 11/264 (4%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISIL 578
+EW + L + R+G G FGEV+ G +N T VA+K + + + F E +++
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLM 62
Query: 579 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 638
+L+H ++ T+ P +ITEYME GSL + KL+ + L M I
Sbjct: 63 KQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAE 120
Query: 639 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS-PMRDSSSAGTPEWMAPE 697
G+ I +HRDL++AN LV+ + KI DFGL+R+I D+ + +W APE
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 698 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLG 754
I FT K D++S G+++ E+ T R + V G R+ P+ L
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY 240
Query: 755 RLIADCWA-EPQERPSCEEILSRL 777
+L+ CW P++RP+ + + S L
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (586), Expect = 2e-70
Identities = 84/263 (31%), Positives = 133/263 (50%), Gaps = 13/263 (4%)
Query: 524 IDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR 582
ID +LT +G G FG V G W DVAIK+ + + ++F E ++ L
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLS 57
Query: 583 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
H ++ G CTK + +ITEYM G L + +L + + ++ L+M +D+C +
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCEAMEY 115
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-AGTPEWMAPELIRN 701
+ + +HRDL + NCLVN VK+ DFGLSR + D S W PE++
Sbjct: 116 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 702 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 757
F+ K DI++ GV+MWE+ +L + P+E +A +G RL P + ++
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIM 234
Query: 758 ADCWA-EPQERPSCEEILSRLLD 779
CW + ERP+ + +LS +LD
Sbjct: 235 YSCWHEKADERPTFKILLSNILD 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 2e-68
Identities = 87/267 (32%), Positives = 128/267 (47%), Gaps = 11/267 (4%)
Query: 517 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-VAIKVFLEQDLTAENMEDFCNEI 575
LA + W I L + ++G G FGEV+ G WNGT VAIK + E F E
Sbjct: 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEA 63
Query: 576 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 635
++ +LRH ++ ++ P ++TEYM GSL + K + + M
Sbjct: 64 QVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQ 121
Query: 636 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-AGTPEWM 694
I G+ + RM VHRDL++AN LV ++ K+ DFGL+R+I D+ +W
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 181
Query: 695 APELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG--- 751
APE FT K D++S G+++ EL T R + R V G R+ P
Sbjct: 182 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 241
Query: 752 PLGRLIADCWA-EPQERPSCEEILSRL 777
L L+ CW EP+ERP+ E + + L
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 224 bits (572), Expect = 4e-68
Identities = 80/266 (30%), Positives = 139/266 (52%), Gaps = 11/266 (4%)
Query: 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEIS 576
Y++W ++ +++T+ ++G G +GEV+ G+W VA+K +E+F E +
Sbjct: 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAA 65
Query: 577 ILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 636
++ ++HPN++ LG CT+ P +ITE+M G+L + ++++S L M I
Sbjct: 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQI 124
Query: 637 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA-GTPEWMA 695
+ + + +HRDL + NCLV ++ VK+ DFGLSR++T + A +W A
Sbjct: 125 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 696 PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---P 752
PE + F+ K D+++ GV++WE+ T + VY + + R+E PEG
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 244
Query: 753 LGRLIADCWA-EPQERPSCEEILSRL 777
+ L+ CW P +RPS EI
Sbjct: 245 VYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 4e-68
Identities = 77/260 (29%), Positives = 127/260 (48%), Gaps = 11/260 (4%)
Query: 524 IDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR 582
ID SELT +G G FG V G W N VAIK A + EDF E ++ +L
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLS 58
Query: 583 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
HP ++ G C + + ++ E+ME G L + Q+ + L M D+C G+
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAY 116
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-AGTPEWMAPELIRN 701
+ ++HRDL + NCLV ++ +K+ DFG++R + D S+ +W +PE+
Sbjct: 117 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 702 EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIA 758
++ K D++S GV+MWE+ + + V + G RL P + +++
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 236
Query: 759 DCWA-EPQERPSCEEILSRL 777
CW P++RP+ +L +L
Sbjct: 237 HCWKERPEDRPAFSRLLRQL 256
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 3e-66
Identities = 77/297 (25%), Positives = 135/297 (45%), Gaps = 37/297 (12%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFC 572
+W L G +G G FG+V G VA+K+ L++ + E
Sbjct: 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM-LKEKADSSEREALM 88
Query: 573 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK---------- 621
+E+ ++++L H N++ LGACT + +I EY G L + + +K
Sbjct: 89 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148
Query: 622 ----------KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 671
L++ L + +G+ + VHRDL + N LV VKICDF
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 208
Query: 672 GLSRIIT--DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWE 728
GL+R I + + ++ +WMAPE + +T K D++S G+++WE+ +L P+
Sbjct: 209 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268
Query: 729 GVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDCE 781
G+ + Y + G +++ P + ++ CWA + ++RPS + S L C+
Sbjct: 269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF-LGCQ 324
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 4e-66
Identities = 70/266 (26%), Positives = 124/266 (46%), Gaps = 17/266 (6%)
Query: 523 NIDFSEL-TVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILS 579
+++ + + +G G FG+V++ T A KV + E +ED+ EI IL+
Sbjct: 7 DLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILA 64
Query: 580 RLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 639
HPN++ L A L ++ E+ G++ ++ ++ L+ + + +
Sbjct: 65 SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML--ELERPLTESQIQVVCKQTLDA 122
Query: 640 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 699
L +H KI+HRDLK+ N L +K+ DFG+S T + R S GTP WMAPE++
Sbjct: 123 LNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 182
Query: 700 -----RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIPEG-- 751
++ P+ K D++SLG+ + E+ + P + P RV+ +A +E L P
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 242
Query: 752 -PLGRLIADCWA-EPQERPSCEEILS 775
+ C R + ++L
Sbjct: 243 SNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (555), Expect = 8e-66
Identities = 70/261 (26%), Positives = 119/261 (45%), Gaps = 15/261 (5%)
Query: 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN 585
+ V +G G +G + +G + K +T + +E+++L L+HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 586 VILFLGACTKPP--RLSMITEYMELGSLYHLIHLSGQKKK-LSWRRKLKMLRDICRGLMC 642
++ + L ++ EY E G L +I ++++ L L+++ + L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 643 IHR-----MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 697
HR ++HRDLK AN ++ VK+ DFGL+RI+ + GTP +M+PE
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE 184
Query: 698 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLG 754
+ + EK DI+SLG +++ELC L P+ + + + G IP L
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSDELN 243
Query: 755 RLIADCWA-EPQERPSCEEIL 774
+I + RPS EEIL
Sbjct: 244 EIITRMLNLKDYHRPSVEEIL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 2e-65
Identities = 67/262 (25%), Positives = 115/262 (43%), Gaps = 16/262 (6%)
Query: 521 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENM-EDFCNEISI 577
+W ++ + +G +G G FG V+ + +A+KV + L + E+ I
Sbjct: 2 QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 59
Query: 578 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
S LRHPN++ G R+ +I EY LG++Y + + K +R + ++
Sbjct: 60 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELA 116
Query: 638 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 697
L H +++HRD+K N L+ +KI DFG S S + GT +++ PE
Sbjct: 117 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPE 174
Query: 698 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLG 754
+I EK D++SLGV+ +E P+E + ++ P+
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDFVTEGAR 232
Query: 755 RLIADCWA-EPQERPSCEEILS 775
LI+ P +RP E+L
Sbjct: 233 DLISRLLKHNPSQRPMLREVLE 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 2e-65
Identities = 77/272 (28%), Positives = 126/272 (46%), Gaps = 17/272 (6%)
Query: 524 IDFSELTVGTRVGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLT-AENMEDFCNEISI 577
I +L + ++G G FG V RG W+ VA+K L+ E M+DF E++
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 578 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
+ L H N+I G PP + M+TE LGSL + + + +
Sbjct: 65 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLR--KHQGHFLLGTLSRYAVQVA 121
Query: 638 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT---DSPMRDSSSAGTPEWM 694
G+ + + +HRDL + N L+ VKI DFGL R + D + W
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 695 APELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG-- 751
APE ++ F+ D + GV +WE+ T + PW G+ ++++ + EG RL PE
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241
Query: 752 -PLGRLIADCWA-EPQERPSCEEILSRLLDCE 781
+ ++ CWA +P++RP+ + LL+ +
Sbjct: 242 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 7e-65
Identities = 66/267 (24%), Positives = 119/267 (44%), Gaps = 18/267 (6%)
Query: 524 IDFSELTVGTRV-GIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISIL 578
+D LT+ + G G FG V +G + VA+K+ + ++ E +++
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 579 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 638
+L +P ++ +G C + ++ E ELG L + Q + + + ++++ +
Sbjct: 63 QQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSM 118
Query: 639 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS---AGTPEWMA 695
G+ + VHRDL + N L+ KI DFGLS+ + + +W A
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 696 PELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG--- 751
PE I F+ K D++S GV+MWE + + P+ G+ V + G R+ P G
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPR 237
Query: 752 PLGRLIADCWA-EPQERPSCEEILSRL 777
+ L+ CW + + RP + RL
Sbjct: 238 EMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 215 bits (548), Expect = 2e-64
Identities = 88/271 (32%), Positives = 132/271 (48%), Gaps = 19/271 (7%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLTAENMEDFCNEIS 576
ID S + + +G G FGEV G VAIK L+ T + DF +E S
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKT-LKSGYTEKQRRDFLSEAS 79
Query: 577 ILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 636
I+ + HPNVI G TK + +ITE+ME GSL + + + + + MLR I
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR--QNDGQFTVIQLVGMLRGI 137
Query: 637 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA-----GTP 691
G+ + M VHRDL + N LVN + K+ DFGLSR + D + ++
Sbjct: 138 AAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 692 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE 750
W APE I+ FT D++S G++MWE+ + P+ + + V+ A+ + RL P
Sbjct: 198 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPM 256
Query: 751 G---PLGRLIADCWA-EPQERPSCEEILSRL 777
L +L+ DCW + RP +I++ L
Sbjct: 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 3e-64
Identities = 74/278 (26%), Positives = 132/278 (47%), Gaps = 18/278 (6%)
Query: 520 EEWNIDFSELTVG-TRVGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNE 574
++ + L + +G G FG V +G++ DVAIKV L+Q + E+ E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMRE 59
Query: 575 ISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 634
I+ +L +P ++ +G C + ++ E G L+ + G+++++ ++L
Sbjct: 60 AQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLV--GKREEIPVSNVAELLH 116
Query: 635 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS---PMRDSSSAGTP 691
+ G+ + VHRDL + N L+ KI DFGLS+ + S+
Sbjct: 117 QVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 692 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE 750
+W APE I F+ + D++S GV MWE + + P++ + V+ + +G R+E P
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMECPP 235
Query: 751 G---PLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 784
L L++DCW + ++RP + R+ C YSL
Sbjct: 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 4e-63
Identities = 76/267 (28%), Positives = 119/267 (44%), Gaps = 14/267 (5%)
Query: 521 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLTAENMEDFCNEI 575
++ I + +G +G G FG+V +GI+ + VAIK + + E F E
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEA 59
Query: 576 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 635
+ + HP+++ +G T+ P +I E LG L + +K L +
Sbjct: 60 LTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQ 116
Query: 636 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-AGTPEWM 694
+ L + + VHRD+ + N LV+ + VK+ DFGLSR + DS +S +WM
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 176
Query: 695 APELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG--- 751
APE I FT D++ GV MWE+ + V G RL +P
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 236
Query: 752 PLGRLIADCWA-EPQERPSCEEILSRL 777
L L+ CWA +P RP E+ ++L
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELKAQL 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 211 bits (538), Expect = 6e-63
Identities = 74/272 (27%), Positives = 116/272 (42%), Gaps = 18/272 (6%)
Query: 515 PLLAYEEWNIDFSEL-TVGTRVGIGFFGEVFRGIW--NGTDVAIKVF-LEQDLTAENMED 570
P +A + D +L + +G G FG V+ N VAIK + E +D
Sbjct: 2 PDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 571 FCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL 630
E+ L +LRHPN I + G + ++ EY + L KK L
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIA 118
Query: 631 KMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGT 690
+ +GL +H ++HRD+K+ N L+++ VK+ DFG + I+ + +S GT
Sbjct: 119 AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGT 174
Query: 691 PEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE 747
P WMAPE+I + K D++SLG+ EL P + +Y +A S
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234
Query: 748 IPEG---PLGRLIADCWA-EPQERPSCEEILS 775
+ C PQ+RP+ E +L
Sbjct: 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 8e-63
Identities = 88/269 (32%), Positives = 129/269 (47%), Gaps = 16/269 (5%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTD------VAIKVFLEQDLTAENMEDFCNEI 575
I S +T +G G FGEV++G+ + VAIK L+ T + DF E
Sbjct: 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT-LKAGYTEKQRVDFLGEA 60
Query: 576 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 635
I+ + H N+I G +K + +ITEYME G+L + + + S + + MLR
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR--EKDGEFSVLQLVGMLRG 118
Query: 636 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA---GTPE 692
I G+ + M VHRDL + N LVN + K+ DFGLSR++ D P +++
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 693 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG- 751
W APE I FT D++S G++MWE+ T L V N+G RL P
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC 238
Query: 752 --PLGRLIADCWA-EPQERPSCEEILSRL 777
+ +L+ CW E RP +I+S L
Sbjct: 239 PSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 1e-62
Identities = 70/253 (27%), Positives = 125/253 (49%), Gaps = 13/253 (5%)
Query: 530 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
T ++G G G V+ + G +VAI+ Q + E NEI ++ ++PN++
Sbjct: 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMRENKNPNIV 80
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
+L + L ++ EY+ GSL ++ + + + + R+ + L +H +
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 648 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 707
++HRD+KS N L+ +VK+ DFG IT + S+ GTP WMAPE++ + + K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 708 CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIADCWA- 762
DI+SLG++ E+ P+ P R +Y +A G+ L+ PE + C
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256
Query: 763 EPQERPSCEEILS 775
+ ++R S +E+L
Sbjct: 257 DVEKRGSAKELLQ 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 2e-62
Identities = 78/276 (28%), Positives = 131/276 (47%), Gaps = 24/276 (8%)
Query: 524 IDFSELTVGTRVGIGFFGEVFRGIWNGT----DVAIKVFLEQDLTAENMEDFCNEISILS 579
+D++++ +G G FG+V + D AIK +++ + ++ DF E+ +L
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEVLC 65
Query: 580 RL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH-------------LSGQKKKLS 625
+L HPN+I LGAC L + EY G+L + + LS
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 626 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 685
++ L D+ RG+ + + + +HRDL + N LV +++ KI DFGLSR + ++ +
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-EVYVKKT 184
Query: 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 745
WMA E + +T D++S GV++WE+ +L + +Y +G R
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244
Query: 746 LEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 777
LE P + L+ CW +P ERPS +IL L
Sbjct: 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 208 bits (530), Expect = 7e-62
Identities = 85/294 (28%), Positives = 133/294 (45%), Gaps = 37/294 (12%)
Query: 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDF 571
+ + +G G FG VF+ T VA+K+ L+++ +A+ DF
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEEASADMQADF 63
Query: 572 CNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH--------------- 616
E ++++ +PN++ LG C + ++ EYM G L +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 617 ------LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICD 670
S LS +L + R + G+ + K VHRDL + NCLV ++ VKI D
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 183
Query: 671 FGLSRII--TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PW 727
FGLSR I D D + A WM PE I +T + D+++ GV++WE+ + P+
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 728 EGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 777
G+ E V+Y V + G+ L PE L L+ CW+ P +RPS I L
Sbjct: 244 YGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 1e-61
Identities = 83/288 (28%), Positives = 140/288 (48%), Gaps = 23/288 (7%)
Query: 511 FQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDL 563
F + +EW + ++T+ +G G FG V+ G+ T VAIK + +
Sbjct: 4 FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAA 62
Query: 564 TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK-- 621
+ +F NE S++ +V+ LG ++ +I E M G L +
Sbjct: 63 SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 122
Query: 622 -----KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676
S + ++M +I G+ ++ K VHRDL + NC+V + +TVKI DFG++R
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182
Query: 677 ITDSP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPE 733
I ++ + WM+PE +++ FT D++S GV++WE+ TL P++G+ E
Sbjct: 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242
Query: 734 RVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 777
+V+ V EG L+ P+ L L+ CW P+ RPS EI+S +
Sbjct: 243 QVLRFVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 3e-61
Identities = 76/288 (26%), Positives = 125/288 (43%), Gaps = 31/288 (10%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFC 572
+W + L+ G +G G FG+V VA+K+ L+ E
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALM 74
Query: 573 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH--------------- 616
+E+ +LS L H N++ LGACT +ITEY G L + +
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 617 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676
+ + L L + +G+ + +HRDL + N L+ KICDFGL+R
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 677 ITDSPMRDSSS--AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW-EGVLPE 733
I + +WMAPE I N +T + D++S G+ +WEL +L G+ +
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 734 RVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 777
Y + EG R+ PE + ++ CW +P +RP+ ++I+ +
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 3e-61
Identities = 68/266 (25%), Positives = 116/266 (43%), Gaps = 20/266 (7%)
Query: 524 IDFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRL 581
D L +G G F V++G+ T VA ++ LT + F E +L L
Sbjct: 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL 65
Query: 582 RHPNVILFLGACTKPPR----LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
+HPN++ F + + + ++TE M G+L + + K + + R I
Sbjct: 66 QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQIL 122
Query: 638 RGLMCIHRMK--IVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM 694
+GL +H I+HRDLK N + +VKI D GL+ + S + + GTPE+M
Sbjct: 123 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFM 180
Query: 695 APELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-- 752
APE+ + E D+++ G+ M E+ T P+ +Y G + +
Sbjct: 181 APEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239
Query: 753 --LGRLIADCWA-EPQERPSCEEILS 775
+ +I C ER S +++L+
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 4e-61
Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 22/276 (7%)
Query: 516 LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLTAENMED 570
++ + F+E+ +G G FG V+ G D A+K L + +
Sbjct: 21 VIGPSSLIVHFNEV-----IGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ 74
Query: 571 FCNEISILSRLRHPNVILFLGACTKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 629
F E I+ HPNV+ LG C + ++ YM+ G L + I + + +
Sbjct: 75 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDL 132
Query: 630 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM----RDS 685
+ + +G+ + K VHRDL + NC++++ +TVK+ DFGL+R + D +
Sbjct: 133 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 192
Query: 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 745
+ +WMA E ++ + FT K D++S GV++WEL T P + + +G R
Sbjct: 193 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 252
Query: 746 LEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 777
L PE PL ++ CW + + RPS E++SR+
Sbjct: 253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 288
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-60
Identities = 79/286 (27%), Positives = 139/286 (48%), Gaps = 30/286 (10%)
Query: 521 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD---------VAIKVFLEQDLTAENMEDF 571
W + L +G +G G FG+V G D VA+K+ L+ D T +++ D
Sbjct: 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEKDLSDL 65
Query: 572 CNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH-------------L 617
+E+ ++ + +H N+I LGACT+ L +I EY G+L +
Sbjct: 66 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125
Query: 618 SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677
+++LS + + + RG+ + K +HRDL + N LV + +KI DFGL+R I
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 678 TDSPMRDSSSA--GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERV 735
++ +WMAPE + + +T + D++S GV++WE+ TL +P
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
Query: 736 VYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 777
++ + EG R++ P L ++ DCW P +RP+ ++++ L
Sbjct: 246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 7e-60
Identities = 59/256 (23%), Positives = 106/256 (41%), Gaps = 14/256 (5%)
Query: 530 TVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
+ +G G +GEV + T+ VA+K+ ++ + E+ EI I L H NV+
Sbjct: 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
F G + + EY G L+ I + + + G++ +H +
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 648 IVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDSSSAGTPEWMAPELIRNEPF- 704
I HRD+K N L+++ +KI DFGL+ + + + GT ++APEL++ F
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 705 TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLG----RLIADC 760
E D++S G+++ + PW+ Y+ E P + L+
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 243
Query: 761 WA-EPQERPSCEEILS 775
P R + +I
Sbjct: 244 LVENPSARITIPDIKK 259
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-59
Identities = 62/250 (24%), Positives = 116/250 (46%), Gaps = 14/250 (5%)
Query: 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR 582
DF +++ +G G G VF+ +G +A K+ + ++ E+ +L
Sbjct: 7 DFEKISE---LGAGNGGVVFKVSHKPSGLVMARKL-IHLEIKPAIRNQIIRELQVLHECN 62
Query: 583 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
P ++ F GA +S+ E+M+ GSL ++ + ++ + K+ + +GL
Sbjct: 63 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTY 119
Query: 643 IH-RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 701
+ + KI+HRD+K +N LVN +K+CDFG+S + DS +S GT +M+PE ++
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQG 177
Query: 702 EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERV--VYAVANEGSRLEIPEGPLGRLIAD 759
++ + DI+S+G+ + E+ P + + ++ EG E P P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 760 CWAEPQERPS 769
RP
Sbjct: 238 SSYGMDSRPP 247
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-59
Identities = 57/257 (22%), Positives = 105/257 (40%), Gaps = 14/257 (5%)
Query: 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHP 584
+ G +G G F V + AIK+ ++ + EN + E ++SRL HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 585 NVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 644
+ +L Y + G L I + +I L +H
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH 125
Query: 645 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT--DSPMRDSSSAGTPEWMAPELIRNE 702
I+HRDLK N L+N+ ++I DFG +++++ R +S GT ++++PEL+ +
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 703 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIAD 759
+ D+++LG I+++L P+ + + + PE L+
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--EYDFPEKFFPKARDLVEK 243
Query: 760 CWA-EPQERPSCEEILS 775
+ +R CEE+
Sbjct: 244 LLVLDATKRLGCEEMEG 260
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 199 bits (508), Expect = 3e-58
Identities = 61/256 (23%), Positives = 106/256 (41%), Gaps = 15/256 (5%)
Query: 530 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
+ +G G FG V R G + A K + + E EI +S LRHP ++
Sbjct: 29 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLV 86
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
A + MI E+M G L+ + + K+S ++ +R +C+GL +H
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMHENN 144
Query: 648 IVHRDLKSANCLVNKHW--TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT 705
VH DLK N + +K+ DFGL+ + ++ GT E+ APE+ +P
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-GTAEFAAPEVAEGKPVG 203
Query: 706 EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-----LGRLIADC 760
D++S+GV+ + L + P+ G + + V + ++ I
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 263
Query: 761 WA-EPQERPSCEEILS 775
+P R + + L
Sbjct: 264 LLADPNTRMTIHQALE 279
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 8e-58
Identities = 68/265 (25%), Positives = 122/265 (46%), Gaps = 19/265 (7%)
Query: 525 DFSELTVGTRVGIGFFGEVFRGIWNGTD------VAIKVFLEQDLTAENMEDFCNEISIL 578
+F ++ V +G G FG V++G+W VAIK L + + + ++ +E ++
Sbjct: 10 EFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEAYVM 65
Query: 579 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 638
+ + +P+V LG C + +IT+ M G L + K + + L I +
Sbjct: 66 ASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAK 122
Query: 639 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDSSSAGTPEWMAP 696
G+ + ++VHRDL + N LV VKI DFGL++++ + +WMA
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 697 ELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PL 753
E I + +T + D++S GV +WEL T +P + ++ +G RL P +
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 242
Query: 754 GRLIADCWA-EPQERPSCEEILSRL 777
++ CW + RP E++
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 197 bits (502), Expect = 2e-57
Identities = 63/256 (24%), Positives = 107/256 (41%), Gaps = 15/256 (5%)
Query: 530 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
+ +G G FG V R + G K + NEISI+++L HP +I
Sbjct: 32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLI 89
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
A + +I E++ G L+ I + K+S + +R C GL +H
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHS 147
Query: 648 IVHRDLKSANCLV--NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT 705
IVH D+K N + K +VKI DFGL+ + + ++ T E+ APE++ EP
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIVDREPVG 206
Query: 706 EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-----LGRLIADC 760
D++++GV+ + L + P+ G + V + I +
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 266
Query: 761 WA-EPQERPSCEEILS 775
EP++R + + L
Sbjct: 267 LQKEPRKRLTVHDALE 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (493), Expect = 2e-56
Identities = 63/257 (24%), Positives = 116/257 (45%), Gaps = 16/257 (6%)
Query: 530 TVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
+G G F EV T VAIK ++ L + NEI++L +++HPN++
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-GSMENEIAVLHKIKHPNIV 70
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
L +I + + G L+ I +K + R +++ + + +H +
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 648 IVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPF 704
IVHRDLK N L ++ + I DFGLS++ + S++ GTP ++APE++ +P+
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL-STACGTPGYVAPEVLAQKPY 186
Query: 705 TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-----LGRLIAD 759
++ D +S+GVI + L P+ ++ + + P I
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246
Query: 760 CWA-EPQERPSCEEILS 775
+P++R +CE+ L
Sbjct: 247 LMEKDPEKRFTCEQALQ 263
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (487), Expect = 5e-56
Identities = 85/287 (29%), Positives = 137/287 (47%), Gaps = 30/287 (10%)
Query: 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFC 572
+W L +G +G G FG+V G D VA+K+ L++ T
Sbjct: 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSEHRALM 64
Query: 573 NEISILSR-LRHPNVILFLGACTKPP-RLSMITEYMELGSLYHLIHLSGQ---------- 620
+E+ IL H NV+ LGACTKP L +I E+ + G+L +
Sbjct: 65 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124
Query: 621 ---KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677
K L+ + + +G+ + K +HRDL + N L+++ VKICDFGL+R I
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 184
Query: 678 TDSP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPER 734
P +R + +WMAPE I + +T + D++S GV++WE+ +L P+ GV +
Sbjct: 185 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244
Query: 735 VVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 777
EG+R+ P+ + + + DCW EP +RP+ E++ L
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 6e-56
Identities = 71/296 (23%), Positives = 125/296 (42%), Gaps = 53/296 (17%)
Query: 528 ELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
+ + +G G FGEV+RG W G +VA+K+F ++ + E EI LRH N++
Sbjct: 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENIL 60
Query: 588 LFLGACTKP----PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 643
F+ A K +L ++++Y E GSL+ ++ + ++ +K+ GL +
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHL 116
Query: 644 H--------RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP----MRDSSSAGTP 691
H + I HRDLKS N LV K+ T I D GL+ + + + GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 692 EWMAPELIRNE------PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY-------- 737
+MAPE++ + ++ DI+++G++ WE+ ++ Y
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 738 -------AVANEGSRLEIPEGP--------LGRLIADCWA-EPQERPSCEEILSRL 777
V + R IP + +++ +CW R + I L
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 4e-55
Identities = 52/259 (20%), Positives = 105/259 (40%), Gaps = 16/259 (6%)
Query: 526 FSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRH 583
+ + + +G G FG V R + + K + + EISIL+ RH
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVLVKKEISILNIARH 60
Query: 584 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 643
N++ + L MI E++ ++ I+ S +L+ R + + +C L +
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFL 118
Query: 644 HRMKIVHRDLKSANCLV--NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 701
H I H D++ N + + T+KI +FG +R + PE+ APE+ ++
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-RLLFTAPEYYAPEVHQH 177
Query: 702 EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-----LGRL 756
+ + D++SLG +++ L + P+ ++++ + N +
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 757 IADCWA-EPQERPSCEEIL 774
+ E + R + E L
Sbjct: 238 VDRLLVKERKSRMTASEAL 256
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 188 bits (478), Expect = 7e-55
Identities = 63/272 (23%), Positives = 116/272 (42%), Gaps = 26/272 (9%)
Query: 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVF-------LEQDLTAENMEDFCNEIS 576
+ +G G V R I + A+K+ + E E E+
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 577 ILSRLR-HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 635
IL ++ HPN+I ++ + M+ G L+ + +K LS + K++R
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRA 118
Query: 636 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMA 695
+ + +H++ IVHRDLK N L++ +K+ DFG S + GTP ++A
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-REVCGTPSYLA 177
Query: 696 PELIRNEP------FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 749
PE+I + ++ D++S GVIM+ L + P+ ++ + + + P
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 750 EGP-----LGRLIADCWA-EPQERPSCEEILS 775
E + L++ +PQ+R + EE L+
Sbjct: 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-53
Identities = 62/255 (24%), Positives = 111/255 (43%), Gaps = 13/255 (5%)
Query: 528 ELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENMEDFCNEISILSR-LRH 583
+ + +G G FG+VF + T+ AIK + L +++E E +LS H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 584 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 643
P + L + EY+ G L + I K R +I GL +
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFL 119
Query: 644 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP 703
H IV+RDLK N L++K +KI DFG+ + + ++ GTP+++APE++ +
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 704 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADC 760
+ D +S GV+++E+ P+ G E + +++ + P L+
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLVKL 237
Query: 761 WA-EPQERPSCEEIL 774
+ EP++R +
Sbjct: 238 FVREPEKRLGVRGDI 252
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 183 bits (464), Expect = 7e-53
Identities = 64/266 (24%), Positives = 119/266 (44%), Gaps = 20/266 (7%)
Query: 530 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENM-EDFCNEISILSRLRHPNV 586
+G +G G EV DVA+KV + F E + L HP +
Sbjct: 10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69
Query: 587 ILFLGAC----TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 642
+ P ++ EY++ +L ++H + ++ +R ++++ D C+ L
Sbjct: 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNF 126
Query: 643 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP---MRDSSSAGTPEWMAPELI 699
H+ I+HRD+K AN +++ VK+ DFG++R I DS + ++ GT ++++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-----LG 754
R + + D++SLG +++E+ T P+ G P V Y E L
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246
Query: 755 RLIADCWA-EPQERP-SCEEILSRLL 778
++ A P+ R + E+ + L+
Sbjct: 247 AVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-52
Identities = 66/262 (25%), Positives = 113/262 (43%), Gaps = 20/262 (7%)
Query: 530 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAEN----MEDFCNEISILSRLRH 583
G +G G F V + G A K ++ + ED E+SIL ++H
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 584 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 643
PNVI + +I E + G L+ + +K+ L+ + L+ I G+ +
Sbjct: 73 PNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYL 129
Query: 644 HRMKIVHRDLKSANCLVNKHWT----VKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 699
H ++I H DLK N ++ +KI DFGL+ I D + GTPE++APE++
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEFKNIFGTPEFVAPEIV 188
Query: 700 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-----LG 754
EP + D++S+GVI + L + P+ G + + V+ E
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248
Query: 755 RLIADCWA-EPQERPSCEEILS 775
I +P++R + ++ L
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 179 bits (454), Expect = 5e-51
Identities = 60/266 (22%), Positives = 122/266 (45%), Gaps = 22/266 (8%)
Query: 522 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAEN-MEDFCNEISIL 578
+++ + + +G G FG V NG A+KV ++ + +E +E +L
Sbjct: 1 YSLQ--DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 58
Query: 579 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 638
S + HP +I G ++ MI +Y+E G L+ L+ + ++ ++C
Sbjct: 59 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCL 115
Query: 639 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 698
L +H I++RDLK N L++K+ +KI DFG ++ + D + GTP+++APE+
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEV 172
Query: 699 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGR 755
+ +P+ + D +S G++++E+ P+ + + N L P +
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKD 230
Query: 756 LIADCWA-EPQER-----PSCEEILS 775
L++ + +R E++ +
Sbjct: 231 LLSRLITRDLSQRLGNLQNGTEDVKN 256
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 8e-51
Identities = 60/264 (22%), Positives = 114/264 (43%), Gaps = 17/264 (6%)
Query: 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAEN-MEDFCNEISILSR 580
+ ++ +G G FG+V G A+K+ ++ + A++ + E +L
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 581 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 640
RHP + A RL + EY G L+ + +++ + R +I L
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSAL 118
Query: 641 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 700
+H +V+RD+K N +++K +KI DFGL + + GTPE++APE++
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 701 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 757
+ + D + LGV+M+E+ P+ ER+ + E + P L+
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLL 236
Query: 758 ADCWA-EPQERPSC-----EEILS 775
A +P++R +E++
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVME 260
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 8e-48
Identities = 54/261 (20%), Positives = 108/261 (41%), Gaps = 29/261 (11%)
Query: 535 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 591
+G+G G+V + A+K+ ++ E+ + R + P+++ +
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD 72
Query: 592 AC----TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
L ++ E ++ G L+ I G + + R ++++ I + +H +
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN 131
Query: 648 IVHRDLKSANCLVNKHW---TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPF 704
I HRD+K N L +K+ DFG ++ T ++ TP ++APE++ E +
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKY 190
Query: 705 TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE--GSRLEIPEGPLGR------- 755
+ CD++SLGVIM+ L P+ + + + E P
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 250
Query: 756 LIADCWA-EPQERPSCEEILS 775
LI + EP +R + E ++
Sbjct: 251 LIRNLLKTEPTQRMTITEFMN 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 1e-47
Identities = 59/260 (22%), Positives = 107/260 (41%), Gaps = 26/260 (10%)
Query: 530 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA----ENMEDFCNEISILSRLR- 582
VG +G G FG V+ GI + VAIK + ++ N E+ +L ++
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 583 -HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
VI L +P +I E E L ++ L + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQD--LFDFITERGALQEELARSFFWQVLEAVR 124
Query: 642 CIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 700
H ++HRD+K N L++ + +K+ DFG ++ D+ + GT + PE IR
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIR 182
Query: 701 NEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRL 756
+ ++SLG++++++ + P+E E ++ ++ + L
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRG------QVFFRQRVSSECQHL 234
Query: 757 IADCWA-EPQERPSCEEILS 775
I C A P +RP+ EEI +
Sbjct: 235 IRWCLALRPSDRPTFEEIQN 254
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 169 bits (428), Expect = 6e-47
Identities = 64/263 (24%), Positives = 112/263 (42%), Gaps = 22/263 (8%)
Query: 530 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFC----NEISILSRLRH 583
+V +G G FGEV+ G A+K ++ + + E +S++S
Sbjct: 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 584 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 643
P ++ A P +LS I + M G L++ + Q S +I GL +
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHM 123
Query: 644 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE-LIRNE 702
H +V+RDLK AN L+++H V+I D GL+ + + +S GT +MAPE L +
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGV 181
Query: 703 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIA 758
+ D FSLG ++++L + P+ + + +E+P+ L L+
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241
Query: 759 DCWA-EPQERPSC-----EEILS 775
+ R C +E+
Sbjct: 242 GLLQRDVNRRLGCLGRGAQEVKE 264
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 161 bits (409), Expect = 3e-45
Identities = 55/279 (19%), Positives = 101/279 (36%), Gaps = 36/279 (12%)
Query: 530 TVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 588
++G G +G V++ N G A+K + EISIL L+H N++
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 589 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 648
RL ++ E+++ L + L L + G+ H ++
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 649 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-PFTEK 707
+HRDLK N L+N+ +KI DFGL+R + + T + AP+++ ++
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 708 CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR------------ 755
DI+S+G I E+ + GV + + P
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 756 ------------------LIADCWA-EPQERPSCEEILS 775
L++ +P +R + ++ L
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (404), Expect = 2e-44
Identities = 49/274 (17%), Positives = 96/274 (35%), Gaps = 30/274 (10%)
Query: 530 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
+G ++G G FG+++ G G +VAIK+ + E I ++ I
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGI 65
Query: 588 LFLGAC-TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 646
+ C + M+ E + +K S + L + + + IH
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 647 KIVHRDLKSANCLVN---KHWTVKICDFGLSRIITDSP-------MRDSSSAGTPEWMAP 696
+HRD+K N L+ K V I DFGL++ D+ + + GT + +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 697 ELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN-EGSRLEIPEGPLGR 755
+ + D+ SLG ++ + PW+G+ ++ P L +
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 756 --------LIADCWA-EPQERPSCEEILSRLLDC 780
+ C + ++P + +
Sbjct: 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 2e-44
Identities = 58/276 (21%), Positives = 101/276 (36%), Gaps = 39/276 (14%)
Query: 535 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAEN---MEDFCNEISILSRLRHPNVILF 589
+G G F V++ T+ VAIK + EI +L L HPN+I
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 590 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 649
L A +S++ ++ME + L+ + +GL +H+ I+
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 650 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKC 708
HRDLK N L++++ +K+ DFGL++ + T + APEL+ +
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182
Query: 709 DIFSLGVIMWELCTLNRPWEGVLPERVVYAV------------------ANEGSRLEIPE 750
D++++G I+ EL G + + + + P
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242
Query: 751 GPLGR-----------LIADCWA-EPQERPSCEEIL 774
PL LI + P R + + L
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 159 bits (402), Expect = 4e-44
Identities = 49/275 (17%), Positives = 93/275 (33%), Gaps = 30/275 (10%)
Query: 530 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
VG R+G G FG +F G N VAIK + + +E L I
Sbjct: 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGI 63
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
+ + +++ + SL L+ L G +K S + + + + IH
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 648 IVHRDLKSANCLVNKHWT-----VKICDFGLSRIITDSP-------MRDSSSAGTPEWMA 695
+V+RD+K N L+ + + + + DFG+ + D + +GT +M+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 696 PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG------SRLEIP 749
+ + D+ +LG + + PW+G+ G E+
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 750 EG---PLGRLIADCWA-EPQERPSCEEILSRLLDC 780
G + + P + +
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 7e-44
Identities = 66/295 (22%), Positives = 120/295 (40%), Gaps = 52/295 (17%)
Query: 530 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
++G G FGEVF+ G VA+K L ++ EI IL L+H NV+
Sbjct: 13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72
Query: 588 LFLGACTKPP--------RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 639
+ C + ++ ++ E L + K + ++++ + G
Sbjct: 73 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNG 129
Query: 640 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS----PMRDSSSAGTPEWMA 695
L IHR KI+HRD+K+AN L+ + +K+ DFGL+R + + P R ++ T +
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 696 PELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN------------- 741
PEL+ E + D++ G IM E+ T + +G + + ++
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 742 ----EGSRLEIPEGPLGR----------------LIADCWA-EPQERPSCEEILS 775
+LE+ +G + LI +P +R ++ L+
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-43
Identities = 57/280 (20%), Positives = 101/280 (36%), Gaps = 36/280 (12%)
Query: 530 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
++G G +G V++ G VA+K T EIS+L L HPN++
Sbjct: 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
L +L ++ E++ + + L + +GL H +
Sbjct: 65 KLLDVIHTENKLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 648 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP-FTE 706
++HRDLK N L+N +K+ DFGL+R + T + APE++ ++
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 707 KCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR----------- 755
DI+SLG I E+ T + G ++ + + P
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242
Query: 756 -------------------LIADCWA-EPQERPSCEEILS 775
L++ +P +R S + L+
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 158 bits (399), Expect = 4e-43
Identities = 62/309 (20%), Positives = 129/309 (41%), Gaps = 36/309 (11%)
Query: 481 SHGSERGGSSGYMANS--EFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIG 538
GSE+ ++A + +F+ W E+P L ++ +G G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKW----ETPSQNTAQLDQFD----------RIKTLGTG 52
Query: 539 FFGEVFRGIW--NGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLGACTK 595
FG V +G A+K+ +Q + +E NE IL + P ++ +
Sbjct: 53 SFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112
Query: 596 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKS 655
L M+ EY+ G ++ + + + S I +H + +++RDLK
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169
Query: 656 ANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGV 715
N L+++ +++ DFG ++ + R + GTPE +APE+I ++ + + D ++LGV
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKG---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGV 226
Query: 716 IMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQER---- 767
+++E+ P+ P ++ + + ++ P L L+ + + +R
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNL 284
Query: 768 -PSCEEILS 775
+I +
Sbjct: 285 KNGVNDIKN 293
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 6e-43
Identities = 63/286 (22%), Positives = 108/286 (37%), Gaps = 43/286 (15%)
Query: 530 TVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL---RH 583
+G G +G+VF+ G VA+K Q E+++L L H
Sbjct: 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69
Query: 584 PNVILFLGACTKPP-----RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 638
PNV+ CT +L+++ E+++ +L + + + M+ + R
Sbjct: 70 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLR 127
Query: 639 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 698
GL +H ++VHRDLK N LV +K+ DFGL+RI + M +S T + APE+
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-QMALTSVVVTLWYRAPEV 186
Query: 699 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR--- 755
+ + D++S+G I E+ + G + + + + P
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 756 -------------------------LIADCWA-EPQERPSCEEILS 775
L+ C P +R S LS
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-42
Identities = 69/285 (24%), Positives = 107/285 (37%), Gaps = 40/285 (14%)
Query: 530 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
T + +G G +G V N VAIK + + EI IL R RH N+I
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKK-ISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
P M Y+ + ++ + + LS L I RGL IH
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 129
Query: 648 IVHRDLKSANCLVNKHWTVKICDFGLSRIIT---DSPMRDSSSAGTPEWMAPELIRNE-P 703
++HRDLK +N L+N +KICDFGL+R+ D + T + APE++ N
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189
Query: 704 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN---------------------E 742
+T+ DI+S+G I+ E+ + + G + +
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 743 GSRLEIPEGPLGR-----------LIADCWA-EPQERPSCEEILS 775
S + P R L+ P +R E+ L+
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 8e-42
Identities = 54/292 (18%), Positives = 99/292 (33%), Gaps = 49/292 (16%)
Query: 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 581
+ +++ V +G G FG V++ +G VAIK L+ + E+ I+ +L
Sbjct: 20 VSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKL 70
Query: 582 RHPNVILFLGACTKP------PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 635
H N++ L+++ +Y+ H S K+ L +
Sbjct: 71 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 636 ICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIITDSPMRDSSSAGTPEWM 694
+ R L IH I HRD+K N L++ +K+CDFG ++ + S
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190
Query: 695 APELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV--------------- 739
+ +T D++S G ++ EL + G + +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 740 ---ANEGSRLEIPEGPLGR------------LIADCWA-EPQERPSCEEILS 775
E +I P + L + P R + E +
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 8e-41
Identities = 57/281 (20%), Positives = 99/281 (35%), Gaps = 38/281 (13%)
Query: 530 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
++G G +G VF+ VA+K D EI +L L+H N++
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
+L+++ E+ + + +G L + +GL H
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCHSRN 121
Query: 648 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP-FTE 706
++HRDLK N L+N++ +K+ +FGL+R S+ T + P+++ ++
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 707 KCDIFSLGVIMWELCTLNRPW----------------EGVLPERVVYAVANEGSRLEIPE 750
D++S G I EL RP G E ++ P
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 751 GPLGR---------------LIADCWA-EPQERPSCEEILS 775
P L+ + P +R S EE L
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-40
Identities = 63/268 (23%), Positives = 117/268 (43%), Gaps = 25/268 (9%)
Query: 530 TVGTRVGIGFFGEVFRGI-----WNGTDVAIKVFLEQDLT--AENMEDFCNEISILSRLR 582
+ +G G +G+VF G A+KV + + A+ E E +L +R
Sbjct: 27 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 86
Query: 583 H-PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 641
P ++ A +L +I +Y+ G L+ + Q+++ + + +I L
Sbjct: 87 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALE 143
Query: 642 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS-SSAGTPEWMAPELIR 700
+H++ I++RD+K N L++ + V + DFGLS+ + GT E+MAP+++R
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 701 --NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-----L 753
+ + D +SLGV+M+EL T P+ + ++ + E P
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 263
Query: 754 GRLIADCWA-EPQERPSC-----EEILS 775
LI +P++R C +EI
Sbjct: 264 KDLIQRLLMKDPKKRLGCGPRDADEIKE 291
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-37
Identities = 66/292 (22%), Positives = 111/292 (38%), Gaps = 41/292 (14%)
Query: 521 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISIL 578
W + + VG G +G V + G VAIK + + E+ +L
Sbjct: 13 AWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 71
Query: 579 SRLRHPNVILFLGACTKPPRLSMITE-YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 637
+RH NVI L T L T+ Y+ + + + + +KL R ++ +
Sbjct: 72 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML 131
Query: 638 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 697
+GL IH I+HRDLK N VN+ +KI DFGL+R + T + APE
Sbjct: 132 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---EMTGYVVTRWYRAPE 188
Query: 698 LIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG------------- 743
+I N +T+ DI+S+G IM E+ T ++G + +
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 744 --------SRLEIPEGPLGRLIADCWAE------------PQERPSCEEILS 775
E+ + ++ + ++R + E L+
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-37
Identities = 53/202 (26%), Positives = 83/202 (41%), Gaps = 3/202 (1%)
Query: 530 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
+G G G V +VAIK + + E+ ++ + H N+I
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 588 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 647
L T L + + L + +L R +L + G+ +H
Sbjct: 80 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG 139
Query: 648 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 707
I+HRDLK +N +V T+KI DFGL+R S M + T + APE+I + E
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYKEN 198
Query: 708 CDIFSLGVIMWELCTLNRPWEG 729
DI+S+G IM E+ + G
Sbjct: 199 VDIWSVGCIMGEMVRHKILFPG 220
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 137 bits (346), Expect = 2e-36
Identities = 47/226 (20%), Positives = 95/226 (42%), Gaps = 22/226 (9%)
Query: 512 QNKPLLAYEEWNIDFS---ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE 566
+ + YE +++ + + ++G G + EVF I N V +K+ L
Sbjct: 17 RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI-----LKPV 71
Query: 567 NMEDFCNEISILSRLR-HPNVILFLGACTKPP--RLSMITEYMELGSLYHLIHLSGQKKK 623
+ EI IL LR PN+I P +++ E++ L +
Sbjct: 72 KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QT 125
Query: 624 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV-NKHWTVKICDFGLSRIITDSPM 682
L+ + +I + L H M I+HRD+K N ++ ++H +++ D+GL+
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-Q 184
Query: 683 RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPW 727
+ + + PEL+ + + + D++SLG ++ + P+
Sbjct: 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 9e-36
Identities = 64/296 (21%), Positives = 110/296 (37%), Gaps = 49/296 (16%)
Query: 521 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISIL 578
W + + VG G +G V G VA+K + + + E+ +L
Sbjct: 13 IWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 579 SRLRHPNVILFLGACTKPPRLS-----MITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 633
++H NVI L T L + ++ L +++ +KL+ ++
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLI 127
Query: 634 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEW 693
I RGL IH I+HRDLK +N VN+ +KI DFGL+R + T +
Sbjct: 128 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWY 184
Query: 694 MAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG--------- 743
APE++ N + + DI+S+G IM EL T + G + +
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 744 ------------SRLEIPEGPLGR-----------LIADCWA-EPQERPSCEEILS 775
S ++P+ L+ + +R + + L+
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (269), Expect = 5e-26
Identities = 45/222 (20%), Positives = 84/222 (37%), Gaps = 28/222 (12%)
Query: 530 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 587
+ ++G G F V+ N T VA+K+ + E ED EI +L R+ +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNT 72
Query: 588 LFLGACTK-------------PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 634
P + ++ + LG + + + + ++ +
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 635 DICRGLM-CIHRMKIVHRDLKSANCLVN------KHWTVKICDFGLSRIITDSPMRDSSS 687
+ GL R I+H D+K N L+ +KI D G + + S
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN---S 189
Query: 688 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 729
T E+ +PE++ P+ DI+S +++EL T + +E
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.1 bits (215), Expect = 3e-20
Identities = 26/169 (15%), Positives = 51/169 (30%), Gaps = 33/169 (19%)
Query: 531 VGTRVGIGFFGEVFRGI-WNGTDVAIKVF----------------LEQDLTAENMEDFCN 573
+G +G G VF + +K + + + N
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 574 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 633
E L +L+ V +++ E ++ + + ++ ++L
Sbjct: 64 EFRALQKLQGLAVPKVYAWE----GNAVLMELID----------AKELYRVRVENPDEVL 109
Query: 634 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682
I + + IVH DL N LV++ + I DF S
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSV-EVGEEG 156
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 785 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.21 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.57 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.2 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.67 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.53 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.06 | |
| d1g83a2 | 104 | Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: | 95.48 | |
| d1qcfa2 | 103 | Hemopoetic cell kinase Hck {Human (Homo sapiens) [ | 95.09 | |
| d1blja_ | 114 | P55 Blk protein tyrosine kinase {Mouse (Mus muscul | 95.03 | |
| d1lkka_ | 105 | p56-lck tyrosine kinase {Human (Homo sapiens) [Tax | 94.96 | |
| d1rjaa_ | 100 | Tyrosine-protein kinase 6 (Breast tumor kinase, Br | 94.56 | |
| d1o48a_ | 106 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 94.17 | |
| d1nrva_ | 105 | Growth factor receptor-bound protein 10, GRB10 {Hu | 93.04 | |
| d1a81a1 | 129 | Syk tyrosine kinase {Human (Homo sapiens) [TaxId: | 92.48 | |
| d2qmsa1 | 113 | Growth factor receptor-bound protein 7 {Human (Hom | 91.8 | |
| d2oq1a1 | 130 | Tyrosine-protein kinase zap-70 {Human (Homo sapien | 91.48 | |
| d1i3za_ | 103 | Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus | 90.78 | |
| d1rpya_ | 86 | Adaptor protein Aps {Rat (Rattus norvegicus) [TaxI | 90.54 | |
| d1r1qa_ | 97 | GRB2-related adaptor protein 2 (MONA, GRID) {Mouse | 89.45 | |
| d1jyra_ | 96 | Growth factor receptor-bound protein 2 (GRB2) {Hum | 89.44 | |
| d1a81a2 | 125 | Syk tyrosine kinase {Human (Homo sapiens) [TaxId: | 87.15 | |
| d2oq1a2 | 124 | Tyrosine-protein kinase zap-70 {Human (Homo sapien | 86.89 | |
| d1d4ta_ | 104 | The Xlp protein Sap {Human (Homo sapiens) [TaxId: | 85.88 | |
| d2shpa2 | 109 | Tyrosine phoshatase shp-2 {Human (Homo sapiens) [T | 85.79 | |
| d1xa6a2 | 141 | Beta-chimaerin, N-terminal domain {Human (Homo sap | 85.15 | |
| d1luia_ | 108 | Itk/tsk protein tyrosine kinase {Mouse (Mus muscul | 84.42 | |
| d1jwoa_ | 97 | Csk homologous kinase Chk {Human (Homo sapiens) [T | 82.65 | |
| d2c9wa2 | 103 | Suppressor of cytokine signaling 2, SOCS-2 {Human | 81.77 | |
| d1k9aa2 | 101 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 81.57 | |
| d2eyva1 | 109 | Crk proto-oncogen {Human (Homo sapiens) [TaxId: 96 | 80.61 | |
| d2izva2 | 112 | Suppressor of cytokine signaling 4, SOCS-4 {Human | 80.46 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=437.85 Aligned_cols=261 Identities=33% Similarity=0.640 Sum_probs=221.5
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCce
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 599 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 599 (785)
++|+++.++|.++++||+|+||+||+|++++ .||||++..........+.|.+|+.+|++++|||||++++++.+ +.+
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence 4789999999999999999999999998765 59999998777667778899999999999999999999998765 468
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++|||||||||+||||+.++++||+|||+|+....
T Consensus 79 ~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EEEEECCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EEEEecCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 999999999999999963 345799999999999999999999999999999999999999999999999999987653
Q ss_pred CC--CCCCCCCCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----CC-
Q 003935 680 SP--MRDSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----IP- 749 (785)
Q Consensus 680 ~~--~~~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~----ip- 749 (785)
.. .......||+.|+|||++.+ .+|+.++|||||||+||||+||+.||.+.............+...+ ++
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 236 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCT
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccc
Confidence 22 22345689999999999964 3589999999999999999999999998877666666555544332 22
Q ss_pred --ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhcc
Q 003935 750 --EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 784 (785)
Q Consensus 750 --~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~sL 784 (785)
+..+.+|+.+||. ||.+|||+.+|+++|+.+.-++
T Consensus 237 ~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 237 NCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 2469999999999 9999999999999999886543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-51 Score=432.14 Aligned_cols=260 Identities=30% Similarity=0.640 Sum_probs=224.8
Q ss_pred ccccccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC
Q 003935 518 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 595 (785)
Q Consensus 518 ~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 595 (785)
.+++|+++.++|.+.++||+|+||+||+|.+ +++.||||++...... .++|.+|+.+|++++|||||+++++|.+
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEee
Confidence 4678999999999999999999999999988 4889999998755433 4679999999999999999999999999
Q ss_pred CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 596 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
++.+++||||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred CCeeEEEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEcccccee
Confidence 99999999999999999998643 45679999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCC-CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC---h
Q 003935 676 IITDSPMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---G 751 (785)
Q Consensus 676 ~l~~~~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~---~ 751 (785)
........ .....|++.|+|||++.+..|+.++|||||||++|||++|..||...........+...+.++..|. .
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 243 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 243 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchH
Confidence 77544322 2334588999999999999999999999999999999997776554444444455556666666554 4
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 752 PLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 752 ~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
.+.+|+.+||+ ||.+|||+.+|++.|+.+.
T Consensus 244 ~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 244 KVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 69999999999 9999999999999998763
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-51 Score=426.54 Aligned_cols=250 Identities=28% Similarity=0.465 Sum_probs=209.0
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC--CCceeE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--PPRLSM 601 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d--~~~l~L 601 (785)
.++|.+.+.||+|+||+||+|.+ +|+.||||++..........+.|.+|+++|++++|||||++++++.+ ...+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 36899999999999999999988 58899999998887777777889999999999999999999999864 456899
Q ss_pred EEEEcccchhhHHHHhhc-ccccchHHHHHHHHHHHHHHHHHHHhcc-----cccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 602 ITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMK-----IVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~-~~~~Ls~~~~l~Ia~QIa~AL~yLHs~g-----IIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
||||+++|+|.+++.... ....+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999986432 3457999999999999999999999976 9999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003935 676 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGP 752 (785)
Q Consensus 676 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~ 752 (785)
.+..........+||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+..++...+..... ..+| +..
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~ 241 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-RRIPYRYSDE 241 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCCTTSCHH
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCCcccCHH
Confidence 876654455567899999999999999999999999999999999999999999988888877765443 3333 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.+|+.+||. ||.+|||+.|+++|
T Consensus 242 l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 242 LNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhC
Confidence 9999999999 99999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=422.64 Aligned_cols=258 Identities=33% Similarity=0.586 Sum_probs=221.0
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC-CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~-g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
.++|+++.++|++.++||+|+||+||+|.++ ++.||||++...... .+.|.+|+.++++++|||||++++++.+ +
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 4789999999999999999999999999985 678999999765443 3679999999999999999999998865 4
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+++||||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+||||++++.+||+|||+|+.+
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CeEEEEEeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEc
Confidence 589999999999999887532 2346899999999999999999999999999999999999999999999999999987
Q ss_pred cCCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHhcCCCCCCCC---hH
Q 003935 678 TDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE---GP 752 (785)
Q Consensus 678 ~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~-PF~~~~~~~~v~~i~~~~~~~~ip~---~~ 752 (785)
..... ......||+.|+|||++.+..++.++|||||||+||||+||.. ||......+....+. .+.++..|. ..
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~ 238 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEE 238 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCcccChHH
Confidence 54432 2345678999999999999999999999999999999999655 556666666665554 455555553 36
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 753 LGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 753 L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
+.+|+.+||+ ||.+|||+.+|++.|+++..
T Consensus 239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 9999999999 99999999999999998754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=419.55 Aligned_cols=253 Identities=31% Similarity=0.633 Sum_probs=209.6
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
++.++|.+.++||+|+||+||+|.+ +++.||||++...... .++|.+|+.++++++|||||+++|+|.+++.+++|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 3567899999999999999999988 5778999998765443 36799999999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
|||+++|+|.+++.. ....+++..++.++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~E~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EECCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEecCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999999998863 346789999999999999999999999999999999999999999999999999987754432
Q ss_pred C-CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHH
Q 003935 683 R-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLI 757 (785)
Q Consensus 683 ~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG-~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI 757 (785)
. .....||+.|+|||++.+..|+.++|||||||++|||+|+ ..||......+....+.. +.++..| +..+.+|+
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li 235 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHVYQIM 235 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH-TCCCCCCTTSCHHHHHHH
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh-cCCCCCccccCHHHHHHH
Confidence 2 2346789999999999999999999999999999999995 566777777666666554 4444444 34699999
Q ss_pred HHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 758 ADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 758 ~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
..||+ ||.+|||+++|+++|+++.-
T Consensus 236 ~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 236 NHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 99999 99999999999999998754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-51 Score=424.51 Aligned_cols=246 Identities=27% Similarity=0.472 Sum_probs=217.3
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
.++|.+++.||+|+||+||+|.+ +++.||+|++.+.... ....+.+.+|+.+++.++|||||++++++.+++.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 46899999999999999999988 4889999998754432 22356788999999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
|||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 85 mEy~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-- 159 (263)
T d2j4za1 85 LEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 159 (263)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred EeecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence 99999999999997 3457999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhh
Q 003935 683 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCW 761 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~CL 761 (785)
.....+||+.|+|||++.+..|+.++|||||||+||+|++|+.||.+.+..+....+.......+ .-+..+.+|+.+||
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 239 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 239 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHc
Confidence 23456899999999999999999999999999999999999999999998888887766543322 22457999999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003935 762 A-EPQERPSCEEILSR 776 (785)
Q Consensus 762 ~-DP~kRPS~~EIL~~ 776 (785)
. ||.+|||+.|+++|
T Consensus 240 ~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 240 KHNPSQRPMLREVLEH 255 (263)
T ss_dssp CSSGGGSCCHHHHHTC
T ss_pred cCCHhHCcCHHHHHcC
Confidence 9 99999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-50 Score=425.86 Aligned_cols=244 Identities=28% Similarity=0.482 Sum_probs=217.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|.+.++||+|+||+||+|.+ +|+.||||++....... .+.+.+|+.+|+.++|||||++++++.+++.+|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 4689999999999999999987 58999999997655432 4678999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
|++||+|.+++.. ..+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.+.......
T Consensus 98 y~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 173 (293)
T d1yhwa1 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (293)
T ss_dssp CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred ecCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccc
Confidence 9999999998752 469999999999999999999999999999999999999999999999999999876655555
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCC---ChHHHHHHHHh
Q 003935 685 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIP---EGPLGRLIADC 760 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~-~~ip---~~~L~~LI~~C 760 (785)
...+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+.......+...... ...+ +..+.+||.+|
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 253 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHH
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHH
Confidence 6778999999999999999999999999999999999999999998888877777665432 2222 34699999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003935 761 WA-EPQERPSCEEILSR 776 (785)
Q Consensus 761 L~-DP~kRPS~~EIL~~ 776 (785)
|. ||.+|||+.|+++|
T Consensus 254 L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 254 LDMDVEKRGSAKELLQH 270 (293)
T ss_dssp TCSSTTTSCCHHHHTTC
T ss_pred ccCChhHCcCHHHHhcC
Confidence 99 99999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=412.88 Aligned_cols=250 Identities=33% Similarity=0.623 Sum_probs=220.7
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
+.++|+++++||+|+||+||+|++ +++.||||++.+..... ++|.+|+.++++++|||||+++|+|.+++.+++||
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 457899999999999999999998 46789999998765543 57999999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+.+|+|..++.. ....+++..+++++.|+++||+|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 79 Ey~~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 79 EYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp ECCTTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EccCCCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 99999999988763 3457889999999999999999999999999999999999999999999999999876544322
Q ss_pred -CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC---hHHHHHHH
Q 003935 684 -DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIA 758 (785)
Q Consensus 684 -~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip~---~~L~~LI~ 758 (785)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++...+.. +.++..|. ..+.+|+.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~ 235 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIMY 235 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHH
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh-CCCCCCcccccHHHHHHHH
Confidence 234678999999999999999999999999999999998 8999999998888777654 44555553 46999999
Q ss_pred Hhhh-CCCCCCCHHHHHHHHHhh
Q 003935 759 DCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 759 ~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
+||+ ||++|||+++|+++|.++
T Consensus 236 ~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 236 SCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHccCCHhHCcCHHHHHHHhhCC
Confidence 9999 999999999999999874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=421.99 Aligned_cols=247 Identities=23% Similarity=0.372 Sum_probs=206.4
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
.++|++.++||+|+||+||+|++ +|+.||||++...... +..+.+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 36799999999999999999988 4889999999765432 23467899999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC--
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-- 681 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~-- 681 (785)
||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||+++++++||+|||+|+.+....
T Consensus 83 Ey~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 83 EYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp ECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred eccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999999885 45689999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCCCCCCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----ChHHHHH
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP----EGPLGRL 756 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip----~~~L~~L 756 (785)
......+||+.|+|||++.+..+ +.++|||||||++|||+||+.||.....................+ +..+.+|
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence 23346789999999999988876 578999999999999999999997665433333333322222211 3468899
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003935 757 IADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.+||+ ||.+|||++|+++|
T Consensus 240 i~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 240 LHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHcCCChhHCcCHHHHhcC
Confidence 999999 99999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-50 Score=429.26 Aligned_cols=258 Identities=29% Similarity=0.536 Sum_probs=220.8
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEECC-------eEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEec
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 591 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~g-------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g 591 (785)
..|+++.++|.++++||+|+||+||+|.+.+ ..||+|++..... ......|.+|+.+|.++ +|||||++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 4578889999999999999999999998732 3689998865433 33456789999999998 8999999999
Q ss_pred cccCCCceeEEEEEcccchhhHHHHhhcc--------------------cccchHHHHHHHHHHHHHHHHHHHhcccccc
Q 003935 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQ--------------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651 (785)
Q Consensus 592 ~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~--------------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHr 651 (785)
+|.+.+.+|+||||+++|+|.++++.... ...+++..++.++.||+.||+|||++|||||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 99999999999999999999999974321 2358999999999999999999999999999
Q ss_pred cCCCCcEEEcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 003935 652 DLKSANCLVNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWE 728 (785)
Q Consensus 652 DLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~ 728 (785)
||||+|||++.++++||+|||+|+........ .....||+.|+|||++.++.|+.++|||||||+||||+| |+.||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876543221 234568999999999999999999999999999999998 899999
Q ss_pred CCChHHHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003935 729 GVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLL 778 (785)
Q Consensus 729 ~~~~~~~v~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPS~~EIL~~L~ 778 (785)
+......+..+...+.+++.|. ..+.+||.+||+ ||.+|||+++|+++|.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 8887777777888777776664 469999999999 9999999999999985
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-49 Score=419.80 Aligned_cols=255 Identities=35% Similarity=0.579 Sum_probs=209.8
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEEC--C---eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIWN--G---TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~~--g---~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
++..++|++.+.||+|+||+||+|.+. + ..||||.+.... .....+.|.+|+.+|++++|||||+++++|.+++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 356678999999999999999999873 3 258888875443 3455678999999999999999999999999999
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+++||||+++|+|.+++.. ..+.+++.+++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++.+
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEEEEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEc
Confidence 99999999999999998863 3457999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCC-----CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 003935 678 TDSPMR-----DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP-- 749 (785)
Q Consensus 678 ~~~~~~-----~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip-- 749 (785)
...... .....||+.|+|||++.++.++.++|||||||+||||+| |+.||.+....++...+.. +.+++.|
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~~~~ 257 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-DYRLPPPMD 257 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTT
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcc
Confidence 543221 122457899999999999999999999999999999998 8999999998888777654 4444444
Q ss_pred -ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 750 -EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 750 -~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
+..+.+|+.+||+ ||.+|||+.+|++.|+++.
T Consensus 258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 3469999999999 9999999999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=416.00 Aligned_cols=257 Identities=28% Similarity=0.529 Sum_probs=220.6
Q ss_pred ccccCCCeeEeeE-EeeeCcEEEEEEEEC----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC
Q 003935 522 WNIDFSELTVGTR-VGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 596 (785)
Q Consensus 522 ~~i~~s~y~i~k~-LG~G~fG~VYkg~~~----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 596 (785)
+-++.++|.+.+. ||+|+||+||+|.+. +..||||++.... .....+.|.+|+.+|++++|||||+++++|..+
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 81 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE 81 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence 4566678888884 999999999999763 4579999986543 455678899999999999999999999998754
Q ss_pred CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
.+|+||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 82 -~~~lvmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 82 -ALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp -SEEEEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred -eEEEEEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhc
Confidence 58999999999999998752 345799999999999999999999999999999999999999999999999999988
Q ss_pred ccCCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC--
Q 003935 677 ITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE-- 750 (785)
Q Consensus 677 l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip~-- 750 (785)
+..... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+....++...+. .+.++..|+
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~ 237 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPEC 237 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTC
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcC
Confidence 754322 2234568999999999999999999999999999999998 899999988877766654 455555553
Q ss_pred -hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003935 751 -GPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 783 (785)
Q Consensus 751 -~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~s 783 (785)
..+.+|+..||. ||.+|||+.+|++.|+.+..+
T Consensus 238 ~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 369999999999 999999999999999987654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-50 Score=423.30 Aligned_cols=246 Identities=27% Similarity=0.447 Sum_probs=213.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
+.|.+.++||+|+||+||+|.+ +|+.||||++..... ...+.|.+|+++|+.++|||||++++++.+++.+|+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 4589999999999999999988 588999999876532 345778999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
|+++|+|.+++.. ....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.........
T Consensus 90 y~~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 90 FCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp CCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred cCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence 9999999998763 24579999999999999999999999999999999999999999999999999998664332233
Q ss_pred CCCCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCC---ChHHHH
Q 003935 685 SSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIP---EGPLGR 755 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~-~ip---~~~L~~ 755 (785)
...+||+.|+|||++. +..|+.++|||||||++|||+||+.||.+.+..+....+....... ..+ +..+.+
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 4678999999999984 4568999999999999999999999999998888888777654322 222 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHH
Q 003935 756 LIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 756 LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
|+.+||+ ||.+|||+.|+++|
T Consensus 248 li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 248 FLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999 99999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-49 Score=411.16 Aligned_cols=255 Identities=35% Similarity=0.559 Sum_probs=210.0
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEECC------eEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 596 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~~g------~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 596 (785)
++..+.|++.+.||+|+||+||+|.+.+ ..||||++.... .......|.+|+.++++++|||||+++|++.+.
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 4567889999999999999999998632 369999986543 344567899999999999999999999999999
Q ss_pred CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
+.+++||||+.++++.+++.. ....+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CceEEEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999999988763 346799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHhcCCCCCCCC--
Q 003935 677 ITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP-WEGVLPERVVYAVANEGSRLEIPE-- 750 (785)
Q Consensus 677 l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~P-F~~~~~~~~v~~i~~~~~~~~ip~-- 750 (785)
+..... ......||+.|+|||++.+..++.++|||||||++|||++|..| |......++... ...+.+++.|.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~-i~~~~~~~~~~~~ 238 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-INDGFRLPTPMDC 238 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCCCTTC
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHH-HhccCCCCCchhh
Confidence 654322 22345689999999999999999999999999999999997655 555555555544 45556666654
Q ss_pred -hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 751 -GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 751 -~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
..+.+|+.+||+ ||.+|||+.+|++.|+++.
T Consensus 239 ~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 239 PSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 469999999999 9999999999999998764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=412.91 Aligned_cols=242 Identities=27% Similarity=0.476 Sum_probs=206.9
Q ss_pred eeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC----CCceeEE
Q 003935 529 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK----PPRLSMI 602 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d----~~~l~LV 602 (785)
|++.++||+|+||+||+|.+ +++.||+|++..........+.|.+|+++|++++|||||++++++.+ ...+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 46778899999999999988 47789999998877777777889999999999999999999999854 3458999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcc--cccccCCCCcEEEc-CCCeEEEEecCccccccC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVN-KHWTVKICDFGLSRIITD 679 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~g--IIHrDLKpsNILLd-~~g~VKL~DFGLA~~l~~ 679 (785)
|||+++|+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+++....
T Consensus 91 mE~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999997 3457999999999999999999999998 99999999999996 578999999999986543
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCC---ChHHHH
Q 003935 680 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIP---EGPLGR 755 (785)
Q Consensus 680 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~-~ip---~~~L~~ 755 (785)
. .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.............+..+ ..+ ...+.+
T Consensus 168 ~--~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (270)
T d1t4ha_ 168 S--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244 (270)
T ss_dssp T--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred C--ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHH
Confidence 3 3346789999999999876 59999999999999999999999998776555554444444332 222 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHH
Q 003935 756 LIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 756 LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
|+.+||. ||++|||++|+++|
T Consensus 245 li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 245 IIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHccCCHhHCcCHHHHhCC
Confidence 9999999 99999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=424.80 Aligned_cols=252 Identities=23% Similarity=0.363 Sum_probs=210.2
Q ss_pred cccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 523 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 523 ~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
++..++|.+.++||+|+||+||+|.+ +|+.||+|++..... ....+.+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45567899999999999999999998 588999999976533 344578999999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-cccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
+||||+++|+|.+++.. .+.+++..++.++.|++.||.|||+ +||+||||||+|||++.++++||+|||+|+.+.+
T Consensus 81 iVmEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999999973 4579999999999999999999997 5999999999999999999999999999987654
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---------------------
Q 003935 680 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYA--------------------- 738 (785)
Q Consensus 680 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~--------------------- 738 (785)
. .....+||+.|+|||++.+.+|+.++|||||||++|||++|+.||.+.+.......
T Consensus 158 ~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp H--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred C--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 3 23457899999999999999999999999999999999999999976543221110
Q ss_pred --------------------HHhcCCCCCCC----ChHHHHHHHHhhh-CCCCCCCHHHHHHH--HHhh
Q 003935 739 --------------------VANEGSRLEIP----EGPLGRLIADCWA-EPQERPSCEEILSR--LLDC 780 (785)
Q Consensus 739 --------------------i~~~~~~~~ip----~~~L~~LI~~CL~-DP~kRPS~~EIL~~--L~~l 780 (785)
.......+..+ ...+.+|+.+||. ||.+|||++|+++| +++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 00111111122 2358899999999 99999999999986 5543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-50 Score=421.76 Aligned_cols=248 Identities=21% Similarity=0.341 Sum_probs=214.2
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
.++|.+++.||+|+||+||+|.+ +|+.||||++.+... .....+.+.+|+++|++++|||||++++++.+++.+|+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 46899999999999999999988 488999999975443 223356789999999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC-
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP- 681 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~- 681 (785)
|||+++|+|.+++. ..+.+++..++.++.|++.||+|||++|||||||||+|||+++++.+||+|||+|+.+....
T Consensus 87 mEy~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999999999887 34579999999999999999999999999999999999999999999999999998875432
Q ss_pred -CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHH
Q 003935 682 -MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIAD 759 (785)
Q Consensus 682 -~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~ 759 (785)
......+||+.|+|||++.+..|+.++|||||||+||||+||+.||.+.+...+...+.......+ .-...+.+||.+
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 243 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 243 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHT
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 223456899999999999999999999999999999999999999999998888888776543321 123468999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003935 760 CWA-EPQERPSCEEILSR 776 (785)
Q Consensus 760 CL~-DP~kRPS~~EIL~~ 776 (785)
||. ||.+|||++|++++
T Consensus 244 ~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 244 LLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp TSCSSGGGSTTSGGGTCH
T ss_pred HccCCHhHCcCHHHHcCC
Confidence 999 99999999987543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=412.53 Aligned_cols=245 Identities=26% Similarity=0.533 Sum_probs=208.1
Q ss_pred eEEeeeCcEEEEEEEEC----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEccc
Q 003935 533 TRVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMEL 608 (785)
Q Consensus 533 k~LG~G~fG~VYkg~~~----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~~g 608 (785)
++||+|+||+||+|.+. ++.||||++.....+....+.|.+|+.+|++++|||||+++++|..+ .+++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 57999999999999762 46799999976655555668899999999999999999999999654 58899999999
Q ss_pred chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC---CC
Q 003935 609 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR---DS 685 (785)
Q Consensus 609 GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~---~~ 685 (785)
|+|.+++. ....+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+...... ..
T Consensus 92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 99999987 4467999999999999999999999999999999999999999999999999999876543221 23
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC---hHHHHHHHHhh
Q 003935 686 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCW 761 (785)
Q Consensus 686 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip~---~~L~~LI~~CL 761 (785)
...||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....++...+. .+.+++.|. ..+.+|+.+||
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~cl 247 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMNLCW 247 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHT
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHHHHHHHc
Confidence 4578999999999999999999999999999999998 899999988877766554 455555553 46999999999
Q ss_pred h-CCCCCCCHHHHHHHHHhhhh
Q 003935 762 A-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 762 ~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
+ ||.+|||+.+|++.|+++.+
T Consensus 248 ~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 248 TYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCHhHCcCHHHHHHHhhCHHh
Confidence 9 99999999999999887644
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-49 Score=419.47 Aligned_cols=242 Identities=29% Similarity=0.430 Sum_probs=213.7
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccC-hHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~-~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
.|.+.++||+|+||+||+|.+ +|+.||||++...... ....+.|.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 489999999999999999987 5889999999766543 3456789999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
||.+|+|..++. ....+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++......
T Consensus 96 ~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (309)
T ss_dssp CCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred ecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC----
Confidence 999999987665 3467999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHH
Q 003935 685 SSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIA 758 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip---~~~L~~LI~ 758 (785)
...+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.........+.........+ +..+.+|+.
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~ 248 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHH
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 35689999999999864 468999999999999999999999999998888888777655443332 346999999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003935 759 DCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 759 ~CL~-DP~kRPS~~EIL~~ 776 (785)
+||. ||.+|||+.++++|
T Consensus 249 ~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 249 SCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHTCSSGGGSCCHHHHTTC
T ss_pred HHCcCChhHCcCHHHHHhC
Confidence 9999 99999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=412.29 Aligned_cols=259 Identities=33% Similarity=0.592 Sum_probs=214.6
Q ss_pred ccccccccCCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCC
Q 003935 518 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 596 (785)
Q Consensus 518 ~~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~ 596 (785)
..++|++++++|++++.||+|+||+||+|.+ +++.||||++...... .+.|.+|+.++++++|||||+++++|.+
T Consensus 8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE- 83 (285)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence 4578999999999999999999999999988 4568999998755443 3679999999999999999999999965
Q ss_pred CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
+.+++||||+++|+|..++... ....+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred CCeEEEEEecCCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhh
Confidence 4589999999999999888643 345699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHhcCCCCCCCC---h
Q 003935 677 ITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP-WEGVLPERVVYAVANEGSRLEIPE---G 751 (785)
Q Consensus 677 l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~P-F~~~~~~~~v~~i~~~~~~~~ip~---~ 751 (785)
...... ......||+.|+|||++..+.++.++|||||||++|||+||..| |......+....+. .+.+.+.+. .
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 241 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPE 241 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCH
T ss_pred ccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCCcccCH
Confidence 654322 22346789999999999999999999999999999999997655 55556655655554 444555543 4
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 752 PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 752 ~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
.+.+|+.+||+ ||++|||+++|++.|+++..
T Consensus 242 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 69999999999 99999999999999988654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=406.77 Aligned_cols=256 Identities=31% Similarity=0.552 Sum_probs=210.1
Q ss_pred cccccCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC
Q 003935 521 EWNIDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 595 (785)
Q Consensus 521 e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d 595 (785)
+|++..++|.+++.||+|+||+||+|.+. +..||||++... ......+.|.+|+.+|++++|||||++++++.+
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 79 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 79 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 47888999999999999999999999873 345888887543 334456789999999999999999999999964
Q ss_pred CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 596 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
+.+|+||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 80 -~~~~iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 80 -NPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp -SSCEEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred -CeEEEEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhe
Confidence 568999999999999988753 34578999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC---
Q 003935 676 IITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE--- 750 (785)
Q Consensus 676 ~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip~--- 750 (785)
.+..... ......||+.|+|||++.+..++.++|||||||++|||+| |..||.+....++...+.. +.++++|.
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~ 235 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERLPMPPNCP 235 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TCCCCCCTTCC
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCC
Confidence 7654322 2335568999999999999999999999999999999998 8999999988888777655 44444543
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 751 GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 751 ~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
..+.+||.+||. ||.+|||+.+|+++|+++.
T Consensus 236 ~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 469999999999 9999999999999998764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=421.92 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=220.9
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
+..++|.+++.||+|+||+||+|.+ +|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++.+...+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 4567999999999999999999987 588999999976543 2233577899999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
+||||++||+|.+++. ....+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 82 iv~ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred cceeccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999999987 3457899999999999999999999999999999999999999999999999999977655
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CChHHHHHHHH
Q 003935 681 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PEGPLGRLIAD 759 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i-p~~~L~~LI~~ 759 (785)
.......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+...+...+.......+. -...+.+||.+
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence 45556788999999999999999999999999999999999999999999998888877765433221 13468999999
Q ss_pred hhh-CCCCCCC-----HHHHHHH
Q 003935 760 CWA-EPQERPS-----CEEILSR 776 (785)
Q Consensus 760 CL~-DP~kRPS-----~~EIL~~ 776 (785)
||+ ||.+||+ +.++++|
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTS
T ss_pred hccCCchhhcccccccHHHHHcC
Confidence 999 9999994 8888875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-49 Score=419.15 Aligned_cols=245 Identities=25% Similarity=0.419 Sum_probs=200.4
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
+.|.+.+.||+|+||+||+|.+ +|+.||||++.+..... ..+.+.+|+.+|+.++|||||++++++.+++.+|+|||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5699999999999999999988 48899999997665433 24668899999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEc---CCCeEEEEecCccccccCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN---KHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd---~~g~VKL~DFGLA~~l~~~~ 681 (785)
|++||+|.+++. ....+++..+..++.||+.||+|||++||+||||||+|||+. +++.+||+|||+++......
T Consensus 88 ~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 88 LVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 999999999997 456899999999999999999999999999999999999995 57899999999998765432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 756 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-----~~~L~~L 756 (785)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+.........+ +..+.+|
T Consensus 165 -~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 243 (307)
T d1a06a_ 165 -VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred -eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHH
Confidence 3346789999999999999999999999999999999999999999999888888887766544332 2468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003935 757 IADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.+||. ||.+|||+.|+++|
T Consensus 244 i~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 244 IRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCCHhHCcCHHHHhcC
Confidence 999999 99999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=410.49 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=216.7
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh----HHHHHHHHHHHHHhhcCCCceeeEeccccCCCcee
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA----ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 600 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~----~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~ 600 (785)
+.|.+++.||+|+||+||+|.+ +|+.||||++.+..... ...+.|.+|+.+|+.++|||||++++++.+...+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5699999999999999999988 48899999997654422 23578999999999999999999999999999999
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC----eEEEEecCcccc
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW----TVKICDFGLSRI 676 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g----~VKL~DFGLA~~ 676 (785)
+|||||++|+|.+++.. .+.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 90 iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 99999999999999973 45799999999999999999999999999999999999998776 599999999988
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CCh
Q 003935 677 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEG 751 (785)
Q Consensus 677 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i-----p~~ 751 (785)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+......... .+.
T Consensus 167 ~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (293)
T d1jksa_ 167 IDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245 (293)
T ss_dssp CTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred cCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence 75432 334678999999999999999999999999999999999999999999998888887765543321 134
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 752 PLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 752 ~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.+.+||.+||. ||.+|||++++++|
T Consensus 246 ~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 68899999999 99999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=405.39 Aligned_cols=252 Identities=29% Similarity=0.576 Sum_probs=214.1
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC-CCcee
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-PPRLS 600 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d-~~~l~ 600 (785)
|++..++|++++.||+|+||.||+|.++|+.||||++.... ..+.|.+|+.++++++|||||+++|+|.+ .+.++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 88899999999999999999999999999999999986543 24678999999999999999999999855 46689
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
+||||+++|+|.+++... ....+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 78 lv~ey~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp EEECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence 999999999999999643 2346899999999999999999999999999999999999999999999999999876442
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC---hHHHHH
Q 003935 681 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRL 756 (785)
Q Consensus 681 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip~---~~L~~L 756 (785)
.....+|+.|+|||++.+..++.++|||||||++|||+| |+.||......++...+ ..+.+++++. ..+.+|
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~l 232 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCPPAVYEV 232 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-TTTCCCCCCTTCCHHHHHH
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCCccCCHHHHHH
Confidence 234568899999999999999999999999999999998 68889888877777665 4455666664 469999
Q ss_pred HHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 757 IADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
+.+||. ||.+|||+.+|+++|++++.
T Consensus 233 i~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 233 MKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 999999 99999999999999998864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.6e-48 Score=418.80 Aligned_cols=246 Identities=25% Similarity=0.414 Sum_probs=217.3
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
.++|.+++.||+|+||+||+|.+ +|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46899999999999999999988 58999999986543 334578899999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEc--CCCeEEEEecCccccccCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN--KHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd--~~g~VKL~DFGLA~~l~~~~ 681 (785)
||++||+|.+++.. ....+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+|||+++.+....
T Consensus 103 E~~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 103 EFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCCCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EcCCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999998852 345799999999999999999999999999999999999996 46789999999998875432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 756 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip-----~~~L~~L 756 (785)
......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+.......... ...+.+|
T Consensus 181 -~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 259 (350)
T d1koaa2 181 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259 (350)
T ss_dssp -CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred -ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 2345689999999999999999999999999999999999999999999988888887665443321 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003935 757 IADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~ 776 (785)
|.+||. ||.+|||++|+++|
T Consensus 260 i~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 260 IRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999 99999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-48 Score=406.11 Aligned_cols=263 Identities=31% Similarity=0.572 Sum_probs=214.7
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEe
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 590 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~ 590 (785)
..+|++..++|.++++||+|+||+||+|.+. ++.||||++..... ....+.+.+|+.++.++ +|+|||.++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-cHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 3678899999999999999999999999862 36799999865433 34457788888888877 689999999
Q ss_pred ccccCC-CceeEEEEEcccchhhHHHHhhcc-------------cccchHHHHHHHHHHHHHHHHHHHhcccccccCCCC
Q 003935 591 GACTKP-PRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 656 (785)
Q Consensus 591 g~~~d~-~~l~LV~Ey~~gGSL~dlL~~~~~-------------~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKps 656 (785)
+++... ..+++||||+++|+|.++++.... ...+++.+++.++.||+.||+|||++|||||||||+
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence 987654 468999999999999999974321 235899999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCChH
Q 003935 657 NCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPE 733 (785)
Q Consensus 657 NILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~-~PF~~~~~~ 733 (785)
||||++++++||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||+||. .||.+....
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987644322 233567999999999999999999999999999999999975 588887766
Q ss_pred HHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 734 RVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 734 ~~v~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
..+......+.++..|+ ..+.+|+.+||. ||.+|||+.+|+++|+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 66666667777776664 369999999999 99999999999999998753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.7e-47 Score=399.33 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=213.0
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC----ce
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPP----RL 599 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~----~l 599 (785)
++|.+.+.||+|+||+||+|.+ +|+.||||++.+... +....+.|.+|+.+++.++|||||++++++.... .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 5699999999999999999987 589999999976654 3455678999999999999999999999987644 37
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
|+||||++|++|.+++. ..+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 87 ~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 99999999999999886 345799999999999999999999999999999999999999999999999999876543
Q ss_pred CC---CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CCh
Q 003935 680 SP---MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEG 751 (785)
Q Consensus 680 ~~---~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i-----p~~ 751 (785)
.. ......+||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..+....+......+.. -+.
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 243 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCH
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 22 2334567999999999999999999999999999999999999999999988888887776554321 134
Q ss_pred HHHHHHHHhhh-CCCCCC-CHHHHHHHHHhhh
Q 003935 752 PLGRLIADCWA-EPQERP-SCEEILSRLLDCE 781 (785)
Q Consensus 752 ~L~~LI~~CL~-DP~kRP-S~~EIL~~L~~l~ 781 (785)
.+.+||.+||. ||.+|| |++++++.|.++.
T Consensus 244 ~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 244 DLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 69999999999 999999 8999999998764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-47 Score=405.75 Aligned_cols=260 Identities=32% Similarity=0.557 Sum_probs=222.7
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEecc
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 592 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~ 592 (785)
.+|++..++|.+.+.||+|+||+||+|++. ++.||||++.... .....++|.+|+.+|++++||||++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 457778899999999999999999999864 3689999986543 44556789999999999999999999999
Q ss_pred ccCCCceeEEEEEcccchhhHHHHhhc---------------------ccccchHHHHHHHHHHHHHHHHHHHhcccccc
Q 003935 593 CTKPPRLSMITEYMELGSLYHLIHLSG---------------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 651 (785)
Q Consensus 593 ~~d~~~l~LV~Ey~~gGSL~dlL~~~~---------------------~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHr 651 (785)
|...+..+++|||+++|+|.+++.... ....+++..++.++.||+.||+|||+++||||
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr 164 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence 999999999999999999999986432 12348899999999999999999999999999
Q ss_pred cCCCCcEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCC-CCCC
Q 003935 652 DLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWE 728 (785)
Q Consensus 652 DLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~-~PF~ 728 (785)
||||+||||+.++++||+|||+++.+..... ......||+.|+|||.+.+..|+.++|||||||++|||++|. .||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 9999999999999999999999987643322 223567889999999999999999999999999999999996 5888
Q ss_pred CCChHHHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 729 GVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 729 ~~~~~~~v~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
+....+....+.. +..+.+|. ..+.+|+..||+ ||.+|||+.+|++.|+++.
T Consensus 245 ~~~~~e~~~~v~~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 245 GMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCHHHHHHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 8888888777654 44555553 369999999999 9999999999999999863
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.6e-48 Score=412.32 Aligned_cols=245 Identities=24% Similarity=0.441 Sum_probs=217.4
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
.++|.+++.||+|+||+||+|.+ +|+.||||++.+... .....+.+.+|+.+++.++|||||++++++.+++.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 46899999999999999999987 488999999975543 223357889999999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
|||+.||+|..++. ....+++..++.++.||+.||+|||++|||||||||+||||+.++++||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp ECCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eeecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 99999999999887 4557888999999999999999999999999999999999999999999999999887543
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhh
Q 003935 683 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCW 761 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~CL 761 (785)
....+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+..+....+.......+ .-+..+.+++.+||
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 236 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI 236 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 3467899999999999999999999999999999999999999999999988888877554332 22346999999999
Q ss_pred h-CCCCCC-----CHHHHHHH
Q 003935 762 A-EPQERP-----SCEEILSR 776 (785)
Q Consensus 762 ~-DP~kRP-----S~~EIL~~ 776 (785)
. ||.+|+ |++++++|
T Consensus 237 ~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 237 TRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CSCTTTCTTSSTTTTHHHHTS
T ss_pred hhCHHhccccchhhHHHHHcC
Confidence 9 999996 89999876
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-47 Score=416.62 Aligned_cols=246 Identities=26% Similarity=0.389 Sum_probs=216.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
++.|.+.+.||+|+||+||+|.+ +|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46799999999999999999987 58899999987654 233567889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEc--CCCeEEEEecCccccccCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN--KHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd--~~g~VKL~DFGLA~~l~~~~ 681 (785)
|||+||+|.+.+. .....+++..++.++.||+.||+|||++|||||||||+||||+ .++.+||+|||+|..+....
T Consensus 106 E~~~gg~L~~~~~--~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 106 EFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp ECCCCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EcCCCChHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 9999999998775 2345799999999999999999999999999999999999997 67899999999998876532
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHH
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRL 756 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i-----p~~~L~~L 756 (785)
......||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+.......+......... -+..+.+|
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 262 (352)
T d1koba_ 184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262 (352)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 234567999999999999999999999999999999999999999999998888888776544332 13468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003935 757 IADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~ 776 (785)
|.+||. ||.+|||+.|+++|
T Consensus 263 i~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 263 IKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999 99999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-48 Score=403.35 Aligned_cols=255 Identities=29% Similarity=0.553 Sum_probs=211.8
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEEC-----CeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPP 597 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~ 597 (785)
++.++|++.+.||+|+||+||+|.++ ...||||++.+... .....+.|.+|+.+|+.++|||||+++|+|.++
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~- 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP- 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-
Confidence 34578999999999999999999762 23689999876544 334467899999999999999999999999764
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 677 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 677 (785)
.+++||||+++|++.+.+.. ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred chheeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 68999999999999988763 3457999999999999999999999999999999999999999999999999999987
Q ss_pred cCCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC---
Q 003935 678 TDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE--- 750 (785)
Q Consensus 678 ~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip~--- 750 (785)
..... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+....+...+.+++.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccccc
Confidence 54322 2234467889999999999999999999999999999998 8999999999999999888887776654
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 751 GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 751 ~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
..+.+|+..||. ||.+|||+.+|++.|++.+
T Consensus 242 ~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 242 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 479999999999 9999999999999998753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.9e-47 Score=398.50 Aligned_cols=247 Identities=25% Similarity=0.414 Sum_probs=217.5
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh-------HHHHHHHHHHHHHhhcC-CCceeeEeccccC
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-------ENMEDFCNEISILSRLR-HPNVILFLGACTK 595 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~-------~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d 595 (785)
+++|.+.+.||+|+||+||+|.+ +|+.||||++.+..... ...+.+.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999988 68999999997665322 22356889999999997 9999999999999
Q ss_pred CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 596 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
++.+|+||||+++|+|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhee
Confidence 9999999999999999999973 4579999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCCCcccCcccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003935 676 IITDSPMRDSSSAGTPEWMAPELIRN------EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 749 (785)
Q Consensus 676 ~l~~~~~~~~~~~GT~~Y~APEvl~~------~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip 749 (785)
...... ......||+.|+|||.+.+ ..++.++||||+||++|+|+||+.||.+.+.......+.........+
T Consensus 159 ~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 159 QLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred EccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 876532 3456789999999999863 457889999999999999999999999999888888887766544332
Q ss_pred -----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 750 -----EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 750 -----~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+..+.+|+.+||+ ||.+|||++|+++|
T Consensus 238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2368999999999 99999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-47 Score=402.48 Aligned_cols=251 Identities=27% Similarity=0.545 Sum_probs=209.4
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC--Ce----EEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCce
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIWN--GT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 599 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~~--g~----~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l 599 (785)
.++|+++++||+|+||+||+|.+. |+ +||+|.+.... .....+.|.+|+.++++++|||||+++++|.++ ..
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 367999999999999999999873 33 58888876433 233467899999999999999999999999875 57
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccC
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 679 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 679 (785)
++++||+.+|+|.+.+.. ....+++..++.++.||+.||+|||++|||||||||+||||+.++++||+|||+++....
T Consensus 86 ~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred eEEEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 888999999999988763 456799999999999999999999999999999999999999999999999999998754
Q ss_pred CCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC---hHH
Q 003935 680 SPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE---GPL 753 (785)
Q Consensus 680 ~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~~~v~~i~~~~~~~~ip~---~~L 753 (785)
.... .....||+.|+|||++.++.|+.++|||||||+||||+| |..||.+.+..++...+ ..+.+++.|. ..+
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i-~~~~~~~~p~~~~~~~ 242 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDV 242 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH-HHTCCCCCCTTBCHHH
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCCcccCHHH
Confidence 3322 234568999999999999999999999999999999998 78899988777665544 4455555553 469
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 754 GRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 754 ~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
.+|+.+||. ||.+|||+.+|+++|..+.
T Consensus 243 ~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 243 YMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 999999999 9999999999999988763
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-47 Score=413.29 Aligned_cols=245 Identities=21% Similarity=0.359 Sum_probs=216.8
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 602 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV 602 (785)
.++|.+++.||+|+||+||+|.+ +|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++.+...+++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 47899999999999999999988 488999999875432 223356789999999999999999999999999999999
Q ss_pred EEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC
Q 003935 603 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 682 (785)
Q Consensus 603 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 682 (785)
|||+.+|+|..++.. .+.+++..++.++.||+.||.|||++|||||||||+||||+.++++||+|||+|+.+...
T Consensus 120 ~e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 999999999999873 457999999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CChHHHHHHHHhh
Q 003935 683 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PEGPLGRLIADCW 761 (785)
Q Consensus 683 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i-p~~~L~~LI~~CL 761 (785)
....+||+.|+|||++.+..|+.++|||||||+||||+||+.||.+.+.......+.......+. -+..+.+||.+||
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 273 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHS
T ss_pred -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHh
Confidence 24568999999999999999999999999999999999999999999988888888765543321 2346999999999
Q ss_pred h-CCCCCC-----CHHHHHHH
Q 003935 762 A-EPQERP-----SCEEILSR 776 (785)
Q Consensus 762 ~-DP~kRP-----S~~EIL~~ 776 (785)
. ||.+|+ |++++++|
T Consensus 274 ~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 274 QVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CSCTTTCTTSSTTTTHHHHTS
T ss_pred hhCHHhccccccccHHHHHcC
Confidence 9 999994 89999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=399.15 Aligned_cols=260 Identities=29% Similarity=0.540 Sum_probs=225.8
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEE-------CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEec
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 591 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~-------~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g 591 (785)
..|++..++|.++++||+|+||+||+|++ .++.||||++..... ......|.+|+.+++.+ +|||||++++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC-HHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 46889999999999999999999999975 246899999876543 44567899999999999 6999999999
Q ss_pred cccCCCceeEEEEEcccchhhHHHHhhc---------------ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCC
Q 003935 592 ACTKPPRLSMITEYMELGSLYHLIHLSG---------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 656 (785)
Q Consensus 592 ~~~d~~~l~LV~Ey~~gGSL~dlL~~~~---------------~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKps 656 (785)
+|.+...+++||||+++|+|.++++... ....+++..++.++.||+.||+|||++|||||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 9999999999999999999999997432 2236899999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 003935 657 NCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 733 (785)
Q Consensus 657 NILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~ 733 (785)
|||++.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||+| |.+||......
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987754322 2234578999999999999999999999999999999998 56677777777
Q ss_pred HHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 734 RVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 734 ~~v~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
..+..+...+.++..+. ..+.+||.+||+ ||.+|||+.+|++.|++.
T Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 77777777777777664 469999999999 999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=408.44 Aligned_cols=248 Identities=25% Similarity=0.398 Sum_probs=215.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeecccc-ChHHHHHHHHHHHHHh-hcCCCceeeEeccccCCCceeE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILS-RLRHPNVILFLGACTKPPRLSM 601 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~-~~~~~e~f~~EI~iLk-~L~HPNIVkL~g~~~d~~~l~L 601 (785)
.++|.+++.||+|+||+||+|++ +|+.||||++.+... .....+.+..|+.++. .++|||||++++++.+++.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 36899999999999999999988 689999999975432 1223466777877765 6899999999999999999999
Q ss_pred EEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCC
Q 003935 602 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 681 (785)
Q Consensus 602 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 681 (785)
||||+++|+|.+++. ....+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++......
T Consensus 81 vmEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 999999999999997 34578999999999999999999999999999999999999999999999999998776555
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHh
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADC 760 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~-ip~~~L~~LI~~C 760 (785)
......+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+...+...+.......+ .-+..+.+||.+|
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHh
Confidence 555667899999999999999999999999999999999999999999999888888766543222 1245799999999
Q ss_pred hh-CCCCCCCHH-HHHHH
Q 003935 761 WA-EPQERPSCE-EILSR 776 (785)
Q Consensus 761 L~-DP~kRPS~~-EIL~~ 776 (785)
|. ||.+||++. ++++|
T Consensus 238 L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 238 FVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp SCSSGGGSBTTBSCGGGS
T ss_pred cccCCCCCcCHHHHHHhC
Confidence 99 999999995 77653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-47 Score=398.11 Aligned_cols=242 Identities=23% Similarity=0.252 Sum_probs=203.5
Q ss_pred eeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChH---HHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEEEc
Q 003935 532 GTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE---NMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 606 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~---~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~Ey~ 606 (785)
+++||+|+||+||+|.+ +|+.||||++........ ..+.+.+|+.+++.++|||||++++++.+++.+|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999999987 588999999865543221 2356889999999999999999999999999999999999
Q ss_pred ccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003935 607 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 686 (785)
Q Consensus 607 ~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~ 686 (785)
.++++..+.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCC
T ss_pred cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccc
Confidence 9988876654 4567999999999999999999999999999999999999999999999999999887665555556
Q ss_pred CCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------------------
Q 003935 687 SAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------------- 746 (785)
Q Consensus 687 ~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~------------------- 746 (785)
.+||+.|+|||++.. ..|+.++|||||||++|||+||..||.+....+....+......+
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 789999999999865 468999999999999999999999999988888777665321110
Q ss_pred --C--------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 --E--------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 --~--------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
. ..+..+.+|+.+||. ||++|||++|+|+|
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0 012358889999999 99999999999985
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=398.01 Aligned_cols=260 Identities=30% Similarity=0.570 Sum_probs=219.8
Q ss_pred ccccccCCCeeEeeEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeE
Q 003935 520 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILF 589 (785)
Q Consensus 520 ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL 589 (785)
.+|.+..++|.+++.||+|+||.||+|.+. +..||||++.... ......++.+|+..+.++ +|||||++
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 358899999999999999999999999752 2469999986544 445567899999999888 79999999
Q ss_pred eccccCCCceeEEEEEcccchhhHHHHhhc-------------ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCC
Q 003935 590 LGACTKPPRLSMITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 656 (785)
Q Consensus 590 ~g~~~d~~~l~LV~Ey~~gGSL~dlL~~~~-------------~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKps 656 (785)
+++|.+++.+++||||+.+|+|.+++.... ....+++.+++.++.||+.||+|||++|||||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 999999999999999999999999997432 1246899999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 003935 657 NCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 733 (785)
Q Consensus 657 NILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLT-G~~PF~~~~~~ 733 (785)
|||++.++.+||+|||+++....... ......+|+.|+|||.+.++.|+.++|||||||++|||++ |..||.+....
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 99999999999999999987754332 2234578999999999999999999999999999999998 68899888887
Q ss_pred HHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 734 RVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 734 ~~v~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
.+...+ ..+.++..|. ..+.+|+.+||+ ||.+|||+.||++.|+++.
T Consensus 245 ~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 245 ELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHH-HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 766555 4466666654 469999999999 9999999999999998874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=397.17 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=210.6
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
.++|++.++||+|+||+||+|++ +|+.||||++..........+.+.+|+.+|++++|||||++++++.++..+|+||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 36899999999999999999998 4889999999765544444578999999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 683 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 683 (785)
||+.++.+..... .....+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+........
T Consensus 81 e~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 81 EFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp ECCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred eecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 9998765554433 24567999999999999999999999999999999999999999999999999999887665555
Q ss_pred CCCCCCCCcccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---------------
Q 003935 684 DSSSAGTPEWMAPELIRNEP-FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE--------------- 747 (785)
Q Consensus 684 ~~~~~GT~~Y~APEvl~~~~-~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~--------------- 747 (785)
.....||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+.......+......+.
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 55678999999999987765 57899999999999999999999999888777776643211100
Q ss_pred -C--------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH--HHhh
Q 003935 748 -I--------------PEGPLGRLIADCWA-EPQERPSCEEILSR--LLDC 780 (785)
Q Consensus 748 -i--------------p~~~L~~LI~~CL~-DP~kRPS~~EIL~~--L~~l 780 (785)
. -...+.+|+.+||. ||.+|||+.|+++| ++++
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0 01347889999999 99999999999987 5544
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=398.77 Aligned_cols=260 Identities=32% Similarity=0.577 Sum_probs=225.0
Q ss_pred cccccccCCCeeEeeEEeeeCcEEEEEEEEC-------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEec
Q 003935 519 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 591 (785)
Q Consensus 519 ~ee~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g 591 (785)
.++|+++.++|.++++||+|+||+||+|.+. ++.||||++.... .......|.+|+.++++++|||||++++
T Consensus 12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence 4679999999999999999999999999763 4689999987543 4455678999999999999999999999
Q ss_pred cccCCCceeEEEEEcccchhhHHHHhhc-------ccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC
Q 003935 592 ACTKPPRLSMITEYMELGSLYHLIHLSG-------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 664 (785)
Q Consensus 592 ~~~d~~~l~LV~Ey~~gGSL~dlL~~~~-------~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g 664 (785)
+|...+..++||||+.+|+|.+++.... ....+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence 9999999999999999999999886432 113468899999999999999999999999999999999999999
Q ss_pred eEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHh
Q 003935 665 TVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVAN 741 (785)
Q Consensus 665 ~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG-~~PF~~~~~~~~v~~i~~ 741 (785)
++||+|||+++.+..... ......||+.|+|||.+.+..++.++|||||||++|||+|| ..||.+.+..+....+..
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~ 250 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 999999999987644322 22345689999999999999999999999999999999998 478988888888877655
Q ss_pred cCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 742 EGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 742 ~~~~~~ip~---~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
+.+++.|. ..+.+|+.+||+ ||.+|||+.+|+++|++.
T Consensus 251 -~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 251 -GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred -CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 44455543 469999999999 999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-47 Score=404.30 Aligned_cols=245 Identities=21% Similarity=0.312 Sum_probs=214.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~ 603 (785)
+++|.+++.||+|+||+||+|.+ +|+.||||++..... ....+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 57899999999999999999988 588999999976532 3356889999999999999999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC--CeEEEEecCccccccCCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH--WTVKICDFGLSRIITDSP 681 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~--g~VKL~DFGLA~~l~~~~ 681 (785)
|||+||+|.+++.. ....+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 81 E~~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 81 EFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred ecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999999999862 23479999999999999999999999999999999999999854 589999999998765432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHH
Q 003935 682 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRL 756 (785)
Q Consensus 682 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i-----p~~~L~~L 756 (785)
......+|+.|+|||.+.+..|+.++|||||||++|+|++|..||.+.+.......+......... -+..+.+|
T Consensus 159 -~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T d1tkia_ 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred -cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHH
Confidence 233567899999999999999999999999999999999999999999999888888776544332 13458999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003935 757 IADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 757 I~~CL~-DP~kRPS~~EIL~~ 776 (785)
+.+||. ||.+|||+.|+++|
T Consensus 238 i~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 238 VDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999 99999999999985
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=398.78 Aligned_cols=255 Identities=32% Similarity=0.586 Sum_probs=213.5
Q ss_pred ccCCCeeEeeEEeeeCcEEEEEEEE--CCe--EEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccCCCc
Q 003935 524 IDFSELTVGTRVGIGFFGEVFRGIW--NGT--DVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPR 598 (785)
Q Consensus 524 i~~s~y~i~k~LG~G~fG~VYkg~~--~g~--~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d~~~ 598 (785)
+++++|++.++||+|+||+||+|.+ +|. .||||.+.... ..+..+.|.+|+.+|+++ +|||||+++++|.+.+.
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence 4678999999999999999999987 454 46777765333 233457899999999998 79999999999999999
Q ss_pred eeEEEEEcccchhhHHHHhh-------------cccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCe
Q 003935 599 LSMITEYMELGSLYHLIHLS-------------GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 665 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~-------------~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~ 665 (785)
+++||||+++|+|.++++.. .....+++..++.++.||+.||.|||+++|+||||||+|||++.++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence 99999999999999999643 12457899999999999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHhcCC
Q 003935 666 VKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGS 744 (785)
Q Consensus 666 VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~-~PF~~~~~~~~v~~i~~~~~ 744 (785)
+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|. .||.+.+..++...+. .+.
T Consensus 166 ~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~-~~~ 243 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGY 243 (309)
T ss_dssp EEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-GTC
T ss_pred eEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH-hcC
Confidence 9999999998654322 223557899999999999999999999999999999999975 5788888887777654 455
Q ss_pred CCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 745 RLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 745 ~~~ip~---~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
++..|. ..+.+||.+||. ||++|||+.+|+++|+++.
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 555553 469999999999 9999999999999998865
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.3e-46 Score=406.68 Aligned_cols=247 Identities=24% Similarity=0.328 Sum_probs=203.9
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChH-HHHHHH---HHHHHHhhcCCCceeeEeccccCCCc
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE-NMEDFC---NEISILSRLRHPNVILFLGACTKPPR 598 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~-~~e~f~---~EI~iLk~L~HPNIVkL~g~~~d~~~ 598 (785)
..++|.+.+.||+|+||+||+|.+ +|+.||||++.+...... ....+. .|+.+++.++|||||++++++.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 467999999999999999999988 588999999865443211 122333 44677778889999999999999999
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
+|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+.
T Consensus 82 ~~ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999999973 4578999999999999999999999999999999999999999999999999998775
Q ss_pred CCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-hcCCCCCCC---ChHH
Q 003935 679 DSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIP---EGPL 753 (785)
Q Consensus 679 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~-~~~~~~~ip---~~~L 753 (785)
.. .....+||+.|+|||++.. ..|+.++|||||||+||||+||+.||.+........... ........+ +..+
T Consensus 159 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (364)
T d1omwa3 159 KK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236 (364)
T ss_dssp SS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHH
T ss_pred CC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHH
Confidence 43 2345689999999999964 568999999999999999999999998754433222111 122223333 3469
Q ss_pred HHHHHHhhh-CCCCCCC-----HHHHHHH
Q 003935 754 GRLIADCWA-EPQERPS-----CEEILSR 776 (785)
Q Consensus 754 ~~LI~~CL~-DP~kRPS-----~~EIL~~ 776 (785)
.+||.+||. ||.+||| ++++++|
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 999999999 9999999 7888875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.7e-46 Score=389.19 Aligned_cols=248 Identities=21% Similarity=0.288 Sum_probs=208.8
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
.++|.+.++||+|+||+||+|.+ +|+.||||++..........+.+.+|+.+|+.++|||||++++++..++..++++|
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 36899999999999999999988 58899999997665544446789999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
|+.++.+..+.. ..+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++..........
T Consensus 81 ~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 81 HLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp CCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred eehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 999888877765 45789999999999999999999999999999999999999999999999999998876655445
Q ss_pred CCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----------------
Q 003935 685 SSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---------------- 747 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~---------------- 747 (785)
....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+.......+......+.
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 56679999999999875 4578999999999999999999999999888777666543111100
Q ss_pred --------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 --------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 --------------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.....+.+|+.+||+ ||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 012357899999999 99999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=391.72 Aligned_cols=250 Identities=29% Similarity=0.519 Sum_probs=206.4
Q ss_pred EeeEEeeeCcEEEEEEEEC-----CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC-CCceeEEEE
Q 003935 531 VGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-PPRLSMITE 604 (785)
Q Consensus 531 i~k~LG~G~fG~VYkg~~~-----g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d-~~~l~LV~E 604 (785)
..++||+|+||+||+|.+. ...||||++... ......++|.+|+++|++++|||||+++|++.+ ++.+++|||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 3678999999999999873 235899998643 345567889999999999999999999999865 457999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCC--
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-- 682 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~-- 682 (785)
|+++|+|.+++.. ....+++..++.++.|++.||.|||+.+|+||||||+||||++++.+||+|||+++.......
T Consensus 110 ~~~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 110 YMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EeecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999999998863 445678889999999999999999999999999999999999999999999999987654322
Q ss_pred --CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC---hHHHHHH
Q 003935 683 --RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRLI 757 (785)
Q Consensus 683 --~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~ip~---~~L~~LI 757 (785)
......||+.|+|||.+....++.++||||||+++|||+||..||...............+.++..|. ..+.+|+
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li 267 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVM 267 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHH
Confidence 22235689999999999999999999999999999999998887765443333333334455555553 4799999
Q ss_pred HHhhh-CCCCCCCHHHHHHHHHhhhhc
Q 003935 758 ADCWA-EPQERPSCEEILSRLLDCEYS 783 (785)
Q Consensus 758 ~~CL~-DP~kRPS~~EIL~~L~~l~~s 783 (785)
.+||. ||.+||++.||+++|+.+..+
T Consensus 268 ~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 268 LKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 99999 999999999999999987643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=389.00 Aligned_cols=253 Identities=25% Similarity=0.334 Sum_probs=208.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEEC---CeEEEEEEeeccccChHHHHHHHHHHHHHhhc---CCCceeeEecccc-----C
Q 003935 527 SELTVGTRVGIGFFGEVFRGIWN---GTDVAIKVFLEQDLTAENMEDFCNEISILSRL---RHPNVILFLGACT-----K 595 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~~---g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L---~HPNIVkL~g~~~-----d 595 (785)
++|.++++||+|+||+||+|.+. ++.||||++............+.+|+.+|+.+ +||||++++++|. .
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 68999999999999999999872 56799999976554433334566788887766 7999999999984 3
Q ss_pred CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 596 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
...++++|||+.++.+..... .....+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||++.
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 346899999999988765543 345678999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------
Q 003935 676 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL--------- 746 (785)
Q Consensus 676 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~--------- 746 (785)
..... .......||+.|+|||++.+.+|+.++|||||||++|||++|+.||.+.+.......+......+
T Consensus 165 ~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 165 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred hhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 65433 23356789999999999999999999999999999999999999999998887777665321100
Q ss_pred -------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH--HHhhhh
Q 003935 747 -------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR--LLDCEY 782 (785)
Q Consensus 747 -------------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~--L~~l~~ 782 (785)
...+..+.+|+.+||. ||.+|||+.|+++| +++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 0012357889999999 99999999999987 665543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=397.09 Aligned_cols=242 Identities=22% Similarity=0.395 Sum_probs=198.4
Q ss_pred CCCeeEee-EEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhc-CCCceeeEeccccC----CC
Q 003935 526 FSELTVGT-RVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTK----PP 597 (785)
Q Consensus 526 ~s~y~i~k-~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L-~HPNIVkL~g~~~d----~~ 597 (785)
.++|.+.. .||+|+||+||+|.+ +++.||||++... ..+.+|+.++.++ +|||||+++++|.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 36898875 599999999999987 5889999998542 4567899987655 89999999999865 45
Q ss_pred ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC---CCeEEEEecCcc
Q 003935 598 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLS 674 (785)
Q Consensus 598 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~---~g~VKL~DFGLA 674 (785)
.+|+|||||+||+|.+++... ....+++.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||++
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 689999999999999999732 2457999999999999999999999999999999999999975 567999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCC---
Q 003935 675 RIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS--RLEIP--- 749 (785)
Q Consensus 675 ~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~--~~~ip--- 749 (785)
+...... .....+||+.|+|||++.+..|+.++|||||||+||+|+||+.||.+.........+..... ....|
T Consensus 162 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (335)
T d2ozaa1 162 KETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240 (335)
T ss_dssp EECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred eeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc
Confidence 8776543 33567899999999999999999999999999999999999999987665444444333221 11222
Q ss_pred ----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 750 ----EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 750 ----~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+..+.+||.+||. ||.+|||+.++++|
T Consensus 241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2358899999999 99999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=385.23 Aligned_cols=239 Identities=25% Similarity=0.413 Sum_probs=199.5
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccCh----HHHHHHHHHHHHHhhcC--CCceeeEeccccCCCc
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA----ENMEDFCNEISILSRLR--HPNVILFLGACTKPPR 598 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~----~~~e~f~~EI~iLk~L~--HPNIVkL~g~~~d~~~ 598 (785)
++|.+++.||+|+||+||+|.+ +|+.||||++.+..... .....+.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999988 58899999987654321 11234678999999997 8999999999999999
Q ss_pred eeEEEEEccc-chhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC-CCeEEEEecCcccc
Q 003935 599 LSMITEYMEL-GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRI 676 (785)
Q Consensus 599 l~LV~Ey~~g-GSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~-~g~VKL~DFGLA~~ 676 (785)
+|+||||+.+ +++.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 9999999975 67777776 3457999999999999999999999999999999999999985 57999999999987
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCCChHHH
Q 003935 677 ITDSPMRDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEGPLG 754 (785)
Q Consensus 677 l~~~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~-~~~ip~~~L~ 754 (785)
.... ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||.... .+..... ....-+..+.
T Consensus 161 ~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~~ 232 (273)
T d1xwsa_ 161 LKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQ 232 (273)
T ss_dssp CCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHH
T ss_pred cccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHHHH
Confidence 6543 3346789999999999987765 567899999999999999999997632 1222221 1122245799
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003935 755 RLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 755 ~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
+|+.+||. ||.+|||++|+++|
T Consensus 233 ~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 233 HLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHccCCHhHCcCHHHHhcC
Confidence 99999999 99999999999985
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-45 Score=385.76 Aligned_cols=247 Identities=28% Similarity=0.487 Sum_probs=200.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHH--HHHHHhhcCCCceeeEeccccCCC----cee
Q 003935 527 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCN--EISILSRLRHPNVILFLGACTKPP----RLS 600 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~--EI~iLk~L~HPNIVkL~g~~~d~~----~l~ 600 (785)
.+|.+.++||+|+||+||+|+++|+.||||++.... .+.+.. |+..+..++|||||+++++|.+.. .++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 468899999999999999999999999999985432 233444 455556789999999999997654 579
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh--------cccccccCCCCcEEEcCCCeEEEEecC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR--------MKIVHRDLKSANCLVNKHWTVKICDFG 672 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs--------~gIIHrDLKpsNILLd~~g~VKL~DFG 672 (785)
+||||+++|+|.++++. ..+++..++.++.|++.||+|||+ +|||||||||+||||+.++.+||+|||
T Consensus 78 lv~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 99999999999999963 368999999999999999999996 599999999999999999999999999
Q ss_pred ccccccCCCC----CCCCCCCCCcccCccccccCC------CCchhhHHHHHHHHHHHHhCCCCCCC-------------
Q 003935 673 LSRIITDSPM----RDSSSAGTPEWMAPELIRNEP------FTEKCDIFSLGVIMWELCTLNRPWEG------------- 729 (785)
Q Consensus 673 LA~~l~~~~~----~~~~~~GT~~Y~APEvl~~~~------~s~ksDVWSLGvILyELLTG~~PF~~------------- 729 (785)
+++....... ......||+.|+|||++.+.. ++.++|||||||+||||+||..||..
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 9988754322 223567999999999987643 56789999999999999999877632
Q ss_pred --CChHHHHHHHHhcCCCCCCCCh--------HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003935 730 --VLPERVVYAVANEGSRLEIPEG--------PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 782 (785)
Q Consensus 730 --~~~~~~v~~i~~~~~~~~ip~~--------~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~~ 782 (785)
...............++.++.. .+.+|+.+||+ ||.+|||+.||+++|+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 2233444444455555655532 37889999999 99999999999999998753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-44 Score=371.20 Aligned_cols=247 Identities=22% Similarity=0.283 Sum_probs=211.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCCceeEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 604 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~~l~LV~E 604 (785)
++|++.++||+|+||+||+|++ +|+.||||++..........+.+.+|+.+|+.++||||++++++|.+...++++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 6899999999999999999998 57889999998776666667899999999999999999999999999999999999
Q ss_pred EcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCCCCCC
Q 003935 605 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 684 (785)
Q Consensus 605 y~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 684 (785)
++.+++|..++. ..+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++.........
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 999999988876 45678999999999999999999999999999999999999999999999999999876655455
Q ss_pred CCCCCCCcccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHhcCCCCC---------------
Q 003935 685 SSSAGTPEWMAPELIRNEP-FTEKCDIFSLGVIMWELCTLNRPW-EGVLPERVVYAVANEGSRLE--------------- 747 (785)
Q Consensus 685 ~~~~GT~~Y~APEvl~~~~-~s~ksDVWSLGvILyELLTG~~PF-~~~~~~~~v~~i~~~~~~~~--------------- 747 (785)
....+++.|+|||++.... ++.++|||||||++|||++|+.|| .+.+..+....+......+.
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 5567888999999987665 689999999999999999999986 44555555554432111100
Q ss_pred ------------C---CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 ------------I---PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 ------------i---p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
. -...+.+|+.+||. ||.+|||++|+|+|
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 01257889999999 99999999999985
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-44 Score=379.07 Aligned_cols=248 Identities=25% Similarity=0.371 Sum_probs=202.8
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC--------
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-------- 595 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d-------- 595 (785)
.++|++.++||+|+||+||+|++ +|+.||||++..........+.+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999988 58899999987665555556778999999999999999999998754
Q ss_pred CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 596 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
...++++|||+.++.+..... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 346899999999887765543 45678999999999999999999999999999999999999999999999999998
Q ss_pred cccCCC----CCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--
Q 003935 676 IITDSP----MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-- 748 (785)
Q Consensus 676 ~l~~~~----~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~i-- 748 (785)
.+.... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+.........
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 765322 122345799999999998765 6899999999999999999999999988877766655432111100
Q ss_pred -------------------------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 749 -------------------------------PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 749 -------------------------------p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
....+.+|+.+||. ||++|||++|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 01235679999999 99999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-44 Score=382.00 Aligned_cols=246 Identities=27% Similarity=0.351 Sum_probs=202.6
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC--
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP-- 597 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~-- 597 (785)
|++ .+.|.++++||+|+||+||+|.+ +|+.||||++..........+.+.+|+.+|+.++|||||+++++|...+
T Consensus 14 ~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 14 WEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92 (346)
T ss_dssp ECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred eec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence 444 47899999999999999999988 4899999999876666667788999999999999999999999987654
Q ss_pred ----ceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCc
Q 003935 598 ----RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGL 673 (785)
Q Consensus 598 ----~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGL 673 (785)
.+|+||||+ +.+|..+.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cccceEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccc
Confidence 479999999 567777664 34699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------
Q 003935 674 SRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------ 746 (785)
Q Consensus 674 A~~l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~------ 746 (785)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......+
T Consensus 168 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 168 ARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp CEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eeccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 9876543 345689999999999876 457899999999999999999999999887766655443211110
Q ss_pred --------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 --------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 --------------------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.-....+.+||.+||. ||.+|||+.|+|+|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0012357889999999 99999999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=380.95 Aligned_cols=242 Identities=23% Similarity=0.274 Sum_probs=200.8
Q ss_pred CeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC------CCce
Q 003935 528 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK------PPRL 599 (785)
Q Consensus 528 ~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d------~~~l 599 (785)
+|+..++||+|+||+||+|++ +|+.||||++...... +.+|+.+|++++||||++++++|.. ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 688999999999999999998 5889999999765432 2379999999999999999999843 3347
Q ss_pred eEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCC-eEEEEecCcccccc
Q 003935 600 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIIT 678 (785)
Q Consensus 600 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g-~VKL~DFGLA~~l~ 678 (785)
++||||++++.+..+.........+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 89999999876666655444567899999999999999999999999999999999999999765 89999999998775
Q ss_pred CCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC------------
Q 003935 679 DSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR------------ 745 (785)
Q Consensus 679 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~------------ 745 (785)
... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+......
T Consensus 175 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 175 RGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp TTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred CCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 433 3345689999999998865 56899999999999999999999999988877766665431100
Q ss_pred ------C------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 746 ------L------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 746 ------~------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
. ......+.+|+.+||. ||.+|||+.|+++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0012358899999999 99999999999976
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-43 Score=376.35 Aligned_cols=245 Identities=27% Similarity=0.352 Sum_probs=199.9
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccCCC----cee
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP----RLS 600 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d~~----~l~ 600 (785)
++|.++++||+|+||+||+|.+ +|+.||||++.+.. .....+.+.+|+.+|+.++||||+++++++.... ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 5699999999999999999987 58999999986544 3445678999999999999999999999986643 245
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCccccccCC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 680 (785)
++++|+.+|+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++......
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 66677889999999862 36999999999999999999999999999999999999999999999999999876432
Q ss_pred C---CCCCCCCCCCcccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------
Q 003935 681 P---MRDSSSAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL---------- 746 (785)
Q Consensus 681 ~---~~~~~~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~---------- 746 (785)
. ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||.+................+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 2 1234567999999999985 4567899999999999999999999999877665554443211110
Q ss_pred --------------CC--------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 --------------EI--------PEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 --------------~i--------p~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.. -+..+.+|+.+||. ||.+|||+.++|+|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 12357899999999 99999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-43 Score=374.47 Aligned_cols=247 Identities=25% Similarity=0.314 Sum_probs=206.2
Q ss_pred ccccCCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC----
Q 003935 522 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK---- 595 (785)
Q Consensus 522 ~~i~~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d---- 595 (785)
|++ .++|.+.++||+|+||+||+|.+ +|+.||||++.+........+.+.+|+.+|+.++|||||++++++..
T Consensus 14 ~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~ 92 (348)
T d2gfsa1 14 WEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 92 (348)
T ss_dssp EEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSST
T ss_pred ccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccc
Confidence 444 37899999999999999999987 58999999998776666677889999999999999999999999853
Q ss_pred -CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcc
Q 003935 596 -PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 674 (785)
Q Consensus 596 -~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 674 (785)
....+++++|+.+|+|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++
T Consensus 93 ~~~~~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 93 EEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp TTCCCCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ccCceEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchh
Confidence 334577788899999999885 346999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------
Q 003935 675 RIITDSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE------ 747 (785)
Q Consensus 675 ~~l~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~~------ 747 (785)
..... ......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+.......+........
T Consensus 169 ~~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 169 RHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp -CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 76543 23456789999999987665 468899999999999999999999998887776666543322111
Q ss_pred --------------------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 748 --------------------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 748 --------------------------ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
-....+.+||.+||. ||.+|||+.|+|+|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 012357889999999 99999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-42 Score=360.97 Aligned_cols=247 Identities=19% Similarity=0.268 Sum_probs=194.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCce-eeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNI-VkL~g~~~d~~~l~LV~ 603 (785)
++|+++++||+|+||+||+|.+ +|+.||||++...... +.+..|+++++.++|+|+ +.+.+++.+.+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 4699999999999999999987 4889999998765432 347789999999987665 45556667778889999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEc---CCCeEEEEecCccccccCC
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN---KHWTVKICDFGLSRIITDS 680 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd---~~g~VKL~DFGLA~~l~~~ 680 (785)
||+.+ +|.+.+.. ....+++..++.++.|++.||+|||++|||||||||+|||++ .+..+||+|||+|+.+...
T Consensus 83 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 83 ELLGP-SLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp ECCCC-BHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEcCC-chhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 99965 55554432 456799999999999999999999999999999999999986 4557999999999987543
Q ss_pred CC-------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---cCCCC----
Q 003935 681 PM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN---EGSRL---- 746 (785)
Q Consensus 681 ~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~---~~~~~---- 746 (785)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||...........+.. .....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 21 22356799999999999999999999999999999999999999987655443332211 11011
Q ss_pred --CCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003935 747 --EIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDC 780 (785)
Q Consensus 747 --~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l 780 (785)
.--+..+.+|+..||. ||.+||++.+|.+.|+++
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1113468999999999 999999999998888765
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=373.64 Aligned_cols=243 Identities=24% Similarity=0.303 Sum_probs=195.3
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCceeeEeccccC------CCc
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK------PPR 598 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNIVkL~g~~~d------~~~ 598 (785)
++|++.++||+|+||+||+|.+ +|+.||||++............+.+|+.+++.++|||||+++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6799999999999999999998 48999999998777777777889999999999999999999999854 357
Q ss_pred eeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccccc
Q 003935 599 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 678 (785)
Q Consensus 599 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 678 (785)
+|+||||+.++.+..+ . ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++...
T Consensus 97 ~~iv~Ey~~~~l~~~~-~-----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI-Q-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSEEHHHHH-T-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eEEEEeccchHHHHhh-h-----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence 8999999987665543 2 358999999999999999999999999999999999999999999999999988765
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------
Q 003935 679 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------ 746 (785)
Q Consensus 679 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~~~~~------------ 746 (785)
.. ......++|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+......+
T Consensus 171 ~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 171 TS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred cc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 43 23356679999999999999999999999999999999999999999887766655543211100
Q ss_pred ----------C------------CC---------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 747 ----------E------------IP---------EGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 747 ----------~------------ip---------~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
. .+ ...+.+|+.+||. ||++|||++|+|+|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 00 1136789999999 99999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=378.44 Aligned_cols=249 Identities=25% Similarity=0.397 Sum_probs=203.9
Q ss_pred cCCCeeEeeEEeeeCcEEEEEEEE-----CCeEEEEEEeecccc--ChHHHHHHHHHHHHHhhcCC-CceeeEeccccCC
Q 003935 525 DFSELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDL--TAENMEDFCNEISILSRLRH-PNVILFLGACTKP 596 (785)
Q Consensus 525 ~~s~y~i~k~LG~G~fG~VYkg~~-----~g~~VAVKil~~~~~--~~~~~e~f~~EI~iLk~L~H-PNIVkL~g~~~d~ 596 (785)
..++|.+++.||+|+||+||+|.+ +|+.||||++.+... .....+.+.+|+.++++++| |||+++++++.+.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 458899999999999999999976 378899999865432 12224567899999999976 8999999999999
Q ss_pred CceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 597 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 597 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
..++++|||+.+|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CceeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999987 344678899999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC-CCCCCCCCCcccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCCCCC--
Q 003935 677 ITDSPM-RDSSSAGTPEWMAPELIRNE--PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE--GSRLEIP-- 749 (785)
Q Consensus 677 l~~~~~-~~~~~~GT~~Y~APEvl~~~--~~s~ksDVWSLGvILyELLTG~~PF~~~~~~~~v~~i~~~--~~~~~ip-- 749 (785)
+..... ......|++.|+|||.+.+. .++.++|||||||+||+|+||+.||.+.........+... ...+.+|
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence 643222 23456799999999999764 4688999999999999999999999776444333333321 1122232
Q ss_pred -ChHHHHHHHHhhh-CCCCCC-----CHHHHHHH
Q 003935 750 -EGPLGRLIADCWA-EPQERP-----SCEEILSR 776 (785)
Q Consensus 750 -~~~L~~LI~~CL~-DP~kRP-----S~~EIL~~ 776 (785)
+..+.+|+.+||. ||.+|| +++|+++|
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 3469999999999 999999 48899875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.9e-42 Score=364.15 Aligned_cols=239 Identities=20% Similarity=0.310 Sum_probs=195.0
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccC--CCcee
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTK--PPRLS 600 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d--~~~l~ 600 (785)
.++|+++++||+|+||+||+|++ +|+.||||++.... .+.+.+|+.+|+.++ ||||+++++++.. ...++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 46899999999999999999998 58999999986432 367889999999996 9999999999864 45699
Q ss_pred EEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCC-CeEEEEecCccccccC
Q 003935 601 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIITD 679 (785)
Q Consensus 601 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~-g~VKL~DFGLA~~l~~ 679 (785)
+||||+.+++|..+. +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 109 ~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999999997653 368999999999999999999999999999999999999865 4799999999987654
Q ss_pred CCCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHh-------------cCC
Q 003935 680 SPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVAN-------------EGS 744 (785)
Q Consensus 680 ~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvILyELLTG~~PF~~~~~~-~~v~~i~~-------------~~~ 744 (785)
.. .....++|+.|+|||.+.+. .++.++||||+||++|+|++|+.||...... .....+.. ...
T Consensus 183 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 183 GQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp TC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 32 33466899999999998765 4799999999999999999999999765432 22111110 000
Q ss_pred CC-------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003935 745 RL-------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 776 (785)
Q Consensus 745 ~~-------------------------~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~ 776 (785)
.. ..-...+.+||.+||. ||.+|||++|+|+|
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0012357889999999 99999999999975
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.3e-41 Score=355.25 Aligned_cols=247 Identities=18% Similarity=0.254 Sum_probs=203.1
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCC-CceeeEeccccCCCceeEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH-PNVILFLGACTKPPRLSMIT 603 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~H-PNIVkL~g~~~d~~~l~LV~ 603 (785)
++|++++.||+|+||+||+|++ +|+.||||++...... ..+.+|+++++.++| +||+.+++++.+....++||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 6799999999999999999987 5889999998654322 346788999999975 89999999999999999999
Q ss_pred EEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcC-----CCeEEEEecCcccccc
Q 003935 604 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-----HWTVKICDFGLSRIIT 678 (785)
Q Consensus 604 Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~-----~g~VKL~DFGLA~~l~ 678 (785)
||+ +++|.+++.. ....+++..+..++.|++.||+|||++|||||||||+|||++. ++.+||+|||+|+.+.
T Consensus 81 e~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 81 DLL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp ECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred Eec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 999 6799888863 3457899999999999999999999999999999999999974 5789999999998865
Q ss_pred CCCC-------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcCCC---
Q 003935 679 DSPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL---PERVVYAVANEGSR--- 745 (785)
Q Consensus 679 ~~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~---~~~~v~~i~~~~~~--- 745 (785)
.... .....+||+.|+|||++.+..++.++|||||||++|||+||+.||.+.. .......+......
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 4311 2235679999999999999999999999999999999999999997543 22333332221111
Q ss_pred ----CCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003935 746 ----LEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 781 (785)
Q Consensus 746 ----~~ip~~~L~~LI~~CL~-DP~kRPS~~EIL~~L~~l~ 781 (785)
..+ +..+.+++..||. +|.+||+++.+.+.|+++.
T Consensus 238 ~~l~~~~-p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 238 RELCAGF-PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HHHTTTS-CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHhcCCC-CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 112 2468999999999 9999999999988887653
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.3e-37 Score=327.02 Aligned_cols=244 Identities=20% Similarity=0.308 Sum_probs=187.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEE--CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-----------CCceeeEeccc
Q 003935 527 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-----------HPNVILFLGAC 593 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-----------HPNIVkL~g~~ 593 (785)
.+|+++++||+|+||+||+|++ +|+.||||++.+.. ...+.+.+|+.+++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 3599999999999999999987 58999999996543 23456788999888875 57899999887
Q ss_pred cC--CCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh-cccccccCCCCcEEEcCCC------
Q 003935 594 TK--PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHW------ 664 (785)
Q Consensus 594 ~d--~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs-~gIIHrDLKpsNILLd~~g------ 664 (785)
.. ....+++++++..+..............+++..++.++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 54 34566777777665544444444466788999999999999999999998 8999999999999998655
Q ss_pred eEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHH
Q 003935 665 TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE------RVVYA 738 (785)
Q Consensus 665 ~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvILyELLTG~~PF~~~~~~------~~v~~ 738 (785)
.++++|||.+...... ....+||+.|+|||++.+..++.++||||+||++++|++|+.||...... .....
T Consensus 170 ~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 4999999999876432 34678999999999999999999999999999999999999999754321 11111
Q ss_pred HHh-cC---------------------CCCC------------------CC---ChHHHHHHHHhhh-CCCCCCCHHHHH
Q 003935 739 VAN-EG---------------------SRLE------------------IP---EGPLGRLIADCWA-EPQERPSCEEIL 774 (785)
Q Consensus 739 i~~-~~---------------------~~~~------------------ip---~~~L~~LI~~CL~-DP~kRPS~~EIL 774 (785)
... -+ .... .+ ...+.+|+.+|+. ||.+|||++|+|
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 100 00 0000 00 1247789999999 999999999999
Q ss_pred HH
Q 003935 775 SR 776 (785)
Q Consensus 775 ~~ 776 (785)
+|
T Consensus 327 ~H 328 (362)
T d1q8ya_ 327 NH 328 (362)
T ss_dssp TC
T ss_pred cC
Confidence 86
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=6e-23 Score=201.47 Aligned_cols=165 Identities=19% Similarity=0.171 Sum_probs=121.7
Q ss_pred eeEeeEEeeeCcEEEEEEEE-CCeEEEEEEeeccccC----------------hHHHHHHHHHHHHHhhcCCCceeeEec
Q 003935 529 LTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLT----------------AENMEDFCNEISILSRLRHPNVILFLG 591 (785)
Q Consensus 529 y~i~k~LG~G~fG~VYkg~~-~g~~VAVKil~~~~~~----------------~~~~e~f~~EI~iLk~L~HPNIVkL~g 591 (785)
+.++++||+|+||+||+|.+ +|+.||||++...... ......+..|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46899999999999999987 6899999987532110 111234567889999999999998876
Q ss_pred cccCCCceeEEEEEcccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHhcccccccCCCCcEEEcCCCeEEEEec
Q 003935 592 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 671 (785)
Q Consensus 592 ~~~d~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DF 671 (785)
+.. .+++|||+++..+.+ ++...+..++.|++.+|+|||++||+||||||+|||++++ .++|+||
T Consensus 82 ~~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred ecC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence 532 379999999866543 3344456799999999999999999999999999999965 5899999
Q ss_pred CccccccCCCCCCCCCCCCCcccCc------cccccCCCCchhhHHHHHHHH
Q 003935 672 GLSRIITDSPMRDSSSAGTPEWMAP------ELIRNEPFTEKCDIFSLGVIM 717 (785)
Q Consensus 672 GLA~~l~~~~~~~~~~~GT~~Y~AP------Evl~~~~~s~ksDVWSLGvIL 717 (785)
|+|.....+.. ..|... +.+ .+.|+.++|+||+.--+
T Consensus 147 G~a~~~~~~~~--------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGW--------REILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTH--------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCc--------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 99976543211 112211 111 34578889999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.21 E-value=1.4e-06 Score=86.23 Aligned_cols=140 Identities=12% Similarity=0.019 Sum_probs=88.6
Q ss_pred CCeeEeeEEeeeCcEEEEEEEECCeEEEEEEeeccccChHHHHHHHHHHHHHhhcC-CCceeeEeccccCCCceeEEEEE
Q 003935 527 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEY 605 (785)
Q Consensus 527 s~y~i~k~LG~G~fG~VYkg~~~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~-HPNIVkL~g~~~d~~~l~LV~Ey 605 (785)
+.|.+.+..+-++.+.||+...+++.++||+....... ....+..|...+..+. +--+-+++.++..++..++||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 45565555443445789999888888999987544321 1234567888877664 21234556666677888999999
Q ss_pred cccchhhHHHHhhcccccchHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 003935 606 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR---------------------------------------- 645 (785)
Q Consensus 606 ~~gGSL~dlL~~~~~~~~Ls~~~~l~Ia~QIa~AL~yLHs---------------------------------------- 645 (785)
++|.++...... . .....++.+++..++.||+
T Consensus 92 l~G~~~~~~~~~---~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 92 ADGVLCSEEYED---E-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHTTT---C-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred cccccccccccc---c-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 999877543210 0 0011122333333333332
Q ss_pred -------------------cccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 646 -------------------MKIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 646 -------------------~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
..++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1269999999999999876667999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.57 E-value=0.00011 Score=72.00 Aligned_cols=138 Identities=17% Similarity=0.106 Sum_probs=80.9
Q ss_pred EEeeeCc-EEEEEEEEC-CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCC--ceeeEeccccCCCceeEEEEEcccc
Q 003935 534 RVGIGFF-GEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHP--NVILFLGACTKPPRLSMITEYMELG 609 (785)
Q Consensus 534 ~LG~G~f-G~VYkg~~~-g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HP--NIVkL~g~~~d~~~l~LV~Ey~~gG 609 (785)
.+..|.. +.||+...+ +..+++|.-..... ..+..|+..++.+... .+.+++.++.+++..+++|++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 4445554 679998775 55688887543322 2356788887776432 2455677777778899999999986
Q ss_pred hhhH--------------HHHhhc----ccccc--hHHHHHH-----H---------------HHHHHHHHHHHHhc---
Q 003935 610 SLYH--------------LIHLSG----QKKKL--SWRRKLK-----M---------------LRDICRGLMCIHRM--- 646 (785)
Q Consensus 610 SL~d--------------lL~~~~----~~~~L--s~~~~l~-----I---------------a~QIa~AL~yLHs~--- 646 (785)
++.. .+.... ....+ ....... + .......+..+...
T Consensus 92 ~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (255)
T d1nd4a_ 92 DLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD 171 (255)
T ss_dssp ETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred ccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCc
Confidence 6532 111100 00000 0000000 0 00122223333332
Q ss_pred ----ccccccCCCCcEEEcCCCeEEEEecCcccc
Q 003935 647 ----KIVHRDLKSANCLVNKHWTVKICDFGLSRI 676 (785)
Q Consensus 647 ----gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 676 (785)
.++|+|+.+.|||++++..+-|+||+.+..
T Consensus 172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp SCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 379999999999999876678999998754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.20 E-value=0.00026 Score=75.21 Aligned_cols=76 Identities=17% Similarity=0.051 Sum_probs=46.9
Q ss_pred eeEEeeeCcEEEEEEEE--CCeEEEEEEeecc------ccChHHHHHHHHHHHHHhhcC-C--CceeeEeccccCCCcee
Q 003935 532 GTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQ------DLTAENMEDFCNEISILSRLR-H--PNVILFLGACTKPPRLS 600 (785)
Q Consensus 532 ~k~LG~G~fG~VYkg~~--~g~~VAVKil~~~------~~~~~~~e~f~~EI~iLk~L~-H--PNIVkL~g~~~d~~~l~ 600 (785)
.+.||.|....||++.. .++.++||.-... ... ........|++.|+.+. + ..+.+++.+ +....+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~-~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~ 107 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWP-LTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 107 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCC-CCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCC-CCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCE
Confidence 45789999999999965 3668889964321 111 11233456888877663 2 234455554 344568
Q ss_pred EEEEEcccch
Q 003935 601 MITEYMELGS 610 (785)
Q Consensus 601 LV~Ey~~gGS 610 (785)
+|||++.+..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 9999998644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.67 E-value=0.0024 Score=65.54 Aligned_cols=70 Identities=11% Similarity=0.089 Sum_probs=43.9
Q ss_pred eCcEEEEEEEE-CCeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCc-----eeeEec--cccCCCceeEEEEEcccc
Q 003935 538 GFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN-----VILFLG--ACTKPPRLSMITEYMELG 609 (785)
Q Consensus 538 G~fG~VYkg~~-~g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPN-----IVkL~g--~~~d~~~l~LV~Ey~~gG 609 (785)
+--..||++.. +|+.|++|+........ +++..|...+..|...+ .+..-+ .+...+..+.+++++.|.
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 33468999976 68889999976554433 55667888877764222 112111 123345578899998864
Q ss_pred h
Q 003935 610 S 610 (785)
Q Consensus 610 S 610 (785)
.
T Consensus 110 ~ 110 (325)
T d1zyla1 110 Q 110 (325)
T ss_dssp E
T ss_pred C
Confidence 3
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.53 E-value=0.0058 Score=61.56 Aligned_cols=30 Identities=20% Similarity=0.223 Sum_probs=27.1
Q ss_pred cccccccCCCCcEEEcCCCeEEEEecCccc
Q 003935 646 MKIVHRDLKSANCLVNKHWTVKICDFGLSR 675 (785)
Q Consensus 646 ~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 675 (785)
.|+||+|+.++||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777899999885
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.06 E-value=0.007 Score=63.49 Aligned_cols=77 Identities=18% Similarity=0.300 Sum_probs=50.9
Q ss_pred CCCeeEeeEEeeeCcEEEEEEEEC---------CeEEEEEEeeccccChHHHHHHHHHHHHHhhcCCCce-eeEeccccC
Q 003935 526 FSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTK 595 (785)
Q Consensus 526 ~s~y~i~k~LG~G~fG~VYkg~~~---------g~~VAVKil~~~~~~~~~~e~f~~EI~iLk~L~HPNI-VkL~g~~~d 595 (785)
.+++.+ ++|+.|-.-.+|++... ...|.+++.... .. .....+|..+++.+.-.++ .++++++.+
T Consensus 42 ~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 42 LEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp GGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred ccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence 345554 67888999999999763 245777776422 11 2345578888888853344 366777653
Q ss_pred CCceeEEEEEcccchh
Q 003935 596 PPRLSMITEYMELGSL 611 (785)
Q Consensus 596 ~~~l~LV~Ey~~gGSL 611 (785)
.+|+||++|.++
T Consensus 117 ----g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ----GRLEEYIPSRPL 128 (395)
T ss_dssp ----EEEECCCCEEEC
T ss_pred ----ceEEEEeccccC
Confidence 689999987554
|
| >d1g83a2 d.93.1.1 (A:142-245) Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine kinase Fyn species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.48 E-value=0.00074 Score=58.56 Aligned_cols=57 Identities=14% Similarity=0.240 Sum_probs=49.0
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|++|+..|+..++.+|+|++|.|+ +..+.+.+|+...+...+++..|+.+.+.
T Consensus 11 g~i~R~eAe~~L~~~g~~~G~FLVR~S~----~~~g~~~Lsv~~~~~~~~~~v~h~~i~~~ 67 (104)
T d1g83a2 11 GKLGRKDAERQLLSFGNPRGTFLIRESE----TTKGAYSLSIRDWDDMKGDHVKHYKIRKL 67 (104)
T ss_dssp TTCCHHHHHHHHHSTTCCTTCEEEEECS----SSTTCEEEEEEEECSSSCEEEEEEEEEEC
T ss_pred CCCCHHHHHHHHHhcCCCCCcEEEeccC----CCCCCeEEEEEEeecCcCCeEEEEEEEEc
Confidence 5689999999999999999999999997 66788899998877777788888876653
|
| >d1qcfa2 d.93.1.1 (A:146-248) Hemopoetic cell kinase Hck {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Hemopoetic cell kinase Hck species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.09 E-value=0.00088 Score=57.99 Aligned_cols=57 Identities=12% Similarity=0.173 Sum_probs=47.0
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.+|+..|+..++.||+|++|.|+ +.++.+.+++...+...+++..|+.+.+.
T Consensus 6 g~isR~eAe~~L~~~~~~~G~FLVR~S~----~~~g~~~Lsv~~~~~~~~~~v~H~~i~~~ 62 (103)
T d1qcfa2 6 KGISRKDAERQLLAPGNMLGSFMIRDSE----TTKGSYSLSVRDYDPRQGDTVKHYKIRTL 62 (103)
T ss_dssp TTCCHHHHHHHHHSTTCCTTCEEEEECS----SSTTSEEEEEEEEETTTEEEEEEEEEEEC
T ss_pred CCCCHHHHHHHHhhcCCCCCcEEEEccC----CCCCCeEEEEEecCCCcCceEEEEEEEEc
Confidence 5689999999999999999999999998 77788888887655555667777776654
|
| >d1blja_ d.93.1.1 (A:) P55 Blk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: P55 Blk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=95.03 E-value=0.0029 Score=55.69 Aligned_cols=57 Identities=14% Similarity=0.178 Sum_probs=45.6
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
.+.|+|.+|+++|+..++.||+|++|.|+ +.++.+.+++.... ..+....|+.+.+.
T Consensus 16 ~g~isR~eAe~~L~~~~~~~G~FLVR~S~----~~~g~~~Lsv~~~~-~~~~~v~H~~i~~~ 72 (114)
T d1blja_ 16 FRTISRKDAERQLLAPMNKAGSFLIRESE----SNKGAFSLSVKDIT-TQGEVVKHYKIRSL 72 (114)
T ss_dssp CCSCCHHHHHHHHSSTTCCTTCEEBCBCT----TCSSCEEEEECBCC-TTTCBCCCEEEEEE
T ss_pred CCCCCHHHHHHHHHhcCCCCceEEEeccC----CCCCCeEEEEEeec-cCCCEEEEEEEEEc
Confidence 35789999999999999999999999997 67888888887632 23456777777654
|
| >d1lkka_ d.93.1.1 (A:) p56-lck tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: p56-lck tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.96 E-value=0.00098 Score=57.94 Aligned_cols=57 Identities=11% Similarity=0.180 Sum_probs=46.5
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.+|+..|+..++.||+|++|.|+ +.++.+.+++...+...+.+..|+.+.+.
T Consensus 9 g~isR~eAe~~L~~~~~~~GtFLVR~S~----~~~g~~~lsv~~~~~~~~~~v~h~~i~~~ 65 (105)
T d1lkka_ 9 KNLSRKDAERQLLAPGNTHGSFLIRESE----STAGSFSLSVRDFDQNQGEVVKHYKIRNL 65 (105)
T ss_dssp TTCCHHHHHHHHTSTTCCTTCEEEEECS----SSTTCEEEEEEEEETTTEEEEEEEEEEEC
T ss_pred CCCCHHHHHHHHHhcCCCCCcEEEEccC----CCCCCEEEEEEEcccCCCccEEEEEEEEc
Confidence 5789999999999999999999999998 67788888887755555566677766543
|
| >d1rjaa_ d.93.1.1 (A:) Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.56 E-value=0.0033 Score=54.19 Aligned_cols=52 Identities=13% Similarity=0.163 Sum_probs=43.8
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.+|++.|+..++.||+|++|.|+ +..+.+.+|+.. +++..|+.+.+.
T Consensus 7 g~isR~~Ae~~L~~~~~~~G~FLvR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 58 (100)
T d1rjaa_ 7 GCISRSEAVRRLQAEGNATGAFLIRVSE----KPSADYVLSVRD-----TQAVRHYKIWRR 58 (100)
T ss_dssp TTCCHHHHHHHHSSTTCSSCCEEEEECS----SSSSCEEEEECT-----TSSCEEEEEEEC
T ss_pred CCCCHHHHHHHHhccCCCCCeEEeecCC----CCCCCEEEEEEc-----CCCceEEEEEEC
Confidence 5689999999999999999999999997 667788889876 457888887764
|
| >d1o48a_ d.93.1.1 (A:) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.17 E-value=0.0015 Score=56.90 Aligned_cols=57 Identities=14% Similarity=0.195 Sum_probs=46.0
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|++|++.|+..++.||+|++|.|+ +..+.+.+|+...+...+.+..|+.+.+.
T Consensus 10 g~i~R~eAe~lL~~~~~~~G~FLVR~S~----~~~g~y~LSv~~~~~~~~~~i~h~~i~~~ 66 (106)
T d1o48a_ 10 GKITRRESERLLLNAENPRGTFLVRESE----TTKGAYCLSVSDFDNAKGLNVKHYKIRKL 66 (106)
T ss_dssp ESCCHHHHHHHHCCTTCCTTCEEEEECS----SSTTCEEEEEEEEETTTEEEEEEEEEEEC
T ss_pred CCCCHHHHHHHHHhcCCCCCcEEEEccc----CCCCCEEEEEEecccCcccceEEEEEEEe
Confidence 4689999999999999999999999997 67778888887766555566667766553
|
| >d1nrva_ d.93.1.1 (A:) Growth factor receptor-bound protein 10, GRB10 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 10, GRB10 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.04 E-value=0.0077 Score=52.07 Aligned_cols=52 Identities=10% Similarity=-0.005 Sum_probs=42.2
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.+|++.|...+..||+|++|.|+ +..+.+.+|+.. ++...|+.+.+.
T Consensus 10 g~isR~~Ae~lL~~~g~~dG~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 61 (105)
T d1nrva_ 10 GRISREESHRIIKQQGLVDGLFLLRDSQ----SNPKAFVLTLCH-----HQKIKNFQILPC 61 (105)
T ss_dssp TTCCHHHHHHHHHHTTCCTTEEEEEECS----SCTTCEEEEEEE-----TTEEEEEEEEEC
T ss_pred CCCCHHHHHHHHhhcCCCCceEEEEeCC----CCCCCEEEEEEE-----CCceeEEEEEEe
Confidence 5689999999999999999999999997 455678888875 456778877654
|
| >d1a81a1 d.93.1.1 (A:9-137) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Syk tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.48 E-value=0.0062 Score=55.09 Aligned_cols=52 Identities=12% Similarity=0.173 Sum_probs=44.1
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.+|+..|+..|..||+|++|.|+ +.++.+.+|+.. +++.+|+.+.+.
T Consensus 10 g~isR~~Ae~lL~~~g~~dG~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 61 (129)
T d1a81a1 10 GNITREEAEDYLVQGGMSDGLYLLRQSR----NYLGGFALSVAH-----GRKAHHYTIERE 61 (129)
T ss_dssp SSCCHHHHHHHHHHTTCCTTEEEEEECS----SSTTCEEEEEEE-----TTEEEEEEEEEC
T ss_pred CCCCHHHHHHHHHhcCCCCccEEEEccC----CCCcceEEEeee-----cccceEEEEEEc
Confidence 4689999999999999999999999998 567788888875 467888888764
|
| >d2qmsa1 d.93.1.1 (A:420-532) Growth factor receptor-bound protein 7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.80 E-value=0.017 Score=50.63 Aligned_cols=52 Identities=12% Similarity=-0.012 Sum_probs=42.1
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.+|++.|+..|..||+|++|.|+ ...+.+.+|+.. +++..|+.+...
T Consensus 15 g~isR~~Ae~lL~~~g~~dG~FLvR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 66 (113)
T d2qmsa1 15 GRISREESQRLIGQQGLVDGLFLVRESQ----RNPQGFVLSLCH-----LQKVKHYLILPS 66 (113)
T ss_dssp EEBCHHHHHHHHHHTTCCTTEEEEEECS----SCTTCEEEEEEE-----TTEEEEEEEEEE
T ss_pred CCCCHHHHHHHHhccCCCCccEEEEecc----CCCCCEEEEEEe-----CCeEEEEEEEEe
Confidence 4689999999999999999999999998 455668888864 456788877653
|
| >d2oq1a1 d.93.1.1 (A:5-134) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase zap-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.48 E-value=0.016 Score=52.26 Aligned_cols=52 Identities=12% Similarity=0.024 Sum_probs=43.5
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.+|+..|+..|+.+|+|++|.|+ +..+.|.+|+.. +++..|+.+.+.
T Consensus 11 g~i~R~~Ae~~L~~~g~~~G~FLVR~S~----~~~g~yvLSv~~-----~~~v~H~~I~~~ 62 (130)
T d2oq1a1 11 GSISRAEAEEHLKLAGMADGLFLLRQCL----RSLGGYVLSLVH-----DVRFHHFPIERQ 62 (130)
T ss_dssp BSCCHHHHHHHHHHTTCCTTCEEEEECS----SSTTCEEEEEEE-----TTEEEEEEEEEC
T ss_pred CCCCHHHHHHHHHhcCCCCceEEEEecC----CCCccEEEEEee-----CCceEEEEEEEc
Confidence 4688999999999999999999999997 667778888875 457888888653
|
| >d1i3za_ d.93.1.1 (A:) Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Ews/fli1 activated transcript 2, Eat2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=90.78 E-value=0.015 Score=50.02 Aligned_cols=51 Identities=16% Similarity=0.144 Sum_probs=39.8
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|..||..|++. +.||+|++|+|+ +..+.+.+|+.. +++..|+.+.+.
T Consensus 8 g~isR~~AE~lL~~~-~~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~~ 58 (103)
T d1i3za_ 8 GCLTKRECEALLLKG-GVDGNFLIRDSE----SVPGALCLCVSF-----KKLVYSYRIFRE 58 (103)
T ss_dssp SSCCHHHHHHHHHTT-CSTTEEEEEECS----SSTTCEEEEEEC-----SSSEEEEEEEEC
T ss_pred CCCCHHHHHHHHHhC-CCCCeEEEEecC----CCCCCEEEEEEe-----CCeEEEEEeEEc
Confidence 458899999777554 589999999997 556778888886 456888888764
|
| >d1rpya_ d.93.1.1 (A:) Adaptor protein Aps {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Adaptor protein Aps species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=90.54 E-value=0.014 Score=48.44 Aligned_cols=52 Identities=10% Similarity=0.123 Sum_probs=40.1
Q ss_pred HHHHHHHHHhhhhhhc-CCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQER-GEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|..++..|++.+ ..||+|++|.|+ ...+.+.+++.. .++..|+.+.+.
T Consensus 10 g~isR~~Ae~lL~~~~~~~dG~FLvR~S~----~~~g~~~Lsv~~-----~~~v~h~~I~~~ 62 (86)
T d1rpya_ 10 GTLSRVKAAQLVLAGGPRSHGLFVIRQSE----TRPGECVLTFNF-----QGKAKHLRLSLN 62 (86)
T ss_dssp TTCCHHHHHHHHHTTGGGGTTCEEEEECS----SSTTCEEEEEEE-----TTEEEEEEC---
T ss_pred CCCCHHHHHHHHHhCCCCCCceEEEEecC----CCCCcEEEEEEE-----CCceEEEEEEEc
Confidence 5789999999999887 489999999997 566778888875 356778877654
|
| >d1r1qa_ d.93.1.1 (A:) GRB2-related adaptor protein 2 (MONA, GRID) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: GRB2-related adaptor protein 2 (MONA, GRID) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=89.45 E-value=0.03 Score=47.68 Aligned_cols=50 Identities=10% Similarity=0.137 Sum_probs=40.1
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|..|++.|. +..+|+|++|.|+ +.++.+.+|+.. .++.+|+.+.+.
T Consensus 11 g~isR~~Ae~lL~--~~~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~~ 60 (97)
T d1r1qa_ 11 EGLSRHQAENLLM--GKDIGFFIIRASQ----SSPGDFSISVRH-----EDDVQHFKVMRD 60 (97)
T ss_dssp TTCCHHHHHHHHH--TSCTTCEEEEECS----SSTTCEEEEEEC-----SSSEEEEECEEC
T ss_pred CCCCHHHHHHHHh--cCCCCCEEEeecC----CCCCCEEEEEEe-----cCCeEEEEEEEc
Confidence 5789999998886 4679999999997 667778888876 346788887764
|
| >d1jyra_ d.93.1.1 (A:) Growth factor receptor-bound protein 2 (GRB2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 2 (GRB2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.44 E-value=0.018 Score=49.12 Aligned_cols=51 Identities=12% Similarity=0.196 Sum_probs=40.0
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.+|+..|++. +.+|+|++|.|+ +.++.+.+|+.. +++.+|+.+.++
T Consensus 8 g~isR~~Ae~lL~~~-~~~G~FLvR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~~ 58 (96)
T d1jyra_ 8 GKIPRAKAEEMLSKQ-RHDGAFLIRESE----SAPGDFSLSVKF-----GNDVQHFKVLRD 58 (96)
T ss_dssp CSCCHHHHHHHHHTC-CSTTBEEEEECS----SSTTCEEEEEEE-----TTEEEEEECEEC
T ss_pred CCCCHHHHHHHHhhC-CCCCeEEEEecC----CCCCCEEEEEEe-----CCceEEEEEEEC
Confidence 468999999988664 479999999997 566778888876 456788887664
|
| >d1a81a2 d.93.1.1 (A:138-262) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Syk tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.15 E-value=0.049 Score=48.49 Aligned_cols=52 Identities=15% Similarity=0.234 Sum_probs=42.3
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
.+.|+|.+|+..|+..+..+|+|++|.|++ .+.+.+|+.. +++..|+.+.+.
T Consensus 33 hg~isR~~Ae~lL~~~g~~~G~FLVR~S~~-----~~~yvLSv~~-----~~~v~H~~I~~~ 84 (125)
T d1a81a2 33 HGKISREESEQIVLIGSKTNGKFLIRARDN-----NGSYALCLLH-----EGKVLHYRIDKD 84 (125)
T ss_dssp EEECCHHHHHHHHHSSCCCTTCEEEEECSS-----SSCEEEEEEE-----TTEEEEEEEEEC
T ss_pred CCCCCHHHHHHHHHhcCCCCceEEEEecCC-----CCCEEEEeec-----cccceeEeeeEc
Confidence 467899999999999999999999998862 4667788765 457888888764
|
| >d2oq1a2 d.93.1.1 (A:135-258) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase zap-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.89 E-value=0.027 Score=50.20 Aligned_cols=52 Identities=15% Similarity=0.171 Sum_probs=42.7
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
.+.|+|.+|+..|+..+..||+|++|.++ + .+.|.+|+.. +++..|+.+.+.
T Consensus 33 hg~isR~eAe~lL~~~~~~dGtFLVR~S~----~-~g~yvLSv~~-----~~~v~H~~I~~~ 84 (124)
T d2oq1a2 33 HSSLTREEAERKLYSGAQTDGKFLLRPRK----E-QGTYALSLIY-----GKTVYHYLISQD 84 (124)
T ss_dssp CSSCCHHHHHHHHHSSCCCTTEEEEEECS----S-TTEEEEEEEE-----TTEEEEEEEEEC
T ss_pred cCCCCHHHHHHHHhhcCCCCceEEeEecC----C-CCCEEEEeec-----CCceEEEEEEEC
Confidence 46789999999999999999999999996 2 4668888875 456888888664
|
| >d1d4ta_ d.93.1.1 (A:) The Xlp protein Sap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: The Xlp protein Sap species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.88 E-value=0.036 Score=47.19 Aligned_cols=51 Identities=14% Similarity=0.141 Sum_probs=38.3
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.+|+..|++.+ .||+|++|.|+ ...+.+.+++... ++..|+.+.+.
T Consensus 9 G~isR~eAe~lL~~~~-~~G~FLVR~S~----~~~g~~~Lsv~~~-----~~v~H~~I~~~ 59 (104)
T d1d4ta_ 9 GKISRETGEKLLLATG-LDGSYLLRDSE----SVPGVYCLCVLYH-----GYIYTYRVSQT 59 (104)
T ss_dssp CSCCHHHHHHHHHHHC-CTTEEEEEECS----SSTTCEEEEEEET-----TEEEEEEEEEC
T ss_pred cCCCHHHHHHHHhhCC-CCCeEEEEecC----CCCCCEEEEEecC-----CCceEEEEEEc
Confidence 4689999999887765 67999999997 4456677777652 35677777664
|
| >d2shpa2 d.93.1.1 (A:2-110) Tyrosine phoshatase shp-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine phoshatase shp-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.79 E-value=0.038 Score=47.91 Aligned_cols=51 Identities=12% Similarity=0.147 Sum_probs=39.9
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.+|+..|++.+ .+|+|++|+|+ +..+.+.+|+.. .++..|+.+...
T Consensus 8 g~isR~~Ae~lL~~~~-~~G~FLvR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 58 (109)
T d2shpa2 8 PNITGVEAENLLLTRG-VDGSFLARPSK----SNPGDLTLSVRR-----NGAVTHIKIQNT 58 (109)
T ss_dssp SSCCHHHHHHHHHHHC-CTTEEEEEECS----SSTTCEEEEEEE-----TTEEEEEEEECS
T ss_pred CCCCHHHHHHHHhhCC-CCCeEEEEecC----CCCCCEEEEEEe-----CCcEEEEEEEEc
Confidence 4689999999987765 58999999997 566778888875 456788877653
|
| >d1xa6a2 d.93.1.1 (A:21-161) Beta-chimaerin, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Beta-chimaerin, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.15 E-value=0.073 Score=48.51 Aligned_cols=50 Identities=14% Similarity=0.181 Sum_probs=39.2
Q ss_pred HHHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 401 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 401 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
.+.|+|.++++.|. +.||+|++|.|+ +..+.+.+|+.. +++..|+.+.++
T Consensus 39 hG~isR~eAe~lL~---~~dGsFLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 88 (141)
T d1xa6a2 39 HGIISREQADELLG---GVEGAYILRESQ----RQPGCYTLALRF-----GNQTLNYRLFHD 88 (141)
T ss_dssp EEECCHHHHHHHHC---SCTTBEEEEECS----SSTTCEEEEEEE-----TTEEEECCCEES
T ss_pred eccCCHHHHHHHHc---CCCCeEEEEecC----CCCCCEEEEEEE-----CCEEEEEEEEEC
Confidence 45789999998774 357999999997 567778888876 456888887664
|
| >d1luia_ d.93.1.1 (A:) Itk/tsk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Itk/tsk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=84.42 E-value=0.094 Score=45.17 Aligned_cols=54 Identities=13% Similarity=0.169 Sum_probs=38.8
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCccc-CCCcccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEIS-GGRSALYNLSR 461 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~-~~rs~~~~l~r 461 (785)
+.|+|.+|+..|++.+ .+|+|++|+|+ + .+.|.+|+....... ++..+|+.+.+
T Consensus 11 g~isR~eAe~lL~~~~-~~G~FLVR~S~----~-~g~y~LSv~~~~~~~~~~~i~h~~I~~ 65 (108)
T d1luia_ 11 KSISRDKAEKLLLDTG-KEGAFMVRDSR----T-PGTYTVSVFTKAIISENPCIKHYHIKE 65 (108)
T ss_dssp TTCCHHHHHHHHHHHC-CTTEEEEEECC----T-TTCEEEEEECSCCTTTCSCEEEEECEE
T ss_pred CCCCHHHHHHHHHhcC-CCCeEEEEecC----C-CCCEEEEEEecCCcccCCceeEEEEEE
Confidence 5689999998887665 78999999986 3 466888887655443 33455666654
|
| >d1jwoa_ d.93.1.1 (A:) Csk homologous kinase Chk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Csk homologous kinase Chk species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.65 E-value=0.065 Score=45.38 Aligned_cols=50 Identities=12% Similarity=0.072 Sum_probs=38.2
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|.|.+|+..|. +..||+|++|+|+ +..+.+.+|+.. +++.+|+.+.+.
T Consensus 9 g~isR~eAe~~L~--~~~~G~FLVR~S~----~~~g~~vLSv~~-----~~~v~H~~I~~~ 58 (97)
T d1jwoa_ 9 GKISGQEAVQQLQ--PPEDGLFLVRESA----RHPGDYVLCVSF-----GRDVIHYRVLHR 58 (97)
T ss_dssp ESCCHHHHHHHTC--SCCTTCEEEEECS----SSTTCEEEEEEE-----TTEEEEEEEEES
T ss_pred CCCCHHHHHHHhc--CCCCCeEEEEecC----CCCccEEEEEEe-----cCceEEEEEEEc
Confidence 4578999999885 4669999999997 556678888775 356788887553
|
| >d2c9wa2 d.93.1.1 (A:32-134) Suppressor of cytokine signaling 2, SOCS-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Suppressor of cytokine signaling 2, SOCS-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.77 E-value=0.094 Score=44.58 Aligned_cols=50 Identities=8% Similarity=0.093 Sum_probs=37.3
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|++++..|. +..+|+|++|.|+ ..++.+.+|+.. .+...|+.+.+.
T Consensus 20 g~i~R~~Ae~~L~--~~~~GtFLVR~S~----~~~~~~~LSv~~-----~~~v~H~~I~~~ 69 (103)
T d2c9wa2 20 GSMTVNEAKEKLK--EAPEGTFLIRDSS----HSDYLLTISVKT-----SAGPTNLRIEYQ 69 (103)
T ss_dssp TTCCHHHHHHHHT--TSCTTCEEEEECC----STTCSEEEEEEE-----TTEEEEEEEEEE
T ss_pred CCCCHHHHHHHhc--CCCCCceEEeccC----CCCCCEEEEEEE-----CCEEEEEEEEEc
Confidence 5679999998885 5679999999997 456667777765 245667766543
|
| >d1k9aa2 d.93.1.1 (A:77-177) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.57 E-value=0.081 Score=45.14 Aligned_cols=50 Identities=10% Similarity=0.102 Sum_probs=38.4
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.+|+..|.. ..+|+|++|.|+ ...+.|.+|+.. .++.+|+.+.+.
T Consensus 9 g~isR~~Ae~lL~~--~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 58 (101)
T d1k9aa2 9 GKITREQAERLLYP--PETGLFLVREST----NYPGDYTLCVSC-----EGKVEHYRIMYH 58 (101)
T ss_dssp TTCCHHHHHHHTCS--CCTTEEEEEECS----SSTTSEEEEEEC-----SSSEEEEEEEEE
T ss_pred CCCCHHHHHHHHcC--CCCCCEEEeccC----CCCCCEEEEEEe-----CCccEEEEEEEc
Confidence 56899999988764 358999999987 555668888875 356888887654
|
| >d2eyva1 d.93.1.1 (A:12-120) Crk proto-oncogen {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Crk proto-oncogen species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.61 E-value=0.29 Score=41.51 Aligned_cols=50 Identities=8% Similarity=0.070 Sum_probs=38.1
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|+|.+|+..|. +..+|+|++|.|+ ...+.+.+|+.. .++..|+.+.+.
T Consensus 5 g~isR~~Ae~lL~--~~~~G~FLVR~S~----~~~~~~~LS~~~-----~~~v~H~~I~~~ 54 (109)
T d2eyva1 5 GRLSRQEAVALLQ--GQRHGVFLVRDSS----TSPGDYVLSVSE-----NSRVSHYIINSS 54 (109)
T ss_dssp BCCCHHHHHHHCS--SCSTTCEEEECCC----SSSSCEEEEEEE-----TTEEEEEEEECC
T ss_pred CCCCHHHHHHHhc--CCCCCeEEeeecC----CCCCCEEEEEEE-----CCEEEEEEEEEc
Confidence 4588999999774 4679999999997 445667778764 356788887775
|
| >d2izva2 d.93.1.1 (A:274-385) Suppressor of cytokine signaling 4, SOCS-4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Suppressor of cytokine signaling 4, SOCS-4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.46 E-value=0.075 Score=46.15 Aligned_cols=50 Identities=10% Similarity=-0.001 Sum_probs=38.5
Q ss_pred HHHHHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCcccCCCCCCcccCCCccccccccc
Q 003935 402 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 462 (785)
Q Consensus 402 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~k~~~~~s~~~~d~~~~~rs~~~~l~r~ 462 (785)
+.|.|..|+..|. +..+|+|++|.|+ ..++.+.+|+.. .++.+|+.+.+.
T Consensus 16 g~isR~~Ae~lL~--~~~~GtFLVR~S~----~~~~~~~LSv~~-----~~~v~H~~I~~~ 65 (112)
T d2izva2 16 GVMDKYAAEALLE--GKPEGTFLLRDSA----QEDYLFSVSFRR-----YSRSLHARIEQW 65 (112)
T ss_dssp EECCHHHHHHHHT--TCCTTEEEEEECS----STTCSEEEEEEE-----TTEEEEEECEEE
T ss_pred CCCCHHHHHHHHc--cCCCCcEEEeecC----CCCCCeEEEEEe-----cCCceEEEEEEe
Confidence 5689999998774 5578999999997 556678888876 346788877664
|